359487751 O

PUOMC O

9075321 O

07676 O

021768 O

12/7/1996 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

ELKSCHIRD O
, O
EBERTA O
R O

UNIT O
NUMBER O
: O

882-95-20 O

ADMISSION O
DATE O
: O

12/07/96 O

DISCHARGE O
DATE O
: O

12/14/96 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

76-year-old O
male O
with O
right B-SYMPTOM
hip I-SYMPTOM
pain I-SYMPTOM
X O
five O
years O
. O

The B-SYMPTOM
pain I-SYMPTOM
is O
often O
severely O
and O
increasing O
at O
night O
especially O
when O
he O
is O
lying O
on O
the O
right O
side O
. O

PAST O
MEDICAL O
HISTORY O
: O

Tonsillectomy B-TREATMENT
. O

History O
of O
high B-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
, O
enlarged B-SYMPTOM
heart I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Zantac B-TREATMENT
. O

Furosemide B-TREATMENT
. O

Aerobid B-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM

PHYSICAL O
EXAMINATION O
: O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
unremarkable O
. O

The O
lungs O
were O
clear O
. O

Heart O
: O

regular O
rate O
and O
rhythm O
. O

The O
abdomen O
was O
soft O
and O
non-tender B-SYMPTOM
. O

Left O
hip O
shows O
flexion O
and O
extension O
40 O
. O

Right O
hip O
flexion O
and O
extension O
40 O
and O
0 O
. O

IMPRESSION O
: O

Right B-SYMPTOM
hip I-SYMPTOM
pain I-SYMPTOM
degenerative B-SYMPTOM
joint I-SYMPTOM
disease I-SYMPTOM
for O
right B-TREATMENT
total I-TREATMENT
hip I-TREATMENT
replacement I-TREATMENT
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
was O
admitted O
to O
the O
hospital O
as O
a O
postoperative O
admit O
on O
December O
7 O
for O
total B-TREATMENT
hip I-TREATMENT
replacement I-TREATMENT
. O

For O
further O
details O
of O
this B-TREATMENT
procedure I-TREATMENT
see O
operative O
note O
. O

Postoperatively O
he O
did O
well O
initially O
in O
the O
first O
12 O
hours O
. O

However O
he O
had O
a O
report O
of O
emesis B-SYMPTOM
of I-SYMPTOM
coffee I-SYMPTOM
grounds I-SYMPTOM
on O
postoperative O
night O
#1 O
. O

This O
with O
no O
electrocardiogram B-SYMPTOM
changes I-SYMPTOM
. O

Due O
to O
this O
GI O
was O
consulted O
and O
felt O
that O
he O
would O
be O
a O
candidate O
for O
esophagogastroduodenoscopy O
. O

He O
was O
placed O
nothing B-TREATMENT
by I-TREATMENT
mouth I-TREATMENT
and O
the O
esophagogastroduodenoscopy O
was O
done O
by O
the O
GI O
Service O
. O

Findings O
showed O
a B-SYMPTOM
Mallory I-SYMPTOM
Weiss I-SYMPTOM
tear I-SYMPTOM
, O
nonspecific B-SYMPTOM
duodenitis I-SYMPTOM
. O

He O
was O
placed O
on O
Zantac B-TREATMENT
150 O
mg. O
PO O
b.i.d. O
and O
H O
Pylori O
serology O
was O
sent O
. O

Post O
EGD O
his O
diet O
was O
advanced O
slowly O
and O
he O
did O
exceptionally O
well O
. O

At O
the O
time O
of O
discharge O
he O
was O
tolerating O
a O
full O
diet O
, O
out O
of O
bed O
with O
pain B-SYMPTOM
, O
tolerated O
on O
po. B-TREATMENT
medications I-TREATMENT
. O

His B-SYMPTOM
wound I-SYMPTOM
was O
intact O
with O
no O
evidence O
of O
infection B-SYMPTOM
. O

Distal O
neurovascular O
status O
was O
intact O
. O

There O
was O
no O
calf B-SYMPTOM
tenderness I-SYMPTOM
and O
lower O
extremity O
arterial O
non-invasive O
studies O
were O
negative O
. O

He O
was O
generally O
well O
in O
all O
regards O
. O

The O
physical O
examination O
was O
unremarkable O
and O
he O
had O
no O
recurrent O
symptoms O
of O
coffee B-SYMPTOM
ground I-SYMPTOM
emesis I-SYMPTOM
. O

He O
was O
doing O
exceptionally O
well O
at O
discharge O
with O
plans O
to O
follow O
up O
with O
Dr. O
Rhalttland O
. O

Discharge O
instructions O
have O
been O
given O
. O

ROYNEO O
WALLA O
, O
M.D. O

DICTATING O
FOR O
: O

LI O
RHALTTLAND O
, O
M.D. O

TR O
: O

hbq O

DD O
: O

12/12/96 O

TD O
: O

12/12/96 O
9:00 O
A O

cc O
: O

LI O
RIJARRED O
RHALTTLAND O
, O
M.D. O
ROYNEO O
MAMAIRE O
WALLA O
, O
M.D. O

Admission O
Date O
: O

2010-08-30 O

Discharge O
Date O
: O

2010-09-06 O

Date O
of O
Birth O
: O

1946-01-08 O

Sex O
: O

M O

Service O
: O

Cardiothoracic O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
64-year-old O
man O
with O
a O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
endocarditis B-SYMPTOM
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
and O
mitral B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
on O
2010-08-13 O
. O

He O
was O
transferred O
to O
Erich O
Lindemann O
Mental O
Health O
Center O
from O
the O
rehabilitation O
center O
where O
he O
had O
been O
discharged O
to O
on O
2010-08-25 O
following O
his B-TREATMENT
CABG/MVR I-TREATMENT
. O

At O
the O
rehabilitation O
center O
the O
patient O
developed O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

A O
chest O
x-ray O
done O
at O
that O
time O
revealed O
a B-SYMPTOM
left-sided I-SYMPTOM
infiltrate I-SYMPTOM
versus O
effusion B-SYMPTOM
. O

He O
was O
transferred O
to O
Mass. O
Eye O
& O
Ear O
Infirmary O
for O
treatment B-TREATMENT
. O

At O
the O
time O
he O
complained O
of O
no O
chest B-SYMPTOM
pain I-SYMPTOM
, O
weakness B-SYMPTOM
or O
cough B-SYMPTOM
, O
although O
he O
is O
intermittently B-SYMPTOM
short I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

He O
had O
been O
anticoagulated B-TREATMENT
during O
his O
stay O
at O
rehabilitation O
for O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Significant O
for O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
status O
post O
CABG/MVR B-TREATMENT
. O

2. O
Endocarditis B-SYMPTOM
. O

3. O
Rectal B-SYMPTOM
cancer I-SYMPTOM
. O

4. O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

ALLERGIES O
: O

The O
patient O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
TRANSFER O
: O

1. O
Amiodarone B-TREATMENT
200 O
mg O
q.d. O

2. O
Lasix B-TREATMENT
20 O
mg O
b.i.d. O

3. O
Potassium B-TREATMENT
chloride I-TREATMENT
20 O
mEq O
b.i.d. O

4. O
Ampicillin B-TREATMENT
2 O
grams O
q. O
4 O
hours O
. O

5. O
Albuterol B-TREATMENT
and O
Atrovent B-TREATMENT
p.r.n. O

6. O
Aspirin B-TREATMENT
325 O
q.d. O

7. O
Coumadin B-TREATMENT
5 O
q.d. O

8. O
Nystatin B-TREATMENT
swish O
and O
swallow O
5 O
cc O
t.i.d. O

9. O
Colace B-TREATMENT
100 O
b.i.d. O

10. O
Percocet B-TREATMENT
5/325 O
, O
1-2 O
tablets O
q. O
4 O
hours O
p.r.n. O

LABORATORY O
DATA O
: O

White O
count O
12.6 O
, O
hematocrit O
28.9 O
, O
platelet O
count O
259 O
, O
PT O
21.4 O
, O
PTT O
40.2 O
, O
INR O
3.0 O
, O
sodium O
137 O
, O
potassium O
4.2 O
, O
chloride O
100 O
, O
CO2 O
27 O
, O
BUN O
26 O
, O
creatinine O
1.3 O
, O
glucose O
120 O
. O

Chest O
x-ray O
shows O
a B-SYMPTOM
large I-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
vital O
signs O
were O
temperature O
100.1 O
, O
heart O
rate O
83 O
and O
sinus O
rhythm O
, O
blood O
pressure O
108/50 O
, O
respiratory O
rate O
25 O
, O
oxygen O
saturation O
97% O
on O
three B-TREATMENT
liters I-TREATMENT
. O

Generally O
he O
was O
a O
pleasant O
man O
with O
mild B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
. O

Lungs O
had O
decreased B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
on O
the O
left O
. O

Cardiac O
examination O
showed O
regular O
rate O
and O
rhythm O
, O
S1 O
and O
S2 O
. O

Chest B-SYMPTOM
incision I-SYMPTOM
was O
with O
Steri-Strips B-TREATMENT
, O
open O
to O
air O
, O
clean O
and O
dry O
. O

Abdomen O
was O
soft O
and O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
with O
positive O
bowel O
sounds O
. O

Extremities O
had O
bilateral B-SYMPTOM
pedal I-SYMPTOM
edema I-SYMPTOM
. O

Right B-SYMPTOM
leg I-SYMPTOM
wound I-SYMPTOM
had O
Steri-Strips B-TREATMENT
, O
open O
to O
air O
, O
clean O
and O
dry O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
Vencor O
Hospital O
. O

He O
was O
given O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
to O
correct O
his O
INR O
and O
a B-TREATMENT
left I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
placed O
. O

Over O
the O
first O
12 O
hours O
the B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
drained O
2,500 O
cc O
. O

On O
hospital O
day O
two O
the O
patient O
was O
transferred O
from O
the O
cardiac O
surgery O
recovery O
unit O
to O
07-02 O
for O
continuing O
care O
. O

He O
remained O
hemodynamically O
stable O
. O

His B-SYMPTOM
chest I-SYMPTOM
tube I-SYMPTOM
drainage I-SYMPTOM
reduced O
significantly O
after O
the O
first O
24 O
hours O
and O
on O
hospital O
day O
three O
his B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
discontinued O
. O

Over O
the O
next O
several O
days O
the O
patient O
remained O
in O
the O
hospital O
to O
reassess O
for O
recurrent B-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

On O
09-02 O
it O
was O
decided O
that O
the O
patient O
was O
stable O
and O
ready O
to O
be O
transferred O
back O
to O
rehabilitation O
, O
however O
case O
management O
was O
unable O
to O
get O
authorization O
from O
the O
patient O
's O
insurance O
company O
and O
he O
remained O
in O
the O
hospital O
throughout O
the O
holiday O
weekend O
awaiting O
insurance O
authorization O
for O
transfer O
back O
to O
rehabilitation O
. O

At O
this O
time O
the O
patient O
's O
physical O
examination O
is O
as O
follows O
: O

Vital O
signs O
were O
temperature O
97.8 O
, O
heart O
rate O
80 O
and O
sinus O
rhythm O
, O
blood O
pressure O
140/82 O
, O
respiratory O
rate O
18 O
, O

O2 O
saturation O
96% O
on O
room O
air O
. O

Weight O
on O
admission O
was O
64 O
kg O
, O
at O
discharge O
was O
51.6 O
kg O
. O

Laboratory O
data O
showed O
an O
hematocrit O
of O
31.6 O
, O
PT O
13 O
, O
INR O
1.2 O
, O
potassium O
4.5 O
, O
BUN O
18 O
, O
creatinine O
0.9 O
. O

He O
was O
alert O
and O
oriented O
x O
3 O
, O
moved O
all O
extremities O
, O
followed O
commands O
. O

Respiratory O
examination O
was O
clear O
to O
auscultation O
bilaterally O
. O

Cardiac O
showed O
a O
regular O
rate O
and O
rhythm O
, O
S1 O
and O
S2 O
. O

Sternum O
was O
stable O
. O

Incisions B-SYMPTOM
had O
Steri-Strips B-TREATMENT
, O
open O
to O
air O
, O
clean O
and O
dry O
. O

Abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
with O
normal O
active O
bowel O
sounds O
. O

Extremities O
were O
warm O
and O
well O
perfused O
with O
no O
edema B-SYMPTOM
. O

Right B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
incision I-SYMPTOM
with O
Steri-Strips B-TREATMENT
, O
open O
to O
air O
, O
clean O
and O
dry O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Colace B-TREATMENT
100 O
mg O
b.i.d. O

2. O
Aspirin B-TREATMENT
325 O
mg O
q.d. O

3. O
Nystatin B-TREATMENT
swish O
and O
swallow O
, O
5 O
cc O
q. O
8 O
hours O
. O

4. O
Ampicillin B-TREATMENT
2 O
grams O
IV O
q. O
6 O
through O
09-08 O
. O

5. O
Amiodarone B-TREATMENT
200 O
mg O
q.d. O

6. O
Percocet B-TREATMENT
5/325 O
, O
1-2 O
tablets O
q. O
6 O
hours O
p.r.n. O

7. O
Milk B-TREATMENT
of I-TREATMENT
Magnesia I-TREATMENT
30 O
cc O
q.h.s. O
p.r.n. O

CONDITION O
ON O
DISCHARGE O
: O

Good O
. O

DISPOSITION O
: O

He O
is O
to O
be O
discharged O
to O
rehabilitation O
. O

FOHintonP O
: O

He O
is O
to O
see O
Dr. O
les O
Dina O
in O
one O
month O
, O
Dr. O
Bennett O
in O
one O
month O
and O
Dr. O
Duval O
in O
one O
month O
. O

Russell O
von O
der O
Hassler O
, O
M.D. O

47-736 O

Dictated O
By O
: O

Leonard O
S. O
Perdue O
, O
M.D. O

MEDQUIST36 O

D O
: O

2010-09-06 O

08:54 O

T O
: O

2010-09-06 O

09:17 O

JOB# O
: O

92751 O

Signed O
electronically O
by O
: O

DR. O
Gene O
au O
Holden O
on O
: O

FRI O
2010-10-01 O
3:26 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2015-06-10 O

Discharge O
Date O
: O

2015-06-11 O

Date O
of O
Birth O
: O

1970-12-08 O

Sex O
: O

M O

Service O
: O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
44 O
- O
year-old O
male O
with O
a O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
9/02 O
, O
status O
post O
stent B-TREATMENT
proximal B-SYMPTOM
and I-SYMPTOM
mid-RCA I-SYMPTOM
lesion I-SYMPTOM
and O
OM B-SYMPTOM
lesion I-SYMPTOM
. O

He O
had O
a O
Myoview O
on O
05-04 O
which O
showed O
fixed B-SYMPTOM
inferior I-SYMPTOM
wall I-SYMPTOM
defect I-SYMPTOM
but O
no O
evidence O
of O
ischemia B-SYMPTOM
. O

He O
has O
been O
getting O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
with O
exertion O
times O
one O
month O
and O
also O
has O
occasional B-SYMPTOM
chest I-SYMPTOM
tightness I-SYMPTOM
. O

He O
denies O
orthopnea B-SYMPTOM
, O
edema B-SYMPTOM
, O
paroxysmal B-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
, O
diaphoresis B-SYMPTOM
, O
claudication B-SYMPTOM
. O

He O
also O
has O
history O
of O
hypertension B-SYMPTOM
, O
high B-SYMPTOM
cholesterol I-SYMPTOM
and O
noninsulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

He O
underwent O
cardiac O
catheterization O
today O
which O
revealed O
OM O
, O
no O
obstructive B-SYMPTOM
disease I-SYMPTOM
, O
left B-SYMPTOM
anterior I-SYMPTOM
descending I-SYMPTOM
minimal I-SYMPTOM
disease I-SYMPTOM
, O
left B-SYMPTOM
circumflex I-SYMPTOM
40% I-SYMPTOM
mid-stenosis I-SYMPTOM
. O

Right B-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
100% I-SYMPTOM
mid-stenosis I-SYMPTOM
. O

Echo O
in O
9/02 O
showed O
LVF O
of O
75% O
with O
moderate B-SYMPTOM
dilatation I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
descending I-SYMPTOM
aorta I-SYMPTOM
. O

He O
is O
now O
preop O
for O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

Noninsulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
high B-SYMPTOM
cholesterol I-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
9/02 O
. O

Status O
post O
stent B-TREATMENT
. O

MEDICATIONS O
: O

1. O
Folic B-TREATMENT
Acid I-TREATMENT
. O

2. O
Metformin B-TREATMENT
. O

3. O
Norvasc B-TREATMENT
. O

4. O
Aspirin B-TREATMENT
. O

5. O
Lopressor B-TREATMENT
. O

6. O
Lipitor B-TREATMENT
. O

7. O
Diovan B-TREATMENT
. O

8. O
Hydrochlorothiazide B-TREATMENT
. O

ALLERGIES O
: O

Penicillin B-TREATMENT
, O
sulfa B-TREATMENT
and O
Codeine B-TREATMENT
. O

FAMILY O
HISTORY O
: O

Strong B-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

No O
tobacco O
, O
no O
alcohol O
, O
lives O
with O
wife O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
is O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
, O
vital O
signs O
stable O
. O

Normocephalic B-SYMPTOM
, O
atraumatic B-SYMPTOM
. O

Pupils O
are O
equal O
, O
round O
, O
and O
reactive O
to O
light O
and O
accommodation O
. O

Extraocular O
movements O
intact O
. O

Oropharynx O
clear O
. O

Neck O
supple O
. O

Full O
range O
of O
motion O
, O
no O
lymphadenopathy B-SYMPTOM
. O

No O
thyromegaly B-SYMPTOM
. O

Carotids O
2+ O
bilaterally O
without O
bruits B-SYMPTOM
. O

Lungs O
clear O
to O
auscultation O
bilaterally O
. O

Cardiac O
: O

Regular O
rate O
and O
rhythm O
. O

No O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
. O

Abdomen B-SYMPTOM
obese I-SYMPTOM
, O
soft O
, O
nontender B-SYMPTOM
without O
masses B-SYMPTOM
, O
no O
hepatosplenomegaly B-SYMPTOM
, O
positive O
bowel O
sounds O
without O
cyanosis B-SYMPTOM
, O
clubbing B-SYMPTOM
or O
edema B-SYMPTOM
. O

Pulses O
2+ O
bilaterally O
throughout O
. O

Neurological O
: O

Nonfocal O
. O

The O
patient O
was O
admitted O
to O
the O
hospital O
on O
2015-06-10 O
and O
taken O
to O
the O
operating O
room O
on O
2015-06-11 O
where O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
four O
was O
performed O
. O

He O
initially O
required O
nitroglycerin B-TREATMENT
drip I-TREATMENT
. O

He O
had O
chest B-TREATMENT
tube I-TREATMENT
and O
pacing B-TREATMENT
wires I-TREATMENT
in O
place O
. O

Received O
perioperative B-TREATMENT
Vancomycin I-TREATMENT
. O

Postoperative O
day O
one O
the O
chest O
x-ray O
showed O
a B-SYMPTOM
collapsed I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
. O

PEEP B-TREATMENT
was O
increased O
and O
a O
chest O
x-ray O
checked O
the O
following O
morning O
. O

The O
patient O
subsequently O
did O
well O
, O
chest B-TREATMENT
tubes I-TREATMENT
were O
removed O
at O
the O
appropriate O
time O
, O
pacing B-TREATMENT
wires I-TREATMENT
removed O
at O
the O
appropriate O
time O
. O

The O
patient O
was O
discharged O
to O
the O
regular O
cardiothoracic O
floor O
where O
his B-TREATMENT
anti-hypertensives I-TREATMENT
were O
manipulated O
to O
improve O
his O
heart O
rate O
and O
blood O
pressure O
. O

The O
patient O
did O
well O
on O
the O
floor O
, O
was O
seen O
by O
physical O
therapy O
who O
quickly O
cleared O
him O
to O
go O
home O
on O
2015-06-15 O
and O
the O
patient O
was O
in O
good O
condition O
. O

Being O
discharged O
to O
home O
. O

The O
patient O
may O
shower O
but O
should O
not O
take O
baths O
. O

Should O
avoid O
strenuous O
activity O
. O

Should O
not O
drive O
while O
on O
pain B-TREATMENT
medication I-TREATMENT
. O

He O
is O
to O
follow-up O
with O
Dr. O
Ellis O
in O
four O
weeks O
, O
Dr. O
Joseph O
Overstreet O
in O
one O
to O
two O
weeks O
. O

Dr. O
Iola O
Alexander O
in O
2 O
to O
3 O
weeks O
. O

He O
is O
on O
Lopressor B-TREATMENT
100 O
mg O
twice O
a O
day O
. O

Metformin B-TREATMENT
500 O
mg O
twice O
a O
day O
. O

Lasix B-TREATMENT
20 O
mg O
twice O
a O
day O
times O
seven O
days O
. O

Potassium B-TREATMENT
20 O
mEq O
twice O
a O
day O
times O
seven O
days O
. O

Potassium B-TREATMENT
chloride I-TREATMENT
20 O
mEq O
times O
seven O
days O
, O
Plavix B-TREATMENT
75 O
mg O
p.o. O
q O
day O
, O
Isosorbide B-TREATMENT
60 O
mg O
q O
day O
, O
Percocet B-TREATMENT
p.r.n. O
, O
Entericoated B-TREATMENT
aspirin I-TREATMENT
325 O
mg O
q O
day O
. O

Colace B-TREATMENT
100 O
mg O
twice O
a O
day O
p.r.n. O

Lipitor B-TREATMENT
20 O
mg O
p.o. O
q O
day O
. O

Folate B-TREATMENT
1 O
mg O
q O
day O
. O

DR. O
Edwards O
, O
Brittany O
92-534 O

Dictated O
By O
: O
William O
H O
Centeno O
, O
M.D. O

MEDQUIST36 O

D O
: O
2015-06-15 O
15:23 O

T O
: O
2015-06-15 O
16:16 O

JOB O
#: O
83178 O

Signed O
electronically O
by O
: O
DR. O
Timothy O
BZ O
Holmes O
on O
: O
TUE O
2015-06-16 O
4:15 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-04-14 O

Discharge O
Date O
: O

2014-04-19 O

Date O
of O
Birth O
: O

2014-04-14 O

Sex O
: O

M O

Service O
: O

CMED O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Baby O
boy O
Liles O
is O
the O
2.985 O
kg O
product O
of O
a O
34 O
week O
gestation O
born O
to O
a O
30-year-old O
G3 O
, O
P0 O
, O
now O
1 O
mother O
. O

Prenatal O
screens O
- O
A O
positive O
, O
antibody O
negative O
, O
hepatitis O
surface O
antigen O
negative O
, O
RPR O
nonreactive O
, O
rubella O
immune O
, O
GBS O
unknown O
. O

PAST O
OBSTETRICAL O
HISTORY O
: O

Remarkable O
for O
an B-SYMPTOM
intrauterine I-SYMPTOM
fetal I-SYMPTOM
demise I-SYMPTOM
at O
30 O
weeks O
gestation O
. O

This O
pregnancy O
complicated O
by O
hydramnios B-SYMPTOM
also O
. O

The O
baby O
's O
autopsy O
was O
reported O
to O
be O
normal O
. O

Dates O
are O
by O
first O
trimester O
ultrasound O
. O

Pregnancy O
was O
complicated O
by O
severe B-SYMPTOM
polyhydramnios I-SYMPTOM
with O
an O
AFI O
of O
45 O
just O
prior O
to O
delivery O
. O

Mother O
has O
had O
multiple O
ultrasounds O
and O
fetal O
surveys O
at O
17 O
and O
21 O
weeks O
that O
had O
been O
unremarkable O
. O

Mother O
was O
transferred O
to O
the O
Debbie-Monaco O
from O
Western O
Mass. O
Hospital O
Hospital O
in O
the O
middle O
of O
January O
with O
increasing B-SYMPTOM
polyhydramnios I-SYMPTOM
and O
preterm B-SYMPTOM
labor I-SYMPTOM
. O

She O
received O
a B-TREATMENT
full I-TREATMENT
course I-TREATMENT
of I-TREATMENT
betamethasone I-TREATMENT
on O
03-28 O
and O
was O
treated O
with O
magnesium B-TREATMENT
sulfate I-TREATMENT
until O
04-12 O
. O

She O
was O
given O
1 O
dose O
of O
nifedipine B-TREATMENT
2 O
days O
ago O
as O
a B-TREATMENT
tocolytic I-TREATMENT
without O
effect O
. O

Delivery O
by O
cesarean B-TREATMENT
section I-TREATMENT
was O
prompted O
by O
ongoing B-SYMPTOM
labor I-SYMPTOM
. O

Preterm B-SYMPTOM
labor I-SYMPTOM
with O
new O
onset O
of O
late B-SYMPTOM
decelerations I-SYMPTOM
and O
breech B-SYMPTOM
presentation I-SYMPTOM
. O

Nuchal B-SYMPTOM
cord I-SYMPTOM
was O
noted O
at O
delivery O
. O

The O
infant O
cried O
after O
bulb B-TREATMENT
suctioning I-TREATMENT
and O
stimulation B-TREATMENT
. O

Apgars O
were O
8 O
and O
8 O
. O

PHYSICAL O
EXAMINATION O
: O

Weight O
2.985 O
kg O
, O
95th O
percentile; O
length O
48 O
cm O
, O
85th O
percentile; O
head O
circumference O
35 O
cm O
, O
greater O
than O
95th O
percentile O
. O

Anterior O
fontanel O
soft O
and O
flat. O
Head O
shape O
normal O
with O
mildly B-SYMPTOM
flattened I-SYMPTOM
on I-SYMPTOM
top I-SYMPTOM
consistent O
with O
breech B-SYMPTOM
positioning I-SYMPTOM
in I-SYMPTOM
utero I-SYMPTOM
. O

Facies O
nondysmorphic B-SYMPTOM
, O
palate O
intact O
. O

Mild B-SYMPTOM
intermittent I-SYMPTOM
grunting I-SYMPTOM
noted O
with O
mild B-SYMPTOM
subcostal I-SYMPTOM
retractions I-SYMPTOM
. O

Good O
air O
entry O
bilaterally O
. O

S1 O
and O
S2 O
normal O
intensity O
. O

No O
murmur B-SYMPTOM
noted O
. O

Perfusion O
good O
. O

Abdomen O
soft O
with O
no O
masses B-SYMPTOM
. O

Three O
vessel O
cord O
. O

Normal O
male O
with O
testes O
palpable O
bilaterally O
. O

Tone B-SYMPTOM
initially I-SYMPTOM
low I-SYMPTOM
normal I-SYMPTOM
but O
improved O
within O
normal O
limits O
on O
admission O
. O

Hips O
increased B-SYMPTOM
lax I-SYMPTOM
knee I-SYMPTOM
but O
no O
obvious B-SYMPTOM
dislocation I-SYMPTOM
. O

SUMMARY O
OF O
HOSPITAL O
COURSE O
BY O
SYSTEMS O
: O

RESPIRATORY O
: O

Jacqueline O
has O
been O
admitted O
to O
the O
newborn O
intensive O
care O
unit O
and O
has O
been O
stable O
in O
room O
air O
since O
admission O
. O

CARDIOVASCULAR O
: O

Infant O
has O
an B-SYMPTOM
audible I-SYMPTOM
murmur I-SYMPTOM
. O

Cardiology O
consult O
of O
the O
infant O
on O
04-18 O
. O

Echocardiogram O
results O
were O
within O
normal O
limits O
revealing O
a B-SYMPTOM
PPS I-SYMPTOM
murmur I-SYMPTOM
. O

FLUIDS O
, O
ELECTROLYTES O
AND O
NUTRITION O
: O

Birth O
weight O
was O
2.985 O
kg O
. O

Discharge O
weight O
.. O

The O
infant O
was O
initially O
started O
on O
60 O
cc O
per O
kg O
per O
day O
of O
D10W B-TREATMENT
. O

Enteral B-TREATMENT
feedings I-TREATMENT
were O
initiated O
on O
day O
of O
life O
No.1 O
. O

The O
infant O
is O
currently O
on O
a O
120 O
cc O
per O
kg O
per O
day O
of O
premature B-TREATMENT
Enfamil I-TREATMENT
20 O
calorie O
or O
breast O
milk O
, O
tolerating O
feeds O
well O
. O

Electrolytes O
on O
day O
of O
life O
1 O
showed O
a O
sodium O
of O
142 O
, O
potassium O
of O
5.1 O
, O
chloride O
of O
108 O
, O
and O
total O
CO2 O
of O
23 O
. O

GASTROINTESTINAL O
: O

Bilirubin O
on O
04-17 O
was O
8.2/0.3 O
. O

Surgery O
was O
consulted O
to O
rule O
out O
a B-SYMPTOM
TE I-SYMPTOM
fistula I-SYMPTOM
as O
the O
infant O
had O
an B-SYMPTOM
incidental I-SYMPTOM
pass I-SYMPTOM
of O
a B-TREATMENT
gavage I-TREATMENT
tube I-TREATMENT
into O
his O
right O
bronchus O
. O

TEF B-SYMPTOM
was O
primarily O
ruled O
out O
as O
Baker O
was O
passed O
easily O
to O
stomach O
and O
x-ray O
revealed O
good O
position O
. O

HEMATOLOGY O
: O

Hematocrit O
on O
admission O
was O
38.2 O
. O

The O
infant O
has O
not O
required O
any B-TREATMENT
blood I-TREATMENT
transfusions I-TREATMENT
. O

INFECTIOUS O
DISEASE O
: O

CBC O
and O
blood O
cultures O
were O
obtained O
on O
admission O
. O

CBC O
was O
benign O
and O
blood O
cultures O
remained O
negative O
at O
48 O
hours O
at O
which O
time O
ampicillin B-TREATMENT
and O
gentamicin B-TREATMENT
were O
discontinued O
. O

Initial O
CBC O
had O
a O
white O
count O
of O
16 O
, O
platelet O
count O
of O
204 O
, O
53 O
polys O
and O
0 O
bands O
. O

NEUROLOGY O
: O

Appropriate O
for O
gestational O
age O
. O

MUSCULOSKELETAL O
: O

Of O
note O
incidental O
finding O
on O
x-ray O
, O
the O
infant O
has O
a B-SYMPTOM
hemivertebra I-SYMPTOM
at I-SYMPTOM
T11 I-SYMPTOM
. O

AUDIOLOGY O
: O

Hearing O
screen O
has O
not O
been O
done O
but O
should O
be O
done O
prior O
to O
discharge O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
DISPOSITION O
: O

To O
Western O
Mass. O
Hospital O
Hospital O
. O

NAME O
OF O
PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Joseph. O

Telephone O
No O
. O

208 O
1429 O
. O

CARE O
RECOMMENDATIONS: O

1. O
Continue O
advancing O
fluid O
volume O
to O
support O
infant O
's O
weight O
gain O
needs O
. O

2. O
Medications B-TREATMENT
: O
Not O
applicable O
. O

3. O
Car O
Seat O
Position O
Screening O
has O
not O
been O
performed O
. O

4. O
State O
Newborn O
Screen O
was O
sent O
on O
day O
of O
life O
3 O
. O

5. O
Immunizations B-TREATMENT
received: O
The O
infant O
has O
not O
received O
any B-TREATMENT
immunizations I-TREATMENT
at O
this O
time O
. O

DISCHARGE O
DIAGNOSES O
: O

Premature O
infant O
born O
at O
34 O
weeks O
. O

Rule O
out O
sepsis B-SYMPTOM
with O
antibiotics B-TREATMENT
. O

Robert O
Mincer O
, O
M.D. O
50AHB O

Dictated O
By:Penny O
K. O
Mcbride O
, O
M.D. O

MEDQUIST36 O

D O
: O

2014-04-18 O
21:56:45 O

T O
: O

2014-04-18 O
22:38:39 O

Job# O
: O

44791 O

Signed O
electronically O
by O
: O

DR. O
Kenneth O
RHEIN O
on O
: O

SAT O
2014-04-19 O
10:03 O
AM O

( O
End O
of O
Report O
) O

421179499 O

BH O

0940729 O

770923 O

3/30/1997 O
12:00:00 O
AM O

ASPIRATION B-SYMPTOM
PNEUMONIA I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O
NAME O
: O

STRAPEFREIRE O
, O
VATALY O
C O

UNIT O
NUMBER O
: O

972-02-46 O

ADMISSION O
DATE O
: O

03/30/97 O

DISCHARGE O
DATE O
: O

04/01/97 O

PRINCIPAL O
DIAGNOSIS O
: O

Aspiration B-SYMPTOM
pneumonia I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Dementia B-SYMPTOM
; O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
AND O
REASON O
FOR O
HOSPITALIZATION O
: O

The O
patient O
was O
a O
108-year-old O
nursing O
home O
resident O
, O
who O
was O
admitted O
with O
a O
two-day O
history O
of O
increased B-SYMPTOM
respiratory I-SYMPTOM
secretions I-SYMPTOM
and O
a O
24-hour O
history O
of O
elevated B-SYMPTOM
fever I-SYMPTOM
. O

Despite O
Augmentin B-TREATMENT
, O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
delirium I-SYMPTOM
worsened O
in O
the O
24 O
hours O
prior O
to O
admission O
, O
and O
her O
temperature O
was O
up O
to O
102 O
. O

She O
was O
refusing O
to O
take O
p.o.&apos;s O
. O

PAST O
MEDICAL O
HISTORY O
: O

Recurrent B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infections I-SYMPTOM
, O
most O
recently O
on O
2/23/97 O
; O
recurrent B-SYMPTOM
aspiration I-SYMPTOM
pneumonias I-SYMPTOM
, O
most O
recently O
on O
2/21/97 O
; O
multi-infarct B-SYMPTOM
dementia I-SYMPTOM
with O
associated B-SYMPTOM
dysphasia I-SYMPTOM
; O
mitral B-SYMPTOM
regurgitation I-SYMPTOM
; O
history O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
; O
pernicious B-SYMPTOM
anemia I-SYMPTOM
; O
chronic B-SYMPTOM
venous I-SYMPTOM
stasis I-SYMPTOM
; O
status O
post O
left B-SYMPTOM
femoral I-SYMPTOM
neck I-SYMPTOM
fracture I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Augmentin B-TREATMENT
500 O
mg O
t.i.d. O

Senokot B-TREATMENT
one O
q.h.s. O

Sertraline B-TREATMENT
75 O
mg O
q.day O
. O

Aspirin B-TREATMENT
81 O
mg O
q.day O
. O

Vitamin B-TREATMENT
B12 I-TREATMENT
100 O
mcg O
IM O
q.month O
. O

Urecholine B-TREATMENT
25 O
mg O
t.i.d. O
Colace B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
resides O
in O
the O
Pcaer,ter O
Medical O
Center O
, O
is O
nonambulatory B-SYMPTOM
, O
and O
her O
code O
status O
is O
do O
not O
resuscitate O
/ O
do O
not O
intubate O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
was O
nonverbal B-SYMPTOM
, O
but O
was O
able O
to O
open O
her O
eyes O
and O
nod O
. O

No O
respiratory B-SYMPTOM
distress I-SYMPTOM
. O

Her O
temperature O
was O
102.2 O
; O
blood O
pressure O
135/64 O
; O
pulse O
rate O
108 O
; O
respirations O
24 O
; O
oxygen O
saturations O
on O
room O
air O
94% O
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
examination O
revealed O
no O
ocular B-SYMPTOM
abnormalities I-SYMPTOM
. O

Neck O
- O
no O
lymphadenopathy B-SYMPTOM
; O
no O
carotid B-SYMPTOM
bruits I-SYMPTOM
; O
jugular O
venous O
pressure O
not O
elevated B-SYMPTOM
; O
no O
goiter B-SYMPTOM
. O

Chest O
- O
reduced B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
bases I-SYMPTOM
with O
faint B-SYMPTOM
inspiratory I-SYMPTOM
rhonchi I-SYMPTOM
anteriorly I-SYMPTOM
. O

Cardiac O
- O
regular O
rate O
and O
rhythm O
with O
frequent B-SYMPTOM
premature I-SYMPTOM
beats I-SYMPTOM
and O
a B-SYMPTOM
2/6 I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
apex I-SYMPTOM
. O

The O
abdomen O
was O
non-tender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
no O
hepatomegaly B-SYMPTOM
, O
normal O
bowel O
sounds O
. O

Extremities O
- O
1+ B-SYMPTOM
edema I-SYMPTOM
; O
2+ O
pulses O
. O

Skin O
- O
intact O
with O
diaper B-TREATMENT
. O

LABORATORY O
DATA O
: O

The O
sodium O
was O
142 O
; O
potassium O
4.5 O
; O
chloride O
105 O
; O
bicarbonate O
27 O
; O
BUN O
and O
creatinine O
31 O
and O
1.3 O
; O
glucose O
107 O
; O
total O
protein O
7.7 O
; O
albumin O
3.2 O
; O
globulin O
4.5 O
; O
uric O
acid O
4.2 O
; O
alkaline O
phosphatase O
114 O
; O
serum O
glutamic O
oxaloacetic O
transaminase O
46 O
; O
lactic O
acid O
dehydrogenase O
370 O
; O
white O
blood O
count O
11,000 O
with O
83 O
polymorphonuclear O
leukocytes O
; O
hematocrit O
42 O
; O
platelet O
count O
227,000 O
. O

A O
chest O
x-ray O
showed O
consolidation B-SYMPTOM
bilateral I-SYMPTOM
lyin I-SYMPTOM
the I-SYMPTOM
lower I-SYMPTOM
lobes I-SYMPTOM
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
was O
admitted O
for O
treatment B-TREATMENT
of O
a O
presumed O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
and O
for O
rehydration B-TREATMENT
. O

She O
was O
started O
on O
Clindamycin B-TREATMENT
and O
Ofloxacin B-TREATMENT
at O
renal O
dose O
to O
cover O
the B-SYMPTOM
aspiration I-SYMPTOM
pneumonia I-SYMPTOM
and O
positive B-SYMPTOM
urine I-SYMPTOM
culture I-SYMPTOM
, O
which O
subsequently O
came O
back O
. O

She O
had O
some B-SYMPTOM
wheezing I-SYMPTOM
, O
which O
responded O
well O
to O
Albuterol B-TREATMENT
nebulizers I-TREATMENT
. O

She O
was O
generally O
doing O
well O
with O
resolution O
of O
her O
temperature O
until O
4/1/97 O
at O
9:20 O
P.M. O
, O
when O
she O
was O
noted O
to O
be O
unresponsive B-SYMPTOM
with O
fixed B-SYMPTOM
dilated I-SYMPTOM
pupils I-SYMPTOM
. O

She O
was O
certified O
dead O
at O
9:20 O
P.M. O

MI O
CUCHSLI O
, O
M.D. O

TR O
: O

vgo O

DD O
: O

05/11/97 O

TD O
: O

05/15/97 O
8:26 O

Acc O
: O

MI O
CUCHSLI O
, O
M.D. O

cc O
: O

Nursing O
Director O
Pcaer,ter O
Medical O
Center O
Sco O
, O
Ohio O

694467643 O

FIH O

7327698 O

47130/04v4 O

120605 O

06/29/1992 O
12:00:00 O
AM O

HEPATOCELLULAR B-SYMPTOM
CARCINOMA I-SYMPTOM
, O
AND O
HEPATITIS B-SYMPTOM
C I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

06/29/92 O

DISCHARGE O
DATE O
: O

07/27/92 O

PRINCIPAL O
DIAGNOSIS O
: O

Hepatocellular B-SYMPTOM
carcinoma I-SYMPTOM
, O
and O
hepatitis B-SYMPTOM
C I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Liver B-TREATMENT
transplant I-TREATMENT
. O

Native B-TREATMENT
hepatectomy I-TREATMENT
. O

Re-exploration O
for O
bleeding B-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Villesatelkscurb O
is O
a O
fifty O
year O
old O
black O
gentleman O
with O
a O
long O
history O
of O
hepatitis B-SYMPTOM
C I-SYMPTOM
, O
believed O
to O
be O
contracted O
during O
transfusions B-TREATMENT
in O
a B-SYMPTOM
previous I-SYMPTOM
trauma I-SYMPTOM
. O

The O
patient O
had O
recently O
prior O
to O
this O
admission O
, O
had O
a B-SYMPTOM
rise I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
alpha I-SYMPTOM
feta I-SYMPTOM
protein I-SYMPTOM
and O
a O
biopsy O
of O
his O
liver O
had O
shown O
hepatocellular B-SYMPTOM
carcinoma I-SYMPTOM
. O

The O
patient O
was O
admitted O
for O
liver O
transplant O
workup O
and O
to O
await O
liver B-TREATMENT
transplant I-TREATMENT
. O

PAST O
MEDICAL O
and O

SURGICAL O
HISTORY O
: O

Significant O
for O
motor O
vehicle O
accident O
in O
1966 O
, O
requiring O
exploratory O
laparotomy O
and O
splenectomy B-TREATMENT
, O
tonsillectomy B-TREATMENT
as O
a O
child O
, O
pneumonia B-SYMPTOM
in O
the O
past O
, O
hepatitis B-SYMPTOM
C I-SYMPTOM
and O
recent O
diagnosis O
of O
hepatocellular B-SYMPTOM
carcinoma I-SYMPTOM
. O

ADVERSE O
DRUG O
REACTIONS O
: O

no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

On O
admission O
medications B-TREATMENT
included O
Lasix B-TREATMENT
and O
iron B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

Significant O
for O
normal O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
exam O
with O
no O
scleral B-SYMPTOM
icterus I-SYMPTOM
. O

Heart O
regular O
rate O
and O
rhythm O
, O
his O
lungs O
were O
clear O
. O

He O
had O
no O
appreciable B-SYMPTOM
ascites I-SYMPTOM
. O

He O
did O
have O
clubbing B-SYMPTOM
and O
palmar B-SYMPTOM
erythema I-SYMPTOM
with O
bilateral B-SYMPTOM
ankle I-SYMPTOM
edema I-SYMPTOM
. O

He O
was O
Neurologically O
intact O
. O

LABORATORY O
DATA O
: O

bilirubin O
to O
be O
.6 O
. O

SGOT O
of O
80 O
. O

HOSPITAL O
COURSE O
: O

Preoperatively O
, O
the O
patient O
underwent O
chemo-embolization B-TREATMENT
for O
his B-SYMPTOM
hepatocellular I-SYMPTOM
carcinoma I-SYMPTOM
. O

The O
remainder O
of O
his O
preoperative O
course O
was O
benign O
. O

On O
July O
15 O
, O
1992 O
, O
a O
liver O
became O
available O
, O
and O
the O
patient O
underwent O
hepatectomy B-TREATMENT
and O
orthotopic B-TREATMENT
liver I-TREATMENT
transplant I-TREATMENT
. O

His B-TREATMENT
operation I-TREATMENT
was O
complicated O
by O
severe B-SYMPTOM
coagulopathy I-SYMPTOM
requiring O
fifty-nine O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
, O
64 O
units O
of O
FFP B-TREATMENT
and O
34 O
units O
of O
platelets B-TREATMENT
. O

Postoperatively O
, O
the O
patient O
continued O
to O
have O
a B-SYMPTOM
coagulopathy I-SYMPTOM
requiring O
re-exploration O
on O
postoperatively O
day O
2 O
, O
with O
findings O
only O
of O
hematoma B-SYMPTOM
and O
no O
active B-SYMPTOM
bleeding I-SYMPTOM
. O

Initially O
, O
the O
patient O
did O
well O
in O
the O
Intensive O
Care O
Unit O
, O
mentally O
alert O
, O
and O
oriented O
, O
however O
, O
he O
continued O
to O
be O
coagulopathic B-SYMPTOM
and O
was O
requiring O
large B-TREATMENT
amounts I-TREATMENT
of I-TREATMENT
blood I-TREATMENT
and O
FFP B-TREATMENT
transfusions I-TREATMENT
, O
with O
a B-SYMPTOM
resultant I-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
. O

He O
developed O
renal B-SYMPTOM
failure I-SYMPTOM
felt O
to O
be O
ATN B-SYMPTOM
secondary O
to O
ischemia B-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
kidneys I-SYMPTOM
. O

The O
patient O
remained O
intubated B-TREATMENT
in O
the O
Intensive O
Care O
Unit O
for O
twelve O
days O
prior O
to O
his O
death O
. O

He O
had O
daily B-TREATMENT
transfusions I-TREATMENT
of O
FFP B-TREATMENT
and O
blood B-TREATMENT
, O
and O
continued O
coagulopathy B-SYMPTOM
. O

He O
also O
developed O
thrombocytopenia B-SYMPTOM
, O
requiring O
persistent B-TREATMENT
platelet I-TREATMENT
transfusions I-TREATMENT
on O
a O
daily O
basis O
. O

His B-TREATMENT
immunosuppression I-TREATMENT
was O
OKT3 B-TREATMENT
and O
Solu B-TREATMENT
Medrol I-TREATMENT
, O
and O
he O
underwent O
hemodialysis B-TREATMENT
and O
ultra B-TREATMENT
filtration I-TREATMENT
to O
remove O
fluid O
. O

While O
in O
the O
ICU O
he O
developed O
seizures B-SYMPTOM
, O
requiring O
large B-TREATMENT
amounts I-TREATMENT
of I-TREATMENT
intravenous I-TREATMENT
Valium I-TREATMENT
to O
break O
his B-SYMPTOM
seizures I-SYMPTOM
, O
and O
he O
was O
maintained O
on O
Tegretol B-TREATMENT
and O
Dilantin B-TREATMENT
. O

However O
, O
he O
became O
progressively O
more O
mentally B-SYMPTOM
obtunded I-SYMPTOM
. O

During O
the B-SYMPTOM
seizure I-SYMPTOM
, O
he O
bit O
his O
tongue O
, O
resulting O
in O
a B-SYMPTOM
large I-SYMPTOM
bleed I-SYMPTOM
from I-SYMPTOM
his I-SYMPTOM
tongue I-SYMPTOM
, O
which O
was O
sutured B-TREATMENT
by O
the O
ENT O
Service O
, O
however O
, O
his B-SYMPTOM
continued I-SYMPTOM
coagulopathy I-SYMPTOM
resulted O
in O
bleeding B-SYMPTOM
from I-SYMPTOM
his I-SYMPTOM
nasopharynx I-SYMPTOM
, O
which O
could O
never O
be O
identified O
, O
and O
also O
upper B-SYMPTOM
gastrointestinal I-SYMPTOM
bleeding I-SYMPTOM
. O

Endoscopy O
never O
revealed O
specific O
sources O
of O
bleeding B-SYMPTOM
, O
although O
he O
appeared O
to O
have O
a B-SYMPTOM
diffuse I-SYMPTOM
duodenitis I-SYMPTOM
. O

He O
was O
started O
on O
Pitressin B-TREATMENT
to O
try O
to O
control O
the B-SYMPTOM
gastrointestinal I-SYMPTOM
bleeding I-SYMPTOM
, O
but O
he O
continued O
to O
have O
severe B-SYMPTOM
bleeding I-SYMPTOM
, O
and O
became O
progressively B-SYMPTOM
hypotensive I-SYMPTOM
, O
with O
eventual B-SYMPTOM
bradycardia I-SYMPTOM
and O
cardiac B-SYMPTOM
arrest I-SYMPTOM
. O

He O
was O
pronounced O
dead O
at O
3:49 O
PM O
on O
July O
15 O
, O
1992 O
. O

STA O
TITCHEGRIESESC O
, O
M.D. O
DICTATING O
FOR O
; O
KIVERL O
NA O
CANTSLEDDJESC O
, O
M.D. O

TR O
: O

wj O
/ O
bmot O

DD O
: O

07/28/92 O

TD O
: O

07/28/92 O

CC O
: O

Admission O
Date O
: O

2018-08-04 O

Discharge O
Date O
: O

2018-08-16 O

Date O
of O
Birth O
: O

1986-03-06 O

Sex O
: O

M O

Service O
: O

SURGERY O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to I-SYMPTOM
Drugs I-SYMPTOM

Attending O
: O
William O
I. O
Sundquist O
, O
M.D. O

Chief O
Complaint O
: O

Abdominal B-SYMPTOM
pain I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O
pheresis O
renal O
biopsy O

History O
of O
Present O
Illness O
: O

This O
is O
a O
32 O
year O
old O
male O
who O
was O
recently O
discharged O
from O
Mediplex O
Rehab O
Hospital O
and O
presents O
again O
to O
us O
with O
chief O
complaint O
of O
abdominal B-SYMPTOM
pain I-SYMPTOM
( O
sudden B-SYMPTOM
onset I-SYMPTOM
left-sided I-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
). O

Of O
note O
, O
he O
had O
a O
recent O
kidney O
biopsy O
on O
2018-07-30 O
and O
his O
Cr O
bumped O
from O
4.7 O
to O
5.7 O
. O

Also O
, O
HCT O
on O
admission O
21 O
from O
25 O
. O

Past O
Medical O
History O
: O

ESRD B-SYMPTOM
on O
HD B-TREATMENT
( O
M,W,F O
) O
( O
03-30 O
glomerulonephritis B-SYMPTOM
) O

HTN B-SYMPTOM

Hypercholesterolemia B-SYMPTOM

PSH O
: O

AVF B-TREATMENT
- I-TREATMENT
R I-TREATMENT
radial I-TREATMENT
- I-TREATMENT
cephalic I-TREATMENT

AVF B-TREATMENT
- I-TREATMENT
L I-TREATMENT
aneurysm I-TREATMENT
resection I-TREATMENT

Tunneled B-TREATMENT
L I-TREATMENT
subclavian I-TREATMENT
catheter I-TREATMENT

Social O
History O
: O
denies O
tobacco O
, O
ETOH O
, O
drugs O

Family O
History O
: O
sister O
who O
is O
26 O
also O
has O
ESRD B-SYMPTOM
on O
HD B-TREATMENT
( O
? O
etiology O
) O

Physical O
Exam O
: O

VS O
: O
Afebrile B-SYMPTOM
, O
HR O
: O
70-80 O
, O
99/70 O

Lungs O
: O
CTA O
bilaterally O

CV O
: O
RRR O

Abd O
: O
Non-distended B-SYMPTOM
, O
tender B-SYMPTOM
to O
palpation O
LLQ O

Pertinent O
Results O
: O

ADMISSION O
LABS O
--> O
2018-08-04 O

WBC O
- O
6.8 O
RBC O
- O
2.50 O
* O
Hgb O
- O
6.8 O
* O
Hct O
- O
21.2 O
* O
MCV O
- O
85 O
MCH O
- O
27.2 O
MCHC O
- O
32.1 O
RDW O
- O
18.0 O
* O
Plt O
Ct O
- O
149 O
* O
PT O
- O
11.9 O
PTT O
- O
31.1 O
INR O
( O
PT O
) O
- O
1.0 O
Fibrinogen O
- O
148 O
* O
Glucose O
- O
144 O
* O
UreaN O
- O
52 O
* O
Creat O
- O
5.7 O
* O
Na O
- O
138 O
K O
- O
4.1 O
Cl O
- O
107 O
HCO3 O
- O
17 O
* O
AnGap O
- O
18 O

2018-08-04 O
06:09 O
PM O
BLOOD O
Calcium O
- O
8.3 O
* O
Phos O
- O
5.0 O
* O
Mg O
- O
2.2 O

Discharge O
Labs O
: O

2018-08-16 O

WBC O
- O
5.7 O
RBC O
- O
3.10 O
* O
Hgb O
- O
8.9 O
* O
Hct O
- O
26.2 O
* O
MCV O
- O
85 O
MCH O
- O
28.7 O
MCHC O
- O
33.9 O
RDW O
- O
15.4 O
Plt O
Ct O
- O
186 O
PT O
- O
11.5 O
PTT O
- O
25.6 O
INR O
( O
PT O
)- O
1.0 O
Fibrinogen O
- O
443 O
* O
Glucose O
- O
104 O
UreaN O
- O
60 O
* O
Creat O
- O
4.8 O
* O
Na O
- O
139 O
K O
- O
4.3 O
Cl O
- O
105 O
HCO3 O
- O
26 O
AnGap O
- O
12 O
Calcium O
- O
8.8 O
Phos O
- O
5.0 O
* O
Mg O
- O
2.2 O

DISCHARGE O
LABS O
---> O

2018-08-16 O
05:47 O
AM O

BLOOD O
WBC O
- O
5.7 O
RBC O
- O
3.10 O
* O
Hgb O
- O
8.9 O
* O
Hct O
- O
26.2 O
* O
MCV O
- O
85 O
MCH O
- O
28.7 O
MCHC O
- O
33.9 O
RDW O
- O
15.4 O
Plt O
Ct O
- O
186 O

2018-08-16 O
05:47 O
AM O

BLOOD O
Plt O
Ct O
- O
186 O

2018-08-16 O
05:47 O
AM O

BLOOD O
PT O
- O
11.5 O
PTT O
- O
25.6 O
INR O
( O
PT O
)- O
1.0 O

2018-08-16 O
05:47 O
AM O

BLOOD O
Fibrino O
- O
443 O
* O

2018-08-16 O
05:47 O
AM O

BLOOD O
Glucose O
- O
104 O
UreaN O
- O
60 O
* O
Creat O
- O
4.8 O
* O
Na O
- O
139 O
K O
- O
4.3 O
Cl O
- O
105 O
HCO3 O
- O
26 O
AnGap O
- O
12 O

2018-08-16 O
05:47 O
AM O

BLOOD O
Calcium O
- O
8.8 O
Phos O
- O
5.0 O
* O
Mg O
- O
2.2 O

Brief O
Hospital O
Course O
: O

This O
patient O
was O
admitted O
on O
08-04 O
after O
a O
recent O
discharge O
from O
the O
hospital O
for O
sudden O
onset O
of O
left B-SYMPTOM
sided I-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
. O

In O
the O
emergency O
room O
, O
his O
ultrasound O
showed O
mild B-SYMPTOM
hydronephrosis I-SYMPTOM
with O
new B-SYMPTOM
perinephric I-SYMPTOM
fluid I-SYMPTOM
surrounding O
the O
transplant O
kidney O
and O
hence O
, O
underwent O
a O
CT O
scan O
of O
his O
abdomen O
/ O
pelvis O
which O
showed O
a O
large O
left-sided O
of O
retroperitoneal B-SYMPTOM
hemorrhage I-SYMPTOM
extending O
down O
to O
the O
level O
of O
the B-TREATMENT
renal I-TREATMENT
transplant I-TREATMENT
possibly O
related O
to O
recent O
transplant O
biopsy O
. O

Renal O
transplant O
medicine O
and O
transplant O
surgery O
were O
made O
aware O
and O
the O
pt O
was O
admitted O
to O
transplant O

CMED O
and O
to O
the O
ICU O
. O

Serial O
hematocrits O
and O
abdominal O
exams O
were O
performed O
. O

He O
was O
not O
taken O
to O
the O
OR O
. O

On O
08-06 O
, O
he O
received O
2 O
units O
of O
pRBC B-TREATMENT
and O
underwent O
plasmaphersis B-TREATMENT
, O
followed O
by O
10mg O
of O
IVIG B-TREATMENT
. O

He O
received O
another B-TREATMENT
unit I-TREATMENT
pRBC I-TREATMENT
on O
08-07 O
. O

By O
08-07 O
, O
it O
was O
thought O
there O
was O
improvement O
of O
his O
labs O
. O

In O
the O
am O
of O
6/13 O
, O
he O
was O
given O
1 B-TREATMENT
unit I-TREATMENT
pRBC I-TREATMENT
for O
a O
Hct O
of O
21.8 O
. O

His O
Hct O
was O
stable O
on O
08-09 O
at O
24.4 O
; O
he O
had O
plasmapheresis B-TREATMENT
on O
08-09 O
( O
followed O
by O
10 O
mg O
IVIG B-TREATMENT
). O

He O
was O
transfered O
to O
the O
floor O
on O
08-09 O
. O

On O
08-10 O
, O
his O
am O
Hct O
was O
21.9 O
, O
hence O
, O
he O
received O
1 B-TREATMENT
unit I-TREATMENT
pRBC I-TREATMENT
. O

On O
08-10 O
class O
I O
and O
II O
antibody O
levels O
were O
sent O
. O

He O
had O
plasmapheresis B-TREATMENT
on O
08-11 O
, O
followed O
by O
10 B-TREATMENT
mg I-TREATMENT
IVIG I-TREATMENT
. O

This O
was O
repeated O
on O
08-13 O
. O

Hct O
remained O
stable O
. O

On O
08-15 O
, O
he O
went O
for O
pheresis B-TREATMENT
/ O
IVIG B-TREATMENT
. O

No O
new B-SYMPTOM
issues I-SYMPTOM
. O

LLQ B-SYMPTOM
pain I-SYMPTOM
has O
improved O
over O
the O
course O
of O
this O
hospitalization O
. O

He O
is O
eating O
and O
ambulating O
w/o O
difficulties B-SYMPTOM
. O

Pheresis B-TREATMENT
to O
continue O
as O
an O
outpatient O
with O
supervision O
of O
transplant O
nephrology O
on O
08-17 O
, O
08-20 O
and O
08-22 O
. O

Prograf B-TREATMENT
was O
increased O
to O
12 O
mg O
bid O
on O
08-16 O
for O
a O
trough O
level O
of O
7.1 O
. O

He O
was O
instructed O
to O
have O
labs O
drawn O
on O
08-17 O
to O
check O
trough O
level O
of O
prograf O
as O
well O
as O
cbc O
, O
chem O
10 O
, O
coags O
. O

Medications O
on O
Admission O
: O

Bactrim B-TREATMENT
, O
Valcyte B-TREATMENT
, O
MMF B-TREATMENT
, O
Prednisone B-TREATMENT
, O
FK B-TREATMENT
, O
Nifedipine B-TREATMENT
, O
Protonix B-TREATMENT

Discharge O
Medications O
: O

1. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
60 O
Capsule O
( O
s O
)* O
Refills O
:* O
2 O
* O

2. O
Mycophenolate B-TREATMENT
Mofetil I-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

3. O
Valganciclovir B-TREATMENT
450 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q48H O
( O
every O
48 O
hours O
) O
. O

4. O
Trimethoprim B-TREATMENT
- O
Sulfamethoxazole B-TREATMENT
80-400 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

5. O
Nifedipine B-TREATMENT
60 O
mg O
Tablet O
Sustained O
Release O
Sig O
: O
One O
( O
1 O
) O
Tablet O
Sustained O
Release O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
60 O
Tablet O
Sustained O
Release O
( O
s O
)* O
Refills O
:* O
2 O
* O

6. O
Labetalol B-TREATMENT
200 O
mg O
Tablet O
Sig O
: O
Four O
( O
4 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

Disp O
:* O
360 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

7. O
Senna B-TREATMENT
8.6 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
60 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

8. O
Oxycodone B-TREATMENT
- O
Acetaminophen B-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

9. O
Sevelamer B-TREATMENT
800 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

10. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q12H O
( O
every O
12 O
hours O
) O
. O

11. O
Minoxidil B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

12. O
Nystatin B-TREATMENT
100,000 O
unit O
/ O
mL O
Suspension O
Sig O
: O
Five O
( O
5 O
) O
ML O
PO O
QID O
( O
4 O
times O
a O
day O
) O
. O

13. O
Prednisone B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

14. O
Epogen B-TREATMENT
40,000 O
unit O
/ O
mL O
Solution O
Sig O
: O
One O
( O
1 O
) O
ml O
Injection O
once O
a O
week O
. O

Disp O
:* O
8 O
* O
Refills O
:* O
2 O
* O

15. O
syringes B-TREATMENT
for O
epogen B-TREATMENT
q O
week O

1 O
box O

refill O
: O
none O

16. O
Tacrolimus B-TREATMENT
5 O
mg O
Capsule O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
PO O
Q12H O
( O
every O
12 O
hours O
) O
. O

17. O
Tacrolimus B-TREATMENT
1 O
mg O
Capsule O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
PO O
twice O
a O
day O
. O

18. O
Outpatient O
Lab O
Work O

Friday O
08-17 O
and O
Monday O
08-20 O
cbc O
, O
chem10 O
, O
pt/ptt/inr O
and O
trough O
prograf O
level O
. O

Discharge O
Disposition O
: O

Home O

Discharge O
Diagnosis O
: O
humoral B-SYMPTOM
rejection I-SYMPTOM
of I-SYMPTOM
renal I-SYMPTOM
transplant I-SYMPTOM
perinephric B-SYMPTOM
transplant I-SYMPTOM
hemorrhage I-SYMPTOM

Discharge O
Condition O
: O
good O

Discharge O
Instructions O
: O

Please O
call O
transplant O
office O
( O
789 O
) O
583 O
5023 O
if O
fevers B-SYMPTOM
, O
chills B-SYMPTOM
, O
nausea B-SYMPTOM
/ O
vomiting B-SYMPTOM
, O
bleeding B-SYMPTOM
, O
decreased B-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
, O
weight B-SYMPTOM
gain I-SYMPTOM
of O
3 O
pounds O
in O
a O
day O
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
or O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM

Pheresis B-TREATMENT
Friday O
08-17 O
then O
Monday O
08-20 O

Labwork O
every O
Monday O
and O
Thursday O
per O
Transplant O
clinic O
: O
CBC O
, O
Chem O
7 O
, O
Ca O
, O
Phos O
, O
AST O
, O
T O
Bili O
, O
U/A O
and O
Trough O
Prograf O
level O
. O

Fax O
results O
to O
326-955-2529 O

Followup O
Instructions O
: O

PHERESIS B-TREATMENT
, O
BED O
FIVE O
PHERESIS O
ROOMS O
Date O
/ O
Time O
: O
2018-08-17 O
9:15 O

PHERESIS B-TREATMENT
, O
BED O
SIX O
PHERESIS O
ROOMS O
Date O
/ O
Time O
: O
2018-08-20 O
2:00 O

Vanessa O
John O
, O
MD O
Phone O
:( O
789 O
) O
583 O
5023 O
Date O
/ O
Time O
: O
2018-08-21 O
9:50 O

Michael O
Douglas O
MD O
87-106 O

Completed O
by O
: O
Edwin O
Marilyn O
MD O
50-613 O
2018-08-16 O
@ O
1456 O

Signed O
electronically O
by O
: O
DR. O
Brian O
B. O
B. O
Chatterjee O
on O
: O
MON O
2018-09-10 O
1:21 O
PM O

( O
End O
of O
Report O
) O

004668411 O

CTMC O

68299235 O

763052 O

9/29/1993 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

09/29/1993 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

10/04/1993 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
28-year-old O
woman O
who O
is O
HIV B-SYMPTOM
positive I-SYMPTOM
for O
two O
years O
. O

She O
presented O
with O
left B-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
pain I-SYMPTOM
as O
well O
as O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
which O
is O
a B-SYMPTOM
long-standing I-SYMPTOM
complaint I-SYMPTOM
. O

She O
was O
diagnosed O
in O
1991 O
during O
the O
birth O
of O
her O
child O
. O

She O
claims O
she O
does O
not O
know O
why O
she O
is O
HIV B-SYMPTOM
positive I-SYMPTOM
. O

She O
is O
from O
Maryland O
, O
apparently O
had O
no O
blood B-TREATMENT
transfusions I-TREATMENT
before O
the O
birth O
of O
her O
children O
so O
it O
is O
presumed O
heterosexual B-SYMPTOM
transmission I-SYMPTOM
. O

At O
that O
time O
, O
she O
also O
had O
cat B-SYMPTOM
scratch I-SYMPTOM
fever I-SYMPTOM
and O
she O
had O
resection B-TREATMENT
of O
an B-SYMPTOM
abscess I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
. O

She O
has O
not O
used O
any B-TREATMENT
anti I-TREATMENT
retroviral I-TREATMENT
therapy I-TREATMENT
since O
then O
, O
because O
of O
pancytopenia B-SYMPTOM
and O
vomiting B-SYMPTOM
on O
DDI B-TREATMENT
. O

She O
has O
complaints O
of O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
as O
well O
as O
left B-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
pain I-SYMPTOM
on O
and O
off O
getting O
progressively O
worse O
over O
the O
past O
month O
. O

She O
has O
had O
similar B-SYMPTOM
pain I-SYMPTOM
intermittently O
for O
last O
year O
. O

She O
described O
the B-SYMPTOM
pain I-SYMPTOM
as O
a B-SYMPTOM
burning I-SYMPTOM
pain I-SYMPTOM
which O
is O
positional O
, O
worse O
when O
she O
walks O
or O
does O
any O
type O
of O
exercise O
. O

She O
has O
no O
relief O
from O
antacids B-TREATMENT
or O
H2 B-TREATMENT
blockers I-TREATMENT
. O

In O
10/92 O
, O
she O
had O
a O
CT O
scan O
which O
showed O
fatty B-SYMPTOM
infiltration I-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
liver I-SYMPTOM
diffusely I-SYMPTOM
with O
a B-SYMPTOM
1 I-SYMPTOM
cm I-SYMPTOM
cyst I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lobe I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
liver I-SYMPTOM
. O

She O
had O
a O
normal O
pancreas O
at O
that O
time O
, O
however O
, O
hyperdense B-SYMPTOM
kidneys I-SYMPTOM
. O

Her O
alkaline O
phosphatase O
was O
slightly B-SYMPTOM
elevated I-SYMPTOM
but O
otherwise O
relatively O
normal O
. O

Her O
amylase O
was O
mildly B-SYMPTOM
elevated I-SYMPTOM
but O
has O
been O
down O
since O
then O
. O

The O
patient O
has O
had O
progressive B-SYMPTOM
failure I-SYMPTOM
to I-SYMPTOM
thrive I-SYMPTOM
and O
steady B-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
. O

She O
was O
brought O
in O
for O
an O
esophagogastroduodenoscopy O
on O
9/26 O
but O
she O
basically O
was O
not O
sufficiently O
sedated B-TREATMENT
and O
readmitted O
at O
this O
time O
for O
a O
GI O
work-up O
as O
well O
as O
an O
evaluation O
of O
new B-SYMPTOM
abscess I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
calf I-SYMPTOM
and O
right O
medial O
lower O
extremity O
quadriceps O
muscle O
. O

She O
was O
also O
admitted O
to O
be O
connected O
up O
with O
social O
services O
for O
HIV B-SYMPTOM
patients O
. O

PAST O
MEDICAL O
HISTORY O
: O

As O
above O
. O

ALLERGIES O
: O

BACTRIM B-TREATMENT
. O

MEDICATIONS O
: O

On O
admission O
included O
Percocet B-TREATMENT
, O
Prinovil B-TREATMENT
, O
Dapsone B-TREATMENT
, O
Mycelex B-TREATMENT
troches I-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
was O
recently O
separated O
from O
her O
husband O
. O

She O
lives O
with O
her O
daughter O
. O

She O
does O
not O
drink O
, O
use O
IV O
drugs O
or O
smoke O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
revealed O
a O
cachetic O
woman O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
with O
stable O
vital O
signs O
. O

She O
was O
afebrile B-SYMPTOM
. O

She O
was O
not O
orthostatic B-SYMPTOM
. O

Blood O
pressure O
110/80 O
. O

HEENT O
exam O
was O
within O
normal O
limits O
. O

Lungs O
were O
clear O
to O
auscultation O
and O
percussion O
bilaterally O
. O

Cardiovascular O
exam O
revealed O
a O
regular O
rate O
and O
rhythm O
without O
murmur B-SYMPTOM
. O

Abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
with O
positive O
bowel O
sounds O
. O

There O
was O
no O
hepatosplenomegaly B-SYMPTOM
. O

Extremities O
revealed O
a B-SYMPTOM
2 I-SYMPTOM
x I-SYMPTOM
3 I-SYMPTOM
cm I-SYMPTOM
tender I-SYMPTOM
mass I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lateral I-SYMPTOM
left I-SYMPTOM
calf I-SYMPTOM
, O
medial B-SYMPTOM
1 I-SYMPTOM
cm I-SYMPTOM
mass I-SYMPTOM
above I-SYMPTOM
her I-SYMPTOM
knee I-SYMPTOM
. O

There O
was O
no O
evidence O
of O
edema B-SYMPTOM
. O

LABORATORY O
DATA O
: O

On O
admission O
included O
BUN O
/ O
creatinine O
of O
33/2.1 O
. O

Sodium O
141 O
. O

Potassium O
4.2 O
. O

Hematocrit O
23 O
. O

White O
blood O
cell O
count O
was O
2.1 O
with O
56 O
polys O
and O
1 O
band O
. O

Platelet O
count O
411,000 O
. O

Amylase O
143 O
. O

Lipase O
was O
elevated B-SYMPTOM
to O
600 O
. O

ESR O
was O
greater O
than O
140 O
. O

Alkaline O
phosphatase O
190 O
. O

ALT O
52 O
. O

AST O
65 O
. O

Beta O
hCG O
was O
negative O
. O

Urinalysis O
was O
positive B-SYMPTOM
for I-SYMPTOM
protein I-SYMPTOM
. O

Bilirubin O
0.4 O
. O

Chest O
x-ray O
revealed O
clear O
lung O
fields O
. O

There O
was O
no O
evidence O
of O
rib B-SYMPTOM
fracture I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
and O
many O
cultures O
were O
sent O
which O
were O
all O
negative O
. O

She O
did O
not O
have O
any O
of O
her B-SYMPTOM
pain I-SYMPTOM
in O
the O
hospital O
. O

On O
the O
third O
hospital O
day O
, O
she O
did O
have O
some B-SYMPTOM
pain I-SYMPTOM
and O
was O
treated O
with O
Percocet B-TREATMENT
. O

She O
went O
for O
a B-TREATMENT
debridement I-TREATMENT
of O
her B-SYMPTOM
left I-SYMPTOM
calf I-SYMPTOM
lesion I-SYMPTOM
on O
10/2/93 O
and O
was O
started O
empirically O
on O
IV B-TREATMENT
ceftriaxone I-TREATMENT
which O
was O
changed O
to O
po B-TREATMENT
doxycycline I-TREATMENT
on O
the O
day O
of O
discharge O
. O

A O
follow-up O
CT O
scan O
was O
done O
which O
did O
not O
show O
any O
evidence O
for O
splenomegaly B-SYMPTOM
or O
hepatomegaly B-SYMPTOM
. O

The B-SYMPTOM
1 I-SYMPTOM
cm I-SYMPTOM
cyst I-SYMPTOM
which O
was O
seen O
in O
10/92 O
was O
still O
present O
. O

There O
was O
a O
question O
of O
a B-SYMPTOM
cyst I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
kidney I-SYMPTOM
with O
a B-SYMPTOM
stone I-SYMPTOM
right O
below O
the B-SYMPTOM
cyst I-SYMPTOM
, O
although O
this O
did O
not O
seem O
to O
be O
clinically O
significant O
. O

DISPOSITION O
: O

The O
patient O
was O
discharged O
to O
home O
in O
stable O
condition O
. O

Cultures O
were O
pending O
on O
her O
aspirate O
and O
will O
be O
treated O
with O
po B-TREATMENT
doxycycline I-TREATMENT
. O

Dictated O
By O
: O

JIMCHARL O
B. O
BUN O
, O
M.D. O
OC33 O

Attending O
: O

I O
BUN O
, O
M.D. O
GR67 O
EF283/9675 O

Batch O
: O

2027 O

Index O
No. O
BOKMII88JZ O

D O
: O

10/03/93 O

T O
: O

10/07/93 O

207132235 O
SC O

51203606 O

132775 O

9/20/2000 O
12:00:00 O
AM O

ENDOMETRIAL B-SYMPTOM
CARCINOMA I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

09/20/2000 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

09/22/2000 O

ADMISSION O
DIAGNOSIS O
: O

ENDOMETRIAL B-SYMPTOM
CANCER I-SYMPTOM
. O

DISCHARGE O
DIAGNOSIS O
: O

ENDOMETRIAL B-SYMPTOM
CANCER I-SYMPTOM
. O

PROCEDURES O
: O

TOTAL B-TREATMENT
ABDOMINAL I-TREATMENT
HYSTERECTOMY I-TREATMENT
AND O
BILATERAL B-TREATMENT
SALPINGO-OOPHORECTOMY I-TREATMENT

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
48-year-old O
G O
3 O
P O
3 O
who O
presented O
to O
Dr. O
Fuscmadril O
&apos;s O
clinic O
after O
having O
an B-SYMPTOM
abnormal I-SYMPTOM
pap I-SYMPTOM
smear I-SYMPTOM
followed O
by O
an O
endometrial O
biopsy O
that O
was O
suggestive O
of O
grade B-SYMPTOM
1 I-SYMPTOM
endometrial I-SYMPTOM
cancer I-SYMPTOM
. O

This O
is O
a O
patient O
who O
, O
over O
the O
past O
year O
, O
has O
had O
no B-SYMPTOM
menses I-SYMPTOM
and O
thought O
she O
had O
become O
menopausal B-SYMPTOM
. O

She O
then O
began O
spotting B-SYMPTOM
for O
several O
months O
with O
some B-SYMPTOM
constant I-SYMPTOM
brown I-SYMPTOM
discharge I-SYMPTOM
. O

A O
pap O
smear O
that O
was O
obtained O
by O
her O
primary O
care O
physician O
showed O
an B-SYMPTOM
endometrial I-SYMPTOM
cell I-SYMPTOM
and O
thus O
she O
was O
referred O
to O
a O
gynecologist O
for O
an O
endometrial O
biopsy O
. O

The O
endometrial O
biopsy O
showed O
grade B-SYMPTOM
1 I-SYMPTOM
endometrial I-SYMPTOM
cancer I-SYMPTOM
. O

A O
decision O
was O
made O
to O
proceed O
with O
surgical B-TREATMENT
management I-TREATMENT
for O
this O
finding O
. O

PAST O
MEDICAL O
HISTORY O
: O

Migraines B-SYMPTOM
. O

ALLERGIES O
: O

Penicillin B-TREATMENT
. O

PAST O
SURGICAL O
HISTORY O
: O

Two B-TREATMENT
cesarean I-TREATMENT
sections I-TREATMENT
. O

PAST O
GYN O
HISTORY O
: O

Menarche O
at O
13 O
, O
regular O
menses O
to O
the O
age O
of O
46 O
. O

Then O
becoming O
irregular B-SYMPTOM
for O
several O
years O
. O

She O
had O
her O
first O
child O
at O
age O
21 O
. O

She O
has O
had O
one O
normal B-TREATMENT
spontaneous I-TREATMENT
vaginal I-TREATMENT
delivery I-TREATMENT
and O
two O
cesarean B-TREATMENT
sections I-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
was O
a O
prior O
off-and-on O
smoker O
but O
has O
quit O
in O
01/19 O
. O

She O
is O
married O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Imitrex B-TREATMENT
; O
Indocin B-TREATMENT
; O
Celebrex B-TREATMENT
; O
Verapamil B-TREATMENT
for O
migraines B-SYMPTOM
. O

FAMILY O
HISTORY O
: O

Mother O
with O
colonic B-SYMPTOM
polyps I-SYMPTOM
. O

She O
has O
a O
maternal O
uncle O
and O
maternal O
aunt O
both O
with O
colon B-SYMPTOM
cancer I-SYMPTOM
who O
have O
passed O
away O
from O
this B-SYMPTOM
disease I-SYMPTOM
. O

There O
was O
no O
additional O
history O
of O
breast B-SYMPTOM
, I-SYMPTOM
ovarian I-SYMPTOM
or I-SYMPTOM
uterine I-SYMPTOM
cancer I-SYMPTOM
in O
her O
family O
. O

PHYSICAL O
EXAMINATION O
: O

GENERAL O
: O

She O
is O
a O
well-developed O
, O
well-nourished O
female O
. O

She O
is O
5 O
foot O
4 O
inches O
and O
159 O
pounds O
. O

BREASTS O
: O

No O
masses B-SYMPTOM
. O

LUNGS O
: O

Clear O
to O
auscultation O
. O

HEART O
: O

Regular O
rate O
and O
rhythm O
. O

ABDOMEN O
: O

Soft O
, O
mildly B-SYMPTOM
obese I-SYMPTOM
with O
Pfannenstiel B-SYMPTOM
scar I-SYMPTOM
visualized O
. O

PELVIC O
: O

Normal O
introitus O
, O
normal O
appearing O
cervix O
, O
a O
small O
, O
mobile O
uterus O
. O

No O
additional B-SYMPTOM
masses I-SYMPTOM
or O
nodules B-SYMPTOM
appreciated O
on O
exam O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
on O
the O
day O
of O
her B-TREATMENT
surgery I-TREATMENT
which O
was O
09/20/00 O
. O

She O
underwent O
a B-TREATMENT
TAH-BSO I-TREATMENT
which O
was O
uncomplicated B-SYMPTOM
. O

Details O
of O
the B-TREATMENT
procedure I-TREATMENT
can O
be O
found O
in O
the O
operative O
dictation O
. O

In O
short O
, O
frozen O
pathology O
from O
the O
uterus O
showed O
that O
there O
was O
a B-SYMPTOM
grade I-SYMPTOM
1 I-SYMPTOM
cancer I-SYMPTOM
with O
no O
invasion B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
myometrium I-SYMPTOM
. O

There O
was O
no O
nodal O
dissection O
done O
at O
that O
time O
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
extremely O
well O
and O
did O
well O
during O
her O
postoperative O
course O
. O

By O
postoperative O
day O
#2 O
she O
was O
eating O
, O
ambulating O
and O
voiding O
on O
her O
own O
. O

She O
decided O
to O
now O
be O
discharged O
home O
at O
this O
time O
. O

She O
was O
discharged O
home O
with O
the B-TREATMENT
following I-TREATMENT
medications I-TREATMENT
: O

DISCHARGE O
MEDICATIONS O
: O

Percocet B-TREATMENT
; O
Colace B-TREATMENT
. O

FOLLOWUP O
: O

She O
will O
have O
a O
follow O
up O
appointment O
with O
Dr. O
Fuscmadril O
in O
four O
weeks O
. O

Dictated O
By O
: O

ARL O
STIREDELS O
, O
M.D. O
ZJ05 O

Attending O
: O

EAN O
L. O
FUSCMADRIL O
, O
M.D. O
RY2 O
JE898/7007 O

Batch O
: O

91309 O

Index O
No. O
DOABVQ3G8W O

D O
: O

09/22/00 O

T O
: O

09/23/00 O

Admission O
Date O
: O

2014-11-13 O

Discharge O
Date O
: O

2014-12-05 O

Date O
of O
Birth O
: O

2014-11-13 O

Sex O
: O

M O

Service O
: O

Neonatology O

HISTORY O
: O

Baby O
Boy O
Timberlake O
was O
born O
to O
a O
25 O
- O
year-old O
G-8 O
, O
P-4 O
to O
5 O
mom O
with O
Julie O
type O
B O
positive O
, O
antibody O
negative O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
rubella O
immune O
, O
RPR O
nonreactive O
, O
GBS B-SYMPTOM
positive I-SYMPTOM
with O
a O
history O
of O
infrequent O
prenatal O
care O
since O
28 O
weeks O
time O
and O
preterm B-SYMPTOM
labor I-SYMPTOM
. O

Mother O
had O
a O
history O
of O
anxiety B-SYMPTOM
and O
asthma B-SYMPTOM
as O
well O
as O
moderate O
cigarette O
smoking O
. O

The O
baby O
was O
delivered O
through O
normal O
spontaneous O
vaginal O
delivery O
with O
brief B-TREATMENT
blow I-TREATMENT
by I-TREATMENT
with O
Apgars O
of O
8 O
and O
9 O
. O

Father O
of O
baby O
not O
involved O
at O
this O
time O
. O

The O
patient O
's O
pediatrician O
is O
Wellesley O
House O
and O
is O
Dr O
. O
Shaw O
. O

The O
patient O
has O
many O
siblings O
, O
all O
of O
which O
are O
girls O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
, O
the O
patient O
's O
birth O
weight O
was O
1.705 O
kilograms O
, O
which O
is O
50th O
percentile O
. O

Length O
was O
40 O
cm O
, O
50th O
percentile O
. O

Head O
circumference O
was O
30 O
cm O
, O
50th O
percentile O
. O

The O
patient O
was O
born O
at O
32 O
and O
4/7 O
weeks O
gestation O
and O
brought O
directly O
to O
the O
CMED O
CSRU O
. O

HOSPITAL O
COURSE O
: O

By O
systems O
: O

Respiratory O
. O

After O
receiving O
brief B-TREATMENT
blow I-TREATMENT
by I-TREATMENT
oxygen I-TREATMENT
in O
the O
delivery O
room O
, O
the O
patient O
had O
no O
further O
episodes O
of O
ventilatory B-TREATMENT
assistance I-TREATMENT
required O
with O
good O
respiratory O
rate O
consistently O
. O

The O
patient O
was O
never O
placed O
on O
caffeine B-TREATMENT
. O

He O
is O
stable O
in O
room O
air O
at O
this O
time O
. O

Cardiovascular O
. O

No O
active O
issues O
. O

No O
history O
of O
hypotension B-SYMPTOM
. O

On O
no O
medications B-TREATMENT
at O
this O
time O
. O

Notably O
with O
respect O
to O
apnea B-SYMPTOM
and O
bradycardia B-SYMPTOM
of O
prematurity B-SYMPTOM
, O
the O
patient O
has O
reached O
5 O
days O
without O
significant B-SYMPTOM
apneic I-SYMPTOM
or I-SYMPTOM
bradycardic I-SYMPTOM
spells I-SYMPTOM
as O
of O
the O
time O
of O
discharge O
. O

Fluids O
, O
electrolytes O
and O
nutrition O
. O

The O
patient O
reached O
full O
volume O
feeds O
by O
day O
of O
life O
6 O
and O
had O
calories O
increased O
to O
maximum O
of O
26 O
kilocalories O
per O
ounce O
of O
Similac B-TREATMENT
special I-TREATMENT
care I-TREATMENT
until O
2014-12-03 O
, O
at O
which O
point O
this O
was O
weaned O
to O
24 O
kilocalories O
per O
ounce O
of O
straight B-TREATMENT
Similac I-TREATMENT
. O

This O
is O
the O
baby O
's O
discharge O
feedings O
and O
he O
is O
p.o. O
ad O
lib O
with O
a O
minimum O
of O
130 O
ml/kg/day O
, O
the O
patient O
has O
taken O
on O
an O
average O
greater O
than O
150 O
ml/kg/day O
ad O
lib O
over O
each O
of O
the O
past O
5 O
days O
. O

GI O
. O

The O
patient O
with O
peak O
bilirubin O
of O
6.5 O
on O
day O
of O
life O
3 O
. O

No O
phototherapy B-TREATMENT
was O
required O
. O

Hematology O
/ O
Infectious O
Disease O
. O

The O
patient O
's O
hematocrit O
at O
delivery O
was O
48 O
, O
with O
a O
white O
count O
of O
11.2 O
and O
platelets O
of O
301,000 O
. O

Initial O
differential O
was O
35 O
polys O
and O
zero O
bands O
, O
not O
suspicious O
for O
infectious B-SYMPTOM
condition I-SYMPTOM
. O

The O
patient O
was O
initially O
treated O
with O
48 O
hours O
of O
ampicillin B-TREATMENT
and O
gentamicin B-TREATMENT
until O
blood O
cultures O
were O
negative O
. O

The O
infant O
has O
had O
no O
antibiotics B-TREATMENT
since O
that O
time O
. O

Neurology O
. O

No O
issues O
. O

Sensory O
. O

Hearing O
screen O
was O
performed O
with O
automated O
auditory O
brainstem O
responses O
and O
was O
normal O
on O
2014-11-24 O
. O

Ophthalmology O
. O

The O
patient O
did O
not O
qualify O
for O
routine O
ophthalmology O
exams O
due O
to O
his O
gestational O
age O
at O
birth O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
DISPOSITION O
: O

Home O
. O

PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Shaw O
at O
Wellesley O
House O
. O

CARE O
RECOMMENDATIONS O
: O

1. O
Feedings O
at O
discharge O
- O
Similac B-TREATMENT
24 O
kilocalories O
per O
ounce O
p.o. O
ad O
lib O
. O

If O
the O
patient O
achieves O
above O
adequate O
weight O
gain O
of O
18-20 O
grams O
per O
kilogram O
per O
day O
, O
consider O
decreasing O
calories O
to O
standard O
20 O
kilocalories O
per O
ounce O
. O

2. O
Car O
seat O
positioning O
screening O
passed O
. O

3. O
State O
newborn O
screening O
sent O
per O
protocol O
and O
no O
abnormal B-SYMPTOM
reports I-SYMPTOM
have O
been O
received O
. O

4. O
Immunizations B-TREATMENT
received O
: O

Synagis B-TREATMENT
RSV I-TREATMENT
prophylaxis I-TREATMENT
given O
today O
due O
to O
multiple O
siblings O
at O
home O
with O
daycare O
exposure O
and O
the O
patient O
being O
between O
32 O
and O
35 O
weeks O
. O

Synagis B-TREATMENT
RSV I-TREATMENT
prophylaxis I-TREATMENT
should O
be O
considered O
in O
general O
from O
November O
through O
March O
for O
infants O
who O
meet O
any O
of O
the O
following O
3 O
criteria O
: O

1. O
Born O
at O
less O
than O
32 O
weeks O
, O

2. O
Born O
between O
32 O
and O
35 O
weeks O
with O
2 O
of O
the O
following O
: O

Daycare O
during O
RSV O
season O
, O
a O
smoker O
in O
the O
household O
, O
neuromuscular B-SYMPTOM
disease I-SYMPTOM
, O
airway B-SYMPTOM
abnormalities I-SYMPTOM
or O
school O
age O
sibling O
, O
or O
3. O
With O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
. O

Influenza B-TREATMENT
immunization I-TREATMENT
is O
recommended O
annually O
in O
the O
fall O
for O
all O
infants O
once O
they O
reach O
6 O
months O
of O
age O
. O

Before O
this O
age O
and O
for O
the O
first O
24 O
months O
of O
the O
child O
's O
life O
, O
immunization B-TREATMENT
against O
influenza B-SYMPTOM
is O
recommended O
for O
household O
contacts O
and O
out O
of O
home O
caregivers O
. O

FOLLOW O
UP O
: O

VNA O
and O
pediatric O
primary O
care O
physician O
appointments O
to O
be O
scheduled O
prior O
to O
discharge O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Prematurity B-SYMPTOM
. O

2. O
Apnea B-SYMPTOM
of O
prematurity B-SYMPTOM
. O

3. O
Rule O
out O
sepsis B-SYMPTOM
. O

Carol O
Eddie O
m.d O
00-112 O

Dictated O
By O
: O
John O
KT O
Bolling O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-12-05 O
15:53:11 O

T O
: O
2014-12-05 O
16:49:10 O

Job O
# O
: O
28583 O

Signed O
electronically O
by O
: O
DR. O
Carol O
Warren O
on O
: O
MON O
2014-12-08 O
11:49 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-05-08 O

Discharge O
Date O
: O

2014-05-19 O

Date O
of O
Birth O
: O

1946-01-06 O

Sex O
: O

F O

Service O
: O

CARDIOTHORACIC O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O

Jana O
V O
Pennington O
, O
M.D. O

Chief O
Complaint O
: O

lightheadedness B-SYMPTOM
, O
slight B-SYMPTOM
DOE I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

2014-05-11 O

Redo B-TREATMENT
AVR I-TREATMENT
with O
aortic B-TREATMENT
root I-TREATMENT
enlargement I-TREATMENT
( O
21 O
mm O
CE O
Magna O
pericardial O
valve O
) O

History O
of O
Present O
Illness O
: O

68 O
yo O
female O
trasnferred O
in O
from O
Catholic O
CMED O
CSRU. O
Ctr. O
with O
periprosthetic B-SYMPTOM
aortic I-SYMPTOM
valve I-SYMPTOM
stenosis I-SYMPTOM
and O
aortic B-SYMPTOM
valve I-SYMPTOM
thrombus I-SYMPTOM
. O

No O
cath O
done O
, O
but O
echo O
05-07 O
showed O
EF O
60-65% O
, O
stenotic B-SYMPTOM
mech. I-SYMPTOM
valve I-SYMPTOM
, O
mean O
gradient O
33 O
mm O
, O
decreased B-SYMPTOM
disc I-SYMPTOM
motion I-SYMPTOM
, O
mobile B-SYMPTOM
mass I-SYMPTOM
in I-SYMPTOM
LVOT I-SYMPTOM
, O
mild B-SYMPTOM
AI I-SYMPTOM
, O
mild B-SYMPTOM
to I-SYMPTOM
moderate I-SYMPTOM
MR I-SYMPTOM
, O
trace B-SYMPTOM
TR. I-SYMPTOM
Referred O
for O
surgical O
evaluation O
. O

Past O
Medical O
History O
: O

HTN B-SYMPTOM
elev. B-SYMPTOM
lipids I-SYMPTOM
hypothyroidism B-SYMPTOM
back B-SYMPTOM
pain I-SYMPTOM

GERD B-SYMPTOM

PSH O
: O

s/p O
AVR B-TREATMENT
2000 O
remote B-TREATMENT
tonsillectomy/adenoidectomy I-TREATMENT
partial B-TREATMENT
thyroidectomy I-TREATMENT
rem. B-TREATMENT
right I-TREATMENT
wrist I-TREATMENT
ganglion I-TREATMENT
cyst I-TREATMENT
left B-TREATMENT
foot I-TREATMENT
bunionectomy I-TREATMENT
breast O
biopsies O

Social O
History O
: O

retired O
, O
lives O
alone O
, O
widowed O
quit O
smoking O
20+ O
years O
ago O
no O
ETOH O
use O

Family O
History O
: O

father O
died O
at O
57 O
of O
heart B-SYMPTOM
problems I-SYMPTOM
brother O
died O
at O
age O
7 O
of O
"leaky B-SYMPTOM
valve" I-SYMPTOM
sister O
with O
CAD/CABG B-SYMPTOM

Physical O
Exam: O

180/88 O

HR O
68 O

RR O
18 O

95% O
sat O

65.5" O

87 O
kg O

NAD B-SYMPTOM
skin/HEENT O
unremarkable O
neck O
supple O
, O
murmur B-SYMPTOM
radiates O
bilat. O
to O
carotids O

CTAB O

RRR O
with O
holosystolic B-SYMPTOM
murmur I-SYMPTOM
soft O
, O
NT B-SYMPTOM
, O
ND B-SYMPTOM
, O
+ O
BS O
warm O
, O
well-perfused O
, O
no O
edema B-SYMPTOM
, O
superficial B-SYMPTOM
varicosities I-SYMPTOM
neuro O
grossly O
intact O

2+ O
bil. O
fem/ O
radials O

1+ O
bil. O
DP/PTs O

Pertinent O
Results O
: O

Cardiology O
Report O
ECHO O
Study O
Date O
of O
2014-05-11 O

POST-BYPASS O
: O

Pt O
is O
being O
AV O
paced O
, O
on O
an B-TREATMENT
infusion I-TREATMENT
of I-TREATMENT
phenylephrine I-TREATMENT

1. O
A B-TREATMENT
bioprosthesis I-TREATMENT
is O
well O
seated O
in O
the O
aortic O
position O
, O
leaflets O
open O
well O
, O
trace B-SYMPTOM
central I-SYMPTOM
AI I-SYMPTOM
is O
seen O
. O

Trace B-SYMPTOM
AI I-SYMPTOM
is O
also O
noted O
between O
the O
left O
and O
right O
coronary O
cusps O
. O

There O
is O
a B-SYMPTOM
small I-SYMPTOM
paravavluar I-SYMPTOM
leak I-SYMPTOM
in O
the O
area O
adjacent O
to O
the O
anterior O
mitral O
leaflet O
, O
resulting O
in O
some B-SYMPTOM
trace I-SYMPTOM
insuffiency I-SYMPTOM
outside O
the O
sewing O
ring O
. O

2. O
Mitral B-SYMPTOM
regurgitation I-SYMPTOM
is O
unchanged O
from O
before O
. O

3. O
Biventricular O
systolic O
function O
is O
unchanged O
. O

4. O
Aorta O
is O
intact O
post O
decannulation B-TREATMENT

5. O
Other O
findings O
are O
unchanged O

6. O
All O
findings O
discussed O
with O
surgeon O
at O
the O
time O
of O
the O
exam O
. O

2014-05-18 O
05:45AM O
BLOOD O

Hct O
- O
29.2* O

2014-05-17 O
04:40AM O
BLOOD O

WBC O
- O
12.4* O
RBC O
- O
2.89* O
Hgb O
- O
9.0* O
Hct O
- O
26.0* O

MCV O
- O
90 O
MCH O
- O
31.3 O
MCHC O
- O
34.9 O
RDW O
- O
13.5 O
Plt O
Ct O
- O
262 O

2014-05-18 O
05:45AM O
BLOOD O

PT O
- O
16.8* O
PTT O
- O
65.3* O
INR O
( O
PT O
) O
- O
1.5* O

2014-05-19 O
07:10AM O
BLOOD O

Glucose O
- O
115* O
UreaN O
- O
20 O
Creat O
- O
1.3* O
Na O
- O
137 O

K O
- O
4.8 O
Cl O
- O
96 O
HCO3 O
- O
34* O
AnGap O
- O
12 O

Brief O
Hospital O
Course O
: O

Admitted O
05-08 O
to O
cardiology O
service O
for O
surgical O
work-up O
. O

INR O
2.7 O
and O
echo O
repeated O
, O
coumadin B-TREATMENT
held O
, O
and O
heparin B-TREATMENT
drips I-TREATMENT
started O
. O

Review O
of O
OSH O
echo O
revealed O
peak O
gradient O
of O
64mm O
( O
not O
30 O
's O
) O
. O

New O
echo O
showed O
pannus B-SYMPTOM
involving O
the O
valve O
and O
? O
thrombus B-SYMPTOM
. O

Seen O
by O
Dr. O
Laura O
of O
cardiac O
surgery O
and O
underwent O
redo B-TREATMENT
AVR I-TREATMENT
with O
aortic B-TREATMENT
root I-TREATMENT
enlargement I-TREATMENT
on O
05-11 O
. O

Transferred O
to O
the O
CSRU O
in O
stable O
condition O
on O
phenylephrine B-TREATMENT
and O
propofol B-TREATMENT
drips I-TREATMENT
. O

Weaned O
to O
extubation O
on O
POD O
#2 O
and O
off O
all B-TREATMENT
drips I-TREATMENT
. O

Episode B-SYMPTOM
of I-SYMPTOM
AFib I-SYMPTOM
that O
evening O
treated O
with O
amiodarone B-TREATMENT
and O
converted O
to O
SR O
. O

Transferred O
to O
the O
floor O
on O
POD O
#3 O
to O
begin O
increasing O
her O
activity O
level O
. O

Chest B-TREATMENT
tubes I-TREATMENT
and O
wires B-TREATMENT
removed O
without O
incident B-SYMPTOM
. O

Cleared O
for O
discharge O
to O
home O
with O
services O
. O

Pt. O
to O
make O
all O
follow-up O
appts. O
per O
discharge O
instructions O
. O

Medications O
on O
Admission O
: O

synthroid B-TREATMENT
75 O
mcg O
daily O

HCTZ B-TREATMENT
37.5 O
mg O
daily O

MVI B-TREATMENT
daily O

Vit.C B-TREATMENT
500 O
mg O
daily O
prevacid B-TREATMENT
15 O
mg O
daily O
coumadin B-TREATMENT
( O
held O
) O
toprol B-TREATMENT
XL I-TREATMENT
100 O
mg O
daily O
zocor B-TREATMENT
40 O
mg O
daily O

KCl B-TREATMENT
12-27 O
mEq O
daily O
cozaar B-TREATMENT
25 O
mg O
daily O

Discharge O
Medications O
: O

1. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
: O
*180 O
Tablet( O
s O
)* O

Refills O
: O
*2* O

2. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
for O
1 O
months O
. O

Disp O
: O
*60 O
Capsule( O
s O
)* O

Refills O
: O
*0* O

3. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
: O
*30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)( O
s O
)* O

Refills O
: O
*2* O

4. O
Oxycodone-Acetaminophen B-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
for O
pain B-SYMPTOM
. O

Disp O
: O
*40 O
Tablet( O
s O
)* O

Refills O
: O
*0* O

5. O
Levothyroxine B-TREATMENT
75 O
mcg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
: O
*30 O
Tablet( O
s O
)* O

Refills O
: O
*2* O

6. O
Simvastatin B-TREATMENT
40 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
: O
*30 O
Tablet( O
s O
)* O

Refills O
: O
*2* O

7. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

Disp O
: O
*30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)( O
s O
)* O

Refills O
: O
*2* O

8. O
Amiodarone B-TREATMENT
200 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
for O
2 O
days O
: O
for O
2 O
days O
, O
then O
start O
200 O
mg O
daily O
ongoing O
on O
05-20 O
. O

Disp O
: O
*60 O
Tablet( O
s O
)* O

Refills O
: O
*1* O

9. O
Potassium B-TREATMENT
Chloride I-TREATMENT
10 O
mEq O
Capsule O
, O
Sustained O
Release O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
, O
Sustained O
Release O
PO O
once O
a O
day O
for O
7 O
days O
. O

Disp O
: O
*14 O
Capsule O
, O
Sustained O
Release( O
s O
)* O

Refills O
: O
*0* O

10. O
Furosemide B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
twice O
a O
day O
for O
7 O
days O
. O

Disp O
: O
*14 O
Tablet( O
s O
)* O

Refills O
: O
*0* O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

prosthetic B-SYMPTOM
aortic I-SYMPTOM
valve I-SYMPTOM
stenosis I-SYMPTOM

HTN B-SYMPTOM
elev. B-SYMPTOM
lipds I-SYMPTOM
hypothyroidism B-SYMPTOM
back B-SYMPTOM
pain I-SYMPTOM

GERD B-SYMPTOM

A B-SYMPTOM
Fib I-SYMPTOM
s/p O
AVR B-TREATMENT
2000 O

Discharge O
Condition O
: O

stable O

Discharge O
Instructions O
: O

no O
driving O
for O
one O
month O
no O
lifting O
greater O
than O
10 O
pounds O
for O
10 O
weeks O
no O
lotions O
, O
creams O
or O
powders O
on O
any O
incision B-SYMPTOM
may O
shower O
over O
incisions B-SYMPTOM
and O
pat O
dry O
call O
for O
fever B-SYMPTOM
greater O
than O
100.5 O
, O
redness B-SYMPTOM
or O
drainage B-SYMPTOM

Followup O
Instructions O
: O

see O
Dr. O
Rodriguez O
in O
1-2 O
weeks O
see O
Dr. O
Laura O
in O
4 O
weeks O

( O
944 O
) O
596 O
7247 O

Anthony O
Louis O
MD O
43-293 O

Completed O
by O
: O

Jerry O
Pamela O
NP O
80-BXH O
2014-05-19 O
@ O
1424 O

Signed O
electronically O
by O
: O

DR. O
Andre O
D. O
Bruner O
on O
: O

WED O
2014-05-21 O
5:55 O
PM O

( O
End O
of O
Report O
) O

387946944 O

FIH O

6652087 O

713765 O

7284844 O

9/21/2003 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

DOUETTWIDOUET O
, O
TAROBY O

MRN O
: O

6652087 O

Age O
: O

80y O

REGISTRATION O
DATE O
: O

09/21/2003 O
06:51 O
PM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
DOUETTWIDOUET O
, O
TAROBY O
arrived O
in O
the O
Emergency O
Department O
at O
Fairm O
of O
Ijordcompmac O
Hospital O
on O
09/21/2003 O
06:51 O
PM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
WEAK B-SYMPTOM
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
of O
the O
visit O
was O
ADMITTED O
AS O
AN O
INPATIENT O
TO O
FAIRM O
OF O
IJORDCOMPMAC O
HOSPITAL O
. O

The O
patient O
&apos;s O
preliminary O
admitting O
physician O
is O
SAPSCLYSS O
, O
LEO O
R O
and O
the O
preliminary O
diagnosis O
is O
WEAKNESS B-SYMPTOM
. O

Please O
note O
this O
information O
may O
have O
been O
updated O
on O
the O
inpatient O
unit O
. O

If O
you O
need O
additional O
information O
please O
call O
834-226-3369 O
. O

PCP O
Name O
: O

ROSORB O
, O
ASALEYSEAN O
I O

Provider O
Number O
: O

80629 O

258418598 O

FIH O

2044357 O

81841/8e23 O

715555 O

4/9/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

04-09-92 O

DISCHARGE O
DATE O
: O

04-20-92 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Kacholera O
Junk O
was O
a O
34 O
year O
old O
gentleman O
with O
no O
significant O
past O
medical O
history O
except O
for O
a O
history O
of O
of O
intravenous O
drug O
abuse O
. O

He O
was O
status O
post O
a B-TREATMENT
rehabilitation I-TREATMENT
hospitalization I-TREATMENT
at O
the O
Raya O
Ma O
Den O
Erinmarg O
Hospital O
with O
a O
recent O
recrudescence O
of O
his O
drug O
abuse O
. O

He O
was O
admitted O
to O
the O
Sephsandpot O
Center O
on O
the O
morning O
of O
4/9 O
and O
was O
subsequently O
transferred O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
for O
further B-TREATMENT
care I-TREATMENT
. O

The O
patient O
was O
apparently O
well O
until O
one O
day O
prior O
to O
admission O
. O

His O
family O
reports O
that O
he O
had O
worked O
that O
day O
. O

He O
relates O
using O
large O
doses O
of O
Cocaine O
and O
Heroin O
early O
in O
the O
morning O
on O
the O
day O
of O
admission O
. O

At O
3:00 O
a.m. O
on O
the O
day O
of O
admission O
he O
was O
found O
by O
the O
emergency O
medical O
technicians O
&quot; O
crawling O
on O
all O
fours O
&quot; O
, O
confused B-SYMPTOM
, O
and O
combative B-SYMPTOM
outside O
his O
home O
. O

He O
gave O
an O
equivocal O
history O
of O
fevers B-SYMPTOM
and O
chills B-SYMPTOM
on O
the O
days O
prior O
to O
admission O
. O

Bystanders O
report O
that O
he O
was O
assaulted O
about O
20 O
minutes O
earlier O
and O
the O
nature O
of O
the O
assault O
was O
not O
known O
. O

He O
was O
taken O
to O
the O
Sephsandpot O
Center O
where O
he O
was O
hypotensive B-SYMPTOM
with O
a O
blood O
pressure O
of O
105/85 O
, O
tachycardic B-SYMPTOM
with O
a O
heart O
rate O
to O
186 O
, O
aneuric B-SYMPTOM
, O
hyperthermic B-SYMPTOM
, O
with O
a O
temperature O
to O
105 O
degrees O
F O
, O
and O
progressively B-SYMPTOM
more I-SYMPTOM
confused I-SYMPTOM
. O

His O
chest O
x-ray O
was O
clear O
. O

He O
was O
treated O
with O
Dopamine B-TREATMENT
for O
hypertension B-SYMPTOM
and O
Inderal B-TREATMENT
for O
tachycardia B-SYMPTOM
. O

He O
received O
two O
amps O
of O
Narcan B-TREATMENT
. O

He O
received O
one O
gram O
of O
Ceftriaxone B-TREATMENT
intravenously O
after O
blood O
cultures O
were O
drawn O
. O

His O
initial O
arterial O
blood O
gas O
at O
the O
Sephsandpot O
Center O
revealed O
a O
p02 O
of O
76 O
, O
pC02 O
14 O
, O
and O
a O
pH O
of O
7.44 O
on O
room O
air O
. O

He O
was O
then O
transferred O
via O
Med O
Flight O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
. O

He O
denied O
any O
history O
of O
recent O
travel O
. O

Toxicology O
screen O
at O
Sephsandpot O
Center O
revealed O
Cocaine O
and O
Quinine B-TREATMENT
. O

Shortly O
after O
his O
arrival O
to O
that O
hospital O
he O
had O
been O
intubated O
for O
a O
respiratory O
rate O
of O
60 O
. O

He O
required O
medical B-TREATMENT
paralysis I-TREATMENT
for O
this O
. O

He O
was O
reported O
to O
have O
a B-SYMPTOM
seizure I-SYMPTOM
, O
although O
the O
nature O
of O
this O
was O
unclear O
, O
and O
received O
Valium B-TREATMENT
for O
this O
. O

PAST O
MEDICAL O
HISTORY O
: O

None O
. O

PAST O
SURGICAL O
HISTORY O
: O

He O
is O
status O
post O
recent B-TREATMENT
left I-TREATMENT
knee I-TREATMENT
surgery I-TREATMENT
, O
status O
post O
left B-TREATMENT
carpal I-TREATMENT
tunnel I-TREATMENT
release I-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

His B-TREATMENT
meds I-TREATMENT
on O
transfer O
to O
FIH O
were O
Levophed B-TREATMENT
, O
Dopamine B-TREATMENT
, O
and O
Ceftriaxone B-TREATMENT
. O

FAMILY O
HISTORY O
: O

The O
patient O
is O
divorced O
with O
no O
children O
. O

His O
mother O
and O
father O
are O
alive O
and O
well O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
works O
as O
a O
welder O
. O

He O
has O
a O
history O
of O
intravenous O
drug O
abuse O
, O
no O
alcohol O
abuse O
or O
tobacco O
abuse O
. O

PHYSICAL O
EXAMINATION O
: O

Revealed O
an O
obtunded O
white O
muscular O
man O
who O
was O
intubated B-TREATMENT
and O
sedated B-TREATMENT
. O

The O
vital O
signs O
showed O
a O
blood O
pressure O
of O
69 O
, O
pulse O
80 O
, O
respirations O
14 O
, O
and O
temperature O
99.8 O
. O

There O
is O
a B-SYMPTOM
contusion I-SYMPTOM
over I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
eye I-SYMPTOM
but O
no O
laceration B-SYMPTOM
, O
abrasion B-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
left I-SYMPTOM
shoulder I-SYMPTOM
, O
no O
flank B-SYMPTOM
discoloration I-SYMPTOM
, O
blanching B-SYMPTOM
papules I-SYMPTOM
over I-SYMPTOM
the I-SYMPTOM
knees I-SYMPTOM
bilaterally I-SYMPTOM
without O
central B-SYMPTOM
necrosis I-SYMPTOM
. O

He O
had O
multiple O
tattoos O
. O

Lymphatic-he O
had O
shotty B-SYMPTOM
cervical I-SYMPTOM
adenopathy I-SYMPTOM
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
exam O
was O
normocephalic O
, O
with O
trauma B-SYMPTOM
as O
described O
, O
pupils O
were O
2 O
mm O
bilaterally O
which O
were O
minimally B-SYMPTOM
reactive I-SYMPTOM
, O
fundi O
was O
not O
seen O
, O
conjunctivae O
without O
erythema B-SYMPTOM
, O
sclerae O
anicteric B-SYMPTOM
, O
positive O
corneal O
reflexes O
noted O
. O

Ears-the O
tympanic O
membranes O
were O
clear O
with O
no O
hemorrhage B-SYMPTOM
at O
the O
time O
of O
admission O
. O

Nose-no O
sinus B-SYMPTOM
discharge I-SYMPTOM
, O
no O
hemorrhage B-SYMPTOM
. O

The O
oropharynx O
was O
intubated B-TREATMENT
. O

Lungs-clear O
with O
good O
air O
movement O
bilaterally O
. O

He O
had O
scattered B-SYMPTOM
wheezes I-SYMPTOM
following O
a B-TREATMENT
3 I-TREATMENT
liter I-TREATMENT
bolus I-TREATMENT
for O
hypotension B-SYMPTOM
. O

No O
effusion B-SYMPTOM
or O
rub B-SYMPTOM
was O
heard O
. O

The O
cardiac O
exam O
showed O
point O
of O
maximal O
impulse O
was O
not O
displaced O
, O
regular O
rate O
and O
rhythm O
with O
normal O
S1 O
, O
S2 O
, O
no O
S3 B-SYMPTOM
or O
S4 B-SYMPTOM
, O
a B-SYMPTOM
grade I-SYMPTOM
II I-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
systolic I-SYMPTOM
murmur I-SYMPTOM
was O
heard O
at O
the O
left O
upper O
sternal O
border O
without O
radiation B-SYMPTOM
, O
likely O
representing O
a B-SYMPTOM
flow I-SYMPTOM
murmur I-SYMPTOM
. O

No O
peripheral B-SYMPTOM
edema I-SYMPTOM
was O
noted O
. O

The O
jugular O
venous O
pressure O
was O
not O
assessed O
secondary O
to O
cervical B-TREATMENT
collar I-TREATMENT
being O
in O
place O
. O

The O
carotid O
pulses O
were O
brisk O
bilaterally O
. O

The O
vascular O
exam O
showed O
normal O
pulses O
bilaterally O
without O
bruits B-SYMPTOM
. O

The O
abdomen O
was O
soft O
, O
bowel O
sounds O
of O
normal O
character O
, O
and O
there O
was O
mild B-SYMPTOM
percussion I-SYMPTOM
tenderness I-SYMPTOM
and O
tenderness B-SYMPTOM
to O
modest O
palpation O
in O
all O
four O
quadrants O
. O

It O
was O
unclear O
whether O
this O
was O
due O
to O
superficial B-SYMPTOM
tenderness I-SYMPTOM
or O
abdominal B-SYMPTOM
tenderness I-SYMPTOM
. O

He O
had O
marked B-SYMPTOM
voluntary I-SYMPTOM
guarding I-SYMPTOM
without O
rigidity B-SYMPTOM
and O
no O
masses B-SYMPTOM
were O
felt O
. O

The O
genitourinary O
exam O
showed O
normal O
penis O
with O
normal O
testicles O
which O
were O
nontender B-SYMPTOM
. O

There O
was O
no O
urethritis B-SYMPTOM
, O
no O
balinitis B-SYMPTOM
, O
normal O
prostate O
, O
nontender B-SYMPTOM
. O

There O
was O
tan B-SYMPTOM
guaiac I-SYMPTOM
positive I-SYMPTOM
stool I-SYMPTOM
with O
no O
masses B-SYMPTOM
. O

The O
musculoskeletal O
exam O
showed O
well O
developed O
, O
symmetrical O
muscular O
development O
with O
no O
fasciculations B-SYMPTOM
, O
no O
joint B-SYMPTOM
erythema I-SYMPTOM
, O
no O
effusions B-SYMPTOM
. O

Neuro O
exam-the O
Mental O
Status O
Exam O
was O
variable O
, O
intermittently B-SYMPTOM
responsive I-SYMPTOM
, O
unable B-SYMPTOM
to O
follow O
commands O
. O

He O
nods O
appropriately O
and O
was O
able O
to O
confirm O
known O
history O
. O

The O
cranial O
nerves O
II-XII O
grossly O
intact O
, O
bilaterally O
symmetric O
. O

The O
motor O
exam-moves O
all O
four O
extremities O
easily O
and O
on O
command O
. O

The O
sensory O
exam O
revealed O
no O
focal B-SYMPTOM
deficits I-SYMPTOM
to O
limited O
exam O
. O

Reflexes O
were O
trace O
in O
the O
upper O
extremities O
and O
absent B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
knees I-SYMPTOM
with O
downgoing O
toes O
bilaterally O
. O

LABORATORY O
DATA O
: O

On O
admission O
the O
sodium O
was O
144 O
, O
potassium O
2.6 O
, O
chloride O
114 O
, O
bicarbonate O
12.3 O
, O
BUN O
30 O
, O
creatinine O
4.0 O
, O
glucose O
89 O
. O

The O
SGOT O
was O
994 O
, O
LDH O
1,888 O
, O
alkaline O
phosphatase O
92 O
, O
total O
bilirubin O
2.9 O
and O
direct O
bilirubin O
11.2 O
. O

Lactate O
was O
6.3 O
, O
acetone O
negative O
, O
ammonia O
26 O
, O
uric O
acids O
26.9 O
, O
albumin O
4.0 O
, O
globulin O
3.0 O
, O
amylase O
259 O
, O
lipase O
34 O
, O
magnesium O
3.5 O
, O
phosphorus O
1.9 O
, O
calcium O
9.4. O
The O
white O
blood O
count O
was O
19.7 O
with O
89% O
polys O
, O
7% O
bands O
, O
4% O
lymphs O
, O
with O
toxic B-SYMPTOM
granulations I-SYMPTOM
. O

Hematocrit O
was O
45.2 O
with O
a O
platelet O
count O
of O
132,000 O
, O
falling O
rapidly O
to O
24,000 O
. O

The O
MCV O
is O
88 O
. O

The O
prothrombin O
time O
is O
27.7 O
, O
partial O
thromboplastin O
time O
is O
greater O
than O
100 O
. O

The O
urinalysis O
revealed O
a O
specific O
gravity O
of O
1.15 O
, O
pH O
5.0 O
, O
and O
4+ B-SYMPTOM
albumin I-SYMPTOM
, O
positive B-SYMPTOM
occult I-SYMPTOM
blood I-SYMPTOM
, O
with O
0-5 B-SYMPTOM
granular I-SYMPTOM
casts I-SYMPTOM
and O
5-10 B-SYMPTOM
RBCs I-SYMPTOM
and O
3-5 B-SYMPTOM
WBCs I-SYMPTOM
. O

The O
CK O
was O
17,890 O
with O
0.6% O
MB O
. O

The O
urine O
sodium O
was O
147 O
. O

The O
serum O
toxicology O
was O
positive B-SYMPTOM
for O
Cocaine O
on O
admission O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
as O
well O
as O
the O
Sephsandpot O
Center O
. O

The O
electrocardiogram O
revealed O
normal O
sinus O
rhythm O
at O
85 O
with O
a B-SYMPTOM
prolonged I-SYMPTOM
QT I-SYMPTOM
at O
0.572 O
. O

An O
I-head O
CT O
revealed O
left O
sphenoid O
and O
left B-SYMPTOM
maxillary I-SYMPTOM
sinusitis I-SYMPTOM
with O
mild B-SYMPTOM
cerebral I-SYMPTOM
edema I-SYMPTOM
and O
no O
focal B-SYMPTOM
hemorrhages I-SYMPTOM
. O

The O
abdominal O
CT O
revealed O
mesenteric B-SYMPTOM
adenopathy I-SYMPTOM
, O
normal O
bowels O
, O
hepatosplenomegaly B-SYMPTOM
, O
and O
? O
fatty B-SYMPTOM
liver I-SYMPTOM
. O

Chest O
x-ray O
revealed O
early B-SYMPTOM
interstitial I-SYMPTOM
edema I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
with O
the O
diagnosis O
of O
Cocaine B-SYMPTOM
induced I-SYMPTOM
rhabdomyolysis I-SYMPTOM
, O
renal B-SYMPTOM
failure I-SYMPTOM
, O
disseminated B-SYMPTOM
intravascular I-SYMPTOM
coagulation I-SYMPTOM
, O
shock B-SYMPTOM
, O
hepatic B-SYMPTOM
failure I-SYMPTOM
, O
pancreatitis B-SYMPTOM
, O
and O
thrombocytopenia B-SYMPTOM
in O
the O
setting O
of O
Cocaine O
intoxication O
. O

He O
was O
accepted O
at O
the O
Vo O
Yd O
Burgsygu O
Hospital O
Center O
Intensive O
Care O
Unit O
and O
his O
hospital O
course O
will O
be O
reviewed O
by O
problems O
. O

1-Rhabdomyolysis B-SYMPTOM
. O

The O
patient O
had O
massive B-SYMPTOM
Cocaine I-SYMPTOM
induced I-SYMPTOM
rhabdomyolysis I-SYMPTOM
. O

This O
resulted O
in O
tremendous B-SYMPTOM
third I-SYMPTOM
spacing I-SYMPTOM
of I-SYMPTOM
fluid I-SYMPTOM
and O
persistent B-SYMPTOM
intervascular I-SYMPTOM
hypovolemia I-SYMPTOM
. O

The O
patient O
&apos;s O
creatinine O
______________ O
kinase O
peaked O
at O
56,160 O
with O
negative O
MB O
percentages O
. O

The O
aldolase O
was O
positive O
at O
142 O
. O

This O
was O
further O
complicated O
by O
hypocalcemia B-SYMPTOM
which O
resulted O
in O
mild B-SYMPTOM
electrocardiographic I-SYMPTOM
abnormalities I-SYMPTOM
. O

The O
patient O
&apos;s O
urine O
was O
alkalinized B-TREATMENT
with O
intravenous B-TREATMENT
bicarbonate I-TREATMENT
to O
maximize O
the O
myoglobin O
secretion O
. O

The O
patient O
&apos;s O
urine O
output O
was O
further O
augmented O
by O
adding O
Dopamine B-TREATMENT
. O

Nevertheless O
, O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
continued O
to O
progress O
. O

Over O
the O
course O
of O
the O
hospitalization O
his O
CK O
fell O
in O
the O
serum O
. O

Much O
of O
his B-SYMPTOM
diffuse I-SYMPTOM
pain I-SYMPTOM
was O
felt O
to O
be O
due O
to O
this B-SYMPTOM
massive I-SYMPTOM
rhabdomyolysis I-SYMPTOM
. O

2-Renal B-SYMPTOM
failure I-SYMPTOM
. O

The O
creatinine O
was O
4.4 O
on O
admission O
and O
peaked O
at O
10.5 O
on O
the O
15th O
. O

The O
urinalysis O
revealed O
4+ B-SYMPTOM
albumin I-SYMPTOM
with O
marked B-SYMPTOM
occult I-SYMPTOM
blood I-SYMPTOM
. O

Peritoneal B-TREATMENT
dialysis I-TREATMENT
was O
instituted O
on O
4/11 O
after O
a B-TREATMENT
Tenckhoff I-TREATMENT
catheter I-TREATMENT
was O
placed O
by O
Drs. O
Freierm O
, O
Le O
, O
and O
Round O
. O

Subsequently O
his O
creatinine O
rose O
for O
three O
days O
and O
then O
stabilized O
at O
10 O
. O

He O
continued O
to O
make O
minimal B-SYMPTOM
urine I-SYMPTOM
throughout O
the O
hospitalization O
. O

3-Disseminated B-SYMPTOM
intravascular I-SYMPTOM
coagulation I-SYMPTOM
. O

On O
admission O
the O
patient O
&apos;s O
prothrombin O
time O
was O
27.7 O
with O
a O
partial O
thromboplastin O
time O
of O
greater O
than O
100 O
and O
a O
d-dimer O
positive O
at O
8 O
with O
a O
fibrinogen O
of O
69 O
. O

He O
went O
on O
to O
develop O
profound B-SYMPTOM
thrombocytopenia I-SYMPTOM
complicated O
by O
hemorrhage B-SYMPTOM
. O

The O
patient O
was O
supported O
with O
abundant O
use O
of O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
, O
cryoprecipitate B-TREATMENT
, O
platelets B-TREATMENT
, O
and O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

His B-SYMPTOM
DIC I-SYMPTOM
was O
further O
complicated O
by O
hepatic B-SYMPTOM
failure I-SYMPTOM
which O
resulted O
in O
poor B-SYMPTOM
endogenous I-SYMPTOM
production I-SYMPTOM
of I-SYMPTOM
clotting I-SYMPTOM
factors I-SYMPTOM
and O
he O
remained O
fresh B-SYMPTOM
frozen I-SYMPTOM
plasma I-SYMPTOM
dependent I-SYMPTOM
. O

4-Septic B-SYMPTOM
shock I-SYMPTOM
. O

The O
patient O
remained O
pressor B-SYMPTOM
dependent I-SYMPTOM
throughout O
his O
hospitalization O
. O

He O
was O
maintained O
variously O
on O
Levophed B-TREATMENT
, O
Dobutamine B-TREATMENT
, O
Dopamine B-TREATMENT
, O
and O
ultimately O
Epinephrine B-TREATMENT
for O
blood B-TREATMENT
pressure I-TREATMENT
support I-TREATMENT
. O

Hemodynamic O
monitoring O
revealed O
low B-SYMPTOM
systemic I-SYMPTOM
vascular I-SYMPTOM
resistance I-SYMPTOM
and O
high B-SYMPTOM
cardiac I-SYMPTOM
output I-SYMPTOM
. O

He O
had O
multiple O
sources O
of O
infection B-SYMPTOM
including O
his O
sinuses O
, O
lungs O
, O
and O
multiple B-TREATMENT
lines I-TREATMENT
. O

This O
will O
be O
discussed O
below O
. O

Further O
he O
had O
massive B-SYMPTOM
muscle I-SYMPTOM
necrosis I-SYMPTOM
and O
hepatic B-SYMPTOM
failure I-SYMPTOM
. O

An O
echocardiogram O
on O
4/12 O
revealed O
a B-SYMPTOM
dilated I-SYMPTOM
left I-SYMPTOM
ventricle I-SYMPTOM
which O
was O
diffusely B-SYMPTOM
mildly I-SYMPTOM
hypokinetic I-SYMPTOM
with O
no O
vegetations B-SYMPTOM
. O

His O
ejection O
fraction O
was O
55% O
. O

On O
4/16 O
the O
pulmonary O
artery O
catheter O
was O
placed O
which O
revealed O
a O
wedge O
pressure O
of O
8 O
, O
cardiac O
index O
of O
4.5 O
, O
and O
an O
SVR O
of O
5.8 O
. O

5-Hepatic B-SYMPTOM
failure I-SYMPTOM
. O

His O
SGPT O
on O
admission O
was O
2,520 O
with O
a O
peak O
at O
7,680 O
on O
hospital O
day O
two O
. O

He O
had O
complete B-SYMPTOM
loss I-SYMPTOM
of I-SYMPTOM
synthetic I-SYMPTOM
and I-SYMPTOM
conjugation I-SYMPTOM
function I-SYMPTOM
of O
the O
liver O
with O
rising B-SYMPTOM
bilirubin I-SYMPTOM
and O
falling B-SYMPTOM
albumin I-SYMPTOM
with O
dependence B-SYMPTOM
on I-SYMPTOM
transfusion I-SYMPTOM
for O
support O
of O
his O
prothrombin O
time O
. O

He O
was O
seen O
in O
consultation O
by O
the O
GI O
Service O
and O
the O
Liver O
Transplantation O
Service O
. O

Given O
his B-SYMPTOM
multiple I-SYMPTOM
other I-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
, O
the O
direness O
of O
his O
situation O
, O
and O
his O
ongoing O
substance O
abuse O
at O
the O
time O
of O
admission O
he O
was O
deemed O
not O
to O
be O
a O
candidate O
for O
a B-TREATMENT
liver I-TREATMENT
transplantation I-TREATMENT
. O

6-Cocaine O
intoxication O
. O

Serum O
Cocaine O
was O
positive B-SYMPTOM
6-12 O
hours O
ingestion O
at O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
. O

Further O
, O
at O
Ceanotsit O
Ortgold O
Center O
his O
serum O
toxicology O
screens O
were O
positive B-SYMPTOM
. O

This O
is O
thought O
to O
be O
the O
insighting O
cause O
of O
his B-SYMPTOM
massive I-SYMPTOM
rhabdomyolysis I-SYMPTOM
and O
hepatic B-SYMPTOM
failure I-SYMPTOM
. O

7-Pneumonia B-SYMPTOM
. O

The O
patient O
developed O
two B-SYMPTOM
pneumonias I-SYMPTOM
with O
two B-SYMPTOM
separate I-SYMPTOM
organisms I-SYMPTOM
. O

The O
first O
was O
Acinetobacter B-SYMPTOM
calcoaceticus I-SYMPTOM
subspecies I-SYMPTOM
anitratus I-SYMPTOM
, O
treated O
with O
Ciprofloxacin B-TREATMENT
and O
Gentamicin B-TREATMENT
. O

He O
subsequently O
developed O
a B-SYMPTOM
staphylococcus I-SYMPTOM
aureus I-SYMPTOM
pneumonia I-SYMPTOM
which O
was O
treated O
with O
Vancomycin B-TREATMENT
, O
dosed O
to O
levels O
appropriate O
for O
his B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
. O

He O
was O
seen O
in O
consultation O
by O
the O
Infectious O
Disease O
Service O
who O
advised O
us O
on O
antibiotic B-TREATMENT
choices I-TREATMENT
daily O
. O

8-Pancreatitis B-SYMPTOM
. O

The O
amylase O
on O
admission O
was O
279 O
with O
a O
lipase O
of O
161 O
. O

Although O
not O
fully O
this O
may O
have O
contributed O
to O
his B-SYMPTOM
hypocalcemia I-SYMPTOM
and O
volume B-SYMPTOM
requirements I-SYMPTOM
. O

9-Catheter B-SYMPTOM
tip I-SYMPTOM
infections I-SYMPTOM
. O

The O
patient O
grew O
out O
coagulase B-SYMPTOM
negative I-SYMPTOM
staphylococcus I-SYMPTOM
from O
the B-TREATMENT
femoral I-TREATMENT
lines I-TREATMENT
which O
were O
placed O
during O
his B-SYMPTOM
profound I-SYMPTOM
hypertension I-SYMPTOM
. O

These O
were O
treated O
with O
Vancomycin B-TREATMENT
. O

10-Anemia B-SYMPTOM
. O

The O
patient O
&apos;s O
hematocrit O
was O
33% O
on O
admission O
and O
fell O
to O
28 O
requiring O
4 O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
over O
the O
course O
of O
his O
hospitalization O
. O

11-Coma B-SYMPTOM
. O

The O
patient O
, O
although O
initially O
minimally B-SYMPTOM
responsive I-SYMPTOM
, O
went O
on O
to O
develop O
a B-SYMPTOM
deep I-SYMPTOM
comatose I-SYMPTOM
state I-SYMPTOM
. O

A O
CT O
scan O
on O
admission O
revealed O
no O
evidence O
of O
hemorrhage B-SYMPTOM
though O
he O
did O
have O
sphenoid B-SYMPTOM
sinusitis I-SYMPTOM
. O

The O
lumbar O
puncture O
and O
sinus O
exploration O
were O
unable O
to O
be O
performed O
given O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
persistent I-SYMPTOM
coagulopathy I-SYMPTOM
. O

The O
patient O
was O
treated O
empirically O
with O
Nafcillin B-TREATMENT
and O
Ceftriaxone B-TREATMENT
for O
meningitis B-SYMPTOM
and O
sinusitis B-SYMPTOM
. O

Further O
complicating O
this O
was O
his B-SYMPTOM
profound I-SYMPTOM
liver I-SYMPTOM
failure I-SYMPTOM
with O
rising B-SYMPTOM
ammonias I-SYMPTOM
and O
hepatic B-SYMPTOM
encephalopathy I-SYMPTOM
. O

Despite O
maximal B-TREATMENT
supports I-TREATMENT
the O
patient O
continued O
to O
be O
hypotensive B-SYMPTOM
. O

Mid-way O
through O
his O
hospital O
course O
he O
developed O
trilobar B-SYMPTOM
pneumonia I-SYMPTOM
and O
this O
was O
probably O
complicated O
further O
by O
adult B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
and O
the B-SYMPTOM
multi-organ I-SYMPTOM
system I-SYMPTOM
failure I-SYMPTOM
syndrome I-SYMPTOM
. O

The O
patient O
remained O
mechanically B-TREATMENT
ventilated I-TREATMENT
throughout O
his O
hospitalization O
. O

Nevertheless O
, O
he O
developed O
refractory B-SYMPTOM
hypoxemia I-SYMPTOM
, O
hypotension B-SYMPTOM
, O
and O
ultimately O
the O
patient O
died O
despite O
total B-TREATMENT
life I-TREATMENT
support I-TREATMENT
. O

DISCHARGE O
DIAGNOSIS O
: O

Cocaine O
intoxication O
, O
rhabdomyolysis B-SYMPTOM
, O
renal B-SYMPTOM
failure I-SYMPTOM
, O
disseminated B-SYMPTOM
intravascular I-SYMPTOM
coagulation I-SYMPTOM
, O
septic B-SYMPTOM
shock I-SYMPTOM
, O
hepatic B-SYMPTOM
failure I-SYMPTOM
, O
pneumonia B-SYMPTOM
, O
pancreatitis B-SYMPTOM
, O
catheter B-SYMPTOM
tip I-SYMPTOM
infection I-SYMPTOM
, O
anemia B-SYMPTOM
, O
coma B-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Peritoneal B-TREATMENT
dialysis I-TREATMENT
catheter I-TREATMENT
placement I-TREATMENT
, O
peritoneal B-TREATMENT
dialysis I-TREATMENT
, O
arterial B-TREATMENT
catheterization I-TREATMENT
, O
venous B-TREATMENT
catheterization I-TREATMENT
, O
continuous B-TREATMENT
mechanical I-TREATMENT
ventilation I-TREATMENT
, O
and O
parenteral B-TREATMENT
nutrition I-TREATMENT
. O

COMPLICATIONS O
DURING O
ADMISSION O
: O

Neck B-SYMPTOM
hematoma I-SYMPTOM
secondary O
to O
pulmonary B-TREATMENT
artery I-TREATMENT
line I-TREATMENT
placement I-TREATMENT
requiring O
transfusion B-TREATMENT
, O
catheter B-SYMPTOM
tip I-SYMPTOM
infection I-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

None O
. O

CONDITION O
ON O
DISCHARGE O
: O

The O
patient O
was O
discharged O
to O
Samfer O
Street O
with O
no O
autopsy O
. O

LENNI O
HEAD O
, O
M.D. O

TR O
: O

be O
/ O
bmot O

DD O
: O

09-05-92 O

TD O
: O

09/07/92 O

CC O
: O

Admission O
Date O
: O

2011-01-21 O

Discharge O
Date O
: O

2011-02-23 O

Date O
of O
Birth O
: O

1988-10-20 O

Sex O
: O

M O

Service O
: O

TRAUMA O
SER O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
20 O
year O
old O
driver O
was O
in O
a O
major O
motor O
vehicle O
accident O
and O
brought O
to O
the O
Emergency O
Saints O
Medical O
Center O
following O
this O
, O
with O
multiple B-SYMPTOM
trauma I-SYMPTOM
. O

The O
patient O
was O
an O
unrestrained O
driver O
in O
a O
car O
versus O
tree O
. O

He O
was O
involved O
in O
a O
long O
extrication O
with O
a O
blood O
pressure O
of O
88 O
at O
the O
scene O
. O

Upon O
extrication O
from O
the O
vehicle O
, O
he O
was O
intubated O
and O
transported O
to O
the O
Emergency O
Room O
. O

He O
was O
tachycardic B-SYMPTOM
with O
an O
initial O
blood O
pressure O
of O
120 O
/ O
palpable O
. O

A B-TREATMENT
groin I-TREATMENT
line I-TREATMENT
was O
placed O
and O
the O
patient O
was O
sedated O
and O
paralyzed O
. O

He O
was O
resuscitated O
with O
Crystalloid B-TREATMENT
and O
remained O
hemodynamically O
stable O
. O

He O
had O
a B-SYMPTOM
grossly I-SYMPTOM
deformed I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
. O

On O
examination O
, O
Belmont O
Coma O
Scale O
was O
6T O
; O
blood O
pressure O
was O
120 O
/ O
palpable O
with O
a O
heart O
rate O
of O
122 O
. O

The O
trachea O
was O
midline O
. O

The O
abdomen O
was O
soft O
. O

Rectal O
was O
heme B-SYMPTOM
positive I-SYMPTOM
with O
normal O
prostate O
. O

There O
were O
no O
meatal B-SYMPTOM
blood I-SYMPTOM
. O

The O
left O
femur O
was O
grossly B-SYMPTOM
deformed I-SYMPTOM
with O
a B-SYMPTOM
pinhole I-SYMPTOM
opening I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lateral I-SYMPTOM
thigh I-SYMPTOM
. O

His O
left O
forearm O
was O
also O
grossly B-SYMPTOM
deformed I-SYMPTOM
. O

There O
is O
no O
step-off B-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
back I-SYMPTOM
. O

Admission O
laboratories O
included O
a O
hematocrit O
of O
43.3 O
and O
white O
blood O
cell O
count O
of O
25.2 O
, O
normal O
electrolytes O
and O
amylase O
of O
98 O
. O

Arterial O
blood O
gas O
showed O
a B-SYMPTOM
mild I-SYMPTOM
metabolic I-SYMPTOM
acidosis I-SYMPTOM
. O

Additional O
assay O
shows O
slight B-SYMPTOM
widening I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
mediastinum I-SYMPTOM
on O
chest O
x-ray O
. O

The O
CT O
scan O
of O
the O
head O
and O
chest O
were O
negative O
. O

There O
was O
a B-SYMPTOM
small I-SYMPTOM
liver I-SYMPTOM
laceration I-SYMPTOM
seen O
on O
the O
A/P O
pelvis O
. O

There O
was O
a B-SYMPTOM
distal I-SYMPTOM
ulnar I-SYMPTOM
and I-SYMPTOM
radial I-SYMPTOM
fracture I-SYMPTOM
as O
well O
as O
a B-SYMPTOM
left I-SYMPTOM
mid-shaft I-SYMPTOM
comminuted I-SYMPTOM
fracture I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
femur I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Intensive O
Care O
Unit O
. O

He O
was O
also O
seen O
by O
the O
Orthopedics O
Service O
and O
Neurosurgical O
Service O
. O

He O
went O
to O
the O
Operating O
Room O
quickly O
and O
had O
an B-TREATMENT
intramedullary I-TREATMENT
rodding I-TREATMENT
of I-TREATMENT
the I-TREATMENT
femur I-TREATMENT
and O
open B-TREATMENT
reduction I-TREATMENT
and O
internal B-TREATMENT
fixation I-TREATMENT
of I-TREATMENT
the I-TREATMENT
radius I-TREATMENT
and I-TREATMENT
ulna I-TREATMENT
. O

He O
was O
evaluated O
by O
Neurosurgery O
for O
his B-SYMPTOM
head I-SYMPTOM
injury I-SYMPTOM
which O
showed O
multiple B-SYMPTOM
contusions I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
frontal I-SYMPTOM
lobe I-SYMPTOM
. O

He O
was O
extubated O
on O
postoperative O
day O
two O
. O

He O
did O
have O
some B-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
anemia I-SYMPTOM
with O
a O
hematocrit O
of O
20.9 O
. O

A O
repeat O
CT O
scan O
showed O
no O
change O
. O

He O
was O
begun O
on O
Physical B-TREATMENT
Therapy I-TREATMENT
but O
remained O
agitated B-SYMPTOM
. O

He O
was O
discharged O
to O
the O
Floor O
. O

His O
hematocrit O
remained O
stable O
. O

His O
cervical O
spine O
was O
cleared O
. O

The O
patient O
was O
seen O
by O
Psychiatry O
due O
to O
some B-SYMPTOM
delirium I-SYMPTOM
and O
question O
of O
suicidal B-SYMPTOM
ideation I-SYMPTOM
. O

He O
was O
also O
evaluated O
by O
the O
Neuro-Rehabilitation O
Service O
who O
thought O
that O
he O
had O
a B-SYMPTOM
post-head I-SYMPTOM
injury I-SYMPTOM
syndrome I-SYMPTOM
with O
diffuse B-SYMPTOM
cognitive I-SYMPTOM
deficits I-SYMPTOM
. O

He O
continued O
to O
have O
some O
episodes O
of O
agitation B-SYMPTOM
which O
were O
treated O
with O
medication B-TREATMENT
. O

He O
required O
some B-TREATMENT
sedation I-TREATMENT
and O
restraint B-TREATMENT
and O
was O
begun O
on O
whatever O
Physical B-TREATMENT
Therapy I-TREATMENT
he O
could O
have O
given O
his B-SYMPTOM
head I-SYMPTOM
injury I-SYMPTOM
. O

He O
was O
continued O
to O
be O
followed O
by O
Psychiatry O
and O
then O
was O
casted O
by O
Orthopedics O
. O

He O
continued O
to O
have O
episodes O
of O
confusion B-SYMPTOM
. O

He O
removed O
the B-TREATMENT
cast I-TREATMENT
that O
had O
been O
placed O
and O
then O
a B-TREATMENT
long-leg I-TREATMENT
cast I-TREATMENT
was O
then O
placed O
so O
it O
would O
be O
difficult O
for O
him O
to O
remove O
or O
to O
ambulate O
on O
his O
leg O
, O
which O
might O
jeopardize O
his O
closure O
. O

It O
continued O
to O
be O
somewhat O
difficult O
to O
control O
his O
activity O
and O
Rehabilitation O
Screen O
was O
in O
place O
but O
there O
was O
difficulty O
finding O
the O
appropriate O
facility O
. O

His O
family O
was O
also O
involved O
in O
his O
care O
and O
orientation O
. O

He O
does O
of O
BuSpar B-TREATMENT
, O
Trazodone B-TREATMENT
and O
Haldol B-TREATMENT
were O
continued O
and O
were O
adjusted O
by O
Psychiatry O
. O

He O
was O
continued O
on O
observation O
and O
sitters O
and O
finally O
became O
more O
docile O
and O
cooperative O
. O

He O
was O
continued O
on O
Physical B-TREATMENT
Therapy I-TREATMENT
and O
with O
his O
mother O
present O
, O
he O
began O
to O
follow O
commands O
much O
more O
appropriately O
and O
was O
able O
to O
be O
rehabilitated B-TREATMENT
. O

He O
was O
finally O
sent O
home O
for O
home B-TREATMENT
rehabilitation I-TREATMENT
on O
2011-02-23 O
. O

FINAL O
DIAGNOSES O
: O

1. O
Multiple B-SYMPTOM
trauma I-SYMPTOM
with O
severe B-SYMPTOM
frontal I-SYMPTOM
head I-SYMPTOM
injury I-SYMPTOM
. O

2. O
Open B-SYMPTOM
fracture I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
femur I-SYMPTOM
. O

3. O
Radial B-SYMPTOM
and I-SYMPTOM
ulnar I-SYMPTOM
fractures I-SYMPTOM
. O

4. O
Liver B-SYMPTOM
laceration I-SYMPTOM
. O

SURGICAL O
PROCEDURES O
: O

1. O
Open B-TREATMENT
reduction I-TREATMENT
and O
internal B-TREATMENT
fixation I-TREATMENT
of I-TREATMENT
femur I-TREATMENT
2011-01-21 O
. O

2. O
Open B-TREATMENT
reduction I-TREATMENT
and O
internal B-TREATMENT
fixation I-TREATMENT
of I-TREATMENT
radius I-TREATMENT
and I-TREATMENT
ulna I-TREATMENT
2011-01-21 O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Percocet B-TREATMENT
, O
one O
p.o. O
q. O
four O
hours O
p.r.n. O
pain B-SYMPTOM
. O

2. O
Haldol B-TREATMENT
1 O
mg O
p.o. O
q. O
four O
to O
six O
hours O
p.r.n. O
agitation B-SYMPTOM
. O

3. O
Trazodone B-TREATMENT
50 O
mg O
p.o. O
q. O
h.s. O

4. O
Droperidol B-TREATMENT
1.5 O
to O
2.5 O
mg O
p.r.n. O
agitation B-SYMPTOM
. O

DISPOSITION O
: O

The O
patient O
is O
discharged O
home O
with O
home B-TREATMENT
rehabilitation I-TREATMENT
. O

DISCHARGE O
INSTRUCTIONS O
: O

1. O
The O
patient O
will O
be O
followed O
by O
Orthopedics O
, O
Dr. O
Johnson O
. O

2. O
To O
be O
followed O
by O
William O
Scheidel O
of O
Neurological O
Rehabilitation O
. O

Maria O
L. O
Bell O
, O
M.D. O
05-084 O

Dictated O
By O
: O
Michael O
X. O
Fisher O
, O
M.D. O

MEDQUIST36 O

D O
: O
2011-04-08 O
14:01 O

T O
: O
2011-04-10 O
08:09 O

JOB O
# O
: O
48774 O

Signed O
electronically O
by O
: O
DR. O
Fredrick O
Rossi O
on O
: O
WED O
2011-04-13 O
1:45 O
PM O

( O
End O
of O
Report O
) O

846470157 O

FIH O

2831385 O

45917/em77 O

071794 O

5/13/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

5-13-92 O

DISCHARGE O
DATE O
: O

5-22-92 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
75 O
year O
old O
righthanded O
Caucasian O
female O
who O
was O
admitted O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
because O
of O
left B-SYMPTOM
facial I-SYMPTOM
droop I-SYMPTOM
and O
hand B-SYMPTOM
weakness I-SYMPTOM
after O
glaucoma B-TREATMENT
laser I-TREATMENT
surgery I-TREATMENT
. O

She O
was O
transferred O
to O
the O
Sas O
General O
Hospital O
for O
further O
evaluation O
of O
some B-SYMPTOM
weakness I-SYMPTOM
in O
the O
setting O
of O
multiple B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
. O

The O
patient O
had O
o.d. B-TREATMENT
glaucoma I-TREATMENT
surgery I-TREATMENT
, O
1400 O
hours O
, O
on O
May O
12th O
, O
1992 O
. O

Soon O
after O
surgery B-TREATMENT
, O
the O
patient O
noted O
her O
left O
lower O
face O
and O
hand O
were O
weak B-SYMPTOM
. O

She O
was O
brought O
to O
the O
emergency O
room O
where O
she O
was O
evaluated O
and O
determined O
to O
have O
had O
a B-SYMPTOM
cerebrovascular I-SYMPTOM
accident I-SYMPTOM
. O

She O
has O
absolutely O
no O
neurologic B-SYMPTOM
disease I-SYMPTOM
in O
past O
. O

The O
review O
of O
systems O
is O
negative O
. O

However O
, O
two O
days O
prior O
to O
admission O
, O
one O
family O
member O
noted O
that O
the O
patient O
had O
a B-SYMPTOM
transient I-SYMPTOM
left I-SYMPTOM
facial I-SYMPTOM
droop I-SYMPTOM
. O

A O
potassium O
three O
days O
prior O
to O
surgery B-TREATMENT
was O
2.8 O
, O
the O
level O
being O
normalized O
with O
p.o. B-TREATMENT
kay I-TREATMENT
ciel I-TREATMENT
prior O
to O
admission O
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
patient O
has O
a O
history O
of O
MI B-SYMPTOM
in O
1989 O
, O
no O
angina B-SYMPTOM
before O
or O
after O
. O

She O
had O
a O
normal O
exercise O
thallium O
test O
in O
08/89 O
, O
per O
Ona O
Hospital O
. O

The O
phone O
no. O
at O
the O
Ona O
Hospital O
is O
337-4296 O
, O
936 O
area O
code O
. O

# O
2. O
History O
of O
M. B-SYMPTOM
kansasaii I-SYMPTOM
with O
workup O
by O
Dr. O
Screen O
at O
Sas O
General O
Hospital O
proceeding O
currently O
. O

# O
3. O
History O
of O
breast B-SYMPTOM
cancer I-SYMPTOM
. O

In O
December O
1990 O
she O
had O
a B-TREATMENT
lumpectomy I-TREATMENT
, I-TREATMENT
from I-TREATMENT
left I-TREATMENT
breast I-TREATMENT
, O
and O
XRT B-TREATMENT
x O
35 O
. O

No O
axillary B-TREATMENT
dissection I-TREATMENT
was O
done O
because O
she O
was O
status O
post O
MI B-SYMPTOM
. O

She O
received O
Tamoxifen B-TREATMENT
briefly O
. O

Mammogram O
was O
normal O
7/92 O
, O
and O
5/92 O
. O

She O
is O
allergic B-SYMPTOM
to O
Amoxicillin B-TREATMENT
, O
having O
developed O
a B-SYMPTOM
rash I-SYMPTOM
, O
does O
not O
smoke O
, O
does O
not O
drink O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Dyazide B-TREATMENT
one O
p.o. O
q.d. O
Propanolol B-TREATMENT
5 O
mg. O
p.o. O
t.i.d. O
Isordil B-TREATMENT
5 O
mg. O
p.o. O
t.i.d. O
Glaucoma B-TREATMENT
drops I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

blood O
pressure O
118/75 O
, O
pulse O
88 O
, O
respirations O
20 O
, O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Head O
and O
neck O
exam O
was O
unremarkable O
, O
except O
for O
the O
right O
eye O
being O
patched O
over O
. O

Lungs O
were O
clear O
. O

Breasts O
were O
unremarkable O
. O

Back O
was O
nontender B-SYMPTOM
. O

Heart O
exam O
: O

regular O
rate O
and O
rhythm O
, O
jugular O
venous O
pressure O
was O
normal O
, O
no O
carotid B-SYMPTOM
bruit I-SYMPTOM
was O
noted O
; O
murmur B-SYMPTOM
, O
rub B-SYMPTOM
, O
gallop B-SYMPTOM
, O
click B-SYMPTOM
and O
ectopy B-SYMPTOM
were O
absent O
. O

Abdomen O
was O
benign O
. O

Rectal O
tone O
was O
normal O
, O
guaiac O
negative O
stool O
. O

Extremities O
: O

without O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
or O
stigmata B-SYMPTOM
of O
subacute B-SYMPTOM
bacterial I-SYMPTOM
endocarditis I-SYMPTOM
. O

Normal O
pulses O
were O
palpated O
. O

Neurologic O
exam O
: O

the O
patient O
was O
alert O
and O
oriented O
x O
4 O
. O

Extensive O
mental O
status O
testing O
was O
normal O
, O
except O
for O
recalling O
only O
one O
out O
of O
three O
objects O
at O
five O
minutes O
. O

There O
was O
a O
touch O
an B-SYMPTOM
anosognosia I-SYMPTOM
. O

Cranial O
nerve O
exam O
: O

visual O
fields O
were O
full O
o.s. O
, O
visual O
acuity O
was O
20/70 O
o.s. O

Pupil O
o.s. O
reacted O
to O
light O
. O

EOMs O
with O
full O
range O
of O
movement O
, O
no O
nystagmus B-SYMPTOM
. O

VIIth O
cranial O
nerve O
: O

inferior B-SYMPTOM
left I-SYMPTOM
weak I-SYMPTOM
. O

No O
gag B-SYMPTOM
was O
present O
. O

Otherwise O
normal O
CN O
&apos;s O
. O

DTRs O
showed O
a O
mild O
decrease O
in O
left B-SYMPTOM
biceps I-SYMPTOM
and I-SYMPTOM
brachioradialis I-SYMPTOM
reflexes I-SYMPTOM
, O
otherwise O
normal O
tone O
, O
symmetrical O
reflexes O
, O
downgoing O
toes O
. O

Motor O
exam O
: O

5+ O
throughout O
, O
except O
left O
hand O
intrinsic O
muscles O
were O
4+ O
, O
3+ O
in O
the O
middle O
digits O
. O

No O
atrophy B-SYMPTOM
was O
noted O
. O

Sensory O
exam O
showed O
some O
leftsided B-SYMPTOM
errors I-SYMPTOM
with O
pinprick O
and O
proprioception O
. O

Cerebellar O
exam O
: O

finger O
/ O
to/nose O
was O
with O
mild B-SYMPTOM
dysmetria I-SYMPTOM
, O
exaggerated O
on O
tracking O
; O
rapid O
alternating O
movements O
normal O
, O
heel-to-shin O
was O
good O
with O
few B-SYMPTOM
errors I-SYMPTOM
. O

LABORATORY O
DATA O
: O

Chest O
xray O
showed O
expanded O
lungs O
with O
biapical B-SYMPTOM
pulmonary I-SYMPTOM
opacities I-SYMPTOM
. O

EKG O
: O

left B-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
. O

Urinalysis O
was O
unremarkable O
. O

BUN O
27 O
, O
with O
a O
creatinine O
of O
.9 O
, O
glucose O
was O
182 O
, O
but O
otherwise O
electrolytes O
were O
normal O
. O

Her O
admitting O
hematocrit O
was O
45% O
, O
white O
count O
7,700 O
, O
with O
an O
MCV O
of O
92 O
, O
platelets O
were O
normal O
at O
263,000 O
. O

Albumin O
2.5 O
. O

HOSPITAL O
COURSE O
: O

# O
1. O
cerebrovascular B-SYMPTOM
accident I-SYMPTOM
. O

The O
patient O
suffered O
some B-SYMPTOM
mild I-SYMPTOM
weakness I-SYMPTOM
which O
was O
attributed O
to O
stenosis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
right I-SYMPTOM
internal I-SYMPTOM
carotid I-SYMPTOM
artery I-SYMPTOM
. O

This O
was O
determined O
by O
head O
CT O
, O
head O
MRI O
, O
head O
MRA O
, O
carotid O
noninvasive O
studies O
, O
transcranial O
Dopplers O
. O

The O
possibility O
of O
a O
cardiac O
origin O
was O
evaluated O
by O
echocardiogram O
and O
Holter O
monitor O
. O

Her O
echocardiogram O
curiously O
showed O
a O
normal O
left O
ventricular O
size O
and O
systolic O
function O
, O
a B-SYMPTOM
patent I-SYMPTOM
foramen I-SYMPTOM
ovale I-SYMPTOM
, O
with O
a B-SYMPTOM
trace I-SYMPTOM
right I-SYMPTOM
to I-SYMPTOM
left I-SYMPTOM
shunt I-SYMPTOM
, O
as O
determined O
by O
bubble O
study O
, O
trace B-SYMPTOM
MR I-SYMPTOM
was O
present O
. O

Previous O
echoes O
have O
shown O
MVP B-SYMPTOM
at O
the O
Ona O
Hospital O
. O

Her O
Holter O
showed O
up O
to O
12 O
beats O
of O
SVT B-SYMPTOM
, O
but O
was O
otherwise O
unremarkable O
. O

The O
patient O
had O
a O
normal O
B12 O
, O
negative O
syphilis O
serologies O
and O
normal O
thyroid O
function O
during O
this O
hospitalization O
. O

She O
was O
anticoagulated O
with O
heparin B-TREATMENT
and O
after O
several O
days O
Coumadin B-TREATMENT
was O
started O
. O

Her B-TREATMENT
exact I-TREATMENT
Coumadin I-TREATMENT
dose I-TREATMENT
is O
undetermined O
at O
this O
point O
, O
however O
it O
looks O
like O
it O
will O
be O
something O
around O
5 O
mg O
a O
day O
. O

Her O
pro O
time O
and O
PTT O
have O
normalized O
at O
the O
time O
of O
discharge O
. O

She O
needs O
to O
be O
given O
5 O
mg O
of O
Coumadin B-TREATMENT
tonight O
, O
5/22/92 O
. O

In O
addition O
heparin B-TREATMENT
should O
be O
started O
to O
drip O
on O
arrival O
at O
400 O
units O
an O
hour O
. O

It O
is O
discontinued O
at O
the O
time O
of O
transport O
. O

The O
patient O
has O
received O
physical B-TREATMENT
therapy I-TREATMENT
and O
occupational B-TREATMENT
therapy I-TREATMENT
and O
her O
recovery O
is O
near O
complete O
. O

During O
evaluation O
of O
her O
neurologic O
status O
, O
it O
was O
determined O
that O
for O
several O
months O
prior O
to O
admission O
, O
the O
patient O
has O
been O
too B-SYMPTOM
unsteady I-SYMPTOM
to I-SYMPTOM
ambulate I-SYMPTOM
. O

On O
our O
exam O
she O
is O
found O
to O
have O
a O
significant O
amount O
of O
ataxia B-SYMPTOM
, O
especially O
in O
the O
midline O
and O
the O
exact O
cause O
of O
this O
is O
unknown O
. O

There O
are O
multiple O
possible O
contributions O
and O
this O
is O
where O
her O
need O
for O
careful O
internal O
medical O
evaluation O
has O
arisen O
. O

At O
the O
time O
we O
were O
to O
embark O
on O
this O
evaluation O
, O
the O
patient O
&apos;s O
family O
strongly O
requested O
that O
she O
be O
transferred O
to O
the O
Sas O
General O
Hospital O
. O

What O
follows O
is O
a O
summary O
of O
her B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
and O
their O
possible O
relationship O
to O
her B-SYMPTOM
ataxia I-SYMPTOM
. O

Her B-SYMPTOM
ataxia I-SYMPTOM
is O
likely O
due O
to O
some O
cerebellar O
function O
, O
though O
this O
is O
not O
certain O
. O

Moreover O
her O
MRI O
did O
not O
show O
any B-SYMPTOM
discrete I-SYMPTOM
cerebellar I-SYMPTOM
lesions I-SYMPTOM
. O

Our O
leading O
theory O
at O
this O
point O
is O
that O
her B-SYMPTOM
cerebellar I-SYMPTOM
dysfunction I-SYMPTOM
relates O
to O
perineoplastic B-SYMPTOM
syndrome I-SYMPTOM
, O
relating O
to O
her O
history O
of O
breast B-SYMPTOM
Ca I-SYMPTOM
. O

As O
I O
mentioned O
above O
, O
her O
evaluation O
was O
limited O
by O
her O
cardiologic O
status O
at O
the O
time O
. O

While O
mammogram O
and O
CA-15.3 O
and O
breast O
exam O
are O
all O
normal O
, O
the O
idea O
of O
a B-SYMPTOM
perineoplastic I-SYMPTOM
syndrome I-SYMPTOM
with O
or O
without O
concomitant B-SYMPTOM
breast I-SYMPTOM
Ca I-SYMPTOM
has O
reared O
its O
head O
. O

Two O
possible O
markers O
are O
anti-Hu B-SYMPTOM
syndrome I-SYMPTOM
and O
anti-Yo O
antibody O
. O

These O
tests O
were O
sent O
on O
the O
18th O
and O
are O
pending O
at O
the O
time O
of O
discharge O
. O

The O
results O
can O
be O
obtained O
by O
paging O
me O
, O
Do O
A. O
Joasscchird O
, O
M.D. O
at O
834-364-2251 O
. O

I O
will O
be O
happy O
to O
furnish O
the O
results O
. O

The O
patient O
has O
a O
history O
of O
MI B-SYMPTOM
in O
1989 O
. O

Echocardiogram O
no O
longer O
shows O
wall B-SYMPTOM
motion I-SYMPTOM
abnormalities I-SYMPTOM
. O

EKG O
, O
when O
the O
patient O
goes O
out O
of O
left B-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
transiently O
shows O
an B-SYMPTOM
anterolateral I-SYMPTOM
Q/wave I-SYMPTOM
inversion I-SYMPTOM
. O

We O
would O
like O
to O
discontinue O
her B-TREATMENT
Isordil I-TREATMENT
to O
improve O
upon O
some B-SYMPTOM
orthostatic I-SYMPTOM
hypotension I-SYMPTOM
, O
but O
we O
are O
not O
certain O
whether O
her O
heart O
will O
tolerate O
this O
. O

Persantine O
thallium O
is O
scheduled O
at O
this O
time O
, O
but O
is O
yet O
to O
be O
performed O
. O

The O
patient O
has O
a O
history O
of O
orthostatic B-SYMPTOM
hypotension I-SYMPTOM
x O
many O
years O
. O

It O
has O
been O
evaluated O
in O
the O
past O
without O
success O
. O

During O
her O
hospitalization O
, O
we O
confirmed O
the O
presence O
of O
this O
, O
even O
when O
she O
was O
hydrated O
with O
saline B-TREATMENT
, O
to O
a O
fractional O
excretion O
of O
sodium O
of O
2% O
. O

Studies O
of O
her O
autonomic O
system O
did O
not O
document O
any B-SYMPTOM
dysautonomia I-SYMPTOM
. O

Studies O
of O
skin O
galvanic O
conduction O
were O
normal O
and O
her O
RR O
interval O
evaluation O
was O
not O
abnormal B-SYMPTOM
. O

This O
is O
a B-SYMPTOM
chronic I-SYMPTOM
problem I-SYMPTOM
but O
may O
be O
contributing O
to O
her B-SYMPTOM
current I-SYMPTOM
weakness I-SYMPTOM
and O
inability B-SYMPTOM
to I-SYMPTOM
walk I-SYMPTOM
. O

Florinef B-TREATMENT
is O
to O
be O
considered O
, O
however O
stopping O
the B-TREATMENT
Isordil I-TREATMENT
is O
one O
goal O
. O

The O
patient O
has O
a O
history O
of O
bronchiectasis B-SYMPTOM
from O
a B-SYMPTOM
childhood I-SYMPTOM
pneumonia I-SYMPTOM
. O

In O
addition O
there O
is O
a O
distant O
history O
of O
M. B-SYMPTOM
kansasaii I-SYMPTOM
infection I-SYMPTOM
. O

This O
has O
been O
evaluated O
by O
Dr. O
Screen O
at O
Sas O
General O
Hospital O
and O
probably O
relates O
to O
her O
lung O
xray O
. O

CT O
at O
the O
Ona O
Hospital O
in O
1989 O
showed O
similar O
findings O
. O

A O
chest O
CT O
was O
to O
be O
performed O
and O
may O
be O
yielding O
. O

A O
PPD O
was O
placed O
and O
is O
to O
be O
read O
on O
Saturday O
, O
4 O
26th O
. O

The O
left O
volar O
forearm O
has O
the O
PPD O
just O
proximal O
to O
the O
wrist O
crease O
and O
a O
candida O
albicans O
placed O
just O
distal O
to O
the O
antecubital O
fossa O
. O

The O
patient O
has O
a O
history O
of O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
in O
1990 O
, O
for O
which O
she O
received O
6 O
months O
of O
Coumadin B-TREATMENT
. O

Dopplers O
of O
her O
lower O
extremities O
were O
negative O
on O
this O
admission O
. O

It O
is O
doubtful O
that O
she O
has O
chronic B-SYMPTOM
PE I-SYMPTOM
, O
but O
this O
is O
one O
consideration O
. O

It O
is O
likely O
that O
she O
has O
pulmonary B-SYMPTOM
hypertension I-SYMPTOM
from O
her B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
, O
and O
so O
this O
is O
a O
consideration O
. O

The O
patient O
had O
mild B-SYMPTOM
hyponatremia I-SYMPTOM
during O
this O
hospitalization O
with O
a O
sodium O
as O
low O
as O
131 O
. O

We O
think O
this O
is O
likely O
due O
to O
an B-SYMPTOM
SIADH I-SYMPTOM
as O
she O
is O
euvolemic O
. O

This O
can O
be O
evaluated O
further O
and O
is O
not O
a O
problem O
at O
this O
time O
. O

The O
patient O
has O
glaucoma B-SYMPTOM
. O

Her B-TREATMENT
medications I-TREATMENT
are O
as O
listed O
below O
. O

Her O
ophthalmologist O
is O
aware O
of O
transfer O
. O

His O
name O
is O
Ettrent O
Can O
and O
he O
can O
be O
reached O
at O
678-233-5033 O
, O
b O
549 O
. O

DOCTORS O
DISCHARGE O
ORDERS O
: O

Propanolol B-TREATMENT
5 O
mg. O
p.o. O
t.i.d. O
[ O
hold O
for O
SBP O
less O
than O
110 O
] O
, O
Isosorbide B-TREATMENT
5 O
mg. O
p.o. O
t.i.d. O
, O
hold O
for O
SBP O
less O
than O
110 O
, O
Colace B-TREATMENT
100 O
mg. O
p.o. O
b.i.d. O
Pilocarpine B-TREATMENT
4% O
one O
drop O
q.i.d. O
O.D. O
Pilocarpine B-TREATMENT
2% O
one O
drop O
b.i.d. O
O.S. O
Betasan B-TREATMENT
0.5% O
one O
drop O
b.i.d. O
O.D. O
. O

Bacitracin B-TREATMENT
ointment I-TREATMENT
one O
drop O
O.D. O
q.h.s. O
Ciprofloxacin B-TREATMENT
500 O
mg. O
one O
p.o. O
b.i.d. O
x O
four O
more O
days O
[ O
until O
5/25/92 O
] O
, O
for O
recently B-SYMPTOM
discovered I-SYMPTOM
siderobacter I-SYMPTOM
UTI I-SYMPTOM
. O

Coumadin B-TREATMENT
5 O
mg. O
p.o. O
q.h.s. O

She O
needs O
her B-TREATMENT
dose I-TREATMENT
on O
5/22/92 O
. O

Heparin B-TREATMENT
i.v. I-TREATMENT
drip I-TREATMENT
at O
400 O
units O
per O
hour O
, O
on O
her O
arrival O
. O

In O
addition O
the O
patient O
requires O
occupational B-TREATMENT
therapy I-TREATMENT
and O
physical B-TREATMENT
therapy I-TREATMENT
. O

DISCHARGE O
DIAGNOSIS O
: O

Amoxicillin B-SYMPTOM
rash I-SYMPTOM
. O

Small B-SYMPTOM
stroke I-SYMPTOM
, O
nearly O
recovered O
, O
likely O
embolic B-SYMPTOM
from I-SYMPTOM
carotid I-SYMPTOM
artery I-SYMPTOM
. O

Glaucoma B-SYMPTOM
, O
under O
therapy B-TREATMENT
, O
status O
post O
laser B-TREATMENT
surgery I-TREATMENT
O.D. I-TREATMENT

Orthostatic B-SYMPTOM
hypotension I-SYMPTOM
. O

Ataxia B-SYMPTOM
with O
gait B-SYMPTOM
abnormality I-SYMPTOM
. O

History O
of O
breast B-SYMPTOM
cancer I-SYMPTOM
. O

History O
of O
atypical B-SYMPTOM
mycobacterial I-SYMPTOM
colonization I-SYMPTOM
. O

History O
of O
DVT B-SYMPTOM
. O

Hyponatremia B-SYMPTOM
. O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
with O
MI B-SYMPTOM
in O
1989 O
. O

DO O
JOASSCCHIRD O
, O
M.D. O

TR O
: O

zg O
/ O
bmot O

DD O
: O

5-22-92 O

TD O
: O

05/22/92 O

CC O
: O

MAVIC O
WORD O
, O
M.D. O
and O
TOMEDANKELL O
EAR O
M.D. O
, O
DEPT O
OF O
NEUROLOGY O
. O

LYNA O
CAN O
, O
M.D. O
DIVISION O
OF O
PULMONARY O
MEDICINE O
, O
JEANES O
CLINIC O
, O
Apem O
and O
ETTRENT O
CAN O
, O
C O
/ O
O O
Valtawnprinceel O
Community O
Memorial O
Hospital O

Admission O
Date O
: O

2015-10-10 O

Discharge O
Date O
: O

2015-10-21 O

Date O
of O
Birth O
: O

1953-07-19 O

Sex O
: O

M O

Service O
: O

CMED O
CSRU O

Allergies O
: O

Coumadin B-TREATMENT

Attending O
: O
James O
I O
Schultz, O
M.D. O

Chief O
Complaint O
: O

fever B-SYMPTOM
, O
left B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
redness I-SYMPTOM
, O
dysuria B-SYMPTOM
, O
inability B-SYMPTOM
to I-SYMPTOM
urinate I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Transesophageal O
Echocardiogram O

History O
of O
Present O
Illness O
: O

62 O
year-old O
status-post O
gastric B-TREATMENT
bypass I-TREATMENT
and O
laprascopic B-TREATMENT
cholecystectomy I-TREATMENT
7 O
weeks O
prior O
to O
admission O
who O
presented O
with O
fever B-SYMPTOM
, O
chills B-SYMPTOM
, O
and O
left B-SYMPTOM
lower I-SYMPTOM
extemity I-SYMPTOM
redness I-SYMPTOM
. O

The O
patient O
has O
a O
history O
of O
multiple O
hospitalizations O
for O
lower B-SYMPTOM
extremity I-SYMPTOM
cellulitis I-SYMPTOM
and O
noted O
that O
his B-SYMPTOM
symptoms I-SYMPTOM
and O
the O
appearance O
of O
his O
left O
leg O
mirrored O
previous B-SYMPTOM
episodes I-SYMPTOM
. O

He O
denied O
recent B-SYMPTOM
trauma I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
area I-SYMPTOM
or O
travel O
. O

Review O
of O
systems O
was O
significant O
only O
for O
painful B-SYMPTOM
urination I-SYMPTOM
over O
the O
past O
few O
days O
and O
a B-SYMPTOM
reduction I-SYMPTOM
in I-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
. O

He O
denied O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
palpitations B-SYMPTOM
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
N/V B-SYMPTOM
, O
penile B-SYMPTOM
discharge I-SYMPTOM
. O

Past O
Medical O
History O
: O

1. O
Morbid B-SYMPTOM
obesity I-SYMPTOM

2. O
Frequent B-SYMPTOM
cellulitis I-SYMPTOM

3. O
Lymphedema B-SYMPTOM
. O

4. O
CAD B-SYMPTOM
s/p O
velocity B-TREATMENT
stenting I-TREATMENT
proximal I-TREATMENT
LAD I-TREATMENT
2002 O

5. O
Osteoarthritis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
knees I-SYMPTOM

6. O
Hypertension B-SYMPTOM

7. O
Hypercholesterolemia B-SYMPTOM

8. O
Obstructive B-SYMPTOM
sleep I-SYMPTOM
apnea I-SYMPTOM

9. O
CVA B-SYMPTOM
x2 O
with O
left-sided B-SYMPTOM
weakness I-SYMPTOM

10. O
Gastric B-TREATMENT
bypass I-TREATMENT
surgery I-TREATMENT
7 O
weeks O
PTA O

11. O
Lap B-TREATMENT
cholecystectomy I-TREATMENT
7 O
weeks O
PTA O

Physical O
Exam O
: O

VS O
T O
101.4 O
BP O
85/50 O
HR O
130 O

RR O
20 O
O2 O
Sat O
: O
98% O
RA O

GEN O
: O
Obese B-SYMPTOM
male O
, O
AAOx3 O

HEENT O
: O
MM B-SYMPTOM
dry I-SYMPTOM
, O
JVD B-SYMPTOM
cannot O
be O
assessed O

CV O
: O
Irregularly B-SYMPTOM
irregular I-SYMPTOM
rhytmm I-SYMPTOM
, O
no O
m/r/g B-SYMPTOM

Chest O
: O
CTAB O

ABD O
: O
Obese B-SYMPTOM
, O
NT/ND B-SYMPTOM
, O
no O
rebound/guarding B-SYMPTOM

EXT O
: O
3+ B-SYMPTOM
bilateral I-SYMPTOM
edema I-SYMPTOM
, O
LLE B-SYMPTOM
edema I-SYMPTOM
and O
erythema B-SYMPTOM
, O
no O
chords B-SYMPTOM
, O
+ O
warmth B-SYMPTOM
, O
+ O
chronic B-SYMPTOM
venous I-SYMPTOM
changes I-SYMPTOM
, O
negative O
Homens O

Pertinent O
Results O
: O

2015-10-10 O
02:16PM O

WBC O
- O
6.3 O
RBC O
- O
4.90 O
HGB O
- O
14.1 O
HCT O
- O
41.0 O
MCV O
- O
84 O
MCH O
- O
28.7 O
MCHC O
- O
34.4 O
RDW O
- O
15.0 O

2015-10-10 O
02:16PM O

NEUTS O
- O
92 O
* O
BANDS O
- O
4 O
LYMPHS O
- O
2 O
* O
MONOS O
- O
2 O
EOS O
- O
0 O
BASOS O
- O
0 O
ATYPS O
- O
0 O
METAS O
- O
0 O
MYELOS O
- O
0 O

2015-10-10 O
02:16PM O

PLT O
SMR O
- O
NORMAL O
PLT O
COUNT O
- O
143 O
*# O

2015-10-10 O
02:16PM O
URINE O

BLOOD O
- O
NEG O
NITRITE O
- O
NEG O
PROTEIN O
- O
NEG O
GLUCOSE O
- O
NEG O
KETONE O
- O
NEG O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
NEG O
PH O
- O
5.0 O
LEUK O
- O
SM O

2015-10-10 O
02:16PM O

CALCIUM O
- O
9.6 O
PHOSPHATE O
- O
0.8 O
*# O
MAGNESIUM O
- O
1.4 O
* O

2015-10-10 O
02:16PM O

CK-MB O
- O
2 O
cTropnT O
-< O
0.01 O

2015-10-10 O
02:16PM O

CK(CPK) O
- O
109 O

2015-10-10 O
02:34PM O

LACTATE O
- O
2.4 O
* O

2015-10-10 O
07:42PM O

PT O
- O
16.6 O
* O
PTT O
- O
32.2 O
INR(PT) O
- O
1.7 O

2015-10-10 O
07:42PM O

ALBUMIN O
- O
3.0 O
* O
CALCIUM O
- O
7.6 O
* O
PHOSPHATE O
- O
1.6 O
* O
MAGNESIUM O
- O
1.1 O
* O

2015-10-10 O
07:42PM O

ALT(SGPT) O
- O
28 O
AST(SGOT) O
- O
27 O
LD(LDH) O
- O
191 O
CK(CPK) O
- O
58 O
ALK O
PHOS O
- O
63 O
AMYLASE O
- O
27 O
TOT O
BILI O
- O
0.9 O

2015-10-10 O
08:19PM O

LACTATE O
- O
1.9 O

Brief O
Hospital O
Course O
: O

This O
62 O
year-old O
obese O
male O
was O
admitted O
with O
cellulitis B-SYMPTOM
and O
presumed O
bacteremia B-SYMPTOM
. O

In O
the O
John O
, O
he O
was O
found O
to O
be O
in O
hypotensive B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
. O

The O
patient O
was O
admitted O
to O
the O
Medical O
ICU O
where O
his B-SYMPTOM
hypotension I-SYMPTOM
was O
managed O
with O
IVF B-TREATMENT
hydration I-TREATMENT
and O
he O
was O
maintained O
on O
a B-TREATMENT
diltiazam I-TREATMENT
drip I-TREATMENT
for O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

After O
his O
heart O
rate O
was O
controlled O
, O
he O
was O
transitioned O
to O
oral B-TREATMENT
medications I-TREATMENT
and O
transferred O
to O
the O
medicine O
service O
. O

1. O
Cellulitis B-SYMPTOM
/ O
Bacteremia B-SYMPTOM

Review O
of O
the O
medical O
record O
revealed O
several O
previous O
admissions O
for O
cellulitis B-SYMPTOM
and O
bacteremia B-SYMPTOM
. O

Blood O
cultures O
on O
this O
admission O
and O
were O
positive O
for O
Beta B-SYMPTOM
streptococcus I-SYMPTOM
Group I-SYMPTOM
B I-SYMPTOM
. O

The O
patient O
had O
previous O
episodes O
of O
the B-SYMPTOM
same I-SYMPTOM
infection I-SYMPTOM
, O
with O
lower B-SYMPTOM
extremity I-SYMPTOM
cellulitis I-SYMPTOM
the O
likely O
source O
. O

A O
left O
lower O
extremity O
ultrasound O
was O
negative O
for O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
. O

The O
patient O
was O
too B-SYMPTOM
large I-SYMPTOM
to O
have O
a O
CTA O
. O

He O
was O
initially O
treated O
with O
vancomycin B-TREATMENT
and O
zosyn B-TREATMENT
while O
awaiting O
culture O
results O
. O

Once O
the B-SYMPTOM
organism I-SYMPTOM
was O
identified O
, O
he O
was O
transitioned O
to O
a O
regimen O
of O
intravenous B-TREATMENT
penicillin I-TREATMENT
and O
oral B-TREATMENT
levofloxacin I-TREATMENT
, O
which O
had O
successfully O
treated O
the B-SYMPTOM
infection I-SYMPTOM
during O
his O
most O
recent O
admission O
1 O
year O
prior O
. O

He O
completed O
7 O
days O
of O
levofloxacin B-TREATMENT
and O
had O
a B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
placed O
to O
facilitate O
a O
2 O
week O
course O
of O
IV B-TREATMENT
Penicillin I-TREATMENT
. O

2. O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM

The O
patient O
's O
development O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
was O
believed O
to O
be O
secondary O
to O
infection B-SYMPTOM
and O
structural B-SYMPTOM
heart I-SYMPTOM
disease I-SYMPTOM
. O

It O
was O
initially O
managed O
with O
intravenous B-TREATMENT
diltiazam I-TREATMENT
, O
and O
it O
was O
later O
managed O
with O
metoprolol B-TREATMENT
and O
anticoagulation B-TREATMENT
. O

A O
transthoracic O
echocardiogram O
showed O
a B-SYMPTOM
mildly I-SYMPTOM
dilated I-SYMPTOM
and I-SYMPTOM
elongated I-SYMPTOM
left I-SYMPTOM
atrium I-SYMPTOM
, O
with O
a B-SYMPTOM
markedly I-SYMPTOM
dilated I-SYMPTOM
right I-SYMPTOM
atrium I-SYMPTOM
. O

He O
had O
occasional O
episodes O
of O
rapid B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
that O
were O
controlled O
with O
responded O
to O
IV B-TREATMENT
metoprolol I-TREATMENT
. O

However O
, O
his O
rate O
proved O
difficult O
to O
control O
despite O
metoprolol B-TREATMENT
and O
diltiazam B-TREATMENT
. O

The O
EP O
service O
was O
consulted O
and O
recommended O
transesophageal O
echocardiogram O
and O
cardioversion B-TREATMENT
. O

The O
TEE O
was O
negative O
for O
thrombus B-SYMPTOM
and O
the O
patient O
was O
successfully O
cardioverted O
to O
normal O
sinus O
rhythm O
with O
ibutilide B-TREATMENT
. O

He O
was O
subsequently O
started O
on O
amiodarone B-TREATMENT
and O
is O
scheduled O
to O
complete O
a O
10 O
week O
course O
. O

EKG O
before O
discharge O
showed O
mild B-SYMPTOM
QT I-SYMPTOM
prolongation I-SYMPTOM
and O
no O
effect O
from O
amiodarone B-TREATMENT
. O

EKG O
and O
LFTs O
should O
be O
monitored O
by O
his O
PCP O
, O
William O
given O
the O
high O
dose O
of O
amiodarone B-TREATMENT
he O
will O
receive O
. O

3. O
FEN O

He O
was O
followed O
by O
the O
nutrition O
team O
throughout O
his O
admission O
and O
their O
recommendations O
were O
followed O
. O

He O
demonstrated O
several B-SYMPTOM
asymptomatic I-SYMPTOM
electrolyte I-SYMPTOM
deficiecies I-SYMPTOM
; O
these O
were O
likely O
due O
to O
inadequate B-SYMPTOM
absorption I-SYMPTOM
following O
his B-TREATMENT
surgery I-TREATMENT
and O
he O
responded O
well O
to O
repletion B-TREATMENT
. O

Vitamin O
D O
and O
parathyroid O
tests O
were O
pending O
at O
the O
time O
of O
discharge O
. O

The O
patient O
was O
discharged O
to O
Kindred O
Park O
View O
Specialty O
Hospital O
of O
Springfield O
Rehabilitation O
Hospital O
in O
good O
condition O
. O

He O
was O
sent O
with O
a O
King O
of O
Hearts O
monitor O
and O
scheduled O
for O
follow-up O
with O
cardiology O
and O
his O
primary O
care O
physician O
. O

Discharge O
Medications O
: O

1. O
Amiodarone B-TREATMENT
HCl I-TREATMENT
400 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
one O
tid O
for O
2 O
weeks O
, O
then O
1 O
qd O
for O
2 O
months O
for O
2 O
months O
: O
Please O
take O
1 O
tablet O
3 O
times O
per O
day O
for O
2 O
weeks O
, O
then O
take O
1 O
tablet O
per O
day O
for O
2 O
months O
. O

Disp O
:* O
105 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

2. O
Atorvastatin B-TREATMENT
Calcium I-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
QD O
( O
once O
a O
day O
). O

Disp O
:* O
30 O
Tablet O
(s)* O
Refills O
:* O
1 O
* O

3. O
Zolpidem B-TREATMENT
Tartrate I-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
HS O
( O
at O
bedtime O
). O

Disp O
:* O
30 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

4. O
Potassium B-TREATMENT
& I-TREATMENT
Sodium I-TREATMENT
Phosphates I-TREATMENT
( O
875 O
) O
623 O
9797 O
mg O
Packet O
Sig O
: O
One O
( O
1 O
) O
Packet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

Disp O
:* O
60 O
Packet O
(s)* O
Refills O
:* O
2 O
* O

5. O
Warfarin B-TREATMENT
Sodium I-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
). O

Disp O
:* O
30 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

6. O
Penicillin B-TREATMENT
G I-TREATMENT
Pot I-TREATMENT
in I-TREATMENT
Dextrose I-TREATMENT
2,000,000 O
unit O
/ O
50 O
mL O
Piggyback O
Sig O
: O
One O
( O
1 O
) O
Intravenous O
Q4H O
( O
every O
4 O
hours O
). O

Disp O
:* O
30 O
bags O
* O
Refills O
:* O
0 O
* O

7. O
Aspirin B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
QD O
( O
once O
a O
day O
). O

8. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

9. O
Pantoprazole B-TREATMENT
Sodium I-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
). O

10. O
Calcium B-TREATMENT
Carbonate I-TREATMENT
500 O
mg O
Tablet O
, O
Chewable O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Chewable O
PO O
BID O
( O
2 O
times O
a O
day O
). O

Disp O
:* O
60 O
Tablet O
, O
Chewable O
(s)* O
Refills O
:* O
2 O
* O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

McLean O
Hospital O
& O
Rehab O
Center O
- O
Tewksbury O
State O
Hospital O

Discharge O
Diagnosis O
: O

Atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
Cellulitis B-SYMPTOM
, O
Bacteremia B-SYMPTOM

Discharge O
Condition O
: O

Good O

Discharge O
Instructions O
: O

Please O
take O
all O
over O
your B-TREATMENT
medications I-TREATMENT
. O

Please O
make O
a O
follow-up O
appointments O
with O
Dr. O
Robinson O
Dr. O
Sturtevant O
. O

Return O
to O
the O
Emergency O
Department O
if O
you O
develop O
fevers B-SYMPTOM
, O
chills B-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
palpitations B-SYMPTOM
, O
or O
lightheadedness B-SYMPTOM
. O

Followup O
Instructions O
: O

Please O
keep O
your O
appointment O
with O
Dr. O
Ryan O
on O
Monday O
, O
12-07 O
at O
11 O
AM O
. O

Please O
call O
Dr. O
Pytel O
( O
760 O
) O
496-3627 O
and O
make O
a O
follow-up O
appointment O
for O
1 O
week O
, O
and O
discuss O
resuming O
your B-TREATMENT
other I-TREATMENT
outpatient I-TREATMENT
medications I-TREATMENT
at O
that O
time O
. O

Janine O
Karina O
MD O
98-439 O

Completed O
by O
: O
Opal O
Anne O
MD O
40-158 O
2015-10-22 O
@ O
1759 O

Signed O
electronically O
by O
: O
DR. O
Stephen O
Williams O
on O
: O
SAT O
2015-10-24 O
9:46 O
AM O

( O
End O
of O
Report O
) O

649917202 O
DH O

8205558 O

997074 O

322941 O

3/25/2001 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O

NAME O
: O

DULDKOTE O
, O
EI O
N O

UNIT O
NUMBER O
: O

904-33-96 O

ADMISSION O
DATE O
: O

03/25/2001 O

DISCHARGE O
DATE O
: O

03/26/2001 O

CHIEF O
COMPLAINT O
: O

Right B-SYMPTOM
shoulder I-SYMPTOM
instability I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
30-year-old O
right O
hand O
dominant O
gentleman O
who O
pleasant O
Software O
Engineer O
. O

In O
1989 O
the O
patient O
was O
dunking O
a O
basketball O
and O
injured O
his O
right O
shoulder O
with O
abduction B-SYMPTOM
external I-SYMPTOM
rotation I-SYMPTOM
injury I-SYMPTOM
. O

He O
has O
had O
persistent B-SYMPTOM
pain I-SYMPTOM
over O
the O
years O
which O
has O
worsened O
in O
the O
past O
several O
months O
including O
inability B-SYMPTOM
to I-SYMPTOM
sleep I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Is O
unremarkable O
. O

PAST O
SURGICAL O
HISTORY O
: O

Knee B-TREATMENT
surgery I-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

None O
. O

SOCIAL O
HISTORY O
: O

Occasional O
alcohol O
, O
does O
not O
smoke O
. O

PHYSICAL O
EXAMINATION O
: O

In O
Clinic O
his O
cervical O
spine O
examination O
was O
benign O
. O

Shoulder O
elevation O
is O
170 O
degrees O
with O
70 O
degrees O
of O
external O
rotation O
and O
internal O
rotation O
of O
the O
right O
shoulder O
to O
T9 O
vertebra O
versus O
T7 O
on O
the O
left O
. O

Rotator O
cuff O
measures O
4-5 O
on O
the O
right O
and O
5 O
out O
of O
5 O
on O
the O
left O
. O

Mild B-SYMPTOM
pain I-SYMPTOM
with O
resistive O
test O
and O
his O
Pigott O
sign O
is O
mildly O
positive O
on O
the O
right O
, O
negative O
on O
the O
left O
. O

There O
is O
1 O
cm. O
sulcus O
sign O
bilaterally O
. O

Laxity B-SYMPTOM
is O
noted O
as O
well O
as O
markedly B-SYMPTOM
positive I-SYMPTOM
apprehension I-SYMPTOM
sign I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
. O

Biceps O
are O
normal O
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
was O
admitted O
to O
the O
Hospital O
and O
was O
taken O
to O
the O
operating O
room O
for O
an B-TREATMENT
open I-TREATMENT
Bankart I-TREATMENT
procedure I-TREATMENT
with O
biceps B-TREATMENT
tenodesis I-TREATMENT
( O
Please O
see O
the O
operative O
note O
for O
full O
details O
) O
. O

Postoperatively O
, O
the O
patient O
did O
very O
well O
and O
was O
neurovascularly O
intact O
. O

His B-SYMPTOM
wound I-SYMPTOM
was O
intact O
, O
clean O
and O
dry O
and O
it O
was O
covered O
with O
perioperative B-TREATMENT
antibiotics I-TREATMENT
. O

He O
was O
discharged O
to O
home O
on O
Percocet B-TREATMENT
. O

He O
was O
given O
strict O
instructions O
to O
limit O
his O
external O
rotation O
no O
more O
than O
30 O
degrees O
. O

He O
was O
seen O
by O
physical O
therapy O
prior O
to O
discharge O
. O

FOLLOW O
UP O
: O

He O
is O
to O
follow O
up O
with O
Dr. O
Rach O
Breutznedeaisscarvwierst O
in O
Clinic O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Percocet B-TREATMENT
1-2 O
tablets O
PO O
q.4-6 O
hours O
prn O
pain B-SYMPTOM
. O

MA O
ANSHI O
PIERNREUKOTEFILLE O
, O
M.D. O

DICTATING O
FOR O
: O

Electronically O
Signed O
RACH O
HY O
BREUTZNEDEAISSCARVWIERST O
, O
M.D. O
05/20/2001 O
18:29 O

_____________________________ O
RACH O
HY O
BREUTZNEDEAISSCARVWIERST O
, O
M.D. O

TR O
: O

wlk O

DD O
: O

03/26/2001 O

TD O
: O

03/31/2001 O
10:13 O
A O

cc O
: O

RACH O
HY O
BREUTZNEDEAISSCARVWIERST O
, O
M.D. O

129714460 O

CTMC O

30735304 O

279659 O

8/31/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

08/31/1992 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

09/07/1992 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
37-year-old O
white O
male O
with O
AIDS B-SYMPTOM
complicated O
by O
recurrent B-SYMPTOM
pseudomonas I-SYMPTOM
infections I-SYMPTOM
presently O
on O
Ceftazidime B-TREATMENT
and O
Aztrenam B-TREATMENT
complicated O
by O
MAI B-SYMPTOM
who O
comes O
in O
with O
fever B-SYMPTOM
, O
chills B-SYMPTOM
and O
blood O
cultures O
positive O
for O
candida B-SYMPTOM
species I-SYMPTOM
. O

The O
patient O
has O
multiple B-SYMPTOM
AIDS I-SYMPTOM
illnesses I-SYMPTOM
including O
MAI B-SYMPTOM
who O
has O
multiple O
admissions O
for O
pseudomonas B-SYMPTOM
pneumonia I-SYMPTOM
. O

His O
most O
recent O
admission O
was O
on O
08/23/92 O
to O
08/25/92 O
with O
fever B-SYMPTOM
and O
chills B-SYMPTOM
. O

He O
was O
again O
treated O
with O
IV B-TREATMENT
Ceftazidime I-TREATMENT
for O
presumed O
pseudomonal B-SYMPTOM
pneumonia I-SYMPTOM
and O
discharged O
home O
on O
IV B-TREATMENT
antibiotics I-TREATMENT
which O
he O
is O
presently O
on O
. O

The O
patient O
did O
well O
at O
home O
with O
decreasing O
fever O
and O
good O
appetite O
until O
the O
night O
prior O
to O
admission O
when O
he O
developed O
fever B-SYMPTOM
and O
chills B-SYMPTOM
. O

Concurrent O
blood O
cultures O
grew O
out O
candida B-SYMPTOM
species I-SYMPTOM
at O
HCHP O
. O

The O
patient O
&apos;s O
baseline O
O2 O
saturation O
is O
92% O
on O
three B-TREATMENT
liters I-TREATMENT
. O

He O
has O
a B-TREATMENT
left I-TREATMENT
arm I-TREATMENT
graft I-TREATMENT
placed O
for O
access O
three O
weeks O
ago O
which O
is O
used O
for O
blood B-TREATMENT
drawing I-TREATMENT
and O
IV B-TREATMENT
medications I-TREATMENT
. O

He O
notes O
no O
tenderness B-SYMPTOM
, O
erythema B-SYMPTOM
, O
warmth B-SYMPTOM
or O
exudate B-SYMPTOM
from O
the B-TREATMENT
passport I-TREATMENT
site I-TREATMENT
. O

Medications O
at O
the O
time O
of O
admission O
include O
Dapsone B-TREATMENT
50 O
mg O
p.o. O
on O
Monday O
, O
Wednesday O
and O
Friday O
, O
Ceftazidime B-TREATMENT
1 O
gram O
IV O
q. O
8 O
hours O
, O
Cipro B-TREATMENT
750 O
mg O
p.o. O
b.i.d. O
, O
Acyclovir B-TREATMENT
400 O
mg O
p.o. O
q. O
day O
, O
Megastrol B-TREATMENT
80 O
mg O
p.o. O
t.i.d. O
and O
G-CSF B-TREATMENT
150 O
micrograms O
subcu O
b.i.d. O

PHYSICAL O
EXAMINATION O
: O

At O
the O
time O
of O
admission O
, O
his O
temperature O
was O
101 O
, O
blood O
pressure O
110/60 O
, O
pulse O
96 O
, O
respirations O
16 O
. O

O2 O
saturation O
on O
three B-TREATMENT
liters I-TREATMENT
was O
96% O
. O

HEENT O
exam O
was O
unremarkable O
. O

The O
neck O
was O
supple O
. O

No O
lymphadenopathy B-SYMPTOM
or O
thyromegaly B-SYMPTOM
. O

Chest O
revealed O
bilateral B-SYMPTOM
basilar I-SYMPTOM
rales I-SYMPTOM
. O

Cardiovascular O
exam O
has O
a O
normal O
S1 O
and O
S2 O
without O
murmurs B-SYMPTOM
. O

The O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

The O
liver O
was O
approximately O
8.0 O
cm O
. O

The O
extremities O
had O
no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

Neurological O
exam O
was O
alert O
and O
oriented O
x O
three O
. O

Nonfocal O
. O

LABORATORY O
DATA O
: O

Notable O
on O
admission O
were O
BUN O
and O
creatinine O
of O
8.0 O
and O
0.7 O
. O

Sodium O
134 O
, O
ALT O
18 O
, O
AST O
27 O
, O
LDH O
221 O
, O
white O
count O
2.05 O
, O
hematocrit O
23 O
, O
platelet O
count O
137,000 O
. O

The O
differential O
showed O
45 O
polys O
, O
6 O
bands O
, O
8 O
lymphs O
, O
32 O
monos O
. O

Urinalysis O
was O
negative O
. O

Sputum O
gram O
stain O
showed O
no O
polys B-SYMPTOM
and O
no O
bacteria B-SYMPTOM
. O

AFB O
stain O
was O
negative O
. O

Chest O
X-ray O
was O
consistent O
with O
an O
old O
chest O
X-ray O
on O
08/08/92 O
showing O
a B-SYMPTOM
resolving I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
and I-SYMPTOM
lingular I-SYMPTOM
infiltrate I-SYMPTOM
and O
resolution O
of O
the B-SYMPTOM
right I-SYMPTOM
mid I-SYMPTOM
lung I-SYMPTOM
infiltrate I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

By O
problems O
: O

1. O
Infectious B-SYMPTOM
Disease I-SYMPTOM
. O

The O
patient O
was O
started O
on O
Amphotericine B-TREATMENT
at O
.6 O
mg O
/ O
kg O
for O
a O
total O
of O
250 O
mg O
for O
positive B-SYMPTOM
blood I-SYMPTOM
cultures I-SYMPTOM
for O
candida B-SYMPTOM
. O

The B-TREATMENT
passport I-TREATMENT
in I-TREATMENT
his I-TREATMENT
left I-TREATMENT
arm I-TREATMENT
was O
pulled O
and O
will O
be O
replaced O
if O
needed O
after O
the B-TREATMENT
Amphotericine I-TREATMENT
is O
completed O
. O

The O
patient O
will O
continue O
on O
his B-TREATMENT
antibiotics I-TREATMENT
for O
pseudomonas B-SYMPTOM
pneumonia I-SYMPTOM
to O
complete O
the O
fourteen O
day O
course O
which O
was O
completed O
on O
09/06/92 O
. O

The O
patient O
was O
continued O
on O
his B-TREATMENT
admission I-TREATMENT
medications I-TREATMENT
. O

2. O
Hematology O
. O

The O
patient O
was O
continued O
on O
his B-TREATMENT
G-CSF I-TREATMENT
with O
an O
increase O
in O
his O
white O
count O
to O
8 O
from O
1.8 O
. O

The O
patient O
required O
multiple B-TREATMENT
blood I-TREATMENT
transfusions I-TREATMENT
for O
a B-SYMPTOM
low I-SYMPTOM
hematocrit I-SYMPTOM
. O

DISPOSITION O
: O

MEDICATIONS B-TREATMENT
at O
the O
time O
of O
discharge O
are O
G-CSF B-TREATMENT
300 O
micrograms O
subcu O
q. O
day O
, O
Acyclovir B-TREATMENT
200 O
mg O
p.o. O
b.i.d. O
, O
Erythromycin B-TREATMENT
500 O
mg O
p.o. O
b.i.d. O
, O
Dapsone B-TREATMENT
50 O
mg O
p.o. O
Monday O
, O
Wednesday O
and O
Friday O
, O
Imodium B-TREATMENT
1-2 O
tablets O
p.o. O
q. O
6 O
hours O
p.r.n. O
, O
Nystatin B-TREATMENT
5 O
cc O
swish O
and O
swallow O
q.i.d. O
, O
Serax B-TREATMENT
50 O
mg O
p.o. O
q. O
6 O
hours O
p.r.n. O
and O
Kay-Ceil B-TREATMENT
40 O
mEq O
p.o. O
b.i.d. O

The O
patient O
needs O
to O
have O
his O
blood O
drawn O
the O
day O
after O
discharge O
to O
check O
a O
potassium O
and O
magnesium O
which O
he O
has O
been O
wasting O
secondary O
to O
Amphotericine B-TREATMENT
. O

He O
will O
probably O
need O
potassium B-TREATMENT
and O
magnesium B-TREATMENT
replacement I-TREATMENT
. O

He O
will O
need O
follow O
up O
lytes O
drawn O
throughout O
the O
week O
. O

CR887/2594 O
TRANGCA O
FERCI O
CHIRDSTEN O
, O
M.D. O
UO2 O

D O
: O

09/07/92 O

Batch O
: O

5346 O

Report O
: O

P4722W3 O

T O
: O

09/09/92 O

Dicatated O
By O
: O

LANETTE O
SC O
, O
M.D. O

Admission O
Date O
: O

2016-03-31 O

Discharge O
Date O
: O

2016-04-01 O

Date O
of O
Birth O
: O

1965-10-09 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Vicodin B-TREATMENT

Attending O
: O
Richard O
S. O
Humphries O
, O
M.D. O

Chief O
Complaint O
: O
chest B-SYMPTOM
pain I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Cardiac O
Catheterization O

History O
of O
Present O
Illness O
: O

50 O
yo O
male O
, O
h/o O
CAD B-SYMPTOM
s/p O
stent B-TREATMENT
to I-TREATMENT
LAD I-TREATMENT
in O
2011 O
, O
Hypercholesterolemia B-SYMPTOM
, O
DM B-SYMPTOM
, O
cocaine O
abuse O
, O
presenting O
with O
chest B-SYMPTOM
pain I-SYMPTOM
. O

He O
states O
he O
had O
onset O
of O
this B-SYMPTOM
pain I-SYMPTOM
today O
; O
described O
as O
anterior B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
with O
radiation B-SYMPTOM
to I-SYMPTOM
right I-SYMPTOM
shoulder I-SYMPTOM
, O
09-26 O
, O
was O
increasing O
over O
the O
course O
of O
45 O
minutes O
to O
1 O
hour O
( O
occurred O
after O
arrested O
). O

He O
states O
that O
he O
also O
felt O
SOB B-SYMPTOM
and O
diaphoretic B-SYMPTOM
but O
denies O
n/v/palpitations B-SYMPTOM
. O

He O
reports O
that O
the B-SYMPTOM
pain I-SYMPTOM
was O
increasing O
in O
intensity O
. O

He O
was O
brought O
to O
Providence O
Behavioral O
Health O
Hospital O
where O
he O
was O
found O
to O
have O
positive O
urine O
cocaine O
, O
EKG O
with O
new O
2-7392 O
W. O
Second O
Cr. O
elevations B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
anterior I-SYMPTOM
leads I-SYMPTOM
( I-SYMPTOM
v2-5 I-SYMPTOM
) I-SYMPTOM
and O
some B-SYMPTOM
ST I-SYMPTOM
depressions I-SYMPTOM
in I-SYMPTOM
II I-SYMPTOM
, I-SYMPTOM
III I-SYMPTOM
, I-SYMPTOM
AvF I-SYMPTOM
. O

He O
was O
given O
lopressor B-TREATMENT
5 O
mg O
x O
2 O
( O
3rd O
dose O
given O
by O
medflight O
, O
5 O
mg O
morphine B-TREATMENT
, O
ativan B-TREATMENT
, O
nitro B-TREATMENT
gtt I-TREATMENT
, O
heparin B-TREATMENT
, O
and O
integrillin B-TREATMENT
. O

Pain B-SYMPTOM
was O
12-28 O
at O
time O
of O
transfer O
. O

In O
the O
cath O
lab O
, O
he O
was O
found O
to O
have O
hazy B-SYMPTOM
plaque I-SYMPTOM
in I-SYMPTOM
LAD I-SYMPTOM
( O
prior B-TREATMENT
stent I-TREATMENT
) O
, O
80% B-SYMPTOM
hazy I-SYMPTOM
plaque I-SYMPTOM
in I-SYMPTOM
circumflex I-SYMPTOM
, O
and O
a B-SYMPTOM
totally I-SYMPTOM
occluded I-SYMPTOM
PLB I-SYMPTOM
( I-SYMPTOM
with I-SYMPTOM
collaterals I-SYMPTOM
) I-SYMPTOM
. O

1 B-TREATMENT
cypher I-TREATMENT
stent I-TREATMENT
was O
place O
in O
the O
LAD O
while O
2 O
were O
placed O
in O
Lcx O
. O

Right O
system O
was O
not O
intervened O
upon O
, O
for O
the O
PLB O
was O
unable O
to O
be O
crossed O
by O
wire B-TREATMENT
. O

He O
was O
transferred O
to O
the O
CCU O
for O
observation O
. O

Past O
Medical O
History O
: O

1. O
CAD B-SYMPTOM
, O
s/p O
MI B-SYMPTOM
in O
2011 O
with O
stenting B-TREATMENT
of I-TREATMENT
LAD I-TREATMENT

2. O
Hypercholesterolemia B-SYMPTOM

3. O
DM B-SYMPTOM

Social O
History O
: O

Lives O
with O
friend O

History O
of O
cocaine O
use O
, O
most O
recent O
use O
day O
of O
admission O

Etoh O
use O
, O
01-21 O
drinks O
/ O
day O
, O
most O
recently O
on O
day O
of O
admission O

Former O
smoker O
, O
quit O
4 O
yrs O
ago O
, O
30 O
pack O
year O
history O

Arrested O
on O
day O
of O
admission O
for O
soliciting O
prostitute O
( O
undercover O
police O
officer O
) O
, O
currently O
in O
police O
custody O

Family O
History O
: O

No O
CAD B-SYMPTOM
in O
1st O
degree O
relatives O
. O

Robert O
sudden B-SYMPTOM
death I-SYMPTOM

Physical O
Exam O
: O

VS O
: O
94.1 O
130/81 O
71 O
21 O
99% O
4L B-TREATMENT
NC I-TREATMENT

Gen O
: O
somnolent B-SYMPTOM
, O
pleasant O
male O
, O
lying O
in O
bed O

HEENT O
: O
PERRL O
, O
some B-SYMPTOM
dried I-SYMPTOM
blood I-SYMPTOM
on I-SYMPTOM
lips I-SYMPTOM
, I-SYMPTOM
tongue I-SYMPTOM

Neck O
: O
no O
LAD B-SYMPTOM
, O
? O
enlarged B-SYMPTOM
parotid I-SYMPTOM
glands I-SYMPTOM
bilaterally I-SYMPTOM

CV O
: O
RRR O
, O
nl O
s1/s2 O
, O
with O
S4 B-SYMPTOM
, O
no O
m/r B-SYMPTOM

Lungs O
: O
CTA O
bilaterally O
, O
no O
w/r/r B-SYMPTOM

Abdomen O
: O
protuberant B-SYMPTOM
, O
nt/nd B-SYMPTOM
, O
nabs O

Right O
groin O
: O
with O
sheath B-TREATMENT
in O
place O

Extr O
: O
DP/PT O
2+ O
bilaterally O
, O
no O
c/c/e B-SYMPTOM

Pertinent O
Results O
: O

Catheterization O
on O
2016-03-31 O
: O

HEMODYNAMICS O
RESULTS O
BODY O
SURFACE O
AREA O
: O

1.87 O
m2 O

HEMOGLOBIN O
: O

14 O
gms O
% O

FICK O

** O
PRESSURES O

RIGHT O
ATRIUM O
{ O
a/v/m O
} O
18/17/13 O

RIGHT O
VENTRICLE O
{ O
s/Ruben O
} O
45/18 O

PULMONARY O
ARTERY O
{ O
s/d/m O
} O
45/22 O

PULMONARY O
WEDGE O
{ O
a/v/m O
} O
21/22/20 O

AORTA O
{ O
s/d/m O
} O
97/66/81 O

** O
CARDIAC O
OUTPUT O

HEART O
RATE O
{ O
beats/min O
} O
88 O

RHYTHM O
SINUS O

O2 O
CONS. O
IND O
{ O
ml/min/m2 O
} O
125 O

A-V O
O2 O
DIFFERENCE O
{ O
ml/ltr O
} O
32 O

CARD. O
OP/IND O
FICK O
{ O
l/mn/m2 O
} O
7.3/3.9 O

** O
RESISTANCES O

SYSTEMIC O
VASC. O
RESISTANCE O
745 O

**% O
SATURATION O
DATA O
( O
NL O
) O

SVC O
LOW O
81 O

PA O
MAIN O
81 O

AO O
98 O

OTHER O
HEMODYNAMIC O
DATA O
: O

The O
oxygen O
consumption O
was O
assumed O
. O

** O
ARTERIOGRAPHY O
RESULTS O
MORPHOLOGY O
% O
STENOSIS O
COLLAT. O
FROM O

** O
RIGHT O
CORONARY O

1) O
PROXIMAL O
RCA O
: O
NORMAL O

2) O
MID O
RCA O
: O
NORMAL O

2A) O
ACUTE O
MARGINAL O
: O
NORMAL O

3) O
DISTAL O
RCA O
: O
NORMAL O

4) O
R-PDA O
: O
NORMAL O

4A) O
R-POST-LAT O
: O
DISCRETE O
100 O

4B) O
R-LV O
: O
NORMAL O

** O
ARTERIOGRAPHY O
RESULTS O
MORPHOLOGY O
% O
STENOSIS O
COLLAT. O
FROM O

** O
LEFT O
CORONARY O

5) O
LEFT O
MAIN O
: O
NORMAL O

6) O
PROXIMAL O
LAD O
: O
ULCERATED B-SYMPTOM

6A) O
SEPTAL-1 O
: O
NORMAL O

7) O
MID-LAD O
: O
NORMAL O

8) O
DISTAL O
LAD O
: O
NORMAL O

9) O
DIAGONAL-1 O
: O
NORMAL O

10) O
DIAGONAL-2 O
: O
NORMAL O

12) O
PROXIMAL O
CX O
: O
DISCRETE O
80 O

13) O
MID O
CX O
: O
NORMAL O

13A) O
DISTAL O
CX O
:NORMAL O

14) O
OBTUSE O
MARGINAL O
- O
1 O
: O
NORMAL O

15) O
OBTUSE O
MARGINAL O
- O
2 O
: O
NORMAL O

16) O
OBTUSE O
MARGINAL O
- O
3 O
: O
NORMAL O

Proximal O
LAD O
with O
hazy B-SYMPTOM
ulceration I-SYMPTOM
, O
proximal O
circumflex O
with O
80% B-SYMPTOM
hazy I-SYMPTOM
, O
totally B-SYMPTOM
occluded I-SYMPTOM
PLB I-SYMPTOM
with I-SYMPTOM
collaterals I-SYMPTOM

1 B-TREATMENT
cypher I-TREATMENT
stent I-TREATMENT
placed O
in O
LAD O
, O
2 B-TREATMENT
cypher I-TREATMENT
stents I-TREATMENT
placed O
in O
Left O

Circ O

Echo O
: O

2016-03-31 O
: O

" O
Conclusions O
: O

1. O
The O
left O
ventricular O
cavity O
is O
moderately B-SYMPTOM
dilated I-SYMPTOM
. O

There O
is O
severe B-SYMPTOM
global I-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
hypokinesis I-SYMPTOM
to O
akinesis B-SYMPTOM
with O
some O
sparing O
of O
basal O
wall O
motion O
. O

Overall O
left O
ventricular O
systolic O
function O
is O
severely B-SYMPTOM
depressed I-SYMPTOM
. O

2. O
The O
mitral O
valve O
leaflets O
are O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

Trivial B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
." O

2016-03-31 O
10:40 O
PM O

GLUCOSE O
- O
180 O
* O
UREA O
N O
- O
10 O
CREAT O
- O
0.8 O
SODIUM O
- O
142 O
POTASSIUM O
- O
3.7 O
CHLORIDE O
- O
104 O
TOTAL O
CO2 O
- O
30 O
* O
ANION O
GAP O
- O
12 O

2016-03-31 O
10:40 O
PM O

CK O
( O
CPK O
)- O
137 O

2016-03-31 O
10:40 O
PM O

CK-MB O
- O
4 O
cTropnT O
-< O
0.01 O

2016-03-31 O
10:40 O
PM O

CALCIUM O
- O
8.6 O
PHOSPHATE O
- O
3.4 O
MAGNESIUM O
- O
1.7 O

2016-03-31 O
10:40 O
PM O

WBC O
- O
9.1 O
RBC O
- O
4.08 O
* O
HGB O
- O
12.7 O
* O
HCT O
- O
35.7 O
* O
MCV O
- O
88 O
MCH O
- O
31.0 O
MCHC O
- O
35.4 O
* O
RDW O
- O
12.7 O

2016-03-31 O
10:40 O
PM O

PLT O
COUNT O
- O
253 O

Brief O
Hospital O
Course O
: O

1. O
CAD B-SYMPTOM
: O
presented O
with O
anginal B-SYMPTOM
symptoms I-SYMPTOM
and O
EKG B-SYMPTOM
changes I-SYMPTOM
( O
STEMI B-SYMPTOM
) O
, O
with O
cardiac O
catheterization O
revealing O
lesions B-SYMPTOM
in I-SYMPTOM
LAD I-SYMPTOM
, I-SYMPTOM
LcX I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
PLB I-SYMPTOM
. O

Unclear O
if O
hazy B-SYMPTOM
lesions I-SYMPTOM
significant O
or O
if O
this O
was O
cocaine O
induced O
vasospasm O
. O

LAD O
and O
LCX O
were O
stented B-TREATMENT
, O
but O
PLB O
could O
not O
be O
crossed O
by O
guidewire B-TREATMENT
( O
were O
collaterals O
) O
. O

- O
continue O
ASA B-TREATMENT
, O
statin B-TREATMENT
, O
Plavix B-TREATMENT
; O
will O
hold O
BB B-TREATMENT
given O
recent O
cocaine O
use O
( O
? O
can O
consider O
labetalol B-TREATMENT
if O
necessary O
) O
, O
Integrillin B-TREATMENT
for O
18 O
hours O

- O
CK O
negative O
. O

TN O
WNL O
. O

- O
post O
cath O
check O
normal O

2. O
CHF B-SYMPTOM
: O
EF O
25% O
on O
Echo O
, O
states O
he O
takes O
lasix B-TREATMENT
at O
home O

- O
Started O
lisinopril B-TREATMENT
. O

- O
Consider O
repeat O
Echo O
in O
1 O
month O
and O
Quincy O
Medical O
Center O
- O
V/ICD B-TREATMENT
per O
discretion O
of O
primary O
cardiologist O
. O

- O
kept O
euvolemic O
and O
monitored O
for O
signs O
of O
overload B-SYMPTOM

- O
Low B-TREATMENT
Na I-TREATMENT
diet I-TREATMENT
with O
1 B-TREATMENT
liter I-TREATMENT
fluid I-TREATMENT
restriction I-TREATMENT

- O
may O
need O
to O
diurese O
based O
on O
clinical O
status O
, O
swan O
numbers O

3. O
Rhythm O
: O
No O
ectopy B-SYMPTOM
post I-SYMPTOM
cath/MI I-SYMPTOM

4. O
DM B-SYMPTOM
: O
on O
metformin B-TREATMENT
at O
home O
, O
will O
hold O
given O
cath B-TREATMENT
/ I-TREATMENT
dye I-TREATMENT
adn O
cover O
with O
SSI B-TREATMENT

5. O
Cocaine O
use O
: O
last O
use O
this O
morning O
, O
no O
BB B-TREATMENT
given O
this O
; O
considered O
using O
CCB B-TREATMENT
/ O
phentolamine B-TREATMENT
if O
chest B-SYMPTOM
pain I-SYMPTOM
recurs O
. O

-- O
Will O
discuss O
beta-blocker B-TREATMENT
risks O
and O
benefits O
with O
primary O
cardiologist O

-- O
Pt O
advised O
of O
medical O
risks O
of O
using O
cocaine O

6. O
EtOH O
use O
: O
unclear O
how O
much O
, O
monitor O
on O
CIWA O
for O
signs O
of O
withdrawal B-SYMPTOM
, O
ativan B-TREATMENT
prn O

-- O
CIWAs O
were O
0 O
throughout O
admission O

7. O
Hyperlipidemia B-SYMPTOM
: O
on O
lipitor B-TREATMENT
80 O
. O

LDL O
79 O
, O
HDL O
51 O

8. O
Social O
: O
in O
police O
custody O
, O
with O
24 O
hr O
guard O
, O
handcuffed O
to O
bed O

9. O
FEN O
: O
cardiac B-TREATMENT
diet I-TREATMENT
, O
watch O
for O
aspiration B-SYMPTOM
given O
somnolent B-SYMPTOM
status I-SYMPTOM
at O
this O
time O
, O
ck O
and O
replete O
Mg/K/Ca B-TREATMENT
aggressively O

10. O
Code O
: O
FULL O

11. O
Dispo O
: O
back O
to O
prison; O
? O
extradition O
to O
Hawaii O

Medications O
on O
Admission O
: O

Lipitor B-TREATMENT
80 O

Coreg B-TREATMENT

ASA B-TREATMENT
81 O
mg O

Lasix B-TREATMENT

Glucophage B-TREATMENT

ALL O
: O
Vicodin B-TREATMENT
-? O
rash B-SYMPTOM

Discharge O
Medications O
: O

1. O
Please O
continue O
your B-TREATMENT
previous I-TREATMENT
diabetes I-TREATMENT
medications I-TREATMENT

2. O
Aspirin B-TREATMENT
325 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
) O
. O

3. O
Clopidogrel B-TREATMENT
Bisulfate I-TREATMENT
75 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

4. O
Multivitamin B-TREATMENT
Capsule I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Cap O
PO O
DAILY O
( O
Daily O
) O
. O

5. O
Pantoprazole B-TREATMENT
Sodium I-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

6. O
Atorvastatin B-TREATMENT
Calcium I-TREATMENT
80 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

7. O
Lisinopril B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Oak O
BluffsCorrectional O
Facility O

Discharge O
Diagnosis O
: O

Cocaine O
Abuse O

ST B-SYMPTOM
Elevation I-SYMPTOM
Myocardial I-SYMPTOM
Infarction I-SYMPTOM

Discharge O
Condition O
: O

stable O

Discharge O
Instructions O
: O

Please O
notify O
nurses O
, O
doctors O
Marilyn O
Kristen O
Layne O
workers O
of O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
palpitations B-SYMPTOM
or O
lightheadedness B-SYMPTOM
. O

Cocaine O
use O
has O
been O
associated O
with O
an O
increased O
risk O
of O
heart B-SYMPTOM
attacks I-SYMPTOM
, O
stroke B-SYMPTOM
and O
death B-SYMPTOM
. O

You O
must O
continue O
to O
take O
plavix B-TREATMENT
. O

Please O
discuss O
the O
use O
of O
beta-blockers B-TREATMENT
with O
your O
cardiologist O
. O

Beta-blockers B-TREATMENT
should O
not O
be O
used O
while O
using O
cocaine O
. O

Followup O
Instructions O
: O

Please O
follow-up O
with O
your O
cardiologist O
within O
2 O
weeks O
of O
leaving O
the O
hospital O
. O

Please O
follow-up O
with O
your O
primary O
doctor O
within O
2 O
weeks O
of O
leaving O
the O
hospital O
. O

Robert O
Melissa O
MD O
41-790 O

Completed O
by O
: O
William O
Bennett O
MD O
47-894 O
2016-04-01 O
@ O
1501 O

Signed O
electronically O
by O
: O
DR. O
Evelyn O
Paulk O
on O
: O
Flora O
2016-06-16 O
2:06 O
PM O

( O
End O
of O
Report O
) O

339460011 O

PUOMC O

5569091 O

946797 O

6020656 O

4/14/2004 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

AKOTE O
, O
RALPRI O

MRN O
: O

5569091 O

Age O
: O

77y O

REGISTRATION O
DATE O
: O

04/14/2004 O
02:47 O
PM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
AKOTE O
, O
RALPRI O
arrived O
in O
the O
Emergency O
Department O
at O
Ph O
University O
Of O
Medical O
Center O
on O
04/14/2004 O
02:47 O
PM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
SOB B-SYMPTOM
, O
FEVER B-SYMPTOM
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
of O
the O
visit O
was O
ADMITTED O
AS O
AN O
INPATIENT O
TO O
PH O
UNIVERSITY O
OF O
MEDICAL O
CENTER O
. O

The O
patient O
&apos;s O
preliminary O
admitting O
physician O
is O
CHIRD O
, O
GRAJORD O
C O
and O
the O
preliminary O
diagnosis O
is O
PNA B-SYMPTOM
. O

Please O
note O
this O
information O
may O
have O
been O
updated O
on O
the O
inpatient O
unit O
. O

If O
you O
need O
additional O
information O
please O
call O
639-873-2993 O
. O

PCP O
Name O
: O

FTLOYD O
, O
LETTE O
D O

Provider O
Number O
: O

49622 O

369195584 O

CTMC O

26248578 O

130467 O

3/10/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

03/10/1992 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

03/22/1992 O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Prostate B-SYMPTOM
cancer I-SYMPTOM
. O

2. O
Alzheimer B-SYMPTOM
's I-SYMPTOM
disease I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
patient O
is O
an O
87-year-old O
male O
with O
stage B-SYMPTOM
D I-SYMPTOM
prostate I-SYMPTOM
was O
cancer B-SYMPTOM
, O
was O
admitted O
for O
fluid B-TREATMENT
hydration I-TREATMENT
on O
the O
10th O
of O
March O
. O

The O
patient O
was O
initially O
diagnosed O
with O
prostate B-SYMPTOM
cancer I-SYMPTOM
in O
August O
of O
1989 O
. O

He O
presented O
with O
gross B-SYMPTOM
hematuria I-SYMPTOM
at O
that O
time O
. O

Subsequent O
prostatic O
biopsy O
revealed O
a B-SYMPTOM
Gleason I-SYMPTOM
's I-SYMPTOM
IV I-SYMPTOM
, I-SYMPTOM
plus I-SYMPTOM
V I-SYMPTOM
tumor I-SYMPTOM
and O
the O
CT O
showed O
an B-SYMPTOM
irregular I-SYMPTOM
large I-SYMPTOM
prostate I-SYMPTOM
with O
tumor B-SYMPTOM
invasion I-SYMPTOM
into I-SYMPTOM
the I-SYMPTOM
bladder I-SYMPTOM
and O
evidence O
of O
bilateral B-SYMPTOM
retroperitoneal I-SYMPTOM
lymph I-SYMPTOM
node I-SYMPTOM
spread I-SYMPTOM
. O

There O
was O
also O
evidence O
of O
bone B-SYMPTOM
metastasis I-SYMPTOM
at O
that O
time O
. O

The O
patient O
was O
admitted O
in O
October O
of O
1991 O
for O
urinary B-SYMPTOM
retention I-SYMPTOM
and O
acute B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
and O
was O
treated O
with O
fluid B-TREATMENT
rehydration I-TREATMENT
and O
Foley B-TREATMENT
catheter I-TREATMENT
placement I-TREATMENT
. O

Over O
the O
past O
one O
month O
prior O
to O
admission O
, O
the O
patient O
's O
wife O
has O
noticed O
a B-SYMPTOM
marked I-SYMPTOM
decrease I-SYMPTOM
in I-SYMPTOM
p.o. I-SYMPTOM
intake I-SYMPTOM
and O
also O
noted O
a B-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
of O
approximately O
ten O
pounds O
in O
the O
preceding O
two O
weeks O
. O

The O
patient O
has O
been O
lethargic B-SYMPTOM
and O
bed B-SYMPTOM
ridden I-SYMPTOM
for O
the O
past O
two O
weeks O
, O
although O
there O
was O
no O
evidence O
of O
fever B-SYMPTOM
or O
chills B-SYMPTOM
over O
this O
time O
. O

The O
patient O
is O
now O
admitted O
for O
fluid B-TREATMENT
rehydration I-TREATMENT
therapy I-TREATMENT
and O
observation O
. O

PAST O
MEDICAL O
HISTORY O
: O

As O
above O
. O

MEDICATIONS O
: O

None O
currently O
. O

ALLERGIES O
: O

None O
. O

HABITS O
: O

No O
history O
of O
cigarette O
smoking O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
is O
afebrile B-SYMPTOM
with O
a O
recumbent O
blood O
pressure O
of O
128/16 O
, O
pulse O
of O
76 O
, O
and O
standing O
blood O
pressure O
of O
110/60 O
with O
a O
pulse O
of O
88 O
. O

Respirations O
are O
unlabored B-SYMPTOM
at O
16 O
. O

HEENT O
: O

Noted O
for O
nonicteric B-SYMPTOM
sclerae I-SYMPTOM
and O
lungs O
that O
are O
clear O
to O
auscultation O
. O

No O
CVA B-SYMPTOM
tenderness I-SYMPTOM
was O
appreciated O
in O
the O
heart O
and O
the O
heart O
appears O
to O
be O
in O
regular O
rate O
and O
rhythm O
. O

EXTREMITIES O
: O

Without O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

ABDOMEN O
: O

Soft O
and O
nontender B-SYMPTOM
. O

SKIN O
: O

Decreased B-SYMPTOM
turgor I-SYMPTOM
with O
dry B-SYMPTOM
mucous I-SYMPTOM
membranes I-SYMPTOM
. O

LABORATORY O
DATA O
: O

White O
count O
of O
7.75 O
, O
hematocrit O
of O
46.2% O
, O
sodium O
144 O
, O
potassium O
3.9 O
, O
creatinine O
25 O
, O
and O
BUN O
was O
1.4 O
with O
a O
blood O
sugar O
of O
88 O
. O

Urinalysis O
demonstrated O
30-50 B-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cells I-SYMPTOM
with O
red B-SYMPTOM
blood I-SYMPTOM
cells I-SYMPTOM
too O
numerous O
to O
count O
and O
2+ B-SYMPTOM
bacteria I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
with O
a O
diagnosis O
of O
prostate B-SYMPTOM
CA I-SYMPTOM
, O
for O
fluid B-TREATMENT
rehydration I-TREATMENT
. O

Initially O
, O
the O
patient O
was O
begun O
on O
Bactrim B-TREATMENT
for O
presumptive O
urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
and O
the O
initial O
course O
of O
his O
hospitalization O
, O
he O
took O
p.o.' O
s O
poorly O
. O

The O
patient O
remained O
afebrile B-SYMPTOM
, O
however O
, O
and O
his O
electrolytes O
were O
within O
normal O
limits O
. O

By O
hospital O
day O
number O
six O
, O
however O
, O
the O
patient O
became O
febrile B-SYMPTOM
to O
100.7 O
and O
repeat O
urinalysis O
showed O
20-30 B-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cells I-SYMPTOM
and O
1+ B-SYMPTOM
bacteria I-SYMPTOM
. O

Antibiotics B-TREATMENT
were O
switched O
to O
IV B-TREATMENT
Ciprofloxacin I-TREATMENT
and O
the O
patient O
defervesced O
; O
however O
, O
by O
hospital O
day O
number O
seven O
, O
the O
patient O
was O
found O
to O
be O
passing O
very O
little O
urine O
through O
his B-TREATMENT
condom I-TREATMENT
catheter I-TREATMENT
and O
electrolyte O
screen O
and O
electrolytes O
from O
hospital O
day O
number O
seven O
showed O
a O
BUN O
of O
27 O
and O
a O
creatinine O
of O
2.7 O
. O

The O
patient O
was O
vigorously B-TREATMENT
fluid I-TREATMENT
rehydrated I-TREATMENT
; O
however O
, O
by O
hospital O
day O
number O
nine O
, O
BUN O
was O
22 O
, O
creatinine O
was O
3.5 O
. O

A B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
was O
placed O
at O
that O
time O
with O
the O
recovery O
of O
approximately O
800 O
cc O
of O
urine O
. O

Subsequently O
, O
the O
patient O
began O
vigorously O
diuresing O
with O
4 O
liters O
urine O
recovered O
the O
following O
hospital O
day O
. O

Blood O
electrolytes O
were O
remarkable O
for O
a O
sodium O
of O
148 O
and O
a O
potassium O
of O
5.1 O
. O

The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
fluid I-TREATMENT
hydration I-TREATMENT
from O
D5 B-TREATMENT
one-half I-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
with O
20 O
mEq O
of O
K B-TREATMENT
to O
D5W B-TREATMENT
and O
acuchecks O
from O
this O
time O
showed O
blood O
sugars O
routinely O
between O
20 O
and O
50 O
. O

The O
patient O
was O
given O
one O
Amp O
of O
D50 B-TREATMENT
for O
each O
acucheck O
for O
blood O
sugars O
of O
less O
than O
40 O
. O

Gradually O
over O
the O
course O
of O
the O
following O
days O
, O
the O
patient O
's O
electrolytes O
again O
normalized O
; O
however O
, O
as O
the O
patient O
continues O
to O
take O
p.o.' O
s O
poorly O
, O
the O
patient O
remained O
on O
IV B-TREATMENT
hydration I-TREATMENT
therapy I-TREATMENT
. O

On O
hospital O
day O
number O
fourteen O
, O
electrolytes O
were O
sodium O
of O
140 O
, O
potassium O
3.9 O
, O
BUN O
of O
11 O
, O
creatinine O
1.3 O
with O
a O
blood O
sugar O
of O
125 O
and O
a O
magnesium O
of O
1.9 O
. O

The O
patient O
was O
taking O
470 O
cc O
of O
liquid O
p.o. O
and O
is O
now O
in O
stable O
condition O
and O
ready O
for O
transfer O
to O
El O
Hospital O
to O
continue O
his O
recovery O
. O

DISPOSITION O
: O

The O
patient O
is O
transferred O
to O
El O
Hospital O
, O
still O
receiving O
IV B-TREATMENT
hydration I-TREATMENT
at O
a O
rate O
currently O
of O
50 O
cc O
an O
hour O
of O
D5 B-TREATMENT
one-half I-TREATMENT
normal I-TREATMENT
with O
20 O
mEq O
of O
K B-TREATMENT
. O

Should O
the O
patient O
's O
p.o. O
intake O
drop O
to O
below O
500 O
, O
the O
patient O
should O
be O
hydrated O
at O
75 O
cc/hour O
. O

If O
the O
patient O
's O
p.o. O
intake O
drop O
below O
300 O
cc O
per O
day O
, O
the O
patient O
should O
be O
hydrated O
at O
100 O
cc O
an O
hour O
. O

The B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
was O
in O
place O
and O
the B-TREATMENT
Bacitracin I-TREATMENT
ointment I-TREATMENT
should O
be O
applied O
to O
the O
urethral O
meatus O
twice O
a O
day O
. O

Periodic O
urinalysis O
should O
be O
conducted O
to O
monitor O
the O
development O
of O
possible O
urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

It O
should O
be O
noted O
that O
while O
in O
the O
hospital O
, O
the O
patient O
received O
an O
abdominal O
ultrasound O
which O
is O
significant O
for O
a B-SYMPTOM
grossly I-SYMPTOM
enlarged I-SYMPTOM
liver I-SYMPTOM
with O
multiple B-SYMPTOM
foci I-SYMPTOM
of I-SYMPTOM
cancer I-SYMPTOM
. O

The O
patient O
is O
discharged O
on O
Mylanta B-TREATMENT
30 O
cc O
with O
meals O
, O
Carafate B-TREATMENT
1 O
gm O
q. O
6 O
, O
Heparin B-TREATMENT
5000 O
units O
subcutaneous O
b.i.d. O
until O
the O
patient O
regains O
full O
activity O
and O
IV B-TREATMENT
hydration I-TREATMENT
. O

The B-TREATMENT
Foley I-TREATMENT
should O
be O
in O
place O
until O
a O
follow-up O
appointment O
with O
Dr. O
Aarhalt O
can O
be O
scheduled O
in O
approximately O
one O
to O
two O
weeks O
at O
which O
time O
a O
decision O
regarding O
the O
status O
of O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
urinary I-SYMPTOM
obstruction I-SYMPTOM
will O
be O
addressed O
. O

Dictated O
By O
: O

CHIEROBEBREUTZ O
, O
M.D. O
AA578/3804 O
CONRELLIE O
S. O
KOTERUDES O
, O
M.D. O
KQ9 O

D O
: O

03/22/92 O

T O
: O

03/22/92 O

Batch O
: O

S541 O

Report O
: O

FS984Q01 O

325924358 O

FIH O

7061594 O

795820 O

418796 O

08/15/1998 O
12:00:00 O
AM O

CORONARY B-SYMPTOM
ARTERY I-SYMPTOM
DISEASE I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O
NAME O
: O

TLANDRAC O
, O
NI O

UNIT O
NUMBER O
: O

388-23-03 O

ADMISSION O
DATE O
: O

08/15/1998 O

DISCHARGE O
DATE O
: O

08/22/1998 O

PRINCIPAL O
DIAGNOSIS O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Failed B-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
bypass I-SYMPTOM
graft I-SYMPTOM
, O
prior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
elevated B-SYMPTOM
cholesterol I-SYMPTOM
, O
renal B-SYMPTOM
insufficiency I-SYMPTOM
, O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

08/20/98 O
dual B-TREATMENT
chamber I-TREATMENT
pacemaker I-TREATMENT
generator I-TREATMENT
change I-TREATMENT
( O
CPI O
1276 O
Meridian O
DR O
) O
. O

ASSOCIATED O
PROCEDURES O
: O

08/15/98 O
bilateral O
heart O
catheterization O
; O
08/15/98 O
left O
ventriculography O
; O
08/15/98 O
bilateral O
coronary O
angiography O
; O
08/15/98 O
bypass O
graft O
angiography O
; O
08/15/98 O
internal O
mammary O
artery O
angiography O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Aspirin B-TREATMENT
325 O
mg. O
PO O
q.d. O

Lipitor B-TREATMENT
80 O
mg. O
PO O
q.d. O

Toprol B-TREATMENT
XL I-TREATMENT
50 O
mg. O
PO O
q.d. O

Lasix B-TREATMENT
80 O
mg. O
q.a.m. O
and O
40 O
mg. O
q.p.m. O

Potassium B-TREATMENT
chloride I-TREATMENT
20 O
mEq. O
PO O
b.i.d. O

Citracal B-TREATMENT
1 O
packet O
q.d. O

Imdur B-TREATMENT
60 O
mg. O
PO O
q.d. O

Vitamin B-TREATMENT
E I-TREATMENT
400 O
international O
units O
q.d. O

Prilosec B-TREATMENT
20 O
mg. O
PO O
q.d. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Breunlinke O
is O
a O
70-year-old O
patient O
of O
Dr. O
Brendniungand O
Asilbekote O
in O
California O
. O

She O
is O
referred O
for O
progressive B-SYMPTOM
angina I-SYMPTOM
. O

She O
had O
rheumatoid B-SYMPTOM
fever I-SYMPTOM
as O
a O
child O
and O
a B-SYMPTOM
heart I-SYMPTOM
murmur I-SYMPTOM
noted O
but O
no O
further O
testing O
. O

She O
has O
used O
antibiotic B-TREATMENT
prophylaxis I-TREATMENT
since O
1980 O
. O

In O
1980 O
she O
had O
quadruple B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
surgery I-TREATMENT
by O
Dr. O
Elks O
at O
Feargunwake O
Otacaa O
Community O
Hospital O
and O
did O
well O
until O
1988 O
when O
she O
had O
exertional B-SYMPTOM
angina I-SYMPTOM
and O
a B-SYMPTOM
positive I-SYMPTOM
stress I-SYMPTOM
test I-SYMPTOM
and O
found O
that O
three B-TREATMENT
or I-TREATMENT
four I-TREATMENT
grafts I-TREATMENT
were O
occluded B-SYMPTOM
. O

In O
October O
, O
1989 O
, O
Dr. O
No O
re-did O
her B-TREATMENT
bypass I-TREATMENT
operation I-TREATMENT
. O

She O
had O
a B-TREATMENT
left I-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
obtuse I-TREATMENT
marginal I-TREATMENT
1 I-TREATMENT
and O
a B-TREATMENT
saphenous I-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
obtuse I-TREATMENT
marginal I-TREATMENT
2 I-TREATMENT
. O

In O
1993 O
she O
had O
a B-TREATMENT
DDD I-TREATMENT
pacemaker I-TREATMENT
for O
complete B-SYMPTOM
heart I-SYMPTOM
block I-SYMPTOM
. O

She O
had O
exertional B-SYMPTOM
angina I-SYMPTOM
at O
that O
time O
. O

In O
November O
, O
1997 O
she O
had O
a B-SYMPTOM
small I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
as O
was O
transferred O
to O
Ona O
Hospital O
where O
a O
cardiac O
catheterization O
showed O
a B-SYMPTOM
tight I-SYMPTOM
left I-SYMPTOM
internal I-SYMPTOM
mammary I-SYMPTOM
artery I-SYMPTOM
to O
left B-SYMPTOM
anterior I-SYMPTOM
descending I-SYMPTOM
stenosis I-SYMPTOM
, O
high O
grade O
saphenous O
vein O
graft O
to O
obtuse B-SYMPTOM
marginal I-SYMPTOM
1 I-SYMPTOM
stenosis I-SYMPTOM
and O
patent O
obtuse O
marginal O
2 O
graft O
. O

She O
had O
normal O
left O
ventricular O
function O
with O
apical B-SYMPTOM
tip I-SYMPTOM
akinesis I-SYMPTOM
. O

Since O
that O
time O
she O
has O
continued O
to O
have O
exertional B-SYMPTOM
left I-SYMPTOM
chest I-SYMPTOM
burning I-SYMPTOM
, O
radiating O
to O
the O
left O
neck O
and O
arm O
, O
relieved O
by O
nitroglycerin B-TREATMENT
. O

She O
was O
turned O
down O
for O
re-do B-TREATMENT
surgery I-TREATMENT
at O
that O
time O
and O
did O
not O
have O
a B-TREATMENT
percutaneous I-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
. O

Because O
these B-SYMPTOM
symptoms I-SYMPTOM
have O
been O
increasing O
, O
particularly O
at O
cardiac O
rehabilitation O
, O
she O
was O
referred O
here O
. O

In O
May O
, O
1998 O
she O
had O
an O
exercise O
tolerance O
test O
in O
which O
her O
heart O
rate O
went O
to O
112 O
and O
her O
blood O
pressure O
fell O
to O
95 O
systolic O
. O

She O
had O
diffuse B-SYMPTOM
ischemic I-SYMPTOM
ST I-SYMPTOM
segment I-SYMPTOM
changes I-SYMPTOM
and O
increased B-SYMPTOM
lung I-SYMPTOM
uptake I-SYMPTOM
and O
a B-SYMPTOM
reversible I-SYMPTOM
anterior I-SYMPTOM
and I-SYMPTOM
lateral I-SYMPTOM
defect I-SYMPTOM
. O

She O
has O
had O
no O
syncope B-SYMPTOM
. O

Her O
cardiac O
risk O
factors O
are O
hypertension B-SYMPTOM
and O
elevated B-SYMPTOM
cholesterol I-SYMPTOM
. O

She O
has O
a O
very O
strong O
family O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
with O
a O
mother O
, O
sister O
and O
brother O
dying O
of O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

She O
is O
a O
remote O
cigarette O
smoker O
. O

She O
also O
has O
a O
history O
of O
lactose B-SYMPTOM
intolerance I-SYMPTOM
, O
peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
, O
with O
a B-SYMPTOM
remote I-SYMPTOM
gastrointestinal I-SYMPTOM
bleed I-SYMPTOM
and O
multiple B-SYMPTOM
ectopic I-SYMPTOM
pregnancies I-SYMPTOM
and O
mid B-SYMPTOM
term I-SYMPTOM
miscarriages I-SYMPTOM
. O

She O
has O
had O
a B-TREATMENT
total I-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
. O

SOCIAL O
HISTORY O
: O

She O
is O
a O
widow O
for O
20 O
years O
and O
retired O
18 O
years O
from O
Palmci O

She O
lives O
alone O
. O

Her O
son O
, O
Nertland O
is O
nearby O
and O
he O
works O
at O
the O
Em O
Nysonken O
Medical O
Center O
on O
Verville O
. O

They O
live O
in O
Ohio O
. O

PHYSICAL O
EXAMINATION O
: O

She O
is O
a O
healthy O
appearing O
female O
, O
5 O
foot O
120 O
pounds O
. O

Her O
blood O
pressure O
was O
120/70 O
, O
pulse O
60 O
and O
regular O
. O

Neck O
veins O
are O
not O
distended B-SYMPTOM
. O

Respiratory O
rate O
12 O
. O

Carotids O
: O

no O
bruits B-SYMPTOM
. O

Lungs O
were O
clear O
. O

Cardiac O
: O

1/6 B-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
. O

Abdomen O
was O
benign O
. O

Peripheral O
pulses O
intact O
. O

Neurological O
examination O
non-focal O
. O

LABORATORY O
DATA O
: O

On O
admission O
, O
includes O
an O
electrocardiogram O
that O
shows O
DDD B-TREATMENT
pacing I-TREATMENT
. O

Hematocrit O
39 O
percent O
, O
white O
blood O
cell O
count O
4500 O
, O
PT O
and O
PTT O
normal O
. O

Sodium O
140 O
, O
potassium O
4.2 O
, O
chloride O
105 O
, O
carbon O
dioxide O
30 O
, O
BUN O
24 O
, O
creatinine O
1.0 O
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
was O
admitted O
to O
the O
Cardiac O
Catheterization O
Laboratory O
. O

There O
, O
her O
pulmonary O
wedge O
pressure O
was O
12 O
and O
her O
right O
atrial O
pressure O
was O
4 O
and O
pulmonary O
artery O
pressure O
44/17 O
. O

Her O
left O
ventricular O
contraction O
showed O
akinesis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
anterior I-SYMPTOM
wall I-SYMPTOM
with O
dyskinesis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
apex I-SYMPTOM
. O

She O
had O
preserved O
inferior O
contraction O
and O
basal O
contraction O
. O

Her O
native O
right O
and O
left O
anterior O
descending O
vessels O
were O
occluded B-SYMPTOM
as O
was O
an O
obtuse O
marginal O
branch O
. O

The O
saphenous O
vein O
to O
the O
high O
diagonal O
or O
high O
obtuse O
marginal O
was O
occluded B-SYMPTOM
. O

The O
left O
internal O
mammary O
artery O
to O
the O
left O
anterior O
descending O
was O
also O
occluded B-SYMPTOM
. O

The B-TREATMENT
saphenous I-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
second I-TREATMENT
obtuse I-TREATMENT
marginal I-TREATMENT
was O
open O
with O
no O
significant B-SYMPTOM
stenosis I-SYMPTOM
, O
but O
there O
was O
an B-SYMPTOM
outflow I-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
obtuse I-SYMPTOM
marginal I-SYMPTOM
2 I-SYMPTOM
as O
well O
as O
severe B-SYMPTOM
distal I-SYMPTOM
lesion I-SYMPTOM
as O
the O
obtuse O
marginal O
2 O
fed O
the O
posterior O
descending O
artery O
. O

This O
was O
considered O
her B-SYMPTOM
culprit I-SYMPTOM
lesion I-SYMPTOM
. O

This O
was O
considered O
too O
high O
risk O
for O
angioplasty B-TREATMENT
because O
of O
the B-SYMPTOM
severe I-SYMPTOM
disease I-SYMPTOM
in O
the B-TREATMENT
graft I-TREATMENT
. O

In O
addition O
, O
it O
was O
noted O
that O
she O
had O
saphenous O
vein O
harvested O
from O
both O
thighs O
. O

Her O
left O
internal O
mammary O
artery O
was O
also O
unused O
. O

It O
was O
also O
noted O
that O
she O
had O
failure O
to O
sense O
with O
the O
atrial O
lead O
. O

She O
would O
not O
sense O
the O
atrial O
contraction O
and O
the O
fire O
and O
this O
occasionally O
led O
to O
competition B-SYMPTOM
of I-SYMPTOM
firing I-SYMPTOM
. O

This O
was O
intermittent O
. O

The O
P O
wave O
amplitude O
was O
.6 O
and O
this O
could O
not O
be O
totally O
sensed O
. O

The O
patient O
was O
admitted O
for O
management B-TREATMENT
of O
her B-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
and O
evaluation O
of O
her B-TREATMENT
pacemaker I-TREATMENT
. O

It O
was O
noted O
that O
she O
became O
very B-SYMPTOM
symptomatic I-SYMPTOM
when O
she O
was O
not O
on O
a B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
but O
that O
on O
a B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
she O
had O
significant B-SYMPTOM
pacemaker I-SYMPTOM
failure I-SYMPTOM
. O

Her B-TREATMENT
pacemaker I-TREATMENT
was O
set O
to O
a O
VVI O
mode O
which O
sensed O
appropriately O
. O

She O
was O
in O
sinus O
rhythm O
with O
most O
of O
the O
time O
. O

When O
her B-TREATMENT
pacemaker I-TREATMENT
was O
in O
a O
sinus O
rhythm O
without O
a B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
, O
she O
had O
significant B-SYMPTOM
angina I-SYMPTOM
. O

Carotid O
non-invasive O
testing O
was O
unremarkable O
. O

The O
situation O
was O
reviewed O
with O
Dr. O
Niste O
Graft O
. O

He O
felt O
the O
patient O
was O
not O
a O
coronary O
artery O
bypass O
graft O
candidate O
because O
of O
the B-SYMPTOM
lack I-SYMPTOM
of I-SYMPTOM
conduit I-SYMPTOM
and O
because O
of O
the O
presence O
of O
a B-SYMPTOM
large I-SYMPTOM
anterior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

For O
this O
reason O
, O
it O
was O
decided O
to O
maximize O
her B-TREATMENT
beta I-TREATMENT
blockers I-TREATMENT
and O
nitrates B-TREATMENT
. O

The O
situation O
was O
reviewed O
with O
Dr. O
No O
of O
the O
Pacemaker O
Service O
. O

On O
August O
20 O
, O
under O
local B-TREATMENT
anesthesia I-TREATMENT
the O
right O
pectoral O
region O
was O
explored O
and O
the O
leads O
disconnected O
and O
the B-TREATMENT
pulse I-TREATMENT
generator I-TREATMENT
changed O
to O
a B-TREATMENT
CPI I-TREATMENT
unit I-TREATMENT
in O
which O
the O
sensitivity O
could O
be O
adjusted O
to O
.15 O
mm. O
, O
which O
permitted O
appropriate O
atrial O
sensing O
. O

There O
was O
nothing O
wrong O
with O
the B-TREATMENT
prior I-TREATMENT
generator I-TREATMENT
and O
nothing O
wrong O
with O
the B-TREATMENT
leads I-TREATMENT
. O

It O
just O
needed O
a O
unit O
that O
could O
have O
more O
sensitivity O
in O
the O
atrial O
mode O
. O

She O
tolerated O
this O
well O
. O

Her B-TREATMENT
medications I-TREATMENT
were O
resumed O
. O

She O
ambulated O
without O
difficulty O
and O
was O
discharged O
to O
home O
to O
be O
followed O
medically O
for O
her B-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
following O
two B-TREATMENT
failed I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
procedure I-TREATMENT
by O
Dr. O
Brendniungand O
Asilbekote O
in O
Bi O
Masase O
, O
KS O
. O

ACHASTHA O
N. O
GRAFT O
, O
M.D. O

TR O
: O

hfr O

DD O
: O

08/22/1998 O

TD O
: O

08/27/1998 O
3:56 O
P O

cc O
: O

ACHASTHA O
NICEMAEN O
GRAFT O
, O
M.D. O
GITTETUMN O
DARNNAMAN O
NO O
, O
M.D. O

Admission O
Date O
: O

2017-01-10 O

Discharge O
Date O
: O

2017-01-16 O

Date O
of O
Birth O
: O

1963-12-23 O

Sex O
: O

F O

Service O
: O

Medical O
ICU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Patient O
is O
a O
53 O
- O
year-old O
female O
found O
down O
in O
hotel O
room O
by O
EMS O
with O
change B-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
and O
lethargy B-SYMPTOM
. O

A O
suicide O
note O
found O
at O
the O
scene O
referenced O
multiple B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
as O
well O
as O
suggested O
ingestion O
of O
beta B-TREATMENT
blocker I-TREATMENT
, O
muscle B-TREATMENT
relaxant I-TREATMENT
, O
and O
Neurontin B-TREATMENT
. O

Vital O
signs O
were O
stable O
on O
arrival O
in O
the O
David O
, O
but O
the O
patient O
was O
minimally B-SYMPTOM
responsive I-SYMPTOM
and O
subsequently O
intubated O
for O
airway B-TREATMENT
protection I-TREATMENT
. O

Patient O
initially O
given O
2 O
mg O
of O
Narcan B-TREATMENT
, O
4 O
amps O
of O
sodium B-TREATMENT
bicarb I-TREATMENT
, O
and O
5 O
grams O
of O
activated B-TREATMENT
charcoal I-TREATMENT
. O

Patient O
's O
blood O
pressures O
were O
noted O
to O
decrease B-SYMPTOM
systolics I-SYMPTOM
to O
the O
80s O
, O
which O
responded O
to O
IV B-TREATMENT
fluids I-TREATMENT
and O
insulin B-TREATMENT
/ O
glucose B-TREATMENT
drips I-TREATMENT
. O

Also O
noted O
to O
be O
bradycardic B-SYMPTOM
to O
the O
50s O
, O
which O
responded O
to O
atropine B-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Hepatitis B-SYMPTOM
C I-SYMPTOM
. O

2. O
Hypertrophic B-SYMPTOM
cardiomyopathy I-SYMPTOM
. O

3. O
Lumbar B-SYMPTOM
and I-SYMPTOM
cervical I-SYMPTOM
degenerative I-SYMPTOM
disk I-SYMPTOM
disease I-SYMPTOM
. O

4. O
Sarcoid B-SYMPTOM
. O

5. O
Depression B-SYMPTOM
. O

6. O
Headaches B-SYMPTOM
. O

MEDICATIONS O
: O

1. O
Neurontin B-TREATMENT
. O

2. O
Propanolol B-TREATMENT
. O

3. O
Tylenol B-TREATMENT
#3 I-TREATMENT
. O

4. O
Butalbital B-TREATMENT
. O

5. O
Morphine B-TREATMENT
. O

6. O
Protonix B-TREATMENT
. O

7. O
Doxepin B-TREATMENT
. O

8. O
Dilaudid B-TREATMENT
. O

9. O
Inderal B-TREATMENT
. O

10. O
Skelaxin B-TREATMENT
. O

11. O
Zantac B-TREATMENT
. O

12. O
Flexeril B-TREATMENT
. O

13. O
MS B-TREATMENT
Contin I-TREATMENT
. O

PHYSICAL O
EXAM O
: O

Temperature O
96.8 O
, O
heart O
rate O
81 O
, O
blood O
pressure O
92/47 O
, O
and O
saturating O
100% O
on O
40% O
FIO2 B-TREATMENT
. O

General O
: O

Patient O
is O
intubated O
and O
sedated O
. O

HEENT O
: O

Pupils O
are O
equal O
, O
round O
, O
and O
reactive O
to O
light O
. O

Cardiovascular O
: O

Regular O
rate O
and O
rhythm O
, O
no O
murmurs B-SYMPTOM
. O

Pulmonary O
is O
clear O
to O
auscultation O
bilaterally O
. O

Abdomen O
is O
soft O
, O
nontender B-SYMPTOM
, O
and O
nondistended B-SYMPTOM
. O

Extremities O
: O

No O
edema B-SYMPTOM
. O

LABORATORIES O
: O

White O
count O
20.0 O
, O
hematocrit O
52 O
, O
platelets O
439 O
. O

Chem-7 O
: O

141 O
/ O
5.6 O
/ O
104 O
/ O
24 O
/ O
23 O
/ O
0.8 O
/ O
118 O
. O

Urinalysis O
negative O
except O
for O
large B-SYMPTOM
blood I-SYMPTOM
. O

EKG O
: O

Sinus B-SYMPTOM
bradycardia I-SYMPTOM
, O
left B-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
, O
prolonged B-SYMPTOM
QRS I-SYMPTOM
. O

Urine O
tox O
positive B-SYMPTOM
for I-SYMPTOM
barbiturates I-SYMPTOM
, I-SYMPTOM
opiates I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
methadone I-SYMPTOM
. O

Serum O
Tylenol O
level O
is O
8.3 O
. O

Positive B-SYMPTOM
for I-SYMPTOM
serum I-SYMPTOM
barbiturates I-SYMPTOM
. O

CK O
15,000 O
. O

ALT O
77 O
, O
AST O
159 O
, O
amylase O
153 O
, O
alkaline O
phosphatase O
216 O
, O
total O
bilirubin O
0.6 O
. O

INR O
1.1 O
. O

HOSPITAL O
COURSE O
: O

In O
summary O
, O
patient O
is O
a O
53 O
- O
year-old O
female O
with O
multiple B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
and O
history O
of O
depression B-SYMPTOM
with O
intentional O
overdose O
of O
barbiturates B-TREATMENT
, O
opiates B-TREATMENT
, O
Tylenol B-TREATMENT
, O
and O
beta B-TREATMENT
blocker I-TREATMENT
. O

CMED O
: O

Patient O
was O
maintained O
on O
insulin B-TREATMENT
, O
D10 B-TREATMENT
and O
glucagon B-TREATMENT
drips I-TREATMENT
to O
maintain O
her O
hemodynamics O
. O

This O
was O
achieved O
with O
good O
effect O
, O
and O
they O
were O
subsequently O
weaned O
off O
. O

Patient O
was O
able O
to O
be O
extubated O
on O
hospital O
day O
three O
. O

Psychiatry O
was O
consulted O
after O
the O
patient O
was O
extubated O
, O
and O
felt O
that O
patient O
had O
a B-SYMPTOM
high I-SYMPTOM
suicide I-SYMPTOM
risk I-SYMPTOM
, O
and O
plan O
was O
for O
her O
to O
be O
admitted O
to O
the O
Psychiatry O
service O
once O
medically O
stable O
. O

Patient O
's O
renal O
function O
remained O
stable O
and O
her O
CKs O
trended O
down O
gradually O
. O

Patient O
remained O
on O
suicide B-TREATMENT
precautions I-TREATMENT
, O
but O
was O
deemed O
not O
to O
need O
ICU O
level O
monitoring O
, O
and O
was O
transferred O
to O
the O
floor O
on O
01-11 O
. O

In O
the O
a.m. O
of O
01/08 O
, O
the O
patient O
experienced O
episode O
of O
tongue B-SYMPTOM
biting I-SYMPTOM
, O
unresponsiveness B-SYMPTOM
, O
disorientation B-SYMPTOM
. O

Was O
loaded O
on O
Dilantin B-TREATMENT
. O

Became O
progressively O
hypoxic B-SYMPTOM
and O
tachypneic B-SYMPTOM
throughout O
the O
day O
with O
respiratory O
rates O
of O
30-40 O
with O
a O
max O
respiratory O
rate O
of O
116 O
, O
tachycardia B-SYMPTOM
to O
120s O
. O

Patient O
subsequently O
was O
transferred O
back O
to O
the O
CMED O
CCU O
on O
2017-01-13 O
for O
further O
monitoring O
. O

Patient B-SYMPTOM
's I-SYMPTOM
hypoxia I-SYMPTOM
was O
felt O
most O
likely O
to O
be O
caused O
by O
pneumonia B-SYMPTOM
. O

She O
was O
started O
on O
appropriate B-TREATMENT
antibiotics I-TREATMENT
. O

Etiology O
of O
patient B-SYMPTOM
's I-SYMPTOM
tachypnea I-SYMPTOM
was O
unclear O
. O

Initially O
, O
the O
patient O
's O
etiology O
of O
seizure B-SYMPTOM
was O
not O
quite O
clear O
, O
but O
thought O
possibly O
secondary O
to O
alcohol B-SYMPTOM
and I-SYMPTOM
benzodiazepine I-SYMPTOM
withdrawal I-SYMPTOM
. O

She O
received O
EEG O
, O
MRI O
, O
LP O
. O

Subsequently O
EEG O
was O
noted O
to O
have O
no O
seizure B-SYMPTOM
activity I-SYMPTOM
. O

MRI O
was O
suboptimal O
due O
to O
motion O
artifact O
and O
LP O
was O
unremarkable O
. O

Despite O
absence O
of O
seizure B-SYMPTOM
activity I-SYMPTOM
on O
EEG O
, O
patient O
was O
continued O
on O
Dilantin B-TREATMENT
. O

Her B-SYMPTOM
delirium I-SYMPTOM
was O
felt O
possibly O
secondary O
to O
withdrawal B-SYMPTOM
versus O
toxic B-SYMPTOM
metabolic I-SYMPTOM
, O
but O
gradually O
improved O
slowly O
, O
and O
therefore O
patient O
did O
not O
receive O
treatment B-TREATMENT
for O
barbiturate B-SYMPTOM
withdrawal I-SYMPTOM
. O

Her O
mental O
status O
, O
tachypnea B-SYMPTOM
, O
and O
hypoxia B-SYMPTOM
all O
improved O
, O
and O
patient O
was O
subsequently O
transferred O
back O
to O
the O
floor O
medical O
team O
on O
2017-01-15 O
. O

While O
on O
the O
floor O
, O
the O
patient O
's O
mental O
status O
was O
noted O
to O
be O
improved O
back O
at O
baseline O
compared O
to O
that O
back O
to O
the O
CMED O
CCU O
, O
and O
she O
exhibited O
no O
evidence O
of O
barbiturate B-SYMPTOM
withdrawal I-SYMPTOM
. O

She O
was O
continued O
on O
suicide B-TREATMENT
precautions I-TREATMENT
with O
a B-TREATMENT
one-to-one I-TREATMENT
sitter I-TREATMENT
, O
and O
plan O
was O
for O
psychiatric O
admission O
when O
medical B-SYMPTOM
issues I-SYMPTOM
had O
resolved O
. O

On O
2017-01-16 O
, O
the O
night O
float O
intern O
was O
called O
to O
see O
the O
patient O
as O
she O
was O
unresponsive B-SYMPTOM
. O

Patient O
unresponsive B-SYMPTOM
to O
verbal O
command O
, O
sternal O
rub O
. O

Pupils O
were O
fixed B-SYMPTOM
and O
dilated B-SYMPTOM
. O

Patient O
noted O
to O
be O
without B-SYMPTOM
corneal I-SYMPTOM
reflexes I-SYMPTOM
, I-SYMPTOM
spontaneous I-SYMPTOM
breathing I-SYMPTOM
, I-SYMPTOM
heart I-SYMPTOM
sounds I-SYMPTOM
, I-SYMPTOM
or I-SYMPTOM
palpable I-SYMPTOM
pulses I-SYMPTOM
. O

Patient O
was O
pronounced O
dead O
at O
6:15 O
a.m. O
on O
2017-01-16 O
. O

Patient O
's O
family O
was O
notified O
and O
declined O
autopsy O
. O

Given O
the O
sudden O
unexpected O
nature O
of O
patient O
's O
death O
, O
the O
medical O
examiner O
was O
contacted O
and O
the O
case O
was O
accepted O
. O

Of O
note O
at O
time O
of O
death O
, O
patient O
was O
DNR B-TREATMENT
/ O
DNI B-TREATMENT
. O

This O
was O
initiated O
after O
several O
conversations O
with O
the O
patient O
's O
mother O
, O
who O
stated O
that O
the O
patient O
had O
desired O
to O
be O
DNR B-TREATMENT
/ O
DNI B-TREATMENT
for O
many O
years O
, O
not O
just O
in O
the O
recent O
past O
. O

These O
facts O
were O
confirmed O
via O
separate O
conversations O
with O
both O
the O
patient O
's O
lawyer O
and O
her O
primary O
care O
physician O
. O

Michael O
N O
Sawyer O
, O
M.D. O

86-331 O

Dictated O
By O
: O
Rebecca O
S O
Jefcoat O
, O
M.D. O

MEDQUIST36 O

D O
: O
2017-03-08 O
10:57 O

T O
: O
2017-03-10 O
07:01 O

JOB O
# O
: O
53408 O

( O
cclist O
) O

*************************** O

Please O
note O
that O
all O
of O
the O
conversations O
regarding O
code O
status O
took O
place O
during O
we O
icu O
admit O
; O
and O
that O
this O
patient O
passed O
away O
in O
early O
am O
hours O
of O
night O
she O
was O
called O
back O
out O
to O
the O
medicine O
floor O
, O
therefore O
she O
had O
not O
yet O
been O
re-evaluated O
by O
the O
floor O
medicine O
attending O
, O
but O
had O
been O
earlier O
that O
day O
by O
the O
icu O
attending O
. O

Signed O
electronically O
by O
: O
DR. O
Dorothy O
Desalvo O
on O
: O
WED O
2017-04-26 O
7:22 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2017-06-28 O

Discharge O
Date O
: O

2017-07-02 O

Date O
of O
Birth O
: O

1977-06-19 O

Sex O
: O

F O

Service O
: O

CMED O
CCU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

A O
40-year-old O
female O
with O
history O
of O
non-ST-elevation B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
2016-09-30 O
with O
stent B-TREATMENT
to I-TREATMENT
the I-TREATMENT
LAD I-TREATMENT
and O
50% O
to O
the O
mid O
LAD O
, O
had O
instent B-SYMPTOM
restenosis I-SYMPTOM
in O
2017-04-02 O
and O
then O
underwent O
brachytherapy B-TREATMENT
to I-TREATMENT
the I-TREATMENT
RCA I-TREATMENT
, O
who O
presented O
to O
Baldpate O
Hospital O
with O
several O
weeks O
of O
chest B-SYMPTOM
pain I-SYMPTOM
similar O
to O
her B-SYMPTOM
anginal I-SYMPTOM
equivalent I-SYMPTOM
and O
MI B-SYMPTOM
in O
the O
past O
. O

It O
started O
at O
rest O
. O

No O
relief O
with O
nitroglycerin B-TREATMENT
x3 O
. O

Radiates O
to O
the O
left O
arm O
. O

Positive O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

Troponins O
have O
been O
less O
than O
0.01. O

With O
history O
, O
will O
go O
for O
cardiac O
catheterization O
evaluation O
. O

Still O
getting O
chest B-SYMPTOM
pain I-SYMPTOM
intermittently O
, O
but O
relieved O
by O
morphine B-TREATMENT
sulfate I-TREATMENT
. O

Was O
on O
a B-TREATMENT
Heparin I-TREATMENT
and O
nitroglycerin B-TREATMENT
drip I-TREATMENT
with O
only O
intermittent O
relief O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Hypercholesterolemia B-SYMPTOM
. O

2. O
Obesity B-SYMPTOM
. O

3. O
Hypertension B-SYMPTOM
. O

4. O
Tobacco O
history O
. O

5. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
: O

2016-09-30 O
non-ST-elevation B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
100% O
RCA O
, O
three B-TREATMENT
stents I-TREATMENT
, O
50% O
mid O
LAD O
. O

2017-04-02 O
instent B-SYMPTOM
restenosis I-SYMPTOM
status O
post O
brachytherapy B-TREATMENT
. O

6. O
GERD B-SYMPTOM
. O

7. O
Asthma B-SYMPTOM
. O

8. O
Sciatica B-SYMPTOM
. O

9. O
Degenerative B-SYMPTOM
joint I-SYMPTOM
disease I-SYMPTOM
. O

10. O
Glomerulosclerosis B-SYMPTOM
. O

FAMILY O
HISTORY O
: O

Brothers O
with O
William B-SYMPTOM
cancer I-SYMPTOM
and O
a B-SYMPTOM
MI I-SYMPTOM
. O

Father O
with O
emphysema B-SYMPTOM
. O

Mother O
with O
lung B-SYMPTOM
cancer I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

Quit O
tobacco O
in O
2016-09-30 O
. O

Occasional O
alcohol O
. O

Lives O
with O
her O
6-year-old O
daughter O
. O

ALLERGIES O
: O

Aspirin B-TREATMENT
under O
which O
she O
develops O
worsening O
of O
her B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
asthma B-SYMPTOM
flare I-SYMPTOM
, O
tetracycline B-TREATMENT
, O
sulfa B-TREATMENT
, O

Demerol B-TREATMENT
. O

MEDICATIONS: O

1. O
Diovan B-TREATMENT
106 O
mg O
q.d. O

2. O
Advair B-TREATMENT
500/50 O
two O
puffs O
b.i.d. O

3. O
Plavix B-TREATMENT
75 O
mg O
q.d. O

4. O
Crestor B-TREATMENT
20 O
mg O
q.d. O

5. O
Neurontin B-TREATMENT
300 O
mg O
t.i.d. O

6. O
Prilosec B-TREATMENT
20 O
mg O
b.i.d. O

7. O
Vicodin B-TREATMENT
as O
needed O
. O

8. O
Trazodone B-TREATMENT
50 O
mg O
q.d. O

9. O
Singulair B-TREATMENT
10 O
mg O
q.d. O

10. O
Flexeril B-TREATMENT
10 O
mg O
t.i.d. O

11. O
Lopressor B-TREATMENT
75 O
mg O
b.i.d. O

12. O
Humibid B-TREATMENT
3600 O
b.i.d. O

13. O
Colace B-TREATMENT
100 O
mg O
b.i.d. O

14. O
Zetia B-TREATMENT
10 O
mg O
q.d. O

15. O
Benadryl B-TREATMENT
as O
needed O
. O

16. O
Tricor B-TREATMENT
106 O
mg O
q.d. O

17. O
Premarin B-TREATMENT
0.3 O
mg O
q.d. O

18. O
Prozac B-TREATMENT
40 O
mg O
q.d. O

19. O
Omega-3 B-TREATMENT
fatty I-TREATMENT
acids I-TREATMENT
t.i.d. O

PHYSICAL O
EXAM O
: O

82 O
, O
119/60 O
, O
22 O
, O
and O
99% O
on O
room O
air O
. O

Well O
appearing O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
. O

Pupils O
are O
equal O
, O
round O
, O
and O
reactive O
to O
light O
. O

Moist O
mucous O
membranes O
. O

No O
JVD B-SYMPTOM
. O

Regular O
rate O
and O
rhythm O
. O

Positive O
tenderness B-SYMPTOM
to I-SYMPTOM
sternum I-SYMPTOM
. O

Chest O
was O
clear O
to O
auscultation O
bilaterally O
. O

Abdomen O
: O

Obese B-SYMPTOM
, O
soft O
. O

Extremities O
show O
no O
edema B-SYMPTOM
, O
2+ O
dorsalis O
pedis O
, O

1+ O
femoral O
pulses O
. O

LABORATORIES O
: O

Troponin-T O
less O
than O
0.01. O

EKG O
: O

Sinus O
, O
84 O
, O
normal O
axis O
, O
QTc O
430 O
, O
Q B-SYMPTOM
's I-SYMPTOM
in I-SYMPTOM
III I-SYMPTOM
and I-SYMPTOM
aVF I-SYMPTOM
, O
no O

ST B-SYMPTOM
changes I-SYMPTOM
as O
compared O
to O
2017-05-01 O
EKG O
. O

HOSPITAL O
COURSE: O

1. O
Chest B-SYMPTOM
pain I-SYMPTOM
: O

The O
patient O
ruled O
out O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

However O
, O
with O
her O
history O
of O
disease B-SYMPTOM
, O
patient O
underwent O
a O
cardiac O
catheterization O
. O

The O
patient O
was O
found O
at O
cardiac O
catheterization O
to O
have O
mild B-SYMPTOM
diffuse I-SYMPTOM
instent I-SYMPTOM
restenosis I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
mid I-SYMPTOM
stent I-SYMPTOM
, O
otherwise O
hemodynamically O
normal O
and O
the O
coronary O
arteries O
otherwise O
were O
without O
flow-limiting B-SYMPTOM
stenoses I-SYMPTOM
. O

The O
patient O
was O
then O
continued O
on O
her B-TREATMENT
cardiac I-TREATMENT
medications I-TREATMENT
. O

It O
was O
felt O
that O
if O
we O
attempted O
aspirin B-TREATMENT
desensitize O
her O
while O
an O
inpatient O
, O
then O
she O
would O
benefit O
from O
the O
use O
of O
aspirin B-TREATMENT
and O
Plavix B-TREATMENT
. O

The O
patient O
was O
sent O
to O
the O
CCU O
and O
underwent O
aspirin B-TREATMENT
desensitization I-TREATMENT
protocol I-TREATMENT
, O
which O
she O
tolerated O
well O
. O

She O
had O
mild O
worsening O
of O
her B-SYMPTOM
asthma I-SYMPTOM
attacks I-SYMPTOM
, O
which O
was O
relieved O
by O
Benadryl B-TREATMENT
and O
occasionally O
albuterol B-TREATMENT
. O

The O
patient O
found O
that O
if O
she O
took O
the B-TREATMENT
aspirin I-TREATMENT
in O
the O
evening O
with O
her B-TREATMENT
Benadryl I-TREATMENT
that O
she O
takes O
for O
sleep O
, O
that O
the B-SYMPTOM
asthma I-SYMPTOM
exacerbation I-SYMPTOM
did O
not O
occur O
. O

Aspirin B-TREATMENT
no O
longer O
should O
be O
considered O
an B-SYMPTOM
allergy I-SYMPTOM
for O
this O
patient O
, O
and O
she O
is O
going O
to O
take O
this O
as O
an O
outpatient O
. O

2. O
Hyperlipidemia B-SYMPTOM
: O

The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
Lipitor I-TREATMENT
was O
increased O
to O
80 O
mg O
q.d. O

3. O
Back B-SYMPTOM
pain I-SYMPTOM
: O

This O
is O
a B-SYMPTOM
chronic I-SYMPTOM
issue I-SYMPTOM
and O
was O
controlled O
with O
Flexeril B-TREATMENT
and O
Vicodin B-TREATMENT
. O

DISPOSITION O
: O

To O
home O
. O

DISCHARGE O
STATUS O
: O

Patient O
is O
able O
to O
ambulate O
without O
any B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
or O
discomfort B-SYMPTOM
. O

Can O
carry O
out O
all O
activities O
of O
daily O
living O
. O

DISCHARGE O
MEDICATIONS: O

1. O
Metoprolol B-TREATMENT
100 O
mg O
b.i.d. O

2. O
Plavix B-TREATMENT
75 O
mg O
q.d. O

3. O
Advair B-TREATMENT
550 O
mcg O
two O
puffs O
b.i.d. O

4. O
Neurontin B-TREATMENT
300 O
mg O
t.i.d. O

5. O
Protonix B-TREATMENT
40 O
mg O
q.d. O

6. O
Montelukast B-TREATMENT
10 O
mg O
q.d. O

7. O
Bethanechol B-TREATMENT
25 O
mg O
b.i.d. O

8. O
Docusate B-TREATMENT
sodium I-TREATMENT
100 O
mg O
b.i.d. O

9. O
Zetia B-TREATMENT
10 O
mg O
q.d. O

10. O
Estrogen B-TREATMENT
0.3 O
mg O
q.d. O

11. O
Fluoxetine B-TREATMENT
40 O
mg O
q.d. O

12. O
Vicodin B-TREATMENT
5-500 O
mg O
tablets O
q.4-6h. O
as O
needed O
for O
pain B-SYMPTOM
. O

13. O
Cyclobenzaprine B-TREATMENT
10 O
mg O
tablet O
one O
tablet O
orally O
t.i.d. O

14. O
Atorvastatin B-TREATMENT
80 O
mg O
q.d. O

15. O
Valsartan B-TREATMENT
320 O
mg O
q.d. O

16. O
Aspirin B-TREATMENT
one O
q.d. O

17. O
Benadryl B-TREATMENT
as O
needed O
. O

FOLLOWUP O
: O

The O
patient O
will O
follow O
up O
with O
her O
primary O
care O
physician O
, O
Dr. O
Benson O
, O
( O
845 O
) O
253 O
6629 O
in O
two O
weeks O
by O
calling O
to O
schedule O
an O
appointment O
. O

DR. O
Luedeman,Melissa O
69-853 O

Dictated O
By O
: O

Andrew O
C O
Hoffman O
, O
M.D. O

MEDQUIST36 O

D O
: O

2017-07-02 O

11:35 O

T O
: O

2017-07-04 O

05:14 O

JOB# O
: O

19444 O

Signed O
electronically O
by O
: O

DR. O
Andrew O
X.. O
Dale O
on O
: O

FRI O
2017-09-22 O
9:13 O
AM O

( O
End O
of O
Report O
) O

901751538 O

CTMC O

71624078 O

425615 O

2/3/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

02/03/1992 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

02/07/1992 O

PRINCIPAL O
DIAGNOSIS O
: O

STERNAL B-SYMPTOM
WOUND I-SYMPTOM
INFECTION I-SYMPTOM
. O

SECONDARY O
DIAGNOSES O
: O

STATUS O
POST O
ORTHOTOPIC B-TREATMENT
CARDIAC I-TREATMENT
TRANSPLANT I-TREATMENT
. O

INSULIN B-SYMPTOM
DEPENDENT I-SYMPTOM
DIABETES I-SYMPTOM
MELLITUS I-SYMPTOM
. O

DILATED B-SYMPTOM
CARDIOMYOPATHY I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
48-year-old O
white O
man O
who O
is O
20 O
days O
status O
post O
orthotopic B-TREATMENT
cardiac I-TREATMENT
transplant I-TREATMENT
who O
was O
readmitted O
for O
sternal B-SYMPTOM
wound I-SYMPTOM
infection I-SYMPTOM
. O

He O
has O
insulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
and O
a O
history O
of O
a B-SYMPTOM
dilated I-SYMPTOM
cardiomyopathy I-SYMPTOM
. O

He O
had O
progressive O
symptoms O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
which O
led O
to O
his O
evaluation O
of O
his B-TREATMENT
cardiac I-TREATMENT
transplant I-TREATMENT
in O
March O
of O
1991 O
. O

Preoperatively O
, O
he O
had O
a B-SYMPTOM
severely I-SYMPTOM
dilated I-SYMPTOM
left I-SYMPTOM
ventricle I-SYMPTOM
with O
markedly B-SYMPTOM
diminished I-SYMPTOM
function I-SYMPTOM
. O

His O
post O
transplant O
course O
was O
initially O
complicated O
by O
hyperglycemia B-SYMPTOM
and O
seizure B-SYMPTOM
on O
postoperative O
day O
number O
one O
. O

He O
was O
, O
however O
, O
extubted O
without O
difficulty O
and O
after O
that O
did O
quite O
well O
. O

He O
had O
a O
predischarge O
biopsy O
. O

He O
felt O
well O
at O
home O
without O
fevers B-SYMPTOM
, O
chills B-SYMPTOM
or O
rigors B-SYMPTOM
. O

There O
were O
no O
rashes B-SYMPTOM
. O

He O
had O
no O
chest B-SYMPTOM
pain I-SYMPTOM
or O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

When O
he O
was O
seen O
on O
2/3 O
in O
the O
Transplant O
Clinic O
, O
his B-SYMPTOM
incision I-SYMPTOM
was O
noted O
to O
be O
more B-SYMPTOM
erythematous I-SYMPTOM
. O

He O
was O
referred O
to O
the O
Surgical O
Clinic O
where O
the B-SYMPTOM
wound I-SYMPTOM
was O
opened O
and O
the O
patient O
was O
admitted O
for O
intravenous B-TREATMENT
antibiotics I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
revealed O
a O
middle O
aged O
man O
in O
no O
distress B-SYMPTOM
. O

Blood O
pressure O
was O
152/88 O
. O

Heart O
rate O
90 O
. O

Respiratory O
rate O
14 O
. O

HEENT O
exam O
was O
within O
normal O
limits O
. O

Neck O
was O
without O
bruits B-SYMPTOM
. O

Lungs O
were O
clear O
bilaterally O
. O

Cardiac O
exam O
showed O
a O
normal O
PMI O
, O
regular O
rate O
and O
rhythm O
, O
normal O
S1 O
, O
physiologically B-SYMPTOM
split I-SYMPTOM
S2 I-SYMPTOM
. O

There O
was O
an B-SYMPTOM
S4 I-SYMPTOM
. O

There O
were O
no O
murmurs B-SYMPTOM
or O
rubs B-SYMPTOM
. O

Abdomen O
was O
benign O
. O

Extremities O
were O
2+ B-SYMPTOM
pedal I-SYMPTOM
edema I-SYMPTOM
to O
the O
knees O
. O

Examination O
of O
the B-SYMPTOM
sternal I-SYMPTOM
wound I-SYMPTOM
showed O
an O
opened O
area O
in O
the O
mid O
region O
of O
the B-SYMPTOM
wound I-SYMPTOM
with O
serosanguineous B-SYMPTOM
drainage I-SYMPTOM
and O
a B-SYMPTOM
scant I-SYMPTOM
amount I-SYMPTOM
of I-SYMPTOM
thick I-SYMPTOM
, I-SYMPTOM
yellow I-SYMPTOM
pus I-SYMPTOM
. O

There O
was O
no O
induration B-SYMPTOM
. O

LABORATORY O
DATA O
: O

On O
admission O
revealed O
a O
white O
blood O
cell O
count O
of O
9.46 O
with O
89% O
polys O
, O
2% O
bands O
, O
7% O
lymphocytes O
, O
2% O
monocytes O
. O

Cyclosporin O
A O
level O
on O
admission O
was O
179 O
. O

Microscopic O
exam O
showed O
4+ B-SYMPTOM
Staph I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
and O
pancultured O
. O

He O
was O
treated O
with O
vancomycin B-TREATMENT
and O
ceftazidime B-TREATMENT
while O
awaiting O
wound O
cultures O
. O

He O
had O
dressing B-TREATMENT
changes I-TREATMENT
twice O
a O
day O
. O

Surgery O
was O
consulted O
and O
followed O
him O
while O
he O
was O
in O
house O
. O

Cyclosporin O
levels O
were O
followed O
and O
his O
sugars O
were O
followed O
with O
a B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

During O
the O
first O
two O
days O
, O
he O
required O
14 B-TREATMENT
and I-TREATMENT
22 I-TREATMENT
units I-TREATMENT
of I-TREATMENT
additional I-TREATMENT
coverage I-TREATMENT
. O

However O
, O
by O
day O
three O
he O
required O
no O
additional B-TREATMENT
insulin I-TREATMENT
coverage I-TREATMENT
. O

On O
the O
day O
prior O
to O
discharge O
, O
his B-TREATMENT
intravenous I-TREATMENT
antibiotics I-TREATMENT
were O
discontinued O
and O
he O
was O
begun O
on O
tetracycline B-TREATMENT
. O

DISPOSITION O
: O

The O
patient O
was O
discharged O
home O
in O
stable O
condition O
. O

MEDICATIONS O
: O

On O
discharge O
included O
tetracycline B-TREATMENT
, O
250 O
mg O
po O
q.i.d. O
; O
cyclosporin B-TREATMENT
, O
325 O
mg O
po O
b.i.d. O
; O
prednisone B-TREATMENT
, O
30 O
mg O
po O
q O
day O
; O
Bactrim B-TREATMENT
DS I-TREATMENT
, O
one O
po O
q.o.d. O
; O
diltiazem B-TREATMENT
, O
30 O
mg O
po O
q.i.d. O
; O
Mycostatin B-TREATMENT
, O
15 O
cc O
swish O
and O
swallow O
q.i.d. O
; O
Lasix B-TREATMENT
, O
40 O
mg O
po O
q O
day O
; O
Colace B-TREATMENT
, O
100 O
mg O
po O
q.i.d. O
; O
Carafate B-TREATMENT
, O
1 O
gram O
po O
q.i.d. O
; O
Imuran B-TREATMENT
, O
50 O
mg O
po O
t.i.d. O
; O
NPH B-TREATMENT
insulin I-TREATMENT
, O
44 O
units O
and O
10 O
units O
of O
regular O
q O
a.m. O
; O
NPH B-TREATMENT
, O
22 O
units O
and O
8 O
units O
of O
regular O
q O
p.m. O

PM296/2413 O
RI O
SEEN O
, O
M.D. O
MC0 O

D O
: O

02/26/92 O

Batch O
: O

4373 O

Report O
: O

O8919E48 O

T O
: O

02/27/92 O

Dicatated O
By O
: O

SUSHA O
I. O
RHIM O
, O
M.D. O

139391631 O

GH O

97368061 O

7/20/1999 O
12:00:00 O
AM O

NEUROPATHIC B-SYMPTOM
PAIN I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

07/20/1999 O

Report O
Status O
: O

Signed O
Discharge O

Date O
: O

07/26/1999 O

PRINCIPAL O
DIAGNOSIS O
: O

Post B-SYMPTOM
thoracotomy I-SYMPTOM
syndrome I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

The O
patient O
had O
a B-TREATMENT
spinal I-TREATMENT
cord I-TREATMENT
stimulator I-TREATMENT
trial I-TREATMENT
on O
07/21/99 O
, O
the O
patient O
had O
an B-TREATMENT
epidural I-TREATMENT
trial I-TREATMENT
on O
07/24/99 O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
65 O
year O
old O
female O
with O
post B-SYMPTOM
thoracotomy I-SYMPTOM
syndrome I-SYMPTOM
that O
occurred O
on O
the O
site O
of O
her B-SYMPTOM
thoracotomy I-SYMPTOM
incision I-SYMPTOM
. O

She O
had O
a B-SYMPTOM
thoracic I-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
repaired O
in O
the O
past O
and O
subsequently O
developed O
neuropathic B-SYMPTOM
pain I-SYMPTOM
at O
the B-SYMPTOM
incision I-SYMPTOM
site I-SYMPTOM
. O

She O
is O
currently O
on O
Vicodin B-TREATMENT
, O
one O
to O
two O
tablets O
every O
four O
hours O
p.r.n. O
, O
Fentanyl B-TREATMENT
patch I-TREATMENT
25 O
mcg O
an O
hour O
, O
change O
of O
patch O
every O
72 O
hours O
, O
Elavil B-TREATMENT
50 O
mgq O
.h.s. O
, O
Neurontin B-TREATMENT
600 O
mg O
p.o. O
t.i.d. O
with O
still O
what O
she O
reports O
as O
stabbing B-SYMPTOM
left-sided I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
that O
can O
be O
as O
severe O
as O
a O
7/10. O

She O
has O
failed O
conservative B-TREATMENT
therapy I-TREATMENT
and O
is O
admitted O
for O
a B-TREATMENT
spinal I-TREATMENT
cord I-TREATMENT
stimulator I-TREATMENT
trial I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Hypertension B-SYMPTOM
. O

2. O
Hypothyroidism B-SYMPTOM
. O

3. O
Paraplegia B-SYMPTOM
status O
post O
thoracic B-TREATMENT
aortic I-TREATMENT
aneurysm I-TREATMENT
repair I-TREATMENT
. O

4. O
Left B-SYMPTOM
hemidiaphragmatic I-SYMPTOM
paralysis I-SYMPTOM
, O
history O
of O
recurrent B-SYMPTOM
lung I-SYMPTOM
infections I-SYMPTOM
. O

5. O
Sacral B-SYMPTOM
decubitus I-SYMPTOM
ulcer I-SYMPTOM
. O

6. O
Home B-TREATMENT
oxygen I-TREATMENT
at O
two O
liters O
a O
minute O
when O
she O
is O
at O
home O
; O
she O
does O
not O
use O
the B-TREATMENT
oxygen I-TREATMENT
when O
she O
is O
in O
a B-TREATMENT
wheelchair I-TREATMENT
or O
is O
out O
of O
the O
house O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Atrovent B-TREATMENT
nebulizers I-TREATMENT
0.5 O
mg O
mixed O
with O
albuterol B-TREATMENT
, O
nebulizer B-TREATMENT
is O
given O
every O
six O
hours O
. O

2. O
Norvasc B-TREATMENT
2.5 O
mg O
p.o. O
q O
day O
. O

3. O
Colistin B-TREATMENT
30 O
mg O
nebulizer O
twice O
a O
day O
, O
give O
30 O
minutes O
post O
albuterol B-TREATMENT
and O
Atrovent B-TREATMENT
. O

4. O
Pressure B-TREATMENT
, I-TREATMENT
dermal I-TREATMENT
ulcer I-TREATMENT
care I-TREATMENT
b.i.d. O
dressing B-TREATMENT
change I-TREATMENT
with O
antibiotic B-TREATMENT
solution I-TREATMENT
. O

5. O
Neurontin B-TREATMENT
600 O
mg O
p.o. O
t.i.d. O

6. O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

7. O
Albuterol B-TREATMENT
neb I-TREATMENT
2.5 O
mg O
every O
six O
hours O
, O
30 O
minutes O
before O
Colistin B-TREATMENT
. O

8. O
Amitriptyline B-TREATMENT
50 O
mg O
q.h.s. O

9. O
Vitamin B-TREATMENT
C I-TREATMENT
500 O
mg O
p.o. O
b.i.d. O

10. O
Calcium B-TREATMENT
carbonate I-TREATMENT
125.0 O
mg O
t.i.d. O

11. O
Fentanyl B-TREATMENT
patch I-TREATMENT
25 O
mcg O
an O
hour O
, O
change O
patch B-TREATMENT
every O
72 O
hours O
. O

12. O
Folate B-TREATMENT
1 O
mg O
p.o. O
q O
day O
. O

13. O
Synthroid B-TREATMENT
50 O
mcg O
p.o. O
q O
day O
. O

14. O
Zinc B-TREATMENT
sulfate I-TREATMENT
220 O
mg O
p.o. O
q O
day O
. O

15. O
Multivitamin B-TREATMENT
, O
one O
tablet O
p.o. O
q O
day O
. O

16. O
Hydrocodone B-TREATMENT
5 O
mg O
with O
Tylenol B-TREATMENT
, O
one O
to O
two O
tablets O
every O
four O
hours O
p.r.n. O
pain B-SYMPTOM
. O

17. O
Milk B-TREATMENT
of I-TREATMENT
Magnesia I-TREATMENT
30 O
cc O
p.o. O
q O
day O
constipation B-SYMPTOM
. O

ALLERGIES O
: O

PENICILLIN B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
in O
Napro O
with O
her O
husband O
who O
is O
her O
primary O
caregiver O
. O

She O
is O
not O
a O
smoker O
. O

She O
has O
approximately O
one O
glass O
of O
wine O
every O
day O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
is O
well-appearing O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Blood O
pressure O
is O
150/90 O
, O
heart O
rate O
of O
90 O
, O
respiratory O
rate O
20 O
with O
saturation O
of O
98% O
. O

HEENT O
: O

Pupils O
are O
equal O
and O
reactive O
to O
light O
. O

The O
patient O
wears O
dentures B-TREATMENT
. O

Neck O
: O

Full O
range O
of O
motion O
with O
no O
lymphadenopathy B-SYMPTOM
. O

Chest O
: O

Clear O
to O
auscultation O
on O
the O
right O
. O

Decreased B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
base I-SYMPTOM
with O
coarse B-SYMPTOM
rales I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
base I-SYMPTOM
. O

Cardiovascular O
: O

Regular O
rate O
and O
rhythm O
with O
normal O
S1 O
and O
S2 O
. O

Abdomen O
: O

Soft O
, O
nondistended B-SYMPTOM
, O
nontender B-SYMPTOM
. O

Positive O
bowel O
sounds O
. O

Back O
: O

Clear O
. O

Epidural O
site O
is O
without O
erythema B-SYMPTOM
, O
drainage B-SYMPTOM
or O
tenderness B-SYMPTOM
. O

Left O
buttock O
area O
has O
a B-TREATMENT
dressing I-TREATMENT
over O
the B-SYMPTOM
sacral I-SYMPTOM
decubitus I-SYMPTOM
ulcer I-SYMPTOM
. O

Extremities O
: O

Well-profused O
. O

4/5 O
motor O
strength O
in O
the O
upper O
extremities O
bilaterally O
. O

Flaccid B-SYMPTOM
paralysis I-SYMPTOM
of I-SYMPTOM
bilateral I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
on O
07/20/99 O
for O
a O
history O
of O
left B-SYMPTOM
chest I-SYMPTOM
wall I-SYMPTOM
pain I-SYMPTOM
from O
postthoracotomy B-SYMPTOM
syndrome I-SYMPTOM
. O

The O
patient O
developed O
the B-SYMPTOM
syndrome I-SYMPTOM
after O
her B-TREATMENT
thoracic I-TREATMENT
aortic I-TREATMENT
aneurysm I-TREATMENT
repair I-TREATMENT
. O

The O
patient O
failed O
the B-TREATMENT
conservative I-TREATMENT
therapy I-TREATMENT
and O
is O
admitted O
for O
a B-TREATMENT
spinal I-TREATMENT
cord I-TREATMENT
stimulator I-TREATMENT
trial I-TREATMENT
. O

The O
patient O
had O
a B-TREATMENT
spinal I-TREATMENT
cord I-TREATMENT
stimulator I-TREATMENT
placed O
on O
07/21/99 O
. O

She O
underwent O
the B-TREATMENT
procedure I-TREATMENT
and O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
very O
well O
. O

The B-TREATMENT
spinal I-TREATMENT
cord I-TREATMENT
stimulator I-TREATMENT
was O
programmed O
with O
setting O
of O
a O
rate O
of O
80 O
, O
power O
450 O
and O
4.0 O
amps O
. O

Channel O
1 O
was O
negative O
, O
2 O
was O
neutral O
, O
3 O
was O
neutral O
, O
4 O
was O
positive O
. O

The O
patient O
the O
next O
two O
days O
did O
not O
notice O
any O
significant O
change O
in O
her B-SYMPTOM
pain I-SYMPTOM
pattern I-SYMPTOM
. O

The O
patient O
was O
also O
noted O
to O
have O
a O
lot O
of O
musculoskeletal B-SYMPTOM
component I-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
pain I-SYMPTOM
. O

So O
, O
an B-TREATMENT
epidural I-TREATMENT
catheter I-TREATMENT
was O
placed O
on O
07/23/99 O
. O

The B-TREATMENT
epidural I-TREATMENT
was O
placed O
in O
the O
L1-2 O
region O
and O
the B-TREATMENT
catheter I-TREATMENT
was O
placed O
in O
the O
T7 O
region O
using O
fluoroscope O
to O
guide O
the B-TREATMENT
catheter I-TREATMENT
. O

Within O
the O
next O
couple O
of O
days O
, O
the O
patient O
noticed O
a O
significant O
improvement O
in O
her B-SYMPTOM
pain I-SYMPTOM
pattern I-SYMPTOM
. O

The B-SYMPTOM
stabbing I-SYMPTOM
, I-SYMPTOM
sharp I-SYMPTOM
pain I-SYMPTOM
that O
she O
occasionally O
has O
on O
the O
left O
chest O
wall O
was O
significantly O
diminished O
and O
she O
also O
noticed O
periods O
of O
time O
when O
she O
did O
not O
have O
any O
of O
that B-SYMPTOM
pain I-SYMPTOM
. O

The B-TREATMENT
epidural I-TREATMENT
catheter I-TREATMENT
had O
a B-TREATMENT
morphine I-TREATMENT
infusion I-TREATMENT
initially O
started O
at O
1 O
mg O
a O
day O
and O
increased O
to O
3 O
mg O
a O
day O
in O
a O
period O
of O
three O
days O
. O

The B-TREATMENT
epidural I-TREATMENT
was O
discontinued O
on O
07/26/99 O
and O
was O
considered O
a B-TREATMENT
successful I-TREATMENT
trial I-TREATMENT
. O

The O
patient O
will O
schedule O
with O
the O
Pain O
Clinic O
regarding O
upcoming B-TREATMENT
epidural I-TREATMENT
pump I-TREATMENT
placement I-TREATMENT
. O

During O
her O
hospitalization O
, O
the O
patient O
was O
also O
seen O
by O
the O
Plastic O
Service O
. O

Dr. O
Falccouette O
would O
like O
to O
perform O
an B-TREATMENT
excision I-TREATMENT
and O
closure B-TREATMENT
flap I-TREATMENT
of O
her B-SYMPTOM
left I-SYMPTOM
ischial I-SYMPTOM
decubitusin I-SYMPTOM
the O
near O
future O
. O

The O
patient O
was O
discharged O
in O
stable O
conditionand O
will O
follow O
up O
for O
( O
1 O
) O
sacral B-TREATMENT
decubitus I-TREATMENT
closure I-TREATMENT
, O
and O
( O
2 O
) O
placement B-TREATMENT
of I-TREATMENT
epidural I-TREATMENT
pump I-TREATMENT
in O
the O
future O
. O

DISCHARGE O
INSTRUCTIONS O
: O

The O
patient O
will O
have O
SMH O
Service O
that O
comes O
to O
her O
home O
once O
a O
day O
for O
adressing B-TREATMENT
change I-TREATMENT
. O

The O
patient O
will O
follow O
up O
with O
Dr. O
Kayschird O
to O
schedule O
for O
the B-TREATMENT
epidural I-TREATMENT
pump I-TREATMENT
. O

The O
patient O
will O
follow O
up O
with O
Dr. O
Falccouette O
to O
schedule O
for O
excision B-TREATMENT
and O
closure B-TREATMENT
of O
her B-SYMPTOM
left I-SYMPTOM
ischial I-SYMPTOM
sacral I-SYMPTOM
decubitus I-SYMPTOM
. O

Dictated O
By O
: O

ECI O
JESCSLAND O
, O
M.D. O
OO63 O

Attending O
: O

FOMAIRE O
KOTEKOTEJESCDREWE O
, O
M.D. O
RY93 O
KE526/9219 O

Batch O
: O

37707 O

Index O
No. O

RWRF75BSI O

D O
: O

07/26/99 O

T O
: O

07/26/99 O

CC O
: O

JOFREDD O
N. O
FALCCOUETTE O
, O
M.D. O
SV7 O

[ O
report_end O
] O

Admission O
Date O
: O

2013-09-05 O

Discharge O
Date O
: O

2013-09-12 O

Date O
of O
Birth O
: O

1934-08-29 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Mary O
N O
Major O
, O
M.D. O

Chief O
Complaint O
: O

change B-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

None O

History O
of O
Present O
Illness O
: O

HPI O
: O
This O
is O
a O
79 O
y/o O
M O
with O
h/o O
of O
HTN B-SYMPTOM
, O
DM B-SYMPTOM
, O
recent B-SYMPTOM
CVA I-SYMPTOM
Theresa O
, O
chronic B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
on O
vent B-TREATMENT
, O
trached B-TREATMENT
, O
ESRD B-SYMPTOM
on O
HD B-TREATMENT
who O
was O
sent O
from O
rehab O
facility O
for O
worsening B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
. O

Per O
refferal O
notes O
, O
he O
went O
to O
hemodyalisis B-TREATMENT
today O
in O
the O
morning O
. O

1 O
L O
was O
removed O
. O

At O
about O
2:30 O
pm O
, O
he O
was O
found O
to O
have O
worsening B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
. O

In O
that O
setting O
he O
was O
hypotensive B-SYMPTOM
down O
to O
the O
92/45 O
, O
and O
was O
given O
1 B-TREATMENT
L I-TREATMENT
NS I-TREATMENT
. O

Fs O
was O
also O
checked O
179 O
. O

At O
that O
time O
, O
it O
seems O
that O
he O
had O
been O
on O
T B-TREATMENT
peace I-TREATMENT
since O
4 O
am O
today O
. O

At O
2:30 O
he O
was O
also O
found O
with O
sats O
in O
the O
90% O
. O

ABG O
done O
7.1 O
, O
89/72 O
- O
he O
was O
placed O
on O
AC B-TREATMENT
600 O
/ O
0.4 O
and O
6 O
PEEP B-TREATMENT
- O
sats O
up O
to O
94% O
. O

Given O
persistent B-SYMPTOM
lethargy I-SYMPTOM
, O
patient O
was O
sent O
to O
Falkener O
Amanda O
. O

Of O
note O
, O
after O
interview O
with O
HCP O
, O
at O
around O
07-23 O
, O
patient O
started O
having O
episodes O
of O
dizziness B-SYMPTOM
, O
and O
had O
unstable B-SYMPTOM
gait I-SYMPTOM
. O

he O
was O
taken O
to O
Williams O
ICU O
until O
08-09 O
when O
he O
was O
discharged O
to O
Waltham/Weston O
Hospital O
Rehab O
. O

he O
had O
a B-TREATMENT
peg I-TREATMENT
tube I-TREATMENT
and O
tracheostomy B-TREATMENT
prior O
to O
d/c O
. O

He O
had O
been O
chronicallyl B-SYMPTOM
vent I-SYMPTOM
dependent I-SYMPTOM
. O

His O
companion O
states O
that O
they O
have O
been O
trying O
to O
wean O
him O
down O
at O
rehab O
. O

his O
basline O
mental O
staus O
apparently O
responds O
with O
his O
head O
shaking O
, O
and O
also O
try O
to O
write O
sentences O
. O

In O
the O
Amanda O
: O
VS O
T O
103 O
rectal O
BP90/44 O
HR O
: O
84 O
RR O
16 O
Sats O
: O
98 O
+ B-SYMPTOM
guiac I-SYMPTOM
stool I-SYMPTOM
. O

He O
received O
tylenol B-TREATMENT
, O
levofloxacin B-TREATMENT
500 O
mg O
IV O
, O
Flagyl B-TREATMENT
500 O
mg O
and O
Vancomycin B-TREATMENT
and O
I B-TREATMENT
L I-TREATMENT
NS I-TREATMENT
. O

ROS O
: O
difficult O
to O
obtain O
2x2 O
to O
patient O
mental O
status O
baselin O

Past O
Medical O
History O
: O

CVA B-SYMPTOM
Theresa O
/ O
2006 O

HTN B-SYMPTOM

DM B-SYMPTOM

CRI B-SYMPTOM
on O
HD B-TREATMENT
since O
Theresa O
( O
Tu, O
Thurs, O
Sat O
) O

Neuropathy B-SYMPTOM
right I-SYMPTOM
leg I-SYMPTOM

s/p O
cCY B-TREATMENT

Social O
History O
: O

Uset O
to O
be O
truck O
driver O
. O

Retired O
15 O
years O
ago O
. O

He O
has O
1 O
son O
, O
two O
grandson O
. O

smoking O
(-), O
alcohol O
- O

Family O
History O
: O

brother O
died O
cerebral B-SYMPTOM
aneurysm I-SYMPTOM

Brother O
Sabina B-SYMPTOM
cancer I-SYMPTOM

brother O
prostate B-SYMPTOM
cancer I-SYMPTOM

father O
Randall O

Physical O
Exam O
: O

Physical O
Exam O
: O

Vitals O
: O
T O
: O
99 O
P O
: O
84 O
BP O
: O
145/62 O
AC B-TREATMENT
: O
600 O
, O
x O
12 O
/ O
0.5 O
/ O
5 O
SaO2 O
: O
100% O

General O
: O
Awake O
, O
alert O
, O
responding O
to O
voice O
. O

HEENT O
: O
PEERLA O
, O
no O
JVD B-SYMPTOM
. O
+ O
tracheostomy B-TREATMENT

Pulmonary O
: O
clear O
anteriorly O
. O

decrease B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
bases I-SYMPTOM
. O

Cardiac O
: O
RRR O
, O
nl O
. O
S1S2 O
, O
soft B-SYMPTOM
holosytolic I-SYMPTOM
murmur I-SYMPTOM
apex I-SYMPTOM

Abdomen O
: O
soft O
, O
NT/ND B-SYMPTOM
, O
normoactive O
bowel O
sounds O
, O
no O
masses B-SYMPTOM
or O
organomegaly B-SYMPTOM
noted O
. O

+ O
g B-TREATMENT
tube I-TREATMENT

Extremities O
: O
Left B-TREATMENT
arm I-TREATMENT
AVF I-TREATMENT

1+ B-SYMPTOM
trace I-SYMPTOM
edemalymphadenopathy I-SYMPTOM
noted O
. O

Skin O
: O
no O
rashes B-SYMPTOM
, O
small B-SYMPTOM
decubit I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
back I-SYMPTOM
. O

Neurologic O
: O
alert O
, O
awake O
, O
partially O
interacting O
and O
responding O
to O
comands O
. O

decreased B-SYMPTOM
reflexes I-SYMPTOM
Lower I-SYMPTOM
extremities I-SYMPTOM
. O

bilaterally O
. O

spastic O
right O

upper O
extremity O
. O

Pertinent O
Results O
: O

141 O
103 O
53 O
167 O

AGap O
= O
14 O

-------------> O

5.7 O
30 O
3.6 O

CK O
: O
29 O
MB O
: O
Notdone O
Trop O
-* O
T O
*: O
0.44 O

Comments O
: O
Notified O
Glenn O
Shives O
2013-09-05 O
6:50 O
p O

Ctropnt O
> O
0.10 O
Ng O
/ O
Ml O
Suggests O
Acute B-SYMPTOM
Mi I-SYMPTOM

Ca O
: O
8.6 O
Mg O
: O
2.4 O
P O
: O
5.0 O

Other O
Blood O
Chemistry O
: O

proBNP O
: O
11065 O

WBC O
15.2 O
Plat O
395 O

HCT O
: O
28.4 O

N O
: O
89.8 O
Band O
: O
0 O
L O
: O
5.8 O
M O
: O
4.1 O
E O
: O
0.3 O
Bas O
: O
0.1 O
PT O
: O
12.1 O
PTT O
: O
37.5 O
INR O
: O
1.0 O

2013-09-05 O

5:04 O
p O

Green O
Top O

K O
: O
5.5 O
Lactate O
: O
1.3 O

Brief O
Hospital O
Course O
: O

Assessment O
and O
Plan O
: O

This O
is O
a O
79 O
y/o O
M O
with O
h/o O
HTN B-SYMPTOM
, O
DM B-SYMPTOM
, O
recent B-SYMPTOM
CVA I-SYMPTOM
, O
chronic B-SYMPTOM
ventilatory I-SYMPTOM
failure I-SYMPTOM
, O
CRI B-SYMPTOM
on O
HD B-TREATMENT
who O
presents O
with O
change B-SYMPTOM
in I-SYMPTOM
MS I-SYMPTOM
and O
febrile B-SYMPTOM
in O
the O
Amanda O
, O
admitted O
to O
CMED O
. O

# O
Altered B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
: O
Ct O
scan O
with O
no O
evidence O
of O
new B-SYMPTOM
intracraneal I-SYMPTOM
bleeding I-SYMPTOM
. O

Patient O
febrile B-SYMPTOM
in O
the O
Amanda O
. O

High B-SYMPTOM
WBC I-SYMPTOM
. O

It O
was O
thought O
that O
it O
could O
have O
been O
a O
combination O
of O
hypotension B-SYMPTOM
, O
hypercapnia B-SYMPTOM
and O
infection B-SYMPTOM
. O

He O
was O
initially O
started O
on O
broad B-TREATMENT
spectrum I-TREATMENT
antibiotics I-TREATMENT
. O

Despite O
having O
a B-SYMPTOM
profund I-SYMPTOM
limitation I-SYMPTOM
communicating I-SYMPTOM
given O
his B-SYMPTOM
neurological I-SYMPTOM
status I-SYMPTOM
, O
his B-SYMPTOM
mental I-SYMPTOM
changes I-SYMPTOM
seemed O
to O
improved O
initially O
. O

However O
later O
on O
during O
his O
course O
, O
his O
mental O
status O
deteriorated O
, O
being O
even O
less B-SYMPTOM
responsive I-SYMPTOM
. O

# O
ID O
: O

Patient O
febrile B-SYMPTOM
and O
with O
a B-SYMPTOM
high I-SYMPTOM
WBC I-SYMPTOM
on O
admission O
. O

After O
starting O
broad B-TREATMENT
spectrum I-TREATMENT
antibiotics I-TREATMENT
- O
cefepime B-TREATMENT
- O
vancomycin B-TREATMENT
and O
flagyl B-TREATMENT
( O
for O
initial O
concern O
of O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
), O
he O
responded O
clinically O
. O

Urine O
cx O
from O
Rehab O
showed O
gram B-SYMPTOM
negative I-SYMPTOM
rods I-SYMPTOM
> B-SYMPTOM
100 I-SYMPTOM
K I-SYMPTOM
enterobacter I-SYMPTOM
cloacae I-SYMPTOM
. O

Urine O
Cx O
in O
house O
grew O
Citrobacter B-SYMPTOM
Freundi I-SYMPTOM
and O
his O
sputum O
grew O
Acinetobacter B-SYMPTOM
Baummani I-SYMPTOM
. O

Since O
there O
was O
no O
more O
evidence O
of O
gram B-SYMPTOM
positive I-SYMPTOM
infections I-SYMPTOM
, O
vancomycin B-TREATMENT
was O
discontinued O
and O
cefepime B-TREATMENT
was O
kept O
. O

# O
Fevers B-SYMPTOM
: O
in O
the O
Amanda O
, O
high B-SYMPTOM
WBC I-SYMPTOM
, O
possible O
pneumonia B-SYMPTOM
. O

Also O
possible O
source O
sinus B-SYMPTOM
infections I-SYMPTOM
given O
findings O
on O
intial O
CT O
( O
see O
summary O
in O
significant O
studies O
). O
He O
did O
not O
spike O
any O
fevers B-SYMPTOM
after O
being O
transfer O
to O
the O
CMED O
from O
the O
Amanda O
. O

# O
Resp O
: O
Patient O
was O
intermitentely O
switched O
from O
AC B-TREATMENT
to O
Pressure B-TREATMENT
support I-TREATMENT
trials I-TREATMENT
. O

However O
, O
after O
Patient O
did O
well O
. O

Then O
trach B-TREATMENT
mask I-TREATMENT
trials I-TREATMENT
were O
done O
. O

He O
tolerated O
this O
well O
, O
although O
he O
required O
PS B-TREATMENT
overnight O
. O

# O
ESRD B-SYMPTOM
on O
hemodyalisis B-TREATMENT
: O
Renal O
service O
was O
consulted O
and O
HD B-TREATMENT
was O
continued O
. O

# O
CV O
: O

Rhythm O
: O
NSR O
, O
not O
tachycardic B-SYMPTOM
. O

Pump O
: O
With O
trace O
of O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
. O

X O
ray O
suggested O
some B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
on O
admission O
. O

Despite O
this O
findings O
, O
he O
was O
supported O
with O
40% B-TREATMENT
FIO2 I-TREATMENT
most O
of O
the O
time O
. O

CAD B-SYMPTOM
: O
On O
admission O
Ck O
low O
normal O
, O
MB O
not O
done O
. O

Troponin O
0.44. O

It O
was O
more O
likely O
due O
to O
CRI B-SYMPTOM
. O

Second O
set O
12 O
hours O
apart O
, O
showed O
no O
changes B-SYMPTOM
. O

s/p O
stroke B-SYMPTOM
: O
continue O
aspirin B-TREATMENT
, O
statin B-TREATMENT
, O
plavix B-TREATMENT

# O
Hypotension B-SYMPTOM
: O
per O
referral O
form O
. O

Intially O
concern O
for O
sepsis B-SYMPTOM
in O
the O
setting O
of O
fevers B-SYMPTOM
and O
high B-SYMPTOM
blood I-SYMPTOM
count I-SYMPTOM
. O

His B-TREATMENT
BP I-TREATMENT
medications I-TREATMENT
were O
held O
on O
admission O
. O

Patient O
did O
not O
require O
pressors B-TREATMENT
. O

His O
blood O
pressure O
remained O
stable O
and O
BP B-TREATMENT
meds I-TREATMENT
were O
restarted O
. O

# O
FEN O
: O

Tube B-TREATMENT
feedings I-TREATMENT
were O
started O
thorugh O
peg B-TREATMENT
tube I-TREATMENT
. O

On O
2013-09-08 O
, O
patient O
pulled O
out O
peg B-TREATMENT
tube I-TREATMENT
. O

Temporary B-TREATMENT
foley I-TREATMENT
was O
placed O
and O
on O
2013-09-11 O
, O

On O
2013-09-12 O
after O
deterioration B-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
and I-SYMPTOM
also I-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
, O
goals O
of O
care O
were O
discussed O
with O
his O
HCP O
. O

It O
was O
decided O
to O
direct O
goals O
of O
care O
towards O
confort B-TREATMENT
care I-TREATMENT
. O

Patient O
passed O
away O
accompanied O
by O
his O
significant O
other O
. O

Medications O
on O
Admission O
: O

Novolin B-TREATMENT
16 O
U O
q O
12h O

Aranesp B-TREATMENT
40 O
mcg O
sc O

Prozac B-TREATMENT
liquid I-TREATMENT
20 O
mg O
q O
am O

Heparin B-TREATMENT
3000 O
U O
tu O
, O
thursday O
saturday O

Norvasc B-TREATMENT
10 O
mg O
daily O
GT O

Tylenol B-TREATMENT
PRN O

Reglan B-TREATMENT
5 O
mg O
q O
6h O
, O

fergon B-TREATMENT
300 O
mg O
BID O

Plavix B-TREATMENT
75 O
mg O
GT O

nephrocaps B-TREATMENT
1 O
daily O

novolin B-TREATMENT
Sliding I-TREATMENT
scale I-TREATMENT

heparin B-TREATMENT
sc O
5000 O
q O
8h O

Protonix B-TREATMENT
40 O
mg O
daily O
GT O

Combivent B-TREATMENT
2 O
puff O
qid O
inh O

zocor B-TREATMENT
10 O
mg O
Tab O
/ O
day O
GT O

aspirin B-TREATMENT
325 O
mg O
tab O

Ferrlecit B-TREATMENT
Sodium I-TREATMENT
ferric I-TREATMENT
gluconate I-TREATMENT
Mo-We O
Fr O
IV O

Discharge O
Medications O
: O

n/a O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

1. O
Change B-SYMPTOM
in I-SYMPTOM
Mental I-SYMPTOM
status I-SYMPTOM

2. O
Urinary B-SYMPTOM
tract I-SYMPTOM
Infection I-SYMPTOM

3. O
Chronic B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM

Secondary O
: O

1. O
Hypertension B-SYMPTOM

2. O
Diabetes B-SYMPTOM
Mellitus I-SYMPTOM

3. O
End B-SYMPTOM
stage I-SYMPTOM
renal I-SYMPTOM
disease I-SYMPTOM
on O
HD B-TREATMENT

Discharge O
Condition O
: O

expired O

Discharge O
Instructions O
: O

n/a O

Followup O
Instructions O
: O

n/a O

Z. O
Mcbride O
WEISS O
MD O
51-615 O

Completed O
by O
: O
Martha O
Fairley O
MD O
53-063 O
2013-11-12 O
@ O
2057 O

Signed O
electronically O
by O
: O
DR. O
V O
Osterman O
WEISS O
on O
: O
WED O
2013-11-13 O
8:40 O
AM O

( O
End O
of O
Report O
) O

139391631 O

GH O

97368061 O

7/20/1999 O
12:00:00 O
AM O

NEUROPATHIC B-SYMPTOM
PAIN I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

07/20/1999 O

Report O
Status O
: O

Signed O
Discharge O

Date O
: O

07/26/1999 O

PRINCIPAL O
DIAGNOSIS O
: O

Post B-SYMPTOM
thoracotomy I-SYMPTOM
syndrome I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

The O
patient O
had O
a O
spinal O
cord O
stimulator O
trial O
on O
07/21/99 O
, O
the O
patient O
had O
an O
epidural O
trial O
on O
07/24/99 O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
65 O
year O
old O
female O
with O
post B-SYMPTOM
thoracotomy I-SYMPTOM
syndrome I-SYMPTOM
that O
occurred O
on O
the O
site O
of O
her B-SYMPTOM
thoracotomy I-SYMPTOM
incision I-SYMPTOM
. O

She O
had O
a B-SYMPTOM
thoracic I-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
repaired O
in O
the O
past O
and O
subsequently O
developed O
neuropathic B-SYMPTOM
pain I-SYMPTOM
at O
the B-SYMPTOM
incision I-SYMPTOM
site I-SYMPTOM
. O

She O
is O
currently O
on O
Vicodin B-TREATMENT
, O
one O
to O
two O
tablets O
every O
four O
hours O
p.r.n. O
, O
Fentanyl B-TREATMENT
patch I-TREATMENT
25 O
mcg O
an O
hour O
, O
change O
of O
patch O
every O
72 O
hours O
, O
Elavil B-TREATMENT
50 O
mgq O
.h.s. O
, O
Neurontin B-TREATMENT
600 O
mg O
p.o. O
t.i.d. O
with O
still O
what O
she O
reports O
as O
stabbing B-SYMPTOM
left-sided I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
that O
can O
be O
as O
severe O
as O
a O
7/10. O

She O
has O
failed O
conservative B-TREATMENT
therapy I-TREATMENT
and O
is O
admitted O
for O
a O
spinal O
cord O
stimulator O
trial O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Hypertension B-SYMPTOM
. O

2. O
Hypothyroidism B-SYMPTOM
. O

3. O
Paraplegia B-SYMPTOM
status O
post O
thoracic B-TREATMENT
aortic I-TREATMENT
aneurysm I-TREATMENT
repair I-TREATMENT
. O

4. O
Left B-SYMPTOM
hemidiaphragmatic I-SYMPTOM
paralysis I-SYMPTOM
, O
history O
of O
recurrent B-SYMPTOM
lung I-SYMPTOM
infections I-SYMPTOM
. O

5. O
Sacral B-SYMPTOM
decubitus I-SYMPTOM
ulcer I-SYMPTOM
. O

6. O
Home B-TREATMENT
oxygen I-TREATMENT
at O
two O
liters O
a O
minute O
when O
she O
is O
at O
home O
; O
she O
does O
not O
use O
the B-TREATMENT
oxygen I-TREATMENT
when O
she O
is O
in O
a B-TREATMENT
wheelchair I-TREATMENT
or O
is O
out O
of O
the O
house O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Atrovent B-TREATMENT
nebulizers I-TREATMENT
0.5 O
mg O
mixed O
with O
albuterol B-TREATMENT
, O
nebulizer B-TREATMENT
is O
given O
every O
six O
hours O
. O

2. O
Norvasc B-TREATMENT
2.5 O
mg O
p.o. O
q O
day O
. O

3. O
Colistin B-TREATMENT
30 O
mg O
nebulizer O
twice O
a O
day O
, O
give O
30 O
minutes O
post O
albuterol B-TREATMENT
and O
Atrovent B-TREATMENT
. O

4. O
Pressure B-TREATMENT
, I-TREATMENT
dermal I-TREATMENT
ulcer I-TREATMENT
care I-TREATMENT
b.i.d. O
dressing B-TREATMENT
change I-TREATMENT
with O
antibiotic B-TREATMENT
solution I-TREATMENT
. O

5. O
Neurontin B-TREATMENT
600 O
mg O
p.o. O
t.i.d. O

6. O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

7. O
Albuterol B-TREATMENT
neb I-TREATMENT
2.5 O
mg O
every O
six O
hours O
, O
30 O
minutes O
before O
Colistin B-TREATMENT
. O

8. O
Amitriptyline B-TREATMENT
50 O
mg O
q.h.s. O

9. O
Vitamin B-TREATMENT
C I-TREATMENT
500 O
mg O
p.o. O
b.i.d. O

10. O
Calcium B-TREATMENT
carbonate I-TREATMENT
125.0 O
mg O
t.i.d. O

11. O
Fentanyl B-TREATMENT
patch I-TREATMENT
25 O
mcg O
an O
hour O
, O
change O
patch O
every O
72 O
hours O
. O

12. O
Folate B-TREATMENT
1 O
mg O
p.o. O
q O
day O
. O

13. O
Synthroid B-TREATMENT
50 O
mcg O
p.o. O
q O
day O
. O

14. O
Zinc B-TREATMENT
sulfate I-TREATMENT
220 O
mg O
p.o. O
q O
day O
. O

15. O
Multivitamin B-TREATMENT
, O
one O
tablet O
p.o. O
q O
day O
. O

16. O
Hydrocodone B-TREATMENT
5 I-TREATMENT
mg I-TREATMENT
with I-TREATMENT
Tylenol I-TREATMENT
, O
one O
to O
two O
tablets O
every O
four O
hours O
p.r.n. O
pain B-SYMPTOM
. O

17. O
Milk B-TREATMENT
of I-TREATMENT
Magnesia I-TREATMENT
30 O
cc O
p.o. O
q O
day O
constipation B-SYMPTOM
. O

ALLERGIES O
: O

PENICILLIN B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
in O
Napro O
with O
her O
husband O
who O
is O
her O
primary O
caregiver O
. O

She O
is O
not O
a O
smoker O
. O

She O
has O
approximately O
one O
glass O
of O
wine O
every O
day O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
is O
well-appearing O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Blood O
pressure O
is O
150/90 O
, O
heart O
rate O
of O
90 O
, O
respiratory O
rate O
20 O
with O
saturation O
of O
98% O
. O

HEENT O
: O

Pupils O
are O
equal O
and O
reactive O
to O
light O
. O

The O
patient O
wears O
dentures B-TREATMENT
. O

Neck O
: O

Full O
range O
of O
motion O
with O
no O
lymphadenopathy B-SYMPTOM
. O

Chest O
: O

Clear O
to O
auscultation O
on O
the O
right O
. O

Decreased B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
base I-SYMPTOM
with O
coarse B-SYMPTOM
rales I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
base I-SYMPTOM
. O

Cardiovascular O
: O

Regular O
rate O
and O
rhythm O
with O
normal O
S1 O
and O
S2 O
. O

Abdomen O
: O

Soft O
, O
nondistended B-SYMPTOM
, O
nontender B-SYMPTOM
. O

Positive O
bowel O
sounds O
. O

Back O
: O

Clear O
. O

Epidural B-TREATMENT
site I-TREATMENT
is O
without O
erythema B-SYMPTOM
, O
drainage B-SYMPTOM
or O
tenderness B-SYMPTOM
. O

Left O
buttock O
area O
has O
a B-TREATMENT
dressing I-TREATMENT
over O
the B-SYMPTOM
sacral I-SYMPTOM
decubitus I-SYMPTOM
ulcer I-SYMPTOM
. O

Extremities O
: O

Well-profused O
. O

4/5 O
motor O
strength O
in O
the O
upper O
extremities O
bilaterally O
. O

Flaccid B-SYMPTOM
paralysis I-SYMPTOM
of I-SYMPTOM
bilateral I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
on O
07/20/99 O
for O
a O
history O
of O
left B-SYMPTOM
chest I-SYMPTOM
wall I-SYMPTOM
pain I-SYMPTOM
from O
postthoracotomy B-SYMPTOM
syndrome I-SYMPTOM
. O

The O
patient O
developed O
the B-SYMPTOM
syndrome I-SYMPTOM
after O
her B-TREATMENT
thoracic I-TREATMENT
aortic I-TREATMENT
aneurysm I-TREATMENT
repair I-TREATMENT
. O

The O
patient O
failed O
the B-TREATMENT
conservative I-TREATMENT
therapy I-TREATMENT
and O
is O
admitted O
for O
a O
spinal O
cord O
stimulator O
trial O
. O

The O
patient O
had O
a B-TREATMENT
spinal I-TREATMENT
cord I-TREATMENT
stimulator I-TREATMENT
placed O
on O
07/21/99 O
. O

She O
underwent O
the B-TREATMENT
procedure I-TREATMENT
and O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
very O
well O
. O

The B-TREATMENT
spinal I-TREATMENT
cord I-TREATMENT
stimulator I-TREATMENT
was O
programmed O
with O
setting O
of O
a O
rate O
of O
80 O
, O
power O
450 O
and O
4.0 O
amps O
. O

Channel O
1 O
was O
negative O
, O
2 O
was O
neutral O
, O
3 O
was O
neutral O
, O
4 O
was O
positive O
. O

The O
patient O
the O
next O
two O
days O
did O
not O
notice O
any O
significant O
change O
in O
her B-SYMPTOM
pain I-SYMPTOM
pattern I-SYMPTOM
. O

The O
patient O
was O
also O
noted O
to O
have O
a O
lot O
of O
musculoskeletal B-SYMPTOM
component I-SYMPTOM
of O
her B-SYMPTOM
pain I-SYMPTOM
. O

So O
, O
an B-TREATMENT
epidural I-TREATMENT
catheter I-TREATMENT
was O
placed O
on O
07/23/99 O
. O

The B-TREATMENT
epidural I-TREATMENT
was O
placed O
in O
the O
L1-2 O
region O
and O
the B-TREATMENT
catheter I-TREATMENT
was O
placed O
in O
the O
T7 O
region O
using O
fluoroscope B-TREATMENT
to O
guide O
the B-TREATMENT
catheter I-TREATMENT
. O

Within O
the O
next O
couple O
of O
days O
, O
the O
patient O
noticed O
a O
significant O
improvement O
in O
her B-SYMPTOM
pain I-SYMPTOM
pattern I-SYMPTOM
. O

The B-SYMPTOM
stabbing I-SYMPTOM
, I-SYMPTOM
sharp I-SYMPTOM
pain I-SYMPTOM
that O
she O
occasionally O
has O
on O
the O
left O
chest O
wall O
was O
significantly O
diminished O
and O
she O
also O
noticed O
periods O
of O
time O
when O
she O
did O
not O
have O
any O
of O
that B-SYMPTOM
pain I-SYMPTOM
. O

The B-TREATMENT
epidural I-TREATMENT
catheter I-TREATMENT
had O
a B-TREATMENT
morphine I-TREATMENT
infusion I-TREATMENT
initially O
started O
at O
1 O
mg O
a O
day O
and O
increased O
to O
3 O
mg O
a O
day O
in O
a O
period O
of O
three O
days O
. O

The B-TREATMENT
epidural I-TREATMENT
was O
discontinued O
on O
07/26/99 O
and O
was O
considered O
a O
successful O
trial O
. O

The O
patient O
will O
schedule O
with O
the O
Pain O
Clinic O
regarding O
upcoming O
epidural B-TREATMENT
pump I-TREATMENT
placement I-TREATMENT
. O

During O
her O
hospitalization O
, O
the O
patient O
was O
also O
seen O
by O
the O
Plastic O
Service O
. O

Dr. O
Falccouette O
would O
like O
to O
perform O
an B-TREATMENT
excision I-TREATMENT
and O
closure B-TREATMENT
flap I-TREATMENT
of O
her B-SYMPTOM
left I-SYMPTOM
ischial I-SYMPTOM
decubitusin I-SYMPTOM
the O
near O
future O
. O

The O
patient O
was O
discharged O
in O
stable O
conditionand O
will O
follow O
up O
for O
( O
1 O
) O
sacral B-TREATMENT
decubitus I-TREATMENT
closure I-TREATMENT
, O
and O
( O
2 O
) O
placement B-TREATMENT
of I-TREATMENT
epidural I-TREATMENT
pump I-TREATMENT
in O
the O
future O
. O

DISCHARGE O
INSTRUCTIONS O
: O

The O
patient O
will O
have O
SMH O
Service O
that O
comes O
to O
her O
home O
once O
a O
day O
for O
adressing B-TREATMENT
change I-TREATMENT
. O

The O
patient O
will O
follow O
up O
with O
Dr. O
Kayschird O
to O
schedule O
for O
the B-TREATMENT
epidural I-TREATMENT
pump I-TREATMENT
. O

The O
patient O
will O
follow O
up O
with O
Dr. O
Falccouette O
to O
schedule O
for O
excision B-TREATMENT
and O
closure B-TREATMENT
of O
her B-SYMPTOM
left I-SYMPTOM
ischial I-SYMPTOM
sacral I-SYMPTOM
decubitus I-SYMPTOM
. O

Dictated O
By O
: O

ECI O
JESCSLAND O
, O
M.D. O
OO63 O

Attending O
: O

FOMAIRE O
KOTEKOTEJESCDREWE O
, O
M.D. O
RY93 O
KE526/9219 O

Batch O
: O

37707 O

Index O
No. O

RWRF75BSI O

D O
: O

07/26/99 O

T O
: O

07/26/99 O

CC O
: O

JOFREDD O
N. O
FALCCOUETTE O
, O
M.D. O
SV7 O

300423900 O

PUOMC O

7191549 O

32395/a42u O

265407 O

12/4/1995 O
12:00:00 O
AM O

MAINTENANCE B-TREATMENT
CHEMOTHERAPY I-TREATMENT
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

12/4/95 O

DISCHARGE O
DATE O
: O

12/8/95 O

His O
date O
of O
birth O
is O
11/7/32 O
. O

PRINCIPAL O
DIAGNOSIS O
: O

maintenance B-TREATMENT
chemotherapy I-TREATMENT
. O

ASSOCIATED O
DIAGNOSES O
: O

malignant B-SYMPTOM
fibrous I-SYMPTOM
histiocytoma I-SYMPTOM
of I-SYMPTOM
duodenum I-SYMPTOM
, O
metastases B-SYMPTOM
to I-SYMPTOM
liver I-SYMPTOM
, O
anemia B-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

intravenous B-TREATMENT
chemotherapy I-TREATMENT
12/4/95 O
through O
12/8/95 O
. O

DISCHARGE O
ORDERS O
: O

Ativan B-TREATMENT
1 O
mg O
or O
Trilafon B-TREATMENT
4 O
mg O
q O
4 O
hours O
prn O
nausea B-SYMPTOM
, O
Carafate B-TREATMENT
one O
gram O
q.i.d. O

PRESENT O
ILLNESS O
: O

This O
63-year-old O
man O
had O
a B-SYMPTOM
mass I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
duodenum I-SYMPTOM
, O
discovered O
in O
02/95 O
. O

A B-SYMPTOM
leiomyosarcoma I-SYMPTOM
was O
resected B-TREATMENT
after O
embolization B-TREATMENT
of I-TREATMENT
the I-TREATMENT
splenic I-TREATMENT
artery I-TREATMENT
. O

However O
, O
it O
could O
not O
be O
completely O
excised O
, O
moreover O
the B-SYMPTOM
tumor I-SYMPTOM
metastasized O
to O
the O
liver O
was O
discovered O
on O
follow O
up O
scan O
in O
06/95 O
. O

He O
has O
been O
receiving O
chemotherapy B-TREATMENT
since O
then O
. O

PHYSICAL O
EXAMINATION O
: O

He O
generally O
looks O
well O
. O

Vital O
signs O
are O
normal O
. O

The O
skin O
is O
intact O
. O

His O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
is O
clear O
. O

The O
neck O
is O
without O
adenopathy B-SYMPTOM
. O

Chest O
clear O
. O

Heart O
without O
gallop B-SYMPTOM
. O

Abdomen O
without O
mass B-SYMPTOM
. O

Extremities O
without O
edema B-SYMPTOM
. O

Neurological O
examination O
intact O
. O

LABORATORY O
EXAMINATION O
: O

hematocrit O
33 O
, O
white O
count O
4.4 O
, O
with O
28% O
monos O
and O
30% O
polys O
and O
bands O
. O

Platelets O
253 O
thousand O
. O

Creatinine O
0.6 O
, O
SGOT O
52 O
, O
bilirubin O
0.5 O
. O

COURSE O
IN O
HOSPITAL O
: O

The O
patient O
was O
hydrated O
well O
and O
given O
Adriamycin B-TREATMENT
27 O
mg O
and O
DTIC B-TREATMENT
450 O
mg O
daily O
for O
four O
days O
. O

He O
also O
got O
ifosfamide B-TREATMENT
3.6 O
grams O
a O
day O
with O
mesna B-TREATMENT
. O

He O
tolerated O
treatment B-TREATMENT
well O
and O
was O
discharged O
in O
good O
condition O
. O

FOLLOWUP O
: O

by O
private O
physician O
. O

LENNI O
BREUTZOLN O
, O
M.D. O

TR O
: O

by O
/ O
bmot O

DD O
: O

12/10/95 O

TD O
: O

12/13/95 O

CC O
: O

Admission O
Date O
: O

2015-03-17 O

Discharge O
Date O
: O

2015-03-23 O

Date O
of O
Birth O
: O

1992-12-06 O

Sex O
: O

M O

Service: O

ADDENDUM O
: O

The O
initial O
part O
to O
this O
Discharge O
Summary O
confirmation O
number O
was O
276836 O
( O
I O
believe O
) O
. O

Please O
add O
this O
dictation O
to O
initial O
dictation O
done O
on O
2015-03-26 O
. O

After O
quoting O
vital O
signs O
, O
please O
include O
: O

The O
patient O
was O
alert O
and O
oriented O
times O
three O
with O
N. O
Ramirez O
Coma O
Scale O
of O
15 O
on O
arrival O
. O

He O
was O
following O
all O
commands O
and O
moving O
all O
extremities O
. O

The O
pupils O
were O
equal O
, O
round O
, O
and O
reactive O
to O
light O
. O

The O
tympanic O
membranes O
were O
clear O
. O

The O
oropharynx O
was O
clear O
. O

The O
extraocular O
muscles O
were O
intact O
. O

Cardiovascular O
examination O
revealed O
regular O
rate O
and O
rhythm O
. O

Chest O
was O
clear O
to O
auscultation O
bilaterally O
. O

Good O
breath O
sounds O
. O

No O
crepitus B-SYMPTOM
. O

Positive O
tenderness B-SYMPTOM
over O
the O
distal O
half O
of O
the O
left O
rib O
cage O
. O

The O
abdomen O
was O
tender B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
. O

Positive O
guarding B-SYMPTOM
. O

The O
pelvis O
was O
stable O
. O

No O
deformities B-SYMPTOM
. O

No O
costovertebral B-SYMPTOM
angle I-SYMPTOM
tenderness I-SYMPTOM
bilaterally I-SYMPTOM
. O

No O
deformities B-SYMPTOM
, O
stepoff B-SYMPTOM
, O
or O
tenderness B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
cervical I-SYMPTOM
spine I-SYMPTOM
. O

Rectal O
examination O
was O
guaiac-negative O
. O

Good O
tone O
. O

The O
right O
upper O
extremity O
was O
positive O
for O
abrasions B-SYMPTOM
. O

The O
right O
lower O
extremity O
was O
positive O
for O
abrasions B-SYMPTOM
. O

Left O
upper O
and O
lower O
extremities O
revealed O
no O
deformities B-SYMPTOM
. O

Strength O
was O
5/5 O
times O
four O
extremities O
. O

Good O
pulses O
throughout O
. O

The O
patient O
was O
brought O
to O
the O
operating O
room O
for O
resuscitation B-TREATMENT
. O

The O
patient O
responded O
to O
aggressive B-TREATMENT
resuscitation I-TREATMENT
and O
was O
hemodynamically O
stable O
. O

At O
this O
time O
, O
the O
decision O
to O
treat O
the O
patient O
nonoperatively O
was O
made O
, O
and O
the O
patient O
was O
admitted O
to O
the O
Intensive O
Care O
Unit O
for O
close O
monitoring O
. O

The O
patient O
was O
kept O
nothing O
by O
mouth O
with O
intravenous B-TREATMENT
fluids I-TREATMENT
, O
bed B-TREATMENT
rest I-TREATMENT
, O
every O
4-hour O
hematocrit O
checks O
, O
and O
serial O
abdominal O
examinations O
. O

The O
Athol O
Memorial O
Hospital O
hospital O
course O
was O
unremarkable O
. O

The O
patient O
remained O
hemodynamically O
stable O
throughout O
the O
course O
of O
his O
hospital O
stay O
, O
and O
his O
hematocrit O
was O
relatively O
stable O
with O
a B-SYMPTOM
gradual I-SYMPTOM
drop I-SYMPTOM
due O
to O
dilutional B-SYMPTOM
changes I-SYMPTOM
. O

On O
post O
trauma O
day O
four O
, O
the O
patient O
remained O
hemodynamically O
stable O
with O
a O
stable O
hematocrit O
and O
a O
soft O
, O
nontender B-SYMPTOM
, O
and O
nondistended B-SYMPTOM
abdomen I-SYMPTOM
. O

The O
patient O
's O
bed O
rest O
status O
was O
changed O
to O
out O
of O
bed O
, O
and O
oral O
intake O
was O
started O
. O

The O
patient O
tolerated O
the O
advancement O
of O
his O
diet O
without O
problems O
. O

The O
patient O
ambulated O
with O
pain B-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
secondary O
to O
the B-SYMPTOM
left I-SYMPTOM
pubic I-SYMPTOM
rami I-SYMPTOM
fractures I-SYMPTOM
. O

Physical O
Therapy O
was O
consulted O
, O
and O
crutches B-TREATMENT
were O
given O
to O
the O
patient O
. O

Pain B-SYMPTOM
was O
managed O
with O
a B-TREATMENT
Fentanyl I-TREATMENT
patch I-TREATMENT
and O
by B-TREATMENT
mouth I-TREATMENT
Dilaudid I-TREATMENT
with O
adequate O
pain B-TREATMENT
control I-TREATMENT
on O
discharge O
. O

DISCHARGE O
STATUS O
: O

The O
patient O
was O
discharged O
to O
home O
. O

DISCHARGE O
DIAGNOSES: O

1. O
Grade B-SYMPTOM
3 I-SYMPTOM
splenic I-SYMPTOM
laceration I-SYMPTOM
. O

2. O
Left B-SYMPTOM
rib I-SYMPTOM
8 I-SYMPTOM
through I-SYMPTOM
12 I-SYMPTOM
fractures I-SYMPTOM
. O

3. O
Left B-SYMPTOM
superior/inferior I-SYMPTOM
pubic I-SYMPTOM
rami I-SYMPTOM
fractures I-SYMPTOM
. O

4. O
Comorbidities O
of O
anxiety B-SYMPTOM
disorder/depression I-SYMPTOM
. O

DISCHARGE O
INSTRUCTIONS/FOLLOWUP: O

1. O
The O
patient O
was O
asked O
to O
call O
his O
physician O
if O
he O
experienced O
any B-SYMPTOM
lightheadedness I-SYMPTOM
, O
dizziness B-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
fevers B-SYMPTOM
, O
or O
chills B-SYMPTOM
. O

2. O
The O
patient O
was O
instructed O
to O
not O
participate O
in O
contact O
sports O
for O
six O
weeks O
. O

3. O
The O
patient O
was O
instructed O
to O
follow O
up O
in O
the O
Trauma O

Clinic O
in O
three O
to O
four O
weeks O
. O

CONDITION O
AT O
DISCHARGE O
: O

The O
patient O
's O
condition O
on O
discharge O
was O
stable O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Fentanyl B-TREATMENT
75-mcg O
per O
hour O
patch O
q.72h. O

2. O
Zoloft B-TREATMENT
50 O
mg O
by O
mouth O
once O
per O
day O
. O

3. O
Wellbutrin B-TREATMENT
200 O
mg O
by O
mouth O
twice O
per O
day O
. O

4. O
Dilaudid B-TREATMENT
one O
to O
two O
tablets O
by O
mouth O
q.4-6h. O
as O
needed O
( O
for O
pain B-SYMPTOM
) O
. O

Ernest O
K. O
Gardner O
, O
M.D. O

09-697 O

Dictated O
By O
: O

Sarah O
Z O
Stephens O
, O
M.D. O

MEDQUIST36 O

D O
: O

2015-03-26 O

18:08 O

T O
: O

2015-03-26 O

21:53 O

JOB# O
: O

81804 O

Signed O
electronically O
by O
: O

DR. O
Billie O
SCHNEIDER O
on O
: O

FRI O
2015-03-27 O
11:01 O
AM O

( O
End O
of O
Report O
) O

825280108 O
PUMC O

2717701 O

366967 O

8348653 O

9/9/2003 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O

NAME O
: O

GUYNLORDSMANTDOUET O
, O
ARYRISTE O
T O

UNIT O
NUMBER O
: O

566-45-49 O

ADMISSION O
DATE O
: O

09/09/2003 O

DISCHARGE O
DATE O
: O

09/12/2003 O

PRINCIPLE O
DIAGNOSIS O
: O

Infrarenal B-SYMPTOM
abdominal I-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSES O
: O

1. O
Hypertension B-SYMPTOM
; O

2. O
Gastroesophageal B-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
; O

3. O
Osteoarthritis B-SYMPTOM
. O

PRINCIPLE O
PROCEDURE O
: O

Endovascular B-TREATMENT
repair I-TREATMENT
of O
abdominal B-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
with O
bifurcated B-TREATMENT
device I-TREATMENT
on O
September O
9 O
, O
2003 O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
an O
84 O
year O
old O
male O
, O
with O
a O
history O
of O
hypertension B-SYMPTOM
, O
who O
was O
discovered O
to O
have O
an B-SYMPTOM
asymptomatic I-SYMPTOM
7 I-SYMPTOM
cm I-SYMPTOM
abdominal I-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
on O
CT O
scan O
obtained O
in O
the O
emergency O
room O
back O
in O
May O
. O

At O
that O
time O
he O
had O
presented O
with O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
and O
was O
found O
to O
have O
acute B-SYMPTOM
cholecystectomy I-SYMPTOM
. O

He O
underwent O
an B-TREATMENT
uncomplicated I-TREATMENT
laparoscopic I-TREATMENT
cholecystectomy I-TREATMENT
. O

He O
presents O
at O
this O
time O
for O
endovascular B-TREATMENT
repair I-TREATMENT
of O
this B-SYMPTOM
abdominal I-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Hypertension B-SYMPTOM
; O

2. O
Gastroesophageal B-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
; O

3. O
H. B-SYMPTOM
pylori I-SYMPTOM
positive I-SYMPTOM
, O
status O
post O
therapy B-TREATMENT
; O

4. O
Osteoarthritis B-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

1. O
Craniotomy B-TREATMENT
for O
meningoma B-SYMPTOM
, O
February O
, O
1994 O
; O

2. O
Laparoscopic B-TREATMENT
cholecystectomy I-TREATMENT
in O
May O
, O
2002 O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Aspirin B-TREATMENT
81 O
mg O
PO O
qd O
; O

2. O
Atenolol B-TREATMENT
25 O
mg O
PO O
qd O
; O

3. O
Protonics B-TREATMENT
40 O
mg O
PO O
qd O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
quit O
smoking O
30 O
years O
ago O
. O

PHYSICAL O
EXAMINATION O
: O

Blood O
pressure O
152/74 O
, O
pulse O
60 O
, O
respirations O
16 O
. O

He O
is O
71 O
inches O
tall O
, O
196 O
lbs O
. O

He O
has O
no O
carotid B-SYMPTOM
bruits I-SYMPTOM
. O

Lungs O
were O
clear O
bilaterally O
. O

Heart O
is O
regular O
rate O
and O
rhythm O
, O
without O
murmur B-SYMPTOM
. O

Abdomen O
is O
soft O
, O
nontender B-SYMPTOM
with O
a B-SYMPTOM
pulsatile I-SYMPTOM
mass I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
epigastrium I-SYMPTOM
. O

Extremities O
reveals O
a O
2+ O
femoral O
and O
pedal O
pulses O
bilaterally O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
Vascular O
Surgery O
Service O
as O
a O
same O
day O
admission O
, O
and O
taken O
to O
the O
operating O
room O
for O
an B-TREATMENT
uncomplicated I-TREATMENT
endovascular I-TREATMENT
repair I-TREATMENT
of O
his B-SYMPTOM
abdominal I-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
, O
and O
Anurx B-TREATMENT
modular I-TREATMENT
bifurcated I-TREATMENT
graft I-TREATMENT
was O
placed O
, O
and O
both O
common O
femoral O
arteries O
were O
repaired O
in O
the O
usual O
fashion O
. O

He O
had O
pulsatile O
pulse O
volume O
recordings O
, O
in O
both O
lower O
extremities O
, O
and O
both O
renal O
arteries O
were O
noted O
to O
be O
patent O
, O
as O
were O
both O
internal O
iliac O
arteries O
. O

His O
angiogram O
in O
the O
operating O
room O
, O
revealed O
no O
evidence O
of O
an B-SYMPTOM
endo I-SYMPTOM
leak I-SYMPTOM
. O

Postoperatively O
, O
his O
course O
was O
relatively O
uncomplicated O
. O

He O
did O
have O
an O
episode O
of O
a B-SYMPTOM
prolonged I-SYMPTOM
sinus I-SYMPTOM
pause I-SYMPTOM
in O
the O
recovery O
room O
, O
which O
resulted O
in O
transient B-SYMPTOM
loss I-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
. O

He O
responded O
to O
a B-TREATMENT
Neo-Synephrine I-TREATMENT
bolus I-TREATMENT
, O
and O
had O
no O
further B-SYMPTOM
complications I-SYMPTOM
from O
this O
standpoint O
. O

Dr. O
Rosean O
Fletcher O
, O
of O
the O
Cardiology O
Department O
was O
consulted O
, O
and O
it O
was O
his O
opinion O
that O
the B-SYMPTOM
sinus I-SYMPTOM
pause I-SYMPTOM
was O
related O
to O
increased B-SYMPTOM
vagal I-SYMPTOM
tone I-SYMPTOM
postoperatively O
, O
perhaps O
secondary O
to O
the B-TREATMENT
epidural I-TREATMENT
, O
as O
well O
as O
the B-TREATMENT
patient I-TREATMENT
&apos;s I-TREATMENT
Atenolol I-TREATMENT
use I-TREATMENT
. O

His B-TREATMENT
Atenolol I-TREATMENT
was O
held O
, O
and O
he O
had O
no O
further B-SYMPTOM
pauses I-SYMPTOM
during O
his O
stay O
. O

His O
postoperative O
CT O
scan O
showed O
no O
evidence O
of O
endo B-SYMPTOM
leak I-SYMPTOM
, O
or O
graft B-SYMPTOM
kinking I-SYMPTOM
. O

He O
maintained O
good O
peripheral O
pulses O
and O
warm O
feet O
postoperatively O
. O

However O
, O
he O
did O
develop O
significant B-SYMPTOM
ecchymosis I-SYMPTOM
in I-SYMPTOM
both I-SYMPTOM
groins I-SYMPTOM
, O
extending O
down O
into O
his O
scrotum O
. O

There O
was O
no O
evidence O
of O
significant B-SYMPTOM
groin I-SYMPTOM
hematomas I-SYMPTOM
. O

He O
tolerated O
a O
regular O
diet O
. O

His B-SYMPTOM
pain I-SYMPTOM
was O
adequately O
controlled O
with O
oral B-TREATMENT
medications I-TREATMENT
. O

Accordingly O
, O
the O
patient O
was O
discharged O
to O
home O
on O
postoperative O
day O
2 O
. O

He O
will O
be O
visited O
by O
LDAMC O
for O
blood O
pressure O
and O
incision O
checks O
. O

He O
will O
follow O
up O
with O
Dr. O
Dye O
in O
the O
Clinic O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Admission B-TREATMENT
medications I-TREATMENT
. O

YERTREY O
TANELI O
SUMCHIRDKAYSMAVVEINDREPS O
, O
M.D. O

DICTATING O
FOR O
: O

Electronically O
Signed O
ALEN O
LAA O
CREDKOTE O
, O
M.D. O

09/30/2003 O
13:34 O

_____________________________ O
ALEN O
LAA O
CREDKOTE O
, O
M.D. O

TR O
: O

ruw O

DD O
: O

09/11/2003 O

TD O
: O

09/12/2003 O
2:23 O
P O
366967 O

cc O
: O

ALEN O
LAA O
CREDKOTE O
, O
M.D. O
, O
ROSEAN O
FLETCHER O
, O
M.D. O
, O
VIENNEE O
BACK O
, O
M.D. O

Admission O
Date O
: O

2011-06-14 O

Discharge O
Date O
: O

2011-06-18 O

Date O
of O
Birth O
: O

1939-11-27 O

Sex O
: O

F O

Service O
: O

FICU O

CHIEF O
COMPLAINT O
: O

Shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
71-year-old-female O
with O
asthma B-SYMPTOM
and O
a O
history O
of O
recent B-SYMPTOM
exacerbation I-SYMPTOM
of O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
who O
, O
at O
her O
baseline O
, O
gets O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
walking O
across O
the O
room O
and O
sleeps O
on O
four O
pillows O
times O
several O
years O
. O

She O
has O
reported O
that O
she O
has O
had O
upper B-SYMPTOM
respiratory I-SYMPTOM
symptoms I-SYMPTOM
times O
several O
days O
with O
increasing B-SYMPTOM
dyspnea I-SYMPTOM
on O
exertion O
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
eventually O
at O
rest O
with O
marked B-SYMPTOM
wheezing I-SYMPTOM
. O

She O
also O
has O
a B-SYMPTOM
cough I-SYMPTOM
with O
a O
small O
amount O
of O
white B-SYMPTOM
sputum I-SYMPTOM
. O

At O
3 O
a.m. O
on O
the O
day O
of O
admission O
, O
she O
became O
much O
worse O
and O
after O
several O
days O
of O
increasing O
her B-TREATMENT
meter-dosed I-TREATMENT
inhaler I-TREATMENT
use O
, O
she O
call O
Emergency O
Medical O
Services O
which O
assessed O
her O
as O
having O
heart B-SYMPTOM
failure I-SYMPTOM
with O
elevated B-SYMPTOM
jugular I-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
and O
rales B-SYMPTOM
. O

She O
received O
aspirin B-TREATMENT
, O
Lasix B-TREATMENT
40 O
mg O
intravenously O
times O
two O
, O
0.8 O
mg O
of O
nitroglycerin B-TREATMENT
times O
four O
, O
plus O
morphine B-TREATMENT
sulfate I-TREATMENT
. O

Her O
blood O
pressure O
was O
noted O
to O
be O
up O
to O
220/110 O
. O

She O
was O
taken O
to O
the O
The O
Hospital O
for O
Orthopedics O
Emergency O
Room O
where O
she O
was O
assessed O
as O
having O
asthma B-SYMPTOM
. O

She O
then O
received O
continuous B-TREATMENT
nebulizer I-TREATMENT
treatments I-TREATMENT
for O
approximately O
eight O
hours O
with O
minimal O
improvement O
. O

She O
did O
receive O
intravenous B-TREATMENT
nitroglycerin I-TREATMENT
in O
the O
Emergency O
Room O
for O
blood O
pressure O
controlled O
to O
the O
170s O
. O

She O
initially O
received O
a O
treatment O
of O
BiPAP B-TREATMENT
on O
arrival O
as O
she O
was O
barely O
able O
to O
speak O
. O

She O
also O
received O
80 B-TREATMENT
mg I-TREATMENT
of I-TREATMENT
Solu-Medrol I-TREATMENT
in O
the O
Emergency O
Department O
. O

She O
was O
never O
hypoxic B-SYMPTOM
but O
initially O
her O
arterial O
blood O
gas O
showed O
a B-SYMPTOM
respiratory I-SYMPTOM
acidosis I-SYMPTOM
with O
a O
PCO2 O
of O
71 O
. O

The O
patient O
does O
have O
a O
vague O
history O
of O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
, O
but O
this O
is O
felt O
to O
be O
inaccurate O
. O

She O
also O
received O
captopril B-TREATMENT
12.5 O
mg O
times O
one O
. O

Recently O
, O
the O
patient O
has O
been O
treated O
with O
several B-TREATMENT
steroid I-TREATMENT
tapers I-TREATMENT
. O

Depending O
on O
the O
family O
, O
patient O
, O
and O
the O
OMR O
records O
, O
the O
exact O
duration O
of O
the O
most O
recent O
one O
was O
unclear O
. O

It O
either O
ended O
in O
2011-04-11 O
or O
continued O
through O
2011-05-11 O
with O
use O
of O
Augmentin B-TREATMENT
; O
and O
, O
by O
report O
, O
lasted O
until O
06-07 O
. O

However O
, O
the O
family O
said O
the O
patient O
has O
been O
on O
steroids B-TREATMENT
for O
several O
weeks O
. O

The O
patient O
denies O
any O
exposure O
to O
smoke O
, O
animals O
, O
unusual O
dust O
or O
vapors O
, O
or O
other O
asthma O
triggers O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Asthma B-SYMPTOM
as O
a O
child O
which O
recurred O
in O
2001 O
. O

She O
takes O
an B-TREATMENT
albuterol I-TREATMENT
and O
Atrovent B-TREATMENT
inhalers I-TREATMENT
as O
well O
as O
Serevent B-TREATMENT
and O
Flovent B-TREATMENT
. O

She O
has O
had O
multiple O
hospitalizations O
and O
has O
never O
been O
intubated B-TREATMENT
. O

She O
has O
had O
multiple B-TREATMENT
prednisone I-TREATMENT
tapers I-TREATMENT
( O
see O
History O
of O
Present O
Illness O
) O
. O

On O
prednisone B-TREATMENT
or O
sometime O
after O
it O
was O
discontinued O
, O
depending O
on O
the O
version O
, O
the O
patient O
developed O
worsening B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
which O
has O
been O
a B-SYMPTOM
Vega I-SYMPTOM
problem I-SYMPTOM
for O
her O
and O
was O
started O
on O
dyazide B-TREATMENT
as O
an O
outpatient O
. O

Pulmonary O
function O
tests O
most O
recently O
in O
2009-01-10 O
were O
not O
obstructive O
. O

They O
showed O
an O
FVC O
of O
91% O
of O
predicted O
, O
and O
a O
FEV1 O
of O
104% O
of O
predicted O
, O
with O
a O
ratio O
of O
114% O
. O

In O
2003 O
, O
there O
was O
19% O
change O
of O
the O
FEV1 O
and O
an O
11% O
change O
in O
the O
FVC O
with O
bronchodilators B-TREATMENT
. O

2. O
Mild B-SYMPTOM
hypertension I-SYMPTOM
, O
especially O
on O
prednisone B-TREATMENT
. O

3. O
Hypoplastic B-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
and O
hip B-TREATMENT
repair I-TREATMENT
at O
the O
age O
of O
five O
. O

4. O
Polio B-SYMPTOM
. O

5. O
Status O
post O
cesarean B-TREATMENT
section I-TREATMENT
. O

6. O
History O
of O
zoster B-SYMPTOM
. O

7. O
Past O
Discharge O
Summary O
mention O
a O
history O
of O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
, O
but O
the O
patient O
has O
never O
smoked O
. O

8. O
Incontinent B-SYMPTOM
of I-SYMPTOM
both I-SYMPTOM
stool I-SYMPTOM
and I-SYMPTOM
urine I-SYMPTOM
. O

9. O
Allergic B-SYMPTOM
rhinitis I-SYMPTOM
. O

FAMILY O
HISTORY O
: O

Brother O
and O
sister O
both O
have O
asthma B-SYMPTOM
. O

Brother O
has O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

There O
is O
no O
family O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
on O
the O
first O
floor O
of O
her O
home O
with O
her O
daughter O
living O
upstairs O
. O

There O
are O
several O
foster O
children O
also O
in O
the O
home O
that O
take O
care O
of O
her O
at O
times O
. O

She O
has O
never O
smoked O
and O
does O
not O
drink O
. O

She O
does O
not O
use O
drugs O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Dyazide B-TREATMENT
25/37.5 O
p.o. O
q.d. O
, O
as O
well O
as O
Atrovent B-TREATMENT
, O
albuterol B-TREATMENT
, O
and O
Flovent B-TREATMENT
inhalers I-TREATMENT
, O
and O
Swanson B-TREATMENT
60 O
mg O
p.o. O
b.i.d. O
, O
and O
Serevent B-TREATMENT
2 O
puffs O
q.12h. O

MEDICATIONS O
ON O
TRANSFER O
: O

On O
transfer O
, O
she O
also O
arrived O
on O
200 O
mcg O
of O
nitroglycerin B-TREATMENT
and O
reports O
p.r.n. O
Alka-Seltzer B-TREATMENT
, O
sinus B-TREATMENT
and O
NyQuil B-TREATMENT
use O
. O

REVIEW O
OF O
SYSTEMS O
: O

Review O
of O
systems O
were O
notable O
for O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
which O
worsened O
in O
May O
. O

She O
says O
she O
has O
had O
this O
intermittently O
with O
hot O
summers O
in O
the O
past O
. O

She O
denies O
chest B-SYMPTOM
pain I-SYMPTOM
. O

She O
does O
have O
chest B-SYMPTOM
tightness I-SYMPTOM
since O
two O
days O
ago O
, O
coinciding O
with O
her B-SYMPTOM
wheezing I-SYMPTOM
. O

She O
had O
paroxysms B-SYMPTOM
of I-SYMPTOM
cough I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
which O
resolves O
with O
water O
and O
sitting O
up O
. O

This O
is O
worse O
when O
she O
has O
asthma B-SYMPTOM
flares I-SYMPTOM
. O

She O
denies O
a B-SYMPTOM
rash I-SYMPTOM
and O
any B-SYMPTOM
genitourinary I-SYMPTOM
symptoms I-SYMPTOM
. O

She O
has O
had O
a B-SYMPTOM
constant I-SYMPTOM
runny I-SYMPTOM
nose I-SYMPTOM
and O
has O
had O
no O
sick O
contacts O
. O

PHYSICAL O
EXAMINATION O
ON O
PRESENTATION O
: O

Physical O
examination O
revealed O
afebrile B-SYMPTOM
, O
respiratory O
rate O
of O
23 O
, O
heart O
rate O
of O
113 O
, O
blood O
pressure O
130s/90s O
. O

In O
general O
, O
this O
was O
a O
female O
in O
moderate B-SYMPTOM
distress I-SYMPTOM
secondary O
to O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
spoke O
in O
short O
phrases O
and O
then O
in O
complete O
sentences O
as O
the O
night O
went O
on O
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
, O
and O
throat O
revealed O
oropharynx O
was O
moist O
. O

There O
was O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
. O

There O
was O
no O
HDR B-SYMPTOM
. O

Sclerae O
were O
anicteric B-SYMPTOM
. O

Cardiovascular O
revealed O
she O
was O
tachycardic B-SYMPTOM
with O
a O
regular O
first O
heart O
sound O
and O
second O
heart O
sound O
. O

Pulmonary O
revealed O
she O
had O
diffuse B-SYMPTOM
wheezes I-SYMPTOM
. O

There O
were O
no O
rales B-SYMPTOM
. O

She O
had O
reduced B-SYMPTOM
but I-SYMPTOM
adequate I-SYMPTOM
air I-SYMPTOM
movement I-SYMPTOM
. O

The O
abdomen O
revealed O
normal O
active O
bowel O
sounds O
, O
soft O
, O
nontender B-SYMPTOM
, O
obese B-SYMPTOM
, O
and O
nondistended B-SYMPTOM
. O

Extremities O
revealed O
left O
lower O
extremity O
was O
hypoplastic B-SYMPTOM
. O

There O
was O
pitting B-SYMPTOM
edema I-SYMPTOM
on I-SYMPTOM
both I-SYMPTOM
sides I-SYMPTOM
of O
the O
lower O
extremities O
. O

The O
right O
ankle O
was O
somewhat B-SYMPTOM
tender I-SYMPTOM
from O
this B-SYMPTOM
edema I-SYMPTOM
. O

Neurologically O
, O
the O
patient O
was O
oriented O
to O
person O
, O
place O
, O
and O
time O
; O
however O
, O
she O
was O
somewhat B-SYMPTOM
drowsy I-SYMPTOM
and O
at O
times O
was O
difficult O
to O
keep O
awake O
during O
conversations O
. O

PERTINENT O
LABORATORY O
DATA O
ON O
PRESENTATION O
: O

White O
blood O
cell O
count O
was O
10.2 O
, O
hematocrit O
of O
37.5 O
, O
platelets O
of O
236 O
. O

INR O
of O
1.3 O
, O
PTT O
of O
30.3 O
. O

Urinalysis O
revealed O
6 O
to O
10 O
red O
blood O
cells O
, O
0 O
to O
2 O
white O
blood O
cells O
, O
4 O
epithelial O
cells O
with O
Foley B-TREATMENT
in O
place O
. O

Urine O
culture O
later O
grew O
out O
contaminated O
specimen O
. O

Differential O
with O
72 O
polys O
, O
16 O
lymphocytes O
, O
4.6 O
monocytes O
, O
6.3 O
eosinophils O
. O

Chem-7 O
was O
notable O
for O
a O
bicarbonate O
of O
31 O
and O
a O
glucose O
of O
156 O
. O

Arterial O
blood O
gas O
was O
7.24/71/227 O
. O

Creatine O
kinase O
was O
243 O
, O
with O
a O
MB O
of O
9 O
, O
and O
a O
troponin O
of O
less O
than O
0.3. O

RADIOLOGY/IMAGING O
: O

Chest O
x-ray O
showed O
low B-SYMPTOM
lung I-SYMPTOM
volumes I-SYMPTOM
but O
no O
evidence O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

Electrocardiogram O
showed O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
at O
115 O
with O
a O
normal O
axis O
, O
intermittent B-SYMPTOM
Q I-SYMPTOM
wave I-SYMPTOM
in I-SYMPTOM
III; I-SYMPTOM
a B-SYMPTOM
wavy I-SYMPTOM
baseline I-SYMPTOM
. O

The O
patient O
had O
a O
stress O
echocardiogram O
with O
a O
normal O
ejection O
fraction O
in O
2007 O
. O

HOSPITAL O
COURSE O
BY O
SYSTEM: O

1. O
PULMONARY O
: O

She O
was O
treated O
with O
albuterol B-TREATMENT
and O
Atrovent B-TREATMENT
continuous I-TREATMENT
nebulizers I-TREATMENT
and O
was O
weaned O
then O
to O
intermittent B-TREATMENT
nebulizer I-TREATMENT
treatments I-TREATMENT
and O
then O
to O
her B-TREATMENT
meter-dosed I-TREATMENT
inhalers I-TREATMENT
taking O
them O
q.4h. O
at O
the O
time O
of O
discharge O
. O

She O
was O
continued O
on O
salmeterol B-TREATMENT
and O
Flovent B-TREATMENT
. O

She O
was O
continued O
on O
Solu-Medrol B-TREATMENT
80 O
mg O
q.8h. O
then O
converted O
to O
prednisone B-TREATMENT
at O
60 O
mg O
p.o. O
q.d. O

She O
was O
started O
on O
Singulair B-TREATMENT
10 O
mg O
p.o. O
q.d. O

Serial O
arterial O
blood O
gases O
were O
followed O
after O
an B-TREATMENT
arterial I-TREATMENT
line I-TREATMENT
was O
placed O
. O

Her O
PCO2 O
gradually O
declined O
to O
the O
48 O
range O
. O

Despite O
episodes O
of O
somnolence B-SYMPTOM
the O
first O
night O
which O
were O
presumably O
due O
to O
having O
spent O
the O
entire O
night O
in O
the O
Emergency O
Department O
, O
she O
never O
became O
more B-SYMPTOM
hypercarbic I-SYMPTOM
, O
and O
her O
PCO2 O
trended O
to O
48 O
by O
the O
time O
the B-TREATMENT
arterial I-TREATMENT
line I-TREATMENT
was O
discontinued O
. O

On O
the O
night O
of O
admission O
and O
thereafter O
, O
she O
was O
noted O
to O
have O
a B-SYMPTOM
very I-SYMPTOM
stridorous I-SYMPTOM
sounding I-SYMPTOM
breathing I-SYMPTOM
when O
the O
patient O
was O
asleep O
. O

This O
would O
disappear O
whenever O
she O
was O
awake O
. O

Her O
case O
was O
discussed O
with O
Ear/Nose/Throat O
and O
the O
Medical O
Intensive O
Care O
Unit O
attending O
. O

She O
was O
given O
a B-TREATMENT
trial I-TREATMENT
of I-TREATMENT
80/20 I-TREATMENT
mixed I-TREATMENT
helium/oxygen I-TREATMENT
to O
decrease O
the B-SYMPTOM
stridor I-SYMPTOM
but O
had O
minimal O
effect O
. O

Ear/Nose/Throat O
recommended O
not O
considering O
this O
an B-SYMPTOM
airway I-SYMPTOM
problem I-SYMPTOM
unless O
she O
was O
stridorous B-SYMPTOM
while I-SYMPTOM
awake I-SYMPTOM
. O

The O
patient O
was O
to O
arrange O
for O
Pulmonary O
and O
Medicine O
followup O
through O
her O
primary O
care O
physician O
upon O
discharge O
as O
she O
has O
not O
been O
seen O
in O
the O
Pulmonary O
Clinic O
in O
two O
years O
. O

2. O
CARDIOVASCULAR O
: O

The O
patient O
ruled O
out O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
with O
serial O
creatine O
kinases O
, O
although O
these O
did O
rise O
to O
816 O
. O

MB O
was O
negative O
. O

She O
was O
treated O
with O
captopril B-TREATMENT
for O
hypertension B-SYMPTOM
, O
and O
this O
was O
switched O
to O
Norvasc B-TREATMENT
7.5 O
mg O
p.o. O
q.d. O
on O
discharge O
. O

She O
had O
an O
echocardiogram O
which O
showed O
a B-SYMPTOM
hyperdynamic I-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
of O
normal O
thickness O
and O
size O
, O
and O
no O
significant B-SYMPTOM
valvular I-SYMPTOM
disease I-SYMPTOM
. O

She O
apparently O
did O
not O
have O
a O
cardiovascular O
component O
to O
her B-SYMPTOM
wheezing I-SYMPTOM
or O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
; O
however O
, O
she O
was O
to O
go O
home O
on O
Lasix B-TREATMENT
20 O
mg O
p.o. O
q.d. O
to O
help O
with O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
, O
as O
she O
experiences O
discomfort B-SYMPTOM
with O
this O
, O
and O
the O
team O
felt O
this O
may O
be O
a O
limiting O
factor O
with O
her B-TREATMENT
prednisone I-TREATMENT
compliance I-TREATMENT
. O

3. O
ENDOCRINE O
: O

She O
was O
treated O
with O
a B-TREATMENT
sliding-scale I-TREATMENT
of I-TREATMENT
regular I-TREATMENT
insulin I-TREATMENT
while O
she O
was O
in O
house O
. O

She O
was O
given O
500 O
mg O
p.o. O
q.d. O
of O
metformin B-TREATMENT
to O
treat O
her B-SYMPTOM
steroid-induced I-SYMPTOM
diabetes I-SYMPTOM
on O
discharge O
. O

This O
should O
be O
followed O
up O
by O
her O
primary O
care O
physician O
. O

4. O
INFECTIOUS O
DISEASE O
: O

She O
was O
treated O
briefly O
with O
levofloxacin B-TREATMENT
because O
of O
the B-SYMPTOM
gram-positive I-SYMPTOM
cocci I-SYMPTOM
in O
her O
sputum O
culture O
; O
however O
, O
her B-SYMPTOM
symptoms I-SYMPTOM
were O
felt O
to O
be O
consistent O
with O
a B-SYMPTOM
viral I-SYMPTOM
upper I-SYMPTOM
respiratory I-SYMPTOM
infection I-SYMPTOM
, O
and O
levofloxacin B-TREATMENT
was O
continued O
at O
the O
time O
of O
discharge O
. O

MEDICATIONS O
ON O
DISCHARGE: O

1. O
Lasix B-TREATMENT
20 O
mg O
p.o. O
q.d. O

2. O
Combivent B-TREATMENT
meter-dosed I-TREATMENT
inhaler I-TREATMENT
2 O
puffs O
q.4h. O
weaning O
to O
albuterol B-TREATMENT
meter-dosed I-TREATMENT
inhaler I-TREATMENT
2 O
puffs O
q.4h. O

3. O
Salmeterol B-TREATMENT
2 O
puffs O
q.12h. O

4. O
Flovent B-TREATMENT
220 O
mcg O
2 O
puffs O
q.12h. O

5. O
Prednisone B-TREATMENT
40 O
mg O
p.o. O
q.d. O
with O
taper O
. O

6. O
Fentress B-TREATMENT
60 O
mg O
p.o. O
b.i.d. O

7. O
Singulair B-TREATMENT
10 O
mg O
p.o. O
q.d. O

8. O
Univasc B-TREATMENT
7.5 O
mg O
p.o. O
q.d. O

9. O
Metformin B-TREATMENT
500 O
mg O
p.o. O
q.d. O

Dyazide B-TREATMENT
was O
discontinued O
. O

DISCHARGE O
STATUS O
: O

Discharge O
services O
included O
visiting O
nursing O
which O
was O
to O
assess O
in O
her O
inhaler O
technique O
, O
monitor O
her O
fasting O
blood O
sugars O
, O
as O
well O
as O
her O
blood O
pressure O
, O
monitor O
her O
peak O
flows O
, O
and O
assess O
her O
mobility O
and O
activities O
of O
daily O
living O
at O
home O
. O

DISCHARGE O
FOLLOWUP O
: O

She O
was O
also O
to O
seek O
the O
next O
available O
appointment O
with O
Dr. O
Jeanette O
Barr O
or O
to O
see O
another O
resident O
in O
the O
Saint O
Vincent O
Hospital O
Clinic O
if O
she O
cannot O
get O
an O
appointment O
within O
one O
week O
. O

CONDITION O
AT O
DISCHARGE O
: O

Condition O
on O
discharge O
was O
good O
.. O

CODE O
STATUS O
: O

Full O
code O
. O

DISCHARGE O
DIAGNOSES: O

1. O
Asthma B-SYMPTOM
flare I-SYMPTOM
. O

2. O
Hypertension B-SYMPTOM
. O

3. O
Steroid-induced B-SYMPTOM
diabetes I-SYMPTOM
. O

James O
Z O
Berg O
, O
M.D. O

19-421 O

Dictated O
By O
: O

Melanie O
L.W. O
Palevic O
, O
M.D. O

MEDQUIST36 O

D O
: O

2011-06-18 O

16:33 O

T O
: O

2011-06-21 O

15:34 O

JOB# O
: O

92012 O

Signed O
electronically O
by O
: O

DR. O
Andrea O
Trotter O
on O
: O

Jose O
2011-06-23 O
12:09 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2019-04-06 O

Discharge O
Date O
: O

2019-04-15 O

Date O
of O
Birth O
: O

1938-02-19 O

Sex O
: O

M O

Service O
: O
ORTHOPAEDICS O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to I-SYMPTOM
Drugs I-SYMPTOM

Attending O
: O
Woodrow O
Y O
Williams O
, O
M.D. O

Addendum O
: O

On O
2019-04-12 O
he O
was O
transfused O
with O
2 O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
due O
to O
post-operative B-SYMPTOM
anemia I-SYMPTOM
. O

Mr. O
Minton O
did O
not O
get O
his B-TREATMENT
IVIG I-TREATMENT
until O
2019-04-14 O
. O

The B-TREATMENT
infusion I-TREATMENT
was O
completed O
without O
incidence O
. O

He O
remained O
stable O
with O
his O
vital O
signs O
and O
lab O
data O
within O
normal O
limits O
. O

Chief O
Complaint O
: O

see O
below O

Pertinent O
Results O
: O

2019-04-15 O
09:25 O
AM O
BLOOD O
WBC O
- O
3.8 O
* O
RBC O
- O
2.88 O
* O
Hgb O
- O
8.9 O
* O
Hct O
- O
25.9 O
* O
MCV O
- O
90 O
MCH O
- O
30.9 O
MCHC O
- O
34.3 O
RDW O
- O
16.4 O
* O
Plt O
Ct O
- O
194 O

2019-04-14 O
08:50 O
AM O
BLOOD O
WBC O
- O
6.5 O
RBC O
- O
3.02 O
* O
Hgb O
- O
9.4 O
* O
Hct O
- O
27.1* O
MCV O
- O
90 O
MCH O
- O
31.0 O
MCHC O
- O
34.6 O
RDW O
- O
16.3 O
* O
Plt O
Ct O
- O
169 O

2019-04-13 O
08:40 O
AM O
BLOOD O
WBC O
- O
6.7 O
RBC O
- O
3.07 O
* O
Hgb O
- O
9.3 O
* O
Hct O
- O
27.1 O
* O
MCV O
- O
88 O
MCH O
- O
30.4 O
MCHC O
- O
34.5 O
RDW O
- O
16.2 O
* O
Plt O
Ct O
- O
144 O
* O

2019-04-12 O
08:00 O
PM O
BLOOD O
Hct O
- O
26.5 O
* O

2019-04-12 O
06:35 O
AM O
BLOOD O
Hct O
- O
23.6 O
* O

2019-04-11 O
12:55 O
PM O
BLOOD O
Hct O
- O
27.1 O
* O

2019-04-11 O
09:50 O
AM O
BLOOD O
WBC O
- O
4.8 O
RBC O
- O
3.02 O
* O
Hgb O
- O
9.5 O
* O
Hct O
- O
26.7 O
* O
MCV O
- O
89 O
MCH O
- O
31.4 O
MCHC O
- O
35.5 O
* O
RDW O
- O
15.2 O
Plt O
Ct O
- O
103 O
* O

2019-04-11 O
06:27 O
AM O
BLOOD O
WBC O
- O
4.4 O
RBC O
- O
3.03 O
* O
Hgb O
- O
9.5 O
* O
Hct O
- O
26.7 O
* O
MCV O
- O
88 O
MCH O
- O
31.2 O
MCHC O
- O
35.4 O
* O
RDW O
- O
14.7 O
Plt O
Ct O
- O
94 O
* O

2019-04-10 O
06:30 O
AM O
BLOOD O
WBC O
- O
4.6 O
RBC O
- O
2.81 O
* O
Hgb O
- O
8.9 O
* O
Hct O
- O
24.8 O
* O
MCV O
- O
88 O
MCH O
- O
31.7 O
MCHC O
- O
36.0 O
* O
RDW O
- O
15.2 O
Plt O
Ct O
- O
95 O
* O

2019-04-09 O
06:45 O
AM O
BLOOD O
WBC O
- O
5.0 O
RBC O
- O
3.33 O
* O
Hgb O
- O
10.4 O
* O
Hct O
- O
29.2 O
* O
MCV O
- O
88 O
MCH O
- O
31.2 O
MCHC O
- O
35.5 O
* O
RDW O
- O
15.0 O
Plt O
Ct O
- O
72 O
* O

2019-04-08 O
12:27 O
AM O
BLOOD O
WBC O
- O
4.9 O
RBC O
- O
3.11 O
* O
Hgb O
- O
9.9 O
* O
Hct O
- O
27.1 O
* O
MCV O
- O
87 O
MCH O
- O
32.0 O
MCHC O
- O
36.6 O
* O
RDW O
- O
15.5 O
Plt O
Ct O
- O
107 O
* O

2019-04-07 O
04:53 O
PM O
BLOOD O
WBC O
- O
4.4 O
RBC O
- O
2.92 O
* O
Hgb O
- O
9.6 O
*# O
Hct O
- O
25.8 O
* O
MCV O
- O
88 O
MCH O
- O
32.8 O
* O
MCHC O
- O
37.1 O
* O
RDW O
- O
14.9 O
Plt O
Ct O
- O
81 O
* O

2019-04-07 O
11:00 O
AM O
BLOOD O
WBC O
- O
4.4 O
RBC O
- O
2.34 O
*# O
Hgb O
- O
7.5 O
* O
Hct O
- O
21.2 O
*# O
MCV O
- O
91 O
MCH O
- O
32.1 O
* O
MCHC O
- O
35.4 O
* O
RDW O
- O
14.5 O
Plt O
Ct O
- O
94 O
* O

2019-04-07 O
06:00 O
AM O
BLOOD O
WBC O
- O
3.2 O
*# O
RBC O
- O
3.14 O
* O
Hgb O
- O
10.0 O
* O
Hct O
- O
28.9 O
* O
MCV O
- O
92 O
MCH O
- O
32.0 O
MCHC O
- O
34.8 O
RDW O
- O
14.1 O
Plt O
Ct O
- O
82 O
*# O

2019-04-06 O
10:40 O
AM O
BLOOD O
WBC O
- O
2.1 O
* O
RBC O
- O
3.51 O
* O
Hgb O
- O
10.9 O
* O
Hct O
- O
31.7 O
* O
MCV O
- O
90 O
MCH O
- O
31.1 O
MCHC O
- O
34.5 O
RDW O
- O
14.3 O
Plt O
Ct O
- O
50 O
* O

2019-04-15 O
09:25 O
AM O
BLOOD O
Plt O
Ct O
- O
194 O

2019-04-14 O
08:50 O
AM O
BLOOD O
Plt O
Ct O
- O
169 O

2019-04-14 O
08:50 O
AM O
BLOOD O
PT O
- O
12.0 O
INR(PT) O
- O
1.0 O

2019-04-15 O
09:25 O
AM O
BLOOD O
Glucose O
- O
134 O
* O
UreaN O
- O
19 O
Creat O
- O
0.8 O
Na O
- O
135 O
K O
- O
3.5 O
Cl O
- O
100 O
HCO3 O
- O
28 O
AnGap O
- O
11 O

Discharge O
Medications O
: O

1. O
Cholecalciferol B-TREATMENT
( I-TREATMENT
Vitamin I-TREATMENT
D3 I-TREATMENT
) I-TREATMENT
400 O
unit O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

2. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
). O

3. O
Lorazepam B-TREATMENT
0.5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
) O
as O
needed O
for O
anxiety B-SYMPTOM
. O

4. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
Q4H O
( O
every O
4 O
hours O
). O

5. O
Lisinopril B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

6. O
Senna B-TREATMENT
8.6 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
as O
needed O
. O

7. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
). O

8. O
Enoxaparin B-TREATMENT
30 O
mg O
/ O
0.3 O
mL O
Syringe O
Sig O
: O
One O
( O
1 O
) O
Subcutaneous O
Q12H O
( O
every O
12 O
hours O
) O
for O
4 O
weeks O
. O

9. O
Oxycodone B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

10. O
Bisacodyl B-TREATMENT
5 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
) O
as O
needed O
. O

11. O
Magnesium B-TREATMENT
Hydroxide I-TREATMENT
400 O
mg O
/ O
5 O
mL O
Suspension O
Sig O
: O
Thirty O
( O
30 O
) O
ML O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

12. O
Trazodone B-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
as O
needed O
for O
insomnia B-SYMPTOM
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Lemuel O
Shattuck O
Hospital O
- O
Malden O

Michelle O
Franklin O
MD O
31-164 O

Completed O
by O
: O
Celia O
Gloria O
NP O
80-CCZ O
2019-04-15 O
@ O
1049 O

Signed O
electronically O
by O
: O
DR. O
Michelle O
K. O
Partin O
on O
: O
WED O
2019-04-17 O
1:13 O
PM O

( O
End O
of O
Report O
) O

466217945 O

BH O

0568574 O

158979 O

3/7/2002 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O
NAME O
: O

JESCOBEJESC O
, O
SON O

UNIT O
NUMBER O
: O

485-03-93 O

ADMISSION O
DATE O
: O

03/07/2002 O

DISCHARGE O
DATE O
: O

03/13/2002 O

PRIMARY O
DIAGNOSIS O
: O

Wound B-SYMPTOM
infection I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

None O
. O

PRINCIPAL O
PROCEDURES O
: O

Incision B-TREATMENT
and O
drainage B-TREATMENT
of O
wound B-SYMPTOM
infection I-SYMPTOM
on O
3/7/02 O
. O

Abdominal O
pelvic O
CT O
scan O
on O
3/10/02 O
. O

Fistulogram O
on O
3/11/02 O
. O

Intravenous B-TREATMENT
antibiotics I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
79-year-old O
man O
status O
postradical B-TREATMENT
cystoprostatectomy I-TREATMENT
with I-TREATMENT
ileal I-TREATMENT
loop I-TREATMENT
for O
locally B-SYMPTOM
invasive I-SYMPTOM
prostate I-SYMPTOM
cancer I-SYMPTOM
. O

This B-TREATMENT
operation I-TREATMENT
was O
performed O
2/11/02 O
by O
Dr. O
Doje O
Para O
. O

The O
postoperative O
course O
was O
complicated O
by O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
with O
transfer O
to O
the O
Cardiac O
Step-Down O
Unit O
. O

This O
transfer O
occurred O
around O
postoperative O
day O
8 O
for O
anticoagulation B-TREATMENT
and O
amiodarone B-TREATMENT
load I-TREATMENT
. O

The B-TREATMENT
anticoagulation I-TREATMENT
was O
stopped O
due O
to O
concern O
for O
postoperative B-SYMPTOM
bleeding I-SYMPTOM
. O

The O
patient O
complained O
of O
fevers B-SYMPTOM
. O

The O
patient O
presented O
to O
the O
emergency O
room O
on O
3/7/02 O
, O
complaining O
of O
fevers B-SYMPTOM
since O
Monday O
3/2/02 O
. O

He O
developed O
erythema B-SYMPTOM
around O
the B-SYMPTOM
wound I-SYMPTOM
on O
Wednesday O
and O
was O
seen O
by O
Dr. O
Para O
, O
who O
started O
Keflex B-TREATMENT
and O
obtained O
a O
CT O
scan O
which O
demonstrated O
a B-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM
at O
the O
site O
of O
erythema B-SYMPTOM
. O

The B-SYMPTOM
fevers I-SYMPTOM
continued O
as O
high O
as O
102.5 O
degrees O
F O
with O
chills B-SYMPTOM
on O
the O
morning O
of O
admission O
. O

He O
was O
draining O
pus B-SYMPTOM
from O
the B-SYMPTOM
wound I-SYMPTOM
site I-SYMPTOM
with O
subsequent O
relief O
of O
discomfort B-SYMPTOM
at O
the O
site O
. O

PAST O
MEDICAL O
HISTORY O
: O

Hypertension B-SYMPTOM
, O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
gout B-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

Cystoprostatectomy B-TREATMENT
, O
bilateral B-TREATMENT
inguinal I-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Keflex B-TREATMENT
500 O
mg O
qid O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
ON O
ADMISSION O
: O

On O
presentation O
, O
temperature O
99.3 O
degrees O
F O
, O
other O
vital O
signs O
were O
within O
normal O
limits O
. O

He O
was O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
, O
non-toxic B-SYMPTOM
. O

Cardiovascular O
: O

Regular O
rate O
and O
rhythm O
. O

Pulmonary O
: O

Clear O
to O
auscultation O
bilaterally O
. O

Abdomen O
soft O
and O
there O
was O
wound B-SYMPTOM
erythema I-SYMPTOM
with O
three B-SYMPTOM
areas I-SYMPTOM
of I-SYMPTOM
dehiscence I-SYMPTOM
draining O
foul-smelling B-SYMPTOM
, I-SYMPTOM
purulent I-SYMPTOM
fluid I-SYMPTOM
. O

The O
fascia O
appeared O
intact O
by O
probing O
. O

The B-TREATMENT
stoma I-TREATMENT
was O
pink O
and O
functional O
. O

The B-SYMPTOM
wound I-SYMPTOM
was O
a B-SYMPTOM
midline I-SYMPTOM
incision I-SYMPTOM
for O
his B-TREATMENT
radical I-TREATMENT
cystoprostatectomy I-TREATMENT
. O

LABORATORY O
DATA O
: O

White O
blood O
cell O
count O
16.9 O
, O
hematocrit O
32.2 O
, O
platelet O
count O
418 O
, O
sodium O
131 O
, O
potassium O
3.4 O
, O
chloride O
102 O
, O
bicarbonate O
21.4 O
, O
BUN27 O
, O
creatinine O
1.4 O
, O
glucose O
150 O
. O

RADIOLOGIC O
STUDIES O
: O

CT O
scan O
3/5/02 O
: O

A B-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM
external I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
fascia I-SYMPTOM
consistent O
with O
site O
of O
erythema B-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
Urology O
. O

After O
the B-SYMPTOM
wound I-SYMPTOM
was O
further O
opened O
, O
he O
was O
started O
on O
ampicillin B-TREATMENT
, O
Gentamicin B-TREATMENT
, O
and O
Flagyl B-TREATMENT
antibiotics I-TREATMENT
and O
he O
was O
placed O
on O
a B-TREATMENT
bid I-TREATMENT
dressing I-TREATMENT
change I-TREATMENT
and O
packing B-TREATMENT
. O

On O
hospital O
day O
2 O
, O
the O
patient O
had O
no O
complaints O
. O

He O
was O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O
and O
good O
urine O
output O
. O

The B-SYMPTOM
wound I-SYMPTOM
erythema I-SYMPTOM
was O
improving O
and O
the B-SYMPTOM
wound I-SYMPTOM
was O
packed O
twice O
a O
day O
. O

Wound O
cultures O
remained O
negative O
at O
that O
time O
. O

We O
continued O
his B-TREATMENT
ampicillin I-TREATMENT
, O
Gentamicin B-TREATMENT
, O
and O
Flagyl B-TREATMENT
. O

By O
hospital O
day O
4 O
, O
he O
remained O
afebrile B-SYMPTOM
throughout O
his O
hospital O
course O
. O

The O
wound O
cultures O
demonstrated O
gram-positive B-SYMPTOM
cocci I-SYMPTOM
in I-SYMPTOM
clusters I-SYMPTOM
and O
gram-negative B-SYMPTOM
rods I-SYMPTOM
. O

Blood O
cultures O
remained O
negative O
. O

The O
patient O
was O
continued O
on O
antibiotics B-TREATMENT
and O
we O
obtained O
a O
CT O
scan O
to O
check O
for O
an B-SYMPTOM
enterocutaneous I-SYMPTOM
fistula I-SYMPTOM
. O

We O
discontinued O
his B-TREATMENT
Flagyl I-TREATMENT
on O
that O
day O
. O

We O
contacted O
the O
patient O
&apos;s O
primary O
care O
physician O
, O
Dr. O
Aslinke O
______ O
, O
regarding O
his B-TREATMENT
cardiac I-TREATMENT
medication I-TREATMENT
management I-TREATMENT
. O

We O
agreed O
that O
he O
should O
resume O
his B-TREATMENT
atenolol I-TREATMENT
. O

He O
was O
started O
on O
2.5 O
mg O
PO O
qd O
. O

He O
was O
continued O
on O
his B-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
. O

We O
changed O
the B-TREATMENT
dressings I-TREATMENT
tid O
instead O
of O
bid O
for O
continued B-SYMPTOM
drainage I-SYMPTOM
. O

The O
CT O
scan O
that O
was O
obtained O
on O
3/10/02 O
demonstrated O
no O
connection O
between O
bowel O
and O
the B-SYMPTOM
wound I-SYMPTOM
. O

The B-SYMPTOM
drainage I-SYMPTOM
had O
been O
decreasing O
and O
the O
patient O
continued O
to O
be O
afebrile B-SYMPTOM
. O

On O
the O
following O
day O
, O
3/11/02 O
, O
a O
fistulogram O
was O
obtained O
which O
was O
negative O
for O
a B-SYMPTOM
fistula I-SYMPTOM
from I-SYMPTOM
the I-SYMPTOM
bowel I-SYMPTOM
to O
the B-SYMPTOM
wound I-SYMPTOM
. O

The O
patient O
was O
continued O
on O
ampicillin B-TREATMENT
and O
Gentamicin B-TREATMENT
. O

Her O
remained O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O
. O

He O
was O
comfortable O
and O
erythema B-SYMPTOM
continued O
to O
decrease O
with O
improvemeent O
in O
the O
appearance O
of O
the B-SYMPTOM
wound I-SYMPTOM
. O

In O
consultation O
with O
Infectious O
Disease O
, O
it O
was O
agreed O
to O
discharge O
the O
patient O
on O
Augmentin B-TREATMENT
for O
coverage O
. O

We O
obtained O
sensitivities O
of O
his B-SYMPTOM
wound I-SYMPTOM
bacteria I-SYMPTOM
. O

His B-TREATMENT
intravenous I-TREATMENT
antibiotics I-TREATMENT
were O
discontinued O
. O

He O
remaineda O
febrile B-SYMPTOM
with O
daily O
improvement O
in O
the O
appearance O
of O
his B-SYMPTOM
wound I-SYMPTOM
. O

On O
hospital O
day O
7 O
, O
the O
patient O
remained O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O
. O

His B-SYMPTOM
wound I-SYMPTOM
demonstrated O
no O
erythema B-SYMPTOM
with O
moderate B-SYMPTOM
dark I-SYMPTOM
drainage I-SYMPTOM
. O

The O
patient O
will O
be O
discharged O
with O
WH O
and O
continued B-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
bid O
. O

DISCHARGE O
INSTRUCTIONS O
: O

1. O
The O
patient O
will O
be O
sent O
home O
on O
7 O
days O
of O
Augmentin B-TREATMENT
PO I-TREATMENT
. O

2. O
The O
patient O
will O
have O
follow-up O
with O
Dr. O
Para O
in O
three O
weeks O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Percocet B-TREATMENT
as O
needed O
for O
pain B-SYMPTOM
. O

Norvasc B-TREATMENT
2.5 O
mg O
PO O
qd O
. O

Augmentin B-TREATMENT
500/125 O
1 O
tab O
PO O
tid O
x O
7 O
days O
. O

LAKO O
C O
SCARVTWI O
, O
M.D. O

DICTATING O
FOR O
: O

Electronically O
Signed O

DOJE O
EED O
PARA O
, O
M.D. O

04/21/2002 O
10:49 O

_____________________________ O
DOJE O
EED O
PARA O
, O
M.D. O

TR O
: O

yh O

DD O
: O

03/13/2002 O

TD O
: O

03/13/2002 O
9:24 O
A O
158979 O

cc O
: O

DOJE O
EED O
PARA O
, O
M.D. O

Admission O
Date O
: O

2014-03-22 O

Discharge O
Date O
: O

2014-03-28 O

Date O
of O
Birth O
: O

1983-03-15 O

Sex O
: O

M O

Service O
: O

ORT O

ADDENDUM O
: O

Mr. O
Olander O
had O
acute B-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
anemia I-SYMPTOM
from O
the O
combination O
of O
the B-SYMPTOM
gunshot I-SYMPTOM
wound I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
distal I-SYMPTOM
femur I-SYMPTOM
as O
well O
as O
requirements O
for O
urgent B-TREATMENT
open I-TREATMENT
reduction I-TREATMENT
, O
internal B-TREATMENT
fixation I-TREATMENT
. O

His O
hematocrit O
dropped O
down O
to O
the O
level O
of O
20 O
. O

Although O
he O
remained O
hemodynamically O
stable O
, O
we O
elected O
to O
move O
ahead O
and O
transfuse O
him O
with O
nonautologous B-TREATMENT
PRBC I-TREATMENT
. O

Bertha O
Patrick O
, O
MD O
20AAQ O

Dictated O
By O
: O
Rose O
D. O
Bordelon O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-04-11 O
13:18:08 O

T O
: O
2014-04-12 O
09:36:49 O

Job O
#: O
32074 O

Signed O
electronically O
by O
: O
DR. O
Josefa O
V. O
Wynn O
on O
: O
WED O
2014-04-16 O
2:19 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2015-09-30 O

Discharge O
Date O
: O

2015-10-02 O

Date O
of O
Birth O
: O

1958-01-16 O

Sex O
: O

F O

Service O
: O

MEDICAL O
ICU O

CHIEF O
COMPLAINT O
: O

Change B-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
57-year-old O
nursing O
home O
resident O
female O
, O
who O
had O
been O
in O
her O
usual O
state O
of O

health O
until O
about O
three O
weeks O
ago O
when O
the O
daughter O
noted O
she O
was O
sleeping O
more O
. O

Per O
record O
, O
she O
has O
had O
multiple O
episodes O
in O
the O
last O
week O
of O
changes B-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
. O

EMTs O
called O
many O
times O
. O

The O
patient O
would O
awake O
prior O
to O
arrival O
and O
not O
need O
transfer O
. O

The O
patient O
was O
seen O
at O
the O
Leonard O
Morse/Metrowest O
Medical O
Center O
on O
09-28 O
. O

No O
localizing O
etiology O
of O
delta B-SYMPTOM
MS I-SYMPTOM
. O

That O
evening O
she O
was O
unresponsive B-SYMPTOM
and O
the O
patient O
was O
brought O
to O
Amesbury O
Hospital O
Hospital O
. O

There O
her O
oxygen O
she O
was O
sating O
65% O
on O
room O
air O
, O
increased O
to O
98% O
with O
a B-TREATMENT
nonrebreather I-TREATMENT
mask I-TREATMENT
. O

There O
an O
ABG O
was O
done O
which O
showed O
an O
ABG O
of O
7.42 O
, O
62 O
, O
and O
55 O
. O

She O
had O
a O
head O
CT O
that O
was O
negative O
. O

Chest O
x-ray O
that O
was O
questionable O
left B-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
infiltrate I-SYMPTOM
. O

Lumbar O
puncture O
was O
performed O
and O
the O
micro O
cultures O
are O
still O
pending O
. O

She O
was O
seen O
by O
Psychiatry O
at O
the O
outside O
hospital O
, O
but O
noted O
there O
was O
no O
psychoses B-SYMPTOM
, O
but O
delirium B-SYMPTOM
. O

The O
patient O
's O
mental O
status O
waxed O
and O
waned O
there O
. O

She O
also O
had O
a O
K O
of O
6.0 O
and O
given O
30 O
of O
Kayexalate B-TREATMENT
, O
5 O
of O
Haldol B-TREATMENT
, O
2 O
mg O
of O
Ativan B-TREATMENT
given O
for O

agitation B-SYMPTOM
, O
and O
2 O
mg O
of O
ceftriaxone B-TREATMENT
was O
given O
for O
a O
temperature O
of O
101.3 O
with O
a O
concern O
for O
meningitis B-SYMPTOM
as O
a O
LP O
was O
done O
prior O
. O

Patient O
was O
transferred O
to O
the O
Kindred O
Hospital O
Melendez O
the O
patient O
's O
primary O
care O
provider O
was O
here O
. O

She O
is O
currently O
being O
seen O
by O
Addison O
Gilbert O
Hospital O
Group O
. O

On O
arrival O
to O
Mass. O
Eye O
& O
Ear O
Infirmary O
, O
she O
was O
unresponsive B-SYMPTOM
with O
an O
oxygen O
saturation O
of O
72% O
on O
6 B-TREATMENT
liters I-TREATMENT
. O

She O
was O
placed O
on O
50% B-TREATMENT
vent I-TREATMENT
mask I-TREATMENT
, O
which O
improved O
her O
oxygenation O
to O
97% O
. O

Patient O
was O
placed O
on O
BiPAP B-TREATMENT
. O

Original O
ABG O
here O
before O
BiPAP B-TREATMENT
was O
7.19 O
, O
102 O
, O
and O
92 O
. O

After O
being O
placed O
on O
BiPAP B-TREATMENT
, O
her O
blood O
pressure O
decreased B-SYMPTOM
to O
the O
80s O
. O

She O
responded O
to O
1 O
liter O
of O
IV B-TREATMENT
fluids I-TREATMENT
, O
normal B-TREATMENT
saline I-TREATMENT
and O
blood O
pressure O
remained O
stable O
. O

Patient O
had O
peripheral B-TREATMENT
IV I-TREATMENT
x1 O
placed O
and O
right B-TREATMENT
femoral I-TREATMENT
line I-TREATMENT
placed O
in O
the O
Matthew O
. O

When O
laying O
flat O
, O
her O
sats O
decreased B-SYMPTOM
to O
50% O
on O
30% O
FIO2 B-TREATMENT
, O
PEEP B-TREATMENT
of O
10 O
, O
and O
pressure B-TREATMENT
support I-TREATMENT
of O
5 O
. O

Her O
ABG O
at O
the O
time O
was O
7.24 O
, O
91 O
, O
and O
38 O
. O

Once O
the O
patient O
sat O
up O
, O
her O
sats O
improved O
and O
her O
airway O
was O
no O
longer O
obstructed O
. O

After O
a O
history O
on O
BiPAP B-TREATMENT
about O
a O
half O
an O
hour O
, O
her O
ABG O
was O
7.29 O
, O
79 O
, O
and O
106 O
on O
30% O
pressure B-TREATMENT
support I-TREATMENT
of O
5 O
and O
PEEP B-TREATMENT
of O
10 O
. O

Patient O
was O
intermittently O
awaking O
. O

She O
denied O
any O
pain B-SYMPTOM
and O
was O
not O
answering O
questions O
at O
the O
time O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Obstructive-sleep B-SYMPTOM
apnea I-SYMPTOM
? O

2. O
Morbid B-SYMPTOM
obesity I-SYMPTOM
. O

3. O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
unknown O
EF O
. O

4. O
Hypertension B-SYMPTOM
. O

5. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

6. O
Depression B-SYMPTOM
. O

7. O
Nursing O
home O
resident O
. O

8. O
Dyspnea B-SYMPTOM
on O
exertion O
. O

9. O
History O
of O
fibroids B-SYMPTOM
. O

10. O
Hypercholesterolemia B-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

She O
is O
a O
nursing O
home O
resident O
. O

Does O
not O
ambulate O
. O

Denies O
alcohol O
or O
tobacco O
use O
. O

MEDICATIONS O
ON O
TRANSFER O
FROM O
NURSING O
HOME O
: O

1. O
Lasix B-TREATMENT
40 O
q.d. O

2. O
Senna B-TREATMENT
two O
tablets O
q.6h. O

3. O
Metoprolol B-TREATMENT
25 O
mg O
b.i.d. O

4. O
Metformin B-TREATMENT
1,000 O
mg O
b.i.d. O

5. O
Colace B-TREATMENT
. O

6. O
Niferex B-TREATMENT
one O
tablet O
b.i.d. O

7. O
Cozaar B-TREATMENT
25 O
mg O
q.d. O

8. O
Ranitidine B-TREATMENT
150 O
mg O
p.o. O
q.d. O

9. O
Peroxetine B-TREATMENT
40 O
mg O
p.o. O
q.d. O

10. O
Insulin B-TREATMENT
: O

NPH B-TREATMENT
70 O
units O
q.a.m. O
, O
50 O
units O
q.p.m. O
, O
regular B-TREATMENT
insulin-sliding I-TREATMENT
scale I-TREATMENT
. O

11. O
SubQ B-TREATMENT
Heparin I-TREATMENT
5,000 O
q.8h. O

12. O
Lactulose B-TREATMENT
. O

13. O
Multivitamins B-TREATMENT
. O

14. O
Albuterol B-TREATMENT
inhalers I-TREATMENT
prn O
. O

ALLERGIES O
: O

Penicillin B-TREATMENT
: O

Shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

Vital O
signs O
: O

Heart O
rate O
108 O
, O
blood O
pressure O
140/82 O
, O
oxygen O
saturation O
96% O
, O
respiratory O
rate O
of O
22 O
on O
BiPAP B-TREATMENT
5/10/30% O
. O

In O
general O
, O
sleepy B-SYMPTOM
but O
arousable O
. O

Arousable O
intermittently O
to O
voice O
. O

HEENT O
: O

Pupils O
3 O
mm O
reactive O
. O

Neck O
: O

Obese B-SYMPTOM
, O
unable O
to O
assess O
lymphadenopathy B-SYMPTOM
or O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
. O

Lungs O
: O

Poor B-SYMPTOM
effort I-SYMPTOM
, O
no O
wheezes B-SYMPTOM
, O
rales B-SYMPTOM
, O
or O
rhonchi B-SYMPTOM
. O

Cardiovascular O
: O

Distant B-SYMPTOM
heart I-SYMPTOM
sounds I-SYMPTOM
, O
tachycardia B-SYMPTOM
, O
regular O
rhythm O
. O

Abdomen O
is O
obese B-SYMPTOM
, O
nontender B-SYMPTOM
, O
decreased B-SYMPTOM
bowel I-SYMPTOM
sounds I-SYMPTOM
. O

Extremities O
: O

Obese B-SYMPTOM
, O
no O
edema B-SYMPTOM
, O
2+ O
pulses O
. O

Neurologic O
: O

Responding O
to O
commands O
. O

Moving O
all O
extremities O
well O
. O

Toes O
are O
downgoing O
. O

PERTINENT O
LABORATORIES O
: O

White O
blood O
cell O
count O
12.8 O
( O
79% O
polys O
, O
13% O
lymphocytes O
, O
8 O
monocytes O
, O
nucleated O
RBCs O
1% O
),hematocrit O
31.7 O
. O

Potassium O
5.2 O
, O
creatinine O
1.3 O
, O
BUN O
35 O
, O
glucose O
152 O
, O
D O
dimer O
1636 O
, O
INR O
1.3 O
. O

Urinalysis O
: O

Moderate O
leukocytes O
, O
06-09 O
RBCs O
, O
21-50 O
lymphocytes O
, O
many B-SYMPTOM
bacteria I-SYMPTOM
, O
06-09 O
epithelial O
cells O
. O

Tox O
screen O
negative O
. O

Urine O
cultures O
pending O
. O

LABORATORIES O
AT O
OUTSIDE O
HOSPITAL O
: O

White O
count O
11.8 O
( O
90% O
polys O
, O
4% O
lymphocytes O
, O
5% O
monocytes O
, O
1% O
basophils O
, O
3% O
nucleated O
RBCs O
). O

Potassium O
6.6 O
, O
creatinine O
1.4 O
, O
alkaline O
phosphatase O
302 O
, O
T O
bilirubin O
0.6 O
, O
AST O
25 O
, O
ALT O
84 O
, O
CK O
of O
15 O
, O
troponin O
0.01 O
. O

Chest O
x-ray O
: O

Left B-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
basal I-SYMPTOM
opacity I-SYMPTOM
. O

EKG O
: O

Sinus B-SYMPTOM
tachycardia I-SYMPTOM
at O
106 O
beats O
per O
minute O
, O
left B-SYMPTOM
axis I-SYMPTOM
deviation I-SYMPTOM
, O
T-wave B-SYMPTOM
inversions I-SYMPTOM
in I-SYMPTOM
leads I-SYMPTOM
I I-SYMPTOM
and I-SYMPTOM
aVL I-SYMPTOM
that O
are O
old O
. O

No O
QRS B-SYMPTOM
widening I-SYMPTOM
and O
no O
peak B-SYMPTOM
T I-SYMPTOM
waves I-SYMPTOM
. O

This O
is O
in O
comparison O
to O
2015-09-27 O
EKG O
. O

Chest O
x-ray O
rotated O
low B-SYMPTOM
lung I-SYMPTOM
volumes I-SYMPTOM
, O
hazy B-SYMPTOM
opacities I-SYMPTOM
at I-SYMPTOM
bases I-SYMPTOM
. O

Echocardiogram O
in O
2010 O
: O

Mild-to-moderate B-SYMPTOM
MR I-SYMPTOM
, O
TR B-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

1. O
Hypercarbic B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
issues I-SYMPTOM
: O

The O
patient O
presented O
with O
changes B-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
, O
pCO2 O
of O
100 O
, O
pH O
of O
7.19 O
, O
decreasing B-SYMPTOM
sats I-SYMPTOM
on O
arrival O
likely O
element O
of O
obstructive-sleep B-SYMPTOM
apnea I-SYMPTOM
. O

She O
was O
monitored O
overnight O
. O

She O
had O
admitted O
to O
the O
CMED O
and O
had O
multiple O
episodes O
of O
apnea B-SYMPTOM
throughout O
the O
night O
. O

She O
was O
placed O
on O
pressure B-TREATMENT
support I-TREATMENT
, O
which O
improved O
her O
saturations O
and O
decreased O
her B-SYMPTOM
hypercarbia I-SYMPTOM
. O

Patient O
improved O
that O
her O
mental O
status O
with O
improvement O
of O
her O
oxygenation O
and O
ventilation O
as O
well O
as O
for O
correction O
of O
her B-SYMPTOM
respiratory I-SYMPTOM
acidosis I-SYMPTOM
. O

Patient O
was O
eventually O
placed O
on O
BiPAP B-TREATMENT
on O
hospital O
day O
three O
, O
on O
the O
date O
prior O
to O
discharge O
of O
BiPAP B-TREATMENT
settings O
of O
12/8/5 B-TREATMENT
liters I-TREATMENT
of I-TREATMENT
oxygen I-TREATMENT
with O
saturations O
of O
96% O
with O
a O
gas O
of O
7.38 O
, O
67 O
, O
and O
91 O
with O
an O
aim O
of O
a O
goal O
pCO2 O
of O
67 O
. O

She O
only O
had O
one O
episode O
of O
apnea B-SYMPTOM
on O
the O
day O
prior O
to O
discharge O
. O

2. O
Delta B-SYMPTOM
MS/mental I-SYMPTOM
status I-SYMPTOM
issues I-SYMPTOM
: O

Most O
likely O
her B-SYMPTOM
waxing I-SYMPTOM
and I-SYMPTOM
waning I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
and O
hypercarbia/hypoxia B-SYMPTOM
compounded O
by O
infection B-SYMPTOM
of I-SYMPTOM
pneumonia I-SYMPTOM
and O
UTI B-SYMPTOM
. O

With O
improvements O
of O
her O
ventilation O
and O
oxygenation O
and O
treatment B-TREATMENT
with O
levofloxacin B-TREATMENT
of O
her B-SYMPTOM
UTI I-SYMPTOM
and O
pneumonia B-SYMPTOM
, O
her O
mental O
status O
greatly O
improved O
on O
hospital O
day O
two O
without O
further B-SYMPTOM
waxing I-SYMPTOM
and I-SYMPTOM
waning I-SYMPTOM
. O

Her O
daughters O
came O
by O
and O
visited O
her O
, O
and O
reported O
that O
she O
was O
at O
her O
baseline O
mental O
status O
on O
the O
day O
prior O
to O
discharge O
. O

B12 O
, O
folate O
, O
RPR O
were O
all O
sent O
that O
were O
unremarkable O
as O
causes O
for O
delta B-SYMPTOM
MS I-SYMPTOM
. O

We O
are O
awaiting O
results O
of O
the O
lumbar O
puncture O
from O
the O
outside O
hospital O
, O
but O
on O
hospital O
day O
two O
. O

Those O
cultures O
are O
still O
pending O
at O
the O
time O
. O

Patient O
was O
also O
given O
multivites B-TREATMENT
. O

3. O
Fever B-SYMPTOM
issues I-SYMPTOM
: O

The O
patient O
initially O
presented O
with O
T O
max O
of O
101.3 O
at O
outside O
hospital O
with O
increasing B-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cell I-SYMPTOM
counts I-SYMPTOM
and O
a O
positive O
urinalysis B-SYMPTOM
. O

A O
chest O
x-ray O
with O
bilateral B-SYMPTOM
patchy I-SYMPTOM
infiltrates I-SYMPTOM
likely O
pneumonia B-SYMPTOM
and O
UTI B-SYMPTOM
. O

Upon O
calling O
the O
outside O
hospital O
, O
the O
urine O
was O
growing O
out O
Klebsiella B-SYMPTOM
, O
and O
patient O
was O
given O
a O
10 O
day O
course O
of O
levofloxacin B-TREATMENT
to O
cover O
both O
the B-SYMPTOM
pneumonia I-SYMPTOM
and O
UTI B-SYMPTOM
. O

Blood O
cultures O
and O
urine O
cultures O
are O
still O
pending O
at O
this O
hospital O
visit O
and O
the O
CSF O
fluid O
from O
Whitter O
Rehabilitation O
Hospital O
needs O
to O
be O
further O
evaluated O
. O

Patient O
on O
the O
day O
of O
discharge O
was O
afebrile B-SYMPTOM
with O
a B-SYMPTOM
decreasing I-SYMPTOM
white I-SYMPTOM
count I-SYMPTOM
x48 O
hours O
. O

4. O
Acute B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
issues I-SYMPTOM
: O

Creatinine O
initially O
presented O
at O
1.3 O
. O

Patient O
is O
known O
to O
have O
a O
baseline O
of O
1.0 O
, O
most O
likely O
hypovolemia B-SYMPTOM
and O
prerenal O
. O

A O
FENa O
was O
sent O
, O
was O
0.3% O
. O

Patient O
was O
gently O
hydrated O
and O
IV B-TREATMENT
fluids I-TREATMENT
started O
up O
on O
a B-TREATMENT
p.o. I-TREATMENT
diet I-TREATMENT
regimen I-TREATMENT
. O

On O
hospital O
day O
two O
, O
her O
creatinine O
returned O
to O
0.8 O
, O
and O
she O
remained O
with O
a O
creatinine O
of O
0.8 O
for O
the O
remainder O
of O
her O
hospital O
stay O
. O

Patient's O
K O
was O
followed O
, O
and O
trended O
back O
down O
to O
normal O
on O
the O
day O
of O
discharge O
at O
3.9 O
. O

5. O
Elevated B-SYMPTOM
transaminases I-SYMPTOM
: O

Patient O
had O
no O
right B-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
pain I-SYMPTOM
. O

Stewart O
sign O
was O
negative O
. O

A O
right O
upper O
quadrant O
ultrasound O
was O
performed O
that O
showed O
no O
hepatic B-SYMPTOM
or I-SYMPTOM
biliary I-SYMPTOM
pathology I-SYMPTOM
likely O
due O
to O
acute B-SYMPTOM
phase I-SYMPTOM
stress I-SYMPTOM
changes I-SYMPTOM
given O
the O
fact O
that O
she O
had O
no O
clinical B-SYMPTOM
symptoms I-SYMPTOM
. O

There O
is O
no O
need O
to O
followup O
these O
transaminases O
. O

6. O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
history O
: O

Patient O
was O
stable O
without O
evidence O
of O
CHF B-SYMPTOM
on O
chest O
x-ray O
. O

Followed O
her O
sats O
likely O
due O
to O
obstructive-sleep B-SYMPTOM
apnea I-SYMPTOM
and O
hypoventilation B-SYMPTOM
. O

Patient O
was O
restarted O
on O
her B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
and O
.......- O
receptor B-TREATMENT
blocker I-TREATMENT
on O
hospital O
day O
two O
given O
that O
her O
creatinine O
had O
stabilized O
. O

Patient O
had O
no O
further B-SYMPTOM
cardiac I-SYMPTOM
issues I-SYMPTOM
at O
this O
time O
. O

She O
was O
on O
telemetry O
without O
any O
episodes O
of O
any B-SYMPTOM
rhythm I-SYMPTOM
abnormalities I-SYMPTOM
. O

7. O
CMED O
CCU O
: O

The O
patient O
had O
some B-SYMPTOM
vaginal I-SYMPTOM
bleeding I-SYMPTOM
x2 O
days O
. O

Patient O
had O
a O
history O
of O
fibroids B-SYMPTOM
during O
this O
hospitalization O
. O

Followed O
her O
examination O
. O

Her O
hematocrit O
remained O
stable O
throughout O
this O
course O
. O

Patient O
is O
strongly O
encouraged O
to O
followup O
with O
her O
outside O
primary O
care O
provider O
to O
followup O
for O
the B-SYMPTOM
vaginal I-SYMPTOM
bleeding I-SYMPTOM
given O
her O
history O
of O
fibroids B-SYMPTOM
and O
question O
metaplasia B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
endometrium I-SYMPTOM
. O

8. O
Heme O
: O

Her O
hematocrit O
remained O
stable O
. O

She O
had O
a O
history O
of O
nucleated B-SYMPTOM
RBCs I-SYMPTOM
likely O
secondary O
to O
stress B-SYMPTOM
and O
hypoxia B-SYMPTOM
during O
this O
admission O
. O

Hemolysis O
laboratories O
were O
negative O
. O

Patient O
was O
restarted O
on O
her B-TREATMENT
iron I-TREATMENT
supplementation I-TREATMENT
. O

Reticulocyte O
count O
was O
performed O
that O
was O
negative O
. O

9. O
FEN O
: O

She O
was O
NPO B-TREATMENT
with O
a B-SYMPTOM
decrease I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
. O

We O
slowly O
advanced O
her O
diet O
as O
her O
mental O
status O
improved O
and O
repleted O
her O
electrolytes O
, O
and O
started O
on O
her B-TREATMENT
p.o. I-TREATMENT
medications I-TREATMENT
on O
hospital O
day O
two O
. O

10. O
Diabetes B-SYMPTOM
: O

Patient O
had O
q.i.d. O
fingersticks O
with O
a B-TREATMENT
Humalog I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
and O
NPH B-TREATMENT
doses I-TREATMENT
were O
cut O
in O
half O
while O
she O
was O
NPO B-TREATMENT
, O
and O
they O
were O
brought O
back O
to O
her B-TREATMENT
normal I-TREATMENT
doses I-TREATMENT
on O
the O
day O
of O
discharge O
with O
a O
full O
diet O
. O

11. O
Code O
status O
: O

Full O
. O

Two O
daughters O
came O
by O
and O
requested O
to O
be O
health O
care O
proxies O
as O
patient O
approved O
. O

Documentation O
is O
in O
her O
medical O
chart O
. O

12. O
Prophylaxis B-TREATMENT
: O

The O
patient O
was O
on O
subQ B-TREATMENT
Heparin I-TREATMENT
for O
DVT B-SYMPTOM
and O
ranitidine B-TREATMENT
for O
GI B-TREATMENT
prophylaxis I-TREATMENT
. O

DISPOSITION: O

The O
patient O
is O
to O
be O
discharged O
today O
to O
Lahey O
Clinic O
- O
North O
Shore O
Hospital O
for O
long-term B-TREATMENT
pulmonary I-TREATMENT
........ I-TREATMENT
therapy I-TREATMENT
and O
further O
evaluation O
of O
her B-SYMPTOM
obstructive-sleep I-SYMPTOM
apnea I-SYMPTOM
. O

DISCHARGE O
CONDITION O
: O

Patient O
was O
stable O
with O
complete O
clearance O
of O
her O
mental O
status O
, O
advancement O
of O
her O
diet O
, O

blood O
pressure O
, O
and O
heart O
rate O
remained O
stable O
, O
and O
her O
oxygen O
saturations O
were O
well O
above O
90% O
during O
the O
daytime O
on O
2 B-TREATMENT
liters I-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
and O
at O
night O
on O
the B-TREATMENT
BiPAP I-TREATMENT
settings O

described O
above O
. O

Physical O
Therapy O
consult O
is O
pending O
today O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
NPH B-TREATMENT
70 O
units O
q.a.m. O
, O
50 O
units O
q.p.m. O

2. O
Humalog B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

3. O
SubQ B-TREATMENT
Heparin I-TREATMENT
5,000 O
units O
t.i.d. O

4. O
Ranitidine B-TREATMENT
150 O
mg O
p.o. O
b.i.d. O

5. O
Multivitamin B-TREATMENT
x1 O
. O

6. O
Losartan B-TREATMENT
25 O
mg O
p.o. O
q.d. O

7. O
Iron B-TREATMENT
supplementation I-TREATMENT
150 O
mg O
p.o. O
q.d. O

8. O
Levofloxacin B-TREATMENT
day O
four O
of O
10 O
to O
be O
completed O
for O
a O
full O
10-day O
course O
, O
500 O
mg O
p.o. O
q.d. O

9. O
Metoprolol B-TREATMENT
25 O
mg O
p.o. O
b.i.d. O

10. O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

Mark O
Nibbe O
, O
M.D. O

87-896 O

Dictated O
By O
: O
Jeffrey O
N. O
Elvington O
, O
M.D. O

MEDQUIST36 O

D O
: O

2015-10-02 O
08:19 O

T O
: O

2015-10-02 O
08:20 O

JOB O
# O
: O

15790 O

Signed O
electronically O
by O
: O
DR. O
Mark O
Nibbe O
on O
: O
TUE O
2015-10-06 O
9:46 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2015-07-09 O

Discharge O
Date O
: O

2015-07-17 O

Date O
of O
Birth O
: O

1947-06-29 O

Sex O
: O

F O

Service: O

ADDENDUM O
: O

Leona O
Wheeler O
had O
continued O
episodes O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
which O
were O
treated O
with O
intravenous B-TREATMENT
Amiodarone I-TREATMENT
and O
later O
intravenous B-TREATMENT
Diltiazem I-TREATMENT
. O

Her B-TREATMENT
Lopressor I-TREATMENT
dose I-TREATMENT
was O
progressively O
increased O
to O
100 O
mg O
tid O
. O

Amiodarone B-TREATMENT
400 O
mg O
tid O
was O
continued O
as O
well O
. O

Due O
to O
this B-SYMPTOM
continued I-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
, O
Leona O
Wheeler O
was O
anticoagulated O
with O
intravenous B-TREATMENT
Heparin I-TREATMENT
. O

Coumadin B-TREATMENT
dose I-TREATMENT
was O
started O
and O
her O
INR O
were O
followed O
. O

These O
episodes O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
have O
diminished O
and O
she O
has O
been O
in O
sinus O
rhythm O
for O
over O
24 O
hours O
now O
. O

At O
this O
time O
Leona O
Wheeler O
was O
felt O
stable O
to O
be O
transferred O
to O
rehabilitation O
facility O
. O

She O
will O
be O
monitored O
with O
a O
King O
of O
Hearts O
monitor O
. O

Changes O
to O
discharge O
medications O
: O

Metoprolol B-TREATMENT
100 O
mg O
tid O
, O
Amiodarone B-TREATMENT
400 O
mg O
tid O
times O
7 O
days O
, O
then O
bid O
times O
14 O
days O
, O
then O
q O
d O
times O
14 O
days O
, O
then O
200 O
mg O
q O
d O
. O

DISCHARGE O
CONDITION O
: O

Stable O
. O

DISCHARGE O
STATUS O
: O

Leona O
Wheeler O
is O
to O
be O
transferred O
on O
2015-07-17 O
to O
a O
rehabilitation O
facility O
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Status O
post O
CABG B-TREATMENT
times O
four O
. O

Meghan O
G. O
Bardin O
, O
M.D. O
43-132 O

Dictated O
By O
: O
Louise O
B. O
Robertson O
, O
M.D. O

MEDQUIST36 O

D O
: O
2015-07-17 O
08:39 O

T O
: O
2015-07-22 O
10:29 O

JOB O
# O
: O
72575 O

Signed O
electronically O
by O
: O
DR. O
Derek O
Vildosola O
on O
: O
WED O
2015-07-29 O
1:15 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2018-08-02 O

Discharge O
Date O
: O

2018-08-08 O

Date O
of O
Birth O
: O

1941-03-03 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Penicillins B-TREATMENT
/ O
Codeine B-TREATMENT
/ O
Heparin B-TREATMENT
Agents I-TREATMENT
/ O
Levofloxacin B-TREATMENT

Attending O
: O
Faye O
B. O
Jones O
, O
M.D. O

Chief O
Complaint O
: O
rectal B-SYMPTOM
bleeding I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O
colonoscopy O
egd O

GI O
bleeding O
study O

History O
of O
Present O
Illness O
: O

Patient O
is O
a O
77 O
year O
old O
female O
with O
a O
past O
medical O
history O
significant O
for O
GI B-SYMPTOM
bleeding I-SYMPTOM
secondary O
to O
arteriovenous B-SYMPTOM
malformations I-SYMPTOM
, O
who O
presents O
with O
maroon B-SYMPTOM
stool I-SYMPTOM
and O
a B-SYMPTOM
hematocrit I-SYMPTOM
drop I-SYMPTOM
. O

Three O
days O
ago O
began O
to O
develop O
black B-SYMPTOM
stools I-SYMPTOM
. O

There O
was O
no O
clear B-SYMPTOM
blood I-SYMPTOM
in O
the O
toilet O
bowl O
. O

In O
addition O
, O
she O
developed O
nausea B-SYMPTOM
and O
decreased B-SYMPTOM
PO I-SYMPTOM
intake I-SYMPTOM
. O

She O
had O
a B-SYMPTOM
cough I-SYMPTOM
productive O
of O
white B-SYMPTOM
sputum I-SYMPTOM
and O
felt O
warm O
, O
although O
she O
did O
not O
record O
her O
temperature O
. O

At O
dialysis O
on O
day O
of O
admission O
, O
she O
related O
these O
symptoms O
for O
the O
first O
time O
and O
had O
a B-SYMPTOM
bloody I-SYMPTOM
bowel I-SYMPTOM
movement I-SYMPTOM
. O

Concerned O
, O
the O
staff O
sent O
her O
directly O
to O
the O
Nantucket O
Cottage O
Hospital O
. O

In O
the O
Deanna O
, O
her O
temperature O
was O
96.5 O
, O
HR O
51 O
, O
BP O
112/60 O
, O
RR O
18 O
, O
and O
oxygen O
saturation O
was O
98% O
on O
ambient O
air O
. O

Her O
hematocrit O
was O
measured O
at O
23.5 O
, O
while O
her O
baseline O
hematocrit O
is O
in O
the O
low O
30 O
s. O

An O
NG O
lavage O
was O
performed O
and O
there O
was O
bilious B-SYMPTOM
return I-SYMPTOM
. O

Rectal O
examination O
was O
notable O
for O
guiaiac B-SYMPTOM
positive I-SYMPTOM
maroon I-SYMPTOM
stool I-SYMPTOM
. O

She O
was O
type O
and O
crossed O
and O
transfused O
two O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

IV B-TREATMENT
PPI I-TREATMENT
was O
given O
and O
the O
GI O
team O
was O
consulted O
and O
she O
was O
scheduled O
for O
colonoscopy O
and O
EGD O
on O
the O
morning O
of O
6/8 O
. O

She O
was O
transferred O
to O
the O
CMED O
CCU O
for O
observation O
. O

Past O
Medical O
History O
: O

DM2 B-SYMPTOM
on O
insulin B-TREATMENT

CRI B-SYMPTOM
03-30 O
HTN B-SYMPTOM
and O
DM B-SYMPTOM
nephropathy I-SYMPTOM
, O
with O
baseline O
creatinine O
4-4.5 O

Chronic B-SYMPTOM
GI I-SYMPTOM
bleeding I-SYMPTOM
: O
documented B-SYMPTOM
AVMs I-SYMPTOM

Anemia B-SYMPTOM
w/ O
baseline O
hct O
27-30 O

Thrombocytopenia B-SYMPTOM

Coagulopathy B-SYMPTOM
, O
HIT B-SYMPTOM
in O
2014 O

Cardiomyopathy B-SYMPTOM

MRSA B-SYMPTOM
endocardiitis I-SYMPTOM
( O
01-28 O
) O

CAD B-SYMPTOM
; O
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
two O
and O
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
2001 O
and O
2000 O
. O

Asthma B-SYMPTOM

Hypothyroidism B-SYMPTOM

Osteoarthritis B-SYMPTOM

Paroxysmal B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM

PUD B-SYMPTOM
, O
Barrett B-SYMPTOM
's I-SYMPTOM
Esophagus I-SYMPTOM

CHF B-SYMPTOM
EF O
50% O

Social O
History O
: O

Primarily O
Togolese O
speaking O
, O
wheelchair B-SYMPTOM
bound I-SYMPTOM
and O
lives O
alone O
but O
cared O
for O
entirely O
by O
her O
daughter O
. O

She O
denies O
EtOH O
, O
tobacco O
, O
and O
drugs O
. O

Patient O
has O
8 O
children O
, O
40 O
grandchildren O
and O
one O
great-grandaughter O
. O

Family O
History O
: O

CAD B-SYMPTOM
and O
DM B-SYMPTOM

Physical O
Exam O
: O

T O
: O
97.2 O
BP O
: O
127/57 O
HR O
: O
68 O
RR O
: O
11 O
O2saturation O
: O
97% O
on O
ambient O
air O

Gen O
: O

Pleasant O
, O
well O
appearing O
heavy O
set O
woman O
laying O
in O
bed O
. O

HEENT O
: O

Slight B-SYMPTOM
conjunctival I-SYMPTOM
pallor I-SYMPTOM
. O

No O
scleral B-SYMPTOM
icterus I-SYMPTOM
. O

Slightly B-SYMPTOM
dry I-SYMPTOM
mucous I-SYMPTOM
membranes I-SYMPTOM
. O

NECK O
: O

Supple O
. O

No O
JVD B-SYMPTOM
. O

CV O
: O

RRR O
. O

Systolic B-SYMPTOM
murmur I-SYMPTOM
in I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
. O

Normal O
S1 O
and O
S2 O
. O

No O
rubs B-SYMPTOM
or O
Andringa B-SYMPTOM
appreciated O
. O

LUNGS O
: O

Crackles B-SYMPTOM
in I-SYMPTOM
lower I-SYMPTOM
lung I-SYMPTOM
fields I-SYMPTOM
. O

No O
wheezes B-SYMPTOM
or O
rhonci B-SYMPTOM
appreciated O
. O

ABD O
: O

Slightly B-SYMPTOM
hyperactive I-SYMPTOM
bowel I-SYMPTOM
sounds I-SYMPTOM
throughout I-SYMPTOM
. O

Soft O
. O

Nontender B-SYMPTOM
and O
nondistended B-SYMPTOM
. O

No O
guarding B-SYMPTOM
or O
rebound B-SYMPTOM
. O

Liver O
edge O
not O
palpated O
. O

No O
splenomegaly B-SYMPTOM
appreciated O
. O

Guaiac B-SYMPTOM
positive I-SYMPTOM
maroon I-SYMPTOM
stool I-SYMPTOM
in O
Deanna O
. O

EXT O
: O

Warm O
and O
well O
perfused O
. O

No O
clubbing B-SYMPTOM
or O
cyanosis B-SYMPTOM
. O

No O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
, I-SYMPTOM
bilaterally I-SYMPTOM
. O

2+ O
dorsalis O
pedis O
and O
radial O
pulse O
on O
left O
. O

No B-SYMPTOM
radial I-SYMPTOM
pulse I-SYMPTOM
on I-SYMPTOM
right I-SYMPTOM
. O

AV B-TREATMENT
fistula I-TREATMENT
on O
right O
. O

Pertinent O
Results O
: O

2018-08-07 O
12:56 O
AM O
BLOOD O
WBC O
- O
4.0 O
RBC O
- O
3.54 O
* O
Hgb O
- O
11.6 O
* O
Hct O
- O
32.9 O
* O
MCV O
- O
93 O
MCH O
- O
32.8 O
* O
MCHC O
- O
35.2 O
* O
RDW O
- O
18.5 O
* O
Plt O
Ct O
- O
65 O
* O

2018-08-02 O
12:29 O
PM O
BLOOD O
Hct O
- O
23.5 O
*# O

2018-08-02 O
04:40 O
PM O
BLOOD O
WBC O
- O
3.2 O
* O
RBC O
- O
2.49 O
*# O
Hgb O
- O
8.4 O
*# O
Hct O
- O
24.5 O
*# O
MCV O
- O
98 O
MCH O
- O
33.7 O
* O
MCHC O
- O
34.3 O
RDW O
- O
18.5 O
* O
Plt O
Ct O
- O
69 O
* O

2018-08-06 O
04:52 O
AM O
BLOOD O
PT O
- O
14.7 O
* O
PTT O
- O
28.9 O
INR O
( O
PT O
)- O
1.3 O
* O

2018-08-07 O
12:56 O
AM O
BLOOD O
UreaN O
- O
27 O
* O
Creat O
- O
4.1 O
* O
Na O
- O
130 O
* O
K O
- O
3.7 O
Cl O
- O
94 O
* O
HCO3 O
- O
27 O
AnGap O
- O
13 O

2018-08-06 O
04:52 O
AM O
BLOOD O
Glucose O
- O
129 O
* O
UreaN O
- O
24 O
* O
Creat O
- O
3.4 O
* O
Na O
- O
134 O
K O
- O
3.2 O
* O
Cl O
- O
96 O
HCO3 O
- O
29 O
AnGap O
- O
12 O

2018-08-02 O
04:40 O
PM O
BLOOD O
Glucose O
- O
187 O
* O
UreaN O
- O
21 O
* O
Creat O
- O
2.0 O
*# O
Na O
- O
139 O
K O
- O
3.2 O
* O
Cl O
- O
96 O
HCO3 O
- O
35 O
* O
AnGap O
- O
11 O

2018-08-07 O
12:56 O
AM O
BLOOD O
Calcium O
- O
8.0 O
* O
Phos O
- O
3.5 O
Mg O
- O
1.8 O

Cardiology O
Report O
ECG O
Study O
Date O
of O
2018-08-02 O
5:40:48 O
PM O

Sinus B-SYMPTOM
bradycardia I-SYMPTOM
with O
markedly B-SYMPTOM
prolonged I-SYMPTOM
P-R I-SYMPTOM
interval I-SYMPTOM
and O
Wenckebach B-SYMPTOM
type I-SYMPTOM

atrio-ventricular B-SYMPTOM
conduction I-SYMPTOM
delay I-SYMPTOM
. O

Right B-SYMPTOM
bundle-branch I-SYMPTOM
block I-SYMPTOM
. O

Indeterminate B-SYMPTOM
frontal I-SYMPTOM
plane I-SYMPTOM
QRS I-SYMPTOM
axis I-SYMPTOM
. O

Compared O
to O
the O
previous O
tracing O
of O
2017-10-12 O
multiple B-SYMPTOM
abnormalities I-SYMPTOM
as O
previously O
noted O
persist O
without O
major B-SYMPTOM
change I-SYMPTOM
. O

Read O
by O
: O
Dunn O
, O
Rachel O
Finch O

Intervals O
Axes O

Rate O
PR O
QRS O
QT/QTc O
P O
QRS O
T O

57 O
0 O
154 O
670-32166 O
-37 O

2018-08-03 O
5:40 O
pm O
SEROLOGY/BLOOD O

Source O
: O

Line-central B-TREATMENT
. O

** O
FINAL O
REPORT O
2018-08-06 O
** O

HELICOBACTER O
PYLORI O
ANTIBODY O
TEST O
( O
Final O
2018-08-06 O
) O
: O

NEGATIVE O
BY O
EIA O
. O

( O
Reference O
Range-Negative O
) O
. O

GI O
bleed O
study O
- O
IMPRESSION O
: O

Active B-SYMPTOM
radiotracer I-SYMPTOM
activity I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
in O
a O
serpingneous O
f O
fashion O
suggestive O
of O
distal O
small O
bowel O
. O

EGD O
- O
Impression O
: O

Angioectasias B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
fundus I-SYMPTOM

Angioectasias B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
antrum I-SYMPTOM

Angioectasias B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
jejunum I-SYMPTOM
and I-SYMPTOM
mid I-SYMPTOM
jejunum I-SYMPTOM

Angioectasia B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
duodenum I-SYMPTOM

Otherwise O
normal O
small O
bowel O
enteroscopy O
to O
mid O
jejunum O

Recommendations O
: O

No O
site O
of O
active B-SYMPTOM
bleeding I-SYMPTOM
was O
seen O
. O

The B-SYMPTOM
fundal I-SYMPTOM
AVMs I-SYMPTOM
are O
a O
potential O
site O
of O
bleeding B-SYMPTOM
although O
do O
not O
explain O
the O
extent O
of O
bleeding B-SYMPTOM
. O

Consider O
endoscopic B-TREATMENT
argon I-TREATMENT
plasma I-TREATMENT
therapy I-TREATMENT

Proceed O
with O
colonoscopy O
. O

Colonoscopy O
- O

Impression O
: O

Blood B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
colon I-SYMPTOM

Grade B-SYMPTOM
1 I-SYMPTOM
external I-SYMPTOM
hemorrhoids I-SYMPTOM

Angioectasia B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
colon I-SYMPTOM

Diverticulosis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
colon I-SYMPTOM

Otherwise O
normal O
colonoscopy O
to O
cecum O

Brief O
Hospital O
Course O
: O

Blood B-SYMPTOM
loss I-SYMPTOM
anemia I-SYMPTOM
from O
GI B-SYMPTOM
bleeding I-SYMPTOM
- O
the B-SYMPTOM
bleeding I-SYMPTOM
was O
likely O
from O
an B-SYMPTOM
AVM I-SYMPTOM
. O

EGD O
, O
colonoscopy O
and O
tagged O
scan O
results O
as O
above O
. O

eventhough O
uptake O
was O
noted O
in O
the O
rt O
LQ O
, O
no O
clear O
site O
of O
bleeding B-SYMPTOM
was O
noticed O
on O
colonoscopy O
. O

hence O
, O
no O
intervention B-TREATMENT
was O
performed O
. O

she O
was O
transfused O
with O
5 O
units O
of O
PRBC B-TREATMENT
in O
the O
ICU O
andsent O
to O
the O
Lahey O
Clinic O
- O
North O
Shore O
. O

Her O
hematocrit O
remained O
stable O
for O
4 O
days O
prior O
to O
discharge O
. O

No O
further B-SYMPTOM
bleeding I-SYMPTOM
noted O
. O

GI O
consult O
team O
followed O
pt O
in O
hospital O
. O

On O
discussion O
with O
Dr O
Leigh O
and O
Dr O
White O
from O
GI O
- O
they O
recommended O
that O
she O
follow O
with O
Dr. O
Taylor O
for O
consideration O
of O
argon B-TREATMENT
photocoagulation I-TREATMENT
as O
out-patient O
. O

Given O
the O
innumerable O
number O
of O
AVM B-SYMPTOM
's I-SYMPTOM
, O
it O
is O
diffcult O
to O
assess O
which O
the B-SYMPTOM
culprit I-SYMPTOM
lesion I-SYMPTOM
is O
and O
GI O
may O
start O
APL B-TREATMENT
from I-TREATMENT
the I-TREATMENT
fundus I-TREATMENT
of O
stomach O
. O

Patient O
to O
get O
CBC O
checked O
with O
PCP O
this O
week O
as O
below O
. O

ASA B-TREATMENT
was O
held O
and O
may O
be O
restarted O
if O
Hct O
stable O
in O
clinic O
at O
the O
PCP O
's O
discretion O
. O

Chronic B-SYMPTOM
thrombocytopenia I-SYMPTOM
was O
noted O
, O
however O
the O
patient O
did O
not O
require O
platelet B-TREATMENT
transfusions I-TREATMENT
. O

Has O
a O
h/o O
HIT B-SYMPTOM
. O

The B-TREATMENT
metoprolol I-TREATMENT
was O
held O
during O
acute B-SYMPTOM
bleeding I-SYMPTOM
phase I-SYMPTOM
and O
restarted O
prior O
to O
discharge O
as O
her O
BP O
stabilized O
. O

Other B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
stable O
. O

Dialysis B-TREATMENT
was O
continued O
3 O
/ O
week O
. O

I O
personally O
talked O
with O
Dr O
Pannell O
at O
the O
time O
of O
discharge O
to O
update O
him O
with O
the O
hospital O
events O
. O

Medications O
on O
Admission O
: O

- O
Atorvastatin B-TREATMENT
80 O
mg O
QD O

- O
Hydroxyzine B-TREATMENT
HCl I-TREATMENT
25 O
mg O
Tablet O
PO O
Q4-6H O
PRN O
for O
itching B-SYMPTOM

- O
Levothyroxine B-TREATMENT
175 O
mcg O
PO O
qd O

- O
Albuterol B-TREATMENT
90 O
mcg O
1-2 O
Puffs O
INH O
q6hr O
PRN O

- O
Nitroglycerin B-TREATMENT
0.3 O
mg O
Tablet O
PRN O

- O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
12.5 O
mg O
BID O

- O
B B-TREATMENT
Complex I-TREATMENT
- O
Vitamin B-TREATMENT
C I-TREATMENT
- O
Folic B-TREATMENT
Acid I-TREATMENT
1 O
mg O
Capsule O
QD O

- O
Insulin B-TREATMENT
NPH I-TREATMENT
75-25 O
20units O
qAM O
and O
humalog B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT

Discharge O
Medications O
: O

1. O
Atorvastatin B-TREATMENT
80 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

2. O
Albuterol B-TREATMENT
90 O
mcg O
/ O
Actuation O
Aerosol O
Sig O
: O
1-2 O
Puffs O
Inhalation O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

3. O
Levothyroxine B-TREATMENT
175 O
mcg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

4. O
Hydroxyzine B-TREATMENT
HCl I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

5. O
B-Complex B-TREATMENT
with O
Vitamin B-TREATMENT
C I-TREATMENT
Tablet I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

6. O
Menthol B-TREATMENT
- I-TREATMENT
Cetylpyridinium I-TREATMENT
Cl I-TREATMENT
2 O
mg O
Lozenge O
Sig O
: O
One O
( O
1 O
) O
Lozenge O
Mucous O
membrane O
PRN O
( O
as O
needed O
) O
. O

7. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q12H O
( O
every O
12 O
hours O
) O
. O

8. O
Nitroglycerin B-TREATMENT
0.3 O
mg O
Tablet O
, O
Sublingual O
Sig O
: O
One O
( O
1 O
) O
Sublingual O
as O
needed O
as O
needed O
for O
chest B-SYMPTOM
pain I-SYMPTOM
. O

9. O
Insulin B-TREATMENT

Continue O
to O
take O
the B-TREATMENT
insulin I-TREATMENT
as O
you O
were O
taking O
prior O
to O
the O
hospital O
visit O

10. O
Outpatient O
Lab O
Work O

CBC O
( O
to O
be O
checked O
by O
Dr O
Pannell O
444-1034 O
on O
2018-08-10 O
) O

11. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

Acute B-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
anemia I-SYMPTOM
from O
rectal B-SYMPTOM
bleeding I-SYMPTOM

Thrombocytopenia B-SYMPTOM
- I-SYMPTOM
chronic I-SYMPTOM

Secondary O
diagnosis O
- O

HTN B-SYMPTOM

DM B-SYMPTOM
type I-SYMPTOM
1 I-SYMPTOM

CKD B-SYMPTOM
stage I-SYMPTOM
5 I-SYMPTOM

Hypothyroidism B-SYMPTOM

Asthma B-SYMPTOM

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM

Discharge O
Condition: O
stable O
. O

Discharge O
Instructions O
: O

Weigh O
yourself O
every O
morning O
, O
call O
MD O
if O
weight B-SYMPTOM
> I-SYMPTOM
3 I-SYMPTOM
lbs I-SYMPTOM
. O

Adhere O
to O
2 B-TREATMENT
gm I-TREATMENT
sodium I-TREATMENT
diet I-TREATMENT

Do O
not O
take O
the B-TREATMENT
aspirin I-TREATMENT
unless O
you O
see O
Dr O
Pannell O
. O

Continue O
to O
take O
the B-TREATMENT
insulin I-TREATMENT
as O
you O
were O
taking O
prior O
to O
hospital O
visit O
. O

Keep O
your O
appointments O
. O

Please O
see O
your O
doctor O
( O
Dr O
Pannell O
) O
on O
Friday O
2018-08-10 O
for O
a O
blood O
test O
( O
cbc O
) O
. O

He O
has O
asked O
you O
call O
the O
clinic O
Friday O
morning O
for O
a O
same O
day O
appointment O
. O

Continue O
the B-TREATMENT
dialysis I-TREATMENT
three O
times O
a O
week O
. O

Return O
to O
the O
hospital O
if O
you O
notice O
bleeding B-SYMPTOM
or O
any B-SYMPTOM
other I-SYMPTOM
symptoms I-SYMPTOM
of O
concern O
to O
you O
. O

Followup O
Instructions O
: O

Provider O
: O

Kim O
Phone O
: O
512 O
0199 O
Date O
/ O
Time O
: O
2018-08-17 O
9:30 O

Gastroenterology O
- O
9092 O
N. O
Eighth O
Cir. O
, O
Wisecup O
Rose O
- O
1st O
floor O
. O

Provider O
: O
Michelle O
Susan O
, O
MD O
Phone O
: O
( O
544 O
) O
439-6335 O
Date O
/ O
Time O
: O
2018-08-14 O
8:20 O

Primary O
doctor O
- O
Dr O
Shirley O
, O
James O
M. O
444-1034 O
- O
please O
see O
your O
doctor O
Mary O
Powell O
2018-08-10 O
for O
a O
blood O
test O
( O
cbc O
) O
. O

Dialysis B-TREATMENT
as O
scheduled O
. O

Ruby O
Charles O
MD O
75-829 O

Completed O
by O
: O
William O
Charles O
MD O
75-829 O
2018-08-08 O
@ O
0822 O

Signed O
electronically O
by O
: O
DR. O
Stoll O
Delacy O
on O
: O
Sandra O
2018-08-09 O
4:36 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-01-26 O

Discharge O
Date O
: O

2014-02-09 O

Date O
of O
Birth O
: O

1937-06-05 O

Sex O
: O

F O

Service O
: O

NSU O

ADDENDUM O
: O

Addendum O
from O
the O
dates O
of O
2014-02-04 O
until O
2014-02-09 O
. O

The O
patient O
had O
no O
complications B-SYMPTOM
or O
further B-SYMPTOM
events I-SYMPTOM
while O
in O
house O
. O

On O
Thursday O
- O
2014-02-06 O
- O
the O
patient O
did O
have O
two O
episodes O
of O
chest B-SYMPTOM
discomfort I-SYMPTOM
; O
for O
which O
he O
was O
given O
nitroglycerin B-TREATMENT
and O
those O
resolved O
. O

The O
patient O
did O
have O
an O
evaluation O
of O
electrocardiogram O
done O
by O
Cardiology O
which O
was O
negative O
and O
had O
laboratory O
results O
for O
rule O
out O
myocardial B-SYMPTOM
infarction I-SYMPTOM
which O
were O
also O
negative O
. O

Cardiology O
was O
aware O
of O
the O
patient O
. O

The O
patient O
had O
no O
further O
episodes O
of O
chest B-SYMPTOM
discomfort I-SYMPTOM
and O
remained O
afebrile B-SYMPTOM
while O
in O
house O
. O

Per O
Infectious O
Disease O
, O
okay O
for O
the O
patient O
to O
be O
discharged O
in O
stable O
condition O
to O
Waltham/Weston O
Hospital O
facility O
. O

Penny O
Clayton O
, O
Texas O
87120 O

Dictated O
By O
: O
Eugene O
F O
Balboa O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-02-09 O
11:17:25 O

T O
: O
2014-02-09 O
17:20:17 O

Job O
#: O
66630 O

Signed O
electronically O
by O
: O
DR. O
Elizabeth O
Fernandez O
on O
: O
MON O
2014-02-10 O
4:27 O
PM O

( O
End O
of O
Report O
) O

972977292 O

PUOMC O

9149486 O

13382 O

713336 O

10/14/1996 O
12:00:00 O
AM O

LEFT B-SYMPTOM
ANTERIOR I-SYMPTOM
TEMPORAL I-SYMPTOM
INTRAPARENCHYMAL I-SYMPTOM
HEMORRHAGE I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

CALL O
, O
GRANRIVERN O
S O

UNIT O
NUMBER O
: O

585-28-96 O

ADMISSION O
DATE O
: O

10/14/96 O

DISCHARGE O
DATE O
: O

10/27/96 O
date O
of O
birth O
; O
September O
30 O
, O
1917 O

PRINCIPAL O
DIAGNOSIS O
: O

Left B-SYMPTOM
anterior I-SYMPTOM
temporal I-SYMPTOM
intraparenchymal I-SYMPTOM
hemorrhage I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
, O
pulmonary B-SYMPTOM
embolus I-SYMPTOM
, O
right B-SYMPTOM
frontal I-SYMPTOM
infarct I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
and O
question O
progressive B-SYMPTOM
supranuclear I-SYMPTOM
palsy I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

magnetic O
resonance O
imaging O
of O
the O
brain O
on O
10/18/96 O
. O

THER O
PROCEDURES O
: O

arterial O
catheterization O
on O
10/14/96 O
, O
head O
CT O
scan O
on O
10/14/96 O

HISTORY O
AND O
REASON O
FOR O
HOSPITALIZATION O
: O

Granrivern O
Call O
is O
a O
79-year-old O
right O
handed O
white O
male O
with O
a O
history O
of O
questionable O
progressive B-SYMPTOM
supranuclear I-SYMPTOM
palsy I-SYMPTOM
, O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
, O
and O
pulmonary B-SYMPTOM
embolus I-SYMPTOM
who O
presents O
with O
a B-SYMPTOM
change I-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
and O
a O
fall O
at O
home O
. O

His O
family O
stated O
that O
he O
had O
a B-SYMPTOM
progressive I-SYMPTOM
mental I-SYMPTOM
decline I-SYMPTOM
over O
the O
past O
three O
years O
and O
was O
initially O
diagnosed O
with O
Parkinson B-SYMPTOM
&apos;s I-SYMPTOM
disease I-SYMPTOM
or O
features B-SYMPTOM
consistent O
with O
Parkinsonism B-SYMPTOM
. O

This O
was O
poorly O
responsive O
to O
Eldopa B-TREATMENT
. O

He O
was O
later O
seen O
by O
Dr. O
Flo O
Cuchkote O
at O
the O
Ph O
University O
Of O
Medical O
Center O
and O
diagnosed O
with O
progressive B-SYMPTOM
supranuclear I-SYMPTOM
palsy I-SYMPTOM
. O

Over O
the O
five O
to O
six O
weeks O
prior O
to O
admission O
he O
had O
a B-SYMPTOM
drop I-SYMPTOM
off I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
mental I-SYMPTOM
functioning I-SYMPTOM
with O
more O
frequent O
episodes O
of O
confusion B-SYMPTOM
and O
disorientation B-SYMPTOM
and O
requiring O
more O
assistance B-TREATMENT
with O
his O
activities O
of O
daily O
living O
. O

He O
also O
developed O
a B-SYMPTOM
urinary I-SYMPTOM
incontinence I-SYMPTOM
. O

He O
had O
had O
two O
falls O
to O
his O
wife O
&apos;s O
recollection O
, O
both O
times O
slipping O
off O
the O
edge O
of O
a O
chair O
backwards O
. O

On O
the O
morning O
of O
admission O
at O
8 O
o&apos;clock O
, O
he O
was O
noted O
to O
be O
moving O
his O
mouth O
less O
and O
speaking O
&quot; O
gibberish O
&quot; O
. O

He O
was O
later O
sitting O
in O
a O
chair O
making O
multiple O
attempts O
to O
get O
up O
, O
which O
he O
subsequently O
did O
and O
promptly O
fell O
directly O
on O
his O
face O
at O
approximately O
11:30 O
a.m. O

There O
was O
no O
definite B-SYMPTOM
clonic I-SYMPTOM
activity I-SYMPTOM
. O

There O
was O
no O
known B-SYMPTOM
incontinence I-SYMPTOM
. O

He O
was O
taken O
to O
an O
outside O
hospital O
and O
nasally O
intubated O
and O
then O
transferred O
to O
the O
Ph O
University O
Of O
Medical O
Center O
Emergency O
Room O
where O
he O
was O
orally O
intubated O
. O

A O
trauma O
evaluation O
was O
negative O
and O
thus O
he O
was O
transferred O
to O
the O
Neurology O
Service O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Coumadin B-TREATMENT
4 O
mgs O
po O
qhs O
, O
Vasotec B-TREATMENT
5 O
mgs O
po O
qd O
, O
Lasix B-TREATMENT
prn O
, O
Digoxin B-TREATMENT
0.25 O
mgs O
poqd O
, O
Proscar B-TREATMENT
and O
Sinemet B-TREATMENT
. O

ALLERGIES O
: O

no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1) O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
on O
coumadin B-TREATMENT
, O

2) O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
and O
pulmonary B-SYMPTOM
embolus I-SYMPTOM
; O
the O
wife O
states O
since O
he O
was O
in O
the O
infantry O
in O
World O
War O
II O
. O

3) O
Question O
progressive B-SYMPTOM
supranuclear I-SYMPTOM
palsy I-SYMPTOM
. O

4) O
old B-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
infarct I-SYMPTOM
. O

5) O
hypertension B-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

He O
lives O
with O
his O
wife O
who O
is O
his O
primary O
care O
giver O
. O

He O
is O
a O
former O
professor O
at O
Montana O
. O

Tobacco O
; O
he O
has O
some O
distant O
history O
of O
some O
very O
minimal O
use O
. O

Alcohol O
; O
he O
has O
no O
recent O
use O
. O

He O
was O
a O
previous O
drinker O
of O
one O
&quot; O
old O
fashioned O
&quot; O
every O
night O
. O

FAMILY O
HISTORY O
: O

He O
has O
a O
father O
who O
had O
dementia B-SYMPTOM
. O

There O
was O
no O
history O
of O
strokes B-SYMPTOM
or O
bleeding B-SYMPTOM
disorders I-SYMPTOM
in O
the O
family O
. O

PHYSICAL O
EXAMINATION O
: O

vital O
signs O
in O
the O
emergency O
room O
were O
210/100 O
for O
blood O
pressure O
, O
heart O
rate O
70 O
and O
irregular B-SYMPTOM
. O

He O
was O
afebrile B-SYMPTOM
. O

In O
general O
he O
was O
an O
intubated O
elderly O
frail O
appearing O
white O
male O
with O
blood B-SYMPTOM
about I-SYMPTOM
his I-SYMPTOM
face I-SYMPTOM
. O

head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
examination O
; O
abrasions B-SYMPTOM
about I-SYMPTOM
his I-SYMPTOM
forehead I-SYMPTOM
, O
there O
was O
some B-SYMPTOM
minimal I-SYMPTOM
swelling I-SYMPTOM
associated O
. O

His O
neck O
was O
rigid B-SYMPTOM
; O
1+ O
carotids O
without O
bruits B-SYMPTOM
. O

oropharynx O
was O
intubated B-TREATMENT
with O
blood B-SYMPTOM
as O
well O
. O

Lungs O
; O
clear O
to O
auscultation O
bilaterally O
. O

Cardiovascular O
examination O
; O
regular O
rate O
and O
rhythm O
with O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
, O
or O
gallops B-SYMPTOM
. O

Abdominal O
examination O
; O
soft O
, O
non-tender B-SYMPTOM
, O
non-distended B-SYMPTOM
, O
normal O
active O
bowel O
sounds O
. O

Extremities O
: O

no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
, O
or O
edema B-SYMPTOM
. O

Neurologically O
; O
he O
opens O
his O
eyes O
to O
voice O
. O

He O
does O
not O
regard O
the O
examiner O
. O

He O
had O
no B-SYMPTOM
blink I-SYMPTOM
to O
threat O
. O

His O
pupils O
were O
three O
down O
to O
two O
on O
the O
right O
and O
five O
down O
to O
four O
on O
the O
left O
. O

According O
to O
the O
family O
this B-SYMPTOM
iansicoria I-SYMPTOM
was O
old O
. O

He O
had O
intact O
corneals O
bilaterally O
and O
intact O
horizontal O
dull O
movements O
bilaterally O
. O

He O
had O
left O
greater O
than O
right O
nasal O
stimulation O
to O
grimace O
. O

He O
had O
no O
gag B-SYMPTOM
to O
tube B-TREATMENT
manipulation I-TREATMENT
. O

Motor O
examination O
he O
had O
a B-SYMPTOM
weak I-SYMPTOM
withdrawal I-SYMPTOM
to O
nail O
bed O
pressure O
in O
both O
hands O
. O

He O
triple O
flexed O
his O
bilateral O
lower O
extremities O
to O
pain B-SYMPTOM
. O

His O
deep O
tendon O
reflexes O
were O
2+ O
at O
the O
right O
brachial O
radialis O
and O
right O
patella O
; O
everywhere O
else O
his O
reflexes O
were O
1 O
. O

His O
toes O
were O
down O
going O
. O

SUMMARY O
OF O
LABORATORY O
AND O
RADIOLOGICAL O
EXAMINATIONS O
: O

sodium O
141 O
, O
potassium O
3.5 O
, O
chloride O
107 O
, O
bicarbonates O
23.8 O
, O
BUN O
23 O
, O
creatinine O
1.1 O
, O
glucose O
165 O
, O
PO2 O
377 O
, O
PCO2 O
32 O
, O
PH O
7.50 O
, O
asomus O
298 O
, O
toxic O
screen O
negative O
, O
white O
blood O
cell O
count O
11.1 O
, O
hematocrit O
39.6 O
, O
platelet O
count O
137 O
, O
prothrombin O
time O
25.2 O
, O
INR O
4.3 O
, O
partial O
thromboplastin O
time O
34.7 O
, O
urinalysis O
1+ B-SYMPTOM
albumin, I-SYMPTOM
0-5 B-SYMPTOM
high I-SYMPTOM
link I-SYMPTOM
caths I-SYMPTOM
, O
cervical O
spine O
negative O
, O
pelvis O
negative O
, O
lumbar O
spine O
; O
negative O
, O
thoracic O
spine O
negative O
. O

chest O
x-ray O
clear O
. O

electrocardiogram O
showed O
2 O
mm O
of O
ST B-SYMPTOM
depressions I-SYMPTOM
in I-SYMPTOM
V4-6 I-SYMPTOM
. O

Head O
CT O
scan O
showed O
a B-SYMPTOM
2 I-SYMPTOM
x I-SYMPTOM
2 I-SYMPTOM
x I-SYMPTOM
2 I-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
temporal I-SYMPTOM
hemorrhage I-SYMPTOM
with O
minimal B-SYMPTOM
surrounding I-SYMPTOM
edema I-SYMPTOM
. O

There O
was O
also O
evidence O
of O
an B-SYMPTOM
old I-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
infarction I-SYMPTOM
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

1) O
NEUROLOGY O
: O

The O
patient O
was O
admitted O
to O
the O
Neurology O
Intensive O
Care O
Unit O
for O
intensive O
monitoring O
due O
to O
his B-SYMPTOM
frail I-SYMPTOM
condition I-SYMPTOM
. O

He O
had O
an O
electroencephalogram O
performed O
on O
his O
initial O
admittance O
to O
the O
Intensive O
Care O
Unit O
which O
did O
not O
show O
any O
evidence O
of O
seizure B-SYMPTOM
activity I-SYMPTOM
. O

It O
did O
, O
however O
, O
show O
diffuse B-SYMPTOM
slowing I-SYMPTOM
. O

He O
was O
given O
1.5 O
grams O
of O
Dilantin B-TREATMENT
in O
the O
emergency O
room O
as O
well O
as O
2 O
mgs O
of O
intravenous B-TREATMENT
Ativan I-TREATMENT
which O
did O
little O
to O
stop O
his B-SYMPTOM
rhythmic I-SYMPTOM
blinking I-SYMPTOM
that O
he O
showed O
from O
time O
to O
time O
on O
examination O
. O

His B-SYMPTOM
hypertension I-SYMPTOM
; O
his B-SYMPTOM
high I-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
was O
controlled O
with O
intravenous B-TREATMENT
nitroglycerine I-TREATMENT
in O
the O
early O
going O
and O
then O
he O
was O
switched O
to O
an B-TREATMENT
oral I-TREATMENT
regimen I-TREATMENT
for O
better O
control O
after O
he O
was O
removed O
from O
the O
Intensive O
Care O
Unit O
. O

He O
continued O
to O
do O
well O
over O
the O
next O
few O
days O
and O
was O
quite O
surprisingly O
intact O
on O
both O
sides O
of O
his O
body O
in O
terms O
of O
his O
ability O
to O
move O
. O

He O
did O
consistently O
have O
more O
movement O
on O
the O
left O
side O
of O
his O
body O
than O
on O
the O
right O
, O
but O
he O
gradually O
became O
more O
awake O
and O
alert O
and O
communicative O
and O
his B-TREATMENT
endotracheal I-TREATMENT
tube I-TREATMENT
was O
removed O
on O
the O
second O
day O
of O
admission O
. O

His O
diagnosis O
of O
progressive B-SYMPTOM
supranuclear I-SYMPTOM
palsy I-SYMPTOM
was O
placed O
under O
question O
on O
further O
examination O
of O
his O
eye O
movement O
since O
he O
was O
able O
to O
have O
excellent O
superior O
gaze O
especially O
with O
the O
bells O
phenomenon O
which O
would O
not O
be O
seen O
with O
progressive B-SYMPTOM
supranuclear I-SYMPTOM
palsy I-SYMPTOM
. O

It O
was O
felt O
that O
his B-SYMPTOM
dementing I-SYMPTOM
illness I-SYMPTOM
and O
rigidity B-SYMPTOM
was O
most O
likely O
due O
to O
some O
type O
of O
cortico-basal B-SYMPTOM
ganglia I-SYMPTOM
degeneration I-SYMPTOM
process I-SYMPTOM
, O
but O
this O
was O
not O
clarified O
during O
this O
admission O
. O

It O
was O
not O
felt O
likely O
to O
be O
due O
to O
Parkinson B-SYMPTOM
&apos;s I-SYMPTOM
disease I-SYMPTOM
, O
as O
he O
had O
no O
significant O
response O
to O
Eldopa B-TREATMENT
in O
the O
past O
and O
the O
patient O
had O
no O
evidence O
of O
tremor B-SYMPTOM
, O
although O
he O
was O
quite B-SYMPTOM
rigid I-SYMPTOM
and O
bradykinetic B-SYMPTOM
. O

He O
had O
an O
magnetic O
resonance O
imaging O
performed O
on O
October O
18 O
, O
1996 O
. O

This O
showed O
the B-SYMPTOM
unchanged I-SYMPTOM
left I-SYMPTOM
temporal I-SYMPTOM
parenchymal I-SYMPTOM
interparenchymal I-SYMPTOM
hematoma I-SYMPTOM
and O
the B-SYMPTOM
old I-SYMPTOM
embolic I-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
infarct I-SYMPTOM
, O
but O
there O
were O
no O
new B-SYMPTOM
lesions I-SYMPTOM
and O
no O
evidence O
of O
his O
susceptibility O
studies O
to O
suggest O
old B-SYMPTOM
bleeds I-SYMPTOM
which O
might O
have O
been O
consistent O
with O
amylase B-SYMPTOM
angiopathy I-SYMPTOM
. O

In O
addition O
, O
he O
gadolinium O
scan O
did O
not O
show O
enhancement B-SYMPTOM
at O
the O
area O
of O
his B-SYMPTOM
hemorrhage I-SYMPTOM
, O
so O
tumor B-SYMPTOM
was O
felt O
to O
be O
unlikely O
. O

However O
, O
this O
issue O
will O
need O
to O
be O
re-evaluated O
in O
six O
months O
time O
once O
the B-SYMPTOM
hematoma I-SYMPTOM
is O
less O
prominent O
to O
see O
if O
there O
is O
possibly O
an B-SYMPTOM
underlying I-SYMPTOM
tumor I-SYMPTOM
or O
arterial B-SYMPTOM
venous I-SYMPTOM
malformation I-SYMPTOM
that O
could O
be O
currently O
compressed O
by O
the O
area O
of O
hemorrhage B-SYMPTOM
. O

The O
etiology O
of O
his B-SYMPTOM
bleed I-SYMPTOM
was O
felt O
to O
be O
most O
likely O
secondary O
to O
hypertension B-SYMPTOM
, O
but O
these O
other O
causes O
could O
also O
not O
be O
ruled O
out O
. O

2) O
CARDIOVASCULAR O
: O

His O
electrocardiogram O
was O
concerning O
for O
ischemia B-SYMPTOM
. O

He O
was O
on O
intravenous B-TREATMENT
TNG I-TREATMENT
and O
was O
supratherapeutic B-SYMPTOM
on O
his B-TREATMENT
anti-coagulation I-TREATMENT
. O

He O
did O
have O
a B-SYMPTOM
slight I-SYMPTOM
elevation I-SYMPTOM
of O
his O
TPK O
with O
an O
additional O
value O
of O
198 O
with O
a O
MB O
fraction O
of O
5.7 O
, O
which O
makes O
for O
a O
percentage O
of O
2.9 O
. O

That O
was O
at O
the O
highest O
percentage O
that O
he O
had O
and O
after O
this O
his O
percentage O
came O
down O
to O
1.6 O
, O
1.0 O
on O
subsequent O
CKMBs O
and O
was O
felt O
that O
he O
had O
a B-SYMPTOM
very I-SYMPTOM
small I-SYMPTOM
&quot; I-SYMPTOM
leaflet I-SYMPTOM
&quot; I-SYMPTOM
. O

He O
remained O
chest B-SYMPTOM
pain I-SYMPTOM
free O
throughout O
his O
admission O
. O

3) O
PULMONARY O
: O

After O
his B-TREATMENT
initial I-TREATMENT
intubation I-TREATMENT
he O
remained O
quite O
stable O
. O

He O
was O
found O
to O
be O
at O
a B-SYMPTOM
large I-SYMPTOM
aspiration I-SYMPTOM
risk I-SYMPTOM
given O
his B-SYMPTOM
decreased I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
and O
the O
lack O
of O
presence O
of O
a O
gag O
reflex O
. O

However O
, O
he O
was O
given O
aggressive B-TREATMENT
pulmonary I-TREATMENT
toilets I-TREATMENT
including O
chest B-TREATMENT
physical I-TREATMENT
therapy I-TREATMENT
and O
aspiration B-TREATMENT
precautions I-TREATMENT
and O
the O
patient O
did O
not O
develop O
any B-SYMPTOM
pulmonary I-SYMPTOM
symptoms I-SYMPTOM
during O
his O
admission O
. O

4) O
HEMATOLOGY O
: O

He O
had O
his O
prothrombin O
time O
reversed O
with O
Vitamin B-TREATMENT
K I-TREATMENT
2 O
mgs O
on O
admission O
subcutaneously O
as O
well O
as O
two O
units O
of O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
given O
in O
the O
emergency O
room O
. O

His O
anticoagulation O
status O
had O
to O
be O
monitored O
very O
closely O
due O
to O
his O
history O
of O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
and O
pulmonary B-SYMPTOM
embolus I-SYMPTOM
as O
well O
as O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
but O
he O
could O
not O
be O
placed O
on O
a O
high O
amount O
of O
anticoagulation B-TREATMENT
because O
of O
the B-SYMPTOM
new I-SYMPTOM
intraparenchymal I-SYMPTOM
bleed I-SYMPTOM
. O

It O
was O
decided O
that O
his O
goal O
INR O
was O
to O
be O
2.0 O
. O

He O
did O
drop O
below O
1.5 O
at O
one O
time O
, O
at O
which O
time O
he O
was O
placed O
on O
heparin B-TREATMENT
intravenous I-TREATMENT
to O
carry O
him O
through O
that O
period O
, O
but O
his O
discharge O
INR O
was O
around O
2 O
and O
he O
was O
off O
of O
heparin B-TREATMENT
at O
that O
time O
. O

It O
was O
decided O
that O
he O
would O
have O
very O
close O
monitoring O
of O
his O
anticoagulation O
status O
in O
the O
future O
to O
prevent O
further B-SYMPTOM
problems I-SYMPTOM
. O

5) O
GASTROINTESTINAL O
: O

He O
was O
evaluated O
by O
the O
speech O
and O
swallow O
pathology O
group O
at O
the O
Ph O
University O
Of O
Medical O
Center O
and O
it O
was O
decided O
that O
he O
was O
able O
to O
swallow O
on O
his O
own O
with O
a B-TREATMENT
soft I-TREATMENT
solid I-TREATMENT
diet I-TREATMENT
with O
supervision O
. O

Thus O
, O
his B-TREATMENT
nasogastric I-TREATMENT
tube I-TREATMENT
was O
discontinued O
on O
October O
19 O
, O
1996 O
and O
he O
tolerated O
feeding O
quite O
well O
. O

In O
discussions O
with O
the O
family O
, O
given O
his O
age O
and O
number O
of O
medical B-SYMPTOM
problems I-SYMPTOM
, O
it O
was O
decided O
that O
the O
patient O
should O
be O
do O
not O
resuscitate O
should O
he O
have O
a B-SYMPTOM
terminal I-SYMPTOM
cardiac I-SYMPTOM
event I-SYMPTOM
during O
his O
admission O
or O
during O
future O
admissions O
. O

However O
, O
he O
was O
still O
an B-TREATMENT
intubation I-TREATMENT
candidate O
if O
it O
were O
felt O
to O
be O
a B-TREATMENT
short I-TREATMENT
term I-TREATMENT
procedure I-TREATMENT
. O

The O
family O
realizes O
that O
the O
long O
term O
outlook O
for O
this O
patient O
is O
not O
very O
good O
, O
but O
they O
would O
like O
to O
currently O
continue O
to O
provide O
him O
with O
all B-TREATMENT
support I-TREATMENT
necessary I-TREATMENT
, O
short O
of O
resuscitation B-TREATMENT
measures I-TREATMENT
or O
heroic B-TREATMENT
measures I-TREATMENT
should O
he O
have O
a B-SYMPTOM
cardiopulmonary I-SYMPTOM
arrest I-SYMPTOM
. O

DISPOSITION O
/ O
PLAN O
ON O
DISCHARGE O
: O

Stable O
. O

DOCTOR O
&apos;S O
DISCHARGE O
ORDERS O
: O

The O
patient O
was O
to O
be O
discharged O
to O
a O
rehabilitation O
hospital O
, O
the O
location O
of O
which O
was O
undetermined O
at O
this O
time O
of O
this O
discharge O
summary O
. O

The O
patient O
is O
to O
follow O
up O
with O
Dr. O
Ria O
in O
clinic O
on O
one O
month O
time O
and O
the O
family O
is O
to O
call O
me O
if O
there O
were O
any O
questions O
in O
the O
interim O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Dilantin B-TREATMENT
100 O
mgs O
po O
tid O
, O
Carafate B-TREATMENT
1 O
gram O
po O
qid O
, O
Digoxin B-TREATMENT
0.25 O
mgs O
po O
qd O
, O
Isordil B-TREATMENT
20 O
mgs O
po O
tid O
, O
Captopril B-TREATMENT
25 O
mgs O
po O
tid O
, O
Lopressor B-TREATMENT
50 O
mgs O
po O
bid O
, O
Colace B-TREATMENT
100 O
mgs O
po O
tid O
, O
and O
Coumadin B-TREATMENT
2 O
mgs O
po O
qhs O
. O

TI O
CALL O
, O
M.D. O

TR O
: O

fcz O

DD O
: O

10/21/96 O

TD O
: O

10/21/96 O
2:07 O
A O

cc O
: O

TI O
SHEMAU O
CALL O
, O
M.D. O
ASHA O
E O
VENGLOAN O
, O
M.D. O
LYDELL O
R O
WORCE O
, O
M.D. O
/ O
STAT O

054478430 O
ELMVH O

79660638 O

1835979 O

12/11/2005 O
12:00:00 O
AM O

Right B-SYMPTOM
LE I-SYMPTOM
pain I-SYMPTOM

DIS O

Admission O
Date O
: O

12/11/2005 O

Report O
Status O
: O

Discharge O
Date O
: O

12/13/2005 O

****** O
FINAL O
DISCHARGE O
ORDERS O
****** O

HIBBSKOTE O
, O
SIALIND O
071-43-95-1 O
W78 O

Room O
: O

65Q-505 O

Service O
: O

ORT O

DISCHARGE O
PATIENT O
ON O
: O

12/13/05 O
AT O
12:00 O
PM O

CONTINGENT O
UPON O

Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

HEAD O
, O
SANTDEL O
L. O
, O
M.D. O

CODE O
STATUS O
: O

Full O
code O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

TYLENOL B-TREATMENT
( I-TREATMENT
ACETAMINOPHEN I-TREATMENT
) I-TREATMENT
325-650 O
MG O
PO O
Q4H O
PRN O
Pain B-SYMPTOM
, O
Headache B-SYMPTOM
, O
Temperature O
greater O
than O
: O

101 O
COLACE B-TREATMENT
( I-TREATMENT
DOCUSATE I-TREATMENT
SODIUM I-TREATMENT
) I-TREATMENT
100 O
MG O
PO O
BID O
OXYCODONE B-TREATMENT
10-25 O
MG O
PO O
Q3H O
PRN O
Pain B-SYMPTOM

HOLD O
IF O
: O

excesive B-SYMPTOM
sedation I-SYMPTOM
RR O
&lt; O
6 O
FLEXERIL B-TREATMENT
( I-TREATMENT
CYCLOBENZAPRINE I-TREATMENT
HCL I-TREATMENT
) I-TREATMENT
10 O
MG O
PO O
TID O
PRN O
Pain B-SYMPTOM

DIET O
: O

House O
/ O
ADA O
2100 O
cals O
/ O
day O
/ O
Low O
saturated O
fat O
low O
cholesterol O
&lt; O
FDI O
&gt; O

ACTIVITY O
: O

Walking O
as O
tolerated O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Dr. O
Maa O
Bloch O
( O
WAMA O
HEALTH O
) O
Call O
ASAP O
to O
schedule O
in O
1-2 O
days O

Phoen O
: O

381-389-5852 O
, O

Dr. O
Santdel O
Head O
Call O
ASAP O
to O
schedule O
in O
2 O
weeks O
. O

449-059-6882 O
, O

ALLERGY O
: O

NKA B-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

R B-SYMPTOM
leg I-SYMPTOM
pain I-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
Right B-SYMPTOM
LE I-SYMPTOM
pain I-SYMPTOM

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O

DM B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

None O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

PT O
Spien O
MRI O
Pelvis O
XR O
R O
hip O
Xray O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

HPI O
: O

Hibbskote O
has O
severe B-SYMPTOM
low I-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
radiating O
down O
the O
right O
leg O
. O

She O
has O
been O
suffering O
from O
this B-SYMPTOM
problem I-SYMPTOM
for O
the O
last O
few O
weeks O
. O

A O
week O
and O
half O
ago O
, O
she O
had O
a B-TREATMENT
steroid I-TREATMENT
injection I-TREATMENT
in O
an O
efforts O
to O
ameliorate O
the B-SYMPTOM
pain I-SYMPTOM
. O

She O
presents O
now O
with O
worsening B-SYMPTOM
low I-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
radiating O
down O
the O
right O
leg O
. O

She O
denies O
numbness B-SYMPTOM
or O
weakness B-SYMPTOM
in O
any O
part O
of O
the O
body O
. O

She O
denies O
fever B-SYMPTOM
. O

She O
denies O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
and O
diarrhea B-SYMPTOM
. O

She O
denies O
chest B-SYMPTOM
pain I-SYMPTOM
. O

She O
says O
the B-SYMPTOM
pain I-SYMPTOM
is O
sharp O
in O
character O
, O
and O
radiates O
with O
a B-SYMPTOM
shock I-SYMPTOM
like I-SYMPTOM
intensity I-SYMPTOM
down I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
leg I-SYMPTOM
. O

She O
says O
that O
oral B-TREATMENT
analgesics I-TREATMENT
have O
been O
of O
little O
help O
. O

On O
detailed O
review O
of O
systems O
, O
she O
admitted O
to O
one O
episode O
of O
urinary B-SYMPTOM
incontinence I-SYMPTOM
. O

She O
denied O
any B-SYMPTOM
changes I-SYMPTOM
in I-SYMPTOM
bowel I-SYMPTOM
habits I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Non-insulin-requiring B-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
, O
and O
hypercholesterolemia B-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

As O
given O
above O
. O

SOCIAL O
HISTORY O
: O

Negative O
for O
tobacco O
, O
drugs O
, O
or O
domestic O
violence O
. O

FAMILY O
HISTORY O
: O

Negative O
. O

REVIEW O
OF O
SYSTEMS O
: O

All O
systems O
were O
reviewed O
and O
were O
negative O
except O
as O
given O
above O
. O

MEDICATIONS O
: O

Metformin B-TREATMENT
, O
Zocor B-TREATMENT
, O
and O
analgesics B-TREATMENT
. O

ALLERGIES O
: O

None O
. O

PHYSICAL O
EXAMINATION O
: O

Awake O
, O
alert O
, O
spontaneous O
and O
appropriate O
, O
and O
somewhat B-SYMPTOM
uncomfortable I-SYMPTOM
due O
to O
pain B-SYMPTOM
but O
looked O
well O
. O

She O
was O
afebrile B-SYMPTOM
and O
had O
normal O
vital O
signs O
. O

The O
oxygen O
saturation O
was O
normal O
at O
98% O
on O
room O
air O
. O

There O
was O
no O
evidence O
of O
head B-SYMPTOM
trauma I-SYMPTOM
. O

There O
was O
no O
scleral B-SYMPTOM
icterus I-SYMPTOM
. O

The O
oropharynx O
was O
clear O
. O

The O
neck O
was O
supple O
with O
no O
lymphadenopathy B-SYMPTOM
. O

The O
chest O
was O
clear O
with O
normal O
excursion O
. O

Heart O
was O
regular O
with O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
, O
or O
gallops B-SYMPTOM
. O

The O
abdomen O
was O
soft O
and O
nontender B-SYMPTOM
with O
no O
masses B-SYMPTOM
, O
no O
organomegaly B-SYMPTOM
. O

The O
skin O
and O
extremities O
were O
normal O
with O
no O
cyanosis B-SYMPTOM
, O
clubbing B-SYMPTOM
, O
edema B-SYMPTOM
, O
lesions B-SYMPTOM
, O
or O
rashes B-SYMPTOM
. O

Neurologic O
examination O
was O
normal O
. O

Strength O
, O
sensation O
, O
coordination O
and O
cranial O
nerve O
function O
were O
all O
normal O
. O

Straight O
leg O
raise O
test O
was O
difficult O
to O
perform O
due O
to O
pain B-SYMPTOM
but O
seemed O
to O
be O
positive B-SYMPTOM
on O
the O
right O
. O

Psychiatric O
examination O
was O
normal O
. O

Examination O
of O
the O
back O
revealed O
lumbar B-SYMPTOM
tenderness I-SYMPTOM
with O
no O
point B-SYMPTOM
tenderness I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

Patient O
was O
evaluated O
by O
the O
orthopedic O
service O
. O

An O
MRI O
of O
the O
spine O
showed O
L4/5 B-SYMPTOM
facet I-SYMPTOM
enhancement I-SYMPTOM
. O

It O
was O
evaluated O
by O
the O
IR O
radiology O
. O

Thad B-SYMPTOM
lesion I-SYMPTOM
was O
read O
as O
a B-SYMPTOM
facet I-SYMPTOM
hypertrophy I-SYMPTOM
and O
not O
an B-SYMPTOM
infectious I-SYMPTOM
process I-SYMPTOM
. O

Patient O
remained O
afebrile B-SYMPTOM
. O

ESR O
was O
within O
normal O
limits O
and O
CPR O
was O
mildly B-SYMPTOM
elevated I-SYMPTOM
. O

An O
AP O
of O
pelvis O
and O
R O
hip O
films O
were O
unremarkable O
. O

Physical O
examination O
of O
the O
RLE O
showed O
mild B-SYMPTOM
pain I-SYMPTOM
in I-SYMPTOM
right I-SYMPTOM
hip I-SYMPTOM
with O
some O
movements O
. O

When O
patient O
was O
distracted O
, O
some O
maneuvers O
were O
not O
painful B-SYMPTOM
. O

Patient O
remained O
cardiovascularly O
stable O
. O

Patient O
was O
weaned O
from O
supplemental B-TREATMENT
oxygen I-TREATMENT
and O
tolerated O
a O
regular O
diet O
prior O
to O
discharge O
. O

The O
patient O
received O
pneumoboots B-TREATMENT
and O
lovenox B-TREATMENT
for O
DVT B-TREATMENT
prophylaxis I-TREATMENT
. O
. O

Patient O
was O
instructed O
by O
PT O
on O
the O
correct O
way O
to O
ambulate O
, O
weight O
bearing O
as O
tolerated O
in O
the O
RLE O
. O
. O

Patient O
was O
able O
to O
void O
and O
ambulated O
without O
assistance O
as O
directed O
by O
P.T. O

The O
team O
decided O
that O
the O
patient O
was O
ready O
for O
discharge O
. O

Patient O
should O
follow O
up O
with O
her O
pain O
doctor O
, O
Dr. O
Maa O
Bloch O
381-389-5852 O
, O
for O
her B-TREATMENT
chronic I-TREATMENT
pain I-TREATMENT
management I-TREATMENT

ADDITIONAL O
COMMENTS O
: O

Do O
not O
drive O
or O
drink O
alcohol O
while O
taking O
narcotics B-TREATMENT
. O

Resume O
all O
of O
your B-TREATMENT
home I-TREATMENT
medications I-TREATMENT
, O
but O
please O
avoid O
motrin B-TREATMENT
/ I-TREATMENT
advil I-TREATMENT
for O
1 O
week O
. O

Call O
449-059-6882 O
if O
you O
have O
any O
questions O
. O

If O
you O
have O
fevers B-SYMPTOM
&gt; O
101.5 O
F O
, O
vomiting B-SYMPTOM
, O
or O
increased B-SYMPTOM
redness I-SYMPTOM
, O
swelling B-SYMPTOM
, O
or O
discharge B-SYMPTOM
from O
your B-SYMPTOM
incision I-SYMPTOM
, O
call O
your O
MD O
or O
go O
to O
the O
nearest O
ER O
. O

You O
may O
bear O
weight O
on O
your O
both O
legs O
. O

Call O
381-389-5852 O
to O
schedule O
an O
apointment O
with O
your O
pain O
doctor O
( O
Dr. O
Maa O
Bloch O
) O
ASAP O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

FLOMKOTEWIERST O
, O
NEENIE O
LAURE O
, O
M.D. O
( O
DK739 O
) O
12/13/05 O
01:01 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2015-08-10 O

Discharge O
Date O
: O

2015-08-15 O

Date O
of O
Birth O
: O

1954-12-08 O

Sex O
: O

M O

Service O
: O

CT O
CMED O
CSRU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Bruno O
is O
a O
60 O
year O
old O
gentleman O
who O
initially O
presented O
with O
hematemesis B-SYMPTOM
, O
hemoptysis B-SYMPTOM
and O
on O
work-up O
was O
found O
to O
have O
a B-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
mass I-SYMPTOM
. O

He O
previously O
underwent O
bronchoscopy O
with O
washings O
which O
showed O
to O
be O
negative O
for O
malignant B-SYMPTOM
cells I-SYMPTOM
and O
showed O
atypical B-SYMPTOM
bronchial I-SYMPTOM
epithelial I-SYMPTOM
cells I-SYMPTOM
, O
likely O
to O
be O
reactive O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Rectal B-SYMPTOM
fissure I-SYMPTOM
. O

2. O
Lumpectomy B-TREATMENT
of O
the B-SYMPTOM
left I-SYMPTOM
breast I-SYMPTOM
nodule I-SYMPTOM
. O

3. O
Knee B-TREATMENT
surgery I-TREATMENT
. O

4. O
Hand B-TREATMENT
surgery I-TREATMENT
. O

ALLERGIES O
: O

The O
patient O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
: O

The O
patient O
had O
no O
home B-TREATMENT
medications I-TREATMENT
. O

REVIEW O
OF O
SYSTEMS O
: O

The O
review O
of O
systems O
was O
essentially O
negative O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
, O
showed O
a O
gentleman O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
; O
afebrile B-SYMPTOM
. O

Chest O
was O
clear O
to O
auscultation O
bilaterally O
. O

Heart O
has O
a O
regular O
rate O
and O
rhythm O
. O

Abdomen O
is O
benign O
, O
no O
mass B-SYMPTOM
. O

Extremities O
were O
well O
perfused O
and O
warm O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
taken O
to O
the O
Operating O
Room O
the O
day O
of O
admission O
. O

He O
underwent O
a B-TREATMENT
left I-TREATMENT
bronchoscopy I-TREATMENT
and O
lower B-TREATMENT
lobectomy I-TREATMENT
of I-TREATMENT
the I-TREATMENT
left I-TREATMENT
side I-TREATMENT
. O

The B-TREATMENT
operation I-TREATMENT
was O
subsequently O
complicated O
by O
a B-SYMPTOM
postoperative I-SYMPTOM
bleeding I-SYMPTOM
. O

The O
patient O
had O
to O
be O
taken O
back O
to O
the O
Operating O
Room O
where O
a B-TREATMENT
repair I-TREATMENT
of I-TREATMENT
the I-TREATMENT
left I-TREATMENT
pulmonary I-TREATMENT
artery I-TREATMENT
was O
performed O
. O

The O
patient O
was O
then O
transferred O
to O
the O
CSRU O
, O
intubated O
, O
in O
stable O
condition O
. O

Vascular O
Surgery O
Service O
was O
also O
consulted O
. O

During O
the B-TREATMENT
operation I-TREATMENT
, O
the O
patient O
received O
13 O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
, O
four O
units O
of O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
and O
one O
unit O
of O
platelets B-TREATMENT
with O
an B-SYMPTOM
estimated I-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
of O
1500 O
cc O
. O

The O
patient O
remained O
to O
be O
stable O
on O
the O
floor O
with O
subsequent O
monitoring O
of O
hematocrit O
within O
a O
normal O
stable O
range O
. O

He O
is O
successfully O
extubated O
on O
08-12 O
and O
hypertension B-SYMPTOM
transferred O
to O
the O
floor O
in O
stable O
condition O
where O
the O
Pain O
Service O
is O
managing O
his B-TREATMENT
epidural I-TREATMENT
with O
very O
good O
effect O
and O
he O
is O
tolerating O
a O
regular O
p.o. O
diet O
and O
is O
making O
adequate O
amount O
of O
urine O
. O

His O
recovery O
was O
essentially O
unremarkable O
. O

His B-TREATMENT
epidural I-TREATMENT
was O
successfully O
discontinued O
and O
he O
is O
discharged O
to O
home O
on O
08-15 O
with O
instructions O
to O
follow-up O
with O
Dr. O
Cordova O
in O
the O
office O
within O
the O
next O
one O
to O
two O
weeks O
. O

He O
is O
discharged O
to O
home O
with O
pain B-TREATMENT
medication I-TREATMENT
which O
is O
percocet B-TREATMENT
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
STATUS O
: O

To O
home O
without O
service O
. O

DISCHARGE O
DIAGNOSES O
: O

Left B-SYMPTOM
lung I-SYMPTOM
mass I-SYMPTOM
status O
post O
resection B-TREATMENT
. O

Harriet O
D. O
Buffington O
, O
M.D. O
51-721 O

Dictated O
By O
: O
Steven O
L. O
Ibarra O
, O
M.D. O

MEDQUIST36 O

D O
: O
2015-08-17 O
10:50 O

T O
: O
2015-08-21 O
16:28 O

JOB O
#: O
00413 O

Signed O
electronically O
by O
: O
DR. O
Natasha O
Toth O
on O
: O
TUE O
2015-10-06 O
5:11 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-11-29 O

Discharge O
Date O
: O

2014-12-05 O

Date O
of O
Birth O
: O

1967-08-29 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Penicillins B-TREATMENT
/ O
Estrogens B-TREATMENT
/ O
Ancef B-TREATMENT
/ O
Tegretol B-TREATMENT
/ O
Keflex B-TREATMENT

Attending O
: O

Mary O
S. O
Corral O
, O
M.D. O

Chief O
Complaint O
: O

hypotension B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure: O

Nephrostomy B-TREATMENT
tube I-TREATMENT
placement I-TREATMENT

History O
of O
Present O
Illness O
: O

47 O
yo O
F O
w/ O
h/o O
steroid-induced B-SYMPTOM
hyperglycemia I-SYMPTOM
, O
SLE B-SYMPTOM
w/ O
h/o O
pericarditis B-SYMPTOM
, O
transverse B-SYMPTOM
myelitis I-SYMPTOM
w/ O
paraplegia B-SYMPTOM
and O
neurogenic B-SYMPTOM
bladder I-SYMPTOM
s/p B-TREATMENT
urostomy I-TREATMENT
w/ O
ileal B-TREATMENT
conduit I-TREATMENT
, O
h/o O
ureteropelvic B-SYMPTOM
stone I-SYMPTOM
and O
urosepsis B-SYMPTOM
, O
and O
h/o O
RLE B-SYMPTOM
DVT I-SYMPTOM
a/w O
F O
2014-11-29 O
transferred O
to O
CMED O
2014-11-30 O
for O
hypotn B-SYMPTOM
resistant O
to O
IVFs B-TREATMENT
and O
stress B-TREATMENT
steroids I-TREATMENT
. O

Patient O
initially O
p/w O
c/o O
sudden B-SYMPTOM
onset I-SYMPTOM
N/abd I-SYMPTOM
pain/chills I-SYMPTOM
w/ O
T O
103 O
at O
NH O
. O

Rigors B-SYMPTOM
progressed O
so O
she O
was O
brought O
to O
Robert O
. O

She O
reported O
h/o O
fatigue B-SYMPTOM
and O
anorexia B-SYMPTOM
for O
the O
past O
few O
days O
and O
had O
noticed O
foul B-SYMPTOM
smelling I-SYMPTOM
urine I-SYMPTOM
and O
some O
abdominal B-SYMPTOM
distension I-SYMPTOM
, O
similar O
to O
prior O
episodes O
of O
pyelo B-SYMPTOM
. O

She O
also O
c/o O
LLQ B-SYMPTOM
and I-SYMPTOM
groin I-SYMPTOM
pain I-SYMPTOM
which O
responded O
to O
tylenol B-TREATMENT
. O

She O
denies O
V B-SYMPTOM
or O
D B-SYMPTOM
. O

No O
AMS B-SYMPTOM
. O

No O
c/o O
CP B-SYMPTOM
. O

On O
arrival O
to O
Shirley O
, O
temperature O
was O
101.2 O
. O

CT O
abd O
showed O
an B-SYMPTOM
8 I-SYMPTOM
mm I-SYMPTOM
right I-SYMPTOM
proximal I-SYMPTOM
ureteral I-SYMPTOM
stone I-SYMPTOM
with O
right-sided B-SYMPTOM
hydronephrosis I-SYMPTOM
and O
inflammatory B-SYMPTOM
stranding I-SYMPTOM
, O
in O
addition O
to O
pyelonephritis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
kidney I-SYMPTOM
without O
left B-SYMPTOM
sided I-SYMPTOM
hydronephrosis I-SYMPTOM
. O

Labs O
were O
remarkable O
for O
wbc O
23.5 O
w/ O
1% O
bands O
which O
decreased O
to O
14 O
today O
but O
now O
w/ O
15% O
bands O
on O
vanc B-TREATMENT
( O
h/o O
MRSA B-SYMPTOM
urosepsis I-SYMPTOM
) O
and O
gent B-TREATMENT
( O
mult B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
) O
. O

AG O
on O
admission O
18 O
( O
bicarb O
17 O
, O
down O
from O
23 O
on O
a O
previous O
admission O
) O
, O
down O
to O
AG O
15 O
this O
AM O
. O

ABG O
prior O
to O
transfer O
( O
on O
room O
air O
) O
: O

7.43/24/69 O
w/ O
lactate O
1.3 O
( O
down O
from O
1.4 O
on O
the O
prior O
day O
) O
. O

Currently O
, O
03-14 O
blood O
cx O
are O
growing O
GNR B-SYMPTOM
in O
both O
anaerobic O
bottles O
. O

Urine O
cx O
is O
pending O
. O

Prior O
to O
transfer O
, O
patient O
dropped O
bp O
to O
68/40s O
. O

BP O
did O
not O
improve O
despite O
2 O
L O
NS B-TREATMENT
and O
100 O
mg O
IV B-TREATMENT
hydrocortisone I-TREATMENT
. O

A B-TREATMENT
central I-TREATMENT
line I-TREATMENT
was O
placed O
and O
she O
was O
sent O
to O
IR O
for O
a B-TREATMENT
right I-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
. O

Past O
Medical O
History O
: O

## O
h/o O
nephrolithiasis B-SYMPTOM
s/p O
lithotripsy B-TREATMENT
and O
h/o O
left B-SYMPTOM
ureteropelvic I-SYMPTOM
junction I-SYMPTOM
stone I-SYMPTOM
'03 O
spontaneously O
passing O
by O
U/S O
, O
no O
evidence O
of O
right B-SYMPTOM
stone I-SYMPTOM
on O
most O
recent O
u/s O
5 O
months O
ago O

## O
h/o O
pyelo B-SYMPTOM
, O
last O
episode O
in O
'03 O
( O
MRSA B-SYMPTOM
in I-SYMPTOM
blood I-SYMPTOM
and I-SYMPTOM
urine I-SYMPTOM
) O

## O
SLE B-SYMPTOM
w/ O
h/o O
pericarditis B-SYMPTOM
, O
last O
flare O
couple O
years O
ago O
, O
didn O
't O
flare O
w/ O
urosepsis B-SYMPTOM

## O
Devic B-SYMPTOM
's I-SYMPTOM
disease I-SYMPTOM
: O

Recurrent B-SYMPTOM
transverse I-SYMPTOM
myelitis I-SYMPTOM
with O
sequelae O
of O
paraplegia-exacerbation B-SYMPTOM
in O
93 O
Recurrent B-SYMPTOM
bilateral I-SYMPTOM
optic I-SYMPTOM
neuritis I-SYMPTOM
with O
legal O

( O
neurologist O
: O
Dr. O
Heaton O
, O
UMass O
Memorial O
Medical O
Center O
) O
- O
( O
steroids B-TREATMENT
increased O
to O
40 O
qd O
in O
Renee O
for O
concern O
for O
recurrent B-SYMPTOM
optic I-SYMPTOM
neuritis I-SYMPTOM
which O
turned O
out O
to O
be O
capsular B-SYMPTOM
ossification I-SYMPTOM
) O

## O
blindness B-SYMPTOM
in I-SYMPTOM
right I-SYMPTOM
CMED O
CSRU O
. O

## O
Bilateral B-SYMPTOM
knee I-SYMPTOM
arthritis I-SYMPTOM

## O
Suspected O
glaucoma B-SYMPTOM
in I-SYMPTOM
left I-SYMPTOM
CMED O
CSRU O
, O
turned O
out O
to O
be O
capsular B-SYMPTOM
ossification I-SYMPTOM
or O
a B-SYMPTOM
secondary I-SYMPTOM
cataract I-SYMPTOM
, O
corrected O
w/ O
laser B-TREATMENT
surgery I-TREATMENT

2014-11-03 O

## O
Urostomy B-TREATMENT
s/p O
ileal B-TREATMENT
loop I-TREATMENT
conduit I-TREATMENT
in O
2007 O
for O
neurogenic B-SYMPTOM
bladder I-SYMPTOM
w/ O
persistent B-SYMPTOM
leak I-SYMPTOM

## O
Steroid-induced B-SYMPTOM
hyperglycemia I-SYMPTOM

## O
Hypothyroid B-SYMPTOM

## O
Osteoporosis B-SYMPTOM

## O
Hx O
of O
DVT B-SYMPTOM
in I-SYMPTOM
RLE I-SYMPTOM
'93 O
- O
on O
coumadin B-TREATMENT
for O
a O
couple O
years O
and O
then O
ASA B-TREATMENT
until O
a O
couple O
months O
ago O

Social O
History O
: O

Retired O
ICU O
nurse O
. O

Thomas O
Haas O
x O
15 O
yrs O
but O
maintains O
her O
certification O
. O

Lives O
at O
Lowell O
Home O
NH O
x O
11 O
yrs O
due O
to O
chronic B-SYMPTOM
CMED I-SYMPTOM
issues I-SYMPTOM
. O

Her O
doctor O
there O
is O
Dr. O
Gerald O
Jones O
. O

No O
h/o O
tobacco O
, O
alcohol O
, O
or O
IVDA O
. O

Wheelchair B-SYMPTOM
dependent I-SYMPTOM
+ O
requires O
Hoyer B-TREATMENT
lift I-TREATMENT
. O

UE O
strength O
intact O
but O
poor B-SYMPTOM
motor I-SYMPTOM
movements I-SYMPTOM
due O
to O
loss B-SYMPTOM
of I-SYMPTOM
sensation I-SYMPTOM
. O

Family O
History O
: O

Mother O
died O
at O
51 O
metastatic B-SYMPTOM
BCA I-SYMPTOM

Father O
died O
at O
36 O
aplastic B-SYMPTOM
anemia I-SYMPTOM
only O
child O

Physical O
Exam O
: O

T O
100.0 O
bp O
109/56 O

CVP O
11 O
hr O
113 O
rr O
16 O

O2 O
95% O
on O
3L B-TREATMENT
NC I-TREATMENT
mixed O
Quinn O
82% O
genrl O
: O
in O
nad B-SYMPTOM
, O
resting O
comfortably O
heent O
: O
perrla O
( O
4->3 O
mm O
) O
bilaterally O
, O
blind B-SYMPTOM
in I-SYMPTOM
right I-SYMPTOM
visual I-SYMPTOM
field I-SYMPTOM
, O
eomi O
, O
dry B-SYMPTOM
mm I-SYMPTOM
, O
? O
thrush B-SYMPTOM
neck O
: O
no O
bruits B-SYMPTOM
cv O
: O
rrr O
, O
no O
m/r/g B-SYMPTOM
, O
faint B-SYMPTOM
s1/s2 I-SYMPTOM
pulm O
: O
cta O
bilaterally O
abd O
: O
midline B-SYMPTOM
scar I-SYMPTOM
( O
from O
urostomy B-TREATMENT
) O
, O
nabs O
, O
soft O
, O
appears O
distended B-SYMPTOM
but O
patient O
denies O
, O
ostomy B-TREATMENT
RLQ O
c/d/i O
, O
NT B-SYMPTOM
to O
palpation O
back O
: O
right B-TREATMENT
flank I-TREATMENT
urostomy I-TREATMENT
tube I-TREATMENT
, O
c/d/i O
, O
nt B-SYMPTOM
to O
palpation O
extr O
: O
no O
Gardner O
neuro O
: O
a O
, O
ox3 O
, O
wiggles O
toes O
bilaterally O
, O
unable B-SYMPTOM
to I-SYMPTOM
lift I-SYMPTOM
LE I-SYMPTOM
, O
06-12 O
grip O
bilaterally O
w/ O
UE O
, O
decrease B-SYMPTOM
sensation I-SYMPTOM
to O
soft O
touch O
in O
left O

UE O
and O
LE O

Pertinent O
Results O
: O

2014-11-29 O
05:11PM O

WBC O
- O
23.5*# O
RBC O
- O
3.81* O
HGB O
- O
9.4* O
HCT O
- O
29.2* O

MCV O
- O
77*# O
MCH O
- O
24.6*# O
MCHC O
- O
32.1 O
RDW O
- O
18.1* O

2014-11-29 O
05:11PM O

NEUTS O
- O
93* O
BANDS O
- O
1 O
LYMPHS O
- O
0 O
MONOS O
- O
6 O
EOS O
- O
0 O

BASOS O
- O
0 O
ATYPS O
- O
0 O
METAS O
- O
0 O
MYELOS O
- O
0 O

2014-11-29 O
05:11PM O

GLUCOSE O
- O
229* O
UREA O
N O
- O
25* O
CREAT O
- O
0.8 O
SODIUM O
- O
136 O

POTASSIUM O
- O
5.3* O
CHLORIDE O
- O
101 O
TOTAL O
CO2 O
- O
17* O
ANION O
GAP O
- O
23* O

2014-11-29 O
05:11PM O

LD O
( O
LDH O
) O
- O
214 O

2014-11-29 O
06:41PM O

LACTATE O
- O
1.4 O

2014-11-29 O
05:11PM O
URINE O

COLOR O
- O
Straw O
APPEAR O
- O
Hazy O
SP O
Thibodeaux O
- O
1.008 O

2014-11-29 O
05:11PM O
URINE O

BLOOD O
- O
LG O
NITRITE O
- O
NEG O
PROTEIN O
- O
TR O

GLUCOSE O
- O
NEG O
KETONE O
- O
NEG O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
NEG O
PH O
- O
9.0* O

LEUK O
- O
SM O

2014-11-29 O
05:11PM O
URINE O

RBC O
- O
21-50* O
WBC O
- O
04-12 O
BACTERIA O
- O
MANY O

YEAST O
- O
NONE O
EPI O
- O
0-2 O

2014-11-29 O
05:11PM O
URINE O

3PHOSPHAT O
- O
OCC O

2014-11-29 O
CT O
CAP O
: O

1. O
An B-SYMPTOM
8 I-SYMPTOM
x I-SYMPTOM
7 I-SYMPTOM
x I-SYMPTOM
7 I-SYMPTOM
mm I-SYMPTOM
stone I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
right I-SYMPTOM
ureter I-SYMPTOM
with O
associated O
right B-SYMPTOM
hydronephrosis I-SYMPTOM
and O
inflammatory B-SYMPTOM
perinephric I-SYMPTOM
stranding I-SYMPTOM
. O

Additional B-SYMPTOM
smaller I-SYMPTOM
non-obstructing I-SYMPTOM
right I-SYMPTOM
renal I-SYMPTOM
stones I-SYMPTOM
. O

2. O
Left B-SYMPTOM
renal I-SYMPTOM
stones I-SYMPTOM
without O
evidence O
of O
hydronephrosis B-SYMPTOM
. O

Ileal B-TREATMENT
conduit I-TREATMENT
is O
not O
well O
evaluated O
. O

3. O
Right B-SYMPTOM
breast I-SYMPTOM
calcification I-SYMPTOM
. O

Correlation O
with O
mammography O
is O
suggested O
. O

. O

2014-11-29 O
CXR O
: O

No O
evidence O
of O
pneumonia B-SYMPTOM
. O

. O

2014-11-29 O
CT O
AP O
#2 O
( O
with O
contrast O
) O
: O

1. O
Eight B-SYMPTOM
mm I-SYMPTOM
right I-SYMPTOM
proximal I-SYMPTOM
ureteral I-SYMPTOM
stone I-SYMPTOM
with O
right-sided B-SYMPTOM
hydronephrosis I-SYMPTOM
and O
inflammatory B-SYMPTOM
stranding I-SYMPTOM
. O

Pyelonephritis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
kidney I-SYMPTOM
without O
left B-SYMPTOM
sided I-SYMPTOM
hydronephrosis I-SYMPTOM
. O

2. O
No O
evidence O
of O
intraabdominal B-SYMPTOM
abscess I-SYMPTOM
or O
of O
diverticulitis B-SYMPTOM
. O

3. O
Bilateral B-SYMPTOM
round I-SYMPTOM
, I-SYMPTOM
hypodense I-SYMPTOM
renal I-SYMPTOM
lesions I-SYMPTOM
, O
too O
small O
to O
accurately O
characterize O
but O
likely O
representing O
cysts B-SYMPTOM
. O

4. O
1.4 B-SYMPTOM
cm I-SYMPTOM
hypodense I-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
right I-SYMPTOM
lobe I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
liver I-SYMPTOM
is O
incompletely O
characterized O
. O

. O

2014-11-30 O
CT O
CAP O
: O

1. O
Nephrostomy B-TREATMENT
tube I-TREATMENT
in I-TREATMENT
the I-TREATMENT
right I-TREATMENT
kidney I-TREATMENT
with O
an B-SYMPTOM
8 I-SYMPTOM
mm I-SYMPTOM
right I-SYMPTOM
ureteric I-SYMPTOM
stone I-SYMPTOM
. O

2. O
6 B-SYMPTOM
mm I-SYMPTOM
nonobstructing I-SYMPTOM
calculus I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
kidney I-SYMPTOM
. O

3. O
Calcified B-SYMPTOM
focus I-SYMPTOM
and O
a B-SYMPTOM
small I-SYMPTOM
hypodense I-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lobe I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
liver I-SYMPTOM
, O
incompletely O
characterized O
. O

4. O
Bibasilar B-SYMPTOM
and I-SYMPTOM
dependent I-SYMPTOM
atelectasis I-SYMPTOM
. O

. O

2014-11-29 O
5:10 O
pm O
BLOOD O
CULTURE O

2. O

**FINAL O
REPORT O
2014-12-04** O

AEROBIC O
BOTTLE O
( O
Final O
2014-12-04 O
) O
: O

KLEBSIELLA B-SYMPTOM
PNEUMONIAE I-SYMPTOM
. O

IDENTIFICATION O
AND O
SENSITIVITIES O
PERFORMED O
FROM O

ANAEROBIC O
BOTTLE O
. O

OF O
TWO B-SYMPTOM
COLONIAL I-SYMPTOM
MORPHOLOGIES I-SYMPTOM
. O

ANAEROBIC O
BOTTLE O
( O
Final O
2014-12-04 O
) O
: O

REPORTED O
BY O
PHONE O
TO O
Robert O
BURGER O
2014-11-30 O
10:35A O
. O

KLEBSIELLA B-SYMPTOM
PNEUMONIAE I-SYMPTOM
. O

FINAL O
SENSITIVITIES O
. O

Trimethoprim/Sulfa O
sensitivity O
testing O
available O
on O
request O
. O

KLEBSIELLA B-SYMPTOM
PNEUMONIAE I-SYMPTOM
. O

FINAL O
SENSITIVITIES O
. O

Trimethoprim/Sulfa O
sensitivity O
testing O
available O
on O
request O
. O

2ND O
STRAIN O
. O

SENSITIVITIES O
: O

MIC O
expressed O
in O
MCG/ML O

_________________________________________________________ O

KLEBSIELLA B-SYMPTOM
PNEUMONIAE I-SYMPTOM

| O

KLEBSIELLA B-SYMPTOM
PNEUMONIAE I-SYMPTOM

| O

| O

AMPICILLIN/SULBACTAM-- B-TREATMENT

=>32 O
R O

=>32 O
R O

CEFAZOLIN------------- B-TREATMENT

<=4 O
S O

<=4 O
S O

CEFEPIME-------------- B-TREATMENT

<=1 O
S O

<=1 O
S O

CEFTAZIDIME----------- B-TREATMENT

<=1 O
S O

<=1 O
S O

CEFTRIAXONE----------- B-TREATMENT

<=1 O
S O

<=1 O
S O

CEFUROXIME------------ B-TREATMENT

4 O
S O

4 O
S O

CIPROFLOXACIN--------- B-TREATMENT

=>4 O
R O

=>4 O
R O

GENTAMICIN------------ B-TREATMENT

8 O
I O

8 O
I O

IMIPENEM-------------- B-TREATMENT

<=1 O
S O

<=1 O
S O

LEVOFLOXACIN---------- B-TREATMENT

=>8 O
R O

=>8 O
R O

MEROPENEM------------- B-TREATMENT

<=0.25 O
S O

<=0.25 O
S O

PIPERACILLIN/TAZO----- B-TREATMENT

<=4 O
S O

<=4 O
S O

TOBRAMYCIN------------ B-TREATMENT

4 O
S O

8 O
I O

. O

2014-11-30 O
1:50 O
pm O
URINE,KIDNEY O

PERC. O
NEPH. O
. O

**FINAL O
REPORT O
2014-12-03** O

FLUID O
CULTURE O
( O
Final O
2014-12-03 O
) O
: O

Due O
to O
mixed B-SYMPTOM
bacterial I-SYMPTOM
types I-SYMPTOM
( O
>= O
3 B-SYMPTOM
colony I-SYMPTOM
types I-SYMPTOM
) O
an O
abbreviated O
workup O
is O
performed O
appropriate O
to O
the O
isolates O
recovered O
from O
the O
site O
( O
including O
a O
screen O
for O
Pseudomonas B-SYMPTOM
aeruginosa I-SYMPTOM
, O
Staphylococcus B-SYMPTOM
aureus I-SYMPTOM
and O
beta B-SYMPTOM
streptococcus I-SYMPTOM
) O
. O

STAPH B-SYMPTOM
AUREUS I-SYMPTOM
COAG I-SYMPTOM
+ I-SYMPTOM
. O

>100,000 O
ORGANISMS/ML. O
. O

OF O
TWO B-SYMPTOM
COLONIAL I-SYMPTOM
MORPHOLOGIES I-SYMPTOM
. O

Oxacillin B-SYMPTOM
RESISTANT I-SYMPTOM
Staphylococci I-SYMPTOM
MUST O
be O
reported O
as O
also O
RESISTANT O
to O
other O
penicillins B-TREATMENT
, O
cephalosporins B-TREATMENT
, O
carbacephems B-TREATMENT
, O
carbapenems B-TREATMENT
, O
and O
beta-lactamase B-TREATMENT
inhibitor I-TREATMENT
combinations I-TREATMENT
. O

Rifampin B-TREATMENT
should O
not O
be O
used O
alone O
for O
therapy B-TREATMENT
. O

GRAM O
NEGATIVE O
ROD( O
S O
) O
. O

>100,000 O
ORGANISMS/ML. O
. O

OF O
TWO B-SYMPTOM
COLONIAL I-SYMPTOM
MORPHOLOGIES I-SYMPTOM
. O

SENSITIVITIES O
: O

MIC O
expressed O
in O

MCG/ML O

_________________________________________________________ O

STAPH B-SYMPTOM
AUREUS I-SYMPTOM
COAG I-SYMPTOM
+ O

| O

GENTAMICIN------------ B-TREATMENT

=>16 O
R O

LEVOFLOXACIN---------- B-TREATMENT

=>8 O
R O

NITROFURANTOIN-------- B-TREATMENT

<=16 O
S O

OXACILLIN------------- B-TREATMENT

=>4 O
R O

PENICILLIN------------ B-TREATMENT

=>0.5 O
R O

TETRACYCLINE---------- B-TREATMENT

=>16 O
R O

VANCOMYCIN------------ B-TREATMENT

<=1 O
S O

. O

2014-12-03 O
BLOOD O
CULTURE O

AEROBIC O
BOTTLE O
- O
PENDING O
; O
ANAEROBIC O
BOTTLE O
- O
PENDING O

2014-12-03 O
BLOOD O
CULTURE O

AEROBIC O
BOTTLE O
- O
PENDING O
; O
ANAEROBIC O
BOTTLE O
- O
PENDING O

2014-12-02 O
URINE O

URINE O
CULTURE O
- O
FINAL O
No O
Growth O

2014-12-02 O
CATHETER B-TREATMENT
TIP I-TREATMENT
- I-TREATMENT
IV I-TREATMENT

WOUND O
CULTURE O
- O
FINAL O
No O
Growth O

2014-12-02 O
BLOOD O
CULTURE O

AEROBIC O
BOTTLE O
- O
PENDING O
; O
ANAEROBIC O
BOTTLE O
- O
PENDING O

Brief O
Hospital O
Course O
: O

47 O
yo O
F O
w/ O
h/o O
steroid-induced B-SYMPTOM
hyperglycemia I-SYMPTOM
, O
SLE B-SYMPTOM
w/ O
h/o O
pericarditis B-SYMPTOM
, O
transverse B-SYMPTOM
myelitis I-SYMPTOM
w/ O
paraplegia B-SYMPTOM
and O
neurogenic B-SYMPTOM
bladder I-SYMPTOM
s/p O
urostomy B-TREATMENT
w/ O
ileal B-TREATMENT
conduit I-TREATMENT
, O
h/o O
ureteropelvic B-SYMPTOM
stone I-SYMPTOM
and O
urosepsis B-SYMPTOM
, O
and O
h/o O
RLE B-SYMPTOM
DVT I-SYMPTOM
admitted O
11-29 O
w/ O
left B-SYMPTOM
pyelo I-SYMPTOM
and O
right B-SYMPTOM
8 I-SYMPTOM
mm I-SYMPTOM
proximal I-SYMPTOM
ureteral I-SYMPTOM
stone I-SYMPTOM
w/ O
right B-SYMPTOM
hydro I-SYMPTOM
s/p O
perc B-TREATMENT
urostomy I-TREATMENT
tube I-TREATMENT
to O
relieve O
right B-SYMPTOM
hydro I-SYMPTOM
. O

. O

## O
GNR B-SYMPTOM
sepsis: I-SYMPTOM

Upon O
admission O
, O
pt O
was O
febrile B-SYMPTOM
to O
101.2 O
with O
U/A O
consistent O
with O
UTI B-SYMPTOM
. O

A O
CT O
abd O
showed O
8mm B-SYMPTOM
obstructing I-SYMPTOM
stone I-SYMPTOM
, O
hydro B-SYMPTOM
with O
stranding B-SYMPTOM
consistent O
with O
pylonephritis B-SYMPTOM
. O

Her O
presentation O
was O
thought O
likely O
due O
to O
urosepsis B-SYMPTOM
given O
h/o O
foul B-SYMPTOM
smelling I-SYMPTOM
urine I-SYMPTOM
and O
in O
setting O
of O
stone B-SYMPTOM
w/ O
hydro B-SYMPTOM
+ O
pyelo B-SYMPTOM
by O
CT. O
The O
patient O
went O
to O
IR O
on O
2014-11-30 O
given O
evidence O
of O
right B-SYMPTOM
hydronephrosis I-SYMPTOM
on O
imaging O
for O
decompression B-TREATMENT
and O
drainage. B-TREATMENT
Upon O
admission O
, O
she O
was O
treated O
with O
Vancomycin B-TREATMENT
and O
Gentamycin B-TREATMENT
and O
Flagyl B-TREATMENT
. O

She O
was O
started O
on O
the B-TREATMENT
MUST I-TREATMENT
protocol I-TREATMENT
with O
high B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
as O
well O
and O
a O
goal O
SVO2 O
>70% O
. O

She O
was O
hypoxic B-SYMPTOM
requiring O
3L B-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
O2 I-TREATMENT
. O

She O
subsequently O
developed O
hypotension B-SYMPTOM
with O
SBP O
in O
the O
70s O
. O

She O
was O
transferred O
to O
the O
CMED O
where O
the O
patient O
was O
continued O
on O
the B-TREATMENT
MUST I-TREATMENT
protocol I-TREATMENT
with O
goais O
of O
CVP O
10-12 O
, O
SVO2 O
greater O
than O
70% O
. O

The O
patient O
was O
bolused O
with O
NS B-TREATMENT
and O
did O
not O
required O
pressors B-TREATMENT
. O

On O
the O
day O
after O
admission O
to O
the O
CMED O
, O
the O
patient O
was O
noted O
to O
have O
small B-SYMPTOM
oxygen I-SYMPTOM
requirement I-SYMPTOM
with O
2L B-TREATMENT
NC I-TREATMENT
. O

Repeat O
imaging O
revealed O
evidence O
of O
mild B-SYMPTOM
pulmonary I-SYMPTOM
congestion I-SYMPTOM
which O
was O
thought O
to O
account O
for O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
mild I-SYMPTOM
hypoxia I-SYMPTOM
. O

Given O
that O
the O
patient O
had O
been O
maintaining O
a O
MAP O
of O
60 O
without O
fluids B-TREATMENT
or O
pressors B-TREATMENT
, O
her O
goal O
CVP O
was O
decreased O
to O
>8 O
to O
avoid O
fluid B-SYMPTOM
overload I-SYMPTOM
. O

The O
patient O
was O
continued O
on O
Vancomycin B-TREATMENT
and O
Gentamycin B-TREATMENT
while O
speciation O
and O
sensitivities O
were O
pending O
. O

Ciprofloxacin B-TREATMENT
was O
added O
on O
2014-12-01 O
for O
synergy O
when O
surveillance O
cultures O
were O
found O
to O
be O
growing O
again O
GNR B-SYMPTOM
. O

Gent B-TREATMENT
and O
Cipro B-TREATMENT
were O
then O
discontinued O
and O
changed O
to O
meropenem B-TREATMENT
when O
blood O
culture O
sensitivities O
became O
available O
revealing O
GNR B-SYMPTOM
sensitive O
to O
Jacoby B-TREATMENT
but O
resistant O
to O
both O
Gent B-TREATMENT
and O
Cipro B-TREATMENT
. O

Additionaly O
surveillance O
cultures O
were O
drawn O
daily O
and O
the O
patient O
was O
transferred O
back O
to O
the O
floor O
with O
no O
subsequent B-SYMPTOM
pressor I-SYMPTOM
requirement I-SYMPTOM
. O

Blood O
cltures O
from O
11-30 O
grew O
KLEBSIELLA B-SYMPTOM
PNEUMONIAE I-SYMPTOM
and O
12-01 O
grew O
KLEBSIELLA B-SYMPTOM
PNEUMONIAE I-SYMPTOM
and O
PROTEUS B-SYMPTOM
MIRABILIS I-SYMPTOM
both O
sensitive O
to O
the B-TREATMENT
Meropenam I-TREATMENT
which O
she O
had O
already O
been O
receiving O
. O

Urine O
cultures O
from O
11-30 O
grew O
STAPH B-SYMPTOM
AUREUS I-SYMPTOM
COAG I-SYMPTOM
+ O
, O
and O
GRAM B-SYMPTOM
NEGATIVE I-SYMPTOM
RODS I-SYMPTOM
of O
two O
morphologies O
( O
not O
further O
speciated O
) O
. O

She O
defervesed O
by O
12-02 O
and O
remained O
clinically O
stable O
with O
normal O
blood O
pressures O
until O
the O
day O
of O
discharge O
. O

At O
the O
time O
of O
discharge O
, O
blood O
cultures O
from O
12-02 O
and O
12-03 O
have O
no O
growth B-SYMPTOM
to O
date O
. O

She O
received O
a B-TREATMENT
midline I-TREATMENT
on O
12-04 O
with O
a O
goal O
of O
16 O
days O
of O
further B-TREATMENT
antibiotic I-TREATMENT
treatment I-TREATMENT
with O
Meropenam B-TREATMENT
( O
for O
a O
total O
of O
3 O
weeks O
) O
upon O
discharge O
back O
to O
the O
nursing O
home O
where O
she O
lives O
. O

. O

## O
Right B-SYMPTOM
hydronephrosis I-SYMPTOM
: O

Given O
right B-SYMPTOM
sided I-SYMPTOM
hydronephrosis I-SYMPTOM
and O
GNR B-SYMPTOM
bactermeia I-SYMPTOM
, O
a B-TREATMENT
percutaneous I-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
was O
placed O
by O
IR O
2014-11-30 O
. O

The O
patient O
put O
out O
1385 O
cc O
urine O
the O
day O
after O
placement O
, O
950 O
cc O
of O
which O
came O
from O
nephrostomy B-TREATMENT
tube I-TREATMENT
. O

The B-TREATMENT
tube I-TREATMENT
appeared O
to O
be O
functioning O
well O
, O
draining O
urine O
with O
occasional B-SYMPTOM
clot I-SYMPTOM
passage I-SYMPTOM
. O

Urology O
was O
notified O
about O
the B-SYMPTOM
clots I-SYMPTOM
and O
occasional B-SYMPTOM
blood I-SYMPTOM
tinged I-SYMPTOM
urine I-SYMPTOM
but O
they O
did O
not O
make O
any O
further O
recommendations O
. O

Cultures O
from O
urine O
drawn O
from O
the B-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
are O
currently O
growing O
> O
100K O
GNR B-SYMPTOM
, O
possibly O
of O
two B-SYMPTOM
colony I-SYMPTOM
morphologies I-SYMPTOM
, O
speciation O
and O
sensitivity O
pending O
. O

. O

## O
Hct B-SYMPTOM
drop I-SYMPTOM
: O

On O
admission O
to O
hospital O
patient O
had O
Hct O
of O
29.2 O
. O

In O
the O
setting O
of O
Right B-TREATMENT
sublavian I-TREATMENT
line I-TREATMENT
placement I-TREATMENT
as O
well O
as O
nephrostomy B-TREATMENT
tube I-TREATMENT
placement I-TREATMENT
the O
patient O
was O
noted O
to O
have O
a B-SYMPTOM
drifting I-SYMPTOM
Hct I-SYMPTOM
, O
concerning O
for O
bleed B-SYMPTOM
, O
with O
nadir O
of O
22.8 O
on O
2014-12-01 O
. O

A O
CT O
abdomen O
was O
performed O
which O
did O
not O
demonstrate O
any B-SYMPTOM
retroperitoneal I-SYMPTOM
bleed I-SYMPTOM
. O

Hct O
stabilized O
to O
24 O
for O
three O
days O
prior O
to O
discharge O
. O

This O
can O
be O
followed O
as O
an O
outpatient O
. O

Anemia O
workup O
revealed O
a O
picture O
of O
anemia B-SYMPTOM
of I-SYMPTOM
chronic I-SYMPTOM
disease I-SYMPTOM
( O
TIBC O
225 O
, O
B12 O
and O
Folate O
normal O
, O
Hapto O
397 O
, O
Ferritin O
51 O
, O
TRF O
173 O
, O
Iron O
35 O
) O
. O

. O

## O
Hypoxia: B-SYMPTOM

The O
patient O
on O
admission O
was O
requiring O
3 B-TREATMENT
L I-TREATMENT
NC I-TREATMENT
in O
the O
setting O
of O
receiving O
2L B-TREATMENT
NS I-TREATMENT
and O
chest O
film O
which O
demonstrated O
pulmonary B-SYMPTOM
congestion I-SYMPTOM
. O

The O
patient O
was O
not O
diuresed O
but O
allowed O
to O
auto-diurese O
any O
additional O
fluids O
and O
is O
currently O
with O
O2 O
sats O
97-98% O
on O
room O
air O
. O

As O
her O
BP O
remained O
stable O
she O
did O
not O
receiving O
any B-TREATMENT
standing I-TREATMENT
fluids I-TREATMENT
but O
was O
be O
bolused B-TREATMENT
as O
appropriate O
for O
a O
MAP O
< O
60 O
or O
CVP O
< O
8 O
with O
careful O
monitoring O
of O
pulmonary O
status O
. O

Patient O
had O
an O
echocardiogram O
in O
2012 O
which O
demonstrated O
an O
EF O
of O
60-65% O
. O

her B-SYMPTOM
O2 I-SYMPTOM
requirement I-SYMPTOM
by O
discharge O
was O
96% O
on O
room O
air O
with O
no O
SOB B-SYMPTOM
. O

. O

## O
Steroid-induced B-SYMPTOM
hyperglycemia I-SYMPTOM
: O

At O
home O
, O
the O
patient O
received O
metformin B-TREATMENT
and O
SSI B-TREATMENT
. O

The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
metformin I-TREATMENT
was O
held O
and O
she O
has O
been O
maintained O
on O
SSI B-TREATMENT
qid O
while O
in O
the O
CMED O
. O

As O
the O
patient O
appeared O
to O
be O
clinically O
stable O
, O
her B-TREATMENT
stress I-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
were O
discontinued O
and O
the O
patient O
was O
changed O
back O
to O
her O
home O
dose O
of O
Prednisone B-TREATMENT
40mg O
PO O
qd O
for O
maintenance O
with O
anticipated O
decrease O
in O
her O
blood O
sugars O
. O

Her B-TREATMENT
Metformin I-TREATMENT
was O
re-added O
2 O
days O
prior O
to O
discharge O
as O
well O
and O
fingerstick O
glucoses O
on O
the O
day O
of O
discharge O
were O
93 O
and O
156 O
, O
respectively O
. O

. O

## O
Hypothyroidism B-SYMPTOM
: O

Repeat O
TSH O
and O
Free O
T4 O
were O
appropriate O
on O
current B-TREATMENT
outpatient I-TREATMENT
regimen. I-TREATMENT
Patient O
was O
continued O
on O
Levothyroxine B-TREATMENT
75mcg O
po O
qd O
. O

. O

## O
H/o O
transverse B-SYMPTOM
myelitis/optic I-SYMPTOM
neuritis I-SYMPTOM
: O

On O
stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
originally O
given O
MUST B-TREATMENT
protocol I-TREATMENT
and O
sepsis B-SYMPTOM
, O
as O
patient O
clinically O
stabilized O
, O
she O
was O
changed O
back O
to O
home O
dose O
of O
Prednisone B-TREATMENT
40mg O
pO O
qd O
. O

. O

## O
SLE B-SYMPTOM
: O

Currently O
no O
sx B-SYMPTOM
of I-SYMPTOM
active I-SYMPTOM
disease I-SYMPTOM
. O

No O
manifestations O
of O
SLE B-SYMPTOM
during O
this O
admission O
. O

. O

# O
Osteoporosis B-SYMPTOM
- O
We O
continued O
actonel/vit B-TREATMENT
D I-TREATMENT
, O
Tums B-TREATMENT

. O

## O
Capsular B-SYMPTOM
ossification I-SYMPTOM
: O

We O
continued O
CMED B-TREATMENT
CSRU I-TREATMENT
gtt I-TREATMENT
. O

. O

## O
FEN: O

She O
had O
a B-SYMPTOM
low I-SYMPTOM
bicarb I-SYMPTOM
likely O
due O
to O
renal B-SYMPTOM
wasting I-SYMPTOM
but O
there O
is O
an B-SYMPTOM
anion I-SYMPTOM
gap I-SYMPTOM
present O
. O

Serum O
acetone O
was O
normal O
. O

We O
followed O
lactate O
while O
she O
was O
in O
the O
CMED O
which O
was O
normal O
. O

She O
was O
NPO B-TREATMENT
periodically O
but O
maintained O
a O
normal O
diet O
prior O
to O
discharge O
. O

. O

# O
PPX O
- O
SQ B-TREATMENT
Heparin I-TREATMENT
during O
this O
admission O
, O
PPI B-TREATMENT

. O

## O
Communication O
: O
patient O

. O

## O
Dispo O
: O

To O
nursing O
home O
for O
follow O
up O
with O
Dr. O
Hipp O
( O
urology O
) O
this O
coming O
Monday O
, O
12-08 O
at O
1:30pm O
and O
with O
her O
PCP O
at O
the O
nursing O
home O

Medications O
on O
Admission O
: O

Home B-TREATMENT
Meds I-TREATMENT
: O

Ascorbic B-TREATMENT
Acid I-TREATMENT
500 O
TID O

Cranberry B-TREATMENT
Extract I-TREATMENT
425 O
BID O

Bisacodyl B-TREATMENT
10mg O

Senna B-TREATMENT

Dephenhydramine B-TREATMENT
50mg O
prn O
loperamide B-TREATMENT
prn O
famotidine B-TREATMENT
20mg O

KCL B-TREATMENT
20mg O
QD O

Metformin B-TREATMENT
1000 O
qd O
tums B-TREATMENT
1500 O
bid O

MVI B-TREATMENT

Timolol B-TREATMENT
1 O
Drop O
BID O
0.5% O
L O
CMED O
CSRU O

Synthroid B-TREATMENT
75 O
QD O

Compro B-TREATMENT
25mg O
pr O

Citrucel B-TREATMENT

Vitamin B-TREATMENT
D I-TREATMENT
50k O
Qmondays O

Oxazepam B-TREATMENT
15mg O
qhs O
tizamidine B-TREATMENT
8mg O
qhs O
actonel B-TREATMENT
35 O
qwed O

Diovan B-TREATMENT
80 O
qd O
prednisone B-TREATMENT
40 O
qd O
bactrim B-TREATMENT
ds I-TREATMENT
qmwf O
baclofen B-TREATMENT
pump I-TREATMENT
2-3yrs O

Insulin B-TREATMENT
SS I-TREATMENT

. O

Meds O
on O
transfer O
: O

Actonel B-TREATMENT
35 O
mg O
Oral O
qwednesdays O

Ascorbic B-TREATMENT
Acid I-TREATMENT
500 O
mg O
PO O
TID O

Sodium B-TREATMENT
Polystyrene I-TREATMENT
Sulfonate I-TREATMENT
15 O
gm O
PO O
ONCE O
11-29 O
@ O
2201 O

Famotidine B-TREATMENT
20 O
mg O
PO O
DAILY O

Sulfameth/Trimethoprim B-TREATMENT
DS O
1 O
TAB O
PO O
QMOWEFR O

Gentamicin B-TREATMENT
80 O
mg O
IV O
Q8H O

Timolol B-TREATMENT
Maleate I-TREATMENT
0.5% O
1 O
DROP O
OS O
BID O

Heparin B-TREATMENT
5000 O
UNIT O
SC O
TID O

Tizanidine B-TREATMENT
HCl I-TREATMENT
8 O
mg O
PO O
QHS O

Hydrocortisone B-TREATMENT
Na I-TREATMENT
Succ. I-TREATMENT
100 O
mg O
IV O
Q8H O

11-30 O
@ O
0906 O

Valsartan B-TREATMENT
80 O
mg O
PO O
DAILY O

Insulin B-TREATMENT
SC I-TREATMENT
( O
per O
Insulin O
Flowsheet O
) O

Vancomycin B-TREATMENT
HCl I-TREATMENT
1000 O
mg O
IV O
Q O
12H O

Levothyroxine B-TREATMENT
Sodium I-TREATMENT
75 O
mcg O
PO O
DAILY O

Vitamin B-TREATMENT
D I-TREATMENT
50,000 O
UNIT O
PO O
QWEDNESDAYS O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

GNR B-SYMPTOM
Sepsis I-SYMPTOM
; O
Steroid B-SYMPTOM
induced I-SYMPTOM
hyperglycemia I-SYMPTOM
; O
Hydronephrosis B-SYMPTOM
; O
SLE B-SYMPTOM

Discharge O
Condition O
: O

Stable O

Discharge O
Instructions O
: O

Pls O
take O
all B-TREATMENT
meds I-TREATMENT
as O
prescribed O
. O

Call O
your O
doctor O
immediately O
if O
any B-SYMPTOM
new I-SYMPTOM
symptoms I-SYMPTOM
develop O
including O
fevers B-SYMPTOM
, O
rash B-SYMPTOM
, O
increase B-SYMPTOM
in I-SYMPTOM
bloody I-SYMPTOM
urine I-SYMPTOM
in O
nephrostomy B-TREATMENT
or O
urostomy B-TREATMENT
bags I-TREATMENT
, O
etc O
. O

Follow O
up O
appointments O
listed O
below O
. O

Followup O
Instructions O
: O

With O
Dr. O
Vivian O
Hansen O
, O
UMass O
Memorial O
Medical O
Center O
, O
3rd O
floor O
Morris O
on O
Monday O
12-08 O
at O
@ O
1:30pm O
( O
you O
also O
have O
an O
appointment O
scheduled O
with O
Dr. O
Hipp O
for O
01-14 O
) O
. O

. O

Provider O
: O

Sheena O

Phone O
: O

361-438-6334 O

Date/Time O
: O
2015-01-07 O
8:30 O

Colleen O
Thomas O
MD O
80-548 O

Completed O
by O
: O

Edward O
James O
MD O
50-497 O
2014-12-05 O
@ O
1042 O

Signed O
electronically O
by O
: O

DR. O
Ronald O
Z. O
Thome O
on O
: O

Robert O
2015-01-15 O
5:13 O
PM O

( O
End O
of O
Report O
) O

100469881 O
EH O

00989464 O

822862 O

06/09/1998 O
12:00:00 O
AM O

OCCIPITAL B-SYMPTOM
CEREBROVASCULAR I-SYMPTOM
ACCIDENT I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

06/09/1998 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

06/12/1998 O

PRINCIPAL O
DIAGNOSES O
: O

1) O
EXTENSIVE B-SYMPTOM
POSTERIOR I-SYMPTOM
CIRCULATION I-SYMPTOM
INFARCTION I-SYMPTOM
. O

2) O
ASPIRATION B-SYMPTOM
PNEUMONIA I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
an O
82 O
year-old O
right O
handed O
gentleman O
who O
has O
a O
past O
medical O
history O
of O
hypertension B-SYMPTOM
and O
tobacco O
use O
presented O
to O
the O
emergency O
room O
with O
acute B-SYMPTOM
change I-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
. O

He O
was O
well O
until O
the O
evening O
prior O
to O
presentation O
to O
the O
emergency O
room O
when O
he O
complained O
of O
headache B-SYMPTOM
across I-SYMPTOM
the I-SYMPTOM
forehead I-SYMPTOM
. O

On O
the O
day O
of O
presentation O
, O
he O
was O
then O
found O
by O
his O
daughter O
lying O
on O
his O
bed O
groaning O
, O
being O
relatively B-SYMPTOM
unresponsive I-SYMPTOM
and O
unable O
to O
speak O
. O

The O
family O
reported O
one O
episode O
of O
vomiting B-SYMPTOM
at O
home O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
was O
afebrile B-SYMPTOM
, O
heart O
rate O
73 O
, O
blood O
pressure O
158/53 O
, O
respiratory O
rate O
16-20 O
, O
oxygen O
saturation O
97% O
on O
three B-TREATMENT
liters I-TREATMENT
. O

General O
: O

The O
patient O
was O
somnolent B-SYMPTOM
, O
breathing O
comfortably O
, O
occasionally B-SYMPTOM
coughing I-SYMPTOM
. O

Neck O
was O
supple O
with O
full O
range O
of O
motion O
. O

No O
bruits B-SYMPTOM
were O
heard O
. O

Chest O
was O
clear O
to O
auscultation O
but O
with O
poor B-SYMPTOM
air I-SYMPTOM
entry I-SYMPTOM
. O

Heart O
sounds O
were O
regular O
with O
one B-SYMPTOM
out I-SYMPTOM
of I-SYMPTOM
six I-SYMPTOM
holosystolic I-SYMPTOM
murmur I-SYMPTOM
at O
the O
left O
lower O
sternal O
border O
. O

Abdomen O
was O
soft O
, O
non-tender B-SYMPTOM
, O
bowel O
sounds O
present O
. O

Extremities O
were O
without O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

Neurological O
examination O
revealed O
a O
patient O
who O
was O
intermittently B-SYMPTOM
alert I-SYMPTOM
, O
opening O
eyes O
to O
voice O
, O
following O
simple O
commands O
, O
but O
without B-SYMPTOM
any I-SYMPTOM
speech I-SYMPTOM
. O

Pupils O
were O
4 O
mm O
reactive O
to O
2 O
mm O
bilaterally O
. O

There O
was O
no O
pupillary B-SYMPTOM
defect I-SYMPTOM
. O

Dolls O
eye O
was O
negative O
. O

There O
was O
a O
possible O
right B-SYMPTOM
gaze I-SYMPTOM
preference I-SYMPTOM
and O
the O
patient O
did O
not O
move O
his O
eyes O
. O

Corneals O
were O
present O
bilaterally O
. O

Gag O
was O
present O
weakly O
. O

Face O
was O
symmetrical O
. O

Tongue O
was O
midline O
. O

The O
patient O
was O
moving O
the O
right O
side O
spontaneously O
, O
but O
could O
not O
hold O
arm O
or O
leg O
up O
for O
any O
length O
of O
time O
. O

There O
was O
only O
minimal B-SYMPTOM
movement I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
side I-SYMPTOM
. O

On O
sensory O
testing O
, O
the O
patient O
withdrew O
all O
extremities O
to O
pain B-SYMPTOM
. O

Reflexes O
were O
2+ O
and O
symmetrical O
all O
over O
. O

The O
left O
toe O
was O
upgoing B-SYMPTOM
, O
the O
right O
toe O
was O
downgoing O
. O

LABORATORY O
: O

Laboratory O
data O
revealed O
a O
sodium O
of O
139 O
, O
potassium O
3.4 O
, O
chloride O
101 O
, O
bicarbonate O
28 O
, O
BUN O
11 O
, O
creatinine O
1.2 O
, O
glucose O
151 O
. O

AST O
was O
20 O
, O
ALT O
12 O
, O
alkaline O
phosphatase O
80 O
, O
bilirubin O
0.5. O
CK O
was O
113 O
. O

Thyroid O
function O
tests O
were O
normal O
. O

Troponin O
I O
was O
0.05 O
. O

Total O
protein O
was O
8 O
, O
albumin O
4.3 O
, O
globulin O
3.7 O
, O
calcium O
9.9 O
, O
phosphate O
2.7 O
, O
magnesium O
2.0. O
White O
blood O
cell O
count O
was O
7 O
, O
hemoglobin O
14.1 O
, O
hematocrit O
43.6 O
, O
platelet O
count O
241 O
. O

Erythrocyte O
sedimentation O
rate O
was O
41 O
. O

PT O
was O
12.3 O
, O
PTT O
27.1. O
An O
EKG O
showed O
sinus B-SYMPTOM
bradycardia I-SYMPTOM
at O
53 O
with O
a O
normal O
axis O
, O
first B-SYMPTOM
degree I-SYMPTOM
atrioventricular I-SYMPTOM
block I-SYMPTOM
, O
biphasic B-SYMPTOM
T-waves I-SYMPTOM
in O
V1 O
to O
V3 O
without O
any B-SYMPTOM
acute I-SYMPTOM
changes I-SYMPTOM
. O

A O
chest O
x-ray O
shows O
left B-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
consolidation I-SYMPTOM
. O

The O
head O
CT O
scan O
revealed O
a B-SYMPTOM
large I-SYMPTOM
right I-SYMPTOM
occipital I-SYMPTOM
infarct I-SYMPTOM
without O
midline B-SYMPTOM
shift I-SYMPTOM
, O
but O
positive B-SYMPTOM
mass I-SYMPTOM
effect I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
temporal I-SYMPTOM
horn I-SYMPTOM
, O
on O
the O
right O
ventricle O
and O
some B-SYMPTOM
effacement I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
sulci I-SYMPTOM
in O
the O
right O
parietal O
area O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
a O
telemetry O
bed O
and O
started O
on O
heparin B-TREATMENT
. O

Around O
4:00 O
AM O
the O
next O
day O
, O
an B-SYMPTOM
acute I-SYMPTOM
decompensation I-SYMPTOM
in I-SYMPTOM
respiratory I-SYMPTOM
status I-SYMPTOM
was O
noted O
. O

Lung O
examination O
at O
that O
point O
showed O
good O
air O
entry O
, O
no O
wheezing B-SYMPTOM
, O
coarse B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
throughout I-SYMPTOM
. O

Neurologically O
, O
the O
patient O
was O
not O
following O
commands O
. O

Eyes O
were O
closed O
. O

He O
was O
moving O
the O
right O
arm O
and O
leg O
spontaneously O
, O
though O
less O
than O
before O
. O

Withdrawal O
to O
pain O
was O
still O
present O
. O

Both O
plantars O
were O
upgoing B-SYMPTOM
. O

A O
blood O
gas O
at O
this O
point O
showed O
a O
pH O
of O
7.49 O
, O
pO2 O
61 O
, O
pCO2 O
of O
33 O
on O
100% B-TREATMENT
non-rebreather I-TREATMENT
mask I-TREATMENT
. O

EKG O
showed O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
. O

The O
patient O
&apos;s O
temperature O
was O
102 O
degrees O
. O

A O
repeat O
CAT O
scan O
of O
the O
head O
was O
performed O
. O

This O
showed O
continued O
evolution O
of O
the B-SYMPTOM
right I-SYMPTOM
posterior I-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
infarction I-SYMPTOM
now O
extending O
into O
the O
right O
cerebellar O
hemisphere O
. O

There O
was O
also O
a B-SYMPTOM
high I-SYMPTOM
density I-SYMPTOM
adjacent O
to O
the B-SYMPTOM
right I-SYMPTOM
cerebellar I-SYMPTOM
infarction I-SYMPTOM
suggesting O
the O
presence O
of O
hemorrhage B-SYMPTOM
. O

At O
this O
point O
, O
the O
patient O
was O
transferred O
to O
the O
intensive O
care O
unit O
. O

An O
MRI O
and O
MRA O
of O
the O
head O
was O
arranged O
to O
evaluate O
the O
extent O
of O
his B-SYMPTOM
stroke I-SYMPTOM
and O
the B-SYMPTOM
posterior I-SYMPTOM
circulation I-SYMPTOM
. O

The O
MRI O
showed O
infarct B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
cerebellar I-SYMPTOM
hemispheres I-SYMPTOM
bilaterally I-SYMPTOM
, O
the O
right O
occipital O
lobe O
, O
the O
right O
thalamus O
and O
bilateral O
pons O
. O

The O
MRA O
of O
the O
intracranial O
circulation O
demonstrated O
gross B-SYMPTOM
patency I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
internal I-SYMPTOM
carotid I-SYMPTOM
arteries I-SYMPTOM
bilaterally I-SYMPTOM
and I-SYMPTOM
the I-SYMPTOM
basilar I-SYMPTOM
arteries I-SYMPTOM
. O

The O
left O
vertebral O
artery O
was O
not O
visualized O
. O

There O
was O
a O
dominant O
right O
vertebral O
artery O
. O

There O
was O
mildly B-SYMPTOM
reduced I-SYMPTOM
flow I-SYMPTOM
in O
the O
branches O
of O
the O
right O
middle O
cerebral O
artery O
compared O
to O
the O
left O
. O

There O
was O
visualization O
of O
flow O
within O
both O
posterior O
cerebral O
arteries O
. O

Clinically O
, O
the O
patient O
continued O
to O
deteriorate O
. O

Neurosurgery O
was O
consulted O
, O
however O
the O
neurosurgeons O
felt O
that O
there O
was O
no O
surgical O
option O
, O
since O
even O
in O
the O
case O
of O
cerebellar B-SYMPTOM
swelling I-SYMPTOM
, O
there O
would O
be O
no O
improvement O
from O
decompensation B-SYMPTOM
. O

The O
patient O
was O
therefore O
treated O
conservatively O
with O
fluid B-TREATMENT
restriction I-TREATMENT
and O
blood B-TREATMENT
pressure I-TREATMENT
management I-TREATMENT
. O

Heparin B-TREATMENT
was O
discontinued O
because O
of O
the O
risk O
of O
intercerebral B-SYMPTOM
hemorrhage I-SYMPTOM
. O

The B-SYMPTOM
aspiration I-SYMPTOM
pneumonia I-SYMPTOM
was O
treated O
with O
Cefotaxime B-TREATMENT
and O
Metronidazole B-TREATMENT
. O

The O
patient O
&apos;s O
family O
was O
involved O
and O
they O
decided O
to O
opt O
for O
DNR O
/ O
DNI O
in O
view O
of O
the O
poor O
prognosis O
. O

The O
patient O
passed O
away O
at O
6:45 O
AM O
on O
June O
12 O
, O
1998 O
. O

CONDITION O
ON O
DISCHARGE O
: O

Deceased O
. O

DISCHARGE O
ORDERS O
: O

None O
. O

Dictated O
By O
: O

GREGSIS O
STREETS O
, O
M.D. O
SQ51 O

Attending O
: O

CHLINO O
B. O
SHAM O
, O
M.D. O
NI76 O
LN647/8356 O

Batch O
: O

57390 O

Index O
No. O
TCVBBUJ1Y O

D O
: O

07/09/98 O

T O
: O

07/10/98 O

CC O
: O

1. O
NATA O
NELMI O
PAIN O
, O
M.D. O
, O
Sonsantna O
. O

285864187 O

OMH O

7792851 O

920021 O

1/1/1998 O
12:00:00 O
AM O

1) O
STAPH B-SYMPTOM
. O

SEPSIS B-SYMPTOM
RELATED O
TO O
PICC B-TREATMENT
LINE I-TREATMENT
. O

2) O
PREVIOUS B-SYMPTOM
ANOXIC I-SYMPTOM

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O
NAME O
: O

GACH O
, O
CH O

UNIT O
NUMBER O
: O

397-72-29 O

ADMISSION O
DATE O
: O

01/01/98 O

DISCHARGE O
DATE O
: O

01/07/98 O

DIAGNOSES O
: O

1) O
Staph. B-SYMPTOM
sepsis I-SYMPTOM
related O
to O
PICC B-TREATMENT
line I-TREATMENT
. O

2) O
Previous B-SYMPTOM
anoxicbrain I-SYMPTOM
damage I-SYMPTOM
. O

3) O
Previous B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

4) O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

5) O
status O
post O
CABG B-TREATMENT
surgery I-TREATMENT
in O
11/97 O
. O

6) O
paroxysmal B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
. O

7) O
mild B-SYMPTOM
chronic I-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

None O
. O

CLINICAL O
INFECTION O
: O

Positive B-SYMPTOM
blood I-SYMPTOM
cultures I-SYMPTOM
with O
Staph. B-SYMPTOM
aureus I-SYMPTOM
sensitiveto O
Methicillin B-TREATMENT
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Hydralazine B-TREATMENT
10 O
mgs O
PO O
t.i.d. O
, O
Digoxin B-TREATMENT
0.125 O
mgs O
PO O
q.d. O
, O
thiamine B-TREATMENT
100 O
mgs O
PO O
q.d. O
, O
multi-vitamin B-TREATMENT
1 O
tab. O
PO O
q.d. O
, O
Peri B-TREATMENT
- I-TREATMENT
Colace I-TREATMENT
100 O
mgs O
PO O
t.i.d. O
, O
folate B-TREATMENT
1 O
mg O
PO O
q.d. O
, O
Norvasc B-TREATMENT
2.5 O
mgs O
PO O
q.HS O
, O
Ritalin B-TREATMENT
10 O
mgs O
PO O
b.i.d. O
, O
Trazodone B-TREATMENT
25 O
mgs O
PO O
q.HS O
, O
Nafcillin B-TREATMENT
2 O
gramsIV O
q.4H O
which O
wil O
conclude O
at O
the O
end O
of O
the O
day O
on O
1/16/98 O
, O
Atroventnebulizer B-TREATMENT
PRN O
, O
Albuterol B-TREATMENT
nebulizer I-TREATMENT
PRN O
, O
Tylenol B-TREATMENT
650 O
mgs O
PO O
q.4H O
PRN O
pain B-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Gach O
is O
an O
80 O
year O
old O
man O
with O
aprevious O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
who O
was O
transferred O
from O
Linghs O
County O
Medical O
Center O
to O
Oaksgekesser/ O
Memorial O
Hospital O
because O
of O
an B-SYMPTOM
apparent I-SYMPTOM
infected I-SYMPTOM
wound I-SYMPTOM
, O
including O
the B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
in O
his O
right O
elbow O
and O
positive B-SYMPTOM
blood I-SYMPTOM
cultures I-SYMPTOM
for O
Staph. B-SYMPTOM
aureus I-SYMPTOM
associated O
with O
fever B-SYMPTOM
. O

He O
has O
a O
history O
of O
myocardial B-SYMPTOM
infarctions I-SYMPTOM
in O
1981 O
, O
1992 O
and O
08/97 O
with O
thelast O
episode O
complicated O
by O
anoxic B-SYMPTOM
encephalopathy I-SYMPTOM
. O

He O
gradually O
improved O
but O
had O
recurrent B-SYMPTOM
angina I-SYMPTOM
requiring O
cardiac O
catheterization O
, O
demonstrating O
90% O
left O
main O
, O
95% O
ostial O
LAD O
and O
30 O
to O
40% O
mid-LAD O
with O
an B-SYMPTOM
occluded I-SYMPTOM
RCA I-SYMPTOM
. O

CABG B-TREATMENT
surgery I-TREATMENT
with O
two B-TREATMENT
vessel I-TREATMENT
bypass I-TREATMENT
was O
done O
on O
11/18/97 O
. O

He O
was O
then O
transferred O
to O
Linghs O
County O
Medical O
Center O
. O

A B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
was O
placed O
in O
his O
left O
antecubital O
fossa O
and O
on O
the O
day O
of O
New O
Years O
Eve O
he O
developed O
a B-SYMPTOM
fever I-SYMPTOM
of O
102 O
and O
became O
lethargic B-SYMPTOM
. O

The B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
site I-TREATMENT
was O
erythematous B-SYMPTOM
. O

Blood O
cultures O
grew O
out O
4 O
out O
of O
4 O
bottles O
for O
gram B-SYMPTOM
positive I-SYMPTOM
cocci I-SYMPTOM
, O
which O
thereafter O
proved O
to O
be O
Staph. B-SYMPTOM
aureus I-SYMPTOM
Methicillin B-TREATMENT
sensitive O
. O

He O
had O
no O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
diarrhea B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Includes O
ischemic B-SYMPTOM
cardiomyopathy I-SYMPTOM
with O
an O
echocardiogram O
done O
on O
11/13/97 O
showing O
an O
ejection O
fraction O
of O
28% O
and O
LV O
that O
is O
diffusely B-SYMPTOM
hypokinetic I-SYMPTOM
. O

OTHER O
MEDICAL O
PROBLEMS O
: O

1) O
Dementia B-SYMPTOM
, O

2) O
paroxysmal B-SYMPTOM
atrial I-SYMPTOM
fibrillation, I-SYMPTOM

3) O
hypertension B-SYMPTOM
, O

4) O
peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
with O
previous B-TREATMENT
left I-TREATMENT
femoral I-TREATMENT
popliteal I-TREATMENT
bypass I-TREATMENT
, O

5) O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O

6) O
chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency, I-SYMPTOM

7) O
COPD B-SYMPTOM
, O

8) O
previous B-TREATMENT
abdominal I-TREATMENT
aortic I-TREATMENT
aneurysm I-TREATMENT
repair I-TREATMENT
in O
1981 O
, O

9) O
benign B-SYMPTOM
prostatic I-SYMPTOM
hypertrophy I-SYMPTOM
status O
post O
TURP B-TREATMENT
surgery I-TREATMENT
in O
1982 O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Aspirin B-TREATMENT
325 O
mgs O
PO O
q.d. O
, O
Prilosec B-TREATMENT
20 O
mgs O
PO O
q.d. O
, O
Azmacort B-TREATMENT
2 O
puffs O
q.i.d. O
PRN O
, O
Atrovent B-TREATMENT
2 O
puffs O
q.i.d. O
PRN O
, O
heparin B-TREATMENT
5,000 O
units O
subcu. O
b.i.d. O
, O
Digoxin B-TREATMENT
0.125 O
mgs O
PO O
q.d. O
, O
Wellbutrin B-TREATMENT
37.5 O
mgs O
PO O
b.i.d. O
, O
Kaopectate B-TREATMENT
PRN O
, O
Betoptic B-TREATMENT
0.25% O
OU O
q.d. O
, O
Ritalin B-TREATMENT
10 O
mgs O
PO O
q.a.m. O
and O
at O
noon O
time O
, O
Norvasc B-TREATMENT
2.5 O
mgs O
PO O
q.d. O

The O
patient O
reported O
disorientation B-SYMPTOM
with O
Ambien B-TREATMENT
and O
Halcyon B-TREATMENT
. O

REVIEW O
OF O
SYSTEMS O
: O

No O
other B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
other O
than O
stated O
above O
. O

PHYSICAL O
EXAMINATION O
: O

Elderly O
white O
male O
who O
was O
somnolent B-SYMPTOM
, O
looking O
his O
stated O
age O
. O

His O
temperature O
was O
97.5 O
, O
pulse O
90 O
, O
respiratory O
rate O
20 O
, O
blood O
pressure O
104/60 O
, O
o2 O
sat. O
97%. O

Eyes O
- O
pupils O
equal O
, O
round O
, O
reactive O
to O
light O
, O
sclera O
non-icteric B-SYMPTOM
. O

Neck O
- O
supple O
without O
masses B-SYMPTOM
or O
thyromegaly B-SYMPTOM
. O

Lungs O
- O
clear O
to O
percussion O
and O
auscultation O
on O
both O
sides O
. O

Cardiovascular O
examination O
- O
normal O
jugular O
venous O
pressure O
, O
normal O
carotid O
upstrokes O
with O
bruits B-SYMPTOM
, O
there O
are O
distant B-SYMPTOM
heart I-SYMPTOM
sounds I-SYMPTOM
, O
S1 O
and O
S2 O
are O
normal O
, O
there O
are O
no O
murmurs B-SYMPTOM
detected O
. O

Abdomen O
- O
soft O
, O
non-tender B-SYMPTOM
without O
organomegaly B-SYMPTOM
or O
masses B-SYMPTOM
. O

Extremities O
- O
without O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

Neurologic O
examination O
- O
somnolent B-SYMPTOM
, O
awake O
, O
arousable O
to O
commands O
, O
though O
he O
falls O
asleep O
rapidly O
. O

Deep O
tendon O
reflexes O
are O
2+ O
and O
symmetric O
, O
toes O
were O
up B-SYMPTOM
going I-SYMPTOM
bilaterally I-SYMPTOM
. O

LABORATORY O
DATA O
: O

Sodium O
131 O
, O
potassium O
4.5 O
, O
BUN O
45 O
, O
creatinine O
2.0 O
, O
glucose O
134 O
, O
bilirubin O
0.4. O
Blood O
gas O
on O
5 B-TREATMENT
liters I-TREATMENT
nasal I-TREATMENT
o2 I-TREATMENT
- O
PO2 O
106 O
, O
PCO227 O
, O
pH O
7.41 O
. O

Blood O
cultures O
were O
obtained O
, O
urine O
cultures O
were O
obtained O
. O

Chest O
x-ray O
- O
low B-SYMPTOM
lung I-SYMPTOM
volumes I-SYMPTOM
, O
bibasilar B-SYMPTOM
opacities I-SYMPTOM
, O
no O
evidence O
of O
heart B-SYMPTOM
failure I-SYMPTOM
. O

EKG O
- O
technically O
poor O
tracing O
with O
what O
appears O
to O
be O
normal O
sinus O
rhythm O
with O
very B-SYMPTOM
small I-SYMPTOM
P I-SYMPTOM
waves I-SYMPTOM
, O
there O
are O
Q-waves B-SYMPTOM
in I-SYMPTOM
leads I-SYMPTOM
V1 I-SYMPTOM
and I-SYMPTOM
V2 I-SYMPTOM
, O
as O
well O
as O
in O
V3 O
. O

There O
are O
non-specific B-SYMPTOM
ST I-SYMPTOM
T I-SYMPTOM
wave I-SYMPTOM
changes. I-SYMPTOM

The O
blood O
cultures O
at O
Linghs O
County O
Medical O
Center O
grew O
out O
Staph. B-SYMPTOM
aureus I-SYMPTOM
sensitive O
to O
methicillin B-TREATMENT
. O

The O
blood O
cultures O
obtained O
a O
Oaksgekesser/ O
Memorial O
Hospital O
were O
negative O
. O

An O
echocardiogram O
obtained O
at O
Oaksgekesser/ O
Memorial O
Hospital O
obtained O
as O
a O
transthoracic O
echocardiogram O
showed O
an O
ejection O
fraction O
of O
33% O
, O
wall O
thickness O
12 O
mms O
at O
the O
septum O
, O
posterior O
wall O
11 O
mms. O
, O
left O
atrial O
size O
40 O
mms O
. O

There O
is O
anteroseptal B-SYMPTOM
hypokinesis I-SYMPTOM
with O
mid B-SYMPTOM
and I-SYMPTOM
apical I-SYMPTOM
akinesis I-SYMPTOM
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
was O
treated O
with O
intravenous B-TREATMENT
antibiotics I-TREATMENT
. O

A O
lumbar O
puncture O
was O
obtained O
which O
showed O
normal O
pressure O
and O
no O
cells B-SYMPTOM
. O

The O
CSF O
culture O
was O
negative O
. O

A O
stool O
assay O
was O
taken O
for O
Clostridium B-SYMPTOM
difficile I-SYMPTOM
which O
was O
negative O
. O

The O
patient O
gradually O
improved O
on O
the B-TREATMENT
current I-TREATMENT
therapy I-TREATMENT
and O
was O
quite O
awake O
and O
alert O
, O
though O
still O
appeared O
to O
have O
some O
evidence O
of O
dementia B-SYMPTOM
and O
disorientation B-SYMPTOM
. O

He O
was O
encouraged O
to O
eat O
and O
it O
was O
decided O
not O
to O
place O
either O
a B-TREATMENT
feeding I-TREATMENT
tube I-TREATMENT
or O
to O
start O
TPN B-TREATMENT
. O

Dr. O
Rhalttland O
was O
called O
at O
Sondi O
Memorial O
to O
update O
him O
on O
the O
patient O
&apos;s O
condition O
. O

He O
still O
needs O
much B-TREATMENT
intensive I-TREATMENT
rehabilitation I-TREATMENT
, O
encouragement O
to O
eat O
and O
encouragement O
to O
get O
out O
of O
bed O
to O
use O
the O
bathroom O
rather O
than O
abed B-TREATMENT
pain I-TREATMENT
or O
a B-TREATMENT
diaper I-TREATMENT
. O

He O
is O
being O
transferred O
to O
Linghs O
County O
Medical O
Center O
for O
further B-TREATMENT
care I-TREATMENT
. O

CONDITION O
: O

Stable O
and O
improved O
. O

LAKO O
C. O
WARM O
, O
M.D. O
STAT O

TR O
: O

lv O

DD O
: O

01/06/98 O

TD O
: O

01/06/98 O
7:41 O

Pcc O
: O

LAKO O
C O
WARM O
, O
M.D. O

100007275 O

OMH O

4153022 O

539937 O

1/4/2001 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

RHALTDEALBBREUTZ O
, O
STA O

MRN O
: O

4153022 O

Age O
: O

94y O

REGISTRATION O
DATE O
: O

01/04/2001 O
07:21 O
PM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
RHALTDEALBBREUTZ O
, O
STA O
arrived O
in O
the O
Emergency O
Department O
at O
Oaksgekesser/ O
Memorial O
Hospital O
on O
01/04/2001 O
07:21 O
PM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
PNEUMONIA B-SYMPTOM
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
of O
the O
visit O
was O
ADMITTED O
AS O
AN O
INPATIENT O
TO O
OAKSGEKESSER/ O
MEMORIAL O
HOSPITAL O
. O

Your O
patient O
was O
admitted O
under O
the O
care O
of O
TUBBOLM O
, O
LISSWHITI O
N O
with O
a O
preliminary O
diagnosis O
of O
PNEUMONIA B-SYMPTOM
. O

If O
you O
need O
additional O
information O
please O
call O
598-754-5083 O
. O

PCP O
Name O
: O

AJESC O
, O
DARLMA O
MARGEA O
L O

Provider O
Number O
: O

63669 O

559197012_a O

FIH O

4469096 O

80486/8ays O

271958 O

9/2/1994 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

9-2-94 O

DISCHARGE O
DATE O
: O

9-18-94 O

ADMISSION O
DIAGNOSIS O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Non-insulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
, O
history O
of O
gastric B-SYMPTOM
ulcer I-SYMPTOM
, O
and O
history O
of O
ETOH O
abuse O
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

September O
11 O
, O
1994 O
, O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
surgery I-TREATMENT
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Coumadin B-TREATMENT
5 O
mg O
PO O
q.day O
, O
Digoxin B-TREATMENT
0.25 O
mg O
PO O
q.day O
, O
Metoprolol B-TREATMENT
25 O
mg O
PO O
b.i.d. O
, O
Baby B-TREATMENT
aspirin I-TREATMENT
80 O
mg O
PO O
q.day O
. O

The O
patient O
will O
be O
followed O
by O
the O
Anticoagulation O
Clinic O
for O
prothrombin O
time O
level O
evaluations O
and O
appropriate B-TREATMENT
Coumadin I-TREATMENT
doses I-TREATMENT
. O

IDENTIFYING O
DATA O
: O

The O
patient O
is O
a O
66 O
year O
old O
Portuguese O
speaking O
gentleman O
with O
a O
history O
of O
hypertension B-SYMPTOM
, O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
increasing B-SYMPTOM
cholesterol I-SYMPTOM
, O
and O
history O
of O
tobacco O
use O
, O
who O
is O
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
September O
of O
1993 O
and O
February O
of O
1993 O
, O
who O
presented O
with O
new O
onset O
of O
left B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
and O
arm B-SYMPTOM
pain I-SYMPTOM
for O
two O
days O
. O

Apparently O
, O
patient O
was O
in O
his O
usual O
state O
of O
health O
until O
two O
days O
prior O
to O
admission O
when O
he O
noted O
new O
onset O
of O
chest B-SYMPTOM
pain I-SYMPTOM
and O
arm B-SYMPTOM
pain I-SYMPTOM
, O
confined O
to O
his O
left O
side O
. O

The B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
was O
considered O
mild O
but O
persistent O
with O
episodes O
lasting O
twenty O
minutes O
. O

He O
came O
to O
the O
emergency O
room O
with O
chest B-SYMPTOM
pain I-SYMPTOM
on O
July O
22 O
, O
1994 O
, O
relieved O
with O
sublingual B-TREATMENT
nitroglycerin I-TREATMENT
. O

No O
history O
of O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
or O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

Denies O
fevers B-SYMPTOM
, O
pleuritic B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
or O
cough B-SYMPTOM
. O

The O
electrocardiogram O
showed O
pseudonormalization B-SYMPTOM
of I-SYMPTOM
T I-SYMPTOM
waves I-SYMPTOM
in O
V1 O
through O
V6 O
and O
Q B-SYMPTOM
waves I-SYMPTOM
in I-SYMPTOM
V1 I-SYMPTOM
through O
V3 O
. O

The O
patient O
&apos;s O
past O
cardiac O
history O
is O
significant O
for O
an B-SYMPTOM
anterior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
September O
of O
1993 O
and O
a B-SYMPTOM
non-Q I-SYMPTOM
wave I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
February O
of O
1993 O
. O

The O
patient O
in O
September O
of O
1993 O
had O
3-4 B-SYMPTOM
millimeter I-SYMPTOM
ST I-SYMPTOM
segment I-SYMPTOM
elevation I-SYMPTOM
in I-SYMPTOM
V1 I-SYMPTOM
through O
V4 O
and O
depression B-SYMPTOM
in I-SYMPTOM
II I-SYMPTOM
, I-SYMPTOM
III I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
AVF I-SYMPTOM
. O

At O
the O
time O
, O
patient O
had O
bright B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
as O
well O
and O
patient O
had O
cardiac O
catheterization O
at O
the O
time O
which O
showed O
95% O
left O
anterior O
descending O
, O
which O
was O
percutaneous O
transluminal O
coronary O
angioplastied O
and O
had O
intra-aortic B-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
placement I-TREATMENT
. O

He O
had O
a O
CPK O
of O
over O
5000 O
with O
MB O
fraction O
of O
26.7 O
. O

The O
echocardiogram O
showed O
a O
44% O
ejection O
fraction O
with O
anterior B-SYMPTOM
akinesis I-SYMPTOM
and O
septal B-SYMPTOM
hypokinesis I-SYMPTOM
. O

He O
had O
a B-SYMPTOM
positive I-SYMPTOM
exercise I-SYMPTOM
tolerance I-SYMPTOM
test I-SYMPTOM
with O
Thallium O
and O
repeat O
cardiac O
catheterization O
showed O
left O
anterior O
descending O
being O
patent O
and O
distal B-SYMPTOM
posterior I-SYMPTOM
descending I-SYMPTOM
artery I-SYMPTOM
lesion I-SYMPTOM
with O
circumflex B-SYMPTOM
lesion I-SYMPTOM
after I-SYMPTOM
the I-SYMPTOM
obtuse I-SYMPTOM
marginal I-SYMPTOM
1 I-SYMPTOM
. O

In O
February O
of O
1993 O
, O
patient O
again O
presented O
with O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
ruled O
in O
for O
a B-SYMPTOM
non-Q I-SYMPTOM
wave I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
with O
CPK O
peak O
of O
219 O
and O
MB O
of O
20.9 O
. O

Repeat O
cardiac O
catheterization O
showed O
re-stenosis B-SYMPTOM
of I-SYMPTOM
proximal I-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
descending I-SYMPTOM
that O
had O
been O
percutaneous O
transluminal O
coronary O
angioplastied O
and O
a B-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
first I-SYMPTOM
obtuse I-SYMPTOM
marginal I-SYMPTOM
and O
a B-SYMPTOM
moderate I-SYMPTOM
to I-SYMPTOM
severe I-SYMPTOM
left I-SYMPTOM
circumflex I-SYMPTOM
lesion I-SYMPTOM
after O
the O
third O
obtuse O
marginal O
. O

He O
also O
had O
an B-SYMPTOM
akinetic I-SYMPTOM
anterolateral I-SYMPTOM
and I-SYMPTOM
apical I-SYMPTOM
ventricle I-SYMPTOM
. O

CARDIAC O
RISK O
FACTORS O
: O

Again O
, O
patient O
&apos;s O
cardiac O
risk O
factors O
include O
hypertension B-SYMPTOM
, O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
increasing B-SYMPTOM
cholesterol I-SYMPTOM
and O
a O
positive O
family O
history O
and O
tobacco O
use O
. O

In O
the O
past O
, O
patient O
had O
been O
noted O
to O
be O
non-compliant B-SYMPTOM
with O
cardiac B-TREATMENT
medications I-TREATMENT
and O
continues O
to O
smoke O
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
patient O
has O
a O
history O
of O
hypertension B-SYMPTOM
, O
non-insulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
, O
diet-controlled O
, O
status O
post O
myocardial B-SYMPTOM
infarctions I-SYMPTOM
x O
two O
as O
mentioned O
above O
. O

PAST O
SURGICAL O
HISTORY O
: O

The O
patient O
is O
status O
post O
appendectomy B-TREATMENT
. O

Lower B-SYMPTOM
gastrointestinal I-SYMPTOM
bleed I-SYMPTOM
in O
February O
of O
1993 O
which O
was O
not O
worked O
up O
due O
to O
patient O
deferment O
. O

ALLERGIES O
: O

The O
patient O
is O
allergic B-SYMPTOM
to O
penicillin B-TREATMENT
, O
develops O
a B-SYMPTOM
rash I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Metoprolol B-TREATMENT
50 O
mg O
PO O
b.i.d. O
, O
Isordil B-TREATMENT
20 O
mg O
PO O
t.i.d. O
, O
Ecotrin B-TREATMENT
aspirin I-TREATMENT
q.day O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
smokes O
one O
pack O
per O
day O
. O

He O
used O
to O
be O
a O
heavy O
drinker O
in O
the O
past O
, O
no O
drugs O
. O

The O
patient O
lives O
in O
Hou O
with O
wife O
and O
daughter O
. O

He O
is O
a O
retired O
taxi O
driver O
. O

PHYSICAL O
EXAMINATION O
: O

The O
physical O
examination O
revealed O
him O
to O
be O
afebrile B-SYMPTOM
, O
blood O
pressure O
of O
130/80 O
with O
a O
pulse O
rate O
of O
56 O
and O
respirations O
of O
24 O
. O

In O
general O
, O
he O
is O
a O
well O
developed O
, O
well O
nourished O
man O
breathing O
easily O
, O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Skin O
: O

multiple B-SYMPTOM
stigmata I-SYMPTOM
of O
burns B-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
arm I-SYMPTOM
and I-SYMPTOM
chest I-SYMPTOM
. O

On O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
examination O
, O
pupils O
equal O
, O
round O
, O
reactive O
to O
light O
and O
accommodation O
, O
fundus O
was O
sharp O
, O
oral O
mucosa O
was O
clear O
. O

Neck O
: O

no O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
at O
five O
centimeters O
, O
neck O
was O
supple O
, O
full O
range O
of O
movement O
, O
no O
bruits B-SYMPTOM
, O
no O
adenopathy B-SYMPTOM
. O

Lungs O
had O
bibasilar B-SYMPTOM
rales I-SYMPTOM
1/4 O
of O
the O
way O
up O
bilaterally O
, O
otherwise O
clear O
. O

Cardiovascular O
exam O
: O

II B-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
left I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
, O
positive O
S3 B-SYMPTOM
, O
question O
of O
S4 B-SYMPTOM
, O
otherwise O
point O
of O
maximal O
impulse O
was O
laterally B-SYMPTOM
displaced I-SYMPTOM
. O

Abdomen O
: O

surgical B-SYMPTOM
midline I-SYMPTOM
incision I-SYMPTOM
and O
previous B-TREATMENT
surgery I-TREATMENT
for O
history O
of O
gastric B-SYMPTOM
ulcer I-SYMPTOM
. O

The O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
mildly B-SYMPTOM
obese I-SYMPTOM
with O
liver O
edge O
two O
centimeters O
below O
the O
right O
costal O
margin O
. O

Extremities O
: O

no O
evidence O
of O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

The O
rectal O
examination O
was O
trace B-SYMPTOM
guaiac I-SYMPTOM
positive I-SYMPTOM
. O

The O
patient O
had O
pulses O
distally O
, O
1+ O
femorals O
, O
1+ O
dorsalis O
pedis O
. O

The O
neurological O
examination O
was O
otherwise O
nonfocal O
with O
mentioned O
left O
upper O
extremity O
3/5 O
strength O
with O
pain B-SYMPTOM
and O
5/5 O
on O
the O
left O
lower O
extremity O
. O

LABORATORY O
DATA O
: O

Admission O
hematocrit O
44 O
, O
BUN O
and O
creatinine O
of O
13 O
and O
0.9 O
, O
prothrombin O
time O
and O
partial O
thromboplastin O
time O
normal O
. O

The O
patient O
had O
a O
chest O
X-ray O
which O
showed O
mild B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
. O

The O
electrocardiogram O
showed O
Q B-SYMPTOM
waves I-SYMPTOM
in I-SYMPTOM
V1 I-SYMPTOM
through O
V6 O
, O
T B-SYMPTOM
wave I-SYMPTOM
pseudonormalization I-SYMPTOM
in I-SYMPTOM
V1 I-SYMPTOM
through O
V6 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
for O
rule O
out O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

The O
patient O
ruled O
in O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
with O
CPK O
maximum O
on O
hospital O
day O
number O
one O
peak O
of O
186 O
and O
iso O
of O
23.8 O
and O
index O
of O
12.8 O
on O
September O
2 O
, O
1994 O
. O

The O
patient O
was O
seen O
in O
consultation O
by O
Dr. O
Signs O
for O
Dr. O
Churlaunt O
of O
Cardiology O
. O

The O
patient O
received O
the B-TREATMENT
appropriate I-TREATMENT
protocol I-TREATMENT
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
, O
intravenous B-TREATMENT
heparin I-TREATMENT
, O
aspirin B-TREATMENT
, O
and O
beta B-TREATMENT
blockers I-TREATMENT
for O
rate B-TREATMENT
and I-TREATMENT
blood I-TREATMENT
pressure I-TREATMENT
control I-TREATMENT
. O

The O
patient O
on O
the O
date O
of O
September O
5 O
, O
1994 O
had O
cardiac O
catheterization O
which O
showed O
normal O
resting O
hemodynamics O
. O

The O
patient O
has O
a O
small O
non-dominant O
right O
coronary O
artery O
, O
left O
anterior O
descending O
showed O
severe B-SYMPTOM
proximal I-SYMPTOM
lesion I-SYMPTOM
with O
more B-SYMPTOM
distal I-SYMPTOM
lesions I-SYMPTOM
of I-SYMPTOM
diagonal I-SYMPTOM
one I-SYMPTOM
. O

The O
left O
circumflex O
was O
dominant O
with O
severe B-SYMPTOM
disease I-SYMPTOM
of I-SYMPTOM
obtuse I-SYMPTOM
marginal I-SYMPTOM
one I-SYMPTOM
, O
with O
moderate B-SYMPTOM
mid-circumflex I-SYMPTOM
stenosis I-SYMPTOM
and O
moderate B-SYMPTOM
posterior I-SYMPTOM
descending I-SYMPTOM
artery I-SYMPTOM
lesion I-SYMPTOM
. O

The O
left O
ventriculography O
shows O
anterior B-SYMPTOM
akinesis I-SYMPTOM
and O
apical B-SYMPTOM
severe I-SYMPTOM
hypokinesis I-SYMPTOM
with O
a B-SYMPTOM
moderately I-SYMPTOM
depressed I-SYMPTOM
ejection I-SYMPTOM
fraction I-SYMPTOM
, O
cardiac O
output O
of O
3.9 O
, O
index O
of O
2.0 O
. O

The O
patient O
was O
seen O
in O
consultation O
by O
Cardiac O
Surgery O
for O
evaluation O
of O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

The O
patient O
had O
stable O
hematocrit O
of O
38% O
on O
intravenous B-TREATMENT
heparin I-TREATMENT
. O

The O
carotid O
noninvasives O
preoperatively O
were O
negative O
. O

Dental O
consult O
was O
negative O
. O

On O
the O
date O
of O
September O
11 O
, O
1994 O
, O
patient O
underwent O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
with O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
posterior I-TREATMENT
descending I-TREATMENT
artery I-TREATMENT
, O
circumflex B-TREATMENT
and I-TREATMENT
diagonal I-TREATMENT
and I-TREATMENT
left I-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
to I-TREATMENT
the I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
. O

The O
patient O
had O
a O
bypass O
time O
of O
one O
hour O
and O
fifty O
minutes O
with O
good O
urine O
output O
and O
pre-bypass O
cardiac O
output O
of O
4.0 O
, O
post-chest O
closure O
5.3 O
, O
arrived O
to O
the O
Surgical O
Intensive O
Care O
Unit O
on O
Nipride B-TREATMENT
, O
Lidocaine B-TREATMENT
of O
1 O
and O
Fentanyl/ B-TREATMENT
Versed B-TREATMENT
of O
10 O
. O

The O
postoperative O
hematocrit O
was O
26% O
. O

The O
patient O
had O
a O
routine O
postoperative O
course O
in O
the O
Surgical O
Intensive O
Care O
Unit O
with O
a O
postoperative O
BUN O
and O
creatinine O
of O
11 O
and O
1.2 O
with O
good O
urine O
output O
of O
over O
100 O
an O
hour O
and O
patient O
received O
two O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
, O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
and O
platelets B-TREATMENT
for O
increasing B-SYMPTOM
chest I-SYMPTOM
tube I-SYMPTOM
drainage I-SYMPTOM
. O

The O
patient O
on O
the O
date O
of O
postoperative O
day O
number O
one O
, O
September O
13 O
, O
1994 O
, O
was O
transferred O
from O
the O
Surgical O
Intensive O
Care O
Unit O
up O
to O
the O
FIH O
18 O
floor O
. O

The O
patient O
&apos;s O
only O
post-Surgical O
Intensive O
Care O
Unit O
course O
was O
remarkable O
for O
hypertension B-SYMPTOM
requiring O
Nipride B-TREATMENT
and O
bleeding B-SYMPTOM
which O
was O
controlled O
with O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
, O
platelets B-TREATMENT
. O

The O
patient O
had O
a O
stable O
hematocrit O
of O
30% O
with O
CPK O
&apos;s O
postoperatively O
maximum O
MB O
fraction O
of O
78 O
. O

On O
postoperative O
day O
number O
three O
, O
patient O
went O
into O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
which O
was O
treated O
appropriately O
with O
metoprolol B-TREATMENT
and O
digoxin B-TREATMENT
and O
converted O
back O
to O
sinus O
rhythm O
. O

The O
patient O
continued O
to O
need O
diuresis B-TREATMENT
. O

The B-TREATMENT
postoperative I-TREATMENT
medications I-TREATMENT
up O
on O
FIH O
were O
Coumadin B-TREATMENT
, O
baby B-TREATMENT
aspirin I-TREATMENT
, O
Isordil B-TREATMENT
10 O
PO O
t.i.d. O
, O
Digoxin B-TREATMENT
.25 O
q.day O
, O
metoprolol B-TREATMENT
25 O
PO O
b.i.d. O
______________ O

Chest B-TREATMENT
tubes I-TREATMENT
and O
wires B-TREATMENT
were O
all O
discontinued O
according O
to O
protocol B-TREATMENT
on O
postoperative O
day O
number O
four O
. O

The B-TREATMENT
Isordil I-TREATMENT
was O
also O
discontinued O
. O

The B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
incisions I-SYMPTOM
sternal O
and O
right O
leg O
were O
clean O
and O
healing O
well O
, O
normal O
sinus O
rhythm O
at O
70-80 O
, O
with O
blood O
pressure O
98-110/60 O
and O
patient O
was O
doing O
well O
, O
recovering O
, O
ambulating O
, O
tolerating O
regular O
diet O
and O
last O
hematocrit O
prior O
to O
discharge O
was O
39% O
with O
a O
BUN O
and O
creatinine O
of O
15 O
and O
1.0 O
, O
prothrombin O
time O
level O
of O
13.8 O
, O
chest O
X-ray O
prior O
to O
discharge O
showed O
small B-SYMPTOM
bilateral I-SYMPTOM
effusions I-SYMPTOM
with O
mild B-SYMPTOM
cardiomegaly I-SYMPTOM
and O
subsegmental B-SYMPTOM
atelectasis I-SYMPTOM
bibasilar I-SYMPTOM
and O
electrocardiogram O
showed O
normal O
sinus O
rhythm O
with O
left B-SYMPTOM
atrial I-SYMPTOM
enlargement I-SYMPTOM
and O
no O
acute B-SYMPTOM
ischemic I-SYMPTOM
changes I-SYMPTOM
on O
electrocardiogram O
. O

Note O
: O

patient O
needs O
anticoagulation B-TREATMENT
for O
large B-TREATMENT
saphenous I-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to O
prevent O
any O
possibility O
of O
thrombosis B-SYMPTOM
. O

The O
patient O
was O
discharged O
home O
in O
stable O
condition O
and O
will O
follow O
up O
with O
his O
cardiologist O
and O
will O
follow O
up O
with O
Dr. O
Hemp O
and O
Dr. O
Signs O
. O

A O
NECESSARY O
, O
M.D. O

DICTATING O
FOR O
: O

G O
HEMP O
, O
M.D. O

TR O
: O

ee O
/ O
bmot O

DD O
: O

9-18-94 O

TD O
: O

09/19/94 O

CC O
: O

Dr. O
Signs O

Admission O
Date O
: O

2014-04-17 O

Discharge O
Date O
: O

2014-04-25 O

Date O
of O
Birth O
: O

1953-07-04 O

Sex O
: O

M O

Service O
: O

CARDIOTHORACIC O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Christopher O
Q O
Thompson O
, O
M.D. O

Chief O
Complaint O
: O

Chest B-SYMPTOM
pain I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

2014-04-18 O
Off B-TREATMENT
Pump I-TREATMENT
Coronary I-TREATMENT
Artery I-TREATMENT
Bypass I-TREATMENT
Grafting I-TREATMENT
utilizing O
the O
left O
internal O
mammary O
artery O
to O
left O
anterior O
descending O
artery O
, O
free O
right O
internal O
mammary O
to O
obtuse O
marginal O
and O
vein B-TREATMENT
graft I-TREATMENT
to I-TREATMENT
diagonal I-TREATMENT
. O

History O
of O
Present O
Illness O
: O

This O
is O
a O
60 O
year O
old O
male O
with O
new B-SYMPTOM
onset I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
. O

Nuclear O
myocardial O
perfusion O
study O
was O
notable O
for O
a B-SYMPTOM
moderate I-SYMPTOM
fixed I-SYMPTOM
defect I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
inferior I-SYMPTOM
wall I-SYMPTOM
and O
cardiac O
apex O
. O

His O
ejection O
fraction O
however O
appeared O
preserved O
at O
73% O
with O
mild B-SYMPTOM
inferior I-SYMPTOM
wall I-SYMPTOM
hypokinesis I-SYMPTOM
. O

Subsequent O
cardiac O
catheterization O
at O
Nantucket O
Cottage O
Hospital O
Hospital O
on O
2014-04-16 O
was O
significant O
for O
severe B-SYMPTOM
two I-SYMPTOM
vessel I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

Angiography O
revealed O
a B-SYMPTOM
right I-SYMPTOM
dominant I-SYMPTOM
system I-SYMPTOM
with O
a B-SYMPTOM
40% I-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
left I-SYMPTOM
main, I-SYMPTOM
several B-SYMPTOM
tight I-SYMPTOM
lesions I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
and I-SYMPTOM
mid I-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
descending I-SYMPTOM
artery I-SYMPTOM
, O
and O
a B-SYMPTOM
90% I-SYMPTOM
stenosis I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
circumflex I-SYMPTOM
. O

The O
right O
coronary O
artery O
had O
mild B-SYMPTOM
diffuse I-SYMPTOM
plaquing I-SYMPTOM
but O
no O
evidence O
of O
focal B-SYMPTOM
stenosis I-SYMPTOM
. O

Based O
upon O
the O
above O
results O
, O
he O
was O
transferred O
to O
the O
Mediplex O
Rehab O
Hospital O
for O
surgical B-TREATMENT
revascularization I-TREATMENT
. O

Past O
Medical O
History O
: O

Asthma B-SYMPTOM

Benign B-SYMPTOM
Prostatic I-SYMPTOM
Hypertrophy I-SYMPTOM

History O
of O
Nephrolithiasis B-SYMPTOM

Hemorrhoids B-SYMPTOM

Social O
History O
: O

Denies O
tobacco O
history O
. O

Admits O
to O
03-08 O
ETOH O
drinks O
per O
week O
. O

He O
works O
as O
an O
accountant O
. O

Family O
History O
: O

Mother O
suffer O
MI B-SYMPTOM
in O
her O
50 O
's, O
died O
at O
age O
59 O
. O

Father O
died O
from O
MI B-SYMPTOM
at O
age O
72 O
. O

Physical O
Exam O
: O

Vitals O
: O
T O
98.9 O
, O
BP O
148/70 O
, O
HR O
57 O
, O
RR O
20 O
, O
SAT O
95 O
on O
room O
air O

General O
: O
well O
developed O
male O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM

HEENT O
: O
oropharynx O
benign O
, O

Neck O
: O
supple O
, O
no O
JVD B-SYMPTOM
, O

Heart O
: O
regular O
rate O
, O
normal O
s1s2 O
, O
no O
murmur B-SYMPTOM
or O
rub B-SYMPTOM

Lungs O
: O
clear O
bilaterally O

Abdomen O
: O
soft O
, O
nontender B-SYMPTOM
, O
normoactive O
bowel O
sounds O

Ext O
: O
warm O
, O
no O
edema B-SYMPTOM
, O
no O
varicosities B-SYMPTOM

Pulses O
: O
2+ O
distally O
, O
no O
carotid B-SYMPTOM
or I-SYMPTOM
femoral I-SYMPTOM
bruits I-SYMPTOM

Neuro O
: O
nonfocal O

Pertinent O
Results O
: O

2014-04-17 O
03:58 O
PM O
BLOOD O
WBC O
- O
6.3 O
RBC O
- O
4.60 O
Hgb O
- O
15.4 O
Hct O
- O
42.9 O
MCV O
- O
93 O
MCH O
- O
33.4 O
* O
MCHC O
- O
35.8 O
* O
RDW O
- O
12.8 O
Plt O
Ct O
- O
168 O

2014-04-17 O
03:58 O
PM O
BLOOD O
PT O
- O
13.2 O
* O
PTT O
- O
30.3 O
INR(PT) O
- O
1.2 O
* O

2014-04-17 O
03:58 O
PM O
BLOOD O
Glucose O
- O
92 O
UreaN O
- O
15 O
Creat O
- O
1.3 O
* O
Na O
- O
142 O
K O
- O
4.5 O
Cl O
- O
104 O
HCO3 O
- O
26 O
AnGap O
- O
17 O

2014-04-17 O
03:58 O
PM O
BLOOD O
ALT O
- O
18 O
AST O
- O
20 O
AlkPhos O
- O
53 O
Amylase O
- O
98 O
TotBili O
- O
0.6 O

2014-04-17 O
03:58 O
PM O
BLOOD O
%HbA1c O
- O
5.8 O
[Hgb] O
- O
DONE O
[A1c] O
- O
DONE O

2014-04-22 O
07:10 O
AM O
BLOOD O
WBC O
- O
6.5 O
RBC O
- O
2.89 O
* O
Hgb O
- O
9.3 O
* O
Hct O
- O
26.4 O
* O
MCV O
- O
92 O
MCH O
- O
32.3 O
* O
MCHC O
- O
35.2 O
* O
RDW O
- O
13.8 O
Plt O
Ct O
- O
155 O

2014-04-22 O
07:10 O
AM O
BLOOD O
Glucose O
- O
97 O
UreaN O
- O
11 O
Creat O
- O
1.3 O
* O
Na O
- O
142 O
K O
- O
4.4 O
Cl O
- O
103 O
HCO3 O
- O
34 O
* O
AnGap O
- O
9 O

2014-04-22 O
07:10 O
AM O
BLOOD O
Mg O
- O
2.0 O

2014-04-22 O
Chest O
x-ray O
: O
No O
evidence O
of O
pneumothorax B-SYMPTOM
. O

Persistent B-SYMPTOM
bibasilar I-SYMPTOM
atelectasis I-SYMPTOM
and O
tiny B-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
. O

Stable B-SYMPTOM
postoperative I-SYMPTOM
cardiac I-SYMPTOM
and I-SYMPTOM
mediastinal I-SYMPTOM
widening I-SYMPTOM
. O

2014-04-24 O
06:35 O
AM O
BLOOD O
WBC O
- O
6.7 O
RBC O
- O
2.96 O
* O
Hgb O
- O
9.1 O
* O
Hct O
- O
28.0 O
* O
MCV O
- O
94 O
MCH O
- O
30.9 O
MCHC O
- O
32.7 O
RDW O
- O
13.6 O
Plt O
Ct O
- O
234 O
# O

2014-04-25 O
06:45 O
AM O
BLOOD O
Glucose O
- O
93 O
UreaN O
- O
13 O
Creat O
- O
1.4 O
* O
Na O
- O
141 O
K O
- O
4.6 O
Cl O
- O
102 O
HCO3 O
- O
31 O
AnGap O
- O
13 O

2014-04-24 O
06:35 O
AM O
BLOOD O
Glucose O
- O
96 O
UreaN O
- O
13 O
Creat O
- O
1.4 O
* O
Na O
- O
143 O
K O
- O
4.8 O
Cl O
- O
104 O
HCO3 O
- O
33 O
* O
AnGap O
- O
11 O

Brief O
Hospital O
Course O
: O

Mr. O
Chester O
was O
admitted O
to O
the O
cardiac O
surgical O
service O
and O
underwent O
routine O
preoperative O
evaluation O
. O

He O
remained O
pain B-SYMPTOM
free O
on O
medical B-TREATMENT
therapy I-TREATMENT
. O

Workup O
was O
unremarkable O
and O
he O
was O
cleared O
for O
surgery B-TREATMENT
. O

On O
04-18 O
, O
Dr. O
Oneill O
performed O
off B-TREATMENT
pump I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

For O
surgical O
details O
, O
please O
see O
seperate O
dictated O
operative O
note O
. O

Following O
the B-TREATMENT
operation I-TREATMENT
, O
he O
was O
brought O
to O
the O
CSRU O
for O
invasive O
monitoring O
. O

Within O
24 O
hours O
, O
he O
awoke O
neurologically O
intact O
and O
was O
extubated O
without O
incident O
. O

Given O
hypotension B-SYMPTOM
and O
bradycardia B-SYMPTOM
, O
he O
was O
slow B-SYMPTOM
to I-SYMPTOM
wean I-SYMPTOM
from O
Neosynephrine B-TREATMENT
. O

Low B-TREATMENT
dose I-TREATMENT
beta I-TREATMENT
blockade I-TREATMENT
was O
eventually O
resumed O
. O

Chest B-TREATMENT
tubes I-TREATMENT
and O
pacing B-TREATMENT
wires I-TREATMENT
were O
removed O
without O
complication B-SYMPTOM
. O

On O
postoperative O
day O
three O
, O
he O
transferred O
to O
the O
SDU O
. O

He O
maintained O
a O
normal O
sinus O
rhythm O
without O
atrial B-SYMPTOM
or I-SYMPTOM
ventricular I-SYMPTOM
arrhythmias I-SYMPTOM
. O

He O
remained O
in O
sinus B-SYMPTOM
bradycardia I-SYMPTOM
( O
rate O
50-60 O
) O
and O
tolerated O
low B-TREATMENT
dose I-TREATMENT
beta I-TREATMENT
blockade I-TREATMENT
. O

On O
POD O
#6 O
his O
creatinine O
became O
slightly B-SYMPTOM
elevated I-SYMPTOM
at O
1.4 O
, O
his B-TREATMENT
lasix I-TREATMENT
was O
discontinued O
and O
the O
following O
day O
his O
creatinine O
was O
stable O
at O
1.4 O
. O

He O
continued O
to O
progress O
and O
was O
eventually O
cleared O
for O
discharge O
to O
home O
on O
postoperative O
day O
7 O
. O

His O
discharge O
chest O
x-ray O
showed O
persistent B-SYMPTOM
bibasilar I-SYMPTOM
atelectasis I-SYMPTOM
with O
only O
tiny B-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
. O

Of O
note O
, O
he O
will O
need O
to O
remain O
on O
Plavix B-TREATMENT
for O
three O
months O
postop O
given O
the B-TREATMENT
off I-TREATMENT
pump I-TREATMENT
procedure I-TREATMENT
. O

In O
addition O
, O
he O
will O
need O
to O
remain O
on O
Imdur B-TREATMENT
given O
use O
of O
his O
right O
internal O
mammary O
artery O
as O
a B-TREATMENT
" I-TREATMENT
free I-TREATMENT
" I-TREATMENT
arterial I-TREATMENT
graft I-TREATMENT
in O
preventing O

vasospasm B-SYMPTOM
. O

Medications O
on O
Admission O
: O

Lopressor B-TREATMENT
? O
dose O

Aspirin B-TREATMENT
325 O
qd O

Zocor B-TREATMENT
40 O
qd O

IV B-TREATMENT
Heparin I-TREATMENT

Discharge O
Medications O
: O

1. O
Furosemide B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
for O
5 O
days O
. O

Disp O
:* O
5 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

2. O
Potassium B-TREATMENT
Chloride I-TREATMENT
10 O
mEq O
Capsule O
, O
Sustained O
Release O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
, O
Sustained O
Release O
PO O
once O
a O
day O
for O
5 O
days O
. O

Disp O
:* O
10 O
Capsule O
, O
Sustained O
Release O
(s)* O
Refills O
:* O
0 O
* O

3. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
). O

Disp O
:* O
60 O
Capsule O
(s)* O
Refills O
:* O
0 O
* O

4. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
). O

Disp O
:* O
30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)(s)* O
Refills O
:* O
0 O
* O

5. O
Oxycodone B-TREATMENT
- I-TREATMENT
Acetaminophen I-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
every O
4-6 O
hours O
as O
needed O
for O
pain B-SYMPTOM
. O

Disp O
:* O
50 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

6. O
Simvastatin B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

Disp O
:* O
60 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

7. O
Fluticasone B-TREATMENT
- I-TREATMENT
Salmeterol I-TREATMENT
250-50 O
mcg O
/ O
Dose O
Disk O
with O
Device O
Sig O
: O
One O
( O
1 O
) O
Disk O
with O
Device O
Inhalation O
BID O
( O
2 O
times O
a O
day O
). O

Disp O
:* O
1 O
Disk O
with O
Device O
(s)* O
Refills O
:* O
0 O
* O

8. O
Isosorbide B-TREATMENT
Mononitrate I-TREATMENT
30 O
mg O
Tablet O
Sustained O
Release O
24 O
hr O
Sig O
: O
One O
( O
1 O
) O
Tablet O
Sustained O
Release O
24 O
hr O
PO O
DAILY O
( O
Daily O
). O

Disp O
:* O
30 O
Tablet O
Sustained O
Release O
24 O
hr O
(s)* O
Refills O
:* O
2 O
* O

9. O
Clopidogrel B-TREATMENT
75 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

Disp O
:* O
30 O
Tablet O
(s)* O
Refills O
:* O
2 O
* O

10. O
Metoprolol B-TREATMENT
Succinate I-TREATMENT
25 O
mg O
Tablet O
Sustained O
Release O
24 O
hr O
Sig O
: O
0.5 O
( O
half O
) O
Tablet O
Sustained O
Release O
24 O
hr O
PO O
DAILY O
( O
Daily O
). O

Disp O
:* O
30 O
Tablet O
Sustained O
Release O
24 O
hr O
(s)* O
Refills O
:* O
0 O
* O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
- O
s/p O
Off B-TREATMENT
Pump I-TREATMENT
CABG I-TREATMENT

Sinus B-SYMPTOM
Bradycardia I-SYMPTOM

Asthma B-SYMPTOM

BPH B-SYMPTOM

Nephrolithiasis B-SYMPTOM

Discharge O
Condition O
: O

Good O

Discharge O
Instructions O
: O

Follow O
medications B-TREATMENT
on O
discharge O
instructions O
. O

Do O
not O
drive O
for O
4 O
weeks O
. O

Do O
not O
lift O
more O
than O
10 O
lbs O
for O
2 O
months O
. O

Shower O
daily O
, O
let O
water O
flow O
over O
wounds B-SYMPTOM
, O
pat O
dry O
with O
a O
towel O
. O

Do O
not O
use O
creams O
, O
lotions O
, O
or O
powders O
on O
wounds B-SYMPTOM
. O

Call O
our O
office O
for O
sternal B-SYMPTOM
drainage I-SYMPTOM
, O
temp B-SYMPTOM
.> O
101.5 O

Followup O
Instructions O
: O

Make O
an O
appointment O
with O
Dr. O
Aguirre O
for O
1-2 O
weeks O
. O

Make O
an O
appointment O
with O
Dr. O
Keller O
for O
4-5 O
weeks O
. O

Alice O
Jordan O
MD O
62-102 O

Completed O
by O
: O
Kitty O
Pamela O
NP O
80-BXH O
2014-04-25 O
@ O
0955 O

Signed O
electronically O
by O
: O
DR. O
Bessie O
R. O
Conners O
on O
: O
WED O
2014-05-21 O
9:31 O
AM O

( O
End O
of O
Report O
) O

435216075 O
YC O

93004953 O

1966777 O

5/26/2005 O
12:00:00 O
AM O

Atypical B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM

DIS O

Admission O
Date O
: O

05/26/2005 O

Report O
Status O
: O

Discharge O
Date O
: O

05/27/2005 O

****** O
DISCHARGE O
ORDERS O
****** O

CHEAMPBUR O
, O
STEENRA O
R. O

789-41-40-5 O
N56 O

Room O
: O

0W-320 O

Service O
: O

CAR O

DISCHARGE O
PATIENT O
ON O
: O

05/27/05 O
AT O
05:30 O
PM O

CONTINGENT O
UPON O

Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

SEISE O
, O
JR O
, O
EJAKE O
L. O
, O
M.D. O

CODE O
STATUS O
: O

Full O
code O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

ECASA B-TREATMENT
( I-TREATMENT
ASPIRIN I-TREATMENT
ENTERIC I-TREATMENT
COATED I-TREATMENT
) I-TREATMENT
81 O
MG O
PO O
QD O
LEVOXYL B-TREATMENT
( I-TREATMENT
LEVOTHYROXINE I-TREATMENT
SODIUM I-TREATMENT
) I-TREATMENT
25 O
MCG O
PO O
QD O
SYNAREL B-TREATMENT
( I-TREATMENT
NAFARELIN I-TREATMENT
ACETATE I-TREATMENT
) I-TREATMENT
1 O
PUFF O
NA O
BID O
NITROGLYCERIN B-TREATMENT
1/150 O
( O
0.4 O
MG O
) O
1 O
TAB O
SL O
Q5MIN O
X O
3 O
doses O
PRN O
Chest B-SYMPTOM
Pain I-SYMPTOM
MULTIVITAMIN B-TREATMENT
THERAPEUTIC I-TREATMENT
( I-TREATMENT
THERAPEUTIC I-TREATMENT
MULTIVI I-TREATMENT
... I-TREATMENT
) I-TREATMENT
1 O
TAB O
PO O
QD O

Alert O
overridden O
: O

Override O
added O
on O
05/26/05 O
by O
SAGELYSS O
, O
TYTUMZE O
V. O
, O
M.D. O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

SIMVASTATIN B-TREATMENT
and O
NIACIN B-TREATMENT
, O
VIT O
. O

B-3 O
Reason O
for O
override O
: O

ok O
TOPROL B-TREATMENT
XL I-TREATMENT
( I-TREATMENT
METOPROLOL I-TREATMENT
( I-TREATMENT
SUST. I-TREATMENT
REL. I-TREATMENT
) I-TREATMENT
) O
200 O
MG O
PO O
QD O

Food O
/ O
Drug O
Interaction O
Instruction O

Take O
consistently O
with O
meals O
or O
on O
empty O
stomach O
. O

Number O
of O
Doses O
Required O
( O
approximate O
) O
: O

8 O
PLAVIX B-TREATMENT
( I-TREATMENT
CLOPIDOGREL I-TREATMENT
) I-TREATMENT
75 O
MG O
PO O
QD O
LIPITOR B-TREATMENT
( I-TREATMENT
ATORVASTATIN I-TREATMENT
) I-TREATMENT
40 O
MG O
PO O
QD O

Alert O
overridden O
: O

Override O
added O
on O
05/27/05 O
by O
: O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

NIACIN B-TREATMENT
, O
VIT O
. O

B-3 O
and O
ATORVASTATIN B-TREATMENT
CALCIUM I-TREATMENT

Reason O
for O
override O
: O

ok O

DIET O
: O

House O
/ O
Low O
saturated O
fat O
low O
cholesterol O
&lt; O
FDI O
&gt; O

ACTIVITY O
: O

Resume O
regular O
exercise O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Follow O
up O
with O
your O
PCP O
within O
2 O
wks O
, O

ALLERGY O
: O

Morphine B-TREATMENT
, O

LEUPROLIDE B-TREATMENT
ADMIT O
DIAGNOSIS O
: O

Chest B-SYMPTOM
Pain I-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
Atypical B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O

s O
/ O
p O
inferior B-SYMPTOM
STEMI I-SYMPTOM
( O
2/17 O
) O
with O
stent B-TREATMENT
to I-TREATMENT
RCA I-TREATMENT
; O
TTE O
( O
2/17 O
) O
- O
LVEF O
55-60% O
, O
inferobasal B-SYMPTOM
HK I-SYMPTOM
; O
cervical B-SYMPTOM
spinal I-SYMPTOM
stenosis I-SYMPTOM
; O
hypothyroidism B-SYMPTOM
; O
GERD B-SYMPTOM
; O
endometriosis B-SYMPTOM
s O
/ O
p O
laparotomy O
and O
L B-TREATMENT
oophorectomy I-TREATMENT
. O

OPERATIONS O
AND O
PROCEDURES O
: O

none O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

ETT O
- O
MIBI O
5/27/05 O
- O
normal O
, O
no O
e O
/ O
o O
ischemia B-SYMPTOM
. O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

45 O
yo O
F O
s O
/ O
p O
recent B-SYMPTOM
inferior I-SYMPTOM
STEMI I-SYMPTOM
( O
2/17 O
) O
w/ O
100% O
RCA O
stented O
-&gt; O
0% O
, O
and O
residual B-SYMPTOM
LAD I-SYMPTOM
/ I-SYMPTOM
Diag1/LCx I-SYMPTOM
/ I-SYMPTOM
OM2 I-SYMPTOM
disease I-SYMPTOM
. O

Developed O
burning B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
before O
bedtime O
the O
night O
PTA O
. O

NO O
associated O
sxs B-SYMPTOM
/ O
radiation B-SYMPTOM
. O

Slept O
well O
, O
but O
on O
the O
am O
of O
admission O
had O
same B-SYMPTOM
burning I-SYMPTOM
across I-SYMPTOM
chest I-SYMPTOM
( O
&quot; O
deeper O
than O
heartburn B-SYMPTOM
&quot; O
) O
so O
went O
to O
her O
MD O
&apos;s O
office O
. O

Transient B-SYMPTOM
diaphoresis I-SYMPTOM
in O
MD O
&apos;s O
office O
that O
patient O
attributed O
to O
heat O
in O
room O
. O

Patient O
says O
pain B-SYMPTOM
is O
similar O
in O
location O
and O
quality O
to O
the B-SYMPTOM
pain I-SYMPTOM
she O
had O
with O
her B-SYMPTOM
MI I-SYMPTOM
, O
although O
with O
her B-SYMPTOM
MI I-SYMPTOM
the B-SYMPTOM
pain I-SYMPTOM
was O
much O
more O
intense O
( O
20x O
worse O
) O
. O

This O
is O
1st B-SYMPTOM
pain I-SYMPTOM
since O
MI B-SYMPTOM
( O
though O
patient O
reports O
chronic B-SYMPTOM
baseline I-SYMPTOM
chest I-SYMPTOM
tightness I-SYMPTOM
x8-10 O
years O
of O
unclear O
etiology O
) O
. O

CP B-SYMPTOM
/ O
burning B-SYMPTOM
lasted O
several O
hours O
and O
was O
relieved O
after O
she O
received O
Maalox B-TREATMENT
, O
lidocaine B-TREATMENT
, O
and O
NTG B-TREATMENT
in O
the O
ED O
. O

She O
reports O
compliance O
with O
her B-TREATMENT
ASA I-TREATMENT
+ O
plavix B-TREATMENT
. O

She O
is O
active O
at O
baseline O
, O
participating O
in O
cardiac B-TREATMENT
rehab I-TREATMENT
for O
2 O
hrs O
/ O
week O
and O
running O
up O
and O
down O
stairs O
at O
home O
without O
CP B-SYMPTOM
/ O
SOB B-SYMPTOM
. O

IN O
ED O
vitals O
p86 O
bp O
127/88 O
sat O
100% O
. O

NAD B-SYMPTOM
. O

No O
JVD B-SYMPTOM
. O

CTAB. O
nl O
s1s2 O
, O
reg O
, O
no O
m B-SYMPTOM
/ O
r. B-SYMPTOM
no O
chest B-SYMPTOM
tenderness I-SYMPTOM
. O

abd O
soft O
, O
NT B-SYMPTOM
/ O
ND B-SYMPTOM
, O
NABS. O
ext O
wwp O
, O
no O
c B-SYMPTOM
/ O
c/e B-SYMPTOM
, O
2+DP O
&apos;s O
b O
/ O
l. O

labs O
: O

A O
set O
: O

trop O
&lt; O
assay O
, O
CK O
67 O
, O
MB O
0.2 O
. O

EKG O
- O
old B-SYMPTOM
TWI I-SYMPTOM
III I-SYMPTOM
. O

A O
/ O
P O
: O

45F O
with O
recent B-SYMPTOM
inferior I-SYMPTOM
STEMI I-SYMPTOM
s O
/ O
p O
stent B-TREATMENT
to I-TREATMENT
RCA I-TREATMENT
. O

1. O
CV O
: O

( O
I O
) O
ROMI O
negative O
. O

ETT O
MIBI O
4/14 O
without O
e O
/ O
o O
ischemia B-SYMPTOM
. O
? O

GERD B-SYMPTOM
as O
etiology O
of O
her B-SYMPTOM
chest I-SYMPTOM
burning I-SYMPTOM
. O

cont O
asa B-TREATMENT
, O
statin B-TREATMENT
, O
plavix B-TREATMENT
, O
bblkr B-TREATMENT
. O

( O
P O
) O
Most O
recent O
echo O
: O

EF O
55% O
and O
inf B-SYMPTOM
/ I-SYMPTOM
post I-SYMPTOM
HK I-SYMPTOM
. O

( O
R O
) O
Patient O
had O
no O
events O
on O
tele O
. O

2. O
ENDO O
: O

continue O
levoxyl B-TREATMENT
for O
hypothyroidism B-SYMPTOM
, O
synarel B-TREATMENT
for O
endometriosis B-SYMPTOM
. O

3. O
MSK O
: O

cervical B-SYMPTOM
spondylosis I-SYMPTOM
, O
tylenol B-TREATMENT
for O
pain B-SYMPTOM
. O

4. O
GI O
: O

h O
/ O
o O
GERD- B-SYMPTOM
nexium B-TREATMENT
. O

FULL O
CODE O
ADDITIONAL O
COMMENTS O
: O

If O
you O
develop O
recurrent B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
or O
any B-SYMPTOM
other I-SYMPTOM
concerning I-SYMPTOM
symptoms I-SYMPTOM
, O
call O
your O
doctor O
or O
return O
to O
the O
hospital O
. O

Continue O
taking O
all O
of O
your B-TREATMENT
regular I-TREATMENT
home I-TREATMENT
medications I-TREATMENT
. O

Follow O
up O
with O
Dr. O
Koteskismanhout O
in O
July O
. O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

SAGELYSS O
, O
TYTUMZE O
V. O
, O
M.D. O
( O
FS69 O
) O
05/27/05 O
05:33 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2019-02-28 O

Discharge O
Date O
: O

2019-03-26 O

Date O
of O
Birth O
: O

1943-06-17 O

Sex O
: O

M O

Service O
: O

CARDIOTHORACIC O

Allergies O
: O

Morphine B-TREATMENT
Sulfate I-TREATMENT
/ O
Codeine B-TREATMENT
/ O
Keflex B-TREATMENT
/ O
Sudafed B-TREATMENT

Attending O
: O
Willa O
D O
Garcia O
, O
M.D. O

Chief O
Complaint O
: O

Fever B-SYMPTOM
/ O
+ O
BC B-SYMPTOM
w/ O
h/o O
MV B-SYMPTOM
endocarditis I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Mitral B-TREATMENT
Valve I-TREATMENT
Replacement I-TREATMENT
with O
31 B-TREATMENT
mm I-TREATMENT
SJM I-TREATMENT
Biocor I-TREATMENT
Tissue I-TREATMENT
valve I-TREATMENT
/ I-TREATMENT
della I-TREATMENT

Copeland B-TREATMENT
resection I-TREATMENT
on O
2019-03-19 O

History O
of O
Present O
Illness O
: O

Mr. O
Pizano O
is O
a O
75 O
y/o O
man O
who O
has O
a O
PMHx O
significant O
for O
Enterococcus B-SYMPTOM
mitral I-SYMPTOM
valve I-SYMPTOM
endocarditis I-SYMPTOM
which O
has O
been O
treated O
since O
09-19 O
. O

He O
has O
had O
2 O
6 O
week O
courses O
of O
antibiotics B-TREATMENT
with O
recurrent B-SYMPTOM
bacteremia I-SYMPTOM
. O

He O
had O
a O
TEE O
on O
2019-01-22 O
which O
revealed O
thickened B-SYMPTOM
mitral I-SYMPTOM
leaflets I-SYMPTOM
with O
small B-SYMPTOM
vegetations I-SYMPTOM
on I-SYMPTOM
both I-SYMPTOM
anterior I-SYMPTOM
and I-SYMPTOM
posterior I-SYMPTOM
leaflets I-SYMPTOM
with O
moderate B-SYMPTOM
to I-SYMPTOM
severe I-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
. O

He O
has O
preserved O
LV O
systolic O
function O
with O
mild B-SYMPTOM
TR I-SYMPTOM
and O
AR B-SYMPTOM
and O
LAE B-SYMPTOM
without O
abscess B-SYMPTOM
. O

He O
had O
a O
repeat O
TEE O
on O
02-19 O
which O
revealed O
4 B-SYMPTOM
+ I-SYMPTOM
MR I-SYMPTOM
. O

Thomasine O
was O
tranferred O
from O
MWMC O
( O
where O
he O
was O
admitted O
on O
02-15 O
with O
fevers B-SYMPTOM
and O
positive B-SYMPTOM
blood I-SYMPTOM
cultures I-SYMPTOM
) O
to O
IDMC O
for O
further B-TREATMENT
treatment I-TREATMENT
and O
possibly O
MVR B-TREATMENT
. O

Past O
Medical O
History O
: O
h/o O
Mitral B-SYMPTOM
Valve I-SYMPTOM
Endocarditis I-SYMPTOM

Hypertension B-SYMPTOM

h/o O
CVA B-SYMPTOM

Spinal B-SYMPTOM
Stenosis I-SYMPTOM
s/p O
Lumbar B-TREATMENT
Laminectomy I-TREATMENT
x O
3 O

Parkinson B-SYMPTOM
's I-SYMPTOM
disease I-SYMPTOM

h/o O
paranoid B-SYMPTOM
delusions I-SYMPTOM

MGUS B-SYMPTOM
vs O
MM B-SYMPTOM

Social O
History O
: O

Lives O
in O
nursing O
home O
. O

Quit O
smoking O
3.5 O
years O
ago O
. O

Denies O
ETOH O
. O

Family O
History O
: O

Non-contributory O

Physical O
Exam O
: O

Preop O

General O
: O

Elderly O
man O
in O
NAD B-SYMPTOM
, O
VSS O

HEENT O
: O

NC/AT B-SYMPTOM
, O
PERRLA O
, O
EOMI O
, O
poor B-SYMPTOM
dentition I-SYMPTOM

Neck O
: O

Supple O
, O
FROM O
, O
- O
thyromegaly B-SYMPTOM
, O
- O
lymphadenopathy B-SYMPTOM
, O
Carotids O
2 O
+ O

Bilat O
w/out O
bruits B-SYMPTOM

Lungs O
: O

CTAB O
- O
w/r/r B-SYMPTOM

Heart O
: O

RRR O
, O
+ O
S1S2 O
, O
02-18 O
mumrmur B-SYMPTOM

Abd O
: O

Soft O
NT/ND B-SYMPTOM
, O
+ O
BS O
without O
masses B-SYMPTOM
or O
hepatomegaly B-SYMPTOM
/ O
splenomegaly B-SYMPTOM

Ext O
: O

Warm O
, O
dry O
- O
c/c/e B-SYMPTOM
, O
pulses O
2+ O
throughout O

Neuro O
: O

Non-focal O
, O
MAE O

Skin O
: O
well-healed B-SYMPTOM
surgical I-SYMPTOM
scars I-SYMPTOM
on I-SYMPTOM
lower I-SYMPTOM
back I-SYMPTOM

Discharge O

Gen O
: O

NAD B-SYMPTOM
/ O
VSS O

Neuro O
: O

Alert O
, O
non O
focal O
exam O

Pulm O
: O

CTA O
bilat O

Card O
: O

RRR O
, O
sternum O
stable O
, O
incision B-SYMPTOM
clean O
and O
dry O
, O
no O
erythema B-SYMPTOM
/ O
drainage B-SYMPTOM

Abdm O
: O
soft O
, O
NT B-SYMPTOM
/ O
ND B-SYMPTOM
/ O
NABS B-SYMPTOM

Ext O
: O
warm O
well O
perfused O
, O
no O
C/C/E B-SYMPTOM

Pertinent O
Results O
: O

2019-02-28 O
07:30 O
PM O

GLUCOSE O
- O
94 O
UREA O
N O
- O
21 O
* O
CREAT O
- O
1.3 O
* O
SODIUM O
- O
138 O
POTASSIUM O
- O
5.0 O
CHLORIDE O
- O
105 O
TOTAL O
CO2 O
- O
25 O
ANION O
GAP O
- O
13 O

2019-02-28 O
07:30 O
PM O

ALT O
( O
SGPT O
)- O
6 O
AST O
( O
SGOT O
)- O
20 O
LD O
( O
LDH O
)- O
255 O
* O
ALK O
PHOS O
- O
134 O
* O
TOT O
BILI O
- O
0.4 O

2019-02-28 O
07:30 O
PM O

CALCIUM O
- O
9.3 O
PHOSPHATE O
- O
3.7 O
MAGNESIUM O
- O
2.3 O

2019-02-28 O
07:30 O
PM O

WBC O
- O
4.9 O
RBC O
- O
4.27 O
* O
HGB O
- O
11.3 O
* O
HCT O
- O
35.1 O
* O
MCV O
- O
82 O
MCH O
- O
26.4 O
* O
MCHC O
- O
32.2 O
RDW O
- O
17.4 O
* O

2019-02-28 O
07:30 O
PM O

NEUTS O
- O
66.3 O
LYMPHS O
- O
25.0 O
MONOS O
- O
5.7 O
EOS O
- O
0.1 O
BASOS O
- O
2.9 O
* O

2019-02-28 O
07:30 O
PM O

PLT O
COUNT O
- O
187 O

2019-02-28 O
07:30 O
PM O

PT O
- O
13.1 O
PTT O
- O
30.1 O
INR O
( O
PT O
)- O
1.1 O

2019-02-28 O
06:27 O
PM O
URINE O

COLOR O
- O
Amber O
APPEAR O
- O
Clear O
SP O
Stickney O
- O
1.015 O

2019-03-23 O
05:31 O
AM O
BLOOD O

WBC O
- O
8.6 O
RBC O
- O
3.43 O
* O
Hgb O
- O
9.9 O
* O
Hct O
- O
28.7 O
* O
MCV O
- O
84 O
MCH O
- O
28.9 O
MCHC O
- O
34.5 O
RDW O
- O
17.8 O
* O
Plt O
Ct O
- O
120 O
* O

2019-03-25 O
01:53 O
AM O
BLOOD O

Glucose O
- O
95 O
UreaN O
- O
35 O
* O
Creat O
- O
1.4 O
* O
Na O
- O
136 O
K O
- O
4.9 O
Cl O
- O
105 O
HCO3 O
- O
21 O
* O
AnGap O
- O
15 O

2019-03-25 O
04:47 O
PM O
BLOOD O
PT O
- O
14.1 O
* O
PTT O
- O
29.4 O
INR O
( O
PT O
)- O
1.3 O
* O

Brief O
Hospital O
Course O
: O

As O
mentioned O
in O
the O
HPI O
, O
Mr. O
Mcculley O
was O
transferred O
from O
MWMC O
to O
Nantucket O
Cottage O
Hospital O
for O
ongoing O
care O
( O
? O
MVR B-TREATMENT
). O

And O
Infectious O
disease O
consult O
was O
immediately O
made O
. O

IV B-TREATMENT
Daptomycin I-TREATMENT
was O
continued O
via O
PICC B-TREATMENT
line I-TREATMENT
which O
was O
inserted O
on O
02-20 O
at O
MWMC O
. O

Mr O
Stutts O
had O
an O
extensive O
preop O
evaluation O
including O
cardiology O
, O
infectious O
diseases O
, O
orthopedics O
, O
psychiatry O
and O
ethics O
services O
. O

He O
ultimately O
was O
brought O
to O
the O
operating O
room O
on O
03-19 O
. O

At O
that O
time O
he O
had O
a B-TREATMENT
Mitral I-TREATMENT
Valve I-TREATMENT
replacement I-TREATMENT
, O
aortoomy B-TREATMENT
, O
and O
left B-TREATMENT
atrial I-TREATMENT
appendage I-TREATMENT
resection I-TREATMENT
. O

His B-TREATMENT
bypass I-TREATMENT
time I-TREATMENT
was O
103 O
minutes O
/ O
crossclamp B-TREATMENT
89 O
mins O
. O

Please O
see O
OR O
report O
for O
full O
details O
. O

He O
tolerated O
the B-TREATMENT
surgery I-TREATMENT
well O
and O
was O
transferred O
from O
the O
OR O
to O
the O
CSRU O
on O
Epinephrinne B-TREATMENT
and O
Propofol B-TREATMENT
infusions I-TREATMENT
. O

He O
did O
well O
in O
immediate O
postoperative O
period O
. O

Following O
surgery B-TREATMENT
his B-TREATMENT
anesthesia I-TREATMENT
was O
reversed O
, O
he O
was O
weaned O
from O
ventilator B-TREATMENT
and O
successfully O
extubated O
. O

His B-TREATMENT
iv I-TREATMENT
medications I-TREATMENT
were O
also O
weaned O
to O
off O
. O

On O
POD1 O
His B-TREATMENT
PA I-TREATMENT
line I-TREATMENT
and O
chest B-TREATMENT
tubes I-TREATMENT
were O
removed O
, O
he O
was O
also O
started O
on O
Beta B-TREATMENT
blockers I-TREATMENT
and O
diuretics B-TREATMENT
. O

On O
POD2 O
the O
patient O
remained O
hemodynamically O
stable O
and O
was O
transferred O
from O
the O
ICU O
to O
F2 O
for O
continued O
postop O
care O
. O

Over O
the O
next O
several O
days O
with O
the O
assisstance O
of O
the O
nursing O
staff O
and O
physical O
therapy O
the O
patients O
activity O
level O
was O
advanced O
, O
he O
was O
transitioned O
to O
all B-TREATMENT
oral I-TREATMENT
medications I-TREATMENT
with O
the O
exception O
of O
his B-TREATMENT
antibiotics I-TREATMENT
. O

On O
POD7 O
it O
was O
decided O
that O
the O
pt O
was O
stable O
and O
ready O
for O
discharge O
to O
rehabilitation O
. O

It O
should O
be O
noted O
that O
the O
patient O
did O
have O
episodes O
of O
postoperative B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
, O
he O
was O
seen O
by O
the O

Electrophysiology O
service O
, O
started O
on O
Procainamide B-TREATMENT
and O
Coumadin B-TREATMENT
. O

Medications O
on O
Admission O
: O

Aricept B-TREATMENT
10 O
mg O
qd O
, O
Aspirin B-TREATMENT
81 O
mg O
qd O
, O
Folic B-TREATMENT
acid I-TREATMENT
, O
Gabapentin B-TREATMENT
200 O
mg O
tid O
, O
Lopressor B-TREATMENT
12.5 O
mg O
bid O
, O
Lisinopril B-TREATMENT
5 O
mg O
qd O
, O
Daptomycin B-TREATMENT
420 O
mg O
IV O
qd O
, O
Protonix B-TREATMENT
40 O
mg O
qd O
, O
Seroquel B-TREATMENT
50 O
mg O
tid O
, O
Heparin B-TREATMENT
5000 O
units O
SQ O
tid O
, O
Colace B-TREATMENT
100 O
mg O
bid O
, O
Lactulose B-TREATMENT
15 O
mg O
bid O
, O
Comtan B-TREATMENT
200 O
mg O
qd O
, O
Mirapex B-TREATMENT
1.5 O
mg O
tid O
, O
Sinemet B-TREATMENT
50 O
/ O
200 O
mg O
tid O

Discharge O
Medications O
: O

1. O
Furosemide B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
for O
2 O
weeks O
. O

2. O
Potassium B-TREATMENT
Chloride I-TREATMENT
20 O
mEq O
Packet O
Sig O
: O
One O
( O
1 O
) O
Packet O
PO O
once O
a O
day O
for O
2 O
weeks O
. O

3. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

4. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

5. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
) O
. O

6. O
Magnesium B-TREATMENT
Hydroxide I-TREATMENT
400 O
mg O
/ O
5 O
mL O
Suspension O
Sig O
: O
Thirty O
( O
30 O
) O
ML O
PO O
HS O
( O
at O
bedtime O
) O
as O
needed O
for O
constipation B-SYMPTOM
. O

7. O
Entacapone B-TREATMENT
200 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

8. O
Pramipexole B-TREATMENT
0.25 O
mg O
Tablet O
Sig O
: O
Six O
( O
6 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

9. O
Carbidopa B-TREATMENT
- I-TREATMENT
Levodopa I-TREATMENT
50 O
- O
200 O
mg O
Tablet O
Sustained O
Release O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

10. O
Quetiapine B-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

11. O
Procainamide B-TREATMENT
250 O
mg O
Capsule O
Sig O
: O
Three O
( O
3 O
) O
Capsule O
PO O
Q6H O
( O
every O
6 O
hours O
) O
: O
x O
6 O
weeks O
. O

12. O
Acetaminophen B-TREATMENT
- I-TREATMENT
Codeine I-TREATMENT
300-30 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
. O

13. O
Warfarin B-TREATMENT
1 O
mg O
Tablet O
Sig O
: O
as O
directed O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

14. O
Daptomycin B-TREATMENT
500 O
mg O
Recon O
Soln O
Sig O
: O
Four O
90y O
( O
480 O
) O
mg O
Intravenous O
Q24H O
( O
every O
24 O
hours O
) O
: O
thru O
05-02 O
. O

Discharge O
Disposition O
: O

Extended B-TREATMENT
Care I-TREATMENT

Discharge O
Diagnosis O
: O
mitral B-SYMPTOM
valve I-SYMPTOM
endocarditis I-SYMPTOM
s/p O
MV B-TREATMENT
replacement I-TREATMENT

HTN B-SYMPTOM

s/p O
CVA B-SYMPTOM

Spinal B-SYMPTOM
stenosis I-SYMPTOM
s/p O
Lumbar B-TREATMENT
Laminectomy I-TREATMENT

Parkingson B-SYMPTOM
's I-SYMPTOM

h/o O
paranoid B-SYMPTOM
delusions I-SYMPTOM

MGUS B-SYMPTOM
vs O
MM B-SYMPTOM

Discharge O
Condition O
: O
good O

Discharge O
Instructions O
: O

May O
take O
shower O
. O

Wash O
incisions B-SYMPTOM
with O
warm O
water O
and O
gentle O
soap O
. O

Do O
no O
take O
bath O
or O
swim O
. O

Do O
not O
apply O
lotions B-TREATMENT
, O
creams B-TREATMENT
, O
ointments B-TREATMENT
or O
powders B-TREATMENT
to O
incision B-SYMPTOM
. O

Do O
not O
drive O
for O
1 O
month O
. O

Do O
not O
lift O
more O
than O
10 O
pounds O
for O
2 O
months O
. O

Please O
contact O
office O
if O
you O
develop O
a B-SYMPTOM
fever I-SYMPTOM
more O
than O
101.5 O
or O
notice O
drainage B-SYMPTOM
from O
chest B-SYMPTOM
incision I-SYMPTOM
. O

Followup O
Instructions O
: O

Dr. O
Portsche O
in O
4 O
weeks O

Dr. O
Bravo O
( O
PCP O
) O
in O
1-2 O
weeks O

Infectious O
disease O
Provider O
: O

Marsha O
Harriet O
, O
MD O

Phone O
: O
574-5036 O

Date O
/ O
Time O
: O
2019-04-29 O
10:00 O

Jeffrey O
Everett O
MD O
23-815 O

Completed O
by O
: O
MARK O
Carolyn O
NP O
80-AUO O
2019-03-26 O
@ O
1033 O

Signed O
electronically O
by O
: O
DR. O
Millard O
Fornataro O
on O
: O
FRI O
2019-03-29 O
4:45 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2017-06-12 O

Discharge O
Date O
: O

2017-06-14 O

Date O
of O
Birth O
: O

1946-06-16 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Penicillins B-TREATMENT
/ O
Keflex B-TREATMENT
/ O
Sulfa B-TREATMENT
( I-TREATMENT
Sulfonamides I-TREATMENT
) O
/ O
Nickel O
/ O
Erythromycin B-TREATMENT
Ethylsuccinate I-TREATMENT

Attending O
: O
Michael O
Y. O
R. O
Xiang O
, O
M.D. O

Chief O
Complaint O
: O

Disconnected B-SYMPTOM
pigtail I-SYMPTOM
catheter I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Removal B-TREATMENT
of I-TREATMENT
catheter I-TREATMENT

History O
of O
Present O
Illness O
: O

70 O
y/o O
F O
w/ O
tracheobronchomalacia B-SYMPTOM
, O
COPD B-SYMPTOM
, O
PMR B-SYMPTOM
, O
recurrent B-SYMPTOM
pneumonias I-SYMPTOM
who O
was O
recently O
discharged O
from O
Hallmark O
Health O
System O
to O
Pocasset O
Mental O
Health O
Center O

06-07 O
after O
tracheobronchoplasty B-TREATMENT
/ O
tracheostomy B-TREATMENT
and O
pigtail B-TREATMENT
catheter I-TREATMENT
placement I-TREATMENT
for O
pleural B-SYMPTOM
effusions I-SYMPTOM
. O

Since O
discharge O
pt O
has O
continued O
at O
rehab O
on O
ps B-TREATMENT
vent I-TREATMENT
settings I-TREATMENT
but O
pigtail B-TREATMENT
catheter I-TREATMENT
fell O
out O
today O
so O
pt O
was O
referred O
here O
for O
monitoring O
. O

On O
ROS O
, O
she O
notes O
feeling O
poorly B-SYMPTOM
, O
nausea B-SYMPTOM
, O
and O
diarrhea B-SYMPTOM
since O
d/c O
. O

She O
has O
pleuritic B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
which O
she O
has O
had O
since O
she O
arrested O
during O
her O
admission O
here O
and O
had O
CPR B-TREATMENT
. O

Per O
husband O
she O
has O
no O
cardiac B-SYMPTOM
history I-SYMPTOM
, O
and O
had O
a O
stress O
test O
( O
unclr O
how O
recent O
) O
that O
was O
normal O

Past O
Medical O
History O
: O

Past O
CMED O
Hx O
: O

Tracheobronchomalacia B-SYMPTOM

PMR B-SYMPTOM
s/p O
TAH B-TREATMENT

COPD B-SYMPTOM

AFib B-SYMPTOM
post O
op O

Recent B-SYMPTOM
UTI I-SYMPTOM
rx O
w/aztreonam B-TREATMENT

MRSA B-SYMPTOM
pna I-SYMPTOM
rx O
w/vanc B-TREATMENT

Anxiety B-SYMPTOM

Hx O
resp B-SYMPTOM
arrest I-SYMPTOM
post-op O

husb O

Social O
History O
: O

Soc O
Hx O
: O
lives O
in O
Va O
with O
her O
husband O
, O
has O
been O
up O
here O
since O
April O
s/p O
month O
long O
hospitalization O
, O
no O
tob/etoh O

Family O
History O
: O
nc O

Physical O
Exam O
: O

VS O
: O

GEN O
: O

NAD B-SYMPTOM

HEENT O
: O

PERRLA O
, O
EOMI O

RESP O
: O

CTA O
- O
ant O

CV O
: O

RRR O
, O
nl O
s1 O
, O
s2 O
, O
no O
m/r/g B-SYMPTOM

abd O
: O
soft O
, O
nt,nd B-SYMPTOM
, O
nabs O

extrem O
: O

1+ B-SYMPTOM
edema I-SYMPTOM
blt I-SYMPTOM

Neuro O
: O

CNII O
- O
XII O
intact O

Pertinent O
Results O
: O

ECG O
: O
rate O
66 O
, O
sinus O
w/PAC B-SYMPTOM
's I-SYMPTOM
, O
QT O
476 O
, O
TWI B-SYMPTOM
in I-SYMPTOM
V1-6 I-SYMPTOM
( O
deep O
in O
v2-4 O
) O

CXR O
: O

IMPRESSION O
: O

Interval O
resolution O
of O
the B-SYMPTOM
right I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
and O
no O
evidence O
of O
pneumothorax B-SYMPTOM
. O

A B-SYMPTOM
small I-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
? O

No O
changes O
in O
the O
position O
or O
alignment O
of O
multiple B-TREATMENT
lines I-TREATMENT
and O
tubes B-TREATMENT

PATIENT O
/ O
TEST O
INFORMATION O
: O

Indication O
: O

Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

Left O
ventricular O
function O
. O

Height O
: O
( O
in O
) O
62 O

Weight O
( O
lb O
) O
: O
180 O

BSA O
( O
m2 O
) O
: O
1.83 O
m2 O

BP O
( O
mm O
Hg O
) O
: O
115/48 O

HR O
( O
bpm O
) O
: O
60 O

Status O
: O
Inpatient O

Date O
/ O
Time O
: O
2017-06-13 O
at O
15:47 O

Test O
: O
TTE O
( O
Complete O
) O

Doppler O
: O
Full O
doppler O
and O
color O
doppler O

Contrast O
: O
None O

Tape O
Number O
: O
2005W251-0:21 O

Test O
Location O
: O
West O
Echo O
Lab O

Technical O
Quality O
: O
Suboptimal O

REFERRING O
DOCTOR O
: O
DR. O
Gregory O
ERNST O

DR. O
Grace O
ERNST O

MEASUREMENTS O
: O

Left O
Atrium O
- O
Four O
Chamber O
Length O
: O
5.1 O
cm O
( O
nl O
<= O
5.2 O
cm O
) O

Right O
Atrium O
- O
Four O
Chamber O
Length O
: O
* O
6.2 O
cm O
( O
nl O
<= O
5.0 O
cm O
) O

Left O
Ventricle O
- O
Septal O
Wall O
Thickness O
: O
0.8 O
cm O
( O
nl O
0.6 O
- O
1.1 O
cm O
) O

Left O
Ventricle O
- O
Inferolateral O
Thickness O
: O
0.8 O
cm O
( O
nl O
0.6 O
- O
1.1 O
cm O
) O

Left O
Ventricle O
- O
Diastolic O
Dimension O
: O
5.3 O
cm O
( O
nl O
<= O
5.6 O
cm O
) O

Left O
Ventricle O
- O
Ejection O
Fraction O
: O
>= O
40% O
( O
nl O
>= O
55% O
) O

Aortic O
Valve O
- O
Peak O
Velocity O
: O
1.4 O
m O
/ O
sec O
( O
nl O
<= O
2.0 O
m O
/ O
sec O
) O

Mitral O
Valve O
- O
E O
Wave O
: O
1.1 O
m O
/ O
sec O

Mitral O
Valve O
- O
A O
Wave O
: O
1.0 O
m O
/ O
sec O

Mitral O
Valve O
- O
E/A O
Ratio O
: O
1.10 O

TR O
Gradient O
( O
+ O
RA O
= O
PASP O
) O
: O
* O
36 O
mm O
Hg O
( O
nl O
<= O
25 O
mm O
Hg O
) O

INTERPRETATION O
: O

Findings O
: O

This O
study O
was O
compared O
to O
the O
prior O
study O
of O
2017-06-01 O
. O

LEFT O
ATRIUM O
: O

Normal O
LA O
size O
. O

LEFT O
VENTRICLE O
: O

Wall O
thickness O
and O
cavity O
dimensions O
were O
obtained O
from O
2D O
images O
. O

Normal O
LV O
wall O
thicknesses O
and O
cavity O
size O
. O

Suboptimal O
technical O
quality O
, O
a B-SYMPTOM
focal I-SYMPTOM
LV I-SYMPTOM
wall I-SYMPTOM
motion I-SYMPTOM
abnormality I-SYMPTOM
cannot O
be O
fully O
excluded O
. O

No O
resting O
LVOT O
gradient O
. O

RIGHT O
VENTRICLE O
: O

Normal O
RV O
chamber O
size O
and O
free O
wall O
motion O
. O

AORTA O
: O

Normal O
aortic O
root O
diameter O
. O

Focal B-SYMPTOM
calcifications I-SYMPTOM
in I-SYMPTOM
aortic I-SYMPTOM
root I-SYMPTOM
. O

AORTIC O
VALVE O
: O

Normal O
aortic O
valve O
leaflets O
. O

No O
AR B-SYMPTOM
. O

MITRAL O
VALVE O
: O

Normal O
mitral O
valve O
leaflets O
. O

Mild B-SYMPTOM
( I-SYMPTOM
1+ I-SYMPTOM
) I-SYMPTOM
MR I-SYMPTOM
. O

TRICUSPID O
VALVE O
: O

Mild B-SYMPTOM
PA I-SYMPTOM
systolic I-SYMPTOM
hypertension I-SYMPTOM
. O

PERICARDIUM O
: O

No O
pericardial B-SYMPTOM
effusion I-SYMPTOM
. O

GENERAL O
COMMENTS O
: O

Suboptimal O
image O
quality O
- O
poor O
echo O
windows O
. O

Based O
on O
1997 O
AHA O
endocarditis O
prophylaxis O
recommendations O
, O
the O
echo O
findings O
indicate O
a O
low O
risk O
( O
prophylaxis B-TREATMENT
not O
recommended O
). O

Clinical O
decisions O
regarding O
the O
need O
for O
prophylaxis B-TREATMENT
should O
be O
based O
on O
clinical O
and O
echocardiographic O
data O
. O

Conclusions O
: O

The O
left O
atrium O
is O
normal O
in O
size O
. O

Left O
ventricular O
wall O
thicknesses O
and O
cavity O
size O
are O
normal O
. O

Due O
to O
suboptimal O
technical O
quality O
, O
a B-SYMPTOM
focal I-SYMPTOM
wall I-SYMPTOM
motion I-SYMPTOM
abnormality I-SYMPTOM
cannot O
be O
fully O
excluded O
. O

Overall O
systolic O
function O
is O
good O
( O
LVEF O
> O
40% O
). O

Right O
ventricular O
chamber O
size O
and O
free O
wall O
motion O
are O
normal O
. O

The O
aortic O
valve O
leaflets O
appear O
structurally O
normal O
with O
good O
leaflet O
excursion O
. O

No O
aortic B-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

The O
mitral O
valve O
leaflets O
are O
structurally O
normal O
. O

Mild B-SYMPTOM
( I-SYMPTOM
1+ I-SYMPTOM
) I-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

There O
is O
mild B-SYMPTOM
pulmonary I-SYMPTOM
artery I-SYMPTOM
systolic I-SYMPTOM
hypertension I-SYMPTOM
. O

There O
is O
no O
pericardial B-SYMPTOM
effusion I-SYMPTOM
. O

IMPRESSION O
: O

Good O
global O
biventricular O
systolic O
function O
. O

Mild B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
. O

The O
prior O
study O
of O
2017-06-01 O
( O
tape O
reviewed O
) O
was O
of O
very O
suboptimal O
technical O
quality O
and O
not O
directly O
comparable O
to O
the O
current O
study O
. O

If O
more O
definitive O
information O
regarding O
ventricualr O
fuynction O
is O
needed O
, O
a O
cardiac O
MRI O
( O
( O
951 O
) O
247-0244 O
) O
or O
radionuclide O
study O
is O
suggested O
. O

Based O
on O
1997 O
AHA O
endocarditis O
prophylaxis O
recommendations O
, O
the O
echo O
findings O
indicate O
a B-SYMPTOM
low I-SYMPTOM
risk I-SYMPTOM
( O
prophylaxis B-TREATMENT
not O
recommended O
). O

Clinical O
decisions O
regarding O
the O
need O
for O
prophylaxis B-TREATMENT
should O
be O
based O
on O
clinical O
and O
echocardiographic O
data O
. O

Electronically O
signed O
by O
Lisa O
John O
, O
MD O
on O
2017-06-13 O
18:41 O
. O

Oak O
Bluffs O
PHYSICIAN O
: O
Gregory,Domingo O
J O
. O

Brief O
Hospital O
Course: O

Pleural B-SYMPTOM
effusion I-SYMPTOM
: O
s/p O
pigtail B-TREATMENT
cath I-TREATMENT
drain I-TREATMENT
. O

Imaging O
indicated O
that O
the B-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
had O
resolved O
. O

Thoracics O
agreed O
to O
no O
need O
for O
pigtail B-TREATMENT
placement I-TREATMENT
. O

CHF B-SYMPTOM
: O

Patient O
was O
seen O
by O
CHF O
( O
echo O
results O
are O
detailed O
above O
) O
. O

They O
recommended O
continuing O
beta-blocker B-TREATMENT
and O
titarting O
ace B-TREATMENT
as O
tolerated O
. O

Patient O
should O
be O
kept O
euvolemic O
once O
peripheral B-SYMPTOM
edema I-SYMPTOM
resolves O
( O
may O
use O
lasix B-TREATMENT
to O
decrease O
edema B-SYMPTOM
). O

She O
will O
need O
a O
repeat O
echo O
in O
3-6 O
months O
( O
since O
this O
echo O
showed O
a O
question O
of O
focal B-SYMPTOM
wall I-SYMPTOM
motion I-SYMPTOM
abnormality I-SYMPTOM
). O

Also O
, O
patient O
was O
started O
on O
amiodarone B-TREATMENT
and O
digoxin B-TREATMENT
was O
held O
secondary O
to O
high B-SYMPTOM
levels I-SYMPTOM
( O
please O
restart O
when O
level O
less O
than O
2 O
) O

Diarrhea B-SYMPTOM
: O

Stool O
c. O
diff O
neg O
x1 O
. O

She O
will O
need O
two O
more O
specimens O
. O

COPD B-SYMPTOM
: O
cont O
nebs B-TREATMENT
. O

PAF B-SYMPTOM
: O
started O
on O
amio B-TREATMENT
, O
cont O
b-blocker B-TREATMENT
, O
and O
patient O
was O
started O
on O
coumadin B-TREATMENT
- O
levels O
( O
inr O
) O
should O
be O
monitored O
. O

Nutrition O
: O

Patient O
should O
be O
started O
on O
tube B-TREATMENT
feeds I-TREATMENT
at O
rehab O

Rash B-SYMPTOM
: O

Patient O
developed O
a B-SYMPTOM
diffuse I-SYMPTOM
erythematous I-SYMPTOM
rash I-SYMPTOM
, O
though O
to O
be O
an B-SYMPTOM
ID I-SYMPTOM
reaction I-SYMPTOM
to O
a B-SYMPTOM
recent I-SYMPTOM
fungal I-SYMPTOM
infection I-SYMPTOM
. O

She O
has O
been O
satrted O
on O
benadryl B-TREATMENT
and O
hydrocort B-TREATMENT
for O
sx O
relief O
. O

Please O
monitor O
this O
( O
may O
need O
dermatology O
consult O
). O

Also O
a B-SYMPTOM
drug I-SYMPTOM
reaction I-SYMPTOM
is O
in O
the O
ddx O
but O
unlikely O
as O
rash B-SYMPTOM
started O
at O
rehab O
prior O
to O
receiving O
drugs B-TREATMENT
here O
. O

Medications O
on O
Admission O
: O

Meds B-TREATMENT
at O
Pocasset O
Mental O
Health O
Center O
: O

SQ B-TREATMENT
heparin I-TREATMENT
, O
MVI B-TREATMENT
, O
nystatin B-TREATMENT
, O
colace B-TREATMENT
, O
albuterol B-TREATMENT
, O
atrovent B-TREATMENT
, O
amiodarone B-TREATMENT
400 O
bid O
, O
pulmicort B-TREATMENT
, O
digoxin B-TREATMENT
, O
metoprolol B-TREATMENT
12.5 O
tid O
, O
reglan B-TREATMENT

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O
tracheobronchomalecia B-SYMPTOM
chf B-SYMPTOM

PAF B-SYMPTOM

COPD B-SYMPTOM

Discharge O
Condition O
: O
deconditioned B-SYMPTOM
but O
stable O

Discharge O
Instructions O
: O

Please O
call O
your O
doctor O
or O
come O
to O
Robert O
if O
you O
develop O
fevers B-SYMPTOM
, O
chills B-SYMPTOM
, O
cp B-SYMPTOM
, O
nausea B-SYMPTOM
or O
vomiting B-SYMPTOM
, O
or O
any B-SYMPTOM
other I-SYMPTOM
concerning I-SYMPTOM
sx I-SYMPTOM

Followup O
Instructions O
: O

Call O
Dr. O
Pederson O
office O
for O
appointment O
in O
2-3 O
weeks O
-( O
869 O
) O
263-1570. O

you O
will O
need O
a O
repeat O
echo O
within O
3-6 O
months O

Please O
call O
your O
PCP O
for O
an O
appointment O
within O
1 O
week O
- O
number O
to O
call O
is O
( O
489 O
) O
489 O
0229 O
ext O
7499 O

ARMIN O
ERNST O
MD O
57-915 O

Completed O
by O
: O
Neva O
Rhonda O
MD O
77-523 O
2017-06-14 O
@ O
1112 O

Signed O
electronically O
by O
: O
DR. O
Rhonda O
ERNST O
on O
: O
FRI O
2017-06-16 O
1:44 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-04-25 O

Discharge O
Date O
: O

2013-05-11 O

Date O
of O
Birth O
: O

1963-05-10 O

Sex O
: O

M O

Service O
: O

CMED O
CSRU O

CHIEF O
COMPLAINT O
: O

Cardiac B-SYMPTOM
arrest I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
49 O
year O
old O
man O
who O
was O
admitted O
to O
the O
Medical O
Intensive O
Care O
Unit O
status O
post O
cardiac B-SYMPTOM
arrest I-SYMPTOM
. O

History O
was O
obtained O
per O
the O
Emergency O
Department O
report O
as O
well O
as O
from O
the O
patient O
's O
family O
. O

Information O
was O
very O
limited O
regarding O
the O
circumstances O
of O
his B-SYMPTOM
cardiac I-SYMPTOM
arrest I-SYMPTOM
. O

Reportedly O
, O
the O
patient O
was O
at O
a O
local O
restaurant O
where O
he O
was O
noted O
to O
be O
unresponsive B-SYMPTOM
. O

EMS O
was O
called O
and O
reported O
to O
arrive O
on O
scene O
within O
three O
minutes O
. O

The O
patient O
was O
asystolic B-SYMPTOM
but O
regained O
a O
perfusing O
rhythm O
after O
2 O
mg O
of O
Epinephrine B-TREATMENT
and O
2 O
mg O
of O
Atropine B-TREATMENT
. O

He O
was O
intubated O
in O
the O
field O
and O
brought O
to O
the O
Emergency O
Department O
. O

He O
remained O
unresponsive B-SYMPTOM
despite O
the O
administration O
of O
Narcan B-TREATMENT
. O

CT O
examinations O
of O
the O
head O
, O
chest O
, O
abdomen O
and O
pelvis O
were O
all O
unremarkable O
. O

Initial O
chest O
x-ray O
showed O
a B-SYMPTOM
left I-SYMPTOM
retrocardiac I-SYMPTOM
opacity I-SYMPTOM
and O
prominent B-SYMPTOM
interstitium I-SYMPTOM
though O
his O
lung O
volumes O
were O
low B-SYMPTOM
. O

Subsequent O
chest O
x-ray O
showed O
right B-TREATMENT
main I-TREATMENT
stem I-TREATMENT
intubation I-TREATMENT
with O
left B-SYMPTOM
lung I-SYMPTOM
collapse I-SYMPTOM
which O
had O
corrected O
with O
withdrawal B-TREATMENT
of I-TREATMENT
the I-TREATMENT
endotracheal I-TREATMENT
tube I-TREATMENT
. O

The O
patient O
was O
then O
transferred O
to O
the O
Medical O
Intensive O
Care O
Unit O
for O
induced B-TREATMENT
hypothermia I-TREATMENT
given O
his O
hemodynamic O
stability O
, O
ongoing B-SYMPTOM
unresponsiveness I-SYMPTOM
and O
recent B-SYMPTOM
out I-SYMPTOM
of I-SYMPTOM
hospital I-SYMPTOM
cardiac I-SYMPTOM
arrest I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1) O
Hypertension B-SYMPTOM
. O

2) O
Chronic B-SYMPTOM
low I-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
, O
s/p O
lumbar B-TREATMENT
discectomy I-TREATMENT
x O
2 O
. O

3) O
Cirrhosis B-SYMPTOM
. O

4) O
h/o O
stab B-SYMPTOM
wound I-SYMPTOM
complicated O
by O
pneumothorax B-SYMPTOM
. O

5) O
h/o O
lower B-SYMPTOM
extremity I-SYMPTOM
cellulitis I-SYMPTOM
. O

6) O
s/p O
cholecystectomy B-TREATMENT
. O

7) O
Peripheral B-SYMPTOM
neuropathy I-SYMPTOM
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

According O
to O
his O
pharmacy O
, O
he O
was O
on O
: O

1. O
OxyContin B-TREATMENT
40 O
mg O
p.o. O
q O
12hours O
. O

2. O
Percocet B-TREATMENT
. O

3. O
Nortriptyline B-TREATMENT
. O

4. O
Neurontin B-TREATMENT
1800 O
mg O
four O
times O
a O
day O

SOCIAL O
HISTORY O
: O

The O
patient O
is O
divorced O
. O

His O
son O
is O
a O
policeman O
working O
in O
Ludlow O
. O

He O
drinks O
greater O
than O
one O
case O
of O
beer O
per O
day O
. O

He O
has O
a O
history O
of O
abuse O
of O
Percocet B-TREATMENT
according O
to O
his O
brother O
. O

James O
is O
currently O
homeless O
. O

He O
was O
recently O
arrested O
for O
altering O
a O
prescription O
according O
to O
his O
pharmacy O
. O

He O
had O
recently O
filled O
a O
prescription O
for O
560 O
tablets O
of O
Percocet B-TREATMENT
as O
well O
as O
60 O
tablets O
of O
OxyContin B-TREATMENT
early O
last O
month O
. O

FAMILY O
HISTORY O
: O

Negative O
for O
any O
history O
of O
sudden B-SYMPTOM
death I-SYMPTOM
or O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
, O
temperature O
was O
96.2 O
, O
blood O
pressure O
150/80 O
, O
heart O
rate O
92 O
, O
respiratory O
rate O
16 O
. O

In O
general O
, O
he O
was O
unarousible B-SYMPTOM
, O
intubated B-TREATMENT
, O
not O
on O
any B-TREATMENT
sedation I-TREATMENT
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
- O
His O
pupils O
were O
equal O
and O
three O
millimeters O
. O

They O
were O
minimally B-SYMPTOM
reactive I-SYMPTOM
. O

His O
sclerae O
were O
anicteric B-SYMPTOM
. O

The O
cardiac O
examination O
was O
unremarkable O
without O
murmurs B-SYMPTOM
. O

The O
lungs O
were O
clear O
to O
auscultation O
bilaterally O
. O

His O
abdomen O
had O
normal O
bowel O
sounds O
, O
soft O
and O
nontender B-SYMPTOM
. O

Extremities O
had O
multiple B-SYMPTOM
bilateral I-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
excoriations I-SYMPTOM
. O

Neurologic O
examination O
- O
he O
was O
unarousible B-SYMPTOM
and O
without O
sedation B-TREATMENT
. O

He O
had O
no B-SYMPTOM
spontaneous I-SYMPTOM
movements I-SYMPTOM
. O

Flaccid B-SYMPTOM
. O

Extremities O
- O
Babinski O
reflex O
was O
equivocal O
bilaterally O
. O

LABORATORY O
DATA O
: O

At O
the O
time O
of O
admission O
, O
laboratories O
were O
remarkable O
for O
a O
partial O
thromboplastin O
time O
of O
31.7 O
, O
INR O
1.4 O
, O
potassium O
3.2 O
, O
glucose O
182 O
, O
lactate O
was O
initially O
6.6 O
. O

Urine O
toxicology O
screen O
was O
negative O
. O

Serum O
toxicology O
screen O
was O
positive O
for O
TCA B-TREATMENT
s. I-TREATMENT

Tylenol O
level O
was O
15 O
. O

Alcohol O
level O
was O
199 O
. O

Initial O
blood O
gas O
was O
7.31/46/500/77 O
. O

HOSPITAL O
COURSE O
: O

Cardiac B-SYMPTOM
arrest I-SYMPTOM
- O
His B-SYMPTOM
arrest I-SYMPTOM
was O
of O
unknown O
etiology O
at O
the O
time O
of O
admission O
. O

No O
further O
history O
was O
ever O
gained O
about O
his B-SYMPTOM
cardiac I-SYMPTOM
arrest I-SYMPTOM
throughout O
his O
hospitalization O
. O

CT O
angiogram O
had O
been O
negative O
for O
pulmonary B-SYMPTOM
embolism I-SYMPTOM
. O

The O
patient O
had O
an O
echocardiogram O
on O
2013-04-26 O
, O
which O
showed O
a O
normal O
ejection O
fraction O
and O
trivial B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
; O
otherwise O
no O
obvious B-SYMPTOM
abnormalities I-SYMPTOM
were O
seen O
. O

Given O
the O
patient O
had O
an B-SYMPTOM
out I-SYMPTOM
of I-SYMPTOM
hospital I-SYMPTOM
arrest I-SYMPTOM
, O
remained O
unresponsive B-SYMPTOM
despite O
hemodynamic O
stability O
, O
he O
was O
treated O
with O
induced B-TREATMENT
hypothermia I-TREATMENT
and O
with O
cold B-TREATMENT
packs I-TREATMENT
and O
a B-TREATMENT
cooling I-TREATMENT
blanket I-TREATMENT
were O
placed O
with O
goals O
of O
reducing O
his O
core O
body O
temperature O
to O
32 O
degrees O
Celsius O
for O
a O
period O
of O
twelve O
hours O
at O
which O
point O
he O
would O
be O
rewarmed O
over O
the O
subsequent O
six O
hours O
. O

This O
was O
done O
, O
however O
, O
as O
in O
problem O
number O
two O
below O
, O
we O
were O
not O
successful O
in O
any O
neurologic O
recovery O
. O

Neurology O
- O
The O
patient O
remained O
unresponsive B-SYMPTOM
after O
the B-TREATMENT
induced I-TREATMENT
hypothermia I-TREATMENT
, O
the O
patient O
was O
noticed O
to O
develop O
myoclonic B-SYMPTOM
jerks I-SYMPTOM
and O
occasional O
fluttering O
of O
his O
eyelids O
. O

Electroencephalogram O
revealed O
the O
patient O
was O
experiencing O
persistent B-SYMPTOM
seizure I-SYMPTOM
activity I-SYMPTOM
. O

Neurology O
was O
consulted O
and O
the O
patient O
was O
treated O
very O
aggressively O
, O
loaded O
with O
multiple B-TREATMENT
drugs I-TREATMENT
, O
including O
Ativan B-TREATMENT
and O
Propofol B-TREATMENT
drips I-TREATMENT
. O

The O
patient O
continued O
to O
demonstrate O
seizure B-SYMPTOM
activity I-SYMPTOM
despite O
this O
. O

He O
was O
loaded O
with O
Dilantin B-TREATMENT
and O
ultimately O
was O
treated O
with O
a B-TREATMENT
Pentobarb I-TREATMENT
coma I-TREATMENT
. O

After O
multiple O
attempts O
of O
weaning O
the B-TREATMENT
Pentobarb I-TREATMENT
, O
the O
patient O
was O
continually O
reverting O
to O
status B-SYMPTOM
epilepticus I-SYMPTOM
which O
was O
never O
able O
to O
be O
suppressed O
. O

Infectious O
disease O
- O
Over O
the O
course O
of O
his O
hospital O
stay O
, O
the O
patient O
's O
white O
blood O
cell O
count O
rose O
to O
a O
peak O
of O
17 O
. O

Multiple O
cultures O
were O
done O
and O
the O
patient O
was O
ultimately O
found O
to O
have O
methicillin B-SYMPTOM
resistant I-SYMPTOM
Staphylococcus I-SYMPTOM
aureus I-SYMPTOM
bacteremia I-SYMPTOM
, O
pneumonia B-SYMPTOM
, O
and O
urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

For O
all O
these B-SYMPTOM
infections I-SYMPTOM
, O
the O
patient O
was O
treated O
with O
Vancomycin B-TREATMENT
and O
he O
was O
also O
on O
Levofloxacin B-TREATMENT
and O
Flagyl B-TREATMENT
for O
presumed O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
at O
the O
time O
of O
his O
admission O
. O

Blood O
cultures O
cleared O
by O
2013-05-03 O
. O

Sputum O
culture O
as O
late O
as O
2013-05-10 O
, O
however O
was O
still O
positive O
for O
coagulase B-SYMPTOM
positive I-SYMPTOM
Staphylococcus I-SYMPTOM
which O
was O
methicillin B-SYMPTOM
resistant I-SYMPTOM
Staphylococcus I-SYMPTOM
aureus I-SYMPTOM
. O

The O
patient O
remained O
gravely B-SYMPTOM
ill I-SYMPTOM
throughout O
his O
hospital O
stay O
and O
had O
multiple O
meetings O
were O
held O
with O
his O
family O
with O
his O
son O
being O
his O
next O
of O
kin O
. O

Ultimately O
it O
was O
decided O
that O
the O
patient O
's O
wishes O
would O
be O
to O
not O
be O
maintained O
in O
a O
vegetative O
state O
and O
given O
his O
poor O
prognosis O
ultimately O
the O
decision O
was O
made O
to O
pursue O
comfort B-TREATMENT
measures I-TREATMENT
only O
. O

With O
these O
goals O
of O
care O
, O
the O
patient O
expired O
on O
2013-05-11 O
. O

The O
family O
did O
consent O
to O
a O
postmortem O
examination O
. O

DISCHARGE O
DIAGNOSES O
: O

Cardiac B-SYMPTOM
arrest I-SYMPTOM
. O

Anoxic B-SYMPTOM
brain I-SYMPTOM
injury I-SYMPTOM

Status B-SYMPTOM
epilepticus I-SYMPTOM

Methicillin B-SYMPTOM
resistant I-SYMPTOM
Staphylococcus I-SYMPTOM
aureus I-SYMPTOM
pneumonia I-SYMPTOM
. O

MRSA B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

MRSA B-SYMPTOM
Bacteremia I-SYMPTOM
. O

Steven O
Welch O
, O
Montana O
61528 O

Dictated O
By O
: O
Julie O
DD O
George O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-12-24 O
13:55:05 O

T O
: O
2013-12-24 O
20:47:07 O

Job O
#: O
52892 O

Signed O
electronically O
by O
: O
DR. O
Patricia O
Henley O
on O
: O
Maxine O
2014-01-02 O
10:45 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2012-05-24 O

Discharge O
Date O
: O

2012-06-19 O

Date O
of O
Birth O
: O

1954-07-01 O

Sex O
: O

M O

Service O
: O

NEUROSURGERY O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Joyce O
V. O
Seidel O
, O
M.D. O

Chief O
Complaint O
: O

Right B-SYMPTOM
parietal I-SYMPTOM
wound I-SYMPTOM
dehiscence I-SYMPTOM
. O

CSF B-SYMPTOM
leak I-SYMPTOM
. O

Perforated B-SYMPTOM
diverticulitis I-SYMPTOM
. O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Lumbar B-TREATMENT
drain I-TREATMENT
placement I-TREATMENT
2012-05-24 O

Exploratory O
laparotomy O
2012-05-26 O

Abdominal B-TREATMENT
washtou I-TREATMENT
2012-05-26 O

Sigmoid B-TREATMENT
colectomy I-TREATMENT
and O
Hartmans B-TREATMENT
pouch I-TREATMENT
2012-05-26 O

Lumbar B-TREATMENT
drain I-TREATMENT
placement I-TREATMENT
2012-05-29 O

CT-guided B-TREATMENT
aspiration I-TREATMENT
06-01 O
for O
pelvic B-SYMPTOM
abscess I-SYMPTOM

Reveision B-TREATMENT
Right I-TREATMENT
craniotomy I-TREATMENT
06-03 O

revsion B-TREATMENT
of I-TREATMENT
bone I-TREATMENT
flap I-TREATMENT
06-03 O

Emergent B-TREATMENT
intubation I-TREATMENT
06-04 O

PICC B-TREATMENT
line I-TREATMENT
placement I-TREATMENT
2012-06-08 O

History O
of O
Present O
Illness O
: O

57 O
yo O
right O
handed O
male O
with O
seizure B-SYMPTOM
history I-SYMPTOM
since O
1988 O
, O
s/p O
craniotomies B-TREATMENT
x O
3 O
( O
most O
recently O
05-05 O
) O
for O
oligodendroglioma B-SYMPTOM
. O

The O
patient O
began O
having O
generalized B-SYMPTOM
tonic I-SYMPTOM
- I-SYMPTOM
clonic I-SYMPTOM
seizures I-SYMPTOM
in O
1988 O
, O
which O
at O
the O
time O
were O
thought O
to O
be O
related O
to O
asthma B-TREATMENT
medications I-TREATMENT
. O

At O
this O
time O
, O
his O
head O
CT O
was O
negative O
, O
and O
he O
was O
treated O
with O
Dilantin B-TREATMENT
and O
Phenobarbital B-TREATMENT
. O

However O
, O
he O
continued O
to O
have O
left B-SYMPTOM
arm I-SYMPTOM
focal I-SYMPTOM
motor I-SYMPTOM
seizures I-SYMPTOM
and O
problems B-SYMPTOM
thinking I-SYMPTOM
. O

In O
2001-08-31 O
he O
stopped O
his B-TREATMENT
medication I-TREATMENT
and O
had O
a B-SYMPTOM
generalized I-SYMPTOM
tonic I-SYMPTOM
- I-SYMPTOM
clonic I-SYMPTOM
seizure I-SYMPTOM
in O
12/94 O
. O

He O
was O
diagnosed O
by O
biopsy O
with O
oligodendroglioma B-SYMPTOM
, O
and O
gross B-TREATMENT
total I-TREATMENT
resection I-TREATMENT
by O
Dr. O
Redner O
in O

95 O
revealed O
a B-SYMPTOM
low-grade I-SYMPTOM
oligodendroglioma I-SYMPTOM
. O

He O
was O
followed O
by O
Dr. O
Gregory O
Dumas O
, O
with O
serial O
MRI O
's. O

In O
2011-05-02 O
, O
he O
was O
requiring O
more B-TREATMENT
ativan I-TREATMENT
to O
control O
his B-SYMPTOM
seizures I-SYMPTOM
, O
and O
was O
increasingly B-SYMPTOM
disoriented I-SYMPTOM
and O
forgetful B-SYMPTOM
with O
headaches B-SYMPTOM
. O

He O
had O
a B-TREATMENT
repeat I-TREATMENT
total I-TREATMENT
resection I-TREATMENT
in O
4/04 O
by O
Dr. O
Peter O
Hoadley O
at O
Hallmark O
Health O
System O
which O
revealed O
anaplastic B-SYMPTOM
oligodendroglioma I-SYMPTOM
grade I-SYMPTOM
III I-SYMPTOM
. O

He O
had O
radiation B-TREATMENT
following O
the B-TREATMENT
resection I-TREATMENT
and O
was O
doing O
well O
on O
monthly B-TREATMENT
Temodar I-TREATMENT
until O
2012-04-23 O
when O
he O
had O
a B-SYMPTOM
marked I-SYMPTOM
change I-SYMPTOM
in I-SYMPTOM
behavior I-SYMPTOM
, O
his O
balance O
was O
off O
, O
speech B-SYMPTOM
slurred I-SYMPTOM
, O
and O
he O
had O
difficulty B-SYMPTOM
using I-SYMPTOM
the I-SYMPTOM
computer I-SYMPTOM
. O

A O
head O
MRI O
on O
2012-04-24 O
revealed O
increasing B-SYMPTOM
tumor I-SYMPTOM
infiltration I-SYMPTOM
with O
increased B-SYMPTOM
edema I-SYMPTOM
and O
mass B-SYMPTOM
effect I-SYMPTOM
. O

He O
underwent O
a B-TREATMENT
right I-TREATMENT
craniotomy I-TREATMENT
with O
resection B-TREATMENT
and O
gliadel B-TREATMENT
wafers I-TREATMENT
on O
2012-05-02 O
at O
Hallmark O
Health O
System O
by O
Dr. O
Ackley O
. O

Came O
for O
neurosurgery O
follow O
up O
on O
05-21 O
, O
and O
had O
been O
having O
clear B-SYMPTOM
fluid I-SYMPTOM
leaking O
from O
his B-SYMPTOM
incision I-SYMPTOM
, O
as O
well O
as O
frontal B-SYMPTOM
headache I-SYMPTOM
, O
imbalance B-SYMPTOM
, O
bumping O
into O
things O
with O
his O
left O
leg O
and O
worsening B-SYMPTOM
tremors I-SYMPTOM
. O

He O
was O
admitted O
for O
Lumbar B-TREATMENT
drain I-TREATMENT
placement I-TREATMENT

Past O
Medical O
History O
: O

Right B-SYMPTOM
parietal I-SYMPTOM
oligodendroglioma I-SYMPTOM
, O
as O
above O
status O
post O
craniotomy B-TREATMENT
x O
3 O
( O
'95 O
, O
'04 O
, O
'05 O
) O

hernia B-TREATMENT
surgery I-TREATMENT
x O
3 O

right B-SYMPTOM
hand I-SYMPTOM
ganglion I-SYMPTOM
cyst I-SYMPTOM
removed O

asthma B-SYMPTOM

Social O
History O
: O

Lives O
w O
wife O
, O
has O
home O
health O
assistance O
. O

Employment O
: O
on O
short O
term O
disability O
, O
has O
boat O
which O
he O
enjoys O
as O
hobby O

Physical O
Exam O
: O

RRR O

CTA O

Abdomen O
soft O
Nontender B-SYMPTOM
and O
nondistended B-SYMPTOM

Alert O
and O
oriented O
times O
3 O

Speech O
fluent O
, O
comprehension O
intact O

Pupils O
equal O
round O
and O
reactive O
to O
light O
, O
extraocular O
movements O
intact O

Face O
symmetric O

Tongue O
midline O

No O
pronator B-SYMPTOM
drift I-SYMPTOM

Strength O
5/5 O
throughout O

Normal O
tone O

2+ O
reflexes O
throughout O

Toes O
downgoing O
bilaterally O

No O
dysmetria B-SYMPTOM

Pertinent O
Results O
: O

Admission O
labs O
: O

2012-05-24 O

WBC O
- O
6.3 O
RBC O
- O
4.17 O
* O
Hgb O
- O
13.7 O
* O
Hct O
- O
40.2 O
MCV O
- O
96 O
MCH O
- O
32.7 O
* O
MCHC O
- O
34.0 O
RDW O
- O
13.6 O
Plt O
Ct O
- O
143 O
* O
PT O
- O
11.9 O
PTT O
- O
21.1 O
* O
INR O
( O
PT O
)- O
0.9 O
Glucose O
- O
207 O
* O
UreaN O
- O
17 O
Creat O
- O
0.9 O
Na O
- O
134 O
K O
- O
4.6 O
Cl O
- O
93 O
* O
HCO3 O
- O
35 O
* O
AnGap O
- O
11 O
Calcium O
- O
8.3 O
* O
Phos O
- O
1.8 O
*# O
Mg O
- O
2.1 O

Discharge O
labs O
: O

2012-06-18 O

WBC O
- O
6.5 O
RBC O
- O
3.20 O
* O
Hgb O
- O
10.5 O
* O
Hct O
- O
30.7 O
* O
MCV O
- O
96 O
MCH O
- O
32.8 O
* O
MCHC O
- O
34.2 O
RDW O
- O
14.3 O
Plt O
Ct O
- O
227 O
PT O
- O
13.4 O
PTT O
- O
24.6 O
INR O
( O
PT O
)- O
1.1 O
Glucose O
- O
117 O
* O
UreaN O
- O
12 O
Creat O
- O
0.6 O
Na O
- O
140 O
K O
- O
4.2 O
Cl O
- O
102 O
HCO3 O
- O
32 O
* O
AnGap O
- O
10 O
Calcium O
- O
9.0 O
Phos O
- O
3.9 O
Mg O
- O
2.0 O

Pathology O
: O

Sigmoid O
colon O
: O

Diverticular B-SYMPTOM
disease I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
colon I-SYMPTOM
: O

1. O
Multiple B-SYMPTOM
diverticula I-SYMPTOM
. O

2. O
Rupture B-SYMPTOM
of I-SYMPTOM
diverticulum I-SYMPTOM
with O
pericolic B-SYMPTOM
abscess I-SYMPTOM
. O

CT O
head O
2012-06-11 O
: O

IMPRESSION O
: O

1) O
Overall O
, O
a O
slight O
decrease O
in O
the B-SYMPTOM
mass I-SYMPTOM
effect I-SYMPTOM
and O
edema B-SYMPTOM
associated O
with O
the O
postoperative O
changes O
. O

2) O
Slight O
increase O
in O
epidural B-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM
adjacent O
to O
the B-SYMPTOM
craniotomy I-SYMPTOM
site I-SYMPTOM
. O

CT O
abdomen O
2012-06-18 O
: O

IMPRESSION O
: O

Small B-SYMPTOM
residual I-SYMPTOM
collection I-SYMPTOM
anterior O
to O
the O
rectum O
, O
smaller O
than O
on O
the O
prior O
study O
, O
and O
without O
substantial B-SYMPTOM
fluid I-SYMPTOM
components I-SYMPTOM
to O
allow O
drainage B-TREATMENT
. O

WOUND O
CULTURE O
( O
Final O
2012-06-05 O
) O
: O

( O
PELVIC B-SYMPTOM
ABSCESS I-SYMPTOM
) O

Due O
to O
mixed B-SYMPTOM
bacterial I-SYMPTOM
types I-SYMPTOM
( O
>= O
3 O
colony O
types O
) O
an O
abbreviated O
workup O
is O
performed O
appropriate O
to O
the O
isolates O
recovered O
from O
the O
site O
( O
including O
a O
screen O
for O
Pseudomonas B-SYMPTOM
aeruginosa I-SYMPTOM
, O
Staphylococcus B-SYMPTOM
aureus I-SYMPTOM
and O
beta B-SYMPTOM
streptococcus I-SYMPTOM
) O
. O

ENTEROCOCCUS B-SYMPTOM
SP. I-SYMPTOM

SPARSE B-SYMPTOM
GROWTH I-SYMPTOM
. O

PSEUDOMONAS B-SYMPTOM
AERUGINOSA I-SYMPTOM
. O

SPARSE B-SYMPTOM
GROWTH I-SYMPTOM
. O

CORYNEBACTERIUM B-SYMPTOM
SPECIES I-SYMPTOM
( I-SYMPTOM
DIPHTHEROIDS I-SYMPTOM
) I-SYMPTOM
. O

SPARSE B-SYMPTOM
GROWTH I-SYMPTOM
. O

SENSITIVITIES O
: O

MIC O
expressed O
in O

MCG/ML O

_________________________________________________________ O

ENTEROCOCCUS B-SYMPTOM
SP I-SYMPTOM
. O

| O

PSEUDOMONAS B-SYMPTOM
AERUGINOSA I-SYMPTOM

| O

| O

AMPICILLIN------------ B-TREATMENT

<=2 O
S O

CEFEPIME-------------- B-TREATMENT

2 O
S O

CEFTAZIDIME----------- B-TREATMENT

4 O
S O

CIPROFLOXACIN--------- B-TREATMENT

<=0.25 O
S O

GENTAMICIN------------ B-TREATMENT

2 O
S O

IMIPENEM-------------- B-TREATMENT

8 O
I O

LEVOFLOXACIN---------- B-TREATMENT

1 O
S O

MEROPENEM------------- B-TREATMENT

4 O
S O

PENICILLIN------------ B-TREATMENT

2 O
S O

PIPERACILLIN---------- B-TREATMENT

8 O
S O

PIPERACILLIN/TAZO----- B-TREATMENT

8 O
S O

TOBRAMYCIN------------ B-TREATMENT

<=1 O
S O

VANCOMYCIN------------ B-TREATMENT

<=1 O
S O

WOUND O
CULTURE O
( O
Final O
2012-06-05 O
) O
: O

( O
from O
OR B-TREATMENT
revision I-TREATMENT
craniotomy I-TREATMENT
) O

STAPH B-SYMPTOM
AUREUS I-SYMPTOM
COAG I-SYMPTOM
+ O
. O

SPARSE B-SYMPTOM
GROWTH I-SYMPTOM
. O

Oxacillin B-SYMPTOM
RESISTANT I-SYMPTOM
Staphylococci I-SYMPTOM
MUST O
be O
reported O
as O
also O
RESISTANT B-SYMPTOM
to O
other O
penicillins B-TREATMENT
, O
cephalosporins B-TREATMENT
, O
carbacephems B-TREATMENT
, O
carbapenems B-TREATMENT
, O
and O
beta-lactamase B-TREATMENT
inhibitor I-TREATMENT
combinations I-TREATMENT
. O

Rifampin B-TREATMENT
should O
not O
be O
used O
alone O
for O
therapy B-TREATMENT
. O

Please O
contact O
the O
Microbiology O
Laboratory O
( O
2313-08-31 O
) O
immediately O
if O
sensitivity O
to O
clindamycin B-TREATMENT
is O
required O
on O
this O
patient O
's O
isolate O
. O

SENSITIVITIES O
: O

MIC O
expressed O
in O

MCG/ML O

_________________________________________________________ O

STAPH B-SYMPTOM
AUREUS I-SYMPTOM
COAG I-SYMPTOM
+ O

| O

ERYTHROMYCIN---------- B-TREATMENT

=>8 O
R O

GENTAMICIN------------ B-TREATMENT
<=0.5 O
S O

LEVOFLOXACIN---------- B-TREATMENT

=>8 O
R O

OXACILLIN------------- B-TREATMENT

=>4 O
R O

PENICILLIN------------ B-TREATMENT
=>0.5 O
R O

RIFAMPIN-------------- B-TREATMENT
<=0.5 O
S O

TETRACYCLINE---------- B-TREATMENT

<=1 O
S O

VANCOMYCIN------------ B-TREATMENT

<=1 O
S O

Brief O
Hospital O
Course O
: O
patient O
was O
admitted O
on O
2012-05-24 O
after O
having O
drainage B-SYMPTOM
from O
his B-SYMPTOM
incision I-SYMPTOM
for O
the O
last O
couple O
of O
days O
. O

He O
was O
seen O
in O
the O
brain O
tumor O
clinic O
on O
05-21 O
and O
stitches B-TREATMENT
were O
placed O
in O
the B-SYMPTOM
incision I-SYMPTOM
, O
however O
it O
continued O
to O
leak O
. O

He O
had O
a B-TREATMENT
lumbar I-TREATMENT
drain I-TREATMENT
placed O
. O

He O
c/o O
of O
abd B-SYMPTOM
pain I-SYMPTOM
and O
distension B-SYMPTOM
on O
05-25 O
he O
had O
a O
kub O
done O
which O
was O
negative O
. O

on O
05-26 O
he O
continued O
to O
c/o O
of O
epigastric B-SYMPTOM
pain I-SYMPTOM
had O
a O
chest O
x-ray O
done O
to O
due O
to O
decreased B-SYMPTOM
lung I-SYMPTOM
sounds I-SYMPTOM
. O

The O
Chest O
x-ray O
showed O
free B-SYMPTOM
air I-SYMPTOM
. O

general O
surgery O
was O
consulted O
and O
the O
patient O
was O
taken O
to O
the O
OR O
for O
exploratory O
laproratomy O
. O

he O
was O
found O
to O
have O
a B-SYMPTOM
perforated I-SYMPTOM
sigmoid I-SYMPTOM
diverticulum I-SYMPTOM
. O

He O
had O
a B-TREATMENT
colostomy I-TREATMENT
and O
partial B-TREATMENT
colectomy I-TREATMENT
. O

patient O
recovered O
well O
from O
colocetomy B-TREATMENT
. O

He O
was O
found O
to O
have O
an B-SYMPTOM
abd I-SYMPTOM
abcess I-SYMPTOM
which O
was O
drained O
via O
CT O
guidance O
on O
06-01 O
. O

On O
06-02 O
his B-TREATMENT
lumbar I-TREATMENT
drain I-TREATMENT
pulled O
out O
. O

he O
had O
to O
have O
it O
replaced O
, O
however O
, O
because O
his B-SYMPTOM
head I-SYMPTOM
incision I-SYMPTOM
began O
to O
leak O
again O
. O

On O
06-03 O
he O
was O
taken O
back O
to O
the O
OR O
for O
debridement B-TREATMENT
of O
his B-SYMPTOM
head I-SYMPTOM
wound I-SYMPTOM
with O
removal B-TREATMENT
of O
the B-SYMPTOM
remaining I-SYMPTOM
gliadel I-SYMPTOM
waffers I-SYMPTOM
. O

He O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
, O
postop O
however O
he O
had O
a B-SYMPTOM
grand I-SYMPTOM
mal I-SYMPTOM
seizure I-SYMPTOM
and O
was O
intubated O
and O
sent O
to O
the O
ICU O
. O

ID O
was O
consulted O
for O
both O
the B-SYMPTOM
abd I-SYMPTOM
abcess I-SYMPTOM
and O
possible O
meningitis B-SYMPTOM
given O
the B-SYMPTOM
large I-SYMPTOM
amount I-SYMPTOM
of I-SYMPTOM
wbc I-SYMPTOM
in O
the O
csf O
cultures O
. O

Patient O
was O
placed O
on O
vancomycin B-TREATMENT
1 O
gm O
IV O
q12 O
and O
zosyn B-TREATMENT
. O

He O
was O
kept O
on O
antibiotics B-TREATMENT
until O
06-17 O
. O

Neurologically O
he O
slowly O
woke O
up O
after O
the B-SYMPTOM
seizures I-SYMPTOM
and O
was O
extubated O
on O
06-03 O
. O

He O
was O
transfered O
to O
the O
step O
down O
unit O
and O
had O
his B-TREATMENT
lumbar I-TREATMENT
drain I-TREATMENT
slowly O
weaned O
. O

The B-TREATMENT
lumbar I-TREATMENT
drain I-TREATMENT
was O
d/ced O
on O
06-14 O
. O

He O
had O
a O
head O
Ct O
which O
remains O
stable O
and O
head B-SYMPTOM
wound I-SYMPTOM
remain O
dry O
. O

Neurologically O
he O
is O
awake O
and O
alert O
and O
oriented O
x O
3 O
he O
is O
07-05 O
in O
all O
muscle O
group O
bilat O
. O

He O
follows O
commands O
, O
he O
is O
out O
of O
bed O
ambulating O
with O
max O
assist O
. O

PT O
and O
OT O
are O
recommending O
rehab B-TREATMENT
. O

He O
will O
follow O
up O
with O
Dr O
Fisher O
the O
general O
surgeon O
in O
two O
weeks O
and O
follow O
up O
in O
the O
brain O
tumor O
clinic O
in O
two O
weeks O
for O
stitch B-TREATMENT
removal I-TREATMENT
. O

H O
ewas O
switched O
to O
oral B-TREATMENT
CIpro I-TREATMENT
for O
the B-SYMPTOM
pelvic I-SYMPTOM
abcess I-SYMPTOM
and O
will O
continue O
it O
until O
he O
has O
his O
followup O
with O
infectious O
disease O
in O
2 O
weeks O
. O

Medications O
on O
Admission O
: O

Neurontin B-TREATMENT
, O
Keppra B-TREATMENT
, O
Lamictal B-TREATMENT
, O
decadron B-TREATMENT
, O
multivitamin B-TREATMENT
, O
Murray O
, O
Calcium B-TREATMENT

Discharge O
Medications O
: O

1. O
Heparin B-TREATMENT
Sodium I-TREATMENT
( I-TREATMENT
Porcine I-TREATMENT
) I-TREATMENT
5,000 O
unit O
/ O
mL O
Solution O
Sig O
: O
One O
( O
1 O
) O
Injection O
TID O
( O
3 O
times O
a O
day O
) O
. O

2. O
Diphenhydramine B-TREATMENT
HCl I-TREATMENT
25 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

3. O
Albuterol B-TREATMENT
- I-TREATMENT
Ipratropium I-TREATMENT
103-18 O
mcg O
/ O
Actuation O
Aerosol O
Sig O
: O
03-04 O
Puffs O
Inhalation O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
. O

4. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

5. O
Fluticasone B-TREATMENT
- I-TREATMENT
Salmeterol I-TREATMENT
250-50 O
mcg O
/ O
Dose O
Disk O
with O
Device O
Sig O
: O
One O
( O
1 O
) O
Disk O
with O
Device O
Inhalation O
BID O
( O
2 O
times O
a O
day O
) O
. O

6. O
Lamotrigine B-TREATMENT
100 O
mg O
Tablet O
Sig O
: O
1.5 O
Tablets O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

7. O
Levetiracetam B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

8. O
Ibuprofen B-TREATMENT
400 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
Q8H O
( O
every O
8 O
hours O
) O
as O
needed O
. O

9. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

10. O
Pantoprazole B-TREATMENT
Sodium I-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

11. O
Ciprofloxacin B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q12H O
( O
every O
12 O
hours O
) O
for O
2 O
weeks. O
Tablet O
( O
s O
) O

12. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

13. O
Lorazepam B-TREATMENT
1 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
as O
needed O
. O

14. O
Dexamethasone B-TREATMENT
2 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q12H O
( O
every O
12 O
hours O
) O
. O

15. O
Insulin B-TREATMENT
Regular I-TREATMENT
Human I-TREATMENT
100 O
unit O
/ O
mL O
Solution O
Sig O
: O
One O
( O
1 O
) O
Injection O
ASDIR O
( O
AS O
DIRECTED O
) O
: O
51-150 O
0 O
Units O

151-200 O
2 O
Units O

201-250 O
4 O
Units O

251-300 O
6 O
Units O

301-350 O
8 O
Units O

351-400 O
10 O
Units O

> O
400 O
Bessie O
MD O

16. O
Hydralazine B-TREATMENT
HCl I-TREATMENT
20 O
mg O
/ O
mL O
Solution O
Sig O
: O
0.5 O
syringe O
Injection O
Q4HR O
( O
) O
as O
needed O
for O
sbp B-SYMPTOM
> O
150 O
. O

Disp O
:* O
qs O
syringe O
* O
Refills O
:* O
0 O
* O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

Cerebrospinal B-SYMPTOM
fluid I-SYMPTOM
leak I-SYMPTOM

Chronic O
steroid O
use O
wound B-SYMPTOM
infection I-SYMPTOM

Perforated B-SYMPTOM
sigmoid I-SYMPTOM
diverticulum I-SYMPTOM
status O
post O
exploratory O
laparotomy O

Status O
post O
sigmoid B-TREATMENT
colectomy I-TREATMENT
, O
hartmans B-TREATMENT
pouch I-TREATMENT
and O
washout B-TREATMENT

Post B-SYMPTOM
operative I-SYMPTOM
fever I-SYMPTOM
fever B-SYMPTOM
status O
post O
Reveision B-TREATMENT
Right I-TREATMENT
craniotomy I-TREATMENT
and O
revsion B-TREATMENT
of I-TREATMENT
bone I-TREATMENT
flap I-TREATMENT
change B-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM

Seizure B-SYMPTOM

Conant B-SYMPTOM
palsy I-SYMPTOM
with O
Left B-SYMPTOM
sided I-SYMPTOM
weakness I-SYMPTOM

Respiratory B-SYMPTOM
failure I-SYMPTOM
requiring O
intubation B-TREATMENT

Methicillin B-SYMPTOM
resistant I-SYMPTOM
staph I-SYMPTOM
aureus I-SYMPTOM
infection I-SYMPTOM
of I-SYMPTOM
central I-SYMPTOM
nervous I-SYMPTOM
system I-SYMPTOM

Pelvic B-SYMPTOM
abscess I-SYMPTOM
oligodendroglioma B-SYMPTOM

Asthma B-SYMPTOM

S/p O
craniotomy B-TREATMENT
x O
3 O

Hernia B-TREATMENT
Surgery I-TREATMENT
x O
3 O

Discharge O
Condition O
: O

Good O

Discharge O
Instructions O
: O

Call O
with O
any B-SYMPTOM
spiking I-SYMPTOM
fevers I-SYMPTOM
, O
leakage B-SYMPTOM
from O
your B-SYMPTOM
head I-SYMPTOM
wound I-SYMPTOM
, O
increase B-SYMPTOM
in I-SYMPTOM
headaches I-SYMPTOM
, O
confusion B-SYMPTOM
, O
blurry B-SYMPTOM
vision I-SYMPTOM
severe B-SYMPTOM
neck I-SYMPTOM
stiffness I-SYMPTOM
, O
redness B-SYMPTOM
, O
swelling B-SYMPTOM
, O
or O
discharge B-SYMPTOM
around O
your B-SYMPTOM
wound I-SYMPTOM
site I-SYMPTOM

Call O
your O
general O
surgeon O
if O
you O
experience O
increased B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
, O
vomiting B-SYMPTOM
, O
decreased B-SYMPTOM
or I-SYMPTOM
increased I-SYMPTOM
ostomy I-SYMPTOM
output I-SYMPTOM
. O

Followup O
Instructions O
: O

1. O
Dr. O
Martha O
Lopez O
or O
Dr. O
Henson O
in O
infectious O
disese O
in O
2 O
weeks O
. O

Call O
for O
an O
appointment O
( O
724 O
) O
875 O
5043 O

2. O
Dr O
Fisher O
in O
General O
surgery O
, O
1 O
week O
, O
call O
his O
office O
for O
an O
appointment O
. O

515-3442 O

3. O
Follow O
up O
in O
1 O
week O
at O
brain O
tumor O
clinic O
. O

Call O
for O
an O
appointment O
908-6508 O

Cherrie O
Celeste O
MD O
44-924 O

Completed O
by O
: O
Angie O
Irene O
MD O
36-512 O
2012-06-19 O
@ O
0950 O

Signed O
electronically O
by O
: O
DR. O
Charles O
Mcwilliams O
on O
: O
Daniel O
2012-07-05 O
3:09 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2016-03-18 O

Discharge O
Date O
: O

2016-04-01 O

Date O
of O
Birth O
: O

1929-07-27 O

Sex O
: O

M O

Service O
: O

SURGERY B-TREATMENT

Allergies O
: O

Tetracycline B-TREATMENT

Attending O
: O
Samuel O
A. O
Brown O
, O
M.D. O

Chief O
Complaint O
: O

Transfer O
from O
Lewis O
to O
Hallmark O
Health O
System O
CMED O
CSRU O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

s/p O
I&D B-TREATMENT
( O
03-17 O
) O

s/p O
Debridement B-TREATMENT
( O
03-18 O
) O

History O
of O
Present O
Illness O
: O

Mr. O
Morton O
is O
a O
86 O
yo O
male O
transferred O
from O
Kindred O
Park O
View O
Specialty O
Hospital O
of O
Springfield-Sample O
. O

He O
developed O
right B-SYMPTOM
foot I-SYMPTOM
pain I-SYMPTOM
the O
Sunday O
prior O
to O
admission O
and O
was O
seen O
by O
his O
Podiatrist O
, O
who O
diagnosed O
him O
with O
gout B-SYMPTOM
. O

He O
was O
given O
colchicine B-TREATMENT
and O
prednisone B-TREATMENT
. O

Mr. O
Morton O
then O
developed O
more B-SYMPTOM
pain I-SYMPTOM
and O
warmth B-SYMPTOM
to I-SYMPTOM
his I-SYMPTOM
right I-SYMPTOM
foot I-SYMPTOM
later O
in O
the O
week O
and O
presented O
to O
the O
Youville O
Hospital O
- O
Woody O
Monica O
. O

At O
this O
hospital O
he O
underwent O
an B-TREATMENT
I&D I-TREATMENT
( O
03-17 O
) O
of O
a B-SYMPTOM
right I-SYMPTOM
foot I-SYMPTOM
infection I-SYMPTOM
and O
subsequently O
underwent O

re-exploration O
( O
03-18 O
) O
for O
developing B-SYMPTOM
necrotizing I-SYMPTOM
fascitis I-SYMPTOM
. O

He O
was O
transferred O
to O
Hallmark O
Health O
System O
for O
further O
care O
. O

Past O
Medical O
History O
: O

PMH O
: O
Prostate B-SYMPTOM
Ca I-SYMPTOM
, O
Glaucoma B-SYMPTOM

PSH O
: O
RIH B-TREATMENT
repair I-TREATMENT
, O
s/p O
TURP B-TREATMENT
, O
s/p O
thyroid B-TREATMENT
excision I-TREATMENT

Social O
History O
: O

EtOH O

Physical O
Exam O
: O

98.9 O
, O
93 O
, O
137/78 O
, O
16 O
, O
98% O

GEN O
: O
NAD O

HEENT O
: O
EOMI O
, O
anicteric, B-SYMPTOM
OP O
pink O

NECK O
: O
no O
masses B-SYMPTOM
, O
supple O

CV O
: O
RRR O
, O
no O
m/r B-SYMPTOM

RESP O
: O
clear O

GI O
: O
soft/NT/ND B-SYMPTOM

EXT O
: O
R O
foot O
with O
erythema B-SYMPTOM
/ O
swelling B-SYMPTOM
; O
muscle O
and O
tendons O
exposed O
, O
with O
necrotic B-SYMPTOM
edges I-SYMPTOM
, O
some B-SYMPTOM
fibrinous I-SYMPTOM
exudate I-SYMPTOM

NEURO O
: O
AxOx3 O

Pertinent O
Results O
: O

MRI O
RLE O
03-21 O

" O
1. B-SYMPTOM
7 I-SYMPTOM
cm I-SYMPTOM
linear I-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM
running O
between O
the O
anterior O
and O
lateral O
muscle O
compartments O
, O
extending O
from O
a O
large O
area O
of O
soft B-SYMPTOM
tissue I-SYMPTOM
loss I-SYMPTOM
seen O
in O
the O
distal O
lateral O
foreleg O
to O
roughly O
the O
mid O
tibia O
/ O
fibula O
, O
18 O
cm O
distal O
to O
the O
knee O
joint O
line O
. O

The B-SYMPTOM
collection I-SYMPTOM
is O
largest O
at O
its O
most O
proximal O
extent O
, O
measuring O
1.4 O
x O
0.7 O
cm O
in O
the O
transverse O
dimension O
. O

2. O
Non-specific B-SYMPTOM
myositis I-SYMPTOM
involving O
multiple O
muscle O
groups O
in O
the O
foreleg O
, O
most O
severe O
in O
the O
anterior O
, O
lateral O
, O
and O
posterior O
deep O
compartments O
. O

3. O
Tendinosis B-SYMPTOM
of O
the O
posterior O
tibialis O
and O
peroneus O
brevis O
tendons O
. O

No O
tendon B-SYMPTOM
tear I-SYMPTOM
. O

4. O
No O
evidence O
of O
abnormal B-SYMPTOM
bone I-SYMPTOM
marrow I-SYMPTOM
signal I-SYMPTOM
intensity I-SYMPTOM
or O
intraosseous B-SYMPTOM
abscess I-SYMPTOM
." O

RLE O
Angio O
03-21 O

" O
1. O
Mild B-SYMPTOM
but I-SYMPTOM
multifocal I-SYMPTOM
atherosclerotic I-SYMPTOM
disease I-SYMPTOM
involving O
the O
infrarenal O
aorta O
and O
iliac O
arteries O
, O
with O
no O
significant B-SYMPTOM
pressure I-SYMPTOM
gradient I-SYMPTOM
associated O
. O

2. O
Significant B-SYMPTOM
segmental I-SYMPTOM
stenosis I-SYMPTOM
( O
approx. O
5-6 O
cm O
long O
) O
in O
the O
mid O
right O
superficial O
femoral O
artery O
. O

3. O
High B-SYMPTOM
bifurcation I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
popliteal I-SYMPTOM
artery I-SYMPTOM
at O
the O
knee O
level O
. O

4. O
In O
the O
proximal O
calf O
, O
severe B-SYMPTOM
stenosis I-SYMPTOM
or O
occlusion B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
two I-SYMPTOM
terminal I-SYMPTOM
branches I-SYMPTOM
arising O
from O
this O
popliteal O
bifurcation O
( O
likely O
the O
anterior O
tibial O
and O
the O
peroneal O
arteries O
). O

Two B-SYMPTOM
significant I-SYMPTOM
focal I-SYMPTOM
stenoses I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
right I-SYMPTOM
anterior I-SYMPTOM
tibial I-SYMPTOM
artery I-SYMPTOM
. O

Right O
posterior O
tibial O
artery O
completely B-SYMPTOM
occluded I-SYMPTOM
. O

5. O
Patent O
medial O
and O
lateral O
plantar O
arteries O
, O
filled O
through O
collaterals O
arising O
mostly O
from O
the O
peroneal O
artery O
. O

Dorsalis O
pedis O
artery O
not O
seen O
." O

Brief O
Hospital O
Course O
: O

Mr. O
Morton O
was O
admitted O
to O
the O
TSICU O
. O

He O
was O
placed O
on O
Penicillin B-TREATMENT
G I-TREATMENT
, O
Clindamycin B-TREATMENT
, O
for O
empiric B-TREATMENT
coverage I-TREATMENT
of O
his B-SYMPTOM
wound I-SYMPTOM
, O
with O
Group B-SYMPTOM
A I-SYMPTOM
strep I-SYMPTOM
growth I-SYMPTOM
from O
the O
New O
England O
Baptist O
Hospital-Bryce O
cultures O
. O

He O
was O
transferred O
to O
the O
floor O
on O
HD#2 O
. O

He O
continued O
to O
undergo O
BID B-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
. O

Plastic O
surgery O
was O
asked O
to O
evaluate O
the O
patient O
. O

Per O
their O
recommendations O
, O
silvadine B-TREATMENT
was O
applied O
to O
the O
tendons O
to O
prevent O
dessication B-SYMPTOM
. O

Vascular O
surgery O
was O
also O
asked O
to O
evaluate O
the O
patient O
's O
right O
lower O
extremity O
blood O
flow O
. O

An O
angiogram O
on O
HD#4 O
showed O
severe B-SYMPTOM
tibial I-SYMPTOM
disease I-SYMPTOM
and O
moderate B-SYMPTOM
SFA I-SYMPTOM
disease I-SYMPTOM
, O
no O
DP O
artery O
was O
seen O
. O

The O
vascular O
team O
recommended O
a B-TREATMENT
femoral-peroneal I-TREATMENT
bypass I-TREATMENT
for O
revascularization B-TREATMENT
and O
performed O
this B-TREATMENT
operation I-TREATMENT
on O
HD#5 O
. O

He O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
, O
please O
see O
Dr. O
Allgood O
Operative O
Note O
for O
detail O
. O

On O
POD#1 O
, O
Mr. O
Morton O
received O
2 O
units O
of O
pRBCs B-TREATMENT
for O
post-op B-SYMPTOM
anemia I-SYMPTOM
( O
Hct O
25 O
). O

Mr. O
Morton O
continued O
to O
be O
followed O
by O
Infectious O
Disease O
, O
whose O
recommendations O
were O
to O
complete O
a O
01-28 O
week O
course O
of O
Penicillin B-TREATMENT
G I-TREATMENT
and O
Clindamycin B-TREATMENT
after O
the O
foot O
was O
completely O
debrided O
and O
the B-TREATMENT
skin I-TREATMENT
flaps I-TREATMENT
completed O
. O

His B-SYMPTOM
wound I-SYMPTOM
continued O
to O
heal O
well O
and O
by O
POD O
#6 O
a B-TREATMENT
VAC I-TREATMENT
dressing I-TREATMENT
was O
placed O
. O

He O
received O
a B-TREATMENT
PICC I-TREATMENT
on O
POD#7 O
for O
his B-TREATMENT
long-term I-TREATMENT
antibiotic I-TREATMENT
therapy I-TREATMENT
. O

At O
the O
time O
of O
discharge O
, O
Mr. O
Morton O
had O
good O
pain O
control O
, O
was O
tolerating O
a O
regular O
diet O
, O
had O
a B-SYMPTOM
well-healing I-SYMPTOM
wound I-SYMPTOM
treated O
with O
a B-TREATMENT
VAC I-TREATMENT
dressing I-TREATMENT
, O
and O
was O
to O
continue O
his B-TREATMENT
IV I-TREATMENT
PCN I-TREATMENT
G I-TREATMENT
and O
Clindamycin B-TREATMENT
. O

He O
was O
discharged O
to O
a O
rehab O
facility O
in O
fair O
condition O
. O

Medications O
on O
Admission O
: O

Timolol B-TREATMENT
.5% O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

Right B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
necrosing I-SYMPTOM
fascitis I-SYMPTOM
history O
of O
prostate B-SYMPTOM
cancer I-SYMPTOM
s/p O
TURP B-TREATMENT
glaucoma B-SYMPTOM

Discharge O
Condition O
: O

Fair O

Discharge O
Instructions O
: O

If O
you O
have O
any B-SYMPTOM
fevers/chills I-SYMPTOM
, O
nausea/vomiting B-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
foot B-SYMPTOM
pain I-SYMPTOM
, O
please O
seek O
medical O
attention O
. O

Followup O
Instructions O
: O

Please O
follow O
up O
with O
Dr. O
Mallard O
in O
one O
week O
, O
call O
421-3721 O
for O
an O
appointment O
. O

Follow O
up O
with O
Dr. O
Adner O
in O
2 O
weeks O
, O
call O
763-9180 O
for O
an O
appointment O
. O

Mark O
William O
MD O
19-081 O

Completed O
by O
: O
Shane O
Gabrielle O
MD O
73-971 O
2016-04-01 O
@ O
0836 O

Signed O
electronically O
by O
: O
DR. O
Robert O
Howell O
on: O
WED O
2016-05-18 O
5:18 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-12-29 O

Discharge O
Date O
: O

2015-01-20 O

Date O
of O
Birth O
: O

1944-09-05 O

Sex O
: O

M O

Service O
: O

SURGERY O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Patricia O
H O
Leonard O
, O
M.D. O

Chief O
Complaint O
: O

End B-SYMPTOM
stage I-SYMPTOM
liver I-SYMPTOM
disease I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Piggyback B-TREATMENT
orthotopic I-TREATMENT
liver I-TREATMENT
transplant I-TREATMENT

Liver O
biopsy O

History O
of O
Present O
Illness O
: O

Mr. O
Reese O
is O
a O
70 O
- O
year-old O
gentleman O
with O
end B-SYMPTOM
stage I-SYMPTOM
liver I-SYMPTOM
disease I-SYMPTOM
secondary O
to O
alcoholic B-SYMPTOM
cirrhosis I-SYMPTOM
. O

Of O
note O
, O
he O
underwent O
radiofrequency B-TREATMENT
ablation I-TREATMENT
of I-TREATMENT
two I-TREATMENT
small I-TREATMENT
liver I-TREATMENT
nodules I-TREATMENT
, O
one O
in O
segment O
VI O
and O
the O
other O
in O
the O
caudate O
lobe O
. O

Both O
are O
less O
than O
2 O
cm O
. O

Cytology O
on O
these B-SYMPTOM
nodules I-SYMPTOM
was O
suspicious O
for O
hepatocellular B-SYMPTOM
carcinoma I-SYMPTOM
. O

The B-TREATMENT
ablation I-TREATMENT
was O
done O
on O
2013-12-04 O
. O

He O
had O
decompensation O
of O
his B-SYMPTOM
cirrhosis I-SYMPTOM
in O
2011 O
with O
ascites B-SYMPTOM
and O
SBP B-SYMPTOM
. O

He O
also O
had O
encephalopathy B-SYMPTOM
during O
that O
period O
. O

The O
liver O
was O
from O
a O
62 O
year-old O
gentleman O
who O
had O
died O
from O
CVA B-SYMPTOM
with O
normal O
liver O
function O
. O

He O
has O
no O
history O
of O
a B-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
or O
varices B-SYMPTOM
by O
endoscopy O
. O

His O
last O
drink O
was O
in O
2009-11-11 O
. O

Prior O
to O
this O
, O
he O
drank O
a O
bottle O
of O
wine O
a O
day O

Past O
Medical O
History O
: O

His O
past O
medical O
history O
is O
also O
remarkable O
for O
non-insulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
and O
hypertension B-SYMPTOM
. O

He O
has O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
and O
underwent O
a B-TREATMENT
CABG I-TREATMENT
in O
1998 O
. O

He O
has O
a O
history O
of O
gastroesophageal B-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
and O
anemia B-SYMPTOM
. O

He O
also O
has O
had O
a B-TREATMENT
prior I-TREATMENT
inguinal I-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT
. O

Social O
History O
: O

The O
patient O
obtained O
a O
degree O
in O
law O
. O

He O
worked O
for O
the O
attorney O
general O
's O
office O
early O
in O
his O
career O
but O
eventually O
started O
his O
own O
business O
in O
foreign O
currency O
exchange O
from O
which O
he O
retired O
in O
2009 O
. O

He O
does O
not O
smoke O
, O
and O
there O
is O
no O
history O
of O
IV O
drug O
abuse O
. O

Physical O
Exam O
: O

On O
pre-operative O
exam O
, O
he O
was O
awake O
, O
alert O
, O
and O
oriented O
x3 O
. O

He O
was O
not O
in O
any B-SYMPTOM
apparent I-SYMPTOM
distress I-SYMPTOM
. O

He O
was O
afebrile B-SYMPTOM
with O
normal O
vitals O
. O

He O
is O
6 O
feet O
1 O
inches O
tall O
and O
has O
a O
pre-op O
weight O
of O
181 O
pounds O
. O

He O
had O
no O
pallor B-SYMPTOM
or O
obvious B-SYMPTOM
jaundice I-SYMPTOM
. O

He O
had O
no O
asterixis B-SYMPTOM
. O

He O
had O
palmar B-SYMPTOM
erythema I-SYMPTOM
. O

There O
was O
no O
clubbing B-SYMPTOM
. O

He O
had O
no O
lymphadenopathy B-SYMPTOM
. O

His O
chest O
was O
clear O
to O
ascultation O
. O

His O
heart O
sounds O
were O
regular O
rate O
rhythm O
. O

His O
abdomen O
is O
soft O
and O
nontender B-SYMPTOM
. O

No O
masses B-SYMPTOM
or O
viscera B-SYMPTOM
was O
felt O
. O

He O
had O
good O
femoral O
pulses O
bilaterally O
. O

He O
had O
no O
pedal B-SYMPTOM
edema I-SYMPTOM
or O
lower B-SYMPTOM
extremity I-SYMPTOM
lesions I-SYMPTOM
. O

His O
neurological O
exam O
was O
intact O
. O

Pertinent O
Results O
: O

2014-12-30 O
10:34 O
AM O
BLOOD O
ALT O
- O
699 O
* O
AST O
- O
1434 O
* O
AlkPhos O
- O
65 O
Amylase O
- O
46 O
TotBili O
- O
5.9 O
* O

2015-01-01 O
11:46 O
AM O
BLOOD O
ALT O
- O
1423 O
* O
AST O
- O
1066 O
* O
AlkPhos O
- O
72 O
TotBili O
- O
6.2 O
* O

2015-01-19 O
04:47 O
AM O
BLOOD O
ALT O
- O
355 O
* O
AST O
- O
90 O
* O
AlkPhos O
- O
352 O
* O
TotBili O
- O
3.2 O
* O

Brief O
Hospital O
Course O
: O

Mr. O
Reese O
Jones O
the B-TREATMENT
procedure I-TREATMENT
well O
. O

Post-operatively O
, O
he O
was O
slow O
to O
recover O
but O
did O
progressed O
nicely O
. O

Within O
the O
fist O
few O
days O
after O
the B-TREATMENT
surgery I-TREATMENT
, O
his O
liver O
function O
tests O
were O
elevated B-SYMPTOM
to O
as O
high O
as O
1484 O
for O
ALT O
, O
915 O
for O
AST O
, O
and O
7.6 O
for O
total O
bilirubin O
. O

His O
Alk O
Phos O
were O
inititially O
low B-SYMPTOM
a O
few O
days O
after O
the B-TREATMENT
operation I-TREATMENT
, O
but O
it O
rised O
up O
to O
422 O
two O
weeks O
after O
, O
but O
down-trended O
, O
as O
with O
the O
rest O
of O
his O
liver O
function O
test O
by O
the O
time O
he O
left O
the O
hospital O
. O

Several O
tests O
, O
including O
Duplex O
Ultrasound O
, O
CT O
of O
the O
Abdomen O
, O
and O
Abdominal O
A-gram O
all O
showed O
patent O
right O
and O
left O
hepatic O
arteries O
arising O
from O
the O
celiac O
trunk O
. O

An O
ERCP O
was O
also O
done O
, O
showing O
a B-SYMPTOM
filling I-SYMPTOM
defect I-SYMPTOM
from O
a B-SYMPTOM
narrowed I-SYMPTOM
donor I-SYMPTOM
duct I-SYMPTOM
, O
but O
no O
strictures B-SYMPTOM
. O

A B-TREATMENT
sphincterotomy I-TREATMENT
wss O
done O
to O
drain O
the B-SYMPTOM
sludge I-SYMPTOM
from I-SYMPTOM
the I-SYMPTOM
central I-SYMPTOM
common I-SYMPTOM
duct I-SYMPTOM
. O

There O
was O
a B-SYMPTOM
small I-SYMPTOM
bleed I-SYMPTOM
resulting O
from O
the B-TREATMENT
sphincterotomy I-TREATMENT
, O
but O
it O
was O
controlled O
by O
epinepherine B-TREATMENT
injections I-TREATMENT
. O

Initial O
biopsy O
of O
the O
allograft O
three O
days O
after O
the B-TREATMENT
operation I-TREATMENT
was O
consistent O
with O
preservation B-SYMPTOM
/ I-SYMPTOM
ischemic I-SYMPTOM
injury I-SYMPTOM
. O

Result O
of O
a O
second O
biopsy O
, O
which O
was O
done O
three O
weeks O
after O
the B-TREATMENT
operation I-TREATMENT
, O
is O
still O
pending O
. O

During O
his O
hospital O
stay O
, O
his O
blood O
glucose O
were O
elevated B-SYMPTOM
and O
labile B-SYMPTOM
ranging O
from O
below B-SYMPTOM
normal I-SYMPTOM
values I-SYMPTOM
[ O
40-60 O
's] O
to O
the O
200-300 O
's O
. O

He O
was O
completely O
assymptomatic B-SYMPTOM
while O
below B-SYMPTOM
normal I-SYMPTOM
values I-SYMPTOM
. O

At O
one O
point O
, O
he O
had O
to O
be O
on O
an B-TREATMENT
insulin I-TREATMENT
drip I-TREATMENT
. O

However O
with O
the O
help O
of O
Albano O
, O
his O
blood O
glucose O
began O
to O
normalize O
. O

He O
has O
also O
been O
working O
with O
Physical O
Therapy O
to O
regain O
his O
strength O
. O

He O
has O
been O
ambulating O
on O
his O
own O
several O
times O
a O
day O
. O

Also O
, O
he O
has O
been O
afebrile B-SYMPTOM
with O
stable O
vitals O
, O
tolerating O
a O
regular O
diet O
, O
producing O
good O
urine O
and O
adequate O
stool O
. O

Furthermore O
, O
he O
has O
had O
no O
complaints B-SYMPTOM
, O
including O
pain B-SYMPTOM
, O
while O
his O
lab O
values O
are O
normalizing O
. O

He O
will O
be O
discharged O
to O
home O
, O
in O
good O
condition O
, O
with O
very O
specific O
intructions O
to O
follow O
up O
with O
Albano O
for O
his B-TREATMENT
diabetic I-TREATMENT
care I-TREATMENT
and O
the O
Transplant O
Clinic O
for O
his B-TREATMENT
transplant I-TREATMENT
care I-TREATMENT
. O

Discharge O
Medications O
: O

1. O
Trimethoprim B-TREATMENT
- I-TREATMENT
Sulfamethoxazole I-TREATMENT
80-400 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

2. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

Disp O
:* O
30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)( O
s O
)* O
Refills O
:* O
2 O
* O

3. O
Mycophenolate B-TREATMENT
Mofetil I-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
120 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

4. O
Prednisone B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

5. O
Valganciclovir B-TREATMENT
450 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
:* O
60 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

6. O
Ursodiol B-TREATMENT
300 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

7. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
1.5 O
Tablets O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

8. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

9. O
Fluconazole B-TREATMENT
200 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

Disp O
:* O
60 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

10. O
Insulin B-TREATMENT
SS I-TREATMENT
and O
fixed B-TREATMENT
dose I-TREATMENT

Fingerstick O
QACHS O
, O
3 O
AM O
Insulin B-TREATMENT
SC I-TREATMENT
Fixed I-TREATMENT
Dose I-TREATMENT
Orders O

Breakfast O

NPH O

17 O
Units O

Insulin B-TREATMENT
SC I-TREATMENT
Sliding I-TREATMENT
Scale I-TREATMENT

Breakfast O
Lunch O
Dinner O
Bedtime O

Regular O
Regular O
Regular O
Regular O

Glucose O
Insulin O
Dose O
Insulin O
Dose O
Insulin O
Dose O
Insulin O
Dose O

0-60 O
mg O
/ O
dL O
4 O
oz. O
Juice O
4 O
oz. O
Juice O
4 O
oz. O
Juice O
4 O
oz. O
Juice O

61-120 O
mg O
/ O
dL O
1 O
Units O
0 O
Units O
0 O
Units O
0 O
Units O

121-160 O
mg O
/ O
dL O
2 O
Units O
0 O
Units O
1 O
Units O
0 O
Units O

161-200 O
mg O
/ O
dL O
3 O
Units O
4 O
Units O
2 O
Units O
0 O
Units O

201-240 O
mg O
/ O
dL O
5 O
Units O
6 O
Units O
4 O
Units O
0 O
Units O

241-280 O
mg O
/ O
dL O
6 O
Units O
7 O
Units O
5 O
Units O
1 O
Units O

281-320 O
mg O
/ O
dL O
7 O
Units O
8 O
Units O
6 O
Units O
2 O
Units O

321-360 O
mg O
/ O
dL O
9 O
Units O
10 O
Units O
8 O
Units O
3 O
Units O

361-400 O
mg O
/ O
dL O
11 O
Units O
11 O
Units O
10 O
Units O
4 O
Units O

> O
400 O
mg O
/ O
dL O
Notify O
M.D. O
Notify O
M.D. O
Notify O
M.D. O
Notify O
M.D. O

11. O
Tacrolimus B-TREATMENT
0.5 O
mg O
Capsule O
Sig O
: O
Three O
( O
3 O
) O
Capsule O
PO O
twice O
a O
day O
. O

Disp O
:* O
180 O
Capsule O
( O
s O
)* O
Refills O
:* O
0 O
* O

12. O
Insulin B-TREATMENT
NPH I-TREATMENT
Human I-TREATMENT
Recomb I-TREATMENT
100 O
unit O
/ O
mL O
Cartridge O
Sig O
: O
One O
( O
1 O
) O
Subcutaneous O
at O
breakfast O
: O
Please O
take O
as O
prescribed O
by O
Albano O
/ O
Transplant O
Team O
. O

Disp O
:* O
10 O
* O
Refills O
:* O
2 O
* O

13. O
Insulin B-TREATMENT
Regular I-TREATMENT
Human I-TREATMENT
300 O
unit O
/ O
3 O
mL O
Insulin O
Pen O
Sig O
: O
One O
( O
1 O
) O
Subcutaneous O
four O
times O
a O
day O
: O
Please O
take O
as O
prescribed O
by O
Albano O
/ O
Transplant O
team O
. O

Disp O
:* O
10 O
* O
Refills O
:* O
2 O
* O

14. O
Insulin B-TREATMENT
Syringe I-TREATMENT
Needless I-TREATMENT
( O
Disp O
) O
1 O
mL O
Syringe O
Sig O
: O
One O
( O
1 O
) O
Miscell. O
as O
directed O
by O
Albano O
/ O
Trasplant O
. O

Disp O
:* O
150 O
* O
Refills O
:* O
2 O
* O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

End B-SYMPTOM
stage I-SYMPTOM
liver I-SYMPTOM
disease I-SYMPTOM

Discharge O
Condition O
: O

Good O

Discharge O
Instructions O
: O

Please O
take O
medications B-TREATMENT
as O
prescribed O
and O
read O
warning O
labels O
carefully O
. O

If O
symptoms O
such O
as O
fever B-SYMPTOM
/ O
chills B-SYMPTOM
, O
nausea B-SYMPTOM
/ O
vomiting B-SYMPTOM
, O
increasing B-SYMPTOM
pain I-SYMPTOM
/ O
redness B-SYMPTOM
/ O
purulent B-SYMPTOM
discharge I-SYMPTOM
from O
incision B-SYMPTOM
, O
increasing B-SYMPTOM
jaundice I-SYMPTOM
, O
please O
call O
or O
go O
to O
the O
emergency O
room O
immediately O
. O

Remember O
to O
call O
for O
a O
follow O
up O
appointment O
( O
bellow O
) O
. O

Light O
activities O
until O
seen O
in O
clinic O
. O

May O
eat O
regular O
food O
. O

May O
shower O
but O
no O
baths O
. O

Pat O
incision B-SYMPTOM
wounds I-SYMPTOM
dry O
, O
do O
not O
scrub O
wound B-SYMPTOM
when O
showering O
. O

Absolutely O
no O
smoking O
. O

Followup O
Instructions O
: O

Provider O
: O

Francis O
Britni O
, O
MD O
Phone O
:( O
646 O
) O
444-8240 O

Date O
/ O
Time O
: O
2015-01-22 O
10:40 O

Provider O
: O

Francis O
Britni O
, O
MD O
Phone O
:( O
646 O
) O
444-8240 O

Date O
/ O
Time O
: O
2015-01-29 O
10:40 O

Provider O
: O

Francis O
Britni O
, O
MD O
Phone O
:( O
646 O
) O
444-8240 O

Date O
/ O
Time O
: O
2015-02-05 O
9:20 O

Please O
follow O
up O
with O
Albano O
, O
as O
direct O
by O
them O
, O
a O
few O
days O
after O
discharge O
from O
the O
hospital O
( O
( O
371 O
) O
400 O
5776 O
. O

Francis O
Britni O
MD O
34-902 O

Completed O
by O
: O
Wayne O
Chris O
MD O
18-062 O
2015-01-20 O
@ O
1208 O

Signed O
electronically O
by O
: O
DR. O
Francis O
VU O
Vila O
on O
: O
MON O
2015-01-26 O
6:12 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-08-24 O

Discharge O
Date O
: O

2013-08-27 O

Date O
of O
Birth O
: O

1987-09-08 O

Sex O
: O

M O

Service O
: O

Trauma O
Surgery O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
25 O
- O
year-old O
gentleman O
who O
is O
status O
post O
a O
motor O
vehicle O
accident O
in O
which O
he O
was O
the O
unrestrained O
driver O
and O
struck O
a O
telephone O
pole O
. O

He O
was O
ejected O
from O
the O
car O
and O
landed O
on O
his O
face O
. O

Extreme O
damage O
was O
reported O
to O
the O
vehicle O
by O
first O
responders O
. O

It O
was O
presumed O
high-speed O
motor O
vehicle O
collision O
. O

The O
patient O
was O
CMED-flighted O
to O
Quincy O
Medical O
Center O
, O
and O
he O
was O
intubated O
upon O
arrival O
in O
the O
Emergency O
Department O
. O

After O
initial O
trauma O
assessment O
and O
initiation O
of O
resuscitation B-TREATMENT
, O
a O
CT O
scan O
was O
performed O
. O

Images O
of O
his O
head O
, O
abdomen O
, O
and O
thorax O
were O
obtained O
. O

His B-SYMPTOM
injuries I-SYMPTOM
included O
bilateral B-SYMPTOM
zygomal I-SYMPTOM
and I-SYMPTOM
orbital I-SYMPTOM
rim I-SYMPTOM
fractures I-SYMPTOM
, O
a B-SYMPTOM
right I-SYMPTOM
temporal I-SYMPTOM
fracture I-SYMPTOM
, O
bilateral B-SYMPTOM
frontal I-SYMPTOM
contusions I-SYMPTOM
, O
and O
a B-SYMPTOM
right I-SYMPTOM
temporal I-SYMPTOM
epidural I-SYMPTOM
versus O
subdural B-SYMPTOM
hematoma I-SYMPTOM
. O

The O
anterior O
and O
posterior O
of O
the O
frontal O
sinus O
was O
fractured B-SYMPTOM
with O
communication B-SYMPTOM
with I-SYMPTOM
the I-SYMPTOM
ethmoid I-SYMPTOM
air I-SYMPTOM
cells I-SYMPTOM
, O
presumably O
caused O
air B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
orbit I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Denies O
. O

PAST O
SURGICAL O
HISTORY O
: O

Denies O
. O

SOCIAL O
HISTORY O
: O

Denies O
. O

ALLERGIES O
: O

Denies O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Denies O
. O

PHYSICAL O
EXAMINATION O
ON O
PRESENTATION O
: O

Initial O
examination O
revealed O
the O
patient O
had O
a O
heart O
rate O
in O
the O
80s O
, O
with O
a O
blood O
pressure O
of O
150/80s O
. O

He O
was O
intubated B-TREATMENT
with O
multiple B-SYMPTOM
abrasions I-SYMPTOM
, O
and O
severe B-SYMPTOM
swelling I-SYMPTOM
and O
contusions B-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
face I-SYMPTOM
. O

He O
was O
not O
following O
commands O
. O

His O
Boston O
Coma O
Scale O
was O
16 O
. O

His O
pupils O
were O
reactive O
on O
the O
right O
going O
from O
3 O
mm O
to O
2 O
mm O
of O
light O
. O

The O
response O
was O
brisk O
. O

On O
the O
left O
, O
his O
pupils O
went O
from O
2.5 O
mm O
to O
2 O
mm O
, O
also O
brisk O
. O

Initial O
evaluation O
revealed O
corticate B-SYMPTOM
posturing I-SYMPTOM
was O
noted O
by O
the O
trauma O
team O
. O

He O
withdrew O
equally O
and O
purposefully O
after O
20 O
minutes O
in O
the O
trauma O
bay O
. O

He O
withdrew O
to O
noxious O
stimuli O
equally O
and O
purposefully O
after O
20 O
minutes O
in O
the O
trauma O
bay O
. O

HOSPITAL O
COURSE O
BY O
SYSTEM O
: O

1. O
NEUROLOGY O
: O

Mr. O
Roach O
was O
transported O
to O
Intensive O
Care O
Unit O
from O
the O
trauma O
bay O
. O

Upon O
arrival O
, O
Neurosurgery O
promptly O
placed O
V. B-TREATMENT
Holtzen I-TREATMENT
bolt I-TREATMENT
. O

This O
allowed O
continuous O
monitoring O
of O
intracranial O
pressure O
. O

Notably O
, O
intracranial O
pressure O
was O
17 O
when O
the B-TREATMENT
bolt I-TREATMENT
was O
placed O
. O

During O
his O
hospitalization O
, O
his O
intracranial O
pressure O
was O
monitored O
very O
closely O
and O
maintained O
to O
a O
level O
of O
less O
than O
20 O
. O

To O
do O
this O
, O
mannitol B-TREATMENT
25 O
mg O
q. O
6h. O
was O
used O
. O

While O
using O
mannitol B-TREATMENT
, O
his O
serum O
osmolalities O
were O
followed O
closely O
. O

In O
addition O
, O
to O
monitoring O
his O
intracranial O
pressure O
, O
his O
systemic O
blood O
pressures O
were O
maintained O
in O
such O
a O
manner O
that O
his O
cerebral O
perfusion O
pressure O
was O
maintained O
at O
70 O
mmHg O
. O

A O
parameter O
monitor O
for O
his O
neurologic O
status O
PaCO2 O
which O
was O
maintained O
between O
35 O
and O
40 O
during O
his O
hospitalization O
. O

Mr. O
Roach O
was O
kept O
sedated B-TREATMENT
with O
propofol B-TREATMENT
and O
was O
given O
Fentanyl B-TREATMENT
and O
/ O
or O
morphine B-TREATMENT
boluses I-TREATMENT
for O
pain B-SYMPTOM
. O

Neurologic O
checks O
were O
followed O
initially O
every O
one O
hour O
and O
then O
every O
two O
hours O
to O
monitor O
for O
change B-SYMPTOM
in I-SYMPTOM
neurologic I-SYMPTOM
examination I-SYMPTOM
. O

During O
his O
hospitalization O
, O
two O
subsequent O
CAT O
scans O
were O
obtained O
; O
one O
on O
hospital O
day O
two O
. O

This O
CAT O
scan O
revealed O
possible O
worsening O
and O
was O
read O
as O
epidural B-SYMPTOM
versus O
subdural B-SYMPTOM
bleed I-SYMPTOM
. O

After O
a O
discussion O
with O
both O
Radiology O
and O
Neurosurgery O
, O
the O
decision O
was O
made O
that O
the O
worsening O
did O
not O
appear O
significant O
, O
and O
this O
was O
not O
accompanied O
by O
a B-SYMPTOM
change I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
clinical I-SYMPTOM
condition I-SYMPTOM
. O

His O
intracranial O
pressure O
remained O
stable O
, O
and O
his O
clinical O
examination O
was O
unchanged O
. O

An O
additional O
CT O
scan O
was O
obtained O
on O
hospital O
day O
three O
. O

This O
examination O
was O
unchanged O
from O
the O
previous O
examination O
. O

Again O
, O
his O
intracranial O
pressure O
and O
neurologic O
examination O
remained O
the O
same O
, O
and O
conservative B-TREATMENT
treatment I-TREATMENT
was O
opted O
for O
. O

2. O
CARDIOVASCULAR O
: O

As O
described O
in O
previous O
section O
, O
Neo-Synephrine B-TREATMENT
and O
eventually O
Levophed B-TREATMENT
were O
used O
to O
maintain O
a O
coronary O
perfusion O
pressure O
of O
greater O
than O
70 O
. O

A B-TREATMENT
pulmonary I-TREATMENT
artery I-TREATMENT
catheter I-TREATMENT
was O
placed O
on O
hospital O
day O
four O
. O

This B-TREATMENT
catheter I-TREATMENT
was O
placed O
when O
the O
patient O
started O
to O
demonstrate O
septic B-SYMPTOM
physiology I-SYMPTOM
and O
for O
increasing O
pressor B-TREATMENT
support I-TREATMENT
. O

Please O
see O
Infectious O
Disease O
section O
for O
more O
details O
. O

3. O
GASTROINTESTINAL O
: O

Mr. O
Roach O
was O
n.p.o. B-TREATMENT
from O
the O
time O
of O
his O
admission O
. O

A B-TREATMENT
orogastric I-TREATMENT
tube I-TREATMENT
was O
passed O
. O

Initially O
during O
admission O
, O
carafate B-TREATMENT
was O
given O
down O
the B-TREATMENT
orogastric I-TREATMENT
tube I-TREATMENT
. O

However O
, O
on O
a O
routine O
chest O
x-ray O
shot O
on O
hospital O
day O
three O
, O
a B-SYMPTOM
mediastinum I-SYMPTOM
was O
noted O
. O

This O
raised O
the O
question O
of O
potential O
esophageal B-SYMPTOM
rupture I-SYMPTOM
. O

Gastroenterology O
was O
consulted O
for O
this O
. O

Gastroenterology O
was O
consulted O
to O
assist O
in O
creating O
the O
most O
appropriate O
diagnostic O
rhythm O
given O
his O
intubated O
and O
sedated O
status O
. O

At O
this O
point O
, O
his B-TREATMENT
carafate I-TREATMENT
was O
switched O
to O
intravenous B-TREATMENT
Protonix I-TREATMENT
and O
he O
was O
strictly B-TREATMENT
n.p.o. I-TREATMENT

4. O
HEMATOLOGY O
: O

Throughout O
Mr. O
Richard O
admission O
, O
his O
hematocrit O
remained O
stable O
in O
the O
low O
30s O
. O

As O
will O
be O
discussed O
in O
the O
Infectious O
Disease O
section O
, O
he O
developed O
an O
episode O
of O
what O
appeared O
to O
be O
sepsis B-SYMPTOM
, O
and O
his O
white O
blood O
cell O
count O
peaked O
at O
23 O
. O

Mr. O
Roach O
was O
on O
Pneumo B-TREATMENT
boots I-TREATMENT
spontaneous I-TREATMENT
compression I-TREATMENT
devices I-TREATMENT
for O
deep B-TREATMENT
venous I-TREATMENT
thrombosis I-TREATMENT
prophylaxis I-TREATMENT
. O

He O
was O
not O
a O
candidate O
for O
subcutaneous B-TREATMENT
heparin I-TREATMENT
as O
we O
were O
concerned O
of O
an B-SYMPTOM
intracranial I-SYMPTOM
hemorrhage I-SYMPTOM
. O

An B-TREATMENT
inferior I-TREATMENT
vena I-TREATMENT
cava I-TREATMENT
filter I-TREATMENT
was O
considered O
but O
was O
deferred O
, O
as O
it O
was O
felt O
that O
Mr. O
Roach O
was O
too B-SYMPTOM
unstable I-SYMPTOM
to O
undergo O
the B-TREATMENT
procedure I-TREATMENT
. O

5. O
ENDOCRINE O
: O

Mr. O
Marian O
blood O
sugar O
was O
maintained O
under O
tight O
control O
from O
100 O
to O
130 O
using O
a B-TREATMENT
regular I-TREATMENT
insulin I-TREATMENT
sliding-scale I-TREATMENT
. O

6. O
INFECTIOUS O
DISEASE O
: O

Mr. O
Roach O
had O
a B-SYMPTOM
spike I-SYMPTOM
in I-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cell I-SYMPTOM
count I-SYMPTOM
and O
developed O
fevers B-SYMPTOM
. O

His O
blood O
urine O
and O
sputum O
were O
all O
cultured O
. O

Blood O
cultures O
were O
pertinent O
for O
one O
bottle O
of O
gram B-SYMPTOM
- I-SYMPTOM
positive I-SYMPTOM
coagulase I-SYMPTOM
- I-SYMPTOM
negative I-SYMPTOM
Staphylococcus I-SYMPTOM
which O
grew O
from O
08-25 O
. O

His O
preliminary O
cultures O
including O
sputum O
from O
08-25 O
grew O
Escherichia B-SYMPTOM
coli I-SYMPTOM
. O

Sputum O
from O
08-27 O
grew O
gram-negative B-SYMPTOM
rods I-SYMPTOM
, O
not O
yet O
speciated O
, O
and O
from O
08-27 O
a O
bronchoalveolar O
lavage O
grew O
1+ B-SYMPTOM
gram-negative I-SYMPTOM
rods I-SYMPTOM
and O
4+ B-SYMPTOM
polymorphonuclear I-SYMPTOM
lymphocytes I-SYMPTOM
. O

Throughout O
this O
time O
, O
Mr. O
Richard O
temperature O
continued O
to O
increase O
and O
was O
such O
that O
on O
hospital O
day O
four O
, O
his O
temperature O
maximum O
was O
42.2 O
degrees O
centigrade O
. O

During O
his O
hospitalization O
, O
his O
was O
treated O
with O
vancomycin B-TREATMENT
for O
his B-SYMPTOM
gram-negative I-SYMPTOM
rods I-SYMPTOM
, O
imipenem B-TREATMENT
, O
and O
Flagyl B-TREATMENT
. O

Initially O
, O
he O
had O
been O
placed O
on O
clindamycin B-TREATMENT
to O
cover O
his B-TREATMENT
drain I-TREATMENT
, O
but O
his O
cultures O
became O
positive B-SYMPTOM
, O
and O
his O
white O
blood O
cell O
count O
increased O
. O

He O
was O
switched O
from O
clindamycin B-TREATMENT
to O
the B-TREATMENT
imipenem I-TREATMENT
and O
Flagyl B-TREATMENT
. O

Vancomycin B-TREATMENT
was O
added O
when O
we O
had O
the B-SYMPTOM
positive I-SYMPTOM
blood I-SYMPTOM
culture I-SYMPTOM
. O

With O
a B-SYMPTOM
fever I-SYMPTOM
of O
102 O
, O
up O
to O
42 O
degrees O
centigrade O
, O
aggressive B-TREATMENT
measures I-TREATMENT
including O
cooling B-TREATMENT
blankets I-TREATMENT
, O
alcohol B-TREATMENT
swabs I-TREATMENT
, O
and O
fans B-TREATMENT
were O
used O
in O
an O
attempt O
to O
bring O
his O
body O
temperature O
down O
. O

Hypercarbia B-SYMPTOM
would O
result O
and O
increase O
in O
cerebral O
perfusion O
, O
paralysis B-TREATMENT
was O
initiated O
to O
decrease O
genesis O
of O
carbon O
dioxide O
secreted O
during O
shivering B-SYMPTOM
. O

7. O
PULMONARY O
: O

As O
discussed O
in O
the O
Infectious O
Disease O
section O
, O
Mr. O
Roach O
developed O
a B-SYMPTOM
pneumonia I-SYMPTOM
likely O
from O
gram-negative B-SYMPTOM
organisms I-SYMPTOM
, O
but O
most O
likely O
from O
Escherichia B-SYMPTOM
coli I-SYMPTOM
. O

For O
this B-SYMPTOM
pneumonia I-SYMPTOM
, O
he O
was O
placed O
empirically O
on O
imipenem B-TREATMENT
, O
vancomycin B-TREATMENT
, O
and O
Flagyl B-TREATMENT
. O

On O
hospital O
day O
three O
, O
Mr. O
Roach O
had O
developed O
an O
episode O
of O
tachycardia B-SYMPTOM
and O
tachypnea B-SYMPTOM
. O

For O
this O
, O
a O
CT O
angiogram O
was O
obtained O
which O
demonstrated O
no O
pulmonary B-SYMPTOM
embolism I-SYMPTOM
. O

On O
hospital O
day O
four O
, O
a O
routine O
chest O
x-ray O
revealed O
a B-SYMPTOM
left-sided I-SYMPTOM
pneumothorax I-SYMPTOM
. O

For O
this O
, O
a B-TREATMENT
left I-TREATMENT
#34 I-TREATMENT
Caucasian I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
placed O
. O

On O
the O
evening O
of O
hospital O
day O
four O
, O
Mr. O
Roach O
had O
an B-SYMPTOM
acute I-SYMPTOM
episode I-SYMPTOM
whereby O
his O
central O
venous O
pressure O
rose O
sharply O
and O
immediately O
followed O
by O
a O
period O
of O
asystole B-SYMPTOM
. O

Urgent B-TREATMENT
resuscitation I-TREATMENT
measures I-TREATMENT
were O
initiated O
. O

The B-TREATMENT
measures I-TREATMENT
included O
attempts O
at O
pacing B-TREATMENT
. O

Epinephrine B-TREATMENT
and O
atropine B-TREATMENT
were O
administered O
as O
were O
bicarbonate B-TREATMENT
and O
calcium B-TREATMENT
. O

He O
had O
a O
differential O
diagnosis O
of O
asystole B-SYMPTOM
preceded O
by O
an B-SYMPTOM
acute I-SYMPTOM
rise I-SYMPTOM
in I-SYMPTOM
central I-SYMPTOM
venous I-SYMPTOM
pressure I-SYMPTOM
included O
attention B-SYMPTOM
pneumothorax I-SYMPTOM
, O
cardiac B-SYMPTOM
tamponade I-SYMPTOM
, O
and O
pulmonary B-SYMPTOM
embolism I-SYMPTOM
. O

During O
the B-TREATMENT
resuscitation I-TREATMENT
afterwards O
, O
it O
was O
noted O
that O
a B-TREATMENT
patent I-TREATMENT
left I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
present O
in O
the O
left O
chest O
, O
so O
initially O
neo-decompression B-TREATMENT
was O
attempted O
in O
the O
right O
chest O
. O

There O
was O
no O
sign O
of O
attention B-SYMPTOM
pneumothorax I-SYMPTOM
with O
decompression B-TREATMENT
, O
and O
a B-TREATMENT
right I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
placed O
. O

During O
this O
time O
, O
a O
needle O
aspiration O
of O
what O
was O
felt O
to O
be O
the O
pericardium O
was O
performed O
revealing O
bloody B-SYMPTOM
fluid I-SYMPTOM
coming O
back O
. O

A B-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
thoracotomy I-TREATMENT
was O
made O
by O
the O
Cardiac O
Surgery O
fellow O
who O
was O
present O
. O

After O
30 O
minutes O
of O
active B-TREATMENT
resuscitation I-TREATMENT
including O
internal B-TREATMENT
cardiac I-TREATMENT
massage I-TREATMENT
, O
there O
was O
no O
evidence O
of O
return O
of O
vital O
signs O
or O
electric O
activity O
to O
the O
heart O
as O
noted O
on O
electrocardiogram O
monitors O
. O

Resuscitation B-TREATMENT
was O
terminated O
at O
1914 O
on O
08-27 O
. O

After O
the O
termination O
of O
resuscitation B-TREATMENT
, O
both O
the O
anesthesia O
Intensive O
Care O
Unit O
attending O
and O
the O
surgical O
attending O
were O
present O
to O
discuss O
the O
proceedings O
events O
with O
the O
patient O
's O
family O
members O
including O
his O
next O
of O
kin O
, O
his O
mother O
. O

Permission O
for O
a O
postmortem O
examination O
was O
granted O
. O

Matthew O
M. O
Barnett O
, O
M.D. O
78-102 O

Dictated O
By O
: O
Mark O
D. O
Eng O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-08-28 O
00:21 O

T O
: O
2013-09-03 O
11:11 O

JOB O
# O
: O
24887 O

Signed O
electronically O
by O
: O
DR. O
Katherin O
Toth O
on O
: O
MON O
2013-10-14 O
3:05 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2011-09-24 O

Discharge O
Date O
: O

2011-09-27 O

Date O
of O
Birth O
: O

1932-02-28 O

Sex O
: O

M O

Service O
: O

ADMISSION O
DIAGNOSIS O
: O

Subarachnoid B-SYMPTOM
hemorrhage I-SYMPTOM
, I-SYMPTOM
posttraumatic I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
was O
a O
79 O
- O
year-old O
gentleman O
found O
down O
at O
home O
unresponsive B-SYMPTOM
by O
his O
wife O
after O
lunch O
. O

He O
had O
an O
unwitnessed O
fall O
. O

He O
had O
no O
history O
of O
headaches B-SYMPTOM
or O
recent B-SYMPTOM
illness I-SYMPTOM
. O

He O
remained O
unresponsive B-SYMPTOM
when O
the O
ambulance O
arrived O
. O

Systolic O
blood O
pressure O
was O
reported O
250 O
on O
arrival O
to O
the O
Mass. O
Eye O
& O
Ear O
Infirmary O
Emergency O
Department O
. O

He O
was O
intubated O
and O
given O
Versed B-TREATMENT
and O
Fentanyl B-TREATMENT
. O

His O
GCS O
was O
reported O
as O
3 O
on O
arrival O
to O
the O
Emergency O
Department O
. O

PAST O
MEDICAL O
HISTORY O
: O

Hypertension B-SYMPTOM
. O

Status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

Pacemaker B-TREATMENT
implantation I-TREATMENT
. O

Atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

Cerebrovascular B-SYMPTOM
accident I-SYMPTOM
. O

Previous B-SYMPTOM
intracranial I-SYMPTOM
hemorrhage I-SYMPTOM
. O

MEDICATIONS O
: O

Aspirin B-TREATMENT
, O
Folate B-TREATMENT
, O
Multivitamin B-TREATMENT
, O
Amiodarone B-TREATMENT
, O
Lasix B-TREATMENT
, O
Imdur B-TREATMENT
, O
Celexa B-TREATMENT
, O
Lipitor B-TREATMENT
, O
Potassium B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

Vital O
signs O
: O

He O
was O
afebrile B-SYMPTOM
, O
blood O
pressure O
154/75 O
, O
on O
Nipride B-TREATMENT
drip I-TREATMENT
, O
heart O
rate O
81 O
, O
oxygen O
saturation O
97% O
. O

General O
: O

He O
was O
intubated B-TREATMENT
and O
sedated B-TREATMENT
at O
the O
time O
. O

Neurological O
: O

Pinpoint B-SYMPTOM
pupils I-SYMPTOM
, O
intact O
corneal O
reflexes O
bilaterally O
. O

Doll B-SYMPTOM
's I-SYMPTOM
eyes I-SYMPTOM
. O

He O
withdrew O
both O
lower O
extremities O
to O
peripheral O
stimulation O
, O
as O
well O
as O
his O
upper O
extremities O
to O
peripheral O
stimulation O
. O

He O
also O
withdrew O
his O
left O
upper O
extremity O
to O
peripheral O
stimulation O
but O
not O
his O
right O
upper O
extremity O
. O

His O
reflexes O
were O
brisk O
in O
his O
patellas O
bilaterally O
, O
and O
he O
had O
upgoing B-SYMPTOM
toes I-SYMPTOM
bilaterally I-SYMPTOM
. O

IMAGING O
: O

Head O
CT O
showed O
diffuse B-SYMPTOM
subarachnoid I-SYMPTOM
hemorrhage I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

He O
was O
admitted O
to O
the O
Neuro O
Surgical O
Intensive O
Care O
Unit O
for O
close O
monitoring O
and O
Neuro-checks O
. O

A B-TREATMENT
Vent I-TREATMENT
drain I-TREATMENT
was O
placed O
to O
monitor O
and O
CP O
and O
relieved O
fluid O
. O

He O
received O
12 O
U O
of O
platelets B-TREATMENT
. O

His O
Intensive O
Care O
Unit O
stay O
was O
unremarkable O
. O

His O
neurologic O
exam O
did O
not O
change O
significantly O
. O

His O
ICPs O
were O
in O
the O
range O
of O
11-22 O
, O
and O
he O
was O
weaned O
off O
the B-TREATMENT
Nipride I-TREATMENT
drip I-TREATMENT
. O

He O
developed O
extensive B-SYMPTOM
posturing I-SYMPTOM
. O

A O
CTA O
showed O
diffuse B-SYMPTOM
subarachnoid I-SYMPTOM
hemorrhage I-SYMPTOM
and O
intraventricular B-SYMPTOM
blood I-SYMPTOM
but O
no O
evidence O
of O
an B-SYMPTOM
aneurysm I-SYMPTOM
. O

A O
repeat O
CT O
on O
09-26 O
showed O
worsening O
of O
the B-SYMPTOM
diffuse I-SYMPTOM
subarachnoid I-SYMPTOM
hemorrhage I-SYMPTOM
and O
a B-SYMPTOM
new I-SYMPTOM
cerebellar I-SYMPTOM
hemorrhage I-SYMPTOM
. O

The O
family O
was O
informed O
of O
the O
patient O
's O
condition O
and O
repeat O
scan O
. O

A O
family O
discussion O
resulted O
in O
the O
decision O
to O
make O
the O
patient O
comfort B-TREATMENT
measures I-TREATMENT
only I-TREATMENT
. O

The O
patient O
was O
placed O
on O
a B-TREATMENT
Morphine I-TREATMENT
drip I-TREATMENT
and O
extubated O
and O
passed O
away O
at O
10:55 O
a.m. O
on O
2011-09-27 O
. O

The O
family O
was O
notified O
of O
the O
patient O
's O
passing O
. O

The O
medical O
examiner O
has O
also O
been O
notified O
of O
the O
passing O
of O
the O
patient O
. O

Shawn O
B O
Crawford O
, O
M.D. O

46-411 O

Dictated O
By O
: O
Linda O
P.F. O
Clark O
, O
M.D. O

MEDQUIST36 O

D O
: O
2011-09-27 O
11:53 O

T O
: O
2011-09-27 O
12:41 O

JOB O
# O
: O
63722 O

Signed O
electronically O
by O
: O
DR. O
Carlos O
Warner O
on O
: O
TUE O
2011-09-27 O
3:42 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2016-05-10 O

Discharge O
Date O
: O

2016-05-16 O

Date O
of O
Birth O
: O

1985-06-12 O

Sex O
: O

F O

Service O
: O

MEDICINE B-TREATMENT

Allergies O
: O

Zosyn B-TREATMENT

Attending O
: O

Gayle O
M O
Whitener O
, O
M.D. O

Chief O
Complaint O
: O

Transfer O
from O
Tewksbury O
State O
Hospital O
Hospital O
CMED O
CCU O
for O
neurologic B-SYMPTOM
compromise I-SYMPTOM
, O
at O
request O
of O
family O
for O
second O
opinion O
. O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

None O

History O
of O
Present O
Illness O
: O

30-year-old O
woman O
with O
metastatic B-SYMPTOM
squamous I-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of O
unknown O
primary O
. O

At O
ChelseaWomens O
' O
, O
about O
04-25 O
, O
she O
developed O
pseudomonal B-SYMPTOM
urosepsis I-SYMPTOM
and O
vaginal B-SYMPTOM
bleeding I-SYMPTOM
from O
tumor B-SYMPTOM
extension/anti-coagulation I-SYMPTOM
. O

She O
was O
transfered O
to O
AttleboroHospital O
after O
an O
arrest O
. O

Her O
course O
was O
complicated O
by O
post-hypotensive B-SYMPTOM
coma I-SYMPTOM
as O
well O
as O
subarachnoid B-SYMPTOM
hemorrhages I-SYMPTOM
and O
intraparenchymal B-SYMPTOM
bleeds I-SYMPTOM
. O

Neurologists O
at O
RIH O
felt O
she O
had O
a O
poor O
prognosis O
, O
but O
communication O
between O
the O
medical O
team O
and O
family O
was O
strained O
and O
transfer O
was O
arranged O
to O
Mediplex O
Rehab O
Hospital O
for O
a O
second O
opinion O
. O

Her O
outside O
course O
in O
more O
detail: O

Patient O
transferred O
from O
Women O
and O
Infants O
Hospital O
to O
RI O
Hospital O
2016-04-25 O
with O
weaknes B-SYMPTOM
, O
vag B-SYMPTOM
bleeding I-SYMPTOM
x O
several O
days O
, O
fever B-SYMPTOM
102.5 O
, O
hypotension B-SYMPTOM
, O
hypoxic B-SYMPTOM
84% O
on O
4L B-TREATMENT
NC I-TREATMENT
, O
tachypnic B-SYMPTOM
to O
30 O
, O
with O
labs O
significant O
for O
lactate O
6.3 O
, O
wbc O
<1.0 O
, O
plt O
9 O
, O
hgb O
8.9 O
, O
and O
INR O
greater O
than O
lab O
threshold O
. O

Intubated B-TREATMENT
for O
airway B-TREATMENT
protection I-TREATMENT
( O
ABG O
7.39/26.5/73.6 O
) O
and O
placed O
on O
levophed B-TREATMENT
. O

. O

Placed O
on O
Reynolds/vanc/fluc/gentamicin B-TREATMENT
for O
neutropenic B-SYMPTOM
fever I-SYMPTOM
and O
thrush B-SYMPTOM
initially O
. O

IVC B-TREATMENT
filter I-TREATMENT
placed O
04-26 O
. O

CT O
abdomen O
consistent O
with O
large B-SYMPTOM
necrotic I-SYMPTOM
pelvic I-SYMPTOM
mass I-SYMPTOM
- O
not O
sampled O
02-12 O
coagulopathy B-SYMPTOM
. O

04-27 O
results O
from O
Blood O
Cx O
from O
W+I O
: O

04-24 O
PICC O
Bld O
Cx O
: O
pseudomonas B-SYMPTOM
Diaz O
to O
zosyn B-TREATMENT
, O
cipro B-TREATMENT
, O
cefepime B-TREATMENT
, O
Tardugno O
-- O
staph B-SYMPTOM
epi- I-SYMPTOM
Gray O
to O
vanc B-TREATMENT

04-24 O
Peripheral O
Bld O
Cx O
: O
pseudomonas B-SYMPTOM
as O
above O

04-24 O
Urine O
Cx O
: O
pseudomonas B-SYMPTOM
as O
above O

Abx B-TREATMENT
changed O
to O
vanc B-TREATMENT
, O
zosyn B-TREATMENT
, O
cipro B-TREATMENT
, O
fluc B-TREATMENT
, O
azith B-TREATMENT
. O

Pressors B-TREATMENT
weaned O
off O
by O
04-27 O
. O

Completed O
7 O
days O
of O
vanc/fluc B-TREATMENT
, O
13/14 O
days O
of O
cipro/zosyn B-TREATMENT
. O

Continued O
to O
have O
recurrent B-SYMPTOM
fevers I-SYMPTOM
. O

. O

Seen O
by O
Urology O
who O
did O
not O
change O
stents B-TREATMENT
given O
severe B-SYMPTOM
coagulopathy I-SYMPTOM
and O
worsening B-SYMPTOM
renal I-SYMPTOM
function I-SYMPTOM
. O

Found O
to O
be O
in O
DIC B-SYMPTOM
and O
supported O
with O
daily B-TREATMENT
blood I-TREATMENT
products I-TREATMENT
. O

Seen O
by O
heme O
and O
GCSF B-TREATMENT
started O
. O

Despite O
aggressive B-TREATMENT
blood I-TREATMENT
product I-TREATMENT
repletion I-TREATMENT
patient O
poorly B-SYMPTOM
responsive I-SYMPTOM
02-12 O
alloimmunization B-SYMPTOM
. O

Plt O
count O
1 O
on O
2016-04-29 O
. O

Supported O
on O
TPN B-TREATMENT
for O
nutrition O
then O
switched O
to O
tube B-TREATMENT
feeds I-TREATMENT
. O

Developed O
renal B-SYMPTOM
failure I-SYMPTOM
with O
Cr O
peak O
of O
2.9. O

Seen O
by O
renal O
who O
felt O
was O
c/w O
ATN B-SYMPTOM
. O

. O

Head O
CT O
done O
05-04 O
with O
bilateral B-SYMPTOM
SAH I-SYMPTOM
and O
L B-SYMPTOM
temporal I-SYMPTOM
parenchymal I-SYMPTOM
hematoma I-SYMPTOM
. O

Also O
with O
multiple B-SYMPTOM
masses I-SYMPTOM
consistent O
with O
metastasis B-SYMPTOM
. O

Placed O
on O
Dilantin B-TREATMENT
. O

Neurosurgery O
consulted O
. O

Felt O
secondary O
to O
low B-SYMPTOM
platelets I-SYMPTOM
with O
no O
surgical B-TREATMENT
intervention I-TREATMENT
indicated O
. O

. O

Mult O
family O
meetings O
given O
poor O
prognosis O
. O

Initially O
decided O
not O
to O
escilate O
care O
and O
make O
DNR O
05-05 O
. O

Then O
progressed O
to O
withdrawal O
of O
care O
05-06 O
with O
plan O
to O
extubate B-TREATMENT
05-07 O
. O

However O
there O
was O
dissent O
among O
neurologists O
about O
patient O
's O
ability O
to O
recover O
from O
the B-SYMPTOM
SAH I-SYMPTOM
while O
awaiting O
family O
members O
and O
the O
patient O
was O
changed O
to O
full O
code O
. O

Given O
48 O
hours O
off O
sedation B-TREATMENT
with O
out O
change B-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
( O
last O
morphine B-TREATMENT
was O
2016-05-07 O
) O
. O

Transferred O
to O
Mediplex O
Rehab O
Hospital O
for O
further O
work O
up O
. O

. O

On O
arrival O
to O
the O
FICU O
the O
patient O
was O
intubated B-TREATMENT
and O
non-sedated O
. O

Past O
Medical O
History O
: O

- O
Retroperitoneal B-SYMPTOM
Squamous I-SYMPTOM
Cell I-SYMPTOM
Carcinoma I-SYMPTOM
of O
unknown O
primary O
, O
dx O

12-15 O
, O
s/p O
XRT B-TREATMENT
( O
last O
tx O
2015-04-20 O
) O
, O
s/p O
cisplatin B-TREATMENT
( O
last O
dose O
3/22 O
) O

- O
L B-SYMPTOM
hydroureter I-SYMPTOM
obstruction I-SYMPTOM
, O
s/p O
R B-TREATMENT
ureteral I-TREATMENT
stent I-TREATMENT
2016-03-24 O

- O
h/o O
LLE B-SYMPTOM
DVT I-SYMPTOM
on O
coumadin B-TREATMENT

- O
laser B-TREATMENT
conization I-TREATMENT
of I-TREATMENT
cervix I-TREATMENT
2004 O

Social O
History O
: O

Lives O
with O
husband O
and O
4 O
y.o. O
son O
. O

Family O
History O
: O

Non-contributory O

Physical O
Exam O
: O

VS O
- O
Tm O
101.7 O

Tc O
99.7 O
P O
123 O
BP O
137/75 O

Resp O
- O
PCV O
Pinsp O
26 O
R O
16 O
FiO2 O
50% O
Rate O
8 O
, O
breathing O
20 O
, O
Sat O
100% O

Gen O
- O
lying O
in O
bed O
unresponsive B-SYMPTOM

HEENT O
- O
OP O
clear O
, O
PERRL O

Neck O
- O
supple O

Cor O
- O
RRR O

Chest O
- O
diffuse B-SYMPTOM
ronchi I-SYMPTOM

Abd O
- O
Mass B-SYMPTOM
in I-SYMPTOM
LLQ I-SYMPTOM
, O
nephrostomy B-TREATMENT
with O
yellow O
clear O
output O

Ext O
- O
diffuse B-SYMPTOM
anasarca I-SYMPTOM
x O
4 O
ext O

Neuro O
- O
PERRL O
, O
corneal O
reflex O
, O
gag O
reflex O
, O
Dolls B-SYMPTOM
eyes I-SYMPTOM
, O
spont O
mvt O
of O
head O
with O
out O
purpose O
side O
to O
side O

Pertinent O
Results O
: O

2016-05-10 O
11:02PM O

PT O
- O
14.6* O
PTT O
- O
29.1 O
INR O
( O
PT O
) O
- O
1.3* O

2016-05-10 O
11:02PM O

PLT O
SMR O
- O
LOW B-SYMPTOM
PLT I-SYMPTOM
COUNT I-SYMPTOM
- O
86* O

2016-05-10 O
11:02PM O

WBC O
- O
3.7* O
RBC O
- O
2.78* O
HGB O
- O
8.6 O
* O
HCT O
- O
25.8* O
MCV O
- O
93 O

MCH O
- O
31.1 O
MCHC O
- O
33.5 O
RDW O
- O
14.9 O

2016-05-10 O
11:02PM O

CALCIUM O
- O
7.1* O
PHOSPHATE O
- O
5.1* O
MAGNESIUM O
- O
1.7 O

2016-05-10 O
11:02PM O

ALT O
( O
SGPT O
) O
- O
23 O
AST O
( O
SGOT O
) O
- O
19 O
ALK O
PHOS O
- O
101 O

2016-05-10 O
11:02PM O

estGFR O
- O
Using O
this O

2016-05-10 O
11:02PM O

GLUCOSE O
- O
96 O
UREA O
N O
- O
113* O
CREAT O
- O
2.3* O
SODIUM O
- O
150* O

POTASSIUM O
- O
3.9 O
CHLORIDE O
- O
110* O
TOTAL O
CO2 O
- O
28 O
ANION O
GAP O
- O
16 O

2016-05-15 O
06:02AM O
BLOOD O

WBC O
- O
9.5 O
RBC O
- O
2.78* O
Hgb O
- O
8.8* O
Hct O
- O
25.7* O

MCV O
- O
93 O
MCH O
- O
31.7 O
MCHC O
- O
34.2 O
RDW O
- O
14.6 O
Plt O
Ct O
- O
26* O

2016-05-11 O
04:30AM O
BLOOD O

Neuts O
- O
80.4* O
Bands O
- O
9.3* O
Lymphs O
- O
4.1* O

Monos O
- O
3.1 O
Eos O
- O
1.0 O
Baso O
- O
0 O
Atyps O
- O
1.0* O
Metas O
- O
1.0* O

2016-05-15 O
06:02AM O
BLOOD O

Fibrino O
- O
406* O

2016-05-15 O
06:02AM O
BLOOD O

Glucose O
- O
120* O
UreaN O
- O
79* O
Creat O
- O
1.8* O
Na O
- O
144 O

K O
- O
3.6 O
Cl O
- O
110* O
HCO3 O
- O
23 O
AnGap O
- O
15 O

2016-05-11 O
04:30AM O
BLOOD O

ALT O
- O
19 O
AST O
- O
18 O
LD O
( O
LDH O
) O
- O
313* O
AlkPhos O
- O
104 O

Amylase O
- O
37 O
TotBili O
- O
0.8 O

2016-05-15 O
06:02AM O
BLOOD O

Calcium O
- O
7.4* O
Phos O
- O
3.6 O
Mg O
- O
2.2 O

2016-05-11 O
04:30AM O
BLOOD O

Albumin O
- O
2.3 O

2016-05-13 O
08:32AM O
BLOOD O

Type O
- O
ART O
Temp O
- O
38.2 O
Tidal O
V O
- O
500 O
PEEP O
- O
5 O

FiO2 O
- O
40 O
pO2 O
- O
104 O
pCO2 O
- O
50* O
pH O
- O
7.36 O
calTCO2 O
- O
29 O
Base O
XS O
- O
1 O

-ASSIST/CON O
Intubat O
- O
INTUBATED B-TREATMENT

2016-05-11 O
02:08AM O
BLOOD O

Lactate O
- O
1.6 O

. O

2016-05-11 O
MRI O
head: O

FINDINGS O
: O

The O
sagittal O
T1 O
images O
demonstrate O
several O
areas O
of O
high B-SYMPTOM
signal I-SYMPTOM
along I-SYMPTOM
the I-SYMPTOM
sulci I-SYMPTOM
bilaterally I-SYMPTOM
which O
could O
be O
secondary O
to O
subarachnoid B-SYMPTOM
hemorrhages I-SYMPTOM
. O

There O
are O
several O
areas O
of O
hyperintensities B-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
convexity I-SYMPTOM
which O
could O
be O
intraaxial O
and O
could O
be O
related O
to O
hemorrhage B-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
metastatic I-SYMPTOM
lesions I-SYMPTOM
but O
in O
absence O
of O
gradient O
echo O
images O
, O
this O
could O
not O
be O
further O
confirmed O
. O

A O
CT O
would O
help O
for O
further O
assessment O
if O
indicated O
. O

There O
is O
increased B-SYMPTOM
signal I-SYMPTOM
seen O
in O
both O
basal O
ganglia O
region O
as O
well O
as O
along O
the O
rolandic O
region O
bilaterally O
which O
is O
suggestive O
of O
global B-SYMPTOM
hypoxic I-SYMPTOM
injury I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
brain I-SYMPTOM
. O

There O
are O
several O
areas O
of O
brain B-SYMPTOM
edema I-SYMPTOM
identified O
in O
the O
left O
frontal O
and O
parietal O
lobe O
and O
both O
temporal O
lobes O
, O
which O
are O
suspicious O
for O
areas B-SYMPTOM
of I-SYMPTOM
metastatic I-SYMPTOM
disease I-SYMPTOM
with O
surrounding B-SYMPTOM
edema I-SYMPTOM
. O

There O
is O
no O
hydrocephalus B-SYMPTOM
or O
midline B-SYMPTOM
shift I-SYMPTOM
seen O
. O

No O
herniation B-SYMPTOM
is O
identified O
. O

Images O
through O
the O
skull O
base O
demonstrate O
soft B-SYMPTOM
tissue I-SYMPTOM
changes I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
sphenoid I-SYMPTOM
sinus I-SYMPTOM
which O
could O
be O
due O
to O
retained B-SYMPTOM
secretions I-SYMPTOM
from O
intubation B-TREATMENT
. O

There O
is O
increased B-SYMPTOM
signal I-SYMPTOM
seen O
along O
the O
sulci O
on O
FLAIR O
images O
at O
the O
convexity O
which O
could O
be O
secondary O
to O
subarachnoid B-SYMPTOM
hemorrhage I-SYMPTOM
. O

A O
CT O
would O
help O
for O
further O
assessment O
and O
exclude O
proteinaceous B-SYMPTOM
material I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
sulci I-SYMPTOM
. O

Gadolinium-enhanced O
MRI O
would O
also O
help O
for O
further O
assessment O
. O

. O

pCXR O
2016-05-11 O
5:01am: O

FINDINGS O
: O

No O
prior O
comparisons O
. O

Tip O
of O
the B-TREATMENT
ETT I-TREATMENT
projects O
roughly O
5 O
cm O
above O
the O
carina O
. O

A B-TREATMENT
right I-TREATMENT
IJ I-TREATMENT
central I-TREATMENT
venous I-TREATMENT
line I-TREATMENT
is O
at O
the O
level O
of O
the O
mid O
SVC O
. O

Tip O
of O
the B-TREATMENT
NGT I-TREATMENT
is O
below O
the O
edge O
of O
the O
image O
. O

IVC B-TREATMENT
filter I-TREATMENT
and O
probable O
NU B-TREATMENT
stent I-TREATMENT
catheter I-TREATMENT
on I-TREATMENT
the I-TREATMENT
left I-TREATMENT
also O
noted O
. O

Heart O
and O
mediastinum O
are O
unremarkable O
allowing O
for O
technique O
, O
no O
sizeable B-SYMPTOM
pneumothorax I-SYMPTOM
. O

There O
is O
a B-SYMPTOM
somewhat I-SYMPTOM
wedge-shaped I-SYMPTOM
opacity I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lung I-SYMPTOM
base I-SYMPTOM
which O
could O
represent O
aspiration B-SYMPTOM
or O
pneumonia B-SYMPTOM
. O

No O
other B-SYMPTOM
confluent I-SYMPTOM
infiltrates I-SYMPTOM
are O
appreciated O

. O

pCXR O
2016-05-11. O
1:46pm: O

1. O
Mild B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
. O

2. O
Vague B-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
opacity I-SYMPTOM
most O
likely O
represents O
pulmonary B-SYMPTOM
edema I-SYMPTOM
though O
if O
opacity B-SYMPTOM
persistent O
after O
diuresis B-TREATMENT
, O
aspiration B-SYMPTOM
and O
pneumonia B-SYMPTOM
will O
become O
considerations O
. O

3. O
ETT B-TREATMENT
4 O
cm O
above O
the O
carina O
with O
NG B-TREATMENT
tube I-TREATMENT
advancement O
into O
the O
stomach O
. O

. O

EEG O
2016-05-12: O

Abnormal B-SYMPTOM
portable I-SYMPTOM
EEG I-SYMPTOM
due O
to O
the B-SYMPTOM
slow I-SYMPTOM
and I-SYMPTOM
disorganized I-SYMPTOM
background I-SYMPTOM
and O
bursts B-SYMPTOM
of I-SYMPTOM
generalized I-SYMPTOM
slowing I-SYMPTOM
. O

These O
findings O
indicate O
a B-SYMPTOM
widespread I-SYMPTOM
encephalopathy I-SYMPTOM
. O

Medications B-TREATMENT
, O
metabolic B-SYMPTOM
disturbances I-SYMPTOM
, O
and O
infection B-SYMPTOM
are O
among O
the O
most O
common O
causes O
. O

Subarachnoid B-SYMPTOM
hemorrhage I-SYMPTOM
is O
another O
possible O
explanation O
. O

There O
were O
no O
areas O
of O
prominent B-SYMPTOM
focal I-SYMPTOM
slowing I-SYMPTOM
, O
and O
there O
were O
no O
epileptiform B-SYMPTOM
features I-SYMPTOM

. O

Trans-thoracic O
echocardiogram O
2016-05-12 O
: O

The O
left O
atrium O
is O
normal O
in O
size O
. O

Left O
ventricular O
wall O
thickness O
, O
cavity O
size O
, O
and O
systolic O
function O
are O
normal O
( O
LVEF>55% O
) O
. O

Regional O
left O
ventricular O
wall O
motion O
is O
normal O
. O

Right O
ventricular O
chamber O
size O
and O
free O
wall O
motion O
are O
normal O
. O

The O
aortic O
valve O
leaflets O
( O
3 O
) O
appear O
structurally O
normal O
with O
good O
leaflet O
excursion O
and O
no O
aortic B-SYMPTOM
regurgitation I-SYMPTOM
. O

The O
mitral O
valve O
appears O
structurally O
normal O
with O
trivial B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
. O

There O
is O
no O
mitral B-SYMPTOM
valve I-SYMPTOM
prolapse I-SYMPTOM
. O

The O
pulmonary O
artery O
systolic O
pressure O
could O
not O
be O
determined O
. O

There O
is O
no O
pericardial B-SYMPTOM
effusion I-SYMPTOM
. O

IMPRESSION O
: O

Normal O
global O
and O
regional O
biventricular O
systolic O
function O
. O

No O
pericardial B-SYMPTOM
effusion I-SYMPTOM
. O

. O

pCXR O
2016-05-13 O
: O

Mild B-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
perihilar I-SYMPTOM
opacification I-SYMPTOM
has O
improved O
, O
probably O
resolving B-SYMPTOM
edema I-SYMPTOM
. O

There O
is O
more B-SYMPTOM
rightward I-SYMPTOM
mediastinal I-SYMPTOM
shift I-SYMPTOM
, O
suggesting O
new B-SYMPTOM
atelectasis I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lung I-SYMPTOM
. O

Enlargement B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
hilus I-SYMPTOM
could O
represent O
adenopathy B-SYMPTOM
. O

Whether O
to O
pursue O
this O
would O
depend O
upon O
clinical O
circumstances O
. O

Heart O
size O
normal O
. O

ET B-TREATMENT
tube I-TREATMENT
in O
standard O
placement O
. O

Nasogastric B-TREATMENT
tube I-TREATMENT
passes O
below O
the O
diaphragm O
and O
out O
of O
view O
. O

No O
appreciable B-SYMPTOM
pneumothorax I-SYMPTOM
or O
pleural B-SYMPTOM
effusions I-SYMPTOM

. O

pCXR O
2016-05-14 O
: O

Increasing B-SYMPTOM
opacification I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lungs I-SYMPTOM
could O
be O
due O
to O
mild B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
and O
multiple B-SYMPTOM
micrometastases I-SYMPTOM
, O
worsened O
slightly O
since O
05-13 O
at O
10:57 O
p.m. O

Heart O
size O
is O
normal O
. O

There O
is O
no O
pleural B-SYMPTOM
effusion I-SYMPTOM
. O

The B-TREATMENT
ET I-TREATMENT
tube I-TREATMENT
and O
right B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
in O
standard O
placements O
. O

Nasogastric B-TREATMENT
tube I-TREATMENT
passes O
below O
the O
diaphragm O
and O
out O
of O
view O
. O

No O
pneumothorax B-SYMPTOM
. O

. O

Microbiology O
: O

05-11- O
Blood O
cultures O
: O
no O
growth B-SYMPTOM
to O
date O
on O
2/2 O
bottles O

05-12- O
Blood O
cultures O
: O
no O
growth B-SYMPTOM
to O
date O
on O
6/6 O
bottles O

05-14- O
Blood O
cultures O
: O
no O
growth B-SYMPTOM
to O
date O
on O
4/4 O
bottles O

. O

05-11- O
Urine O
culture O
: O
no O
growth B-SYMPTOM
( O
final O
) O

05-12- O
Urine O
culture O
: O
no O
growth B-SYMPTOM
( O
final O
) O

05-14- O
Urine O
culture O
: O
no O
growth B-SYMPTOM
to O
date O

. O

05-11- O
Stool O
: O
negative O
for O
Cdiff B-SYMPTOM
toxin I-SYMPTOM

05-12- O
Stool O
: O
negative O
for O
Cdiff B-SYMPTOM
toxin I-SYMPTOM

. O

05-12- O
Swab O
from O
Nephrostomy B-TREATMENT
: O

GRAM O
STAIN O
( O
Final O
2016-05-12 O
) O
: O

NO O
POLYMORPHONUCLEAR B-SYMPTOM
LEUKOCYTES I-SYMPTOM
SEEN O
. O

NO O
MICROORGANISMS B-SYMPTOM
SEEN O
. O

WOUND O
CULTURE O
( O
Preliminary O
) O
: O

Due O
to O
mixed B-SYMPTOM
bacterial I-SYMPTOM
types I-SYMPTOM
( O
>= O
3 O
colony O
types O
) O
an O
abbreviated O
workup O
is O
performed O
appropriate O
to O
the O
isolates O
recovered O
from O
the O
site O
( O
including O
a O
screen O
for O
Pseudomonas B-SYMPTOM
aeruginosa I-SYMPTOM
, O
Staphylococcus B-SYMPTOM
aureus I-SYMPTOM
and O
beta B-SYMPTOM
streptococcus I-SYMPTOM
) O
. O

STAPHYLOCOCCUS B-SYMPTOM
, I-SYMPTOM
COAGULASE I-SYMPTOM
NEGATIVE O
. O

RARE B-SYMPTOM
GROWTH I-SYMPTOM
. O

CORYNEBACTERIUM B-SYMPTOM
SPECIES I-SYMPTOM
( I-SYMPTOM
DIPHTHEROIDS I-SYMPTOM
) I-SYMPTOM
. O

SPARSE B-SYMPTOM
GROWTH I-SYMPTOM
. O

PSEUDOMONAS B-SYMPTOM
AERUGINOSA I-SYMPTOM
. O

RARE B-SYMPTOM
GROWTH I-SYMPTOM
. O

SENSITIVITIES O
: O

MIC O
expressed O
in O

MCG/ML O

_________________________________________________________ O

PSEUDOMONAS B-SYMPTOM
AERUGINOSA I-SYMPTOM

| O

. O

05-12- O
Sputum O
: O

Source O
: O

Endotracheal O
. O

GRAM O
STAIN O
( O
Final O
2016-05-12 O
) O
: O

11-03 O
PMNs O
and O
<10 O
epithelial O
cells/100X O
field O
. O

NO O
MICROORGANISMS B-SYMPTOM
SEEN O
. O

RESPIRATORY O
CULTURE O
( O
Final O
2016-05-14 O
) O
: O

NO O
GROWTH B-SYMPTOM
. O

FUNGAL O
CULTURE O
( O
Preliminary O
) O
: O

NO O
FUNGUS B-SYMPTOM
ISOLATED O
. O

NOCARDIA O
CULTURE O
( O
Preliminary O
) O
: O

NO O
NOCARDIA B-SYMPTOM
ISOLATED O
. O

. O

05-14- O
Sputum O
: O

Source O
Endotracheal O
. O

GRAM O
STAIN O
( O
Final O
2016-05-14 O
) O
: O

>25 O
PMNs O
and O
<10 O
epithelial O
cells/100X O
field O
. O

1+ O
( O
<1 O
per O
1000X O
FIELD O
) O
: O

GRAM B-SYMPTOM
POSITIVE I-SYMPTOM
COCCI I-SYMPTOM
. O

IN O
PAIRS O
AND O
CLUSTERS O
. O

1+ O
( O
<1 O
per O
1000X O
FIELD O
) O
: O

YEAST( B-SYMPTOM
S I-SYMPTOM
) I-SYMPTOM
. O

. O

05-14- O
Catheter B-TREATMENT
tip I-TREATMENT
( I-TREATMENT
IV I-TREATMENT
): I-TREATMENT

WOUND O
CULTURE O
( O
Final O
2016-05-15 O
) O
: O

No O
significant B-SYMPTOM
growth I-SYMPTOM

Brief O
Hospital O
Course O
: O

30 O
yo O
F O
with O
metastatic B-SYMPTOM
squamous I-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of O
unknown O
primary O
who O
presented O
to O
OSH O
04-25 O
with O
pseudomonal B-SYMPTOM
urosepsis I-SYMPTOM
, O
vaginal B-SYMPTOM
bleeding I-SYMPTOM
from O
tumor B-SYMPTOM
extension/anti-coagulation I-SYMPTOM
. O

Course O
complicated O
by O
sub B-SYMPTOM
arachnoid I-SYMPTOM
hemorrhages I-SYMPTOM
and O
intraparenchymal B-SYMPTOM
bleeds I-SYMPTOM
as O
well O
as O
potential O
hypotensive B-SYMPTOM
brain I-SYMPTOM
injury I-SYMPTOM
with O
poor O
prognosis O
per O
neurology O
. O

Transferred O
here O
for O
second O
opinion O
on O
poor O
prognosis O
. O

. O

# O
Neurologic O
- O
The O
patient O
was O
seen O
by O
the O
Neurology O
consult O
service O
and O
underwent O
MRI O
head O
which O
revealed O
lesions B-SYMPTOM
suspicious O
for O
metastases B-SYMPTOM
, O
possible O
hemorrhages B-SYMPTOM
, O
and O
findings O
consistent O
with O
hypoxic B-SYMPTOM
brain I-SYMPTOM
injury I-SYMPTOM
. O

EEG O
was O
performed O
and O
revealed O
encephalopathy B-SYMPTOM
. O

The O
patient O
's O
neurologic O
exam O
( O
performed O
after O
sedation B-TREATMENT
removed O
>48 O
hours O
) O
revealed O
intact O
brainstem O
function O
without O
evidence O
of O
higher O
cortical O
activity O
. O

She O
had O
some B-SYMPTOM
metabolic I-SYMPTOM
abnormalities I-SYMPTOM
which O
were O
corrected O
( O
hypernatremia B-SYMPTOM
, O
hyperphosphatemia B-SYMPTOM
) O
, O
but O
neurologic O
exam O
was O
unchanged O
. O

A O
family O
meeting O
on O
2016-05-13 O
was O
held O
and O
these O
findings O
communicated O
with O
the O
patient O
's O
family O
. O

Final O
neurologic O
assessment O
was O
that O
the O
patient O
was O
unlikely O
to O
regain O
meaningful O
neurologic O
functioning O
. O

At O
the O
request O
of O
her O
family O
, O
she O
will O
be O
transferred O
closer O
to O
her O
home O
in O
Wyoming O
, O
to O
Women O
and O

Infants O
hospital O
. O

. O

# O
Respiratory B-SYMPTOM
Failure I-SYMPTOM
- O
Pt O
arrived O
on O
pressure B-TREATMENT
support I-TREATMENT
ventilation I-TREATMENT
, O
which O
was O
changed O
to O
Assist B-TREATMENT
control I-TREATMENT
to O
make O
patient O
more O
comfortable O
. O

She O
was O
originally O
intubated B-TREATMENT
for O
airway B-TREATMENT
protection I-TREATMENT
, O
and O
it O
is O
felt O
she O
could O
likely O
be O
weaned O
from O
the B-TREATMENT
ventilator I-TREATMENT
although O
she O
would O
be O
extremely O
high O
risk O
for O
aspiration B-SYMPTOM
. O

Due O
to O
family O
request O
to O
move O
patient O
to O
a O
hospital O
closer O
to O
home O
, O
she O
will O
remain O
intubated B-TREATMENT
until O
transfer O
, O
with O
plan O
to O
extubate B-TREATMENT
upon O
arrival O
to O
Women O
and O
Infants O
hospital O
with O
initiation O
of O
full B-TREATMENT
palliative I-TREATMENT
care I-TREATMENT
and O
compliance O
of O
DNI O
status O
. O

. O

# O
Fevers/Infection B-SYMPTOM
- O
Per O
outside O
hospital O
records O
, O
the O
patient O
grew O
pseudomonas B-SYMPTOM
from O
blood O
and O
urine O
. O

At O
OSH O
, O
she O
was O
treated O
with O
7 O
days O
of O
vancomycin B-TREATMENT
, O
as O
well O
as O
13 O
days O
( O
of O
14-day O
planned O
course O
) O
of O
Ciprofloxacin B-TREATMENT
and O
Zosyn B-TREATMENT
. O

She O
was O
intially O
continued O
on O
Cipro/Zosyn B-TREATMENT
. O

CXR O
05-11 O
revealed O
? O
pneumonia B-SYMPTOM
vs O
atelectasis B-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
R I-SYMPTOM
lung I-SYMPTOM
base I-SYMPTOM
. O

Continues O
to O
spike O
fever B-SYMPTOM
. O

Could O
have O
still O
seeding O
of O
nephrostomy B-TREATMENT
tube I-TREATMENT
. O

Urology O
at O
OSH O
against O
pulling O
tube B-TREATMENT
because O
coagulopathy B-SYMPTOM
and O
may O
not O
be O
able O
to O
replace O
. O

Fevers B-SYMPTOM
also O
may O
be O
from O
head B-SYMPTOM
bleed I-SYMPTOM
, O
cancer B-SYMPTOM
, O
or O
drug B-TREATMENT
. O

She O
was O
continued O
on O
zosyn B-TREATMENT
and O
vancomycin B-TREATMENT
to O
complete O
a O
>14 O
day O
course O
. O

She O
continued O
to O
have O
fevers B-SYMPTOM
. O

Antibiotics B-TREATMENT
were O
discontinued O
on O
05-15 O
. O

No O
further B-SYMPTOM
infectious I-SYMPTOM
course I-SYMPTOM
was O
identified O
and O
the B-SYMPTOM
fevers I-SYMPTOM
may O
have O
been O
due O
to O
underlying B-SYMPTOM
malignant I-SYMPTOM
process I-SYMPTOM
. O

. O

# O
Squamous B-SYMPTOM
Cell I-SYMPTOM
Cancer I-SYMPTOM
- O
unknown O
primary O
. O

The O
patient O
was O
seen O
by O
the O
oncology O
consult O
service O
who O
contacted O
her O
outside O
hematologist O
Dr. O
Pauling O
. O

Upon O
discussion O
with O
him O
it O
was O
noted O
that O
the O
patient O
had O
progression O
of O
her B-SYMPTOM
disease I-SYMPTOM
after O
systemic B-TREATMENT
therapy I-TREATMENT
with O
topotecan B-TREATMENT
and O
cisplatin B-TREATMENT
. O

She O
then O
proceed O
to O
XRT B-TREATMENT
with O
cisplatin B-TREATMENT
which O
she O
was O
unable O
to O
tolerate O
this O
secondary O
to O
thrombocytopenia B-SYMPTOM
( O
40-50K O
) O
. O

Given O
this O
we O
were O
unable O
to O
offer O
her O
additional B-TREATMENT
therapy. I-TREATMENT
Hematology/Oncology O
service O
at O
Mediplex O
Rehab O
Hospital O
confirmed O
her O
grim O
prognosis O
and O
expective O
survival O
in O
terms O
of O
weeks O
to O
months O
with O
no O
further B-TREATMENT
available I-TREATMENT
treatment I-TREATMENT
. O

. O

# O
h/o O
DVT B-SYMPTOM
- O
patient O
with O
head B-SYMPTOM
bleed I-SYMPTOM
which O
is O
contraindication O
to O
anti-coagulation B-TREATMENT
. O

IVC B-TREATMENT
filter I-TREATMENT
in O
place O
. O

Patient O
was O
on O
pneumoboots B-TREATMENT
while O
in O
hospital O
. O

. O

# O
Hypernatremia B-SYMPTOM
- O
Improved O
from O
OSH O
. O

Total B-SYMPTOM
body I-SYMPTOM
volume I-SYMPTOM
overloaded I-SYMPTOM
. O

Water O
Deficit O
2.5 O
L O
. O

She O
was O
continued O
on O
free B-TREATMENT
H20 I-TREATMENT
boluses I-TREATMENT
and O
D5 B-TREATMENT
1/2 I-TREATMENT
NS I-TREATMENT
and O
corrected O
. O

. O

# O
Acute B-SYMPTOM
Renal I-SYMPTOM
Failure I-SYMPTOM
- O
stable O
, O
likely O
02-12 O
hypotension B-SYMPTOM
leading O
to O
ATN B-SYMPTOM
that O
is O
slowly O
improving O
. O

. O

# O
Access O
- O
R B-TREATMENT
IJ I-TREATMENT
changed O
sterilly O
over O
wire B-TREATMENT
05-01 O

. O

# O
FEN O
- O
tube B-TREATMENT
feeds I-TREATMENT
are O
held O
in O
route O
in O
anticipation O
of O
extubation O
. O

. O

. O

# O
Code O
Status O
: O

After O
multiple O
discussion O
with O
family O
and O
the O
doctor O
accepting O
the O
patient O
at O
Women O
and O
Infants O
Hospital( O
Dr O
. O
Pauling O
) O
at O
RI O
. O

She O
was O
made O
DNR/DNI O
and O
the O
plan O
is O
that O
she O
will O
be O
transferred O
to O
WIH O
and O
extubated B-TREATMENT
there O
upon O
arrival O
with O
initiation O
of O
full B-TREATMENT
palliative I-TREATMENT
care I-TREATMENT
. O

The O
family O
understood O
this; O
all O
questions O
were O
answered O
and O
they O
wished O
to O
proceed O
. O

They O
understand O
that O
there O
is O
no O
ICU O
at O
WIH O
and O
no O
further O
advanced B-TREATMENT
pulmonary I-TREATMENT
support I-TREATMENT
can O
be O
offered O
. O

Discharge O
Medications O
: O

1. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
for O
fever B-SYMPTOM
or O
pain B-SYMPTOM
. O

2. O
Albuterol-Ipratropium B-TREATMENT
103-18 O
mcg/Actuation O
Aerosol O
Sig O
: O
06-17 O
Puffs O
Inhalation O
Q2-4H O
( O
every O
2 O
to O
4 O
hours O
) O
as O
needed O
. O

3. O
Calcium B-TREATMENT
Acetate I-TREATMENT
667 O
mg O
Capsule O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
PO O
TID O
W/MEALS O
( O
3 O
TIMES O
A O
DAY O
WITH O
MEALS O
) O
. O

4. O
Fentanyl B-TREATMENT
Citrate I-TREATMENT
( O
PF O
) O
0.05 O
mg/mL O
Solution O
Sig O
: O
25-100 O
mcg O
Injection O
Q2H O
( O
every O
2 O
hours O
) O
as O
needed O
for O
comfort O
. O

5. O
Insulin B-TREATMENT
Regular I-TREATMENT
Human I-TREATMENT
100 O
unit/mL O
Solution O
Sig O
: O
2-10 O
units O
Injection O
ASDIR O
( O
AS O
DIRECTED O
) O
: O
per O
sliding B-TREATMENT
scale I-TREATMENT
for O
blood O
sugars O
> O
150mg/dl O
. O

6. O
Midazolam B-TREATMENT
1 O
mg/mL O
Solution O
Sig O
: O
1-2 O
mg O
Injection O
Q2H O
( O
every O
2 O
hours O
) O
as O
needed O
for O
comfort O
. O

7. O
Phenytoin B-TREATMENT
Sodium I-TREATMENT
50 O
mg/mL O
Solution O
Sig O
: O
One O
95y O
( O
150 O
) O
mg O
Intravenous O
Q8H O
( O
every O
8 O
hours O
) O
. O

8. O
Ranitidine B-TREATMENT
HCl O
15 O
mg/mL O
Syrup O
Sig O
: O
One O
95y O
( O
150 O
) O
mg O
PO O
DAILY O
( O
Daily O
) O
. O

9. O
Polyvinyl B-TREATMENT
Alcohol-Povidone I-TREATMENT
1.4-0.6 O
% O
Dropperette O
Sig O
: O
01-12 O
Drops O
Ophthalmic O
QID O
( O
4 O
times O
a O
day O
) O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

1. O
Hypoxic B-SYMPTOM
brain I-SYMPTOM
injury I-SYMPTOM

2. O
Cranial B-SYMPTOM
hemorrages I-SYMPTOM
( I-SYMPTOM
sub I-SYMPTOM
arachnoid I-SYMPTOM
and I-SYMPTOM
parenchemal I-SYMPTOM
) I-SYMPTOM

3. O
Pseudomonal B-SYMPTOM
sepsis I-SYMPTOM
, O
completed O
antibiotic B-TREATMENT
course I-TREATMENT

4. O
Metastatic B-SYMPTOM
Squamous I-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of O
unknown O
primary O
. O

5. O
Thrombocytopenia B-SYMPTOM

6. O
Blood B-SYMPTOM
loss I-SYMPTOM
anemia I-SYMPTOM

Discharge O
Condition O
: O

Intubated B-TREATMENT
, O
stable O

Discharge O
Instructions O
: O

You O
are O
being O
transferred O
to O
another O
hospital O
, O
intubated B-TREATMENT
, O
with O
the O
plan O
to O
extubate B-TREATMENT
upon O
arrival O
to O
Women O
's O
and O
Infants O
hosptial O
and O
initiation O
of O
palliative B-TREATMENT
care I-TREATMENT
. O

. O

Your B-TREATMENT
antibiotics I-TREATMENT
were O
stopped O
2016-05-15 O
( O
Vancomycin B-TREATMENT
1000mg O
q24 O
and O
Aztreonam B-TREATMENT
1000mg O
q8 O
) O
as O
your O
micorbiology O
data O
has O
been O
negative O
and O
your O
course O
for O
pseudomonal B-SYMPTOM
sepsis I-SYMPTOM
has O
been O
completed O
. O

If O
you O
continue O
to O
have O
fevers B-SYMPTOM
, O
blood O
cultures O
should O
be O
repeated O
. O

Followup O
Instructions O
: O

As O
directed O
. O

Jacque O
John O
MD O
40-836 O

Completed O
by O
: O

Marcy O
Caroline O
Latham O
MD O
51-251 O
2016-05-31 O
@ O
1628 O

Signed O
electronically O
by O
: O

DR. O
Richard O
Ronald O
Lockett O
on O
: O

MON O
2016-08-01 O
3:08 O
PM O

( O
End O
of O
Report O
) O

895872725 O
ELMVH O

99080881 O

979718 O

5/25/2002 O
12:00:00 O
AM O

Chest B-SYMPTOM
pain I-SYMPTOM

DIS O

Admission O
Date O
: O

05/25/2002 O

Report O
Status O
: O

Discharge O
Date O
: O

05/27/2002 O

****** O
DISCHARGE O
ORDERS O
****** O

FYFEWIERST O
, O
MIER O

799-99-77-2 O
X12 O

Room O
: O

33C-139 O

Service O
: O

CAR O

DISCHARGE O
PATIENT O
ON O
: O

05/27/02 O
AT O
04:00 O
PM O

CONTINGENT O
UPON O

Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

SAGELYSS O
, O
TYTUMZE O
VACHOLLE O
, O
M.D. O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

LOPRESSOR B-TREATMENT
( I-TREATMENT
METOPROLOL I-TREATMENT
TARTRATE I-TREATMENT
) I-TREATMENT
12.5 O
MG O
PO O
BID O

Food O
/ O
Drug O
Interaction O
Instruction O

Take O
consistently O
with O
meals O
or O
on O
empty O
stomach O
. O

ENALAPRIL B-TREATMENT
MALEATE I-TREATMENT
20 O

MG O
PO O
BID O
DIET O
: O

House O
/ O
Low O
chol O
/ O
low O
sat. O
fat O

Activity O
- O
As O
tolerated O

RETURN O
TO O
WORK O
: O

After O
Appt O
with O
local O
physician O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Dr. O
Hashimoto O
, O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

chest B-SYMPTOM
pressure I-SYMPTOM
; O
r O
/ O
o O
mi B-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
Chest B-SYMPTOM
pain I-SYMPTOM

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O

Chest B-SYMPTOM
pain I-SYMPTOM
; O
R O
/ O
o O

MI B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

Echocardiogram O
MRA O
Kidney O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

51 O
yo O
F O
h O
/ O
o O
HTN B-SYMPTOM
, O
hyperchol B-SYMPTOM
, O
p O
/ O
w O
SS B-SYMPTOM
chest I-SYMPTOM
pressure I-SYMPTOM
x O
3 O
days O
. O

USOH O
until O
3 O
day O
PTa O
, O
dev O
new B-SYMPTOM
SS I-SYMPTOM
chest I-SYMPTOM
pressure I-SYMPTOM
sometimes O
rad O
to O
back O
and O
L O
neck O
/ O
jaw O
. O

Not O
assoc O
with O
exertion O
( O
pt O
has O
active O
lifestyle O
) O
. O

Pressure B-SYMPTOM
lasted O
for O
hours O
at O
a O
time O
. O

Variably O
assoc O
with O
SOB B-SYMPTOM
, O
nausea B-SYMPTOM
, O
palpitations B-SYMPTOM
, O
tremulousness B-SYMPTOM
, O
diaphoresis B-SYMPTOM
. O

Pt O
has O
HTN B-SYMPTOM
, O
measured O
BP O
home O
200/100 O
. O

Reported O
to O
a O
local O
ED O
was O
found O
to O
have O
BP O
up O
to O
200/100 O
. O

Put O
on O
NTG B-TREATMENT
drip I-TREATMENT
without O
relief O
. O

Pain B-SYMPTOM
2/10 O
persisted O
, O
relieved O
by O
MSO4 B-TREATMENT
. O

At O
ELMVH O
ED O
, O
BP O
160/87 O
. O

Now O
adm O
for O
r O
/ O
o O
MI B-SYMPTOM
, O
eval O
of O
? O
demand B-SYMPTOM
ischemia I-SYMPTOM
, O
plus O
w O
/ O
u O
of O
HTN B-SYMPTOM
urgency I-SYMPTOM
( O
which O
may O
be O
very O
new O
in O
onset O
) O
. O

PE O
T97.5 O
P59 O
BP O
( O
l O
) O
180/86 O
( O
r O
) O
186/98 O
RR20 O
98% O
2L B-TREATMENT
. O

Exam O
only O
notable O
for O
II B-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
systolic I-SYMPTOM
murmur I-SYMPTOM
. O

Labs O
only O
notable O
for O
CK O
54 O
( O
nl O
) O
, O
Trop O
0.03 O
, O
Hct O
35.6 O
MCV O
79 O
. O

EKG O
LBBB B-SYMPTOM
NSR O
. O

CXR O
negative O
. O

Plan O
ROMI O
protocol O
. O

CP B-TREATMENT
protocol I-TREATMENT
. O

Captopril B-TREATMENT
and O
nitropaste B-TREATMENT
to O
control O
pressure B-SYMPTOM
. O

MSO4 B-TREATMENT
for O
CP B-SYMPTOM
. O

Echo O
, O
MRA O
( O
r O
/ O
o O
dissection B-SYMPTOM
) O
, O
urine O
catecholamines O
and O
VMA O
. O

Guaiac O
all O
stools O
, O
check O
iron O
studies O
. O

HOSPITAL O
COURSE O

1. O
Chest B-SYMPTOM
Pain I-SYMPTOM

- O
Pt O
placed O
on O
captopril B-TREATMENT
25 O
tid O
, O
lopressor B-TREATMENT
12.5 O
BID O
and O
NTG B-TREATMENT
paste I-TREATMENT
SS O
, O
achieving O
normal O
BP O
w O
/ O
in O
5 O
hrs O
of O
adm O
to O
floor O
. O

Her B-SYMPTOM
CPress I-SYMPTOM
dissappeared O
over O
the O
same O
timeframe O
. O

- O
pt O
r&apos;d O
/ O
o O
for O
mi B-SYMPTOM
by O
CPK O
( O
54-&gt; O
38-&gt; O
33 O
) O
and O
TPN O
( O
0.03 O
) O
, O
and O
stable O
EKG O
. O

2. O
Hypertension B-SYMPTOM

- O
controlled O
on O
captopril B-TREATMENT
+ O
lopressor B-TREATMENT
to O
110-130s O
; O
NTG B-TREATMENT
paste I-TREATMENT
causing O
30 O
pt O
drop O
so O
d O
/ O
c&apos;d O
. O

- O
MRA O
kidney O
: O

no O
stenosis B-SYMPTOM
; O
no O
parenchymal B-SYMPTOM
lesions I-SYMPTOM

- O
CXR O
: O

no O
obvious B-SYMPTOM
mediastinal I-SYMPTOM
widening I-SYMPTOM
, O
but O
no O
comp O
arison O
film O
; O
wnl O

- O
echo O
: O

prelim O
: O

EF O
55-60 O
, O
? O
septal B-SYMPTOM
flattening I-SYMPTOM
, O
mild B-SYMPTOM
TR I-SYMPTOM
and O
MR B-SYMPTOM
, O
trace B-SYMPTOM
effusion I-SYMPTOM
-24h O
urine O
study O
: O

pending O
. O

ADDITIONAL O
COMMENTS O
: O

DISCHARGE O
CONDITION O
: O

Satisfactory O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

MEED O
, O
CILE O
PRILARA O
, O
M.D. O
, O
PH.D. O
( O
RG185 O
) O
05/27/02 O
05:35 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

060972300 O

NVH O

58893318 O

2/1/2002 O
12:00:00 O
AM O

CONGESTIVE B-SYMPTOM
HEART I-SYMPTOM
FAILURE I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

02/01/2002 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

02/08/2002 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Saujule O
Study O
is O
a O
77-year-old O
woman O
with O
a O
history O
of O
obesity B-SYMPTOM
and O
hypertension B-SYMPTOM
who O
presents O
with O
increased B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
x O
5 O
days O
. O

Her B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
has O
been O
progressive O
over O
the O
last O
2-3 O
years O
. O

She O
has O
an B-SYMPTOM
associated I-SYMPTOM
dry I-SYMPTOM
cough I-SYMPTOM
but O
no O
fevers B-SYMPTOM
, O
chills B-SYMPTOM
, O
or O
leg B-SYMPTOM
pain I-SYMPTOM
. O

She O
has O
dyspnea B-SYMPTOM
on O
exertion O
. O

She O
ambulates O
with O
walker B-TREATMENT
and O
a B-TREATMENT
cane I-TREATMENT
secondary O
to O
osteoarthritis B-SYMPTOM
. O

She O
becomes O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
just O
by O
getting O
up O
from O
her O
chair O
and O
can O
only O
walk O
2-3 O
steps O
on O
a O
flat O
surface O
. O

She O
feels O
light B-SYMPTOM
headed I-SYMPTOM
when O
getting O
up O
. O

Her B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
dyspnea B-SYMPTOM
on O
exertion O
has O
been O
progressive O
for O
the O
past O
several O
years O
. O

It O
has O
not O
been O
sudden O
or O
acute O
. O

She O
sleeps O
in O
a O
chair O
up O
right O
for O
the O
last O
2 O
1/2 O
years O
secondary O
to O
osteoarthritis B-SYMPTOM
. O

She O
has O
orthopnea B-SYMPTOM
as O
well O
but O
noparoxysmal B-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
. O

She O
occasionally O
feels O
chest B-SYMPTOM
twinges I-SYMPTOM
which O
are O
nonradiating B-SYMPTOM
but O
are O
sharp B-SYMPTOM
. O

They O
last O
a O
few O
seconds O
on O
the O
left O
side O
and O
are O
not O
associated O
with O
sweating B-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
or O
syncope B-SYMPTOM
. O

She O
has O
had O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
for O
thelast O
several O
years O
with O
multiple O
episodes O
of O
cellulitis B-SYMPTOM
. O

Her B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
has O
increased O
for O
the O
several O
weeks O
prior O
to O
admission O
secondary O
to O
an O
inability O
to O
elevate O
her O
legs O
due O
to O
a O
broken O
chair O
at O
home O
. O

She O
denies O
any B-SYMPTOM
pleural I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
. O

REVIEW O
OF O
SYSTEMS O
: O

Negative O
for O
headaches B-SYMPTOM
, O
vision B-SYMPTOM
changes I-SYMPTOM
, O
numbness B-SYMPTOM
, O
tingling B-SYMPTOM
, O
dyspnea B-SYMPTOM
, O
hematuria B-SYMPTOM
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
diarrhea B-SYMPTOM
, O
melena B-SYMPTOM
or O
hematochezia B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Obesity B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
lower B-SYMPTOM
extremity I-SYMPTOM
cellulitis I-SYMPTOM
and O
edema B-SYMPTOM
, O
breast B-SYMPTOM
cancer I-SYMPTOM
in O
1988 O
treated O
with O
right B-TREATMENT
lumpectomy I-TREATMENT
and O
XRT B-TREATMENT
, O
partial B-TREATMENT
thyroidectomy I-TREATMENT
in O
1963 O
, O
osteoarthritis B-SYMPTOM
with O
right B-SYMPTOM
leg I-SYMPTOM
deformities I-SYMPTOM
, O
hernia B-TREATMENT
repair I-TREATMENT
50 O
years O
ago O
, O
bilateral B-TREATMENT
cataract I-TREATMENT
surgery I-TREATMENT
. O

ALLERGIES O
: O

Codeine B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Hydrochlorothiazide B-TREATMENT
50 O
mg O
p.o. O
q O
day O
, O
atenolol B-TREATMENT
50 O
mg O
p.o. O
q O
day O
, O
dicloxacillin B-TREATMENT
started O
on O
December O
29 O
, O
2002 O
, O
Naproxen B-TREATMENT
500 O
mg O
p.o. O
t.i.d. O
, O
aspirin B-TREATMENT
81 O
mg O
p.o. O
q O
day O
, O
Tylenol B-TREATMENT
p.r.n. O

SOCIAL O
HISTORY O
: O

Widowed O
since O
1972 O
, O
no O
tobacco O
, O
no O
alcohol O
, O
lives O
alone O
. O

Smoked O
3 O
packs O
per O
day O
x O
17 O
years O
. O

FAMILY O
HISTORY O
: O

Son O
died O
at O
50 O
of O
diabetes B-SYMPTOM
and O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

PHYSICAL O
EXAM O
: O

In O
the O
emergency O
room O
, O
vitals O
were O
temperature O
96.4 O
, O
pulse O
40-50 O
, O
blood O
pressure O
154-58 O
, O
satting O
86% O
on O
room O
air O
, O
99% O
on O
3 O
liters O
of O
3 B-TREATMENT
liters I-TREATMENT
cannula I-TREATMENT
. O

Rate O
28 O
. O

HEENT O
: O

Anicteric B-SYMPTOM
. O

Extraocular O
movements O
intact O
. O

2 O
plus O
carotids O
. O

No O
delayed B-SYMPTOM
upstroke I-SYMPTOM
. O

Oropharynx O
is O
clear O
without O
lymphadenopathyin B-SYMPTOM
the I-SYMPTOM
neck I-SYMPTOM
. O

Jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
to O
the O
jaw O
. O

Positive O
hepatojugular O
reflexes O
. O

LUNGS O
: O

Crackles B-SYMPTOM
1/3 I-SYMPTOM
up I-SYMPTOM
bilaterally I-SYMPTOM
. O

CARDIAC O
: O

Regular O
, O
rate O
and O
rhythm O
. O

Normal O
S1 O
and O
S2 O
. O

3/6 B-SYMPTOM
crescendo I-SYMPTOM
decrescendo I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
with O
radiation B-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
carotids I-SYMPTOM
. O

No O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
. O

ABDOMEN O
: O

Soft O
, O
obese B-SYMPTOM
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
normal O
active O
bowel O
sounds O
. O

No O
hepatosplenomegaly B-SYMPTOM
. O

EXTREMITIES O
: O

3 B-SYMPTOM
plus I-SYMPTOM
pitting I-SYMPTOM
edema I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
knee I-SYMPTOM
bilaterally I-SYMPTOM
with O
areas O
of O
darkened B-SYMPTOM
erythema I-SYMPTOM
which O
is O
crusted B-SYMPTOM
, O
indented B-SYMPTOM
. O

A B-SYMPTOM
shallow I-SYMPTOM
chronic I-SYMPTOM
ulcer I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
shin I-SYMPTOM
with O
desquamation B-SYMPTOM
bilaterally I-SYMPTOM
around I-SYMPTOM
the I-SYMPTOM
ankle I-SYMPTOM
and O
half O
way O
up O
the O
shin O
. O

1 B-SYMPTOM
x I-SYMPTOM
2 I-SYMPTOM
cm I-SYMPTOM
ulcer I-SYMPTOM
with O
clean O
sharp O
borders O
to O
the O
dermatome O
on O
the O
left O
posterior O
thigh O
. O

NEUROLOGICAL O
: O

Alert O
and O
oriented O
x O
3 O
. O

Cranial O
nerves O
II-XII O
intact O
. O

4/5 O
lower O
extremity O
bilaterally O
. O

5/5 O
strength O
upper O
extremities O
bilaterally O
. O

Unable O
to O
assess O
reflexes O
due O
to O
the B-SYMPTOM
knee I-SYMPTOM
deformities I-SYMPTOM
. O

2 O
plus O
reflexes O
in O
the O
upper O
extremities O
symmetrically O
bilaterally O
. O

Toes O
downgoing O
. O

LABORATORY O
DATA O
ON O
ADMISSION O
: O

Sodium O
134 O
, O
potassium O
4.0 O
, O
chloride O
91 O
, O
bicarbonate O
33 O
, O
BUN O
21 O
, O
creatinine O
1.1 O
, O
glucose O
99 O
, O
CK O
22 O
, O
troponin O
0 O
. O

Calcium O
8.8 O
, O
white O
blood O
cell O
count O
10.6 O
, O
hematocrit O
37.1 O
, O
platelets O
289 O
. O

INR O
1.1 O
, O
PTT O
30.3.Chest O
x-ray O
shows O
cardiomegaly B-SYMPTOM
. O

Small B-SYMPTOM
left I-SYMPTOM
effusion I-SYMPTOM
. O

Lobular B-SYMPTOM
density I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
hilum I-SYMPTOM
. O

No O
pneumonia B-SYMPTOM
. O

Electrocardiogram O
shows O
normal O
sinus O
rhythm O
at O
50 O
. O

Normal O
axis O
. O

primary B-SYMPTOM
AV I-SYMPTOM
block I-SYMPTOM
. O

Left B-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
hospital O
for O
acute B-SYMPTOM
and I-SYMPTOM
chronic I-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

1. O
Cardiovascular O
: O

The O
patient O
was O
found O
to O
be O
in O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
and O
thought O
likely O
secondary O
to O
diastolic B-SYMPTOM
dysfunction I-SYMPTOM
secondary O
to O
hypertension B-SYMPTOM
. O

The O
patient O
was O
also O
found O
to O
have O
pulmonary B-SYMPTOM
hypertension I-SYMPTOM
. O

She O
ruled O
out O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
with O
3 O
negative O
enzymes O
. O

On O
admission O
, O
she O
was O
diuresed O
with O
Lasix B-TREATMENT
and O
was O
negative O
1-2 O
liters O
per O
day O
for O
several O
days O
. O

The B-TREATMENT
diuresis I-TREATMENT
was O
backed O
off O
when O
her O
bicarbonate O
increased O
from O
36 O
to O
39 O
. O

She O
was O
restarted O
on O
20 O
mg O
p.o. O
q O
day O
prior O
to O
discharge O
. O

Her O
lipids O
were O
checked O
with O
a O
total O
cholesterol O
of O
110 O
, O
triglycerides O
59 O
, O
HDL32 O
, O
LDL O
64 O
. O

The O
patient O
had O
a O
D-dimer O
greater O
than O
1000 O
with O
lower O
extremity O
non-invasive O
studies O
which O
were O
positive O
for O
a B-SYMPTOM
small I-SYMPTOM
right I-SYMPTOM
common I-SYMPTOM
femoral I-SYMPTOM
clot I-SYMPTOM
. O

It O
was O
unclear O
whether O
this O
was O
old O
or O
new O
. O

A O
TTE O
showed O
an O
ejection O
fraction O
of O
60% O
, O
mild B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
, O
left B-SYMPTOM
atrial I-SYMPTOM
enlargement I-SYMPTOM
, O
mild B-SYMPTOM
tricuspid I-SYMPTOM
regurgitation I-SYMPTOM
, O
pulmonary O
artery O
pressures O
of O
44 O
plus O
right O
atrial O
pressure O
. O

There O
was O
an B-SYMPTOM
intra-atrial I-SYMPTOM
shunt I-SYMPTOM
from O
the O
right O
to O
the O
left O
through O
a B-SYMPTOM
patent I-SYMPTOM
foramen I-SYMPTOM
ovale I-SYMPTOM
. O

Chest O
CT O
was O
a O
poor O
study O
but O
did O
not O
show O
a B-SYMPTOM
pulmonary I-SYMPTOM
embolus I-SYMPTOM
. O

The O
patient O
had O
subsequent O
dobutamine O
MIBI O
which O
was O
positive O
for O
inducible B-SYMPTOM
ischemia I-SYMPTOM
in O
the O
distribution O
of O
posterior O
descending O
coronary O
artery O
and O
posterolateral O
coronary O
artery O
with O
a B-SYMPTOM
small I-SYMPTOM
to I-SYMPTOM
medium I-SYMPTOM
perfusion I-SYMPTOM
defect I-SYMPTOM
in O
the O
inferolateral O
wall O
and O
basal O
inferior O
wall O
which O
was O
partially O
reversible O
. O

The O
cardiology O
service O
saw O
the O
patient O
and O
recommended O
medical O
management O
only O
without O
catheterization O
. O

Her O
blood O
pressure O
was O
high B-SYMPTOM
so O
Captopril B-TREATMENT
was O
titrated O
up O
to O
50 O
mg O
p.o. O
t.i.d. O
. O

She O
will O
be O
discharged O
on O
Lisinopril B-TREATMENT
with O
further O
titration O
as O
an O
outpatient O
. O

She O
is O
on O
hydrochlorothiazide B-TREATMENT
50 O
mg O
p.o. O
q O
day O
. O

Her B-TREATMENT
atenolol I-TREATMENT
was O
stopped O
due O
to O
bradycardia B-SYMPTOM
on O
admission O
but O
this O
may O
be O
restarted O
as O
an O
outpatient O
in O
gentle B-TREATMENT
doses I-TREATMENT
with O
careful O
monitoring O
of O
heart O
rate O
. O

She O
is O
on O
an B-TREATMENT
aspirin I-TREATMENT
. O

She O
will O
be O
discharged O
on O
Lasix B-TREATMENT
20 O
mg O
for O
continued O
control O
of O
her B-SYMPTOM
edema I-SYMPTOM
. O

2. O
Pulmonary O
; O

Pulmonary B-SYMPTOM
hypertension I-SYMPTOM
as O
seen O
on O
echocardiogram O
. O

Unclear O
whether O
there O
are O
chronic B-SYMPTOM
pulmonary I-SYMPTOM
embolus I-SYMPTOM
but O
did O
have O
positive O
test O
for O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
and O
will O
be O
treated O
with O
Coumadin B-TREATMENT
. O

An O
ABG O
was O
done O
which O
showed O
pH O
7.34 O
, O
pCO2 O
78 O
, O
pO2 O
92 O
on O
2 O
liters O
. O

Her O
bicarbonate O
peaked O
at O
39 O
and O
generally O
is O
in O
the O
36-38 O
range O
. O

She O
has O
severe B-SYMPTOM
sleep I-SYMPTOM
apnea I-SYMPTOM
and O
falls O
asleep O
midsentence O
. O

She O
has O
episodes O
of O
not B-SYMPTOM
breathing I-SYMPTOM
. O

BIPAP B-TREATMENT
was O
attempted O
for O
3 O
nights O
in O
a O
row O
and O
the O
patient O
did O
not O
tolerate O
this O
. O

She O
will O
need O
pulmonary O
function O
studies O
as O
an O
outpatient O
as O
these O
were O
not O
done O
in O
the O
hospital O
. O

The O
pulmonary O
team O
saw O
the O
patient O
and O
only O
recommended O
the O
above O
testing O
. O

She O
needs O
home B-TREATMENT
oxygen I-TREATMENT
and O
is O
currently O
at O
2 B-TREATMENT
liters I-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
oxygen I-TREATMENT
. O

3. O
Infectious B-SYMPTOM
disease I-SYMPTOM
: O

Evidence O
for O
cellulitis B-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
legs I-SYMPTOM
, O
likely O
due O
to O
distention B-SYMPTOM
from O
edema B-SYMPTOM
and O
poor B-SYMPTOM
perfusion I-SYMPTOM
. O

She O
was O
originally O
started O
on O
cefazolin B-TREATMENT
which O
was O
then O
changed O
to O
Keflex B-TREATMENT
with O
good O
improvement O
. O

She O
will O
need O
to O
continue O
for O
at O
least O
10 O
more O
days O
or O
as O
clinically O
indicated O
by O
the O
course O
of O
her B-SYMPTOM
cellulitis I-SYMPTOM
. O

4. O
Hematology O
: O

D-dimer O
in O
the O
emergency O
room O
was O
greater O
than O
1000 O
and O
a B-SYMPTOM
right I-SYMPTOM
common I-SYMPTOM
femoral I-SYMPTOM
clot I-SYMPTOM
was O
seen O
. O

This B-SYMPTOM
clot I-SYMPTOM
was O
small O
and O
it O
was O
questionable O
as O
to O
whether O
it O
was O
old O
or O
new O
. O

She O
was O
started O
on O
anticoagulation B-TREATMENT
given O
the B-SYMPTOM
positive I-SYMPTOM
D-dimer I-SYMPTOM
. O

Chest O
CT O
was O
nondiagnostic O
but O
did O
not O
show O
pulmonary B-SYMPTOM
embolus I-SYMPTOM
. O

It O
was O
a O
poor O
study O
. O

Heparin B-TREATMENT
was O
maintained O
during O
her O
hospital O
course O
and O
then O
Lovenox B-TREATMENT
was O
started O
. O

Her B-TREATMENT
dose I-TREATMENT
was O
increased O
to O
7.5 O
mg O
q O
day O
the O
day O
prior O
to O
discharge O
. O

She O
will O
be O
discharged O
on O
this O
dose O
in O
addition O
to O
1 O
day O
of O
Lovenox B-TREATMENT
. O

Discharge O
INR O
1.8 O
. O

Goal O
INR O
is O
2.0-3.0 O
. O

5. O
Fluids O
/ O
electrolytes O
/ O
nutrition O
: O

Low B-TREATMENT
salt I-TREATMENT
diet I-TREATMENT
. O

Low B-TREATMENT
cholesterol I-TREATMENT
, I-TREATMENT
low I-TREATMENT
fat I-TREATMENT
diet I-TREATMENT
. O

DISPOSITION O
ON O
DISCHARGE O
: O

To O
rehabilitation B-TREATMENT
. O

DISCHARGE O
INSTRUCTIONS O
: O

House O
diet O
. O

No O
added O
salt O
. O

Low O
saturated O
fat O
. O

Low O
cholesterol O
. O

ACTIVITY O
: O

As O
tolerated O
. O

ADDITIONAL O
COMMENTS O
: O

The O
patient O
needs O
physical B-TREATMENT
therapy I-TREATMENT
to O
increase O
stability O
in O
mobilization O
. O

Need O
to O
try O
to O
control O
blood O
pressure O
. O

Can O
increase O
her B-TREATMENT
Ace I-TREATMENT
inhibitor I-TREATMENT
as O
tolerated O
. O

May O
start O
beta-blocker B-TREATMENT
at O
a O
low O
dose O
given O
mild B-SYMPTOM
bradycardia I-SYMPTOM
at O
atenolol B-TREATMENT
50 O
mg O
p.o. O
q O
day O
. O

Need O
to O
continue O
oxygen B-TREATMENT
2 O
liters O
via O
nasal B-TREATMENT
cannula I-TREATMENT
. O

Needs O
anticoagulation B-TREATMENT
for O
6 O
months O
for O
right B-SYMPTOM
common I-SYMPTOM
femoral I-SYMPTOM
artery I-SYMPTOM
deep I-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
. O

Goal O
INR O
is O
2.0-3.0 O
. O

Should O
continue O
Keflex B-TREATMENT
for O
10 O
more O
days O
or O
as O
clinically O
indicated O
. O

Need O
to O
follow O
INR O
after O
Keflex B-TREATMENT
is O
discontinued O
as O
expect O
it O
will O
change O
. O

The O
patient O
has O
severe B-SYMPTOM
sleep I-SYMPTOM
apnea I-SYMPTOM
and O
stops O
breathing O
during O
sleep O
. O

This O
is O
her O
baseline O
status O
. O

CONDITION O
ON O
DISCHARGE O
: O

Satisfactory O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Tylenol B-TREATMENT
650 O
mg O
p.o. O
q O
4-6 O
hours O
p.r.n. O
headache B-SYMPTOM
, O
enteric B-TREATMENT
coated I-TREATMENT
aspirin I-TREATMENT
325 O
mg O
p.o. O
q O
day O
, O
calcium B-TREATMENT
gluconate I-TREATMENT
1000 O
mg O
p.o. O
b.i.d. O
, O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O
, O
enema B-TREATMENT
of I-TREATMENT
choice I-TREATMENT
and O
laxative B-TREATMENT
of I-TREATMENT
choice I-TREATMENT
p.o. O
q O
day O
p.r.n. O
constipation B-SYMPTOM
, O
Lasix B-TREATMENT
20 O
mg O
p.o. O
q O
day O
, O
Coumadin B-TREATMENT
7.5 O
mg O
p.o.q.h.s. O
for O
goal O
INR O
of O
2.0-3.0 O
. O

Keflex B-TREATMENT
500 O
mg O
p.o. O
q.i.d. O
x O
10 O
more O
days O
, O
Miconazole B-TREATMENT
2% O
powder O
topically O
b.i.d. O
apply O
to O
affected O
areas O
of O
breasts O
and O
groins O
b.i.d. O
, O
Lisinopril B-TREATMENT
20 O
mg O
p.o. O
q O
day O
hold O
of O
systolic O
blood O
pressure O
less O
than O
110 O
, O
Lovenox B-TREATMENT
100 O
mg O
subcutaneously O
q O
12 O
hours O
x O
2 O
doses O
and O
then O
discontinued O
, O
atenolol B-TREATMENT
12.5 O
mg O
p.o. O
q O
day O
hold O
for O
a O
systolic O
blood O
pressure O
of O
less O
than O
110 O
, O
heart O
rate O
less O
than O
55 O
. O

Dictated O
By O
: O

MONAHA O
SCREEN O
, O
M.D. O
YR61 O

Attending O
: O

CAR O
APRUESS O
, O
M.D. O
FS15 O
TX837/072487 O

Batch O
: O

3205 O

V2ZAS8884 O
J O

D O
: O

02/08/02 O

T O
: O

02/08/02 O

551969782 O

HLGMC O

2743471 O

05215/8895 O

3/26/1993 O
12:00:00 O
AM O

POST-INFARCTION B-SYMPTOM
UNSTABLE I-SYMPTOM
ANGINA I-SYMPTOM
PECTORIS I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

3-26-93 O

DISCHARGE O
DATE O
: O

4-3-93 O

PRINCIPAL O
DIAGNOSIS O
: O

Post-infarction B-SYMPTOM
unstable I-SYMPTOM
angina I-SYMPTOM
pectoris I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Inferior B-SYMPTOM
wall I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
ventricular B-SYMPTOM
fibrillation I-SYMPTOM
arrest I-SYMPTOM
, O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
paroxysmal B-SYMPTOM
atrial I-SYMPTOM
tachycardia I-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
psychosis B-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

3-27-93 O
, O
cardiac O
catheterization O
and O
coronary O
and O
left O
ventricular O
angiography O
; O
4-2-93 O
, O
exercise O
tolerance O
test O
with O
Thallium O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Vasotec B-TREATMENT
5 O
mg O
PO O
b.i.d. O
, O
Isordil B-TREATMENT
10 O
mg O
PO O
q.i.d. O
, O
Ticlopidine B-TREATMENT
50 O
mg O
PO O
b.i.d. O
, O
Metoprolol B-TREATMENT
50 O
mg O
PO O
b.i.d. O
, O
Ciprofloxacin B-TREATMENT
500 O
mg O
PO O
q12h O
x O
seven O
days O
, O
nitroglycerin B-TREATMENT
0.3 O
mg O
sublingually O
prn O
chest B-SYMPTOM
pain I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
73 O
year O
old O
female O
who O
was O
transferred O
for O
cardiac O
catheterization O
after O
ventricular B-SYMPTOM
fibrillation I-SYMPTOM
arrest I-SYMPTOM
in O
the O
setting O
of O
an B-SYMPTOM
acute I-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
and O
a B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

The O
patient O
was O
admitted O
on O
3-16-93 O
to O
Diy O
Hospital O
for O
an B-SYMPTOM
E. I-SYMPTOM
coli I-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

The O
patient O
was O
readmitted O
on O
3-20-93 O
because O
of O
fever B-SYMPTOM
, O
chills B-SYMPTOM
and O
a O
sudden O
onset O
of O
ventricular B-SYMPTOM
fibrillation I-SYMPTOM
arrest I-SYMPTOM
, O
successfully O
cardioverted O
back O
to O
rapid B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
and O
finally O
to O
sinus O
rhythm O
, O
where O
an O
electrocardiogram O
then O
showed O
ST B-SYMPTOM
elevation I-SYMPTOM
in I-SYMPTOM
inferior I-SYMPTOM
leads I-SYMPTOM
. O

Peak O
CPK O
was O
2494 O
with O
18% O
MB O
's O
. O

She O
required O
intubation B-TREATMENT
for O
mild B-SYMPTOM
to I-SYMPTOM
moderate I-SYMPTOM
congestive I-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
treated O
with O
diuretics B-TREATMENT
, O
intravenous B-TREATMENT
nitroglycerin I-TREATMENT
and O
heparin B-TREATMENT
. O

She O
had O
post-infarction B-SYMPTOM
angina I-SYMPTOM
, O
was O
transferred O
here O
for O
angiography O
and O
possible O
percutaneous B-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
examination O
, O
blood O
pressure O
is O
130/80 O
, O
pulse O
74 O
and O
regular O
, O
respirations O
14 O
. O

Her O
chest O
demonstrated O
bibasilar B-SYMPTOM
crackles I-SYMPTOM
. O

Cardiovascular O
exam O
: O

the O
jugular O
venous O
pressure O
was O
seven O
centimeters O
, O
carotid O
upstroke O
normal O
. O

The O
heart O
exam O
revealed O
a O
normal O
Sl O
and O
S2 O
was O
normally O
split O
. O

There O
was O
an B-SYMPTOM
S4 I-SYMPTOM
, O
no O
S3 B-SYMPTOM
, O
grade B-SYMPTOM
II/VI I-SYMPTOM
apical I-SYMPTOM
murmur I-SYMPTOM
in I-SYMPTOM
systole I-SYMPTOM
, O
no O
rubs B-SYMPTOM
. O

The O
abdomen O
was O
benign O
, O
unremarkable O
. O

Extremities O
: O

no O
calf B-SYMPTOM
tenderness I-SYMPTOM
or O
peripheral B-SYMPTOM
edema I-SYMPTOM
. O

Peripheral O
pulses O
were O
2+ O
and O
symmetrical O
bilaterally O
. O

HOSPITAL O
COURSE O
: O

On O
3-27-93 O
, O
patient O
underwent O
cardiac O
catheterization O
, O
coronary O
and O
left O
ventricular O
angiography O
without O
complications B-SYMPTOM
. O

Review O
of O
these O
angiograms O
demonstrated O
a O
dominant O
right O
coronary O
artery O
with O
a B-SYMPTOM
focal I-SYMPTOM
50% I-SYMPTOM
stenosis I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
mid-portion I-SYMPTOM
. O

The O
left O
main O
coronary O
artery O
was O
clear O
. O

The O
left O
anterior O
descending O
had O
moderate B-SYMPTOM
plaques I-SYMPTOM
with O
a B-SYMPTOM
50% I-SYMPTOM
proximal I-SYMPTOM
stenosis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
anterior I-SYMPTOM
oblique I-SYMPTOM
caudal I-SYMPTOM
view O
. O

The O
proximal O
diagonal O
D1 O
had O
a B-SYMPTOM
50% I-SYMPTOM
stenosis I-SYMPTOM
. O

The O
circumflex O
had O
a B-SYMPTOM
long I-SYMPTOM
30% I-SYMPTOM
stenosis I-SYMPTOM
proximally O
and O
an B-SYMPTOM
80% I-SYMPTOM
stenosis I-SYMPTOM
at O
the O
origin O
of O
the O
second O
major O
marginal O
artery O
. O

The O
left O
ventricular O
angiogram O
showed O
akinesis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
posterobasal I-SYMPTOM
walls I-SYMPTOM
, O
severe B-SYMPTOM
hypokinesis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
diaphragmatic I-SYMPTOM
wall I-SYMPTOM
and O
trace B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
. O

The O
patient O
was O
maintained O
on O
heparin B-TREATMENT
anticoagulation I-TREATMENT
. O

An O
exercise O
tolerance O
test O
with O
Thallium O
was O
to O
be O
performed O
in O
order O
to O
assess O
myocardial O
viability O
in O
the B-SYMPTOM
infarct I-SYMPTOM
zone I-SYMPTOM
. O

The B-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
lesion I-SYMPTOM
was O
complex O
and O
there O
was O
severe B-SYMPTOM
stenosis I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
obtuse I-SYMPTOM
marginal I-SYMPTOM
1 I-SYMPTOM
. O

The O
patient O
had O
no O
further B-SYMPTOM
angina I-SYMPTOM
. O

On O
4-2-93 O
, O
she O
underwent O
a O
Persantine O
Thallium O
study O
. O

This O
showed O
no O
diagnostic B-SYMPTOM
electrocardiogram I-SYMPTOM
changes I-SYMPTOM
for O
ischemia B-SYMPTOM
and O
no O
angina B-SYMPTOM
pectoris I-SYMPTOM
. O

The O
thallium O
images O
showed O
a B-SYMPTOM
large I-SYMPTOM
region I-SYMPTOM
of I-SYMPTOM
persistently I-SYMPTOM
reduced I-SYMPTOM
blood I-SYMPTOM
flow I-SYMPTOM
involving O
the O
apex O
and O
inferoposterior O
segments O
of O
the O
left O
ventricular O
wall O
. O

This O
was O
consistent O
with O
scar B-SYMPTOM
. O

There O
was O
no O
definite B-SYMPTOM
perfusion I-SYMPTOM
abnormality I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
circumflex I-SYMPTOM
zone I-SYMPTOM
. O

In O
view O
of O
these O
findings O
, O
it O
was O
elected O
to O
discharge O
her O
on O
her O
present O
medical O
program O
. O

The O
patient O
is O
to O
return O
to O
the O
follow O
up O
care O
of O
Dr. O
Ko O
Kollciem O
at O
the O
Diy O
Hospital O
. O

CHPO O
E. O
JESCOBEA O
, O
M.D. O

TR O
: O

sq O
/ O
bmot O

DD O
: O

06-13-93 O

TD O
: O

06/15/93 O

CC O
: O

Dr. O
Ko O
Kollciem O
, O
Retchard O
Healthcare O
to O
Dr. O
Wall O

656225945 O
YC O

76593195 O

2774375 O

01/19/2003 O
12:00:00 O
AM O

cellulitis B-SYMPTOM

DIS O

Admission O
Date O
: O

01/19/2003 O

Report O
Status O
: O

Discharge O
Date O
: O

01/24/2003 O

****** O
DISCHARGE O
ORDERS O
****** O

MONG O
, O
RISHRIELI O

156-02-38-0 O
P22 O

Room O
: O

15L-305 O

Service O
: O

MED O

DISCHARGE O
PATIENT O
ON O
: O

01/24/03 O
AT O
02:00 O
PM O

CONTINGENT O
UPON O

Attending O
evaluation O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

SHONESGANS O
, O
AH O
B. O
, O
M.D. O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

LEVOFLOXACIN B-TREATMENT
500 O
MG O
PO O
QD O
X O
14 O
Days O

Food O
/ O
Drug O
Interaction O
Instruction O

Administer O
iron B-TREATMENT
products I-TREATMENT
a O
minimum O
of O
2 O
hours O
before O
or O
after O
a B-TREATMENT
levofloxacin I-TREATMENT
or O
ciprofloxacin B-TREATMENT
dose I-TREATMENT
dose O
If O
on O
tube B-TREATMENT
feeds I-TREATMENT
, O
please O
cycle O
( O
hold O
1 O
hr O
before O
to O
2 O
hr O
after O
) O
Take O
2 O
hours O
before O
or O
2 O
hours O
after O
dairy O
products O
. O

DIET O
: O

No O
Restrictions O

ACTIVITY O
: O

Resume O
regular O
exercise O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Ica O
Gachcienne O
- O
in O
PCP O
office O
01/26/03 O
, O

ALLERGY O
: O

Penicillins B-TREATMENT

ADMIT O
DIAGNOSIS O
: O

Cellulitis B-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
cellulitis B-SYMPTOM

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
cellulitis B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

None O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

CT O
of O
neck O
with O
contrast O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

Pt O
is O
22 O
y O
/ O
o O
female O
with O
hx O
of O
HIV B-SYMPTOM
and O
CD4 O
ct O
of O
297 O
who O
presented O
to O
ED O
on O
01/14 O
with O
sebaceous B-SYMPTOM
cyst I-SYMPTOM
that O
was O
infected B-SYMPTOM
. O

Cyst B-SYMPTOM
was O
drained O
and O
pt O
was O
sent O
home O
with O
Duracef B-TREATMENT
. O

She O
did O
not O
fill O
script B-TREATMENT
for O
2 O
days O
and O
even O
then O
was O
not B-SYMPTOM
compliant I-SYMPTOM
with O
her B-TREATMENT
meds I-TREATMENT
. O

She O
now O
returns O
to O
ED O
with O
pain B-SYMPTOM
and O
erythema B-SYMPTOM
from I-SYMPTOM
the I-SYMPTOM
midline I-SYMPTOM
posterior I-SYMPTOM
neck I-SYMPTOM
to O
her O
submental O
area O
and O
2-3 O
d O
of O
intermittent B-SYMPTOM
fevers I-SYMPTOM
and O
chills B-SYMPTOM
. O
+ O
nausea B-SYMPTOM
. O

No O
dysphagia B-SYMPTOM
, O
trouble O
hearing O
. O

PMH O
: O

HIV B-SYMPTOM
, O
viral O
load O
954 O
, O
7/03 O
- O
H. B-SYMPTOM
Pylori I-SYMPTOM
pos. O
, O
asthma B-SYMPTOM

FHX O
/ O
SHX O
: O

Lives O
with O
boyfriend O
in O
apt O
. O

Smokes O
2-3 O
cig O
/ O
day O
, O
occ O
etoh O
, O
and O
no O
drugs O
except O
marijuana O
Exam O
: O

98.6 O
54 O
119/59 O
18 O
100% O
RA O
. O

Exam O
sig. O
for O
erthyema B-SYMPTOM
as O
described O
previously O
and O
tenderness B-SYMPTOM
to O
minimal O
palpation O
. O

Data O
: O

Neck O
CT O
neg O
for O
abcess B-SYMPTOM
. O

Pt O
with O
WBC O
of O
15.4 O
with O
70% O
seg O
. O

Plan O
: O

(1) O
ID O
- O
Pt O
received O
Clinda B-TREATMENT
and O
Ancef B-TREATMENT
in O
ED O
. O

Will O
cont O
Ancef B-TREATMENT
1q8 O
overnight O
and O
trans O
to O
Keflex B-TREATMENT
. O

CD4 O
ct O
. O

Bacitracin B-TREATMENT
oint I-TREATMENT
. O

Percocet B-TREATMENT
and O
morphine B-TREATMENT
sulfate I-TREATMENT
for O
pain B-SYMPTOM
. O

(2) O
GI O
- O
Nexium B-TREATMENT

(3) O
FEN O
- O
NS B-TREATMENT
overnight O

(4) O
Pulm O
- O
Albuterol B-TREATMENT
inhalers I-TREATMENT
prn O
Patient O
seems O
to O
be O
improving O
and O
afebrile B-SYMPTOM
and O
resting O
comfortably O
. O

The B-SYMPTOM
erythematous I-SYMPTOM
region I-SYMPTOM
is O
retreating O
and O
the B-SYMPTOM
wound I-SYMPTOM
cleaned O
. O

She O
is O
ready O
to O
be O
sent O
home O
with O
antibiotics B-TREATMENT
. O

Repeat O
CT O
was O
neg. O
for O
abcess B-SYMPTOM
or O
fascitis B-SYMPTOM
. O

ADDITIONAL O
COMMENTS O
: O

1 O
- O
be O
sure O
to O
finish O
all O
antibiotic B-TREATMENT
even O
if O
pain B-SYMPTOM
subsides O
adn O
inflammation B-SYMPTOM
goes O
down O
. O

2 O
- O
clean O
wound B-SYMPTOM

3 O
- O
Follow O
up O
with O
PCP O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

1 O
- O
Fill O
Rx O
for O
antibiotics B-TREATMENT
today O
and O
take O
until O
finished O
even O
if O
neck B-SYMPTOM
pain I-SYMPTOM
subsides O
x O
14 O
days O

2 O
- O
Clean O
wound B-SYMPTOM

3 O
- O
Return O
to O
ED O
or O
call O
PCP O
if O
neck B-SYMPTOM
inflammation I-SYMPTOM
and O
red B-SYMPTOM
swollen I-SYMPTOM
area I-SYMPTOM
does O
not O
continue O
to O
get O
better O
or O
if O
temperature B-SYMPTOM
returns O
. O

4 O
- O
Visit O
PCP O
on O
Monday O
at O
2:30 O
No O
dictated O
summary O

ENTERED O
BY O
: O

DRIN O
, O
FONDT O
L. O
, O
M.D. O
( O
CR90 O
) O
01/24/03 O
12:48 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2016-09-05 O

Discharge O
Date O
: O

2016-09-14 O

Date O
of O
Birth O
: O

1940-08-17 O

Sex O
: O

M O

Service O
: O

CSU O

CHIEF O
COMPLAINT O
: O

Chest B-SYMPTOM
pain I-SYMPTOM
and O
back B-SYMPTOM
pain I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Hohlt O
is O
a O
76 O
- O
year-old O
man O
with O
a O
history O
of O
hypertension B-SYMPTOM
, O
hyperlipidemia B-SYMPTOM
and O
prior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
with O
a B-TREATMENT
percutaneous I-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
of I-TREATMENT
the I-TREATMENT
right I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
in O
2005 O
at O
the O
Cambridge O
Health O
Alliance O
. O

He O
states O
that O
he O
has O
experienced O
pain B-SYMPTOM
and O
tightness B-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
back I-SYMPTOM
radiating O
into O
both O
shoulders O
starting O
on O
2016-09-02 O
. O

The O
patient O
denies O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
dizziness B-SYMPTOM
, O
diaphoresis B-SYMPTOM
, O
or O
nausea B-SYMPTOM
. O

The B-SYMPTOM
pain I-SYMPTOM
lasted O
for O
30 O
seconds O
following O
pushing O
a O
wheelbarrow O
and O
resolved O
with O
rest O
. O

The O
patient O
denied O
any O
prior O
episodes O
of O
pain B-SYMPTOM
or O
any O
since O
2005 O
following O
the O
initial O
episode O
of O
pain B-SYMPTOM
. O

The O
patient O
informs O
his O
primary O
care O
provider O
who O
referred O
him O
to O
the O
emergency O
room O
. O

He O
then O
presented O
to O
Mass. O
Mental O
Health O
Center O
where O
he O
was O
ruled O
out O
for O
an B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
by O
enzymes O
and O
electrocardiograms O
. O

The O
patient O
also O
underwent O
a O
negative O
evaluation O
for O
dissecting B-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
. O

On O
2016-09-03 O
, O
the O
patient O
began O
experiencing O
continuing B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
of O
increasing O
intensity O
. O

He O
was O
treated O
with O
nitroglycerin B-TREATMENT
paste I-TREATMENT
and O
IV B-TREATMENT
Integrelin I-TREATMENT
as O
well O
as O
Plavix B-TREATMENT
. O

At O
that O
time O
, O
he O
ruled O
in O
for O
an B-SYMPTOM
NST I-SYMPTOM
EMI I-SYMPTOM
with O
a O
peak O
CK O
of O
412 O
and O
a O
troponin O
of O
6.23 O
. O

Electrocardiograms O
progressed O
to O
inverted B-SYMPTOM
T I-SYMPTOM
waves I-SYMPTOM
in I-SYMPTOM
V5 I-SYMPTOM
and I-SYMPTOM
V6 I-SYMPTOM
. O

The O
patient O
is O
now O
transferred O
to O
Cambridge O
Health O
Alliance O
for O
cardiac O
catheterization O
. O

PAST O
MEDICAL O
HISTORY O
: O

Hypertension B-SYMPTOM
, O
hyperlipidemia B-SYMPTOM
, O
IMI B-SYMPTOM
in O
2005 O
. O

PAST O
SURGICAL O
HISTORY O
: O

Partial B-TREATMENT
thyroidectomy I-TREATMENT
, O
herniorrhaphy B-TREATMENT
, O
percutaneous B-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
of I-TREATMENT
the I-TREATMENT
RCA I-TREATMENT
in O
2005 O
, O
left B-TREATMENT
knee I-TREATMENT
surgery I-TREATMENT
as O
well O
as O
tonsil B-TREATMENT
and I-TREATMENT
adenoid I-TREATMENT
surgery I-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
AT O
HOME O
: O

1. O
Flomax B-TREATMENT
0.4 O
q.d. O

2. O
Aspirin B-TREATMENT
325 O
q.d. O

3. O
Lipitor B-TREATMENT
10 O
q.d. O

4. O
Naproxen B-TREATMENT
p.r.n. O
as O
well O
as O
several B-TREATMENT
vitamins I-TREATMENT
and O
supplements B-TREATMENT
. O

5. O
Zestoretic B-TREATMENT
with O
an O
unknown O
dose O
. O

MEDICATIONS O
ON O
TRANSFER O
: O

1. O
Captopril B-TREATMENT
25 O
t.i.d. O

2. O
Protonix B-TREATMENT
q.d. O
40 O
. O

3. O
Nitroglycerin B-TREATMENT
paste I-TREATMENT
1 O
inch O
q. O
6 O
hours O
. O

4. O
Lopressor B-TREATMENT
25 O
b.i.d. O

5. O
Plavix B-TREATMENT
75 O
q.d. O

6. O
Lovenox B-TREATMENT
90 O
b.i.d. O

7. O
Aspirin B-TREATMENT
325 O
q.d. O

8. O
Lipitor B-TREATMENT
10 O
q.d. O

SOCIAL O
HISTORY O
: O

Married O
, O
retired O
accountant O
with O
six O
children O
. O

He O
denies O
any O
tobacco O
use O
, O
2 O
to O
3 O
alcohol O
drinks O
per O
week O
. O

FAMILY O
HISTORY O
: O

Father O
died O
in O
his O
80 O
's O
of O
pacemaker B-SYMPTOM
failure I-SYMPTOM
, O
also O
had O
a B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
his O
70 O
's. O

PHYSICAL O
EXAMINATION O
: O

Vital O
signs O
: O

Heart O
rate O
is O
55 O
, O
blood O
pressure O
is O
129/79 O
, O
Respiratory O
rate O
is O
22 O
, O
O2 O
sat O
is O
96 O
percent O
on O
2 B-TREATMENT
liters I-TREATMENT
. O

In O
general O
, O
well-appearing O
man O
, O
lying O
on O
a O
stretcher O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Neck O
: O

2 O
plus O
carotids O
with O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
and O
no O
bruits B-SYMPTOM
and O
no O
thyromegaly B-SYMPTOM
. O

Lungs O
: O

Fine B-SYMPTOM
crackles I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
bases I-SYMPTOM
, O
otherwise O
clear O
. O

Cardiovascular O
: O

Regular O
rate O
and O
rhythm O
, O
S1 O
and O
S2 O
with O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
. O

Abdomen O
: O
Soft O
and O
nontender B-SYMPTOM
and O
nondistended B-SYMPTOM
, O
normal O
active O
bowel O
sounds O
and O
no O
bruits B-SYMPTOM
. O

Pulses O
are O
2 O
plus O
femoral O
bilaterally O
, O
2 O
plus O
dorsalis O
pedis O
as O
well O
as O
posterior O
tibial O
bilaterally O
. O

No O
edema B-SYMPTOM
. O

Neurological O
: O

Alert O
and O
oriented O
times O
3 O
. O

Chest O
CT O
done O
at O
the O
outside O
hospital O
showed O
no O
gallstones B-SYMPTOM
. O

Left O
kidney O
with O
a B-SYMPTOM
small I-SYMPTOM
cyst I-SYMPTOM
splenic I-SYMPTOM
lesion I-SYMPTOM
and O
no O
triple B-SYMPTOM
A I-SYMPTOM
. O

Electrocardiogram O
has O
sinus O
rhythm O
with O
Q B-SYMPTOM
wave I-SYMPTOM
in I-SYMPTOM
2 I-SYMPTOM
, I-SYMPTOM
3 I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
F I-SYMPTOM
, O
flattened B-SYMPTOM
T I-SYMPTOM
waves I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lateral I-SYMPTOM
leads I-SYMPTOM
, O
sinus O
rhythm O
at O
a O
rate O
of O
56 O
. O

LABORATORY O
DATA O
: O

White O
blood O
cell O
count O
is O
8.3 O
, O
hematocrit O
42.7 O
, O
platelets O
180 O
, O
INR O
was O
1.1 O
, O
sodium O
135 O
, O
potassium O
4.0 O
, O
chloride O
99 O
, O
CO2 O
33 O
, O
BUN O
13 O
, O
creatinine O
1.0 O
, O
glucose O
96 O
. O

While O
on O
transfer O
, O
the O
patient O
underwent O
cardiac O
catheterization O
. O

Please O
see O
cathed O
report O
for O
full O
details O
. O

In O
summary O
, O
the O
catheterization O
showed O
left O
main O
with O
no O
obstructive B-SYMPTOM
disease I-SYMPTOM
, O
LAD O
with O
70 B-SYMPTOM
percent I-SYMPTOM
serial I-SYMPTOM
lesion I-SYMPTOM
, O
left O
circumflex O
with O
70 O
percent O
proximal O
, O
OM1 O
and O
OM2 O
both O
70 B-SYMPTOM
percent I-SYMPTOM
lesions I-SYMPTOM
, O
RCA O
with O
nonobstructive B-SYMPTOM
disease I-SYMPTOM
and O
ejection O

fraction O
of O
25 O
percent O
. O

The O
patient O
was O
referred O
to O
CT O
surgery O
who O
was O
seen O
and O
accepted O
for O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

On O
09-06 O
, O
he O
was O
brought O
to O
the O
Operating O
Room O
, O
please O
see O
the O
Operating O
Room O
report O
for O
full O
details O
. O

In O
summary O
, O
he O
had O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
4 O
with O
a B-TREATMENT
LIMA I-TREATMENT
to I-TREATMENT
the I-TREATMENT
LAD I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
OM1 I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
OM2 I-TREATMENT
and O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
of I-TREATMENT
the I-TREATMENT
diagonal I-TREATMENT
. O

His O
bypass O
time O
was O
105 O
minutes O
with O
a O
cross O
clamp O
time O
of O
87 O
minutes O
. O

He O
tolerated O
the B-TREATMENT
operation I-TREATMENT
well O
and O
was O
transferred O
from O
the O
Operating O
Room O
to O
the O
cardiothoracic O
ICU O
. O

At O
the O
time O
of O
transfer O
, O
he O
was O
AV B-TREATMENT
paced I-TREATMENT
at O
a O
rate O
of O
88 O
beats O
per O
minute O
. O

He O
had O
Propofol B-TREATMENT
at O
30 O
mc O
per O
kg O
per O
minute O
and O
Neo-Synephrine B-TREATMENT
to O
maintain O
his O
blood O
pressure O
. O

The O
patient O
did O
well O
in O
the O
immediate O
postoperative O
period O
. O

His B-TREATMENT
anesthesia I-TREATMENT
was O
reversed O
. O

He O
was O
weaned O
from O
the B-TREATMENT
ventilator I-TREATMENT
and O
successfully O
extubated O
. O

He O
remained O
hemodynamically O
stable O
throughout O
the O
remainder O
of O
his O
operative O
day O
. O

On O
postoperative O
day O
1 O
, O
the O
patient O
remained O
hemodynamically O
stable O
on O
a B-TREATMENT
Neo-Synephrine I-TREATMENT
drip I-TREATMENT
to O
maintain O
an O
adequate O
blood O

pressure O
. O

He O
remained O
in O
the O
Intensive O
Care O
Unit O
as O
he O
was O
unable O
to O
be O
weaned O
off O
of O
his B-TREATMENT
Neo-Synephrine I-TREATMENT
drip I-TREATMENT
. O

On O
postoperative O
day O
1 O
, O
his B-TREATMENT
Swan-Ganz I-TREATMENT
catheter I-TREATMENT
was O
removed O
as O
well O
. O

On O
postoperative O
day O
2 O
, O
another O
attempt O
was O
made O
to O
wean O
the O
patient O
off O
of O
Neo-Synephrine B-TREATMENT
unsuccessfully O
. O

His B-TREATMENT
chest I-TREATMENT
tubes I-TREATMENT
were O
removed O
. O

However O
, O
because O
he O
could O
not O
be O
weaned O
from O
the B-TREATMENT
Neo-Synephrine I-TREATMENT
, O
he O
again O
remained O
in O
the O
Intensive O
Care O
Unit O
. O

On O
postoperative O
day O
3 O
, O
an O
additional O
attempt O
was O
made O
to O
wean O
the O
patient O
from O
his B-TREATMENT
Neo-Synephrine I-TREATMENT
unsuccessfully O
. O

The O
patient O
also O
received O
a B-TREATMENT
unit I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
in O
an O
additional O
attempt O
to O
wean O
from O
Neo-Synephrine B-TREATMENT
. O

This O
also O
did O
not O
help O
in O
the O
attempt O
to O
wean O
from O
Neo-Synephrine B-TREATMENT
. O

His B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
was O
removed O
and O
he O
remained O
again O
in O
the O
ICU O
. O

On O
postoperative O
day O
4 O
, O
additional O
attempts O
were O
made O
to O
wean O
the O
patient O
off O
of O
his B-TREATMENT
Neo-Synephrine I-TREATMENT
, O
however O
, O
he O
continued O
to O
drop O
his O
blood O
pressure O
whenever O
an O
attempt O
was O
made O
. O

Other O
than O
that O
, O
the O
patient O
remained O
completely O
stable O
. O

On O
postoperative O
day O
5 O
, O
the O
patient O
was O
finally O
weaned O
off O
of O
his B-TREATMENT
Neo-Synephrine I-TREATMENT
and O
diuresis B-TREATMENT
was O
begun O
. O

He O
remained O
in O
the O
Intensive O
Care O
Unit O
for O
an O
additional O
day O
to O
monitor O
his O
hemodynamics O
. O

On O
postoperative O
day O
6 O
, O
the O
patient O
remained O
hemodynamically O
stable O
and O
he O
was O
transferred O
to O
the O
floor O
for O
continuing B-TREATMENT
postoperative I-TREATMENT
care I-TREATMENT
and O
cardiac B-TREATMENT
rehabilitation I-TREATMENT
. O

Over O
the O
next O
two O
days O
, O
the O
patient O
had O
an O
uneventful O
hospitalization O
. O

His O
activity O
level O
was O
increased O
with O
the O
assistance O
of O
physical O
therapy O
department O
and O
the O
nursing O
staff O
. O

On O
postoperative O
day O
7 O
, O
it O
was O
decided O
that O
the O
patient O
would O
be O
stable O
and O
ready O
to O
be O
discharged O
to O
home O
on O
the O
following O
day O
. O

At O
the O
time O
of O
this O
dictation O
, O
the O
patient O
's O
physical O
examination O
is O
as O
follows O
: O
Vital O
signs O
were O
temperature O
99 O
, O
heart O
rate O
84 O
in O
sinus O
rhythm O
, O
blood O
pressure O
was O
114/63 O
, O
Respiratory O
rate O
was O
18 O
, O
O2 O
sat O
was O
94 O
percent O
on O
room O
air O
. O

Weight O
preoperatively O
was O
88.5 O
kilos O
, O
at O
discharge O
was O
90.4 O
kilos O
. O

LABORATORY O
DATA O
: O

White O
blood O
cell O
count O
8.8 O
, O
hematocrit O
29.7 O
, O
platelets O
367 O
, O
sodium O
139 O
, O
potassium O
4.7 O
, O
chloride O
102 O
, O
CO2 O
27 O
, O
BUN O
17 O
, O
creatinine O
1.1 O
, O
glucose O
95 O
. O

PHYSICAL O
EXAMINATION O
: O

Neurological O
: O
Alert O
and O
oriented O
times O
3 O
. O

Moves O
all O
extremities O
and O
follows O
commands O
. O

Respiratory O
: O

Clear O
to O
auscultation O
bilaterally O
. O

Cardiovascular O
: O
Regular O
rate O
and O
rhythm O
, O
S1 O
and O
S2 O
. O

No O
murmurs B-SYMPTOM
. O

Sternum O
is O
stable O
, O
incision B-SYMPTOM
with O
staples B-TREATMENT
, O
opened O
to O
air O
, O
clean O
and O
dry O
. O

Abdomen O
: O
Soft O
and O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
with O
positive O
bowel O
sounds O
. O

Extremities O
: O

Warm O
and O
well O
profuse O
with O
1 B-SYMPTOM
to I-SYMPTOM
2 I-SYMPTOM
plus I-SYMPTOM
edema I-SYMPTOM
. O

Right B-SYMPTOM
saphenous I-SYMPTOM
vein I-SYMPTOM
graft I-SYMPTOM
site I-SYMPTOM
with O
Steri-strips B-TREATMENT
, O
open O
to O
air O
, O
clean O
and O
dry O
. O

The O
patient O
's O
condition O
at O
discharge O
is O
good O
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
times O
4 O
with O
LIMA B-TREATMENT
to I-TREATMENT
the I-TREATMENT
LAD I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
OM1 I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
OM2 I-TREATMENT
and O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
diagonal I-TREATMENT
. O

2. O
Hypertension B-SYMPTOM
. O

3. O
Hypercholesterolemia B-SYMPTOM
. O

4. O
Status O
post O
partial B-TREATMENT
thyroidectomy I-TREATMENT
. O

5. O
Status O
post O
hernia B-TREATMENT
repair I-TREATMENT
. O

6. O
Status O
post O
left B-TREATMENT
knee I-TREATMENT
surgery I-TREATMENT
. O

7. O
Status O
post O
tonsil B-TREATMENT
and I-TREATMENT
adenoid I-TREATMENT
surgery I-TREATMENT
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Atorvastatin B-TREATMENT
10 O
mg O
q.d. O

2. O
Plavix B-TREATMENT
75 O
mg O
q.d. O
times O
3 O
months O
. O

3. O
Aspirin B-TREATMENT
325 O
mg O
q.d. O

4. O
Lasix B-TREATMENT
20 O
mg O
q.d. O
times O
two O
weeks O
. O

5. O
Potassium B-TREATMENT
chloride I-TREATMENT
20 O
mEq O
q.d. O
times O
two O
weeks O
. O

6. O
Metoprolol B-TREATMENT
12.5 O
mg O
b.i.d. O

7. O
Percocet B-TREATMENT
1 O
to O
2 O
tabs O
q. O
4 O
hours O
p.r.n. O

The O
patient O
is O
to O
be O
discharged O
home O
with O
visiting O
nurses O
. O

He O
is O
to O
have O
follow O
up O
in O
the O
wound O
clinic O
in O
two O
weeks O
and O
follow O
up O
with O
Dr. O
Brewster O
in O
two O
to O
three O
weeks O
and O
follow O
up O
with O
Dr. O
Rota O
in O
4 O
weeks O
. O

Herbert O
Jesus O
, O
Georgia O
01835 O

Dictated O
By O
: O
Scott O
OK O
Astarita O
, O
M.D. O

MEDQUIST36 O

D O
: O
2016-09-14 O
12:52:27 O

T O
: O
2016-09-14 O
13:28:05 O

Job O
#: O
15604 O

Signed O
electronically O
by O
: O
DR. O
Richard O
Gomez O
on O
: O
FRI O
2016-09-16 O
7:05 O
AM O

( O
End O
of O
Report O
) O

176318078_c O

FIH O

4189699 O

78088/7792 O

080216 O

8/21/1993 O
12:00:00 O
AM O

EPISTAXIS B-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

8/21/93 O

DISCHARGE O
DATE O
: O

8/23/93 O

PRINCIPAL O
DIAGNOSIS O
: O

Epistaxis B-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Mitral B-SYMPTOM
stenosis I-SYMPTOM
, O
tricuspid B-SYMPTOM
regurgitation I-SYMPTOM
, O
heart B-SYMPTOM
failure I-SYMPTOM
, O
chronic B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
, O
chronic B-SYMPTOM
ventricular I-SYMPTOM
ectopy I-SYMPTOM
, O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
. O

ADVERSE O
DRUG O
REACTIONS O
: O

Epistaxis B-SYMPTOM
on O
Coumadin B-TREATMENT
in O
the O
past O
. O

PRINCIPAL O
PROCEDURE O
: O

Partial B-TREATMENT
embolization I-TREATMENT
of I-TREATMENT
blood I-TREATMENT
supply I-TREATMENT
to O
nose O
, O
8/22 O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
68 O
year O
old O
female O
has O
rheumatic B-SYMPTOM
heart I-SYMPTOM
disease I-SYMPTOM
. O

Mitral B-TREATMENT
and I-TREATMENT
possibly I-TREATMENT
tricuspid I-TREATMENT
valve I-TREATMENT
surgery I-TREATMENT
is O
scheduled O
for O
Labor O
Day O
by O
Dr. O
Riemund O
C. O
Kennedy O
. O

Her O
history O
is O
detailed O
in O
the O
discharge O
summary O
of O
August O
10 O
of O
this O
year O
. O

She O
is O
admitted O
now O
for O
a B-TREATMENT
neuro-interventional I-TREATMENT
radiology I-TREATMENT
procedure I-TREATMENT
to O
decrease O
the O
likelihood O
of O
epistaxis B-SYMPTOM
on O
Coumadin B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

Chest O
was O
clear O
. O

Right B-SYMPTOM
neck I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
groin I-SYMPTOM
catheterization I-SYMPTOM
sites I-SYMPTOM
were O
benign O
. O

No O
edema B-SYMPTOM
. O

Examination O
was O
otherwise O
unchanged O
. O

LABORATORY O
DATA O
: O

Hematocrit O
was O
42 O
, O
PT O
was O
10 O
, O
potassium O
was O
3.6 O
, O
BUN O
was O
29 O
, O
creatinine O
was O
1.4 O
, O
blood O
sugar O
was O
111 O
. O

EKG O
showed O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
moderate B-SYMPTOM
ventricular I-SYMPTOM
response I-SYMPTOM
, O
right B-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
, O
right B-SYMPTOM
axis I-SYMPTOM
deviation I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The B-TREATMENT
interventional I-TREATMENT
neuro-radiology I-TREATMENT
procedure I-TREATMENT
was O
performed O
by O
Dr. O
A O
Skizeis O
, O
on O
August O
22 O
, O
via O
the O
right O
femoral O
artery O
. O

The O
right O
internal O
maxillary O
artery O
supply O
to O
the O
nasal O
mucosa O
was O
embolized B-TREATMENT
. O

The O
left O
external O
carotid O
artery O
was O
occluded B-SYMPTOM
at O
its O
origin O
, O
with O
collaterals O
from O
the O
internal O
carotid O
artery O
. O

Thus O
, O
embolization B-TREATMENT
on I-TREATMENT
the I-TREATMENT
left I-TREATMENT
side I-TREATMENT
was O
not O
possible O
. O

The O
patient O
received O
Coumadin B-TREATMENT
, O
10 O
mg. O
, O
on O
the O
evening O
following O
the O
procedure O
, O
and O
is O
discharged O
the O
next O
day O
. O

Her O
prothrombin O
time O
will O
be O
rechecked O
on O
August O
27 O
by O
her O
primary O
care O
physician O
, O
Dr. O
Naka O
Gift O
. O

Once O
her O
prothrombin O
time O
is O
in O
therapeutic O
range O
, O
she O
will O
be O
observed O
for O
epistaxis B-SYMPTOM
. O

She O
will O
take O
her O
last O
dose O
of O
Coumadin B-TREATMENT
on O
September O
1 O
in O
anticipation O
of O
cardiac B-TREATMENT
surgery I-TREATMENT
. O

If O
her O
prothrombin O
time O
does O
not O
come O
into O
therapeutic O
range O
promptly O
, O
then O
surgery B-TREATMENT
may O
be O
delayed O
. O

DISCHARGE O
REGIMEN O
: O

Coumadin B-TREATMENT
, O
5 O
mg. O
, O
alternating O
with O
2.5 O
mg. O
, O
qD O
, O
digoxin B-TREATMENT
, O
0.125 O
mg. O
, O
qD O
, O
Lasix B-TREATMENT
, O
80 O
mg. O
, O
qAM O
and O
40 O
mg. O
, O
qPM O
, O
Vanceril B-TREATMENT
, O
3 O
puffs O
, O
b.i.d. O

CA O
N. O
SHUFF O
, O
M.D. O

TR O
: O

yqv O
/ O
bmot O

DD O
: O

8/23/93 O

TD O
: O

08/23/93 O

CC O
: O

A O
copy O
to O
Dr. O
Ca O
Shuff O
at O
Valtawnprinceel O
Community O
Memorial O
Hospital O
, O
a O
copy O
to O
Dr. O
A O
Skizeis O
, O
a O
copy O
to O
Dr. O
Riemund O
C. O
Kennedy O
, O
and O
three O
copies O
to O
Dr. O
Shuff O
&apos;s O
office O
. O

405728860 O

FIH O

7150860 O

05849/1xpu O

994032 O

1/3/1994 O
12:00:00 O
AM O

MEDIASTINAL B-SYMPTOM
TUMOR I-SYMPTOM
MASS I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

1-3-94 O

DISCHARGE O
DATE O
: O

1-9-94 O

PRINCIPAL O
DIAGNOSIS O
: O

Mediastinal B-SYMPTOM
tumor I-SYMPTOM
mass I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

History O
of O
colon B-SYMPTOM
cancer I-SYMPTOM
, O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
, O
obesity B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
history O
of O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

January O
3 O
, O
1994 O
, O
median O
sternotomy O
with O
mediastinal O
exploration O
, O
radical B-TREATMENT
resection I-TREATMENT
of O
tumor B-SYMPTOM
and O
aortopulmonary B-SYMPTOM
window I-SYMPTOM
; O
partial B-TREATMENT
resection I-TREATMENT
of I-TREATMENT
adjacent I-TREATMENT
lung I-TREATMENT
, O
en B-TREATMENT
bloc I-TREATMENT
resection I-TREATMENT
of I-TREATMENT
vagus I-TREATMENT
and I-TREATMENT
phrenic I-TREATMENT
nerves I-TREATMENT
; O
partial B-TREATMENT
pericardectomy I-TREATMENT
; O
fiberoptic O
bronchoscopy O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
66 O
year O
old O
white O
female O
with O
metastatic B-SYMPTOM
colon I-SYMPTOM
carcinoma I-SYMPTOM
with O
a B-SYMPTOM
mass I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
superhilar I-SYMPTOM
region I-SYMPTOM
, O
who O
presents O
for O
bronchoscopy O
, O
mediastinal O
exploration O
and O
resection B-TREATMENT
. O

The O
patient O
was O
in O
her O
usual O
state O
of O
health O
until O
she O
experienced O
the O
onset O
of O
abdominal B-SYMPTOM
pain I-SYMPTOM
in O
early O
1992 O
. O

In O
December O
of O
1992 O
, O
she O
underwent O
a B-TREATMENT
transverse I-TREATMENT
colectomy I-TREATMENT
for O
colon B-SYMPTOM
carcinoma I-SYMPTOM
which O
was O
Duke B-SYMPTOM
&apos;s I-SYMPTOM
grade I-SYMPTOM
B-II I-SYMPTOM
, O
lymph O
nodes O
were O
negative O
. O

She O
received O
postoperative B-TREATMENT
chemotherapy I-TREATMENT
. O

In O
September O
of O
1992 O
, O
she O
underwent O
an O
exploratory O
laparotomy O
because O
of O
an B-SYMPTOM
increased I-SYMPTOM
level I-SYMPTOM
of I-SYMPTOM
CEA I-SYMPTOM
in O
her O
blood O
with O
the O
presence O
of O
a B-SYMPTOM
liver I-SYMPTOM
abnormality I-SYMPTOM
on O
computerized O
tomography O
scan O
. O

The O
exploratory O
laparotomy O
was O
negative O
. O

She O
continued O
to O
have O
a B-SYMPTOM
rise I-SYMPTOM
in O
her O
CEA O
level O
which O
prompted O
a O
further O
work O
up O
. O

In O
September O
of O
1993 O
, O
an O
abdominal O
and O
pelvic O
computerized O
tomography O
scan O
was O
negative O
and O
in O
June O
of O
1993 O
, O
she O
had O
a O
negative O
bone O
scan O
. O

In O
December O
of O
1994 O
, O
a O
thoracic O
computerized O
tomography O
scan O
showed O
a B-SYMPTOM
four I-SYMPTOM
centimeter I-SYMPTOM
soft I-SYMPTOM
tissue I-SYMPTOM
mass I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
suprahilar I-SYMPTOM
region I-SYMPTOM
, O
adjacent O
to O
the B-SYMPTOM
aortopulmonary I-SYMPTOM
window I-SYMPTOM
. O

She O
also O
experienced O
increased B-SYMPTOM
hoarseness I-SYMPTOM
over O
the O
preceding O
months O
, O
which O
was O
due O
to O
left B-SYMPTOM
vocal I-SYMPTOM
cord I-SYMPTOM
paralysis I-SYMPTOM
. O

She O
also O
complains O
of O
increased B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
for O
the O
preceding O
month O
and O
now O
presents O
for O
mediastinal O
exploration O
and O
resection B-TREATMENT
of O
her O
probable O
metastatic B-SYMPTOM
mass I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
patient O
has O
a O
history O
of O
hypertension B-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
previous B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
1983 O
, O
hypothyroidism B-SYMPTOM
, O
history O
of O
breast B-SYMPTOM
cancer I-SYMPTOM
and O
history O
of O
colon B-SYMPTOM
cancer I-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

The O
past O
surgical O
history O
is O
notable O
for O
a O
1971 O
mastectomy B-TREATMENT
on I-TREATMENT
the I-TREATMENT
right I-TREATMENT
, O
1937 O
appendectomy B-TREATMENT
, O
1991 O
cholecystectomy B-TREATMENT
, O
1992 O
transverse B-TREATMENT
colectomy I-TREATMENT
, O
1992 O
exploratory O
laparotomy O
, O
1991 O
bilateral B-TREATMENT
cataract I-TREATMENT
surgery I-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Levoxine B-TREATMENT
0.125 O
mg O
PO O
q.day O
, O
Vasotec B-TREATMENT
10 O
mg O
PO O
b.i.d. O
, O
Maxzide B-TREATMENT
75/50 O
, O
30 O
mg O
PO O
q.day O
. O

ALLERGIES O
: O

The O
patient O
is O
allergic B-SYMPTOM
to O
sulfa B-TREATMENT
. O

HABITS O
: O

50 O
pack O
year O
smoking O
history O
, O
still O
smoking O
currently O
. O

Ethanol O
: O

none O
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
examination O
, O
she O
is O
an O
obese O
white O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
with O
a B-SYMPTOM
hoarse I-SYMPTOM
voice I-SYMPTOM
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
examination O
shows O
that O
she O
is O
normocephalic O
, O
atraumatic B-SYMPTOM
, O
extra O
ocular O
movements O
are O
intact O
, O
pupils O
equal O
, O
round O
, O
reactive O
to O
light O
and O
accommodation O
, O
and O
the O
oropharynx O
was O
clear O
, O
neck O
was O
supple O
without O
lymphadenopathy B-SYMPTOM
, O
either O
axillary O
or O
supraclavicular O
. O

Chest O
is O
clear O
with O
decreased B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
base I-SYMPTOM
. O

She O
has O
a B-TREATMENT
previous I-TREATMENT
right I-TREATMENT
mastectomy I-TREATMENT
. O

Cardiovascular O
exam O
: O

regular O
rate O
and O
rhythm O
, O
without O
murmur B-SYMPTOM
, O
rub B-SYMPTOM
or O
gallop B-SYMPTOM
. O

Abdomen O
: O

obese B-SYMPTOM
with O
multiple B-SYMPTOM
well I-SYMPTOM
healed I-SYMPTOM
surgical I-SYMPTOM
incisions I-SYMPTOM
, O
positive O
bowel O
sounds O
. O

The O
rectal O
examination O
is O
guaiac O
negative O
without O
masses B-SYMPTOM
. O

Extremities O
: O

no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

The O
neurological O
examination O
is O
nonfocal O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
. O

The O
patient O
was O
brought O
to O
the O
Operating O
Room O
on O
January O
3 O
, O
1994 O
where O
she O
underwent O
a B-TREATMENT
median I-TREATMENT
sternotomy I-TREATMENT
with O
removal B-TREATMENT
of O
her B-SYMPTOM
mediastinal I-SYMPTOM
mass I-SYMPTOM
. O

This B-SYMPTOM
mass I-SYMPTOM
was O
situated O
in O
the B-SYMPTOM
aortopulmonary I-SYMPTOM
window I-SYMPTOM
and O
was O
sent O
to O
pathology O
. O

The O
frozen O
section O
analysis O
revealed O
this O
to O
be O
adenocarcinoma B-SYMPTOM
, O
metastatic B-SYMPTOM
disease I-SYMPTOM
from I-SYMPTOM
the I-SYMPTOM
colon I-SYMPTOM
most O
likely O
. O

She O
had O
a B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
placed O
intraoperatively O
and O
another O
placed O
postoperatively O
in O
the O
recovery O
room O
, O
for O
what O
was O
presumed O
to O
be O
a B-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

This B-TREATMENT
tube I-TREATMENT
drained O
only O
a O
small O
amount O
of O
fluid O
and O
it O
was O
likely O
that O
the B-SYMPTOM
effusion I-SYMPTOM
was O
made O
to O
look O
more O
severe O
in O
the O
presence O
of O
left B-SYMPTOM
hemidiaphragm I-SYMPTOM
elevation I-SYMPTOM
. O

This B-TREATMENT
additional I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
removed O
the O
following O
day O
. O

Her O
postoperative O
hematocrit O
was O
31 O
, O
compared O
to O
a O
preoperative O
level O
of O
43 O
. O

Her O
postoperative O
recovery O
was O
really O
quite O
remarkable O
. O

Mediastinal B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
removed O
on O
postoperative O
day O
three O
. O

The O
patient O
was O
discharged O
home O
in O
stable O
condition O
on O
postoperative O
day O
six O
. O

DOCTORS O
DISCHARGE O
ORDERS O
: O

Percocet B-TREATMENT
for O
pain B-SYMPTOM
. O

Follow O
up O
with O
Dr. O
Fede O
Duhenile O
. O

She O
will O
have O
a O
home O
health O
aide O
to O
visit O
and O
help O
her O
with O
meals O
. O

CA O
SHUFF O
, O
M.D. O

DICTATING O
FOR O
: O

FEDE O
LEVEL O
, O
M.D. O

TR O
: O

kw O
/ O
bmot O

DD O
: O

1-9-94 O

TD O
: O

01/10/94 O

CC O
: O

013496896 O

FIH O

4925669 O

21983/7jk2 O

129165 O

02/22/1992 O
12:00:00 O
AM O

LEFT B-SYMPTOM
CORONARY I-SYMPTOM
ARTERY I-SYMPTOM
STENOSIS I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

02/22/92 O

DISCHARGE O
DATE O
: O

03/08/92 O

PRINCIPAL O
DIAGNOSIS O
: O

left B-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
stenosis I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

diabetes B-SYMPTOM
mellitus I-SYMPTOM
with O
diabetic B-SYMPTOM
renopathy I-SYMPTOM
, O
renovascular B-SYMPTOM
occlusive I-SYMPTOM
disease I-SYMPTOM
, O
with O
thrombosis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
renal I-SYMPTOM
artery I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
probably O
renal O
vascular O
, O
hypertensive B-SYMPTOM
cardiac I-SYMPTOM
disease I-SYMPTOM
with O
history O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

03/03/92 O
- O
left B-TREATMENT
carotid I-TREATMENT
endarterectomy I-TREATMENT
with O
continuous O
interoperative O
electroencephalogram O
monitoring O
and O
saphenous B-TREATMENT
vein I-TREATMENT
patch I-TREATMENT
closure I-TREATMENT
. O

ASSOCIATED O
PROCEDURES O
: O

Sep/24/05 O
cardiac O
catheterization O
and O
coronary O
angiography O
, O
02/23/92 O
- O
transfemoral O
aortogram O
, O
bilateral O
carotid O
arteriogram O
, O
abdominal O
aortogram O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Patient O
is O
a O
72 O
year O
old O
female O
with O
known B-SYMPTOM
carotid I-SYMPTOM
stenosis I-SYMPTOM
, O
and O
recent O
carotid O
noninvasives O
at O
an O
outside O
hospital O
, O
which O
showed O
90% B-SYMPTOM
left I-SYMPTOM
sided I-SYMPTOM
stenosis I-SYMPTOM
. O

She O
has O
not O
had O
a B-SYMPTOM
stroke I-SYMPTOM
, O
or O
transient B-SYMPTOM
ischemic I-SYMPTOM
attack I-SYMPTOM
. O

She O
was O
recently O
discharged O
from O
the O
Per O
Naplesspecrycet O
Hospital O
after O
an O
admission O
for O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

As O
noted O
. O

PAST O
SURGICAL O
HISTORY O
: O

Significant O
for O
having O
had O
a B-TREATMENT
cholecystectomy I-TREATMENT
and O
hysterectomy B-TREATMENT
, O
tonsillectomy B-TREATMENT
and O
adenoidectomy B-TREATMENT
, O
and O
mastoidectomy B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Insulin B-TREATMENT
44 O
units O
NPH B-TREATMENT
qam O
; O
8 O
units O
qpm O
; O
Vasotec B-TREATMENT
2.5 O
qd O
; O
Lasix B-TREATMENT
40 O
qd O
; O
Mevacor B-TREATMENT
40 O
qd O
; O
Cardizem B-TREATMENT
CD I-TREATMENT
180 O
qd O
; O
Ciprofloxacin B-TREATMENT
for O
urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
; O
aspirin B-TREATMENT
. O

ALLERGIES O
: O

Seldane B-TREATMENT
causes O
gastrointestinal B-SYMPTOM
distress I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

Clear O
chest O
. O

Cardiac O
: O

regular O
rate O
and O
rhythm O
. O

Extremities O
: O

revealed O
2+ O
carotid O
pulses O
with O
bruits B-SYMPTOM
bilaterally I-SYMPTOM
, O
2+ O
radial O
, O
2+ O
femoral O
, O
1+ O
dorsalis O
pedis O
bilaterally O
. O

LABORATORY O
DATA O
ON O
ADMISSION O
: O

Significant O
for O
BUN O
and O
creatinine O
33/2.4 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Tau O
Memorial O
Hospital O
. O

She O
was O
seen O
by O
Dr. O
Freiermthalskush O
of O
the O
renal O
service O
for O
management B-TREATMENT
of O
her B-SYMPTOM
chronic I-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

On O
02/22 O
, O
she O
underwent O
angiography O
, O
which O
revealed O
minimal B-SYMPTOM
right I-SYMPTOM
internal I-SYMPTOM
carotid I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
and O
proximal B-SYMPTOM
left I-SYMPTOM
internal I-SYMPTOM
carotid I-SYMPTOM
artery I-SYMPTOM
stenosis I-SYMPTOM
, O
2 O
cm O
in O
length O
for O
the O
1 O
mm O
residual O
lumen O
. O

The O
left O
anterior O
communicating O
artery O
fell O
from O
the O
right O
. O

She O
was O
also O
seen O
by O
Cardiology O
, O
and O
she O
underwent O
cardiac O
catheterization O
, O
as O
part O
of O
her O
preop O
evaluation O
, O
which O
revealed O
normal O
resting O
hemodynamics O
, O
and O
a O
moderate O
posterior O
descending O
artery O
, O
and O
obtuse B-SYMPTOM
marginal I-SYMPTOM
stenoses I-SYMPTOM
. O

She O
was O
, O
therefore O
, O
cleared O
for O
the O
operating O
room O
, O
and O
on O
3/3/92 O
, O
she O
underwent O
a B-TREATMENT
left I-TREATMENT
carotid I-TREATMENT
endarterectomy I-TREATMENT
, O
with O
continuous O
electroencephalogram O
monitoring O
and O
vein B-TREATMENT
patch I-TREATMENT
angioplasty I-TREATMENT
, O
which O
was O
uneventful O
. O

Her O
postoperative O
course O
was O
marked O
only O
by O
prolonged B-SYMPTOM
ileus I-SYMPTOM
, O
perhaps O
secondary O
to O
constipation B-SYMPTOM
, O
with O
persistent B-SYMPTOM
vomiting I-SYMPTOM
, O
requiring O
intravenous B-TREATMENT
fluids I-TREATMENT
, O
however O
, O
on O
03/07/92 O
, O
she O
had O
a O
large O
bowel O
movement O
, O
after O
aggressive B-TREATMENT
bowel I-TREATMENT
regime I-TREATMENT
, O
felt O
significantly O
better O
, O
was O
able O
to O
tolerate O
PO O
&apos;s O
. O

She O
is O
now O
able O
to O
be O
discharged O
home O
on O
her B-TREATMENT
admission I-TREATMENT
medications I-TREATMENT
, O
with O
the O
exception O
of O
the O
fact O
that O
Vasotec B-TREATMENT
was O
increased O
to O
10 O
mg O
PO O
bid O
. O

SHERMENE O
JESCSELC O
, O
M.D. O

DICTATING O
FOR O
: O

LENNI O
BREUTZOLN O
, O
M.D. O
. O

TR O
: O

pv O
/ O
bmot O

DD O
: O

03/08/92 O

TD O
: O

03/10/92 O

CC O
: O

Dr. O
Person O

420033129 O
YC O

87142319 O

129591 O

12/12/1996 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

12/12/1996 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

12/16/1996 O

PRINCIPAL O
DIAGNOSIS O
: O

STATUS O
POST O
TOTAL B-TREATMENT
ABDOMINAL I-TREATMENT
HYSTERECTOMY I-TREATMENT
AND O
BILATERAL B-TREATMENT
SALPINGO-OOPHORECTOMY I-TREATMENT
. O

ASSOCIATED O
DIAGNOSIS O
: O

1) O
MENORRHAGIA B-SYMPTOM
. O

2) O
PELVIC B-SYMPTOM
PAIN I-SYMPTOM
. O

3) O
ENDOMETRIOSIS B-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

TAH-BSO B-TREATMENT
. O

HISTORY O
/ O
REASON O
FOR O
HOSPITALIZATION O
: O

The O
patient O
is O
a O
42 O
year O
old O
gravida O
II O
, O
para O
I O
female O
with O
a O
long O
history O
of O
menorrhagia B-SYMPTOM
and O
pelvic B-SYMPTOM
pain I-SYMPTOM
. O

She O
also O
has O
a O
history O
of O
endometriosis B-SYMPTOM
that O
is O
symptomatic B-SYMPTOM
. O

She O
used O
Danocrine B-TREATMENT
for O
approximately O
nine O
months O
and O
was O
pain B-SYMPTOM
free O
, O
but O
was O
unable O
to O
tolerate O
the B-SYMPTOM
side I-SYMPTOM
effects I-SYMPTOM
. O

She O
is O
status O
post O
several O
laparoscopies O
in O
the O
past O
with O
which O
she O
was O
diagnosed O
with O
endometriosis B-SYMPTOM
. O

She O
has O
recently O
been O
on O
Depo-Provera B-TREATMENT
and O
has O
had O
episodes O
of O
break-through B-SYMPTOM
bleeding I-SYMPTOM
for O
six O
weeks O
at O
a O
time O
. O

She O
desired O
surgical B-TREATMENT
therapy I-TREATMENT
. O

HOSPITAL O
COURSE O
: O

On O
12/12/96 O
she O
had O
an B-TREATMENT
uncomplicated I-TREATMENT
total I-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
and O
bilateral B-TREATMENT
salpingo-oophorectomy I-TREATMENT
. O

Estimated B-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
was O
100 O
cc O
and O
she O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
. O

On O
postop O
day O
number O
one O
she O
was O
afebrile B-SYMPTOM
and O
doing O
well O
with O
a B-TREATMENT
PCA I-TREATMENT
for O
pain B-TREATMENT
control I-TREATMENT
. O

On O
postop O
day O
number O
two O
she O
was O
also O
afebrile B-SYMPTOM
and O
had O
not O
passed O
any B-SYMPTOM
flatus I-SYMPTOM
yet O
. O

She O
was O
ambulating O
frequently O
. O

Her O
hematocrit O
was O
34.2 O
and O
stable O
from O
her O
preoperative O
value O
. O

On O
postop O
day O
number O
three O
her O
abdomen O
was O
noted O
to O
be O
distended B-SYMPTOM
with O
a O
few O
bowel O
sounds O
and O
she O
still O
had O
not O
passed O
gas B-SYMPTOM
. O

The O
patient O
decreased O
the O
amount O
of O
Demerol B-TREATMENT
she O
was O
using O
and O
supplemented O
with O
Tylenol B-TREATMENT
and O
continued O
her O
frequent O
ambulation O
. O

On O
postop O
day O
number O
four O
she O
had O
passed O
flatus B-SYMPTOM
and O
was O
feeling O
much O
better O
. O

She O
was O
discharged O
to O
home O
in O
good O
condition O
on O
the B-TREATMENT
following I-TREATMENT
medications I-TREATMENT
. O

DISCHARGE O
MEDICATIONS O
: O

Demerol B-TREATMENT
for O
pain B-SYMPTOM
. O

Motrin B-TREATMENT
for O
pain B-SYMPTOM
. O

Colace B-TREATMENT
stool I-TREATMENT
softener I-TREATMENT
. O

DISPOSITION O
: O

The O
patient O
should O
follow-up O
with O
Dr. O
Side O
in O
two O
weeks O
. O

Dictated O
By O
: O

IEDEARC O
SIDE O
, O
M.D. O
LB28 O

Attending O
: O

MITERY O
D. O
LOSS O
, O
M.D. O
CB51 O
II795/2112 O

Batch O
: O

42100 O

Index O
No. O
ZMFX3O4G1 O

D O
: O

01/04/97 O

T O
: O

01/06/97 O

CC O
: O

1. O
MITERY O
D. O
LOSS O
, O
M.D. O
NT11 O

[ O
report O
_ O
end O
] O

Admission O
Date O
: O

2019-12-28 O

Discharge O
Date O
: O

2020-01-20 O

Date O
of O
Birth O
: O

2019-12-28 O

Sex O
: O

F O

Service O
: O

CMED O
CCU O

HISTORY O
: O

Baby O
Girl O
Rizza-Gannaway O
is O
the O
1515 O
gram O
product O
of O
a O
32 O
and O
06-30 O
week O
twin O
gestation O
born O
to O
a O
37-year-old O
G O
- O
2 O
, O
P O
- O
0 O
, O
now O
2 O
, O
mother O
. O

Prenatal O
Edward O
: O

A O
negative O
, O
antibody O
negative O
, O
hepatitis O
surface O
antigen O
negative O
, O
RPR O
nonreactive O
, O
rubella O
immune O
and O
GBS O
negative O
. O

Pregnancy O
was O
IUI O
assisted O
for O
di-di O
twin O
gestation O
and O
was O
relatively O
uncomplicated B-SYMPTOM
until O
mother O
presented O
on O
12-15 O
, O
with O
spontaneous O
rupture O
of O
membranes O
. O

She O
was O
found O
to O
be O
having O
preterm B-SYMPTOM
contractions I-SYMPTOM
without O
cervical B-SYMPTOM
change I-SYMPTOM
and O
was O
admitted O
for O
bedrest B-TREATMENT
. O

She O
received O
a O
full O
course O
of O
betamethasone B-TREATMENT
complete O
on O
12-17 O
, O
magnesium B-TREATMENT
and O
erythromycin B-TREATMENT
for O
latency O
through O
12-21 O
. O

Intermittent B-SYMPTOM
maternal I-SYMPTOM
hypertension I-SYMPTOM
noted O
but O
without O
proteinuria B-SYMPTOM
. O

Ultrasounds O
have O
been O
reassuring O
with O
biophysicals O
8 O
out O
of O
8 O
x2 O
. O

On O
the O
evening O
of O
12-27 O
, O
monitoring O
noted O
child O
's O
increased B-SYMPTOM
preterm I-SYMPTOM
contractions I-SYMPTOM
, O
uterine B-SYMPTOM
tenderness I-SYMPTOM
and O
mildly B-SYMPTOM
increased I-SYMPTOM
fetal I-SYMPTOM
heart I-SYMPTOM
rates I-SYMPTOM
, O
due O
to O
concerns O
of O
possible O
chorioamnionitis B-SYMPTOM
, O
the O
mother O
was O
taken O
for O
cesarean B-TREATMENT
delivery I-TREATMENT
. O

The O
infant O
delivered O
with O
moderate O
tone O
and O
respiratory O
effort O
responding O
well O
to O
stimulation B-TREATMENT
and O
brief B-TREATMENT
blow I-TREATMENT
by I-TREATMENT
O2 I-TREATMENT
. O

Apgars O
were O
8 O
and O
8 O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
, O
weight O
1515 O
grams O
, O
10th O
to O
25th O
percentile O
, O
head O
circumference O
30 O
cm O
, O
25th O
to O
50th O
percentile O
, O
length O
41 O
cm O
, O
10th O
to O
25th O
percentile O
. O

Warm O
, O
dry O
, O
premature B-SYMPTOM
infant O
, O
active O
with O
exam O
, O
mild B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
at O
rest O
. O

Overall O
appearance O
consistent O
with O
estimated O
gestational O
age O
. O

Thin O
, O
warm O
, O
dry O
, O
pink O
, O
no O
rashes B-SYMPTOM
. O

Fontanelle O
soft O
and O
flat O
. O

Ears O
normal O
. O

Palate O
intact O
. O

Nondysmorphic B-SYMPTOM
. O

Positive O
red O
reflex O
bilaterally O
. O

Neck O
supple O
, O
no O
lesions B-SYMPTOM
. O

Chest O
moderately O
aerated O
. O

Mild B-SYMPTOM
grunting I-SYMPTOM
. O

Cardiovascular O
: O

Regular O
rate O
and O
rhythm O
, O
no O
murmur B-SYMPTOM
, O
femoral O
pulses O
2+ O
. O

Abdomen O
soft O
, O
no O
hepatosplenomegaly B-SYMPTOM
, O
quiet O
bowel O
sounds O
, O
3 O
vessel O
cord O
. O

CMED O
CSRU O
: O

Normal O
female O
, O
anus O
patent O
. O

Hips O
stable O
. O

Back O
normal O
. O

No O
lesions B-SYMPTOM
. O

Appropriate O
tone O
and O
activity O
for O
gestational O
age O
. O

HOSPITAL O
COURSE O
: O

By O
systems O
: O

Respiratory O
: O

Pocasset O
was O
admitted O
to O
the O
newborn O
intensive O
care O
unit O
with O
mild B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
. O

Chest O
x-ray O
revealed O
a B-SYMPTOM
left I-SYMPTOM
pneumothorax I-SYMPTOM
which O
resolved O
on O
its O
own O
without O
intervention B-TREATMENT
. O

The O
infant O
has O
remained O
in O
room O
air O
throughout O
her O
hospital O
course O
with O
occasional B-SYMPTOM
apnea I-SYMPTOM
and O
bradycardia B-SYMPTOM
episodes I-SYMPTOM
, O
the O
last O
being O
documented O
on O
2020-01-14 O
. O

Cardiovascular O
: O

Attleboro O
has O
been O
stable O
throughout O
her O
newborn O
intensive O
care O
course O
without O
issue O
. O

Fluids O
and O
electrolytes O
: O

Birth O
weight O
was O
1515 O
grams O
. O

She O
was O
initially O
started O
on O
80 O
cc O
per O
kilo O
per O
day O
of O
D10W B-TREATMENT
. O

Enteral B-TREATMENT
feedings I-TREATMENT
were O
initiated O
on O
day O
of O
life O
#1 O
. O

Full B-TREATMENT
enteral I-TREATMENT
feedings I-TREATMENT
were O
achieved O
by O
day O
of O
life O
#7 O
. O

The O
infant O
had O
a O
course O
of O
heme B-SYMPTOM
positive I-SYMPTOM
stools I-SYMPTOM
with O
grossly B-SYMPTOM
bloody I-SYMPTOM
streaks I-SYMPTOM
and O
mucus B-SYMPTOM
felt O
to O
be O
protein B-SYMPTOM
allergy I-SYMPTOM
. O

The O
infant O
is O
now O
receiving O
breast O
milk O
with O
Nutramigen B-TREATMENT
powder I-TREATMENT
concentrate I-TREATMENT
to O
24 O
calorie O
. O

Stools O
have O
been O
negative O
to O
trace B-SYMPTOM
positive I-SYMPTOM
and O
abdominal O
exam O
is O
reassuring O
. O

Discharge O
weight O
is O
2040 O
gm O
, O
the O
head O
circumference O
is O
32 O
cm O
and O
the O
length O
is O
46 O
cm. O
. O

GI O
: O

Peak O
bilirubin O
was O
on O
day O
of O
life O
#2 O
of O
4.8/0.3 O
. O

Hematology O
: O

Hematocrit O
on O
admission O
was O
41 O
. O

The O
infant O
did O
not O
require O
any B-TREATMENT
blood I-TREATMENT
transfusions I-TREATMENT
during O
this O
hospital O
course O
. O

Infectious O
disease O
: O

CBC O
and O
blood O
culture O
were O
obtained O
on O
admission O
. O

White O
count O
was O
4.8 O
, O
7 O
polys O
, O
zero O
bands O
, O
platelet O
count O
of O
316,000 O
. O

ANC O
at O
that O
time O
was O
336 O
. O

A O
24 O
hour O
CBC O
was O
obtained O
. O

White O
blood O
cell O
count O
was O
5.1 O
, O
22 O
polys O
, O
zero O
bands O
with O
a O
hematocrit O
of O
39.3 O
and O
platelets O
of O
313,000 O
. O

The O
infant O
received O
48 O
hours O
of O
ampicillin B-TREATMENT
and O
gentamicin B-TREATMENT
which O
were O
discontinued O
with O
a O
negative O
blood O
culture O
. O

Neurology O
: O

The O
infant O
has O
been O
appropriate O
for O
gestational O
age O
. O

Sensory O
: O

Audiology O
hearing O
screen O
was O
performed O
with O
automated O
auditory O
brainstem O
responses O
and O
the O
infant O
passed O
on O
both O
ears O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
DISPOSITION O
: O

To O
home O
. O

PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Donald O
Carrion O
, O
telephone O
number O
( O
861 O
) O
840 O
7928 O
. O

CARE O
RECOMMENDATIONS O
: O

1. O
Continue O
breast O
milk O
24 O
calories O
of O
Nutramigen B-TREATMENT
for O
concentration O
. O

2. O
Medications B-TREATMENT
: O
The O
infant O
is O
receiving O
Fer-in-Phillip B-TREATMENT
supplementation I-TREATMENT
of O
0.15 O
ml O
p.o. O
once O
daily O
. O

3. O
Car O
seat O
position O
screening O
was O
performed O
for O
screening O
and O
the O
infant O
passed O
. O

4. O
State O
newborn O
screens O
have O
been O
sent O
per O
protocol O
, O
most O
recently O
on O
01-11 O
, O
and O
have O
been O
within O
normal O
limits O
. O

5. O
Immunizations B-TREATMENT
received O
: O
Hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
on O
2020-01-19 O
. O

6. O
Immunizations B-TREATMENT
recommended O
: O

Synagis B-TREATMENT
RSV I-TREATMENT
prophylaxis I-TREATMENT
should O
be O
considered O
from O
November O
through O
March O
for O
infants O
who O
meet O
any O
of O
the O
following O
3 O
criteria O
: O

Born O
at O
less O
than O
32 O
weeks O
, O
born O
between O
32 O
and O
35 O
weeks O
with O
2 O
of O
the O
following O
: O

Daycare O
during O
RSV O
season O
, O
a O
smoker O
in O
the O
household O
, O
neuromuscular B-SYMPTOM
disease I-SYMPTOM
, O
airway B-SYMPTOM
abnormalities I-SYMPTOM
or O
school O
age O
sibling O
, O
or O
3 O
with O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
. O

Influenza B-TREATMENT
immunization I-TREATMENT
is O
recommended O
annually O
in O
the O
fall O
for O
all O
infants O
once O
they O
reach O
6 O
months O
of O
age O
. O

Before O
this O
age O
and O
for O
the O
first O
24 O
months O
of O
the O
child O
's O
life O
, O
immunization B-TREATMENT
against O
influenza B-SYMPTOM
is O
recommended O
for O
household O
contacts O
and O
out O
of O
home O
caregivers O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Premature B-SYMPTOM
twin I-SYMPTOM
#1 O
born O
at O
32 O
and O
5/7 O
weeks O
. O

2. O
Rule O
out O
sepsis B-SYMPTOM
with O
antibiotics B-TREATMENT
. O

3. O
Respiratory B-SYMPTOM
distress I-SYMPTOM
with O
left B-SYMPTOM
pneumothorax I-SYMPTOM
resolved O
. O

4. O
Mild B-SYMPTOM
hyperbilirubinemia I-SYMPTOM
. O

5. O
Mild B-SYMPTOM
apnea I-SYMPTOM
and I-SYMPTOM
bradycardia I-SYMPTOM
of O
prematurity B-SYMPTOM
resolved O
. O

6. O
Possible O
milk B-SYMPTOM
proteine I-SYMPTOM
allergy I-SYMPTOM

FOLLOW O
UP O
: O

Appointments O
recommended O
: O

A O
hip O
ultrasound O
due O
to O
breech B-SYMPTOM
/ O
breech B-SYMPTOM
presentation I-SYMPTOM
of I-SYMPTOM
twins I-SYMPTOM
. O

Tai O
Pamela O
Christopher O
, O
Oklahoma O
05158 O

Dictated O
By O
: O
John O
T O
Hall O
, O
M.D. O

MEDQUIST36 O

D O
: O
2020-01-19 O
02:52:47 O

T O
: O
2020-01-19 O
09:12:10 O

Job O
#: O
76780 O

Signed O
electronically O
by O
: O
DR. O
Charles O
TRAN O
on O
: O
MON O
2020-01-20 O
8:22 O
AM O

( O
End O
of O
Report O
) O

648746074 O

CTMC O

84164942 O

960919 O

9/7/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

09/07/1992 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

09/12/1992 O

ADMISSION O
DIAGNOSES O
: O

1. O
STAGE B-SYMPTOM
IV I-SYMPTOM
ENDOMETRIAL I-SYMPTOM
CANCER I-SYMPTOM

2. O
STAGE B-SYMPTOM
III-C I-SYMPTOM
OVARIAN I-SYMPTOM
CANCER I-SYMPTOM

DISCHARGE O
DIAGNOSES O
: O

1. O
STAGE B-SYMPTOM
IV I-SYMPTOM
ENDOMETRIAL I-SYMPTOM
CANCER I-SYMPTOM

2. O
STAGE B-SYMPTOM
III-C I-SYMPTOM
OVARIAN I-SYMPTOM
CANCER I-SYMPTOM

TREATMENTS O
: O

Chemotherapy B-TREATMENT
of O
IFEX B-TREATMENT
, O
MESNA B-TREATMENT
and O
VP-16 B-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
31 O
year O
old O
gravida O
0 O
with O
stage B-SYMPTOM
IV I-SYMPTOM
endometrial I-SYMPTOM
cancer I-SYMPTOM
and O
stage B-SYMPTOM
III-C I-SYMPTOM
ovarian I-SYMPTOM
cancer I-SYMPTOM
vs O
metastatic B-SYMPTOM
endometrial I-SYMPTOM
cancer I-SYMPTOM
for O
line O
2 O
, O
cycle B-TREATMENT
1 I-TREATMENT
chemotherapy I-TREATMENT
. O

The O
patient O
presented O
in O
10-90 O
, O
with O
heavy B-SYMPTOM
bleeding I-SYMPTOM
per I-SYMPTOM
vagina I-SYMPTOM
. O

D O
and O
C O
showed O
grade B-SYMPTOM
II-III I-SYMPTOM
adenocarcinoma I-SYMPTOM
with O
squamous B-SYMPTOM
differentiation I-SYMPTOM
at O
Wellla O
Uxinny O
: O
mount O
Medical O
Center O
in O
Com O
St. O
, O
Tton O
, O
Arkansas O
32167 O
. O

The O
patient O
underwent O
TAH B-TREATMENT
/ O
BSO B-TREATMENT
, O
partial B-TREATMENT
omentectomy I-TREATMENT
at O
CTMC O
in O
10-90 O
. O

At O
that O
time O
, O
tumor B-SYMPTOM
was O
found O
to O
be O
studding B-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
diaphragm I-SYMPTOM
, O
gross B-SYMPTOM
tumor I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
omentum I-SYMPTOM
and I-SYMPTOM
large I-SYMPTOM
bowel I-SYMPTOM
, O
tumor B-SYMPTOM
through I-SYMPTOM
the I-SYMPTOM
uterine I-SYMPTOM
serosa I-SYMPTOM
. O

Pathology O
showed O
grade B-SYMPTOM
II-III I-SYMPTOM
papillary I-SYMPTOM
adenocarcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
endometrium I-SYMPTOM
with O
squamous B-SYMPTOM
differentiation I-SYMPTOM
which O
was O
focally B-SYMPTOM
invasive I-SYMPTOM
and O
superficial B-SYMPTOM
myometrium I-SYMPTOM
. O

The O
ovary O
showed O
papillary B-SYMPTOM
serous I-SYMPTOM
adeno I-SYMPTOM
with O
omental B-SYMPTOM
involvement I-SYMPTOM
consistent O
with O
an B-SYMPTOM
endometroid I-SYMPTOM
adenocarcinoma I-SYMPTOM
. O

The O
question O
was O
whether O
or O
not O
whether O
she O
had O
two B-SYMPTOM
primaries I-SYMPTOM
vs O
metastatic B-SYMPTOM
endometrial I-SYMPTOM
cancer I-SYMPTOM
. O

The O
patient O
underwent O
6 O
cycles O
of O
CAP B-TREATMENT
in O
Pemrancetul O
Tonsst. O
. O

However O
, O
during O
the B-TREATMENT
fourth I-TREATMENT
cycle I-TREATMENT
, O
Cytoxan B-TREATMENT
was O
dropped O
. O

Her O
CA-125 O
on O
6-27-91 O
, O
was O
249 O
and O
on O
8-29-91 O
, O
was O
734 O
. O

In O
05-92 O
, O
the O
patient O
was O
admitted O
to O
Wellla O
Uxinny O
: O
mount O
Medical O
Center O
with O
left B-SYMPTOM
leg I-SYMPTOM
DVT I-SYMPTOM
and O
started O
on O
Heparin B-TREATMENT
therapy I-TREATMENT
. O

She O
was O
discharged O
from O
there O
on O
Coumadin B-TREATMENT
therapy I-TREATMENT
. O

On O
admission O
, O
the O
patient O
has O
no O
complaints O
except O
anxiety B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Negative O
except O
as O
above O
. O

PAST O
SURGICAL O
HISTORY O
: O

Negative O
except O
as O
above O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Coumadin B-TREATMENT
5 O
mg O
po O
q O
d O
, O
Tagamet B-TREATMENT
400 O
mg O
po O
q O
d O
, O
Amoxicillin B-TREATMENT
which O
was O
started O
on O
Labor O
Day O
, O
for O
a B-SYMPTOM
sore I-SYMPTOM
throat I-SYMPTOM
and O
Ativan B-TREATMENT
1 O
mg O
po O
prn O
nausea B-SYMPTOM
/ O
anxiety B-SYMPTOM
. O

ALLERGIES O
: O

The O
patient O
gets O
hives B-SYMPTOM
to O
aspirin B-TREATMENT
and O
tomatoes O
also O
cause O
her O
hives B-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

The O
temp O
was O
99.4 O
, O
BP O
114/78 O
, O
pulse O
128 O
and O
respirations O
20 O
. O

She O
was O
an O
anxious O
female O
, O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

HEENT O
exam O
showed O
PERRLA O
, O
EOMI O
, O
oropharynx O
benign O
. O

The O
lungs O
were O
clear O
to O
auscultation O
. O

CV O
was O
regular O
rate O
and O
rhythm O
without O
murmurs B-SYMPTOM
. O

The O
abdomen O
was O
soft O
, O
positive O
bowel O
sounds O
, O
non B-SYMPTOM
tender I-SYMPTOM
, O
large B-SYMPTOM
, I-SYMPTOM
hard I-SYMPTOM
mass I-SYMPTOM
occupying O
the O
lower O
abdomen O
and O
left O
upper O
quadrant O
. O

The O
extremities O
were O
non B-SYMPTOM
tender I-SYMPTOM
without O
edema B-SYMPTOM
. O

LABORATORY O
DATA O
: O

On O
admission O
, O
the O
sodium O
was O
136 O
, O
potassium O
3.0 O
, O
chloride O
98 O
, O
CO2 O
20 O
, O
BUN O
8 O
, O
creatinine O
0.8 O
and O
glucose O
94 O
, O
ALT O
5 O
, O
AST O
10 O
, O
LDH O
166 O
, O
alkaline O
phosphatase O
81 O
, O
total O
bili O
0.6 O
, O
direct O
bili O
.3 O
, O
albumin O
3.3 O
, O
calcium O
8.8 O
and O
uric O
acid O
3.1 O
. O

She O
had O
CA-125 O
which O
was O
pending O
at O
the O
time O
of O
discharge O
. O

Her O
hematocrit O
was O
31.1 O
, O
WBC O
11.6 O
and O
151,000 O
platelets O
. O

PLAN O
: O

The O
patient O
is O
thus O
stage B-SYMPTOM
IV I-SYMPTOM
endometrial I-SYMPTOM
and O
stage B-SYMPTOM
III-C I-SYMPTOM
ovarian I-SYMPTOM
vs O
metastatic B-SYMPTOM
endometrial I-SYMPTOM
for I-SYMPTOM
line I-SYMPTOM
II I-SYMPTOM
, O
cycle B-TREATMENT
I I-TREATMENT
chemotherapy I-TREATMENT
IFEX B-TREATMENT
, O
MESNA B-TREATMENT
and O
VP-16 B-TREATMENT
. O

The O
plan O
was O
for O
urinalysis O
q O
d O
. O

With O
the O
history O
of O
DVT B-SYMPTOM
, O
we O
plan O
Coumadin B-TREATMENT
and O
check O
her O
coags O
. O

The O
patient O
was O
tachycardiac B-SYMPTOM
on O
admission O
and O
it O
was O
felt O
she O
was O
dehydrated B-SYMPTOM
and O
/ O
or O
anxious B-SYMPTOM
at O
the O
time O
of O
her O
initial O
evaluation O
. O

EKG O
showed O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
and O
incomplete B-SYMPTOM
right I-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
. O

When O
compared O
with O
ECG O
of O
11-06-90 O
, O
there O
was O
borderline O
criteria O
for O
anterior B-SYMPTOM
MI I-SYMPTOM
although O
the O
patient O
denied O
any B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
at O
any O
point O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
underwent O
chemotherapy B-TREATMENT
on O
the O
following O
doses O
: O

IFEX B-TREATMENT
1.2 O
grams O
per O
meter O
squared O
x O
3 O
days O
, O
MESNA B-TREATMENT
1.2 O
grams O
per O
meter O
squared O
x O
3 O
days O
continuous B-TREATMENT
IV I-TREATMENT
infusion I-TREATMENT
. O

She O
had O
VP-16 B-TREATMENT
mixed O
with O
250 O
cc O
IV B-TREATMENT
fluid I-TREATMENT
given O
over O
1 O
hour O
each O
day O
for O
3 O
days O
. O

She O
also O
had O
MESNA B-TREATMENT
dose I-TREATMENT
of O
.6 O
grams O
per O
meter O
squared O
after O
her B-TREATMENT
IFEX I-TREATMENT
/ O
MESNA B-TREATMENT
were O
completed O
. O

The O
patient O
's O
urinalysis O
on O
admission O
was O
significant O
for O
red B-SYMPTOM
blood I-SYMPTOM
cells I-SYMPTOM
which O
were O
TNTC O
as O
well O
as O
uric O
acid O
. O

Because O
it O
was O
felt O
the O
patient O
was O
bleeding O
and O
the O
patient O
was O
contaminated O
, O
she O
received O
her O
IFEX B-TREATMENT
/ O
MESNA B-TREATMENT
. O

A O
repeat O
straight O
cath O
was O
negative O
for O
RBC B-SYMPTOM
's I-SYMPTOM
. O

After O
1 O
day O
of O
chemotherapy B-TREATMENT
, O
the O
patient O
had O
8-10 B-SYMPTOM
RBC I-SYMPTOM
's I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
urine I-SYMPTOM
but O
by O
the O
second O
day O
of O
her B-TREATMENT
IFEX I-TREATMENT
infusion I-TREATMENT
, O
she O
had O
50-80 B-SYMPTOM
RBC I-SYMPTOM
's I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
urine I-SYMPTOM
as O
well O
as O
a B-SYMPTOM
few I-SYMPTOM
transitional I-SYMPTOM
epithelial I-SYMPTOM
cells I-SYMPTOM
. O

Because O
of O
this O
finding O
, O
her B-TREATMENT
IFEX I-TREATMENT
was O
stopped O
before O
completion O
of O
her O
second O
day O
of O
infusion B-TREATMENT
. O

Her B-TREATMENT
MESNA I-TREATMENT
alone O
was O
continued O
at O
that O
time O
for O
IV B-TREATMENT
infusion I-TREATMENT
. O

She O
did O
receive O
her B-TREATMENT
VP-16 I-TREATMENT
without O
complication B-SYMPTOM
. O

Other O
significant O
issues O
were O
the O
patient O
's O
hematocrit O
on O
admission O
at O
31.1 O
which O
dwindled O
down O
to O
26.2 O
by O
9-10 O
. O

The O
patient O
was O
counselled O
and O
received O
2 O
units O
of O
packed B-TREATMENT
RBC I-TREATMENT
's I-TREATMENT
at O
that O
time O
. O

However O
, O
the O
patient O
's O
hematocrit O
bumped O
only O
to O
28.1 O
and O
a O
repeat O
later O
on O
9-11 O
, O
showed O
hematocrit O
of O
27.6 O
. O

At O
this O
time O
, O
an O
additional O
2 O
units O
of O
packed B-TREATMENT
RBC I-TREATMENT
's I-TREATMENT
were O
transfused O
. O

The O
third O
issue O
was O
that O
her B-TREATMENT
anticoagulation I-TREATMENT
was O
grossly O
out O
of O
control O
on O
admission O
with O
PT O
of O
25.6 O
and O
PTT O
of O
42.2 O
. O

Her O
repeat O
on O
9-8 O
, O
was O
36.0 O
/ O
68.2 O
and O
her B-TREATMENT
Coumadin I-TREATMENT
was O
held O
. O

She O
received O
no O
Coumadin B-TREATMENT
during O
her O
admission O
and O
by O
the O
time O
of O
discharge O
, O
her O
PT O
was O
down O
to O
16.2 O
. O

She O
was O
restarted O
on O
Coumadin B-TREATMENT
2.5 O
mg O
per O
day O
. O

The O
patient O
's O
hematocrit O
on O
the O
day O
of O
discharge O
was O
35.6 O
showing O
significant O
bump O
in O
her O
count O
after O
her O
second O
two O
units O
of O
packed B-TREATMENT
RBC I-TREATMENT
's I-TREATMENT
. O

Her O
PT O
on O
the O
day O
of O
discharge O
was O
13.2 O
and O
she O
was O
started O
on O
Coumadin B-TREATMENT
2.5 O
mg O
po O
q O
d O
as O
mentioned O
. O

The O
patient O
was O
discharged O
on O
9-12-92 O
, O
with O
the O
approval O
of O
her O
attending O
physiciana O
, O
Dr. O
Porriede O
Friednantflirt O
. O

FOLLOW O
UP O
CARE O
: O

On O
9-28-92 O
, O
the O
patient O
will O
return O
for O
chemotherapy B-TREATMENT
and O
she O
will O
follow O
up O
with O
her O
primary O
doctor O
, O
Dr. O
Jescspald O
, O
for O
repeat O
PT O
and O
Coumadin B-TREATMENT
dosing I-TREATMENT
on O
Monday O
, O
9-14-02 O
. O

LT503/7456 O
LAKO O
C. O
SCARVTWI O
, O
M.D. O
TH0 O

D O
: O
09/14/92 O

Batch O
: O
3799 O

Report O
: O
V1670V4 O

T O
: O
09/15/92 O

Dicatated O
By O
: O
GRA O
A. O
SPARDBOUILLNAPPS O
, O
M.D. O
AM57 O

[ O
report O
_ O
end O
] O

991070824 O
SC O

67707063 O

467502 O

9/26/2001 O
12:00:00 O
AM O

FEVER B-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

09/26/2001 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

10/06/2001 O

PRINCIPAL O
DIAGNOSES O
: O

1. O
NEUTROPENIA B-SYMPTOM

2. O
CELLULITIS B-SYMPTOM
. O

3. O
FEVER B-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
60-year-old O
male O
with O
a O
past O
medical O
history O
notable O
for O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
and O
CABG B-TREATMENT
x2 O
in O
2001 O
. O

The O
patient O
has O
felt O
unwell B-SYMPTOM
since O
7/21 O
after O
his B-SYMPTOM
non-Q I-SYMPTOM
wave I-SYMPTOM
MI I-SYMPTOM
. O

The O
patient O
, O
at O
this O
time O
, O
was O
started O
on O
Statin B-TREATMENT
and O
developed O
in O
arthritis B-SYMPTOM
approximately O
one O
month O
later O
with O
joint B-SYMPTOM
pain I-SYMPTOM
, O
myalgia B-SYMPTOM
and O
fatigue B-SYMPTOM
. O

No O
clear O
diagnosis O
was O
made O
. O

The O
patient O
was O
presumed O
to O
have O
a B-SYMPTOM
rheumatoid I-SYMPTOM
factor I-SYMPTOM
negative I-SYMPTOM
, I-SYMPTOM
rheumatoid I-SYMPTOM
arthritis I-SYMPTOM
and O
he O
was O
prescribed O
Naprosyn B-TREATMENT
, O
prednisone B-TREATMENT
and O
sulfasalazine B-TREATMENT
. O

He O
had O
a O
CABG O
review O
in O
2/21 O
. O

His B-TREATMENT
first I-TREATMENT
CABG I-TREATMENT
was O
in O
02/89 O
. O

Since O
2/21 O
, O
he O
has O
had O
increasing B-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
of O
30-49 O
pounds O
, O
night B-SYMPTOM
sweats I-SYMPTOM
which O
he O
attributed O
to O
the B-TREATMENT
prednisone I-TREATMENT
and O
increased B-SYMPTOM
fatigue I-SYMPTOM
and O
myalgias B-SYMPTOM
. O

The O
patient O
has O
gradually O
taken O
to O
bed O
with O
decreasing O
activity O
. O

In O
late O
7/22 O
, O
sulfasalazine B-TREATMENT
was O
started O
at O
one O
tab O
three O
times O
a O
day O
. O

The O
patient O
subsequently O
developed O
diffuse B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
and O
decreased B-SYMPTOM
p.o. I-SYMPTOM
intake I-SYMPTOM
. O

A B-SYMPTOM
guaiac I-SYMPTOM
positive I-SYMPTOM
stool I-SYMPTOM
was O
also O
noted O
in O
the O
month O
of O
July O
. O

10 O
days O
prior O
to O
admission O
, O
the O
patient O
&apos;s O
primary O
care O
physician O
increased O
his B-TREATMENT
sulfasalazine I-TREATMENT
dose I-TREATMENT
to O
two O
tabs O
three O
times O
a O
day O
. O

The B-TREATMENT
patient I-TREATMENT
&apos;s I-TREATMENT
prednisone I-TREATMENT
was O
increased O
to O
60 O
mg O
q.d. O
as O
the O
patient O
was O
diagnosed O
with O
an B-SYMPTOM
arthritis I-SYMPTOM
flare I-SYMPTOM
. O

The B-TREATMENT
prednisone I-TREATMENT
dose I-TREATMENT
was O
gradually O
tapered O
to O
20 O
mg O
q.d. O

The O
day O
before O
admission O
, O
the O
patient O
developed O
a B-SYMPTOM
fever I-SYMPTOM
to O
102 O
degrees O
and O
increasing B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
. O

He O
presented O
to O
an O
outside O
hops O
where O
he O
was O
noted O
to O
be O
leukopenic B-SYMPTOM
with O
a O
white O
blood O
cell O
count O
of O
0.6 O
, O
0 O
neutrophils O
, O
a O
hematocrit O
of O
32 O
, O
platelets O
of O
326 O
, O
a O
MCV O
of O
79 O
, O
and O
RDW O
of O
22 O
. O

The O
patient O
was O
given O
IV B-TREATMENT
fluids I-TREATMENT
and O
treated O
with O
imipenem B-TREATMENT
, O
transferred O
to O
Ca O
Valley O
Hospital O
ED O
, O
where O
it O
was O
noted O
that O
the O
patient O
had O
face B-SYMPTOM
and I-SYMPTOM
neck I-SYMPTOM
swelling I-SYMPTOM
, O
as O
well O
as O
erythema B-SYMPTOM
and O
cervical B-SYMPTOM
lymphadenopathy I-SYMPTOM
. O

The O
patient O
states O
that O
his B-SYMPTOM
swelling I-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
face I-SYMPTOM
began O
two O
days O
prior O
to O
admission O
and O
has O
doubled O
since O
then O
. O

In O
the O
emergency O
department O
, O
CT O
of O
head O
, O
neck O
and O
abdomen O
were O
performed O
. O

The O
CT O
of O
the O
abdomen O
was O
without O
lymphadenopathy B-SYMPTOM
, O
revealed O
a B-SYMPTOM
right I-SYMPTOM
renal I-SYMPTOM
cyst I-SYMPTOM
, O
otherwise O
unremarkable O
. O

The O
CT O
of O
head O
and O
neck O
was O
likewise O
unremarkable O
showing O
no O
evidence O
of O
fasciitis B-SYMPTOM
or O
deep B-SYMPTOM
tissue I-SYMPTOM
thread I-SYMPTOM
. O

No O
abscesses B-SYMPTOM
were O
noted O
. O

REVIEW O
OF O
SYSTEMS O
: O

The O
patient O
denies O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
orthopnea B-SYMPTOM
, O
no O
dysuria B-SYMPTOM
, O
hematuria B-SYMPTOM
, O
no O
visual B-SYMPTOM
changes I-SYMPTOM
, O
no O
rashes B-SYMPTOM
, O
no O
blurry B-SYMPTOM
vision I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
MI B-SYMPTOM
x2 O
, O
CABG B-TREATMENT
x2 O
in O
02/89 O
and O
2/21 O
, O
history O
of O
arthritis B-SYMPTOM
, O
history O
of O
bilateral B-SYMPTOM
rotator I-SYMPTOM
cuff I-SYMPTOM
degeneration I-SYMPTOM
and O
tears B-SYMPTOM
, O
history O
of O
hypertension B-SYMPTOM
, O
history O
of O
hyperlipidemia B-SYMPTOM
. O

MEDICATIONS O
: O

Sulfasalazine B-TREATMENT
, O
prednisone B-TREATMENT
20 O
mg O
q.d. O
, O
Naprosyn B-TREATMENT
500 O
mg O
t.i.d. O
, O
Zestril B-TREATMENT
10 O
mg O
q.d. O
, O
Lopressor B-TREATMENT
50 O
mg O
b.i.d. O
and O
iron B-TREATMENT
supplementation I-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
with O
wife O
. O

He O
is O
a O
realtor O
. O

The O
patient O
has O
history O
of O
heavy O
cigar O
smoking O
, O
no O
cigarettes O
. O

Social O
use O
of O
alcohol O
. O

FAMILY O
HISTORY O
: O

Positive O
for O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
and O
MI B-SYMPTOM
. O

No O
history O
of O
cancer B-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

VITAL O
SIGNS O
: O

The O
patient O
&apos;s O
temperature O
was O
102 O
, O
heart O
rate O
118 O
, O
blood O
pressure O
111/56 O
, O
respiratory O
rate O
28 O
, O
satting O
92% O
on O
room O
air O
. O

HEENT O
: O

Pupils O
equal O
, O
round O
, O
and O
reactive O
to O
light O
, O
extraocular O
movements O
, O
fundi O
bilaterally O
without O
exudate B-SYMPTOM
or O
hemorrhage B-SYMPTOM
. O

On O
the O
left O
nasolabial O
, O
there O
was O
a B-SYMPTOM
boil I-SYMPTOM
with O
pus B-SYMPTOM
and O
surrounding B-SYMPTOM
erythema I-SYMPTOM
and O
tenderness B-SYMPTOM
. O

Left O
eye O
with O
conjunctivae B-SYMPTOM
injected I-SYMPTOM
, O
no O
exudate B-SYMPTOM
or O
pus B-SYMPTOM
. O

Dentition B-SYMPTOM
very I-SYMPTOM
poor I-SYMPTOM
, O
large B-SYMPTOM
bilateral I-SYMPTOM
neck I-SYMPTOM
and I-SYMPTOM
submandibular I-SYMPTOM
swelling I-SYMPTOM
very B-SYMPTOM
tender I-SYMPTOM
to O
palpation O
. O

CHEST O
: O

Scattered B-SYMPTOM
bibasilar I-SYMPTOM
rales I-SYMPTOM
, O
no O
wheezes B-SYMPTOM
. O

CARDIAC O
: O

Regular O
rhythm O
, O
tachycardia B-SYMPTOM
, O
no O
murmurs B-SYMPTOM
, O
no O
JVD B-SYMPTOM
. O

ABDOMEN O
: O

Obese B-SYMPTOM
, O
non-distended B-SYMPTOM
, O
positive O
bowel O
sounds O
, O
mild B-SYMPTOM
diffuse I-SYMPTOM
tenderness I-SYMPTOM
. O

EXTREMITIES O
: O

No O
edema B-SYMPTOM
, O
positive O
dorsalis O
pedis O
pulses O
. O

NEUROLOGICAL O
: O

Non-focal O
, O
alert O
and O
oriented O
x3 O
, O
5/5 O
motor O
strength O
in O
the O
upper O
extremities O
and O
lower O
extremities O
, O
Babinski O
reflex O
, O
toes O
are O
downgoing O
. O

LABORATORY O
DATA O
: O

Remarkable O
for O
a O
white O
cell O
count O
of O
0.4 O
, O
with O
0 O
neutrophils O
, O
0 O
bands O
, O
19 O
lymphs O
, O
0 O
monos O
, O
hematocrit O
28.8% O
, O
platelets O
300,000 O
. O

ALT O
141 O
, O
AST O
40 O
, O
alk O
phos O
108 O
, O
and O
a O
total O
bili O
of O
1.0. O
Total O
protein O
was O
5.7 O
, O
albumin O
2.5 O
and O
globulin O
3.2 O
. O

His O
electrolyte O
panel O
of O
sodium O
135 O
, O
sodium O
4.1 O
, O
chloride O
99 O
, O
bicarb O
30 O
, O
BUN O
15 O
, O
creatinine O
2.1 O
, O
blood O
glucose O
of O
196 O
. O

Iron O
studies O
included O
a O
ferritin O
of O
607 O
, O
an O
iron O
of O
10 O
, O
and O
a O
TIBC O
of O
239 O
. O

EKG O
showed O
tachycardia B-SYMPTOM
with O
a O
sinus O
rhythm O
of O
103 O
, O
normal O
axis O
, O
normal O
intervals O
, O
no O
Q-waves B-SYMPTOM
, O
no O
ST-T B-SYMPTOM
wave I-SYMPTOM
changes I-SYMPTOM
. O

The O
patient O
had O
a O
history O
from O
7/12/01 O
of O
a O
normal O
white O
blood O
cell O
count O
, O
with O
a O
normal O
absolute O
neutrophil O
count O
. O

The O
patient O
&apos;s O
chest O
x-ray O
at O
the O
outside O
hospital O
was O
unremarkable O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
started O
on O
ceftazidime B-TREATMENT
, O
nafcillin B-TREATMENT
and O
Flagyl B-TREATMENT
for O
concern O
of O
a B-SYMPTOM
soft I-SYMPTOM
tissue I-SYMPTOM
infection I-SYMPTOM
. O

Neutropenic B-TREATMENT
precautions I-TREATMENT
were O
taken O
. O

The O
patient O
had O
a O
bone O
marrow O
biopsy O
which O
showed O
myeloid B-SYMPTOM
arrest I-SYMPTOM
and O
probable O
neutropenia B-SYMPTOM
from O
a O
drug-related O
cause O
presumed O
to O
be O
the B-TREATMENT
sulfasalazine I-TREATMENT
. O

Over O
the O
course O
of O
the O
hospitalization O
, O
the O
patient O
&apos;s O
white O
blood O
cell O
count O
rose O
from O
0.4 O
to O
6.3 O
after O
he O
was O
given O
G-CSF B-TREATMENT
, O
a O
course O
lasting O
from O
9/28/01 O
until O
9/30/01 O
. O

After O
the B-TREATMENT
G-CSF I-TREATMENT
, O
the O
absolute O
neutrophil O
count O
was O
greater O
than O
8000 O
. O

On O
10/3/01 O
, O
the O
patient O
had O
a O
repeat O
head O
and O
neck O
CT O
, O
which O
showed O
a B-SYMPTOM
right I-SYMPTOM
parotitis I-SYMPTOM
and O
left B-SYMPTOM
submandibular I-SYMPTOM
lymphadenopathy I-SYMPTOM
with O
some B-SYMPTOM
necrosis I-SYMPTOM
. O

No O
frank B-SYMPTOM
abscesses I-SYMPTOM
. O

The B-TREATMENT
patient I-TREATMENT
&apos;s I-TREATMENT
antibiotics I-TREATMENT
were O
changed O
to O
clindamycin B-TREATMENT
300 O
mg O
q.i.d. O
and O
patient O
was O
also O
put O
on O
sialagogue B-TREATMENT
. O

Over O
the O
course O
of O
the O
hospitalization O
, O
the B-SYMPTOM
swelling I-SYMPTOM
and O
tenderness B-SYMPTOM
and O
erythema B-SYMPTOM
have O
steadily O
decreased O
. O

Recommendations O
on O
antibiotics B-TREATMENT
were O
made O
by O
infectious O
disease O
team O
, O
who O
was O
consulted O
. O

Rheumatology O
was O
also O
consulted O
for O
patient O
and O
after O
workup O
, O
it O
was O
believed O
that O
arthritis B-SYMPTOM
may O
be O
a O
rheumatoid B-SYMPTOM
factor I-SYMPTOM
negative I-SYMPTOM
, I-SYMPTOM
rheumatoid I-SYMPTOM
polyarthritis I-SYMPTOM
. O

Rheumatology O
recommended O
a B-TREATMENT
taper I-TREATMENT
of I-TREATMENT
his I-TREATMENT
prednisone I-TREATMENT
to O
20 O
mg O
q.d. O
and O
the O
patient O
will O
be O
followed O
by O
the O
rheumatology O
service O
. O

The O
oncology O
service O
was O
also O
consulted O
for O
patient O
and O
performed O
a O
bone O
marrow O
biopsy O
. O

Throughout O
his O
course O
during O
this O
hospitalization O
, O
the O
patient O
was O
also O
followed O
by O
the O
ENT O
service O
. O

The O
ENT O
physicians O
did O
not O
recommend O
any B-TREATMENT
procedures I-TREATMENT
, O
incision B-TREATMENT
and O
drainage B-TREATMENT
for O
his B-SYMPTOM
right I-SYMPTOM
parotitis I-SYMPTOM
or O
left B-SYMPTOM
submandibular I-SYMPTOM
cervical I-SYMPTOM
lymph I-SYMPTOM
node I-SYMPTOM
necrosis I-SYMPTOM
. O

The O
ENT O
team O
recommended O
watching O
patient O
in-house O
for O
two O
days O
after O
his O
repeat O
imaging O
on O
10/3/01 O
, O
and O
to O
continue O
antibiotic B-TREATMENT
coverage I-TREATMENT
with O
clindamycin B-TREATMENT
. O

The O
patient O
had O
no O
positive B-SYMPTOM
blood I-SYMPTOM
cultures I-SYMPTOM
during O
his O
hospitalization O
and O
remained O
afebrile B-SYMPTOM
after O
the O
second O
day O
of O
admission O
. O

DISCHARGE O
MEDICATIONS O
: O

Topical B-TREATMENT
Bactroban I-TREATMENT
to O
be O
applied O
three O
times O
a O
day O
to O
affected O
naris O
, O
prednisone B-TREATMENT
5 O
mg O
p.o. O
q.a.m. O
, O
K-Dur B-TREATMENT
10 O
mEq O
x2 O
p.o. O
q.d. O
, O
OxyContin B-TREATMENT
10 O
mg O
p.o. O
q.12h. O
, O
clindamycin B-TREATMENT
300 O
mg O
p.o. O
q.i.d. O
, O
lisinopril B-TREATMENT
10 O
mg O
p.o. O
q.d. O
, O
atenolol B-TREATMENT
25 O
mg O
p.o. O
q.d. O
, O
trazodone B-TREATMENT
100 O
mg O
p.o. O
q.h.s. O
, O
Prilosec B-TREATMENT
40 O
mg O
p.o. O
q.d O
, O
clotrimazole B-TREATMENT
1% I-TREATMENT
cream I-TREATMENT
topical I-TREATMENT
to O
be O
applied O
b.i.d. O

DISCHARGE O
FOLLOW-UP O
: O

The O
patient O
was O
arranged O
for O
follow-up O
appointment O
with O
Dr. O
Scarvzine O
of O
rheumatology O
on O
10/11/01 O
. O

Also O
, O
with O
Dr. O
Fyfe O
of O
ENT O
scheduled O
for O
Halloween O
. O

Dr. O
Twada O
, O
his O
primary O
care O
physician O
at O
the O
SBH O
clinic O
for O
10/11/01 O
and O
Dr. O
Fyfechird O
, O
gastroenterologist O
, O
on O
10/13/01 O
. O

COMPLICATIONS O
: O

There O
were O
no O
complications B-SYMPTOM
during O
the O
patient O
&apos;s O
hospitalization O
and O
he O
was O
discharged O
in O
stable O
condition O
. O

Dictated O
By O
: O

THRYNE O
ANA O
, O
M.D. O
GN628 O

Attending O
: O

DRIS O
UPHKOTE O
, O
M.D. O
IF67 O
TB150/196806 O

Batch O
: O

48373 O

Index O
No. O
RYZKWV6XG4 O

D O
: O

10/08/01 O

T O
: O

10/08/01 O

Admission O
Date O
: O

2016-11-02 O

Discharge O
Date O
: O

2016-11-15 O

Date O
of O
Birth O
: O

1938-06-17 O

Sex O
: O

M O

Service O
: O

CARDIOTHORACIC O
SURGERY O

ADDENDUM O
: O

The O
patient O
had O
INR O
of O
3.2 O
that O
came O
back O
on O
date O
of O
discharge O
. O

Please O
hold O
dose O
of O
warfarin B-TREATMENT
on O
the O
night O
of O
the O
16 O
, O
and O
please O
recheck O
INR O
on O
2016-11-16 O
and O
dose O
warfarin B-TREATMENT
appropriately O
for O
INR O
of O
2 O
to O
2.5. O

Dolly O
K. O
Reyes O
, O
M.D. O

04-100 O

Dictated O
By O
: O
Todd O
N. O
Brannon O
, O
M.D. O

MEDQUIST36 O

D O
: O
2016-11-15 O
11:54 O

T O
: O
2016-11-15 O
11:02 O

JOB O
#: O
75150 O

Signed O
electronically O
by O
: O

DR. O
Dolly O
N O
Wardlaw O
on O
: O
TUE O
2016-12-27 O
5:21 O
PM O

( O
End O
of O
Report O
) O

669952543 O

CTMC O

98431395 O

329475 O

2/8/1990 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Admission O
Date O
: O

02/08/1990 O

Report O
Status O
: O

Unsigned O

Discharge O
Date O
: O

02/13/1990 O

ADMISSION O
DIAGNOSIS O
: O

VULVAR B-SYMPTOM
CANCER I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
43-year-old O
gravida O
II O
para O
II O
white O
female O
referred O
by O
Dr. O
Ca O
Shuff O
for O
evaluation O
. O

She O
was O
in O
her O
usual O
state O
of O
good O
health O
until O
December O
when O
she O
was O
seen O
emergently O
for O
treatment B-TREATMENT
of O
a B-SYMPTOM
perforated I-SYMPTOM
colon I-SYMPTOM
cancer I-SYMPTOM
. O

That O
area O
was O
resected O
with O
no O
evidence O
of O
metastatic B-SYMPTOM
disease I-SYMPTOM
. O

She O
has O
had O
subsequent O
CEA&apos;s O
and O
scans O
which O
were O
negative O
. O

A B-SYMPTOM
tumor I-SYMPTOM
was O
noted O
on O
her O
vulva O
which O
was O
biopsied O
and O
revealed O
squamous B-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
in I-SYMPTOM
situ I-SYMPTOM
. O

ALLERGIES O
: O

NO O
KNOWN B-SYMPTOM
DRUG I-SYMPTOM
ALLERGIES I-SYMPTOM
. O

MEDICATIONS O
: O

None O
. O

PAST O
SURGICAL O
HISTORY O
: O

As O
above O
with O
colostomy B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
included O
HEENT O
exam O
which O
was O
normal O
. O

Chest O
was O
clear O
. O

Heart O
revealed O
a O
regular O
rate O
and O
rhythm O
. O

Abdomen O
was O
soft O
and O
nontender B-SYMPTOM
. O

Vulva O
and O
right O
labia O
replaced O
by O
reddish B-SYMPTOM
lesion I-SYMPTOM
, O
somewhat O
raised O
in O
the O
center O
extending O
from O
adjacent O
to O
the O
cuterus O
to O
the O
posterior O
forchette O
. O

Otherwise O
, O
her O
pelvic O
exam O
was O
negative O
. O

IMPRESSION O
: O

STAGE B-SYMPTOM
II I-SYMPTOM
SQUAMOUS I-SYMPTOM
CELL I-SYMPTOM
CARCINOMA I-SYMPTOM
OF I-SYMPTOM
THE I-SYMPTOM
VULVA I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
plan O
was O
for O
right B-TREATMENT
radical I-TREATMENT
vulvectomy I-TREATMENT
. O

1. O
Vulvectomy B-TREATMENT
: O

The O
patient O
on O
2/8/90 O
underwent O
a B-TREATMENT
right I-TREATMENT
radical I-TREATMENT
vulvectomy I-TREATMENT
with O
excellent O
results O
and O
negative O
margins O
on O
frozen O
section O
. O

Her O
postoperative O
course O
was O
unremarkble O
. O

She O
was O
kept O
on O
bedrest B-TREATMENT
for O
two O
days O
and O
then O
was O
ambulating O
and O
voiding O
well O
without O
trouble O
on O
postoperative O
day O
number O
three O
when O
the B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
was O
discontinued O
. O

She O
has O
been O
doing O
Betadine B-TREATMENT
paint I-TREATMENT
and O
blow O
drying O
the O
area O
several O
times O
a O
day O
and O
after O
each O
bowel O
movement O
and O
urine O
without O
incident O
. O

DISPOSITION O
: O

The O
discharge O
is O
to O
home O
. O

The O
patient O
will O
follow-up O
with O
Dr. O
Friednantflirt O
. O

She O
will O
have O
AH O
for O
support O
. O

________________________________ O
YT844/9769 O
LAKO O
SCARVTWI O
, O
M.D. O
TH0 O

D O
: O

02/12/90 O

Batch O
: O

7753 O

Report O
: O

Y6201H2 O

T O
: O

02/13/90 O

Dicatated O
By O
: O

RORIEZAILA O
KOTEKAYSKOTEKAYSCOA O
, O
M.D. O
SE85 O

303694252 O
EH O

14027692 O

097370 O

08/05/2001 O
12:00:00 O
AM O

erosive B-SYMPTOM
esophagitis I-SYMPTOM

DIS O

Admission O
Date O
: O

08/05/2001 O

Report O
Status O
: O

Discharge O
Date O
: O

08/08/2001 O

****** O
DISCHARGE O
ORDERS O
****** O

RHALTHEAGLE O
, O
LEELO O
506-20-55-6 O
K40 O

Room O
: O

89N-803 O

Service O
: O

MED O

DISCHARGE O
PATIENT O
ON O
: O

08/08/01 O
AT O
04:00 O
PM O

CONTINGENT O
UPON O

SNF O
/ O
rehab O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

GRENDZISKLEEB O
, O
FACISA O
TIELO O
, O
M.D. O

CODE O
STATUS O
: O

No O
CPR B-TREATMENT
/ O
No O
defib B-TREATMENT
/ O

DISPOSITION O
: O

No- O
Ter O
Chipold O
Medical O
Center O

DISCHARGE O
MEDICATIONS O
: O

ROBITUSSIN B-TREATMENT
( I-TREATMENT
GUAIFENESIN I-TREATMENT
) I-TREATMENT
10 O
MILLILITERS O
PO O
Q4H O
PRN O
cough B-SYMPTOM
FLAGYL B-TREATMENT
( I-TREATMENT
METRONIDAZOLE I-TREATMENT
) I-TREATMENT
500 O
MG O
PO O
TID O
X O
5 O
Days O
Starting O
Today O
( O
08/08 O
) O
NITROGLYCERIN B-TREATMENT
1/150 O
( O
0.4 O
MG O
) O
1 O
TAB O
SL O
q5min O
x O
3 O
PRN O
chest B-SYMPTOM
pain I-SYMPTOM

HOLD O
IF O
: O

SBP O
&lt; O
100 O
AMBIEN B-TREATMENT
( I-TREATMENT
ZOLPIDEM I-TREATMENT
TARTRATE I-TREATMENT
) I-TREATMENT
5 O
MG O
PO O
QHS O
PRN O
insomnia B-SYMPTOM

Food O
/ O
Drug O
Interaction O
Instruction O

Give O
on O
an O
empty O
stomach O
( O
give O
1hr O
before O
or O
2hr O
after O
food O
) O

Number O
of O
Doses O
Required O
( O
approximate O
) O
: O

5 B-TREATMENT
LEVOFLOXACIN I-TREATMENT
250 O
MG O
PO O
QD O
X O
5 O
Days O
Starting O
Today O
( O
08/08 O
) O

Alert O
overridden O
: O

Override O
added O
on O
08/08/01 O
by O
: O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

HALOPERIDOL B-TREATMENT
and O
LEVOFLOXACIN B-TREATMENT

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

HALOPERIDOL B-TREATMENT
and O
LEVOFLOXACIN B-TREATMENT

Reason O
for O
override O
: O

aware O

Previous O
Override O
Notice O

Override O
added O
on O
08/07/01 O
by O
ZISKFUSCJALK O
, O
ACRI O
, O
M.D. O
on O
order O
for O
HALDOL B-TREATMENT
IM I-TREATMENT
( O
ref O
# O
09647807 O
) O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

LEVOFLOXACIN B-TREATMENT
and O
HALOPERIDOL B-TREATMENT

Reason O
for O
override O
: O

awre O

Previous O
override O
information O
: O

Override O
added O
on O
08/07/01 O
by O
ZISKFUSCJALK O
, O
ACRI O
, O
M.D. O
on O
order O
for O
HALDOL B-TREATMENT
PO I-TREATMENT
( O
ref O
# O
60739147 O
) O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

LEVOFLOXACIN B-TREATMENT
and O
HALOPERIDOL B-TREATMENT

Reason O
for O
override O
: O

aware O

OMEPRAZOLE B-TREATMENT
40 O
MG O
PO O
BID O
X O
45 O
Days O
ATENOLOL B-TREATMENT
25 O
MG O
PO O
BID O

Food O
/ O
Drug O
Interaction O
Instruction O

Take O
consistently O
with O
meals O
or O
on O
empty O
stomach O
. O

RETURN O
TO O
WORK O
: O

Not O
Applicable O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Dr. O
Scaher O
Grend O
, O
RAMMCO O
8/20 O
, O
3:30pm O
scheduled O
, O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

hematemesis B-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
erosive B-SYMPTOM
esophagitis I-SYMPTOM

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
right B-SYMPTOM
scrotal I-SYMPTOM
hydrocele I-SYMPTOM
bph B-SYMPTOM
( I-SYMPTOM
benign I-SYMPTOM
prostatic I-SYMPTOM
hypertrophy I-SYMPTOM
) I-SYMPTOM
? O
nph B-SYMPTOM
( O
? O
hydrocephalus B-SYMPTOM
) O
dementia B-SYMPTOM
( I-SYMPTOM
dementia I-SYMPTOM
) I-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

Esophagogastroduodenoscopy B-TREATMENT

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

86 O
yo O
male O
with O
one O
day O
of O
hematemesis B-SYMPTOM
( O
history O
unclear O
) O
. O

No O
known O
TB B-SYMPTOM
or O
CA B-SYMPTOM
history O
. O

No O
SOB B-SYMPTOM
, O
? O
fever B-SYMPTOM
at O
home O
. O

No O
known O
dysphagia B-SYMPTOM
. O

Also O
c O
/ O
o O
chest B-SYMPTOM
pain I-SYMPTOM
, O
substernal B-SYMPTOM
discomfort I-SYMPTOM
for O
past O
few O
days O
. O

Brought O
in O
from O
assisted O
living O
facility O
. O

In O
ED O
HR O
70 O
, O
BP O
130/80 O
, O
O2sat O
96% O
. O

Hct O
44 O
. O

CXR O
notable O
for O
RLL B-SYMPTOM
infiltrate I-SYMPTOM
with O
old B-SYMPTOM
B I-SYMPTOM
upper I-SYMPTOM
lung I-SYMPTOM
field I-SYMPTOM
granulomas I-SYMPTOM
. O

Chest O
CT O
notable O
for O
esophageal B-SYMPTOM
diverticulum I-SYMPTOM
and O
thickened B-SYMPTOM
distal I-SYMPTOM
1/3 I-SYMPTOM
of I-SYMPTOM
esophagus I-SYMPTOM
, O
suspicious O
for O
malignancy B-SYMPTOM
. O

+ O
alveolar B-SYMPTOM
opacities I-SYMPTOM
c O
/ O
w O
alveolar B-SYMPTOM
hemorrhage I-SYMPTOM
or O
aspirated B-SYMPTOM
blood I-SYMPTOM
. O

Also O
with O
multiple B-SYMPTOM
cystic I-SYMPTOM
hypodensities I-SYMPTOM
in I-SYMPTOM
liver I-SYMPTOM
seen O
in O
previous O
scans O
. O

1 O
) O
GI O
: O

Throughout O
admission O
, O
hematemesis B-SYMPTOM
flow O
decreased O
while O
on O
PPI B-TREATMENT
and O
clear B-TREATMENT
liquids I-TREATMENT
. O

EGD O
08/08/01 O
showed O
mulitple B-SYMPTOM
non-bleeding I-SYMPTOM
linear I-SYMPTOM
erosions I-SYMPTOM
with O
an B-SYMPTOM
irregular I-SYMPTOM
circumfrencial I-SYMPTOM
ulcer I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
GE I-SYMPTOM
junction I-SYMPTOM
. O

Tolerated O
advancement O
to O
a B-TREATMENT
soft I-TREATMENT
mechanical I-TREATMENT
diet I-TREATMENT
well O
. O

Started O
on O
omeprazole B-TREATMENT
40 O
mg O
po O
bid O
x6 O
wks O
. O

2 O
) O
CV O
: O

CP B-SYMPTOM
, O
low O
prob O
with O
atypical B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
, O
CK O
&apos;s O
x3 O
flat O
, O
and O
no O
further O
episodes O
of O
CP B-SYMPTOM
during O
the O
admission O
. O

BP O
remained O
stable O
throughout O
the O
admission O
; O
initially O
, O
BP B-TREATMENT
meds I-TREATMENT
were O
held O
, O
but O
as O
VS O
remai O
ned O
stable O
and O
bleeding B-SYMPTOM
subsided O
, O
lopressor B-TREATMENT
was O
titrated O
up O
to O
25 O
mg O
po O
tid O
. O

He O
was O
switched O
back O
to O
his O
home O
dose O
of O
atenolol B-TREATMENT
25 O
mg O
po O
bid O

3 O
) O
ID O
: O

Levo B-TREATMENT
and O
flagyl B-TREATMENT
for O
presumed O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
/ O
pneuomonitis B-SYMPTOM
. O

4 O
) O
GU O
: O

h O
/ O
o O
obstructive B-SYMPTOM
uropathy I-SYMPTOM
-- O
UOP O
was O
erratic O
, O
but O
no O
foley B-TREATMENT
was O
needed O
. O

Bun O
/ O
Cr O
were O
stable O
. O

5 O
) O
FEN O
: O

Started O
on O
clear B-TREATMENT
liquids I-TREATMENT
. O

Once O
bleed B-SYMPTOM
ing I-SYMPTOM
stopped O
, O
advanced O
diet O
to O
soft-mechanical B-TREATMENT
. O

CODE O
: O

DNR B-TREATMENT
, O
NO O
CPR B-TREATMENT
, O
may O
intubate O
for O
airway B-TREATMENT
protection I-TREATMENT
, O
call O
son O
. O

Disposition O
Plans O
: O

Will O
follow-up O
with O
his O
PMD O
; O
biopsy O
results O
to O
be O
followed O
closely O
. O

If O
biopsy O
results O
abnormal B-SYMPTOM
, O
will O
need O
follow-up O
intra-esophageal O
ultrasound O
by O
GI O
service O
. O

ADDITIONAL O
COMMENTS O
: O

You O
have O
been O
admitted O
for O
evaluation O
of O
an B-SYMPTOM
esophageal I-SYMPTOM
bleed I-SYMPTOM
. O

You O
have O
some B-SYMPTOM
erosions I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
esophagus I-SYMPTOM
which O
are O
no O
longer O
bleeding B-SYMPTOM
. O

You O
will O
need O
to O
continue O
to O
take O
special B-TREATMENT
medications I-TREATMENT
for O
these B-SYMPTOM
erosions I-SYMPTOM
. O

If O
you O
experience O
further B-SYMPTOM
bleeding I-SYMPTOM
or O
increasing B-SYMPTOM
discomfort I-SYMPTOM
with O
swallowing O
, O
you O
must O
tell O
your O
nurse O
and O
call O
your O
doctor O
right O
away O
. O

Please O
follow-up O
the O
biopsy O
results O
with O
your O
doctor O
. O

You O
may O
need O
to O
have O
further O
studies O
at O
a O
later O
date O
. O

Continue O
all O
your B-TREATMENT
previous I-TREATMENT
medications I-TREATMENT
as O
directed O
. O

DISCHARGE O
CONDITION O
: O

Satisfactory O

TO O
DO O
/ O
PLAN O
: O

1 O
) O
Follow-up O
esophageal O
biopsy O
results O

2 O
) O
Schedule O
GI O
follow-up O
if O
biopsy O
results O
abnormal B-SYMPTOM
or O
if O
continued B-SYMPTOM
bleeding I-SYMPTOM
. O

3 O
) O
Consider O
oncology O
follow-up O
if O
biopsies O
suggestive O
of O
malignancy B-SYMPTOM

4 O
) O
Omeprazole B-TREATMENT
40 O
mg O
po O
bid O
x6 O
wks O
. O

No O
dictated O
summary O

ENTERED O
BY O
: O

ZISKFUSCJALK O
, O
ACRI O
, O
M.D. O
( O
AN36 O
) O

08/08/01 O
03:06 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

625433852 O

FIH O

3767370 O

25103/5cy1 O

160996 O

10/1/1994 O
12:00:00 O
AM O

METASTATIC B-SYMPTOM
CANCER I-SYMPTOM
TO I-SYMPTOM
THE I-SYMPTOM
LIVER I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

10-01-94 O

DISCHARGE O
DATE O
: O

10-10-94 O

PRINCIPAL O
DIAGNOSIS O
: O

Metastatic B-SYMPTOM
cancer I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
liver I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
peripheral B-SYMPTOM
neuropathy I-SYMPTOM
, O
rectal B-SYMPTOM
carcinoma I-SYMPTOM
, O
premature B-SYMPTOM
ventricular I-SYMPTOM
contractions I-SYMPTOM
, O
right B-SYMPTOM
hemidiaphragmatic I-SYMPTOM
paralysis I-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

10-02-94 O
left B-TREATMENT
hepatectomy I-TREATMENT
, O
10-01-94 O
celiac O
and O
superior O
mesenteric O
angiogram O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
60 O
year O
old O
diabetic O
who O
underwent O
an B-TREATMENT
APR I-TREATMENT
in O
1989 O
for O
rectal B-SYMPTOM
carcinoma I-SYMPTOM
and O
has O
been O
doing O
following O
radiation B-TREATMENT
therapy I-TREATMENT
and O
5FU B-TREATMENT
. O

He O
recently O
developed O
fatigue B-SYMPTOM
and O
dyspnea B-SYMPTOM
and O
workup O
disclosed O
a B-SYMPTOM
large I-SYMPTOM
liver I-SYMPTOM
mass I-SYMPTOM
which O
was O
biopsied O
and O
revealed O
to O
be O
poorly B-SYMPTOM
differentiated I-SYMPTOM
neoplasm I-SYMPTOM
most O
consistent O
with O
metastatic B-SYMPTOM
rectal I-SYMPTOM
discontinued I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

remarkable O
for O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
premature B-SYMPTOM
ventricular I-SYMPTOM
contractions I-SYMPTOM
, O
rectal B-SYMPTOM
carcinoma I-SYMPTOM
, O
diabetic B-SYMPTOM
neuropathy I-SYMPTOM
both O
peripherally O
and O
involving O
the O
right O
diaphragm O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Diabeta B-TREATMENT
10 O
mg. O
po. O
bid O
. O

Serax B-TREATMENT
20 O
mg. O
po. O
qhs O
. O

Sudafed B-TREATMENT
30 O
mg. O
po. O
bid O
. O

Theo-dur B-TREATMENT
300 O
mg. O
po. O
bid O
. O

Betoptic B-TREATMENT
0.5% O
one O
drop O
OU O
bid O
, O
Propene B-TREATMENT
0.1% O
one O
drop O
OU O
bid O
, O
Pred-Forte B-TREATMENT
1% O
one O
drop O
OS O
bid O
, O
Percocet B-TREATMENT
two O
tabs. O
po. O
q4hours O
prn O
. O

Proventil B-TREATMENT
2 O
puffs O
q6hours O
prn O
. O

PAST O
SURGICAL O
HISTORY O
: O

includes O
and O
abdominoperineal B-TREATMENT
resection I-TREATMENT
in O
1989 O
. O

ALLERGIES O
: O

no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM

PHYSICAL O
EXAMINATION O
: O

demonstrated O
an O
obese O
man O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

The O
blood O
pressure O
140/75 O
, O
pulse O
90 O
and O
irregular B-SYMPTOM
, O
respirations O
20 O
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
and O
neck O
examinations O
were O
unremarkable O
. O

Cardiac O
examination O
was O
remarkable O
for O
frequent B-SYMPTOM
ectopic I-SYMPTOM
beats I-SYMPTOM
. O

The O
lung O
examination O
was O
clear O
but O
breath O
sounds O
were O
more O
pronounced O
on O
the O
left O
than O
the O
right O
. O

Abdomen O
: O

soft O
, O
obese B-SYMPTOM
with O
mild B-SYMPTOM
epigastric I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
tenderness I-SYMPTOM
. O

An B-TREATMENT
intact I-TREATMENT
colostomy I-TREATMENT
was O
present O
. O

No O
masses B-SYMPTOM
could O
be O
palpated O
secondary O
to O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
extreme I-SYMPTOM
obesity I-SYMPTOM
. O

Extremities O
: O

unremarkable O
. O

The O
neurological O
examination O
was O
remarkable O
for O
a B-SYMPTOM
peripheral I-SYMPTOM
neuropathy I-SYMPTOM
including O
decreased B-SYMPTOM
sensation I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
with O
decreased B-SYMPTOM
strength I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
upper I-SYMPTOM
and I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
most O
pronounced O
in O
the O
legs O
and O
feet O
. O

A O
chest O
X-ray O
demonstrated O
right B-SYMPTOM
hemidiaphragmatic I-SYMPTOM
elevation I-SYMPTOM
. O

The O
electrocardiogram O
was O
remarkable O
for O
trigeminy B-SYMPTOM
at O
91 O
per O
minute O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
and O
underwent O
celiac O
and O
superior O
mesenteric O
artery O
angiography O
which O
demonstrated O
a O
patent O
celiac O
and O
superior O
mesenteric O
artery O
with O
normal O
branching O
pattern O
. O

His O
preoperative O
workup O
was O
completed O
and O
included O
a O
normal O
white O
count O
, O
hematocrit O
42 O
. O

normal O
electrolytes O
, O
normal O
coags O
and O
normal O
renal O
function O
. O

On O
10-02-94 O
the O
patient O
was O
brought O
to O
the O
operating O
room O
where O
he O
underwent O
exploratory O
laparotomy O
and O
left B-TREATMENT
hepatectomy I-TREATMENT
and O
cholecystectomy B-TREATMENT
by O
Dr. O
Duhenile O
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
with O
a B-SYMPTOM
2000 I-SYMPTOM
cc. I-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
and O
was O
autotransfused O
two O
units O
of O
blood B-TREATMENT
. O

In O
the O
postoperative O
course O
Mr. O
Fyfe O
did O
surprisingly O
well O
given O
his B-SYMPTOM
underlying I-SYMPTOM
medical I-SYMPTOM
condition I-SYMPTOM
. O
, O

He O
did O
require O
two O
units O
of O
transfused B-TREATMENT
blood I-TREATMENT
but O
otherwise O
did O
quite O
well O
and O
was O
extubated O
on O
the O
night O
of O
surgery O
. O

He O
remained O
in O
the O
Intensive O
Care O
Unit O
for O
two O
days O
but O
was O
hemodynamically O
stable O
throughout O
. O

He O
continued O
to O
manifest O
occasional B-SYMPTOM
premature I-SYMPTOM
ventricular I-SYMPTOM
contractions I-SYMPTOM
, O
but O
these O
were O
unchanged O
from O
preoperatively O
and O
the O
patient O
otherwise O
did O
well O
. O

His B-TREATMENT
nasogastric I-TREATMENT
tube I-TREATMENT
was O
discontinued O
and O
he O
was O
begun O
on O
clear B-TREATMENT
liquids I-TREATMENT
and O
subsequently O
advanced O
to O
a O
regular O
diet O
without O
difficulty O
. O

Both O
of O
his B-TREATMENT
Jackson-Pratt I-TREATMENT
drains I-TREATMENT
were O
removed O
without O
incident O
. O

By O
postoperative O
day O
# O
7 O
, O
Mr. O
Fyfe O
was O
tolerating O
a B-TREATMENT
regular I-TREATMENT
ADA I-TREATMENT
1800 I-TREATMENT
kilocalorie I-TREATMENT
diet I-TREATMENT
without O
difficulty O
with O
all O
of O
his B-TREATMENT
tubes I-TREATMENT
and O
drains B-TREATMENT
removed O
. O

His B-SYMPTOM
wound I-SYMPTOM
was O
noted O
to O
be O
healing O
well O
and O
his B-TREATMENT
colostomy I-TREATMENT
functioning O
appropriately O
without O
significant O
difficulty O
. O

He O
is O
being O
transferred O
back O
to O
the O
Per O
Naplesspecrycet O
Hospital O
in O
stable O
condition O
on O
the B-TREATMENT
same I-TREATMENT
medications I-TREATMENT
which O
he O
was O
on O
preoperatively O
. O

These O
include O
Diabeta B-TREATMENT
10 O
mg. O
po. O
bid O
. O

Serax B-TREATMENT
20 O
mg. O
po. O
qhs O
. O

Sudafed B-TREATMENT
30 O
po. O
bid O
. O

Theo-dur B-TREATMENT
300 O
mg. O
po. O
bid O
. O

Betoptic B-TREATMENT
0.5% O
one O
drop O
OU O
bid O
, O
Propene B-TREATMENT
0.1% O
one O
drop O
OU O
bid O
. O

Pred-Forte B-TREATMENT
1% O
one O
drop O
OS O
bid O
. O

Percocet B-TREATMENT
two O
tabs O
po. O
q4h O
prn O
. O

Proventil B-TREATMENT
2 O
puffs O
q6hours O
prn O
.. O

The O
patient O
will O
followup O
with O
Dr. O
Fede O
Duhenile O
in O
two O
weeks O
in O
Dr. O
Duhenile O
&apos;s O
office O
. O

LENNI O
BREUTZOLN O
, O
M.D. O

DICTATING O
FOR O
: O

FEDE O
A. O
DUHENILE O
, O
M.D. O

TR O
: O

eb O
/ O
bmot O

DD O
: O

10-10-94 O

TD O
: O

10/09/94 O

CC O
: O

STAT O

Admission O
Date O
: O

2012-07-17 O

Discharge O
Date O
: O

2012-07-22 O

Date O
of O
Birth O
: O

1953-12-04 O

Sex O
: O

F O

Service O
: O

SURGERY O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Steve O
M. O
Estes O
, O
M.D. O

Chief O
Complaint O
: O

ABDOMENAL B-SYMPTOM
PAIN I-SYMPTOM
AND O
NAUSEA B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

SMALL B-TREATMENT
BOWEL I-TREATMENT
RESECTION I-TREATMENT

History O
of O
Present O
Illness O
: O

58 O
YEAR-OLD O
FEMALE O
S/P O
GASTRIC B-TREATMENT
BYPASS I-TREATMENT
03-01 O
WITHOUT O
COMPLICATIONS B-SYMPTOM
POST-OPERATIVELY O
, O
NOW O
PRESENTS O
WITH O
ABOMENAL B-SYMPTOM
AND I-SYMPTOM
AND I-SYMPTOM
ASCOCIATED I-SYMPTOM
NAUSEA I-SYMPTOM
SINCE O
THE O
NIGHT O
BEFORE O
ADMISSION O
. O

PAIN B-SYMPTOM
IS O
DIFFUSED O
, O
06-05 O
OUT O
OF O
10 O
IN O
INTENSITY O
, O
AND O
HAS O
NOT O
IMPROVED O
OVERNIGHT O
. O

NO O
FLATUS B-SYMPTOM
X O
1 O
DAY O
. O

Past O
Medical O
History O
: O

OBESITY B-SYMPTOM

HYPERTENSION B-SYMPTOM

GERD B-SYMPTOM

HYPERLIPIDEMIA B-SYMPTOM

APPENDECTOMY B-TREATMENT

OVARIAN B-SYMPTOM
CYST I-SYMPTOM

Physical O
Exam O
: O

AFEBRILE B-SYMPTOM
, O
PULSE O
70-80 O
'S O
, O
VITAL O
STABLE O
AND O
WITHIN O
NORMAL O
LIMITS O

GENERAL O
: O

ALERT O
, O
ANICTERUS B-SYMPTOM
, O
OROPHARYNX O
CLEAR O

NO O
LYMPHANOPATHY B-SYMPTOM

LUNGS O
CLEAR O
TO O
ASCULTATION O

HEART O
REGULAR O
RATE O
RHYTHM O

ABDOMEN O
SOFT O
, O
NON-DISTENDED B-SYMPTOM
, O
DIFFUSE B-SYMPTOM
TENDERNESS I-SYMPTOM
, O
NO O
PERITOMEAL B-SYMPTOM

SIGNS O

EXTREMITIES O
NO O
EDEMA B-SYMPTOM

Pertinent O
Results O
: O

CT O
PELVIS O
( O
07-17 O
) O
An B-SYMPTOM
abnormal I-SYMPTOM
loop I-SYMPTOM
of O
slightly B-SYMPTOM
dilated I-SYMPTOM
small I-SYMPTOM
bowel I-SYMPTOM
with O
fecalization B-SYMPTOM
and O
possible O
bowel B-SYMPTOM
wall I-SYMPTOM
thickening I-SYMPTOM
. O

A O
clear O
transit O
point O
is O
not O
visualized O
. O

This B-SYMPTOM
small I-SYMPTOM
bowel I-SYMPTOM
obstruction I-SYMPTOM
is O
likely O
secondary O
to O
closed B-SYMPTOM
loop I-SYMPTOM
obstruction I-SYMPTOM
. O

This O
could O
be O
due O
to O
internal B-SYMPTOM
hernia I-SYMPTOM
or O
could O
be O
stricture B-SYMPTOM
related O
. O

Other O
differential O
includes O
ischemia B-SYMPTOM
. O

Infectious B-SYMPTOM
etiology I-SYMPTOM
is O
less O
likely O
due O
to O
the O
focal O
nature O
of O
the O
involvement O
. O

Brief O
Hospital O
Course O
: O

UPON O
PRESENTATION O
TO O
THE O
HOSPITAL O
AND O
INTIAL O
WORK-UP O
, O
THE O
PATIENT O
WAS O
IMMEDIATELY O
TAKEN O
TO O
THE O
OPERATING O
ROOM O
FOR O
AN O
EXPLORATORY O
LAPORATOMY O
. O

INTRAOPERATIVELY O
, O
THE O
PATIENT O
WAS O
FOUND O
TO O
HAVE O
SMALL B-SYMPTOM
BOWEL I-SYMPTOM
OBSTRUCTION I-SYMPTOM
WITH O
ISCHEMIC B-SYMPTOM
SMALL I-SYMPTOM
BOWEL I-SYMPTOM
. O

PORTIONS O
OF O
THE O
SMALL O
BOWEL O
WERE O
RESECTED O
. O

SHE O
TOLERATED O
THE B-TREATMENT
PROCEDURE I-TREATMENT
AND O
WAS O
ADMITTED O
TO O
THE O
INTENSIVE O
CARE O
UNIT O
. O

SHE O
DID O
WELL O
IN O
THE O
ICU O
AND O
WAS O
SUBSEQUENTLY O
TRANSFERED O
TO O
THE O
FLOOR O
. O

SHE O
HAS O
BEEN O
AFEBRILE B-SYMPTOM
POST-OPERATIVELY O
, O
MAKING O
GOOD O
URINE O
, O
AMBULATING O
, O
EATING O
A O
REGULAR O
DIET O
WITHOUT O
ANY B-SYMPTOM
COMPLICATIONS I-SYMPTOM
. O

SHE O
WILL O
BE O
DISCHARGED O
IN O
GOOD O
CONDITION O
. O

Discharge O
Medications O
: O

1. O
Oxycodone-Acetaminophen B-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

Disp O
:* O
40 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

2. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Discharge O
Disposition O
: O

Home O

Discharge O
Diagnosis O
: O

SMALL B-SYMPTOM
BOWEL I-SYMPTOM
OBSTRUCTION I-SYMPTOM

ISCHEMIC B-SYMPTOM
SMALL I-SYMPTOM
BOWEL I-SYMPTOM

Discharge O
Condition O
: O

GOOD O

Discharge O
Instructions O
: O

PLEASE O
TAKE O
MEDICATIONS B-TREATMENT
AS O
PRESCRIBED O
AND O
READ O
WARNING O
LABELS O
CAREFULLY O
. O

IF O
SIGNS O
AND O
SYMPTOMS O
OF O
WOUND B-SYMPTOM
INFECTION I-SYMPTOM
, O
SUCH O
AS O
SUDDEN B-SYMPTOM
FEVER I-SYMPTOM
, O
INCREASED B-SYMPTOM
PAIN I-SYMPTOM
, O
NAUSEA B-SYMPTOM
/ O
VOMITING B-SYMPTOM
, O
PURULENT B-SYMPTOM
DISCHARGE I-SYMPTOM
, O
PLEASE O
GO O
TO O
THE O
EMERGENCY O
ROOM O
OR O
CALL O
. O

MAY O
SHOWER O
, O
NO O
BATHS O
. O

PAD O
DRY O
-- O
DO O
NOT O
SCRUB O
WOUND B-SYMPTOM
. O

Followup O
Instructions O
: O

PLEASE O
CALL O
DR. O
Barnett O
OFFICE O
( O
( O
443 O
) O
316 O
6447 O
FOR O
A O
FOLLOW-UP O
APPOINTMENT O
IN O
1-2 O
WEEKS O
. O

Ruby O
John O
MD O
54-596 O

Completed O
by O
: O

Thomas O
Louis O
MD O
12-223 O
2012-07-22 O
@ O
1423 O

Signed O
electronically O
by O
: O
DR. O
Edgar O
SCHNEIDER O
on O
: O
SUN O
2012-07-22 O
2:47 O
PM O

( O
End O
of O
Report O
) O

025897906 O

CTMC O

81515170 O

481064 O

06/11/1991 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

06/11/1991 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

06/22/1991 O

DISCHARGE O
DIAGNOSIS O
: O

METASTATIC B-SYMPTOM
CERVICAL I-SYMPTOM
CARCINOMA I-SYMPTOM
. O

SECONDARY O
DIAGNOSES O
INCLUDE O
PERICARDIAL B-SYMPTOM
EFFUSION I-SYMPTOM
, O
PULMONARY B-SYMPTOM
LYMPHANGITIC I-SYMPTOM
SPREAD I-SYMPTOM
, O
AND O
LIVER B-SYMPTOM
AND I-SYMPTOM
SPLEEN I-SYMPTOM
METASTASES I-SYMPTOM
. O

OPERATIONS O
AND O
PROCEDURES O
: O

Echocardiogram O
times O
two O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Patient O
is O
a O
28 O
year O
old O
gravida O
IV O
, O
para O
2 O
with O
metastatic B-SYMPTOM
cervical I-SYMPTOM
cancer I-SYMPTOM
admitted O
with O
a O
question O
of O
malignant B-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
. O

Patient O
underwent O
a B-TREATMENT
total I-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
in O
02/90 O
for O
a B-SYMPTOM
4x3.6x2 I-SYMPTOM
cm I-SYMPTOM
cervical I-SYMPTOM
mass I-SYMPTOM
felt O
to O
be O
a B-SYMPTOM
fibroid I-SYMPTOM
at O
Vanor O
. O

Pathology O
revealed O
poorly B-SYMPTOM
differentiated I-SYMPTOM
squamous I-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
cervix I-SYMPTOM
with O
spots O
of O
vaginal O
margins O
and O
metastatic B-SYMPTOM
squamous I-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
cardinal I-SYMPTOM
ligaments I-SYMPTOM
with O
extensive B-SYMPTOM
lymphatic I-SYMPTOM
invasion I-SYMPTOM
. O

Patient O
was O
felt O
to O
have O
stage B-SYMPTOM
2B I-SYMPTOM
disease I-SYMPTOM
and O
post-operatively O
, O
she O
was O
treated O
with O
intracavitary B-TREATMENT
and I-TREATMENT
external I-TREATMENT
beam I-TREATMENT
radiation I-TREATMENT
therapy I-TREATMENT
and O
low B-TREATMENT
dose I-TREATMENT
Cisplatin I-TREATMENT
. O

On O
ultrasound O
in O
02/91 O
, O
the O
patient O
was O
found O
to O
have O
bilateral B-SYMPTOM
cystic I-SYMPTOM
adnexal I-SYMPTOM
masses I-SYMPTOM
confirmed O
on O
physical O
examination O
. O

She O
underwent O
exploratory O
laparotomy O
and O
had O
a B-TREATMENT
bilateral I-TREATMENT
salpingo-oophorectomy I-TREATMENT
and O
appendectomy B-TREATMENT
. O

Pathology O
was O
negative O
for O
tumor B-SYMPTOM
and O
showed O
peritubal B-SYMPTOM
and I-SYMPTOM
periovarian I-SYMPTOM
adhesions I-SYMPTOM
. O

The O
patient O
now O
presents O
with O
a O
three O
to O
four O
week O
history O
of O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
a B-SYMPTOM
dry I-SYMPTOM
non-productive I-SYMPTOM
cough I-SYMPTOM
. O

She O
was O
evaluated O
by O
Dr. O
Mielke O
, O
a O
Pulmonologist O
, O
who O
found O
her O
to O
be O
wheezing B-SYMPTOM
and O
performed O
pulmonary O
function O
tests O
which O
showed O
an O
FEV1 O
of O
1.1 O
and O
an O
FVC O
of O
1.8 O
. O

She O
was O
admitted O
to O
Weekscook O
University O
Medical O
Center O
with O
a O
diagnosis O
of O
possible O
asthma B-SYMPTOM
. O

Room O
air O
arterial O
blood O
gas O
showed O
a O
pO2 O
of O
56 O
, O
a O
pCO2 O
of O
35 O
, O
and O
a O
pH O
of O
7.52 O
. O

EKG O
showed O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
at O
100 O
and O
echo O
revealed O
pericardial B-SYMPTOM
effusion I-SYMPTOM
, O
a B-SYMPTOM
10 I-SYMPTOM
mm I-SYMPTOM
pulsus I-SYMPTOM
paradoxus I-SYMPTOM
was O
noted O
, O
and O
no O
evidence O
of O
tamponade B-SYMPTOM
. O

Given O
the O
patient O
&apos;s O
history O
of O
cervical B-SYMPTOM
cancer I-SYMPTOM
, O
the B-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
was O
felt O
most O
likely O
to O
be O
malignant B-SYMPTOM
. O

She O
was O
therefore O
transferred O
to O
the O
Retelk O
County O
Medical O
Center O
for O
further B-TREATMENT
care I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

As O
above O
. O

PAST O
SURGICAL O
HISTORY O
: O

02/90 O
, O
total B-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
complicated O
by O
ureteral B-TREATMENT
transection I-TREATMENT
with O
right B-TREATMENT
ureteral I-TREATMENT
tube I-TREATMENT
placed O
for O
six O
weeks O
, O
stent B-TREATMENT
tube I-TREATMENT
placed O
in O
left O
ureter O
six O
weeks O
prior O
to O
admission O
for O
a B-SYMPTOM
hydronephrosis I-SYMPTOM
post O
, O
in O
03/91 O
, O
bilateral B-TREATMENT
salpingo-oophorectomy I-TREATMENT
and O
appendectomy B-TREATMENT
. O

CURRENT O
MEDICATIONS O
: O

Prednisone B-TREATMENT
20 O
mg O
p.o. O
q.a.m. O
with O
10 O
mg O
p.o. O
q.p.m. O
, O
Uniphyl B-TREATMENT
400 O
mg O
p.o. O
q.d. O
, O
Augmentin B-TREATMENT
250 O
p.o. O
t.i.d. O
, O
Estrase B-TREATMENT
2 O
mg O
p.o. O
q.d. O
, O
MS B-TREATMENT
Contin I-TREATMENT
30 O
mg O
q.12h. O
, O
and O
Morphine B-TREATMENT
p.r.n. O

PHYSICAL O
EXAMINATION O
: O

Emaciated O
white O
female O
in O
mild B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
. O

Temperature O
was O
98.1 O
, O
heart O
rate O
116 O
, O
blood O
pressure O
120/68 O
, O
and O
room O
air O
O2 O
saturation O
was O
93% O
. O

HEENT O
: O

Dry B-SYMPTOM
mucous I-SYMPTOM
membranes I-SYMPTOM
and O
myotic B-SYMPTOM
pupils I-SYMPTOM
. O

NECK O
: O

No O
lymphadenopathy B-SYMPTOM
. O

CHEST O
: O

Few B-SYMPTOM
inspiratory I-SYMPTOM
wheezes I-SYMPTOM
and O
no O
rhonchi B-SYMPTOM
. O

HEART O
: O

Regular O
rate O
and O
rhythm O
with O
tachycardia B-SYMPTOM
and O
no O
rubs B-SYMPTOM
or O
murmur B-SYMPTOM
. O

ABDOMEN O
: O

Well B-SYMPTOM
healed I-SYMPTOM
Pfannenstiel I-SYMPTOM
scars I-SYMPTOM
and O
no O
masses B-SYMPTOM
. O

PELVIC O
: O

No O
masses B-SYMPTOM
. O

RECTAL O
: O

No O
masses B-SYMPTOM
and O
guaiac O
negative O
. O

EXTREMITIES O
: O

No O
edema B-SYMPTOM
or O
cyanosis B-SYMPTOM
. O

LABORATORY O
EXAMINATION O
: O

Hematocrit O
was O
40 O
, O
white O
count O
was O
21 O
, O
and O
platelet O
count O
of O
723,000 O
. O

PT O
and O
PTT O
were O
12 O
and O
26 O
. O

Electrolytes O
were O
within O
normal O
limits O
, O
liver O
function O
tests O
within O
normal O
limits O
, O
and O
EKG O
showed O
a O
heart O
rate O
of O
128 O
, O
axis O
73 O
, O
and O
possible O
ectopic B-SYMPTOM
P I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
for O
a B-SYMPTOM
new I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
which O
was O
felt O
most O
likely O
to O
be O
secondary O
to O
metastatic B-SYMPTOM
cervical I-SYMPTOM
cancer I-SYMPTOM
. O

There O
was O
no O
evidence O
of O
tamponade B-SYMPTOM
. O

An O
echocardiogram O
was O
scheduled O
and O
Cardiology O
was O
consulted O
. O

Echocardiogram O
showed O
moderate B-SYMPTOM
anterior I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
of O
approximately O
600 O
cc O
with O
diastolic B-SYMPTOM
indications I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
ventricle I-SYMPTOM
and O
low B-SYMPTOM
velocity I-SYMPTOM
paradox I-SYMPTOM
. O

Cardiology O
did O
not O
feel O
that O
tamponade B-SYMPTOM
at O
this O
time O
was O
a O
concern O
and O
that O
a B-TREATMENT
tap I-TREATMENT
need O
not O
be O
performed O
. O

She O
continued O
to O
have O
pulmonary B-SYMPTOM
wheezing I-SYMPTOM
, O
unknown O
origin O
, O
without O
history O
of O
asthma B-SYMPTOM
. O

Her B-TREATMENT
steroids I-TREATMENT
were O
tapered O
and O
Pulmonary O
was O
consulted O
who O
recommended O
a O
CT O
scan O
of O
the O
chest O
to O
evaluate O
the O
lung O
parenchyma O
, O
induce O
sputum O
for O
CBC O
, O
arterial O
blood O
gas O
, O
continuing O
of O
the B-TREATMENT
beta I-TREATMENT
agonist I-TREATMENT
inhalers I-TREATMENT
, O
and O
trial O
of O
steroid B-TREATMENT
inhalers I-TREATMENT
. O

They O
felt O
it O
was O
most O
likely O
a B-SYMPTOM
malignant I-SYMPTOM
lymphangitic I-SYMPTOM
spread I-SYMPTOM
with O
pericardial B-SYMPTOM
involvement I-SYMPTOM
versus O
infectious B-SYMPTOM
, O
other B-SYMPTOM
cardiovascular I-SYMPTOM
causes I-SYMPTOM
, O
or O
viral B-SYMPTOM
bronchiolitis I-SYMPTOM
. O

She O
had O
pulmonary O
function O
tests O
repeated O
which O
showed O
an O
FEV1 O
of O
36% O
of O
predicted O
and O
FVC O
of O
56% O
of O
predicted O
. O

Room O
air O
arterial O
blood O
gas O
showed O
a O
pH O
of O
7.45 O
, O
pO2 O
of O
63 O
, O
a O
pCO2 O
of O
41 O
, O
and O
fairly B-SYMPTOM
significant I-SYMPTOM
AA I-SYMPTOM
gradient I-SYMPTOM
. O

She O
was O
continued O
on O
two O
liters O
of O
oxygen B-TREATMENT
awaiting O
her O
CT O
scan O
on O
06/14 O
and O
she O
developed O
a B-SYMPTOM
new I-SYMPTOM
junctional I-SYMPTOM
rhythm I-SYMPTOM
with O
a O
question O
of O
a B-SYMPTOM
new I-SYMPTOM
rub I-SYMPTOM
versus O
murmur B-SYMPTOM
on O
examination O
. O

Cardiology O
felt O
she O
had O
a B-SYMPTOM
rub I-SYMPTOM
and O
her O
pulsus O
was O
still O
10 O
. O

EKG O
showed O
an B-SYMPTOM
ectopic I-SYMPTOM
low I-SYMPTOM
atrial I-SYMPTOM
P I-SYMPTOM
and O
they O
thought O
she O
was O
still O
stable O
without O
evidence O
of O
tamponade B-SYMPTOM
. O

She O
should O
have O
a O
follow-up O
echocardiogram O
. O

Echocardiogram O
showed O
left O
ventricle O
at O
the O
upper O
limits O
of O
normal O
for O
size O
, O
low B-SYMPTOM
normal I-SYMPTOM
function I-SYMPTOM
, O
moderate B-SYMPTOM
to I-SYMPTOM
mild I-SYMPTOM
effusion I-SYMPTOM
with O
pericardial O
pressures O
exceeding O
right O
atrial O
pressures O
, O
and O
right O
ventricular O
pressures O
at O
various O
points O
of O
patient O
&apos;s O
cycle O
without O
any O
change O
in O
the B-SYMPTOM
effusion I-SYMPTOM
from O
06/11 O
. O

Thoracic O
Surgery O
was O
also O
consulted O
and O
they O
felt O
that O
there O
was O
no O
need O
for O
a B-TREATMENT
pericardial I-TREATMENT
window I-TREATMENT
at O
the O
time O
. O

She O
should O
be O
continued O
with O
pulmonary O
oximetry O
testing O
. O

She O
underwent O
her O
CT O
scan O
. O

This O
showed O
lymphangitic B-SYMPTOM
spread I-SYMPTOM
of O
cancer B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
chest I-SYMPTOM
, O
question O
of O
pulmonary B-SYMPTOM
nodules I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
chest I-SYMPTOM
, O
pericardial B-SYMPTOM
effusion I-SYMPTOM
, O
multiple B-SYMPTOM
liver I-SYMPTOM
metastases I-SYMPTOM
, O
decreased B-SYMPTOM
function I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
kidney I-SYMPTOM
, O
dilated B-SYMPTOM
left I-SYMPTOM
intrarenal I-SYMPTOM
collecting I-SYMPTOM
system I-SYMPTOM
and I-SYMPTOM
proximal I-SYMPTOM
ureter I-SYMPTOM
, O
and O
periaortic B-SYMPTOM
lymphadenopathy I-SYMPTOM
. O

Pulmonary O
felt O
this O
was O
consistent O
also O
with O
lymphangitic B-SYMPTOM
spread I-SYMPTOM
and O
they O
did O
not O
feel O
that O
a O
bronchoscopy O
would O
be O
of O
any O
assistance O
at O
this O
time O
. O

Chemotherapy B-TREATMENT
for O
metastatic B-SYMPTOM
cervical I-SYMPTOM
cancer I-SYMPTOM
was O
discussed O
with O
the O
patient O
and O
she O
was O
started O
on O
5-FU B-TREATMENT
800 O
mg O
per O
meter O
squared O
days O
06/18 O
, O
06/19 O
, O
and O
06/20 O
. O

She O
also O
received O
Cisplatin B-TREATMENT
35 O
per O
meter O
squared O
on O
06/19 O
and O
Ifex B-TREATMENT
and O
Mesna B-TREATMENT
on O
06/18 O
. O

She O
was O
noted O
, O
on O
06/16 O
, O
to O
have O
numerous B-SYMPTOM
erythematous I-SYMPTOM
maculopapules I-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
back I-SYMPTOM
and O
chest O
. O

Dermatology O
was O
consulted O
and O
they O
felt O
that O
this O
was O
most O
likely O
steroid B-SYMPTOM
acne I-SYMPTOM
. O

They O
therefore O
felt O
a B-TREATMENT
rapid I-TREATMENT
steroid I-TREATMENT
taper I-TREATMENT
was O
indicated O
and O
topical B-TREATMENT
Erythromycin I-TREATMENT
if O
desired O
by O
the O
patient O
. O

The B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
wheezing B-SYMPTOM
continued O
but O
without O
change O
. O

Her O
cardiac O
examination O
remained O
the O
same O
and O
there O
continued O
to O
be O
no O
evidence O
of O
tamponade B-SYMPTOM
. O

Cardiology O
felt O
that O
follow-up O
echo O
was O
indicated O
on O
06/18 O
as O
she O
had O
another O
echocardiogram O
which O
showed O
no O
change O
or O
evidence O
of O
tamponade B-SYMPTOM
. O

They O
therefore O
felt O
that O
she O
could O
be O
continued O
to O
be O
followed O
by O
examination O
. O

She O
had O
some B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
changes I-SYMPTOM
with O
confusion B-SYMPTOM
and O
hallucinations B-SYMPTOM
on O
06/18 O
originating O
from O
narcotics B-TREATMENT
versus O
decreased B-SYMPTOM
pO2 I-SYMPTOM
. O

The B-TREATMENT
Ifex I-TREATMENT
was O
held O
as O
it O
was O
felt O
that O
it O
could O
have O
precipitated O
the B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
changes I-SYMPTOM
and O
that O
she O
was O
to O
receive O
no O
further B-TREATMENT
Ifex I-TREATMENT
. O

She O
had O
no O
further B-SYMPTOM
hallucinations I-SYMPTOM
since O
stopping O
the O
Ifex B-TREATMENT
. O

Psychiatry O
was O
also O
consulted O
to O
help O
her O
with O
the O
changes O
she O
was O
feeling O
since O
her O
new O
diagnosis O
. O

She O
was O
hooked O
up O
with O
support O
services O
in O
Collot O
Ln O
, O
Dugo O
, O
Indiana O
68961 O
for O
further B-TREATMENT
counselling I-TREATMENT
and O
given O
Xanax B-TREATMENT
for O
symptoms B-SYMPTOM
of O
anxiety B-SYMPTOM
. O

She O
continued O
to O
have O
no O
change O
in O
her B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
cardiac O
examination O
and O
was O
discharged O
home O
on O
06/22/91 O
after O
completing O
her B-TREATMENT
5-FU I-TREATMENT
and O
Cisplatin B-TREATMENT
chemotherapy I-TREATMENT
. O

DISPOSITION O
: O

She O
will O
be O
followed O
by O
Dr. O
Mielke O
and O
home O
care O
services O
. O

DISCHARGE O
MEDICATIONS O
: O

Premarin B-TREATMENT
0.625 O
q.d. O
, O
Proventil B-TREATMENT
Inhaler I-TREATMENT
two O
puffs O
q.i.d. O
, O
Beclovent B-TREATMENT
four O
puffs O
b.i.d. O
, O
Colace B-TREATMENT
100 O
mg O
p.o. O
t.i.d. O
, O
MS B-TREATMENT
Contin I-TREATMENT
30 O
mg O
p.o. O
t.i.d. O
, O
Elavil B-TREATMENT
25 O
mg O
p.o. O
q.h.s. O
, O
Trilisate B-TREATMENT
750 O
mg O
p.o. O
b.i.d. O
, O
MS B-TREATMENT
Elixir I-TREATMENT
100 O
mg O
p.o. O
q.2h. O
p.r.n. O
, O
Robitussin B-TREATMENT
with O
Codeine B-TREATMENT
5 O
cc O
p.o. O
q.2h. O
, O
and O
home B-TREATMENT
O2 I-TREATMENT
two I-TREATMENT
liters I-TREATMENT
via O
nasal B-TREATMENT
prong I-TREATMENT
with O
increase O
to O
four O
liters O
as O
needed O
for O
symptoms B-SYMPTOM
p.r.n. O

ZQ233/5272 O
EARLLAMARG O
S. O
MIELKE O
, O
M.D. O
RP75 O

D O
: O

07/17/91 O

Batch O
: O

8600 O

Report O
: O

J4678A87 O

T O
: O

07/21/91 O

Dicatated O
By O
: O

SONRELLE O
LOUELLPASCGACH O
, O
M.D. O
EH41 O

Admission O
Date O
: O

2015-11-22 O

Discharge O
Date O
: O

2015-11-27 O

Date O
of O
Birth O
: O

1942-03-04 O

Sex O
: O

M O

Service O
: O

CMED O
CCU-GREEN O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
73 O
year O
old O
male O
with O
a O
recent O
history O
of O
paroxysmal B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
and O
hypercholesterolemia B-SYMPTOM
who O
presented O
to O
the O
Emergency O
Department O
with O
the O
chief O
complaint O
of O
syncope B-SYMPTOM
. O

The O
patient O
was O
discharged O
from O
The O
Hospital O
for O
Orthopedics O
with O
the O
diagnosis O
of O
pulmonary B-SYMPTOM
embolism I-SYMPTOM
about O
six O
months O
prior O
to O
the O
current O
admission O
and O
was O
started O
on O
Warfarin B-TREATMENT
. O

One O
month O
prior O
to O
this O
admission O
, O
the O
patient O
reports O
not O
feeling O
well O
with O
worsening B-SYMPTOM
gastric I-SYMPTOM
distress I-SYMPTOM
. O

A O
few O
weeks O
prior O
to O
admission O
, O
he O
fell O
down O
on O
his O
back O
and O
started O
taking O
ibuprofen B-TREATMENT
1000 O
mg O
once O
a O
day O
for O
pain B-SYMPTOM
and O
Vioxx B-TREATMENT
in O
addition O
to O
his B-TREATMENT
aspirin I-TREATMENT
and O
Coumadin B-TREATMENT
regimen I-TREATMENT
. O

The O
night O
prior O
to O
admission O
, O
he O
was O
found O
by O
his O
wife O
on O
the O
bathroom O
floor O
in O
a O
pool O
of O
urine O
, O
unresponsive B-SYMPTOM
without O
any O
body O
movements O
, O
post-ictal B-SYMPTOM
state I-SYMPTOM
. O

EMS O
was O
activated O
, O
however O
, O
the O
patient O
refused O
to O
go O
to O
the O
hospital O
. O

A O
similar O
episode O
happened O
at O
2 O
a.m. O
the O
same O
night O
and O
at O
07:45 O
on O
the O
day O
of O
admission O
, O
the O
patient O
lost O
consciousness O
once O
again O
when O
he O
was O
trying O
to O
sit O
up O
. O

He O
was O
then O
transferred O
to O
The O
Hospital O
for O
Orthopedics O
. O

The O
patient O
reports O
some B-SYMPTOM
nausea I-SYMPTOM
and O
epigastric B-SYMPTOM
pressure I-SYMPTOM
which O
is O
post-prandial O
. O

He O
denies O
any O
emesis B-SYMPTOM
, O
melena B-SYMPTOM
, O
diarrhea B-SYMPTOM
or O
constipation B-SYMPTOM
. O

He O
describes O
the O
room O
spinning O
with O
attempts O
to O
sit O
upright O
. O

No O
history O
of O
previous O
episodes O
was O
noted O
. O

Denies O
incontinence B-SYMPTOM
. O

He O
does O
have O
diaphoresis B-SYMPTOM
and O
weakness B-SYMPTOM
with O
orthostatic O
changes O
. O

In O
the O
Emergency O
Department O
, O
stool O
guaiac O
was O
trace B-SYMPTOM
positive I-SYMPTOM
. O

Hematocrit O
was O
24.8 O
, O
with O
a O
baseline O
of O
46 O
. O

Gastric B-TREATMENT
lavage I-TREATMENT
was O
grossly O
positive O
for O
coffee B-SYMPTOM
ground I-SYMPTOM
material I-SYMPTOM
. O

His O
INR O
was O
found O
to O
be O
4.4 O
. O

He O
was O
given O
Vitamin B-TREATMENT
K I-TREATMENT
10 O
mg O
subcutaneously O
, O
2.5 O
liters O
of O
normal B-TREATMENT
saline I-TREATMENT
, O
two O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
and O
two O
units O
of O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
and O
transferred O
to O
the O
Medical O
Intensive O
Care O
Unit O
for O
further O
management O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Hyperthyroid B-SYMPTOM
disease I-SYMPTOM
status O
post O
radioactive B-TREATMENT
iodine I-TREATMENT
ablation I-TREATMENT
, O
now O
hypothyroid B-SYMPTOM
on O
Levoxyl B-TREATMENT
. O

2. O
History O
of O
pulmonary B-SYMPTOM
embolism I-SYMPTOM
, O
etiology O
unknown O
. O

It O
was O
thought O
to O
be O
induced O
by O
frequent O
flying O
to O
California O
. O

The O
patient O
was O
started O
on O
Coumadin B-TREATMENT
five O
months O
prior O
to O
this O
admission O
. O

3. O
Hypercholesterolemia B-SYMPTOM
. O

Well O
controlled O
on O
Lipitor B-TREATMENT
. O

Last O
total O
cholesterol O
was O
168 O
in O
2015-08-24 O
. O

4. O
Paroxysmal B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
in O
the O
setting O
of O
pulmonary B-SYMPTOM
embolism I-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

1. O
Only O
significant O
for O
a B-TREATMENT
right I-TREATMENT
inguinal I-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT
. O

ALLERGIES O
: O

Penicillin B-TREATMENT
. O

OUTPATIENT O
MEDICATIONS O
: O

1. O
Lipitor B-TREATMENT
10 O
mg O
three O
times O
a O
week O
. O

2. O
Aspirin B-TREATMENT
81 O
. O

3. O
Propranolol B-TREATMENT
10 O
mg O
three O
times O
a O
day O
. O

4. O
Coumadin B-TREATMENT
6.25 O
mg O
once O
a O
day O
. O

5. O
Levoxyl B-TREATMENT
100 O
mEq O
q. O
day O
. O

6. O
Ambien B-TREATMENT
p.r.n. O

7. O
Vitamins B-TREATMENT
. O

8. O
Vioxx B-TREATMENT
times O
three O
weeks O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
quit O
smoking O
20 O
years O
ago O
; O
ethanol O
one O
glass O
of O
wine O
a O
day O
. O

He O
is O
a O
retired O
elementary O
school O
principal O
and O
now O
works O
in O
Johnson O
management O
. O

FAMILY O
HISTORY O
: O

Significant O
for O
mother O
who O
has O
hypertension B-SYMPTOM
and O
stroke B-SYMPTOM
at O
the O
age O
of O
70 O
. O

PHYSICAL O
EXAMINATION O
: O

Temperature O
was O
100.3 O
F. O
; O
heart O
rate O
was O
115 O
. O

In O
general O
, O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Alert O
and O
oriented O
times O
three O
. O

HEENT O
: O

Extraocular O
movements O
are O
intact O
. O

Pupils O
equally O
round O
and O
reactive O
to O
light O
and O
accommodation O
bilaterally O
. O

Oropharynx O
clear O
. O

Mucosal O
membranes O
are O
moist O
. O

Cardiovascular O
: O

Regular O
rate O
and O
rhythm O
, O
normal O
S1 O
, O
S2 O
, O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
. O

Pulmonary O
clear O
to O
auscultation O
anteriorly O
. O

Abdomen O
soft O
, O
mildly B-SYMPTOM
distended I-SYMPTOM
, O
nontender B-SYMPTOM
, O
positive O
bowel O
sounds O
. O

Extremities O
with O
no O
edema B-SYMPTOM
, O
one O
to O
two O
pulses O
in O
all O
four O
extremities O
. O

LABORATORY O
: O

Sodium O
141 O
, O
potassium O
4.4 O
, O
chloride O
108 O
, O
bicarbonate O
23 O
, O
BUN O
57 O
, O
creatinine O
0.7 O
, O
glucose O
115 O
. O

White O
blood O
cell O
count O
11.0 O
, O
differential O
with O
76 O
neutrophils O
, O
2 O
monos O
, O
21 O
lymphocytes O
, O
and O
no O
eosinophils O
. O

Hematocrit O
24.8 O
, O
platelets O
223 O
, O
INR O
2.4 O
, O
CK O
234 O
. O

CT O
scan O
of O
the O
head O
showed O
no O
hemorrhage B-SYMPTOM
or O
edema B-SYMPTOM
. O

EKG O
showed O
normal O
sinus O
rhythm O
at O
90 O
with O
normal O
intervals O
and O
ST B-SYMPTOM
wave I-SYMPTOM
inversions I-SYMPTOM
and O
early B-SYMPTOM
R I-SYMPTOM
wave I-SYMPTOM
progression I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
transferred O
to O
Medical O
Intensive O
Care O
Unit O
for O
further O
management O
for O
acute B-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
. O

1. O
Gastrointestinal B-SYMPTOM
bleed I-SYMPTOM
: O

The O
patient O
continued O
to O
receive O
blood B-TREATMENT
transfusions I-TREATMENT
on O
the O
floor O
and O
serial O
hematocrits O
with O
serial O
INR O
checks O
were O
drawn O
. O

As O
he O
was O
receiving O
his O
third O
unit O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
, O
the O
patient O
became O
tachycardic B-SYMPTOM
and O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

His O
temperature O
raised O
from O
98.6 O
F. O
, O
to O
101.0 O
F. O

He O
was O
shown O
to O
have O
rigors B-SYMPTOM
. O

The B-TREATMENT
transfusion I-TREATMENT
was O
stopped O
and O
the O
patient O
was O
given O
Tylenol B-TREATMENT
1 O
mg O
with O
epinephrine B-TREATMENT
, O
100 O
mg O
of O
hydrocortisone B-TREATMENT
, O
25 O
mg O
of O
Benadryl B-TREATMENT
and O
Demerol B-TREATMENT
15 I-TREATMENT
as O
well O
as O
Pepcid B-TREATMENT
. O

He O
had O
emesis B-SYMPTOM
times O
three O
of O
75 O
cc O
of O
coffee B-SYMPTOM
ground I-SYMPTOM
material I-SYMPTOM
. O

The O
patient O
also O
desaturated O
to O
the O
low O
80 O
s O
and O
was O
started O
on O
a B-TREATMENT
non-rebreather I-TREATMENT
mask I-TREATMENT
. O

His O
saturations O
improved O
quickly O
on O
100% B-TREATMENT
non-rebreather I-TREATMENT
mask I-TREATMENT
within O
15 O
to O
20 O
minutes O
. O

Shortly O
after O
his O
mental O
status O
changed O
; O
he O
became O
disoriented B-SYMPTOM
and O
euphoric B-SYMPTOM
and O
continued O
to O
be O
in O
this O
state O
for O
two O
more O
hours O
. O

After O
that O
period O
of O
time O
, O
his O
mental O
status O
gradually O
improved O
and O
he O
continued O
to O
receive O
his B-TREATMENT
blood I-TREATMENT
transfusions I-TREATMENT
requiring O
a O
total O
of O
ten O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
and O
four O
units O
of O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
to O
reach O
a O
hematocrit O
of O
30.0 O
, O
which O
remained O
stable O
for O
the O
duration O
of O
his O
stay O
. O

On O
admission O
, O
the O
patient O
was O
started O
on O
high B-TREATMENT
dose I-TREATMENT
proton I-TREATMENT
pump I-TREATMENT
inhibitors I-TREATMENT
for O
prophylaxis B-TREATMENT
. O

On O
Wednesday O
, O
11-25 O
, O
an O
esophagogastroduodenoscopy O
was O
performed O
and O
was O
significant O
for O
the O
following O
findings O
: O

Medium B-SYMPTOM
hiatal I-SYMPTOM
hernia I-SYMPTOM
, O
Barrett's B-SYMPTOM
esophagus I-SYMPTOM
, O
erosion B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
gastroesophageal I-SYMPTOM
junction I-SYMPTOM
, O
granularity B-SYMPTOM
, O
erythema B-SYMPTOM
and O
congestion B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
antrum I-SYMPTOM
in O
the O
pre-pyloric O
region O
compatible O
with O
gastritis B-SYMPTOM
. O

Erosions B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
antrum I-SYMPTOM
and I-SYMPTOM
pre-pyloric I-SYMPTOM
region I-SYMPTOM
, O
granularity B-SYMPTOM
, O
erythema B-SYMPTOM
and O
congestion B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
anterior I-SYMPTOM
bulb I-SYMPTOM
and I-SYMPTOM
posterior I-SYMPTOM
bulb I-SYMPTOM
compatible O
with O
duodenitis B-SYMPTOM
. O

It O
was O
recommended O
by O
Gastroenterology O
that O
the O
patient O
is O
to O
stay O
off O
aspirin B-TREATMENT
for O
at O
least O
four O
to O
six O
weeks O
at O
discharge O
to O
prevent O
further B-SYMPTOM
bleeding I-SYMPTOM
. O

2. O
Cardiovascular O
: O

During O
transfusion B-SYMPTOM
reaction I-SYMPTOM
episode I-SYMPTOM
, O
the O
patient O
had O
an O
episode O
of O
tachycardia B-SYMPTOM
ranging O
from O
134 O
to O
158 O
, O
for O
one O
to O
two O
hours O
. O

EKG O
during O
this O
episode O
was O
taken O
and O
showed O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
; O
however O
, O
serial O
enzymes O
were O
significant O
for O
CK O
peaking O
at O
1075 O
, O
MB O
peaking O
at O
114 O
and O
MB O
index O
peaking O
at O
10.8 O
, O
consistent O
with O
myocardial B-SYMPTOM
damage I-SYMPTOM
. O

The O
day O
following O
this O
episode O
, O
EKG O
showed O
loss B-SYMPTOM
of I-SYMPTOM
R I-SYMPTOM
wave I-SYMPTOM
progression I-SYMPTOM
in O
anterior O
leads O
and O
Q B-SYMPTOM
waves I-SYMPTOM
in I-SYMPTOM
leads I-SYMPTOM
III I-SYMPTOM
and O
AVF B-SYMPTOM
consistent O
with O
anteroseptal B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

The O
patient O
's O
blood O
pressures O
remained O
stable O
during O
his O
stay O
. O

He O
had O
no O
episodes O
of O
arrhythmia B-SYMPTOM
on O
Telemetry O
. O

Cardiology O
consultation O
was O
obtained O
. O

The B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
was O
attributed O
to O
demand B-SYMPTOM
ischemia I-SYMPTOM
secondary O
to O
acute B-SYMPTOM
hematocrit I-SYMPTOM
drop I-SYMPTOM
exacerbated O
by O
tachycardia B-SYMPTOM
secondary O
to O
blood B-SYMPTOM
transfusion I-SYMPTOM
reaction I-SYMPTOM
. O

Further O
Cardiologic O
work-up O
was O
suggested O
as O
an O
outpatient O
at O
four O
to O
six O
weeks O
post O
discharge O
. O

The O
patient O
was O
started O
on O
Lopressor B-TREATMENT
, O
Lipitor B-TREATMENT
and O
Lisinopril B-TREATMENT
. O

3. O
After O
ten O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
and O
four O
units O
of O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
transfusions I-TREATMENT
, O
the O
patient O
's O
hematocrit O
remained O
stable O
at O
above O
30 O
. O

His O
INR O
decreased O
to O
1.3 O
at O
the O
time O
of O
discharge O
. O

He O
required O
no O
blood B-TREATMENT
transfusions I-TREATMENT
for O
four O
days O
prior O
to O
discharge O
. O

4. O
History O
of O
pulmonary B-SYMPTOM
embolism I-SYMPTOM
likely O
secondary O
to O
frequent O
flying O
. O

The O
need O
for O
further B-TREATMENT
anti-coagulation I-TREATMENT
was O
discussed O
with O
the O
patient O
's O
attending O
, O
Dr. O
Coleman O
, O
and O
it O
was O
decided O
not O
to O
continue O
anti-coagulation B-TREATMENT
due O
to O
increased O
risk B-SYMPTOM
of I-SYMPTOM
gastrointestinal I-SYMPTOM
bleeding I-SYMPTOM
. O

The O
patient O
remained O
symptom O
free O
during O
his O
stay O
in O
the O
hospital O
, O
saturating O
well O
in O
room O
air O
. O

5. O
Endocrine O
: O

The O
patient O
was O
restarted O
on O
Levothyroxine B-TREATMENT
soon O
after O
admission O
. O

His O
hemoglobin O
A1C O
was O
sent O
and O
it O
was O
pending O
at O
the O
time O
of O
discharge O
. O

6. O
Single B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
change I-SYMPTOM
times O
two O
hours O
during O
episode O
of O
blood B-SYMPTOM
transfusion I-SYMPTOM
reaction I-SYMPTOM
. O

Was O
most O
likely O
due O
to O
multiple B-TREATMENT
drugs I-TREATMENT
administered O
during O
the O
episode O
including O
Demerol B-TREATMENT
. O

After O
this O
episode O
, O
the O
patient O
's O
mental O
status O
remained O
clear O
for O
the O
rest O
of O
the O
duration O
of O
his O
stay O
. O

7. O
Prophylaxis B-TREATMENT
: O

The O
patient O
was O
sent O
home O
on O
proton B-TREATMENT
pump I-TREATMENT
inhibitors I-TREATMENT
. O

His O
Helicobacter O
pylori O
serology O
was O
sent O
and O
was O
pending O
at O
the O
time O
of O
discharge O
. O

CONDITION O
AT O
DISCHARGE O
: O

Good O
. O

DISPOSITION O
: O

The O
patient O
was O
discharged O
to O
home O
on O
the B-TREATMENT
following I-TREATMENT
medications I-TREATMENT
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Lisinopril B-TREATMENT
5 O
mg O
p.o. O
q. O
day O
. O

2. O
Metoprolol B-TREATMENT
37.5 O
mg O
p.o. O
twice O
a O
day O
. O

3. O
Lipitor B-TREATMENT
10 O
mg O
p.o. O
q. O
day O
. O

4. O
Pantoprazole B-TREATMENT
40 O
mg O
p.o. O
q. O
day O
. O

5. O
Levothyroxine B-TREATMENT
100 O
micrograms O
p.o. O
q. O
day O
. O

DISCHARGE O
INSTRUCTIONS O
: O

1. O
The O
patient O
was O
to O
arrange O
his O
follow-up O
with O
his O
primary O
care O
physician O
, O
Bryan O
Smith O
. O

2. O
To O
follow-up O
with O
his O
Cardiologist O
, O
Dr. O
Delores O
Padilla O
within O
one O
to O
two O
weeks O
of O
discharge O
. O

Tammy O
Thompson O
, O
M.D. O

40-318 O

Dictated O
By O
: O
Randolph O
Q O
Barber O
, O
M.D. O

MEDQUIST36 O

D O
: O
2015-11-26 O
15:15 O

T O
: O
2015-11-26 O
16:10 O

JOB O
#: O

90402 O

Signed O
electronically O
by O
: O
DR. O
Tammy O
Thompson O
on O
: O
FRI O
2015-11-27 O
8:46 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2019-07-17 O

Discharge O
Date O
: O

2019-07-27 O

Date O
of O
Birth O
: O

1980-01-29 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Cephalosporins B-TREATMENT
/ O
Dilaudid B-TREATMENT
/ O
Metoclopramide B-TREATMENT

Attending O
: O
Bradley O
A. O
Goldware O
, O
M.D. O

Chief O
Complaint O
: O
respiratory B-SYMPTOM
failure I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Intubation B-TREATMENT

Central B-TREATMENT
line I-TREATMENT
placement I-TREATMENT

Bronchoscopy O

History O
of O
Present O
Illness O
: O

This O
is O
a O
39 O
year-old O
female O
with O
a O
history O
of O
diabetes B-SYMPTOM
type I-SYMPTOM
I I-SYMPTOM
on O
an B-TREATMENT
insulin I-TREATMENT
pump I-TREATMENT
, O
anemia B-SYMPTOM
, O
hypothyroidism B-SYMPTOM
, O
gastroparesis B-SYMPTOM
, O
GERD B-SYMPTOM
, O
who O
was O
transferred O
from O
Mediplex O
Rehab O
Hospital O
Hospital O
for O
further B-TREATMENT
management I-TREATMENT
of O
hypoxic B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
. O

She O
arrived O
at O
Mediplex O
Rehab O
Hospital O
Hospital O
on O
07-01 O
for O
1 O
day O
of O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
and O
was O
found O
to O
be O
febrile B-SYMPTOM
to O
99 O
at O
that O
time O
. O

She O
was O
admitted O
for O
likely O
gastroparesis B-SYMPTOM
and O
eventually O
had O
a O
complete O
fever O
work-up O
that O
included O
a O
negative O
chest O
x-ray O
, O
blood O
cultures O
, O
and O
urine O
culture O
. O

She O
was O
discharged O
on O
07-02 O
and O
represented O
that O
day O
with O
continued B-SYMPTOM
nause I-SYMPTOM
, O
vomiting B-SYMPTOM
, O
and O
fever B-SYMPTOM
. O

She O
was O
readmitted O
and O
had O
a O
complete O
febrile O
work-up O
that O
included O
CT O
abdomene O
/ O
pelvis O
, O
chest O
x-ray O
, O
blood O
culture O
's O
, O
urine O
cultures O
, O
all O
of O
which O
were O
unremarkable O
. O

She O
was O
intubated O
on O
07-03 O
for O
progressive B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
. O

Workup O
continued O
to O
be O
negative O
. O

Extubation B-TREATMENT
was O
attempted O
on O
07-14 O
, O
but O
she O
was O
re-intubated O
due O
to O
inspiratory B-SYMPTOM
stridor I-SYMPTOM
. O

A O
CT O
neck O
showed O
soft B-SYMPTOM
tissue I-SYMPTOM
swelling I-SYMPTOM
obliterating O
the O
airway O
surrounding O
the B-TREATMENT
ETT I-TREATMENT
tube I-TREATMENT
. O

She O
was O
transferred O
to O
Providence O
Behavioral O
Health O
Hospital O
for O
further O
management O
. O

Past O
Medical O
History O
: O

1. O
Type B-SYMPTOM
I I-SYMPTOM
diabetes I-SYMPTOM
diagnosed O
at O
age O
27 O
. O

She O
is O
usually O
managed O
on O
an B-TREATMENT
insulin I-TREATMENT
pump I-TREATMENT
. O

2. O
Hashimoto B-SYMPTOM
's I-SYMPTOM
thyroiditis I-SYMPTOM
. O

3. O
Gastroparesis B-SYMPTOM

4. O
History O
of O
bulemia B-SYMPTOM

5. O
Anxiety B-SYMPTOM
on O
clonazepam B-TREATMENT

6. O
History O
of O
diabetic B-SYMPTOM
foot I-SYMPTOM
ulcer I-SYMPTOM
. O

Social O
History O
: O

She O
is O
married O
and O
lives O
with O
her O
husband O
. O

She O
has O
a O
10 O
month O
old O
child O
. O

She O
denies O
any O
alcohol O
, O
tobacco O
, O
or O
other O
drugs O
. O

Family O
History O
: O

Non-contributory O
. O

Physical O
Exam O
: O

Vitals O
: O

Temperature O
: O
98.8 O
Pulse O
: O
79 O

Blood O
Pressure O
: O
125/89 O

Respiratory O
Rate O
: O
12 O

Oxygen O
Saturation O
: O
100% O
on O
AC B-TREATMENT
500x12 O
, O
PEEP5 B-TREATMENT
, O
50% O

GENERAL O
: O

Intubated B-TREATMENT
, O
sedated B-TREATMENT
, O
not B-SYMPTOM
responsive I-SYMPTOM
to O
command O
, O
retracts O
to O
pain O

HEENT O
: O

Anicteric B-SYMPTOM
sclera I-SYMPTOM
bilat I-SYMPTOM
. O

Pupils B-SYMPTOM
minimally I-SYMPTOM
reactive I-SYMPTOM

NECK O
: O

No O
elevated B-SYMPTOM
JVP I-SYMPTOM
appreciated O
. O

CARDIAC O
: O

Regular O
, O
s1,s2 O
. O

No O
murmurs B-SYMPTOM

RESPIRATORY O
: O

Clear O
to O
auscultation O
anteriorly O
. O

ABDOMEN O
: O

Soft O
. O

Nondistended B-SYMPTOM
. O

No O
hepatosplenomegally B-SYMPTOM
. O

Mildly B-SYMPTOM
hypoactive I-SYMPTOM
bowelsounds I-SYMPTOM
. O

EXTREMITIES O
: O

No O
edema B-SYMPTOM
bilaterally I-SYMPTOM
. O

Pulses B-SYMPTOM
diminished I-SYMPTOM
but O
symmetric O
. O

NEURO O
: O

Sedated B-TREATMENT
. O

Retracts O
to O
painful O
stimuli O

SKIN O
: O

No O
rashes B-SYMPTOM

Pertinent O
Results O
: O

Hematology O
: O

WBC O
- O
29.9 O
HGB O
- O
8.5 O
HCT O
- O
26.8 O
PLT O
COUNT O
- O
323 O
NEUTS O
- O
75 O
BANDS O
- O
13 O
LYMPHS O
- O
6 O
MONOS O
- O
5 O
EOS O
- O
1 O
BASOS O
- O
0 O
ATYPS O
- O
0 O
METAS O
- O
0 O
MYELOS O
- O
0 O

Chemistries O
: O

SODIUM O
- O
137 O
POTASSIUM O
- O
4.5 O
CHLORIDE O
- O
106 O
TOTAL O
CO2 O
- O
22 O
UREA O
N O
- O
41 O
* O
CREAT O
- O
1.3 O
GLUCOSE O
- O
231 O
CALCIUM O
- O
7.7 O
PHOSPHATE O
- O
3.6 O
MAGNESIUM O
- O
2.4 O

Liver O
Function O
: O

ALT O
( O
SGPT O
)- O
249 O
AST O
( O
SGOT O
)- O
147 O
LD O
( O
LDH O
)- O
241 O
ALK O
PHOS O
- O
230 O
AMYLASE O
- O
28 O
TOT O
BILI O
- O
0.9 O
LIPASE O
- O
12 O
ALBUMIN O
- O
2.6 O

Coagulation O
: O

PT O
- O
13.8 O
PTT O
- O
24.3 O
INR O
( O
PT O
)- O
1.2 O

Thyroid O
: O

TSH O
- O
3.3 O

Imaging O
: O

1. O
Nexk O
CT O
: O

Increased B-SYMPTOM
soft I-SYMPTOM
tissues I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
pharynx I-SYMPTOM
. O

This O
may O
be O
secondary O
to O
soft B-SYMPTOM
tissue I-SYMPTOM
swelling I-SYMPTOM
as O
indicated O
in O
the O
patient O
's O
history O
, O
and O
some O
may O
be O
secondary O
to O
secretions B-SYMPTOM
above I-SYMPTOM
the I-SYMPTOM
ETT I-SYMPTOM
balloon I-SYMPTOM
. O

No O
retropharyngeal B-SYMPTOM
fluid I-SYMPTOM
is O
identified O
. O

Dependent B-SYMPTOM
atelectasis I-SYMPTOM
is O
present O
within O
the O
visualized O
portions O
of O
the O
lung O
apices O
. O

2. O
Chest O
CT O
: O

Bilateral B-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
consolidations I-SYMPTOM
mostly O
in O
dependent O
portion O
, O
with O
small B-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
and O
diffuse B-SYMPTOM
ground-glass I-SYMPTOM
opacity I-SYMPTOM
in I-SYMPTOM
bilateral I-SYMPTOM
upper I-SYMPTOM
and I-SYMPTOM
lower I-SYMPTOM
lobes I-SYMPTOM
, O
consistent O
with O
ARDS B-SYMPTOM
with O
pulmonary B-SYMPTOM
edema I-SYMPTOM
given O
the O
history O
. O

Ground-glass B-SYMPTOM
opacity I-SYMPTOM
is O
somewhat O
more O
prominent O
in O
right O
upper O
lobe O
, O
and O
superimposed B-SYMPTOM
infection I-SYMPTOM
cannot O
be O
totally O
excluded O
. O

Brief O
Hospital O
Course O
: O

This O
is O
a O
39 O
year-old O
female O
with O
diabetes B-SYMPTOM
type I-SYMPTOM
I I-SYMPTOM
, O
hypothyroidism B-SYMPTOM
, O
gastroparesis B-SYMPTOM
who O
was O
transfered O
for O
hypoxic B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
. O

1. O
Hypoxic B-SYMPTOM
Rspiratory I-SYMPTOM
Failure I-SYMPTOM
: O

She O
arrived O
intubated B-TREATMENT
and O
sedated B-TREATMENT
from O
Esteban O
Hospital O
. O

On O
arrival O
a O
chest O
x-ray O
showed O
perihilar B-SYMPTOM
and I-SYMPTOM
bibasilar I-SYMPTOM
opacities I-SYMPTOM
, O
which O
appeared O
conistent O
with O
pulmonary B-SYMPTOM
edema I-SYMPTOM
but O
also O
possibly O
consistent O
with O
a B-SYMPTOM
pneumonia I-SYMPTOM
. O

There O
was O
no O
evidence O
of O
ARDS B-SYMPTOM
. O

She O
was O
known O
to O
have O
gram-positive B-SYMPTOM
cocci I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
sputum I-SYMPTOM
at O
the O
outside O
hospital O
. O

A O
bronchoscopy O
with O
BAL O
was O
performed O
and O
a O
sputum O
sample O
eventually O
grew O
out O
MRSA B-SYMPTOM
. O

She O
was O
treated O
with O
vancomycin B-TREATMENT
to O
cover O
her B-SYMPTOM
MRSA I-SYMPTOM
pneumonia I-SYMPTOM
. O

A O
CT O
scan O
was O
performed O
on O
07-17 O
to O
evaluate O
the B-SYMPTOM
soft I-SYMPTOM
tissue I-SYMPTOM
swelling I-SYMPTOM
seen O
on O
CT O
at O
the O
outside O
hospital O
. O

The O
CT O
showed O
increased B-SYMPTOM
soft I-SYMPTOM
tissues I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
pharynx I-SYMPTOM
which O
was O
felt O
to O
be O
secondary O
to O
prolonged B-TREATMENT
intubation I-TREATMENT
/ O
trauma B-SYMPTOM
. O

She O
was O
treated O
with O
steroids B-TREATMENT
for O
this B-SYMPTOM
swelling I-SYMPTOM
at O
the O
outside O
hospital O
, O
and O
these O
were O
continued O
. O

It O
was O
decided O
that O
patient O
should O
receive O
one O
more O
trial O
off O
the B-TREATMENT
vent I-TREATMENT
before O
committing O
her O
to O
a B-TREATMENT
tracheotomy I-TREATMENT
. O

She O
did O
well O
on O
minimal B-TREATMENT
vent I-TREATMENT
settings I-TREATMENT
but O
it O
was O
decided O
to O
delay O
extubating O
the O
patient O
until O
the O
morning O
of O
6/2 O
. O

Overnight O
, O
the O
patient O
became O
hypoxic B-SYMPTOM
, O
dropping O
to O
the O
80 O
's O
. O

A O
chest O
x-ray O
showed O
that O
the B-TREATMENT
ET I-TREATMENT
tube I-TREATMENT
was O
displaced B-SYMPTOM
to O
very O
high O
in O
the O
trachea O
. O

The B-TREATMENT
cuff I-TREATMENT
was O
deflated O
and O
the O
patient O
was O
extubated O
. O

She O
was O
placed O
in O
supplemental B-TREATMENT
oxygen I-TREATMENT
by O
shovel B-TREATMENT
mask I-TREATMENT
and O
her O
sats O
immediately O
improved O
. O

She O
was O
weaned O
down O
until O
she O
was O
maintaining O
her O
oxygen O
saturation O
above O
90% O
on O
6L O
by O
nasal B-TREATMENT
cannuala I-TREATMENT
. O

As O
she O
was O
doing O
well O
without O
evidence O
of O
stridor B-SYMPTOM
, O
the B-TREATMENT
steroids I-TREATMENT
were O
stopped O
. O

She O
did O
well O
and O
was O
weaned O
from O
supplemental B-TREATMENT
oxygen I-TREATMENT
. O

At O
the O
time O
of O
discharge O
, O
she O
was O
oxygenating O
well O
on O
room O
air O
. O

She O
Will O
need O
to O
complete O
a O
14 O
day O
course O
of O
vancomycin B-TREATMENT
for O
her B-SYMPTOM
MRSA I-SYMPTOM
pneumonia I-SYMPTOM
on O
2019-07-30 O
. O

2. O
Enterobacter B-SYMPTOM
bacteremia I-SYMPTOM
: O

She O
was O
initially O
covered O
broadly O
with O
vancomycin B-TREATMENT
, O
ciprofloxacin B-TREATMENT
, O
and O
falgyl B-TREATMENT
. O

She O
had O
positive B-SYMPTOM
blood I-SYMPTOM
cultures I-SYMPTOM
at O
Mediplex O
Rehab O
Hospital O
Hospital O
for O
gram B-SYMPTOM
negative I-SYMPTOM
rods I-SYMPTOM
. O

Subsequently O
, O
zosyn B-TREATMENT
was O
added O
. O

The O
cultures O
grew O
out O
enterobacter B-SYMPTOM
cloacae I-SYMPTOM
. O

It O
was O
unclear O
the O
source O
of O
her B-SYMPTOM
bacteremia I-SYMPTOM
. O

Her O
stool O
cultures O
were O
negative O
. O

Her B-TREATMENT
central I-TREATMENT
line I-TREATMENT
was O
removed O
and O
the B-TREATMENT
tip I-TREATMENT
was O
culture O
negative O
. O

She O
was O
transitioned O
to O
on O
levofloxacin B-TREATMENT
for O
her B-SYMPTOM
bacteremia I-SYMPTOM
. O

She O
had O
no O
positive B-SYMPTOM
cultures I-SYMPTOM
during O
this O
admission O
. O

Once O
she O
was O
more O
stable O
, O
an O
abdominal O
CT O
was O
performed O
to O
look O
for O
an B-SYMPTOM
abscess I-SYMPTOM
. O

This O
study O
was O
negative O
. O

However O
, O
the O
study O
was O
limited O
due O
to O
inadequate O
po O
contrast O
intake O
by O
the O
patient O
; O
it O
did O
show O
a O
question O
of O
a B-SYMPTOM
cecal I-SYMPTOM
cystic I-SYMPTOM
lesion I-SYMPTOM
verse O
normal O
loop O
of O
bowel O
. O

This O
study O
will O
need O
to O
be O
repeated O
once O
she O
is O
tolerating O
po O
's O
. O

She O
will O
complete O
a O
14 O
day O
course O
of O
levofloxacin B-TREATMENT
for O
her B-SYMPTOM
bacteremia I-SYMPTOM
on O
2019-07-30 O
. O

3. O
Diabetes B-SYMPTOM
type I-SYMPTOM
I I-SYMPTOM
: O

She O
was O
intially O
maintained O
on O
an B-TREATMENT
insulin I-TREATMENT
drip I-TREATMENT
for O
tight B-TREATMENT
glycemic I-TREATMENT
control I-TREATMENT
. O

She O
was O
followed O
by O
Albano O
during O
the O
admission O
. O

She O
was O
initially O
maintained O
on O
D5W B-TREATMENT
, O
which O
was O
increased O
to O
D10W B-TREATMENT
as O
the O
patient O
was O
persistently B-SYMPTOM
borderline I-SYMPTOM
hypoglycemic I-SYMPTOM
while O
on O
insulin B-TREATMENT
drip I-TREATMENT
. O

Once O
she O
began O
to O
take O
PO O
's O
, O
the B-TREATMENT
insulin I-TREATMENT
drip I-TREATMENT
was O
stopped O
and O
patient O
was O
started O
on O
glargine B-TREATMENT
with O
a B-TREATMENT
humalog I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

While O
her O
po O
intake O
was O
minimal O
she O
was O
maintained O
on O
supplemental B-TREATMENT
IV I-TREATMENT
dextrose I-TREATMENT
to O
suppress O
ketosis B-SYMPTOM
. O

While O
she O
was O
on O
the B-TREATMENT
IV I-TREATMENT
dextrose I-TREATMENT
, O
she O
required O
up O
to O
26 O
units O
of O
glargine B-TREATMENT
for O
glycemic B-TREATMENT
control I-TREATMENT
. O

As O
she O
starting O
taking O
some O
foods O
, O
her B-TREATMENT
glargine I-TREATMENT
was O
decrease O
. O

At O
the O
time O
of O
discharge O
her B-TREATMENT
glargine I-TREATMENT
was O
10 O
. O

Her O
blood O
glucose O
were O
under O
good O
control O
. O

The O
day O
prior O
to O
discharge O
, O
she O
was O
nauseated B-SYMPTOM
and O
not O
taking O
pos O
. O

Therefore O
, O
she O
received O
1L O
of O
D5 B-TREATMENT
, O
and O
her O
sugars O
were O
elevated B-SYMPTOM
to O
400 O
the O
day O
of O
discharge O
. O

4. O
Gastroparesis B-SYMPTOM
: O

She O
has O
a O
history O
of O
gastroparesis B-SYMPTOM
secondary O
to O
long-standing B-SYMPTOM
type I-SYMPTOM
I I-SYMPTOM
diabetes I-SYMPTOM
. O

Once O
she O
was O
extubated O
, O
she O
was O
nauseated B-SYMPTOM
with O
emesis B-SYMPTOM
. O

She O
was O
intially O
treated O
with O
erythromycin B-TREATMENT
for O
pro-motility O
as O
she O
had O
a B-SYMPTOM
bad I-SYMPTOM
reaction I-SYMPTOM
to O
reglan B-TREATMENT
in O
the O
past O
. O

She O
continued O
to O
remained O
nauseated B-SYMPTOM
so O
she O
was O
treated O
with O
phenergan B-TREATMENT
, O
anzemet B-TREATMENT
, O
zofran B-TREATMENT
, O
and O
ativan B-TREATMENT
. O

She O
intermittently O
was O
able O
tolerate O
pos O
. O

Her B-SYMPTOM
nausea I-SYMPTOM
was O
accompanied O
by O
abdominal B-SYMPTOM
pain I-SYMPTOM
for O
which O
she O
was O
treated O
with O
morphine B-TREATMENT
. O

She O
was O
transitioned O
to O
a B-TREATMENT
PCA I-TREATMENT
for O
better B-TREATMENT
pain I-TREATMENT
control I-TREATMENT
. O

She O
continued O
to O
have O
nausea B-SYMPTOM
despite O
an B-TREATMENT
agressive I-TREATMENT
anti-emetic I-TREATMENT
regimen I-TREATMENT
. O

It O
was O
felt O
that O
her B-SYMPTOM
symptoms I-SYMPTOM
were O
secondary O
to O
gastroparesis B-SYMPTOM
. O

However O
, O
other O
causes O
were O
looked O
for O
including O
adrenal B-SYMPTOM
insufficiency I-SYMPTOM
and O
bowel B-SYMPTOM
obstruction I-SYMPTOM
. O

She O
had O
a O
normal O
cortisol O
stimulation O
test O
. O

A O
abdominal O
plain O
film O
showed O
non-specific B-SYMPTOM
bowel I-SYMPTOM
gas I-SYMPTOM
patterns I-SYMPTOM
that O
may O
represent O
an B-SYMPTOM
early I-SYMPTOM
obstruction I-SYMPTOM
. O

A B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
was O
placed O
for O
decompression B-TREATMENT
given O
the O
signs O
of O
early B-SYMPTOM
obstruction I-SYMPTOM
the O
day O
of O
transfer O
. O

The O
GI O
service O
was O
consulted O
and O
they O
felt O
that O
her B-SYMPTOM
symptoms I-SYMPTOM
were O
all O
gastroparesis B-SYMPTOM
. O

They O
recommended O
erythromycin B-TREATMENT
and O
zelnorm B-TREATMENT
. O

She O
should O
eventually O
have O
a O
tissue O
transglutaminase O
to O
rule O
out O
celiac B-SYMPTOM
disease I-SYMPTOM
. O

5. O
Transaminitis B-SYMPTOM
: O

Per O
report O
, O
She O
had O
elevated B-SYMPTOM
LFTs I-SYMPTOM
at O
the O
outside O
hospital O
. O

A O
right O
upper O
quadrant O
ultrasound O
was O
performed O
and O
was O
negative O
for O
any B-SYMPTOM
acute I-SYMPTOM
pathology I-SYMPTOM
. O

Her O
LFTs O
trended O
down O
during O
this O
admission O
. O

6. O
Hypothyroidism B-SYMPTOM
: O

She O
was O
maintained O
on O
her B-TREATMENT
levothyroxine I-TREATMENT
. O

While O
she O
was O
not O
taking O
adequate O
pos O
, O
she O
was O
on O
IV B-TREATMENT
levothyroxine I-TREATMENT
. O

7. O
F/E/N O
: O

She O
was O
NPO B-TREATMENT
while O
intubated B-TREATMENT
and O
recived O
tube B-TREATMENT
feedings I-TREATMENT
for O
nutrition O
. O

After O
extubation B-TREATMENT
, O
patient O
was O
started O
on O
sips O
and O
had O
a O
speech O
and O
swallow O
evaluation O
. O

She O
was O
cleared O
to O
advance O
her O
diet O
as O
tolerated O
. O

She O
only O
tolerated O
some O
clear O
liquids O
. O

At O
the O
time O
of O
transfer O
, O
she O
was O
NPO B-TREATMENT
given O
her B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
. O

8. O
Prophylaxis B-TREATMENT
: O

PPI B-TREATMENT
, O
Heparin B-TREATMENT
SQ I-TREATMENT
. O

9. O
Access O
: O

Her B-TREATMENT
central I-TREATMENT
line I-TREATMENT
was O
removed O
given O
the O
concern O
for O
a B-SYMPTOM
line I-SYMPTOM
infection I-SYMPTOM
. O

She O
had O
a B-TREATMENT
double I-TREATMENT
lumen I-TREATMENT
PICC I-TREATMENT
place O
. O

10. O
CODE O
: O

FULL B-TREATMENT

11. O
Dispo O
: O

She O
was O
transfered O
back O
to O
Mediplex O
Rehab O
Hospital O
Hospital O
per O
the O
patient O
's O
and O
husband O
's O
request O
so O
that O
she O
would O
be O
closer O
to O
home O
once O
her O
respiratory O
status O
was O
stable O
. O

anti-GBM O
is O
pending O
. O

Medications O
on O
Admission O
: O

Meds O
: O

Vitamin B-TREATMENT
D I-TREATMENT
50000 O
4662442 O
one O
time O
a O
week O

Cozaar B-TREATMENT
25 O
mg O
1 O
time O
per O
day O

Procrit B-TREATMENT
- O
Multidose O
20000 O
u O
/ O
ml O
20,000 O
units O
SQ O
every O
other O
week O

Levoxyl B-TREATMENT
150 O
mcg O
1 O
1 O
time O
per O
day O

Iron B-TREATMENT
325 O
( O
65 O
) O
mg O
twice O
a O
day O

Zoloft B-TREATMENT
100 O
mg O
1 O
per O
day O
, O
2 O
TABS O

Freestyle O
as O
directed O

Clonazepam B-TREATMENT
0.5 O
mg O

Humalog B-TREATMENT
100 O
U O
/ O
ml O
1 O
as O
directed O
pump O

Zofran B-TREATMENT
8 O
mg O
1 O
as O
directed O

Prevacid B-TREATMENT
30 O
mg O
1 O
1 O
time O
per O
day O

Lorazepam B-TREATMENT
0.5 O
mg O
1 O
to O
2 O
tablets O
twice O
daily O
if O
needed O

on O
transfer O
: O

Cipro B-TREATMENT
400 O
" O

Vanco B-TREATMENT
1 O
g O
qD O

Flagyl B-TREATMENT
500 O
q8 O

Levophed B-TREATMENT
gtt I-TREATMENT

Propofol B-TREATMENT
gtt I-TREATMENT

Solumedrol B-TREATMENT
40 O
q6 O

( O
started O
07-14 O
) O

Pepcid B-TREATMENT

FeSo4 B-TREATMENT
325 O
' O

Insulin B-TREATMENT
35 O
lantus B-TREATMENT
qhs O

Synthroid B-TREATMENT
150 O
' O

Losartan B-TREATMENT
25 O
' O

Zoloft B-TREATMENT
200 O
' O

Zelnorm B-TREATMENT
6 O
" O

MS O
Lori O
Harwood O

Discharge O
Medications O
: O

1. O
Sertraline B-TREATMENT
100 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

2. O
Heparin B-TREATMENT
( I-TREATMENT
Porcine I-TREATMENT
) O
5,000 O
unit O
/ O
mL O
Solution O
Sig O
: O
One O
( O
1 O
) O
Injection O
TID O
( O
3 O
times O
a O
day O
) O
. O

3. O
Acetaminophen B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
as O
needed O
for O
headache B-SYMPTOM
. O

4. O
Ondansetron B-TREATMENT
HCl I-TREATMENT
2 O
mg O
/ O
mL O
Solution O
Sig O
: O
One O
( O
1 O
) O
ML O
Intravenous O
Q12H O
( O
every O
12 O
hours O
) O
as O
needed O
for O
nausea B-SYMPTOM
. O

5. O
Pyridoxine B-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

6. O
Olanzapine B-TREATMENT
5 O
mg O
Tablet O
, O
Rapid O
Dissolve O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Rapid O
Dissolve O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

7. O
Insulin B-TREATMENT
Glargine I-TREATMENT
100 O
unit O
/ O
mL O
Cartridge O
Sig O
: O
Ten O
( O
10 O
) O
units O
Subcutaneous O
once O
a O
day O
. O

8. O
Humalog B-TREATMENT
100 O
unit O
/ O
mL O
Cartridge O
Sig O
: O
asdir O
Subcutaneous O
once O
a O
day O
: O
see O
attached O
sheet O
for O
sliding O
scale O
. O

9. O
Morphine B-TREATMENT
2 O
mg O
/ O
mL O
Syringe O
Sig O
: O
One O
( O
1 O
) O
Injection O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
. O

10. O
Tegaserod B-TREATMENT
Hydrogen I-TREATMENT
Maleate I-TREATMENT
6 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
bid O
( O
) O
. O

11. O
Levofloxacin B-TREATMENT
500 O
mg O
IV O
Q24H O

12. O
Vancomycin B-TREATMENT
HCl O
750 O
mg O
IV O
Q O
12H O

13. O
Dolasetron B-TREATMENT
Mesylate I-TREATMENT
25 O
mg O
IV O
Q8H O
: O
PRN O
nausea B-SYMPTOM

14. O
Promethazine B-TREATMENT
HCl I-TREATMENT
25 O
mg O
IV O
Q6H O
: O
PRN O

15. O
Lorazepam B-TREATMENT
0.5-1 O
mg O
IV O
Q3-4H O
: O
PRN O
anxiety B-SYMPTOM
, O
nausea B-SYMPTOM
hold O
for O
sedation B-SYMPTOM
. O

16. O
Levothyroxine B-TREATMENT
Sodium I-TREATMENT
75 O
mcg O
IV O
DAILY O

17. O
Pantoprazole B-TREATMENT
40 O
mg O
IV O
Q12H O

18. O
Erythromycin B-TREATMENT
500 O
mg O
IV O
Q6H O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

MRSA B-SYMPTOM
pneumonia I-SYMPTOM

Gastroparesis B-SYMPTOM

Enterobacter B-SYMPTOM
bacteremia I-SYMPTOM

Diabetes B-SYMPTOM
type I-SYMPTOM
I I-SYMPTOM

Hypothyroidism B-SYMPTOM

Discharge O
Condition O
: O

Stable O
. O

She O
was O
oxygenating O
well O
on O
room O
air O
. O

She O
continued O
to O
have O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
. O

She O
was O
unable O
to O
tolerate O
pos O
. O

Discharge O
Instructions O
: O

You O
are O
being O
transfered O
to O
Mediplex O
Rehab O
Hospital O
Hospital O
for O
further O
care O
as O
you O
have O
requested O
to O
be O
closer O
to O
home O
. O

Followup O
Instructions O
: O

You O
should O
have O
a O
anti-Tissue O
Transglutaminase O
Antibody O
, O
IgA O
to O
rule O
out O
celiac B-SYMPTOM
disease I-SYMPTOM
given O
your B-SYMPTOM
abdominal I-SYMPTOM
symptoms I-SYMPTOM
. O

Jayme O
Gary O
MD O
57-021 O

Completed O
by O
: O
Melvina O
Holland O
MD O
20-010 O
2019-07-27 O
@ O
1645 O

Signed O
electronically O
by O
: O
DR. O
Melvin O
N.I. O
Lichtenberger O
on O
: O
WED O
2019-07-31 O
7:26 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-10-21 O

Discharge O
Date O
: O

2013-10-31 O

Date O
of O
Birth O
: O

1928-10-14 O

Sex O
: O

F O

Service O
: O

CARDIOTHORACIC O

Allergies O
: O

Codeine B-TREATMENT
/ O
Shellfish O
/ O
Ciprofloxacin B-TREATMENT

Attending O
: O
Pamela O
I O
Wickman O
, O
M.D. O

Chief O
Complaint O
: O

Exertional B-SYMPTOM
angina I-SYMPTOM
and O
dyspnea B-SYMPTOM
on O
exertion O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

2013-10-21 O
CABG B-TREATMENT
x O
3 O
( O
LIMA O
-> O
LAD O
, O
SVG O
-> O
OM O
, O
SVG O
-> O
PDA O
) O

History O
of O
Present O
Illness O
: O

This O
is O
an O
85 O
year O
old O
female O
with O
prior O
history O
of O
non-hodgkins B-SYMPTOM
lymphoma I-SYMPTOM
, O
s/p O
Cytoxan B-TREATMENT
in O
2003 O
a O
with O
recurrence B-SYMPTOM
in O
2009 O
. O

Follow O
up O
examinations O
have O
found O
a B-SYMPTOM
suspicious I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
finding I-SYMPTOM
. O

Cardiac O
workup O
prior O
to O
left B-TREATMENT
lower I-TREATMENT
lobe I-TREATMENT
resection I-TREATMENT
led O
to O
cardiac O
catheterization O
which O
found O
severe B-SYMPTOM
three I-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
with O
04-05+ B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
. O

She O
now O
present O
for O
surgical B-TREATMENT
intervention I-TREATMENT
. O

Past O
Medical O
History O
: O

Non-hodgkins B-SYMPTOM
lymphoma I-SYMPTOM
- O
s/p O
Cytoxan B-TREATMENT
in O
2003 O
and O
2001 O
, O
History O
of O
Varicella B-SYMPTOM
Zoster I-SYMPTOM
with O
opthalmic B-SYMPTOM
lesions I-SYMPTOM
, O
History O
of O
Menieres B-SYMPTOM
Disease I-SYMPTOM
, O
GERD B-SYMPTOM
, O
Glaucoma B-SYMPTOM
, O
History O
of O
chronic B-SYMPTOM
sinusitis I-SYMPTOM
, O
s/p O
cataract B-TREATMENT
surgery I-TREATMENT
, O
s/p O
TAH B-TREATMENT
and O
BSO B-TREATMENT
, O
s/p O
appendectomy B-TREATMENT
, O
s/p O
bilateral B-TREATMENT
breast I-TREATMENT
reduction I-TREATMENT

Social O
History O
: O

Retired O
RN O
. O

Lives O
alone O
but O
family O
is O
close O
. O

Denies O
tobacco O
and O
ETOH O
. O

Family O
History O
: O

Daughter O
died O
of O
MI B-SYMPTOM
at O
age O
49 O
. O

Physical O
Exam O
: O

Vitals O
: O

BP O
160-170/80-84 O
, O
HR O
82 O
, O
Resp O
20 O

General O
: O

Elderly O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM

HEENT O
: O

Oropharynx O
benign O

Neck O
: O

Supple O
, O
no O
JVD B-SYMPTOM
, O
no O
carotid B-SYMPTOM
bruits I-SYMPTOM

Chest O
: O

Lungs O
CTA O
bilaterally O

Heart O
: O

Regular O
rate O
, O
04-07 O
holosystolic B-SYMPTOM
murmur I-SYMPTOM

Abdomen O
: O

Soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM

Ext O
: O

Warm O
, O
no O
edema B-SYMPTOM

Pulses O
: O

2+ O
distally O

Neuro O
: O

Nonfocal O

Pertinent O
Results O
: O

2013-10-29 O
06:10 O
AM O
BLOOD O
WBC O
- O
10.9 O
RBC O
- O
3.99 O
* O
Hgb O
- O
12.6 O
Hct O
- O
37.9 O
MCV O
- O
95 O
MCH O
- O
31.5 O
MCHC O
- O
33.2 O
RDW O
- O
13.9 O
Plt O
Ct O
- O
330 O
# O

2013-10-29 O
06:10 O
AM O
BLOOD O
Glucose O
- O
76 O
UreaN O
- O
12 O
Creat O
- O
0.9 O
Na O
- O
141 O
K O
- O
3.5 O
Cl O
- O
104 O
HCO3 O
- O
26 O
AnGap O
- O
15 O

2013-10-30 O
06:28 O
AM O
BLOOD O
Phenyto O
- O
5.5 O
* O

Brief O
Hospital O
Course O
: O

Mrs. O
Mandelbaum O
was O
admitted O
and O
underwent O
three B-TREATMENT
vessel I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
by O
Dr. O
Larry O
Mckinney O
. O

Of O
note O
, O
intraoperative O
transesophageal O
echocardiogram O
evaluation O
showed O
only O
mild B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
, O
so O
no O
repair/replacement B-TREATMENT
was O
indicated O
. O

Following O
the B-TREATMENT
operation I-TREATMENT
, O
she O
was O
brought O
to O
the O
CSRU O
. O

On O
postoperative O
day O
one O
, O
she O
was O
noted O
to O
be O
largely B-SYMPTOM
unresponsive I-SYMPTOM
with O
left B-SYMPTOM
hemiparesis I-SYMPTOM
. O

Restlessness B-SYMPTOM
with O
body B-SYMPTOM
tremors I-SYMPTOM
were O
also O
noted O
. O

A O
stat O
MRI O
was O
notable O
for O
multiple B-SYMPTOM
abnormal I-SYMPTOM
foci I-SYMPTOM
consistent O
with O
systemic B-SYMPTOM
emboli I-SYMPTOM
. O

These O
were O
found O
in O
the O
right O
cerebellar O
, O
occipital O
and O
anterior O
parietal O
lobes O
. O

The O
neurology O
service O
was O
consulted O
and O
attributed O
these O
findings O
to O
cholesterol B-SYMPTOM
emboli I-SYMPTOM
. O

Due O
to O
seizure B-SYMPTOM
activity I-SYMPTOM
, O
Dilantin B-TREATMENT
was O
started O
. O

Anticoagulation B-TREATMENT
was O
not O
recommended O
. O

Over O
the O
next O
several O
days O
, O
her O
neurological O
status O
slowly O
improved O
. O

She O
was O
eventually O
extubated O
without O
incident B-SYMPTOM
. O

She O
went O
on O
to O
experience O
paroxysmal B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
which O
was O
initially O
treated O
with O
intravenous B-TREATMENT
Amiodarone I-TREATMENT
. O

She O
concomitantly O
had O
loose B-SYMPTOM
stools I-SYMPTOM
which O
were O
C. O
diff O
negative O
. O

Her O
clinical O
status O
stablized O
and O
she O
transferred O
to O
the O
step O
down O
unit O
on O
postoperative O
day O
six O
. O

She O
remained O
mostly O
in O
a O
normal O
sinus O
rhythm O
and O
transitioned O
to O
oral B-TREATMENT
Amiodarone I-TREATMENT
which O
will O
need O
to O
continue O
for O
three O
months O
postop O
. O

She O
tolerated O
beta B-TREATMENT
blockade I-TREATMENT
which O
was O
slowly O
advanced O
as O
tolerated O
. O

She O
worked O
daily O
with O
physical O
and O
occupational O
therapy O
. O

Her O
neurological O
status O
continued O
to O
improve O
. O

Acyclovir B-TREATMENT
was O
eventually O
increased O
from O
her B-TREATMENT
maintenance I-TREATMENT
dose I-TREATMENT
for O
a B-SYMPTOM
herpes I-SYMPTOM
zoster I-SYMPTOM
breakout I-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
back I-SYMPTOM
. O

In O
addition O
, O
she O
was O
empirically O
started O
on O
Flagyl B-TREATMENT
for O
persistent B-SYMPTOM
diarrhea I-SYMPTOM
( O
despite O
negative O
C. O
diff O
cultures O
) O
, O
however O
she O
developed O
an B-SYMPTOM
additional I-SYMPTOM
rash I-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
buttocks I-SYMPTOM
after O
the O
first O
dose O
of O
flagyl B-TREATMENT
, O
so O
the B-TREATMENT
flagyl I-TREATMENT
was O
discontinued O
. O

She O
developed O
a B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
for O
which O
she O
was O
started O
on O
Bactrim B-TREATMENT
. O

A B-TREATMENT
foley I-TREATMENT
catheter I-TREATMENT
was O
inserted O
given O
her O
mutiple O
episodes O
of O
incontinence B-SYMPTOM
that O
were O
adding O
to O
skin B-SYMPTOM
irritation I-SYMPTOM
. O

On O
insertion B-TREATMENT
she O
was O
found O
to O
be O
retaining O
1400 O
cc O
of O
urine O
, O
so O
the B-TREATMENT
foley I-TREATMENT
catheter I-TREATMENT
was O
left O
in O
. O

She O
continued O
to O
make O
clinical O
improvements O
and O
was O
cleared O
for O
discharge O
to O
rehab O
on O
postoperative O
day O
10 O
. O

Medications O
on O
Admission O
: O

Acyclovir B-TREATMENT
800 O
qd O
, O
Nexium B-TREATMENT
40 O
qd O
, O
Lipitor B-TREATMENT
40 O
qd O
, O
Coreg B-TREATMENT
6.25 O
bid O
, O
Asa B-TREATMENT
81 O
qd O
, O
Timolol B-TREATMENT
CMED I-TREATMENT
CSRU I-TREATMENT
gtts I-TREATMENT
, O
Calcium B-TREATMENT
, O
MVI B-TREATMENT
, O
Vitamin B-TREATMENT
C I-TREATMENT

Discharge O
Medications O
: O

1. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
for O
fever B-SYMPTOM
or O
pain B-SYMPTOM
. O

Tablet O
( O
s O
) O

2. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

3. O
Phenytoin B-TREATMENT
Sodium I-TREATMENT
Extended I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

4. O
Furosemide B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

Tablet O
( O
s O
) O

5. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

6. O
Amiodarone B-TREATMENT
200 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
once O
a O
day O
for O
7 O
days O
: O
400 O
mg O
PO O
daily O
for O
1 O
week O
, O
then O
decrease O
to O
200 O
mg O
PO O
daily O
. O

Tablet O
( O
s O
) O

7. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
) O
. O

8. O
Acyclovir B-TREATMENT
800 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
5X/D O
( O
5 O
times O
a O
day O
) O
for O
5 O
days O
: O
Then O
decrease O
dose O
to O
800 O
mg O
PO O
daily O
. O

9. O
Lipitor B-TREATMENT
40 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

10. O
Potassium B-TREATMENT
Chloride I-TREATMENT
20 O
mEq O
Packet O
Sig O
: O
One O
( O
1 O
) O
Packet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

11. O
Trimethoprim B-TREATMENT
- I-TREATMENT
Sulfamethoxazole I-TREATMENT
160-800 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

12. O
Miconazole B-TREATMENT
Nitrate I-TREATMENT
2 O
% O
Powder O
Sig O
: O
One O
( O
1 O
) O
Appl O
Topical O
BID O
( O
2 O
times O
a O
day O
) O
as O
needed O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
- O
s/p O
CABG B-TREATMENT

Varicella B-SYMPTOM
Zoster I-SYMPTOM

Postop B-SYMPTOM
CVA I-SYMPTOM

Postop B-SYMPTOM
Atrial I-SYMPTOM
fibrillation I-SYMPTOM

Discharge O
Condition O
: O

Good O
. O

Discharge O
Instructions O
: O

Follow O
medications B-TREATMENT
on O
discharge O
instructions O
. O

Do O
not O
lift O
more O
than O
10 O
lbs. O
for O
2 O
months O
. O

Do O
not O
drive O
for O
4 O
weeks O
. O

Call O
our O
office O
for O
sternal B-SYMPTOM
drainage I-SYMPTOM
, O
temp B-SYMPTOM
> O
101.5 O

No O
lotions O
, O
creams O
, O
or O
powders O
on O
wounds B-SYMPTOM
. O

Followup O
Instructions O
: O

Make O
an O
appointment O
with O
Dr. O
Madden O
for O
1-2 O
weeks O
. O

Make O
an O
appointment O
with O
Dr. O
Murray O
for O
4 O
weeks O
. O

Make O
an O
appointment O
with O
Dr. O
Mclaughlin O
in O
neurology O
clinic O
for O
4 O
weeks O
. O

Briley O
von O
der O
Ross O
MD O
67-576 O

Completed O
by O
: O
Ann O
Kenneth O
NP O
80-BXH O
2013-10-31 O
@ O
1005 O

Signed O
electronically O
by O
: O
DR. O
Santos O
von O
der O
Ross O
on O
: O
TUE O
2013-11-05 O
7:12 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2017-05-14 O

Discharge O
Date O
: O

2017-06-26 O

Date O
of O
Birth O
: O

2017-05-14 O

Sex O
: O

F O

Service O
: O

CMED O
CCU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Jadiara O
Harrison O
is O
twin O
#1 O
born O
to O
a O
17 O
year-old O
primiparous O
mother O
at O
31 O
weeks O
gestation O
. O

Mother O
was O
admitted O
to O
the O
Nantucket O
Cottage O
Hospital O
from O
Lawrence O
General O
Hospital O
Hospital O
on O
05-01 O
with O
cervical O
effacement O
and O
preterm B-SYMPTOM
labor I-SYMPTOM
. O

She O
was O
treated O
with O
magnesium B-TREATMENT
sulfate I-TREATMENT
. O

She O
had O
previously O
been O
admitted O
here O
at O
the O
24th O
week O
after O
a O
motor O
vehicle O
accident. O
She O
was O
treated O
with O
tocolysis B-TREATMENT
and O
betamethasone B-TREATMENT
at O
that O
time O
. O

Due O
to O
progressing O
labor O
and O
presentation O
of O
twins O
, O
delivery O
was O
by O
Cesarean B-TREATMENT
section I-TREATMENT
. O

Prenatal O
screens O
were O
notable O
for O
blood O
type O
0 O
positive O
, O
antibody O
negative O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
RPR O
nonreactive O
. O

Rubella O
status O
was O
not O
documented O
. O

Group O
B O
strep O
status O
was O
unknown O
. O

Infant O
emerged O
from O
the B-SYMPTOM
breech I-SYMPTOM
position I-SYMPTOM
. O

She O
was O
vigorous O
. O

She O
was O
given O
blow-by B-TREATMENT
oxygen I-TREATMENT
and O
stimulation B-TREATMENT
. O

Her O
Apgars O
were O
7 O
at O
1 O
minute O
and O
9 O
at O
5 O
minutes O
. O

She O
was O
brought O
to O
the O
CMED O
CSRU O
for O
further O
evaluation O
. O

PHYSICAL O
EXAMINATION O
: O

ON O
admission O
, O
physical O
examination O
reveals O
a B-SYMPTOM
non I-SYMPTOM
dysmorphic I-SYMPTOM
infant I-SYMPTOM
, O
well O
saturated O
and O
perfused O
with O
multiple B-SYMPTOM
bruises I-SYMPTOM
noted O
over O
the O
upper O
legs O
, O
left O
arm O
and O
chest O
. O

No O
bony B-SYMPTOM
abnormalities I-SYMPTOM
or O
petechiae B-SYMPTOM
noted O
. O

She O
was O
moving O
all O
joints O
and O
extremities O
well O
. O

HEENT O
: O

Within O
normal O
limits O
. O

CV O
: O

Normal O
S1 O
and O
S2 O
without O
a B-SYMPTOM
murmur I-SYMPTOM
. O

Lungs O
were O
clear O
. O

Abdomen O
was O
benign O
. O

Genitalia O
normal O
. O

Premature O
female O
. O

Neuro O
: O

Non O
focal O
and O
age O
appropriate O
. O

Hips O
normal O
, O
held O
in O
the O
breech O
position O
. O

Anus O
patent O
. O

Spine O
intact O
. O

HOSPITAL O
COURSE O
: O

Respiratory O
: O

On O
admission O
, O
infant O
did O
not O
require O
supplemental B-TREATMENT
oxygen I-TREATMENT
or O
respiratory B-TREATMENT
support I-TREATMENT
. O

Since O
that O
time O
, O
Jadiara O
has O
always O
been O
in O
room O
air O
without O
requiring O
supplemental B-TREATMENT
oxygen I-TREATMENT
. O

She O
was O
noted O
to O
have O
apnea B-SYMPTOM
of I-SYMPTOM
prematurity I-SYMPTOM
, O
treated O
with O
caffeine B-TREATMENT
until O
2017-06-04 O
. O

Since O
that O
time O
, O
she O
has O
had O
very B-SYMPTOM
rare I-SYMPTOM
spells I-SYMPTOM
, O
with O
none O
for O
over O
one O
week O
by O
the O
time O
of O
discharge O
. O

Cardiovascular O
: O

She O
was O
hemodynamically O
stable O
upon O
admission O
with O
normal O
blood O
pressures O
and O
heart O
rate O
. O

On O
day O
of O
life O
15 O
, O
she O
was O
noted O
to O
have O
a B-SYMPTOM
murmur I-SYMPTOM
, O
eventually O
prompting O
evaluation O
by O
ECHO O
. O

The O
ECHO O
revealed O
an B-SYMPTOM
anomalous I-SYMPTOM
left I-SYMPTOM
coronary I-SYMPTOM
, O
with O
one O
end O
entering O
the O
right O
ventricular O
outflow O
tract O
and O
the O
other O
end O
not O
clearly O
defined O
. O

It O
was O
unable O
to O
be O
delineated O
whether O
this O
represented O
an B-SYMPTOM
anomalous I-SYMPTOM
left I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
arising I-SYMPTOM
from I-SYMPTOM
the I-SYMPTOM
pulmonary I-SYMPTOM
artery I-SYMPTOM
( I-SYMPTOM
LCAPA I-SYMPTOM
) I-SYMPTOM
or O
a B-SYMPTOM
left I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
fistula I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
pulmonar I-SYMPTOM
artery I-SYMPTOM
. O

The O
right O
coronary O
was O
prominent O
, O
and O
there O
appeared O
to O
be O
coronary B-SYMPTOM
artery I-SYMPTOM
collateral I-SYMPTOM
vessels I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
posterior I-SYMPTOM
apical I-SYMPTOM
myocardium I-SYMPTOM
. O

A B-SYMPTOM
small I-SYMPTOM
apical I-SYMPTOM
muscular I-SYMPTOM
VSD I-SYMPTOM
was O
also O
noted O
. O

Several O
additional O
ECHOs O
were O
performed O
, O
including O
an O
ECHO O
in O
the O
cardiology O
department O
at O
HealthSouth O
Rehab O
Hospital O
of O
Western O
Mass. O
, O
but O
the O
anatomy O
of O
the O
left O
coronary O
artery O
could O
not O
be O
further O
defined O
. O

Due O
to O
the O
risks O
of O
coronary B-SYMPTOM
ischemia I-SYMPTOM
if O
this O
represented O
an B-SYMPTOM
LCAPA I-SYMPTOM
, O
the O
infant O
was O
followed O
with O
regular O
ECHOs O
and O
EKGs O
during O
the O
remainder O
of O
hospitalization O
, O
with O
no O
evidence O
of O
ischemia B-SYMPTOM
, O
valvular B-SYMPTOM
regurgitation I-SYMPTOM
, O
or O
compromised B-SYMPTOM
ventricular I-SYMPTOM
function I-SYMPTOM
. O

She O
will O
be O
continued O
to O
be O
followed O
closely O
by O
cardiology O
as O
an O
outpatient O
, O
with O
likely O
plans O
for O
cardiac O
catheterization O
and O
surgical B-TREATMENT
repair I-TREATMENT
when O
she O
grows O
to O
3.5 O
to O
4 O
kg O
. O

Fluids O
, O
electrolytes O
and O
nutrition O
: O

The O
infant O
was O
initially O
maintained O
on O
IVF B-TREATMENT
, O
with O
introduction O
of O
enteral B-TREATMENT
feeds I-TREATMENT
on O
day O
of O
life O
2 O
. O

She O
was O
advanced O
to O
full B-TREATMENT
volume I-TREATMENT
enteral I-TREATMENT
feeds I-TREATMENT
by O
day O
of O
life O
7 O
, O
and O
then O
to O
a B-TREATMENT
maximum I-TREATMENT
caloric I-TREATMENT
density I-TREATMENT
of O
28 O
cals O
/ O
oz O
. O

Oral O
feedings O
were O
introduced O
as O
tolerated O
. O

By O
the O
time O
of O
discharge O
, O
infant O
is O
feedign O
BM O
or O
enfamil B-TREATMENT
24 O
cals O
/ O
oz O
PO O
ad O
lib O
, O
with O
adequate O
intake O
and O
adequate O
weight O
gain O
. O

Last O
nutrition O
labs O
were O
on O
06-20 O
with O
AP O
of O
208 O
, O
Ca O
10.8 O
, O
and O
Phos O
7.4. O

Gastrointestinal O
: O

The O
infant O
required O
phototherapy B-TREATMENT
for O
hyperbilirubinemia B-SYMPTOM
through O
day O
of O
life O
7 O
, O
with O
peak O
bilirubin O
of O
7 O
/ O
0.3 O
on O
day O
of O
life O
3 O
, O
and O
last O
bilirubin O
of O
4.9 O
/ O
0.3 O
on O
day O
of O
life O
9 O
. O

Hematologic O
/ O
Infectious O
disease O
: O

CBC O
and O
blood O
culture O
were O
obtained O
upon O
admission O
revealing O
a O
white O
blood O
cell O
count O
of O
9.0 O
with O
25 O
polys O
and O
0 O
bands O
; O
hematocrit O
was O
46.9% O
and O
platelets O
of O
222,000 O
. O

Baby O
received O
48 O
hours O
of O
Ampicillin B-TREATMENT
and O
Gentamycin B-TREATMENT
with O
negative O
cultures O
and O
a O
stable O
clinical O
course O
. O

Infant O
was O
treated O
with O
supplemental B-TREATMENT
iron I-TREATMENT
, O
and O
did O
not O
receive O
any B-TREATMENT
blood I-TREATMENT
transfusions I-TREATMENT
. O

Last O
Hct O
was O
30.6 O
on O
06-20 O
with O
a O
reticulocyte O
count O
of O
6.5%. O

Neurologic O
: O

Baby O
has O
been O
appropriate O
for O
gestational O
age O
. O

Social O
: O

Mother O
is O
17 O
years O
old O
, O
and O
has O
been O
accompanied O
on O
the O
majority O
of O
her O
visits O
by O
her O
parents O
, O
both O
of O
whom O
are O
students O
. O

The O
infant O
's O
maternal O
grandparents O
have O
been O
very O
involved O
in O
her O
care O
. O

Sensory O
: O

Initial O
opthalmologic O
exam O
on O
06-05 O
revealed O
immature B-SYMPTOM
retinas I-SYMPTOM
in O
zone O
3 O
, O
and O
repeat O
exam O
on O
06-26 O
revealed O
mature O
retinas O
bilaterally O
. O

Infant O
passed O
hearing O
screen O
prior O
to O
discharge O
. O

CONDITION O
ON O
DISCHARGE O
: O

Good O
. O

DISCHARGE O
DISPOSITION O
: O

To O
home O
. O

PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Robinson O
, O
Lawrence O
General O
Hospital O
Hospital O

Pediatrics O
, O
4952 O
Washington O
St. O
in O
Dr. O
John O
C. O
Corrigan O
Mental O
Health O
Center O
. O

( O
589 O
) O
690-3703 O
. O

CARE O
RECOMMENDATIONS O
: O

Diet O
: O

Enfamil B-TREATMENT
or O
breast O
milk O
24 O
calories O
per O
oz O
, O
with O
enfamil O
powder O
. O

Medications O
: O

Ferinsol B-TREATMENT
0.2 O
mL O
po O
qd O
. O

Newborn O
screen O
: O

Sent O
as O
per O
protocol; O
one O
specimen O
from O
2017-05-28 O
returned O
with O
borderline B-SYMPTOM
low I-SYMPTOM
thyroxine I-SYMPTOM
, O
but O
repeat O
was O
within O
normal O
limits O
. O

Immunizations O
: O

Hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
given O
06-17 O
. O

Car O
seat O
: O

Car O
seat O
safety O
screening O
passed O
prior O
to O
discharge O
. O

Follow-up O
: O

Infant O
will O
follow-up O
with O
primary O
pediatrician O
within O
2 O
days O
of O
discharge O
, O
and O
will O
see O
Dr. O
Dale O
Merkel O
of O
Pediatric O
Cardiology O
in O
Dr. O
John O
C. O
Corrigan O
Mental O
Health O
Center O
on O
2017-07-07 O
at O
1:30 O
pm O
. O

Due O
to O
breech B-SYMPTOM
presentation I-SYMPTOM
, O
a O
hip O
ultrasound O
can O
be O
considered O
in O
2-4 O
weeks O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Prematurity B-SYMPTOM
at O
31 O
weeks O
, O
twin O
#1 O
. O

2. O
Breech B-SYMPTOM
presentation I-SYMPTOM
. O

3. O
Sepsis B-SYMPTOM
suspect O
ruled O
out O
with O
antibiotics B-TREATMENT
. O

4. O
Physiologic B-SYMPTOM
jaundice I-SYMPTOM
. O

5. O
Apnea B-SYMPTOM
of I-SYMPTOM
prematurity I-SYMPTOM
. O

6. O
Anemia B-SYMPTOM
of I-SYMPTOM
prematurity I-SYMPTOM
. O

7. O
Aberrant B-SYMPTOM
left I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
. O

8. O
Muscular B-SYMPTOM
ventricular I-SYMPTOM
septal I-SYMPTOM
defect I-SYMPTOM
. O

Lisa O
Annie O
, O
MD O
50ABQ O

Dictated O
By O
: O
Ehtel O
Z O
Ebert O
, O
M.D. O

MEDQUIST36 O

D O
: O
2017-06-02 O
03:49:08 O

T O
: O
2017-06-02 O
05:32:26 O

Job O
# O
: O
12559 O

Signed O
electronically O
by O
: O
DR. O
Ann O
Nguyen O
on O
: O
TUE O
2017-06-27 O
8:40 O
AM O

( O
End O
of O
Report O
) O

116752045 O

CTMC O

20515082 O

422603 O

12/23/1991 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

12/23/1991 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

01/02/1992 O

ADMISSION O
DIAGNOSIS O
: O

ABDOMINAL B-SYMPTOM
AORTIC I-SYMPTOM
ANEURYSM I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Patient O
is O
a O
64 O
year O
old O
white O
male O
with O
a O
past O
medical O
history O
of O
smoking O
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disese I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
and O
hypercholesterolemia B-SYMPTOM
with O
a B-SYMPTOM
l0 I-SYMPTOM
cm I-SYMPTOM
abdominal I-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
. O

Patient O
presented O
to O
his O
private O
medical O
doctor O
in O
Gewestster O
with O
transient B-SYMPTOM
calf I-SYMPTOM
pain I-SYMPTOM
on O
walking O
less O
than O
fifty O
yards O
. O

Abdominal B-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
was O
discovered O
on O
examination O
and O
patient O
was O
referred O
to O
Retelk O
County O
Medical O
Center O
. O

He O
was O
admitted O
on O
10/17/06 O
and O
echocardiogram O
done O
on O
11/13/09 O
revealed O
poor B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
function I-SYMPTOM
and O
cardiac O
catheterization O
was O
done O
on O
admission O
which O
showed O
three B-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
. O

Patient O
was O
referred O
to O
Cardiology O
and O
underwent O
a B-TREATMENT
three I-TREATMENT
vessel I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
on O
11/25/09 O
. O

His O
post-operative O
course O
was O
complicated O
by O
an B-SYMPTOM
E. I-SYMPTOM
coli I-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
and O
transient B-SYMPTOM
acute I-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
with O
increasing B-SYMPTOM
creatinine I-SYMPTOM
. O

Patient O
&apos;s O
renal O
function O
returned O
to O
normal O
over O
several O
days O
, O
however O
. O

The O
patient O
&apos;s O
last O
ultrasound O
of O
his O
aorta O
revealed O
a B-SYMPTOM
l0 I-SYMPTOM
cm I-SYMPTOM
aneurysm I-SYMPTOM
and O
he O
presented O
at O
the O
time O
of O
admission O
for O
an B-TREATMENT
abdominal I-TREATMENT
aortic I-TREATMENT
aneurysm I-TREATMENT
repair I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

As O
above O
. O

Myocardial B-SYMPTOM
infarction I-SYMPTOM
also O
in O
l983 O
and O
l988 O
, O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
in O
l989 O
, O
diverticulitis B-SYMPTOM
in O
l978 O
, O
and O
spontaneous B-SYMPTOM
pneumothorax I-SYMPTOM
in O
l956 O
. O

He O
had O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times I-TREATMENT
three I-TREATMENT
as O
mentioned O
above O
. O

CURRENT O
MEDICATIONS O
: O

He O
came O
in O
on O
Carafate B-TREATMENT
, O
Enteric B-TREATMENT
Coated I-TREATMENT
Aspirin I-TREATMENT
, O
Albuterol B-TREATMENT
Inhaler I-TREATMENT
, O
Atrovent B-TREATMENT
Inhaler I-TREATMENT
, O
Procan B-TREATMENT
SR I-TREATMENT
, O
Mevacor B-TREATMENT
, O
and O
Digoxin B-TREATMENT
. O

ALLERGIES O
: O

He O
is O
allergic B-SYMPTOM
to O
Penicillin B-TREATMENT
, O
Inderal B-TREATMENT
, O
and O
also O
to O
Procan B-TREATMENT
. O

Patient O
has O
a O
seventy O
pack O
year O
history O
of O
smoking O
which O
he O
quit O
ten O
years O
ago O
and O
he O
has O
previously O
had O
problems O
with O
alcohol O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
was O
remarkable O
for O
an O
abdomen O
which O
was O
soft O
and O
non-tender B-SYMPTOM
. O

There O
was O
a B-SYMPTOM
pulsatile I-SYMPTOM
mass I-SYMPTOM
felt O
in O
the O
right O
upper O
quadrant O
near O
the O
midline O
. O

He O
had O
dopplerable B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
pulses I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
and O
on O
the O
right O
, O
they O
were O
palpable O
. O

HOSPITAL O
COURSE O
: O

Patient O
was O
admitted O
and O
taken O
to O
the O
Operating O
Room O
the O
next O
day O
on O
12/24/09 O
where O
patient O
underwent O
an B-TREATMENT
abdominal I-TREATMENT
aortic I-TREATMENT
aneurysm I-TREATMENT
repair I-TREATMENT
. O

In O
his O
post-operative O
course O
, O
patient O
was O
sent O
to O
the O
unit O
and O
was O
put O
on O
perioperative B-TREATMENT
Vancomycin I-TREATMENT
. O

Post-operatively O
, O
patient O
was O
found O
to O
have O
frequent B-SYMPTOM
aberrant I-SYMPTOM
atrial I-SYMPTOM
premature I-SYMPTOM
beats I-SYMPTOM
and O
some B-SYMPTOM
rare I-SYMPTOM
ventricular I-SYMPTOM
premature I-SYMPTOM
beats I-SYMPTOM
. O

His O
lungs O
were O
found O
to O
have O
decreased B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
with O
a O
question O
of O
fluid B-SYMPTOM
overload I-SYMPTOM
. O

There O
was O
a O
question O
of O
whether O
to O
start O
him O
on O
Quinidine B-TREATMENT
versus O
beta B-TREATMENT
blockers I-TREATMENT
. O

An O
echocardiogram O
was O
obtained O
which O
showed O
moderate B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
dysfunction I-SYMPTOM
with O
hypokinetic B-SYMPTOM
and I-SYMPTOM
akinetic I-SYMPTOM
areas I-SYMPTOM
throughout I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
ventricle I-SYMPTOM
. O

Patient O
was O
loaded O
with O
Quinidine B-TREATMENT
and O
then O
started O
on O
a B-TREATMENT
maintenance I-TREATMENT
dose I-TREATMENT
. O

Patient O
converted O
to O
normal O
sinus O
rhythm O
once O
on O
Quinidine B-TREATMENT
. O

Patient O
was O
discharged O
from O
the O
unit O
on O
12/30/09 O
and O
was O
sent O
to O
the O
floor O
. O

His B-TREATMENT
digoxin I-TREATMENT
was O
found O
to O
be O
elevated B-SYMPTOM
so O
his B-TREATMENT
Digoxin I-TREATMENT
was O
held O
for O
four O
days O
while O
levels O
slowly O
came O
down O
. O

Patient O
was O
restarted O
on O
Digoxin B-TREATMENT
just O
prior O
to O
discharge O
. O

Patient O
also O
was O
found O
to O
have O
elevated B-SYMPTOM
LDH I-SYMPTOM
, I-SYMPTOM
alkaline I-SYMPTOM
phosphatase I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
amylase I-SYMPTOM
prior O
to O
admission O
. O

Lipase O
was O
within O
normal O
limits O
. O

Ultrasound O
was O
obtained O
of O
the O
biliary O
tree O
which O
demonstrated O
no O
abnormalities B-SYMPTOM
. O

Patient O
was O
also O
found O
to O
have O
several O
complaints O
of O
awaking O
in O
the O
middle O
of O
the O
night O
with O
tachypnea B-SYMPTOM
and O
some B-SYMPTOM
bilateral I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
associated O
with O
breathing O
. O

Serial O
EKG O
and O
CK O
were O
obtained O
which O
were O
negative O
. O

A O
chest O
X-Ray O
demonstrated O
some B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
. O

An O
arterial O
blood O
gas O
at O
that O
time O
showed O
pO2 O
of O
68 O
, O
saturation O
of O
95% O
, O
a O
pH O
of O
7.5l O
, O
pCO2 O
of O
37 O
, O
a O
bicarbonate O
of O
37 O
, O
and O
a O
pCO2 O
of O
3l O
with O
a O
+7 O
base O
. O

Patient O
&apos;s O
chest O
X-Ray O
, O
as O
mentioned O
above O
, O
showed O
pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

Patient O
was O
aggressively O
diuresed O
with O
resolution O
of O
symptoms B-SYMPTOM
. O

DISPOSITION O
: O

DISCHARGE O
MEDICATIONS O
: O

Patient O
is O
being O
sent O
home O
on O
Ecotrin B-TREATMENT
one O
q.d. O
, O
Digoxin B-TREATMENT
0.l25 O
mg O
every O
three O
days O
, O
Quinidine B-TREATMENT
648 O
mg O
q.a.m. O
and O
324 O
mg O
q.p.m. O
and O
q.h.s. O
, O
Mevacor B-TREATMENT
20 O
mg O
p.o. O
q.d. O
, O
Carafate B-TREATMENT
one O
gram O
p.o. O
q.i.d. O
, O
Colace B-TREATMENT
l00 O
mg O
p.o. O
t.i.d. O
, O
Lasix B-TREATMENT
80 O
mg O
p.o. O
q.d. O
, O
Potassium B-TREATMENT
20 O
mEq O
p.o. O
q.d. O
, O
and O
iron B-TREATMENT
supplements I-TREATMENT
. O

Patient O
has O
follow-up O
with O
Dr. O
Merkel O
and O
with O
his O
private O
medical O
doctor O
. O

EV956/4659 O
RISHAN O
M. O
MERKEL O
, O
M.D. O
BS9 O

D O
: O

01/02/92 O

Batch O
: O

3669 O

Report O
: O

F6644X53 O

T O
: O

01/02/92 O

Dicatated O
By O
: O

RAMA O
R. O
KOTEOBE O
, O
M.D. O

cc O
: O

1. O
DWAINCO O
L. O
MERKEL O
, O
M.D. O

Admission O
Date O
: O

2013-08-05 O

Discharge O
Date O
: O

2013-08-15 O

Date O
of O
Birth O
: O

1949-01-18 O

Sex O
: O

M O

Service O
: O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

In O
brief O
, O
the O
patient O
is O
a O
64 O
- O
year-old O
male O
with O
a O
significant O
history O
for O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
three B-SYMPTOM
myocardial I-SYMPTOM
infarctions I-SYMPTOM
and O
also O
status O
post O
five B-TREATMENT
vessel I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
in O
' O
89 O
and O
status O
post O
multiple B-TREATMENT
percutaneous I-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasties I-TREATMENT
who O
recently O
had O
a O
catheterization O
done O
in O
Mississippi O
and O
stent B-TREATMENT
placed O
in O
2013-03-24 O
. O

The O
patient O
did O
well O
until O
approximately O
three O
to O
four O
weeks O
prior O
to O
presentation O
when O
he O
began O
to O
experience O
increased B-SYMPTOM
dyspnea I-SYMPTOM
on O
exertion O
. O

One O
week O
prior O
to O
presentation O
, O
he O
had O
chest B-SYMPTOM
pain I-SYMPTOM
leading O
to O
a O
repeat O
catheterization O
at O
Springfield O
on O
07-30 O
which O
showed O
narrowing B-SYMPTOM
of O
the B-TREATMENT
stent I-TREATMENT
and O
an O
ejection O
fraction O
of O
approximately O
20% O
. O

No O
intervention B-TREATMENT
was O
done O
at O
that O
point O
. O

On O
the O
evening O
prior O
to O
admission O
, O
the O
patient O
was O
awoken O
with O
chest B-SYMPTOM
pressure I-SYMPTOM
radiating O
to O
the O
neck O
anginal O

equivalent O
which O
was O
relieved O
by O
sublingual B-TREATMENT
nitroglycerin I-TREATMENT
. O

This O
episode O
happened O
three O
times O
that O
night O
and O
finally O
on O
the O
fourth O
re-awakening O
, O
the O
patient O
presented O
to O
the O
Emergency O
Department O
at O
Springfield O
and O
was O
transferred O
to O
the O
Faulkner O
Hospital O
for O
coronary B-TREATMENT
revascularization I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM

2. O
Myocardial B-SYMPTOM
infarction I-SYMPTOM
x3 I-SYMPTOM

3. O
Coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT

4. O
Systemic B-SYMPTOM
lupus I-SYMPTOM
erythematosus I-SYMPTOM
in O
remission O

HOME O
MEDICATIONS O
: O

1. O
Coreg B-TREATMENT
6.25 O
mg O
po O
bid O

2. O
Lasix B-TREATMENT
25 O
mg O
po O
qd O

3. O
Imdur B-TREATMENT
30 O
mg O
po O
qd O

4. O
K-Dur B-TREATMENT
10 O
milliequivalents O
po O
qd O

5. O
Zestril B-TREATMENT
2.5 O
mg O
po O
bid O

6. O
Multivitamin B-TREATMENT

7. O
Folate B-TREATMENT

ALLERGIES O
: O

He O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PHYSICAL O
EXAM O
: O

VITAL O
SIGNS O
: O

He O
was O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O

HEART O
: O

Regular O
rate O
and O
rhythm O
with O
a B-SYMPTOM
2 I-SYMPTOM
out I-SYMPTOM
of I-SYMPTOM
6 I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
heard O
loudest O
at O
the O
apex O
. O

LUNGS O
: O

Clear O
to O
auscultation O
. O

ABDOMEN O
: O

Soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

EXTREMITIES O
: O

No O
cyanosis B-SYMPTOM
, O
clubbing B-SYMPTOM
or O
edema B-SYMPTOM
. O

Palpable O
DP O
s O
bilaterally O
. O

PERTINENT O
LABS O
: O

His O
hematocrit O
was O
44 O
. O

White O
count O
was O
8 O
. O

Potassium O
was O
3.9 O
. O

BUN O
and O
creatinine O
was O
18 O
and O
0.9 O
. O

His O
troponin O
was O
29.7 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
medically O
managed O
initially O
and O
then O
underwent O
on O
2013-08-09 O
, O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
x2 O
and O
a B-TREATMENT
mitral I-TREATMENT
valve I-TREATMENT
annuloplasty I-TREATMENT
with O
placement B-TREATMENT
of I-TREATMENT
intra-aortic I-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
. O

He O
was O
transferred O
to O
the O
Intensive O
Care O
Unit O
in O
relatively O
stable O
condition O
. O

On O
postoperative O
day O
#1 O
, O
his B-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
was O
weaned O
and O
the O
patient O
was O
transferred O
at O
2 B-TREATMENT
units I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

He O
also O
began O
to O
wean O
off O
the B-TREATMENT
ventilator I-TREATMENT
. O

On O
postoperative O
day O
#1 O
in O
the O
evening O
, O
the O
patient O
was O
noted O
to O
go O
into O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
for O
which O
he O
was O
controlled O
and O
started O
on O
amiodarone B-TREATMENT
, O
after O
which O
he O
converted O
again O
to O
normal O
sinus O
rhythm O
. O

He O
was O
extubated O
during O
postoperative O
day O
#1 O
. O

On O
postoperative O
day O
#2 O
, O
the O
patient O
was O
noted O
to O
be O
relatively O
stable O
. O

His B-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
had O
already O
been O
removed O
and O
on O
postoperative O
day O
#3 O
, O
he O
was O
transferred O
to O
the O
floor O
on O
Lopressor B-TREATMENT
and O
amiodarone B-TREATMENT
in O
normal O
sinus O
rhythm O
. O

On O
the O
floor O
, O
the O
patient O
was O
noted O
to O
do O
extremely O
well O
. O

Physical O
therapy O
was O
consulted O
and O
the O
patient O
was O
ambulating O
extremely O
well O
with O
minimal O
assistance O
. O

On O
postoperative O
day O
#4 O
, O
he O
remained O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O
on O
Lopressor B-TREATMENT
at O
25 O
mg O
po O
bid O
and O
an B-TREATMENT
amiodarone I-TREATMENT
dose I-TREATMENT
. O

His B-TREATMENT
left I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
discontinued O
at O
this O
time O
and O
his B-TREATMENT
right I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
removed O
the O
following O
day O
on O

postoperative O
day O
#5 O
. O

Currently O
, O
the O
patient O
is O
postoperative O
day O
#6 O
. O

He O
remains O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O
and O
the O
patient O
is O
ambulating O
to O
a O
level O
5 O
with O
physical B-TREATMENT
therapy I-TREATMENT
and O
wishes O
to O
be O
discharged O
home O
today O
. O

DISCHARGE O
CONDITION O
: O

Stable O

DISCHARGE O
DIAGNOSES O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM

2. O
Mitral B-SYMPTOM
valve I-SYMPTOM
regurgitation I-SYMPTOM
, O
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
x2 O
and O
mitral B-TREATMENT
valve I-TREATMENT
annuloplasty I-TREATMENT

SECONDARY O
DIAGNOSES O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM

2. O
Myocardial B-SYMPTOM
infarction I-SYMPTOM
x3 O

3. O
Coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT

DISCHARGE O
MEDICATIONS O
: O

1. O
Lopressor B-TREATMENT
25 O
mg O
po O
bid O

2. O
Amiodarone B-TREATMENT
taper I-TREATMENT
400 O
mg O
po O
tid O
x4 O
days O
, O
then O
bid O
x7 O
days O
, O
qd O
x7 O
days O
, O
then O
200 O
mg O
po O
qd O

3. O
Lasix B-TREATMENT
20 O
mg O
po O
qd O

4. O
K-Dur B-TREATMENT
20 O
milliequivalents O
po O
qd O

5. O
Aspirin B-TREATMENT
81 O
mg O
po O
qd O

6. O
Percocet B-TREATMENT
1 O
to O
2 O
po O
q O
4 O
to O
6 O
hours O
prn O

7. O
Colace B-TREATMENT
100 O
mg O
po O
bid O

8. O
Percocet B-TREATMENT

9. O
Protonix B-TREATMENT
20 O
mg O
po O
qd O

DIGrimmE O
INSTRUCTIONS O
: O

The O
patient O
should O
follow O
up O
with O
Dr. O
von O
Diamond O
in O
approximately O
three O
weeks O
. O

The O
patient O
should O
also O
follow O
up O
with O
his O
primary O
care O
doctor O
, O
Dr. O
Beals O
, O
in O
approximately O
three O
weeks O
. O

Briley O
von O
der O
Ross O
, O
M.D. O

67-576 O

Dictated O
By O
: O
Julie O
H. O
Bullock O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-08-15 O
07:55 O

T O
: O
2013-08-15 O
09:01 O

JOB O
#: O

15357 O

Signed O
electronically O
by O
: O
DR. O
Santos O
von O
der O
Ross O
on O
: O
WED O
2013-08-21 O
2:56 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-09-22 O

Discharge O
Date O
: O

2013-09-26 O

Date O
of O
Birth O
: O

1934-05-15 O

Sex O
: O

F O

Service O
: O

SURGERY O

Allergies O
: O

Iodine B-TREATMENT

Attending O
: O
Ronald O
B O
Tekautz O
, O
M.D. O

Chief O
Complaint O
: O
sp O
cardiac B-SYMPTOM
arrest I-SYMPTOM
/ O
colitis B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

sp O
Left B-TREATMENT
subclavian I-TREATMENT
CVL I-TREATMENT
placement I-TREATMENT

sp O
Right B-TREATMENT
femoral I-TREATMENT
CVL I-TREATMENT
placement I-TREATMENT

History O
of O
Present O
Illness O
: O

79F O
Pmhx O
CHF,COPD B-SYMPTOM
, O
found O
down O
at O
home O
, O
pulseless B-SYMPTOM
- O
CPR B-TREATMENT
initiated O
w/ O
conciousness O
regained O
on O
scene O
. O

At O
OSH O
ABG O
7.19/94/110 O
, O
BiPAP B-TREATMENT
started O
. O

Pt O
found O
to O
be O
hypothermic B-SYMPTOM
w/ O
WBC O
17 O
( O
pt O
on O
steroids B-TREATMENT
) O
pnuemobilia B-SYMPTOM
and O
thickening B-SYMPTOM
of I-SYMPTOM
sigmoid I-SYMPTOM
. O

Currently O
on O
Nasal B-TREATMENT
cannula I-TREATMENT
02 I-TREATMENT
+ O
hemodymamically O
stable O
. O

Past O
Medical O
History O
: O

CHF B-SYMPTOM
( O
EF O
25% O
, O
mod B-SYMPTOM
AS,AR I-SYMPTOM
, O
mod B-SYMPTOM
MR I-SYMPTOM
, O
CAD,PAF B-SYMPTOM
, O
angina B-SYMPTOM
, O
COPD B-SYMPTOM
( O
O2 B-SYMPTOM
dependent I-SYMPTOM
- O
2 O
L O
) O
PVD B-SYMPTOM
, O
recurrent B-SYMPTOM
UTI I-SYMPTOM
's I-SYMPTOM
, O
Chronic B-SYMPTOM
bronchitis I-SYMPTOM
, O
? O
h/o O

DM B-SYMPTOM
, O
sp O
L B-TREATMENT
ax-bifem I-TREATMENT
, O
L B-TREATMENT
fem-CMED I-TREATMENT
, O
ERCP B-TREATMENT
'04 O
, O
T+A B-TREATMENT
, O
Appy B-TREATMENT
, O
CEA B-TREATMENT
, O
L4-L5 B-TREATMENT
laminectomy I-TREATMENT
. O

Social O
History O
: O
ex O
tobacco O
denies O
ETOH O
nursing O
home O
resident O

Family O
History O
: O

NC O

Physical O
Exam O
: O
thin O
, O
A&O O
X O
1 O

IRRR B-SYMPTOM

Decreased B-SYMPTOM
BS I-SYMPTOM
bilaterally I-SYMPTOM

soft O
, O
mild B-SYMPTOM
tenderness I-SYMPTOM
R I-SYMPTOM
and I-SYMPTOM
L I-SYMPTOM
lower I-SYMPTOM
quadrants I-SYMPTOM
- O
not O
reproducible O

visible B-TREATMENT
fem-fem I-TREATMENT
graft I-TREATMENT

ext O
warm O
, O
+ B-SYMPTOM
1 I-SYMPTOM
edema I-SYMPTOM

Pertinent O
Results O
: O

2013-09-22 O
04:20 O
AM O
BLOOD O
WBC O
- O
13.8 O
* O
RBC O
- O
3.17 O
* O
Hgb O
- O
8.9 O
* O
Hct O
- O
28.4 O
* O
MCV O
- O
90 O
MCH O
- O
28.2 O
MCHC O
- O
31.4 O
RDW O
- O
15.0 O
Plt O
Ct O
- O
185 O

2013-09-24 O
03:15 O
AM O
BLOOD O
WBC O
- O
6.8 O
RBC O
- O
2.86 O
* O
Hgb O
- O
7.7 O
* O
Hct O
- O
25.9 O
* O
MCV O
- O
91 O
MCH O
- O
27.0 O
MCHC O
- O
29.9 O
* O
RDW O
- O
15.1 O
Plt O
Ct O
- O
178 O

2013-09-25 O
02:41 O
AM O
BLOOD O
WBC O
- O
5.3 O
RBC O
- O
2.94 O
* O
Hgb O
- O
8.2 O
* O
Hct O
- O
27.4 O
* O
MCV O
- O
93 O
MCH O
- O
27.9 O
MCHC O
- O
29.9 O
* O
RDW O
- O
15.0 O
Plt O
Ct O
- O
194 O

2013-09-23 O
03:07 O
AM O
BLOOD O
PT O
- O
14.0 O
* O
PTT O
- O
30.1 O
INR O
( O
PT O
)- O
1.2 O
* O

2013-09-22 O
04:20 O
AM O
BLOOD O
Glucose O
- O
86 O
UreaN O
- O
18 O
Creat O
- O
0.8 O
Na O
- O
144 O
K O
- O
3.7 O
Cl O
- O
101 O
HCO3 O
- O
40 O
* O
AnGap O
- O
7 O
* O

2013-09-24 O
09:36 O
AM O
BLOOD O
Glucose O
- O
202 O
* O
UreaN O
- O
25 O
* O
Creat O
- O
1.1 O
Na O
- O
139 O
K O
- O
3.9 O
Cl O
- O
100 O
HCO3 O
- O
37 O
* O
AnGap O
- O
6 O
* O

2013-09-25 O
02:41 O
AM O
BLOOD O
Glucose O
- O
122 O
* O
UreaN O
- O
31 O
* O
Creat O
- O
1.3 O
* O
Na O
- O
139 O
K O
- O
4.1 O
Cl O
- O
99 O
HCO3 O
- O
35 O
* O
AnGap O
- O
9 O

2013-09-22 O
04:20 O
AM O
BLOOD O
ALT O
- O
51 O
* O
AST O
- O
86 O
* O
CK O
( O
CPK O
)- O
638 O
* O
AlkPhos O
- O
65 O
Amylase O
- O
120 O
* O
TotBili O
- O
0.4 O

2013-09-22 O
12:38 O
PM O
BLOOD O
CK O
( O
CPK O
)- O
1086 O
* O

2013-09-22 O
09:45 O
PM O
BLOOD O
CK O
( O
CPK O
)- O
972 O
* O

2013-09-25 O
02:41 O
AM O
BLOOD O
CK O
( O
CPK O
)- O
218 O
* O

2013-09-22 O
04:20 O
AM O
BLOOD O
cTropnT O
- O
0.18 O
* O

2013-09-22 O
12:38 O
PM O
BLOOD O
CK-MB O
- O
18 O
* O
MB O
Indx O
- O
1.7 O
cTropnT O
- O
0.17 O
* O

2013-09-22 O
09:45 O
PM O
BLOOD O
CK-MB O
-14 O
* O
MB O
Indx O
- O
1.4 O

2013-09-23 O
04:26 O
AM O
BLOOD O
CK-MB O
- O
10 O
MB O
Indx O
- O
1.4 O
cTropnT O
- O
0.12 O
* O

2013-09-25 O
02:41 O
AM O
BLOOD O
CK-MB O
- O
5 O
cTropnT O
- O
0.10 O
* O

2013-09-22 O
04:20 O
AM O
BLOOD O
Calcium O
- O
8.1 O
* O
Phos O
- O
3.2 O
Mg O
- O
2.0 O

2013-09-25 O
02:41 O
AM O
BLOOD O
Calcium O
- O
8.2 O
* O
Phos O
- O
5.3 O
* O
Mg O
- O
1.9 O

2013-09-23 O
07:36 O
AM O
BLOOD O
Vanco O
- O
16.2 O
* O

2013-09-24 O
10:26 O
AM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
105 O
pCO2 O
- O
95 O
* O
pH O
- O
7.19 O
* O
calTCO2 O
- O
38 O
* O
Base O
XS O
- O
4 O

2013-09-24 O
11:05 O
AM O
BLOOD O
Type O
- O
May O
pO2 O
- O
35 O
* O
pCO2 O
- O
107 O
* O
pH O
- O
7.17 O
* O
calTCO2 O
- O
41 O
* O
Base O
XS O
- O
5 O

2013-09-24 O
11:31 O
AM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
144 O
* O
pCO2 O
- O
80 O
* O
pH O
- O
7.23 O
* O
calTCO2 O
- O
35 O
* O
Base O
XS O
- O
3 O

2013-09-24 O
07:42 O
PM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
127 O
* O
pCO2 O
- O
105 O
* O
pH O
- O
7.16 O
* O
calTCO2 O
- O
40 O
* O
Base O
XS O
- O
4 O

2013-09-24 O
09:19 O
PM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
76 O
* O
pCO2 O
- O
85 O
* O
pH O
- O
7.26 O
* O
calTCO2 O
- O
40 O
* O
Base O
XS O
- O
7 O

2013-09-25 O
01:50 O
AM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
47 O
* O
pCO2 O
- O
105 O
* O
pH O
- O
7.15 O
* O
calTCO2 O
- O
39 O
* O
Base O
XS O
- O
3 O

2013-09-25 O
02:54 O
AM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
64 O
* O
pCO2 O
- O
91 O
* O
pH O
- O
7.23 O
* O
calTCO2 O
- O
40 O
* O
Base O
XS O
- O
6 O

CT O
CSpine O
: O

No O
evidence O
of O
cervical B-SYMPTOM
spine I-SYMPTOM
fracture I-SYMPTOM
. O

Cervical B-SYMPTOM
spondylosis I-SYMPTOM
as O
described O
above O
. O

CXR O
post O
CVL B-TREATMENT
placement I-TREATMENT
09-23 O
: O

A B-TREATMENT
left I-TREATMENT
subclavian I-TREATMENT
vascular I-TREATMENT
catheter I-TREATMENT
terminates O
in O
the O
superior O
vena O
cava O
. O

Several O
skin O
folds O
are O
present O
in O
the O
left O
hemithorax O
but O
there O
is O
no O
pneumothorax B-SYMPTOM
. O

There O
are O
bilateral B-SYMPTOM
moderate I-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
, O
both O
of O
which O
have O
increased O
in O
size O
since O
the O
previous O
study O
. O

New B-SYMPTOM
perihilar I-SYMPTOM
and I-SYMPTOM
basilar I-SYMPTOM
opacities I-SYMPTOM
may O
reflect O
pulmonary B-SYMPTOM
edema I-SYMPTOM
sparing O
the O
upper O
lobes O
in O
the O
setting O
of O
emphysema B-SYMPTOM
, O
but O
it O
is O
difficult O
to O
exclude O
underlying B-SYMPTOM
aspiration I-SYMPTOM
or O
infectious B-SYMPTOM
pneumonia I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lung I-SYMPTOM
bases I-SYMPTOM
. O

Surgical B-TREATMENT
clips I-TREATMENT
are O
present O
in O
the O
left O
axilla O
. O

09-25 O
CXR O
: O

Interval O
development O
of O
large B-SYMPTOM
left I-SYMPTOM
pneumothorax I-SYMPTOM
with O
almost B-SYMPTOM
complete I-SYMPTOM
collapse I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lung I-SYMPTOM
. O

Brief O
Hospital O
Course O
: O

79F O
w/ O
a O
multiple B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
including O
Sylvia O
( O
EF20% O
) O
, O
COPD B-SYMPTOM
( O
on O
home B-TREATMENT
O2 I-TREATMENT
) O
, O
found O
down O
at O
home O
, O
pulseless B-SYMPTOM
- O
CPR B-TREATMENT
initiated O
w/conciousness O
regained O
on O
scene O
. O

At O
OSH O
ABG O
7.19/94/110 O
, O
BiPAP B-TREATMENT
started O
. O

Pt O
found O
to O
be O
hypothermic B-SYMPTOM
w/ O
WBC O
17 O
( O
pt O
on O
steroids B-TREATMENT
) O
pnuemobilia B-SYMPTOM
and O
thickening B-SYMPTOM
of I-SYMPTOM
sigmoid I-SYMPTOM
. O

Pt O
was O
transferred O
to O
The O
Hospital O
for O
Orthopedics O
for O
further B-TREATMENT
management I-TREATMENT
with O
wishes O
from O
the O
pt O
and O
family O
to O
reverse O
DNR/DNI O
status O
if O
surgery B-TREATMENT
was O
indicated O
. O

On O
transfer O
, O
the O
pt O
had O
VSS O
with O
a B-SYMPTOM
mildly I-SYMPTOM
tender I-SYMPTOM
abdomen I-SYMPTOM
without O
peritoneal O
signs O
. O

It O
was O
decided O
to O
treat O
her O
conservatively O
with O
bowel B-TREATMENT
and I-TREATMENT
IV I-TREATMENT
antibiotics I-TREATMENT
. O

She O
improved O
and O
was O
tolerating O
PO O
's O
without O
difficulty O
after O
passing O
a O
swallow O
study O
. O

Her O
Cpine O
was O
clearly O
with O
both O
a O
negative O
CT O
Cspine O
and O
clinical O
exam O
. O

Her B-TREATMENT
groin I-TREATMENT
CVL I-TREATMENT
was O
DC O
'd O
after O
a B-TREATMENT
L I-TREATMENT
SC I-TREATMENT
SVL I-TREATMENT
was O
palced O
. O

CXR O
confirmed O
good O
position O
and O
no O
PTx B-SYMPTOM
. O

Overnight O
on O
HD O
3 O
, O
pt O
became O
mildly B-SYMPTOM
agitated I-SYMPTOM
and O
an O
ABG O
was O
drawn O
which O
showed O
a B-SYMPTOM
severe I-SYMPTOM
resp I-SYMPTOM
acidosis I-SYMPTOM
and O
BiPAP B-TREATMENT
was O
initiated O
. O

The O
pt O
subsequently O
developed O
severe B-SYMPTOM
hypoxia I-SYMPTOM
with O
hypotension B-SYMPTOM
. O

A O
CXR O
was O
obtained O
which O
showed O
complete B-SYMPTOM
collapse I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
L I-SYMPTOM
lung I-SYMPTOM
thought O
to O
be O
a O
result O
of O
bursting O
a B-SYMPTOM
bleb I-SYMPTOM
associated O
with O
her B-SYMPTOM
severe I-SYMPTOM
COPD I-SYMPTOM
. O

Family O
did O
not O
want O
a B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
placed O
and O
decided O
to O
make O
the O
pt O
CMO B-TREATMENT
measures I-TREATMENT
. O

On O
HD O
4 O
pt O
continued O
to O
show O
a B-SYMPTOM
severe I-SYMPTOM
respiratory I-SYMPTOM
acidosis I-SYMPTOM
, O
was O
continued O
on O
a B-TREATMENT
morphine I-TREATMENT
drip I-TREATMENT
, O
and O
was O
difficult O
to O
arouse O
. O

At O
6pm O
pt O
's O
respiratory O
status O
worsened O
and O
she O
died O
. O

Medications O
on O
Admission O
: O

coreg B-TREATMENT
6.25 O
" O
, O
captopril B-TREATMENT
12.5 O
" O
, O
effexor B-TREATMENT
150 O
' O
, O
colace B-TREATMENT
100 O
" O
prn O
, O
calcium B-TREATMENT
" O
, O
lasix B-TREATMENT
40 O
' O
, O
KCL B-TREATMENT
20 O
' O
, O
Pred B-TREATMENT
5 O
' O
, O
opscal B-TREATMENT
' O
, O
protonix B-TREATMENT
40 O
' O
, O
diamoxx B-TREATMENT
250 O
' O
, O
albuterol B-TREATMENT
prn O
, O
darvocet B-TREATMENT
prn O
, O
senekot B-TREATMENT
, O
trazadone B-TREATMENT
25 O
' O

Discharge O
Medications O
: O

NA O

Discharge O
Disposition O
: O

Expired O

Discharge O
Diagnosis O
: O
respiratory B-SYMPTOM
failure I-SYMPTOM

Discharge O
Condition O
: O

NA O

Discharge O
Instructions O
: O

NA O

Followup O
Instructions O
: O

NA O

Keith O
Clint O
MD O
44-982 O

Completed O
by O
: O
Christine O
Mary O
MD O
00-155 O
2013-09-27 O
@ O
0902 O

Signed O
electronically O
by O
: O
DR. O
William O
Lawson O
on O
: O
MON O
2013-10-14 O
8:51 O
PM O

( O
End O
of O
Report O
) O

220536305 O

CMC O

82863580 O

10/8/1994 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

10/08/1994 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

10/18/1994 O

The O
patient O
was O
scheduled O
for O
discharge O
to O
rehab O
. O

It O
was O
noted O
on O
10/8/94 O
that O
she O
had O
a B-SYMPTOM
decreased I-SYMPTOM
range I-SYMPTOM
of I-SYMPTOM
motion I-SYMPTOM
in O
both O
her O
knees O
with O
flexion O
to O
approximately O
40 O
degrees O
with O
maximum O
physical B-TREATMENT
therapy I-TREATMENT
. O

It O
was O
decided O
to O
postpone O
her O
discharge O
to O
rehab O
and O
take O
her O
back O
to O
the O
operating O
room O
for O
a B-TREATMENT
manipulation I-TREATMENT
under O
anesthesia B-TREATMENT
. O

On O
10/9/94 O
, O
she O
was O
taken O
back O
to O
the O
operating O
room O
. O

Dictated O
By O
: O

NA O
BENGSTEN O
, O
M.D O
, O
HM72 O

Attending O
: O

LUPEVICKETTE O
L. O
MELENA O
, O
M.D. O
YL7 O
TD803/0252 O

Batch O
: O

473 O

Index O
No. O
KRUQ8L9 O
GVZ O

D O
: O

10/17/94 O

T O
: O

10/18/94 O

600720722 O
SC O

86426538 O

5408181 O

9/17/2005 O
12:00:00 O
AM O

pp O

DIS O

Admission O
Date O
: O

09/17/2005 O

Report O
Status O
: O

Discharge O
Date O
: O

09/20/2005 O

****** O
FINAL O
DISCHARGE O
ORDERS O
****** O

CRASSBELBKOTE O
, O
NEE O
537-39-30-6 O
T83 O

Room O
: O

EIZ0-059 O

Service O
: O

OBS O

DISCHARGE O
PATIENT O
ON O
: O

09/20/05 O
AT O
10:00 O
AM O

CONTINGENT O
UPON O

HO O
evaluation O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

GIENGPRATLSHUFF O
, O
QUASARZELL O
KATECHEL O
, O
M.D. O
, O
PH.D. O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

DIET O
: O

No O
Restrictions O

ACTIVITY O
: O

Resume O
regular O
exercise O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

QH O
2/6wks O
, O

ALLERGY O
: O

NKA B-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

pp B-SYMPTOM
/ O
pps B-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O
Responsible O
After O
Study O
for O
Causing O
Admission O
) O
pp B-SYMPTOM

OTHER O
DIAGNOSIS O
; O
Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
pp B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

Primary O
Anesthesia O
: O

Epidural B-TREATMENT

Secondary O
Anesthesia O
: O

Local O
Procedures O
: O

PPS B-SYMPTOM
, O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

bilateral B-TREATMENT
tubal I-TREATMENT
ligation I-TREATMENT

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

G3 O
T3 O
P0 O
A0 O
L3 O

Estimated O
EDC O
: O

Maternal O
transfer O
: O

No O

ADDITIONAL O
COMMENTS O
: O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

JOAS O
, O
CENI O
, O
C.N.M. O
( O
FJ992 O
) O
09/19/05 O
09:50 O
AM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

277175072 O

NVH O

87686746 O

1/3/1997 O
12:00:00 O
AM O

10% B-SYMPTOM
BODY I-SYMPTOM
BURNS I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

01/03/1997 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

01/07/1997 O

FINAL O
DIAGNOSIS O
: O

(1) O
THIRD B-SYMPTOM
DEGREE I-SYMPTOM
BURN I-SYMPTOM
TO I-SYMPTOM
RIGHT I-SYMPTOM
HAND I-SYMPTOM
AND I-SYMPTOM
FOREARM I-SYMPTOM

(2) O
SECOND B-SYMPTOM
DEGREE I-SYMPTOM
BURN I-SYMPTOM
TO I-SYMPTOM
FACE I-SYMPTOM
PROCEDURE O
: O

(1) O
1/5/97 O
: O

DEBRIDEMENT B-TREATMENT
OF O
BURN B-SYMPTOM
AND O
APPLICATION B-TREATMENT
OF I-TREATMENT
ARTIFICIAL I-TREATMENT
SKIN I-TREATMENT

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
59 O
year O
old O
gentleman O
who O
experienced O
a B-SYMPTOM
flash I-SYMPTOM
burn I-SYMPTOM
from O
grease O
while O
working O
on O
a O
stove O
on O
the O
night O
prior O
to O
admission O
. O

The O
patient O
at O
that O
time O
treated O
himself O
symptomatically O
at O
home O
but O
presented O
to O
Roing O
Hospital O
on O
the O
day O
after O
the O
event O
and O
was O
transferred O
to O
the O
Nimaconwood O
Valley O
Hospital O
immediately O
for O
evaluation O
because O
of O
his B-SYMPTOM
extensive I-SYMPTOM
burns I-SYMPTOM
. O

The O
patient O
was O
walking O
, O
talking O
, O
and O
was O
breathing O
without O
difficulty B-SYMPTOM
on O
arrival O
. O

PAST O
SURGICAL O
HISTORY O
: O

No O
significant O
history O
. O

PAST O
MEDICAL O
HISTORY O
: O

Only O
significant O
for O
excessive O
alcohol O
use O
. O

MEDICATIONS O
: O

None O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

99% O
saturation O
on O
room O
air O
. O

Heart O
rate O
76 O
, O
blood O
pressure O
169/100 O
. O

Other O
vital O
signs O
were O
within O
normal O
limits O
. O

The O
patient O
was O
not O
anxious O
or O
ill-appearing B-SYMPTOM
. O

HEENT O
: O

Extensive B-SYMPTOM
first I-SYMPTOM
degree I-SYMPTOM
and I-SYMPTOM
second I-SYMPTOM
degree I-SYMPTOM
burns I-SYMPTOM
around I-SYMPTOM
the I-SYMPTOM
face I-SYMPTOM
, O
superficial O
in O
nature O
, O
with O
no O
blistering B-SYMPTOM
. O

His O
oropharynx O
was O
wide O
open O
with O
no O
evidence O
of O
burn B-SYMPTOM
. O

Lungs O
clear O
to O
auscultation O
bilaterally O
. O

Heart O
: O

Regular O
. O

Abdomen O
: O

Soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Extremities O
: O

Good O
pulses O
bilaterally O
. O

Skin O
: O

Third B-SYMPTOM
degree I-SYMPTOM
burn I-SYMPTOM
on I-SYMPTOM
dorsum I-SYMPTOM
of O
forearm O
and O
on O
dorsum O
of O
hand O
with O
extensive B-SYMPTOM
second I-SYMPTOM
degree I-SYMPTOM
burn I-SYMPTOM
around O
the O
remainder O
of O
his O
hand O
circumferentially O
and O
on O
his O
forearm O
. O

Pulses O
were O
intact O
. O

No O
evidence O
of O
compartment B-SYMPTOM
syndrome I-SYMPTOM
. O

Evaluation O
in O
the O
emergency O
room O
revealed O
the O
patient O
to O
be O
stable O
and O
he O
was O
evaluated O
by O
ophthalmology O
who O
also O
felt O
that O
the O
patient O
had O
no O
injury B-SYMPTOM
to I-SYMPTOM
his I-SYMPTOM
eyes I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
taken O
from O
the O
emergency O
room O
and O
transferred O
to O
the O
Surgical O
Intensive O
Care O
Unit O
for O
airway O
observation O
. O

He O
was O
given O
three O
liters O
of O
IV B-TREATMENT
hydration I-TREATMENT
with O
good O
urine O
output O
response O
. O

His B-SYMPTOM
wounds I-SYMPTOM
were O
dressed O
with O
antiointment B-TREATMENT
and O
Xeroform B-TREATMENT
with O
the O
plan O
to O
take O
him O
to O
the O
operating O
room O
for O
debridement B-TREATMENT
under O
general B-TREATMENT
anesthesia I-TREATMENT
and O
application B-TREATMENT
of I-TREATMENT
artificial I-TREATMENT
skin I-TREATMENT
. O

The O
patient O
remained O
hemodynamically O
stable O
with O
good O
urine O
output O
. O

While O
in O
the O
Intensive O
Care O
Unit O
the O
patient O
was O
put O
on O
delirium B-TREATMENT
tremons I-TREATMENT
prophylaxis I-TREATMENT
with O
Serax B-TREATMENT
around O
the O
clock O
. O

There O
was O
no O
evidence O
while O
in O
the O
hospital O
. O

The O
patient O
was O
taken O
to O
the O
operating O
room O
on O
1/5/97 O
. O

At O
that O
time O
the O
patient O
underwent O
debridement B-TREATMENT
of O
his B-SYMPTOM
facial I-SYMPTOM
wounds I-SYMPTOM
and O
debridement B-TREATMENT
of I-TREATMENT
his I-TREATMENT
right I-TREATMENT
hand I-TREATMENT
and I-TREATMENT
forearm I-TREATMENT
with O
application B-TREATMENT
of I-TREATMENT
artificial I-TREATMENT
skin I-TREATMENT
which O
is O
the O
dermagraft B-TREATMENT
TC I-TREATMENT
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
. O

There O
were O
no O
complications B-SYMPTOM
. O

Postoperatively O
the O
patient O
was O
transferred O
out O
of O
the O
Intensive O
Care O
Unit O
to O
the O
burn O
floor O
where O
he O
received O
dressing B-TREATMENT
changes I-TREATMENT
p.r.n. O

The O
patient O
remained O
afebrile B-SYMPTOM
and O
other O
vital O
signs O
were O
within O
normal O
limits O
. O

On O
the O
day O
of O
discharge O
the B-TREATMENT
patient I-TREATMENT
&apos;s I-TREATMENT
dressing I-TREATMENT
was O
taken O
down O
completely O
and O
evaluation O
of O
the B-TREATMENT
derma I-TREATMENT
graft I-TREATMENT
was O
made O
. O

At O
that O
time O
it O
appeared O
well O
adhered O
to O
the O
underlying O
skin O
. O

There O
was O
no O
evidence O
of O
infection B-SYMPTOM
. O

The O
patient O
was O
screened O
by O
the O
rehabilitation O
facility O
and O
felt O
to O
be O
an O
acceptable O
candidate O
. O

The O
patient O
and O
his O
family O
agreed O
to O
transfer O
from O
Nimaconwood O
Valley O
Hospital O
to O
Ianehutche O
Medical O
Center O
. O

DISPOSITION O
: O

DISCHARGE O
MEDICATIONS O
: O

Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O
, O
Folate B-TREATMENT
1 O
mg O
q.d. O
, O
Artificial B-TREATMENT
Tears I-TREATMENT
2 O
drops O
each O
eye O
b.i.d. O
and O
p.r.n. O
, O
Serax B-TREATMENT
15 O
mg O
p.o. O
q6h O
- O
hold O
if O
patient O
excessively B-SYMPTOM
sleepy I-SYMPTOM
, O
Thiamine B-TREATMENT
100 O
mg O
p.o. O
q.d. O
, O
MS B-TREATMENT
- I-TREATMENT
Contin I-TREATMENT
30 O
mg O
p.o.b.i.d. O
, O
multivitamin B-TREATMENT
q.d. O
, O
MSIR B-TREATMENT
15 O
mg O
p.o. O
q3-4h O
p.r.n. O
pain B-SYMPTOM
, O
and O
Axid B-TREATMENT
150 O
mg O
p.o. O
b.i.d. O

The O
patient O
is O
to O
undergo O
dry B-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
and O
splint B-TREATMENT
to I-TREATMENT
his I-TREATMENT
right I-TREATMENT
arm I-TREATMENT
q.d. O

DIET O
: O

Regular O
. O

FOLLOWUP O
: O

The O
patient O
is O
to O
be O
seen O
in O
the O
burn O
clinic O
two O
days O
after O
discharge O
. O

The O
patient O
was O
discharged O
in O
stable O
condition O
. O

Dictated O
By O
: O

TELSHEY O
K. O
PAP O
, O
M.D. O
IK06 O

Attending O
: O

TELSHEY O
K. O
PAP O
, O
M.D. O
BH2 O
MC084/4189 O

Batch O
: O

9441 O

Index O
No. O

YROINI4 O
PGM O

D O
: O

01/07/97 O

T O
: O

01/07/97 O

CC O
: O

1. O
ERFIBOULDNON O
VALLEY O
MEMORIAL O
HOSPITAL O

Admission O
Date O
: O

2010-02-05 O

Discharge O
Date O
: O

2010-02-06 O

Date O
of O
Birth O
: O

1986-06-14 O

Sex O
: O

F O

Service O
: O

TRAUMA O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
23 O
year O
old O
female O
, O
status O
post O
fall O
from O
standing O
position O
after O
slipping O
on O
ice O
. O

She O
had O
no O
loss B-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
. O

She O
recalled O
the O
entire O
event O
. O

She O
was O
found O
by O
family O
and O
friends O
to O
be O
somewhat B-SYMPTOM
confused I-SYMPTOM
and O
was O
therefore O
taken O
to O
Newton-Wellesley O
Hospital O
thereafter O
. O

Workup O
at O
the O
outside O
hospital O
included O
a O
CT O
scan O
of O
the O
head O
revealing O
a O
possible O
parietal B-SYMPTOM
subdural I-SYMPTOM
bleed I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
side I-SYMPTOM
. O

The O
patient O
's O
GCS O
was O
15 O
. O

She O
was O
hemodynamically O
stable O
. O

She O
was O
thereafter O
transferred O
to O
Beverly O
Hospital O
for O
further O
evaluation O
and O
management B-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
for O
depression B-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Prozac B-TREATMENT
. O

2. O
Tetracycline B-TREATMENT
for O
acne B-SYMPTOM
. O

ALLERGIES O
: O

She O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

On O
presentation O
, O
her O
temperature O
was O
98.8 O
with O
a O
heart O
rate O
of O
100 O
, O
blood O
pressure O
110/65 O
, O
respiratory O
rate O
18 O
, O
and O
she O
was O
saturating O
at O
100% O
in O
room O
air O
. O

In O
general O
, O
she O
is O
well O
appearing O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
examination O
- O
The O
pupils O
are O
equal O
, O
round O
, O
and O
reactive O
to O
light O
and O
accommodation O
. O

Extraocular O
movements O
are O
intact O
. O

The O
oropharynx O
is O
negative O
. O

Face O
is O
stable O
. O

No O
obvious O
evidence O
of O
trauma B-SYMPTOM
. O

She O
is O
normocephalic O
otherwise O
. O

Trachea O
was O
midline O
. O

The O
heart O
was O
regular O
. O

The O
lungs O
were O
clear O
to O
auscultation O
bilaterally O
. O

No O
crepitus B-SYMPTOM
. O

The O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Extremities O
with O
no O
evidence O
of O
step-off B-SYMPTOM
, O
palpable O
pulses O
peripherally O
. O

She O
had O
brisk O
capillary O
refill O
. O

Rectal O
examination O
was O
heme O
negative O
with O
normal O
tone O
. O

Neurologic O
examination O
was O
nonfocal O
. O

Neurosensory O
was O
intact O
and O
she O
had O
normal O
motor O
examination O
with O
5/5 O
strength O
throughout O
all O
her O
upper O
and O
lower O
extremities O
. O

LABORATORY O
DATA O
: O

Admission O
laboratories O
were O
notable O
for O
a O
white O
count O
of O
13.1 O
, O
hematocrit O
34.0 O
, O
platelet O
count O
280,000 O
. O

Chemistries O
were O
notable O
for O
a O
sodium O
of O
143 O
, O
potassium O
3.2 O
, O
chloride O
and O
bicarbonate O
of O
104 O
and O
24 O
, O
respectively O
, O
with O
blood O
urea O
nitrogen O
and O
creatinine O
of O
7 O
and O
0.4 O
, O
respectively O
. O

Blood O
glucose O
was O
116 O
. O

Her O
admission O
coagulation O
studies O
were O
notable O
for O
a O
prothrombin O
time O
INR O
of O
11.8 O
and O
0.9 O
, O
respectively O
with O
a O
partial O
thromboplastin O
time O
of O
25.2 O
. O

Admission O
lactate O
was O
0.8 O
. O

Amylase O
was O
87 O
. O

Fibrinogen O
was O
346 O
. O

HCG O
was O
negative O
. O

Serum O
toxicology O
and O
urine O
toxicology O
were O
negative O
. O

Urinalysis O
obtained O
on O
admission O
was O
additionally O
negative O
. O

She O
had O
three O
views O
of O
the O
cervical O
spine O
that O
were O
negative O
. O

Chest O
x-ray O
was O
negative O
. O

Pelvis O
film O
was O
negative O
. O

Head O
CT O
from O
the O
outside O
hospital O
just O
revealed O
a B-SYMPTOM
small I-SYMPTOM
right I-SYMPTOM
parietal I-SYMPTOM
subdural I-SYMPTOM
blood I-SYMPTOM
. O

She O
was O
evaluated O
. O

Her O
cervical O
spine O
was O
cleared O
. O

She O
was O
off O
TLS B-TREATMENT
precautions I-TREATMENT
. O

She O
was O
sent O
to O
the O
Intensive O
Care O
Unit O
for O
monitoring O
overnight O
for O
neural O
checks O
and O
neurosurgical O
consultation O
was O
obtained O
. O

Neurosurgical O
evaluation O
just O
recommended O
serial O
neurologic O
checks O
and O
a O
repeat O
CAT O
scan O
on O
the O
second O
day O
of O
admission O
to O
see O
if O
there O
was O
any O
evidence O
of O
progression O
of O
the B-SYMPTOM
bleeding I-SYMPTOM
. O

On O
2010-02-05 O
, O
the O
patient O
had O
a O
repeat O
CAT O
scan O
of O
the O
head O
revealing O
no O
change B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
subdural I-SYMPTOM
bleed I-SYMPTOM
. O

Her O
neurologic O
examination O
remained O
nonfocal O
. O

She O
was O
kept O
in O
the O
hospital O
for O
an O
additional O
24 O
hours O
for O
further O
evaluation O
. O

By O
2010-02-06 O
, O
which O
would O
correlate O
with O
hospital O
day O
number O
two O
, O
the O
patient O
had O
no O
complaints O
except O
for O
some B-SYMPTOM
small I-SYMPTOM
frontal I-SYMPTOM
pressure I-SYMPTOM
in O
the O
region O
of O
where O
the B-SYMPTOM
bleed I-SYMPTOM
had O
been O
localized O
on O
the O
right O
side O
. O

She O
remained O
afebrile B-SYMPTOM
and O
hemodynamically O
. O

She O
was O
tolerating O
diet O
and O
able O
to O
ambulate O
without O
difficulty O
. O

She O
had O
no O
other O
complaints O
by O
examination O
. O

Her O
neurologic O
examination O
remained O
completely O
nonfocal O
and O
otherwise O
normal O
. O

She O
was O
seen O
by O
the O
trauma O
attending O
with O
Dr. O
Walters O
and O
she O
was O
cleared O
for O
discharge O
to O
home O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Tylenol B-TREATMENT
#3 I-TREATMENT
one O
to O
two O
tablets O
p.o. O
q O
4-6 O
hours O
p.r.n. O

2. O
Motrin B-TREATMENT
as O
needed O
. O

3. O
Prozac B-TREATMENT
20 O
mg O
p.o. O
once O
daily O
. O

4. O
Tetracycline B-TREATMENT
which O
she O
was O
taking O
for O
her B-SYMPTOM
acne I-SYMPTOM
. O

FOLLOW-UP O
: O

She O
will O
follow-up O
with O
Dr. O
Langley O
in O
approximately O
one O
month O
. O

Her O
trauma O
clinic O
follow-up O
is O
strictly O
p.r.n. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Right B-SYMPTOM
parietal I-SYMPTOM
subdural I-SYMPTOM
bleed I-SYMPTOM
, O
status O
post O
fall O
from O
standing O
position O
with O
no O
loss B-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
and O
no O
neurologic B-SYMPTOM
deficits I-SYMPTOM
or O
progression B-SYMPTOM
. O

2. O
Depression B-SYMPTOM
. O

3. O
Acne B-SYMPTOM
. O

DISCHARGE O
STATUS O
: O

The O
patient O
was O
discharged O
to O
home O
in O
stable O
condition O
. O

Charles O
I. O
. O
Sanders O
, O
M.D. O
76-364 O

Dictated O
By O
: O
Hayden O
Y. O
Ferguson O
, O
M.D. O

MEDQUIST36 O

D O
: O
2010-02-06 O
08:59 O

T O
: O
2010-02-06 O
09:10 O

JOB O
#: O
73118 O

Signed O
electronically O
by O
: O
DR. O
Theresa O
MOORMAN O
on O
: O
FRI O
2010-02-26 O
3:21 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2010-06-07 O

Discharge O
Date O
: O

2010-06-12 O

Date O
of O
Birth O
: O

1955-03-30 O

Sex O
: O

M O

Service O
: O

CARDIOTHORACIC O
SURGERY O

HISTORY O
OF O
THE O
PRESENT O
ILLNESS O
: O

This O
is O
a O
55 O
- O
year-old O
male O
with O
critical B-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM
who O
was O
referred O
to O
Dr. O
Brenda O
Hummer O
for O
discussion O
for O
surgical B-TREATMENT
options I-TREATMENT
to O
free O
this B-SYMPTOM
condition I-SYMPTOM
. O

The O
patient O
reportedly O
had O
been O
experiencing O
increasing B-SYMPTOM
fatigue I-SYMPTOM
and O
dyspnea B-SYMPTOM
with O
exertion O
for O
the O
year O
prior O
to O
his O
admission O
. O

The O
patient O
reported O
increasingly O
frequent O
episodes O
of O
dizziness B-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
accompanied O
with O
coughing B-SYMPTOM
spells I-SYMPTOM
after O
walking O
approximately O
a O
half O
a O
mile O
or O
climbing O
three O
flights O
of O
stairs O
. O

On O
2010-05-27 O
, O
an O
echocardiogram O
was O
done O
which O
revealed O
critical B-SYMPTOM
fibrocalcific I-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM
with O
a O
peak O
gradient O
of O
125 O
mmHg O
, O
a O
mean O
gradient O
of O
74 O
mmHg O
, O
an O
Oak O
Bluffs O
of O
0.44 O
, O
and O
1+ B-SYMPTOM
aortic I-SYMPTOM
and I-SYMPTOM
mitral I-SYMPTOM
insufficiency I-SYMPTOM
. O

The O
patient O
subsequently O
underwent O
a O
cardiac O
catheterization O
on O
2010-06-01 O
, O
which O
demonstrated O
no O
hemodynamically B-SYMPTOM
significant I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
but O
critical B-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM
consistent O
with O
his O
echocardiogram O
study O
results O
. O

The O
patient O
was O
subsequently O
scheduled O
for O
a B-TREATMENT
mechanical I-TREATMENT
aortic I-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
procedure I-TREATMENT
with O
aortic B-TREATMENT
replacement I-TREATMENT
on O
2010-06-07 O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Diabetes B-SYMPTOM
. O

2. O
Hypertension B-SYMPTOM
. O

3. O
Seasonal B-SYMPTOM
allergies I-SYMPTOM
. O

4. O
Arthritis B-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

Negative O
. O

AT O
- O
HOME O
MEDICATIONS O
: O

1. O
Metformin B-TREATMENT
. O

2. O
Celexa B-TREATMENT
. O

3. O
Lipitor B-TREATMENT
. O

4. O
Aspirin B-TREATMENT
. O

5. O
Toprol B-TREATMENT
XL I-TREATMENT
. O

ALLERGIES O
: O

The O
patient O
is O
allergic B-SYMPTOM
to O
penicillin B-TREATMENT
and O
shell O
fish O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
is O
married O
with O
two O
children O
and O
is O
currently O
unemployed O
. O

The O
patient O
denied O
any O
tobacco O
or O
alcohol O
history O
. O

HOSPITAL O
COURSE O
: O

On O
2010-06-07 O
, O
the O
patient O
underwent O
a B-TREATMENT
mechanical I-TREATMENT
aortic I-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
with O
a B-TREATMENT
23 I-TREATMENT
mm I-TREATMENT
Carbomedics I-TREATMENT
mechanical I-TREATMENT
valve I-TREATMENT
and O
a B-TREATMENT
Supra I-TREATMENT
coronary I-TREATMENT
aortic I-TREATMENT
graft I-TREATMENT
with O
gelweave B-TREATMENT
28 O
mm O
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
with O
a B-TREATMENT
bypass I-TREATMENT
time I-TREATMENT
of O
155 O
minutes O
and O
a B-TREATMENT
crossclamp I-TREATMENT
time I-TREATMENT
of O

130 O
minutes O
, O
and O
a O
rest O
time O
of O
16 O
minutes O
. O

The O
patient O
's O
pericardium O
was O
left O
open O
; O
lines B-TREATMENT
placed O
included O
a B-TREATMENT
right I-TREATMENT
radial I-TREATMENT
line I-TREATMENT
and O
a B-TREATMENT
right I-TREATMENT
IJ I-TREATMENT
line I-TREATMENT
; O
both O
ventricular B-TREATMENT
and I-TREATMENT
atrial I-TREATMENT
wires I-TREATMENT
were O
placed O
; O
two B-TREATMENT
mediastinal I-TREATMENT
tubes I-TREATMENT
were O
placed O
. O

The O
patient O
was O
subsequently O
transferred O
to O
the O
Cardiac O
Surgery O
Recovery O
Unit O
, O
intubated B-TREATMENT
, O
for O
further O
evaluation O
and O
management O
. O

On O
transfer O
, O
the O
patient O
's O
mean O
arterial O
pressure O
was O
76 O
, O
CVP O
12 O
, O
PAD O
17 O
, O
and O
his O
Bennie O
was O
25 O
. O

The O
patient O
was O
AV B-TREATMENT
paced I-TREATMENT
at O
a O
rate O
of O
88 O
beats O
per O
minute O
. O

Active B-TREATMENT
drips I-TREATMENT
included O
milrinone B-TREATMENT
, O
Levophed B-TREATMENT
, O
propofol B-TREATMENT
, O
and O
insulin B-TREATMENT
. O

On O
postoperative O
day O
number O
one O
, O
the O
patient O
was O
successfully O
weaned O
and O
extubated O
without O
complication B-SYMPTOM
. O

The O
patient O
was O
then O
advanced O
to O
oral O
intake O
which O
he O
tolerated O
without O
complication B-SYMPTOM
. O

On O
postoperative O
day O
number O
two O
, O
the B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
chest I-TREATMENT
tubes I-TREATMENT
were O
removed O
without O
complication B-SYMPTOM
and O
the O
patient O
was O
subsequently O
cleared O
for O
transfer O
to O
the O
floor O
. O

The O
patient O
was O
subsequently O
admitted O
to O
the O
cardiothoracic O
service O
under O
the O
direction O
of O
Dr. O
Brenda O
Hummer O
. O

Postoperatively O
, O
the O
patient O
's O
clinical O
course O
was O
largely O
unremarkable O
. O

The O
patient O
was O
evaluated O
by O
Physical O
Therapy O
, O
who O
declared O
him O
a O
suitable O
candidate O
for O
discharge O
directly O
to O
home O
following O
resolution O
of O
his B-TREATMENT
medical I-TREATMENT
therapy I-TREATMENT
. O

The O
patient O
was O
advanced O
to O
a O
full O
regular O
diet O
, O
which O
he O
tolerated O
without O
complication B-SYMPTOM
, O
and O
had O
adequate B-TREATMENT
pain I-TREATMENT
control I-TREATMENT
provided O
via O
oral B-TREATMENT
pain I-TREATMENT
medications I-TREATMENT
. O

The O
patient O
was O
begun O
on O
anticoagulation B-TREATMENT
therapy I-TREATMENT
for O
a O
target O
INR O
of O
2.5 O
. O

On O
the O
evening O
of O
postoperative O
day O
number O
four O
, O
the O
patient O
had O
a O
transient O
episode O
of O
disorientation B-SYMPTOM
and O
confusion B-SYMPTOM
which O
subsequently O
resolved O
spontaneously O
. O

By O
postoperative O
day O
number O
five O
, O
the O
patient O
was O
noted O
to O
be O
afebrile B-SYMPTOM
and O
stable O
. O

His B-SYMPTOM
incision I-SYMPTOM
was O
noted O
to O
be O
clean O
, O
dry O
, O
and O
intact O
with O
no O
evidence O
of O
cellulitis B-SYMPTOM
or O
purulent B-SYMPTOM
drainage I-SYMPTOM
. O

The O
patient O
was O
noted O
to O
be O
independently O
ambulatory O
and O
was O
productive O
of O
adequate O
amounts O
of O
urine O
. O

The O
patient O
was O
tolerant O
of O
a O
full O
regular O
diet O
and O
had O
his B-SYMPTOM
pain I-SYMPTOM
well O
controlled O
via O
oral B-TREATMENT
pain I-TREATMENT
medications I-TREATMENT
. O

The O
patient O
's O
INR O
was O
noted O
to O
be O
2.3 O
. O

The O
patient O
was O
subsequently O
cleared O
for O
discharge O
to O
home O
with O
instructions O
for O
follow-up O
on O
postoperative O
day O
number O
five O
, O
2010-06-12 O
. O

CONDITION O
AT O
DISCHARGE O
: O

The O
patient O
is O
to O
be O
discharged O
to O
home O
with O
instructions O
for O
follow-up O
. O

STATUS O
AT O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Lopressor B-TREATMENT
25 O
mg O
p.o. O
b.i.d. O

2. O
Lasix B-TREATMENT
20 O
mg O
p.o. O
q. O
12 O
hours O
times O
seven O
days O
. O

3. O
Potassium B-TREATMENT
chloride I-TREATMENT
20 O
mEq O
p.o. O
q. O
12 O
hours O
times O
seven O
days O
. O

4. O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

5. O
Metformin B-TREATMENT
500 O
mg O
p.o. O
b.i.d. O

6. O
Percocet B-TREATMENT
5/325 O
one O
to O
two O
tablets O
p.o. O
q. O
four O
to O
six O
hours O
p.r.n. O

7. O
Celexa B-TREATMENT
20 O
mg O
p.o. O
q.d. O

8. O
Lipitor B-TREATMENT
20 O
mg O
p.o. O
q.d. O

9. O
Warfarin B-TREATMENT
5 O
mg O
p.o. O
q.d. O
times O
four O
days O
, O
after O
which O
point O
the O
patient O
's O
dosage O
schedule O
is O
to O
be O
coordinated O
by O
his O
PCP O
, O
Dr. O
Jerold O
Esqueda O
. O

DISCHARGE O
INSTRUCTIONS O
: O

The O
patient O
is O
to O
maintain O
his B-SYMPTOM
incisions I-SYMPTOM
clean O
and O
dry O
at O
all O
times O
. O

The O
patient O
may O
shower O
but O
should O
pat O
dry O
incisions B-SYMPTOM
afterwards O
; O
no O
bathing O
or O
swimming O
until O
further O
notice O
. O

The O
patient O
may O
resume O
a B-TREATMENT
Heart I-TREATMENT
Healthy I-TREATMENT
Diet I-TREATMENT
. O

The O
patient O
had O
been O
advised O
to O
limit O
his O
physical O
exercise O
; O
no O
heavy O
exertion O
. O

No O
driving O
while O
taking O
prescription B-TREATMENT
pain I-TREATMENT
medications I-TREATMENT
. O

The O
patient O
is O
to O
have O
his B-TREATMENT
Coumadin I-TREATMENT
managed O
by O
his O
primary O
care O
provider O
, O
Dr. O
Jerold O
Esqueda O
, O
for O
a O
target O
INR O
of O
2.5 O
. O

The O
patient O
is O
to O
report O
to O
Dr. O
Jones O
office O
on O
2010-06-14 O
for O
an O
initial O
blood O
draw O
and O
subsequent B-TREATMENT
Coumadin I-TREATMENT
titration I-TREATMENT
; O
Coumadin O
levels O
are O
to O
be O
monitored O
per O
his O
PCP O
David O
. O

The O
patient O
is O
to O
follow-up O
with O
Dr. O
Leanne O
Larimore O
in O
Cardiology O
within O
two O
to O
three O
weeks O
following O
discharge O
. O

The O
patient O
is O
to O
follow-up O
with O
Dr. O
Brenda O
Hummer O
four O
weeks O
following O
discharge O
. O

The O
patient O
is O
to O
call O
to O
schedule O
all O
appointments O
. O

Tracy O
X. O
Carmen O
, O
M.D. O

76-050 O

Dictated O
By O
: O
Gerald O
R. O
Quiroz O
, O
M.D. O

MEDQUIST36 O

D O
: O
2010-06-12 O
02:00 O

T O
: O
2010-06-12 O
14:21 O

JOB O
#: O
47222 O

Signed O
electronically O
by O
: O
DR. O
Tiffany O
D. O
Picklesimer O
on O
: O
WED O
2010-07-28 O
4:41 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2015-01-19 O

Discharge O
Date O
: O

2015-01-22 O

Date O
of O
Birth O
: O

1948-02-29 O

Sex O
: O

F O

Service O
: O

CCU O

DISCHARGE O
SUMMARY O
ADDENDUM O
: O
The O
patient O
during O
her O
admission O
from O
2015-01-19 O
to O
2015-01-22 O
during O
that O
admission O
she O
had O
an O
echocardiogram O
which O
revealed O
essentially O
an O
ejection O
fraction O
of O
40% O
with O
a B-SYMPTOM
patent I-SYMPTOM
foramen I-SYMPTOM
ovale I-SYMPTOM
mildly B-SYMPTOM
dilated I-SYMPTOM
left I-SYMPTOM
atrium I-SYMPTOM
. O

It O
also O
showed O
intraseptal B-SYMPTOM
and I-SYMPTOM
inferior I-SYMPTOM
akinesis I-SYMPTOM
. O

Additionally O
because O
of O
her O
history O
of O
contrast B-SYMPTOM
allergy I-SYMPTOM
, O
she O
was O
given O
Solu-Medrol B-TREATMENT
40 O
milligrams O
IV O
prior O
to O
the B-TREATMENT
procedure I-TREATMENT
. O

She O
did O
not O
have O
any B-SYMPTOM
untoward I-SYMPTOM
affects I-SYMPTOM
or O
allergic B-SYMPTOM
reactions I-SYMPTOM
to O
the B-TREATMENT
procedure I-TREATMENT
. O

Barbara O
Gallant O
, O
M.D. O

66-480 O

Dictated O
By O
: O
Troy O
X. O
Hall O
, O
M.D. O

MEDQUIST36 O

D O
: O
2015-03-12 O
18:30 O

T O
: O
2015-03-16 O
11:19 O

JOB O
#: O
24204 O

Signed O
electronically O
by O
: O
DR. O
Barbara O
Rogers O
on O
: O
WED O
2015-03-25 O
9:51 O
AM O

( O
End O
of O
Report O
) O

693519617 O

PUOMC O

2328487 O

769151 O

388371 O

12/16/1997 O
12:00:00 O
AM O

END-STAGE B-SYMPTOM
RENAL I-SYMPTOM
DISEASE I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

LESS O
, O
LIESEANALE O

UNIT O
NUMBER O
: O

589-25-50 O

ADMISSION O
DATE O
: O

12/16/97 O

DISCHARGE O
DATE O
: O

01/16/98 O

PRINCIPAL O
DIAGNOSIS O
: O

End-stage B-SYMPTOM
renal I-SYMPTOM
disease I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

1. O
Right B-TREATMENT
nephrectomy I-TREATMENT
. O

2. O
Cadaveric B-TREATMENT
renal I-TREATMENT
transplant I-TREATMENT
. O

3. O
Acute B-SYMPTOM
thrombosis I-SYMPTOM
. O

4. O
Transplant B-TREATMENT
nephrectomy I-TREATMENT
. O

5. O
Pulmonary B-SYMPTOM
emboli I-SYMPTOM
. O

6. O
Hypertension B-SYMPTOM
. O

7. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

8. O
Chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
. O

9. O
Hypercoagulable B-SYMPTOM
state I-SYMPTOM
. O

10. O
Perforated B-SYMPTOM
viscus I-SYMPTOM
. O

11. O
Abdominal B-SYMPTOM
abscesses I-SYMPTOM
. O

12. O
Sepsis B-SYMPTOM
. O

13. O
Respiratory B-SYMPTOM
failure I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
was O
a O
53-year-old O
male O
with O
a O
longstanding O
history O
of O
renal B-SYMPTOM
disease I-SYMPTOM
with O
multiple B-SYMPTOM
complications I-SYMPTOM
and O
problems B-SYMPTOM
related O
to O
vascular O
access O
and O
hypercoagulable B-SYMPTOM
state I-SYMPTOM
. O

These O
culminated O
in O
an B-TREATMENT
attempted I-TREATMENT
cadaveric I-TREATMENT
kidney I-TREATMENT
transplant I-TREATMENT
undertaken O
on O
12/16/97 O
, O
which O
was O
complicated O
by O
thrombosis B-SYMPTOM
and O
necrosis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
cadaveric I-SYMPTOM
renal I-SYMPTOM
vein I-SYMPTOM
within O
24 O
hours O
. O

This O
required O
a B-TREATMENT
transplant I-TREATMENT
nephrectomy I-TREATMENT
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
&apos;s O
course O
was O
subsequently O
characterized O
by O
recurrent B-SYMPTOM
pneumonias I-SYMPTOM
, O
possibly O
due O
to O
aspiration B-SYMPTOM
, O
and O
by O
hemodynamic B-SYMPTOM
instability I-SYMPTOM
. O

He O
was O
transferred O
to O
the O
Medical O
Intensive O
Care O
Unit O
from O
the O
Transplant O
Service O
for O
ventilatory B-TREATMENT
management I-TREATMENT
in O
the O
setting O
of O
hypotension B-SYMPTOM
. O

On O
transfer O
, O
the O
patient O
was O
not O
sedated B-TREATMENT
, O
but O
was O
unresponsive B-SYMPTOM
and O
extremely B-SYMPTOM
dyssynchronous I-SYMPTOM
with O
the B-TREATMENT
ventilator I-TREATMENT
. O

The O
patient O
was O
found O
to O
have O
substantial B-SYMPTOM
auto I-SYMPTOM
PEEP I-SYMPTOM
with O
an B-SYMPTOM
elevated I-SYMPTOM
dead I-SYMPTOM
space I-SYMPTOM
. O

A O
pulmonary O
arteriogram O
on O
01/03/98 O
demonstrated O
multiple B-SYMPTOM
pulmonary I-SYMPTOM
emboli I-SYMPTOM
, O
likely O
less O
than O
one O
week O
old O
, O
possibly O
introduced O
at O
the O
time O
of O
the B-SYMPTOM
renal I-SYMPTOM
vein I-SYMPTOM
thrombosis I-SYMPTOM
of O
12/19/97 O
. O

An B-TREATMENT
inferior I-TREATMENT
vena I-TREATMENT
cava I-TREATMENT
filter I-TREATMENT
was O
placed O
; O
lower O
extremity O
noninvasive O
studies O
were O
negative O
. O

The O
patient O
required O
high B-TREATMENT
pressures I-TREATMENT
to O
ventilate O
adequately O
, O
possibly O
related O
to O
an B-SYMPTOM
abdominal I-SYMPTOM
compartment I-SYMPTOM
syndrome I-SYMPTOM
. O

The O
patient O
had O
undergone O
two B-TREATMENT
abdominal I-TREATMENT
procedures I-TREATMENT
following O
explantation O
. O

The O
physiology O
at O
the O
time O
of O
transfer O
to O
the O
Medical O
Intensive O
Care O
Unit O
was O
consistent O
with O
a B-SYMPTOM
septic I-SYMPTOM
process I-SYMPTOM
. O

CT O
scan O
demonstrated O
retroperitoneal B-SYMPTOM
collection I-SYMPTOM
containing O
both O
free B-SYMPTOM
air I-SYMPTOM
and O
extravasated B-SYMPTOM
contrast I-SYMPTOM
material I-SYMPTOM
. O

For O
the O
concern O
of O
a B-SYMPTOM
perforated I-SYMPTOM
viscus I-SYMPTOM
, O
the O
patient O
was O
taken O
to O
exploratory O
laparotomy O
on O
01/06/98 O
, O
during O
which O
the O
bowel O
was O
run O
without O
evidence O
of O
perforation B-SYMPTOM
. O

The O
patient O
remained O
unstable B-SYMPTOM
. O

He O
was O
taken O
to O
fluoroscopy O
, O
where O
oral O
contrast O
was O
demonstrated O
to O
be O
extravasating O
through O
a O
posterior O
duodenum O
. O

For O
this O
reason O
, O
he O
was O
taken O
again O
to O
the O
operating O
room O
on O
01/08/98 O
, O
at O
which O
time O
a B-TREATMENT
gastrojejunostomy I-TREATMENT
was O
performed O
with O
stapling B-TREATMENT
across I-TREATMENT
the I-TREATMENT
gastroduodenal I-TREATMENT
junction I-TREATMENT
, O
introduction O
of O
five B-TREATMENT
Jackson-Pratt I-TREATMENT
drains I-TREATMENT
into O
the B-SYMPTOM
retroperitoneal I-SYMPTOM
mass I-SYMPTOM
, O
cholecystotomy B-TREATMENT
tube I-TREATMENT
, O
gastrostomy B-TREATMENT
tube I-TREATMENT
, O
and O
jejunostomy B-TREATMENT
tube I-TREATMENT
. O

The O
patient O
had O
an B-SYMPTOM
extensive I-SYMPTOM
estimated I-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
requiring O
multiple B-TREATMENT
blood I-TREATMENT
products I-TREATMENT
and O
fluid B-TREATMENT
resuscitation I-TREATMENT
therapy I-TREATMENT
. O

Accompanying O
this O
during O
this O
period O
were O
elevations B-SYMPTOM
in O
liver O
function O
studies O
and O
amylase O
and O
lipase O
consistent O
with O
pancreatic B-SYMPTOM
inflammation I-SYMPTOM
. O

The O
patient O
was O
aggressively O
treated O
with O
fluid B-TREATMENT
resuscitation I-TREATMENT
and O
pressors B-TREATMENT
for O
his B-SYMPTOM
septic I-SYMPTOM
physiology I-SYMPTOM
. O

There O
was O
no O
evidence O
of O
cardiac B-SYMPTOM
tamponade I-SYMPTOM
or O
specific B-SYMPTOM
underlying I-SYMPTOM
coronary I-SYMPTOM
dysfunction I-SYMPTOM
. O

He O
was O
treated O
with O
appropriate B-TREATMENT
antibiotics I-TREATMENT
for O
his B-SYMPTOM
Serratia I-SYMPTOM
pneumonia I-SYMPTOM
, O
as O
well O
as O
for O
his B-SYMPTOM
abdominal I-SYMPTOM
process I-SYMPTOM
. O

The O
patient O
was O
felt O
to O
have O
an B-SYMPTOM
underlying I-SYMPTOM
hypercoagulable I-SYMPTOM
state I-SYMPTOM
, O
thought O
to O
be O
the O
source O
for O
the B-SYMPTOM
repeated I-SYMPTOM
clots I-SYMPTOM
. O

Because O
of O
the B-SYMPTOM
bleeding I-SYMPTOM
problems I-SYMPTOM
, O
however O
, O
it O
was O
felt O
that O
full B-TREATMENT
heparinization I-TREATMENT
would O
not O
be O
prudent O
, O
and O
the O
patient O
was O
treated O
with O
pneumo-boots B-TREATMENT
and O
subcutaneous B-TREATMENT
heparin I-TREATMENT
. O

Attention O
was O
paid O
to O
a O
variety O
of O
metabolic B-SYMPTOM
and I-SYMPTOM
electrolyte I-SYMPTOM
abnormalities I-SYMPTOM
, O
which O
were O
corrected O
appropriately O
. O

Nonetheless O
, O
Mr. O
Less O
continued O
to O
remain O
critically B-SYMPTOM
ill I-SYMPTOM
with O
only O
very O
transient O
mild O
improvement O
with O
drainage B-TREATMENT
of O
additional B-SYMPTOM
retroperitoneal I-SYMPTOM
fluid I-SYMPTOM
. O

He O
remained O
pressor B-SYMPTOM
dependent I-SYMPTOM
, O
as O
well O
as O
dependent B-SYMPTOM
upon O
mechanical B-TREATMENT
ventilatory I-TREATMENT
assistance I-TREATMENT
. O

His O
course O
was O
complicated O
by O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
requiring O
cardioversion B-TREATMENT
. O

He O
had O
an B-SYMPTOM
ongoing I-SYMPTOM
requirement I-SYMPTOM
for O
high B-TREATMENT
volume I-TREATMENT
resuscitation I-TREATMENT
and O
was O
persistently B-SYMPTOM
acidotic I-SYMPTOM
despite O
CV-VVH B-TREATMENT
in O
the O
face O
of O
bicarbonate B-TREATMENT
replenishment I-TREATMENT
. O

The O
patient O
also O
appeared O
to O
have O
stool O
from O
his B-SYMPTOM
Jackson-Pratt I-SYMPTOM
site I-SYMPTOM
and O
right B-SYMPTOM
oblique I-SYMPTOM
incision I-SYMPTOM
. O

Bloody B-SYMPTOM
drainage I-SYMPTOM
from O
his B-SYMPTOM
increasingly I-SYMPTOM
distended I-SYMPTOM
abdomen I-SYMPTOM
was O
noted O
. O

Extensive O
discussions O
were O
carried O
out O
with O
Mrs. O
Less O
condition O
was O
irretrievable O
. O

It O
was O
felt O
that O
the O
patient O
had O
continued O
massive B-SYMPTOM
retroperitoneal I-SYMPTOM
contamination I-SYMPTOM
and O
probable O
multiple B-SYMPTOM
enteric I-SYMPTOM
fistulae I-SYMPTOM
from O
an B-SYMPTOM
ischemic I-SYMPTOM
bowel I-SYMPTOM
. O

Dr. O
Cantsleddjesc O
felt O
that O
no O
surgical B-TREATMENT
approach I-TREATMENT
to O
this B-SYMPTOM
problem I-SYMPTOM
or O
further B-TREATMENT
intervention I-TREATMENT
or O
radiologic B-TREATMENT
procedures I-TREATMENT
would O
be O
helpful O
. O

All O
physicians O
and O
the O
family O
were O
in O
agreement O
that O
the O
most O
appropriate O
approach O
was O
to O
institute O
comfort B-TREATMENT
measures I-TREATMENT
. O

This O
was O
done O
, O
and O
the O
patient O
appeared O
to O
be O
comfortable O
at O
the O
time O
of O
death O
with O
his O
family O
at O
his O
side O
on O
1/16/98 O
. O

I O
L. O
STERPSKOLK O
, O
M.D. O

TR O
: O

vcp O

DD O
: O

05/25/98 O

TD O
: O

05/30/98 O
8:30 O
A O

cc O
: O

LE O
FREIERM O
, O
JR O
, O
M.D. O
KIVERL O
NA O
CANTSLEDDJESC O
, O
M.D. O
I O
LYNIN O
STERPSKOLK O
, O
M.D. O
ETI O
CHAELKA O
MULKEVI O
, O
M.D. O

cc O
: O

Dr. O
Less O

260257442 O
DH O

0145802 O

292408 O

9739205 O

2/11/2003 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O
/ O
SUMMARY O

DUHETLAND O
, O
RIE O

MRN O
: O

0145802 O

Age O
: O

29y O

REGISTRATION O
DATE O
: O

02/11/2003 O
02:42 O
PM O

Provider O
: O

AMINE O
GUAYTREFTSCOST O

PRELIMINARY O
REPORT O

PCP O
notified O
by O
MD O
: O

Yes O
- O
Direct O
contact O
with O
PCP O

Discharge O
Date O
/ O
Time O
: O

02/11/2003 O
16:52 O

Discharge O
Status O
: O

Discharged O

Condition O
on O
Discharge O
: O

Stable O

Patient O
States O
Complaint O
: O

BACK B-SYMPTOM
PAIN I-SYMPTOM

Standardized O
Discharge O
Instructions O
: O

The O
patient O
was O
given O
printed O
instructions O
for O
back B-SYMPTOM
pain I-SYMPTOM
( O
English O
) O
. O

Diagnosis O
: O

Back B-SYMPTOM
pain I-SYMPTOM

Disposition O
, O
Follow O
up O
and O
Instructions O
to O
Patient O
: O

Call O
your O
doctor O
in O
the O
morning O
for O
an O
appointment O
with O
the O
pain O
clinic O
. O

If O
you O
have O
any O
bladder B-SYMPTOM
incontinence I-SYMPTOM
, O
bowel B-SYMPTOM
incontinence I-SYMPTOM
, O
worse B-SYMPTOM
numbness I-SYMPTOM
, O
any B-SYMPTOM
weakness I-SYMPTOM
, O
or O
any O
other B-SYMPTOM
concerns I-SYMPTOM
, O
call O
your O
doctor O
or O
return O
to O
the O
emergency O
department O
immediately O
. O

PCP O
Name O
: O

PULESHUFF O
, O
SACA O
G O

Provider O
Number O
: O

79863 O

This O
report O
was O
created O
by O
GUAYTREFTSCOST O
, O
AMINE O
02/11/2003 O
04:53 O
PM O

Admission O
Date O
: O

2015-05-13 O

Discharge O
Date O
: O

2015-05-20 O

Date O
of O
Birth O
: O

1813-05-16 O

Sex O
: O

F O

Service O
: O

CME O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
104 O
year O
old O
female O
patient O
with O
a O
history O
of O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
hypertension B-SYMPTOM
and O
cerebrovascular B-SYMPTOM
accident I-SYMPTOM
who O
presents O
with O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
cough B-SYMPTOM
. O

The O
patient O
states O
that O
she O
has O
no O
idea O
why O
she O
was O
brought O
to O
the O
Emergency O
Department O
and O
denies O
any B-SYMPTOM
symptoms I-SYMPTOM
. O

She O
reports O
an B-SYMPTOM
occasional I-SYMPTOM
nonproductive I-SYMPTOM
cough I-SYMPTOM
that O
she O
has O
had O
"for O
years" O
and O
feels O
that O
she O
has O
been O
experiencing O
alternating B-SYMPTOM
chills I-SYMPTOM
and I-SYMPTOM
feeling I-SYMPTOM
hot I-SYMPTOM
. O

A O
progress O
note O
in O
the O
patient O
's O
chart O
from O
her O
assisted O
living O
facility O
indicates O
that O
the O
patient O
has O
had O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
cough B-SYMPTOM
for O
one O
day O
with O
chills B-SYMPTOM
but O
no O
fever B-SYMPTOM
. O

She O
has O
been O
recently O
evaluated O
as O
an O
outpatient O
for O
bradycardia B-SYMPTOM
. O

She O
was O
seen O
by O
her O
cardiologist O
, O
Dr. O
Clements O
and O
had O
a O
Holter O
monitor O
on O
2015-05-01 O
, O
that O
showed O
first B-SYMPTOM
degree I-SYMPTOM
AV I-SYMPTOM
block I-SYMPTOM
with O
a O
rate O
that O
ranged O
between O
35 O
to O
53 O
beats O
per O
minute O
. O

In O
the O
Emergency O
Department O
, O
the O
patient O
was O
given O
nebulizer B-TREATMENT
treatment I-TREATMENT
, O
started O
on O
antibiotics B-TREATMENT
for O
presumed O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
exacerbation I-SYMPTOM
. O

She O
was O
noted O
to O
have O
lateral B-SYMPTOM
ST I-SYMPTOM
depressions I-SYMPTOM
and O
given O
Aspirin B-TREATMENT
. O

She O
continues O
to O
deny O
chest B-SYMPTOM
pain I-SYMPTOM
, O
palpitations B-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
fevers B-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
bright B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
, O
melena B-SYMPTOM
, O
dysuria B-SYMPTOM
, O
urinary B-SYMPTOM
frequency I-SYMPTOM
and I-SYMPTOM
urgency I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
with O
asthmatic B-SYMPTOM
component I-SYMPTOM
. O

Hypothyroidism B-SYMPTOM
. O

Gastroenteritis B-SYMPTOM
. O

Anxiety B-SYMPTOM
. O

Insomnia B-SYMPTOM
. O

Hypertension B-SYMPTOM
. O

Osteoporosis B-SYMPTOM
. O

History O
of O
cerebrovascular B-SYMPTOM
accident I-SYMPTOM
with O
residual B-SYMPTOM
right I-SYMPTOM
sided I-SYMPTOM
weakness I-SYMPTOM
. O

Scoliosis B-SYMPTOM
. O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

History O
of O
kidney B-SYMPTOM
mass I-SYMPTOM
. O

History O
of O
lower B-SYMPTOM
gastrointestinal I-SYMPTOM
bleed I-SYMPTOM
. O

Status O
post O
total B-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
, O
bilateral B-TREATMENT
salpingo- I-TREATMENT
oophorectomy I-TREATMENT
. O

Left B-SYMPTOM
cataract I-SYMPTOM
. O

Bradycardia B-SYMPTOM
followed O
by O
outpatient O
cardiologist O
with O
a O
Holter O
monitor O
on O
2015-05-01 O
, O
with O
first B-SYMPTOM
degree I-SYMPTOM
AV I-SYMPTOM
block I-SYMPTOM
and O
a O
heart O
rate O
ranging O
between O
35 O
to O
53 O
beats O
per O
minute O
. O

ALLERGIES O
: O

Penicillin B-TREATMENT
, O
Erythromycin B-TREATMENT
, O
Valium B-TREATMENT
, O
Compazine B-TREATMENT
, O

Demerol B-TREATMENT
, O
Percodan B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION: O

1. O
Levothyroxine B-TREATMENT
50 O
mcg O
p.o. O
once O
daily O
. O

2. O
Combivent B-TREATMENT
two O
puffs O
four O
times O
a O
day O
. O

3. O
Flovent B-TREATMENT
two O
puffs O
four O
times O
a O
day O
. O

4. O
Protonix B-TREATMENT
40 O
mg O
once O
daily O
. O

5. O
Lisinopril B-TREATMENT
5 O
mg O
p.o. O
once O
daily O
. O

6. O
Norvasc B-TREATMENT
5 O
mg O
twice O
a O
day O
. O

7. O
Lasix B-TREATMENT
40 O
mg O
once O
daily O
. O

8. O
Senna B-TREATMENT
one O
once O
daily O
. O

9. O
Dulcolax B-TREATMENT
10 O
mg O
once O
daily O
p.r.n. O

10 O
. O

TUMS B-TREATMENT
500 O
mg O
twice O
a O
day O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
at O
Norwood O
in O
assisted O
living O
section O
. O

She O
has O
a O
24 O
hour O
caregiver O
. O

The O
patient O
quit O
smoking O
fifty O
years O
ago O
but O
previously O
was O
a O
heavy O
smoker O
, O
though O
states O
that O
she O
never O
inhaled O
. O

The O
patient O
denies O
use O
of O
alcohol O
or O
drugs O
. O

PHYSICAL O
EXAMINATION O
: O

Temperature O
98.1 O
, O
blood O
pressure O

144/38 O
, O
heart O
rate O
41 O
, O
respiratory O
rate O
20 O
, O
oxygen O
saturation O

94 O
percent O
in O
room O
air O
and O
96 O
percent O
on O
three O
liters O
. O

In O
general O
, O
a O
well O
appearing O
elderly O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Skin O
is O
warm O
and O
dry O
with O
decreased B-SYMPTOM
skin I-SYMPTOM
turgor I-SYMPTOM
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
examination O
- O
The O
pupils O
are O
equal O
, O
round O
and O
reactive O
to O
light O
and O
accommodation O
. O

Extraocular O
movements O
are O
intact O
. O

Dry B-SYMPTOM
mucous I-SYMPTOM
membranes I-SYMPTOM
. O

The O
oropharynx O
is O
clear O
. O

Neck O
is O
supple O
, O
full O
range O
of O
motion O
, O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distension I-SYMPTOM
or O
lymphadenopathy B-SYMPTOM
. O

The O
heart O
was O
bradycardic B-SYMPTOM
with O
regular O
rhythm O
, O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
. O

Lungs O
- O
diffuse B-SYMPTOM
expiratory I-SYMPTOM
wheezes I-SYMPTOM
with O
bibasilar B-SYMPTOM
rales I-SYMPTOM
, O
left O
over O
right O
. O

The O
abdomen O
revealed O
normoactive O
bowel O
sounds O
, O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Rectal O
is O
guaiac B-SYMPTOM
positive I-SYMPTOM
per O
Emergency O
Department O
. O

Extremities O
- O
no O
cyanosis B-SYMPTOM
or O
clubbing B-SYMPTOM
, O
one B-SYMPTOM
plus I-SYMPTOM
bilateral I-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
with O
right O
worse O
than O
left O
. O

Neurologically O
, O
the O
patient O
is O
awake O
, O
alert O
and O
oriented O
times O
three O
. O

LABORATORY O
DATA O
: O

White O
blood O
cell O
count O
was O
8.5 O
( O
80 O
percent O
neutrophils O
, O
13 O
percent O
lymphocytes O
) O
, O
hematocrit O
27.4 O
, O
platelet O
count O
277,000 O
. O

Sodium O
133 O
, O
potassium O
4.8 O
, O
chloride O

94 O
, O
bicarbonate O
24 O
, O
blood O
urea O
nitrogen O
39 O
, O
creatinine O
2.0 O
, O
glucose O
111 O
. O

CK O
152 O
, O
CK O
MB O
3.0 O
, O
troponin O
0.04. O

INR O
1.1. O

Chest O
x-ray O
showed O
equivocal B-SYMPTOM
retrocardiac I-SYMPTOM
opacity I-SYMPTOM
. O

Electrocardiogram O
showed O
sinus B-SYMPTOM
bradycardia I-SYMPTOM
at O
40 O
beats O
per O
minute O
. O

First B-SYMPTOM
degree I-SYMPTOM
AV I-SYMPTOM
block I-SYMPTOM
with O
PR O
interval O
220 O
, O
left B-SYMPTOM
axis I-SYMPTOM
deviation I-SYMPTOM
, O
right B-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
with O
a B-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
fascicular I-SYMPTOM
block I-SYMPTOM
, O
0.1103 O
N. O
Fifth O
Cir. O
depressions O
in O

V4 O
through O
V6 O
. O

HOSPITAL O
COURSE O
: O

Shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
- O
Though O
the O
patient O
denied O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
on O
admission O
, O
a O
progress O
note O
from O

Norwood O
nursing O
facility O
suggested O
that O
the O
patient O
had O
been O
having O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
cough B-SYMPTOM
for O
approximately O
one O
day O
with O
difficulty B-SYMPTOM
ambulating I-SYMPTOM
, O
needing O
to O
travel O
in O
a B-TREATMENT
wheelchair I-TREATMENT
. O

The O
patient O
was O
afebrile B-SYMPTOM
on O
admission O
with O
a O
normal O
white O
blood O
cell O
count O
but O
had O
significant B-SYMPTOM
wheezing I-SYMPTOM
and O
rales B-SYMPTOM
on O
physical O
examination O
with O
a O
possible O
left B-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
opacity I-SYMPTOM
seen O
on O
chest O
x-ray O
. O

The O
etiology O
of O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
was O
considered O
a O
likely O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
exacerbation I-SYMPTOM
and O
the O
patient O
was O
started O
on O
Albuterol B-TREATMENT
and O
Atrovent B-TREATMENT
nebulizers I-TREATMENT
. O

The O
patient O
was O
also O
started O
on O
Doxycycline B-TREATMENT
given O
the O
concern O
for O
pneumonia B-SYMPTOM
on O
chest O
x-ray O
. O

She O
was O
also O
continued O
on O
steroids B-TREATMENT
given O
evidence O
of O
severe B-SYMPTOM
airway I-SYMPTOM
obstruction I-SYMPTOM
. O

The B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
was O
also O
considered O
possibly O
related O
to O
a B-SYMPTOM
coronary I-SYMPTOM
event I-SYMPTOM
and O
she O
was O
admitted O
for O
rule O
out O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

The O
patient O
's O
enzymes O
were O
cycled O
and O
were O
negative O
. O

The O
patient O
's O
electrocardiogram O
performed O
on O
hospital O
day O
number O
two O
was O
concerning O
for O
2:1 B-SYMPTOM
heart I-SYMPTOM
block I-SYMPTOM
and O
the O
cardiology O
consult O
service O
was O
contacted O
for O
evaluation O
. O

The O
patient O
was O
taken O
to O
the O
Coronary O
Care O
Unit O
late O
on O
hospital O
day O
number O
two O
and O
received O
a B-TREATMENT
temporary I-TREATMENT
wire I-TREATMENT
. O

The O
following O
day O
the O
patient O
received O
a B-TREATMENT
permanent I-TREATMENT
dual I-TREATMENT
chamber I-TREATMENT
rate I-TREATMENT
responsive I-TREATMENT
pacemaker I-TREATMENT
. O

The O
patient O
was O
transferred O
back O
to O
the O
general O
medicine O
service O
where O
she O
continued O
to O
exhibit O
signs O
of O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
exacerbation I-SYMPTOM
and O
nebulizers B-TREATMENT
, O
steroids B-TREATMENT
and O
antibiotics B-TREATMENT
were O
continued O
. O

The O
patient O
's O
respiratory O
status O
improved O
throughout O
the O
remainder O
of O
her O
hospitalization O
and O
oxygen B-TREATMENT
was O
eventually O
weaned O
. O

Once O
the O
patient O
was O
transferred O
out O
of O
the O
Coronary O
Care O
Unit O
, O
she O
appeared O
to O
have O
an B-SYMPTOM
element I-SYMPTOM
of I-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
in O
addition O
to O
her B-SYMPTOM
chronic I-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
. O

She O
was O
given O
20 O
mg O
of O
intravenous B-TREATMENT
Lasix I-TREATMENT
with O
impressive O
urine O
output O
and O
improvement O
in O
her O
overall O
fluid O
status O
. O

The O
patient O
was O
eventually O
restarted O
on O
her O
outpatient O
dose O
of O
Lasix B-TREATMENT
once O
her O
renal O
function O
improved O
to O
baseline O
and O
remained O
hemodynamically O
stable O
throughout O
the O
remainder O
of O
her B-TREATMENT
hospitalization I-TREATMENT
. O

Heart B-SYMPTOM
block I-SYMPTOM
- O
As O
noted O
previously O
, O
the O
patient O
's O
electrocardiogram O
was O
significant O
for O
a B-SYMPTOM
2:1 I-SYMPTOM
heart I-SYMPTOM
block I-SYMPTOM
and O
cardiology O
consult O
service O
was O
contacted O
for O
evaluation O
. O

The O
patient O
received O
a B-TREATMENT
temporary I-TREATMENT
pacing I-TREATMENT
wire I-TREATMENT
on O
the O
evening O
of O
hospital O
day O
number O
two O
and O
on O
hospital O
day O
number O
three O
received O
a B-TREATMENT
dual I-TREATMENT
chamber I-TREATMENT
pacemaker I-TREATMENT
. O

Renal O
- O
The O
patient O
was O
admitted O
with O
a O
creatinine O
of O
1.8 O
, O
considered O
likely O
secondary O
to O
hypovolemia B-SYMPTOM
. O

Her O
calculated O
fractional O
excretion O
of O
sodium O
was O
0.13 O
percent O
suggesting O
a B-SYMPTOM
prerenal I-SYMPTOM
cause I-SYMPTOM
. O

The O
patient O
's O
creatinine O
improved O
to O
1.1 O
with O
hydration B-TREATMENT
. O

Once O
the O
patient O
's O
creatinine O
had O
improved O
to O
baseline O
, O
her B-TREATMENT
Lasix I-TREATMENT
and O
ace B-TREATMENT
inhibitor I-TREATMENT
were O
restarted O
and O
the O
patient O
's O
creatinine O
was O
noted O
to O
be O
stable O
. O

Gastrointestinal O
- O
The O
patient O
was O
admitted O
with O
a O
history O
of O
gastrointestinal B-SYMPTOM
bleed I-SYMPTOM
with O
guaiac B-SYMPTOM
positive I-SYMPTOM
stools I-SYMPTOM
on O
admission O
. O

Her O
hematocrit O
was O
noted O
to O
trend O
down O
after O
transfusion B-TREATMENT
of O
one O
unit O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
on O
admission O
. O

Given O
guaiac B-SYMPTOM
positive I-SYMPTOM
stools I-SYMPTOM
and O
her O
history O
of O
gastrointestinal B-SYMPTOM
bleed I-SYMPTOM
in O
addition O
to O
use O
of O
steroids B-TREATMENT
for O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
exacerbation I-SYMPTOM
, O
the O
gastroenterology O
consult O
service O
was O
contacted O
. O

The O
results O
of O
that O
consultation O
and O
potential O
esophagogastroduodenoscopy O
are O
pending O
at O
the O
time O
of O
dictation O
. O

Hypertension B-SYMPTOM
- O
The O
patient O
had O
moderate O
control O
of O
her O
blood O
pressure O
throughout O
her O
admission O
. O

Her B-TREATMENT
calcium I-TREATMENT
channel I-TREATMENT
blocker I-TREATMENT
and O
ace B-TREATMENT
inhibitor I-TREATMENT
were O
continued O
. O

Hematology O
- O
As O
noted O
previously O
, O
the O
patient O
's O
hematocrit O
was O
noted O
to O
drop O
after O
transfusion B-TREATMENT
with O
one O
unit O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
on O
admission O
. O

Given O
guaiac B-SYMPTOM
positive I-SYMPTOM
stools I-SYMPTOM
and O
the O
patient O
's O
history O
of O
gastrointestinal B-SYMPTOM
bleed I-SYMPTOM
, O
gastroenterology O
consult O
service O
was O
contacted O
for O
possible O
esophagogastroduodenoscopy O
and/or O
colonoscopy O
. O

The O
results O
of O
this O
consultation O
are O
pending O
at O
the O
time O
of O
dictation O
. O

The O
remainder O
of O
the O
Hubbard O
Regional O
Hospital O
hospital O
course O
, O
discharge O
diagnoses O
, O
medications B-TREATMENT
and O
follow-up O
will O
be O
dictated O
at O
the O
time O
of O
discharge O
. O

Justin O
Q. O
Yagi O
, O
M.D. O
12AKK O

Dictated O
By:Miriam O
H O
Hines O
, O
M.D. O

MEDQUIST36 O

D O
: O

2015-05-18 O
11:24:17 O

T O
: O

2015-05-18 O
14:58:16 O

Job# O
: O

21080 O

Signed O
electronically O
by O
: O

DR. O
Jose O
M. O
Rosales O
on O
: O

MON O
2015-07-27 O
9:58 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-11-11 O

Discharge O
Date O
: O

2013-11-13 O

Date O
of O
Birth O
: O

1938-06-09 O

Sex O
: O

M O

Service O
: O

CMED O

Allergies O
: O

No O
Drug B-SYMPTOM
Allergy I-SYMPTOM
Information O
on O
File O

Attending O
: O
Leroy O
F O
Stalnaker O
, O
M.D. O

Chief O
Complaint O
: O

Left B-SYMPTOM
sided I-SYMPTOM
weakness I-SYMPTOM
, O
slurred B-SYMPTOM
speech I-SYMPTOM
. O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Intubation B-TREATMENT
and O
mechanical B-TREATMENT
ventilation I-TREATMENT
. O

History O
of O
Present O
Illness O
: O

Patient O
is O
a O
75 O
year O
old O
right O
handed O
male O
with O
past O
medical O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
s/p O
NQWMI B-SYMPTOM
02-25 O
, O
s/p O
LAD B-TREATMENT
angioplasty I-TREATMENT
and O
stent B-TREATMENT
05-26 O
, O
dementia B-SYMPTOM
, O
hyperlipidemia B-SYMPTOM
, O
aortic B-SYMPTOM
stenosis I-SYMPTOM
, O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
on O
coumadin B-TREATMENT
who O
presented O
from O
his O
CMED O
CSRU O
doctor O
's O
office O
wtih O
acute B-SYMPTOM
onset I-SYMPTOM
left I-SYMPTOM
sided I-SYMPTOM
weakness I-SYMPTOM
and O
dysarthria B-SYMPTOM
. O

Patient O
was O
in O
his O
usual O
state O
of O
health O
until O
around O
12:15 O
on O
day O
of O
admission O
. O

Was O
at O
this O
doctor O
's O
office O
and O
complained O
of O
severe B-SYMPTOM
headache I-SYMPTOM
. O

Thereafter O
, O
wife O
noted O
development O
of O
left B-SYMPTOM
sided I-SYMPTOM
weakness I-SYMPTOM
, O
facial B-SYMPTOM
droop I-SYMPTOM
, O
slurring B-SYMPTOM
of I-SYMPTOM
speech I-SYMPTOM
. O

Sent O
to O
Hahnemann O
General O
Hospital O
for O
evaluation O
emergently O
. O

Tom O
course O
: O

Arrived O
at O
Hahnemann O
General O
Hospital O
at O
12:30 O
. O

Finger O
stick O
blood O
glucose O
120 O
. O

Rest O
of O
vitals O
BP O
112/70 O
, O
HR O
60 O
. O

Blood O
pressure O
up O
to O
230 O
s O
systolic O
. O

Seen O
emergently O
by O
stroke O
team O
. O

Initial O
NIH O
stroke O
scale O
of O
33 O
. O

Head O
CT O
showed O
large B-SYMPTOM
right I-SYMPTOM
intracerebral I-SYMPTOM
hemorrhage I-SYMPTOM
. O

Intubated O
for O
airway B-TREATMENT
protection I-TREATMENT
at O
13:35 O
after O
Fentanyl B-TREATMENT
, O
Etomidate B-TREATMENT
, O
Vecuronium B-TREATMENT
and O
Succhinylcholine B-TREATMENT
given O
. O

Started O
on O
Labetalol B-TREATMENT
and O
then O
Nipride B-TREATMENT
drip I-TREATMENT
for O
BP B-TREATMENT
control I-TREATMENT
; O
discontinued O
as O
goal O
BP O
in O
130-160 O
s. O

Received O
10 B-TREATMENT
mg I-TREATMENT
SC I-TREATMENT
Vitamin I-TREATMENT
K I-TREATMENT
and O
2 B-TREATMENT
units I-TREATMENT
FFP I-TREATMENT
while O
in O
Gary O
. O

Pupils O
noted O
to O
be O
fixed B-SYMPTOM
and O
dilated B-SYMPTOM
at O
14:10 O
. O

Loaded O
with O
Dilantin B-TREATMENT
and O
50 B-TREATMENT
grams I-TREATMENT
Mannitol I-TREATMENT
. O

Transferred O
to O
intensive O
care O
unit O
. O

Past O
Medical O
History O
: O

1. O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
on O
coumadin B-TREATMENT

2. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
status O
post O
NQWMI B-SYMPTOM
02-25 O
, O
s/p O
LAD B-TREATMENT
angioplasty I-TREATMENT
and O
stent B-TREATMENT
05-26 O
. O
Known B-SYMPTOM
non-dominant I-SYMPTOM
90% I-SYMPTOM
RCA I-SYMPTOM
lesion I-SYMPTOM
not O
intervened O
upon O
. O

3. O
Dementia B-SYMPTOM

4. O
Mild-moderate B-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM

5. O
Hyperlipidemia B-SYMPTOM

6. O
Colon B-SYMPTOM
cancer I-SYMPTOM

7. O
Obstructive B-SYMPTOM
sleep I-SYMPTOM
apnea I-SYMPTOM

8. O
Anxiety B-SYMPTOM

9. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
on O
oral B-TREATMENT
medications I-TREATMENT

Social O
History O
: O

Married O
. O

Lives O
with O
wife O
. O

One O
son O
, O
in O
area O
. O

Social O
alcohol O
. O

No O
tobacco O
, O
drug O
use O
. O

Family O
History O
: O

Non-contributory O
. O

Physical O
Exam O
: O

PHYSICAL O
EXAM O
( O
Examined O
off O
of O
Propofol B-TREATMENT
): O

Tc O
: O
96.7 O

BP O
: O
120/48 O

HR O
: O
61 O

RR O
: O
14 O

O2Sat. O
: O
100% O
, O
ventilated B-TREATMENT
. O

Gen O
: O
WD/WN O
male O
, O
comfortable O
appearing O
, O
intubated B-TREATMENT
, O
not O
sedated B-TREATMENT
. O

HEENT O
: O
NC/AT B-SYMPTOM
. O

Anicteric B-SYMPTOM
. O

MMM O
. O

+Endotracheal B-TREATMENT
tube I-TREATMENT
. O

Neck O
: O
Supple O
. O

No O
masses B-SYMPTOM
or O
LAD B-SYMPTOM
. O

No O
JVD B-SYMPTOM
. O

No O
thyromegaly B-SYMPTOM
. O

No O
carotid B-SYMPTOM
bruits I-SYMPTOM
. O

Lungs O
: O
Coarse B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
anterolaterally I-SYMPTOM
. O

Cardiac O
: O
Irregularly B-SYMPTOM
irregular I-SYMPTOM
. O

S1/S2 O
. O

No O
M/R/G B-SYMPTOM
. O

Abd O
: O
Soft O
, O
NT B-SYMPTOM
, O
ND B-SYMPTOM
, O
+NABS O
. O

No O
rebound B-SYMPTOM
or O
guarding B-SYMPTOM
. O

No O
HSM B-SYMPTOM
. O

Extrem O
: O
Warm O
and O
well-perfused O
. O

No O
C/C/E B-SYMPTOM
. O

Neuro O
: O

Mental O
status O
: O

No B-SYMPTOM
response I-SYMPTOM
to I-SYMPTOM
voice I-SYMPTOM
, O
sternal O
rub O
. O

Grimaces O
to O
nasal O
tickle O
. O

Cranial O
Nerves O
: O

Pupils B-SYMPTOM
fixed I-SYMPTOM
at O
7 O
mm O
bilaterally O
. O

Very O
weak O
flicker O
of O
inner O
canthus O
on O
left O
with O
corneal O
stimulation O
. O

No B-SYMPTOM
oculocephalic I-SYMPTOM
reflex I-SYMPTOM
. O

Left B-SYMPTOM
facial I-SYMPTOM
droop I-SYMPTOM
. O

No B-SYMPTOM
gag I-SYMPTOM
provoked O
, O
but O
biting O
ETT B-TREATMENT
at O
times O
. O

Tongue O
midline O
. O

Motor O
: O

Normal O
bulk O
. O

Increased O
tone O
x4 O
with O
LEs O
> O
UEs O
. O

No B-SYMPTOM
withdrawal I-SYMPTOM
to O
noxious O
stimuli O
. O

Bilateral O
feet O
externally O
rotated O
. O

Sensation O
: O

No B-SYMPTOM
withdrawal I-SYMPTOM
to O
noxious O
stimuli O
. O

Reflexes O
: O

Absent O
in O
LUE O
, O
left O
ankle O
. O

Striking O
left O
patellar O
tendon O
results O
in O
sustained B-SYMPTOM
clonus I-SYMPTOM
of I-SYMPTOM
left I-SYMPTOM
leg I-SYMPTOM
. O

Toes B-SYMPTOM
upgoing I-SYMPTOM
bilaterally I-SYMPTOM
. O

02-27 O
RUE O
, O
absent O
right O
ankle O
. O

Coordination O
: O

Unable O
to O
assess O
. O

Gait O
: O

Unable O
to O
assess O
. O

Pertinent O
Results O
: O

2013-11-11 O
12:39 O
PM O

WBC O
- O
9.1 O
RBC O
- O
4.29 O
* O
HGB O
- O
14.1 O
HCT O
- O
38.7 O
* O
MCV O
- O
90 O
MCH O
- O
32.8 O
* O
MCHC O
- O
36.4 O
* O
RDW O
- O
14.7 O

2013-11-11 O
12:39 O
PM O

PLT O
COUNT O
- O
147 O
* O

2013-11-11 O
12:39 O
PM O

PT O
- O
20.0 O
* O
PTT O
- O
32.4 O
INR O
( O
PT O
)- O
2.5 O

2013-11-11 O
12:39 O
PM O

GLUCOSE O
- O
101 O
UREA O
N O
- O
25 O
* O
CREAT O
- O
1.0 O
SODIUM O
- O
142 O
POTASSIUM O
- O
4.2 O
CHLORIDE O
- O
106 O
TOTAL O
CO2 O
- O
27 O
ANION O
GAP O
- O
13 O

2013-11-11 O
12:39 O
PM O

CK O
( O
CPK O
)- O
200 O
* O

2013-11-11 O
12:39 O
PM O
cTropnT O
-< O
0.01 O

2013-11-11 O
12:39 O
PM O

CK-MB O
- O
7 O

2013-11-11 O
09:45 O
PM O

CK O
( O
CPK O
)- O
196 O
* O

2013-11-11 O
09:45 O
PM O

CK-MB O
- O
3 O
cTropnT O
-< O
0.01 O

2013-11-12 O
03:30 O
AM O
BLOOD O
CK O
( O
CPK O
)- O
312 O
* O

2013-11-12 O
03:30 O
AM O
BLOOD O
CK-MB O
- O
5 O
cTropnT O
-< O
0.01 O

2013-11-11 O
01:55 O
PM O
URINE O
BLOOD O
- O
SM O
NITRITE O
- O
NEG O
PROTEIN O
- O
100 O
GLUCOSE O
- O
NEG O
KETONE O
- O
NEG O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
NEG O
PH O
- O
6.5 O
LEUK O
- O
NEG O

2013-11-12 O
11:16 O
AM O
BLOOD O
ASA O
- O
NEG O
Ethanol O
- O
NEG O
Acetmnp O
- O
NEG O
Bnzodzp O
- O
NEG O
Barbitr O
- O
NEG O
Tricycl O
- O
NEG O

2013-11-12 O
10:17 O
AM O
URINE O
bnzodzp O
- O
NEG O
barbitr O
- O
NEG O
opiates O
- O
NEG O
cocaine O
- O
NEG O
amphetm O
- O
NEG O
mthdone O
- O
NEG O

CT O
head O
without O
contrast O
2013-11-11 O
: O

FINDINGS O
: O

There O
is O
a O
large O
region O
of O
high B-SYMPTOM
attenuation I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
lobe I-SYMPTOM
and O
the O
region O
of O
the O
right O
basal O
ganglia O
. O

This O
is O
consistent O
with O
intraparenchymal B-SYMPTOM
hemorrhage I-SYMPTOM
, O
more O
likely O
hypertensive B-SYMPTOM
in O
etiology O
. O

No O
significant B-SYMPTOM
subarachnoid I-SYMPTOM
or O
intraventricular B-SYMPTOM
hemorrhage I-SYMPTOM
is O
appreciated O
. O

There O
is O
mass B-SYMPTOM
effect I-SYMPTOM
present O
with O
shift B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
normally I-SYMPTOM
midline I-SYMPTOM
structures I-SYMPTOM
towards O
the O
left O
. O

There O
is O
also O
left B-SYMPTOM
sided I-SYMPTOM
subfalcine I-SYMPTOM
herniation I-SYMPTOM
. O

There O
is O
no O
hydrocephalus B-SYMPTOM
. O

The O
visualized O
osseous O
structures O
and O
paranasal O
sinuses O
are O
unremarkable O
. O

IMPRESSION O
: O

Large B-SYMPTOM
intraparenchymal I-SYMPTOM
hemorrhage I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
lobe I-SYMPTOM
. O

This O
most O
likely O
relates O
to O
hypertensive B-SYMPTOM
hemorrhage I-SYMPTOM
, O
as O
opposed O
to O
a B-SYMPTOM
ruptured I-SYMPTOM
right I-SYMPTOM
middle I-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
aneurysm I-SYMPTOM
. O

Brief O
Hospital O
Course O
: O

Patient O
was O
a O
75 O
year O
old O
right O
handed O
male O
with O
past O
medical O
history O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
on O
coumadin B-TREATMENT
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
hyperlipidemia B-SYMPTOM
, O
dementia B-SYMPTOM
with O
sudden B-SYMPTOM
onset I-SYMPTOM
left I-SYMPTOM
sided I-SYMPTOM
weakness I-SYMPTOM
, O
dysarthria B-SYMPTOM
. O

Head O
CT O
demonstrated O
a B-SYMPTOM
large I-SYMPTOM
right I-SYMPTOM
intracerebral I-SYMPTOM
hemorrhage I-SYMPTOM
, O
centered O
around O
basal O
ganglia O
and O
putamen O
. O

We O
felt O
this O
was O
likely O
secondary O
to O
hypertension B-SYMPTOM
. O

While O
still O
in O
the O
emergency O
department O
, O
he O
had O
rapid B-SYMPTOM
decompensation I-SYMPTOM
necessitating O
intubation B-TREATMENT
for O
airway B-TREATMENT
protection I-TREATMENT
. O

Examination O
post O
intubation B-TREATMENT
but O
off O
intubations B-TREATMENT
showed O
clinical O
evidence O
of O
elevated B-SYMPTOM
intracranial I-SYMPTOM
pressure I-SYMPTOM
and O
brainstem B-SYMPTOM
compression I-SYMPTOM
. O

The O
overall O
prognosis O
was O
guarded O
. O

He O
was O
admitted O
to O
the O
Neurology O
/ O
Neurosurgery O
ICU O
. O

He O
was O
loaded O
with O
Mannitol B-TREATMENT
and O
Dilantin B-TREATMENT
in O
the O
emergency O
room O
. O

He O
was O
evaluated O
by O
the O
Neurosurgery O
service O
and O
they O
did O
not O
feel O
a B-TREATMENT
surgical I-TREATMENT
intervention I-TREATMENT
or O
ventriculary B-TREATMENT
drain I-TREATMENT
was O
warranted O
. O

After O
arrival O
in O
the O
ICU O
, O
patient O
was O
followed O
with O
neuro O
checks O
every O
1 O
hour O
. O

Sedation B-TREATMENT
was O
held O
to O
allow O
for O
frequent O
exams O
. O

Head O
of O
bed O
was O
kept O
at O
30 O
degrees O
. O

Labetalol B-TREATMENT
continuous I-TREATMENT
infusion I-TREATMENT
was O
titrated O
for O
systolic O
blood O
pressure O
of O
130-160 O
. O

Mannitol B-TREATMENT
and O
Dilantin B-TREATMENT
were O
continued O
. O

After O
lengthy O
discussion O
, O
the O
patient O
's O
wife O
opted O
to O
make O
him O
DNR O
on O
afternoon O
of O
2013-11-11 O
. O

Overnight O
, O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
was O
given O
for O
goal O
INR O
of O
< O
1.4 O
. O

On O
serial O
exams O
by O
neurology O
and O
ICU O
attendings O
in O
the O
morning O
on O
2013-11-12 O
, O
patient O
had O
no B-SYMPTOM
clinical I-SYMPTOM
signs I-SYMPTOM
of I-SYMPTOM
brainstem I-SYMPTOM
activity I-SYMPTOM
. O

Namely O
, O
he O
was O
unresponsive B-SYMPTOM
. O

Pupils O
were O
fixed B-SYMPTOM
and O
dilated B-SYMPTOM
. O

No O
corneal O
, O
gag O
, O
oculocephalic O
, O
and O
oculovestibular O
reflexes O
were O
elicited O
. O

He O
was O
not O
overbreathing O
his B-TREATMENT
ventilator I-TREATMENT
. O

At O
this O
point O
, O
patient O
was O
felt O
to O
have O
clinical O
signs O
consistent O
with O
brain B-SYMPTOM
death I-SYMPTOM
. O

Plans O
were O
made O
to O
proceed O
with O
apnea O
testing O
. O

However O
, O
after O
discussion O
with O
patient O
's O
wife O
, O
this O
was O
postponed O
with O
test O
planned O
on O
2013-11-13 O
. O

Full B-TREATMENT
medical I-TREATMENT
care I-TREATMENT
and O
managment B-TREATMENT
continued O
overnight O
11/9-11/20/2002 O
. O

At O
approximately O
06:00 O
on O
2013-11-13 O
, O
the O
patient O
became O
bradycardic B-SYMPTOM
. O

He O
lapsed O
first O
into O
a B-SYMPTOM
junctional I-SYMPTOM
rhythm I-SYMPTOM
and O
then O
had O
very B-SYMPTOM
infrequent I-SYMPTOM
ventricular I-SYMPTOM
escape I-SYMPTOM
beats I-SYMPTOM
on O
telemetry O
. O

Finally O
, O
he O
went O
asystolic B-SYMPTOM
. O

He O
was O
not O
resuscitated O
as O
per O
previous O
conversations O
with O
his O
wife O
. O

Ronald O
was O
pronounced O
dead B-SYMPTOM
at O
06:59 O
am O
. O

The O
patient O
's O
wife O
was O
notified O
. O

The O
attending O
was O
notified O
as O
well O
. O

Medications O
on O
Admission O
: O

1. O
Coumadin B-TREATMENT

2. O
Lipitor B-TREATMENT

3. O
Toprol B-TREATMENT
XL I-TREATMENT

4. O
ASA B-TREATMENT

5. O
Zoloft B-TREATMENT

6. O
Glucophage B-TREATMENT

7. O
Aricept B-TREATMENT

8. O
Namenda B-TREATMENT

9. O
Artificial B-TREATMENT
Tears I-TREATMENT

Discharge O
Medications O
: O

Not O
applicable O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Patient O
deceased O
. O

Discharge O
Diagnosis O
: O

Not O
applicable; O
patient O
deceased O
. O

Discharge O
Condition O
: O

Not O
applicable O
. O

Discharge O
Instructions O
: O

Not O
applicable O
. O

Followup O
Instructions O
: O

Not O
applicable O
. O

William O
William O
MD O
, O
PHD O
13-279 O

Completed O
by O
: O
Barbara O
Josephine O
MD O
21-547 O
2013-11-15 O
@ O
1413 O

Signed O
electronically O
by O
: O
DR. O
Exie O
Culbreath O
on O
: O
MON O
2013-11-18 O
10:06 O
AM O

( O
End O
of O
Report O
) O

268157859 O
YC O

35980943 O

4198660 O

5/30/2005 O
12:00:00 O
AM O

s O
/ O
p O
total B-TREATMENT
thyoidectomy I-TREATMENT

DIS O

Admission O
Date O
: O

05/30/2005 O

Report O
Status O
: O

Discharge O
Date O
: O

05/31/2005 O

****** O
DISCHARGE O
ORDERS O
****** O

KOTEBITZWEERTS O
, O
LIXYNA O
N O

306-08-68-0 O
K78 O

Room O
: O

58W-275 O

Service O
: O

GGI O

DISCHARGE O
PATIENT O
ON O
: O

05/31/05 O
AT O
02:00 O
PM O

CONTINGENT O
UPON O

Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

TLAND O
, O
JR O
, O
VOTRIBRENDEVE O
N. O
, O
M.D. O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

ROCALTROL B-TREATMENT
( I-TREATMENT
CALCITRIOL I-TREATMENT
) I-TREATMENT
0.5 O
MCG O
PO O
QD O
Starting O
Today O
( O
05/31 O
) O

Instructions O
: O

Start O
on O
day O
of O
surgery B-TREATMENT
and O
continue O
throughout O
hospitalization O
. O

SYNTHROID B-TREATMENT
( I-TREATMENT
LEVOTHYROXINE I-TREATMENT
SODIUM I-TREATMENT
) I-TREATMENT
125 O
MCG O
PO O
QD O

Instructions O
: O

( O
typical O
dose O
is O
1 O
mcg O
per O
lb. O
) O

OXYCODONE B-TREATMENT
5-10 O
MG O
PO O
Q4H O
PRN O
Pain B-SYMPTOM
ADVAIR B-TREATMENT
DISKUS I-TREATMENT
100/50 O
( O
FLUTICASONE B-TREATMENT
PROPIONATE/... I-TREATMENT
) O
1 O
PUFF O
INH O
BID O
CALCIUM B-TREATMENT
CARBONATE I-TREATMENT
2,400 O
MG O
PO O
QID O
Starting O
Today O
( O
05/31 O
) O

DIET O
: O

No O
Restrictions O

ACTIVITY O
: O

Resume O
regular O
exercise O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Dr. O
Tland O
, O
462-352-5678 O
1-2 O
weeks O
please O
call O
for O
appointment O
if O
not O
made O
, O

ALLERGY O
: O

NKA B-SYMPTOM
ADMIT O
DIAGNOSIS O
: O

total B-TREATMENT
thyroidectomy I-TREATMENT

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
s O
/ O
p O
total B-TREATMENT
thyoidectomy I-TREATMENT

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
asthma B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

05/30/05 O
TLAND O
, O
JR O
, O
VOTRIBRENDEVE O
N. O
, O
M.D. O
TOTAL B-TREATMENT
THYROIDECTOMY I-TREATMENT

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

none O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

40F O
with O
hurtle B-SYMPTOM
cell I-SYMPTOM
tumor I-SYMPTOM
of I-SYMPTOM
thyroid I-SYMPTOM
had O
total B-TREATMENT
thyroidectomy I-TREATMENT
without O
complication B-SYMPTOM
. O

POD# O
1 O
pt O
was O
tolerating O
regular O
diet O
, O
ambulating O
, O
afebrile B-SYMPTOM
, O
and O
calcium O
was O
stable O
. O

Incicsion B-SYMPTOM
was O
clean O
dry O
and O
intact O
and O
pt O
was O
discharged O
home O
in O
stable O
condition O

ADDITIONAL O
COMMENTS O
: O

Keep O
incision B-SYMPTOM
clean O
and O
dry O
, O
may O
shower O
Wed O
. O

Do O
not O
drive O
if O
taking O
narcotics B-TREATMENT
Call O
doctor O
if O
fever B-SYMPTOM
&gt; O
101.5 O
, O
worsening B-SYMPTOM
pain I-SYMPTOM
, O
swelling B-SYMPTOM
, O
or O
redness B-SYMPTOM
of I-SYMPTOM
wound I-SYMPTOM
, O
numbness B-SYMPTOM
or I-SYMPTOM
tingling I-SYMPTOM
in I-SYMPTOM
extremities I-SYMPTOM
or O
face O
or O
any O
other O
concerns O
. O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

LILLETLANDTRIEV O
, O
ROSEEN O
ERTONDON O
( O
BZ30 O
) O
05/31/05 O
09:05 O
AM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2017-05-08 O

Discharge O
Date O
: O

2017-05-16 O

Date O
of O
Birth O
: O

1931-10-04 O

Sex O
: O

M O

Service O
: O

CARDIOTHORACIC O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Walter O
G O
Gaines O
, O
M.D. O

Chief O
Complaint O
: O
worsening B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
x O
2 O
/ O
Aortic B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
05-08 O

History O
of O
Present O
Illness O
: O

Mr. O
Williams O
is O
an O
85 O
yo O
gentleman O
who O
has O
a B-SYMPTOM
known I-SYMPTOM
cardiac I-SYMPTOM
history I-SYMPTOM
and O
has O
had O
a O
h/o O
worsening B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

He O
had O
an O
echocardiogram O
which O
showed O
an O
EF O
40-45% O
and O
severe B-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM
. O

He O
underwent O
cardiac O
catheterization O
which O
showed O
an B-SYMPTOM
80% I-SYMPTOM
LAD I-SYMPTOM
lesion I-SYMPTOM
, O
chronically B-SYMPTOM
occluded I-SYMPTOM
RCA I-SYMPTOM
, O
anneurysmal B-SYMPTOM
mid I-SYMPTOM
LCX I-SYMPTOM
w/50% B-SYMPTOM
lesion I-SYMPTOM
. O

He O
was O
refered O
to O
Dr. O
Barber O
for O
surgical B-TREATMENT
treatment I-TREATMENT
. O

Past O
Medical O
History O
: O

s/p O
MI B-SYMPTOM
1992 O

AS B-SYMPTOM

h/o O
prostate B-SYMPTOM
CA I-SYMPTOM
s/p O
brachytherapy B-TREATMENT
and O
hormone B-TREATMENT
treatment I-TREATMENT

hyperlipidemia B-SYMPTOM

HTN B-SYMPTOM

PAF B-SYMPTOM
h/o O
rectal B-SYMPTOM
bleeding I-SYMPTOM
s/p O
cauterization B-TREATMENT

cholelithiasis B-SYMPTOM

s/p O
AAA B-TREATMENT
repair I-TREATMENT
'95 O

s/p O
bilateral B-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT

s/p O
R B-TREATMENT
lung I-TREATMENT
surgery I-TREATMENT

CRI B-SYMPTOM

chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM

Pertinent O
Results: O

2017-05-16 O
06:20 O
AM O
BLOOD O
WBC O
- O
8.0 O
RBC O
- O
3.35 O
* O
Hgb O
- O
10.3 O
* O
Hct O
- O
31.0 O
* O
MCV O
- O
93 O
MCH O
- O
30.7 O
MCHC O
- O
33.1 O
RDW O
- O
13.0 O
Plt O
Ct O
- O
201 O

2017-05-16 O
06:20 O
AM O
BLOOD O
Plt O
Ct O
- O
201 O

2017-05-16 O
06:20 O
AM O
BLOOD O
PT O
- O
19.0 O
* O
INR O
( O
PT O
)- O
2.3 O

2017-05-16 O
09:50 O
AM O
BLOOD O
Glucose O
- O
118 O
* O
UreaN O
- O
18 O
Creat O
- O
1.6 O
* O
Na O
- O
137 O
K O
- O
5.1 O
Cl O
- O
98 O
HCO3 O
- O
29 O
AnGap O
- O
15 O

Brief O
Hospital O
Course O
: O

Mr. O
Williams O
was O
admitted O
to O
Hallmark O
Health O
System O
on O
05-08 O
and O
taken O
to O
the O
operating O
room O
with O
Dr. O
Barber O
for O
a B-TREATMENT
CABGx2 I-TREATMENT
and O
AVR B-TREATMENT
w/ O
25 B-TREATMENT
mm I-TREATMENT
pericardial I-TREATMENT
valve I-TREATMENT
. O

Please O
see O
operative O
note O
for O
full O
details O
. O

He O
was O
transfered O
to O
the O
ICU O
in O
stable O
condition O
. O

He O
was O
weaned O
and O
extubated O
from O
mechanical B-TREATMENT
ventillation I-TREATMENT
on O
POD#1 O
without O
difficulty B-SYMPTOM
. O

He O
was O
transfered O
to O
the O
regular O
part O
of O
the O
hospital O
on O
POD#2 O
, O
where O
he O
began O
working O
with O
physical O
therapy O
. O

He O
developed O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
on O
POD#2 O
with O
well O
controlled O
rate O
and O
hemodynamically O
stable O
. O

He O
was O
started O
on O
heparin B-TREATMENT
and O
coumadin B-TREATMENT
for O
anticoagulation B-TREATMENT
on O
POD#5 O
. O

On O
POD#7 O
he O
was O
cleared O
for O
discharge O
to O
home O
by O
physical O
therapy O
and O
on O
POD#8 O
he O
was O
discharged O
. O

Medications O
on O
Admission O
: O

lasix B-TREATMENT
40 O
mg O
q O
M-W-F O

Klorcon B-TREATMENT
10 O
mEq O
q O
M-W-F O

Pepcid B-TREATMENT
40 O
mg O
qd O

colexa B-TREATMENT
10 O
mg O
qd O

metoprolol B-TREATMENT
50 O
mg O
bid O

lipitor B-TREATMENT
20 O
mg O
qd O

aspirin B-TREATMENT
325 O
mg O
qd O

flovent B-TREATMENT
110 O
mcg O
inhaler O
bid O

atrovent B-TREATMENT
inhaler I-TREATMENT
tid O

Discharge O
Medications O
: O

1. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
:* O
30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)( O
s O
)* O
Refills O
:* O
0 O
* O

2. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
60 O
Capsule O
( O
s O
)* O
Refills O
:* O
0 O
* O

3. O
Fluticasone B-TREATMENT
Propionate I-TREATMENT
110 O
mcg O
/ O
Actuation O
Aerosol O
Sig O
: O
Two O
( O
2 O
) O
Puff O
Inhalation O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
1 O
canister O
* O
Refills O
:* O
0 O
* O

4. O
Oxycodone B-TREATMENT
- I-TREATMENT
Acetaminophen I-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
every O
4-6 O
hours O
as O
needed O
for O
pain B-SYMPTOM
. O

Disp O
:* O
40 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

5. O
Ipratropium B-TREATMENT
Bromide I-TREATMENT
18 O
mcg O
/ O
Actuation O
Aerosol O
Sig O
: O
Two O
( O
2 O
) O
Puff O
Inhalation O
QID O
( O
4 O
times O
a O
day O
) O
. O

Disp O
:* O
1 O
canister O
* O
Refills O
:* O
0 O
* O

6. O
Pantoprazole B-TREATMENT
Sodium I-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

Disp O
:* O
30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)( O
s O
)* O
Refills O
:* O
0 O
* O

7. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
60 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

8. O
Lipitor B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
: O
* O
0 O
* O

9. O
Bacitracin B-TREATMENT
Zinc I-TREATMENT
500 O
unit O
/ O
g O
Ointment O
Sig O
: O
One O
( O
1 O
) O
Appl O
Topical O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
1 O
tube O
* O
Refills O
:* O
0 O
* O

10. O
Celexa B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

Tablet O
( O
s O
) O

11. O
Warfarin B-TREATMENT
Sodium I-TREATMENT
1 O
mg O
Tablet O
Sig O
: O
Five O
( O
5 O
) O
Tablet O
PO O
once O
a O
day O
: O
Take O
5 O
mg O
on O
04-18 O
. O

MD O
to O
dose O
daily O
. O

Disp O
:* O
150 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

12. O
Lasix B-TREATMENT
40 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
q O
M-W-F O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

13. O
Potassium B-TREATMENT
Chloride I-TREATMENT
10 O
mEq O
Capsule O
, O
Sustained O
Release O
Sig O
: O
One O
( O
1 O
) O
Capsule O
, O
Sustained O
Release O
PO O
q O
M-W-F O
. O

Disp O
:* O
30 O
Capsule O
, O
Sustained O
Release O
( O
s O
)* O
Refills O
:* O
2 O
* O

14. O
Coumadin B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
: O
as O
directed O
for O
goal O
INR O
2.0-2.5. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

Aortic B-SYMPTOM
stenosis I-SYMPTOM
. O

Hyperlipidemia B-SYMPTOM
. O

Atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

Chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM

Discharge O
Condition O
: O

Good O
. O

Discharge O
Instructions O
: O

Shower O
daily O
and O
wash O
incisions B-SYMPTOM
with O
soap O
and O
water O
. O

Rinse O
well O
. O

Do O
not O
apply O
any O
creams O
, O
lotions O
, O
powders O
, O
or O
ointments O
. O

No O
bathing O
in O
tub O
or O
swimming O
. O

No O
heavy O
lifting O
, O
greater O
than O
10 O
pounds O
. O

No O
driving O
for O
6 O
weeks O
. O

Followup O
Instructions O
: O

Make O
follow-appointment O
with O
Dr. O
Barber O
in O
4-6 O
weeks O
. O

Make O
follow-up O
appointment O
with O
Dr. O
Jo O
in O
1-2 O
weeks O
. O

Dustin O
Elmer O
MD O
22-708 O

Completed O
by O
: O
Ann O
J. O
Haley O
PA O
80-AXP O
2017-05-17 O
@ O
1251 O

Signed O
electronically O
by O
: O
DR. O
Jackie O
Mcafee O
on O
: O
TUE O
2017-07-11 O
8:43 O
AM O

( O
End O
of O
Report O
) O

860059421 O

SH O

17511921 O

6/10/1999 O
12:00:00 O
AM O

GASTROINTESTINAL B-SYMPTOM
BLEED I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

06/10/1999 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

06/26/1999 O

DISCHARGE O
DIAGNOSIS O
: O

SEPSIS B-SYMPTOM
. O

SIGNIFICANT O
PROBLEMS O
: O

1 O
) O
GASTROINTESTINAL B-SYMPTOM
BLEED I-SYMPTOM
. O

2 O
) O
HEPATIC B-SYMPTOM
ENCEPHALOPATHY I-SYMPTOM
. O

3 O
) O
END B-SYMPTOM
STAGE I-SYMPTOM
RENAL I-SYMPTOM
DISEASE I-SYMPTOM
ON O
DIALYSIS B-TREATMENT
. O

HISTORY O
OF O
THE O
PRESENT O
ILLNESS O
: O

Mr. O
Vinktlandfreierm O
was O
admitted O
from O
Owaleharbo O
Tanaminer O
Hospital O
to O
which O
he O
had O
been O
discharged O
approximately O
four O
days O
prior O
to O
admission O
. O

He O
was O
noted O
to O
have O
dark B-SYMPTOM
stools I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
and O
to O
be O
somewhat B-SYMPTOM
fluid I-SYMPTOM
overloaded I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

He O
was O
admitted O
and O
found O
to O
have O
a O
significant O
hematocrit B-SYMPTOM
drop I-SYMPTOM
from O
33.8 O
to O
24.3 O
. O

He O
was O
found O
operation O
be O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
was O
taken O
to O
dialysis B-TREATMENT
for O
apparent B-SYMPTOM
fluid I-SYMPTOM
overload I-SYMPTOM
. O

His B-SYMPTOM
gastrointestinal I-SYMPTOM
bleeding I-SYMPTOM
issues I-SYMPTOM
were O
investigated O
with O
an O
upper O
endoscopy O
which O
revealed O
multiple O
superficial O
gastric B-SYMPTOM
ulcerations I-SYMPTOM
consistent O
with O
an B-SYMPTOM
non-steroidal I-SYMPTOM
anti-inflammatory I-SYMPTOM
drugs I-SYMPTOM
gastropathy I-SYMPTOM
. O

He O
had O
been O
discharged O
on O
one B-TREATMENT
aspirin I-TREATMENT
a O
day O
with O
20 O
of O
Prilosec B-TREATMENT
b.i.d. O

The B-TREATMENT
aspirin I-TREATMENT
was O
discontinued O
and O
he O
had O
no O
further O
problems O
with O
gastrointestinal B-SYMPTOM
bleeding I-SYMPTOM
and O
a O
stable O
hematocrit O
the O
rest O
of O
his O
hospitalization O
. O

During O
the O
course O
of O
his O
hospitalization O
, O
he O
became O
increasingly B-SYMPTOM
lethargic I-SYMPTOM
. O

An O
extensive O
work-up O
was O
done O
for O
any B-SYMPTOM
metabolic I-SYMPTOM
abnormalities I-SYMPTOM
which O
was O
unrevealing O
. O

He O
responded O
somewhat O
to O
lactulose B-TREATMENT
for O
hepatic B-SYMPTOM
encephalopathy I-SYMPTOM
. O

He O
had O
one B-SYMPTOM
positive I-SYMPTOM
blood I-SYMPTOM
culture I-SYMPTOM
for O
Vancomycin B-SYMPTOM
resistant I-SYMPTOM
enterococcus I-SYMPTOM
. O

In O
the O
few O
days O
prior O
to O
his O
demise O
, O
he O
was O
intermittently O
somewhat B-SYMPTOM
lethargic I-SYMPTOM
buton O
the O
morning O
of O
June O
25 O
, O
1999 O
, O
his O
white O
count O
was O
noted O
to O
have O
increased O
from O
8 O
to O
13,000 O
. O

That O
day O
, O
he O
was O
found O
to O
be O
acutely B-SYMPTOM
short I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
with O
a O
respiratory O
rate O
of O
40 O
and O
oxygen O
saturations O
in O
the O
mid O
seventies O
. O

He O
was O
put O
on O
100% B-TREATMENT
nonrebreather I-TREATMENT
and O
his O
oxygen O
saturations O
improved O
to O
the O
low O
nineties O
. O

Nasal B-TREATMENT
trumpet I-TREATMENT
suction I-TREATMENT
was O
done O
and O
he O
was O
found O
to O
have O
food O
like O
material O
that O
was O
easily O
suctioned O
out O
. O

He O
was O
also O
found O
to O
havesome O
pieces O
of O
toast O
in O
his O
mouth O
. O

Blood O
gases O
were O
done O
and O
he O
was O
found O
to O
have O
a O
pH O
of O
7.2 O
with O
a O
pCO2 O
of O
21 O
. O

Fingerstick O
glucose O
revealed O
a O
sugar O
of O
12 O
. O

A O
stat O
panel O
7 O
confirmed O
that O
the O
sugar O
was O
23 O
and O
that O
he O
had O
a O
new O
anion O
gap O
of O
40 O
. O

Repeat O
blood O
gas O
was O
done O
which O
was O
almost O
identical O
to O
the O
first O
. O

The O
family O
was O
called O
and O
came O
in O
to O
see O
the O
patient O
. O

An O
extensive O
family O
meeting O
was O
held O
and O
the O
family O
agreed O
that O
it O
did O
not O
make O
sense O
to O
intubate O
the O
patient O
and O
send O
him O
to O
the O
Intensive O
Care O
Unit O
. O

In O
the O
acute O
setting O
, O
he O
had O
been O
started O
on O
levofloxacin B-TREATMENT
, O
Flagyl B-TREATMENT
, O
and O
Vancomycin B-TREATMENT
. O

These B-TREATMENT
antibiotics I-TREATMENT
were O
continued O
but O
the O
family O
decided O
that O
they O
wanted O
us O
to O
emphasize O
the O
comfort O
of O
the O
patient O
and O
pursue O
no O
further B-TREATMENT
invasive I-TREATMENT
measures I-TREATMENT
. O

The O
patient O
was O
made O
do O
not O
resuscitate O
/ O
do O
not O
intubate O
. O

At O
2:30 O
on O
June O
26 O
, O
1999 O
, O
I O
was O
called O
to O
see O
the O
patient O
who O
had O
expired O
. O

DISPOSITION O
: O

The O
family O
was O
notified O
and O
came O
in O
to O
see O
the O
patient O
. O

The O
family O
declined O
an O
autopsy O
saying O
that O
they O
felt O
that O
the O
patient O
had O
been O
through O
enough O
. O

The O
patient O
&apos;s O
attending O
physician O
, O
Dr. O
Erm O
Neidwierst O
, O
was O
notified O
as O
well O
. O

Dictated O
By O
: O

CONRELLIE O
KOTERUDES O
, O
M.D. O
UK0 O

Attending O
: O

ERM O
K. O
NEIDWIERST O
, O
M.D. O
QQ62 O
OC499/5391 O

Batch O
: O

15168 O

Index O
No. O

VKRPJQ81J6 O

D O
: O

06/26/99 O

T O
: O

06/29/99 O

289724916 O

HLGMC O

0051811 O

56075/pu8n O

6/30/1992 O
12:00:00 O
AM O

CARCINOMA B-SYMPTOM
OF I-SYMPTOM
THE I-SYMPTOM
KIDNEY I-SYMPTOM
, O
HYPOVOLEMIA B-SYMPTOM
, O
METASTATIC B-SYMPTOM
LIVER I-SYMPTOM

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

6-30-92 O

DISCHARGE O
DATE O
: O

7-1-92 O
( O
SOUTHOBASSKING&apos;S O
VILLEMARG O
HOSPITAL O
) O

PRINCIPAL O
DIAGNOSIS O
: O

carcinoma B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
kidney I-SYMPTOM
, O
hypovolemia B-SYMPTOM
, O
metastatic B-SYMPTOM
liver I-SYMPTOM
disease I-SYMPTOM
and O
intrathoracic B-SYMPTOM
lymphadenopathy I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
history O
of O
this O
49 O
year O
old O
male O
is O
provided O
in O
detail O
in O
the O
typed O
admission O
note O
dated O
June O
30 O
, O
1992 O
. O

PHYSICAL O
EXAMINATION O
: O

( O
at O
time O
of O
admission O
) O
the O
blood O
pressure O
100/65 O
; O

head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
: O

no O
masses B-SYMPTOM
, O
neck O
revealed O
lymphadenopathy B-SYMPTOM
. O

The O
lungs O
were O
clear O
, O
heart O
normal O
. O

Abdomen O
: O

liver B-SYMPTOM
massively I-SYMPTOM
enlarged I-SYMPTOM
down O
15 O
cm O
. O

Extremities O
: O

normal O
; O

neurological O
examination O
: O

generally O
intact O
. O

LABORATORY O
DATA O
: O

( O
at O
time O
of O
admission O
) O
hematocrit O
32.7 O
; O
white O
blood O
count O
9,000 O
; O
platelet O
count O
336,000 O
; O
sodium O
126 O
, O
potassium O
4.3 O
, O
chloride O
93 O
, O
CO2 O
19 O
, O
BUN O
36 O
, O
creatinine O
1.5 O
, O
blood O
sugar O
84 O
, O
calcium O
11.7 O
; O
the O
chest O
X-ray O
normal O
. O

KUB O
: O

consistent O
with O
adynamic B-SYMPTOM
ileus I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
worsened O
rapidly O
following O
admission O
and O
it O
was O
clear O
to O
his O
family O
and O
to O
his O
physician O
that O
he O
was O
pre-terminal O
. O

All O
efforts O
were O
directed O
to O
his O
comfort O
and O
he O
died O
on O
July O
1 O
, O
1992 O
. O

Autopsy O
permission O
was O
declined O
by O
the O
family O
. O

NU O
L. O
GALL O
, O
M.D. O

TR O
: O

vb O
/ O
bmot O

DD O
: O

7-30-92 O

TD O
: O

08/03/92 O

CC O
: O

DR. O
VERD O
CHURLAUNT O

DR. O
NU O
L. O
GALL O
, O
LI O
HOSPITAL O

032890433 O

CTMC O

75066875 O

828710 O

02/21/1991 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Admission O
Date O
: O

02/21/1991 O

Report O
Status O
: O

Unsigned O

Discharge O
Date O
: O

02/26/1991 O

DISCHARGE O
DIAGNOSIS O
: O

LEFT B-SYMPTOM
RENAL I-SYMPTOM
MASS I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
was O
a O
63 O
year O
old O
female O
with O
long-standing O
history O
of O
polycythemia B-SYMPTOM
vera I-SYMPTOM
, O
managed O
medically O
, O
who O
on O
a O
routine O
follow-up O
examination O
complained O
of O
left B-SYMPTOM
side I-SYMPTOM
pain I-SYMPTOM
and O
had O
an O
ultrasound O
that O
demonstrated O
a B-SYMPTOM
complex I-SYMPTOM
left I-SYMPTOM
renal I-SYMPTOM
mass I-SYMPTOM
. O

A O
computerized O
tomography O
scan O
demonstrated O
a B-SYMPTOM
contrast I-SYMPTOM
enhancing I-SYMPTOM
complex I-SYMPTOM
left I-SYMPTOM
renal I-SYMPTOM
mass I-SYMPTOM
. O

Metastatic O
work-up O
was O
negative O
. O

The O
patient O
presented O
for O
nephrectomy B-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
included O
polycythemia B-SYMPTOM
vera I-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
included O
appendectomy B-TREATMENT
and O
bunionectomy B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
were O
Hydrea B-TREATMENT
. O

REVIEW O
OF O
SYSTEMS O
was O
negative O
in O
detail O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
was O
a O
robust O
white O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
, O
afebrile B-SYMPTOM
, O
blood O
pressure O
165/80 O
. O

Head O
and O
neck O
were O
unremarkable O
. O

Lungs O
were O
clear O
. O

Heart O
had O
regular O
rate O
and O
rhythm O
. O

Abdomen O
was O
benign O
. O

Rectal O
examination O
was O
guaiac O
negative O
. O

Extremities O
and O
neurological O
examinations O
were O
unremarkable O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
taken O
to O
the O
operating O
room O
by O
Dr. O
Suot O
N. O
Dragtente O
on O
02-21-91 O
, O
where O
a B-TREATMENT
left I-TREATMENT
radical I-TREATMENT
nephrectomy I-TREATMENT
was O
performed O
. O

At O
operation B-TREATMENT
, O
there O
was O
no O
gross B-SYMPTOM
adenopathy I-SYMPTOM
or O
renal B-SYMPTOM
vein I-SYMPTOM
involvement I-SYMPTOM
, O
and O
it O
was O
felt O
that O
the B-SYMPTOM
tumor I-SYMPTOM
was O
completely O
excised O
. O

The O
patient O
thereafter O
had O
a O
benign O
convalescence O
, O
and O
was O
discharged O
on O
the O
5th O
postoperative O
day O
. O

The O
oncology O
fellows O
from O
Venbonlea O
Health O
followed O
her O
course O
and O
recommended O
holding O
off O
on O
her B-TREATMENT
Hydrea I-TREATMENT
while O
she O
is O
hospitalized O
, O
and O
they O
will O
follow O
her O
as O
an O
outpatient O
and O
restart O
her B-TREATMENT
Hydrea I-TREATMENT
when O
her O
hematocrit O
is O
over O
40% O
. O

DISPOSITION O
: O

The O
patient O
was O
discharged O
to O
home O
. O

The O
patient O
was O
discharged O
on O
a O
regular O
diet O
. O

CONDITION O
ON O
DISCHARGE O
was O
stable O
. O

FOLLOW-UP O
will O
be O
with O
Dr. O
Suot O
N. O
Dragtente O
and O
with O
her O
Venbonlea O
Health O
oncology O
fellows O
. O

MEDICATIONS O
ON O
DISCHARGE O
included O
Percocet B-TREATMENT
1 O
to O
2 O
tablets O
by O
mouth O
every O
4 O
hours O
as O
needed O
for O
pain B-SYMPTOM
, O
Colace B-TREATMENT
100 O
milligrams O
by O
mouth O
twice O
a O
day O
. O

PL926/1533 O
SUOT O
N. O
DRAGTENTE O
, O
M.D. O
GJ7 O

D O
: O

02/26/91 O

Batch O
: O

8776 O

Report O
: O

P9055V6 O

T O
: O

03/02/91 O

Dicatated O
By O
: O

ESPEXIINE O
BRIZ O
, O
M.D. O
XT67 O

cc O
: O

1. O
VENBONLEA O
HEALTH O

Admission O
Date O
: O

2009-06-23 O

Discharge O
Date O
: O

2009-07-12 O

Date O
of O
Birth O
: O

1926-02-07 O

Sex O
: O

M O

Service O
: O

CMI O
; O
then O
to O
Medcine O
; O
then O
transferred O
to O
CCU O

CHIEF O
COMPLAINT O
: O

Renal B-SYMPTOM
failure I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
an O
83-year-old O
male O
with O
a O
history O
of O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
steroid-treated B-SYMPTOM
polymyalgia I-SYMPTOM
rheumatica I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
benign B-SYMPTOM
prostatic I-SYMPTOM
hypertrophy I-SYMPTOM
, O
and O
high B-SYMPTOM
cholesterol I-SYMPTOM
who O
presented O
for O
a O
lower O
extremity O
peripheral O
angiography O
for O
bilateral B-SYMPTOM
foot I-SYMPTOM
ulcers I-SYMPTOM
, O
and O
he O
was O
found O
to O
an B-SYMPTOM
evaluated I-SYMPTOM
blood I-SYMPTOM
urea I-SYMPTOM
nitrogen I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
creatinine I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
potassium I-SYMPTOM
. O

The O
patient O
notes O
he O
developed O
worsening B-SYMPTOM
foot I-SYMPTOM
pain I-SYMPTOM
and O
ulcers B-SYMPTOM
four O
months O
ago O
. O

Due O
to O
his B-SYMPTOM
worsening I-SYMPTOM
blood I-SYMPTOM
glucose I-SYMPTOM
, O
he O
was O
started O
on O
insulin B-TREATMENT
. O

His B-SYMPTOM
foot I-SYMPTOM
ulcers I-SYMPTOM
continued O
to O
develop O
, O
and O
the O
patient O
complained O
of O
pain B-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
feet I-SYMPTOM
; O
primarily O
at O
night O
. O

The O
patient O
was O
referred O
to O
for O
Vascular O
consultation O
because O
of O
the B-SYMPTOM
ulcerations I-SYMPTOM
and O
pain B-SYMPTOM
and O
scheduled O
for O
a O
lower O

extremity O
angiography O
on O
the O
day O
of O
admission O
, O
but O
due O
to O
his B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
the O
procedure O
was O
cancelled O
. O

The O
patient O
showed O
peaked B-SYMPTOM
T I-SYMPTOM
waves I-SYMPTOM
on O
electrocardiogram O
, O
and O
he O
was O
transferred O
to O
Medicine O
. O

The O
patient O
denied O
any O
oliguria B-SYMPTOM
, O
hematuria B-SYMPTOM
, O
dysuria B-SYMPTOM
, O
foamy B-SYMPTOM
urine I-SYMPTOM
, O
flank B-SYMPTOM
pain I-SYMPTOM
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
or O
urinary B-SYMPTOM
hesitancy I-SYMPTOM
. O

He O
has O
complained O
of O
fatigue B-SYMPTOM
, O
anorexia B-SYMPTOM
, O
and O
a B-SYMPTOM
10-pound I-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
in O
the O
last O
four O
months O
. O

He O
gets O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
with O
one O
flight O
of O
stairs O
. O

He O
denies O
any B-SYMPTOM
fevers I-SYMPTOM
, O
chills B-SYMPTOM
, O
recent B-SYMPTOM
infections I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
orthopnea B-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
diarrhea B-SYMPTOM
, O
hematemesis B-SYMPTOM
, O
melena B-SYMPTOM
, O
or O
hematochezia B-SYMPTOM
. O

The O
patient O
also O
notes O
he O
has O
had O
hoarseness B-SYMPTOM
for O
the O
last O
two O
to O
three O
weeks O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
times O
four O
years O
; O
recently O
started O
insulin B-TREATMENT
and O
metformin B-TREATMENT
due O
to O
his B-TREATMENT
concurrent I-TREATMENT
steroid I-TREATMENT
use I-TREATMENT
. O

Last O
hemoglobin O
A1c O
was O
11.4 O
. O

2. O
Polymyalgia B-SYMPTOM
rheumatica I-SYMPTOM
diagnosed O
four O
years O
ago O
; O
on O
steroids B-TREATMENT
. O

3. O
Benign B-SYMPTOM
prostatic I-SYMPTOM
hypertrophy I-SYMPTOM
, O
status O
post O
transurethral B-TREATMENT
resection I-TREATMENT
of I-TREATMENT
prostate I-TREATMENT
. O

4. O
Hypertension B-SYMPTOM
. O

5. O
High B-SYMPTOM
cholesterol I-SYMPTOM
. O

6. O
Lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Methylprednisolone B-TREATMENT
4 O
mg O
q. O
a.m. O
and O
2 O
mg O
p.o. O
q.h.s. O
, O
spironolactone B-TREATMENT
50 O
mg O
p.o. O
q.d. O
, O
metformin B-TREATMENT
1500 O
mg O
p.o. O
q.h.s. O
, O
Pravastatin B-TREATMENT
10 O
mg O
p.o. O
q.h.s. O
, O
lisinopril B-TREATMENT
20 O
mg O
p.o. O
q. O
a.m. O
, O
Lasix B-TREATMENT
80 O
mg O
p.o. O
q. O
a.m. O
, O
Tylenol B-TREATMENT
as O
needed O
, O
insulin B-TREATMENT
regular I-TREATMENT
22 O
units O
in O
the O
morning O
and O
12 O
units O
at O
night O
( O
lispro B-TREATMENT
regular I-TREATMENT
). O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

FAMILY O
HISTORY O
: O

Type B-SYMPTOM
1 I-SYMPTOM
diabetes I-SYMPTOM
in O
twin O
brother O
, O
type B-SYMPTOM
2 I-SYMPTOM
diabetes I-SYMPTOM
in O
mother O
and O
brother O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
is O
a O
former O
smoker O
; O
he O
quit O
50 O
years O
ago O
. O

He O
drinks O
one O
glass O
of O
wine O
per O
night O
. O

He O
is O
married O
and O
lives O
with O
his O
wife O
. O

John O
was O
in O
the O
Army O
during O
World O
War O
II O
. O

PHYSICAL O
EXAMINATION O
ON O
PRESENTATION O
: O

On O
admission O
, O
temperature O
was O
98.1 O
, O
blood O
pressure O
was O
140/70 O
, O
pulse O
was O
95 O
, O
respiratory O
rate O
was O
18 O
, O
oxygen O
saturation O
was O
98% O
on O
room O
air O
. O

In O
general O
, O
the O
patient O
was O
a O
thin O
white O
male O
, O
lying O
in O
bed O
, O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
, O
with O
a B-SYMPTOM
hoarse I-SYMPTOM
voice I-SYMPTOM
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
, O
and O
throat O
revealed O
pupils O
were O
equally O
round O
and O
reactive O
to O
light O
and O
accommodation O
. O

Extraocular O
movements O
were O
intact O
. O

Sclerae O
were O
anicteric B-SYMPTOM
. O

Mucous O
membranes O
were O
moist O
. O

Neck O
revealed O
no O
lymphadenopathy B-SYMPTOM
. O

No O
thyromegaly B-SYMPTOM
. O

No O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
. O

Cardiovascular O
examination O
revealed O
a O
regular O
rate O
and O
rhythm O
. O

Normal O
first O
heart O
sound O
and O
second O
heart O
sound O
. O

A B-SYMPTOM
2/6 I-SYMPTOM
systolic I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
upper I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
. O

Lungs O
were O
clear O
to O
auscultation O
bilaterally O
with O
faint B-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
crackles I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
. O

Back O
revealed O
no O
costovertebral B-SYMPTOM
angle I-SYMPTOM
tenderness I-SYMPTOM
. O

The O
abdomen O
was O
soft O
and O
nontender B-SYMPTOM
. O

No O
rebound B-SYMPTOM
or O
guarding B-SYMPTOM
. O

No O
hepatosplenomegaly B-SYMPTOM
. O

Extremities O
revealed O
2+ O
femoral O
pulses O
bilaterally O
, O
1+ O
dorsalis O
pedis O
pulses O
bilaterally O
. O

No O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
. O

Left O
foot O
with O
a B-SYMPTOM
dry I-SYMPTOM
crusted I-SYMPTOM
ulcer I-SYMPTOM
over O
the O
medial O
aspect O
of O
the O
first O
metatarsal O
head O
and O
the O
lateral O
posterior O
heel O
. O

On O
the B-SYMPTOM
right I-SYMPTOM
foot I-SYMPTOM
dry I-SYMPTOM
crusted I-SYMPTOM
ulcer I-SYMPTOM
over O
the O
medial O
aspect O
of O
the O
first O
metatarsal O
head O
and O
medial O
posterior O
heel O
. O

Neurologic O
examination O
was O
grossly O
intact O
. O

PERTINENT O
LABORATORY O
DATA O
ON O
PRESENTATION O
: O

On O
admission O
, O
white O
blood O
cell O
count O
was O
11 O
, O
hematocrit O
was O
30 O
, O
platelets O
were O
269 O
. O

Sodium O
was O
139 O
, O
potassium O
was O
6.1 O
, O
chloride O
was O
102 O
, O
bicarbonate O
was O
18 O
, O
blood O
urea O
nitrogen O
was O
100 O
, O
creatinine O
was O
2.3 O
, O
and O
blood O
glucose O
was O
189 O
. O

FENa O
was O
0.37 O
. O

RADIOLOGY O
/ O
IMAGING O
: O

Renal O
ultrasound O
was O
normal O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
is O
an O
83 O
- O
year-old O
male O
with O
a O
history O
of O
diabetes B-SYMPTOM
, O
steroid-treated B-SYMPTOM
polymyalgia I-SYMPTOM
rheumatica I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
benign B-SYMPTOM
prostatic I-SYMPTOM
hypertrophy I-SYMPTOM
, O
and O
high B-SYMPTOM
cholesterol I-SYMPTOM
without O
presented O
to O
the O
hospital O
for O
lower O
extremity O
angiograph O
; O
however O
, O
that O
was O
deferred O
due O
to O
new B-SYMPTOM
onset I-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
. O

1. O
RENAL B-SYMPTOM
FAILURE I-SYMPTOM
: O

The O
patient O
was O
initially O
thought O
to O
be O
prerenal B-SYMPTOM
, O
and O
his O
renal O
status O
improved O
after O
hydration B-TREATMENT
and O
increased B-TREATMENT
oral I-TREATMENT
intake I-TREATMENT
. O

He O
did O
have O
a O
magnetic O
resonance O
angiography O
of O
his O
kidneys O
which O
showed O
mild B-SYMPTOM
right-sided I-SYMPTOM
renal I-SYMPTOM
artery I-SYMPTOM
stenosis I-SYMPTOM
. O

His O
renal O
function O
fluctuated O
throughout O
his O
hospital O
stay O
, O
and O
when O
he O
was O
in O
the O
Medical O
Intensive O
Care O
Unit O
he O
did O
have O
decreased B-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
in O
the O
setting O
of O
cardiogenic B-SYMPTOM
shock I-SYMPTOM
. O

2. O
CARDIOVASCULAR O
: O

The O
patient O
with O
severe B-SYMPTOM
peripheral I-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
. O

During O
his O
hospital O
stay O
, O
he O
developed O
some B-SYMPTOM
nonsustained I-SYMPTOM
ventricular I-SYMPTOM
tachycardia I-SYMPTOM
. O

He O
also O
became O
hypotensive B-SYMPTOM
on O
07-02 O
in O
the O
setting O
of O
infection B-SYMPTOM
. O

The O
patient O
had O
a B-TREATMENT
central I-TREATMENT
line I-TREATMENT
placed O
and O
went O
into O
sustained B-SYMPTOM
ventricular I-SYMPTOM
tachycardia I-SYMPTOM
that O
was O
treated O
with O
lidocaine B-TREATMENT
. O

After O
being O
treated O
with O
lidocaine B-TREATMENT
, O
the O
patient O
became O
apneic B-SYMPTOM
requiring O
intubation B-TREATMENT
and O
transfer O
to O
the O
Coronary O
Care O
Unit O
. O

His B-SYMPTOM
nonsustained I-SYMPTOM
ventricular I-SYMPTOM
tachycardia I-SYMPTOM
was O
treated O
with O
a B-TREATMENT
lidocaine I-TREATMENT
drip I-TREATMENT
. O

It O
was O
found O
that O
he O
had O
elevated B-SYMPTOM
troponins I-SYMPTOM
and O
likely O
an B-SYMPTOM
ischemic I-SYMPTOM
event I-SYMPTOM
on O
the O
07-02 O
. O

A O
repeat O
echocardiogram O
showed O
a B-SYMPTOM
decreased I-SYMPTOM
ejection I-SYMPTOM
fraction I-SYMPTOM
from O
prior O
. O

He O
had O
a O
cardiac O
catheterization O
which O
revealed O
3-vessel B-SYMPTOM
disease I-SYMPTOM
. O

Cardiothoracic O
Surgery O
was O
consulted O
, O
and O
due O
to O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
acute I-SYMPTOM
illness I-SYMPTOM
, O
they O
wanted O
to O
re-evaluate O
after O
the O
patient O
was O
extubated O
. O

The O
patient O
continued O
to O
have O
intermittent O
episodes O
of O
ventricular B-SYMPTOM
tachycardia I-SYMPTOM
. O

He O
was O
continued O
on O
lidocaine B-TREATMENT
and O
eventually O
changed O
over O
to O
amiodarone B-TREATMENT
. O

He O
was O
noted O
to O
be O
cardiogenic B-SYMPTOM
shock I-SYMPTOM
requiring O
pressors B-TREATMENT
. O

Of O
note O
, O
he O
likely O
suffered O
a B-SYMPTOM
second I-SYMPTOM
ischemic I-SYMPTOM
event I-SYMPTOM
during O
his O
Coronary O
Care O
Unit O
stay O
. O

The O
patient O
did O
have O
a O
Swan-Ganz O
catheter O
in O
place O
and O
had O
a B-SYMPTOM
low I-SYMPTOM
cardiac I-SYMPTOM
output I-SYMPTOM
. O

The O
patient O
's O
family O
eventually O
decided O
to O
withdraw O
care O
, O
and O
the O
patient O
was O
extubated O
and O
passed O
away O
on O
2009-07-12 O
. O

2. O
INFECTIOUS O
DISEASE O
: O

The O
patient O
was O
initially O
treated O
with O
levofloxacin B-TREATMENT
for O
a B-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
infiltrate I-SYMPTOM
and O
a B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

He O
then O
developed O
positive B-SYMPTOM
blood I-SYMPTOM
cultures I-SYMPTOM
with O
Staphylococcus B-SYMPTOM
aureus I-SYMPTOM
sensitive O
to O
levofloxacin B-TREATMENT
, O
and O
that O
was O
continued O
. O

When O
the O
patient O
became O
hypotensive B-SYMPTOM
and O
required O
intubation B-TREATMENT
and O
pressors B-TREATMENT
, O
his B-TREATMENT
antibiotics I-TREATMENT
were O
broadened O
, O
and O
he O
was O
put O
on O
stress-dose B-TREATMENT
steroids I-TREATMENT
. O

He O
was O
found O
to O
have O
bilateral B-SYMPTOM
Staphylococcus I-SYMPTOM
pneumonia I-SYMPTOM
. O

3. O
PULMONARY O
: O

The O
patient O
required O
intubation B-TREATMENT
in O
the O
setting O
of O
hypotension B-SYMPTOM
and O
ventricular B-SYMPTOM
tachycardia I-SYMPTOM
. O

He O
was O
actually O
extubated O
on O
07-09 O
, O
but O
then O
reintubated O
one O
hour O
later O
due O
to O
hypoxia B-SYMPTOM
. O

He O
was O
also O
found O
to O
have O
a B-SYMPTOM
bilateral I-SYMPTOM
Staphylococcus I-SYMPTOM
pneumonia I-SYMPTOM
. O

DISCHARGE O
DISPOSITION O
: O

On O
07-12 O
, O
after O
and O
extensive O
family O
meeting O
, O
the O
family O
decided O
to O
extubate O
the O
patient O
and O
make O
him O
comfortable O
, O
and O
he O
passed O
away O
at O
5:20 O
on O
2009-07-12 O
. O

Hattie O
L O
Breaux O
, O
M.D. O

33-679 O

Dictated O
By O
: O
Larry O
W. O
Nagy O
, O
M.D. O

MEDQUIST36 O

D O
: O
2009-12-03 O
09:18 O

T O
: O
2009-12-08 O
10:47 O

JOB O
#: O

32151 O

Signed O
electronically O
by O
: O
DR. O
Stephanie O
Francis O
on O
: O
TUE O
2009-12-08 O
4:59 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2015-09-20 O

Discharge O
Date O
: O

2015-09-30 O

Date O
of O
Birth O
: O

1961-09-28 O

Sex O
: O

F O

Service O
: O

NEUROLOGY O

Allergies O
: O

Lamictal B-TREATMENT
/ O
Keflex B-TREATMENT
/ O
Navane B-TREATMENT
/ O
Inderal B-TREATMENT
/ O
Depakote B-TREATMENT

Attending O
: O
Cindy O
U. O
Kelly O
, O
M.D. O

Chief O
Complaint O
: O

transfer O
from O
OSH O
, O
seizure B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Lumbar O
puncture O

History O
of O
Present O
Illness O
: O

Ms. O
Swanson O
is O
a O
53 O
yo O
woman O
with O
PMH O
significant O
for O
seizure B-SYMPTOM
disorder I-SYMPTOM
, O
brain B-SYMPTOM
injury I-SYMPTOM
, O
and O
? O
atypical B-SYMPTOM
multiple I-SYMPTOM
sclerosis I-SYMPTOM
who O
presents O
with O
right B-SYMPTOM
face I-SYMPTOM
twitch I-SYMPTOM
and O
right B-SYMPTOM
arm I-SYMPTOM
shaking I-SYMPTOM
. O

History O
is O
obtained O
from O
her O
sister O
, O
William O
from O
Lawrence O
General O
Hospital O
, O
and O
from O
her O
primary O
neurologist O
, O
Dr. O
Brian O
. O

She O
lives O
in O
an O
assisted O
living O
, O
and O
was O
noted O
yesterday O
to O
have O
generalized B-SYMPTOM
tonic-clonic I-SYMPTOM
activity I-SYMPTOM
beginning O
on O
the O
right O
side O
and O
lasting O
90 O
minutes O
. O

EMS O
gave O
her O
valium B-TREATMENT
5 O
mg O
pr O
at O
the O
facility O
and O
brought O
her O
to O
Barnstable O
County O
Hospital O
. O

She O
persisted O
with O
right B-SYMPTOM
sided I-SYMPTOM
seizure I-SYMPTOM
activity I-SYMPTOM
there O
and O
was O
given O
valium B-TREATMENT
10 O
mg O
and O
ativan B-TREATMENT
1 O
mg O
, O
as O
well O
as O
loaded O
with O
dilantin B-TREATMENT
1000 O
mg O
. O

She O
was O
transferred O
to O
the O
Providence O
Behavioral O
Health O
Hospital O
CMED O
. O

Here O
she O
was O
given O
an B-TREATMENT
additional I-TREATMENT
valium I-TREATMENT
5 O
mg O
x O
2 O
and O
ativan B-TREATMENT
1 O
mg O
x O
3 O
for O
persistent B-SYMPTOM
twitching I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
face I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
hand I-SYMPTOM
. O

Since O
the B-TREATMENT
ativan I-TREATMENT
, O
her B-SYMPTOM
facial I-SYMPTOM
twitching I-SYMPTOM
has O
apparently O
improved O
, O
but O
she O
continues O
to O
have O
hand B-SYMPTOM
twitches I-SYMPTOM
. O

She O
also O
had O
an O
EEG O
, O
which O
showed O
left B-SYMPTOM
sided I-SYMPTOM
slowing I-SYMPTOM
on O
preliminary O
read O
. O

Apparently O
she O
has O
a O
long O
history O
of O
seizure B-SYMPTOM
disorder I-SYMPTOM
, O
possibly O
from O
a O
history O
of O
traumatic B-SYMPTOM
brain I-SYMPTOM
injury I-SYMPTOM
( O
though O
per O
Dr. O
Paula O
, O

records O
from O
that O
hospitalization O
indicate O
she O
may O
have O
only O
had O
a B-SYMPTOM
very I-SYMPTOM
mild I-SYMPTOM
injury I-SYMPTOM
) O
and O
has O
been O
managed O
on O
dilantin B-TREATMENT
and O
keppra B-TREATMENT
. O

Since O
she O
has O
seen O
Dr. O
Ollie O
, O
she O
has O
had O
at O
least O
two O
episodes O
of O
status B-SYMPTOM
epilepticus I-SYMPTOM
and O
one B-SYMPTOM
generalized I-SYMPTOM
seizure I-SYMPTOM
, O
as O
well O
as O
some B-SYMPTOM
less I-SYMPTOM
significant I-SYMPTOM
seizures I-SYMPTOM
which O
are O
characterized O
by O
left B-SYMPTOM
gaze I-SYMPTOM
preference I-SYMPTOM
and O
left B-SYMPTOM
sided I-SYMPTOM
tonic-clonic I-SYMPTOM
activity I-SYMPTOM
. O

Her O
dilantin O
levels O
had O
been O
somewhat O
difficult O
to O
control O
. O

He O
tried O
adding O
lamictal B-TREATMENT
, O
but O
this O
caused O
a B-SYMPTOM
rash I-SYMPTOM
. O

At O
the O
time O
of O
her O
last O
visit O
( O
2015-03-18 O
) O
Dr. O
Bradley O
had O
discussed O
the O
addition O
of O
a B-TREATMENT
third I-TREATMENT
Castelluccio I-TREATMENT
, O
possibly O
zonegran B-TREATMENT
( O
less O
likely O
topamax B-TREATMENT
), O
to O
the B-TREATMENT
dilantin I-TREATMENT
200 O
mg O
bid O
and O
keppra B-TREATMENT
1500 O
mg O
bid O
. O

Her O
sister O
had O
wanted O
to O
keep O
the O
current O
course O
because O
she O
felt O
she O
was O
doing O
well O
where O
she O
was O
living O
and O
did O
not O
want O
to O
upset O
that O
. O

However O
, O
she O
had O
several O
dilantin O
levels O
drawn O
since O
her O
last O
visit O
, O
with O
15.4 O
in O
05 O
- O
23.5 O
in O
Theresa O
, O
and O
3.09 O
- O
18 O
. O

Her O
sister O
reports O
that O
the B-TREATMENT
medication I-TREATMENT
dose I-TREATMENT
had O
been O
changed O
to O
200 O
mg O
qam O
and O
100 O
mg O
qpm O
in O
Theresa O
, O
and O
a O
review O
of O
her O
Union O
Hospital O
- O
North O
Shore O
Medical O
Center O
records O
indicates O
that O
this O
may O
have O
occurred O
in O
an O
urgent O
care O
appointment O
secondary O
to O
slurred B-SYMPTOM
speech I-SYMPTOM
and O
a O
recent O
fall O
and O
a B-SYMPTOM
non-trough I-SYMPTOM
level I-SYMPTOM
of O
15.9 O
. O

According O
to O
her O
sister O
, O
the O
patient O
has O
no B-SYMPTOM
short-term I-SYMPTOM
memory I-SYMPTOM
. O

She O
has O
been O
living O
in O
an O
assisted O
living O
facility O
and O
frequently O
calls O
her O
even O
right O
after O
she O
has O
left O
without O
remembering O
her O
visit O
. O

The O
patient O
walks O
with O
a B-TREATMENT
walker I-TREATMENT
at O
baseline O
and O
goes O
out O
for O
dinner O
and O
shopping O
with O
her O
sister O
. O

Ms. O
Swanson O
also O
carries O
a O
diagnosis O
of O
" O
atypical B-SYMPTOM
MS I-SYMPTOM
", O
which O
she O
brought O
with O
her O
to O
Dr. O
Billie O
. O

According O
to O
Dr. O
Nicole O
, O
she O
has O
had O
stable B-SYMPTOM
deficits I-SYMPTOM
for O
many O
years O
without O
any B-SYMPTOM
flare-like I-SYMPTOM
episodes I-SYMPTOM
. O

She O
had O
an O
MRI O
in O
2014 O
that O
showed O
multiple B-SYMPTOM
plaque-like I-SYMPTOM
lesions I-SYMPTOM
, O
but O
these O
were O
entirely O
stable O
since O
2010 O
. O

She O
is O
not O
undergoing O
any B-TREATMENT
treatment I-TREATMENT
. O

Reportedly O
she O
has O
been O
evaluated O
at O
Shriner's O
Hospital O
for O
Crippled O
Children O
, O
HealthSouth O
Braintree O
Rehab O
Hospital O
, O
and O
possibly O
St. O
Elizabeth's O
Medical O
Center O
of O
Boston O
. O

She O
has O
not O
had O
an O
LP O
as O
far O
as O
Dr. O
Ginger O
knows O
. O

Past O
Medical O
History O
: O

h/o O
head B-SYMPTOM
trauma I-SYMPTOM

atypical B-SYMPTOM
MS I-SYMPTOM

seizures B-SYMPTOM

depression B-SYMPTOM

hypercholesterolemia B-SYMPTOM

Social O
History O
: O

lives O
in O
assisted O
living O
. O

Sister O
Andrew O
is O
HCP O

Family O
History O
: O

not O
elicited O

Physical O
Exam O
: O

ICU O
exam O
: O

VS O
: O
T99.5 O
, O
BP O
126/72 O
, O
HR O
99 O
, O
RR O
15 O
, O
SaO2 O
99% O
/ O
RA O

Genl O
: O
lying O
in O
bed O
, O
right O
hand O
moving O
rhythmically O
, O
NGT B-TREATMENT
in O
place O

MS O
: O
not B-SYMPTOM
following I-SYMPTOM
commands I-SYMPTOM
, O
withdraws O
to O
noxious O
stimuli O
, O
making O
incomprehensible B-SYMPTOM
vocalizations I-SYMPTOM

CN O
: O
PERRL O
, O
corneal O
reflex O
intact O
, O
nasal O
tickle O
intact O
, O
face O
symmetric O
. O

Motor O
: O
moving O
right O
hand O
rhythmically O
with O
occasional B-SYMPTOM
right I-SYMPTOM
face I-SYMPTOM
twitching I-SYMPTOM
as O
well O
. O

Moves O
all O
extremities O
to O
stimuli O
, O
L O
> O
R O

Sensation O
: O
intact O
to O
noxious O
stimuli O
in O
all O
four O
extremities O

Reflexes O
: O
3+ O
throughout O
, O
both O
toes O
upgoing O

Recent O
exam O
: O

Afebrile B-SYMPTOM
, O
VSS O

Following O
commands O
, O
oriented O
to O
name O
, O
place O
. O

Able O
to O
carry O
on O
simple O
conversation O
. O

No O
dysarthria B-SYMPTOM
, O
speech O
fluent O
. O

CN O
: O
PEERL O
, O
EOM O
full O
, O
tongue O
midline O

Motor O
: O
moves O
all O
extremities O
with O
some O
strength, O
improved O
bilaterally O

Reflexes O
: O
as O
above O

Pertinent O
Results O
: O

Admission O
labs O
: O

2015-09-20 O
03:54 O
AM O
BLOOD O
WBC O
- O
11.4 O
*# O
RBC O
- O
3.96 O
* O
Hgb O
- O
12.1 O
Hct O
- O
35.1 O
* O
MCV O
- O
88 O
MCH O
- O
30.6 O
MCHC O
- O
34.6 O
RDW O
- O
13.1 O
Plt O
Ct O
- O
152 O

2015-09-28 O
07:50 O
AM O
BLOOD O
Neuts O
- O
83.3 O
* O
Lymphs O
- O
10.1 O
* O
Monos O
- O
5.3 O
Eos O
- O
1.1 O
Baso O
- O
0.2 O

2015-09-20 O
03:54 O
AM O
BLOOD O
PT O
- O
12.3 O
PTT O
- O
26.7 O
INR(PT) O
- O
1.1 O

2015-09-20 O
03:54 O
AM O
BLOOD O
Glucose O
- O
97 O
UreaN O
- O
12 O
Creat O
- O
0.4 O
Na O
- O
137 O
K O
- O
3.8 O
Cl O
- O
101 O
HCO3 O
- O
26 O
AnGap O
- O
14 O

2015-09-20 O
03:54 O
AM O
BLOOD O
Albumin O
- O
4.0 O
Calcium O
- O
8.0 O
* O
Phos O
- O
2.9 O
Mg O
- O
2.0 O

2015-09-20 O
03:54 O
AM O
BLOOD O
ALT O
- O
14 O
AST O
- O
18 O
AlkPhos O
- O
92 O
TotBili O
- O
0.3 O

2015-09-20 O
03:54 O
AM O
BLOOD O
Phenyto O
- O
18.4 O

Discharge O
labs O
: O

2015-09-29 O
07:25 O
AM O
BLOOD O
Phenyto O
- O
5.1 O
* O

U/A O
: O

2015-09-22 O
03:04 O
PM O
URINE O
Color O
- O
Straw O
Appear O
- O
Clear O
Sp O
Dixon O
- O
1.010 O

2015-09-22 O
03:04 O
PM O
URINE O
Blood O
- O
SM O
Nitrite O
- O
NEG O
Protein O
- O
NEG O
Glucose O
- O
NEG O
Ketone O
- O
15 O
Bilirub O
- O
NEG O
Urobiln O
- O
NEG O
pH O
- O
5.0 O
Leuks O
- O
MOD O

2015-09-22 O
03:04 O
PM O
URINE O
RBC O
- O
6 O
* O
WBC O
- O
29 O
* O
Bacteri O
- O
OCC O
Yeast O
- O
NONE O
Epi O
- O
< O
1 O

2015-09-28 O
03:04 O
PM O
URINE O
Color O
- O
Yellow O
Appear O
- O
Clear O
Sp O
Brown O
- O
1.015 O

2015-09-28 O
03:04 O
PM O
URINE O
Blood O
- O
LG O
Nitrite O
- O
NEG O
Protein O
- O
TR O
Glucose O
- O
NEG O
Ketone O
- O
NEG O
Bilirub O
- O
NEG O
Urobiln O
- O
0.2 O
pH O
- O
6.5 O
Leuks O
- O
NEG O

2015-09-28 O
03:04 O
PM O
URINE O
RBC O
- O
01-04 O
* O
WBC O
- O
04-19 O
Bacteri O
- O
FEW O
Yeast O
- O
NONE O
Epi O
- O
0-2 O

CSF O
: O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
WBC O
- O
6 O
RBC O
- O
2 O
* O
Polys O
- O
0 O
Lymphs O
- O
92 O
Monos O
- O
8 O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
WBC O
- O
6 O
RBC O
- O
0 O
Polys O
- O
0 O
Lymphs O
- O
95 O
Monos O
- O
5 O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
TotProt O
- O
56 O
* O
Glucose O
- O
77 O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
ANGIOTENSIN O
1 O
CONVERTING O
ENZYME O
- O
PND O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
VDRL O
- O
PND O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
Ernest O
VIRUS O
( O
JCV O
) O
DNA O
DETECTION O
BY O
POLYMERASE O
CHAIN O
REACTION O
( O
PCR O
)- O
PND O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
VARICELLA O
DNA O
( O
PCR O
)- O
PND O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
HERPES O
SIMPLEX O
VIRUS O
PCR O
- O
PND O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
EBV O
- O
PCR O
- O
PND O

2015-09-25 O
02:20 O
PM O
CEREBROSPINAL O
FLUID O
( O
CSF O
) O
CYTOMEGALOVIRUS O
- O
PCR O
- O
negative O

Other O
: O

cryptococcus B-SYMPTOM
: O
negative O

CSF O
negative O

blood O
cx O
NGTD O

urine O
cx O
lactobacillus B-SYMPTOM

CSF O
cytology O
: O
NEGATIVE O
FOR O
MALIGNANT B-SYMPTOM
CELLS I-SYMPTOM
. O

Reactive B-SYMPTOM
lymphoid I-SYMPTOM
cells I-SYMPTOM
. O

immunotyping O
negative O
. O

CXR O
09-28 O
: O
No O
evidence O
for O
pneumonia B-SYMPTOM
. O

No O
change O
since O
prior O
study O
of O
2015-09-24 O
. O

CT O
HEAD O
FINDINGS O
: O
There O
is O
moderately B-SYMPTOM
severe I-SYMPTOM
, I-SYMPTOM
confluent I-SYMPTOM
periventricular I-SYMPTOM
white I-SYMPTOM
matter I-SYMPTOM
hypodensity I-SYMPTOM
surrounding O
the O
frontal O
horns O
, O
posterior O
horns O
, O
and O
more O
superiorly O
, O
involving O
the O
centra O
semiovale O
. O

These O
findings O
are O
unchanged O
from O
prior O
studies O
, O
and O
may O
relate O
to O
the B-SYMPTOM
" I-SYMPTOM
atypical I-SYMPTOM
" I-SYMPTOM
demyelinating I-SYMPTOM
process I-SYMPTOM
, O
suggested O
in O
the O
indication O
on O
the O
prior O
MRI O
; O
however O
, O
they O
are O
non-specific O
. O

There O
is O
no O
evidence O
of O
acute B-SYMPTOM
intra I-SYMPTOM
- I-SYMPTOM
or I-SYMPTOM
extra I-SYMPTOM
- I-SYMPTOM
axial I-SYMPTOM
hemorrhage I-SYMPTOM
. O

There O
is O
no O
shift B-SYMPTOM
of I-SYMPTOM
normally I-SYMPTOM
midline I-SYMPTOM
structures I-SYMPTOM
. O

The O
ventricles O
are O
mildly B-SYMPTOM
prominent I-SYMPTOM
, O
but O
are O
unchanged O
from O
the O
prior O
study O
. O

There O
is O
no O
interval B-SYMPTOM
loss I-SYMPTOM
of I-SYMPTOM
focal I-SYMPTOM
gray I-SYMPTOM
- I-SYMPTOM
white I-SYMPTOM
matter I-SYMPTOM
differentiation I-SYMPTOM
to O
suggest O
acute B-SYMPTOM
infarction I-SYMPTOM
, O
though O
CT O
is O
not O
sensitive O
in O
the O
early O
stages O
. O

No O
focal B-SYMPTOM
masses I-SYMPTOM
is O
seen O
. O

IMPRESSION O
: O

1) O
No O
intracranial B-SYMPTOM
hemorrhage I-SYMPTOM
or O
mass B-SYMPTOM
effect I-SYMPTOM
; O
no O
significant B-SYMPTOM
interval I-SYMPTOM
change I-SYMPTOM
from O
CT O
of O
2015-07-20 O
. O

2) O
Diffuse B-SYMPTOM
, I-SYMPTOM
confluent I-SYMPTOM
periventricular I-SYMPTOM
white I-SYMPTOM
matter I-SYMPTOM
hypodensity I-SYMPTOM
, O
which O
may O
relate O
to O
an B-SYMPTOM
underlying I-SYMPTOM
demyelinating I-SYMPTOM
process I-SYMPTOM
( O
as O
suggested O
in O
the O
indication O
provided O
for O
the O
prior O
MRI O
). O

The B-SYMPTOM
markedly I-SYMPTOM
low I-SYMPTOM
- I-SYMPTOM
attenation I-SYMPTOM
( O
14-15 O
HU O
) O
centered O
within O
this O
process O
suggests O
either O
irreversible B-SYMPTOM
demyelination I-SYMPTOM
with O
cavitation B-SYMPTOM
(" I-SYMPTOM
black I-SYMPTOM
hole I-SYMPTOM
"), O
or O
lacunar B-SYMPTOM
infarction I-SYMPTOM
on I-SYMPTOM
a I-SYMPTOM
vascular I-SYMPTOM
basis I-SYMPTOM
. O

Generalized O
and O
marked B-SYMPTOM
callosal I-SYMPTOM
atrophy I-SYMPTOM
( O
on O
the O
MR O
) O
also O
suggest O
advanced B-SYMPTOM
, I-SYMPTOM
irreversible I-SYMPTOM
disease I-SYMPTOM
. O

3) O
No O
mass B-SYMPTOM
is O
appreciated O
on O
this O
limited O
non-contrast O
study O
; O
if O
clinically O
concerned O
, O
an O
MRI O
with O
gadolinium O
is O
recommended O
. O

MRI O
: O
There O
is O
a O
similar O
configuration O
of O
increased B-SYMPTOM
T2 I-SYMPTOM
signal I-SYMPTOM
in O
the O
periventricular O
white O
matter O
of O
both O
cerebral O
hemispheres O
, O
suggesting O
demyelinating B-SYMPTOM
disease I-SYMPTOM
. O

As O
previously O
noted O
, O
there O
is O
associated B-SYMPTOM
volume I-SYMPTOM
loss I-SYMPTOM
, O
thinning B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
corpus I-SYMPTOM
callosum I-SYMPTOM
, O
and O
slight B-SYMPTOM
widening I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
ventricles I-SYMPTOM
. O

On O
post-contrast O
images O
, O
there O
is O
a O
probably O
stable O
appearance O
of O
a B-SYMPTOM
5 I-SYMPTOM
mm I-SYMPTOM
linear I-SYMPTOM
, I-SYMPTOM
focal I-SYMPTOM
area I-SYMPTOM
of I-SYMPTOM
enhancement I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
centrum I-SYMPTOM
semiovale I-SYMPTOM
, O
of O
uncertain O
etiology O
. O

Also O
ehancing O
is O
3 B-SYMPTOM
mm I-SYMPTOM
linear I-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
hippocampal I-SYMPTOM
cortex I-SYMPTOM
anteriorly I-SYMPTOM
, O
not O
seen O
on O
the O
08-20 O
MR O
, O
but O
that O
study O
was O
very O
motion O
- O
degraded O
. O

The O
hippocampus O
would O
be O
a O
most O
unusual O
site O
for O
involvement O
by O
multiple B-SYMPTOM
sclerosis I-SYMPTOM
. O

There O
is O
no O
apparent B-SYMPTOM
mass I-SYMPTOM
lesion I-SYMPTOM
or O
mass B-SYMPTOM
effect I-SYMPTOM
. O

No O
changes B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
overall I-SYMPTOM
morphology I-SYMPTOM
of O
the O
brain O
are O
identified O
. O

The O
surrounding O
osseous O
and O
soft O
tissue O
structures O
are O
unremarkable O
. O

The O
major O
vascular O
flow O
patterns O
are O
normal O
. O

IMPRESSION O
: O

1. O
Stable O
appearance O
of O
confluent O
areas O
of O
increased B-SYMPTOM
T2 I-SYMPTOM
signal I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
periventricular I-SYMPTOM
white I-SYMPTOM
matter I-SYMPTOM
, O
consistent O
with O
severe B-SYMPTOM
demyelinating I-SYMPTOM
disease I-SYMPTOM
. O

2. O
Enhancing B-SYMPTOM
lesions I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
centrum I-SYMPTOM
semiovale I-SYMPTOM
and O
also O
left O
hippocampal O
cortex O
. O

This B-SYMPTOM
former I-SYMPTOM
lesion I-SYMPTOM
was O
evident O
on O
MR O
dating O
back O
to O
2014-08-15 O
, O
though O
is O
more O
prominent O
at O
this O
time O
, O
likely O
due O
to O
less O
motion O
degradation O
of O
the O
current O
scan O
. O

Etiology O
of O
these B-SYMPTOM
enhancing I-SYMPTOM
lesions I-SYMPTOM
is O
uncertain O
, O
but O
could O
be O
atypical B-SYMPTOM
manifestations I-SYMPTOM
of I-SYMPTOM
demyelination I-SYMPTOM
. O

EEG O
: O

ABNORMALITY O
#1: O
Throughout O
the O
recording O
there O
were O
frequent O
bursts O
of O
generalized B-SYMPTOM
theta I-SYMPTOM
and I-SYMPTOM
delta I-SYMPTOM
slowing I-SYMPTOM
. O

Facial B-SYMPTOM
twitching I-SYMPTOM
was O
described O
by O
the O
technologist O
and O
seen O
on O
the O
video O
. O

This O
is O
primarily O
right-sided B-SYMPTOM
, I-SYMPTOM
facial I-SYMPTOM
movement I-SYMPTOM
clinically O
and O
did O
not O
appear O
to O
involve O
the O
forehead O
or O
CMED O
CSRU O
. O

There O
were O
no O
clear O
EEG O
correlate O
. O

ABNORMALITY O
#2: O
The O
background O
voltages O
were O
occasionally B-SYMPTOM
lower I-SYMPTOM
on O
the O
left O
side O
, O
and O
there O
were O
additional B-SYMPTOM
bursts I-SYMPTOM
of I-SYMPTOM
delta I-SYMPTOM
slowing I-SYMPTOM
seen O
broadly O
on O
the O
left O
side O
alone O
. O

ABNORMALITY O
#3: O
The O
background O
rhythms O
were O
dominated O
by O
much B-SYMPTOM
faster I-SYMPTOM
beta I-SYMPTOM
rhythm I-SYMPTOM
. O

They O
appeared O
to O
reach O
an O
8 O
Hz O
frequency O
on O
the O
right O
at O
times O
, O
though O
the O
background O
was O
disorganized O
and O
slow O
on O
both O
sides O
for O

much O
of O
the O
recording O
. O

It O
was O
of O
much O
lower O
voltage O
on O
the O
left O
. O

HYPERVENTILATION B-TREATMENT
: O
Could O
not O
be O
performed O
. O

INTERMITTENT O
PHOTIC O
STIMULATION O
: O
Could O
not O
be O
performed O
. O

SLEEP O
: O
No O
normal O
waking O
or O
sleeping O
morphologies O
were O
seen O
. O

CARDIAC O
MONITOR O
: O
Showed O
a O
generally O
regular O
rhythm O
. O

IMPRESSION O
: O
Abnormal B-SYMPTOM
portable I-SYMPTOM
EEG I-SYMPTOM
due O
to O
the B-SYMPTOM
bursts I-SYMPTOM
of I-SYMPTOM
generalized I-SYMPTOM
slowing I-SYMPTOM
and O
additional B-SYMPTOM
left-sided I-SYMPTOM
slowing I-SYMPTOM
and O
voltage B-SYMPTOM
dimunition I-SYMPTOM
, O
along O
with O
some B-SYMPTOM
slowing I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
background I-SYMPTOM
. O

The O
generalized O
and O
background O
features O
indicate O
a B-SYMPTOM
wide-spread I-SYMPTOM
encephalopathy I-SYMPTOM
. O

The B-SYMPTOM
left I-SYMPTOM
sided I-SYMPTOM
slowing I-SYMPTOM
and O
voltage B-SYMPTOM
reduction I-SYMPTOM
surpassed O
an B-SYMPTOM
additional I-SYMPTOM
dysfunction I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
side I-SYMPTOM
, O
possibly O
wide-spread B-SYMPTOM
cortical I-SYMPTOM
dysfunction I-SYMPTOM
. O

There O
is O
a O
possibility O
of O
a B-SYMPTOM
structural I-SYMPTOM
lesion I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
, O
but O
the B-SYMPTOM
encephalopathy I-SYMPTOM
dominated O
the O
overall O
picture O
. O

There O
were O
no O
clear B-SYMPTOM
epileptiform I-SYMPTOM
discharges I-SYMPTOM
. O

No O
EEG O
correlate O
was O
established O
for O
the B-SYMPTOM
facial I-SYMPTOM
twitching I-SYMPTOM
. O

The O
lack O
of O
EEG O
correlate O
to O
the B-SYMPTOM
facial I-SYMPTOM
twitching I-SYMPTOM
does O
not O
exclude O
a O
central O
cause O
( O
and O
, O
indeed O
, O
this O
appeared O
most O
likely O
based O
on O
the O
clinical O
and O
video O
observations O
). O

Brief O
Hospital O
Course O
: O

53 O
yo O
woman O
with O
h/o O
seizure B-SYMPTOM
disorder I-SYMPTOM
, O
demyelinating B-SYMPTOM
disease I-SYMPTOM
, O
and O
brain B-SYMPTOM
injury I-SYMPTOM
, O
presents O
with O
prolonged B-SYMPTOM
seizure I-SYMPTOM
, O
now O
unresponsive B-SYMPTOM
with O
persistent B-SYMPTOM
twitching I-SYMPTOM
of I-SYMPTOM
right I-SYMPTOM
arm I-SYMPTOM
and I-SYMPTOM
face I-SYMPTOM
. O

This O
is O
most O
consistent O
with O
complex B-SYMPTOM
partial I-SYMPTOM
seizures I-SYMPTOM
with O
a O
focus O
in O
the O
left O
hemisphere O
, O
most O
likely O
the O
motor O
strip O
. O

In O
the O
past O
, O
her B-SYMPTOM
seizures I-SYMPTOM
were O
on O
the O
left O
side O
, O
which O
implies O
that O
she O
now O
has O
a O
new O
focus O
. O

It O
is O
possible O
that O
this O
is O
secondary O
to O
her B-SYMPTOM
underlying I-SYMPTOM
demyelinating I-SYMPTOM
disease I-SYMPTOM
, O
but O
per O
report O
this O
has O
not O
been O
very O
active O
. O

Other O
possibilities O
include O
infection B-SYMPTOM
, O
including O
her B-SYMPTOM
UTI I-SYMPTOM
. O

It O
is O
likely O
that O
these B-SYMPTOM
seizures I-SYMPTOM
began O
due O
to O
subtherapeutic B-SYMPTOM
dilantin I-SYMPTOM
levels I-SYMPTOM
on O
her B-TREATMENT
new I-TREATMENT
dose I-TREATMENT
of O
200 O
mg O
/ O
100 O
mg O
. O

Her B-TREATMENT
seizure I-TREATMENT
management I-TREATMENT
is O
difficult O
, O
given O
the B-TREATMENT
higher I-TREATMENT
doses I-TREATMENT
were O
causing O
her O
to O
fall O
and O
slur O
her O
speech O
. O

Discussed O
with O
Dr. O
Joaquin O
the O
addition O
of O
an B-TREATMENT
alternate I-TREATMENT
Castelluccio I-TREATMENT
with O
the O
possibility O
of O
tapering O
down O
the B-TREATMENT
dilantin I-TREATMENT
in O
the O
future O
, O
and O
he O
agreed O
that O
she O
may O
benefit O
from O
zonegran B-TREATMENT
. O

Cannot O
use O
lamictal B-TREATMENT
or O
depakote B-TREATMENT
due O
to O
reactions B-SYMPTOM
. O

Topamax B-TREATMENT
is O
another O
possibility O
, O
but O
not O
ideal O
in O
a O
patient O
with O
preexisting B-SYMPTOM
cognitive I-SYMPTOM
deficits I-SYMPTOM
. O

She O
was O
started O
on O
zonegran B-TREATMENT
at O
50 O
mg O
daily O
with O
plans O
to O
increase O
by O
50 O
mg O
every O
other O
week O
to O
a O
goal O
dose O
of O
200 O
mg O
/ O
day O
; O
she O
was O
on O
100 O
mg O
daily O
at O
discharge O
and O
should O
have O
her O
dose O
increased O
on O
10-12 O
and O
again O
on O
10-26 O
. O

She O
was O
continued O
on O
keppra B-TREATMENT
and O
dilantin B-TREATMENT
with O
trough O
checked O
frequently O
and O
adjustment O
as O
needed O
. O

Ativan B-TREATMENT
was O
used O
for O
breakthrough B-SYMPTOM
seizures I-SYMPTOM
( O
facial B-SYMPTOM
twitching I-SYMPTOM
). O

MRI/MRA O
showed O
new B-SYMPTOM
temporal I-SYMPTOM
lesions I-SYMPTOM
, O
but O
it O
is O
unclear O
if O
these O
are O
the O
cause O
or O
effect O
of O
her B-SYMPTOM
seizures I-SYMPTOM
. O

She O
will O
need O
to O
have O
a O
repeat O
MRI O
in O
several O
months O
for O
further O
evaluation O
. O

LP O
was O
done O
and O
had O
no O
changes O
to O
suggest O
a O
different O
etiology O
( O
ie O
negative O
cytology O
and O
negative O
immunophenotyping O
). O

Oligoclonal O
bands O
were O
not O
assessed O
as O
there O
was O
not O
enough O
CSF O
per O
the O
laboratory O
. O

She O
will O
need O
repeated O
dilantin O
troughs O
with O
one O
time O
dose O
when O
trough O
is O
subtherapeutic O
. O

Pending O
tests O
: O

ANGIOTENSIN O
1 O
CONVERTING O
ENZYME O

EBV-PCR O

HERPES O
SIMPLEX O
VIRUS O
PCR O

Ernest O
VIRUS O
( O
JCV O
) O
DNA O
PCR O

LYME O
, O
TOTAL O
EIA O
WITH O
REFLEX O
TO O
CSF O
RATIO O

VARICELLA O
DNA O
( O
PCR O
) O

VDRL O

2. O
atypical B-SYMPTOM
MS I-SYMPTOM
: O
discussed O
with O
her O
outpt O
neurologist O
( O
Dr. O
Ford O
in O
Boston O
Medical O
Center O
); O
no O
current O
role O
for O
MS B-TREATMENT
medications I-TREATMENT
. O

MRI O
was O
performed O
and O
showed O
new B-SYMPTOM
lesions I-SYMPTOM
vs O
sz B-SYMPTOM
effects I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
temporal I-SYMPTOM
lobe I-SYMPTOM
. O

She O
also O
had O
a B-SYMPTOM
new I-SYMPTOM
lesion I-SYMPTOM
on O
her O
last O
MRI O
in O
the O
centrum O
semiovale O
. O

LP O
was O
done O
to O
evaluate O
for O
malignancy B-SYMPTOM
, O
and O
no O
malignant B-SYMPTOM
cells I-SYMPTOM
were O
seen O
. O

Immunotyping O
was O
negative O
as O
well O
( O
per O
verbal O
report O
). O

Unfortunately O
, O
oligoclonal O
bands O
could O
not O
be O
sent O
from O
the O
CSF O
( O
lab O
sent O
CSF O
for O
other O
studies O
and O
there O
was O
not O
enough O
left O
over O
for O
OCB O
s). O

This O
was O
relayed O
to O
the O
family O
( O
Kirk O
). O

Given O
that O
she O
does O
have O
new B-SYMPTOM
lesions I-SYMPTOM
on O
MRI O
, O
if O
OCB O
s O
were O
sent O
this O
would O
have O
weighed O
in O
in O
her O
dx O
of O
MS B-SYMPTOM
, O
and O
it's O
possible O
she O
could O
benefit O
from O
MS B-TREATMENT
therapy I-TREATMENT
. O

This O
was O
relayed O
to O
the O
family O
, O
and O
they O
will O
readdress O
this O
with O
Dr. O
Ford O
( O
MS O
Hoyos O
). O

The O
family O
is O
confident O
in O
any O
decision O
Dr. O
Ford O
would O
make O
re O
: O
therapy B-TREATMENT
for O
her B-SYMPTOM
MS I-SYMPTOM
. O

3. O
fevers B-SYMPTOM
on O
admission O
: O
Pt O
w/ O
positive B-SYMPTOM
U/A I-SYMPTOM
, O
treated O
with O
bactrim B-TREATMENT
x O
3 O
days O
with O
defervescence O
. O

4. O
depression B-SYMPTOM
: O
continue O
escitalopram B-TREATMENT
; O
assess O
need O
to O
change O
medication B-TREATMENT
as O
an O
outpatient O
. O

5. O
FEN O
: O
NGT B-TREATMENT
was O
placed O
given O
her B-SYMPTOM
altered I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
, O
and O
she O
has O
been O
unable O
to O
pass O
a O
swallow O
evaluation O
, O
but O
has O
improved O
. O

This O
should O
be O
repeated O
in O
several O
days O
as O
her O
mental O
status O
continues O
to O
clear O
. O

Commun O
: O
Sister O
Andrew O
is O
HCP O
. O
( O
780 O
) O
970-0261 O

Dispo O
: O
PT/OT O
worked O
with O
patient O
during O
admission O

Medications O
on O
Admission O
: O

Dilantin B-TREATMENT
200/100 O

Keppra B-TREATMENT
1500 O
mg O
bid O

Lexapro B-TREATMENT
20 O
mg O
q O
day O

Folate B-TREATMENT
1 O
mg O
q O
day O

Calcium B-TREATMENT
1 O
tab O
bid O

Discharge O
Medications O
: O

1. O
Zonisamide B-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
DAILY O
( O
Daily O
): O
Increase O
by O
50 O
mg O
every O
other O
week O
( O
next O
increase O
2015-10-12 O
). O

2. O
Phenytoin B-TREATMENT
50 O
mg O
Tablet O
, O
Chewable O
Sig O
: O
Four O
( O
4 O
) O
Tablet O
, O
Chewable O
PO O
QAM O
( O
once O
a O
day O
( O
in O
the O
morning O
)). O

3. O
Phenytoin B-TREATMENT
50 O
mg O
Tablet O
, O
Chewable O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
, O
Chewable O
PO O
QPM O
( O
once O
a O
day O
( O
in O
the O
evening O
)). O

4. O
Phenytoin B-TREATMENT
50 O
mg O
Tablet O
, O
Chewable O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Chewable O
PO O
EVERY O
OTHER O
DAY O
( O
Every O
Other O
Day O
). O

5. O
Levetiracetam B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
Four O
( O
4 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

6. O
Escitalopram B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

7. O
Folic B-TREATMENT
Acid I-TREATMENT
1 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

8. O
Lansoprazole B-TREATMENT
30 O
mg O
Tablet O
, O
Rapid O
Dissolve O
, O
DR O
Turner O
: O
One O
( O
1 O
) O
Tablet O
, O
Rapid O
Dissolve O
, O
DR O
Hughes O
DAILY O
( O
Daily O
). O

9. O
Docusate B-TREATMENT
Sodium I-TREATMENT
150 O
mg O
/ O
15 O
mL O
Liquid O
Sig O
: O
One O
Hundred O
( O
100 O
) O
mg O
PO O
BID O
( O
2 O
times O
a O
day O
). O

10. O
Senna B-TREATMENT
8.6 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

11. O
Bisacodyl B-TREATMENT
10 O
mg O
Suppository O
Sig O
: O
One O
( O
1 O
) O
Suppository O
Rectal O
DAILY O
( O
Daily O
) O
as O
needed O
for O
constipation B-SYMPTOM
. O

12. O
Heparin B-TREATMENT
( I-TREATMENT
Porcine I-TREATMENT
) O
5,000 O
unit O
/ O
mL O
Solution O
Sig O
: O
5000 O
( O
5000 O
) O
units O
Injection O
TID O
( O
3 O
times O
a O
day O
). O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

L.F. O
Quigley O
Memorial O
Hospital O
& O
Rehab O
Center O
- O
Berkshire O
Medical O
Center O

Discharge O
Diagnosis O
: O

Seizure B-SYMPTOM

History O
of O
atypical B-SYMPTOM
multiple I-SYMPTOM
sclerosis I-SYMPTOM

Memory B-SYMPTOM
loss I-SYMPTOM

Status O
post O
brain B-SYMPTOM
injury I-SYMPTOM

Urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM

Discharge O
Condition O
: O

Stable O
, O
much O
improved O
from O
admission O
, O
and O
almost O
at O
baseline O
. O

Discharge O
Instructions O
: O

Take O
all B-TREATMENT
medications I-TREATMENT
as O
prescribed O
. O

Please O
increase O
zonegran B-TREATMENT
dose I-TREATMENT
by O
50 O
every O
other O
week O
until O
it O
reaches O
200 O
mg O
daily O
, O
with O
first O
dose O
change O
10-12 O
to O
150 O
mg O
daily O
and O
second O
dose O
change O
10-26 O
to O
200 O
mg O
daily O
. O

Follow O
up O
with O
Dr. O
Pilcher O
, O
Dr. O
Donnie O
, O
and O
Dr. O
Harris O
upon O
discharge O
. O

Call O
the O
doctor O
or O
go O
to O
the O
emergency O
room O
with O
increased B-SYMPTOM
seizure I-SYMPTOM
frequency I-SYMPTOM
, O
unresponsiveness B-SYMPTOM
, O
new B-SYMPTOM
weakness I-SYMPTOM
or O
numbness B-SYMPTOM
, O
or O
any B-SYMPTOM
other I-SYMPTOM
concerning I-SYMPTOM
symptoms I-SYMPTOM
. O

Followup O
Instructions O
: O

Please O
follow O
up O
with O
a O
repeat O
MRI O
in O
several O
months O
to O
evaluate O
new B-SYMPTOM
lesions I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
brain I-SYMPTOM
. O

Follow O
up O
with O
: O

Dr. O
Harris O
( O
859-847-5149 O
) O
on O
2015-10-05 O
at O
915 O
am O
. O

Dr. O
Alejandro O
(( O
211 O
) O
394-5801 O
) O
on O
2015-10-20 O
at O
145 O
pm O
. O

Dr. O
Sheets O
(( O
506 O
) O
858 O
7552) O
on O
2015-10-26 O
at O
10 O
am O
. O

Wayne O
Deloris O
MD O
55-122 O

Completed O
by O
: O
Meghan O
Mark O
MD O
99-323 O
2015-09-30 O
@ O
1502 O

Signed O
electronically O
by O
: O
DR. O
Sheila O
SHEEN O
on O
: O
WED O
2015-09-30 O
4:59 O
PM O

( O
End O
of O
Report O
) O

291181306 O

FIH O

0231078 O

718719 O

9555422 O

03/11/2002 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O
NAME O
: O

GETZZOCHTLAND O
, O
SYNNANI O
F O

UNIT O
NUMBER O
: O

451-52-66 O

ADMISSION O
DATE O
: O

03/11/2002 O

DISCHARGE O
DATE O
: O

03/14/2002 O

PRINCIPAL O
DIAGNOSIS O
: O

Right B-SYMPTOM
hip I-SYMPTOM
osteoarthritis I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSES O
: O

Asthma B-SYMPTOM
, O
gastroesophageal B-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
, O
and O
constipation B-SYMPTOM
. O

OPERATIONS O
AND O
PROCEDURES O
: O

Right B-TREATMENT
total I-TREATMENT
hip I-TREATMENT
arthroplasty I-TREATMENT
. O

CHIEF O
COMPLAINT O
: O

Right B-SYMPTOM
hip I-SYMPTOM
pain I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
62-year-old O
hospice O
chaplain O
who O
was O
referred O
by O
Dr. O
Tomedankell O
Flowayles O
and O
Dr. O
Es O
Oarekote O
for O
evaluation O
of O
his B-SYMPTOM
right I-SYMPTOM
hip I-SYMPTOM
pain I-SYMPTOM
. O

He O
states O
that O
his B-SYMPTOM
pain I-SYMPTOM
has O
been O
of O
seven O
to O
eight O
durations O
, O
and O
rated O
as O
moderate O
to O
severe O
( O
7/10 O
) O
. O

He O
does O
limp O
. O

He O
does O
not O
use O
a B-TREATMENT
cane I-TREATMENT
and O
he O
requires O
a O
bannister O
for O
going O
up O
and O
down O
stairs O
. O

He O
has O
trouble O
with O
his O
shoes O
and O
socks O
. O

He O
uses O
a B-TREATMENT
walker I-TREATMENT
. O

He O
can O
walk O
about O
a O
quarter O
of O
a O
mile O
without O
stopping O
. O

PAST O
MEDICAL O
HISTORY O
: O

Asthma B-SYMPTOM
, O
history O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
non-small-cell B-SYMPTOM
lung I-SYMPTOM
cancer I-SYMPTOM
removed O
from O
his O
right O
lung O
by O
Dr. O
Vital O
four O
years O
prior O
to O
admission O
, O
status O
post O
chemotherapy B-TREATMENT
and O
radiation B-TREATMENT
for O
the B-SYMPTOM
non-small-cell I-SYMPTOM
lung I-SYMPTOM
cancer I-SYMPTOM
, O
gastroesophageal B-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
, O
and O
history O
of O
constipation B-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Prilosec B-TREATMENT
, O
20 O
mg. O
PO O
q.day O
; O
Singulair B-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

He O
is O
5 O
feet O
, O
9 O
inches O
, O
225 O
pounds O
. O

He O
walks O
with O
a B-SYMPTOM
limp I-SYMPTOM
related O
to O
his O
right O
hip O
. O

His O
right O
hip O
is O
irritable B-SYMPTOM
with O
a B-SYMPTOM
10-degree I-SYMPTOM
fixed I-SYMPTOM
flexion I-SYMPTOM
contracture I-SYMPTOM
. O

He O
is O
able O
to O
flex O
his O
right O
hip O
to O
100 O
degrees O
. O

He O
has O
10 O
degrees O
of O
internal O
and O
external O
rotation O
. O

He O
has O
intact O
distal O
pulses O
and O
5/5 O
muscle O
strength O
in O
all O
major O
muscle O
groups O
. O

His O
X-rays O
show O
advanced B-SYMPTOM
osteoarthritis I-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
right I-SYMPTOM
hip I-SYMPTOM
. O

IMPRESSION O
AND O
PLAN O
: O

This O
is O
a O
62-year-old O
male O
with O
severe B-SYMPTOM
osteoarthritis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
hip I-SYMPTOM
who O
after O
discussion O
, O
including O
the O
nature O
, O
risks O
, O
benefits O
and O
alternative O
treatment O
plans O
, O
signed O
informed O
consent O
for O
a B-TREATMENT
right I-TREATMENT
total I-TREATMENT
hip I-TREATMENT
replacement I-TREATMENT
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
taken O
to O
the O
operating O
room O
on O
March O
11 O
, O
2002 O
, O
and O
underwent O
an B-TREATMENT
uncomplicated I-TREATMENT
right I-TREATMENT
total I-TREATMENT
hip I-TREATMENT
replacement I-TREATMENT
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
and O
was O
transferred O
to O
the O
Post O
Anesthesia O
Care O
Unit O
and O
then O
to O
the O
floor O
in O
stable O
condition O
. O

On O
postoperative O
check O
, O
he O
was O
doing O
well O
. O

He O
was O
afebrile B-SYMPTOM
and O
his O
vital O
signs O
were O
stable O
. O

He O
was O
neurovascularly O
intact O
. O

His O
hematocrit O
was O
34.7 O
. O

He O
was O
started O
on O
Coumadin B-TREATMENT
for O
DVT B-TREATMENT
prophylaxis I-TREATMENT
and O
Ancef B-TREATMENT
for O
routine B-TREATMENT
antimicrobial I-TREATMENT
coverage I-TREATMENT
. O

He O
was O
made O
partial O
weight-bearing O
for O
his O
right O
lower O
extremity O
. O

He O
was O
placed O
on O
posterior B-TREATMENT
hip I-TREATMENT
dislocation I-TREATMENT
precautions I-TREATMENT
and O
was O
out O
of O
bed O
with O
physical O
therapy O
and O
occupational O
therapy O
. O

On O
postoperative O
day O
one O
, O
there O
were O
no O
active O
issues O
. O

He O
was O
afebrile B-SYMPTOM
. O

His O
vital O
signs O
were O
stable O
. O

He O
was O
neurovascularly O
intact O
. O

On O
postoperative O
day O
two O
, O
he O
was O
afebrile B-SYMPTOM
, O
vital O
signs O
were O
stable O
. O

His B-SYMPTOM
incision I-SYMPTOM
was O
clean O
, O
dry O
and O
intact O
with O
no O
erythema B-SYMPTOM
. O

He O
remained O
neurovascularly O
intact O
. O

His O
hematocrit O
was O
34.8 O
. O

On O
postoperative O
day O
three O
, O
lower O
extremity O
noninvasive O
ultrasounds O
were O
performed O
, O
which O
showed O
no O
evidence O
of O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
. O

The O
remainder O
of O
his O
hospitalization O
was O
uncomplicated O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Folic B-TREATMENT
acid I-TREATMENT
, O
1 O
mg. O
PO O
q.d.; O
multivitamin B-TREATMENT
, O
one O
capsule O
PO O
q.day O
; O

ferrous B-TREATMENT
sulfate I-TREATMENT
, O
325 O
mg. O
PO O
t.i.d.; O

Colace B-TREATMENT
, O
100 O
mg. O
PO O
t.i.d.; O

Tylenol B-TREATMENT
, O
650 O
mg. O
PO O
q.4 O
hours O
, O
p.r.n. O
pain B-SYMPTOM
; O

Milk B-TREATMENT
of I-TREATMENT
Magnesia I-TREATMENT
, O
30 O
ml. O
PO O
q.day O
, O
p.r.n. O
constipation B-SYMPTOM
; O

Coumadin B-TREATMENT
, O
2.5 O
mg. O
PO O
q.p.m. O
, O
dose O
to O
vary O
per O
INR O
level O
; O

Percocet B-TREATMENT
5/325 O
mg. O
s O
, O
one O
to O
two O
tablets O
PO O
q.4 O
to O
6 O
hours O
p.r.n. O
pain B-SYMPTOM
; O

Singulair B-TREATMENT
, O
10 O
mg. O
PO O
q.h.s.; O

Nexium B-TREATMENT
, O
10 O
mg. O
PO O
q.day O
; O

Metamucil B-TREATMENT
instant I-TREATMENT
mix I-TREATMENT
, O
one O
teaspoon O
PO O
q.day O
; O

Peri-Colace B-TREATMENT
, O
two O
capsules O
PO O
b.i.d.; O
Dulcolax B-TREATMENT
, O
10 O
mg. O
PR O
q.day O
, O
p.r.n. O
constipation B-SYMPTOM
. O

DISCHARGE O
INSTRUCTIONS O
: O

The O
patient O
is O
to O
follow-up O
with O
Dr. O
Class O
six O
weeks O
from O
the O
date O
of O
surgery B-TREATMENT
. O

His B-TREATMENT
staples I-TREATMENT
should O
be O
removed O
10 O
to O
14 O
days O
from O
the O
date O
of O
surgery B-TREATMENT
. O

If O
his B-SYMPTOM
wound I-SYMPTOM
is O
dry O
, O
he O
may O
shower O
. O

He O
is O
to O
ambulate O
with O
crutches B-TREATMENT
or O
a B-TREATMENT
walker I-TREATMENT
and O
be O
on O
posterior B-TREATMENT
hip I-TREATMENT
dislocation I-TREATMENT
precautions I-TREATMENT
for O
three O
months O
following O
the O
date O
of O
surgery B-TREATMENT
. O

He O
should O
be O
on O
Coumadin B-TREATMENT
for O
anticoagulation B-TREATMENT
for O
three O
weeks O
from O
the O
date O
of O
surgery B-TREATMENT
with O
twice O
weekly O
blood O
draws O
for O
INR O
with O
a O
goal O
of O
1.5 O
to O
2.0 O
. O

He O
is O
to O
call O
Dr. O
Class O
&apos;s O
office O
with O
any O
questions O
or O
concerns O
. O

LENNI O
E. O
BREUTZOLN O
, O
M.D. O

DICTATING O
FOR O
: O

Electronically O
Signed O
LI O
RIJARRED O
CLASS O
, O
M.D. O
03/27/2002 O
12:39 O
_____________________________ O
LI O
RIJARRED O
CLASS O
, O
M.D. O

TR O
: O

jt O

DD O
: O

03/13/2002 O

TD O
: O

03/13/2002 O
10:05 O
P O
718719 O

cc O
: O

LI O
RIJARRED O
CLASS O
, O
M.D. O
STAT O

766212923 O
ELMVH O

70097548 O

1264110 O

11/9/2003 O
12:00:00 O
AM O

GASTROINTESTINAL B-SYMPTOM
BLEEDING I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

11/09/2003 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

11/16/2003 O

ATTENDING O
: O

GROSRIANNE O
SISANDLEE O
JERGJESC O
M.D. O

SERVICE O
: O

GMS O
1 O
Medical O
Service O
. O

DISCHARGE O
DIAGNOSIS O
: O

GI B-SYMPTOM
bleed I-SYMPTOM
. O

DISCHARGE O
CONDITION O
: O

Stable O
. O

HOSPITAL O
COURSE O
: O

Patient O
&apos;s O
hospital O
course O
is O
as O
follows O
: O

Patient O
is O
an O
84-year-old O
male O
who O
was O
transferred O
from O
an O
outside O
hospital O
with O
a B-SYMPTOM
low I-SYMPTOM
hematocrit I-SYMPTOM
of O
21 O
and O
with O
guaiac-positive B-SYMPTOM
stool I-SYMPTOM
. O

The O
day O
prior O
to O
admission O
, O
he O
experienced O
dyspnea B-SYMPTOM
on O
exertion O
, O
and O
on O
the O
day O
of O
admission O
he O
collapsed O
and O
complained O
of O
substantial B-SYMPTOM
weakness I-SYMPTOM
. O

He O
denied O
any B-SYMPTOM
melana I-SYMPTOM
, O
any B-SYMPTOM
hematemesis I-SYMPTOM
, O
nausea B-SYMPTOM
or O
vomiting B-SYMPTOM
. O

He O
was O
taken O
to O
an O
outside O
hospital O
at O
the O
time O
at O
which O
time O
it O
was O
found O
that O
his O
hematocrit O
was O
21 O
, O
blood O
pressure O
90/60 O
, O
and O
his O
INR O
was O
3.3 O
. O

Of O
note O
, O
he O
is O
anti-coagulated B-TREATMENT
for O
an B-TREATMENT
artificial I-TREATMENT
heart I-TREATMENT
valve I-TREATMENT
. O

He O
was O
at O
that O
point O
given O
1 B-TREATMENT
unit I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

On O
further O
questioning O
, O
the O
patient O
reported O
that O
he O
started O
to O
feel O
&quot; O
different O
&quot; O
several O
days O
ago O
with O
slowing B-SYMPTOM
and I-SYMPTOM
difficult I-SYMPTOM
ambulation I-SYMPTOM
progressing O
to O
complete O
inability O
to O
ambulate O
. O

He O
was O
also O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
with O
ambulation O
, O
but O
he O
does O
have O
baseline B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
with O
exertion O
. O

He O
denied O
any B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
, O
dysuria B-SYMPTOM
, O
loss B-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
, O
fevers B-SYMPTOM
, O
chills B-SYMPTOM
or O
any O
history O
of O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

Patient O
was O
last O
admitted O
to O
Padrugmoff O
Hospital O
with O
a O
hematocrit O
of O
24.5 O
, O
and O
was O
asymptomatic B-SYMPTOM
prior O
to O
admission O
. O

At O
that O
time O
, O
he O
had O
guaiac-positive B-SYMPTOM
and O
had O
a O
small O
bowel O
follow O
through O
which O
was O
negative O
. O

He O
was O
transfused O
4 B-TREATMENT
units I-TREATMENT
during O
that O
admission O
and O
discharged O
with O
a O
hematocrit O
of O
34 O
on O
vitamin B-TREATMENT
C I-TREATMENT
and O
iron B-TREATMENT
sulfate I-TREATMENT
. O

EXAM O
ON O
ARRIVAL O
IN O
THE O
LO O
HOSPITAL O
EMERGENCY O
ROOM O
: O

On O
arrival O
at O
the O
Lo O
Hospital O
Emergency O
Room O
: O

He O
was O
found O
to O
have O
a O
temperature O
of O
97.4 O
, O
heart O
rate O
65 O
, O
pressure O
107/52 O
, O
respiratory O
rate O
22 O
and O
saturating O
100% O
on O
2 O
L O
of O
a B-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
. O

General O
exam O
at O
the O
time O
was O
notable O
for O
pale B-SYMPTOM
mucous I-SYMPTOM
membranes I-SYMPTOM
, O
left B-SYMPTOM
lateral I-SYMPTOM
eye I-SYMPTOM
deviation I-SYMPTOM
, O
clear O
lungs O
, O
2/6 B-SYMPTOM
holosystolic I-SYMPTOM
murmur I-SYMPTOM
, O
best O
heard O
at O
the O
apex O
, O
abdomen O
was O
mildly B-SYMPTOM
distended I-SYMPTOM
but O
was O
soft O
and O
nontender B-SYMPTOM
and O
his O
extremities O
were O
without O
edema B-SYMPTOM
and O
skin O
without O
any B-SYMPTOM
rashes I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Is O
as O
follows O
: O

History O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
with O
status O
post O
two-vessel B-TREATMENT
CABG I-TREATMENT
in O
1986 O
, O
also O
he O
was O
treated O
for O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
aortic B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
, O
and O
mitral B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
with O
St. B-TREATMENT
Jude I-TREATMENT
&apos;s I-TREATMENT
valve I-TREATMENT
in O
09/2001 O
, O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
history O
of O
prior B-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
requiring O
blood B-TREATMENT
transfusions I-TREATMENT
during O
which O
he O
also O
had O
a O
colonoscopy O
on O
05/2003 O
which O
demonstrated O
no O
neoplasia B-SYMPTOM
and O
scattered B-SYMPTOM
diverticuli I-SYMPTOM
. O

The O
patient O
also O
, O
following O
his B-SYMPTOM
first I-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
, O
had O
an O
EEG O
done O
in O
07/2003 O
which O
showed O
gastritis B-SYMPTOM
with O
oozing B-SYMPTOM
and O
evidence O
of O
a B-SYMPTOM
recent I-SYMPTOM
bleed I-SYMPTOM
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
: O

Included O
Lasix B-TREATMENT
, O
Lopressor B-TREATMENT
, O
Coumadin B-TREATMENT
, O
Diovan B-TREATMENT
, O
torsemide B-TREATMENT
, O
Flomax B-TREATMENT
, O
Protonix B-TREATMENT
, O
Senekot B-TREATMENT
, O
potassium B-TREATMENT
, O
vitamin B-TREATMENT
C I-TREATMENT
, O
iron B-TREATMENT
, O
and O
a B-TREATMENT
multivitamin I-TREATMENT
. O

SOCIAL O
HISTORY O
: O

Notable O
for O
no O
tobacco O
, O
no O
alcohol O
. O

He O
has O
a O
wife O
with O
Alzheimer B-SYMPTOM
&apos;s I-SYMPTOM
who O
lives O
in O
a O
skilled-nursing O
facility O
. O

LABORATORY O
DATA O
: O

Notable O
for O
a O
BUN O
and O
creatinine O
of O
78 O
, O
1.7 O
; O
for O
a O
sodium O
, O
potassium O
139 O
and O
3.6 O
; O
chloride O
and O
bicarb O
108 O
, O
21 O
. O

White O
count O
7 O
, O
hematocrit O
24.2 O
, O
platelet O
count O
was O
183 O
. O

His O
INR O
was O
also O
3.4 O
. O

PTT O
was O
55 O
. O

His O
EKG O
was O
notable O
for O
right B-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
, O
left B-SYMPTOM
axis I-SYMPTOM
deviation I-SYMPTOM
, O
but O
was O
in O
sinus O
rhythm O
. O

His O
UA O
had O
10-17 B-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cells I-SYMPTOM
; O
trace B-SYMPTOM
leukocyte I-SYMPTOM
esterase I-SYMPTOM
hyaline B-SYMPTOM
casts I-SYMPTOM
numbering O
60-70 O
. O

His O
chest O
x-ray O
was O
notable O
for O
clear O
lungs O
with O
no O
edema B-SYMPTOM
or O
infiltrates B-SYMPTOM
and O
small B-SYMPTOM
bilateral I-SYMPTOM
effusions I-SYMPTOM
. O

OTHER O
NOTALBE O
LABS O
: O

Patient O
was O
found O
to O
have O
a O
troponin O
of O
0.71 O
on O
admission O
with O
a O
CK O
of O
46 O
and O
CKMB O
of O
3.4 O
. O

ASSESSMENT O
: O

At O
that O
time O
, O
it O
was O
felt O
that O
the O
patient O
was O
likely O
having O
a B-SYMPTOM
repeat I-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
and O
while O
he O
was O
hemodynamically O
stable O
, O
he O
had O
evidently O
lost O
a O
substantial O
amount O
of O
blood O
. O

HOSPITAL O
COURSE O
: O

1. O
GI O
: O

Patient O
was O
transfused O
2 B-TREATMENT
units I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
overnight O
, O
the O
first O
night O
after O
admission O
and O
his O
hematocrit O
bumped O
up O
appropriately O
. O

He O
remained O
hemodynamically O
stable O
throughout O
his O
admission O
. O

He O
was O
continued O
on O
a B-TREATMENT
proton I-TREATMENT
pump I-TREATMENT
inhibitor I-TREATMENT
and O
on O
iron B-TREATMENT
sulfate I-TREATMENT
and O
vitamin B-TREATMENT
C I-TREATMENT
. O

His B-TREATMENT
Coumadin I-TREATMENT
was O
held O
at O
the O
time O
given O
the B-SYMPTOM
bleeding I-SYMPTOM
, O
even O
though O
it O
was O
important O
to O
keep O
his O
INR O
2.5-3.5 O
, O
given O
his B-TREATMENT
artificial I-TREATMENT
valve I-TREATMENT
it O
was O
felt O
that O
the O
risk O
of O
continued B-SYMPTOM
bleeding I-SYMPTOM
was O
to O
great O
to O
continue O
the B-TREATMENT
Coumadin I-TREATMENT
. O

He O
was O
subsequently O
seen O
by O
the O
GI O
team O
who O
performed O
an O
upper O
endoscopy O
which O
demonstrated O
the O
following O
: O

In O
the O
esophagus O
, O
there O
was O
a B-SYMPTOM
small I-SYMPTOM
hiatal I-SYMPTOM
hernia I-SYMPTOM
and O
in O
the O
stomach O
there O
is O
evidence O
of O
erosive B-SYMPTOM
gastritis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
body I-SYMPTOM
of O
the O
stomach O
and O
the O
antrum O
, O
the O
mucous O
appeared O
edematous B-SYMPTOM
. O

A B-SYMPTOM
small I-SYMPTOM
polyp I-SYMPTOM
was O
found O
in O
the O
fundus O
which O
stigmata B-SYMPTOM
of O
old B-SYMPTOM
bleeding I-SYMPTOM
; O
an B-TREATMENT
Endoclip I-TREATMENT
was O
applied O
to O
this O
. O

Another B-SYMPTOM
polyp I-SYMPTOM
was O
found O
in O
the O
antrum O
and O
cold O
biopsies O
were O
obtained O
there O
. O

In O
the O
duodenum O
, O
a B-SYMPTOM
small I-SYMPTOM
AVM I-SYMPTOM
was O
noted O
in O
the O
second O
portion O
of O
the O
duodenum O
and O
was O
cauterized O
. O

The O
biopsy O
subsequently O
demonstrated O
a B-SYMPTOM
hyperplastic I-SYMPTOM
polyp I-SYMPTOM
with O
acute B-SYMPTOM
and I-SYMPTOM
chronic I-SYMPTOM
inflammation I-SYMPTOM
and O
erosion B-SYMPTOM
and O
reactive B-SYMPTOM
epithelial I-SYMPTOM
changes I-SYMPTOM
but O
no O
dysplasia B-SYMPTOM
. O

Also O
of O
note O
, O
prior O
to O
the O
upper O
endoscopy O
, O
the O
patient O
received O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
to O
reverse O
his B-TREATMENT
anticoagulation I-TREATMENT
. O

Patient O
remained O
hemodynamically O
stable O
during O
and O
after O
the O
upper O
endoscopy O
and O
his O
hematocrit O
remained O
above O
30 O
following O
this O
until O
the O
point O
of O
discharge O
. O

His O
last O
recorded O
hematocrit O
on O
discharge O
was O
31.3 O
. O

His O
last O
BUN O
and O
creatinine O
were O
42 O
and O
1.5 O
with O
an O
INR O
of O
2.5 O
. O

Consideration O
was O
given O
to O
performing O
a O
repeat O
colonoscopy O
. O

This O
was O
discussed O
with O
the O
GI O
Service O
who O
felt O
that O
this O
was O
not O
necessary O
given O
the O
recent O
colonoscopy O
that O
he O
had O
had O
in O
05/2003 O
. O

2. O
Cardiovascular O
: O

A O
: O

Ischemia B-SYMPTOM
: O

Patient B-SYMPTOM
&apos;s I-SYMPTOM
troponin I-SYMPTOM
bump I-SYMPTOM
was O
found O
to O
be O
likely O
to O
demand B-SYMPTOM
ischemia I-SYMPTOM
in O
the O
setting O
of O
his B-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
, O
it O
was O
not O
felt O
that O
he O
was O
having O
acute B-SYMPTOM
coronary I-SYMPTOM
syndrome I-SYMPTOM
. O

On O
discharge O
, O
he O
was O
continued O
on O
his B-TREATMENT
aspirin I-TREATMENT
, O
simvastatin B-TREATMENT
and O
his B-TREATMENT
Lopressor I-TREATMENT
which O
was O
initially O
held O
, O
and O
subsequently O
restarted O
. O

B O
: O

Rhythm O
: O

Patient O
continued O
to O
be O
in O
A-fib. B-SYMPTOM
throughout O
the O
admission O
and O
was O
restarted O
on O
his B-TREATMENT
Coumadin I-TREATMENT
concurrently O
with O
heparin B-TREATMENT
. O

Heparin B-TREATMENT
was O
subsequently O
DCd O
once O
his O
INR O
reached O
a O
therapeutic O
level O
between O
2.5-3.5 O
. O

His O
last O
reported O
INR O
on O
discharge O
was O
2.5 O
. O

C O
: O

Valves O
: O

Patient O
had O
, O
as O
noted O
above O
, O
his B-TREATMENT
anticoagulation I-TREATMENT
was O
initially O
reversed O
despite O
his O
having O
artificial B-TREATMENT
valves I-TREATMENT
. O

However O
, O
his B-TREATMENT
Coumadin I-TREATMENT
was O
subsequently O
restarted O
and O
he O
achieved O
therapeutic O
INR O
levels O
before O
discharge O
. O

D O
: O

Pump O
: O

Patient O
, O
during O
this O
hospital O
course O
, O
became O
hypervolemic B-SYMPTOM
likely O
due O
to O
his B-TREATMENT
diuretics I-TREATMENT
being O
held O
and O
due O
to O
his O
receiving O
blood B-TREATMENT
products I-TREATMENT
. O

He O
was O
diuresed O
initially O
with O
one O
dose O
of O
Lasix B-TREATMENT
and O
subsequently O
with O
one O
dose O
of O
torsemide B-TREATMENT
after O
it O
was O
discovered O
that O
he O
developed O
thrombocytopenia B-SYMPTOM
on O
a O
prior O
admission O
in O
reaction O
to O
Lasix B-TREATMENT
. O

He O
subsequently O
was O
diuresed O
to O
a O
euvolemic O
state O
. O

Of O
note O
, O
he O
did O
not O
become O
thrombocytopenic B-SYMPTOM
on O
this O
admission O
. O

DISPOSITION O
: O

Was O
discharged O
on O
11/16/2003 O
in O
stable O
condition O
with O
the O
last O
recorded O
hematocrit O
of O
31.3 O
. O

He O
was O
asked O
to O
continue O
on O
his B-TREATMENT
Nexium I-TREATMENT
, O
iron B-TREATMENT
and O
vitamin B-TREATMENT
C I-TREATMENT
and O
was O
continued O
on O
his B-TREATMENT
other I-TREATMENT
home I-TREATMENT
medications I-TREATMENT
. O

DISCHARGE O
MEDICATIONS O
: O

His B-TREATMENT
final I-TREATMENT
medications I-TREATMENT
on O
discharge O
were O
as O
follows O
: O

Aspirin B-TREATMENT
325 O
, O
he O
was O
restarted O
on O
a B-TREATMENT
PPI I-TREATMENT
, O
also O
on O
iron B-TREATMENT
, O
vitamin B-TREATMENT
C I-TREATMENT
, O
Lopressor B-TREATMENT
12.5 O
b.i.d O
. O

Of O
note O
, O
this O
was O
at O
a O
decreased O
dose O
compared O
to O
that O
which O
he O
came O
in O
on O
, O
Coumadin B-TREATMENT
7.5 O
, O
mg O
, O
torsemide B-TREATMENT
100 O
q.d. O
, O
sucralfate B-TREATMENT
, O
simvastatin B-TREATMENT
, O
Diovan B-TREATMENT
. O

CONDITION O
ON O
DISCHARGE O
: O

He O
was O
discharged O
in O
stable O
condition O
with O
instructions O
to O
follow O
up O
with O
his O
PCP O
as O
well O
as O
to O
follow O
up O
with O
the O
Anticoagulation O
Clinic O
and O
Dr. O
Gilbert O
. O

eScription O
document O
: O

4-9918752 O
IEEHttd O
Tel O

Dictated O
By O
: O

NETPEAKE O
, O
SHIRLH O

Attending O
: O

JERGJESC O
, O
GROSRIANNE O
SISANDLEE O
Dictation O
ID O
4535172 O

D O
: O

12/22/03 O

T O
: O

12/22/03 O

649953363_c O

FIH O

8723483 O

824333 O

005999 O

5/12/2000 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O
NAME O
: O

UPH O
, O
JIM O

UNIT O
NUMBER O
: O

089-44-01 O

ADMISSION O
DATE O
: O

05/12/2000 O

DISCHARGE O
DATE O
: O

05/20/2000 O

REASON O
FOR O
ADMISSION O
: O

Small B-SYMPTOM
cell I-SYMPTOM
lung I-SYMPTOM
cancer I-SYMPTOM
. O

Chemotherapy B-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Provided O
in O
the O
house O
staff O
note O
from O
the O
admission O
date O
. O

Briefly O
this O
is O
a O
Hispanic O
patient O
with O
history O
of O
advanced B-SYMPTOM
lung I-SYMPTOM
cancer I-SYMPTOM
, O
small O
cell O
in O
histology O
. O

The O
patient O
presented O
with O
almost B-SYMPTOM
a I-SYMPTOM
stridor I-SYMPTOM
and O
a B-SYMPTOM
large I-SYMPTOM
mediastinal I-SYMPTOM
mass I-SYMPTOM
with O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

He O
was O
transferred O
to O
the O
Oncology O
Service O
after O
discussions O
about O
the O
utility O
of O
chemotherapy B-TREATMENT
. O

HOSPITAL O
COURSE O
: O

In O
the O
Oncology O
Floor O
he O
received O
Carboplatin B-TREATMENT
and O
Etoposide B-TREATMENT
to O
which O
he O
reacted O
well O
. O

There O
were O
no O
major O
issues O
and O
he O
was O
discharged O
home O
on O
5/20/00 O
. O

________________________ O

MAREN O
TLANDFLENT O
, O
M.D. O

Electronically O
Signed O

MAREN O
STEA O
TLANDFLENT O
, O
M.D. O

07/15/2000 O
21:36 O

TR O
: O

se O

DD O
: O

07/06/2000 O

TD O
: O

07/11/2000 O
12:44 O
P O

cc O
: O

MAREN O
STEA O
TLANDFLENT O
, O
M.D. O

Admission O
Date O
: O

2012-10-31 O

Discharge O
Date O
: O

2012-11-07 O

Date O
of O
Birth O
: O

1941-03-23 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Nsaids/Anti-Inflammatory B-TREATMENT
Classifier I-TREATMENT
/ O
Vancomycin B-TREATMENT

Attending O
: O

Kristie O
R. O
Hamby O
, O
M.D. O

Chief O
Complaint O
: O

CC O
: O
Antonio O
M. O
Z. O
Eddings O
, O
M.D. O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Mesenteric O
angiograpm O
w/ O
coil B-TREATMENT
embolization I-TREATMENT
of O
bleeding B-SYMPTOM
vessel I-SYMPTOM
. O

Sigmoidoscopy O
. O

Colonoscopy O
. O

History O
of O
Present O
Illness O
: O

HPI: O
Pt O
is O
a O
71 O
y/o O
male O
with O
h/o O
dm2 B-SYMPTOM
, O
cad B-SYMPTOM
s/p O
cabg B-TREATMENT
, O
DVT/PE B-SYMPTOM
on O
long B-TREATMENT
term I-TREATMENT
anti-coagulation I-TREATMENT
, O
ulcerative B-SYMPTOM
colitis I-SYMPTOM
on O
Asacol B-TREATMENT
presents O
with O
brbpr B-SYMPTOM
starting O
at O
9am O
of O
the O
morning O
of O
admission O
. O

He O
'd O
been O
having O
lower B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
for O
approximately O
the O
past O
week O
, O
a B-SYMPTOM
symptom I-SYMPTOM
for O
which O
he O
's O
been O
admitted O
in O
the O
past O
. O

His O
PCP O
had O
recently O
started O
ciprofloxacin B-TREATMENT
for O
a B-SYMPTOM
UTI I-SYMPTOM
. O

At O
9am O
the O
morning O
of O
admission O
he O
passed O
a B-SYMPTOM
large I-SYMPTOM
, I-SYMPTOM
bloody I-SYMPTOM
bowel I-SYMPTOM
movement I-SYMPTOM
and O
came O
to O
the O
Michael O
. O
There O
, O
his O
vitals O
were O
intially O
stable O
with O
a O
hct O
of O
36.7 O
, O
though O
he O
was O
felt O
to O
be O
hypovolemic B-SYMPTOM
and O
this O
hemoconcentrated B-SYMPTOM
; O
his O
previous O
hct O
was O
39 O
about O
five O
months O
ago O
. O

He O
refused O
an B-TREATMENT
NG I-TREATMENT
lavage I-TREATMENT
. O

Although O
an O
initial O
DRE O
showed O
only O
clot B-SYMPTOM
, O
he O
later O
passed O
a B-SYMPTOM
large I-SYMPTOM
, I-SYMPTOM
bloody I-SYMPTOM
bowel I-SYMPTOM
movement I-SYMPTOM
, O
and O
his O
bp O
nadired O
to O
the O
low O
90's O
but O
rested O
there O
only O
transiently O
and O
easily O
rebounded O
to O
the O
130's-140's O
with O
fluid B-TREATMENT
; O
he O
then O
went O
to O
angiography O
for O
a O
tagged O
RBC O
scan O
where O
they O
found O
and O
embolized O
two O
vessels O
to O
the O
sigmoid O
colon O
. O

His O
HCT O
had O
dropped O
from O
36.7 O
to O
30.8 O
despite O
2U B-TREATMENT
PRBC I-TREATMENT
and O
3 B-TREATMENT
U I-TREATMENT
FFP I-TREATMENT
. O

Is O
called O
out O
of O
the O
FICU O
as O
has O
been O
been O
HD O
and O
stable O
HCT O
. O

Currently O
denies O
CP B-SYMPTOM
, O
SOB B-SYMPTOM
, O
abd B-SYMPTOM
pain I-SYMPTOM
or O
continued B-SYMPTOM
BRBPR I-SYMPTOM
. O

Past O
Medical O
History O
: O

PMH O
: O

1.) O
DM-2 B-SYMPTOM

2.) O
CAD B-SYMPTOM
s/p O
3v-CABG B-TREATMENT
2003 O
and O
subsequent O
stenting B-TREATMENT
of O
SVG B-TREATMENT
and O
LIMA O

3.) O
CHF B-SYMPTOM
with O
EF O
30-35% O
on O
07-10 O
echo O

4.) O
Right B-SYMPTOM
parietal I-SYMPTOM
intracranial I-SYMPTOM
bleeding I-SYMPTOM
following O
1996 O
cardiac O
cath O

5.) O
LBBB B-SYMPTOM

6.) O
Sinus B-SYMPTOM
node I-SYMPTOM
dysfunction I-SYMPTOM
s/p O
pacemaker B-TREATMENT

7.) O
H/O O
DVT B-SYMPTOM
( O
right O
sided O
) O
and O
subsequent O
PE B-SYMPTOM
, O
put O
onto O
lifetime O
warfarin B-TREATMENT

8.) O
Ulcerative B-SYMPTOM
colitis I-SYMPTOM

PSH O
: O

1.) O
C4-7 B-TREATMENT
anterior I-TREATMENT
discectomies I-TREATMENT

2.) O
CABG B-TREATMENT
2003 O

3.) O
R B-TREATMENT
intracerebral I-TREATMENT
hemorrhage I-TREATMENT
drainage I-TREATMENT

Social O
History O
: O

SocHx O
: O
Mr O
Peres O
generally O
lives O
with O
his O
wife O
but O
has O
spent O
a O
great O
deal O
of O
time O
recently O
at O
rehab B-TREATMENT
. O

He O
has O
no O
h/o O
ETOH/IVDA O
but O
quit O
tob O
15 O
years O
ago O
. O

Family O
History O
: O

Noncontributory O
. O

Physical O
Exam O
: O

VS O
98.4 O
, O
62 O
, O
103/37 O
, O
15 O
97%2L O

gen O
- O
lying O
in O
bed O
, O
NAD B-SYMPTOM

heent O
- O
anicteric B-SYMPTOM
sclera I-SYMPTOM
, O
op O
clear O
with O
mmm O

neck O
- O
jvd B-SYMPTOM
flat O

cv O
- O
rrr O
, O
s1s2 O
, O
no O
m/r/g B-SYMPTOM

pul O
- O
CTAB O
without O
rales B-SYMPTOM

abd O
- O
soft O
, O
minimally B-SYMPTOM
distended I-SYMPTOM
, O
nt B-SYMPTOM
, O
no O
rebound/guarding B-SYMPTOM
, O
nabs O

extrm O
- O
trace B-SYMPTOM
edema I-SYMPTOM
at I-SYMPTOM
ankles I-SYMPTOM
, O
no O
cyanosis B-SYMPTOM
, O
warm/dry O

Pertinent O
Results O
: O

2012-10-31 O
05:47PM O
URINE O

COLOR O
- O
Straw O
APPEAR O
- O
Clear O
SP O
Marquez O
- O
1.021 O

2012-10-31 O
05:47PM O
URINE O

BLOOD O
- O
LG O
NITRITE O
- O
NEG O
PROTEIN O
- O
NEG O

GLUCOSE O
- O
NEG O
KETONE O
- O
NEG O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
NEG O
PH O
- O
7.0 O
LEUK O
- O
NEG O

2012-10-31 O
05:47PM O
URINE O

RBC-21-50* O
WBC-0-2 O
BACTERIA O
- O
FEW O

YEAST O
- O
NONE O
EPI O
- O
<1 O

2012-10-31 O
02:32PM O

LACTATE O
- O
1.8 O

2012-10-31 O
12:20PM O

GLUCOSE O
- O
197* O
UREA O
N-25* O
CREAT O
- O
0.8 O
SODIUM O
- O
141 O

POTASSIUM O
- O
3.7 O
CHLORIDE O
- O
105 O
TOTAL O
CO2 O
- O
22 O
ANION O
GAP O
- O
18 O

2012-10-31 O
12:20PM O

WBC O
- O
5.6 O
RBC O
- O
4.35* O
HGB O
- O
12.6* O
HCT O
- O
36.7* O
MCV O
- O
84 O

MCH O
- O
28.9 O
MCHC O
- O
34.3 O
RDW O
- O
15.7* O

2012-10-31 O
12:20PM O

NEUTS O
- O
80.5* O
LYMPHS O
- O
13.1* O
MONOS O
- O
3.5 O
EOS O
- O
2.5 O

BASOS O
- O
0.4 O

2012-10-31 O
12:20PM O

POIKILOCY O
- O
1+ O
MICROCYT O
- O
1+ O

2012-10-31 O
12:20PM O

PLT O
COUNT O
- O
102* O

2012-10-31 O
12:20PM O

PT O
- O
20.5* O
PTT O
- O
29.4 O
INR(PT) O
- O
3.0 O

GI O
BLEEDING O
STUDY O

2012-10-31 O

IMPRESSION O
: O
Increased B-SYMPTOM
tracer I-SYMPTOM
activity I-SYMPTOM
demonstrated O
within O
the O
left O
lower O
quadrant O
, O
most O
likely O
sigmoid O
colonic O
loops O
of O
bowel O
, O
consistent O
with O
active B-SYMPTOM
bleeding I-SYMPTOM
. O

CT O
ABDOMEN O
W/CONTRAST O

2012-10-31 O
3:27 O
PM O

IMPRESSION O
: O

1. O
No O
evidence O
of O
colitis B-SYMPTOM
or O
other B-SYMPTOM
bowel I-SYMPTOM
pathology I-SYMPTOM
present O
to O
explain O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
bright I-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
. O

2. O
Stable O
appearance O
of O
left B-SYMPTOM
adrenal I-SYMPTOM
fat-containing I-SYMPTOM
lesion I-SYMPTOM
consistent O
with O
a B-SYMPTOM
myelolipoma I-SYMPTOM
. O

3. O
Stable O
appearance O
of O
hypodense B-SYMPTOM
lesion I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
caudate I-SYMPTOM
lobe I-SYMPTOM
of O
the O
liver O
, O
too O
small O
to O
fully O
characterize O
. O

4. O
Subcentimeter B-SYMPTOM
attenuation I-SYMPTOM
lesion I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
lower I-SYMPTOM
pole I-SYMPTOM
of O
the O
right O
kidney O
, O
too O
small O
to O
characterize O
. O

5. O
3-mm B-SYMPTOM
noncalcified I-SYMPTOM
pulmonary I-SYMPTOM
nodule I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
. O

If O
the O
patient O
does O
not O
have O
a O
history O
of O
a B-SYMPTOM
primary I-SYMPTOM
malignancy I-SYMPTOM
, O
followup O
CT O
of O
the O
chest O
in O
1 O
year O
is O
recommended O
to O
evaluate O
for O
stability O
of O
this O
finding O
. O

Brief O
Hospital O
Course O
: O

Initial O
A/P O
: O

71 O
y/o O
male O
with O
dm2 B-SYMPTOM
, O
cad B-SYMPTOM
, O
chf B-SYMPTOM
, O
uc B-SYMPTOM
presents O
with O
one O
week O
of O
lower B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
and O
2 O
episodes O
of O
brpbr B-SYMPTOM
on O
the O
day O
of O
admission O
. O

# O
BRBPR B-SYMPTOM
-- O
The O
patient O
was O
in O
the O
intensive O
care O
unit O
given O
his B-SYMPTOM
lower I-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
. O

An O
angiography O
showed O
bleeding B-SYMPTOM
in I-SYMPTOM
two I-SYMPTOM
vessels I-SYMPTOM
off O
of O
the O
Minnie O
supplying O
the O
sigmoid O
that O
were O
succesfully O
embolized O
. O

The O
patient O
was O
transfused O
from O
a O
Hct O
29 O
to O
34 O
on O
the O
day O
of O
discharge O
. O

His B-TREATMENT
coumadin I-TREATMENT
was O
held O
during O
his O
stay O
given O
his B-SYMPTOM
acute I-SYMPTOM
bleed I-SYMPTOM
but O
restarted O
per O
his O
PCP O
with O
the O
guidance O
of O
GI O
on O
the O
day O
of O
discharge O
. O

- O
The O
patient O
underwent O
a O
flex O
sigmoidoscopy O
on O
Friday O
, O
11-02 O
, O
which O
showed O
old B-SYMPTOM
blood I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
rectal I-SYMPTOM
vault I-SYMPTOM
but O
no O
active B-SYMPTOM
source I-SYMPTOM
of I-SYMPTOM
bleeding I-SYMPTOM
. O

Given O
this O
, O
it O
was O
advised O
that O
the O
patient O
have O
a O
colonoscopy O
to O
rule O
out O
further O
bleeding B-SYMPTOM
. O

- O
The O
patient O
had O
a O
colonoscopy O
on O
Monday O
11-05 O
but O
unfortunately O
, O
was O
unable O
to O
complete O
the O
study O
as O
his O
bowel O

prep O
was O
inadequate O
. O

Therefore O
, O
he O
had O
a O
repeat O
colonoscopy O
on O
11-06 O
which O
showed O
expected O
mucosal B-SYMPTOM
signs I-SYMPTOM
of O
moderate B-SYMPTOM
ulcerative I-SYMPTOM
colitis I-SYMPTOM
, O
no O
polyps B-SYMPTOM
, O
w/ O
8 B-SYMPTOM
mm I-SYMPTOM
ulcer I-SYMPTOM
at I-SYMPTOM
junction I-SYMPTOM
of I-SYMPTOM
distal I-SYMPTOM
descending I-SYMPTOM
colon I-SYMPTOM
and I-SYMPTOM
sigmoid I-SYMPTOM
colon I-SYMPTOM
. O

- O
Biopsies O
were O
obtained O
during O
his O
colonoscopy O
and O
he O
should O
follow O
up O
with O
gastroenterology O
for O
the O
results O
. O

# O
Ulcerative B-SYMPTOM
colitis I-SYMPTOM
-- O
The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
Asacol I-TREATMENT
was O
originally O
held O
but O
restarted O
the O
day O
prior O
to O
discharge O
per O
GI O
. O

# O
CAD/CHF B-SYMPTOM
- O
The O
patient O
was O
restarted O
on O
his B-TREATMENT
home I-TREATMENT
regimen I-TREATMENT
prior O
to O
discharge O
as O
it O
was O
held O
temporarily O
given O
his B-SYMPTOM
acute I-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
. O

The O
exception O
is O
that O
per O
his O
PCP O
, O
Jason O
aspirin B-TREATMENT
will O
be O
held O
for O
2 O
weeks O
given O
that O
he O
was O
restarted O
on O
coumadin B-TREATMENT
with O

his B-SYMPTOM
risk I-SYMPTOM
of I-SYMPTOM
bleeding I-SYMPTOM
. O

# O
DM-2 B-SYMPTOM
-- O
The O
patient O
was O
maintained O
on O
his B-TREATMENT
home I-TREATMENT
insulin I-TREATMENT
regimen I-TREATMENT
. O

# O
h/o O
DVT/PE B-SYMPTOM
: O

Coumadin B-TREATMENT
was O
initially O
held O
. O

It O
was O
unclear O
at O
first O
as O
to O
why O
the O
patient O
required O
life-long B-TREATMENT
anticoagulation I-TREATMENT
. O

After O
discussing O
this O
with O
his O
PCP O
, O
Leon O
was O
clear O
that O
the O
patient O
had O
had O
recurrent B-SYMPTOM
DVTs I-SYMPTOM
and O
ultimately O
a B-SYMPTOM
PE I-SYMPTOM
and O
his O
PCP O
felt O
strongly O
that O
he O
required O
long-term B-TREATMENT
anticoagulation I-TREATMENT
. O

His O
goal O
INR O
should O
be O
1.6-2.0 O
. O
If O
bleeding B-SYMPTOM
continues O
to O
occur O
, O
consider O
V. B-TREATMENT
Winchester I-TREATMENT
filter I-TREATMENT
. O

# O
Access O
-- O
2 B-TREATMENT
large I-TREATMENT
bore I-TREATMENT
PIV's I-TREATMENT

# O
Code O
-- O
full O

Medications O
on O
Admission O
: O

Meds O
on O
Admission O
: O

1.) O
Spironolactone/hctz B-TREATMENT
25/25 O
daily O

2.) O
Atenolol B-TREATMENT
12.5mg O
daily O

3.) O
Insulin B-TREATMENT
45N/8R O
qAM O
and O
33N O
qPM O

4.) O
Furosemide B-TREATMENT
10 O
mg O
every O
other O
day O

5.) O
Aspirin B-TREATMENT
81 O
mg O
daily O

6.) O
Zoloft B-TREATMENT
40 O
mg O
qAM O

7.) O
Flomax B-TREATMENT

8.) O
Atorvastatin B-TREATMENT
40 O
mg O
daily O

9.) O
Ritalin B-TREATMENT
20 O
mg O
daily O

10.) O
Ramipril B-TREATMENT
2.5 O
mg O
daily O

11.) O
Asacol B-TREATMENT
400 O
mg O
3 O
, O
TID O

12.) O
Carafate B-TREATMENT
1 O
gm O
bid O

13.) O
Actos B-TREATMENT
15 O
mg O
daily O

14.) O
Folate B-TREATMENT
1 O
mg O
daily O

15.) O
Warfarin B-TREATMENT
2 O
mg O
daily O

Discharge O
Medications O
: O

1. O
Tamsulosin B-TREATMENT
0.4 O
mg O
Capsule O
, O
Sust O
. O
Release O
24HR O
Sig O
: O
One O
( O
1 O
) O
Capsule O
, O
Sust O
. O
Release O
24HR O
PO O
HS O
( O
at O
bedtime O
) O
. O

2. O
Atorvastatin B-TREATMENT
40 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

3. O
Methylphenidate B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

4. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

5. O
Folic B-TREATMENT
Acid I-TREATMENT
1 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

6. O
Atenolol B-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

7. O
Spironolactone B-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

8. O
Ramipril B-TREATMENT
1.25 O
mg O
Capsule O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
PO O
DAILY O
( O
Daily O
) O
. O

9. O
Hydrochlorothiazide B-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

10. O
Pioglitazone B-TREATMENT
15 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
as O
needed O
for O
DM B-SYMPTOM
. O

11. O
Mesalamine B-TREATMENT
400 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
TID O
( O
3 O
times O
a O
day O
) O
as O
needed O
for O
ulcerative B-SYMPTOM
colitis I-SYMPTOM
w/o O
recent O
severe B-SYMPTOM
flares I-SYMPTOM
. O

12. O
Insulin B-TREATMENT
45 O
NPH B-TREATMENT
in O
am O
with O
33 O
NPH B-TREATMENT
at O
bedtime O

Continue O
Sliding B-TREATMENT
scale I-TREATMENT
insulin I-TREATMENT
as O
needed O
. O

13. O
Sertraline B-TREATMENT
20 O
mg/mL O
Concentrate O
Sig O
: O
Two O
( O
2 O
) O
PO O
at O
bedtime O
. O

14. O
Coumadin B-TREATMENT
2 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Oak O
Bluffs O
Of O
Greenfield O

Discharge O
Diagnosis O
: O

Rectal B-SYMPTOM
bleeding I-SYMPTOM
from I-SYMPTOM
inferior I-SYMPTOM
mesenteric I-SYMPTOM
artery I-SYMPTOM
tributaries I-SYMPTOM
supplying O
sigmoid O
colon O
. O

Discharge O
Condition O
: O
Good O
. O

Discharge O
Instructions O
: O

Please O
call O
physician O
if O
you O
develop O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
weakness B-SYMPTOM
in I-SYMPTOM
your I-SYMPTOM
legs I-SYMPTOM
or I-SYMPTOM
arms I-SYMPTOM
, O
sudden B-SYMPTOM
blurry I-SYMPTOM
vision I-SYMPTOM
or O
slurred B-SYMPTOM
speech I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
faintness B-SYMPTOM
, O
or O
significant B-SYMPTOM
unexplained I-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
. O

Followup O
Instructions O
: O

Provider O
: O
Lucio O
Y. O
Matthews O
, O
M.D. O
Phone O
: O
( O
967 O
) O
675 O
1641 O
Date/Time O
: O
2012-12-28 O
2:30 O

Provider O
: O
Greg O
CLINIC O
Phone O
: O
( O
212 O
) O
442 O
0438 O
Date/Time O
: O
2013-01-11 O
1:30 O

Provider O
: O
Lucio O
F. O
R. O
Matthews O
, O
M.D. O
Phone O
: O
( O
967 O
) O
675 O
1641 O
Date/Time O
: O
2013-01-11 O
2:00 O

Please O
call O
White O
, O
Leslie O
L. O
at O
( O
602 O
) O
743 O
8709 O
to O
schedule O
an O
appointment O
with O
him O
in O
1 O
week O
. O

Please O
call O
your O
gastroenterologist O
to O
schedule O
a O
follow O
up O
appointment O
in O
2 O
weeks O
. O

Alan O
John O
MD O
54-745 O

Completed O
by O
: O
Bertha O
Janice O
Motta O
MD O
52-860 O
2012-11-07 O
@ O
1207 O

Signed O
electronically O
by O
: O
DR. O
Melody O
PARKS O
on: O
WED O
2012-11-21 O
6:22 O
PM O

( O
End O
of O
Report O
) O

313251236 O
WGH O

1429918 O

816995 O

0854768 O

5/1/2004 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

KATESJESC O
, O
RAI O

MRN O
: O

1429918 O

Age O
: O

60y O

REGISTRATION O
DATE O
: O

05/01/2004 O
06:30 O
PM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
KATESJESC O
, O
RAI O
arrived O
in O
the O
Emergency O
Department O
at O
Well O
General O
Hospital O
on O
05/01/2004 O
06:30 O
PM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
SSCP B-SYMPTOM
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
of O
the O
visit O
was O
ADMITTED O
AS O
AN O
INPATIENT O
TO O
WELL O
GENERAL O
HOSPITAL O
. O

The O
patient O
&apos;s O
preliminary O
admitting O
physician O
is O
REKE O
, O
ATOTA O
S O
and O
the O
preliminary O
diagnosis O
is O
ACS B-SYMPTOM
.. O

Please O
note O
this O
information O
may O
have O
been O
updated O
on O
the O
inpatient O
unit O
. O

If O
you O
need O
additional O
information O
please O
call O
366-686-5449 O
. O

PCP O
Name O
: O

REKE O
, O
ATOTA O
S O

Provider O
Number O
: O

36860 O

917563546 O
ELMVH O

73397283 O

7646550 O

1/23/2003 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

01/23/2003 O

Date O
of O
Discharge O
: O

01/23/2003 O

ATTENDING O
: O

DOTA O
SPACE O
M.D. O

ADMITTING O
DIAGNOSIS O
: O

Lumbar B-SYMPTOM
spinal I-SYMPTOM
stenosis I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

L2 B-TREATMENT
to I-TREATMENT
L5 I-TREATMENT
laminectomy I-TREATMENT
, O
L2 B-TREATMENT
through I-TREATMENT
L5 I-TREATMENT
posterior I-TREATMENT
fusion I-TREATMENT
with O
segmental B-TREATMENT
instrumentation I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
50-year-old O
female O
with O
history O
of O
low B-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
radiating B-SYMPTOM
to I-SYMPTOM
both I-SYMPTOM
legs I-SYMPTOM
. O

She O
had O
increasing B-SYMPTOM
symptoms I-SYMPTOM
overtime O
, O
not O
controlled O
by O
conservative B-TREATMENT
management I-TREATMENT
. O

She O
therefore O
elected O
to O
undergo O
surgical B-TREATMENT
treatment I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

Her O
past O
medical O
history O
is O
notable O
for O
bilateral B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
venous I-SYMPTOM
insufficiency I-SYMPTOM
with O
edema B-SYMPTOM
, O
hypertension B-SYMPTOM
. O

She O
takes O
lisinopril B-TREATMENT
/ O
hydrochlorothiazide B-TREATMENT
20/25 O
mg O
p.o. O
q.d. O
, O
Vioxx B-TREATMENT
50 O
mg O
p.o. O
q.d. O
, O
Lipitor B-TREATMENT
10 O
mg O
p.o. O
q.d. O
, O
Nortriptyline B-TREATMENT
25 O
mg O
p.o. O
q.h.s. O
, O
Neurontin B-TREATMENT
300 O
mg O
p.o. O
t.i.d. O

ALLERGIES O
: O

She O
has O
nausea B-SYMPTOM
with O
Codeine B-TREATMENT
otherwise O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

Past O
surgical O
history O
is O
notable O
of O
D O
and O
C O
in O
1980 O
and O
cyst B-TREATMENT
excision I-TREATMENT
. O

HABITS O
: O

She O
denies O
smoking O
or O
alcohol O
. O

PHYSICAL O
EXAMINATION O
: O

On O
examination O
, O
her O
lungs O
were O
clear O
. O

She O
had O
a O
regular O
heart O
rate O
and O
rhythm O
. O

She O
had O
2+ O
bilateral O
DP O
and O
radial O
pulses O
. O

She O
has O
mild B-SYMPTOM
swelling I-SYMPTOM
in I-SYMPTOM
both I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
. O

She O
has O
pain B-SYMPTOM
with O
straight O
leg O
raise O
, O
left O
greater O
than O
right O
and O
5/5 O
strength O
in O
right O
quads O
compared O
to O
4/5 O
on O
the O
left O
. O

Please O
see O
Dr. O
Uph O
&apos;s O
office O
note O
for O
further O
details O
. O

HOSPITAL O
COURSE O
: O

She O
was O
taken O
to O
the O
operating O
room O
on O
01/16/2003 O
for O
decompression B-TREATMENT
at I-TREATMENT
L2 I-TREATMENT
, I-TREATMENT
L5 I-TREATMENT
and O
laminectomy B-TREATMENT
with O
posterior B-TREATMENT
instrumented I-TREATMENT
fusion I-TREATMENT
at I-TREATMENT
L3 I-TREATMENT
to I-TREATMENT
L5 I-TREATMENT
. O

She O
tolerated O
the B-TREATMENT
surgery I-TREATMENT
well O
. O

She O
was O
transferred O
to O
recovery O
room O
in O
stable O
condition O
. O

She O
received O
blood B-TREATMENT
transfusions I-TREATMENT
intraoperatively O
and O
postoperatively O
in O
addition O
to O
autologous B-TREATMENT
blood I-TREATMENT
. O

Her O
hematocrit O
was O
stable O
postoperatively O
. O

Her O
neurologic O
exam O
was O
stable O
postoperatively O
with O
5/5 O
bilaterally O
, O
tibial O
, O
EHL O
, O
FHL O
, O
gastroc O
soleus O
, O
and O
intact O
quadriceps O
. O

She O
has O
intact O
sensation O
L3 O
to O
S1 O
and O
bilateral O
lower O
extremities O
. O

She O
was O
fitted O
for O
Verholl B-TREATMENT
Aet I-TREATMENT
over I-TREATMENT
leg I-TREATMENT
brace I-TREATMENT
and O
mobilized O
out O
of O
the O
bed O
in O
the B-TREATMENT
brace I-TREATMENT
with O
physical B-TREATMENT
therapy I-TREATMENT
. O

Her B-SYMPTOM
wounds I-SYMPTOM
were O
stable O
without O
any B-SYMPTOM
erythema I-SYMPTOM
or O
drainage B-SYMPTOM
. O

She O
reported O
nausea B-SYMPTOM
on O
pain B-TREATMENT
medications I-TREATMENT
. O

Her B-TREATMENT
pain I-TREATMENT
medications I-TREATMENT
were O
changed O
around O
until O
an O
acceptable O
regime O
was O
accomplished O
. O

She O
is O
stable O
for O
discharge O
to O
rehab O
. O

DISCHARGE O
ACTIVITY O
: O

She O
should O
continue O
to O
wear O
the B-TREATMENT
brace I-TREATMENT
when O
out O
of O
bed O
and O
there O
should O
be O
no O
heavy O
lifting O
, O
twisting O
or O
bending O
activities O
. O

She O
will O
need O
to O
follow O
up O
with O
Dr. O
Uph O
on O
02/21/03 O
at O
9:30 O
a.m. O

DISCHARGE O
MEDICATIONS O
: O

Tylenol B-TREATMENT
650 O
mg O
p.o. O
q.4h. O
p.r.n. O
, O
Benadryl B-TREATMENT
25 O
mg O
p.o. O
q.h.s. O
p.r.n. O
, O
Colace B-TREATMENT
100 O
mg O
p.o. O
q.i.d. O
, O
Nortriptyline B-TREATMENT
25 O
mg O
p.o. O
q.h.s. O
, O
Simvastatin B-TREATMENT
10 O
mg O
p.o. O
q.h.s. O
, O
Metamucil B-TREATMENT
one O
packet O
p.o. O
b.i.d. O
p.r.n. O
, O
Neurontin B-TREATMENT
300 O
mg O
p.o. O
t.i.d. O
, O
Levsinex B-TREATMENT
0.375 O
mg O
p.o. O
q.12h. O
, O
Lisinopril B-TREATMENT
/ O
hydrochlorothiazide B-TREATMENT
20/25 O
mg O
p.o. O
q.d. O
, O
hydrocortisone B-TREATMENT
topical I-TREATMENT
ointment I-TREATMENT
to O
affected B-SYMPTOM
areas I-SYMPTOM
, O
MS B-TREATMENT
Contin I-TREATMENT
30 O
mg O
p.o. O
b.i.d. O
, O
MSIR B-TREATMENT
15 O
to O
30 O
mg O
p.o. O
q.4h. O
p.r.n. O
pain B-SYMPTOM
. O

The O
patient O
should O
continue O
to O
have O
dry B-TREATMENT
sterile I-TREATMENT
dressings I-TREATMENT
to O
her B-SYMPTOM
back I-SYMPTOM
and I-SYMPTOM
iliac I-SYMPTOM
crest I-SYMPTOM
wounds I-SYMPTOM
until O
follow O
up O
with O
Dr. O
Uph O
. O

Should O
there O
be O
any B-SYMPTOM
wound I-SYMPTOM
erythema I-SYMPTOM
or O
drainage B-SYMPTOM
, O
please O
contact O
Dr. O
Uph O
&apos;s O
office O
immediately O
. O

eScription O
document O
: O

2-7712488 O
ZNHKjeu O
Tel O

Dictated O
By O
: O

MAULPLACKAGNELEEB O
, O
INACHELLE O

Attending O
: O

SPACE O
, O
DOTA O
Dictation O
ID O
3624752 O

D O
: O

01/23/03 O

T O
: O

01/23/03 O

Admission O
Date O
: O

2012-04-27 O

Discharge O
Date O
: O

2012-04-30 O

Date O
of O
Birth O
: O

1933-02-05 O

Sex O
: O

F O

Service O
: O

Neurosurgery O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Patient O
is O
a O
79 O
- O
year-old O
female O
with O
a O
history O
of O
cataracts B-SYMPTOM
, O
glaucoma B-SYMPTOM
, O
and O
diabetes B-SYMPTOM
, O
who O
fell O
and O
tripped O
over O
a O
wheelchair O
of O
a O
friend O
with O
no O
loss B-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
, O
no O
dizziness B-SYMPTOM
, O
no O
chest B-SYMPTOM
pain I-SYMPTOM
, O
and O
no O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

PHYSICAL O
EXAM O
: O

She O
was O
afebrile B-SYMPTOM
. O

Heart O
rate O
was O
77 O
. O

Blood O
pressure O
132/48 O
. O

Respiratory O
rate O
was O
17 O
. O

Sats O
96% O
on O
room O
air O
. O

Her O
temperature O
was O
97.6 O
. O

She O
neurologically O
, O
she O
had O
a O
nonfocal O
neurologic O
examination O
. O

Her O
cardiovascular O
was O
regular O
rate O
and O
rhythm O
. O

Her O
pulmonary O
: O

Chest O
was O
clear O
to O
auscultation O
bilaterally O
. O

Extremities O
: O

No O
cyanosis B-SYMPTOM
, O
clubbing B-SYMPTOM
, O
or O
edema B-SYMPTOM
. O

Head O
CT O
showed O
a B-SYMPTOM
front I-SYMPTOM
focal I-SYMPTOM
hemorrhage I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
occipital I-SYMPTOM
lobe I-SYMPTOM
adjacent O
to O
the O
falx O
with O
intraparenchymal B-SYMPTOM
hemorrhage I-SYMPTOM
or O
epidural B-SYMPTOM
or I-SYMPTOM
subdural I-SYMPTOM
hemorrhage I-SYMPTOM
near I-SYMPTOM
the I-SYMPTOM
falx I-SYMPTOM
with O
no O
shift B-SYMPTOM
. O

CT O
of O
the O
C O
spine O
was O
negative O
and O
her O
cervical O
spine O
was O
cleared O
. O

HOSPITAL O
COURSE O
: O

She O
was O
admitted O
to O
the O
ICU O
for O
close O
neurosurgical O
and O
neurological O
observation O
. O

She O
remained O
neurologically O
stable O
. O

Repeat O
head O
CT O
showed O
stable B-SYMPTOM
bleed I-SYMPTOM
. O

The O
patient O
was O
transferred O
to O
the O
regular O
floor O
. O

She O
was O
out O
of O
bed O
ambulating O
, O
tolerating O
a O
regular O
diet O
, O
voiding O
spontaneously O
. O

She O
will O
be O
discharged O
to O
home O
with O
followup O
with O
Dr. O
Wilson O
in O
two O
weeks O
with O
a O
repeat O
head O
CT O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Levofloxacin B-TREATMENT
250 O
mg O
p.o. O
q.24h. O
x3 O
days O
. O

2. O
Dilantin B-TREATMENT
100 O
mg O
p.o. O
t.i.d. O

3. O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

4. O
Timoptic B-TREATMENT
0.25 O
one O
drop O
O.U. O
b.i.d. O

5. O
Lantoprost B-TREATMENT
0.005 O
ophthalmic O
solution O
one O
drop O
O.U. O
q.h.s. O

6. O
Zantac B-TREATMENT
150 O
mg O
p.o. O
b.i.d. O

7. O
Insulin-sliding B-TREATMENT
scale I-TREATMENT
as O
well O
as O
40 O
units O
of O
Humalog B-TREATMENT
in O
the O
a.m. O
and O
20 O
at O
night O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

FOLLOW-UP O
INSTRUCTIONS O
: O

She O
will O
follow O
up O
with O
Dr. O
Perez O
in O
two O
weeks O
with O
repeat O
head O
CT O
. O

Danvers O
T O
Sharp O
, O
M.D. O

16-530 O

Dictated O
By O
: O
David O
GA O
Crane O
, O
M.D. O

MEDQUIST36 O

D O
: O
2012-04-30 O
11:30 O

T O
: O
2012-05-01 O
08:13 O

JOB O
#: O
10027 O

Signed O
electronically O
by O
: O
DR. O
Margarita O
Martin O
on O
: O
TUE O
2012-06-05 O
8:08 O
AM O

( O
End O
of O
Report O
) O

478767824 O

OMH O

1644158 O

248222 O

4/27/1998 O
12:00:00 O
AM O

ADULT B-SYMPTOM
RESPIRATORY I-SYMPTOM
DISTRESS I-SYMPTOM
SYNDROME I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

WYNDEALB O
, O
AUALE O

UNIT O
NUMBER O
: O

309-82-41 O

ADMISSION O
DATE O
: O

04/27/1998 O

DISCHARGE O
DATE O
: O

05/02/1998 O

PRINCIPAL O
DIAGNOSIS O
: O

adult B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

acute B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
72 O
year O
old O
white O
male O
with O
a O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
a B-TREATMENT
four I-TREATMENT
vessel I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
in O
1983 O
, O
pulmonary B-SYMPTOM
hypertension I-SYMPTOM
, O
hepatitis B-SYMPTOM
C I-SYMPTOM
positive O
cirrhosis B-SYMPTOM
history O
with O
history O
of O
portal B-SYMPTOM
hypertension I-SYMPTOM
and O
status O
post O
an B-SYMPTOM
upper I-SYMPTOM
gastrointestinal I-SYMPTOM
bleed I-SYMPTOM
on O
4-10-98 O
, O
who O
presents O
from O
Sondi O
Memorial O
for O
work O
up O
of O
pulmonary B-SYMPTOM
infiltrates I-SYMPTOM
, O
acute B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
and O
pulmonary B-SYMPTOM
hypertension I-SYMPTOM
. O

The O
patient O
presented O
to O
Sondi O
Memorial O
on O
4-10-98 O
with O
fatigue B-SYMPTOM
and O
fall O
, O
found O
to O
have O
a O
hematocrit O
of O
29 O
, O
baseline O
37 O
. O

The O
patient O
was O
transfused O
two B-TREATMENT
units I-TREATMENT
and O
an O
esophagogastroduodenoscopy O
done O
where O
it O
showed O
gastritis B-SYMPTOM
, O
candidal B-SYMPTOM
esophagitis I-SYMPTOM
and O
portal B-SYMPTOM
hypertensive I-SYMPTOM
gastropathy I-SYMPTOM
without O
varices B-SYMPTOM
. O

A O
colonoscopy O
showed O
anteriordysplasia B-SYMPTOM
, O
no O
bleeding B-SYMPTOM
was O
seen O
. O

The O
patient O
was O
discharged O
after O
one O
week O
on O
iron B-TREATMENT
sulfate I-TREATMENT
. O

On O
4-24 O
, O
the O
patient O
was O
seen O
again O
at O
Sondi O
Memorial O
when O
he O
experienced O
at O
home O
a O
fall O
, O
no O
loss B-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
, O
positive O
substernal B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
, O
pleuritic B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
cough B-SYMPTOM
. O

He O
went O
to O
Sondi O
Memorial O
where O
he O
ruled O
out O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
and O
was O
found O
to O
have O
a B-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
infiltrate I-SYMPTOM
/ O
pneumonia B-SYMPTOM
, O
started O
on O
cefuroxime B-TREATMENT
. O

His O
respiratory O
condition O
continued O
to O
deteriorate O
despite O
aggressive B-TREATMENT
chest I-TREATMENT
physical I-TREATMENT
therapy I-TREATMENT
for O
possible O
blood O
, O
given O
Lasix B-TREATMENT
for O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
became O
hypotensive B-SYMPTOM
, O
hypoxic B-SYMPTOM
and O
intubated B-TREATMENT
. O

The O
patient O
was O
found O
to O
have O
expanding B-SYMPTOM
pulmonary I-SYMPTOM
infiltrates I-SYMPTOM
on O
chest O
x-ray O
, O
developed O
acute B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
with O
minimal B-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
, O
less O
than O
10 O
cc O
an O
hour O
, O
started O
on O
dopamine B-TREATMENT
for O
hemodynamic B-SYMPTOM
instability I-SYMPTOM
. O

An O
echocardiogram O
was O
obtained O
on O
4-26 O
which O
showed O
concentric B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
with O
normal O
_____ O
left O
ventricular O
function O
, O
severe B-SYMPTOM
right I-SYMPTOM
ventricular I-SYMPTOM
dilatation I-SYMPTOM
with O
septal B-SYMPTOM
hypokinesis I-SYMPTOM
and I-SYMPTOM
flattening I-SYMPTOM
with O
a O
question O
of O
right B-SYMPTOM
ventricular I-SYMPTOM
apical I-SYMPTOM
clot I-SYMPTOM
raised O
with O
mild B-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM
, O
severe B-SYMPTOM
tricuspid I-SYMPTOM
regurgitation I-SYMPTOM
and O
increased B-SYMPTOM
pulmonary I-SYMPTOM
artery I-SYMPTOM
pressure I-SYMPTOM
of O
approximately O
70 O
millimeters O
, O
consistent O
with O
fairly B-SYMPTOM
severe I-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
. O

Blood O
cultures O
x O
two O
sent O
off O
with O
no O
growth B-SYMPTOM
. O

The O
patient O
ruled O
out O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
with O
flat O
creatine O
kinases O
and O
he O
was O
sent O
to O
Oaksgekesser/ O
Memorial O
Hospital O
for O
further O
work O
up O
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

At O
the O
Oaksgekesser/ O
Memorial O
Hospital O
he O
was O
quite B-SYMPTOM
hypotensive I-SYMPTOM
, O
requiring O
dopamine B-TREATMENT
at O
1,000 O
, O
Levo B-TREATMENT
at O
12 O
. O

His O
chest O
x-ray O
showed O
diffuse B-SYMPTOM
patchy I-SYMPTOM
infiltrates I-SYMPTOM
on I-SYMPTOM
left I-SYMPTOM
lung I-SYMPTOM
with O
left B-SYMPTOM
upper I-SYMPTOM
lung I-SYMPTOM
patchy I-SYMPTOM
infiltrates I-SYMPTOM
and O
right B-SYMPTOM
hemidiaphragm I-SYMPTOM
elevated I-SYMPTOM
, O
consistent O
with O
adult B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
from O
possible O
pneumonia B-SYMPTOM
. O

A O
urinalysis O
was O
obtained O
which O
showed O
blood B-SYMPTOM
, O
urine B-SYMPTOM
sediment I-SYMPTOM
was O
active B-SYMPTOM
with O
positive O
dysmorphic B-SYMPTOM
cells I-SYMPTOM
, O
red B-SYMPTOM
cell I-SYMPTOM
casts I-SYMPTOM
, O
and O
1+ B-SYMPTOM
albumin I-SYMPTOM
with O
mild B-SYMPTOM
protein I-SYMPTOM
uria I-SYMPTOM
. O

The O
patient O
had O
ANCA O
, O
anti-GBM O
, O
anti-streptolycin O
, O
ANA O
, O
UPEP O
, O
SPEP O
, O
renal O
ultrasound O
, O
hepatitis O
C O
cryoglobulin O
sent O
out O
. O

He O
had O
a O
bronchoscopy O
immediately O
done O
which O
showed O
no O
fresh B-SYMPTOM
blood I-SYMPTOM
, O
just O
old B-SYMPTOM
clot I-SYMPTOM
and O
a B-TREATMENT
pulmonary I-TREATMENT
arterial I-TREATMENT
line I-TREATMENT
placed O
in O
the O
right O
internal O
jugular O
vein O
. O

Question O
of O
pulmonary-renal B-SYMPTOM
syndrome I-SYMPTOM
was O
raised O
. O

The O
patient O
subsequently O
deteriorated O
over O
time O
, O
was O
started O
on O
CVVH B-TREATMENT
and O
suffered O
significant B-SYMPTOM
complications I-SYMPTOM
without O
improvement O
of O
his O
pulmonary O
/ O
renal O
situation O
. O

A O
family O
meeting O
was O
held O
on O
5-2-98 O
and O
it O
was O
decided O
that O
the O
patient O
should O
be O
made O
comfort B-TREATMENT
care I-TREATMENT
only O
. O

All O
CVVH B-TREATMENT
and O
the B-TREATMENT
ventilator I-TREATMENT
was O
removed O
and O
the O
patient O
spontaneously O
passed O
away O
on O
5-2-98 O
, O
at O
4:55 O
p.m. O

Family O
and O
primary O
carephysician O
informed O
. O

________________________ O
SONRIELA O
RED O
, O
M.D. O

TR O
: O

xbr O

DD O
: O

07/12/1998 O

TD O
: O

07/27/1998 O
12:36 O

Pcc O
: O

Admission O
Date O
: O

2012-03-23 O

Discharge O
Date O
: O

2012-03-26 O

Date O
of O
Birth O
: O

1972-06-27 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
George O
XL O
Patrick O
, O
M.D. O

Chief O
Complaint O
: O

mental B-SYMPTOM
status I-SYMPTOM
change I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

intubation B-TREATMENT

History O
of O
Present O
Illness O
: O

39 O
year O
old O
male O
w/ O
h/o O
low B-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
on O
chronic B-TREATMENT
narcotics I-TREATMENT
presents O
after O
being O
found O
unresponsive B-SYMPTOM
at O
home O
. O

His O
daughter O
awoke O
him O
at O
7 O
a.m. O
, O
reports O
he O
said O
he O
felt O
" O
cold B-SYMPTOM
and O
shivery B-SYMPTOM
," O
vomited O
several O
times O
, O
then O
drove O
her O
to O
school O
. O

According O
to O
his O
wife O
, O
he O
came O
home O
and O
went O
to O
sleep O
. O

When O
she O
tried O
to O
awaken O
him O
at O
11 O
a.m. O
, O
she O
was O
unable O
to O
do O
so O
and O
called O
EMS O
. O

She O
did O
not O
notice O
any B-SYMPTOM
blood I-SYMPTOM
/ I-SYMPTOM
urine I-SYMPTOM
/ I-SYMPTOM
emesis I-SYMPTOM
/ I-SYMPTOM
stool I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
bed I-SYMPTOM
. O

EMS O
found O
him O
with O
agonal B-SYMPTOM
respirations I-SYMPTOM
and O
pinpoint B-SYMPTOM
pupils I-SYMPTOM
. O

FS O
420 O
. O

He O
received O
1 O
mg O
IV B-TREATMENT
Narcan I-TREATMENT
( O
numerous O
bottles O
of O
oxycontin B-TREATMENT
, O
percocet B-TREATMENT
were O
found O
in O
room O
); O
his O
pupils O
dilated O
to O
~ O
8 O
mm O
and O
he O
became O
combative B-SYMPTOM
/ O
agitated B-SYMPTOM
. O

He O
was O
then O
intubated O
for O
airway B-TREATMENT
protection I-TREATMENT
( O
etomidate B-TREATMENT
/ O
succinate B-TREATMENT
); O
it O
was O
a B-TREATMENT
traumatic I-TREATMENT
intubation I-TREATMENT

and O
one O
of O
his O
teeth O
was O
chipped O
. O

He O
was O
transported O
to O
Hallmark O
Health O
System O
Monica O
, O
where O
ABG O
7.14/82/44 O
while O
bagging O
on O
100% B-TREATMENT
FiO2 I-TREATMENT
. O

Wife O
reports O
that O
he O
drank O
a O
large O
amt O
of O
alcohol O
( O
12 O
bottles O
of O
beer O
) O
night O
PTA O
. O

For O
2 O
days O
PTA O
, O
he O
has O
expressed O
a O
wish O
to O
kill O
himself O
( O
no O
clear O
plan O
, O
but O
fixing O
things O
around O
the O
house O
" O
so O
things O
will O
be O
ready O
when O
I O
'm O
gone O
"). O

In O
Monica O
, O
pt O
received O
charcoal B-TREATMENT
, O
500 O
mg O
IV B-TREATMENT
levofloxacin I-TREATMENT
, O
500 O
mg O
IV B-TREATMENT
metronidazole I-TREATMENT
for O
presumed O
aspiration B-SYMPTOM
pna I-SYMPTOM
. O

Past O
Medical O
History O
: O

chronic B-SYMPTOM
LBP I-SYMPTOM
, O
HTN B-SYMPTOM
, O
anxiety B-SYMPTOM
, O
depression B-SYMPTOM
, O
L B-TREATMENT
arm I-TREATMENT
surgeries I-TREATMENT
( O
hardware B-TREATMENT
in O
place O
) O

Social O
History O
: O

lives O
with O
wife O
and O
daughters O
. O

On O
disability O
secondary O
to O
work-related B-SYMPTOM
back I-SYMPTOM
injury I-SYMPTOM
. O

Heavy O
EtOH O
( O
12 O
beers O
several O
times O
a O
week O
). O

Smokes O
~ O
1 O
pk O
/ O
week O
. O

No O
other O
known O
drug O
use O
other O
than O
Oxycontin B-TREATMENT
/ O
percocet B-TREATMENT
. O

Family O
History O
: O

No O
family O
history O
of O
heart B-SYMPTOM
disease I-SYMPTOM
or O
cancer B-SYMPTOM

Physical O
Exam O
: O

PE O
: O
Tc O
98.7 O
, O
pc O
88 O
, O
bpc O
120/60 O
, O
AC O
600/20 O
, O
FiO2 O
100% O
, O
PEEP O
10 O

Gen O
: O
young O
male O
, O
intubated B-TREATMENT
, O
sedated B-TREATMENT
, O
in O
hard B-TREATMENT
collar I-TREATMENT
. O

HEENT O
: O
Pupils B-SYMPTOM
pinpoint I-SYMPTOM
, O
equal O
, O
anicteric B-SYMPTOM
, O
normal O
conjunctiva O
, O
intubated B-TREATMENT
, O
OGT B-TREATMENT
in O
place O
, O
OMMM O
, O
normocephalic O
, O
atraumatic B-SYMPTOM

Cardiac O
: O
RRR O
, O
I/VI B-SYMPTOM
SM I-SYMPTOM
at I-SYMPTOM
apex I-SYMPTOM
, O
no O
R/G B-SYMPTOM
appreciated O

Pulm O
: O
coarse B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
throughout I-SYMPTOM

Abd O
: O
mildly B-SYMPTOM
distended I-SYMPTOM
, O
hypoactive B-SYMPTOM
BS I-SYMPTOM
, O
soft O
, O
no O
HSM B-SYMPTOM

Ext O
: O
trace B-SYMPTOM
LE I-SYMPTOM
edema I-SYMPTOM
at I-SYMPTOM
ankles I-SYMPTOM
, O
extremities B-SYMPTOM
cool I-SYMPTOM
w/ O
2+ O
radial O
, O
1+ O
DP/PT O
pulses O
. O

Well-healed B-SYMPTOM
scars I-SYMPTOM
over I-SYMPTOM
dorsal I-SYMPTOM
/ I-SYMPTOM
lateral I-SYMPTOM
distal I-SYMPTOM
LUE I-SYMPTOM

Neuro O
: O
DTR O
3+ O
upper O
and O
lower O
extremities O
, O
symmetric O
bilaterally O
. O

Toes O
equivocal O
bilaterally O
. O

(+) O
gag O

Pertinent O
Results O
: O

EKG O
NSR O
@ O
92 O
bpm O
, O
nl O
axis O
, O
borderline B-SYMPTOM
QT I-SYMPTOM
( O
QTc O
0.442 O
), O
J B-SYMPTOM
Pt I-SYMPTOM
elevtation I-SYMPTOM
V3 O
, O
TWF O
II O
, O
III O
, O
avF O
, O
I O
, O
avL O
( O
no O
prior O
EKG O
for O
comparison O
) O

2012-03-23 O
03:39 O
PM O

TYPE O
- O
ART O
PO2 O
- O
122 O
* O
PCO2 O
- O
38 O
PH O
- O
7.43 O
TOTAL O
CO2 O
- O
26 O
BASE O
XS O
- O
1 O

2012-03-23 O
03:39 O
PM O

LACTATE O
- O
2.0 O

2012-03-23 O
01:30 O
PM O
URINE O

HOURS O
- O
RANDOM O

2012-03-23 O
01:30 O
PM O
URINE O

bnzodzpn O
- O
POS B-SYMPTOM
barbitrt O
- O
NEG O
opiates O
- O
NEG O
cocaine O
- O
NEG O
amphetmn O
- O
NEG O
mthdone O
- O
NEG O

2012-03-23 O
01:30 O
PM O
URINE O

COLOR O
- O
Straw O
APPEAR O
- O
Clear O
SP O
Barajas O
- O
1.015 O

2012-03-23 O
01:30 O
PM O
URINE O

BLOOD O
- O
SM O
NITRITE O
- O
NEG O
PROTEIN O
- O
30 O
GLUCOSE O
- O
1000 O
KETONE O
- O
NEG O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
NEG O
PH O
- O
6.0 O
LEUK O
- O
NEG O

2012-03-23 O
01:30 O
PM O
URINE O

RBC O
- O
03-10 O
* O
WBC O
- O
0-2 O
BACTERIA O
- O
FEW B-SYMPTOM
YEAST O
- O
NONE O
EPI O
- O
0 O

2012-03-23 O
01:30 O
PM O
URINE O

MUCOUS O
- O
FEW O

2012-03-23 O
12:22 O
PM O

PO2 O
- O
44 O
* O
PCO2 O
- O
82 O
* O
PH O
- O
7.14 O
* O
TOTAL O
CO2 O
- O
30 O
BASE O
XS O
-- O
4 O

2012-03-23 O
12:22 O
PM O

GLUCOSE O
- O
296 O
* O
LACTATE O
- O
4.8 O
* O
NA+ O
- O
140 O
K+ O
- O
5.2 O
CL O
-- O
101 O

2012-03-23 O
12:20 O
PM O

UREA O
N O
- O
20 O
CREAT O
- O
1.1 O

2012-03-23 O
12:20 O
PM O

ALT(SGPT) O
- O
30 O
AST(SGOT) O
- O
38 O
LD(LDH) O
- O
217 O
CK(CPK) O
- O
1152 O
* O
ALK O
PHOS O
- O
52 O
AMYLASE O
- O
426 O
* O
TOT O
BILI O
- O
0.4 O

2012-03-23 O
12:20 O
PM O

LIPASE O
- O
22 O

2012-03-23 O
12:20 O
PM O

CK-MB O
- O
45 O
* O
MB O
INDX O
- O
3.9 O
cTropnT O
-< O
0.01 O

2012-03-23 O
12:20 O
PM O

ALBUMIN O
- O
4.4 O

2012-03-23 O
12:20 O
PM O

ASA O
- O
NEG O
ETHANOL O
- O
NEG O
ACETMNPHN O
- O
NEG O
bnzodzpn O
- O
NEG O
barbitrt O
- O
NEG O
tricyclic O
- O
NEG O

2012-03-23 O
12:20 O
PM O

WBC O
- O
8.9 O
RBC O
- O
3.93 O
* O
HGB O
- O
12.1 O
* O
HCT O
- O
36.7 O
* O
MCV O
- O
93 O
MCH O
- O
30.8 O
MCHC O
- O
33.0 O
RDW O
- O
13.0 O

2012-03-23 O
12:20 O
PM O

NEUTS O
- O
84.7 O
* O
LYMPHS O
- O
13.1 O
* O
MONOS O
- O
1.5 O
* O
EOS O
- O
0.3 O
BASOS O
- O
0.4 O

2012-03-23 O
12:20 O
PM O

PLT O
COUNT O
- O
227 O

2012-03-23 O
12:20 O
PM O

PT O
- O
14.1 O
* O
PTT O
- O
21.0 O
* O
INR(PT) O
- O
1.2 O

2012-03-23 O
12:20 O
PM O

FIBRINOGE O
- O
375 O

2012-03-26 O
04:30 O
AM O
BLOOD O
WBC O
- O
6.9 O
RBC O
- O
3.28 O
* O
Hgb O
- O
9.8 O
* O
Hct O
- O
29.0 O
* O
MCV O
- O
89 O
MCH O
- O
29.7 O
MCHC O
- O
33.6 O
RDW O
- O
13.1 O
Plt O
Ct O
- O
206 O

2012-03-26 O
04:30 O
AM O
BLOOD O
Plt O
Ct O
- O
206 O

2012-03-26 O
04:30 O
AM O
BLOOD O
Glucose O
- O
88 O
UreaN O
- O
10 O
Creat O
- O
0.7 O
Na O
- O
143 O
K-3.6 O
Cl O
- O
108 O
HCO3 O
- O
28 O
AnGap O
- O
11 O

2012-03-26 O
04:30 O
AM O
BLOOD O
Calcium O
- O
8.5 O
Phos O
- O
3.1 O
Mg O
- O
1.9 O

2012-03-25 O
04:00 O
AM O
BLOOD O
calTIBC O
- O
237 O
* O
Ferritn O
- O
534 O
* O
TRF O
- O
182 O
* O

Brief O
Hospital O
Course O
: O

A O
: O
39 O
year O
old O
male O
w/ O
HTN B-SYMPTOM
, O
chronic B-SYMPTOM
LBP I-SYMPTOM
on O
narcotics B-TREATMENT
presents O
after O
being O
found O
unresponsive B-SYMPTOM
at O
home O
. O

P O
: O

1) O
Unresponsiveness B-SYMPTOM
: O
This O
is O
likely O
due O
todrug B-SYMPTOM
overdose I-SYMPTOM
( O
known O
oxycontin B-TREATMENT
use O
, O
(+) B-SYMPTOM
BNZ I-SYMPTOM
on O
tox O
screen O
). O

Ddx O
: O
cardiac B-SYMPTOM
ischemia I-SYMPTOM
( O
no O
ischemic B-SYMPTOM
EKG I-SYMPTOM
changes I-SYMPTOM
noted O
), O
seizure B-SYMPTOM
w/ O
post-ictal B-SYMPTOM
state I-SYMPTOM
, O
CVA B-SYMPTOM
( O
head O
CT O
neg O
). O

His O
cardiac O
enzymes O
include O
only O
elevated B-SYMPTOM
CK I-SYMPTOM
, O
but O
not O
Shaffer O
, O
Juan O
he O
ruled O
out O
for O
MI B-SYMPTOM
. O

His O
mental O
status O
gradually O
improved O
from O
03-23 O
to O
03-24 O
. O

He O
was O
able O
to O
communicate O
appropriately O
as O
his O
level O
of O
narcotic B-TREATMENT
medications I-TREATMENT
waned O
in O
his O
blood O
. O

He O
was O
able O
to O
maintain O
a O
stable O
mental O
level O
for O
extubation B-TREATMENT
on O
03-24 O
. O

As O
of O
3/21 O
, O
he O
was O
alert O
, O
appropriate O
and O
answers O
questions O
and O
follows O
command O
on O
exam O
. O

2) O
Pulmonary B-SYMPTOM
infiltrates I-SYMPTOM
: O
THere O
was O
initially O
concern O
that O
he O
was O
developing O
ARDS B-SYMPTOM
from O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
in O
the O
setting O
of O
being O
found O
unconscious B-SYMPTOM
. O

He O
was O
intubated O
and O
was O
on O
mechanical B-TREATMENT
ventilation I-TREATMENT
from O
9/13-10/11 O
, O
but O
he O
was O
started O
on O
levofloxacin B-TREATMENT

and O
flagyl B-TREATMENT
for O
total O
of O
4 O
days O
. O

ON O
03-26 O
, O
his B-TREATMENT
antibiotics I-TREATMENT
were O
started O
as O
this O
most O
likely O
represent O
a B-SYMPTOM
transiet I-SYMPTOM
aspiration I-SYMPTOM
episode I-SYMPTOM
and O
not O
ARDS B-SYMPTOM
. O

3) O
Airway B-TREATMENT
protection I-TREATMENT
: O
He O
was O
intubated B-TREATMENT
in O
the O
field O
for O
airway B-TREATMENT
protection I-TREATMENT

He O
was O
extubated B-TREATMENT
on O
03-24 O
and O
was O
weaned O
off O
oxygen B-TREATMENT
slowly O
from O
03-24 O
to O
03-26 O
without O
significant O
event O
. O

4) O
Hypertension B-SYMPTOM
: O
He O
was O
restarted O
on O
his B-TREATMENT
atenolol I-TREATMENT
and O
verapamil B-TREATMENT
once O
his O
blood O
pressure O
stabilized O
on O
03-25 O
. O

5) O
Depression B-SYMPTOM
: O
He O
was O
restarted O
on O
his B-TREATMENT
paxil I-TREATMENT
on O
03-25 O
and O
was O
given B-TREATMENT
1:1 I-TREATMENT
sitter I-TREATMENT
for O
suicidal B-SYMPTOM
ideation I-SYMPTOM
leading O
up O
to O
his O
suicide O
leading O
up O
to O
this O
admission O
. O

He O
has O
not O
had O
further B-SYMPTOM
episodes I-SYMPTOM
while O
he O
was O
in O
the O
hospital O
. O

- O
plan O
to O
restart O
Paxil B-TREATMENT
when O
taking O
PO O

6) O
Hyperglycemia B-SYMPTOM
: O
Although O
he O
has O
no O
known O
history O
of O
diabetes B-SYMPTOM
, O
his B-SYMPTOM
elevated I-SYMPTOM
FS I-SYMPTOM
noted O
in O
field O
with O
glycosuria B-SYMPTOM
prompted O
fingerstick O
check O
but O
he O
has O
not O
required O
insulin B-TREATMENT
coverage I-TREATMENT
. O

7) O
High B-SYMPTOM
amylase I-SYMPTOM
: O
He O
was O
admitted O
on O
03-23 O
with O
elevated B-SYMPTOM
amylase I-SYMPTOM
but O
non-elevated B-SYMPTOM
lipase I-SYMPTOM
. O

This O
likely O
is O
not O
concerning O
of O
pancreatic O
process O
. O

His O
amylase O
trended O
down O
. O

He O
was O
restarted O
on O
regular O
diet O
on O
4/14-4/17 O
after O
his B-TREATMENT
extubation I-TREATMENT

8) O
Anemia B-SYMPTOM
- O
He O
was O
admitted O
with O
borderline B-SYMPTOM
anemia I-SYMPTOM
with O
Fe O
studies O
suggestive O
of O
anemia B-SYMPTOM
of I-SYMPTOM
chronic I-SYMPTOM
disease I-SYMPTOM
and O
his O
hct O
decreased O
in O
the O
setting O
fluid B-TREATMENT
resucitation I-TREATMENT
. O

His O
hct O
has O
stabilized O
and O
improved O
to O
close O
to O
30 O
at O
the O
time O
of O
3/21 O
. O

He O
reports O
that O
his O
primary O
physician O
is O
aware O
of O
his B-SYMPTOM
anemia I-SYMPTOM
and O
was O
in O
the O
process O
of O
followup O
. O

Medications O
on O
Admission O
: O

Oxycontin B-TREATMENT

Percocet B-TREATMENT

Paxil B-TREATMENT

Gabapentin B-TREATMENT

Atenolol B-TREATMENT

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

benzodiazipine B-SYMPTOM
overdose I-SYMPTOM

Discharge O
Condition O
: O

stable O

Discharge O
Instructions O
: O

please O
take O
your B-TREATMENT
medications I-TREATMENT
and O
call O
your O
doctor O
if O
you O
experience O
chest B-SYMPTOM
pain I-SYMPTOM
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
or O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
any B-SYMPTOM
thoughts I-SYMPTOM
of I-SYMPTOM
hurting I-SYMPTOM
yourself I-SYMPTOM
or I-SYMPTOM
anyone I-SYMPTOM
else I-SYMPTOM
. O

Followup O
Instructions O
: O

please O
call O
your O
primary O
doctor O
Edmund O
Starke O
once O
your O
are O
discharge O
from O
the O
hospital O

Clemmie O
Shawn O
MD O
65-948 O

Completed O
by O
: O
Michael O
Melvin O
Kinzer O
MD O
51-991 O
2012-03-26 O
@ O
1709 O

Signed O
electronically O
by O
: O
DR. O
Justin O
Pappas O
on: O
MON O
2012-05-07 O
4:52 O
PM O

( O
End O
of O
Report O
) O

534644131 O

FIH O

9393835 O

24529/65a4 O

204379 O

4/28/1993 O
12:00:00 O
AM O

RIGHT B-SYMPTOM
THYROID I-SYMPTOM
PAPILLARY I-SYMPTOM
CARCINOMA I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

4/28/93 O

DISCHARGE O
DATE O
: O

5/15/93 O

PRINCIPAL O
DIAGNOSIS O
: O

Right B-SYMPTOM
thyroid I-SYMPTOM
papillary I-SYMPTOM
carcinoma I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

1. O
Pulmonary B-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
iliac I-SYMPTOM
bone I-SYMPTOM
metastases I-SYMPTOM
. O

2. O
Eosinophilia B-SYMPTOM
. O

3. O
Chronic B-SYMPTOM
leg I-SYMPTOM
edema I-SYMPTOM
. O

4. O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

5. O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

6. O
Left B-SYMPTOM
subclavian I-SYMPTOM
vein I-SYMPTOM
thrombosis I-SYMPTOM
. O

7. O
Urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
74 O
year O
old O
female O
with O
metastatic B-SYMPTOM
papillary I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
thyroid I-SYMPTOM
who O
presented O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
on O
4/28/93 O
with O
progressive B-SYMPTOM
weakness I-SYMPTOM
, O
weight B-SYMPTOM
loss I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

The O
patient O
was O
in O
a O
good O
state O
of O
health O
until O
January O
of O
1993 O
when O
she O
developed O
a B-SYMPTOM
serious I-SYMPTOM
upper I-SYMPTOM
respiratory I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
associated O
with O
weakness B-SYMPTOM
and O
fatigue B-SYMPTOM
. O

She O
had O
also O
reported O
a B-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
of I-SYMPTOM
15 I-SYMPTOM
pounds I-SYMPTOM
over O
the O
past O
two O
months O
. O

Although O
her B-SYMPTOM
upper I-SYMPTOM
respiratory I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
seemed O
to O
be O
resolving O
, O
her B-SYMPTOM
weakness I-SYMPTOM
persisted O
. O

A O
work O
up O
begun O
by O
her O
internist O
, O
Dr. O
Brain O
, O
revealed O
a O
white O
blood O
cell O
count O
of O
49,000 O
with O
50% O
eosinophils O
. O

She O
was O
admitted O
to O
Box O
Memorial O
Hospital O
Nursing O
Home O
for O
further O
evaluation O
. O

Data O
collected O
there O
included O
a O
chest O
x-ray O
which O
was O
unremarkable O
. O

The O
liver O
function O
tests O
showed O
an O
alkaline O
phosphatase O
of O
303 O
, O
LDH O
310 O
, O
SGOT O
66 O
, O
albumin O
2.5 O
. O

A O
peripheral O
blood O
smear O
showed O
mature O
eosinophils O
in O
increased B-SYMPTOM
numbers I-SYMPTOM
. O

Chromosomal O
studies O
were O
negative O
. O

A O
bone O
scan O
showed O
increased B-SYMPTOM
uptake I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
manubrium I-SYMPTOM
at O
the O
site O
of O
an B-SYMPTOM
old I-SYMPTOM
fracture I-SYMPTOM
, O
as O
well O
as O
in O
the O
right O
supraclavicular O
area O
. O

A O
thyroid O
ultrasound O
showed O
an B-SYMPTOM
inferior I-SYMPTOM
thyroid I-SYMPTOM
mass I-SYMPTOM
. O

This O
was O
followed O
by O
an O
abdominal O
CT O
which O
showed O
an B-SYMPTOM
enlarged I-SYMPTOM
spleen I-SYMPTOM
, O
a B-SYMPTOM
lytic I-SYMPTOM
lesion I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
iliac I-SYMPTOM
bone I-SYMPTOM
and O
a B-SYMPTOM
benign I-SYMPTOM
renal I-SYMPTOM
cyst I-SYMPTOM
. O

Biopsy O
of O
the O
lytic O
lesion O
was O
consistent O
with O
metastases B-SYMPTOM
papillary I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
thyroid I-SYMPTOM
. O

An O
upper O
gastrointestinal O
was O
unremarkable O
. O

The O
small O
bowel O
follow O
through O
was O
within O
normal O
limits O
. O

A O
thyroid O
scan O
revealed O
decreased B-SYMPTOM
function I-SYMPTOM
and O
displacement B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
thyroid I-SYMPTOM
by O
a B-SYMPTOM
cold I-SYMPTOM
mass I-SYMPTOM
located O
inferiorly O
with O
calcifications B-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
side I-SYMPTOM
. O

A O
chest O
CT O
also O
revealed O
a B-SYMPTOM
small I-SYMPTOM
pulmonary I-SYMPTOM
nodule I-SYMPTOM
with O
a B-SYMPTOM
necrotic I-SYMPTOM
mass I-SYMPTOM
involving O
the O
right O
lung O
posteriorly O
. O

The O
patient O
was O
subsequently O
referred O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
under O
the O
service O
of O
Dr. O
Brain O
. O

She O
continued O
to O
have O
profound B-SYMPTOM
weakness I-SYMPTOM
, O
a B-SYMPTOM
decreased I-SYMPTOM
appetite I-SYMPTOM
and O
weight B-SYMPTOM
loss I-SYMPTOM
. O

She O
also O
developed O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
as O
well O
as O
left B-SYMPTOM
upper I-SYMPTOM
extremity I-SYMPTOM
swelling I-SYMPTOM
associated O
with O
increased B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
on O
exertion O
. O

A O
needle O
biopsy O
of O
the O
right O
thyroid O
nodule O
showed O
papillary B-SYMPTOM
thyroid I-SYMPTOM
carcinoma I-SYMPTOM
. O

The O
patient O
reports O
no O
history O
of O
radiation B-SYMPTOM
exposure I-SYMPTOM
, O
no O
family O
history O
of O
thyroid B-SYMPTOM
carcinoma I-SYMPTOM
, O
no O
recent O
travels O
or O
exposure B-SYMPTOM
to I-SYMPTOM
tuberculosis I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Includes O
a O
history O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
with O
good O
heart B-TREATMENT
rate I-TREATMENT
control I-TREATMENT
on O
Digoxin B-TREATMENT
. O

She O
reports O
no O
prior O
surgical O
history O
. O

The O
patient O
also O
reports O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergy I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
alone O
in O
Leschle O
Drive O
, O
Sonpo O
, O
and O
does O
not O
report O
a O
smoking O
or O
alcohol O
history O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Lanoxin B-TREATMENT
, O
0.25 O
mg O
po O
qd O
; O
Lasix B-TREATMENT
, O
20 O
mg O
po O
qd O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
is O
a O
pleasant O
, O
elderly O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Her O
vital O
signs O
showed O
a O
blood O
pressure O
of O
126/72 O
, O
pulse O
84 O
, O
respirations O
22 O
, O
temperature O
98.6 O
. O

She O
had O
a B-SYMPTOM
3 I-SYMPTOM
x I-SYMPTOM
4 I-SYMPTOM
cm I-SYMPTOM
firm I-SYMPTOM
, I-SYMPTOM
nontender I-SYMPTOM
right I-SYMPTOM
thyroid I-SYMPTOM
mass I-SYMPTOM
that O
seemed O
to O
be O
fixed O
to O
the O
trachea O
. O

She O
had O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
or O
bruits B-SYMPTOM
. O

The O
lungs O
exhibited O
right B-SYMPTOM
basilar I-SYMPTOM
dullness I-SYMPTOM
one O
quarter O
of O
the O
way O
up O
. O

She O
had O
no O
definite B-SYMPTOM
S3 I-SYMPTOM
. O

The O
liver O
edge O
was O
palpable O
to O
6 O
cm O
below O
the O
right O
costal O
margin O
. O

Her O
spleen O
could O
not O
be O
palpated O
. O

She O
had O
4+ B-SYMPTOM
edema I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
knees I-SYMPTOM
bilaterally I-SYMPTOM
. O

LABORATORY O
DATA O
: O

On O
admission O
the O
white O
blood O
count O
was O
67.3 O
with O
a O
differential O
of O
21% O
polys O
, O
16% O
bands O
, O
3% O
lymphocytes O
, O
2% O
monocytes O
, O
57% O
eosinophils O
and O
1% O
myelocytes O
. O

Her O
hematocrit O
was O
38.8 O
, O
hemoglobin O
13.7 O
, O
platelet O
count O
155,000 O
, O
PT O
12.7/10.1 O
, O
PTT O
33.9 O
, O
erythrocyte O
sedimentation O
rate O
18 O
, O
calcium O
7.5 O
, O
phosphorus O
3.5 O
, O
sodium O
136 O
, O
potassium O
3.7 O
, O
BUN O
15 O
, O
total O
protein O
5.9 O
, O
albumin O
2.3 O
, O
globulin O
3.6 O
, O
alkaline O
phosphatase O
379 O
, O
SGOT O
37 O
, O
Digoxin O
level O
0.7 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
Dr. O
Shatermivaet O
S O
Brain O
on O
4/28/93 O
with O
a O
history O
of O
papillary B-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
thyroid I-SYMPTOM
with O
bone B-SYMPTOM
involvement I-SYMPTOM
and O
possible O
lung B-SYMPTOM
involvement I-SYMPTOM
. O

Work O
up O
was O
begun O
for O
the O
possible O
myeloproliferative B-SYMPTOM
/ I-SYMPTOM
myelodysplastic I-SYMPTOM
disorder I-SYMPTOM
associated O
with O
the B-SYMPTOM
hyper-eosinophilic I-SYMPTOM
syndrome I-SYMPTOM
. O

Accordingly O
, O
an O
Oncology O
consult O
was O
called O
on O
4/29/93 O
and O
a O
bone O
marrow O
aspirate O
biopsy O
was O
performed O
. O

This O
revealed O
maturation O
of O
leukocytes O
to O
all O
stages O
with O
markedly B-SYMPTOM
increased I-SYMPTOM
eosinophilic I-SYMPTOM
proliferation I-SYMPTOM
. O

A O
lung O
biopsy O
was O
performed O
on O
4/30/93 O
without O
definitive O
results O
. O

During O
this O
time O
the O
patient O
&apos;s O
coagulation O
status O
had O
improved O
with O
Vitamin B-TREATMENT
K I-TREATMENT
therapy I-TREATMENT
with O
PTs O
normalizing O
. O

ANCA O
serum O
results O
were O
negative O
. O

ANA O
results O
were O
also O
nonsuggestive O
. O

The O
patient O
continued O
to O
suffer O
from O
edema B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
extremity I-SYMPTOM
and O
a O
Vascular O
Radiology O
consult O
revealed O
a B-SYMPTOM
thrombosis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
subclavian I-SYMPTOM
vein I-SYMPTOM
extending O
into O
the O
axillary O
vein O
. O

There O
was O
some B-SYMPTOM
thrombosis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
internal I-SYMPTOM
jugular I-SYMPTOM
vein I-SYMPTOM
as O
well O
. O

A O
head O
CT O
was O
performed O
and O
was O
completely O
negative O
for O
any B-SYMPTOM
metastatic I-SYMPTOM
process I-SYMPTOM
involving O
the O
brain O
. O

Thus O
, O
a B-TREATMENT
heparin I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
was O
begun O
. O

Meanwhile O
, O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
eosinophilia I-SYMPTOM
was O
treated O
with O
a B-TREATMENT
trial I-TREATMENT
of I-TREATMENT
prednisone I-TREATMENT
. O

She O
also O
developed O
a B-SYMPTOM
mild I-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
which O
responded O
to O
Bactrim B-TREATMENT
, O
but O
which O
was O
subsequently O
stopped O
because O
of O
diarrhea B-SYMPTOM
. O

The O
conclusions O
at O
this O
time O
of O
the O
thyroid O
cytologist O
, O
as O
well O
as O
the O
bone O
pathologist O
, O
were O
that O
the O
findings O
were O
diagnostic O
of O
papillary B-SYMPTOM
thyroid I-SYMPTOM
carcinoma I-SYMPTOM
with O
pulmonary B-SYMPTOM
metastases I-SYMPTOM
. O

Dr. O
Trial O
was O
subsequently O
consulted O
on O
5/5 O
for O
surgical B-TREATMENT
intervention I-TREATMENT
. O

On O
5/6/93 O
the O
patient O
underwent O
a B-TREATMENT
right I-TREATMENT
thyroidectomy I-TREATMENT
with O
sacrifice O
of O
the O
right O
recurrent O
laryngeal O
nerve O
as O
well O
as O
the O
right O
sternothyroid O
muscle O
and O
lower O
parathyroid O
gland O
. O

She O
underwent O
autotransplantation B-TREATMENT
of I-TREATMENT
the I-TREATMENT
right I-TREATMENT
upper I-TREATMENT
parathyroid I-TREATMENT
gland I-TREATMENT
, O
as O
well O
as O
repair B-TREATMENT
of O
a B-TREATMENT
right I-TREATMENT
posterior I-TREATMENT
membranous I-TREATMENT
tracheotomy I-TREATMENT
. O

She O
was O
received O
in O
the O
Respiratory O
Intensive O
Care O
Unit O
immediately O
postoperatively O
in O
stable O
condition O
. O

Her O
rate O
was O
well O
controlled O
on O
Digoxin B-TREATMENT
. O

The O
patient O
was O
transferred O
to O
the O
floor O
on O
5/7 O
. O

On O
the O
ward O
she O
continued O
a B-TREATMENT
gentle I-TREATMENT
diuresis I-TREATMENT
as O
well O
as O
Solu-Medrol B-TREATMENT
therapy I-TREATMENT
. O

Calcium O
levels O
remained O
7.2 O
to O
7.5 O
postoperatively O
. O

She O
continued O
to O
improve O
with O
a B-SYMPTOM
slight I-SYMPTOM
hoarseness I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
voice I-SYMPTOM
that O
was O
expected O
. O

She O
continued O
to O
exhibit O
asymptomatic B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
. O

Anticoagulation B-TREATMENT
was O
begun O
on O
the O
third O
postoperative O
day O
with O
Coumadin B-TREATMENT
. O

She O
was O
effectively B-TREATMENT
anticoagulated I-TREATMENT
with O
a O
PT O
in O
the O
range O
between O
15 O
and O
17 O
over O
a O
control O
of O
10 O
. O

She O
also O
received O
a O
Radiation O
Therapy O
consult O
for O
local B-TREATMENT
control I-TREATMENT
of O
her B-SYMPTOM
invasive I-SYMPTOM
carcinoma I-SYMPTOM
. O

She O
did O
well O
on O
the O
ward O
and O
was O
discharged O
on O
her O
ninth O
postoperative O
day O
. O

DISCHARGE O
DIAGNOSIS O
: O

Metastatic B-SYMPTOM
papillary I-SYMPTOM
thyroid I-SYMPTOM
carcinoma I-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Coumadin B-TREATMENT
, O
5 O
mg O
po O
alternating O
with O
2.5 O
mg O
po O
; O
prednisolone B-TREATMENT
, O
30 O
mg O
po O
bid O
; O
hydrochlorothiazide B-TREATMENT
, O
50 O
mg O
po O
bid O
; O
potassium B-TREATMENT
chloride I-TREATMENT
, O
40 O
mEq O
po O
bid O
; O
Augmentin B-TREATMENT
, O
500 O
mg O
po O
tid O
; O
Digoxin B-TREATMENT
, O
0.125 O
mg O
po O
qd O
; O
Tylenol B-TREATMENT
, O
650 O
mg O
po O
q4h O
prn O
; O
Carafate B-TREATMENT
, O
1 O
gram O
po O
bid O
; O
Synthroid B-TREATMENT
, O
0.125 O
mg O
po O
qd O
. O

DISPOSITION O
: O

The O
patient O
was O
discharged O
home O
with O
Terchestlumnesamp O
Medical O
Center O
referral O
for O
weekly O
blood O
tests O
, O
potassium O
and O
PT O
. O

The O
patient O
is O
also O
to O
keep O
her B-TREATMENT
left I-TREATMENT
arm I-TREATMENT
elevated I-TREATMENT
and O
to O
remain O
on O
a B-TREATMENT
low I-TREATMENT
sodium I-TREATMENT
diet I-TREATMENT
. O

She O
will O
be O
maintained O
on O
a O
PT O
between O
15 O
and O
17 O
with O
Coumadin B-TREATMENT
. O

Arrangements O
will O
be O
made O
for O
radiation B-TREATMENT
therapy I-TREATMENT
to I-TREATMENT
the I-TREATMENT
right I-TREATMENT
neck I-TREATMENT
and I-TREATMENT
right I-TREATMENT
iliac I-TREATMENT
crest I-TREATMENT
. O

The O
prognosis O
for O
rehabilitation O
potential O
is O
guarded O
. O

LENNI O
BRAIN O
, O
M.D. O

DICTATING O
FOR O
: O

ERTCA O
TRIAL O
, O
M.D. O

TR O
: O

ak O
/ O
bmot O

DD O
: O

05/15/93 O

TD O
: O

05/15/93 O

CC O
: O

Dr. O
Trial O
, O
Ertca O
Dirk O
, O
Dr. O
Lenni O
Brain O

062287942 O

PRGH O

14021094 O

430901 O

12/22/2000 O
12:00:00 O
AM O

SYNCOPE B-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

12/22/2000 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

01/01/2001 O

PRINCIPAL O
DIAGNOSES O
: O

1 O
) O
PRESYNCOPE B-SYMPTOM
. O

2 O
) O
DIZZINESS B-SYMPTOM
. O

SECONDARY O
DIAGNOSES O
: O

1 O
) O
IRON B-SYMPTOM
DEFICIENCY I-SYMPTOM
ANEMIA I-SYMPTOM
, O
COLONOSCOPY O
IN O
1990 O
FOLLOWED O
BY O
HEMATOLOGY O
ONCOLOGY O
THROUGH O
LYMPNANIER O
HEALTH O
SERVICES O
, O
DR. O
NUMBER O
. O

2 O
) O
HISTORY O
OF O
DIASTOLIC B-SYMPTOM
DYSFUNCTION I-SYMPTOM
WITH O
AN O
ECHOCARDIOGRAM O
IN O
February O
OF O
1998 O
DEMONSTRATING O
A O
NORMAL O
EJECTION O
FRACTION O
WITH O
LEFT B-SYMPTOM
VENTRICULAR I-SYMPTOM
HYPERTROPHY I-SYMPTOM
, O
STATUS O
POST O
ADMISSION O
AT O
LYMPNANIER O
HEALTH O
SERVICES O
IN O
January O
OF O
1999 O
FOR O
DIASTOLIC B-SYMPTOM
CONGESTIVE I-SYMPTOM
HEART I-SYMPTOM
FAILURE I-SYMPTOM
REQUIRING O
AN O
ADMISSION O
TO O
THE O
CORONARY O
CARE O
UNIT O
. O

3 O
) O
HYPOTHYROIDISM B-SYMPTOM
. O

4 O
) O
RHEUMATOID B-SYMPTOM
ARTHRITIS I-SYMPTOM
/ O
CUTANEOUS B-SYMPTOM
LUPUS I-SYMPTOM
( I-SYMPTOM
MIXED I-SYMPTOM
CONNECTIVE I-SYMPTOM
TISSUE I-SYMPTOM
DISEASE I-SYMPTOM
) I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
an O
80 O
female O
with O
a O
history O
of O
diastolic B-SYMPTOM
function I-SYMPTOM
and O
heart B-SYMPTOM
failure I-SYMPTOM
, O
hypertension B-SYMPTOM
and O
rheumatoid B-SYMPTOM
arthritis I-SYMPTOM
who O
presents O
from O
an O
outside O
hospital O
with O
presyncope B-SYMPTOM
. O

The O
patient O
reports O
dizziness B-SYMPTOM
intermittently I-SYMPTOM
times O
several O
months O
now O
increasing O
in O
frequency O
described O
as O
episodes O
where O
she O
feels O
faint B-SYMPTOM
. O

The O
room O
spins O
with O
no O
visual B-SYMPTOM
changes I-SYMPTOM
, O
no O
loss B-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
, O
no O
palpitations B-SYMPTOM
or O
chest B-SYMPTOM
pain I-SYMPTOM
, O
no O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
diaphoresis B-SYMPTOM
. O

On O
the O
day O
of O
admission O
, O
the O
patient O
was O
with O
some O
friends O
, O
rose O
from O
a O
chair O
to O
leave O
and O
felt O
dizzy B-SYMPTOM
while O
ambulating O
, O
fell O
and O
hit O
elbow O
with O
minor B-SYMPTOM
head I-SYMPTOM
trauma I-SYMPTOM
. O

The O
patient O
denied O
loss B-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
, O
no O
bowel B-SYMPTOM
or I-SYMPTOM
bladder I-SYMPTOM
incontinence I-SYMPTOM
. O

The O
patient O
was O
transferred O
to O
an O
outside O
hospital O
where O
she O
was O
noted O
to O
have O
a B-SYMPTOM
50 I-SYMPTOM
point I-SYMPTOM
discrepancy I-SYMPTOM
in O
her O
upper O
extremity O
blood O
pressures O
, O
right O
greater O
than O
left O
. O

This O
had O
been O
noted O
in O
the O
outpatient O
setting O
approximately O
one O
to O
two O
years O
prior O
to O
admission O
. O

The O
patient O
had O
no O
mediastinal B-SYMPTOM
widening I-SYMPTOM
on O
chest O
x-ray O
, O
but O
was O
transferred O
to O
Verg O
Medical O
Center O
for O
further O
evaluation O
. O

In O
the O
emergency O
room O
, O
the O
patient O
&apos;s O
temperature O
was O
98.8 O
degrees O
, O
heart O
rate O
73 O
, O
respiratory O
rate O
18 O
, O
oxygen O
saturation O
98% O
on O
room O
air O
. O

Blood O
pressure O
in O
the O
left O
arm O
demonstrated O
125/89 O
, O
blood O
pressure O
in O
the O
right O
arm O
was O
177/119 O
. O

The O
patient O
had O
a B-SYMPTOM
systolic I-SYMPTOM
murmur I-SYMPTOM
3/6 O
that O
radiated O
to O
the O
carotids O
with O
a B-SYMPTOM
decreased I-SYMPTOM
left I-SYMPTOM
radial I-SYMPTOM
pulse I-SYMPTOM
per O
the O
emergency O
room O
. O

The O
patient O
had O
a O
chest O
CT O
scan O
demonstrating O
no O
dissection B-SYMPTOM
or O
evidence O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

She O
received O
Nitropaste B-TREATMENT
, O
aspirin B-TREATMENT
, O
laboratory O
studies O
and O
was O
taken O
to O
the O
floor O
for O
further O
management O
. O

The O
patient O
denies O
melena B-SYMPTOM
, O
bright B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
, O
no O
emesis B-SYMPTOM
, O
or O
fevers B-SYMPTOM
or O
chills B-SYMPTOM
. O

The O
patient O
has O
a O
history O
of O
anemia B-SYMPTOM
as O
per O
past O
medical O
history O
above O
. O

REVIEW O
OF O
SYSTEMS O
: O

Otherwise O
negative O
. O

PHYSICAL O
EXAMINATION O
: O

Vital O
signs O
: O

Heart O
rate O
62 O
, O
respiratory O
rate O
16 O
, O
blood O
pressure O
right O
arm O
205/84 O
, O
oxygen O
saturation O
97% O
on O
two B-TREATMENT
liters I-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
. O

General O
: O

She O
was O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
, O
tired B-SYMPTOM
, O
easily O
arousable O
older O
female O
. O

HEENT O
examination O
demonstrated O
that O
the O
pupils O
were O
equal O
, O
round O
and O
reactive O
to O
light O
. O

Extraocular O
movements O
were O
intact O
. O

There O
was O
a B-SYMPTOM
left I-SYMPTOM
cataract I-SYMPTOM
on O
the O
fundoscopic O
examination O
. O

Neck O
was O
supple O
, O
bilateral B-SYMPTOM
bruits I-SYMPTOM
, O
although O
possibly O
radiating O
from O
cardiac O
base O
. O

There O
was O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distension I-SYMPTOM
. O

Chest O
demonstrated O
bilateral B-SYMPTOM
holosystolic I-SYMPTOM
bruits I-SYMPTOM
over I-SYMPTOM
the I-SYMPTOM
subclavians I-SYMPTOM
, O
left O
greater O
than O
right O
with O
few B-SYMPTOM
bibasilar I-SYMPTOM
crackles I-SYMPTOM
. O

Cardiovascular O
examination O
demonstrated O
a O
regular O
rate O
and O
rhythm O
with O
2/6 B-SYMPTOM
cresendo I-SYMPTOM
/ I-SYMPTOM
descrecendo I-SYMPTOM
murmur I-SYMPTOM
heard O
best O
at O
the O
apex O
with O
preservation O
of O
the O
second O
heart O
sound O
, O
no O
S3 B-SYMPTOM
or O
S4 B-SYMPTOM
. O

Abdominal O
examination O
was O
soft O
, O
non-tender B-SYMPTOM
, O
non-distended B-SYMPTOM
, O
positive O
bowel O
sounds O
, O
no O
hepatosplenomegaly B-SYMPTOM
, O
no O
abdominal B-SYMPTOM
tenderness I-SYMPTOM
. O

However O
, O
there O
were O
bilateral B-SYMPTOM
bilateral I-SYMPTOM
renal I-SYMPTOM
bruits I-SYMPTOM
and O
femoral B-SYMPTOM
bruits I-SYMPTOM
. O

The O
patient O
was O
guaiac O
negative O
per O
the O
emergency O
room O
. O

Extremities O
demonstrated O
no O
edema B-SYMPTOM
. O

Extremity O
pulses O
revealed O
a O
right O
radial O
of O
2+ O
, O
left O
radial O
of O
1+ O
, O
2+ O
distal O
pulses O
in O
the O
lower O
extremities O
bilaterally O
. O

Lower O
extremity O
blood O
pressures O
demonstrated O
systolics O
of O
205-210 O
. O

LABORATORY O
: O

Laboratory O
values O
on O
admission O
included O
a O
sodium O
of O
142 O
, O
potassium O
4.8 O
, O
chloride O
106 O
, O
bicarbonate O
27 O
, O
BUN O
and O
creatinine O
of O
39 O
and O
1.6 O
respectively O
, O
glucose O
113 O
. O

Calcium O
was O
9.6 O
. O

CK O
was O
62 O
. O

Troponin O
was O
0.2 O
. O

White O
blood O
cell O
count O
was O
11.5 O
, O
85 O
polys O
, O
5 O
bands O
, O
hematocrit O
37.6 O
, O
platelet O
count O
328 O
. O

Coagulation O
studies O
were O
11.3/25.5/0.9 O
. O

Urinalysis O
demonstrated O
trace B-SYMPTOM
leukocyte I-SYMPTOM
esterase I-SYMPTOM
, O
5-10 B-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cells I-SYMPTOM
and O
1+ B-SYMPTOM
squamous I-SYMPTOM
epithelial I-SYMPTOM
cells I-SYMPTOM
. O

EKG O
demonstrated O
normal O
sinus O
rhythm O
, O
rate O
of O
73 O
, O
borderline B-SYMPTOM
left I-SYMPTOM
atrial I-SYMPTOM
enlargement I-SYMPTOM
, O
axis O
of-28 O
, O
T-wave B-SYMPTOM
inversions I-SYMPTOM
in I-SYMPTOM
V4 I-SYMPTOM
through O
V6 O
, O
I O
and O
aVL O
, O
borderline B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
with O
strain B-SYMPTOM
compared O
to O
earlier O
this O
AM O
. O

There O
appeared O
to O
be O
a B-SYMPTOM
new I-SYMPTOM
T-wave I-SYMPTOM
inversion I-SYMPTOM
in O
V4 O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1 O
) O
Aspirin B-TREATMENT
81 O
mg O
p.o. O
q. O
day O
. O

2 O
) O
Os-Cal B-TREATMENT
1250 O
mg O
p.o. O
three O
times O
a O
day O
. O

3 O
) O
Lasix B-TREATMENT
40 O
mg O
p.o. O
q.o.d. O

4 O
) O
Plaquenil B-TREATMENT
200 O
mg O
p.o. O
q. O
day O
. O

5 O
) O
Ibuprofen B-TREATMENT
400 O
mg O
p.o. O
t.i.d. O

6 O
) O
Levoxyl B-TREATMENT
100 O
mg O
p.o. O
q. O
day O
. O

7 O
) O
Arava B-TREATMENT
20 O
mg O
p.o. O
q. O
day O
. O

8 O
) O
Zantac B-TREATMENT
150 O
mg O
p.o. O
b.i.d. O

9 O
) O
Isosorbide B-TREATMENT
dinitrate I-TREATMENT
unclear O
dose O
. O

10 O
) O
Diltiazem B-TREATMENT
240 O
mg O
p.o. O
q. O
day O
. O

11 O
) O
Epogen B-TREATMENT
q. O
two O
weeks O
. O

SOCIAL O
HISTORY O
: O

Negative O
for O
tobacco O
, O
negative O
for O
alcohol O
. O

The O
patient O
lives O
alone O
, O
but O
in O
a O
senior O
living O
facility O
adjacent O
to O
friends O
. O

HOSPITAL O
COURSE O
: O

1 O
) O
Cardiovascular O
: O

The O
patient O
was O
admitted O
for O
rule O
out O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

She O
remained O
on O
telemetry O
for O
greater O
than O
48 O
hours O
which O
demonstrated O
no O
dysrhythmia B-SYMPTOM
during O
this O
time O
. O

The O
patient O
underwent O
an O
echocardiogram O
which O
demonstrated O
a O
preserved O
ejection O
fraction O
with O
left B-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
and O
no O
significant B-SYMPTOM
valvular I-SYMPTOM
abnormalities I-SYMPTOM
. O

The O
patient O
was O
maintained O
on O
her B-TREATMENT
aspirin I-TREATMENT
and O
Lasix B-TREATMENT
. O

The B-TREATMENT
patient I-TREATMENT
&apos;s I-TREATMENT
Diltiazem I-TREATMENT
was O
stopped O
due O
to O
her B-SYMPTOM
increased I-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
and O
was O
started O
on O
Labetalol B-TREATMENT
which O
was O
gradually O
titrated O
up O
to O
a O
target O
blood O
pressure O
of O
160-170 O
systolic O
in O
her O
right O
arm O
. O

The O
patient O
also O
underwent O
an O
Adenosine O
MIBI O
stress O
test O
which O
showed O
only O
mild B-SYMPTOM
lateral I-SYMPTOM
ischemia I-SYMPTOM
. O

At O
this O
time O
, O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
presyncopal I-SYMPTOM
symptoms I-SYMPTOM
were O
not O
felt O
to O
be O
secondary O
to O
a O
cardiovascular O
etiology O
. O

2 O
) O
Neurological O
/ O
vascular O
: O

The B-SYMPTOM
discrepancy I-SYMPTOM
in O
the O
patient O
&apos;s O
pulses O
and O
blood O
pressure O
was O
felt O
to O
be O
consistent O
with O
a B-SYMPTOM
subclavian I-SYMPTOM
artery I-SYMPTOM
stenosis I-SYMPTOM
. O

The O
patient O
underwent O
MRI O
/ O
MRA O
of O
the O
head O
, O
neck O
and O
upper O
chest O
which O
demonstrated O
a B-SYMPTOM
proximal I-SYMPTOM
left I-SYMPTOM
subclavian I-SYMPTOM
artery I-SYMPTOM
stenosis I-SYMPTOM
, O
proximal O
to O
the O
take O
off O
of O
the O
left O
vertebral O
artery O
. O

The O
left O
vertebral O
artery O
had O
a B-SYMPTOM
decreased I-SYMPTOM
flow I-SYMPTOM
consistent O
with O
either O
native B-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
or O
some B-SYMPTOM
degree I-SYMPTOM
of I-SYMPTOM
retrograde I-SYMPTOM
flow I-SYMPTOM
with O
subclavian B-SYMPTOM
steal I-SYMPTOM
phenomenon I-SYMPTOM
. O

The O
patient O
had O
patent O
carotids O
bilaterally O
on O
her O
neck O
MRA O
. O

MRI O
of O
the O
head O
demonstrated O
a B-SYMPTOM
small I-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
and O
was O
likely O
an B-SYMPTOM
old I-SYMPTOM
right I-SYMPTOM
cerebellar I-SYMPTOM
infarct I-SYMPTOM
. O

The O
patient O
underwent O
non-invasive O
carotid O
ultrasounds O
which O
demonstrated O
no O
significant B-SYMPTOM
carotid I-SYMPTOM
disease I-SYMPTOM
. O

The O
patient O
was O
also O
noted O
to O
have O
antegrade B-SYMPTOM
flow I-SYMPTOM
in O
both O
of O
her O
vertebral O
arteries O
bilaterally O
. O

The O
results O
of O
these O
studies O
suggested O
that O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
symptoms I-SYMPTOM
were O
not O
due O
to O
subclavian B-SYMPTOM
steal I-SYMPTOM
phenomenon I-SYMPTOM
, O
and O
therefore O
, O
it O
was O
decided O
that O
the O
patient O
would O
not O
go O
further O
to O
angio B-TREATMENT
and O
/ O
or O
surgical B-TREATMENT
or I-TREATMENT
percutaneous I-TREATMENT
intervention I-TREATMENT
. O

A O
Neurology O
consult O
was O
obtained O
and O
it O
was O
felt O
that O
the B-TREATMENT
most I-TREATMENT
valuable I-TREATMENT
intervention I-TREATMENT
that O
could O
be O
done O
for O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
intervascular I-SYMPTOM
disease I-SYMPTOM
would O
be O
adequate O
control O
of O
her O
blood O
pressure O
. O

3 O
) O
Orthopedic O
: O

The O
patient O
suffered O
a O
fall O
at O
home O
with O
her O
initial O
event O
. O

Outside O
hip O
films O
were O
obtained O
, O
but O
were O
not O
available O
for O
view O
. O

Repeat O
hip O
films O
demonstrated O
a B-SYMPTOM
right I-SYMPTOM
sided I-SYMPTOM
pubic I-SYMPTOM
rami I-SYMPTOM
fracture I-SYMPTOM
, O
likely O
new O
. O

An O
Orthopedics O
consult O
was O
obtained O
and O
the O
patient O
was O
encouraged O
to O
weight O
bear O
as O
tolerated O
with O
Physical B-TREATMENT
Therapy I-TREATMENT
assistance I-TREATMENT
. O

A O
bone O
scan O
was O
also O
obtained O
to O
rule O
out O
an B-SYMPTOM
occult I-SYMPTOM
hip I-SYMPTOM
fracture I-SYMPTOM
which O
was O
negative O
. O

At O
the O
time O
of O
this O
dictation O
, O
the O
patient O
was O
able O
to O
bear O
weight O
with O
the O
assistance O
of O
Physical O
Therapy O
and O
a B-TREATMENT
walker I-TREATMENT
. O

Plans O
were O
made O
for O
the O
patient O
to O
be O
discharged O
to O
Dwardmegriff O
Rehabilitation O
for O
rehabilitation B-TREATMENT
of O
her B-SYMPTOM
rami I-SYMPTOM
fracture I-SYMPTOM
. O

4 O
) O
Gastrointestinal O
: O

The O
patient O
had O
an O
episode O
of O
her B-SYMPTOM
described I-SYMPTOM
vertigo I-SYMPTOM
while O
lying O
in O
bed O
and O
on O
the O
monitor O
during O
which O
no O
dysrhythmia B-SYMPTOM
was O
noted O
. O

The O
patient O
also O
complained O
of O
frequent B-SYMPTOM
vomiting I-SYMPTOM
at O
least O
once O
a O
day O
, O
occasionally O
associated O
with O
ingestion O
of O
her B-TREATMENT
medications I-TREATMENT
, O
but O
sometimes O
associated O
with O
ambulation O
. O

The O
patient O
has O
a O
long-standing O
history O
of O
spontaneous B-SYMPTOM
emesis I-SYMPTOM
due O
to O
overwhelming O
stress O
or O
excitement O
. O

However O
, O
the O
patient O
reports O
emesis B-SYMPTOM
in O
the O
hospital O
more O
frequently O
. O

The B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
emesis I-SYMPTOM
was O
noted O
to O
be O
bilious B-SYMPTOM
without O
evidence O
of O
new B-SYMPTOM
or I-SYMPTOM
old I-SYMPTOM
blood I-SYMPTOM
. O

The O
etiology O
of O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
nausea I-SYMPTOM
remained O
unclear O
as O
she O
demonstrated O
ability O
to O
keep O
down O
many O
of O
her O
meals O
which O
did O
not O
suggest O
an B-SYMPTOM
anatomical I-SYMPTOM
lesion I-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
gastrointestinal I-SYMPTOM
tract I-SYMPTOM
. O

The O
patient O
was O
started O
on O
Meclizine B-TREATMENT
on O
December O
31 O
, O
2000 O
for O
her B-SYMPTOM
nausea I-SYMPTOM
and O
vertigo B-SYMPTOM
. O

An O
attempt O
was O
also O
made O
to O
reduce O
the O
patient O
&apos;s O
large O
number O
of O
medications B-TREATMENT
and O
the B-TREATMENT
patient I-TREATMENT
&apos;s I-TREATMENT
Os-Cal I-TREATMENT
, O
multivitamin B-TREATMENT
, O
Lasix B-TREATMENT
and O
Colace B-TREATMENT
were O
discontinued O
. O

5 O
) O
Infectious O
disease O
: O

The O
patient O
complained O
of O
some B-SYMPTOM
urinary I-SYMPTOM
incontinence I-SYMPTOM
and O
difficulty O
initiating O
urine O
on O
December O
30 O
, O
2000 O
. O

Urinalysis O
demonstrated O
a B-SYMPTOM
likely I-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

The O
patient O
was O
started O
on O
Levofloxacin B-TREATMENT
250 O
mg O
p.o. O
q. O
day O
times O
seven O
days O
for O
a O
possible O
nosocomial B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

The O
urine O
culture O
was O
pending O
at O
the O
time O
of O
this O
dictation O
. O

6 O
) O
Fluids O
, O
electrolytes O
and O
nutrition O
: O

The O
patient O
had O
a B-SYMPTOM
mild I-SYMPTOM
increase I-SYMPTOM
in O
her O
BUN O
and O
creatinine O
during O
her O
hospitalization O
which O
promptly O
returned O
to O
her O
baseline O
levels O
with O
intravenous B-TREATMENT
fluids I-TREATMENT
. O

The O
patient O
was O
encouraged O
to O
increase O
her O
p.o. O
intake O
. O

Dictated O
By O
: O

BONE O
A O
, O
M.D. O
IQ35 O

Attending O
: O

LANAY O
I. O
IRON O
, O
M.D. O
TJ93 O
YB914/4843 O

Batch O
: O

9056 O

Index O
No. O
FPOF6TO0Q7 O

D O
: O

New O
Years O
Eve O

T O
: O

New O
Years O
Day O

Admission O
Date O
: O

2017-02-04 O

Discharge O
Date O
: O

2017-03-04 O

Date O
of O
Birth O
: O

1958-07-29 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Betalactams B-TREATMENT
/ O
Levofloxacin B-TREATMENT

Attending O
: O
Cayla O
R O
Turner O
, O
M.D. O

Chief O
Complaint O
: O
respiratory B-SYMPTOM
distress I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O
s/p O
intracranial B-TREATMENT
pressure I-TREATMENT
bolt I-TREATMENT
placement I-TREATMENT

History O
of O
Present O
Illness O
: O

The O
patient O
is O
a O
58 O
- O
year-old O
man O
with O
history O
of O
IDDM B-SYMPTOM
, O
PVD B-SYMPTOM
, O
status O
post O
toe B-TREATMENT
amputations I-TREATMENT
, O
diabetic B-SYMPTOM
neuropathy I-SYMPTOM
, O
and O
retinopathy B-SYMPTOM
recently O
admitted O
to O
McLean O
Hospital O
from O
2017-01-13 O
, O
through O
2017-01-18 O
, O
with O
a O
diagnosis O
of O
right B-SYMPTOM
heel I-SYMPTOM
diabetic I-SYMPTOM
ulcer I-SYMPTOM
with O
MSSA B-SYMPTOM
osteomyelitis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
calcaneus I-SYMPTOM
, O
MSSA B-SYMPTOM
bacteremia I-SYMPTOM
, O
acute B-SYMPTOM
interstitial I-SYMPTOM
nephritis I-SYMPTOM
secondary O
to O
oxacillin B-TREATMENT
, O
and O
RLL B-SYMPTOM
pna I-SYMPTOM
. O

He O
was O
sent O
home O
with O
a B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
and O
IV B-TREATMENT
antibiotics I-TREATMENT
. O

He O
returned O
to O
the O
Wing O
Memorial O
& O
Medical O
Center O
intubated B-TREATMENT
from O
an O
outside O
hospital O
on O
2017-02-04 O
, O
for O
respiratory B-SYMPTOM
failure I-SYMPTOM
and O
was O
sent O
to O
CMED O
CSRU O
. O

Prior O
to O
his O
re-admission O
, O
his O
sister O
had O
noted O
that O
he O
was O
having O
some B-SYMPTOM
shaking I-SYMPTOM
chills I-SYMPTOM
and O
heavy B-SYMPTOM
breathing I-SYMPTOM
. O

When O
he O
came O
back O
to O
Faulkner O
Hospital O
Hospital O
for O
confusion B-SYMPTOM
and O
diaphoresis B-SYMPTOM
, O
his O
initial O
oxygen O
sat O
was O
only O
80% O
with O
a O
fingerstick O
of O
29 O
. O

He O
was O
given O
D50 B-TREATMENT
, O
but O
continued O
to O
have O
progressive B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
, O
was O
therefore O
intubated O
and O
transferred O
to O
the O
Austen O
Riggs O
Center O
where O
he O
was O
noted O
to O
have O
multifocal B-SYMPTOM
pneumonia I-SYMPTOM
and O
bacteremia B-SYMPTOM
with O
enterobacter B-SYMPTOM
and O
MSSA B-SYMPTOM
. O

Past O
Medical O
History O
: O
diabetes B-SYMPTOM
type I-SYMPTOM
1 I-SYMPTOM
since O
age O
24 O
after O
pancreatic B-SYMPTOM
trauma I-SYMPTOM

diabetic B-SYMPTOM
retinopathy I-SYMPTOM

direct B-SYMPTOM
neuropathy I-SYMPTOM

PVD B-SYMPTOM

status O
post O
multiple B-TREATMENT
toe I-TREATMENT
amputations I-TREATMENT

recent B-SYMPTOM
right I-SYMPTOM
heel I-SYMPTOM
osteomyelitis I-SYMPTOM

recent B-SYMPTOM
MSSA I-SYMPTOM
bacteremia I-SYMPTOM

multifocal B-SYMPTOM
pneumonia I-SYMPTOM

acute B-SYMPTOM
interstitial I-SYMPTOM
nephritis I-SYMPTOM

cataract B-TREATMENT
surgery I-TREATMENT
. O

Social O
History O
: O
divorced O
truck O
driver O

tobacco O
: O
16 O
pack O
year O
hx O
; O
quit O
24 O
years O
ago O

ETOH O
: O
occasional O
beer O

Family O
History O
: O

NC O

Physical O
Exam O
: O

On O
transfer O
to O
the O
floor O
from O
the O
CMED O
CSRU O
on O
2017-02-15 O
temp O
: O

97.4 O
HR O
: O

78 O
BP O
: O

141/64 O
RR O
: O

20 O
O2sat O
: O

94-95% O
on O
3L B-TREATMENT
NC I-TREATMENT

Gen O
: O
somnolent B-SYMPTOM
but O
arousable O
to O
voice O

HEENT O
: O

MM O
moist O
, O
PERRLA O

CV O
: O

RRR O
, O
no O
m/r/g B-SYMPTOM

Lungs O
: O
crackles B-SYMPTOM
bibasilar I-SYMPTOM

Abd O
: O
soft O
, O
slightly B-SYMPTOM
distended I-SYMPTOM
, O
nontender B-SYMPTOM
, O
+BS O

Ext O
: O

2+ B-SYMPTOM
pitting I-SYMPTOM
edema I-SYMPTOM
B I-SYMPTOM
LE I-SYMPTOM
to I-SYMPTOM
knee I-SYMPTOM
, O
nonpitting B-SYMPTOM
edema I-SYMPTOM
in I-SYMPTOM
B I-SYMPTOM
hands I-SYMPTOM
and I-SYMPTOM
arms I-SYMPTOM
. O

1+ O
DP O
pulses O
bilaterally O
. O

Missing B-SYMPTOM
R I-SYMPTOM
1st I-SYMPTOM
toe I-SYMPTOM
and I-SYMPTOM
L I-SYMPTOM
2nd I-SYMPTOM
toe I-SYMPTOM
. O

Wound B-TREATMENT
vac I-TREATMENT
in O
place O
on O
R O
foot O
. O

Access O
: O

L B-TREATMENT
PICC I-TREATMENT
( O
2017-02-14 O
) O
. O

Neuro O
: O
arousable O
. O

States O
he O
is O
at O
home O
, O
name O
is O
" O
Henry O
" O
and O
year O
is O
1992 O
. O

Not O
answering O
other O
questions O
. O

Not O
following O
commands O
but O
moves O
UE O
's O
to O
try O
to O
pull O
out O
NG B-TREATMENT
tube I-TREATMENT
. O

Pertinent O
Results O
: O

CT O
chest O
2017-02-06 O

IMPRESSION O
: O

1. O
Extensive B-SYMPTOM
bilateral I-SYMPTOM
diffuse I-SYMPTOM
ground I-SYMPTOM
glass I-SYMPTOM
and O
more O
confluent O
areas O
of O
consolidation B-SYMPTOM
in I-SYMPTOM
both I-SYMPTOM
lungs I-SYMPTOM
consistent O
with O
the O
recent O
chest O
x-ray O
. O

This B-SYMPTOM
non I-SYMPTOM
- I-SYMPTOM
specific I-SYMPTOM
pattern I-SYMPTOM
could O
represent O
diffuse B-SYMPTOM
pneumonia I-SYMPTOM
complicated O
by O
ARDS B-SYMPTOM
. O

This O
would O
likely O
less O
represent O
asymmetric B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
. O

2. O
Small B-SYMPTOM
bilateral I-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
. O

Echo O
2018-02-06 O

Conclusions O
: O

1. O
No O
spontaneous B-SYMPTOM
echo I-SYMPTOM
contrast I-SYMPTOM
or O
thrombus B-SYMPTOM
is O
seen O
in O
the O
body O
of O
the O
left O
atrium O
or O
left O
atrial O
appendage O
. O

No O
atrial B-SYMPTOM
septal I-SYMPTOM
defect I-SYMPTOM
is O
seen O
by O
2D O
or O
color O
Doppler O
. O

2. O
Left O
ventricular O
wall O
thickness O
, O
cavity O
size O
, O
and O
systolic O
function O
are O
normal O
( O
LVEF O
> O
55% O
) O
. O

3. O
Right O
ventricular O
chamber O
size O
and O
free O
wall O
motion O
are O
normal O
. O

4. O
The O
ascending O
, O
transverse O
and O
descending O
thoracic O
aorta O
are O
normal O
in O
diameter O
and O
free O
of O
atherosclerotic B-SYMPTOM
plaque I-SYMPTOM
. O

5. O
The O
aortic O
valve O
leaflets O
( O
3 O
) O
appear O
structurally O
normal O
with O
good O
leaflet O
excursion O
. O

No O
masses B-SYMPTOM
or O
vegetations B-SYMPTOM
are O
seen O
on O
the O
aortic O
valve O
. O

Trace B-SYMPTOM
aortic I-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

6. O
The O
mitral O
valve O
appears O
structurally O
normal O
with O
trivial B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
. O

No O
mass B-SYMPTOM
or O
vegetation B-SYMPTOM
is O
seen O
on O
the O
mitral O
valve O
. O

7. O
No O
vegetation B-SYMPTOM
/ O
mass B-SYMPTOM
is O
seen O
on O
the O
pulmonic O
valve O
. O

8. O
There O
is O
a O
trivial O
/ O
physiologic B-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
. O

Head O
CT O
2017-02-08 O

FINDINGS O
: O

No O
intracranial B-SYMPTOM
hemorrhage I-SYMPTOM
is O
identified O
. O

There O
is O
no O
mass B-SYMPTOM
effect I-SYMPTOM
or O
shift B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
normally I-SYMPTOM
midline I-SYMPTOM
structures I-SYMPTOM
. O

No O
major B-SYMPTOM
vascular I-SYMPTOM
territorial I-SYMPTOM
infarction I-SYMPTOM
is O
identified O
. O

The O
ventricles O
and O
sulci O
are O
normal O
in O
size O
and O
symmetrical O
. O

No O
osseous B-SYMPTOM
lesions I-SYMPTOM
are O
seen O
. O

IMPRESSION O
: O

No O
intracranial B-SYMPTOM
hemorrhage I-SYMPTOM
or O
CT O
evidence O
of O
acute B-SYMPTOM
infarction I-SYMPTOM
. O

EEG O
2017-02-10 O

IMPRESSION O
: O

This O
is O
an B-SYMPTOM
abnormal I-SYMPTOM
EEG I-SYMPTOM
due O
to O
the O
presence O
of O
a B-SYMPTOM
low I-SYMPTOM
voltage I-SYMPTOM
and O
slow B-SYMPTOM
background I-SYMPTOM
consistent O
with O
a B-SYMPTOM
severe I-SYMPTOM
encephalopathy I-SYMPTOM
of O
toxic O
, O
metabolic O
, O
or O
anoxic O
etiology O
. O

Note O
that O
with O
the O
documented O
movements O
of O
the O
patient O
's O
head O
and O
mouth O
, O
no O
change O
on O
the O
EEG O
was O
seen O
. O

No O
evidence O
of O
ongoing B-SYMPTOM
seizures I-SYMPTOM
was O
seen O
. O

Cultures O
: O

Urine O
: O

2017-02-04 O
and O
2017-02-07 O
and O
2017-02-11 O
: O
yeast B-SYMPTOM

Sputum O
2017-02-04 O

ENTEROBACTER B-SYMPTOM
CLOACAE I-SYMPTOM

IV B-TREATMENT
catheter I-TREATMENT
tip I-TREATMENT
2017-02-05: O

STAPHYLOCOCCUS B-SYMPTOM
, I-SYMPTOM
COAGULASE I-SYMPTOM
NEGATIVE I-SYMPTOM
sensitive O
to O
vanc B-TREATMENT

Blood O
: O

2017-02-04 O

ENTEROBACTER B-SYMPTOM
CLOACAE I-SYMPTOM

ENTEROCOCCUS B-SYMPTOM
FAECIUM I-SYMPTOM
. O

STAPHYLOCOCCUS B-SYMPTOM
, I-SYMPTOM
COAGULASE I-SYMPTOM
NEGATIVE I-SYMPTOM
. O

ISOLATED O
FROM O
ONE O
SET O
ONLY O
. O

Stool O
2017-02-07 O
: O
c. B-SYMPTOM
diff I-SYMPTOM
negative O

Brief O
Hospital O
Course O
: O

1) O
Respiratory B-SYMPTOM
failure I-SYMPTOM
: O

On O
admission O
, O
this O
was O
felt O
to O
be O
likely O
03-15 O
worsening B-SYMPTOM
PNA I-SYMPTOM
. O

Pt O
remained O
intubated B-TREATMENT
until O
2017-02-14 O
. O

He O
had O
difficulty O
weaning O
from O
the B-TREATMENT
vent I-TREATMENT
due O
to O
difficulties B-SYMPTOM
with I-SYMPTOM
neurological I-SYMPTOM
status I-SYMPTOM
( O
he O
remained O
drowsy B-SYMPTOM
and O
unresponsive B-SYMPTOM
for O
many O
days O
) O
but O
eventually O
awoke O
enough O
and O
was O
extubated O
without O
difficulty O
and O
remained O
stable O
on O
3L B-TREATMENT
NC I-TREATMENT
. O

He O
was O
transferred O
to O
the O
floor O
but O
a O
few O
days O
later O
began O
to O
show O
signs O
of O
respiratory B-SYMPTOM
distress I-SYMPTOM
and O
was O
transferred O
back O
to O
the O
CMED O
CSRU O
for O
reintubation B-TREATMENT
for O
likely O
aspiration B-SYMPTOM
event I-SYMPTOM
leading O
to O
worsening B-SYMPTOM
pneumonia I-SYMPTOM
as O
well O
as O
some O
component O
of O
pulm B-SYMPTOM
edema I-SYMPTOM
. O

He O
was O
extubated O
a O
few O
days O
later O
and O
transferred O
back O
to O
the O
floor O
where O
his O
pulm O
status O
improved O
dramatically O
with O
lasix B-TREATMENT
and O
continued B-TREATMENT
nebulizer I-TREATMENT
treatments I-TREATMENT
. O

The O
patient O
was O
prepared O
for O
discharge O
on O
05-29 O
, O
when O
he O
was O
sat O
' O
ing O
in O
the O
high O
90 O
's O
on O
room O
air O
. O

However O
, O
on O
2017-03-01 O
at O
6 O
am O
the O
pt O
was O
found O
with O
labored B-SYMPTOM
respirations I-SYMPTOM
( O
rr O
= O
24 O
) O
and O
SaO2 O
89% O
, O
which O
improved O
to O
only O
SaO290 O
- O
91% O
on O
100% O
NRB B-TREATMENT
. O

ABG O
( O
7.42 O
/ O
38 O
/ O
88 O
) O
was O
performed O
, O
80 O
mg O
lasix B-TREATMENT
was O
given O
and O
the O
patietn O
had O
foley B-TREATMENT
placed O
and O
had O
good O
urine O
output O
and O
good O
mentation O
. O

He O
was O
also O
given O
nebulizers B-TREATMENT
without O
improvement O
. O

His O
chest O
radiograph O
had O
fluffy B-SYMPTOM
bilateral I-SYMPTOM
infiltrates I-SYMPTOM
. O

Although O
the O
pt O
was O
w/o O
fever B-SYMPTOM
, O
he O
had O
chills B-SYMPTOM
. O

He O
was O
readmitted O
tot O
he O
CMED O
CSRU O
for O
respiratory B-SYMPTOM
distress I-SYMPTOM
likely O
secondary O
to O
a B-SYMPTOM
recurrent I-SYMPTOM
aspiration I-SYMPTOM
event I-SYMPTOM
. O

He O
was O
continued O
on O
meropenem B-TREATMENT
, O
started O
on O
BiPAP B-TREATMENT
and O
aggressively O
suctioned O
in O
an O
attempt O
to O
avoid O
intubation B-TREATMENT
. O

On O
03-02 O
at O
10 O
am O
, O
the O
patient O
had O
an B-SYMPTOM
acutechange I-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
with O
bradycardia B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
pinpoint B-SYMPTOM
pupils I-SYMPTOM
, O
decerebrate B-SYMPTOM
posturing I-SYMPTOM
and O
increased B-SYMPTOM
tone I-SYMPTOM
in I-SYMPTOM
bilateral I-SYMPTOM
upper I-SYMPTOM
extremities I-SYMPTOM
and O
unresponsiveness B-SYMPTOM
. O

The O
patient O
was O
brought O
to O
CT O
immediately O
for O
stat O
scan O
and O
was O
found O
to O
have O
a B-SYMPTOM
massive I-SYMPTOM
occipital I-SYMPTOM
spontaneous I-SYMPTOM
hemorrhage I-SYMPTOM
into I-SYMPTOM
the I-SYMPTOM
L I-SYMPTOM
ventricle I-SYMPTOM
requiring O
ventricular B-TREATMENT
drainage I-TREATMENT
. O

Neurosurgery O
was O
immediately O
called O
for O
an B-TREATMENT
EVD I-TREATMENT
and O
anesthesia O
was O
called O
STAT O
to O
the O
bedside O
for O
intubation B-TREATMENT
at O
10:45 O
am O
in O
order O
to O
assist O
in O
hyperventilation B-TREATMENT
. O

After O
endotracheal B-TREATMENT
intubation I-TREATMENT
, O
MAPs O
were O
maintained O
between O
70 O
and O
90 O
, O
dilantin B-TREATMENT
was O
dose O
to O
maintain O
an O
appropriate O
level O
. O

L B-TREATMENT
frontal I-TREATMENT
ICP I-TREATMENT
bolt I-TREATMENT
was O
placed O
by O
neurosurgery O
under O
sterile O
conditions O
on O
antibiotics B-TREATMENT
. O

Mannitol B-TREATMENT
75 O
mg O
iv O
x O
1 O
then O
50 O
gm O
iv O
tid O
was O
begun O
to O
maintain O
serum O
osm O
> O
320 O
and O
Na O
> O
147 O
. O

The O
patient O
was O
hyperventilated B-TREATMENT
to O
goal O
PCO2 O
30-35 O
with O
ICP O
improvement O
. O

Serial O
head O
CT O
studies O
and O
neurologic O
exams O
were O
performed O
but O
the O
patient O
was O
unchaged O
, O
unresponsive B-SYMPTOM
with O
posturing B-SYMPTOM
and O
no B-SYMPTOM
spontaneous I-SYMPTOM
movement I-SYMPTOM
despite O
ICP O
being O
maintained O
in O
good O
range O
( O
< O
20 O
). O

On O
2017-03-03 O
, O
a O
family O
meeting O
resulted O
in O
the O
patient O
's O
code O
being O
changed O
to O
comfort B-TREATMENT
measures I-TREATMENT
only I-TREATMENT
. O

The O
patient O
was O
terminally O
extubated O
on O
a B-TREATMENT
morphine I-TREATMENT
drip I-TREATMENT
and O
ativan B-TREATMENT
titrated O
for O
agonal B-SYMPTOM
breathing I-SYMPTOM
and O
discomfort B-SYMPTOM
; O
scopolamine B-TREATMENT
was O
used O
as O
an O
adjunct O
to O
control O
secretions B-SYMPTOM
and O
appeared O
comfortable O
when O
he O
died O
at O
12:27 O
pm O
on O
2017-03-04 O
. O

The O
family O
refused O
autopsy O
or O
post-mortem O
examination O
to O
deduce O
secondary O
causes O
of O
death O
. O

2. O
ID O
- O
Bacteremia B-SYMPTOM
and O
PNA B-SYMPTOM
: O

Pt B-TREATMENT
's I-TREATMENT
triple I-TREATMENT
lumen I-TREATMENT
catheter I-TREATMENT
was O
found O
to O
be O
growing O
coag B-SYMPTOM
neg I-SYMPTOM
staph I-SYMPTOM
. O
and O
PICC B-TREATMENT
tip I-TREATMENT
and O
sputum O
growing O
enterobacter B-SYMPTOM
cloacae I-SYMPTOM
. O

The B-TREATMENT
PICC I-TREATMENT
was O
d/c O
'ed O
and O
pt O
was O
continued O
on O
vancomycin B-TREATMENT
( O
for O
course O
of O
6 O
weeks O
) O
and O
meropenem B-TREATMENT
was O
added O
on O
02-09 O
( O
for O
3 O
week O
course O
). O

TEE O
was O
negative O
. O

Pt O
finished O
the O
3 O
week O
course O
of O
meropenem B-TREATMENT
while O
in O
house O
and O
was O
discharged O
to O
rehab O
on O
day O
34/42 O
of O
the B-TREATMENT
vancomycin I-TREATMENT
. O

3) O
AIN B-SYMPTOM
: O

Pt O
received O
oxacillin B-TREATMENT
during O
his O
prior O
hospitalization O
and O
had O
AIN B-SYMPTOM
from O
this B-TREATMENT
medication I-TREATMENT
. O

On O
this O
admission O
he O
was O
continued O
on O
prednisone B-TREATMENT
taper I-TREATMENT
. O

Fluoroquinolones B-TREATMENT
and O
other O
renal O
toxins O
were O
avoided O
. O

Renal O
function O
gradually O
improved O
and O
Cr O
trended O
down O
from O
peak O
of O
7.6 O
to O
1.4 O
. O

Before O
the O
patient O
acutely O
decompensated O
as O
above O
, O
the O
plan O
was O
for O
steroid B-TREATMENT
taper I-TREATMENT
: O

60 O
mg O
x O
10 O
days O
( O
already O
completed O
) O
, O
40 O
mg O
x O
14 O
d O
( O
already O
completed O
) O
, O
20 O
mg O
x O
14 O
d O
( O
now O
day O
11-24 O
) O
, O
10 O
mg O
x O
10 O
d O
, O
5 O
mg O
x O
10 O
d O
. O

4) O
Foot B-SYMPTOM
ulcer I-SYMPTOM
: O
The O
pt O
was O
followed O
by O
podiatry O
and O
had O
several B-TREATMENT
further I-TREATMENT
debridement I-TREATMENT
of O
his B-SYMPTOM
R I-SYMPTOM
heel I-SYMPTOM
wound I-SYMPTOM
. O

on O
abx B-TREATMENT
, O
podiatry O
following O
, O
changed O
vac B-TREATMENT
q3 O
days O
. O

5) O
Encephalopathy B-SYMPTOM
: O
It O
was O
unclear O
why O
the O
pt O
's O
mental O
status O
initially O
did O
not O
improve O
more O
quickly O
after O
all B-TREATMENT
sedatives I-TREATMENT
were O
removed O
and O
he O
was O
extubated O
. O

His O
MS O
waxed O
and O
waned O
for O
many O
days O
and O
uremia B-SYMPTOM
vs. O
failure B-SYMPTOM
to I-SYMPTOM
clear I-SYMPTOM
sedatives I-SYMPTOM
were O
considered O
( O
although O
pt O
was O
making O
urine O
and O
LFT O
's O
are O
wnl O
). O

The O
pt O
had O
an O
EEG O
and O
2 O
head O
CT O
's O
which O
did O
not O
show O
anoxic B-SYMPTOM
brain I-SYMPTOM
injury I-SYMPTOM
or O
bleeding B-SYMPTOM
. O

He O
gradually O
improved O
and O
was O
A&Ox3 O
and O
near O
baseline O
before O
Amesbury O
Hospital O
transferred O
to O
the O
CMED O
CSRU O
in O
respiratory B-SYMPTOM
distress I-SYMPTOM
. O

6) O
DM B-SYMPTOM
: O

Pt O
was O
maintained O
on O
SSI B-TREATMENT
with O
small O
amount O
of O
standing B-TREATMENT
insulin I-TREATMENT
while O
he O
was O
NPO B-TREATMENT
and O
then O
his B-TREATMENT
dose I-TREATMENT
was O
gradually O
increased O
as O
he O
received O
tube B-TREATMENT
feeds I-TREATMENT
. O

7) O
FEN O
: O

The O
pt O
had O
an B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
placed O
and O
received O
tube B-TREATMENT
feeds I-TREATMENT
for O
the O
majority O
of O
his B-TREATMENT
hospitalization I-TREATMENT
. O

Upon O
extubation B-TREATMENT
and O
transfer O
to O
the O
floor O
he O
pulled O
out O
the B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
time O
several O
times O
and O
required O
restraints B-TREATMENT
. O

Albumin O
was O
very B-SYMPTOM
low I-SYMPTOM
and O
pt O
had O
significant B-SYMPTOM
edema I-SYMPTOM
likely O
03-15 O
this O
. O

A O
few O
days O
before O
decompensating O
, O
his O
mental O
status O
improved O
to O
the O
degree O
that O
he O
was O
able O
to O
eat O
normal O
food O
without O
aspirating O
. O

8) O
CV O
: O

Pump O
/ O
HTN B-SYMPTOM
: O
pt O
had O
episodes O
of O
both O
hypertension B-SYMPTOM
and O
hypotension B-SYMPTOM
during O
his O
stay O
. O

He O
was O
managed O
with O
Metoprolol B-TREATMENT
, O
Hydralazine B-TREATMENT
, O
and O
Amlodipine B-TREATMENT
. O

Near O
discharge O
his O
BP O
was O
controlled O
with O
Metoprolol B-TREATMENT
only O
. O

9) O
Hypernatremia B-SYMPTOM
- O
While O
in O
the O
CMED O
CSRU O
the O
pt O
developed O
hypernatremia B-SYMPTOM
. O

This O
was O
felt O
to O
be O
likely O
03-15 O
intravascular B-SYMPTOM
volume I-SYMPTOM
depletion I-SYMPTOM
since O
the O
pt O
's O
albumin O
was O
so B-SYMPTOM
low I-SYMPTOM
and O
he O
was O
third O
spacing O
all O
of O
his O
fluid O
. O

He O
was O
volume O
resuscitated O
and O
managed O
with O
D5W B-TREATMENT
and O
lasix B-TREATMENT
as O
well O
as O
receving O
FW B-TREATMENT
boluses I-TREATMENT
with O
his B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
feeds I-TREATMENT
. O

The B-SYMPTOM
hypernatremia I-SYMPTOM
fully O
resolved O
when O
he O
resumed O
eating O
on O
his O
own O
and O
had O
access O
to O
free O
water O
. O

10) O
Anemia B-SYMPTOM
: O

Pt O
's O
Hct O
trended O
down O
slowly O
throughout O
his O
hospitalization O
. O

Labs O
were O
consistent O
with O
anemia B-SYMPTOM
of O
chronic B-SYMPTOM
disease I-SYMPTOM
. O

He O
was O
transfused O
3 B-TREATMENT
units I-TREATMENT
pRBC I-TREATMENT
's I-TREATMENT
near O
the O
end O
of O
his O
hospitalization O
and O
had O
an O
appropriate O
bump O
. O

11) O
CMED O
CCU O
: O

When O
the O
pt O
's O
MS O
improved O
to O
near O
baseline O
before O
again O
decompensating O
, O
he O
became O
extremely B-SYMPTOM
tearful I-SYMPTOM
and O
expressed O
feelings O
of O
depression B-SYMPTOM
after O
being O
in O
the O
hospital O
for O
so O
long O
. O

He O
expressed O
interest O
in O
taking O
an B-TREATMENT
anti-depressant I-TREATMENT
for O
a O
short O
time O
while O
he O
was O
recovering O
and O
was O
started O
on O
Celexa B-TREATMENT
. O

Medications O
on O
Admission O
: O
vancomycin B-TREATMENT
1g O
IV O
q48 O

MVI B-TREATMENT

Neurontin B-TREATMENT
300 O
qd O

RISS B-TREATMENT

Prednisone B-TREATMENT
taper I-TREATMENT
60 O
qd O

Prilosec B-TREATMENT
20 O
qd O

Metoprolol B-TREATMENT
25 O
bid O

Lantus B-TREATMENT
480 O
qd O

Calcium B-TREATMENT
Carbonate I-TREATMENT
tid O
with O
meals O

Discharge O
Medications O
: O
n/a O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O
subarachnoid B-SYMPTOM
hemorrhage I-SYMPTOM

Diabetes B-SYMPTOM
Mellitis I-SYMPTOM
( O
Pancreatic B-SYMPTOM
Trauma I-SYMPTOM
) O

Acute B-SYMPTOM
Interstitial I-SYMPTOM
Nephritis I-SYMPTOM
( O
Oxacillin B-TREATMENT
) O

Peripheral B-SYMPTOM
Neuropathy I-SYMPTOM

Peripheral B-SYMPTOM
Vascular I-SYMPTOM
Disease I-SYMPTOM

Digital B-SYMPTOM
Necrosis I-SYMPTOM

Multiple B-TREATMENT
Toe I-TREATMENT
Amputations I-TREATMENT

Diabetic B-SYMPTOM
Nephropathy I-SYMPTOM

Hypertension B-SYMPTOM

MSSA B-SYMPTOM
Bacteremia I-SYMPTOM

Enterococcal B-SYMPTOM
Bacteremia I-SYMPTOM

Enterbactor B-SYMPTOM
Cloacae I-SYMPTOM
Bacteremia I-SYMPTOM

Multifocal B-SYMPTOM
Pneumonia I-SYMPTOM

Respiratory B-SYMPTOM
Failure I-SYMPTOM

MSSA B-SYMPTOM
osteomyelitis I-SYMPTOM
of I-SYMPTOM
Calcaneous I-SYMPTOM

Toxic B-SYMPTOM
/ I-SYMPTOM
Metabolic I-SYMPTOM
Encephalopathy I-SYMPTOM

Hypernatremia B-SYMPTOM

Discharge O
Condition O
: O

Deceased O

Sims O
Kenneth O
Jason O
MD O
95-149 O

Completed O
by O
: O
Michael O
Sulzer O
ROSENTHAL O
MD O
58-540 O
2017-05-24 O
@ O
2309 O

Signed O
electronically O
by O
: O
DR. O
Cheryl O
James O
on O
: O
Larry O
2017-05-25 O
2:28 O
PM O

( O
End O
of O
Report O
) O

082738817 O

CMC O

19153629 O

6/3/1993 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

06/03/1993 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

06/06/1993 O

DISCHARGE O
DIAGNOSIS O
: O

UTERINE B-SYMPTOM
PROLAPSE I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
70 O
year O
old O
gravida O
IV O
, O
para O
4 O
who O
presented O
for O
a B-TREATMENT
vaginal I-TREATMENT
hysterectomy I-TREATMENT
secondary O
to O
uterine B-SYMPTOM
prolapse I-SYMPTOM
and O
also O
presented O
for O
evaluation O
of O
a B-SYMPTOM
suspicious I-SYMPTOM
lesion I-SYMPTOM
seen O
on O
a O
mammogram O
. O

Patient B-SYMPTOM
&apos;s I-SYMPTOM
problem I-SYMPTOM
started O
four O
years O
ago O
when O
she O
first O
experienced O
a B-SYMPTOM
pushing I-SYMPTOM
forward I-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
uterus I-SYMPTOM
. O

The O
patient O
described O
this O
sensation O
as O
uncomfortable B-SYMPTOM
and O
becoming O
more O
prominent O
over O
the O
following O
three O
years O
with O
increasing B-SYMPTOM
pressure I-SYMPTOM
and O
pain B-SYMPTOM
. O

Two O
months O
ago O
, O
the O
patient O
slipped O
and O
fell O
with O
valsalva O
that O
precipitated O
an O
exacerbation O
of O
her B-SYMPTOM
prolapse I-SYMPTOM
. O

She O
subsequently O
could O
not O
urinate O
and O
was O
in O
pain B-SYMPTOM
secondary O
to O
her B-SYMPTOM
problem I-SYMPTOM
. O

At O
this O
time O
, O
she O
decided O
that O
she O
needed O
the B-SYMPTOM
prolapse I-SYMPTOM
fixed O
and O
actually O
wrote O
to O
the O
Norri O
Hospital O
to O
try O
and O
find O
a O
Gynecologist O
. O

Her O
letter O
was O
referred O
to O
Dr. O
Earllamarg O
Para O
who O
saw O
her O
in O
the O
office O
and O
recommended O
vaginal B-TREATMENT
hysterectomy I-TREATMENT
. O

Patient O
has O
never O
had O
a B-TREATMENT
pessary I-TREATMENT
and O
refused O
one O
and O
denies O
nausea B-SYMPTOM
, O
fever B-SYMPTOM
, O
chills B-SYMPTOM
, O
dysuria B-SYMPTOM
, O
or O
stress B-SYMPTOM
incontinence I-SYMPTOM
on O
her O
current O
admission O
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
for O
a B-SYMPTOM
lower I-SYMPTOM
left I-SYMPTOM
saphenous I-SYMPTOM
vein I-SYMPTOM
thrombosis I-SYMPTOM
diagnosed O
with O
lower O
extremity O
non-invasives O
and O
on O
May O
2 O
, O
1993 O
with O
no O
evidence O
of O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
and O
clearance O
by O
Dr. O
Ribreefcheampner O
for O
further B-TREATMENT
intervention I-TREATMENT
. O

She O
also O
has O
a B-SYMPTOM
heart I-SYMPTOM
murmur I-SYMPTOM
since O
childhood O
. O

PAST O
SURGICAL O
HISTORY O
: O

Negative O
. O

PAST O
OBSTETRICAL O
HISTORY O
: O

Significant O
for O
vaginal O
deliveries O
times O
four O
. O

PAST O
GYNECOLOGICAL O
HISTORY O
: O

Last O
menstrual O
period O
was O
at O
age O
fifty O
, O
the O
patient O
is O
not O
on O
hormonal B-TREATMENT
replacement I-TREATMENT
and O
she O
has O
a O
four O
history O
of O
uterine B-SYMPTOM
prolapse I-SYMPTOM
. O

CURRENT O
MEDICATIONS O
: O

Aspirin B-TREATMENT
one O
per O
day O
which O
the O
patient O
quit O
taking O
two O
weeks O
prior O
to O
admission O
. O

ALLERGIES O
: O

None O
. O

SOCIAL O
HISTORY O
: O

Patient O
lives O
on O
Sauxdo O
Lo O
with O
her O
husband O
and O
denies O
alcohol O
and O
denies O
drug O
abuse O
. O

PHYSICAL O
EXAMINATION O
: O

GENERAL O
: O

This O
was O
a O
well-developed O
, O
well-nourished O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Patient O
had O
a O
blood O
pressure O
of O
128/72 O
, O
a O
pulse O
of O
84 O
that O
was O
regular O
, O
and O
she O
was O
afebrile B-SYMPTOM
at O
98.4 O
. O

SKIN O
: O

Examination O
showed O
right B-SYMPTOM
axillary I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
posterior I-SYMPTOM
axillary I-SYMPTOM
skin I-SYMPTOM
tags I-SYMPTOM
and O
crusted B-SYMPTOM
lesions I-SYMPTOM
. O

HEENT O
: O

Pupils O
were O
equal O
, O
round O
, O
and O
reactive O
to O
light O
, O
extraocular O
muscles O
were O
intact O
, O
and O
no O
lymphadenopathy B-SYMPTOM
. O

CARDIAC O
: O

Examination O
showed O
regular O
rate O
and O
rhythm O
with O
no O
S3 B-SYMPTOM
or O
S4 B-SYMPTOM
heard O
and O
a B-SYMPTOM
grade I-SYMPTOM
II/VI I-SYMPTOM
holosystolic I-SYMPTOM
murmur I-SYMPTOM
loudest O
at O
the O
left O
sternal O
border O
. O

LUNGS O
: O

Examination O
was O
clear O
to O
auscultation O
. O

BREASTS O
: O

Examination O
showed O
a B-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
mid I-SYMPTOM
small I-SYMPTOM
breast I-SYMPTOM
mass I-SYMPTOM
which O
was O
detected O
actually O
by O
Dr. O
Para O
. O

ABDOMEN O
: O

Soft O
and O
non-tender B-SYMPTOM
. O

PELVIC O
: O

Deferred O
until O
the O
Operating O
Room O
. O

EXTREMITIES O
: O

She O
had O
left B-SYMPTOM
lower I-SYMPTOM
leg I-SYMPTOM
varicose I-SYMPTOM
veins I-SYMPTOM
, O
no O
venous B-SYMPTOM
cords I-SYMPTOM
, O
and O
bilateral O
2+ O
pedal O
pulses O
. O

LABORATORY O
EXAMINATION O
: O

The O
patient O
had O
a O
BUN O
and O
creatinine O
of O
12 O
and O
1.2 O
, O
a O
white O
count O
of O
6.7 O
, O
a O
hematocrit O
of O
39.4 O
, O
negative O
urinalysis O
, O
and O
a O
potassium O
of O
4.6 O
. O

Her O
CA-125 O
was O
20 O
and O
she O
had O
a O
chest O
X-Ray O
that O
showed O
no O
infiltrates B-SYMPTOM
and O
a O
mammogram O
that O
showed O
a B-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
large I-SYMPTOM
calcified I-SYMPTOM
fibroadenoma I-SYMPTOM
and O
right B-SYMPTOM
upper I-SYMPTOM
mid I-SYMPTOM
area I-SYMPTOM
of I-SYMPTOM
calcification I-SYMPTOM
. O

She O
had O
an O
EKG O
that O
showed O
a O
question O
of O
an B-SYMPTOM
old I-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

Cardiology O
was O
consulted O
to O
evaluate O
this O
and O
felt O
that O
the B-SYMPTOM
changes I-SYMPTOM
seen O
on O
the O
EKG O
were O
not O
significant O
. O

The O
patient O
was O
also O
seen O
by O
Dr. O
Nusc O
from O
General O
Surgery O
for O
evaluation O
of O
micro B-SYMPTOM
calcifications I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
breast I-SYMPTOM
. O

The O
patient O
refused O
a O
biopsy O
for O
this O
admission O
and O
desires O
follow-up O
mammograms O
. O

She O
is O
to O
be O
followed O
up O
by O
General O
Surgery O
. O

The O
patient O
underwent O
a B-TREATMENT
total I-TREATMENT
vaginal I-TREATMENT
hysterectomy I-TREATMENT
on O
June O
4 O
, O
1993 O
which O
she O
tolerated O
without O
complications B-SYMPTOM
. O

Her O
post-operative O
course O
has O
been O
uncomplicated O
. O

She O
remained O
afebrile B-SYMPTOM
throughout O
her O
admission O
tolerating O
a O
regular O
diet O
by O
post-operative O
day O
two O
and O
was O
discharged O
on O
June O
6 O
, O
1993 O
with O
Percocet B-TREATMENT
for O
pain B-SYMPTOM
. O

The B-TREATMENT
Foley I-TREATMENT
was O
discontinued O
and O
the O
patient O
was O
urinating O
on O
her O
own O
. O

DISPOSITION O
: O

DISCHARGE O
MEDICATIONS O
: O

Percocet B-TREATMENT
one O
to O
two O
tablets O
p.o. O
q.4-6h. O
p.r.n. O
, O
Iron B-TREATMENT
Sulfate I-TREATMENT
325 O
mg O
p.o. O
b.i.d. O
, O
Colace B-TREATMENT
100 O
mg O
b.i.d. O
, O
and O
one O
Aspirin B-TREATMENT
q.d. O

She O
is O
to O
follow-up O
with O
Dr. O
Para O
for O
follow-up O
. O

Dictated O
By O
: O

RIMARVNAA O
D. O
KUSHDREPS O
, O
M.D. O
AV94 O

Attending O
: O

EARLLAMARG O
S. O
PARA O
, O
M.D. O
FT99 O
OH475/4059 O

Batch O
: O

2446 O

Index O
No. O
LXAIB23C4 O
L O

D O
: O

06/07/93 O

T O
: O

06/11/93 O

Admission O
Date: O

2014-03-31 O

Discharge O
Date O
: O

2014-04-01 O

Date O
of O
Birth O
: O

2014-03-31 O

Sex O
: O

M O

Service O
: O

CMED O

HISTORY O
: O

Baby O
Alfonso O
Carroll O
is O
a O
full O
term O
infant O
born O
at O
3.325 O
kg O
to O
a O
35-year-old O
G2 O
, O
P1 O
, O
now O
2 O
mother O
. O

Prenatal O
screens O
- O
blood O
type O
O O
positive O
, O
antibody O
screen O
negative O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
RPR O
nonreactive O
, O
rubella O
immune O
. O

GBS B-SYMPTOM
negative O
. O

Maternal O
history O
notable O
for O
hypothyroidism B-SYMPTOM
on O
Levoxyl B-TREATMENT
. O

Primary B-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
with O
previous O
pregnancy O
for O
arrest B-SYMPTOM
of I-SYMPTOM
descent I-SYMPTOM
. O

Other B-TREATMENT
meds I-TREATMENT
: O
Paxil B-TREATMENT
. O

This O
pregnancy O
is O
complicated O
by O
a B-SYMPTOM
cyst I-SYMPTOM
noted O
on O
the O
umbilical O
cord O
on O
fetal O
ultrasound O
study O
at O
18 O
weeks O
gestation O
. O

Mother O
presented O
in O
spontaneous O
labor O
. O

No O
perineal B-SYMPTOM
sepsis I-SYMPTOM
risk I-SYMPTOM
factors I-SYMPTOM
. O

No O
maternal B-SYMPTOM
fever I-SYMPTOM
. O

No O
prolonged B-SYMPTOM
rupture I-SYMPTOM
of I-SYMPTOM
membranes I-SYMPTOM
. O

Clear O
amniotic O
fluid O
. O

Anesthesia B-TREATMENT
by O
epidural B-TREATMENT
. O

Vaginal O
delivery O
. O

Apgars O
were O
8 O
and O
9 O
. O

PHYSICAL O
EXAMINATION O
: O

Weight O
3.325 O
kg O
, O
length O
was O
20 O
inches O
i.e. O
51 O
cm O
, O
head O
circumference O
34.5 O
cm O
. O

Nondysmorphic B-SYMPTOM
infant O
. O

Active O
, O
pink O
newborn O
in O
no O
distress B-SYMPTOM
on O
radiate B-TREATMENT
warmer I-TREATMENT
. O

Anterior O
fontanel O
soft O
and O
flat O
. O

Palate O
and O
clavicles O
intact O
. O

Neck O
supple O
. O

Lungs O
clear O
to O
apex O
and O
equal O
. O

CARDIOVASCULAR O
: O

Regular O
rate O
and O
rhythm O
. O

No O
murmurs B-SYMPTOM
. O

2+ O
femoral O
pulses O
. O

ABDOMEN O
: O
Soft O
. O

Positive O
bowel O
sounds O
. O

Umbilical O
cord O
with O
Braintree O
jelly B-SYMPTOM
cysts I-SYMPTOM
but O
also O
with O
pink B-SYMPTOM
tubular I-SYMPTOM
discoloration I-SYMPTOM
at I-SYMPTOM
base I-SYMPTOM
. O

Umbilical O
ring O
intact O
. O

Normal O
male O
. O

Testes O
down O
bilaterally O
. O

Patent O
anus O
. O

No O
sacral B-SYMPTOM
anomalies I-SYMPTOM
. O

EXTREMITIES O
: O
Pink O
and O
well O
perfused O
. O

SUMMARY O
OF O
HOSPITAL O
COURSE O
BY O
SYSTEMS O
: O

RESPIRATORY O
: O
He O
has O
been O
stable O
in O
room O
air O
throughout O
hospital O
course O
. O

CARDIOVASCULAR O
: O
No O
cardiovascular B-SYMPTOM
issues I-SYMPTOM
. O

FLUIDS O
, O
ELECTROLYTES O
AND O
NUTRITION O
: O
Infant O
initiated O
on O
60 O
cc O
per O
kg O
per O
day O
of O
D10W B-TREATMENT
. O

D-sticks O
have O
been O
stable O
. O
Infant O
is O
allowed O
to O
ad O
lib O
breast O
feed O
which O
he O
is O
doing O
vigorously O
. O

GASTROINTESTINAL O
: O
Infant O
is O
ad O
lib O
feeding O
. O

An O
abdominal O
ultrasound O
was O
performed O
. O

Initial O
impression O
included O
omphalocele B-SYMPTOM
with O
further O
imaging O
of O
the O
bowel O
to O
be O
done O
. O

Surgery O
was O
consulted O
and O
Dr. O
Boston O
took O
patient O
to O
OR O
for O
exploration O
of O
cord O
on O
04-01 O
. O

Urachal B-SYMPTOM
duct I-SYMPTOM
remnanr I-SYMPTOM
found O
, O
removed O
and O
bladder O
repaired O
. O

Post O
op O
course O
unremrakable O
. O

PAtient O
began O
feeding O
first O
post O
op O
day O
and O
has O
done O
well O
. O

HEMATOLOGY O
: O
Hematocrit O
on O
admission O
was O
52.8 O
. O

The O
infant O
does O
not O
require O
a B-TREATMENT
new I-TREATMENT
blood I-TREATMENT
transfusion I-TREATMENT
. O

INFECTIOUS O
DISEASE O
: O
CBC O
and O
blood O
culture O
obtained O
on O
admission O
. O

Initial O
CBC O
had O
a O
white O
count O
of O
20 O
, O
platelet O
count O
of O
386 O
, O
63 O
polys O
, O
2 O
bands O
, O
23 O
lymphs O
. O

Blood O
cultures O
remained O
negative O
at O
this O
time O
. O

Infant O
has O
not O
received O
any B-TREATMENT
antibiotics I-TREATMENT
. O

NEUROLOGIC O
: O
Infant O
has O
been O
appropriate O
for O
gestational O
age O
. O

SENSORY O
: O
Hearing O
screen O
has O
not O
yet O
been O
performed O
but O
should O
be O
done O
prior O
to O
discharge O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
DISPOSITION O
: O

To O
Massachusetts O
General O
Hospital O
. O

NAME O
OF O
PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Joan O
Derringer O
. O

DISCHARGE O
DIAGNOSES O
: O

Urachal B-SYMPTOM
duct I-SYMPTOM
remnant I-SYMPTOM
. O

CARE O
RECOMMENDATIONS O
: O

1. O
Dressing B-TREATMENT
to O
remain O
in O
place O
for O
10 O
days O
unless O
signs O
of O
bleeding B-SYMPTOM
, O
infection B-SYMPTOM
or O
is O
soiled O
. O

2. O
F/U O
with O
primary O
pediatricians O
in O
3-4 O
days O
or O
earlier O
as O
needed O
. O

3. O
F/U O
appt O
with O
Dr O
Boston O
, O
Massachusetts O
General O
Hospital O
Surgery O
in O
approx O
4 O
weeks O
. O

Mother O
has O
Dr O
Fishman's O
contact O
information O
. O

Emma O
Nicolas O
, O
MD O
79-770 O

Dictated O
By O
: O
Jerry O
E O
Ross O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-04-01 O
01:57:51 O

T O
: O
2014-04-01 O
02:59:13 O

Job O
#: O
96281 O

Signed O
electronically O
by O
: O
DR. O
James O
GRAY O
on O
: O
Roger O
2014-04-03 O
3:20 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2012-03-01 O

Discharge O
Date O
: O

2012-03-13 O

Date O
of O
Birth O
: O

1985-11-02 O

Sex O
: O

F O

Service O
: O

CMED O
CCU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Patient O
is O
a O
26 O
- O
year-old O
female O
with O
a O
past O
medical O
history O
significant O
for O
nonischemic B-SYMPTOM
dilated I-SYMPTOM
cardiomyopathy I-SYMPTOM
with O
an O
ejection O
fraction O
of O
15-20% O
, O
who O
presents O
with O
a O
one-week O
history O
of O
progressive B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

She O
reports O
orthopnea B-SYMPTOM
with O
an B-SYMPTOM
increasing I-SYMPTOM
pillow I-SYMPTOM
requirement I-SYMPTOM
of O
2-4 O
with O
paroxysmal B-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
. O

Patient O
also O
reports O
a B-SYMPTOM
6-pound I-SYMPTOM
weight I-SYMPTOM
gain I-SYMPTOM
over O
the O
last O
four O
days O
with O
associated O
lower B-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
. O

She O
also O
reports O
positional B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
, O
which O
is O
worse O
with O
lying O
down O
and O
relieved O
with O
sitting O
up O
. O

She O
denies O
any B-SYMPTOM
pain I-SYMPTOM
with O
activity O
. O

She O
also O
reports O
a B-SYMPTOM
cough I-SYMPTOM
productive O
of O
green B-SYMPTOM
sputum I-SYMPTOM
for O
approximately O
one O
week O
. O

She O
does O
report O
chills B-SYMPTOM
, O
but O
no O
fevers B-SYMPTOM
. O

In O
the O
Emergency O
Department O
, O
she O
was O
started O
on O
a B-TREATMENT
nesiritide I-TREATMENT
drip I-TREATMENT
and O
responded O
well O
with O
2000 O
cc O
urine O
output O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Nonischemic B-SYMPTOM
dilated I-SYMPTOM
cardiomyopathy I-SYMPTOM
with O
an O
ejection O
fraction O
of O
15-20% O
. O

2. O
Status O
post O
cardiac O
catheterization O
in O
2011-11-19 O
which O
showed O
normal O
coronaries O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Toprol B-TREATMENT
. O

2. O
Lasix B-TREATMENT
. O

3. O
Digoxin B-TREATMENT
. O

4. O
Coumadin B-TREATMENT
. O

5. O
Flovent B-TREATMENT
. O

6. O
Albuterol B-TREATMENT
. O

7. O
Lisinopril B-TREATMENT
. O

ALLERGIES O
: O

She O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

She O
is O
a O
positive O
tobacco O
user O
. O

She O
smoked O
a O
half O
pack O
a O
day O
for O
eight O
years O
and O
quit O
in O
2011-11-19 O
. O

She O
denies O
any O
alcohol O
or O
drug O
use O
. O

She O
has O
a O
5-year-old O
son O
. O

FAMILY O
HISTORY O
: O

There O
is O
no O
family O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

VITALS O
ON O
ADMISSION O
: O

She O
had O
a O
temperature O
of O
98.1 O
, O
blood O
pressure O
of O
130/99 O
, O
pulse O
of O
111 O
, O
respiratory O
rate O
of O
16 O
. O

She O
was O
saturating O
100% O
on O
room O
air O
. O

PHYSICAL O
EXAM O
: O

General O
: O

She O
is O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
. O

She O
is O
obese B-SYMPTOM
. O

She O
is O
slightly B-SYMPTOM
tachypneic I-SYMPTOM
. O

HEENT O
: O

Pupils O
are O
equal O
, O
round O
, O
and O
reactive O
to O
light O
. O

Her O
oropharynx O
is O
clear O
. O

Mucous O
membranes O
are O
moist O
. O

Neck O
: O

She O
has O
JVD B-SYMPTOM
to O
angle O
of O
the O
jaw O
, O
no O
bruits B-SYMPTOM
. O

Chest O
: O

She O
has O
got O
bilateral B-SYMPTOM
basilar I-SYMPTOM
crackles I-SYMPTOM
, O
no O
wheezing B-SYMPTOM
. O

Cardiac O
examination O
: O

She O
had O
a O
normal O
S1 O
, O
S2 O
with O
a B-SYMPTOM
2/6 I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
. O

She O
had O
a O
positive O
S4 B-SYMPTOM
. O

Her O
abdomen O
was O
obese B-SYMPTOM
, O
soft O
, O
nontender B-SYMPTOM
. O

Extremities O
: O

2+ B-SYMPTOM
edema I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
knees I-SYMPTOM
. O

LABORATORIES O
ON O
ADMISSION O
: O

She O
had O
a O
white O
count O
of O
9.3 O
, O
hematocrit O
of O
37.7 O
, O
platelets O
of O
293 O
. O

She O
had O
a O
CK O
of O
212 O
and O
MB O
of O
21 O
, O
and O
a O
troponin O
of O
0.56 O
. O

She O
had O
a O
Chem-7 O
which O
was O
normal O
. O

She O
had O
an O
INR O
of O
1.5 O
on O
her B-TREATMENT
Coumadin I-TREATMENT
. O

Chest O
x-ray O
showed O
right B-SYMPTOM
patchy I-SYMPTOM
opacity I-SYMPTOM
with O
a B-SYMPTOM
right I-SYMPTOM
effusion I-SYMPTOM
. O

EKG O
showed O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
, O
borderline B-SYMPTOM
left I-SYMPTOM
axis I-SYMPTOM
, O
normal O
intervals O
, O
LVH B-SYMPTOM
, O
left B-SYMPTOM
atrial I-SYMPTOM
enlargement I-SYMPTOM
, O
no O
Q B-SYMPTOM
waves I-SYMPTOM
, O
no O
P-R B-SYMPTOM
depressions I-SYMPTOM
, O
no O
ST B-SYMPTOM
segment I-SYMPTOM
elevations I-SYMPTOM
or O
depression B-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

1. O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
: O

Patient O
was O
diuresed O
effectively O
with O
nesiritide B-TREATMENT
and O
Lasix B-TREATMENT
. O

Patient O
's O
weight O
on O
admission O
was O
250 O
pounds O
, O
and O
on O
the O
day O
of O
discharge O
was O
244 O
pounds O
which O
was O
back O
to O
her O
dry O
weight O
. O

She O
had O
lost O
the O
6 O
pounds O
that O
she O
reported O
gaining O
in O
the O
four O
days O
prior O
to O
her O
hospitalization O
. O

Patient O
was O
continued O
on O
her B-TREATMENT
Toprol I-TREATMENT
, O
her B-TREATMENT
lisinopril I-TREATMENT
, O
and O
her B-TREATMENT
digoxin I-TREATMENT
. O

Patient B-TREATMENT
's I-TREATMENT
Coumadin I-TREATMENT
was O
held O
for O
right O
heart O
catheterization O
and O
biopsy O
, O
and O
then O
EP O
study O
with O
ICD B-TREATMENT
placement I-TREATMENT
. O

Patient O
did O
have O
Woodrow O
Betty O
, O
SPEP O
, O
and O
anticardiolipin O
antibody O
sent O
for O
further O
workup O
of O
the O
etiology O
of O
her B-SYMPTOM
cardiomyopathy I-SYMPTOM
. O

The O
Courtney O
, O
SPEP O
, O
and O
anticardiolipin O
antibody O
were O
all O
negative O
. O

Her O
CKs O
did O
trend O
down O
over O
the O
course O
of O
her O
hospital O
stay O
, O
and O
in O
the O
setting O
of O
her O
known O
clean O
coronaries O
on O
cardiac O
catheterization O
in O
2011-11-19 O
, O
it O
was O
believed O
that O
a B-SYMPTOM
myocarditis I-SYMPTOM
might O
be O
the O
cause O
of O
her B-SYMPTOM
elevated I-SYMPTOM
cardiac I-SYMPTOM
enzymes I-SYMPTOM
and O
also O
could O
have O
exacerbated O
her B-SYMPTOM
congestive I-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

Patient O
did O
receive O
a O
right O
heart O
catheterization O
, O
which O
showed O
elevated B-SYMPTOM
wedge I-SYMPTOM
pressures I-SYMPTOM
and O
biopsy O
specimens O
were O
obtained O
of O
the O
right O
ventricle O
. O

The O
results O
of O
these O
biopsies O
are O
still O
pending O
in O
pathology O
. O

Post O
right O
heart O
catheterization O
and O
right O
ventricular O
biopsy O
, O
the O
patient O
was O
sent O
to O
the O
CCU O
for O
a B-TREATMENT
Swan I-TREATMENT
- I-TREATMENT
guided I-TREATMENT
therapy I-TREATMENT
in O
the O
setting O
of O
her B-SYMPTOM
elevated I-SYMPTOM
wedge I-SYMPTOM
pressures I-SYMPTOM
and O
low B-SYMPTOM
cardiac I-SYMPTOM
output I-SYMPTOM
. O

In O
the O
CCU O
, O
she O
was O
put O
on O
milrinone B-TREATMENT
with O
good O
results O
. O

Patient O
was O
also O
seen O
by O
the O
Pulmonary O
service O
here O
and O
had O
pulmonary O
function O
tests O
done O
as O
part O
of O
a O
pretransplant O
workup O
. O

There O
is O
no O
pulmonary O
process O
to O
exclude O
her O
from O
the O
transplant O
list O
as O
noted O
by O
the O
Pulmonary O
service O
. O

Patient O
did O
receive O
an B-TREATMENT
ICD I-TREATMENT
during O
this O
hospital O
admission O
without O
complication B-SYMPTOM
. O

Patient O
was O
in O
bigeminy B-SYMPTOM
during O
the O
course O
of O
her O
hospital O
stay O
, O
and O
did O
have O
frequent O
runs O
of O
ectopy B-SYMPTOM
as O
noted O
on O
telemetry O
. O

2. O
Her B-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
infiltrate I-SYMPTOM
: O

Patient O
did O
report O
a B-SYMPTOM
cough I-SYMPTOM
productive O
of O
green B-SYMPTOM
sputum I-SYMPTOM
on O
admission O
. O

She O
received O
a O
full O
course O
of O
azithromycin B-TREATMENT
for O
this O
with O
resolution O
of O
her B-SYMPTOM
cough I-SYMPTOM
and O
sputum B-SYMPTOM
production I-SYMPTOM
. O

On O
discharge O
, O
the O
patient O
was O
restarted O
on O
her B-TREATMENT
Coumadin I-TREATMENT
, O
which O
was O
held O
for O
her O
right O
heart O
catheterization O
, O
and O
her O
biopsy O
, O
and O
her B-TREATMENT
ICD I-TREATMENT
placement I-TREATMENT
. O

She O
was O
also O
continued O
on O
all B-TREATMENT
her I-TREATMENT
heart I-TREATMENT
failure I-TREATMENT
medications I-TREATMENT
including O
her B-TREATMENT
Toprol I-TREATMENT
, O
her B-TREATMENT
lisinopril I-TREATMENT
, O
her B-TREATMENT
digoxin I-TREATMENT
, O
and O
her B-TREATMENT
Lasix I-TREATMENT
. O

CONDITION O
ON O
DISCHARGE O
: O

Good O
. O

DISCHARGE O
STATUS O
: O

To O
home O
. O

DISCHARGE O
DIAGNOSIS O
: O

Nonischemic B-SYMPTOM
dilated I-SYMPTOM
cardiomyopathy I-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Digoxin B-TREATMENT
375 O
mcg O
and O
250 O
mcg O
alternating O
doses O
each O
day O
. O

2. O
Lisinopril B-TREATMENT
40 O
mg O
p.o. O
q.d. O

3. O
Toprol B-TREATMENT
XL I-TREATMENT
75 O
mg O
p.o. O
q.d. O

4. O
Flovent B-TREATMENT
110 O
mcg O
two O
puffs O
b.i.d. O

5. O
Albuterol B-TREATMENT
1-2 O
puffs O
q.6h. O
prn O
. O

6. O
Coumadin B-TREATMENT
10 O
mg O
p.o. O
q.h.s. O

7. O
Lasix B-TREATMENT
40 O
mg O
p.o. O
q.d. O

8. O
Keflex B-TREATMENT
500 O
mg O
x6 O
doses O
. O

FOLLOW-UP O
INSTRUCTIONS O
: O

The O
patient O
will O
follow O
up O
in O
EP O
Clinic O
on O
2012-03-19 O
. O

She O
will O
also O
be O
seen O
in O
the O
Heart O
Failure O
Clinic O
on O
2012-03-28 O
. O

Patient O
will O
also O
followup O
with O
her O
primary O
care O
provider O
, O
Dr. O
Sandra O
Lamar O
for O
check O
of O
her O
INR O
in O
one O
week O
's O
time O
. O

Felix O
Weiss O
, O
M.D. O

95-771 O

Dictated O
By O
: O
Randy O
EB O
Brooks O
, O
M.D. O

MEDQUIST36 O

D O
: O
2012-03-13 O
12:25 O

T O
: O
2012-03-13 O
14:00 O

JOB O
#: O
15824 O

Signed O
electronically O
by O
: O
DR. O
Felix O
Willis O
on O
: O
FRI O
2012-06-22 O
12:49 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2019-10-10 O

Discharge O
Date O
: O

2019-10-19 O

Date O
of O
Birth O
: O

1994-01-10 O

Sex O
: O

M O

Service O
: O

ORTHOPAEDICS O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
George O
G O
Lindsey O
, O
M.D. O

Chief O
Complaint O
: O
s/p O
fall O
with O
Left B-SYMPTOM
arm I-SYMPTOM
pain I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

2019-10-11 O
: O

ORIF B-TREATMENT
Left B-SYMPTOM
distal I-SYMPTOM
radius I-SYMPTOM
fracture I-SYMPTOM

History O
of O
Present O
Illness O
: O

Mr. O
Steadman O
is O
a O
25 O
year O
old O
man O
who O
was O
locked O
out O
of O
his O
apartment O
and O
tried O
to O
enter O
by O
climbing O
up O
two O
stories O
to O
get O
in O
by O
a O
window O
. O

He O
fell O
15-20 O
feet O
onto O
concrete O
, O
denies O
any O
loss B-SYMPTOM
of I-SYMPTOM
consiousness I-SYMPTOM
. O

Past O
Medical O
History O
: O
denies O

Social O
History O
: O

+ETOH O
, O
had O
12 O
cans O
of O
beer O
prior O
to O
accident O

Family O
History O
: O
n/a O

Physical O
Exam O
: O

Upon O
admission O
: O

Alert O
and O
oriented O

Cardiac O
: O

Tachycardiac B-SYMPTOM
120-140 O
, O
regular O

Chest O
: O

Clear O
to O
auscultation O

Abdomen O
: O

Soft O
non-tender B-SYMPTOM
non-distended B-SYMPTOM

Extremities O
: O

Left B-SYMPTOM
elbow I-SYMPTOM
, I-SYMPTOM
gross I-SYMPTOM
deformity I-SYMPTOM
swelling I-SYMPTOM
over I-SYMPTOM
dorsal I-SYMPTOM
forearm I-SYMPTOM
, O
gross B-SYMPTOM
deformity I-SYMPTOM
left I-SYMPTOM
wrist I-SYMPTOM
, O
no O
skin B-SYMPTOM
lacerations I-SYMPTOM
. O

SILT O

R/U/M O
LUE O

Bilateral O
lower O
extremities O
: O

+ O
sensation O
, O
movment O
, O
pulses O
, O
some B-SYMPTOM
pain I-SYMPTOM
with O
ROM O

Brief O
Hospital O
Course O
: O

Mr. O
Steadman O
is O
a O
25 O
year O
old O
man O
who O
presented O
to O
the O
The O
Hospital O
for O
Orthopedics O
on O

2019-10-10 O
via O
ambulance O
after O
falling O
15-20 O
feet O
onto O
concrete O
. O

He O
was O
evaluated O
by O
the O
trauma O
surgery O
department O
and O
the O
orthopaedic O
surgery O
department O
. O

He O
was O
intoxicated O
and O
tachycardic B-SYMPTOM
in O
the O
trauma O
bay O
. O

His B-SYMPTOM
injuries I-SYMPTOM
were O
identified O
as O
a B-SYMPTOM
left I-SYMPTOM
elbow I-SYMPTOM
disloaction I-SYMPTOM
with O
was O
reduced O
and O
splinted O
. O

Also O
a B-SYMPTOM
left I-SYMPTOM
distal I-SYMPTOM
radius I-SYMPTOM
fracture I-SYMPTOM
with O
was O
reduced O
and O
splinted O
. O

Also O
a B-SYMPTOM
Left I-SYMPTOM
non I-SYMPTOM
displaced I-SYMPTOM
sacral I-SYMPTOM
wing I-SYMPTOM
fracture I-SYMPTOM
and O
left B-SYMPTOM
inferior I-SYMPTOM
pubic I-SYMPTOM
ramus I-SYMPTOM
fx I-SYMPTOM
extending O
the O
to O
inferior O
acetabulum O
. O

He O
was O
admitted O
to O
the O
trauma O
intensive O
care O
unit O
due O
to O
his B-SYMPTOM
tachycardia I-SYMPTOM
which O
was O
not O
resolved O
with O
pain B-TREATMENT
medication I-TREATMENT
. O

On O
2019-10-11 O
he O
was O
started O
on O
lopressor B-TREATMENT
for O
his B-SYMPTOM
tachycardia I-SYMPTOM
which O
had O
good O
effect O
. O

He O
was O
then O
transfered O
to O
the O
floor O
in O
the O
care O
of O
the O
orthopaedic O
surgery O
service O
. O

Also O
on O
2019-10-11 O
he O
was O
taken O
to O
the O
operating O
room O
for O
an B-TREATMENT
ORIF I-TREATMENT
of O
his B-SYMPTOM
left I-SYMPTOM
distal I-SYMPTOM
radius I-SYMPTOM
fracture I-SYMPTOM
. O

His B-SYMPTOM
pelvis I-SYMPTOM
fracture I-SYMPTOM
are O
closed O
treated O
and O
he O
can O
be O
weight O
bearing O
as O
tolerated O
on O
his O
right O
leg O
and O
and O
nonweight O
bearing O
on O
his O
left O
leg O
. O

He O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
without O
difficulty B-SYMPTOM
. O

He O
begain O
to O
work O
with O
physical O
therapy O
to O
improve O
his O
strenght O
and O
mobility O
. O

His O
heart O
rate O
continued O
to O
be O
well O
controlled O
with O
his B-TREATMENT
lopressor I-TREATMENT
. O

Throught O
the O
stay O
his O
labs O
remained O
normal O
and O
his B-SYMPTOM
pain I-SYMPTOM
controlled O
. O

He O
was O
discharged O
home O
in O
stable O
conditions O
. O

He O
was O
instructed O
to O
follow O
up O
with O
Dr. O
Conway O
in O
2 O
weeks O
and O
an O
appointment O
was O
made O
on O
11-15 O
for O
him O
at O
the O
Louis O
Schubert O
Community O
Health O
Center O
to O
follow O
his O
heart O
rate O
and O
continued O
need O
for O
lopressor B-TREATMENT
. O

Medications O
on O
Admission O
: O
none O

Discharge O
Medications O
: O

1. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
60 O
Capsule O
( O
s O
)* O
Refills O
:* O
2 O
* O

2. O
Enoxaparin B-TREATMENT
30 O
mg O
/ O
0.3 O
mL O
Syringe O
Sig O
: O
One O
( O
1 O
) O
30 O
mg O
syringe O
Subcutaneous O
Q12H O
( O
every O
12 O
hours O
) O
for O
4 O
weeks O
. O

Disp O
:* O
56 O
30 O
mg O
syringe O
* O
Refills O
:* O
0 O
* O

3. O
Oxycodone B-TREATMENT
- O
Acetaminophen B-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

Disp O
:* O
90 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

4. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

Discharge O
Disposition O
: O

Home O

Discharge O
Diagnosis O
: O
s/p O
fall O
from O
15-20 O
feet O

Discharge O
Condition O
: O

Stable O

Discharge O
Instructions O
: O

Continue O
to O
be O
non-weight O
bearing O
on O
your O
left O
leg O

Continue O
to O
wear O
your B-TREATMENT
left I-TREATMENT
arm I-TREATMENT
splint I-TREATMENT
, O
but O
take O
it O
off O
daily O
to O
inspect O
your O
skin O

Continue O
your B-TREATMENT
Lovenox I-TREATMENT
injections I-TREATMENT
as O
instructed O

If O
you O
notice O
any O
increase B-SYMPTOM
in I-SYMPTOM
swelling I-SYMPTOM
or O
erythemia B-SYMPTOM
at O
the B-SYMPTOM
incisions I-SYMPTOM
, O
or O
if O
you O
become O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
if O
you O
have O
a O
temperature O
greater O
than O
101.4 O
please O
call O
the O
office O
or O
go O
to O
the O
emergency O
room O

Physical O
Therapy O
: O

Activity O
: O

Activity O
as O
tolerated O

Left O
upper O
extremity O
: O

Non O
weight O
bearing O

Non-weight O
bearing O
left O
leg O

Treatments O
Frequency O
: O
splint B-TREATMENT
to I-TREATMENT
left I-TREATMENT
arm I-TREATMENT

Followup O
Instructions O
: O

Please O
follow O
up O
with O
Dr. O
Bergeron O
in O
clinic O
in O
2 O
weeks O
, O
please O
call O
953 O
6923 O
to O
Posada O
that O
appointment O
. O

An O
appointment O
has O
been O
made O
for O
you O
with O
Nurse O
Daniel O
Crump O
at O
the O
Loretta O
Schubert O
Community O
Health O
Center O
on O
Friday O
Novemeber O
24 O
at O
2pm O
. O

It O
is O
located O
at O
2249 O
S. O
Lincoln O
Ave. O
in O
Nantucket O
Cottage O
Hospital O
the O
phone O
to O
the O
clinic O
is O
( O
451 O
) O
376-3200 O
. O

They O
will O
monitor O
your O
blood O
pressure O
and O
heart O
rate O
and O
lopressor B-TREATMENT
. O

Gregory O
Robert O
MD O
06-807 O

Completed O
by O
: O
Genevieve O
Gehlert O
PA O
80-BZQ O
2019-10-19 O
@ O
1248 O

Signed O
electronically O
by O
: O
DR. O
Ron O
Scott O
on O
: O
WED O
2019-11-27 O
7:42 O
AM O

( O
End O
of O
Report O
) O

559197012_b O

FIH O

4469096 O

64024/p16e O

909222 O

10/24/1993 O
12:00:00 O
AM O

NON-Q B-SYMPTOM
WAVE I-SYMPTOM
MYOCARDIAL I-SYMPTOM
INFARCTION I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

10-24-93 O

DISCHARGE O
DATE O
: O

11-2-93 O

PRINCIPAL O
DIAGNOSIS O
: O

Non-Q B-SYMPTOM
wave I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Status O
post O
anterior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
05-93 O
, O
status O
post O
percutaneous B-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
of I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
in O
05-93 O
, O
hypertension B-SYMPTOM
, O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Coronary B-TREATMENT
angiography I-TREATMENT
, O
exercise O
tolerance O
test O
with O
Thallium O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Metoprolol B-TREATMENT
50 O
mg O
PO O
bid O
, O
Isordil B-TREATMENT
20 O
mg O
PO O
tid O
, O
enteric B-TREATMENT
coated I-TREATMENT
aspirin I-TREATMENT
1 O
PO O
qd O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
65 O
year O
old O
Portuguese O
male O
with O
a O
history O
of O
an B-SYMPTOM
anterior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
i O
May O
1993 O
and O
is O
status O
post O
a B-TREATMENT
percutaneous I-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
of I-TREATMENT
the I-TREATMENT
LAD I-TREATMENT
who O
presented O
on O
10-24-93 O
with O
crushing B-SYMPTOM
substernal I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

He O
had O
no O
prior O
cardiac O
history O
until O
May O
1993 O
when O
on O
5-24 O
he O
had O
crushing B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
which O
radiated O
to O
his O
left O
arm O
. O

He O
was O
found O
at O
that O
time O
to O
have O
3-4 B-SYMPTOM
mm I-SYMPTOM
ST I-SYMPTOM
segment I-SYMPTOM
elevations I-SYMPTOM
in I-SYMPTOM
V1 I-SYMPTOM
through O
V4 O
at O
Pre O
Health O
. O

The O
patient O
was O
transferred O
to O
Fairm O
of O
Ijordcompmac O
Hospital O
and O
had O
4-7 B-SYMPTOM
mm I-SYMPTOM
ST I-SYMPTOM
segment I-SYMPTOM
elevations I-SYMPTOM
across I-SYMPTOM
the I-SYMPTOM
precordium I-SYMPTOM
with O
Q&apos;s B-SYMPTOM
in I-SYMPTOM
V1 I-SYMPTOM
and I-SYMPTOM
V2 I-SYMPTOM
, O
2 B-SYMPTOM
mm I-SYMPTOM
ST I-SYMPTOM
elevation I-SYMPTOM
in I-SYMPTOM
AVL I-SYMPTOM
, O
and O
1-2 B-SYMPTOM
mm I-SYMPTOM
reciprocal I-SYMPTOM
ST I-SYMPTOM
depression I-SYMPTOM
in I-SYMPTOM
II I-SYMPTOM
, I-SYMPTOM
III I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
F. I-SYMPTOM

On O
physical O
examination O
at O
that O
time O
he O
had O
bright B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
and O
therefore O
lysis B-TREATMENT
was O
deferred O
and O
he O
was O
taken O
directly O
to O
the O
cardiac O
catheterization O
lab O
. O

The O
cardiac O
catheterization O
results O
at O
that O
time O
revealed O
a O
right O
atrial O
pressure O
of O
7 O
, O
pulmonary O
artery O
pressure O
of O
29/16 O
, O
RV O
33/8 O
, O
pulmonary O
capillary O
wedge O
pressure O
of O
16 O
. O

He O
had O
a B-SYMPTOM
95% I-SYMPTOM
proximal I-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
descending I-SYMPTOM
lesion I-SYMPTOM
which O
was O
PTCA O
&apos;d O
to O
a O
residual O
of O
30% O
and O
an B-TREATMENT
intra-aortic I-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
was O
placed O
. O

He O
also O
had O
some B-SYMPTOM
mild I-SYMPTOM
to I-SYMPTOM
moderate I-SYMPTOM
disease I-SYMPTOM
at O
the O
OM1 O
noted O
at O
that O
time O
. O

The O
patient O
was O
transferred O
to O
the O
Cardiac O
Care O
Unit O
where O
he O
had O
a O
peak O
CPK O
of O
5,042 O
and O
26.7% O
MB&apos;s O
. O

His B-TREATMENT
intra-aortic I-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
was O
weaned O
without O
problems B-SYMPTOM
. O

He O
had O
hypotension B-SYMPTOM
with O
beta B-TREATMENT
blockers I-TREATMENT
and O
therefore O
they O
were O
not O
started O
. O

On O
day O
six O
, O
an O
echocardiogram O
showed O
an O
ejection O
fraction O
of O
44% O
with O
anterior B-SYMPTOM
akinesis I-SYMPTOM
and O
septal B-SYMPTOM
hypokinesis I-SYMPTOM
. O

On O
day O
nine O
, O
he O
had O
a O
low O
level O
exercise O
tolerance O
test O
with O
Thallium O
which O
was O
positive O
for O
2.5 B-SYMPTOM
mm I-SYMPTOM
horizontal I-SYMPTOM
depressions I-SYMPTOM
in I-SYMPTOM
II I-SYMPTOM
, I-SYMPTOM
III I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
AVF I-SYMPTOM
, O
and O
1.5 B-SYMPTOM
mm I-SYMPTOM
downsloping I-SYMPTOM
ST I-SYMPTOM
depressions I-SYMPTOM
in I-SYMPTOM
V5 I-SYMPTOM
and I-SYMPTOM
V6 I-SYMPTOM
, O
as O
well O
as O
some B-SYMPTOM
anteroseptal I-SYMPTOM
redistribution I-SYMPTOM
on O
Thallium B-TREATMENT
. O

Therefore O
, O
he O
went O
to O
repeat O
cardiac O
catheterization O
which O
revealed O
that O
the O
left O
anterior O
descending O
site O
was O
patent O
and O
revealed O
a B-SYMPTOM
distal I-SYMPTOM
PDA I-SYMPTOM
lesion I-SYMPTOM
and O
a B-SYMPTOM
circumflex I-SYMPTOM
lesion I-SYMPTOM
after O
the O
OM O
. O

The O
patient O
was O
discharged O
to O
home O
and O
is O
supposed O
to O
follow O
up O
with O
Dr. O
Shuffburle O
of O
Gastroenterology O
for O
work O
up O
of O
his B-SYMPTOM
bright I-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
and O
is O
supposed O
to O
follow O
up O
with O
Dr. O
Amesin O
of O
Cardiology O
and O
Dr. O
Shuffpasc O
of O
Dingclearf O
Alllirefaith O
Memorial O
Hospital O
. O

However O
, O
he O
did O
not O
keep O
any O
of O
these O
appointments O
. O

He O
went O
home O
and O
did O
not O
take O
any O
of O
his B-TREATMENT
medications I-TREATMENT
and O
smoked O
and O
drank O
heavily O
throughout O
the O
several O
months O
. O

On O
the O
a.m. O
of O
10-24-93 O
, O
the O
patient O
developed O
crushing B-SYMPTOM
substernal I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

He O
came O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
Emergency O
Ward O
where O
he O
was O
noted O
to O
be O
ashen B-SYMPTOM
and O
diaphoretic B-SYMPTOM
. O

He O
was O
treated O
with O
oxygen B-TREATMENT
, O
aspirin B-TREATMENT
, O
five B-TREATMENT
sublingual I-TREATMENT
nitroglycerins I-TREATMENT
, O
heparin B-TREATMENT
, O
and O
was O
eventually O
made O
pain O
free O
with O
that B-TREATMENT
regimen I-TREATMENT
. O

CARDIAC O
RISK O
FACTORS O
: O

His O
cardiac O
risk O
factors O
included O
hypertension B-SYMPTOM
, O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
hypercholesterolemia B-SYMPTOM
, O
cigarette O
smoking O
, O
and O
a O
positive O
family O
history O
. O

PAST O
MEDICAL O
HISTORY O
: O

His O
past O
medical O
history O
included O
hypertension B-SYMPTOM
and O
non-insulin B-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
which O
is O
diet O
controlled O
. O

PAST O
SURGICAL O
HISTORY O
: O

His O
past O
surgical O
history O
had O
included O
gastric B-TREATMENT
ulcer I-TREATMENT
surgery I-TREATMENT
and O
appendectomy B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

On O
admission O
, O
he O
was O
on O
Isordil B-TREATMENT
10 O
tid O
and O
enteric B-TREATMENT
coated I-TREATMENT
aspirin I-TREATMENT
, O
but O
he O
was O
not O
taking O
either O
of O
these B-TREATMENT
medications I-TREATMENT
. O

HABITS O
: O

The O
patient O
smokes O
one O
pack O
per O
day O
and O
has O
a O
history O
of O
heavy O
alcohol O
use O
. O

PHYSICAL O
EXAMINATION O
: O

The O
physical O
examination O
on O
admission O
revealed O
a O
blood O
pressure O
of O
110/70 O
, O
a O
heart O
rate O
of O
66 O
, O
respirations O
of O
24 O
, O
temperature O
of O
98 O
. O

The O
HEENT O
exam O
revealed O
the O
extra O
ocular O
movements O
intact O
. O

The O
pupils O
equal O
, O
round O
, O
reactive O
to O
light O
. O

The O
oropharynx O
was O
clear O
and O
the O
fundi O
were O
normal O
. O

There O
were O
no O
hypertensive B-SYMPTOM
or I-SYMPTOM
diabetic I-SYMPTOM
changes I-SYMPTOM
. O

The O
neck O
was O
suppled O
, O
with O
no O
lymphadenopathy B-SYMPTOM
and O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
. O

The O
carotids O
were O
1+ O
without O
bruits B-SYMPTOM
. O

The O
heart O
was O
regular O
rate O
and O
rhythm O
, O
S4 O
, O
S1 O
, O
S2 O
, O
with O
a B-SYMPTOM
I I-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
systolic I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
. O

The O
lungs O
were O
clear O
, O
except O
for O
a B-SYMPTOM
few I-SYMPTOM
dry I-SYMPTOM
crackles I-SYMPTOM
bibasilarly I-SYMPTOM
. O

The O
abdomen O
revealed O
a B-SYMPTOM
midline I-SYMPTOM
scar I-SYMPTOM
and O
a B-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
scar I-SYMPTOM
, O
and O
it O
was O
soft O
and O
nontender B-SYMPTOM
wit O
positive O
bowel O
sounds O
. O

The O
liver O
edge O
was O
2 O
cm O
below O
the O
right O
costal O
margin O
, O
but O
smooth O
and O
nontender B-SYMPTOM
. O

There O
was O
no O
splenomegaly B-SYMPTOM
. O

The O
femoral O
pulses O
were O
diminished B-SYMPTOM
. O

He O
had O
bilateral B-SYMPTOM
intertrigo I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
femoral I-SYMPTOM
region I-SYMPTOM
as O
well O
as O
his O
axillae O
. O

The O
extremities O
revealed O
no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

The O
pulses O
were O
1+ O
bilaterally O
. O

The O
skin O
exam O
revealed O
changes O
consistent O
with O
vitiligo B-SYMPTOM
. O

The O
rectal O
examination O
was O
guaiac O
negative O
. O

LABORATORY O
DATA O
: O

The O
laboratory O
data O
revealed O
normal O
electrolytes O
, O
BUN O
and O
creatinine O
, O
normal O
liver O
function O
tests O
, O
a O
first O
CPK O
of O
140 O
, O
and O
a O
hematocrit O
of O
43.1 O
. O

The O
portable O
chest O
X-ray O
showed O
clear O
lungs O
, O
slight B-SYMPTOM
enlarged I-SYMPTOM
heart I-SYMPTOM
, O
and O
a B-SYMPTOM
mildly I-SYMPTOM
elevated I-SYMPTOM
hemidiaphragm I-SYMPTOM
. O

The O
electrocardiogram O
was O
normal O
sinus O
rhythm O
at O
81 O
, O
with O
normal O
intervals O
and O
normal O
axis O
, O
had O
poor B-SYMPTOM
R-wave I-SYMPTOM
progression I-SYMPTOM
consistent O
with O
an B-SYMPTOM
old I-SYMPTOM
anterior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
had O
flipped B-SYMPTOM
T-waves I-SYMPTOM
in I-SYMPTOM
V1 I-SYMPTOM
through O
V5 O
, O
which O
were O
of O
no O
significant B-SYMPTOM
change I-SYMPTOM
since O
his O
last O
EKG O
on O
5-25-93 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Step O
Down O
Unit O
for O
a O
rule O
out O
MI B-TREATMENT
protocol I-TREATMENT
. O

He O
was O
treated O
with O
aspirin B-TREATMENT
, O
heparin B-TREATMENT
, O
and O
intravenous B-TREATMENT
nitroglycerin I-TREATMENT
. O

No O
beta B-TREATMENT
blockers I-TREATMENT
was O
started O
because O
of O
his O
history O
of O
hypertension B-SYMPTOM
with O
beta B-TREATMENT
blockers I-TREATMENT
and O
because O
his O
blood O
pressure O
of O
only O
110/70 O
. O

The O
patient O
ruled O
in O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
with O
a O
peak O
CPK O
of O
219 O
and O
20.9% O
MB O
fraction O
. O

This O
was O
a B-SYMPTOM
non-Q I-SYMPTOM
wave I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
as O
there O
were O
no O
diagnostic B-SYMPTOM
electrocardiogram I-SYMPTOM
changes I-SYMPTOM
. O

on O
10-27-93 O
, O
the O
patient O
went O
to O
the O
cath O
lab O
which O
revealed O
a O
small O
nondominant O
right O
coronary O
artery O
without O
any B-SYMPTOM
lesions I-SYMPTOM
, O
a B-SYMPTOM
restenosis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
descending I-SYMPTOM
lesion I-SYMPTOM
that O
had O
been O
PTCA B-TREATMENT
&apos;d I-TREATMENT
, O
a B-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
first I-SYMPTOM
OM I-SYMPTOM
, O
and O
a B-SYMPTOM
moderately I-SYMPTOM
severe I-SYMPTOM
left I-SYMPTOM
circumflex I-SYMPTOM
lesion I-SYMPTOM
after I-SYMPTOM
the I-SYMPTOM
OM3 I-SYMPTOM
. O

The O
left O
ventriculogram O
revealed O
an B-SYMPTOM
akinetic I-SYMPTOM
anterolateral I-SYMPTOM
and I-SYMPTOM
apical I-SYMPTOM
ventricle I-SYMPTOM
. O

Given O
the O
results O
of O
this O
cardiac O
catheterization O
, O
which O
were O
not O
significantly O
changed O
from O
his O
previous O
cardiac O
catheterization O
prior O
to O
the B-TREATMENT
PTCA I-TREATMENT
, O
it O
was O
elected O
to O
attempt O
to O
medically O
manage O
the O
patient O
. O

He O
was O
ambulated O
progressively O
on O
the O
floor O
. O

A B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
was O
started O
with O
Metoprolol B-TREATMENT
initially O
at O
25 O
mg O
PO O
bid O
and O
eventually O
increased O
to O
50 O
mg O
PO O
bid O
. O

The O
patient O
ambulated O
extensively O
on O
the O
FIH O
20 O
floor O
each O
day O
without O
any O
episodes O
of O
chest B-SYMPTOM
pain I-SYMPTOM
or O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

On O
11-2-93 O
, O
the O
patient O
underwent O
a O
low O
level O
treadmill O
exercise O
test O
with O
Thallium O
imaging O
. O

This O
treadmill O
test O
was O
done O
on O
medications B-TREATMENT
, O
including O
beta B-TREATMENT
blockers I-TREATMENT
, O
in O
hopes O
to O
assess O
an O
amount O
of O
ischemia B-SYMPTOM
on O
treatment B-TREATMENT
. O

The O
patient O
was O
able O
to O
exercise O
for O
approximately O
nine O
minutes O
on O
a B-TREATMENT
modified I-TREATMENT
Bruce I-TREATMENT
protocol I-TREATMENT
, O
however O
, O
he O
did O
not O
reach O
his O
predicted O
maximal O
heart O
rate O
while O
he O
was O
on O
the B-TREATMENT
beta I-TREATMENT
blockade I-TREATMENT
. O

There O
were O
no O
diagnostic B-SYMPTOM
electrocardiogram I-SYMPTOM
changes I-SYMPTOM
during O
the O
treadmill O
exercise O
test O
, O
although O
he O
did O
have O
0.5 B-SYMPTOM
to I-SYMPTOM
1 I-SYMPTOM
mm I-SYMPTOM
ST I-SYMPTOM
depression I-SYMPTOM
in I-SYMPTOM
II I-SYMPTOM
, I-SYMPTOM
III I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
AVF I-SYMPTOM
. O

The O
study O
was O
halted O
for O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
there O
was O
no O
chest B-SYMPTOM
pain I-SYMPTOM
. O

Thallium O
images O
revealed O
a B-SYMPTOM
moderate I-SYMPTOM
sized I-SYMPTOM
region I-SYMPTOM
of I-SYMPTOM
ischemic I-SYMPTOM
but I-SYMPTOM
viable I-SYMPTOM
myocardium I-SYMPTOM
involving O
the O
anteroseptal O
and O
lateral O
segments O
of O
the O
left O
ventricle O
. O

There O
was O
also O
some O
evidence O
of O
left B-SYMPTOM
ventricular I-SYMPTOM
dysfunction I-SYMPTOM
during O
the O
test O
. O

These O
images O
were O
essentially O
unchanged O
compared O
with O
the O
previous O
Thallium O
images O
in O
May O
1993 O
. O

After O
extensive O
discussion O
between O
myself O
, O
Dr. O
Amesin O
, O
and O
Dr. O
Scgach O
, O
it O
was O
elected O
to O
discharge O
the O
patient O
to O
home O
with O
medical B-TREATMENT
management I-TREATMENT
. O

The O
patient O
was O
extremely O
reluctant O
to O
undergo O
surgery B-TREATMENT
, O
although O
he O
understands O
that O
this O
may O
become O
necessary O
in O
the O
future O
. O

Dr. O
Amesin O
had O
a O
long O
discussion O
with O
the O
patient O
&apos;s O
daughters O
revolving O
primarily O
around O
issues O
of O
the O
patient O
&apos;s O
compliance O
. O

Previously O
he O
had O
not O
taken O
any O
of O
his B-TREATMENT
medicines I-TREATMENT
and O
smoked O
heavily O
on O
the O
outside O
and O
not O
kept O
any O
of O
his O
appointments O
. O

The O
importance O
of O
quitting O
smoking O
as O
well O
as O
continuing O
to O
follow O
his B-TREATMENT
medical I-TREATMENT
regimen I-TREATMENT
was O
emphasized O
to O
the O
daughter O
and O
to O
the O
patient O
. O

She O
will O
be O
actively O
involved O
in O
encouraging O
the O
patient O
to O
comply O
with O
this B-TREATMENT
medical I-TREATMENT
regimen I-TREATMENT
and O
also O
to O
follow O
up O
with O
Dr. O
Amesin O
as O
well O
as O
Dr. O
Lfsquarc O
on O
the O
outside O
. O

The O
patient O
remained O
guaiac O
negative O
throughout O
the O
entire O
hospitalization O
. O

Despite O
being O
on O
heparin B-TREATMENT
for O
a O
short O
time O
, O
his O
hematocrit O
remained O
very O
stable O
with O
only O
a B-SYMPTOM
small I-SYMPTOM
dip I-SYMPTOM
after O
the B-TREATMENT
catheterization I-TREATMENT
was O
done O
. O

He O
will O
need O
to O
be O
followed O
up O
as O
an O
out O
patient O
for O
guaiac B-SYMPTOM
positive I-SYMPTOM
stools I-SYMPTOM
and O
possibly O
worked O
up O
for O
this O
in O
the O
future O
. O

CAGHALA O
UINTEELE O
, O
M.D. O

TR O
: O

yf O
/ O
bmot O

DD O
: O

11-3-93 O

TD O
: O

11/04/93 O

CC O
: O

Dr. O
Telshey O
Swatlleebtik O
Dr. O
Eri O
Lfsquarc O

506243692_b O

FIH O

6305145 O

963632 O

439524 O

11/4/2000 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O
NAME O
: O

STATE O
, O
ELRO O

UNIT O
NUMBER O
: O

413-18-46 O

ADMISSION O
DATE O
: O

11/04/2000 O

DISCHARGE O
DATE O
: O

11/09/2000 O

PRINCIPAL O
DIAGNOSIS O
: O

Pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
mediastinal B-SYMPTOM
mass I-SYMPTOM
, O
inferior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
bronchiectasis B-SYMPTOM
. O

ADVERSE O
DRUG O
REACTIONS O
: O

None O
. O

CLINICAL O
INFECTIONS O
: O

None O
. O

PRINCIPAL O
PROCEDURE O
: O

Cardiac O
catheterization O
. O

ASSOCIATED O
PROCEDURES O
: O

VQ O
scan O
, O
lower O
extremities O
noninvasive O
Doppler O
studies O
and O
overnight O
oximetry O
saturation O
monitoring O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
State O
is O
an O
81-year-old O
man O
with O
a O
history O
of O
restrictive B-SYMPTOM
and I-SYMPTOM
obstructive I-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
, O
dilated B-SYMPTOM
cardiomyopathy I-SYMPTOM
, O
inferior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
and O
anterior B-SYMPTOM
mediastinal I-SYMPTOM
masses I-SYMPTOM
admitted O
with O
acute O
onset O
of O
pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

In O
the O
setting O
of O
inadvertently O
decreasing O
Lasix B-TREATMENT
from O
80 O
mg. O
po O
40 O
mg. O
a O
day O
Mr. O
State O
had O
sudden B-SYMPTOM
onset I-SYMPTOM
dyspnea I-SYMPTOM
after O
approximate O
day O
and O
a O
half O
prodrome B-SYMPTOM
culminating O
in O
severe B-SYMPTOM
dyspnea I-SYMPTOM
. O

Upon O
arrival O
in O
the O
Emergency O
Room O
Mr. O
State O
&apos;s O
saturations O
were O
in O
the O
mid O
80s O
and O
he O
was O
promptly O
rendered O
more O
comfortable O
with O
high B-TREATMENT
flow I-TREATMENT
oxygen I-TREATMENT
, O
morphine B-TREATMENT
, O
and O
nitrates B-TREATMENT
and O
intravenous B-TREATMENT
Lasix I-TREATMENT
. O

Chest O
x-ray O
was O
relatively O
unrevealing O
for O
interstitial B-SYMPTOM
or I-SYMPTOM
alveolar I-SYMPTOM
edema I-SYMPTOM
and O
with O
clinical O
improvement O
ensued O
with O
the O
immediate B-TREATMENT
therapy I-TREATMENT
in O
the O
Emergency O
Room O
as O
noted O
. O

The O
patient O
denied O
angina B-SYMPTOM
, O
syncope B-SYMPTOM
, O
preceding B-SYMPTOM
worsening I-SYMPTOM
orthopnea I-SYMPTOM
, O
paroxysmal B-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
, O
palpitations B-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
hematemesis B-SYMPTOM
or O
melena B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Is O
notable O
for O
an B-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
restrictive B-SYMPTOM
and I-SYMPTOM
obstructive I-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
with O
an O
FEV1 O
of O
.9 O
and O
FVC O
of O
1.34 O
and O
a O
moderate O
at O
best O
response O
to O
bronchodilators B-TREATMENT
, O
and O
a O
negative O
sestamibi O
scan O
in O
May O
, O
1999 O
apart O
from O
a B-SYMPTOM
severe I-SYMPTOM
fixed I-SYMPTOM
inferolateral I-SYMPTOM
defect I-SYMPTOM
, O
systolic B-SYMPTOM
dysfunction I-SYMPTOM
with O
recent O
echocardiography O
revealing O
an O
LVID O
of O
62 O
mm. O
and O
ejection O
fraction O
of O
28 O
percent O
, O
moderate B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
and O
mild-to-moderate B-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM
with O
a O
peak O
gradient O
of O
33 O
and O
a O
mean O
gradient O
of O
19 O
and O
a O
valve O
area O
of O
1.4 O
cm. O
squared O
. O

In O
addition O
, O
Mr. O
State O
has O
an B-SYMPTOM
anterior I-SYMPTOM
mediastinal I-SYMPTOM
mass I-SYMPTOM
2x2x1.7 O
cm. O
by O
recent O
computerized O
tomography O
scan O
without O
surrounding B-SYMPTOM
or I-SYMPTOM
adjacent I-SYMPTOM
adenopathy I-SYMPTOM
or O
parenchymal B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
apart O
from O
bronchiectasis B-SYMPTOM
. O

His O
cardiomyopathy O
work O
up O
entailed O
a O
negative O
ANA O
, O
negative O
SPEP O
, O
UPEP O
and O
Benz-Jones O
proteins O
, O
normal O
ferritin O
, O
thyroid O
stimulating O
hormone O
and O
a O
recent O
work O
up O
for O
possible O
bimomatous B-SYMPTOM
associated O
myasthenia B-SYMPTOM
gravis I-SYMPTOM
that O
was O
negative O
. O

The O
patient O
lives O
on O
Quelene O
with O
his O
wife O
. O

He O
is O
a O
non-smoker O
and O
drinks O
rare O
alcohol O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
was O
a O
very O
pleasant O
man O
who O
appeared O
his O
stated O
age O
. O

Blood O
pressure O
was O
155/60 O
, O
heart O
rate O
70 O
with O
occasional B-SYMPTOM
premature I-SYMPTOM
ventricular I-SYMPTOM
contractions I-SYMPTOM
, O
respirations O
14 O
. O

Mr. O
State O
was O
dyspneic B-SYMPTOM
speaking O
in O
short O
sentences O
initially O
on O
high B-TREATMENT
flow I-TREATMENT
oxygen I-TREATMENT
. O

Jugular O
venous O
pressure O
was O
8 O
with O
a B-SYMPTOM
brisk I-SYMPTOM
inspiratory I-SYMPTOM
descent I-SYMPTOM
. O

There O
was O
no O
thyromegaly B-SYMPTOM
. O

Carotids O
were O
2+ O
. O

Breath O
sounds O
were O
decreased B-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
bases I-SYMPTOM
only O
with O
distant B-SYMPTOM
heart I-SYMPTOM
sounds I-SYMPTOM
and O
a B-SYMPTOM
2 I-SYMPTOM
out I-SYMPTOM
of I-SYMPTOM
6 I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
consistent O
with O
aortic B-SYMPTOM
stenosis I-SYMPTOM
with O
Gallavardin B-SYMPTOM
like I-SYMPTOM
radiation I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
apex I-SYMPTOM
. O

Abdomen O
: O

soft O
, O
nontender B-SYMPTOM
with O
hepatosplenomegaly B-SYMPTOM
, O
or O
hepatojugular B-SYMPTOM
reflex I-SYMPTOM
, O
bruits B-SYMPTOM
or O
pulsations B-SYMPTOM
. O

There O
was O
no O
rash B-SYMPTOM
and O
no O
edema B-SYMPTOM
and O
the O
neurological O
examination O
was O
non-focal O
. O

LABORATORY O
DATA O
: O

Notable O
for O
a O
sodium O
of O
145 O
, O
potassium O
3.6 O
, O
BUN O
23 O
, O
creatinine O
1.3 O
, O
glucose O
104 O
, O
hematocrit O
42 O
, O
white O
count O
8.7 O
, O
platelet O
count O
235 O
and O
a O
PT O
of O
12.9 O
seconds O
. O

The O
urinalysis O
was O
negative O
. O

The O
Troponin O
I O
was O
less O
than O
.4 O
and O
the O
creatine O
kinase O
was O
114 O
. O

Chest O
x-ray O
revealed O
moderate B-SYMPTOM
cardiomegaly I-SYMPTOM
with O
no O
clear B-SYMPTOM
interstitial I-SYMPTOM
or I-SYMPTOM
alveolar I-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
and O
chronic B-SYMPTOM
atelectasis I-SYMPTOM
and O
/ O
or O
scarring B-SYMPTOM
at I-SYMPTOM
both I-SYMPTOM
lung I-SYMPTOM
bases I-SYMPTOM
. O

The O
electrocardiogram O
revealed O
normal O
sinus O
rhythm O
with O
premature B-SYMPTOM
atrial I-SYMPTOM
complexes I-SYMPTOM
and O
right B-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
with O
left B-SYMPTOM
anterior I-SYMPTOM
hemiblock I-SYMPTOM
and O
old B-SYMPTOM
anterior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Hospital O
and O
underwent O
an B-TREATMENT
approximate I-TREATMENT
1.5 I-TREATMENT
liter I-TREATMENT
diuresis I-TREATMENT
within O
the O
first O
24 O
hours O
with O
improvement O
in O
his B-SYMPTOM
symptoms I-SYMPTOM
and O
improvement O
in O
his O
oxygen O
saturations O
. O

After O
a O
long O
discussion O
with O
the O
patient O
and O
his O
family O
it O
was O
determined O
that O
a O
cardiac O
catheterization O
would O
be O
prudent O
. O

Prior O
to O
catheterization O
a O
VQ O
scan O
was O
performed O
which O
revealed O
a O
moderate O
probability O
for O
PE B-SYMPTOM
with O
a B-SYMPTOM
subsegmental I-SYMPTOM
defect I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lingular I-SYMPTOM
on O
the O
left O
lung O
. O

Subsequent O
lower O
extremities O
noninvasive O
studies O
and O
D-dimer O
test O
were O
both O
negative O
rendering O
the O
probability O
of O
acute B-SYMPTOM
pulmonary I-SYMPTOM
embolism I-SYMPTOM
less O
than O
2 O
percent O
. O

It O
was O
not O
felt O
that O
the O
patient O
would O
be O
in O
need O
of O
chronic B-TREATMENT
Coumadin I-TREATMENT
therapy I-TREATMENT
in O
lieu O
of O
this O
low O
probability O
findings O
in O
toto O
. O

Coronary O
angiography O
revealed O
occlusion B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
proximally I-SYMPTOM
with O
insignificant B-SYMPTOM
plaquing I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
descending I-SYMPTOM
artery I-SYMPTOM
and O
circumflex O
arteries O
. O

After O
a B-TREATMENT
approximate I-TREATMENT
3 I-TREATMENT
liter I-TREATMENT
total I-TREATMENT
diuresis I-TREATMENT
the O
right O
atrial O
pressure O
was O
5 O
, O
pulmonary O
capillary O
wedge O
pressure O
14 O
, O
pulmonary O
vacuolar O
resistance O
353 O
and O
the O
cardiac O
output O
depressed O
at O
2.95 O
liters O
per O
minute O
, O
or O
a O
cardiac O
index O
of O
1.7 O
liters O
per O
minute O
. O

Based O
upon O
these O
findings O
it O
was O
felt O
that O
Mr. O
State O
most O
likely O
has O
multi-factorial B-SYMPTOM
dyspnea I-SYMPTOM
owing O
to O
both O
his B-SYMPTOM
ventilatory I-SYMPTOM
limitation I-SYMPTOM
and O
to O
a B-SYMPTOM
chronic I-SYMPTOM
low I-SYMPTOM
output I-SYMPTOM
state I-SYMPTOM
. O

In O
Hospital O
he O
was O
seen O
by O
both O
Speech O
Therapy O
, O
physical O
therapy O
, O
and O
the O
Uspend O
Harmemewood O
Medical O
Center O
Congestive O
Heart O
Failure O
Nurse O
Practitioner O
Program O
. O

His B-TREATMENT
Isordil I-TREATMENT
was O
increased O
in O
Hospital O
and O
blood B-TREATMENT
pressure I-TREATMENT
control I-TREATMENT
was O
relative O
episodic O
with O
systolic O
pressures O
ranging O
between O
100 O
and O
160 O
. O

Future O
adjustments O
will O
be O
made O
at O
home O
pending O
his O
blood O
pressure O
measures O
. O

At O
a O
goal O
weight O
of O
142 O
pounds O
, O
Mr. O
State O
&apos;s O
filling O
pressures O
appeared O
ideal O
with O
a O
wedge O
pressure O
of O
14 O
and O
his O
goal O
weight O
range O
will O
be O
between O
142 O
and O
44 O
pounds O
at O
home O
. O

The O
patient O
will O
be O
followed O
by O
Dr. O
State O
within O
a O
week O
of O
discharge O
and O
by O
Nieie O
Naebrand O
Freierm O
of O
the O
Dyathenslycha O
Medical O
Center O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Imdur B-TREATMENT
120 O
mg. O
PO O
q.d. O
Captopril B-TREATMENT
100mg. O
PO O
t.i.d. O
Lasix B-TREATMENT
80 O
mg. O
PO O
q.d. O
Potassium B-TREATMENT
chloride I-TREATMENT
40 O
mEq. O
PO O
q.d. O
Coreg B-TREATMENT
12.5 O
mg. O
b.i.d. O
Cozaar B-TREATMENT
100 O
mg. O
b.i.d. O
Plavix B-TREATMENT
75 O
mg. O
q.d. O
Allopurinol B-TREATMENT
300 O
mg. O
q.d. O
Pulmacort B-TREATMENT
and O
Serevent B-TREATMENT
inhalers I-TREATMENT
2 O
puffs O
b.i.d. O
Zocor B-TREATMENT
20 O
mg. O
q.d. O
Prilosec B-TREATMENT
20 O
mg. O
q.d. O
Colace B-TREATMENT
100 O
mg. O
t.i.d. O

FOLLOW O
UP O
: O

The O
patient O
will O
see O
Dr. O
State O
, O
as O
noted O
, O
in O
follow O
up O
. O

AKA O
G O
STATE O
, O
M.D. O
CARDIAC O
TRANSPLANT O
STEMSTRICTALLE O
MEDICAL O
CENTER O
Electronically O
Signed O
AKA O
G O
STATE O
, O
M.D. O
11/17/2000 O
12:46 O
_____________________________ O
?? O

TR O
: O

rij O

DD O
: O

11/09/2000 O

TD O
: O

11/14/2000 O
1:09 O
P O

cc O
: O

AKA O
G O
STATE O
, O
M.D. O
AMAN O
SCKOLLMINEVUILLE O
, O
M.D. O
FA O
HEN O
KNOTTIPPSFYFE O
, O
M.D. O

Admission O
Date O
: O

2017-06-16 O

Discharge O
Date O
: O

2017-07-27 O

Date O
of O
Birth O
: O

1959-03-24 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Andre O
K. O
Young O
, O
M.D. O

Chief O
Complaint O
: O

Fever B-SYMPTOM
, O
tachycardia B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

None O

History O
of O
Present O
Illness O
: O

Patient O
is O
a O
58 O
year O
old O
male O
with O
a O
recent O
admission O
for O
abdominal B-SYMPTOM
pain I-SYMPTOM
s/p O
negative O
exploratory O
laparotomy O
for O
suspected O
intussuception B-SYMPTOM
now O
returns O
on O
day O
of O
discharge O
with O
fever B-SYMPTOM
and O
tachycardia B-SYMPTOM
. O

Patient O
has O
a O
history O
for O
terrible B-SYMPTOM
vasculopathy I-SYMPTOM
s/p O
recent B-TREATMENT
right I-TREATMENT
BKA I-TREATMENT
with O
dry B-SYMPTOM
gangrene I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
stump I-SYMPTOM
. O

Patient O
's O
last O
admission O
was O
significant O
for O
a O
negative O
ex-lap O
. O

Post-operatively O
, O
his O
course O
was O
complicated O
by O
respiratory B-SYMPTOM
distress I-SYMPTOM
necessitating O
an O
urgent O
return O
to O
the O
ICU O
and O
was O
intubated O
. O

After O
multuple O
failed O
attempts O
at O
extubation B-TREATMENT
, O
the O
patient O
was O
trached O
. O

Patient O
then O
did O
well O
on O
a B-TREATMENT
trach I-TREATMENT
mask I-TREATMENT
and O
was O
transferred O
to O
rehab O
on O
the O
day O
of O
admission O
but O
now O
returns O
with O
tachycardia B-SYMPTOM
to O
the O
120 O
's O
, O
and O
fever B-SYMPTOM
to O
102 O
degrees O
F O
. O

Past O
Medical O
History O
: O

PVD B-SYMPTOM
s/p O
multiple B-SYMPTOM
failed I-SYMPTOM
femoral I-SYMPTOM
distal I-SYMPTOM
bypass I-SYMPTOM

Diabetes B-SYMPTOM
mellitus I-SYMPTOM

CAD B-SYMPTOM
s/p O
CABG B-TREATMENT
2003 O
s/p O

ex O
lap O
05-23 O

Physical O
Exam O
: O

T O
101 O
HR O
120 O
BP O
144/90 O
RR O
18 O
SpO2 O
99% O
on O
70% O
TM B-TREATMENT

Moderately B-SYMPTOM
distressed I-SYMPTOM

Coarse B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
b/l I-SYMPTOM

Tachycardic B-SYMPTOM
, O
nl O
S1 O
and O
S2 O

Abd O
soft O
, O
NT/ND B-SYMPTOM

Right B-SYMPTOM
AKA I-SYMPTOM
stump I-SYMPTOM
with O
dry B-SYMPTOM
gangrene I-SYMPTOM

Left O
lower O
extremity O
warm O
and O
well-perfused O

Pertinent O
Results O
: O

MRI O
HEAD O
: O

The O
diffusion O
images O
demonstrate O
no O
evidence O
of O
slow B-SYMPTOM
diffusion I-SYMPTOM
to O
indicate O
acute B-SYMPTOM
infarct I-SYMPTOM
. O

There O
is O
moderate B-SYMPTOM
prominence I-SYMPTOM
of I-SYMPTOM
ventricles I-SYMPTOM
and I-SYMPTOM
sulci I-SYMPTOM
, O
inappropriate O
for O
the O
patient O
's O
age O
. O

There O
is O
no O
midline B-SYMPTOM
shift I-SYMPTOM
, O
mass B-SYMPTOM
effect I-SYMPTOM
, O
hydrocephalus B-SYMPTOM
, O
or O
territorial B-SYMPTOM
infarct I-SYMPTOM
. O

Following O
gadolinium O
, O
no O
evidence O
of O
abnormal B-SYMPTOM
parenchymal I-SYMPTOM
, I-SYMPTOM
vascular I-SYMPTOM
, I-SYMPTOM
or I-SYMPTOM
meningeal I-SYMPTOM
enhancement I-SYMPTOM
seen O
. O

Gastric O
biopsy O
: O
negative O
for O
H. B-SYMPTOM
pylori I-SYMPTOM
. O

Brief O
Hospital O
Course O
: O

The O
patient O
was O
re-admitted O
to O
the O
surgical O
service O
and O
taken O
to O
the O
CMED O
. O

A O
chest O
x-ray O
on O
admission O
showed O
effusions B-SYMPTOM
consistent O
with O
CHF B-SYMPTOM
along O
with O
overlying B-SYMPTOM
pnumonia I-SYMPTOM
. O

Urine O
cultures O
were O
significant O
for O
Klebsiella B-SYMPTOM
UTI I-SYMPTOM
and O
sputum O
cultures O
were O
significant O
for O
MRSA B-SYMPTOM
. O

He O
was O
placed O
on O
vancomycin B-TREATMENT
, O
levofloxacin B-TREATMENT
and O
fluconazole B-TREATMENT
. O

He O
underwent O
PICC B-TREATMENT
line I-TREATMENT
placement I-TREATMENT
on O
06-18 O
. O

A B-TREATMENT
trach I-TREATMENT
collar I-TREATMENT
was O
placed O
on O
06-19 O
. O

GI O
was O
consulted O
for O
colonoscopy O
. O

Patient O
was O
transferred O
to O
the O
floor O
on O
06-20 O
. O

He O
was O
seen O
by O
respiratory O
therapy O
and O
suctioned O
continually O
throughout O
his O
hospital O
course O
. O

His O
respiratory O
status O
improved O
. O

He O
tolerated O
his B-TREATMENT
trach I-TREATMENT
collar I-TREATMENT
, O
and O
tube B-TREATMENT
feeds I-TREATMENT
at O
goal O
. O

The B-TREATMENT
fluconazole I-TREATMENT
was O
discontinued O
. O

On O
06-21 O
the O
patient O
was O
seen O
by O
physical O
therapy O
. O

A O
nutrition O
consult O
was O
obtained O
on O
06-22 O
. O

He O
underwent O
a B-SYMPTOM
failed I-SYMPTOM
bedside I-SYMPTOM
swallow I-SYMPTOM
study I-SYMPTOM
. O

Based O
on O
a O
chest O
x-ray O
that O
showed O
a B-SYMPTOM
small I-SYMPTOM
hydro-pneumothorax I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
of O
the O
lung O
, O
a O
thoracic O
surgery O
consult O
was O
obtained O
, O
though O
no O
specific B-TREATMENT
interventions I-TREATMENT
were O
warranted O
at O
the O
time O
. O

On O
06-23 O
the B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
tube I-TREATMENT
feed I-TREATMENT
were O
changed O
from O
Respalor B-TREATMENT
to O
Deliver B-TREATMENT
2.0 I-TREATMENT
to O
give O
increased O
calories O
. O

On O
06-25 O
, O
urine O
cultures O
grew O
out O
VRE B-SYMPTOM
, O
and O
a O
C O
diff O
was O
negative O
. O

He O
experienced O
low B-SYMPTOM
grade I-SYMPTOM
fevers I-SYMPTOM
. O

He O
was O
pan-cultured O
on O
06-26 O
for O
continued B-SYMPTOM
fevers I-SYMPTOM
. O

On O
06-27 O
, O
his B-TREATMENT
nutrition I-TREATMENT
regimen I-TREATMENT
was O
changed O
to O
Deliver B-TREATMENT
2.0 I-TREATMENT
at O
70 O
cc O
/ O
hr O
with O
15 O
g O
ProMod B-TREATMENT
. O

On O
06-28 O
, O
the O
patient O
experienced O
PVC B-SYMPTOM
's I-SYMPTOM
. O

An O
EKG O
showed O
ST B-SYMPTOM
segment I-SYMPTOM
depression I-SYMPTOM
along O
the O
lateral O
pre-cordial O
leads O
. O

Serial O
enzymes O
showed O
mild B-SYMPTOM
elevation I-SYMPTOM
of O
troponins O
. O

A O
cardiology O
consult O
was O
obtained O
. O

The O
cardiology O
service O
simply O
recommended O
increasing O
the B-TREATMENT
beta-blockade I-TREATMENT
and O
maximizing O
the O
patient O
's O
electrolyte O
status O
. O

On O
06-29 O
, O
the O
patient O
was O
transferred O
to O
the O
medical O
service O
. O

Pt B-TREATMENT
's I-TREATMENT
vancomycin I-TREATMENT
was O
stopped O
after O
14 O
days O
of O
treatment B-TREATMENT
. O

HIV O
test O
was O
found O
to O
be O
negative O
. O

MRI O
head O
was O
obtained O
to O
further O
w/u O
patient B-SYMPTOM
's I-SYMPTOM
apparent I-SYMPTOM
cognitive I-SYMPTOM
decline I-SYMPTOM
. O

MRI O
showed O
prominent B-SYMPTOM
sulci I-SYMPTOM
and O
enlarged B-SYMPTOM
ventricles I-SYMPTOM
abnormal O
for O
the O
patient O
's O
age O
. O

Due O
to O
concerns O
for O
dementia B-SYMPTOM
, O
neurology O
consult O
was O
obtained O
. O

Neurology O
felt O
that O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
cognitive I-SYMPTOM
symptoms I-SYMPTOM
were O
consistent O
w/ O
metabolic B-SYMPTOM
encephalopathy I-SYMPTOM
due O
to O
his B-SYMPTOM
multiple I-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
. O

They O
felt O
that O
his O
mental O
status O
would O
improve O
as O
his O
health O
improved O
. O

Underlying B-SYMPTOM
dementia I-SYMPTOM
was O
possible O
but O
difficult O
to O
assess O
with O
an B-SYMPTOM
overlying I-SYMPTOM
delerium I-SYMPTOM
. O

The O
patient O
continued O
to O
pull O
out O
his B-TREATMENT
doboff I-TREATMENT
tube I-TREATMENT
. O

Pt O
had O
EGD O
performed O
to O
evaluate O
his B-SYMPTOM
poor I-SYMPTOM
nutritional I-SYMPTOM
status I-SYMPTOM
. O

He O
was O
found O
to O
have O
a B-SYMPTOM
large I-SYMPTOM
gastric I-SYMPTOM
ulcer I-SYMPTOM
and O
high B-TREATMENT
dose I-TREATMENT
PPI I-TREATMENT
was O
started O
. O

The O
gastric O
biopsy O
and O
the O
serology O
were O
both O
negative O
for O
H. B-SYMPTOM
pylori I-SYMPTOM
. O

PEG B-TREATMENT
placement I-TREATMENT
was O
unsuccessful O
by O
GI O
due O
to O
the O
patient O
's O
anantomy O
. O

07-05 O
the O
patient O
had O
a B-TREATMENT
J I-TREATMENT
tube I-TREATMENT
placed O
in O
interventional O
radiology O
for O
nutritional B-TREATMENT
support I-TREATMENT
. O

He O
was O
re-started O
on O
tube B-TREATMENT
feeds I-TREATMENT
. O

07-06 O
patient O
failed O
a O
repeat O
swallow O
evaluation O
due O
to O
discoordinated B-SYMPTOM
swallow I-SYMPTOM
. O

07-07 O
the O
patient O
was O
taken O
for O
colonoscopy O
and O
found O
to O
have O
a O
normal O
colon O
to O
cecum O
. O

07-12 O
the O
patient O
was O
found O
to O
be O
C B-SYMPTOM
diff I-SYMPTOM
positive I-SYMPTOM
and O
was O
started O
on O
14 O
day O
course O
of O
Flagyl B-TREATMENT
. O

On O
07-18 O
, O
as O
his O
mental O
status O
improved O
, O
he O
did O
well O
at O
the O
bed O
side O
swall O
evaluation O
. O

On O
07-19 O
, O
he O
underwent O
video O
swallow O
evaluation O
and O
was O
able O
to O
tolerate O
ground B-TREATMENT
consistent I-TREATMENT
food I-TREATMENT
and O
thin B-TREATMENT
liquids I-TREATMENT
. O

His B-TREATMENT
meds I-TREATMENT
should O
be O
crushed O
and O
mixed O
with O
puree B-TREATMENT
thick I-TREATMENT
liquid I-TREATMENT
. O

He O
has O
gained O
30 B-SYMPTOM
lb I-SYMPTOM
since O
the B-TREATMENT
tubefeed I-TREATMENT
was O
initiated O
( O
70 O
lb O
to O
100 O
lb O
) O
during O
this O
admission O
. O

He O
will O
still O
need O
to O
be O
on O
tubefeed B-TREATMENT
to O
support O
his O
nutrition O
until O
he O
is O
cleared O
by O
a O
nutritionist O
. O

In O
terms O
of O
his O
mental O
status O
, O
he O
continued O
to O
improve O
steadily O
over O
the O
last O
few O
weeks O
of O
his O
hospital O
stay O
. O

He O
was O
more O
alert O
and O
engaged O
with O
activity O
. O

He O
did O
much O
better O
with O
PT B-TREATMENT
and O
OT B-TREATMENT
at O
the O
end O
after O
his O
mental O
status O
improved O
. O

As O
noted O
above O
, O
his B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
change I-SYMPTOM
was O
likely O
toxic-metabolic B-SYMPTOM
from O
acute B-SYMPTOM
infection I-SYMPTOM
. O

He O
started O
to O
develop O
more B-SYMPTOM
pain I-SYMPTOM
around I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
stump I-SYMPTOM
since O
07-17 O
. O

He O
was O
seen O
by O
the O
vascular O
surgery O
who O
felt O
that O
he O
is O
too O
medically B-SYMPTOM
sick I-SYMPTOM
and O
malnourished B-SYMPTOM
to O
have O
surgery B-TREATMENT
at O
this O
time O
. O

He O
will O
follow O
up O
with O
Dr. O
Javier O
as O
outpatient O
. O

Initially O
, O
his B-SYMPTOM
pain I-SYMPTOM
was O
controlled O
with O
titrating O
up O
the B-TREATMENT
Oxycontin I-TREATMENT
. O

However O
, O
it O
was O
titrated O
too O
quickly O
from O
10 O
mg O
bid O
to O
30 O
mg O
bid O
. O

He O
then O
developed O
urinary B-SYMPTOM
retention I-SYMPTOM
requiring O
foley B-TREATMENT
placement I-TREATMENT
. O

After O
he O
passed O
the O
video O
swallowing O
, O
he O
was O
tolerating O
ground B-TREATMENT
consistent I-TREATMENT
solids I-TREATMENT
. O

On O
07-24 O
, O
he O
had O
an B-SYMPTOM
emesis I-SYMPTOM
x O
1 O
, O
and O
had O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
( O
+ O
interstital B-SYMPTOM
markings I-SYMPTOM
on O
the O
left O
on O
CXR O
, O
fever B-SYMPTOM
, O
leukocytosis B-SYMPTOM
) O
. O

His B-TREATMENT
Flagyl I-TREATMENT
course I-TREATMENT
was O
extended O
, O
and O
Vanc B-TREATMENT
/ O
Levo B-TREATMENT
were O
added O
. O

His O
sputum O
showed O
many B-SYMPTOM
GPC I-SYMPTOM
which O
later O
grew O
Staph B-SYMPTOM
aureus I-SYMPTOM
. O

Given O
his B-SYMPTOM
recent I-SYMPTOM
MRSA I-SYMPTOM
pneumonia I-SYMPTOM
, O
he O
will O
be O
treated O
with O
2 O
week O
course O
of O
Vanc B-TREATMENT
/ O
Levo B-TREATMENT
/ O
Flagyl B-TREATMENT
. O

He O
was O
seen O
by O
the O
pain O
service O
who O
recommended O
to O
discontinue O
Oxycontin B-TREATMENT
, O
and O
start O
Neurontin B-TREATMENT
, O
MSIR B-TREATMENT
, O
and O
lidocaine B-TREATMENT
patch I-TREATMENT
in O
addition O
to O
the B-TREATMENT
standing I-TREATMENT
Tylenol I-TREATMENT
. O

On O
07-25 O
, O
his B-TREATMENT
J-tube I-TREATMENT
was O
noted O
to O
be O
obstructed B-SYMPTOM
but O
was O
able O
to O
be O
flushed O
by O
IR O
on O
07-26 O
. O

Tubefeed B-TREATMENT
was O
resumed O
without O
any B-SYMPTOM
difficulty I-SYMPTOM
since O
. O

Since O
oxycontin B-TREATMENT
was O
discontinued O
, O
the B-TREATMENT
foley I-TREATMENT
was O
removed O
on O
07-27 O
and O
was O
able O
to O
void O
without O
any B-SYMPTOM
difficulty I-SYMPTOM
. O

Medications O
on O
Admission O
: O

Lopressor B-TREATMENT
50 O
mg O
BID O

percocet B-TREATMENT

nebulizer B-TREATMENT

lipitor B-TREATMENT

klonopin B-TREATMENT
0.5 O
mg O
TID O

RISS B-TREATMENT

heparin B-TREATMENT
sc I-TREATMENT

lasix B-TREATMENT
40 O
mg O
TID O

prevacid B-TREATMENT

milk B-TREATMENT
of I-TREATMENT
mag I-TREATMENT

multivitamin B-TREATMENT

papain B-TREATMENT

zinc B-TREATMENT

Discharge O
Medications O
: O

1. O
Albuterol B-TREATMENT
- O
Ipratropium B-TREATMENT
103-18 O
mcg O
/ O
Actuation O
Aerosol O
Sig O
: O
02-19 O
Puffs O
Inhalation O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

2. O
Multivitamins B-TREATMENT
Tablet I-TREATMENT
, O
Chewable O
Sig O
: O
One O
( O
1 O
) O
Cap O
PO O
DAILY O
( O
Daily O
) O
. O

3. O
Magnesium B-TREATMENT
Hydroxide I-TREATMENT
400 O
mg O
/ O
5 O
mL O
Suspension O
Sig O
: O
Thirty O
( O
30 O
) O
ML O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

4. O
Ipratropium B-TREATMENT
Bromide I-TREATMENT
0.02 O
% O
Solution O
Sig O
: O
One O
( O
1 O
) O
Inhalation O
Q6H O
( O
every O
6 O
hours O
) O
. O

5. O
Heparin B-TREATMENT
Sodium I-TREATMENT
( I-TREATMENT
Porcine I-TREATMENT
) I-TREATMENT
5,000 O
unit O
/ O
mL O
Solution O
Sig O
: O
One O
( O
1 O
) O
Injection O
TID O
( O
3 O
times O
a O
day O
) O
. O

6. O
Atorvastatin B-TREATMENT
Calcium I-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

7. O
Papain B-TREATMENT
- I-TREATMENT
Urea I-TREATMENT
830,000-10 O
unit O
-% O
Spray O
, O
Non-Aerosol O
Sig O
: O
One O
( O
1 O
) O
Appl O
Topical O
DAILY O
( O
Daily O
) O
. O

8. O
Insulin B-TREATMENT
Regular I-TREATMENT
Human I-TREATMENT
100 O
unit O
/ O
mL O
Solution O
Sig O
: O
Sliding B-TREATMENT
scale I-TREATMENT
Injection I-TREATMENT
ASDIR O
( O
AS O
DIRECTED O
) O
: O
See O
the B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

9. O
Zinc B-TREATMENT
Sulfate I-TREATMENT
220 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
DAILY O
( O
Daily O
) O
. O

10. O
Ascorbic B-TREATMENT
Acid I-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

11. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

12. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Chewable O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Chewable O
PO O
DAILY O
( O
Daily O
) O
. O

13. O
Clopidogrel B-TREATMENT
Bisulfate I-TREATMENT
75 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

14. O
Metronidazole B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
) O
for O
6 O
days O
: O
Last O
day O
2017-07-25 O
. O

15. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
Q6H O
( O
every O
6 O
hours O
) O
. O

16. O
Olanzapine B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
as O
needed O
for O
confusion B-SYMPTOM
. O

17. O
Protonix B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
twice O
a O
day O
. O

18. O
Morphine B-TREATMENT
Sulfate I-TREATMENT
15 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

19. O
Levofloxacin B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q24H O
( O
every O
24 O
hours O
) O
: O
Last O
day O
08-07 O
. O

20. O
Vancomycin B-TREATMENT
HCl I-TREATMENT
in O
Dextrose B-TREATMENT
1 O
g O
/ O
200 O
mL O
Piggyback O
Sig O
: O
One O
( O
1 O
) O
Intravenous O
Q O
12H O
( O
Every O
12 O
Hours O
) O
: O
Last O
day O
08-07 O
. O

21. O
Gabapentin B-TREATMENT
300 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

22. O
Lidocaine B-TREATMENT
5 O
%( O
700 O
mg O
/ O
patch O
) O
Adhesive O
Patch O
, O
Medicated O
Sig O
: O
One O
( O
1 O
) O
Adhesive O
Patch O
, O
Medicated O
Topical O
QD O
( O
) O
. O

23. O
Morphine B-TREATMENT
Sulfate I-TREATMENT
2 O
mg O
/ O
mL O
Syringe O
Sig O
: O
02-19 O
Injection O
Q12H O
( O
every O
12 O
hours O
) O
as O
needed O
. O

24. O
Prochlorperazine B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Mediplex O
Rehab O
Hospital O
- O
Lawrence O

Discharge O
Diagnosis O
: O

Primary O
: O

1) O
Gangrenous B-SYMPTOM
leg I-SYMPTOM

2) O
Urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM

3) O
MRSA B-SYMPTOM
pneumonia I-SYMPTOM

4) O
Failure B-SYMPTOM
to I-SYMPTOM
thrive I-SYMPTOM
and O
weight B-SYMPTOM
loss I-SYMPTOM

5) O
Altered B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM

6) O
Gastric B-SYMPTOM
ulcer I-SYMPTOM

7) O
C.diff B-SYMPTOM
colitis I-SYMPTOM

Secondary O
: O

1) O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM

2) O
Anemia B-SYMPTOM

3) O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM

4) O
Peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM

5) O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM

6) O
Hypertension B-SYMPTOM

Discharge O
Condition O
: O

Hemodynamically O
stable O
, O
pt O
doing O
much O
better O
with O
physical B-TREATMENT
therapy I-TREATMENT
, O
passed O
video O
swallow O
evaluation O
tolerating O
po O
. O

Discharge O
Instructions O
: O

Patient O
needs O
to O
take O
all O
of O
the B-TREATMENT
medications I-TREATMENT
as O
directed O
. O

Patient O
needs O
to O
continue O
the B-TREATMENT
tube I-TREATMENT
feed I-TREATMENT
nutrition I-TREATMENT
until O
re-assessed O
by O
the O
nutrionist O
. O

He O
can O
also O
take O
oral O
food O
as O
directed O
below O
. O

He O
needs O
to O
seek O
medical O
attention O
if O
he O
develops O
fever B-SYMPTOM
, O
chills B-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
worsening B-SYMPTOM
pain I-SYMPTOM
, O
worsening B-SYMPTOM
wound I-SYMPTOM
, O
or O
any B-SYMPTOM
other I-SYMPTOM
concerning I-SYMPTOM
symptoms I-SYMPTOM
. O

Followup O
Instructions O
: O

Please O
follow O
up O
with O
Dr. O
Cynthia O
Kabzinski O
( O
672-3879 O
) O
on O
2017-08-08 O

10:45 O

Provider O
: O

Sarah O
, O
Santo O
S. O
Isom O

SURGERY O

Where O
: O

VASCULAR O
SURGERY O

Date O
/ O
Time O
: O
2017-08-08 O
10:45 O

Vernon O
Karen O
MD O
28-960 O

Completed O
by O
: O
Marquita O
Sherry O
MD O
09-161 O
2017-07-27 O
@ O
1440 O

Signed O
electronically O
by O
: O
DR. O
Frank O
Z.K. O
Delgado O
on O
: O
Maxine O
2017-07-27 O
3:37 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-09-06 O

Discharge O
Date O
: O

2013-09-18 O

Date O
of O
Birth O
: O

1927-08-07 O

Sex O
: O

F O

Service O
: O

NEUROLOGIC O
MEDICINE O

DISCHARGE O
DIAGNOSIS O
: O

Large B-SYMPTOM
left I-SYMPTOM
middle I-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
stroke I-SYMPTOM
along O
with O
posterior B-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
strokes I-SYMPTOM
bilaterally I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
an O
86 O
year O
old O
woman O
who O
has O
a O
history O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
, O
and O
a O
history O
of O
atrial B-SYMPTOM
emboli I-SYMPTOM
who O
was O
admitted O
on O
2013-09-06 O
, O
to O
the O
Neurologic O
Intensive O
Care O
Unit O
service O
after O
collapsing O
at O
home O
at O
8:30 O
p.m O
. O

She O
was O
found O
to O
have O
right B-SYMPTOM
sided I-SYMPTOM
weakness I-SYMPTOM
and O
was O
noted O
by O
her O
husband O
to O
have O
vomited O
. O

She O
was O
found O
comatose B-SYMPTOM
at O
home O
by O
EMS O
and O
was O
brought O
to O
the O
Emergency O
Department O
. O

On O
arrival O
to O
the O
Emergency O
Department O
, O
she O
was O
noted O
to O
have O
a O
temperature O
of O
98.2 O
, O
blood O
pressure O
164/110 O
, O
respiratory O
rate O
28 O
, O
and O
heart O
rate O
of O
74 O
. O

She O
was O
found O
to O
be O
responsive B-SYMPTOM
only I-SYMPTOM
to I-SYMPTOM
painful I-SYMPTOM
stimuli I-SYMPTOM
at O
this O
time O
. O

She O
was O
intubated O
for O
airway B-TREATMENT
protection I-TREATMENT
and O
received O
multiple B-TREATMENT
medications I-TREATMENT
prior O
to O
her O
initial O
neurologic O
examination O
. O

She O
was O
also O
noted O
to O
have O
a B-SYMPTOM
cold I-SYMPTOM
distal I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
extremity I-SYMPTOM
which O
was O
operated O
on O
and O
she O
is O
now O
status O
post O
left B-TREATMENT
brachial I-TREATMENT
artery I-TREATMENT
embolectomy I-TREATMENT
. O

Throughout O
her O
course O
on O
the O
Intensive O
Care O
Unit O
service O
, O
she O
has O
remained O
unresponsive B-SYMPTOM
with O
imaging O
studies O
consistent O
with O
a O
large O
left O
middle O
cerebral O
artery O
and O
posterior B-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
distribution I-SYMPTOM
cerebral I-SYMPTOM
infarction I-SYMPTOM
with O
mass B-SYMPTOM
effect I-SYMPTOM
and O
midline B-SYMPTOM
shift I-SYMPTOM
. O

There O
is O
evidence O
of O
bilateral B-SYMPTOM
occipital I-SYMPTOM
and I-SYMPTOM
cerebellar I-SYMPTOM
infarctions I-SYMPTOM
as O
well O
. O

Discussion O
with O
the O
patient O
's O
family O
by O
the O
Intensive O
Care O
Unit O
service O
has O
resulted O
in O
focusing O
on O
her B-TREATMENT
comfort I-TREATMENT
care I-TREATMENT
. O

This O
decision O
was O
made O
after O
an O
extensive O
discussion O
with O
her O
husband O
and O
family O
as O
the O
likelihood O
of O
significant O
meaningful O
recovery O
is O
extremely O
low O
. O

Based O
on O
this O
, O
she O
is O
transferred O
to O
the O
Neurology O
service O
for O
focus O
on O
comfort B-TREATMENT
care I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Breast B-SYMPTOM
cancer I-SYMPTOM
, O
status O
post O
lumpectomy B-TREATMENT
. O

2. O
Mitral B-TREATMENT
commissurectomy I-TREATMENT
. O

3. O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

4. O
Peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
. O

5. O
Arterial B-SYMPTOM
emboli I-SYMPTOM
, I-SYMPTOM
left I-SYMPTOM
femoral I-SYMPTOM
artery I-SYMPTOM
. O

6. O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

MEDICATIONS O
ON O
TRANSFER O
: O

1. O
Lopressor B-TREATMENT
intravenous I-TREATMENT
q O
6 O
hours O
. O

2. O
Morphine B-TREATMENT
Sulfate I-TREATMENT
1 O
mg O
intravenous O
p.r.n. O

ALLERGIES O
: O

Penicillin B-TREATMENT
, O
Sulfa B-TREATMENT
and O
Quinidine B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

She O
lived O
with O
her O
husband O
caring O
for O
him O
. O

PHYSICAL O
EXAMINATION O
: O

On O
the O
date O
of O
transfer O
, O
temperature O
98.5 O
, O
heart O
rate O
80 O
and O
irregular B-SYMPTOM
, O
blood O
pressure O
140/60 O
, O
oxygen O
saturation O
100% O
in O
room O
air O
. O

in O
general O
, O
the O
patient O
is O
minimally B-SYMPTOM
responsive I-SYMPTOM
woman O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Head O
and O
neck O
- O
normocephalic O
, O
supple O
, O
no O
lymphadenopathy B-SYMPTOM
. O

Cardiovascular O
- O
irregular B-SYMPTOM
rhythm I-SYMPTOM
, O
normal O
rate O
. O

Pulmonary O
- O
Good O
air O
movement O
, O
but O
occasional B-SYMPTOM
rhonchi I-SYMPTOM
. O

Abdomen O
reveals O
positive O
bowel O
sounds O
, O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Extremities O
- O
no O
edema B-SYMPTOM
. O

Neurologic O
- O
The O
patient O
is O
unresponsive B-SYMPTOM
to O
verbal O
stimuli O
, O
withdrawals O
the O
left O
extremities O
to O
noxious O
stimulation O
. O

The O
right O
side O
does O
not O
move O
. O

Tone O
is O
increased O
on O
the O
right O
. O

Toes O
are O
upgoing O
on O
the O
right O
. O

Cranial O
nerves O
- O
The O
pupils O
are O
equal O
and O
reactive O
to O
light O
and O
accommodation O
. O

There O
is O
a B-SYMPTOM
left I-SYMPTOM
gaze I-SYMPTOM
preference I-SYMPTOM
. O

The O
fundi O
Belmont O
difficult O
to O
visualize O
but O
there O
is O
no O
evidence O
of O
papilledema B-SYMPTOM
. O

Reflexes O
are O
down B-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
side I-SYMPTOM
. O

Normal O
reflexes O
on O
the O
left O
side O
. O

LABORATORY O
DATA O
: O

White O
blood O
cell O
count O
11.5 O
, O
hematocrit O
31.0 O
, O
platelet O
count O
290,000 O
. O

INR O
3.0 O
. O

Potassium O
was O
3.0 O
, O
glucose O
131 O
. O

MR O
studies O
revealed O
a B-SYMPTOM
large I-SYMPTOM
left I-SYMPTOM
middle I-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
infarction I-SYMPTOM
with O
multiple B-SYMPTOM
smaller I-SYMPTOM
posterior I-SYMPTOM
circulation I-SYMPTOM
infarctions I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
's O
course O
up O
to O
the O
date O
of O
transfer O
to O
Neurology O
has O
been O
outlined O
above O
. O

Briefly O
, O
she O
is O
an O
86 O
year O
old O
woman O
who O
has O
suffered O
multiple B-SYMPTOM
cardioembolic I-SYMPTOM
cerebral I-SYMPTOM
infarctions I-SYMPTOM
in I-SYMPTOM
multiple I-SYMPTOM
arterial I-SYMPTOM
territories I-SYMPTOM
. O

She O
has O
remained O
unresponsive B-SYMPTOM
throughout O
the O
hospitalization O
and O
currently O
only O
withdraws O
to O
pain B-SYMPTOM
. O

After O
extensive O
discussion O
with O
her O
family O
, O
her O
care O
was O
focused O
on O
comfort O
. O

A B-TREATMENT
low I-TREATMENT
dose I-TREATMENT
Morphine I-TREATMENT
drip I-TREATMENT
was O
initiated O
after O
further O
serious O
discussion O
with O
her O
husband O
and O
nieces O
and O
nephews O
. O

The O
patient O
passed O
away O
peacefully O
on O
2013-09-18 O
. O

The O
family O
did O
not O
want O
postmortem O
examination O
. O

Michael O
P O
Galuszka O
, O
M.D. O

46-348 O

Dictated O
By O
: O
Melissa O
U O
Sangi O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-11-11 O
18:47 O

T O
: O
2013-11-11 O
19:46 O

JOB O
#: O

93375 O

Signed O
electronically O
by O
: O
DR. O
Ryann O
W. O
U. O
Galuszka O
on O
: O
TUE O
2013-11-19 O
12:45 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2016-02-15 O

Discharge O
Date O
: O

2016-02-21 O

Date O
of O
Birth O
: O

2016-02-15 O

Sex O
: O

M O

Service O
: O

NEONATOLOGY O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
infant O
is O
a O
32 O
and O
03-05 O
week O
male O
, O
twin O
A O
, O
who O
was O
admitted O
to O
the O
Neonatal O
Intensive O
Care O
Unit O
for O
management B-TREATMENT
of O
prematurity B-SYMPTOM
. O

The O
infant O
was O
born O
to O
a O
38 O
year O
old O
, O
gravida O
V O
, O
para O
III O
, O
woman O
. O

Serologies O
: O

A O
positive O
, O
antibody O
negative O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
RPR O
nonreactive O
, O
rubella O
immune O
, O
GBS O
unknown O
. O

Pregnancy B-SYMPTOM
notable O
for: O

1. O
Gestational O
carrier O
for O
brother O
and O
his O
wife O
( O
donor O
eggs O
). O

2. O
IVF B-TREATMENT
with O
diamniotic O
, O
dichorionic O
twins O
. O

3. O
At O
29-30 O
week O
gestation O
concern O
for O
fetal B-SYMPTOM
decelerations I-SYMPTOM
of O
twin O
A O
, O
admitted O
to O
Cambridge O
Health O
Alliance O
, O
completed O
a O
course O
of O
Betamethasone B-TREATMENT
, O
discharged O
to O
home O
. O

4. O
Elevated B-SYMPTOM
one I-SYMPTOM
hour I-SYMPTOM
glucose I-SYMPTOM
tolerance I-SYMPTOM
test I-SYMPTOM
, O
normal O
three O
hour O
glucose O
tolerance O
test O
. O

5. O
Declined O
triple O
screen O
and O
amniocentesis O
. O

Gestational O
carrier O
for O
brother O
and O
sister-in-law O
as O
noted O
above O
. O

Presented O
with O
spontaneous B-SYMPTOM
, I-SYMPTOM
premature I-SYMPTOM
rupture I-SYMPTOM
of I-SYMPTOM
membranes I-SYMPTOM
. O

No O
maternal B-SYMPTOM
fever I-SYMPTOM
. O

Clear O
fluid O
. O

Delivery B-TREATMENT
by I-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
secondary O
to O
twin B-SYMPTOM
B I-SYMPTOM
breech I-SYMPTOM
presentation I-SYMPTOM
. O

Apgars O
eight O
at O
one O
minute O
and O
eight O
at O
five O
minutes O
. O

PHYSICAL O
EXAMINATION O
: O

Birth O
weight O
1865 O
grams O
. O

HOSPITAL O
COURSE O
: O

1. O
Respiratory O
- O
The O
infant O
has O
remained O
in O
room O
air O
throughout O
this O
hospitalization O
with O
respiratory O
rates O
40 O
s O
to O
50 O
s, O
oxygen O
saturation O
greater O
than O
94% O
. O

One B-SYMPTOM
apnea I-SYMPTOM
and I-SYMPTOM
bradycardia I-SYMPTOM
event I-SYMPTOM
which O
was O
self O
resolved O
on O
day O
of O
life O
four O
. O

2. O
Cardiovascular O
- O
The O
infant O
was O
noted O
on O
CR-monitor O
to O
have O
premature B-SYMPTOM
ventricular I-SYMPTOM
contractions I-SYMPTOM
which O
resolved O
spontaneously O
. O

A O
twelve O
lead O
electrocardiogram O
was O
recommended O
if O
this O
persists O
. O

No O
murmur B-SYMPTOM
. O

Heart O
rates O
140 O
s O
to O
150 O
s. O

Mean O
blood O
pressure O
has O
been O
46 O
to O
54 O
. O

3. O
Fluid O
, O
electrolytes O
and O
nutrition O
- O
The O
infant O
was O
started O
on O
enteral B-TREATMENT
feedings I-TREATMENT
on O
day O
of O
life O
one O
and O
advanced O
to O
full B-TREATMENT
volume I-TREATMENT
feedings I-TREATMENT
by O
day O
of O
life O
four O
. O

The O
infant O
was O
initially O
started O
on O
80 O
cc O
/ O
kg O
/ O
day O
of O
intravenous B-TREATMENT
fluid I-TREATMENT
D10W I-TREATMENT
and O
advanced O
to O
150 O
cc O
/ O
kg O
/ O
day O
by O
day O
of O
life O
four O
. O

The O
infant O
tolerated O
feeding O
advancement O
without O
difficulty O
. O

The O
infant O
did O
not O
receive O
parenteral B-TREATMENT
nutrition I-TREATMENT
. O

The O
most O
recent O
electrolytes O
on O
day O
of O
life O
two O
showed O
a O
sodium O
of O
145 O
, O
chloride O
111 O
, O
potassium O
3.8 O
, O
bicarbonate O
21 O
. O

The O
infant O
is O
currently O
receiving O
breast O
milk O
22 O
calories O
per O
ounce O
or O
premature O
Enfamil O
22 O
calories O
per O
ounce O
, O
150 O
cc O
/ O
kg O
/ O
day O
p.o. O
and O
gavage B-TREATMENT
. O

The O
most O
recent O
weight O
today O
is O
1810 O
grams O
which O
was O
no O
change O
from O
the O
previous O
day O
. O

4. O
Gastrointestinal O
- O
The O
infant O
was O
started O
on O
single B-TREATMENT
phototherapy I-TREATMENT
on O
day O
of O
life O
two O
for O
a O
maximum O
bilirubin O
level O
of O
9.1 O
with O
a O
direct O
of O
0.3 O
. O

Phototherapy B-TREATMENT
was O
discontinued O
on O
day O
of O
life O
five O
and O
the O
rebound O
bilirubin O
level O
on O
day O
of O
life O
six O
is O
7.7 O
with O
a O
direct O
of O
0.2 O
. O

5. O
Hematology O
- O
The O
most O
recent O
hematocrit O
on O
day O
of O
life O
two O
was O
45.8% O
. O

Hematocrit O
on O
admission O
was O
54.0% O
. O

The O
infant O
has O
not O
received O
any B-TREATMENT
blood I-TREATMENT
transfusions I-TREATMENT
this O
hospitalization O
. O

6. O
Infectious O
disease O
- O
The O
infant O
received O
48 O
hours O
of O
Ampicillin B-TREATMENT
and O
Gentamicin B-TREATMENT
for O
rule O
out O
sepsis B-SYMPTOM
. O

The O
complete O
blood O
count O
on O
admission O
showed O
a O
white O
blood O
cell O
count O
of O
8.0 O
, O
hematocrit O
54.0% O
, O
platelet O
count O
190,000 O
, O
11 O

neutrophils O
, O
0 O
bands O
. O

A O
repeat O
complete O
blood O
count O
on O
day O
of O
life O
two O
showed O
a O
white O
blood O
cell O
count O
of O
6.3 O
, O
hematocrit O
45.8% O
, O
platelet O
count O
199,000 O
, O
37 O
neutrophils O
, O
0 O
bands O
, O
53 O
lymphocytes O
. O

Blood O
cultures O
remained O
negative O
to O
date O
. O

7. O
Neurology O
- O
Normal O
neurologic O
examination O
. O

The O
infant O
does O
not O
meet O
criteria O
for O
head O
ultrasound O
. O

8. O
Sensory O
- O
Hearing O
screening O
is O
recommended O
prior O
to O
discharge O
. O

9. O
Psychosocial O
- O
As O
noted O
above O
, O
paternal O
aunt O
was O
the O
gestational O
carrier O
. O

The O
infants O
are O
legally O
under O
the O
parents O
' O
names O
and O
they O
are O
involved O
with O
the B-TREATMENT
infant I-TREATMENT
's I-TREATMENT
care I-TREATMENT
. O

The O
gestational O
carrier O
is O
not O
involved O
. O

Noted O
in O
the O
chart O
are O
legal O
documents O
. O

The O
contact O
social O
worker O
can O
be O
reached O
at O
( O
756 O
) O
599-4849 O
. O

CONDITION O
ON O
DISCHARGE O
: O

32 O
and O
4/7 O
weeks O
, O
now O
day O
of O
life O
six O
, O
stable O
in O
room O
air O
. O

DISCHARGE O
DISPOSITION O
: O

To O
nursery O
at O
VA O
Hospital O
Jamaica O
Plain O
Hospital O
. O

PRIMARY O
PEDIATRICIAN O
: O

Dr. O
James O
Ramos O
, O
telephone O
( O
346 O
) O
741 O
2728 O
. O

FEEDINGS O
AT O
DISCHARGE O
: O

150 O
cc O
/ O
kg O
/ O
day O
of O
breast O
milk O
22 O
calories O
or O
premature O
Enfamil O
22 O
calories O
per O
ounce O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

None O
. O

CAR O
SEAT O
POSITION O
SCREENING O
: O

Recommended O
prior O
to O
discharge O
. O

STATE O
NEWBORN O
SCREEN O
: O

Screens O
have O
been O
sent O
and O
results O
are O
pending O
. O

IMMUNIZATIONS B-TREATMENT
: O

The O
infant O
has O
not O
received O
any B-TREATMENT
immunizations I-TREATMENT
this O
hospitalization O
. O

IMMUNIZATIONS O
RECOMMENDED O
: O

Synagis B-TREATMENT
RSV I-TREATMENT
prophylaxis I-TREATMENT
should O
be O
considered O
from O
October O
through O
April O
for O
infants O
who O
meet O
any O
of O
the O
following O
three O
criteria O
: O

1. O
Born O
at O
less O
than O
32 O
weeks O
. O

2. O
Born O
between O
32 O
and O
35 O
weeks O
with O
two O
of O
the O
following O
: O

a. O
Day O
Care O
during O
RSV O
season O
. O

b. O
A O
smoker O
in O
the O
household O
, O

c. O
neuromuscular B-SYMPTOM
disease I-SYMPTOM
, O

d. O
airway B-SYMPTOM
abnormalities I-SYMPTOM
or O

e. O
a O
school O
age O
sibling O
. O

3. O
With O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Prematurity B-SYMPTOM
32 I-SYMPTOM
and I-SYMPTOM
4/7 I-SYMPTOM
weeks I-SYMPTOM
, O
Twin O
#1 O
. O

2. O
Rule O
out O
sepsis B-SYMPTOM
, O
ruled O
out O
. O

3. O
Apnea B-SYMPTOM
of I-SYMPTOM
prematurity I-SYMPTOM
. O

4. O
Indirect B-SYMPTOM
hyperbilirubinemia I-SYMPTOM
. O

Gregory O
R O
Godfrey O
, O
M.D. O
28-526 O

Dictated O
By O
: O
Crystal O
K. O
Carter O
, O
M.D. O

MEDQUIST36 O

D O
: O
2016-02-21 O
09:53 O

T O
: O
2016-02-21 O
10:12 O

JOB O
#: O
02200 O

Signed O
electronically O
by O
: O
DR. O
Cynthia O
Short O
on O
: O
MON O
2016-02-22 O
8:16 O
AM O

( O
End O
of O
Report O
) O

099147779 O
WGH O

2346613 O

367017 O

2170984 O

11/17/2004 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O

NAME O
: O

BRENOCE O
, O
T O
N O

UNIT O
NUMBER O
: O

254-05-39 O

ADMISSION O
DATE O
: O

11/17/2004 O

DISCHARGE O
DATE O
: O

11/26/2004 O

PRINCIPAL O
DIAGNOSIS O
: O

Pneumonia B-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

1. O
Pill B-SYMPTOM
esophagitis I-SYMPTOM
. O

2. O
Right B-SYMPTOM
ventricular I-SYMPTOM
hypokinesis I-SYMPTOM
. O

OPERATIONS O
/ O
PROCEDURES O
: O

Dobutamine O
stress O
test O
, O
cardiac O
ultrasound O
, O
EGD O
, O
chest O
x-ray O
, O
PICC B-TREATMENT
placement I-TREATMENT
. O

The O
patient O
is O
a O
62-year-old O
female O
with O
a O
history O
of O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
COPD B-SYMPTOM
, O
hypercholesterolemia B-SYMPTOM
, O
depression B-SYMPTOM
and O
CHF B-SYMPTOM
who O
was O
lying O
in O
bed O
on O
the O
night O
prior O
to O
admission O
when O
she O
developed O
left-sided B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
located O
in O
the O
mid-breast O
region O
with O
some B-SYMPTOM
fluttering I-SYMPTOM
her I-SYMPTOM
chest I-SYMPTOM
. O

The O
patient O
radiated O
down O
her O
left O
arm O
associated O
with O
some B-SYMPTOM
nausea I-SYMPTOM
, O
no O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
cough B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
diarrhea B-SYMPTOM
. O

She O
slept O
through O
the O
night O
, O
woke O
with O
persistent B-SYMPTOM
pain I-SYMPTOM
. O

She O
went O
with O
her O
sister O
&apos;s O
husband O
to O
La O
Community O
Hospital O
where O
she O
was O
given O
sublingual B-TREATMENT
nitroglycerin I-TREATMENT
with O
complete O
relief O
of O
pain B-SYMPTOM
. O

She O
refused O
ambulance O
to O
the O
Emergency O
Room O
and O
was O
driven O
to O
Well O
General O
Hospital O
Emergency O
Room O
by O
her O
sister O
. O

She O
arrived O
pain B-SYMPTOM
free O
. O

She O
was O
given O
Aspirin B-TREATMENT
, O
Lopressor B-TREATMENT
and O
Insulin B-TREATMENT
for O
hyperglycemia B-SYMPTOM
. O

EKG O
was O
unchanged O
compared O
to O
the O
prior O
EKG O
several O
months O
ago O
. O

PAST O
MEDICAL O
HISTORY O
: O

Insulin-dependent B-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
depression B-SYMPTOM
, O
back B-SYMPTOM
pain I-SYMPTOM
, O
COPD B-SYMPTOM
, O
allergic B-SYMPTOM
rhinitis I-SYMPTOM
, O
GERD B-SYMPTOM
, O
obesity B-SYMPTOM
, O
hyperlipidemia B-SYMPTOM
. O

ALLERGIES O
: O

Codeine B-TREATMENT
, O
reaction O
unknown O
. O

MEDICATIONS O
: O

Atrovent B-TREATMENT
. O

Aspirin B-TREATMENT
. O

Flonase B-TREATMENT
. O

Quinine B-TREATMENT
Celebrex B-TREATMENT
. O

Compazine B-TREATMENT
. O

Oxybutynin B-TREATMENT
Amitriptyline B-TREATMENT
. O

Zyrtec B-TREATMENT
. O

Prozac B-TREATMENT
. O

Trazodone B-TREATMENT
. O

Humulin B-TREATMENT
70 O
units O
bid O
. O

Albuterol B-TREATMENT
. O

Lasix B-TREATMENT
40 O
PO O
bid O
. O

Triamcinolone B-TREATMENT
cream I-TREATMENT
. O

Miconazole B-TREATMENT
cream I-TREATMENT
Flovent B-TREATMENT
. O

Nifedipine B-TREATMENT
ER I-TREATMENT
60 O
daily O
. O

Lisinopril B-TREATMENT
, O
30 O
daily O
. O

KCl B-TREATMENT
10 O
mEq O
q O
day O
. O

Protonix B-TREATMENT
, O
40 O
daily O
. O

Lipitor B-TREATMENT
, O
20 O
daily O
. O

Methadone B-TREATMENT
10 O
bid O
. O

FAMILY O
HISTORY O
: O

Non-contributory O
. O

HABITS O
: O

Tobacco O
: O

Quit O
20 O
years O
ago O
. O

Alcohol O
: O

Rare O
drinks O
per O
week O
. O

SOCIAL O
HISTORY O
: O

Lives O
along O
, O
takes O
care O
of O
herself O
. O

Retired O
. O

Used O
to O
work O
in O
fast O
food O
. O

VITAL O
SIGNS O
: O

On O
admission O
blood O
pressure O
165/70 O
. O

temperature O
99.8 O
, O
pulse O
86 O
, O
respiratory O
rate O
18 O
. O

PHYSICAL O
EXAMINATION O
: O

Obese B-SYMPTOM
, O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Multiple O
tattoos O
. O

Skin O
normal O
. O

HEENT O
, O
ears O
poor B-SYMPTOM
hearing I-SYMPTOM
. O

Extraocular O
movements O
intact O
. O

Moist O
mucous O
membranes O
. O

No O
lymphadenopathy B-SYMPTOM
. O

Chest O
, O
lungs O
clear O
to O
auscultation O
with O
faint B-SYMPTOM
wheezes I-SYMPTOM
, O
no O
rales B-SYMPTOM
. O

Cardiac O
, O
normal O
S1 O
, O
S2 O
, O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
. O

Abdomen O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Positive O
bowel O
sounds O
. O

Neurologic O
: O

Alert O
and O
oriented O
x3 O
. O

Cranial O
nerves O
II O
through O
XII O
intact O
. O

Motor O
and O
sensory O
intact O
. O

Extremities O
: O

Feet O
no O
edema B-SYMPTOM
. O

Pulses O
2+ O
PT O
and O
DP O
. O

LABORATORY O
: O

Unremarkable O
with O
normal O
electrolytes O
except O
for O
glucose O
of O
328 O
. O

CBC O
, O
white O
count O
6.7 O
, O
hematocrit O
37.4 O
, O
platelets O
280 O
. O

Chest O
x-ray O
was O
low B-SYMPTOM
lung I-SYMPTOM
volumes I-SYMPTOM
, O
no O
consolidation B-SYMPTOM
. O

EKG O
showed O
sinus B-SYMPTOM
brady I-SYMPTOM
at O
16 O
, O
normal O
axis O
, O
normal O
intervals O
, O
no O
STT B-SYMPTOM
wave I-SYMPTOM
abnormalities I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
Team O
Four O
for O
cardiac O
monitoring O
and O
ruling O
out O
for O
MI B-SYMPTOM
. O

Hospital O
course O
by O
system O
: O

1. O
Cardiovascular O
: O

The O
patient O
ruled O
out O
for O
MI B-SYMPTOM
by O
cardiac O
markers O
. O

The O
patient O
was O
set O
to O
go O
for O
a O
dobutamine O
stress O
test O
on O
11/16/04 O
given O
her O
history O
of O
COPD B-SYMPTOM
, O
but O
the O
stress O
portion O
was O
canceled O
when O
she O
was O
down O
there O
due O
to O
fever B-SYMPTOM
and O
hypotension B-SYMPTOM
. O

The O
next O
day O
, O
she O
underwent O
a O
cardiac O
echo O
( O
transthoracic O
echocardiogram O
) O
. O

This O
echo O
showed O
LV O
ejection O
fraction O
of O
50% O
with O
no O
wall B-SYMPTOM
motion I-SYMPTOM
abnormality I-SYMPTOM
. O

However O
, O
the O
right O
ventricular O
was O
diffusely B-SYMPTOM
hypokinetic I-SYMPTOM
. O

It O
was O
suboptimally O
imaged O
, O
so O
there O
was O
no O
RVSP O
given O
. O

The O
patient O
also O
suffered O
a B-SYMPTOM
hypotensive I-SYMPTOM
episode I-SYMPTOM
while O
in O
the O
endoscopy O
suite O
for O
her O
EGD O
on O
11/17/04 O
. O

This O
responded O
to O
fluid B-TREATMENT
bolus I-TREATMENT
. O

The O
patient O
was O
then O
transferred O
to O
Medicine O
Team O
D O
given O
her B-SYMPTOM
tenuous I-SYMPTOM
hemodynamic I-SYMPTOM
status I-SYMPTOM
. O

The O
patient O
, O
several O
days O
later O
11/23 O
, O
underwent O
another O
dobutamine O
stress O
test O
. O

This O
stress O
test O
, O
although O
complicated O
by O
hypotension B-SYMPTOM
again O
, O
to O
the O
60 O
&apos;s O
or O
70 O
&apos;s O
was O
completed O
and O
there O
was O
some B-SYMPTOM
mild I-SYMPTOM
anterior I-SYMPTOM
septal I-SYMPTOM
thinning I-SYMPTOM
, O
but O
no O
evidence O
of O
ischemia B-SYMPTOM
and O
an O
EF O
from O
this O
test O
was O
76% O
. O

Clearly O
, O
the O
patient O
&apos;s O
hemodynamic O
vascular O
status O
was O
very O
sensitive O
to O
dobutamine B-TREATMENT
. O

2. O
Infectious O
Disease O
: O

On O
hospital O
day O
#2 O
, O
the O
patient O
was O
noted O
to O
have O
increased B-SYMPTOM
dyspnea I-SYMPTOM
on O
exertion O
. O

The O
next O
day O
she O
developed O
a B-SYMPTOM
fever I-SYMPTOM
and O
she O
was O
started O
on O
levofloxacin B-TREATMENT
for O
a O
potential O
UTI B-SYMPTOM
. O

She O
continued O
to O
have O
low-grade B-SYMPTOM
fevers I-SYMPTOM
and O
on O
the O
next O
day O
, O
11/17/04 O
, O
her O
chest O
x-ray O
showed O
possible O
new B-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
infiltrates I-SYMPTOM
. O

She O
was O
then O
started O
on O
ceftriaxone B-TREATMENT
and O
azithromycin B-TREATMENT
. O

Her O
urine O
legionella O
antigen O
was O
negative O
. O

On O
11/22/04 O
, O
she O
was O
noted O
to O
have O
gram-positive B-SYMPTOM
cocci I-SYMPTOM
in O
her O
sputum O
. O

She O
was O
started O
on O
vancomycin B-TREATMENT
for O
this O
. O

These B-SYMPTOM
bacteria I-SYMPTOM
turned O
out O
to O
be O
MRSA B-SYMPTOM
and O
she O
was O
continued O
on O
her B-TREATMENT
vancomycin I-TREATMENT
. O

She O
had O
PICC B-TREATMENT
line I-TREATMENT
placed O
on O
the O
day O
prior O
to O
discharge O
for O
home B-TREATMENT
vancomycin I-TREATMENT
administration I-TREATMENT
. O

3. O
GI O
: O

The O
patient O
had O
an O
episode O
of O
nausea B-SYMPTOM
on O
the O
morning O
of O
11/16/04 O
associated O
with O
some B-SYMPTOM
cough I-SYMPTOM
, O
apparent B-SYMPTOM
emesis I-SYMPTOM
. O

GI O
was O
consulted O
for O
an O
EGD O
, O
however O
, O
while O
she O
was O
in O
the O
Endoscopy O
Suite O
, O
as O
mentioned O
above O
, O
she O
had O
a B-SYMPTOM
hypotensive I-SYMPTOM
episode I-SYMPTOM
, O
which O
responded O
to O
some B-TREATMENT
fluid I-TREATMENT
boluses I-TREATMENT
. O

Finally O
, O
on O
the O
day O
prior O
to O
discharge O
, O
she O
was O
stabilized O
to O
the O
point O
that O
she O
could O
have O
her O
EGD O
. O

The O
EGD O
did O
show O
three B-SYMPTOM
esophageal I-SYMPTOM
ulcers I-SYMPTOM
that O
were O
localized O
and O
apparent O
suggestion O
of O
pill B-SYMPTOM
esophagitis I-SYMPTOM
. O

Her O
stomach O
and O
duodenum O
were O
normal O
and O
it O
was O
suggested O
that O
she O
change O
her B-TREATMENT
Nexium I-TREATMENT
doses I-TREATMENT
to O
daily O
and O
that O
she O
also O
drink O
plenty O
of O
fluids O
and O
water O
with O
meals O
, O
sit O
upright O
when O
she O
would O
eat O
her O
meals O
to O
decrease O
the O
chance O
of O
pills B-TREATMENT
eroding O
her O
esophagus O
. O

4. O
Shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
: O

As O
mentioned O
above O
, O
the O
patient O
did O
develop O
MRSA B-SYMPTOM
pneumonia I-SYMPTOM
that O
was O
started O
to O
be O
treated O
with O
vancomycin B-TREATMENT
and O
she O
did O
also O
develop O
an B-SYMPTOM
oxygen I-SYMPTOM
requirement I-SYMPTOM
the O
day O
prior O
to O
discharge O
. O

At O
most O
, O
her B-SYMPTOM
oxygen I-SYMPTOM
requirement I-SYMPTOM
was O
4-5 O
liters O
and O
on O
the O
day O
prior O
to O
discharge O
, O
she O
was O
satting O
well O
on O
two O
liters O
of O
nasal B-TREATMENT
cannula I-TREATMENT
. O

This O
was O
thought O
to O
be O
due O
to O
her B-SYMPTOM
pneumonia I-SYMPTOM
; O
however O
, O
with O
her B-SYMPTOM
right I-SYMPTOM
ventricular I-SYMPTOM
hypokinesis I-SYMPTOM
, O
it O
is O
also O
possible O
that O
she O
may O
have O
an O
element O
of O
pulmonary B-SYMPTOM
hypertension I-SYMPTOM
and O
may O
warrant O
further O
investigation O
as O
an O
outpatient O
, O
for O
example O
, O
with O
chest O
CT O
. O

5. O
Derm O
: O

Several O
days O
prior O
to O
discharge O
, O
the O
patient O
developed O
some B-SYMPTOM
erythematous I-SYMPTOM
rash I-SYMPTOM
under O
her O
left O
breast O
and O
left O
side O
that O
was O
thought O
to O
be O
due O
to O
yeast B-SYMPTOM
. O

She O
was O
started O
on O
some B-TREATMENT
Miconazole I-TREATMENT
Cream I-TREATMENT
. O

The B-SYMPTOM
rash I-SYMPTOM
was O
always O
localized O
to O
her O
left O
side O
, O
sometimes O
extending O
down O
to O
her O
leg O
, O
but O
never O
on O
the O
right O
side O
. O

The B-SYMPTOM
rash I-SYMPTOM
appeared O
to O
be O
resolving O
by O
the O
time O
of O
discharge O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Tums B-TREATMENT
, O
500-1250 O
mg O
PO O
tid O
. O

Albuterol B-TREATMENT
inhaler I-TREATMENT
. O

Lipitor B-TREATMENT
, O
20 O
daily O
. O

Prozac B-TREATMENT
, O
60 O
daily O
. O

Flovent B-TREATMENT
inhaler I-TREATMENT
, O
220 O
mcg O
bid O
. O

Atrovent B-TREATMENT
, O
two O
puffs O
qid O
. O

Ditropan B-TREATMENT
, O
5 O
mg O
tid O
. O

Colace B-TREATMENT
, O
100 O
mg O
tid O
. O

Aspirin B-TREATMENT
, O
325 O
mg O
daily O
. O

Insulin B-TREATMENT
NPH I-TREATMENT
, O
36 O
subcu O
q O
AM O
, O
30 O
subcu O
q O
PM O
. O

Nystatin B-TREATMENT
Mouthwash I-TREATMENT
Swish O
and O
Swallow O
. O

Nexium B-TREATMENT
, O
20 O
mg O
PO O
daily O
. O

Vancomycin B-TREATMENT
1 O
gm O
IV O
q12h O
. O

The O
patient O
will O
follow-up O
with O
her O
primary O
care O
provider O
, O
Dr. O
Na O
Fongbain O
at O
the O
Cord O
Memorial O
Hospital O
. O

IEVE O
MANUAL O
, O
MD O

DICTATING O
FOR O
: O

Electronically O
Signed O
IEVE O
MANUAL O
, O
MD O
12/23/2004 O
11:19 O

_____________________________ O
IEVE O
MANUAL O
, O
MD O

TR O
: O

mm O

DD O
: O

11/25/2004 O

TD O
: O

11/25/2004 O
8:49 O
P O
367017 O

cc O
: O

IEVE O
MANUAL O
, O
MD O

017480654 O

FIH O

6160323 O

59147/s876 O

971818 O

2/15/1994 O
12:00:00 O
AM O

CHRONIC B-SYMPTOM
MYELOMONOCYTIC I-SYMPTOM
LEUKEMIA I-SYMPTOM
, O
WITHOUT O
REMISSION O
, O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

2/15/94 O

DISCHARGE O
DATE O
: O

2/28/94 O

PRINCIPAL O
DIAGNOSIS O
: O

Chronic B-SYMPTOM
myelomonocytic I-SYMPTOM
leukemia I-SYMPTOM
, O
without O
remission O
, O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
chronic B-SYMPTOM
airway I-SYMPTOM
obstruction I-SYMPTOM
, O
hypopotassemia B-SYMPTOM
, O
cellulitis B-SYMPTOM
, O
orbital B-SYMPTOM
hemorrhage I-SYMPTOM
, O
protein B-SYMPTOM
calorie I-SYMPTOM
malnutrition I-SYMPTOM
, O
gastrointestinal B-SYMPTOM
hemorrhage I-SYMPTOM
, O
pulmonary B-SYMPTOM
hemorrhage I-SYMPTOM
/ O
pneumonia B-SYMPTOM
, O
hyperglycemia B-SYMPTOM
, O
renal B-SYMPTOM
insufficiency I-SYMPTOM
, O
hyperuricemia B-SYMPTOM
, O
hypophosphatemia B-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
75 O
year O
old O
male O
had O
been O
noted O
to O
be O
anemic B-SYMPTOM
with O
an B-SYMPTOM
abnormal I-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
count I-SYMPTOM
since O
at O
least O
November O
1993 O
, O
while O
he O
was O
living O
in O
Aersing O
Rocuch O
Sun O
and O
his O
physicians O
there O
had O
begun O
to O
manage O
him O
with O
transfusions B-TREATMENT
, O
and O
low B-TREATMENT
dose I-TREATMENT
hydroxyurea I-TREATMENT
. O

Apparently O
, O
a O
bone O
marrow O
biopsy O
at O
the O
time O
confirmed O
the O
diagnosis O
of O
chronic B-SYMPTOM
myelomonocytic I-SYMPTOM
leukemia I-SYMPTOM
. O

He O
came O
to O
this O
country O
in O
late O
December O
1994 O
to O
live O
with O
his O
son O
for O
a O
few O
months O
and O
was O
referred O
to O
me O
for O
follow O
up O
. O

He O
had O
been O
noting O
night B-SYMPTOM
sweats I-SYMPTOM
, O
increasing B-SYMPTOM
fatigue I-SYMPTOM
, O
anorexia B-SYMPTOM
, O
and O
dyspnea B-SYMPTOM
, O
which O
were O
not O
particularly O
improved O
by O
increased B-TREATMENT
transfusions I-TREATMENT
or O
alterations O
of O
hydroxy B-TREATMENT
urea I-TREATMENT
. O

He O
became O
profoundly B-SYMPTOM
thrombocytopenic I-SYMPTOM
, O
and O
ultimately O
was O
admitted O
to O
the O
hospital O
on O
2/15 O
with O
headache B-SYMPTOM
and O
weakness B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
for O
chronic B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
, O
managed O
with O
an O
Italian O
variation O
of O
Digoxin B-TREATMENT
, O
and O
Amioadrone B-TREATMENT
, O
hypertension B-SYMPTOM
managed O
with O
an B-TREATMENT
ACE I-TREATMENT
inhibitor I-TREATMENT
, O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
managed O
with O
a B-TREATMENT
zanthine I-TREATMENT
preparation I-TREATMENT
and O
low B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
, O
as O
well O
as O
an B-TREATMENT
occasional I-TREATMENT
inhaler I-TREATMENT
. O

Other B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
included O
chronic B-SYMPTOM
liver I-SYMPTOM
disease I-SYMPTOM
of O
uncertain O
etiology O
, O
for O
which O
he O
had O
been O
advised O
not O
to O
drink O
any O
alcohol O
. O

He O
also O
had O
a B-SYMPTOM
penetrating I-SYMPTOM
injury I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
eye I-SYMPTOM
, O
which O
had O
rendered O
him O
blind B-SYMPTOM
10 O
years O
previously O
. O

PHYSICAL O
EXAMINATION O
: O

He O
was O
a O
chronically O
ill O
appearing O
elderly O
man O
, O
with O
a O
respiratory O
rate O
of O
30 O
, O
temperature O
99.6 O
, O
pulse O
100 O
, O
and O
irregularly B-SYMPTOM
irregular I-SYMPTOM
, O
blood O
pressure O
148/71 O
. O

He O
had O
some B-SYMPTOM
petechiae I-SYMPTOM
on I-SYMPTOM
his I-SYMPTOM
extremities I-SYMPTOM
, O
as O
well O
as O
in O
his O
mucosal O
membranes O
with O
some B-SYMPTOM
hemorrhagic I-SYMPTOM
bullae I-SYMPTOM
. O

There O
were O
bibasilar B-SYMPTOM
rales I-SYMPTOM
with O
some B-SYMPTOM
wheezing I-SYMPTOM
. O

He O
had O
no O
cardiac B-SYMPTOM
murmur I-SYMPTOM
. O

His O
abdomen O
was O
distended B-SYMPTOM
with O
massive B-SYMPTOM
hepatosplenomegaly I-SYMPTOM
, O
which O
was O
somewhat B-SYMPTOM
tender I-SYMPTOM
. O

The O
neurological O
examination O
aside O
from O
the B-SYMPTOM
blind I-SYMPTOM
right I-SYMPTOM
eye I-SYMPTOM
was O
unremarkable O
. O

LABORATORY O
DATA O
: O

Included O
a O
white O
blood O
count O
of O
140,000 O
, O
7% O
polys O
, O
1% O
bands O
, O
3% O
lymphs O
, O
1% O
monos O
, O
2 O
basos O
, O
4 O
blasts O
, O
76% O
pearl O
monocytes O
, O
6% O
meta O
&apos;s O
, O
3 O
nucleated O
red O
blood O
cells O
. O

There O
were O
some O
oval B-SYMPTOM
tear I-SYMPTOM
drop I-SYMPTOM
cells I-SYMPTOM
and O
target B-SYMPTOM
cells I-SYMPTOM
with O
a B-SYMPTOM
few I-SYMPTOM
schistocytes I-SYMPTOM
. O

The O
platelet O
count O
was O
9,000 O
, O
hematocrit O
was O
26.5 O
, O
with O
an O
mean O
corpuscular O
volume O
of O
about O
73 O
. O

His O
prothrombin O
time O
and O
partial O
thromboplastin O
time O
were O
normal O
. O

His O
uric O
acid O
was O
up O
at O
97 O
, O
his O
total O
bilirubin O
was O
up O
at O
1.8 O
, O
his O
LDH O
was O
428 O
, O
his O
phosphorus O
was O
1.2 O
, O
calcium O
8.6 O
, O
Digoxin O
level O
was O
1.0 O
, O
potassium O
on O
admission O
was O
2.9 O
, O
sodium O
135 O
, O
BUN O
and O
creatinine O
13/1.6 O
, O
and O
sugar O
of O
267 O
. O

A O
computerized O
tomography O
scan O
of O
his O
head O
showed O
no O
signs O
of O
an B-SYMPTOM
acute I-SYMPTOM
bleed I-SYMPTOM
, O
a O
chest O
X-ray O
showed O
no O
new B-SYMPTOM
infiltrates I-SYMPTOM
or O
masses B-SYMPTOM
. O

There O
was O
cardiomegaly B-SYMPTOM
with O
prominent B-SYMPTOM
vascularity I-SYMPTOM
, O
but O
no O
effusions B-SYMPTOM
. O

An O
electrocardiogram O
was O
consistent O
with O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
hospital O
and O
begun O
on O
high B-TREATMENT
dose I-TREATMENT
Hydroxyurea I-TREATMENT
, O
with O
a O
gradual O
improvement O
in O
his O
white O
blood O
count O
over O
the O
next O
few O
days O
. O

He O
did O
spike O
a B-SYMPTOM
fever I-SYMPTOM
and O
began O
Ancef B-TREATMENT
and O
Gentamicin B-TREATMENT
, O
although O
cultures O
never O
revealed O
a O
source O
for O
this O
. O

He O
also O
tried O
Amicar B-TREATMENT
and O
continued O
on O
low B-TREATMENT
dose I-TREATMENT
Prednisone I-TREATMENT
. O

His B-SYMPTOM
headache I-SYMPTOM
improved O
, O
but O
her O
remained O
profoundly B-SYMPTOM
weak I-SYMPTOM
and O
intermittently B-SYMPTOM
febrile I-SYMPTOM
with O
dyspnea B-SYMPTOM
. O

There O
was O
hemoptysis B-SYMPTOM
and O
intermittent B-SYMPTOM
gastrointestinal I-SYMPTOM
bleeding I-SYMPTOM
, O
while O
he O
remained O
profoundly B-SYMPTOM
thrombocytopenia I-SYMPTOM
. O

Transfusions B-TREATMENT
of I-TREATMENT
platelets I-TREATMENT
did O
not O
change O
his O
platelet O
count O
, O
presumably O
because O
of O
sequestration B-SYMPTOM
and O
a B-SYMPTOM
massive I-SYMPTOM
spleen I-SYMPTOM
. O

Amicar B-TREATMENT
was O
of O
uncertain O
value O
, O
but O
used O
intermittently O
. O

A O
bone O
marrow O
biopsy O
revealed O
the O
transformation O
of O
his B-SYMPTOM
CMML I-SYMPTOM
to O
acute B-SYMPTOM
myelogenous I-SYMPTOM
leukemia I-SYMPTOM
, O
and O
given O
his B-SYMPTOM
other I-SYMPTOM
underlying I-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
, O
we O
chose O
chemotherapy B-TREATMENT
with O
subcutaneous B-TREATMENT
Cystosine I-TREATMENT
Arabinoside I-TREATMENT
and O
6-Thioguanine B-TREATMENT
, O
which O
he O
tolerated O
without O
incident O
and O
this O
brought O
his O
white O
blood O
count O
down O
to O
below O
1,000 O
, O
and O
his O
spleen O
shrank O
noticeably O
, O
but O
he O
still O
could O
not O
maintain O
a O
bump O
in O
platelet O
count O
with O
platelet B-TREATMENT
transfusions I-TREATMENT
. O

He O
was O
intermittently B-SYMPTOM
congested I-SYMPTOM
limiting O
our O
ability O
to O
give O
intravenous B-TREATMENT
fluid I-TREATMENT
, O
for O
his B-TREATMENT
hydrea I-TREATMENT
, O
although O
we O
kept O
him O
on O
Allopurinol B-TREATMENT
. O

The O
renal O
function O
deteriorated O
somewhat O
, O
hampering O
our O
ability O
to O
give O
him O
his B-TREATMENT
Gentamicin I-TREATMENT
. O

The O
family O
maintained O
an O
extraordinary O
vigil O
over O
the O
days O
of O
his O
hospitalization O
, O
providing O
him O
with O
some O
food O
and O
constant O
attention O
, O
while O
we O
awaited O
the O
results O
of O
his B-TREATMENT
chemotherapy I-TREATMENT
and O
treatment B-TREATMENT
of O
his B-SYMPTOM
infection I-SYMPTOM
. O

He O
was O
intermittently B-SYMPTOM
restless I-SYMPTOM
and O
somewhat B-SYMPTOM
confused I-SYMPTOM
, O
and O
as O
his O
respiratory O
status O
deteriorated O
, O
the O
family O
agreed O
to O
a B-TREATMENT
low I-TREATMENT
dose I-TREATMENT
Morphine I-TREATMENT
drip I-TREATMENT
which O
made O
him O
much O
more O
comfortable O
. O

They O
agreed O
with O
a O
do O
not O
resuscitate O
status O
early O
on O
in O
the O
hospitalization O
and O
in O
the O
course O
of O
being O
maintain O
on O
low B-TREATMENT
dose I-TREATMENT
Morphine I-TREATMENT
, O
he O
ultimately O
expired O
on O
2/28/94 O
with O
the O
family O
present O
. O

No O
autopsy O
was O
obtained O
. O

LENNI O
BREUTZOLN O
, O
M.D. O

TR O
: O

lj O
/ O
bmot O

DD O
: O

3/12/94 O

TD O
: O

03/13/94 O

CC O
: O

Dr. O
Ca O
Shuff O
, O
FIH O
Oregon O
Dr. O
Ille O
Kote O

Admission O
Date O
: O

2013-01-03 O

Discharge O
Date O
: O

2013-01-09 O

Date O
of O
Birth O
: O

1954-07-20 O

Sex O
: O

F O

Service O
: O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
58 O
- O
year-old O
woman O
who O
was O
transferred O
from O
Shaugnessy-Kaplan O
Rehab O
Hospital O
Hospital O
for O
cardiac O
catheterization O
. O

The O
patient O
had O
a O
long O
history O
of O
hypertension B-SYMPTOM
, O
hypercholesterolemia B-SYMPTOM
, O
tobacco O
abuse O
, O
and O
family O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
who O
was O
in O
the O
usual O
state O
of O
health O
until O
Saturday O
previous O
to O
admission O
when O
she O
experienced O
bilateral B-SYMPTOM
arm I-SYMPTOM
and I-SYMPTOM
chest I-SYMPTOM
discomfort I-SYMPTOM
while O
carrying O
groceries O
. O

Her B-SYMPTOM
symptoms I-SYMPTOM
resolved O
with O
rest B-TREATMENT
. O

The B-SYMPTOM
same I-SYMPTOM
symptoms I-SYMPTOM
occurred O
again O
the O
same O
evening O
with O
exertion O
and O
then O
were O
again O
relieved O
with O
rest B-TREATMENT
. O

The O
patient O
presented O
to O
the O
outside O
hospital O
Emergency O
Room O
where O
she O
was O
started O
on O
Aspirin B-TREATMENT
, O
Lovenox B-TREATMENT
and O
beta B-TREATMENT
blocker I-TREATMENT
. O

She O
ruled O
out O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
by O
CPK O
and O
troponin O
and O
had O
non B-SYMPTOM
diagnostic I-SYMPTOM
EKG I-SYMPTOM
changes I-SYMPTOM
. O

She O
is O
being O
transferred O
to O
Arbour-Fuller O
Hospital O
for O
cardiac O
catheterization O
. O

Results O
of O
the O
catheterization O
indicated O
the O
patient O
had O
three B-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
and O
was O
a O
candidate O
for O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

The O
patient O
went O
to O
the O
operating O
room O
, O
was O
admitted O
to O
go O
to O
the O
operating O
room O
on O
2013-01-04 O
. O

Her O
risk O
factors O
: O
Hypertension B-SYMPTOM
, O
tobacco O
abuse O
( O
one O
pack O
per O
day O
times O
45 O
years O
), O
family O
history O
( O
father O
diagnosed O
with O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
in O
his O
50 O
's, O
patient O
's O
mother O
had O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
patient O
's O
brother O
has O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
). O

Hypercholesterolemia B-SYMPTOM
( O
total O
cholesterol O
on O
admission O
300 O
's O
several O
years O
ago O
). O

The O
patient O
denies O
any O
history O
of O
diabetes B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Status O
post O
CVA B-SYMPTOM
times O
two O
in O
2010 O
, O
arthritis B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
hypercholesterolemia B-SYMPTOM
, O
status O
post O
remote B-SYMPTOM
pneumonia I-SYMPTOM
, O
status O
post O
remote B-SYMPTOM
pleurisy I-SYMPTOM
, O
psoriasis B-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

Status O
post O
tubal B-TREATMENT
ligation I-TREATMENT
. O

MEDICATIONS O
: O

At O
home O
, O
Aggrenox B-TREATMENT
250 O
mg O
po O
q O
day O
. O

ALLERGIES O
: O

Sulfa B-TREATMENT
causes O
rash B-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
alone O
and O
works O
full O
time O
doing O
secretarial O
work O
. O

She O
has O
a O
son O
who O
is O
mentally B-SYMPTOM
handicapped I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
vital O
signs O
, O
heart O
rate O
71 O
, O
blood O
pressure O
134/75 O
, O
respiratory O
rate O
20 O
. O

Neck O
, O
no O
jugulovenous B-SYMPTOM
distension I-SYMPTOM
, O
carotids B-SYMPTOM
, O
no O
bruit B-SYMPTOM
in I-SYMPTOM
either I-SYMPTOM
right I-SYMPTOM
or I-SYMPTOM
left I-SYMPTOM
carotid I-SYMPTOM
artery I-SYMPTOM
. O

Lungs O
clear O
to O
auscultation O
bilaterally O
. O

Heart O
, O
S1 O
and O
S2 O
appreciated O
, O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
. O

Abdomen O
soft O
, O
non B-SYMPTOM
distended I-SYMPTOM
, O
nontender B-SYMPTOM
. O

There O
is O
ecchymosis B-SYMPTOM
in I-SYMPTOM
mid I-SYMPTOM
abdomen I-SYMPTOM
, O
left O
of O
midline O
, O
likely O
secondary O
to O
Lovenox B-TREATMENT
injections I-TREATMENT
. O

Extremities O
, O
no O
bruit B-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
or I-SYMPTOM
right I-SYMPTOM
femoral I-SYMPTOM
arteries I-SYMPTOM
. O

DP O
and O
PT O
pulses O
are O
2+ O
bilaterally O
. O

There O
is O
no O
pedal B-SYMPTOM
edema I-SYMPTOM
but O
there O
is O
evidence O
of O
some B-SYMPTOM
psoriasis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
, O
right O
greater O
than O
left O
. O

LABORATORY O
DATA O
: O

Cardiac O
catheterization O
performed O
on O
2013-01-03 O
: O
Three B-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
dominant I-SYMPTOM
system I-SYMPTOM
. O

Left O
main O
coronary O
artery O
with O
short O
vessel O
without O
significant B-SYMPTOM
lesions I-SYMPTOM
. O

The B-SYMPTOM
LAD I-SYMPTOM
diffusely I-SYMPTOM
diseased I-SYMPTOM
proximal I-SYMPTOM
section I-SYMPTOM
up O
to O
50% O
with O
focal O
70% B-SYMPTOM
mid I-SYMPTOM
segment I-SYMPTOM
lesion I-SYMPTOM
. O

D1 O
was O
mildly B-SYMPTOM
diseased I-SYMPTOM
diffusely I-SYMPTOM
. O

Left O
circumflex O
had O
80% B-SYMPTOM
stenosis I-SYMPTOM
in I-SYMPTOM
a I-SYMPTOM
large I-SYMPTOM
OM1 I-SYMPTOM
branch I-SYMPTOM
. O

The O
right O
coronary O
artery O
was O
diffusely B-SYMPTOM
diseased I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
mid I-SYMPTOM
segment I-SYMPTOM
with O
serial B-SYMPTOM
80-90% I-SYMPTOM
stenosis I-SYMPTOM
. O

Limited O
hemodynamics O
showed O
elevated B-SYMPTOM
LV I-SYMPTOM
and I-SYMPTOM
diastolic I-SYMPTOM
pressure I-SYMPTOM
( O
21 O
mmHg O
). O

Left O
ventriculogram O
demonstrates O
a B-SYMPTOM
mild I-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
and O
left O
ventricular O
ejection O
fraction O
of O
58% O
with O
normal O
regional O
wall O
motion O
. O

HOWeaver O
COURSE O
: O

The O
patient O
was O
admitted O
to O
Edith O
Nourse O
Rogers O
Memorial O
VA O
Hospital O
and O
brought O
to O
the O
operating O
room O
on O
2013-01-04 O
by O
Dr. O
van O
der O
Talbot O
where O
she O
received O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
three O
. O

She O
had O
an B-TREATMENT
anastomosis I-TREATMENT
between I-TREATMENT
the I-TREATMENT
left I-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
and I-TREATMENT
the I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
artery I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
RCA I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
OM I-TREATMENT
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
and O
was O
transported O
to O
the O
cardiac O
surgery O
recovery O
room O
. O

The O
patient O
was O
extubated O
on O
arrival O
in O
the O
cardiac O
surgery O
recovery O
room O
but O
was O
on O
no O
drips B-TREATMENT
. O

The O
patient O
's O
postoperative O
course O
was O
uncomplicated O
and O
she O
was O
extubated O
on O
the O
first O
postoperative O
day O
. O

On O
the O
first O
postoperative O
day O
her O
diet O
was O
advanced O
as O
tolerated O
and O
she O
was O
transferred O
to O
the O
patient O
care O
floor O
. O

On O
postoperative O
day O
#2 O
her B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
and O
chest B-TREATMENT
tubes I-TREATMENT
were O
discontinued O
. O

By O
postoperative O
day O
#3 O
she O
began O
ambulating O
with O
some B-SYMPTOM
great I-SYMPTOM
hesitancy I-SYMPTOM
. O

Foley B-TREATMENT
catheter I-TREATMENT
was O
removed O
. O

By O
postoperative O
day O
#5 O
she O
was O
ambulating O
at O
level O
IV O
, O
was O
tolerating O
po O
, O
was O
able O
to O
void O
and O
felt O
comfortable O
to O
go O
to O
rehab B-TREATMENT
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
STATUS O
: O

Discharged O
to O
rehab O
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
three O
on O
2013-01-04 O
. O

DISCHARGE O
MEDICATIONS O
: O

Toprol B-TREATMENT
75 O
mg O
po O
bid O
, O
Furosemide B-TREATMENT
20 O
mg O
po O
bid O
times O
one O
week O
, O
potassium B-TREATMENT
chloride I-TREATMENT
20 O
mEq O
po O
bid O
while O
on O
Lasix B-TREATMENT
, O
Colace B-TREATMENT
100 O
mg O
po O
bid O
while O
on O
Percocet B-TREATMENT
, O
enteric B-TREATMENT
coated I-TREATMENT
Aspirin I-TREATMENT
325 O
mg O
po O
q O
day O
, O
Indocin B-TREATMENT
25 O
mg O
po O
bid O
, O
Sarna B-TREATMENT
cream I-TREATMENT
applied O
to O
affected O
area O
prn O
, O
Percocet B-TREATMENT
1-2 O
tabs O
po O
q O
4-6 O
hours O
prn O
, O
Ibuprofen B-TREATMENT
400 O
mg O
po O
q O
6 O
hours O
prn O
, O
Tylenol B-TREATMENT
650 O
mg O
po O
q O
4-6 O
hours O
prn O
, O
Ativan B-TREATMENT
0.5 O
mg O
po O
q O
8 O
hours O
prn O
. O

FOAnterP O
: O

The O
patient O
will O
follow-up O
in O
the O
wound O
care O
clinic O
in O
two O
weeks O
. O

The O
patient O
will O
also O
follow-up O
with O
Dr. O
Fairchild O
, O
her O
primary O
care O
physician O
in O
three O
weeks O
. O

The O
patient O
will O
follow-up O
with O
Dr. O
vel O
Diaz O
in O
3-4 O
weeks O
. O

Briley O
von O
der O
Ross, O
M.D. O
67-576 O

Dictated O
By O
: O
Emily O
O O
Ennis O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-01-08 O
16:46 O

T O
: O
2013-01-08 O
17:08 O

JOB O
#: O
67252 O

Signed O
electronically O
by O
: O
DR. O
Santos O
von O
der O
Ross O
on O
: O
Elizabeth O
2013-02-21 O
3:05 O
PM O

( O
End O
of O
Report O
) O

389977469 O

SH O

30431630 O

12/19/2004 O
12:00:00 O
AM O

abdominal B-SYMPTOM
pain I-SYMPTOM

DIS O

Admission O
Date O
: O

12/19/2004 O

Report O
Status O
: O

Discharge O
Date O
: O

12/23/2004 O

****** O
DISCHARGE O
ORDERS****** O

MEEDHEYSKUDZRO O
, O
LEENLEE O
C O

360-93-28-7P31 O

Room O
: O

3M-963 O

Service O
: O

PUL O

DISCHARGE O
PATIENT O
ON O
: O

12/23/04 O
AT O
05:00 O
PM O

CONTINGENT O
UPON O
Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

SADDCHIRD O
, O
ALINE O
CHPIE O
, O
M.D. O

CODE O
STATUS O
: O

No O
CPR B-TREATMENT
/ O
No O
defib B-TREATMENT
/ O
No O
intubation B-TREATMENT
/ O
No O
pressors B-TREATMENT

/DISPOSITION O
: O

Home O
w/ O
services O

DISCHARGE O
MEDICATIONS O
: O

ALBUTEROL B-TREATMENT
INHALER I-TREATMENT
2 O
PUFF O
INH O
QID O
PRN O
Shortness B-SYMPTOM
of I-SYMPTOM
Breath I-SYMPTOM
, O
Wheezing B-SYMPTOM
VITAMIN B-TREATMENT
C I-TREATMENT
( I-TREATMENT
ASCORBIC I-TREATMENT
ACID I-TREATMENT
) I-TREATMENT
500 O
MG O
PO O
BID O
MIACALCIN B-TREATMENT
( I-TREATMENT
CALCITONIN I-TREATMENT
- I-TREATMENT
SALMON I-TREATMENT
) I-TREATMENT
1 O
SPRAY O
INH O
QD O

Number O
of O
Doses O
Required O
( O
approximate O
) O
: O

1MAG B-TREATMENT
CITRATE I-TREATMENT
( I-TREATMENT
CITRATE I-TREATMENT
OF I-TREATMENT
MAGNESIA I-TREATMENT
) I-TREATMENT
300 O
MILLILITERS O
PO O
QD O
PRN O
Constipation B-SYMPTOM
COLACE B-TREATMENT
( I-TREATMENT
DOCUSATE I-TREATMENT
SODIUM I-TREATMENT
) I-TREATMENT
100 O
MG O
PO O
TID O
GLYBURIDE B-TREATMENT
5 O
MG O
PO O
BID O
Starting O
IN O
AM O
on O
12/21/04 O
LACTULOSE B-TREATMENT
30 O
MILLILITERS O
PO O
Q6 O

HOLD O
IF O
: O

diarrhea B-SYMPTOM

SENNA B-TREATMENT
TABLETS I-TREATMENT
2 O
TAB O
PO O
BID O
SIMETHICONE B-TREATMENT
160 O
MG O
PO O
QID O
Starting O
Today O
( O
12/23 O
) O
PRN O

Other O
: O

gas B-SYMPTOM
, O
upset B-SYMPTOM
stomach I-SYMPTOM
. O

TAMOXIFEN B-TREATMENT
20 O
MG O
PO O
QD O

Override O
Notice O
: O

Override O
added O
on O
12/19/04 O
by O
SAPMOORES O
, O
NELL O
RILET O
, O
M.D. O
on O
order O
for O
LEVOFLOXACIN B-TREATMENT
PO I-TREATMENT
( O
ref O
# O
88006031 O
) O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

TAMOXIFEN B-TREATMENT
CITRATE I-TREATMENT
and O
LEVOFLOXACIN B-TREATMENT

Reason O
for O
override O
: O

aware O
MVI B-TREATMENT
THERAPEUTIC I-TREATMENT
W I-TREATMENT
/ I-TREATMENT
MINERALS I-TREATMENT
( I-TREATMENT
THERAP I-TREATMENT
VITS I-TREATMENT
/ I-TREATMENT
MINERALS I-TREATMENT
) I-TREATMENT
1 O
TAB O
PO O
QD O
PILOCARPINE B-TREATMENT
4% I-TREATMENT
SOLUTION I-TREATMENT
1 O
DROP O
OS O
QID O
FLONASE B-TREATMENT
( I-TREATMENT
FLUTICASONE I-TREATMENT
NASAL I-TREATMENT
SPRAY I-TREATMENT
) I-TREATMENT
2 O
SPRAY O
INH O
BID O

Number O
of O
Doses O
Required O
( O
approximate O
) O
: O

2 B-TREATMENT
ALPHAGAN I-TREATMENT
( I-TREATMENT
BRIMONIDINE I-TREATMENT
TARTRATE I-TREATMENT
) I-TREATMENT
1 O
DROP O
OS O
BID O

Number O
of O
Doses O
Required O
( O
approximate O
) O
: O

2 B-TREATMENT
LEVOFLOXACIN I-TREATMENT
250 O
MG O
PO O
QD O
X O
1 O
Days O
Starting O
Today O
( O
12/21 O
) O

Food O
/ O
Drug O
Interaction O
Instruction O

Administer O
iron B-TREATMENT
products I-TREATMENT
a O
minimum O
of O
2 O
hours O
before O
or O
after O
a B-TREATMENT
levofloxacin I-TREATMENT
or O
ciprofloxacin B-TREATMENT
dose O
dose O

If O
on O
tube B-TREATMENT
feeds I-TREATMENT
, O
please O
cycle O
( O
hold O
1 O
hr O
before O
to O
2 O
hr O
after O
) O

Take O
2 O
hours O
before O
or O
2 O
hours O
after O
dairy O
products O
. O

Alert O
overridden O
: O

Override O
added O
on O
12/19/04 O
by O
SAPMOORES O
, O
NELL O
RILET O
, O
M.D. O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

TAMOXIFEN B-TREATMENT
CITRATE I-TREATMENT
and O
LEVOFLOXACIN B-TREATMENT

Reason O
for O
override O
: O

aware O

CELEXA B-TREATMENT
( I-TREATMENT
CITALOPRAM I-TREATMENT
) I-TREATMENT
20 O
MG O
PO O
QD O
CALCIUM B-TREATMENT
CARB I-TREATMENT
+ I-TREATMENT
D I-TREATMENT
( O
600MG O
ELEM B-TREATMENT
CA I-TREATMENT
+ I-TREATMENT
VIT I-TREATMENT
D/200 I-TREATMENT
IU O
) O
1 O
TAB O
PO O
BID O
LUMIGAN B-TREATMENT
( I-TREATMENT
BIMATOPROST I-TREATMENT
0.03% I-TREATMENT
) I-TREATMENT
1 O
DROP O
OU O
QHS O

DIET O
: O

No O
Restrictions O

ACTIVITY O
: O

as O
tolerated O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Dr. O
Faleschird O
, O
Dr. O
Cuchbreunjesc O
, O
Dr. O
Roziesc O
, O

ALLERGY O
: O

CEFUROXIME B-TREATMENT
AXETILADMIT O
DIAGNOSIS O
: O

abdominal B-SYMPTOM
pain I-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
abdominal B-SYMPTOM
pain I-SYMPTOM

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
Allergies B-SYMPTOM
- O
PCN B-TREATMENT
- O
rash B-SYMPTOM
- O
Bactrim B-TREATMENT
- O
hives B-SYMPTOM
- O
Erythro B-TREATMENT
- O
nausea B-SYMPTOM
- O
Ceclor B-TREATMENT
- O
nausea B-SYMPTOM
- O
Clarythro B-TREATMENT
= O
rash B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

None O
. O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

NONEBRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

67 O
y/o O
F O
w/ O
hx O
poliomyelitis B-SYMPTOM
, O
breast B-SYMPTOM
CA I-SYMPTOM
stable O
on O
tamoxifen B-TREATMENT
, O
vent B-SYMPTOM
dependent I-SYMPTOM
in O
an B-TREATMENT
iron I-TREATMENT
lung I-TREATMENT
admitted O
w/ O
1 O
day O
hx O
of O
abdominal B-SYMPTOM
pain I-SYMPTOM
. O

Pt O
was O
recently O
admitted O
1 O
week O
ago O
w/ O
epigastric B-SYMPTOM
pain I-SYMPTOM
. O

Pain B-SYMPTOM
worse O
with O
movement O
. O

She O
denies O
any B-SYMPTOM
fever I-SYMPTOM
, O
BRBPR B-SYMPTOM
, O
melena B-SYMPTOM
, O
dysuria B-SYMPTOM
. O

On O
admision O
, O
T O
97.5 O
, O
HR O
86 O
, O
BP O
111/47 O
, O
R O
20 O
. O

Sat O
94% O
on O
4L B-TREATMENT
. O

Exam O
notable O
for O
hyperactive B-SYMPTOM
bowel I-SYMPTOM
sounds I-SYMPTOM
with O
abd B-SYMPTOM
distention I-SYMPTOM
and O
tenderness B-SYMPTOM
to O
palpation O
at O
LLQ O
and O
RLQ O
. O

No O
rebound B-SYMPTOM
or O
guarding B-SYMPTOM
. O

Abd O
CT O
showed O
stable O
findings O
compared O
to O
12/10/04 O
except O
for O
distended B-SYMPTOM
right I-SYMPTOM
colon I-SYMPTOM
consistent O
with O
ileus B-SYMPTOM
. O

Hospital O
course O
: O

GI O
: O

pt O
&apos;s O
clinical O
picture O
was O
consistent O
with O
constipation-related B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
. O

pt O
was O
started O
on O
bowel B-TREATMENT
regimen I-TREATMENT
with O
Senna B-TREATMENT
, O
magcitrate B-TREATMENT
and O
Lactulose B-TREATMENT
. O

Several O
loose O
bowel O
movements O
were O
induced O
with O
above O
regimen O
. O

Her B-SYMPTOM
abd I-SYMPTOM
distention I-SYMPTOM
and O
tenderness B-SYMPTOM
improved O
after O
bowel O
movement O
. O

ID O
: O

pt O
was O
Levo B-TREATMENT
250mg O
x O
3 O
days O
for O
UTI B-SYMPTOM
( O
pyuria B-SYMPTOM
on O
admisstion O
) O
. O

Pulm O
: O

pt O
has O
been O
using O
iron B-TREATMENT
lung I-TREATMENT
for O
breathing O
and O
has O
been O
satting O
well O
duing O
her O
hospital O
course O
. O

Code O
: O

DNR O
/ O
DNI O
. O

ADDITIONAL O
COMMENTS O
: O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

1. O
Please O
follow O
up O
with O
Dr. O
Faleschird O
, O
Dr. O
Cuchbreunjesc O
and O
Dr. O
Roziesc O
. O

No O
dictated O
summary O

ENTERED O
BY O
: O

LEESEPLASSBREAN O
, O
RIDELT O
, O
M.D. O
( O
FR98 O
) O

12/23/04 O
04:37 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2011-11-18 O

Discharge O
Date O
: O

2011-11-22 O

Date O
of O
Birth O
: O

1950-04-21 O

Sex O
: O

M O

Service O
: O

CCU O

REASON O
FOR O
ADMISSION O
: O

Acute B-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
and O
right B-SYMPTOM
ventricular I-SYMPTOM
infarction I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
61 O
- O
year-old O
Caucasian-speaking O
woman O
with O
a O
history O
of O
hypercholesterolemia B-SYMPTOM
and O
tobacco O
use O
who O
developed O
waxing B-SYMPTOM
and I-SYMPTOM
waning I-SYMPTOM
left I-SYMPTOM
substernal I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
with O
radiation B-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
shoulder I-SYMPTOM
on O
2011-11-17 O
which O
lasted O
that O
entire O
day O
. O

Upon O
waking O
on O
the O
morning O
of O
admission O
, O
she O
had O
10/10 O
chest B-SYMPTOM
pain I-SYMPTOM
associated O
with O
nausea B-SYMPTOM
. O

She O
presented O
to O
Charlton O
Memorial O
Hospital O
Hospital O
Emergency O
Department O
with O
inferior B-SYMPTOM
ST I-SYMPTOM
elevations I-SYMPTOM
; O
at O
which O
time O
she O
became O
acutely B-SYMPTOM
hypotensive I-SYMPTOM
to O
a O
systolic O
blood O
pressure O
of O
70 O
to O
80 O
after O
receiving O
one O
ublingual B-TREATMENT
nitroglycerin I-TREATMENT
. O

She O
then O
became O
bradycardic B-SYMPTOM
which O
responded O
to O
atropine B-TREATMENT
and O
intravenous B-TREATMENT
fluids I-TREATMENT
. O

In O
addition O
, O
she O
was O
given O
aspirin B-TREATMENT
, O
Plavix B-TREATMENT
, O
heparin B-TREATMENT
, O
and O
morphine B-TREATMENT
. O

Immediately O
prior O
to O
transfer O
to O
Worcester O
State O
Hospital O
, O
she O
went O
into O
ventricular B-SYMPTOM
fibrillation I-SYMPTOM
arrest I-SYMPTOM
at O
12:30 O
p.m. O
, O
at O
which O
time O
she O
was O
intubated B-TREATMENT
and O
defibrillated B-TREATMENT
back O
to O
sinus O
rhythm O
after O
five B-TREATMENT
shocks I-TREATMENT
. O

She O
received O
an B-TREATMENT
amiodarone I-TREATMENT
bolus I-TREATMENT
of O
150 O
mg O
intravenously O
and O
was O
continued O
on O
an B-TREATMENT
amiodarone I-TREATMENT
drip I-TREATMENT
while O
CMED O
CSRU-flighted O
to O
Boston O
Regional O
Medical O
Centerr O
where O
she O
underwent O
a O
catheterization O
. O

The O
cardiac O
catheterization O
revealed O
a B-SYMPTOM
total I-SYMPTOM
occlusion I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
and O
diffuse B-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

She O
received O
three B-TREATMENT
stents I-TREATMENT
to I-TREATMENT
the I-TREATMENT
right I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
which O
was O
complicated O
by O
a B-SYMPTOM
proximal I-SYMPTOM
dissection I-SYMPTOM
. O

She O
had O
good O
post O
percutaneous O
coronary O
intervention O
angiographic O
results O
. O

Incidentally O
, O
an O
aortogram O
during O
the O
catheterization O
revealed O
a B-SYMPTOM
Debakey I-SYMPTOM
class I-SYMPTOM
I I-SYMPTOM
aortic I-SYMPTOM
ascending I-SYMPTOM
aneurysm I-SYMPTOM
, O
and O
the O
patient O
had O
a O
pulmonary O
capillary O
wedge O
pressure O
of O
20 O
at O
the O
time O
of O
catheterization O
. O

She O
was O
transferred O
to O
the O
Coronary O
Care O
Unit O
in O
stable O
condition O
and O
still O
intubated B-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

Hypercholesterolemia B-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

" O
Flumaran B-TREATMENT
" O
for O
circulatory B-SYMPTOM
problems I-SYMPTOM
. O

She O
receives O
this B-TREATMENT
medication I-TREATMENT
by O
mail O
from O
her O
relatives O
in O
Jill O
. O

MEDICATIONS O
ON O
ADMISSION O
TO O
CORONARY O
CARE O
0408398 O
. O

Amiodarone B-TREATMENT
drip I-TREATMENT
. O

2. O
Integrilin B-TREATMENT
drip I-TREATMENT
. O

3. O
Intravenous B-TREATMENT
fluids I-TREATMENT
. O

ALLERGIES O
: O

A O
question O
of O
a B-TREATMENT
SULFA I-TREATMENT
allergy B-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
alone O
in O
Woburn O
. O

She O
came O
from O
Czech O
Republic O
14 O
years O
ago O
. O

She O
works O
as O
a O
nursing O
assistant O
in O
a O
nursing O
home O
. O

She O
smokes O
approximately O
one O
and O
a O
half O
packs O
of O
cigarettes O
per O
day O
for O
the O
last O
30 O
years O
. O

FAMILY O
HISTORY O
: O

Family O
history O
is O
not O
significant O
for O
any O
early O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
ON O
PRESENTATION O
: O

Examination O
on O
admission O
to O
the O
Coronary O
Care O
Unit O
revealed O
blood O
pressure O
was O
100/57 O
, O
with O
a O
mean O
arterial O
pressure O
of O
75 O
, O
heart O
rate O
was O
sinus O
rhythm O
at O
75 O
, O
temperature O
was O
97.6 O
, O
oxygen O
saturation O
was O
99% O
on O
assist B-TREATMENT
control I-TREATMENT
with O
a B-TREATMENT
tidal I-TREATMENT
volume I-TREATMENT
of O
600 O
on O
60% O
FIO2 B-TREATMENT
, O
5 O
of O
positive B-TREATMENT
end-expiratory I-TREATMENT
pressure I-TREATMENT
. O

In O
general O
, O
she O
was O
sedated B-TREATMENT
at O
the O
time O
, O
responsive O
to O
stimuli O
, O
and O
was O
following O
commands O
. O

She O
had O
moist O
mucous O
membranes O
. O

Her O
carotids O
were O
2+ O
bilaterally O
. O

Her O
lungs O
were O
clear O
to O
auscultation O
anteriorly O
. O

Her O
heart O
revealed O
a O
regular O
rate O
and O
rhythm O
with O
a B-SYMPTOM
faint I-SYMPTOM
second I-SYMPTOM
heart I-SYMPTOM
sound I-SYMPTOM
and O
second O
heart O
sound O
. O

No O
audible B-SYMPTOM
extra I-SYMPTOM
heart I-SYMPTOM
sounds I-SYMPTOM
. O

Her O
abdomen O
was O
obese B-SYMPTOM
and O
had O
positive O
bowel O
sounds O
. O

It O
was O
soft O
and O
nontender B-SYMPTOM
. O

She O
had O
peripheral B-SYMPTOM
edema I-SYMPTOM
with O
2+ O
peripheral O
pulses O
bilaterally O
. O

PERTINENT O
LABORATORY O
DATA O
ON O
PRESENTATION O
: O

Her O
laboratories O
at O
the O
time O
of O
transfer O
to O
Saint O
Vincent O
Hospital O
revealed O
white O
blood O
cell O
count O
was O
11.5 O
, O
hematocrit O
was O
42 O
on O
admission O
, O
platelets O
were O
242 O
. O

Chemistry-7 O
was O
unremarkable O
. O

Creatine O
kinase O
on O
admission O
was O
309 O
, O
with O
a O
MB O
of O
19.6 O
, O
an O
index O
of O
6.3 O
, O
and O
an O
initial O
troponin O
of O
0.73 O
. O

RADIOLOGY O
/ O
IMAGING O
: O

A O
chest O
x-ray O
revealed O
an B-SYMPTOM
enlarged I-SYMPTOM
mediastinum I-SYMPTOM
with O
clear O
lung O
fields O
bilaterally O
. O

Initial O
electrocardiogram O
showed O
a O
normal O
sinus O
rhythm O
at O
65 O
, O
normal O
axis O
, O
2-mm B-SYMPTOM
ST I-SYMPTOM
elevations I-SYMPTOM
in I-SYMPTOM
lead I-SYMPTOM
III I-SYMPTOM
, O
1-mm B-SYMPTOM
ST I-SYMPTOM
elevations I-SYMPTOM
in I-SYMPTOM
aVF I-SYMPTOM
and I-SYMPTOM
V1 I-SYMPTOM
, O
1-mm B-SYMPTOM
ST I-SYMPTOM
depressions I-SYMPTOM
in I-SYMPTOM
I I-SYMPTOM
and I-SYMPTOM
aVL I-SYMPTOM
; O
consistent O
with O
an B-SYMPTOM
inferior I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
ventricular I-SYMPTOM
infarction I-SYMPTOM
. O

Right-sided O
electrocardiograms O
showed O
1-mm B-SYMPTOM
ST I-SYMPTOM
elevations I-SYMPTOM
in I-SYMPTOM
V4 I-SYMPTOM
; O
consistent O
with O
a B-SYMPTOM
right I-SYMPTOM
ventricular I-SYMPTOM
infarct I-SYMPTOM
. O

Electrocardiogram O
status O
post O
percutaneous B-TREATMENT
coronary I-TREATMENT
intervention I-TREATMENT
revealed O
a O
normal O
sinus O
rhythm O
at O
84 O
, O
with O
a O

normal O
axis O
, O
and O
normalizing O
of O
the B-SYMPTOM
inferior I-SYMPTOM
ST I-SYMPTOM
segments I-SYMPTOM
, O
with O
Q O
waves O
evolving O
in O
leads O
III O
and O
aVF O
. O

An O
echocardiogram O
status O
post O
percutaneous B-TREATMENT
coronary I-TREATMENT
intervention I-TREATMENT
revealed O
an B-SYMPTOM
akinetic I-SYMPTOM
inferior I-SYMPTOM
wall I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
ventricle I-SYMPTOM
, O
mild B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
, O
and O
ascending O
aorta O
measuring O
5 O
cm O
. O

There O
was O
no O
effusion B-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

1. O
CARDIOVASCULAR O
SYSTEM O
: O

On O
the O
night O
of O
admission O
, O
the O
patient O
experienced O
post B-SYMPTOM
catheterization I-SYMPTOM
hypotension I-SYMPTOM
which O
required O
intravenous B-TREATMENT
fluids I-TREATMENT
and O
dopamine B-TREATMENT
. O

Electrocardiogram O
the O
following O
morning O
revealed O
normalization O
of O
her O
ST O
segments O
with O
evolution B-SYMPTOM
of I-SYMPTOM
Q I-SYMPTOM
waves I-SYMPTOM
. O

Her B-TREATMENT
dopamine I-TREATMENT
was O
weaned O
off O
the O
following O
day O
, O
and O
her B-TREATMENT
heparin I-TREATMENT
was O
discontinued O
secondary O
to O
a B-SYMPTOM
right I-SYMPTOM
groin I-SYMPTOM
hematoma I-SYMPTOM
which O
had O
developed O
after O
the B-TREATMENT
sheath I-TREATMENT
had O
been O
pulled O
out O
by O
the O
fellow O
. O

Her O
creatine O
kinases O
climbed O
; O
reaching O
a O
peak O
of O
3523 O
, O
which O
was O
down O
to O
1500 O
at O
the O
time O
of O
discharge O
. O

Also O
noted O
on O
the O
day O
of O
11-20 O
, O
the O
patient O
self-extubated O
herself O
. O

For O
her B-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
catheterization O
, O
she O
was O
given O
Integrilin B-TREATMENT
for O
18 O
hours O
. O

She O
was O
continued O
on O
aspirin B-TREATMENT
, O
Plavix B-TREATMENT
, O
and O
Lipitor B-TREATMENT
. O

For O
her O
rhythm O
, O
amiodarone B-TREATMENT
was O
discontinued O
as O
she O
was O
maintained O
in O
sinus O
rhythm O
after O
moving O
to O
the O
floor O
. O

For O
pump O
, O
once O
transferred O
out O
of O
the O
Coronary O
Care O
Unit O
on O
2011-11-20 O
, O
a B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
was O
begun O
at O
12.5 O
mg O
of O
Lopressor B-TREATMENT
p.o. O
b.i.d. O
which O
was O
titrated O
to O
25 O
mg O
at O
the O
time O
of O
discharge O
. O

Also O
, O
at O
the O
time O
of O
discharge O
, O
for O
increased B-TREATMENT
afterload I-TREATMENT
reduction I-TREATMENT
, O
she O
was O
started O
on O
lisinopril B-TREATMENT
5 O
mg O
p.o. O
q.d. O

On O
2011-11-21 O
, O
the O
patient O
experienced O
atypical B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
which O
was O
made O
worse O
with O
inspiration O
and O
movement O
. O

It O
was O
not O
associated O
with O
any B-SYMPTOM
nausea I-SYMPTOM
or O
vomiting B-SYMPTOM
. O

It O
did O
not O
radiate O
. O

It O
was O
felt O
to O
be O
pain B-SYMPTOM
secondary O
to O
her B-SYMPTOM
self-extubation I-SYMPTOM
and O
noncardiac B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
. O

An O
electrocardiogram O
was O
checked O
which O
revealed O
no O
ST B-SYMPTOM
changes I-SYMPTOM
, O
and O
there O
was O
no O
increase O
in O
her O
downward O
trending O
creatine O
phosphokinases O
. O

No O
further B-TREATMENT
intervention I-TREATMENT
was O
done O
. O

The O
patient O
was O
treated O
with O
Tylenol B-TREATMENT
orally I-TREATMENT
as O
well O
as O
Ativan B-TREATMENT
for O
anxiety B-SYMPTOM
that O
she O
had O
about O
going O
home O
. O

She O
was O
pain B-SYMPTOM
free O
on O
the O
day O
of O
discharge O
. O

Regarding O
her B-SYMPTOM
aortic I-SYMPTOM
ascending I-SYMPTOM
aneurysm I-SYMPTOM
, O
Cardiothoracic O
Surgery O
was O
consulted O
regarding O
further O
workup O
. O

At O
their O
request O
, O
a O
CT O
scan O
of O
the O
chest O
with O
contrast O
was O
performed O
on O
the O
day O
of O
discharge O
. O

Dr. O
Streeter O
from O
Cardiothoracic O
Surgery O
will O
follow O
up O
with O
the O
patient O
for O
further B-TREATMENT
management I-TREATMENT
in O
approximately O
one O
month O
as O
an O
outpatient O
. O

His O
office O
will O
contact O
her O
to O
make O
that O
appointment O
. O

2. O
PULMONARY O
SYSTEM O
: O

As O
stated O
above O
, O
the O
patient O
self-extubated O
herself O
. O

She O
complained O
of O
a B-SYMPTOM
sore I-SYMPTOM
throat I-SYMPTOM
which O
was O
likely O
the O
etiology O
of O
her B-SYMPTOM
atypical I-SYMPTOM
chest I-SYMPTOM
complaints I-SYMPTOM
. O

This O
resolved O
with O
Tylenol B-TREATMENT
and O
as O
needed O
doses O
of O
oxycodone B-TREATMENT
. O

Her O
lungs O
remained O
clear O
to O
auscultation O
bilaterally O
throughout O
the O
remainder O
of O
her O
hospital O
course O
. O

At O
the O
time O
of O
this O
dictation O
, O
the O
CT O
of O
her O
chest O
was O
still O
pending O
. O

The O
official O
result O
was O
not O
yet O
in O
. O

3. O
FLUIDS O
/ O
ELECTROLYTES O
/ O
NUTRITION O
: O

The O
patient O
's O
electrolytes O
sere O
managed O
daily O
and O
repleted O
on O
an O
as O
needed O
basis O
. O

She O
did O
receive O
intravenous B-TREATMENT
K-Phos I-TREATMENT
for O
a B-SYMPTOM
low I-SYMPTOM
phosphorous I-SYMPTOM
of O
1.5 O
. O

Her O
phosphorous O
rose O
appropriately O
to O
3.6 O
at O
the O
time O
of O
discharge O
. O

DISCHARGE O
FOLLOWUP O
: O

1. O
The O
patient O
has O
an O
appointment O
to O
initiate O
primary O
care O
, O
as O
she O
no O
longer O
had O
a O
primary O
care O
physician O
. O

Claire O
was O
to O
see O
Dr. O
Michael O
Majerowski O
at O
the O
Sturdy O
Memorial O
Clinic O
on O
the O
east O
campus O
, O
on O
Bissonette O
Six O
, O
in O
the O
South O
Suite O
, O
on O
31-05-03 O
at O
11:30 O
a.m. O

2. O
In O
addition O
, O
as O
stated O
above O
, O
Dr.Hastings O
office O
from O
Cardiothoracic O
Surgery O
will O
be O
in O
contact O
with O
Ms. O
Williams O
to O
arrange O
followup O
for O
her B-SYMPTOM
ascending I-SYMPTOM
aortic I-SYMPTOM
aneurysm I-SYMPTOM
in O
approximately O
one O
month O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Lisinopril B-TREATMENT
5 O
mg O
p.o. O
q.d. O

2. O
Lopressor B-TREATMENT
25 O
mg O
p.o. O
b.i.d. O

3. O
Plavix B-TREATMENT
75 O
mg O
p.o. O
q.d. O

4. O
Lipitor B-TREATMENT
10 O
mg O
p.o. O
q.d. O

5. O
Protonix B-TREATMENT
40 O
mg O
p.o. O
q.d. O

6. O
Enteric-coated B-TREATMENT
aspirin I-TREATMENT
325 O
mg O
p.o. O
q.d. O

CONDITION O
AT O
DISCHARGE O
: O

Condition O
on O
discharge O
was O
stable O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Inferior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
and O
right B-SYMPTOM
ventricular I-SYMPTOM
infarction I-SYMPTOM
. O

Status O
post O
cardiac O
catheterization O
and O
stents B-TREATMENT
times O
three O
of O
the O
right O
coronary O
artery O
. O

2. O
Hypertension B-SYMPTOM
. O

3. O
Hypercholesterolemia B-SYMPTOM
. O

Rosemary O
D O
Mccluskey O
, O
M.D. O
39-696 O

Dictated O
By O
: O
Harriet O
E. O
Evans O
, O
M.D. O

MEDQUIST36 O

D O
: O
2011-11-22 O
14:09 O

T O
: O
2011-11-23 O
11:59 O

JOB O
#: O
15087 O

Signed O
electronically O
by O
: O
DR. O
Sandra O
BURGER O
on O
: O
WED O
2011-11-30 O
9:46 O
AM O

( O
End O
of O
Report O
) O

395715290 O

PUOMC O

2681723 O

64704/9r71 O

946667 O

4/6/1995 O
12:00:00 O
AM O

ACUTE B-SYMPTOM
MYOCARDIAL I-SYMPTOM
INFARCTION I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

4/6/95 O

DISCHARGE O
DATE O
: O

4/16/95 O

PRINCIPAL O
DIAGNOSIS O
: O

Acute B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

status O
post O
aortic B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
, O
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

PRINCIPAL O
PROCEDURE O
: O

Percutaneous B-TREATMENT
angioplasty I-TREATMENT
of I-TREATMENT
the I-TREATMENT
right I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
, O
4/9/95 O
. O

OTHER O
PROCEDURES O
: O

directional B-TREATMENT
angioplasty I-TREATMENT
of I-TREATMENT
the I-TREATMENT
right I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
, I-TREATMENT
left I-TREATMENT
main I-TREATMENT
and I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
vessels I-TREATMENT
. O

4/11/95 O
. O

DOCTORS O
DISCHARGE O
ORDERS O
: O

Lanoxin B-TREATMENT
0.375 O
mg. O
daily O
. O

Coumadin B-TREATMENT
as O
adjusted O
by O
Prothrombin O
times O
, O
Isordil B-TREATMENT
20 O
mg. O
tid O
, O
Micronase B-TREATMENT
1.25 O
mg. O
daily O
, O
aspirin B-TREATMENT
81 O
mg. O
daily O
, O
nitroglycerin B-TREATMENT
0.3 O
mg. O
SL O
prn O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
seventy O
two O
year O
old O
man O
who O
a O
number O
of O
years O
ago O
underwent O
coronary B-TREATMENT
bypass I-TREATMENT
surgery I-TREATMENT
at O
another O
institution O
. O

This O
took O
place O
in O
1983 O
. O

In O
1992 O
he O
underwent O
redo B-TREATMENT
surgery I-TREATMENT
and O
aortic B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
. O

In O
April O
1994 O
he O
presented O
with O
an B-SYMPTOM
acute I-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
and O
was O
given O
Streptokinase B-TREATMENT
. O

He O
had O
recurrent B-SYMPTOM
pain I-SYMPTOM
and O
went O
to O
the O
Catheter O
Laboratory O
where O
a B-SYMPTOM
proximal I-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
lesion I-SYMPTOM
was O
angioplastied O
. O

A O
relook O
several O
days O
later O
led O
to O
a B-TREATMENT
repeat I-TREATMENT
percutaneous I-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
. O

He O
has O
has O
stable B-SYMPTOM
, I-SYMPTOM
mild I-SYMPTOM
angina I-SYMPTOM
, O
subsequently O
, O
mostly O
in O
the O
setting O
of O
stress B-SYMPTOM
. O

Slightly O
increased O
in O
recent O
months O
. O

On O
the O
day O
of O
admission O
, O
he O
was O
involved O
in O
a O
minor O
motor O
vehicle O
accident O
, O
and O
there O
was O
some O
apparent O
controversy O
with O
the O
driver O
of O
the O
other O
vehicle O
, O
during O
the O
course O
of O
which O
he O
developed O
substernal B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
radiating O
to O
the O
left O
arm O
and O
shoulder O
. O

This O
waxed O
and O
waned O
for O
thirty O
to O
sixty O
minutes O
, O
and O
he O
took O
a O
number O
of O
nitroglycerins B-TREATMENT
. O

After O
returning O
home O
after O
conferring O
with O
his O
wife O
, O
and O
the B-SYMPTOM
pain I-SYMPTOM
lasted O
another O
half O
hour O
, O
he O
came O
to O
the O
emergency O
room O
. O

His O
electrocardiogram O
showed O
increased B-SYMPTOM
T I-SYMPTOM
wave I-SYMPTOM
inversions I-SYMPTOM
in I-SYMPTOM
V3 I-SYMPTOM
and O
V4 O
and O
1 O
mm O
. O

ST B-SYMPTOM
segment I-SYMPTOM
depression I-SYMPTOM
in I-SYMPTOM
V3 I-SYMPTOM
through O
V6 O
. O

His O
examination O
was O
largely O
benign O
after O
he O
was O
made O
pain B-SYMPTOM
free O
. O

The O
pulse O
was O
75 O
, O
blood O
pressure O
120/80 O
, O
respirations O
18 O
, O
and O
he O
was O
afebrile B-SYMPTOM
. O

The O
jugular O
veins O
were O
not O
distended B-SYMPTOM
, O
the O
carotid O
volume O
was O
diminished B-SYMPTOM
. O

The O
chest O
was O
clear O
and O
the O
cardiac O
rhythm O
was O
regular O
. O

There O
were O
normal B-TREATMENT
prothetic I-TREATMENT
valves I-TREATMENT
. O

There O
was O
a B-SYMPTOM
grade I-SYMPTOM
II-II I-SYMPTOM
apical I-SYMPTOM
and I-SYMPTOM
systolic I-SYMPTOM
murmur I-SYMPTOM
. O

The O
abdomen O
was O
negative O
and O
there O
was O
no O
edema B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
feet I-SYMPTOM
. O

The O
electrocardiogram O
demonstrated O
normal O
sinus O
rhythm O
with O
poor B-SYMPTOM
R I-SYMPTOM
wave I-SYMPTOM
progression I-SYMPTOM
, O
left B-SYMPTOM
atrial I-SYMPTOM
enlargement I-SYMPTOM
and O
T B-SYMPTOM
wave I-SYMPTOM
inversion I-SYMPTOM
in I-SYMPTOM
leads I-SYMPTOM
V I-SYMPTOM
4 I-SYMPTOM
, I-SYMPTOM
5 I-SYMPTOM
, O
and O

165342718 O

CTMC O

79284819 O

181252 O

11/30/1993 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Admission O
Date O
: O

11/30/1993 O

Report O
Status O
: O

Unsigned O

Discharge O
Date O
: O

12/07/1993 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
40 O
year O
old O
woman O
with O
end B-SYMPTOM
stage I-SYMPTOM
renal I-SYMPTOM
disease I-SYMPTOM
, O
on O
hemodialysis B-TREATMENT
since O
12/91 O
. O

This O
was O
secondary O
to O
polycystic B-SYMPTOM
kidneydisease I-SYMPTOM
, O
which O
was O
noted O
since O
age O
12 O
. O

She O
is O
status O
post O
cadaveric B-TREATMENT
renal I-TREATMENT
allograft I-TREATMENT
in O
03/93 O
, O
and O
she O
subsequently O
underwent O
an B-TREATMENT
early I-TREATMENT
postoperative I-TREATMENT
transplant I-TREATMENT
nephrectomy I-TREATMENT
secondary O
to O
rupture B-SYMPTOM
. O

He O
has O
been O
having O
difficult B-SYMPTOM
access I-SYMPTOM
problems I-SYMPTOM
and O
now O
has O
a B-TREATMENT
left I-TREATMENT
upper I-TREATMENT
arm I-TREATMENT
PTFE I-TREATMENT
. O

She O
had O
been O
placed O
on O
emergency B-TREATMENT
transplant I-TREATMENT
for O
this B-SYMPTOM
difficult I-SYMPTOM
access I-SYMPTOM
problem I-SYMPTOM
. O

Otherwise O
, O
she O
has O
been O
healthy O
and O
her B-TREATMENT
last I-TREATMENT
hemodialysis I-TREATMENT
was O
the O
day O
prior O
to O
transplant B-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
for O
hypertension B-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

Multiple B-TREATMENT
angio I-TREATMENT
accesses I-TREATMENT
, O
TAH B-TREATMENT
at O
age O
18 O
, O
cadaveric B-TREATMENT
renal I-TREATMENT
allograft I-TREATMENT
in O
03/93 O
, O
reoperation B-TREATMENT
for O
bleed B-SYMPTOM
followed O
by O
transplant B-TREATMENT
nephrectomy I-TREATMENT
. O

MEDICATIONS O
ON O
ADMIT O
: O

Iron B-TREATMENT
, O
Nephro-Caps B-TREATMENT
, O
calcium B-TREATMENT
carbonate I-TREATMENT
and O
Valium B-TREATMENT
. O

HOSPITAL O
COURSE O
: O

She O
was O
taken O
to O
the O
Operating O
Room O
on O
11/30/93 O
where O
Dr. O
Tiveloydherdes O
performed O
a B-TREATMENT
cadaveric I-TREATMENT
renal I-TREATMENT
allograft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
left I-TREATMENT
iliac I-TREATMENT
fossa I-TREATMENT
which O
she O
tolerated O
well O
. O

Postoperative O
course O
was O
unremarkable O
. O

She O
was O
started O
on O
her B-TREATMENT
immunosuppressive I-TREATMENT
agents I-TREATMENT
as O
per O
protocol O
. O

Her O
creatinine O
fell O
to O
the O
normal O
range O
early O
. O

Over O
several O
days O
she O
continued O
to O
make O
good O
amounts O
or O
urine O
. O

She O
was O
gradually O
advanced O
to O
a O
regular O
diet O
. O

Her B-TREATMENT
prednisone I-TREATMENT
was O
tapered O
to O
a B-TREATMENT
stable I-TREATMENT
dose I-TREATMENT
. O

DISPOSITION O
: O

Discharge B-TREATMENT
medications I-TREATMENT
were O
prednisone B-TREATMENT
30 O
q.d. O
, O
Imuran B-TREATMENT
120 O
q.d. O
, O
cyclosporin B-TREATMENT
400 O
b.i.d. O
and O
Pepcid B-TREATMENT
20 O
b.i.d. O
and O
Colace B-TREATMENT
100 O
b.i.d. O

Dicatated O
By O
: O

IA O
A O
, O
M.D. O
AX37 O

Attending O
: O

AE O
Z. O
TIVELOYDHERDES O
, O
M.D. O
ZC5 O
GI592/4-03 O

Batch O
: O

6066 O

Index O
No. O
VQCUHL4S7Y O

D O
: O

12/07/93 O

T O
: O

12/08/93 O

456424011 O

PUOMC O

4107358 O

541797 O

858595 O

4/7/1997 O
12:00:00 O
AM O

CORONARY B-SYMPTOM
ARTERY I-SYMPTOM
DISEASE I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

VESSELS O
, O
TISTIE O
D O

UNIT O
NUMBER O
: O

125-10-86 O

ADMISSION O
DATE O
: O

04/07/97 O

DISCHARGE O
DATE O
: O

04/08/97 O

PRINCIPAL O
DIAGNOSIS O
: O

coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Ischemic B-SYMPTOM
cardiomyopathy I-SYMPTOM
, O
orthotopic B-TREATMENT
heart I-TREATMENT
transplantation I-TREATMENT
, O
hyperlipidemia B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
coronary B-SYMPTOM
graft I-SYMPTOM
disease I-SYMPTOM
, O
medical B-SYMPTOM
noncompliance I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Cardiac O
echocardiogram O
. O

OTHER O
PROCEDURES O
: O

None O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Vessels O
is O
a O
49-year-old O
man O
status O
post O
orthotopic B-TREATMENT
heart I-TREATMENT
transplantation I-TREATMENT
in O
1991 O
at O
Dautenorwe O
Stuart O
Erec O
Hillpa O
Of O
Hospital O
who O
is O
admitted O
with O
dyspnea B-SYMPTOM
and O
severe B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

Mr. O
Vessels O
&apos;s O
postoperative O
course O
has O
been O
marked O
by O
CMV B-SYMPTOM
infection I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
poorly B-SYMPTOM
controlled I-SYMPTOM
lipids I-SYMPTOM
, O
peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
, O
and O
chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
with O
a O
creatinine O
of O
1.8 O
or O
so O
. O

Recently O
he O
had O
documented O
coronary O
angiography O
based O
on O
a O
catheterization O
performed O
in O
January O
1996 O
with O
moderate B-SYMPTOM
to I-SYMPTOM
diffuse I-SYMPTOM
atherosclerosis I-SYMPTOM
. O

A O
repeat O
angiogram O
performed O
a O
year O
later O
showed O
marked O
progression O
of O
coronary B-SYMPTOM
allograft I-SYMPTOM
disease I-SYMPTOM
. O

A O
biopsy O
at O
that O
time O
revealed O
grade B-SYMPTOM
1B I-SYMPTOM
rejection I-SYMPTOM
with O
endothelialitis B-SYMPTOM
and O
eosinophils B-SYMPTOM
. O

He O
was O
treated O
with O
pulsed B-TREATMENT
IV I-TREATMENT
steroids I-TREATMENT
and O
Imuran B-TREATMENT
, O
was O
augmented O
with O
mycophenolate B-TREATMENT
Mofetil I-TREATMENT
. O

Chest O
x-ray O
showed O
cariogenic B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
and O
he O
was O
faring O
poorly O
. O

Prior O
to O
admission O
he O
was O
seen O
approximately O
1 O
week O
in O
the O
office O
with O
mild B-SYMPTOM
congestive I-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

An O
echocardiogram O
then O
revealed O
an O
ejection O
fraction O
of O
40% O
and O
an O
endomyocardial O
biopsy O
revealed O
no O
ejection B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Notable O
for O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
coronary B-SYMPTOM
allograft I-SYMPTOM
vasculopathy I-SYMPTOM
, O
hyperlipidemia B-SYMPTOM
, O
peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
, O
CMV B-SYMPTOM
infection I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
depression B-SYMPTOM
, O
and O
tricuspid B-SYMPTOM
regurgitation I-SYMPTOM
. O

Examination O
revealed O
a O
tired O
, O
fatigued O
man O
with O
cool B-SYMPTOM
extremities I-SYMPTOM
. O

His O
blood O
pressure O
is O
130/80 O
and O
heart O
rate O
was O
100. O
jugular O
venous O
pressure O
was O
increasing O
. O

Carotids O
were O
2+ O
. O

Crackles B-SYMPTOM
were O
increased O
1/4 O
of O
the O
way O
up O
. O

There O
was O
a B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
heave I-SYMPTOM
and O
an B-SYMPTOM
S3 I-SYMPTOM
galop I-SYMPTOM
. O

The O
abdomen O
was O
soft O
and O
nontender B-SYMPTOM
with O
a O
palpable O
liver O
edge O
and O
the O
pulses O
were O
diminished O
. O

LABORATORY O
DATA O
: O

Revealed O
a O
sodium O
136 O
, O
potassium O
4.5 O
, O
BUN O
47 O
, O
creatinine O
2.4 O
, O
glucose O
136. O
hematocrit O
40% O
. O

The O
electrocardiogram O
revealed O
poor B-SYMPTOM
R I-SYMPTOM
wave I-SYMPTOM
progression I-SYMPTOM
and O
marked B-SYMPTOM
decrease I-SYMPTOM
in I-SYMPTOM
all I-SYMPTOM
volts I-SYMPTOM
. O

chest O
x-ray O
revealed O
prominent B-SYMPTOM
pulmonary I-SYMPTOM
vessels I-SYMPTOM
and O
enlarged B-SYMPTOM
heart I-SYMPTOM
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
was O
admitted O
to O
the O
hospital O
via O
the O
emergency O
room O
where O
a O
bedside O
echocardiogram O
was O
performed O
. O

The O
echocardiogram O
revealed O
no O
pericardial B-SYMPTOM
effusion I-SYMPTOM
, O
an O
ejection O
fraction O
of O
30% O
and O
worsening B-SYMPTOM
systolic I-SYMPTOM
dysfunction I-SYMPTOM
. O

Hydrocortisone B-TREATMENT
was O
given O
1 O
g O
in O
an O
attempt O
to O
reverse O
what O
was O
thought O
to O
be O
aggressive B-SYMPTOM
coronary I-SYMPTOM
allograft I-SYMPTOM
vasculopathy I-SYMPTOM
. O

The O
patient O
diuresed O
and O
responded O
to O
Lasix B-TREATMENT
100 O
mg O
administered O
in O
the O
emergency O
room O
and O
was O
admitted O
to O
a O
monitored O
bed O
. O

At O
4:30 O
AM O
the O
following O
morning O
the O
patient O
was O
found O
in O
cardiac B-SYMPTOM
arrest I-SYMPTOM
. O

Despite O
intravenous B-TREATMENT
fluids I-TREATMENT
, O
intravenous B-TREATMENT
epinephrine I-TREATMENT
, O
and O
multiple O
attempts O
at O
defibrillation B-TREATMENT
, O
the O
patient O
was O
unable O
to O
be O
resuscitated O
. O

Upon O
arrival O
of O
the O
covering O
access O
physician O
the O
patient O
was O
being O
ventilated O
mechanically O
and O
CPR B-TREATMENT
was O
being O
performed O
. O

The O
rhythm O
revealed O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
with O
no O
palpable O
or O
measurable O
blood O
pressure O
. O

There O
were O
also O
runs O
of O
ventricular B-SYMPTOM
tachycardia I-SYMPTOM
which O
generated O
into O
ventricular B-SYMPTOM
fibrillation I-SYMPTOM
that O
was O
refractory O
to O
multiple B-TREATMENT
cardioversions I-TREATMENT
. O

A O
pericardiocentesis O
was O
attempted O
with O
no O
yield O
of O
pericardial O
fluid O
. O

A B-TREATMENT
transvenous I-TREATMENT
pacing I-TREATMENT
wire I-TREATMENT
was O
attempted O
and O
a O
pacing O
rhythm O
was O
obtained O
but O
with O
no O
palpable O
blood O
pressure O
. O

In O
total O
, O
the O
patient O
was O
defibrillated O
10 O
times O
, O
given O
5 O
courses O
of O
intravenous B-TREATMENT
epinephrine I-TREATMENT
, O
one O
course O
of O
intravenous B-TREATMENT
Atropine I-TREATMENT
and O
intravenous B-TREATMENT
calcium I-TREATMENT
x O
1 O
in O
addition O
to O
an B-TREATMENT
amp I-TREATMENT
of I-TREATMENT
bicarbonate I-TREATMENT
. O

The B-TREATMENT
resuscitation I-TREATMENT
efforts I-TREATMENT
were O
discontinued O
at O
4:15 O
AM O
and O
were O
begun O
at O
3:38 O
AM O
. O

The O
patient O
was O
pronounced O
dead O
. O

Patient O
&apos;s O
mother O
was O
informed O
by O
Dr. O
Vessels O
. O

An O
autopsy O
permission O
was O
granted O
. O

DOCTOR O
&apos;S O
DISCHARGE O
ORDERS O
: O

None O
. O

AKA O
MAM O
, O
M.D. O

TR O
: O

ok O

DD O
: O

05/14/97 O

TD O
: O

05/17/97 O
9:40 O
A O

cc O
: O

AKA O
G O
MAM O
, O
M.D. O

143484920 O

GH O

57104201 O

7/10/1991 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Admission O
Date O
: O

07/10/1991 O

Report O
Status O
: O

Unsigned O

Discharge O
Date O
: O

07/18/1991 O

PRINCIPAL O
DIAGNOSIS O
: O

C. B-SYMPTOM
difficile I-SYMPTOM
colitis I-SYMPTOM
. O

SECONDARY O
DIAGNOSIS O
: O

1. O
Chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
. O

2. O
Chronic B-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

3. O
History O
of O
ischemic B-SYMPTOM
bowel I-SYMPTOM
. O

4. O
Chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
with O
azotemia B-SYMPTOM
. O

PROCEDURES O
: O

Thoracentesis B-TREATMENT
was O
performed O
on O
7-12-91 O
. O

REASON O
FOR O
ADMISSION O
: O

The O
patient O
is O
an O
85-year-old O
white O
male O
with O
a O
history O
of O
ischemic B-SYMPTOM
bowel I-SYMPTOM
status O
post O
recent O
admission O
for O
urosepsis B-SYMPTOM
and O
C. B-SYMPTOM
difficile I-SYMPTOM
colitis I-SYMPTOM
. O

He O
returns O
from O
the O
nursing O
home O
with O
fever B-SYMPTOM
, O
leukocytosis B-SYMPTOM
, O
and O
azotemia B-SYMPTOM
. O

PRESENT O
ILLNESS O
: O

Briefly O
, O
the O
patient O
has O
a O
history O
of O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
, O
ethanol O
abuse O
, O
chronic B-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
, O
and O
chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

He O
presented O
to O
Gaanvantsir O
on O
04-17-92 O
with O
abdominal B-SYMPTOM
pain I-SYMPTOM
and O
bloody B-SYMPTOM
diarrhea I-SYMPTOM
. O

Workup O
revealed O
ischemic B-SYMPTOM
bowel I-SYMPTOM
secondary O
to O
Celiac B-SYMPTOM
and O
SMA B-SYMPTOM
stenoses I-SYMPTOM
. O

The O
patient O
underwent O
an B-TREATMENT
angioplasty I-TREATMENT
of O
his B-SYMPTOM
SMA I-SYMPTOM
from O
90-20% O
residual O
. O

The O
patient O
was O
also O
found O
to O
have O
gram B-SYMPTOM
negative I-SYMPTOM
rod I-SYMPTOM
sepsis I-SYMPTOM
with O
blood O
cultures O
times O
two O
growing O
E. B-SYMPTOM
coli I-SYMPTOM
and O
B. B-SYMPTOM
fragilis I-SYMPTOM
. O

The O
patient O
was O
treated O
with O
ampicillin B-TREATMENT
, O
gentamicin B-TREATMENT
, O
and O
Flagyl B-TREATMENT
. O

The O
patient O
was O
readmitted O
on O
5-21-91 O
with O
a B-SYMPTOM
falling I-SYMPTOM
hematocrit I-SYMPTOM
from O
36 O
to O
22 O
, O
mild B-SYMPTOM
congestive I-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
and O
guaiac B-SYMPTOM
positive I-SYMPTOM
stool I-SYMPTOM
. O

The O
colonoscopy O
and O
upper O
gastrointestinal O
series O
were O
negative O
. O

The O
patient O
was O
given O
two O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
and O
H2 B-TREATMENT
blockers I-TREATMENT
. O

His O
hematocrit O
was O
31 O
on O
discharge O
. O

His O
hematocrit O
was O
31 O
on O
discharge O
. O

On O
6-12-91 O
the O
patient O
was O
admitted O
to O
Ingtermst.gay O
Health O
Center O
with O
fever B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
and O
diarrhea B-SYMPTOM
. O

The O
BUN O
and O
creatinine O
equalled O
128/8.6 O
, O
CO2 O
equaled O
12 O
. O

The O
patient O
was O
treated O
with O
intravenous B-TREATMENT
fluids I-TREATMENT
, O
Kefzol B-TREATMENT
, O
gentamicin B-TREATMENT
, O
Vancomycin B-TREATMENT
, O
and O
he O
was O
transferred O
to O
Gaanvantsir O
. O

He O
was O
hospitalized O
from O
6-12-91 O
to O
7-9-91 O
with O
a O
prolonged O
course O
notable O
for O
: O

1) O
Serratia B-SYMPTOM
urosepsis I-SYMPTOM
treated O
with O
ceftizoxime B-TREATMENT
. O

2) O
Azotemia B-SYMPTOM
presumed O
secondary O
to O
sepsis B-SYMPTOM
and O
dehydration B-SYMPTOM
, O
creatinine O
decreased O
to O
2.1 O
with O
intravenous B-TREATMENT
fluids I-TREATMENT
and O
antibiotics B-TREATMENT
. O

Renal O
ultrasound O
was O
negative O
for O
abscess B-SYMPTOM
orhydronephrosis I-SYMPTOM
. O

3) O
Loculated B-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
. O

Thoracentesis O
revealed O
a O
pH O
of O
7.18 O
, O
glucose O
52 O
, O
white O
blood O
cell O
count O
200 O
; O
evaluated O
by O
thoracic O
surgery O
, O
no O
chest B-TREATMENT
tube I-TREATMENT
placed O
. O

4) O
C. B-SYMPTOM
difficile I-SYMPTOM
colitis I-SYMPTOM
with O
white O
blood O
cell O
count O
rising O
to O
51,000 O
, O
treated O
with O
intravenous B-TREATMENT
and I-TREATMENT
p.o. I-TREATMENT
Flagyl I-TREATMENT
. O

C. O
difficile O
was O
negative O
times O
three O
prior O
to O
discharge O
. O

The O
patient O
went O
to O
his O
nursing O
home O
on O
7-9-91 O
but O
the O
next O
day O
he O
developed O
a B-SYMPTOM
temperature I-SYMPTOM
to O
102.4 O
degrees O
, O
diarrhea B-SYMPTOM
, O
and O
orthostasis B-SYMPTOM
and O
he O
was O
transferred O
back O
to O
Gaanvantsir O
. O

The O
patient O
was O
admitted O
to O
the O
medical O
intensive O
care O
unit O
with O
question O
of O
sepsis B-SYMPTOM
. O

White O
blood O
cell O
count O
was O
40,000 O
with O
left B-SYMPTOM
shift I-SYMPTOM
. O

The O
BUN O
was O
35 O
, O
creatinine O
4.3 O
. O

Urinalysis O
had O
5-10 O
white O
blood O
cells O
and O
2+ O
bacteria O
. O

The O
patient O
underwent O
thoracentesis O
without O
evidence O
of O
empyema B-SYMPTOM
. O

He O
was O
treated O
with O
intravenous B-TREATMENT
fluids I-TREATMENT
and O
intravenous B-TREATMENT
antibiotics I-TREATMENT
with O
ceftizoxime B-TREATMENT
, O
gentamicin B-TREATMENT
, O
and O
Flagyl B-TREATMENT
. O

He O
was O
also O
started O
on O
p.o. B-TREATMENT
Vancomycin I-TREATMENT
for O
question O
C. B-SYMPTOM
difficile I-SYMPTOM
colitis I-SYMPTOM
. O

He O
is O
now O
transferred O
to O
the O
medicine O
service O
for O
further B-TREATMENT
care I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

1) O
Alcohol O
abuse O
in O
the O
past O
. O

2) O
Chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
. O

3) O
Chronic B-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
. O

4) O
Chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
with O
baseline O
creatinine O
1.8-2 O
. O

5) O
Ischemic B-SYMPTOM
bowel I-SYMPTOM
status O
post O
SMA B-TREATMENT
Percutaneous I-TREATMENT
Transluminal I-TREATMENT
Coronary I-TREATMENT
Angioplasty I-TREATMENT
. O

6) O
Serratiaurosepsis B-SYMPTOM
. O

7) O
Positive B-SYMPTOM
PPD I-SYMPTOM
. O

8) O
Status O
post O
total B-TREATMENT
hip I-TREATMENT
replacement I-TREATMENT
. O

9) O
Right B-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
with O
left B-SYMPTOM
anterior I-SYMPTOM
hemiblock I-SYMPTOM
on O
electrocardiogram O
. O

Allergies B-SYMPTOM
to O
penicillin B-TREATMENT
, O
sulfa B-TREATMENT
, O
codeine B-TREATMENT
, O
morphine B-TREATMENT
sulfate I-TREATMENT
.Medications B-TREATMENT
on I-TREATMENT
transfer I-TREATMENT
included O
thiamine B-TREATMENT
; O
multivitamin B-TREATMENT
; O
Pepcid B-TREATMENT
; O
ceftizoxime B-TREATMENT
1 O
gm O
intravenously O
q. O
eight O
hours O
; O
Flagyl B-TREATMENT
500 O
mg O
intravenously O
q. O
eight O
hours O
; O
gentamicin B-TREATMENT
80 O
mg O
IV O
q. O
24 O
hours O
; O
Ventolin B-TREATMENT
inhaler I-TREATMENT
; O
Lotrimin B-TREATMENT
cream I-TREATMENT
; O
sliding B-TREATMENT
scale I-TREATMENT
nitro I-TREATMENT
paste I-TREATMENT
; O
pyridium B-TREATMENT
; O
Vancomycin B-TREATMENT
125 O
mg O
p.o. O
q.i.d. O
; O
and O
calcium B-TREATMENT
carbonate I-TREATMENT
. O

Habits O
: O

Positive O
for O
cigarettes O
of O
40 O
pack O
/ O
years O
quit O
in O
1990. O

Positive O
alcohol O
abuse O
in O
the O
distant O
past O
. O

Family O
history O
is O
positive O
for O
tuberculosis B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
and O
alcoholism O
. O

Social O
history O
: O

Former O
Vermont O
blacksmith O
. O

He O
has O
one O
son O
and O
lives O
in O
a O
nursing O
home O
. O

PHYSICAL O
EXAMINATION O
: O

GENERAL O
: O

He O
is O
a O
drowsy O
, O
elderly O
white O
male O
lying O
with O
O2 B-TREATMENT
on O
, O
asking O
to O
be O
scratched O
. O

Blood O
pressure O
110/50 O
, O
pulse O
rate O
94 O
, O
respiratory O
rate O
22 O
, O
temperature O
maximum O
101 O
degrees O
, O
decreasing O
to O
99 O
degrees O
. O

SKIN O
: O

Without O
rash B-SYMPTOM
or O
petechiae B-SYMPTOM
. O

HEENT O
: O

Dry B-SYMPTOM
mucous I-SYMPTOM
membranes I-SYMPTOM
. O

NECK O
: O

Supple O
. O

LUNGS O
: O

Bibasilar B-SYMPTOM
crackles I-SYMPTOM
, O
right O
greater O
than O
left O
, O
no O
wheezes B-SYMPTOM
. O

CARDIAC O
: O

Regular O
rate O
and O
rhythm O
, O
S1 O
, O
S2 O
, O
I B-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
. O

ABDOMEN O
: O

Distended B-SYMPTOM
, O
positive O
bowel O
sounds O
, O
soft O
, O
mild B-SYMPTOM
tenderness I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
, O
no O
rebound B-SYMPTOM
. O

RECTAL O
: O

Tender B-SYMPTOM
, O
external B-SYMPTOM
hemorrhoids I-SYMPTOM
, O
guaiac O
negative O
. O

EXTREMITIES O
: O

Without O
edema B-SYMPTOM
. O

NEUROLOGIC O
: O

Alert O
and O
oriented O
to O
person O
and O
place O
, O
no O
asterixis B-SYMPTOM
or O
tremor B-SYMPTOM
. O

LABORATORY O
DATA O
: O

Significant O
for O
sodium O
140 O
, O
potassium O
3 O
, O
BUN O
35 O
, O
creatinine O
3.6 O
, O
liver O
function O
tests O
within O
normal O
limits O
, O
calcium O
6.6 O
, O
albumin O
2 O
, O
magnesium1.4 O
, O
PT O
14 O
, O
white O
count O
30.1 O
with O
77 O
polys O
, O
13 O
bands O
, O
5 O
lymphs O
, O
and O
5 O
monos O
. O

Urine O
sodium O
is O
75 O
, O
urine O
creatinine O
143 O
, O
urine O
osmose O
392 O
. O

Pleural O
fluid O
pH O
is O
7.29 O
, O
glucose O
91 O
, O
total O
protein3.1 O
, O
LDH O
296 O
, O
70 O
white O
blood O
cells O
, O
50 O
red O
blood O
cells O
. O

HOSPITAL O
COURSE O
: O

1. O
Colitis B-SYMPTOM
. O

The O
patient O
has O
a O
history O
of O
ischemic B-SYMPTOM
bowel I-SYMPTOM
status O
post O
SMA B-TREATMENT
Percutaneous I-TREATMENT
Transluminal I-TREATMENT
Coronary I-TREATMENT
Angioplasty I-TREATMENT
with O
recent O
admission O
for O
gram B-SYMPTOM
negative I-SYMPTOM
rod I-SYMPTOM
urosepsis I-SYMPTOM
complicated O
by O
C. B-SYMPTOM
difficile I-SYMPTOM
colitis I-SYMPTOM
. O

The O
patient O
received O
a B-TREATMENT
full I-TREATMENT
course I-TREATMENT
of I-TREATMENT
Flagyl I-TREATMENT
and O
was O
C. O
difficile O
toxin O
negative O
times O
three O
prior O
to O
transfer O
. O

He O
now O
returns O
with O
fever B-SYMPTOM
, O
rising B-SYMPTOM
white I-SYMPTOM
count I-SYMPTOM
, O
diarrhea B-SYMPTOM
, O
and O
dehydration B-SYMPTOM
. O

Initially O
treated O
with O
intravenous B-TREATMENT
ceftizoxime I-TREATMENT
, O
gentamicin B-TREATMENT
, O
and O
Flagyl B-TREATMENT
for O
presumed O
sepsis B-SYMPTOM
, O
either O
with O
urine O
or O
bowel O
source O
. O

He O
was O
also O
started O
on O
p.o. B-TREATMENT
Vancomycin I-TREATMENT
. O

Blood O
cultures O
and O
urine O
cultures O
came O
back O
negative O
. O

Stool O
for O
C. O
difficile O
returned O
positive B-SYMPTOM
. O

The O
diagnosis O
, O
therefore O
, O
was O
relapsed B-SYMPTOM
C. I-SYMPTOM
difficile I-SYMPTOM
colitis I-SYMPTOM
. O

Intravenous B-TREATMENT
antibiotics I-TREATMENT
were O
discontinued O
and O
the O
patient O
was O
continued O
on O
p.o. B-TREATMENT
Vancomycin I-TREATMENT
. O

He O
improved O
clinically O
with O
defervescence O
, O
decreased O
white O
blood O
cell O
count O
to O
10,000 O
with O
resolution O
of O
left B-SYMPTOM
shift I-SYMPTOM
, O
and O
some O
decrease O
in O
abdominal B-SYMPTOM
distention I-SYMPTOM
on O
exam O
. O

An O
abdominal O
CAT O
scan O
revealed O
thickened B-SYMPTOM
bowel I-SYMPTOM
wall I-SYMPTOM
and O
thumb B-SYMPTOM
printing I-SYMPTOM
, O
primarily O
involving O
the O
cecum O
and O
right O
colon O
greater O
than O
the O
left O
, O
consistent O
with O
C. B-SYMPTOM
difficile I-SYMPTOM
colitis I-SYMPTOM
. O

The O
diagnosis O
of O
recurrent B-SYMPTOM
bowel I-SYMPTOM
ischemia I-SYMPTOM
, O
however O
, O
was O
not O
ruled O
out O
and O
this O
will O
continue O
to O
be O
a O
concern O
in O
the O
future O
. O

The O
patient O
was O
initially O
n.p.o. B-TREATMENT
and O
was O
then O
advanced O
to O
clear B-TREATMENT
liquids I-TREATMENT
which O
he O
tolerated O
. O

He O
will O
be O
advanced O
to O
soft B-TREATMENT
solids I-TREATMENT
prior O
to O
discharge O
. O

2. O
Azotemia B-SYMPTOM
. O

The O
patient O
has O
chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
with O
baseline O
creatinine O
1.8-2 O
. O

Creatinine O
had O
risen O
to O
4.3 O
on O
admission O
presumed O
secondary O
to O
sepsis B-SYMPTOM
and O
dehydration B-SYMPTOM
. O

With O
intravenous B-TREATMENT
hydration I-TREATMENT
the O
BUN O
and O
creatinine O
fell O
to O
12/1.9 O
which O
is O
within O
normal O
limits O
for O
this O
patient O
. O

The O
abdominal O
CAT O
scan O
showed O
no O
evidence O
of O
hydronephrosis B-SYMPTOM
orrenal B-SYMPTOM
abscess I-SYMPTOM
. O

3. O
Mental O
status O
. O

The O
patient O
was O
alert O
and O
oriented O
throughout O
the O
admission O
; O
however O
, O
by O
personality O
, O
he O
is O
somewhat O
cantankerous O
and O
demanding O
of O
the O
nurses O
. O

He O
was O
written O
for O
Haldol B-TREATMENT
1 O
mg O
p.o.b.i.d. O
p.r.n. O
to O
help O
with O
this B-SYMPTOM
problem I-SYMPTOM
. O

DISCHARGE O
DISPOSITION O
: O

Medications B-TREATMENT
on I-TREATMENT
transfer I-TREATMENT
include O
multivitamin B-TREATMENT
1 O
tablet O
p.o. O
q.d. O
; O
Pepcid B-TREATMENT
20 O
mg O
p.o. O
b.i.d. O
; O
Ventolin B-TREATMENT
inhaler I-TREATMENT
two O
puffs O
q.i.d. O
; O
Vancomycin B-TREATMENT
125 O
mg O
p.o. O
q.i.d. O
times O
seven O
days O
; O
calcium B-TREATMENT
carbonate I-TREATMENT
1250 O
mg O
p.o. O
b.i.d. O
; O
Lotrimin B-TREATMENT
cream I-TREATMENT
to O
groin O
b.i.d. O
p.r.n. O
; O
O2 B-TREATMENT
at O
four O
liters O
per O
minute O
; O
and O
Haldol B-TREATMENT
1 O
mg O
p.o. O
b.i.d. O
p.r.n. O

Dictated O
By O
: O

CA O
NA O
SHUFF O
, O
M.D. O
SO92 O
VX072/9578 O

TRANGCA O
CHIRDSTEN O
, O
M.D. O
ZO84 O

D O
: O

07/17/91 O

T O
: O

07/17/91 O

Batch O
: O

T099 O

Report O
: O

XM487M32 O

957770228 O

FIH O

0408267 O

46769/5v7d O

237890 O

2/5/1994 O
12:00:00 O
AM O

TRACHEOESOPHAGEAL B-SYMPTOM
FISTULA I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

2-5-94 O

DISCHARGE O
DATE O
: O

4-2-94 O

PRINCIPAL O
DIAGNOSIS O
: O

Tracheoesophageal B-SYMPTOM
fistula I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
pneumonia B-SYMPTOM
, O
sepsis B-SYMPTOM
, O
respiratory B-SYMPTOM
failure I-SYMPTOM
, O
pleural B-SYMPTOM
effusion I-SYMPTOM
, O
postoperative B-SYMPTOM
encephalopathy I-SYMPTOM
, O
postoperative B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
and O
thrombocytopenia B-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

February O
6 O
, O
1994 O
, O
rigid O
bronchoscopy O
with O
biopsy O
and O
upper O
gastrointestinal O
endoscopy O
. O

ASSOCIATED O
PROCEDURES O
: O

On O
February O
10 O
, O
1994 O
, O
flexible O
bronchoscopy O
, O
flexible O
esophagoscopy O
, O
rigid O
bronchoscopy O
, O
transhiatal B-TREATMENT
esophagectomy I-TREATMENT
( I-TREATMENT
partial I-TREATMENT
) I-TREATMENT
, O
substernal B-TREATMENT
gastric I-TREATMENT
interposition I-TREATMENT
and O
jejunostomy B-TREATMENT
. O

Multiple O
bronchoscopies O
, O
chest B-TREATMENT
tube I-TREATMENT
insertion I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
was O
a O
71 O
year O
old O
white O
female O
with O
a O
history O
of O
carcinoid B-SYMPTOM
lung I-SYMPTOM
cancer I-SYMPTOM
who O
presented O
for O
evaluation O
of O
a B-SYMPTOM
tracheoesophageal I-SYMPTOM
fistula I-SYMPTOM
. O

The O
patient O
was O
initially O
diagnosed O
in O
1978 O
with O
atypical B-SYMPTOM
small I-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lung I-SYMPTOM
and O
treated O
with O
chemotherapy B-TREATMENT
and O
radiation B-TREATMENT
therapy I-TREATMENT
until O
1980 O
. O

She O
did O
well O
for O
approximately O
twelve O
years O
until O
she O
was O
diagnosed O
with O
carcinoid B-SYMPTOM
cancer I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
same I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
. O

This O
may O
have O
been O
the B-SYMPTOM
initial I-SYMPTOM
primary I-SYMPTOM
cancer I-SYMPTOM
although O
it O
is O
unclear O
at O
present O
. O

Bronchoscopy O
at O
that O
time O
showed O
an B-SYMPTOM
endobronchial I-SYMPTOM
tumor I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
bronchus I-SYMPTOM
and O
it O
was O
felt O
to O
be O
unresectable O
. O

She O
underwent O
four B-TREATMENT
treatments I-TREATMENT
of O
brachytherapy B-TREATMENT
in O
March O
through O
May O
of O
1993 O
. O

She O
had O
been O
doing O
reasonably O
well O
until O
December O
of O
1993 O
when O
she O
presented O
with O
persistent B-SYMPTOM
and I-SYMPTOM
worsening I-SYMPTOM
cough I-SYMPTOM
and O
near B-SYMPTOM
strangulation I-SYMPTOM
on O
attempts O
at O
eating O
solids O
or O
drinking O
liquids O
. O

A O
bronchoscopy O
showed O
a B-SYMPTOM
tracheoesophageal I-SYMPTOM
fistula I-SYMPTOM
with O
an O
opening O
into O
the O
trachea O
above O
the O
carina O
and O
no O
tumor B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
. O

She O
has O
been O
on O
total B-TREATMENT
parenteral I-TREATMENT
nutrition I-TREATMENT
and O
has O
been O
nothing B-TREATMENT
by I-TREATMENT
mouth I-TREATMENT
since O
then O
. O

A O
barium O
swallow O
prior O
to O
admission O
showed O
the O
presence O
of O
a B-SYMPTOM
tracheoesophageal I-SYMPTOM
fistula I-SYMPTOM
with O
entrance O
into O
the O
right O
mainstem O
bronchus O
below O
the O
carina O
. O

PAST O
MEDICAL O
HISTORY O
: O

Bronchitis B-SYMPTOM
, O
asthma B-SYMPTOM
, O
carcinoid B-SYMPTOM
cancer I-SYMPTOM
, O
no O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
or O
cerebrovascular B-SYMPTOM
accident I-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

The O
patient O
is O
status O
post O
appendectomy B-TREATMENT
, O
hysterectomy B-TREATMENT
and O
right B-TREATMENT
salpingo-oophorectomy I-TREATMENT
, O
bladder B-TREATMENT
suspension I-TREATMENT
and O
a B-TREATMENT
tumor I-TREATMENT
removal I-TREATMENT
from I-TREATMENT
the I-TREATMENT
right I-TREATMENT
neck I-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Cefuroxime B-TREATMENT
1.5 O
grams O
intravenously O
q8h O
, O
Solu-Medrol B-TREATMENT
62.5 O
mg O
intravenously O
q8h O
, O
Ventolin B-TREATMENT
metered I-TREATMENT
dose I-TREATMENT
inhaler I-TREATMENT
, O
2 O
puffs O
PO O
q.i.d. O
, O
Pepcid B-TREATMENT
20 O
mg O
intravenously O
b.i.d. O

ALLERGIES O
: O

The O
patient O
is O
allergic B-SYMPTOM
to O
penicillin B-TREATMENT
, O
morphine B-TREATMENT
, O
codeine B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
is O
a O
pleasant O
white O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

She O
is O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
examination O
was O
unremarkable O
. O

Neck O
shows O
a B-SYMPTOM
well I-SYMPTOM
healed I-SYMPTOM
low I-SYMPTOM
collar I-SYMPTOM
incision I-SYMPTOM
without O
adenopathy B-SYMPTOM
or O
bruit B-SYMPTOM
. O

The O
lungs O
showed O
mild B-SYMPTOM
inspiratory I-SYMPTOM
wheeze I-SYMPTOM
and O
moderate B-SYMPTOM
expiratory I-SYMPTOM
wheezes I-SYMPTOM
. O

Breath O
sounds O
are O
present O
bilaterally O
. O

Cardiovascular O
exam O
: O

regular O
rate O
and O
rhythm O
. O

The O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Extremities O
: O

no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

The O
rectal O
examination O
is O
guaiac O
negative O
with O
a O
minimal O
amount O
of O
stool O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
on O
February O
5 O
, O
1994 O
and O
had O
a B-TREATMENT
central I-TREATMENT
venous I-TREATMENT
line I-TREATMENT
placed O
in O
her O
right O
subclavian O
. O

The O
patient O
was O
brought O
to O
the O
Operating O
Room O
on O
February O
6 O
, O
1994 O
where O
she O
underwent O
rigid O
and O
flexible O
bronchoscopy O
and O
upper O
gastrointestinal O
endoscopy O
. O

Findings O
included O
necrotic B-SYMPTOM
debris I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
trachea I-SYMPTOM
at O
the O
carina O
and O
right O
mainstem O
bronchus O
. O

Esophageal O
mucosa O
was O
visible O
through O
the O
trachea O
. O

Her B-TREATMENT
steroids I-TREATMENT
were O
weaned O
and O
the O
patient O
was O
brought O
to O
the O
Operating O
Room O
on O
February O
10 O
, O
1994 O
where O
she O
underwent O
once O
again O
flexible O
bronchoscopy O
and O
flexible O
esophagoscopy O
, O
as O
well O
as O
rigid O
bronchoscopy O
. O

She O
then O
had O
a B-TREATMENT
transhiatal I-TREATMENT
esophagectomy I-TREATMENT
which O
was O
partial O
, O
and O
a B-TREATMENT
substernal I-TREATMENT
gastric I-TREATMENT
interposition I-TREATMENT
as O
well O
as O
a B-TREATMENT
jejunostomy I-TREATMENT
. O

The O
pathology O
report O
suggested O
that O
the O
area O
was O
involved O
with O
radiation B-SYMPTOM
esophagitis I-SYMPTOM
and O
focal B-SYMPTOM
ulceration I-SYMPTOM
. O

She O
remained O
ventilator B-SYMPTOM
dependent I-SYMPTOM
postoperatively O
and O
was O
taken O
to O
the O
Respiratory O
Intensive O
Care O
Unit O
. O

The O
patient O
was O
maintained O
on O
triple B-TREATMENT
antibiotics I-TREATMENT
which O
included O
Vancomycin B-TREATMENT
, O
ceftazidime B-TREATMENT
and O
Gentamicin B-TREATMENT
. O

On O
postoperative O
day O
two O
, O
she O
had O
an O
electroencephalogram O
which O
showed O
no O
evidence O
of O
seizure B-SYMPTOM
activity I-SYMPTOM
but O
some B-SYMPTOM
generalized I-SYMPTOM
slowing I-SYMPTOM
. O

The O
patient O
was O
seen O
in O
consultation O
by O
the O
Neurology O
Service O
for O
her B-SYMPTOM
apparent I-SYMPTOM
postoperative I-SYMPTOM
encephalopathy I-SYMPTOM
and O
episodes O
of O
shaking B-SYMPTOM
. O

An O
endoscopy O
was O
also O
performed O
on O
postoperative O
day O
two O
which O
showed O
clean O
anastomosis B-TREATMENT
. O

She O
received O
multiple O
bronchoscopies O
for O
pulmonary B-TREATMENT
toilet I-TREATMENT
. O

The O
patient O
was O
maintained O
on O
tube B-TREATMENT
feedings I-TREATMENT
and O
the B-TREATMENT
ventilator I-TREATMENT
. O

A O
repeat O
echocardiogram O
on O
February O
18 O
showed O
no O
significant B-SYMPTOM
change I-SYMPTOM
of O
her O
previous O
echocardiogram O
on O
February O
11 O
, O
which O
showed O
only O
a B-SYMPTOM
small I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
. O

A O
pelvic O
and O
abdominal O
computerized O
tomography O
scan O
on O
February O
18 O
also O
showed O
no O
evidence O
of O
a B-SYMPTOM
focal I-SYMPTOM
collection I-SYMPTOM
or O
abscess B-SYMPTOM
. O

She O
remained O
intermittently B-SYMPTOM
febrile I-SYMPTOM
despite O
numerous B-TREATMENT
antibiotics I-TREATMENT
. O

Her O
chest O
X-ray O
showed O
bilateral B-SYMPTOM
air I-SYMPTOM
space I-SYMPTOM
disease I-SYMPTOM
, O
consistent O
with O
pneumonia B-SYMPTOM
or O
adult B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
. O

She O
suffered O
an O
episode O
of O
renal B-SYMPTOM
failure I-SYMPTOM
which O
was O
felt O
attributable O
to O
aminoglycoside B-SYMPTOM
toxicity I-SYMPTOM
. O

Her B-TREATMENT
steroids I-TREATMENT
were O
weaned O
. O

Because O
of O
her B-TREATMENT
prolonged I-TREATMENT
intubation I-TREATMENT
and O
inability B-SYMPTOM
to I-SYMPTOM
wean I-SYMPTOM
, O
on O
February O
24 O
, O
1994 O
, O
she O
had O
a B-TREATMENT
tracheostomy I-TREATMENT
placed O
. O

She O
remained O
in O
a B-SYMPTOM
coma I-SYMPTOM
. O

The O
blood O
cultures O
on O
February O
26 O
, O
1994 O
grew O
out O
Staphylococcus B-SYMPTOM
and O
she O
was O
treated O
for O
septicemia B-SYMPTOM
. O

Her O
sputum O
grew O
out O
Pseudomonas B-SYMPTOM
aeruginosa I-SYMPTOM
as O
well O
. O

The O
urine O
contained O
yeast B-SYMPTOM
and O
she O
was O
treated O
with O
amphotericin B-TREATMENT
. O

On O
March O
3 O
, O
1994 O
, O
a O
repeat O
chest O
and O
abdominal O
and O
pelvis O
computerized O
tomography O
scan O
showed O
no O
evidence O
of O
fluid B-SYMPTOM
collections I-SYMPTOM
. O

There O
was O
a B-SYMPTOM
large I-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
however O
. O

This O
was O
drained O
with O
a B-TREATMENT
left I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
. O

Her O
sputum O
then O
grew O
out O
Klebsiella B-SYMPTOM
and O
she O
was O
treated O
with O
amikacin B-TREATMENT
and O
imipenem B-TREATMENT
. O

She O
developed O
a B-SYMPTOM
right I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
and O
had O
a B-TREATMENT
right I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
placed O
. O

On O
March O
13 O
, O
1994 O
, O
she O
regained O
some O
level O
of O
consciousness O
. O

She O
was O
able O
to O
fix O
and O
follow O
with O
her O
eyes O
, O
respond O
to O
commands O
. O

On O
March O
14 O
, O
1994 O
, O
her O
right O
lung O
was O
pleurodesed O
. O

Attempts O
were O
made O
to O
facilitate O
her B-TREATMENT
wean I-TREATMENT
by O
resting O
her O
overnight O
with O
a O
combination O
of O
propafol B-TREATMENT
and O
Fentanyl B-TREATMENT
. O

This O
was O
tried O
for O
approximately O
seven O
days O
with O
no O
real O
progress O
made O
toward O
facilitating O
her B-TREATMENT
vent I-TREATMENT
wean I-TREATMENT
. O

She O
continued O
to O
require O
pressor B-TREATMENT
support I-TREATMENT
in O
the O
high O
30 O
&apos;s O
. O

She O
also O
fell O
into O
a B-SYMPTOM
coma I-SYMPTOM
once O
again O
. O

On O
March O
31 O
, O
1994 O
, O
her B-SYMPTOM
pressor I-SYMPTOM
support I-SYMPTOM
requirement I-SYMPTOM
increased O
and O
she O
continued O
to O
have O
tachypneic B-SYMPTOM
episodes I-SYMPTOM
. O

On O
April O
2 O
, O
1994 O
, O
she O
had O
several O
episodes O
of O
bradycardia B-SYMPTOM
and O
asystole B-SYMPTOM
, O
which O
responded O
only O
to O
manual B-TREATMENT
ventilation I-TREATMENT
. O

Discussions O
were O
held O
with O
the O
patient O
&apos;s O
family O
with O
regard O
to O
her O
previously O
expressed O
wishes O
not O
to O
be O
maintained O
on O
artificial B-TREATMENT
life I-TREATMENT
support I-TREATMENT
for O
extended O
period O
of O
time O
with O
little O
or O
no O
hope O
for O
recovery O
. O

She O
had O
expressed O
these O
wishes O
in O
writing O
on O
several O
legal O
forms O
from O
the O
state O
of O
Jose O
Pineston O
, O
as O
well O
as O
in O
discussions O
with O
her O
loved O
ones O
. O

Decision O
was O
made O
in O
conjunction O
with O
the O
family O
and O
Dr. O
Caslighlourdes O
to O
terminate O
artificial B-TREATMENT
respiratory I-TREATMENT
support I-TREATMENT
. O

The O
patient O
was O
removed O
from O
the B-TREATMENT
ventilator I-TREATMENT
and O
placed O
on O
a B-TREATMENT
T-piece I-TREATMENT
in I-TREATMENT
her I-TREATMENT
trachea I-TREATMENT
only O
and O
was O
made O
comfortable O
with O
narcotics B-TREATMENT
. O

Her O
respirations O
ceased O
and O
she O
died O
at O
10:15 O
a.m. O
on O
April O
2 O
, O
1994 O
. O

DISPOSITION O
/ O
PLAN O
ON O
DISCHARGE O
: O

The O
family O
will O
return O
the O
body O
to O
Sa O
for O
burial O
. O

They O
have O
declined O
a O
post-mortem O
examination O
. O

CA O
SHUFF O
, O
M.D. O

DICTATING O
FOR O
: O

RIEMIND O
CASLIGHLOURDES O
, O
M.D. O

TR O
: O

yu O
/ O
bmot O

DD O
: O

4-2-94 O

TD O
: O

04/03/94 O

CC O
: O

Admission O
Date O
: O

2012-05-08 O

Discharge O
Date O
: O

2012-05-18 O

Date O
of O
Birth O
: O

2012-05-08 O

Sex O
: O

M O

Service O
: O

Neonatology O

HISTORY O
: O

Baby O
Barbara O
Stead O
is O
a O
term O
infant O
admitted O
with O
increasing B-SYMPTOM
head I-SYMPTOM
circumference I-SYMPTOM
and O
bruising B-SYMPTOM
. O

He O
was O
born O
to O
a O
31-year-old O
G1 O
P0 O
now O
1 O
mother O
with O
unremarkable O
prenatal O
screens O
as O
follows O
: O

O O
positive O
, O
antibody O
negative O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
RPR O
nonreactive O
, O
rubella O
immune O

PREGNANCY O
HISTORY O
: O

Estimated O
date O
of O
delivery O
was O
2012-05-14 O
for O
estimated O
gestational O
age O
of O
39-1/7 O
weeks O
. O

Pregnancy O
was O
complicated O
by O
oligohydramnios B-SYMPTOM
with O
an O
AFI O
of O
3.5 O
and O
by O
multiple O
evaluations O
for O
decreased B-SYMPTOM
fetal I-SYMPTOM
movement I-SYMPTOM
. O

There O
was O
spontaneous B-SYMPTOM
onset I-SYMPTOM
of I-SYMPTOM
labor I-SYMPTOM
progressing O
through O
vacuum B-TREATMENT
assisted I-TREATMENT
vaginal I-TREATMENT
delivery I-TREATMENT
under O
epidural B-TREATMENT
anesthesia I-TREATMENT
. O

clear O
amniotic O
fluid O
, O
no O
antepartum B-SYMPTOM
maternal I-SYMPTOM
fever I-SYMPTOM
or O
fetal B-SYMPTOM
tachycardia I-SYMPTOM
, O
no O
antepartum B-TREATMENT
antibiotic I-TREATMENT
prophylaxis I-TREATMENT
. O

Baby O
was O
vigorous O
at O
delivery O
, O
was O
bulb B-TREATMENT
suction I-TREATMENT
, O
dried O
, O
and O
had O
free B-TREATMENT
flow I-TREATMENT
oxygen I-TREATMENT
administered O
briefly O
. O

Apgars O
were O
nine O
and O
nine O
. O

In O
the O
Newborn O
Nursery O
, O
he O
initially O
had O
a B-SYMPTOM
caput I-SYMPTOM
which O
increased O
in O
the O
amount O
of O
swelling B-SYMPTOM
and O
bruising B-SYMPTOM
in O
the O
subsequent O
24 O
hours O
. O

He O
was O
then O
referred O
to O
the O
CMED O
CCU O
for O
assessment O
and O
management B-TREATMENT
of O
the B-SYMPTOM
increased I-SYMPTOM
bleeding I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
UPON O
ADMISSION O
TO O
THE O
CMED O
CCU O
: O

Birth O
weight O
was O
3850 O
grams O
. O

Head O
circumference O
was O
41 O
cm O
. O

HEENT O
was O
significant O
for O
swelling B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
scalp I-SYMPTOM
tissue I-SYMPTOM
in O
generalized O
distribution O
with O
ecchymosis B-SYMPTOM
extending O
from O
the O
occiput O
to O
the O
posterior O
auricular O
area O
and O
dorsal O
aspect O
of O
the O
neck O
to O
the O
mid O
cervical O
level O
. O

Ears O
were O
displaced O
forward O
. O

Eyes O
were O
normal O
. O

Neck O
and O
mouth O
were O
normal O
. O

No O
nasal B-SYMPTOM
flaring I-SYMPTOM
. O

Chest O
: O

No O
retractions B-SYMPTOM
, O
good O
breath O
sounds O
bilaterally O
, O
no O
crackles B-SYMPTOM
. O

Cardiovascular O
: O

Regular O
, O
rate O
, O
and O
rhythm O
. O

Femoral O
pulses O
normal O
, O
S1 O
, O
S2 O
were O
normal O
. O

There O
was O
a B-SYMPTOM
1/6 I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
in O
the O
upper O
left O
sternal O
border O
without O
radiation B-SYMPTOM
. O

Abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
no O
organomegaly B-SYMPTOM
, O
no O
masses B-SYMPTOM
. O

Bowel O
sounds O
are O
active O
and O
patent O
. O

CNS O
active O
, O
responsive O
to O
stimulation O
. O

Pupils O
are O
reactive O
to O
light O
. O

Tone O
is O
normal O
, O
moving O
all O
limbs O
symmetrically O
, O
irritable B-SYMPTOM
with O
palpation O
of O
the O
scalp O
. O

Suck O
, O
root O
, O
gag O
, O
grasp O
, O
and O
morrow O
were O
normal O
. O

Skin O
: O

Pale O
as O
above O
, O
nonicteric B-SYMPTOM
. O

Musculoskeletal O
: O

Normal O
spine O
, O
hip O
, O
clavicles O
, O
small B-SYMPTOM
mass I-SYMPTOM
at O
the O
site O
of O
previous B-TREATMENT
right I-TREATMENT
quadriceps I-TREATMENT
intramuscular I-TREATMENT
injection I-TREATMENT
. O

An O
initial O
head O
CT O
scan O
had O
revealed O
extracranial B-SYMPTOM
soft I-SYMPTOM
tissue I-SYMPTOM
swelling I-SYMPTOM
most O
prominently O
at O
the O
right O
frontal-parietal-occipital O
area O
extending O
to O
the O
left O
and O
to O
the O
upper O
cervical O
region O
. O

Ventricles O
were O
symmetrical O
and O
not O
compressed O
. O

No O
gross B-SYMPTOM
intraparenchymal I-SYMPTOM
hemorrhage I-SYMPTOM
. O

But O
upon O
further O
radiology O
attending O
Stoughton O
, O
there O
was O
a B-SYMPTOM
small I-SYMPTOM
bilateral I-SYMPTOM
occipital I-SYMPTOM
subdural I-SYMPTOM
hemorrhage I-SYMPTOM
noted O
. O

The O
initial O
hematocrit O
was O
21.2 O
, O
platelets O
186 O
. O

PT O
was O
14.6 O
, O
PTT O
77 O
with O
an O
INR O
of O
1.4 O
. O

Fibrinogen O
was O
192 O
. O

D-dimer O
was O
negative O
. O

ASSESSMENT O
: O

This O
is O
a O
term O
infant O
with O
significant B-SYMPTOM
subgaleal I-SYMPTOM
hematoma I-SYMPTOM
with O
apparent O
extension O
over O
the O
past O
six O
hours O
. O

There O
was O
also O
elevation B-SYMPTOM
of O
the O
PTT O
suggesting O
possible O
inborn B-SYMPTOM
coagulopathy I-SYMPTOM
. O

There O
is O
also O
critical B-SYMPTOM
anemia I-SYMPTOM
secondary O
to O
the B-SYMPTOM
subgaleal I-SYMPTOM
hemorrhage I-SYMPTOM
. O

He O
was O
admitted O
to O
the O
CMED O
CCU O
for O
further B-TREATMENT
management I-TREATMENT
. O

SUMMARY O
OF O
HOSPITAL O
COURSE O
BY O
SYSTEMS O
: O

1. O
Respiratory O
: O

Patient O
has O
been O
on O
room O
air O
maintaining O
sats O
above O
95% O
. O

No O
apnea B-SYMPTOM
or O
bradycardia B-SYMPTOM
. O

2. O
Cardiovascular O
: O

There O
was O
an B-SYMPTOM
initial I-SYMPTOM
murmur I-SYMPTOM
on O
admission O
likely O
secondary O
to O
severe B-SYMPTOM
anemia I-SYMPTOM
which O
has O
since O
resolved O
. O

He O
remained O
hemodynamically O
stable O
throughout O
this O
admission O
. O

3. O
FEN O
: O

Patient O
was O
restarted O
on O
po O
feeds O
as O
of O
day O
of O
life O
three O
after O
the B-SYMPTOM
bleeding I-SYMPTOM
had O
stabilized O
. O

He O
has O
been O
taking O
breast O
milk O
or O
Enfamil O
20 O
po O
adlib O
. O

His O
admission O
weight O
was O
3850 O
grams O
. O

His O
weight O
on O
discharge O
was O
4055 O
. O

4. O
GI O
: O

Given O
the O
significant O
amount O
of O
bleeding B-SYMPTOM
, O
baby O
was O
started O
prophylactically O
on O
phototherapy B-TREATMENT
. O

His O
bilirubin O
peaked O
on O
day O
of O
life O
three O
at O
5.4 O
with O
a O
subsequent O
bilirubin O
of O
4.6 O
at O
which O
time O
phototherapy B-TREATMENT
was O
discontinued O
. O

5. O
Hematology O
: O

Given O
the O
rapid O
extension O
of O
the B-SYMPTOM
subgaleal I-SYMPTOM
bleed I-SYMPTOM
, O
coagulopathy O
workup O
was O
initiated O
revealing O
an B-SYMPTOM
elevated I-SYMPTOM
PTT I-SYMPTOM
level I-SYMPTOM
of O
77 O
as O
well O
as O
factor O
8 O
level O
that O
was O
below O
detection O
in O
the O
presence O
of O
normal O
factors O
5 O
, O
9 O
, O
10 O
, O
and O
11 O
. O

He O
was O
started O
on O
a B-TREATMENT
50 I-TREATMENT
units I-TREATMENT
/ I-TREATMENT
kg I-TREATMENT
bolus I-TREATMENT
of I-TREATMENT
factor I-TREATMENT
8 I-TREATMENT
followed O
by O
continuous B-TREATMENT
factor I-TREATMENT
8 I-TREATMENT
infusions I-TREATMENT
at O
50 O
units O
/ O
kg O
/ O
day O
divided O
until O
hourly O
infusion O
rates O
at O
05-10 O
. O

Subsequent O
factor O
8 O
levels O
varied O
with O
an O
initial O
factor O
8 O
level O
of O
18 O
after O
the B-TREATMENT
bolus I-TREATMENT
with O
which O
he O
received O
another O
bolus O
of O
factor B-TREATMENT
8 I-TREATMENT
of O
50 O
units O
/ O
kg O
and O
increased B-TREATMENT
factor I-TREATMENT
8 I-TREATMENT
infusion I-TREATMENT
rate I-TREATMENT
to O
65 O
units O
/ O
kg O
/ O
day O
. O

As O
of O
05-17 O
, O
he O
was O
switched O
over O
to O
bolus B-TREATMENT
infusion I-TREATMENT
in O
preparation O
of O
continued B-TREATMENT
home I-TREATMENT
factor I-TREATMENT
8 I-TREATMENT
administration I-TREATMENT
. O

His O
peak O
level O
after O
a O
bolus O
of O
75 O
units O
/ O
kg O
of O
factor B-TREATMENT
8 I-TREATMENT
was O
131 O
. O

A O
trough O
level O
at O
20 O
hours O
after O
the B-TREATMENT
bolus I-TREATMENT
on O
day O
of O
discharge O
was O
29 O
. O

He O
will O
continue O
to O
receive O
factor B-TREATMENT
8 I-TREATMENT
bolus I-TREATMENT
q O
day O
for O
a O
total O
of O
2-3 O
weeks O
in O
light O
of O
the B-SYMPTOM
intracranial I-SYMPTOM
hemorrhage I-SYMPTOM
, O
and O
will O
be O
followed O
by O
Hematology O
visiting O
nurse O
Michael O
Edwards O
level O
checks O
at O
home O
. O

Currently O
, O
the B-TREATMENT
infusion I-TREATMENT
of O
factor B-TREATMENT
8 I-TREATMENT
are O
going O
through O
a B-TREATMENT
jugular I-TREATMENT
Broviac I-TREATMENT
which O
was O
placed O
on O
05-15 O
for O
administration O
of O
factor B-TREATMENT
. O

His O
last O
PTT O
on O
05-16 O
was O
68.3 O
. O

The O
last O
hematocrit O
was O
on O
05-16 O
of O
54.5 O
. O

6. O
Neurology O
: O

Baby O
Mary O
Stead O
initially O
presented O
with O
significant B-SYMPTOM
subgaleal I-SYMPTOM
bleed I-SYMPTOM
as O
well O
as O
a B-SYMPTOM
small I-SYMPTOM
subdural I-SYMPTOM
hemorrhage I-SYMPTOM
. O

A O
repeat O
head O
CT O
scan O
on O
05-15 O
had O
shown O
the O
resolution O
of O
the B-SYMPTOM
subdural I-SYMPTOM
hematoma I-SYMPTOM
and O
significant O
improvement O
of O
the B-SYMPTOM
subgaleal I-SYMPTOM
bleed I-SYMPTOM
. O

His O
head O
ultrasound O
on O
05-14 O
reveals O
no O
interventricular B-SYMPTOM
hemorrhage I-SYMPTOM
. O

He O
had O
remained O
neurologically O
stable O
. O

His O
head O
circumference O
on O
05-18 O
was O
36.5 O
cm O
with O
a O
maximum O
head O
circumference O
on O

admission O
of O
40.5 O
cm O
. O

7. O
Social O
: O

Both O
parents O
are O
very O
involved O
in O
the O
care O
of O
Baby O
Norman O
Stead O
. O

They O
have O
been O
informed O
up O
to O
date O
on O
his O
needs O
, O
discharge O
from O
the O
hospital O
. O

Teaching O
has O
been O
completed O
on O
the O
care O
of O
the B-TREATMENT
Boviak I-TREATMENT
as O
well O
as O
administration O
of O
factor B-TREATMENT
8 I-TREATMENT
. O

8. O
Sensory O
: O

Audiology O
: O

Hearing O
screen O
was O
performed O
automated O
auditory O
brain O
stem O
responses O
and O
Baby O
David O
Stead O

passed O
bilaterally O
. O

CONDITION O
ON O
DISCHARGE O
: O

Baby O
Julian O
Stead O
had O
been O
stable O
with O
improvement O
of O
the B-SYMPTOM
subgaleal I-SYMPTOM
bleed I-SYMPTOM
and O
good O
peak O
and O
trough O
factor O
8 O
levels O
after O
the B-TREATMENT
bolus I-TREATMENT
infusion I-TREATMENT
. O

DISPOSITION O
: O

Baby O
Corine O
Stead O
is O
to O
be O
discharged O
home O
with O
parents O
with O
close O
Hematology O
VNA O
followup O
. O

NAME O
OF O
PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Pearly O
Reilly O
, O
208-4200 O
. O

CARE O
AND O
RECOMMENDATIONS O
: O

1. O
Feeds O
at O
discharge O
: O

Breast O
milk O
Enfamil O
20 O
po O
adlib O
as O
tolerated O
. O

2. O
Medications O
: O

Factor B-TREATMENT
8 I-TREATMENT
boluses I-TREATMENT
at O
75 O
units O
/ O
kg O
/ O
day O
. O

3. O
Car O
seat O
position O
screening O
passed O
. O

4. O
State O
Newborn O
Screen O
sent O
. O

5. O
Immunizations O
: O

Received O
hepatitis B-TREATMENT
B I-TREATMENT
vaccination I-TREATMENT
on O
05-16 O
. O

FOLLOW-UP O
APPOINTMENT O
: O

Scheduled O
for O
05-21 O
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Factor B-SYMPTOM
8 I-SYMPTOM
deficiency I-SYMPTOM
. O

2. O
Subgaleal B-SYMPTOM
hemorrhage I-SYMPTOM
, O
resolved O
. O

3. O
Small B-SYMPTOM
occipital I-SYMPTOM
subdural I-SYMPTOM
hemorrhage I-SYMPTOM
, O
resolved O

Reviewed O
By O
: O
Mavis O
W. O
Mobley, O
M.D. O

21-114 O

Dictated O
By O
: O
William O
A. O
Hunter O
, O
M.D. O

MEDQUIST36 O

D O
: O
2012-05-18 O
13:58 O

T O
: O
2012-05-18 O
14:22 O

JOB O
#: O

93716 O

Signed O
electronically O
by O
: O
DR. O
George O
Sherwood O
on O
: O
MON O
2012-05-21 O
11:57 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2011-09-18 O

Discharge O
Date O
: O

2011-09-26 O

Date O
of O
Birth O
: O

1962-05-08 O

Sex O
: O

F O

Service O
: O

CMED O
CCU O

Allergies O
: O

Sulfonamides B-TREATMENT
/ O
Zithromax B-TREATMENT
/ O
Floxin B-TREATMENT
/ O
Penicillins B-TREATMENT
/ O
Neurontin B-TREATMENT
/ O
Demerol B-TREATMENT
/ O
Morphine B-TREATMENT
Sulfate I-TREATMENT
/ O
Ativan B-TREATMENT

Attending O
: O
James O
I O
Schultz O
, O
M.D. O

Chief O
Complaint O
: O
see O
dc O
summary O

Major O
Surgical O
or O
Invasive O
Procedure O
: O
see O
dc O
summary O

History O
of O
Present O
Illness O
: O
see O
dc O
summary O

Past O
Medical O
History O
: O
see O
dc O
summary O

Social O
History O
: O
see O
dc O
summary O

Family O
History O
: O
see O
dc O
summary O

Physical O
Exam O
: O
see O
dc O
summary O

Pertinent O
Results O
: O
see O
dc O
summary O

Brief O
Hospital O
Course O
: O
see O
dc O
summary O

Medications O
on O
Admission O
: O
see O
dc O
summary O

Discharge O
Medications O
: O

Change O
: O

Pyridium B-TREATMENT
200 O
mg O
po O
three O
times O
a O
day O
for O
UTI B-SYMPTOM
symptoms I-SYMPTOM
x O
2 O
days O
. O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O
see O
dc O
summary O

Discharge O
Condition O
: O
see O
dc O
summary O

Discharge O
Instructions O
: O
see O
dc O
summary O

Followup O
Instructions O
: O
see O
dc O
summary O

Janine O
Karina O
MD O
98-439 O

Completed O
by O
: O

Harvey O
Aaron O
MD O
37-052 O
2011-09-26 O
@ O
1232 O

Signed O
electronically O
by O
: O
DR. O
Stephen O
Williams O
on O
: O
SAT O
2011-10-08 O
9:45 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

1989-03-20 O

Discharge O
Date O
: O

2015-12-31 O

Date O
of O
Birth O
: O

1931-12-09 O

Sex O
: O

M O

Service O
: O

This O
is O
an O
addendum O
to O
the O
discharge O
summary O
that O
was O
dictated O
earlier O
this O
morning O
. O

Continuing O
throughout O
his O
course O
he O
had O
multiple B-SYMPTOM
infectious I-SYMPTOM
disease I-SYMPTOM
issues I-SYMPTOM
. O

He O
developed O
zoster B-SYMPTOM
for O
which O
he O
received O
a B-TREATMENT
course I-TREATMENT
of I-TREATMENT
acyclovir I-TREATMENT
. O

His O
cultures O
came O
back O
as O
noted O
with O
Klebsiella B-SYMPTOM
ultimately O
in O
his B-SYMPTOM
chest I-SYMPTOM
wound I-SYMPTOM
, O
MRSA B-SYMPTOM
in O
his O
sputum O
. O

He O
had O
multiple B-SYMPTOM
sources I-SYMPTOM
of I-SYMPTOM
yeast I-SYMPTOM
. O

Currently O
his B-SYMPTOM
only I-SYMPTOM
yeast I-SYMPTOM
source I-SYMPTOM
is O
urine O
. O

Negative O
blood O
cultures O
at O
this O
point O
. O

Also O
in O
the O
course O
of O
the O
month O
that O
he O
was O
in O
the O
ICU O
he O
had O
a B-TREATMENT
left I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
placed O
for O
fluid B-SYMPTOM
and O
then O
a B-TREATMENT
right I-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
placed O
ultimately O
for O
fluid B-SYMPTOM
. O

He O
received O
O.T. O
and O
P.T. O
consults O
. O

He O
developed O
another O
round O
of O
acute B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
with O
ATN B-SYMPTOM
and O
casts B-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
urine I-SYMPTOM
. O

On O
11-18 O
a O
DNR O
order O
was O
put O
into O
place O
. O

He O
also O
started O
treatment B-TREATMENT
for O
gallstones B-SYMPTOM
with O
cholestasis B-SYMPTOM
on O
the O
medication O
ursodiol B-TREATMENT
. O

He O
received O
a O
course O
of O
cefepime B-TREATMENT
also O
. O

He O
continued O
to O
have O
multiple B-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
after O
his B-TREATMENT
split I-TREATMENT
thickness I-TREATMENT
skin I-TREATMENT
grafts I-TREATMENT
, O
which O
he O
does O
to O
this O
day O
. O

In O
early O
November O
he O
started O
dialysis B-TREATMENT
after O
a B-TREATMENT
PermCath I-TREATMENT
was O
placed O
. O

His B-TREATMENT
Dobbhoff I-TREATMENT
tube I-TREATMENT
was O
removed O
. O

He O
was O
able O
to O
use O
a B-TREATMENT
Passy-Muir I-TREATMENT
valve I-TREATMENT
intermittently O
for O
his B-TREATMENT
trach I-TREATMENT
. O

On O
12-23 O
he O
went O
back O
to O
the O
operating O
room O
for O
open B-SYMPTOM
jejunostomy I-SYMPTOM
tube I-SYMPTOM
dehiscence I-SYMPTOM
site I-SYMPTOM
. O

His B-TREATMENT
J I-TREATMENT
tube I-TREATMENT
is O
now O
functioning O
. O

This O
was O
repaired O
and O
stay B-TREATMENT
sutures I-TREATMENT
are O
in O
place O
. O

This O
was O
done O
on O
11-23 O
. O

On O
11-24 O
he O
received O
a B-TREATMENT
permanent I-TREATMENT
DDD I-TREATMENT
pacemaker I-TREATMENT
with O
a B-TREATMENT
lead I-TREATMENT
that O
was O
externally O
placed O
on O
his O
chest O
wall O
due O
to O
his O
healing O
and O
infected B-SYMPTOM
chest I-SYMPTOM
wound I-SYMPTOM
. O

From O
the O
point O
of O
discharge O
today O
on O
12-31 O
his O
most O
recent O
labs O
are O
as O
follows O
. O

White O
count O
13.9 O
, O
hematocrit O
35.9 O
, O
platelet O
count O
81,000 O
. O

Sodium O
139 O
, O
K O
4.8 O
, O
chloride O
109 O
, O
CO2 O
31 O
, O
BUN O
33 O
, O
creatinine O
2.2 O
, O
blood O
sugar O
164 O
. O

Albumin O
2.5 O
. O

Vancomycin O
level O
was O
21 O
. O

To O
go O
by O
systems O
, O
currently O
he O
is O
neurologically O
alert O
and O
follows O
commands O
. O

He O
occasionally O
gets O
agitated B-SYMPTOM
. O

From O
a O
cardiac O
point O
of O
view O
, O
he O
is O
in O
sinus O
rhythm O
today O
. O

He O
does O
have O
his B-TREATMENT
pacing I-TREATMENT
lead I-TREATMENT
with O
his B-TREATMENT
external I-TREATMENT
pacemaker I-TREATMENT
DDD I-TREATMENT
available O
to O
him O
and O
is O
being O
followed O
by O
the O
EP O
service O
and O
Dr. O
Janet O
Gutkin O
for O
further O
outpatient O
treatment O
of O
this O

in O
the O
future O
. O

From O
a O
respiratory O
point O
of O
view O
, O
he O
is O
on O
CPAP B-TREATMENT
and O
pressure B-TREATMENT
support I-TREATMENT
at O
5 O
and O
5 O
at O
40% O
. O

He O
does O
use O
the B-TREATMENT
Passy-Muir I-TREATMENT
valve I-TREATMENT
intermittently O
for O
his B-TREATMENT
trach I-TREATMENT
. O

He O
is O
on O
a B-TREATMENT
trach I-TREATMENT
collar I-TREATMENT
this O
week O
during O
the O
day O
only O
and O
rested O
on O
the B-TREATMENT
ventilator I-TREATMENT
at O

night O
. O

Abdominally O
, O
he O
does O
have O
his B-SYMPTOM
midabdominal I-SYMPTOM
incision I-SYMPTOM
with O
good O
approximated O
margins O
and O
stay B-TREATMENT
sutures I-TREATMENT
in O
place O
. O

From O
a O
GI O
point O
of O
view O
, O
he O
is O
receiving O
Promote B-TREATMENT
tube I-TREATMENT
feeds I-TREATMENT
through O
his B-TREATMENT
jejunostomy I-TREATMENT
tube I-TREATMENT
. O

His B-SYMPTOM
chest I-SYMPTOM
incision I-SYMPTOM
is O
granulating O
in O
well O
. O

He O
currently O
receives O
saline B-TREATMENT
washes I-TREATMENT
and O
Adaptic B-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
twice O
a O
day O
. O

From O
a O
CMED O
CCU O
point O
of O
view O
, O
he O
gets O
straight B-TREATMENT
cathed I-TREATMENT
every O
other O
day O
. O

He O
has O
a B-TREATMENT
left I-TREATMENT
subclavian I-TREATMENT
PermCath I-TREATMENT
access O
for O
his B-TREATMENT
dialysis I-TREATMENT
which O
takes O
place O
on O
Monday O
, O
Wednesday O
and O
Friday O
. O

Hematology O
. O

He O
is O
HITT O
negative O
. O

He O
has O
received O
no O
transfusions B-TREATMENT
in O
the O
past O
week O
or O
so O
. O

His O
hematocrit O
has O
been O
stable O
in O
the O
mid-30s O
. O

He O
has O
a B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
in O
place O
for O
his B-TREATMENT
antibiotics I-TREATMENT
which O
are O
as O
follows O
. O

The B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
was O
placed O
on O
12-29 O
. O

His B-TREATMENT
antibiotics I-TREATMENT
currently O
are O
vancomycin B-TREATMENT
, O
ceftazidime B-TREATMENT
, O
fluconazole B-TREATMENT
and O
caspofungin B-TREATMENT
. O

I O
will O
give O
doses O
and O
administration O
information O
in O
his O
list O
of O
discharge B-TREATMENT
medications I-TREATMENT
. O

In O
addition O
, O
his O
albumin O
today O
is O
2.5 O
. O

He O
is O
being O
covered O
by O
regular B-TREATMENT
insulin I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

Exam O
today O
shows O
he O
is O
neurologically O
alert O
. O

Heart O
was O
regular O
rate O
and O
rhythm O
. O

He O
had O
coarse B-SYMPTOM
respiratory I-SYMPTOM
sounds I-SYMPTOM
. O

Abdomen O
was O
soft O
. O

His B-TREATMENT
graft I-TREATMENT
is O
granulating O
in O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Docusate B-TREATMENT
sodium I-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

2. O
Ursodiol B-TREATMENT
300 O
mg O
p.o. O
b.i.d. O

3. O
Ascorbic B-TREATMENT
acid I-TREATMENT
500 O
mg O
p.o. O
q.d. O

4. O
Zinc B-TREATMENT
sulfate I-TREATMENT
220 O
mg O
p.o. O
q.d. O

5. O
Lansoprazole B-TREATMENT
oral I-TREATMENT
solution I-TREATMENT
30 O
mg O
per O
gastric O
tube O
q.d. O

6. O
Caspofungin B-TREATMENT
acetate I-TREATMENT
50 O
mg O
IV O
q.d. O
, O
day O
23 O
of O
treatment B-TREATMENT
and O
patient O
should O
remain O
on O
it O
indefinitely O
. O

7. O
Nephrocaps B-TREATMENT
one O
cap O
p.o. O
q.d. O

If O
on O
dialysis, B-TREATMENT
please O
take O
after O
dialysis B-TREATMENT
treatment I-TREATMENT
. O

8. O
Metoclopramide B-TREATMENT
5 O
mg O
p.o. O
b.i.d. O
, O
take O
30 O
minutes O
before O
meals O
. O

9. O
Fluconazole B-TREATMENT
200 O
mg O
p.o. O
q.h.d. O

Patient O
should O
remain O
on O
this O
medication B-TREATMENT
. O

10. O
Magnesium B-TREATMENT
sulfate I-TREATMENT
2 O
gm O
in O
100 O
ml O
of O
D5W B-TREATMENT
IV O
as O
needed O
for O
repletion O
p.r.n. O

11. O
Miconazole B-TREATMENT
powder I-TREATMENT
2% O
one O
application O
t.p. O
t.i.d. O
p.r.n. O

12. O
Acetaminophen B-TREATMENT
325 O
mg O
to O
650 O
mg O
p.o. O
q.four O
to O
six O
hours O
p.r.n. O

13. O
Albuterol B-TREATMENT
one O
to O
two O
puffs O
inhaled O
q. O
six O
hours O
p.r.n. O

14. O
Bisacodyl B-TREATMENT
10 O
mg O
per O
rectum O
h.s. O
as O
needed O
p.r.n. O

15. O
Hydralazine B-TREATMENT
hydrochloride I-TREATMENT
10 O
mg O
IV O
q. O
six O
hours O
p.r.n. O
systolic O
blood O
pressure O
greater O
than O
140 O
. O

16. O
Vancomycin B-TREATMENT
1 O
gm O
IV O
as O
needed O
for O
vancomycin O
level O
less O
than O
15 O
. O

This O
is O
day O
23 O
of O
treatment B-TREATMENT
for O
an O
approximate O
six O
week O
course O
. O

17. O
Ceftazidime B-TREATMENT
1 O
gm O
IV O
q.h.d. O
after O
dialysis B-TREATMENT
. O

18. O
Alteplase B-TREATMENT
for O
catheter O
clearance O
2 O
mg O
IV O
once O
times O
one O
dose O
for O
indwelling B-TREATMENT
PermCath I-TREATMENT
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Status O
post O
aortic B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
and O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
times O
four O
. O

2. O
Status O
post O
sternal B-TREATMENT
debridement I-TREATMENT
. O

3. O
Status O
post O
skin B-TREATMENT
graft I-TREATMENT
to O
chest B-SYMPTOM
incision I-SYMPTOM
. O

4. O
Status O
post O
open B-TREATMENT
jejunostomy I-TREATMENT
tube I-TREATMENT
placement I-TREATMENT
, O
open B-TREATMENT
left I-TREATMENT
subclavian I-TREATMENT
PermCath I-TREATMENT
placement I-TREATMENT
. O

5. O
Status O
post O
DDD B-TREATMENT
pacer I-TREATMENT
placement I-TREATMENT
with O
external B-TREATMENT
generator I-TREATMENT
. O

6. O
Status O
post O
abdominal B-TREATMENT
repair I-TREATMENT
of O
wound B-SYMPTOM
dehiscence I-SYMPTOM
of I-SYMPTOM
jejunostomy I-SYMPTOM
site I-SYMPTOM
. O

7. O
Status O
post O
percutaneous B-TREATMENT
tracheostomy I-TREATMENT
. O

8. O
Status O
post O
acute B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
. O

9. O
Status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

10. O
Hypertension B-SYMPTOM
. O

11. O
Hypercholesterolemia B-SYMPTOM
. O

12. O
Asthma B-SYMPTOM
. O

13. O
Peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
status O
post O
gastrectomy B-TREATMENT
30 O
years O
ago O
. O

14. O
Colon B-SYMPTOM
cancer I-SYMPTOM
status O
post O
colectomy B-TREATMENT
with O
XRT B-TREATMENT
four O
years O
ago O
. O

15. O
Peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
with O
history O
of O
bilateral B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
claudication I-SYMPTOM
. O

16. O
COPD B-SYMPTOM
with O
asbestosis B-SYMPTOM
on O
chest O
CT O
scan O
. O

The O
patient O
is O
discharged O
on O
Thursday O
, O
12-31 O
, O
to O
a O
rehabilitation O
facility O
, O
on O
postoperative O
day O
93 O
, O
in O
stable O
condition O
, O
from O
the O
cardiac O
surgery O
recovery O
unit O
. O

Perry O
G. O
Ozuna O
, O
M.D. O

83-390 O

Dictated O
By O
: O
Keith O
E. O
Shafer O
, O
M.D. O

MEDQUIST36 O

D O
: O
2015-12-31 O
11:12 O

T O
: O
2015-12-31 O
11:19 O

JOB O
#: O

04648 O

Signed O
electronically O
by O
: O
DR. O
Kelsey O
MOORMAN O
on O
: O
FRI O
2016-01-08 O
9:29 O
PM O

( O
End O
of O
Report O
) O

763970014 O

CMC O

85905567 O

04/21/1994 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

04/21/1994 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

04/29/1994 O

DISCHARGE O
DIAGNOSIS O
: O

LEFT B-SYMPTOM
PARIETAL I-SYMPTOM
GLIOBLASTOMA I-SYMPTOM
MULTIFORME I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Patient O
is O
an O
88 O
year O
old O
female O
with O
fatigue B-SYMPTOM
and O
decreased B-SYMPTOM
short I-SYMPTOM
term I-SYMPTOM
memory I-SYMPTOM
for O
the O
past O
six O
months O
. O

The O
past O
six O
weeks O
, O
she O
has O
also O
been O
complaining O
of O
hot B-SYMPTOM
sensation I-SYMPTOM
and O
tingling B-SYMPTOM
sensation I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
hands I-SYMPTOM
bilaterally I-SYMPTOM
. O

For O
the O
past O
five O
weeks O
, O
the O
patient O
has O
experienced O
dragging B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
leg I-SYMPTOM
with O
weakness B-SYMPTOM
throughout O
that O
side O
. O

Head O
CT O
was O
done O
which O
patient O
reported O
demonstrated O
three B-SYMPTOM
lesions I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
parietal I-SYMPTOM
region I-SYMPTOM
of O
the O
brain O
. O

Bone O
scan O
, O
CT O
of O
the O
abdomen O
, O
chest O
X-Ray O
, O
and O
mammogram O
were O
all O
negative O
. O

Patient O
noted O
the B-SYMPTOM
foot I-SYMPTOM
dragging I-SYMPTOM
to O
have O
worsened O
over O
the O
past O
few O
weeks O
but O
improved O
since O
on O
Decadron B-TREATMENT
the O
past O
week O
before O
admission O
. O

Patient O
is O
now O
admitted O
for O
elective O
left O
parietal O
stereotactic O
biopsy O
of O
the B-SYMPTOM
tumor I-SYMPTOM
. O

PAST O
MEDICAL O
/ O
SURGICAL O
HISTORY O
: O

Significant O
for O
a O
history O
of O
hypertension B-SYMPTOM
, O
basal B-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
nose I-SYMPTOM
six O
years O
ago O
, O
cataracts B-SYMPTOM
, O
and O
a B-TREATMENT
hysterectomy I-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

CURRENT O
MEDICATIONS O
: O

Hydrochlorothiazide B-TREATMENT
25 O
mg O
q.d. O
and O
Decadron B-TREATMENT
25 O
mg O
b.i.d. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
demonstrated O
a O
well-developed O
, O
well-nourished O
female O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
dragging O
her O
right O
foot O
. O

HEENT O
: O

Head O
was O
atraumatic B-SYMPTOM
and O
normocephalic O
with O
pupils O
equal O
, O
round O
, O
and O
reactive O
to O
light O
. O

LUNGS O
: O

Clear O
to O
auscultation O
. O

HEART O
: O

Examination O
demonstrated O
a O
regular O
rate O
and O
rhythm O
without O
any B-SYMPTOM
murmurs I-SYMPTOM
noted O
. O

ABDOMEN O
: O

Benign O
with O
a B-SYMPTOM
hysterectomy I-SYMPTOM
scar I-SYMPTOM
which O
was O
well O
healed O
. O

NEUROLOGICAL O
: O

Examination O
showed O
that O
the O
patient O
was O
noted O
to O
be O
alert O
and O
oriented O
times O
three O
, O
short O
term O
memory O
was O
deficient B-SYMPTOM
, O
patient O
remembered O
zero O
out O
of O
three O
things O
to O
remember O
at O
one O
minute O
, O
speech O
was O
noted O
to O
be O
fluent O
, O
and O
cranial O
nerves O
II-XII O
were O
intact O
. O

On O
motor O
examination O
, O
patient O
was O
noted O
to O
be O
of O
normal O
motor O
function O
throughout O
except O
for O
a B-SYMPTOM
slight I-SYMPTOM
weakness I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
dorsi I-SYMPTOM
flexion I-SYMPTOM
and I-SYMPTOM
plantar I-SYMPTOM
flexion I-SYMPTOM
, O
both O
noted O
to O
be O
about O
4/5 O
and O
sensory O
examination O
was O
intact O
throughout O
. O

Patient O
's O
gait O
was O
noted O
to O
have O
a B-SYMPTOM
right I-SYMPTOM
foot I-SYMPTOM
drag I-SYMPTOM
as O
well O
as O
right B-SYMPTOM
foot I-SYMPTOM
drop I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

Patient O
was O
taken O
to O
the O
Operating O
Room O
on O
April O
21 O
where O
patient O
underwent O
a O
left O
parietal O
stereotactic O
guided O
brain O
biopsy O
. O

Patient O
tolerated O
the O
procedure O
well O
without O
any B-SYMPTOM
complications I-SYMPTOM
and O
was O
taken O
to O
the O
Recovery O
Room O
awake O
and O
stable O
then O
subsequently O
transferred O
to O
the O
floor O
. O

Patient O
did O
well O
post-operatively O
, O
continued O
to O
have O
a B-SYMPTOM
right I-SYMPTOM
sided I-SYMPTOM
deficit I-SYMPTOM
, O
and O
Physical O
Therapy O
and O
Occupational O
Therapy O
visited O
the O
patient O
, O
worked O
with O
the O
patient O
, O
and O
determined O
that O
patient O
needed O
rehabilitation B-TREATMENT
with O
Physical O
Therapy O
. O

The O
patient O
was O
evaluated O
by O
Doing O
and O
was O
subsequently O
accepted O
into O
that O
program O
. O

Patient O
is O
now O
discharged O
to O
Harl O
Wa O
Healthcare O
Network O
on O
April O
29 O
, O
1994 O
in O
stable O
condition O
. O

DISPOSITION O
: O

She O
is O
to O
receive O
rehabilitation B-TREATMENT
to O
increase O
her O
mobility O
and O
strength O
, O
rehabilitation B-TREATMENT
potential O
is O
good O
, O
and O
she O
is O
to O
receive O
the O
following O
medications O
at O
that O
facility O
: O

Decadron B-TREATMENT
3 O
mg O
p.o. O
q.6h. O
times O
one O
week O
then O
2 O
mg O
p.o.q.6h. O
thereafter O
, O
Colace B-TREATMENT
100 O
mg O
b.i.d. O
, O
Heparin B-TREATMENT
5000 O
units O
subcutaneously O
b.i.d. O
until O
ambulating O
well O
, O
Hydrochlorothiazide B-TREATMENT
25mg O
q.d. O
, O
Dilantin B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O
, O
Zantac B-TREATMENT
150 O
mg O
b.i.d. O
, O
and O
Percocet B-TREATMENT
p.r.n. O

Patient O
is O
to O
be O
subsequently O
followed O
up O
by O
Dr. O
Memory O
. O

Pathology O
of O
the O
biopsy O
demonstrated O
glioblastoma B-SYMPTOM
multiforme I-SYMPTOM
, I-SYMPTOM
grade I-SYMPTOM
IIi/III I-SYMPTOM
. O

Radiation O
Oncology O
saw O
the O
patient O
while O
in O
the O
hospital O
and O
is O
to O
follow O
her O
over O
at O
Colning O
. O

Dictated O
By O
: O

TELSHEY O
MEMORY O
, O
M.D. O

Attending O
: O

BESTI O
T. O
DROP O
, O
M.D. O
ND32 O
UZ561/2906 O

Batch O
: O

349 O

Index O
No. O
WZGE1 O
XNHQ O

D O
: O

04/29/94 O

T O
: O

04/29/94 O

677051476 O

FIH O

4871976 O

46286/a787 O

826393 O

1/11/1992 O
12:00:00 O
AM O

GASTRIC B-SYMPTOM
CARCINOMA I-SYMPTOM

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

01-11-92 O

DISCHARGE O
DATE O
: O

01-22-92 O

PRINCIPAL O
DIAGNOSIS O
: O

Gastric B-SYMPTOM
carcinoma I-SYMPTOM

ASSOCIATED O
DIAGNOSIS O
: O

hypothyroidism B-SYMPTOM
following O
near B-TREATMENT
total I-TREATMENT
thyroidectomy I-TREATMENT
. O

PRINCIPAL O
PROCEDURE O
: O

On O
1/12/92 O
near B-TREATMENT
total I-TREATMENT
gastrectomy I-TREATMENT
with O
retrocolic B-TREATMENT
Bill-Roth I-TREATMENT
II I-TREATMENT
gastrojejunostomy I-TREATMENT
, O
portal B-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
, O
repair B-TREATMENT
of O
ventral B-SYMPTOM
hernia I-SYMPTOM
, O
and O
needle B-TREATMENT
jejunostomy I-TREATMENT
tube I-TREATMENT
placement I-TREATMENT
. O

OTHER O
PROCEDURES O
: O

None O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Ms. O
Tikrhalt O
is O
an O
86 O
year O
old O
female O
, O
previously O
healthy O
, O
who O
presents O
with O
a O
3 O
month O
history O
of O
dysphagia B-SYMPTOM
. O

A O
subsequent O
workup O
including O
upper O
gastrointestinal O
series O
and O
abdominal O
computerized O
tomography O
scan O
suggested O
the O
presence O
of O
a B-SYMPTOM
gastric I-SYMPTOM
mass I-SYMPTOM
. O

Endoscopy O
with O
biopsy O
revealed O
gastric B-SYMPTOM
carcinoma I-SYMPTOM
, O
poorly O
differentiated O
, O
within O
the O
body O
of O
the O
stomach O
along O
the O
greater O
curvature O
. O

She O
was O
subsequently O
referred O
to O
Dr. O
Ko O
for O
a O
possible O
resection B-TREATMENT
of O
this B-SYMPTOM
carcinoma I-SYMPTOM
. O

She O
reports O
a B-SYMPTOM
10 I-SYMPTOM
pound I-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
over O
the O
past O
several O
months O
. O

She O
denies O
any B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
for O
an B-TREATMENT
appendectomy I-TREATMENT
in O
the O
distant O
past O
, O
cholecystectomy B-TREATMENT
in O
the O
past O
, O
history O
of O
of O
Cesarean B-TREATMENT
section I-TREATMENT
in O
the O
past O
and O
a O
history O
of O
near B-TREATMENT
total I-TREATMENT
thyroidectomy I-TREATMENT
for O
nodular B-SYMPTOM
goiter I-SYMPTOM
in O
the O
past O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Her B-TREATMENT
only I-TREATMENT
medication I-TREATMENT
is O
Thyrolar B-TREATMENT
for O
her B-SYMPTOM
relative I-SYMPTOM
hypothyroidism I-SYMPTOM
following O
resection B-TREATMENT
. O

There O
is O
a O
question O
of O
an B-SYMPTOM
allergy I-SYMPTOM
to O
Tylenol B-TREATMENT
. O

She O
denies O
any O
history O
of O
hypertension B-SYMPTOM
, O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
or O
peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
. O

Interestingly O
, O
she O
reports O
that O
both O
her O
mother O
and O
father O
died O
of O
stomach B-SYMPTOM
carcinoma I-SYMPTOM
. O

She O
is O
a O
former O
smoker O
, O
and O
drinks O
alcohol O
occasionally O
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
examination O
she O
is O
an O
elderly O
but O
spry O
white O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Her O
sclera O
were O
nonicteric B-SYMPTOM
. O

Her O
oropharynx O
was O
clear O
. O

Her O
neck O
was O
supple O
without O
masses B-SYMPTOM
or O
bruits B-SYMPTOM
noted O
. O

Her O
lungs O
were O
clear O
to O
auscultation O
. O

Her O
cardiac O
examination O
was O
unremarkable O
. O

Examination O
of O
her O
abdomen O
revealed O
a B-SYMPTOM
flat I-SYMPTOM
nontender I-SYMPTOM
abdomen I-SYMPTOM
without O
palpable B-SYMPTOM
masses I-SYMPTOM
. O

There O
were O
multiple B-SYMPTOM
well I-SYMPTOM
healed I-SYMPTOM
surgical I-SYMPTOM
scars I-SYMPTOM
. O

She O
was O
guaiac O
negative O
. O

There O
was O
no O
cva B-SYMPTOM
tenderness I-SYMPTOM
or O
spinal B-SYMPTOM
tenderness I-SYMPTOM
noted O
. O

Her O
pulses O
were O
intact O
throughout O
. O

LABORATORY O
DATA O
: O

Sodium O
139 O
, O
potassium O
3.7 O
and O
BUN O
of O
19 O
. O

Her O
hematocrit O
was O
37.2 O
with O
a O
white O
blood O
count O
of O
6.6 O
. O

Her O
Bilirubin O
direct O
and O
total O
were O
0.1 O
and O
0.3 O
respectively O
. O

Her O
alkaline O
phosphatase O
was O
134 O
. O

Her O
electrocardiogram O
demonstrated O
normal O
sinus O
rhythm O
without O
acute B-SYMPTOM
ischemic I-SYMPTOM
changes I-SYMPTOM
. O

Chest O
X-Ray O
was O
unremarkable O
. O

The O
assessment O
at O
the O
time O
of O
admission O
was O
that O
of O
an O
86 O
year O
old O
female O
with O
poorly B-SYMPTOM
differentiated I-SYMPTOM
gastric I-SYMPTOM
adenocarcinoma I-SYMPTOM
, O
admitted O
for O
resection B-TREATMENT
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Service O
of O
Dr. O
Fede O
A. O
Duhenile O
. O

On O
1/12/92 O
she O
was O
taken O
to O
the O
operating O
room O
where O
she O
underwent O
a B-TREATMENT
neart I-TREATMENT
total I-TREATMENT
gastrectomy I-TREATMENT
with O
a B-TREATMENT
retrocolic I-TREATMENT
Bill-Roth I-TREATMENT
II I-TREATMENT
gastrojejunostomy I-TREATMENT
reconstruction I-TREATMENT
. O

In O
addition O
a B-SYMPTOM
small I-SYMPTOM
ventral I-SYMPTOM
hernia I-SYMPTOM
was O
noted O
upon O
abdominal O
exploration O
within O
a B-TREATMENT
previous I-TREATMENT
surgical I-TREATMENT
incision I-TREATMENT
. O

This O
was O
repaired B-TREATMENT
. O

A B-TREATMENT
needle I-TREATMENT
jejunostomy I-TREATMENT
catheter I-TREATMENT
was O
placed O
at O
the O
time O
of O
her B-TREATMENT
operation I-TREATMENT
to O
facilitate O
postoperative B-TREATMENT
nutrition I-TREATMENT
. O

With O
regards O
to O
the B-SYMPTOM
cancer I-SYMPTOM
, O
there O
was O
a B-SYMPTOM
large I-SYMPTOM
mass I-SYMPTOM
along O
the O
greater O
curvature O
in O
the O
body O
of O
the O
stomach O
, O
and O
several O
perigastric O
lymph O
nodes O
which O
were O
taken O
with O
the O
specimen O
. O

In O
addition O
, O
there O
were O
at O
least O
two O
lymph O
nodes O
within O
the O
porta O
hepatis O
which O
were O
dissected B-TREATMENT
free I-TREATMENT
and O
taken O
en O
bloc O
with O
the O
specimen O
. O

The O
remainder O
of O
her O
abdomen O
was O
unremarkable O
without O
evidence O
of O
metastatic B-SYMPTOM
spread I-SYMPTOM
elsewhere O
, O
including O
the O
liver O
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
and O
was O
taken O
to O
the O
recovery O
room O
in O
good O
condition O
. O

The O
patient O
's O
postoperative O
course O
was O
for O
the O
most O
part O
unremarkable O
. O

Her B-SYMPTOM
wounds I-SYMPTOM
healed O
well O
without O
incident O
and O
the B-TREATMENT
needle I-TREATMENT
jejunostomy I-TREATMENT
tube I-TREATMENT
was O
utilized O
on O
the O
first O
postoperative O
day O
right O
up O
until O
the O
time O
of O
discharge O
, O
infusing O
Vivonex B-TREATMENT
T.E.N. I-TREATMENT

The O
patient O
tolerated O
this O
without O
difficulty B-SYMPTOM
. O

The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
nasogastric I-TREATMENT
tube I-TREATMENT
was O
removed O
on O
the O
3rd O
postoperative O
day O
, O
and O
with O
the O
passage O
of O
flatus O
and O
good O
bowel O
sounds O
noted O
, O
she O
was O
started O
on O
a B-TREATMENT
liquid I-TREATMENT
diet I-TREATMENT
which O
was O
advanced O
slowly O
. O

She O
was O
seen O
by O
the O
dietician O
and O
was O
advised O
with O
regard O
to O
needing O
numerous O
small O
meals O
during O
the O
day O
rather O
than O
3 O
larger O
meals O
as O
she O
previously O
was O
used O
to O
. O

Her O
ambulation O
and O
mobilization O
increased O
gradually O
and O
by O
the O
time O
of O
discharge O
she O
was O
walking O
in O
the O
halls O
without O
assistance O
. O

As O
mentioned O
, O
her B-SYMPTOM
wounds I-SYMPTOM
healed O
well O
without O
incident O
and O
the B-TREATMENT
staples I-TREATMENT
were O
removed O
on O
the O
10th O
postoperative O
day O
just O
prior O
to O
discharge O
. O

She O
had O
some B-SYMPTOM
difficulties I-SYMPTOM
with O
confusion B-SYMPTOM
in O
the O
early O
postoperative O
period O
which O
were O
attributable O
to O
her O
advanced O
age O
and O
a B-SYMPTOM
sundowning I-SYMPTOM
effect I-SYMPTOM
. O

These O
problems O
resolved O
by O
the O
4th O
or O
5th O
postoperative O
day O
and O
she O
remained O
lucid O
and O
alert O
for O
the O
remainder O
of O
her O
hospital O
stay O
. O

Surgical O
pathology O
report O
was O
completed O
prior O
to O
discharge O
which O
revealed O
poorly B-SYMPTOM
differentiated I-SYMPTOM
adenocarcinoma I-SYMPTOM
ulcerating O
and O
extending O
through O
the O
wall O
into O
the O
serosa O
of O
the O
stomach O
. O

Metastatic B-SYMPTOM
carcinoma I-SYMPTOM
was O
present O
in O
3 O
of O
3 O
lymph O
nodes O
. O

The O
gastric O
resection O
margins O
were O
free O
of O
carcinoma B-SYMPTOM
. O

The O
patient O
was O
set O
for O
discharge O
on O
the O
11th O
postoperative O
day O
doing O
well O
. O

On O
the O
day O
prior O
to O
discharge O
she O
complained O
of O
some B-SYMPTOM
dysuria I-SYMPTOM
, O
a O
urine O
specimen O
was O
obtained O
, O
which O
showed O
numerous B-SYMPTOM
white I-SYMPTOM
cells I-SYMPTOM
consistent O
with O
a B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

She O
was O
started O
empirically O
on O
Bactrim B-TREATMENT
, O
while O
culture O
and O
sensitivity O
results O
were O
pending O
and O
remained O
pending O
at O
the O
time O
of O
this O
dictation O
. O

She O
will O
be O
discharged O
to O
home O
and O
will O
be O
seen O
in O
follow-up O
by O
her O
regular O
physicians O
as O
well O
as O
Dr. O
Ko O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Bactrim B-TREATMENT
, I-TREATMENT
single I-TREATMENT
strength I-TREATMENT
, O
one O
p.o. O
b.i.d. O
times O
10 O
days O
, O
initiated O
9/27/92 O
, O
Synthroid B-TREATMENT
0.1 O
mg O
p.o. O
q.day O
, O
Ferrous B-TREATMENT
Gluconate I-TREATMENT
300 O
mg O
p.o. O
t.i.d. O
and O
Folate B-TREATMENT
1 O
mg O
p.o. O
q. O
day O
. O

She O
will O
be O
seen O
by O
Visiting O
Nurses O
Association O
to O
help O
with O
general O
aspects O
of O
daily O
living O
as O
well O
as O
adequate O
diet O
planning O
following O
her B-TREATMENT
gastric I-TREATMENT
resection I-TREATMENT
. O

TOMEDANKELL O
FLOWAYLES O
, O
M.D. O

TR O
: O

cdw O
/ O
bmot O

DD O
: O

01-21-92 O

TD O
: O

01/22/92 O

CC O
: O

Dr. O
Ko O

892163777 O

TGCHO O

3997057 O

299593 O

8/5/1998 O
12:00:00 O
AM O

RULE O
OUT O
FOR O
MYOCARDIAL B-SYMPTOM
INFARCTION I-SYMPTOM

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O
NAME O
: O

FYFEREOSKOTE O
, O
CILLMA O
M O

UNIT O
NUMBER O
: O

333-10-08 O

ADMISSION O
DATE O
: O

08/05/98 O

DISCHARGE O
DATE O
: O

08/07/98 O

PRINCIPAL O
DIAGNOSIS O
: O

Rule O
out O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM

ASSOCIATED O
DIAGNOSIS O
: O

1 O
) O
aortic B-SYMPTOM
insufficiency I-SYMPTOM
; O
2 O
) O
Parkinson B-SYMPTOM
's I-SYMPTOM
Disease I-SYMPTOM
; O
3 O
) O
a O
history O
of O
colon B-SYMPTOM
carcinoma I-SYMPTOM
; O
4 O
) O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

An O
exercise O
tolerance O
test O
with O
imaging O
. O

CHIEF O
COMPLAINT O
: O

Right B-SYMPTOM
sided I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
by O
several O
hours O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Miss O
Siehjesc O
is O
an O
85-year-old O
woman O
with O
a O
past O
medical O
history O
significant O
for O
Parkinson B-SYMPTOM
's I-SYMPTOM
Disease I-SYMPTOM
of O
ten O
years O
duration O
, O
supraventricular B-SYMPTOM
tachycardia I-SYMPTOM
, O
and O
a O
history O
of O
colon B-SYMPTOM
carcinoma I-SYMPTOM
, O
who O
was O
in O
her O
usual O
state O
of O
health O
until O
11:30 O
on O
the O
morning O
of O
admission O
when O
she O
felt O
the O
acute O
on O
set O
of O
5 O
out O
of O
10 O
right B-SYMPTOM
sided I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
with O
radiation B-SYMPTOM
to I-SYMPTOM
her I-SYMPTOM
sternum I-SYMPTOM
but O
not O
to O
her O
neck O
or O
arms O
or O
back O
. O

It O
was O
not O
relieved O
by O
2 B-TREATMENT
sublingual I-TREATMENT
nitroglycerins I-TREATMENT
. O

She O
did O
state O
that O
she O
experienced O
some B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
( O
her O
usual O
anginal O
equivalent O
) O
and O
believes O
she O
did O
experience O
some B-SYMPTOM
lightheadedness I-SYMPTOM
as O
well O
, O
but O
denies O
blacking O
out O
or O
falling O
. O

While O
the B-SYMPTOM
pain I-SYMPTOM
was O
initially O
intermittent O
, O
it O
became O
steady O
at O
about O
1:00 O
p.m. O
at O
which O
time O
she O
presented O
to O
the O
Tecal O
Galecounxopt O
Community O
Hospital O
Emergency O
Room O
and O
following O
this O
experience O
a O
spontaneous O
remission O
of O
her B-SYMPTOM
right I-SYMPTOM
sided I-SYMPTOM
pain I-SYMPTOM
. O

Since O
that O
time O
she O
has O
experience O
occasional O
episodes O
of O
the B-SYMPTOM
same I-SYMPTOM
focal I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
but O
finds O
that O
it O
spontaneously O
remits O
. O

It O
is O
made O
better O
by O
direct B-TREATMENT
pressure I-TREATMENT
to I-TREATMENT
the I-TREATMENT
point I-TREATMENT
and O
she O
recalls O
no O
factors O
which O
worsened O
it O
. O

She O
is O
admitted O
to O
rule O
out O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1 O
) O
Parkinson B-SYMPTOM
's I-SYMPTOM
Disease I-SYMPTOM
; O

2 O
) O
hypertension B-SYMPTOM
; O

3 O
) O
aorticsclerosis B-SYMPTOM
; O

4 O
) O
history O
of O
colon B-SYMPTOM
carcinoma I-SYMPTOM
; O

5 O
) O
severe B-SYMPTOM
kyphosis I-SYMPTOM
. O

ALLERGIES O
: O

Codeine B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1 O
) O
Lasix B-TREATMENT
20 O
mg. O
PO O
q.d. O

2 O
) O
Sinemet B-TREATMENT
25/100 O
1 O
t.i.d. O

3 O
) O
Cogentin B-TREATMENT
0.5 O
mg. O
1 O
tabs O
PO O
q.a.m. O
and O
1 O
q.noon O
as O
well O
as O
1 O
q.h.s. O

4 O
) O
Eldepryl B-TREATMENT
5 O
mg. O
PO O
b.i.d. O

5 O
) O
Enteric B-TREATMENT
coated I-TREATMENT
aspirin I-TREATMENT
325 O
mg. O
PO O
q.d. O

6 O
) O
Potassium B-TREATMENT
chloride I-TREATMENT
10 O
mEq. O
PO O
q.d. O

SOCIAL O
HISTORY O
: O

The O
patient O
smoked O
one O
pack O
of O
cigarettes O
per O
day O
from O
age O
16 O
to O
50 O
. O

She O
quit O
35 O
years O
ago O
. O

She O
takes O
one O
sip O
of O
wine O
on O
Fridays O
. O

She O
denies O
any O
history O
of O
elicit O
drug O
use O
. O

She O
did O
not O
work O
after O
the O
age O
of O
approximately O
65 O
. O

The O
patient O
is O
now O
widowed O
. O

She O
lives O
with O
her O
single O
daughter O
. O

She O
does O
have O
one O
son O
who O
died O
at O
the O
age O
of O
21 O
years O
old O
. O

FAMILY O
HISTORY O
: O

Is O
significant O
for O
a O
father O
who O
had O
a B-SYMPTOM
stroke I-SYMPTOM
and O
also O
suffered O
from O
hypertension B-SYMPTOM
. O

She O
denies O
any O
family O
history O
of O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

The O
vital O
signs O
showed O
a O
temperature O
of O
96.8 O
, O
heart O
rate O
80 O
, O
blood O
pressure O
180/78 O
, O
respiratory O
rate O
18 O
, O
and O
she O
was O
satting O
95 O
percent O
on O
two B-TREATMENT
liters I-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
. O

In O
general O
the O
patient O
was O
resting O
comfortably O
in O
bed O
with O
a B-SYMPTOM
visible I-SYMPTOM
tremor I-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
right I-SYMPTOM
hand I-SYMPTOM
and I-SYMPTOM
foot I-SYMPTOM
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
, O
normocephalic O
, O
atraumatic B-SYMPTOM
, O
pupils O
equal O
, O
round O
, O
reactive O
to O
light O
and O
accommodation O
, O
extraocular O
muscles O
intact O
, O
sclera B-SYMPTOM
anicteric I-SYMPTOM
. O

Neck O
: O

supple O
, O
no O
bruits B-SYMPTOM
, O
nodes B-SYMPTOM
or O
thyromegaly B-SYMPTOM
. O

Thorax O
: O

crackles B-SYMPTOM
at I-SYMPTOM
both I-SYMPTOM
bases I-SYMPTOM
, O
kyphotic B-SYMPTOM
, O
no O
costovertebral B-SYMPTOM
angle I-SYMPTOM
tenderness I-SYMPTOM
. O

Cardiovascular O
exam O
: O

regular O
rate O
and O
rhythm O
with O
1 B-SYMPTOM
out I-SYMPTOM
of I-SYMPTOM
6 I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
. O

Abdomen O
: O

soft O
, O
well B-SYMPTOM
healed I-SYMPTOM
scar I-SYMPTOM
, O
positive O
bowel O
sounds O
, O
no O
tenderness B-SYMPTOM
or O
organomegaly B-SYMPTOM
noted O
. O

Extremities O
: O

without O
clubbing B-SYMPTOM
, O
claudication B-SYMPTOM
, O
or O
edema B-SYMPTOM
. O

Rectal O
: O

negative O
per O
the O
emergency O
room O
. O

Neurologically O
the O
patient O
was O
alert O
and O
oriented O
x3 O
. O

Tremors B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
hand I-SYMPTOM
and I-SYMPTOM
foot I-SYMPTOM
at O
rest O
. O

Equivocal B-SYMPTOM
cogwheeling I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
, O
normal O
tone O
on O
the O
left O
. O

LABORATORY O
DATA O
: O

The O
patient O
's O
SMA O
7 O
was O
notable O
for O
a O
BUN O
of O
28 O
, O
creatinine O
1.3 O
, O
and O
a O
glucose O
of O
102 O
. O

Extended O
chemistries O
were O
within O
normal O
limits O
with O
a O
creatine O
kinase O
of O
122 O
and O
no O
measured O
methylene O
blue O
fraction O
given O
the O
low O
value O
. O

The O
complete O
blood O
count O
was O
notable O
for O
a O
white O
count O
of O
5.3,000 O
, O
hematocrit O
39 O
1/2 O
and O
platelet O
count O
of O
180,000 O
and O
normal O
coags O
were O
measured O
. O

RADIOLOGY O
: O

Portable O
chest O
x-ray O
was O
without O
evidence O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
or O
pneumonia B-SYMPTOM
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
proceeded O
to O
rule O
out O
formyocardial B-SYMPTOM
infarction I-SYMPTOM
by O
enzymes O
. O

Additionally O
, O
the O
patient O
underwent O
a O
exercise O
stress O
test O
on O
8/6/98 O
with O
a O
heart O
rate O
proceeding O
from O
76 O
to O
93 O
beats O
per O
minute O
. O

There O
were O
no O
electrocardiogram B-SYMPTOM
changes I-SYMPTOM
noted O
and O
there O
were O
no O
arrhythmias B-SYMPTOM
noted O
as O
well O
. O

During O
the O
test O
the O
patient O
experienced O
no O
chest B-SYMPTOM
pressure I-SYMPTOM
or O
pain B-SYMPTOM
or O
dyspnea B-SYMPTOM
and O
nuclear O
medical O
imaging O
was O
without O
evidence O
of O
ischemia B-SYMPTOM
. O

The O
patient O
was O
in O
this O
fashion O
discharged O
from O
the O
service O
to O
continue O
on O
her B-TREATMENT
current I-TREATMENT
medications I-TREATMENT
and O
to O
call O
in O
oneweek O
to O
follow O
up O
with O
Dr. O
Sterpbreutzsterp O
and O
Cardiology O
. O

The O
patient O
already O
had O
a O
follow O
up O
appointment O
with O
Dr. O
Sterpbreutzsterp O
in O
three O
weeks O
, O
and O
was O
instructed O
to O
keep O
that O
appointment O
. O

CONDITION O
ON O
DISCHARGE O
: O

Good O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1) O
Lasix B-TREATMENT
20 O
mg. O
PO O
q.d. O

2) O
Sinemet B-TREATMENT
25/100 O
PO O
t.i.d. O

3) O
Cogentin B-TREATMENT
0.5 O
mg. O
2 O
tabs O
q.a.m. O
, O
1 O
q.lunch O
time O
, O
1 O
q.bed O
time O
. O

4) O
Eldepryl B-TREATMENT
5 O
mg. O
PO O
q.d. O

5) O
Enteric B-TREATMENT
coated I-TREATMENT
aspirin I-TREATMENT
325 O
mg. O
PO O
q.d. O

6) O
Potassium B-TREATMENT
chloride I-TREATMENT
10 O
mEq. O
PO O
q.d. O

7) O
Metoprolol B-TREATMENT
25 O
mg. O
PO O
b.i.d. O

DOCTOR O
' O
S O
DISCHARGE O
ORDERS O
: O

The O
patient O
will O
follow O
up O
with O
her O
primary O
care O
physician O
, O
Dr. O
Stoa O
Sterpbreutzsterp O
as O
has O
already O
been O
scheduled O
three O
weeks O
after O
the O
discharge O
date O
. O

NILA O
H. O
LEFT O
, O
M.D. O

DICTATING O
FOR O
: O

STOA O
STERPBREUTZSTERP O
, O
M.D. O

TR O
: O

fgz O

DD O
: O

10/12/98 O

TD O
: O

10/17/98 O
11:52 O

Acc O
: O

NILA O
H O
LEFT O
, O
M.D. O
STOA O
STERPBREUTZSTERP O
, O
M.D. O

006544894 O

NVH O

65104826 O

1/2/2004 O
12:00:00 O
AM O

VT B-SYMPTOM
s/p O
cardiac O
cath O
, O
stent B-TREATMENT
and O
amp O
; O
amio B-TREATMENT
loading I-TREATMENT

DIS O

Admission O
Date O
: O

01/02/2004 O

Report O
Status O
: O

Discharge O
Date O
: O

01/07/2004 O

****** O
DISCHARGE O
ORDERS O
****** O

NERSLET O
, O
BERISS O
665-07-74-6Q06 O

Room O
: O

89H-593 O

Service O
: O

CAR O

DISCHARGE O
PATIENT O
ON O
: O

01/07/04 O
AT O
02:00 O
PM O

CONTINGENT O
UPON O
Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

MOST O
, O
ANNETIFF O
SIAYUDE O
, O
M.D. O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

AMIODARONE B-TREATMENT
400 O
MG O
PO O
BID O
Starting O
Today O
( O
01/06 O
) O

Instructions O
: O

For O
7 O
days O

Alert O
overridden O
: O

Override O
added O
on O
01/03/04 O
by O
TIKNEAV O
, O
JEFFCI O
SUOT O
A. O
, O
M.D. O

SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

DIGOXIN B-TREATMENT
and O
AMIODARONE B-TREATMENT
HCL I-TREATMENT

Reason O
for O
override O
: O

ok O
ENTERIC B-TREATMENT
COATED I-TREATMENT
ASA I-TREATMENT
( I-TREATMENT
ASPIRIN I-TREATMENT
ENTERIC I-TREATMENT
COATED I-TREATMENT
) I-TREATMENT
325 O
MG O
PO O
QD O
DIGOXIN B-TREATMENT
0.0625 O
MG O
PO O
QD O

Override O
Notice O
: O

Override O
added O
on O
01/03/04 O
by O
TIKNEAV O
, O
JEFFCI O
SUOT O
A. O
, O
M.D. O
on O
order O
for O
AMIODARONE B-TREATMENT
PO I-TREATMENT
( O
ref O
# O
23731718 O
) O

SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

DIGOXIN B-TREATMENT
and O
AMIODARONE B-TREATMENT
HCL I-TREATMENT

Reason O
for O
override O
: O

ok O

Previous O
override O
information O
: O

Override O
added O
on O
01/02/04 O
by O
KOTESLENT O
, O
ANT O
ODEWYJU O
, O
M.D. O
on O
order O
for O
AMIODARONE B-TREATMENT
IV I-TREATMENT
1 O
( O
ref O
# O
45803793 O
) O

SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

DIGOXIN B-TREATMENT
and O
AMIODARONE B-TREATMENT
HCL I-TREATMENT

Reason O
for O
override O
: O

will O
follow O

Previous O
override O
information O
: O

Override O
added O
on O
01/02/04 O
by O
KOTESLENT O
, O
ANT O
ODEWYJU O
, O
M.D. O

SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

AMIODARONE B-TREATMENT
HCL I-TREATMENT
and O
DIGOXIN B-TREATMENT

Reason O
for O
override O
: O

will O
follow O

MVI B-TREATMENT
THERAPEUTIC I-TREATMENT
W I-TREATMENT
/ I-TREATMENT
MINERALS I-TREATMENT
( I-TREATMENT
THERAP I-TREATMENT
VITS I-TREATMENT
/ I-TREATMENT
MINERALS I-TREATMENT
) I-TREATMENT
1 O
TAB O
PO O
QD O

Override O
Notice O
: O

Override O
added O
on O
01/02/04 O
by O
KOTESLENT O
, O
ANT O
ODEWYJU O
, O
M.D. O
on O
order O
for O
ZOCOR B-TREATMENT
PO I-TREATMENT
( O
ref O
# O
71920299 O
) O

POTENTIALLY O
SERIOUS O
INTERACTION O
: O

NIACIN B-TREATMENT
, O
VIT O
. O

B-3 O
and O
SIMVASTATIN B-TREATMENT

Reason O
for O
override O
: O

wil O
follow O

ZOCOR B-TREATMENT
( I-TREATMENT
SIMVASTATIN I-TREATMENT
) I-TREATMENT
40 O
MG O
PO O
QHS O

Food O
/ O
Drug O
Interaction O
Instruction O

Avoid O
grapefruit O
unless O
MD O
instructs O
otherwise O
. O

Alert O
overridden O
: O

Override O
added O
on O
01/02/04 O
by O
KOTESLENT O
, O
ANT O
ODEWYJU O
, O
M.D. O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

NIACIN B-TREATMENT
, O
VIT O
. O

B-3 O
and O
SIMVASTATIN B-TREATMENT

Reason O
for O
override O
: O

wil O
follow O

TOPROL B-TREATMENT
XL I-TREATMENT
( I-TREATMENT
METOPROLOL I-TREATMENT
( I-TREATMENT
SUST. I-TREATMENT
REL. I-TREATMENT
) I-TREATMENT
) I-TREATMENT
100 O
MG O
PO O
QD O

Food O
/ O
Drug O
Interaction O
Instruction O

Take O
consistently O
with O
meals O
or O
on O
empty O
stomach O
. O

Number O
of O
Doses O
Required O
( O
approximate O
) O
: O

5 B-TREATMENT
PLAVIX I-TREATMENT
( I-TREATMENT
CLOPIDOGREL I-TREATMENT
) I-TREATMENT
75 O
MG O
PO O
QD O
Starting O
Today O
( O
01/06 O
) O
KEFLEX B-TREATMENT
( I-TREATMENT
CEPHALEXIN I-TREATMENT
) I-TREATMENT
500 O
MG O
PO O
QID O
X O
40 O
doses O
AMIODARONE B-TREATMENT
400 O
MG O
PO O
QD O

Instructions O
: O

After O
7 O
days O

Alert O
overridden O
: O

Override O
added O
on O
01/07/04 O
by: O

SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

DIGOXIN B-TREATMENT
and O
AMIODARONE B-TREATMENT
HCL I-TREATMENT

Reason O
for O
override O
: O

ok O

DIET O
: O

House O
/ O
Low O
chol O
/ O
low O
sat. O
fat O

ACTIVITY O
: O

Walking O
as O
tolerated O
FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Dr. O
Levels O
( O
Electrophysiology O
) O
4 O
weeks O
, O
PCP O
1-2 O
weeks O
, O

ALLERGY O
: O

NKA B-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O
Responsible O
After O
Study O
for O
Causing O
Admission O
) O
VT B-SYMPTOM
s O
/ O
p O
cardiac O
cath O
, O
stent B-TREATMENT
and O
amio B-TREATMENT
loading I-TREATMENT

OTHER O
DIAGNOSIS O
; O
Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
VT B-SYMPTOM
, O
CAD B-SYMPTOM
s O
/ O
p O
MI B-SYMPTOM
ischemic B-SYMPTOM
cardiomyopathy I-SYMPTOM
bilateral B-TREATMENT
knee I-TREATMENT
replacement I-TREATMENT

OPERATIONS O
AND O
PROCEDURES O
: O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

Cardiac O
Cath O
1/6/0004 O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

78 O
M O
w/ O
longstanding B-SYMPTOM
CAD I-SYMPTOM
s O
/ O
p O
CABG B-TREATMENT
'97 O
, O
had O
PPM B-TREATMENT
and O
AICD B-TREATMENT
placed O
in O
'02 O
after O
admitted O
for O
presyncope B-SYMPTOM
and O
found O
to O
have O
inducible B-SYMPTOM
VT I-SYMPTOM
. O

in O
USOH O
until O
this O
am O
when O
felt O
LH B-SYMPTOM
and O
then O
ICD B-TREATMENT
discharge I-TREATMENT
. O

Subsequent O
4 B-TREATMENT
ICD I-TREATMENT
discharges I-TREATMENT
at O
rest O
. O

Denies O
change B-SYMPTOM
in I-SYMPTOM
ET I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
SOB B-SYMPTOM
. O

Went O
to O
OSH O
c O
further B-TREATMENT
ICD I-TREATMENT
shocks I-TREATMENT
, O
VT B-SYMPTOM
on O
monitor O
but O
stable O
VS O
. O

Given O
amio B-TREATMENT
bolu I-TREATMENT
, O
started O
on O
gtt B-TREATMENT
and O
transferred O
to O
NVH O
for O
further O
evaluation O
. O

Exam O
remarkable O
for O
b B-SYMPTOM
/ I-SYMPTOM
l I-SYMPTOM
carotid I-SYMPTOM
bruits I-SYMPTOM
, O
soft B-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
L I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
, O
clear O
chest O
, O
1+ B-SYMPTOM
b I-SYMPTOM
/ I-SYMPTOM
l I-SYMPTOM
edema I-SYMPTOM
. O

Labs O
at O
OSH O
c O
Cr O
: O

1.9 O
, O

Hct O
: O

39.1 O
, O

gluc O
: O

214 O
, O

CK O
: O

130 O
, O

MB O
: O

2.6. O

ECG O
is O
AV O
paced O
but O
prior O
shower B-SYMPTOM
R I-SYMPTOM
on I-SYMPTOM
T I-SYMPTOM
VPB I-SYMPTOM
c O
monomorphic B-SYMPTOM
VT I-SYMPTOM
then O
overdrive O
paced O
. O

**** O
Course O

1) O
CV O
( O
R O
) O
finished O
amio B-TREATMENT
IV I-TREATMENT
load I-TREATMENT
then O
started O
on O
po O
, O
agressive B-TREATMENT
lytes I-TREATMENT
; O
although O
interrogation O
showed O
>100 O
episodes O
of O
VT B-SYMPTOM
( O
as O
/ O
x O
) O
, O
pt O
prefers O
med B-TREATMENT
therapy I-TREATMENT
as O
opposed O
to O
ablation B-TREATMENT
( O
I O
) O
enzymes O
mildly B-SYMPTOM
elevated I-SYMPTOM
but O
not O
actively B-SYMPTOM
ischemic I-SYMPTOM
; O
lipids O
, O
ASA B-TREATMENT
, O
statin B-TREATMENT
, O
BB B-TREATMENT
; O
Adenosine O
thal O
1/4 O
and O
echo O
1/4 O
to O
look O
for O
signs O
of O
ischemia B-SYMPTOM
as O
active O
cause O
for O
VT B-SYMPTOM
( O
P O
) O
JVP O
at O
angle O
of O
jaw O
1/4 O
--> O
giving O
20 B-TREATMENT
Lasix I-TREATMENT
; O
dig O
level O
1/4 O
1.3 O
--> O
1/2 O
dose O
as O
on O
Amio B-TREATMENT

2) O
Endo O
: O

elevated B-SYMPTOM
glu I-SYMPTOM
on O
admit O
BMP O
and O
FSG O
also O
concurring O
--> O
follow O
and O
Lispro B-TREATMENT
; O
will O
probably O
need O
w O
/ O
u O
as O
outpt O

3) O
Pulm O
: O

baseline O
PFTs O
as O
staring O
amio B-TREATMENT

4) O
GI O
: O

baseline O
LFTs O
wnl O
; O
taking O
cardiac B-TREATMENT
/ I-TREATMENT
ADA I-TREATMENT
diet I-TREATMENT
as O
glu O
remains O
elevated B-SYMPTOM

5) O
Renal O
: O

baseline O
CRI O
( O
1.2-1.6 O
) O
with O
elevation B-SYMPTOM
at O
admission O
probably O
prerenal O
; O
will O
monitor O
BUN O
/ O
Cr O
after O
giving O
Lasix B-TREATMENT

6) O
Proph O
: O

PPI B-TREATMENT
and O
pneumoboots B-TREATMENT

HOSPITAL O
COURSE O
and O
OUTCOME O
: O

The O
patient O
was O
admitted O
to O
the O
cardiology O
service O
and O
commenced O
amiodarone B-TREATMENT
loading I-TREATMENT
. O

Adenosine O
stress O
MIBI O
revealed O
a B-SYMPTOM
small I-SYMPTOM
reversible I-SYMPTOM
defect I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
PDA I-SYMPTOM
territory I-SYMPTOM
and O
the O
patient O
underwent O
coronary O
catheterisation O
on O
1/6/0004 O
which O
revealed O
a B-SYMPTOM
70% I-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
SVG I-SYMPTOM
to I-SYMPTOM
PDA I-SYMPTOM
-> O
cypher B-TREATMENT
stented I-TREATMENT
successfully O
. O

He O
had O
occasional B-SYMPTOM
ventricular I-SYMPTOM
extopyon I-SYMPTOM
telemetry O
but O
no O
further B-SYMPTOM
recurrence I-SYMPTOM
of O
ventricular B-SYMPTOM
tachycardia I-SYMPTOM
. O

During O
his O
admission O
, O
his O
am O
fasting O
glucose O
levels O
were O
intermittently B-SYMPTOM
elevated I-SYMPTOM
and O
his O
HbA1C O
was O
greater O
than O
7 O
. O

I O
have O
explained O
to O
him O
that O
he O
may O
have O
developed O
some B-SYMPTOM
glucose I-SYMPTOM
intolerance I-SYMPTOM
and O
that O
, O
in O
the O
first O
instance O
, O
he O
should O
see O
his O
Primary O
Care O
Physician O
and O
attempt O
dietary B-TREATMENT
control I-TREATMENT
. O

On O
the O
day O
prior O
to O
discharge O
he O
noticed O
a O
small O
area O
of O
erythema B-SYMPTOM
surrounding O
his B-TREATMENT
R I-TREATMENT
antecubital I-TREATMENT
venous I-TREATMENT
access I-TREATMENT
site I-TREATMENT
. O

This O
will O
be O
treated O
empirically O
with O
a O
10 O
day O
course O
of O
Keflex B-TREATMENT
. O

I O
have O
instructed O
him O
to O
see O
his O
PCP O
if O
it O
does O
not O
improve O
in O
a O
few O
days O
or O
if O
he O
develops O
fevers B-SYMPTOM
. O

In O
terms O
of O
his B-TREATMENT
amiodarone I-TREATMENT
, O
he O
will O
be O
discharged O
on O
400mg O
po O
bid O
for O
a O
further O
7 O
days O
followed O
by O
400mg O
qd O
thereafter O
. O

He O
will O
followup O
with O
Dr. O
Levels O
in O
device O
clinic O
in O
4 O
weeks O
. O

I O
have O
advised O
him O
that O
he O
must O
not O
drive O
until O
he O
is O
seena O
gain O
in O
clinic O
and O
his B-TREATMENT
device I-TREATMENT
interrogated O
. O

ADDITIONAL O
COMMENTS O
: O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

STENVERS O
, O
IMARL O
, O
M.D. O
( O
AW45 O
) O
01/07/04 O
02:14 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

948986258 O
YC O

28079279 O

1027681 O

04/06/2005 O
12:00:00 O
AM O

abdominal B-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM

DIS O

Admission O
Date O
: O

04/06/2005 O

Report O
Status O
: O

Discharge O
Date O
: O

04/12/2005 O

****** O
FINAL O
DISCHARGE O
ORDERS O
****** O

LILEY O
, O
PEANTSALL O
885-17-29-8 O
M12 O

Room O
: O

5Y-704 O

Service O
: O

GGI O

DISCHARGE O
PATIENT O
ON O
: O

04/12/05 O
AT O
01:00 O
PM O

CONTINGENT O
UPON O

HO O
evaluation O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

LILEY O
, O
BER O
, O
M.D. O

DISPOSITION O
: O

Home O
w/ O
services O

DISCHARGE O
MEDICATIONS O
: O

MOTRIN B-TREATMENT
( I-TREATMENT
IBUPROFEN I-TREATMENT
) I-TREATMENT
600 O
MG O
PO O
Q6H O
PRN O
Pain B-SYMPTOM
, O
Headache B-SYMPTOM
, O
Temperature O
greater O
than O
: O

100 O

Food O
/ O
Drug O
Interaction O
Instruction O

Take O
with O
food O
FLAGYL B-TREATMENT
( I-TREATMENT
METRONIDAZOLE I-TREATMENT
) I-TREATMENT
500 O
MG O
PO O
Q8H O
X O
10 O
Days O
Starting O
Today O
( O
04/12 O
) O

Instructions O
: O

Take O
for O
10 O
days O
or O
until O
drains B-TREATMENT
come O
out O
; O
whichever O
is O
of O
longer O
duration O
. O

Food O
/ O
Drug O
Interaction O
Instruction O

Take O
with O
food O
OXYCODONE B-TREATMENT
10 O
MG O
PO O
Q4H O
PRN O
Pain B-SYMPTOM
LEVOFLOXACIN B-TREATMENT
500 O
MG O
PO O
QD O
X O
10 O
Days O
Starting O
Today O
( O
04/12 O
) O

Instructions O
: O

Take O
for O
10 O
days O
or O
until O
drains B-TREATMENT
come O
out O
; O
whichever O
is O
of O
longer O
duration O
. O

Food O
/ O
Drug O
Interaction O
Instruction O

Administer O
iron B-TREATMENT
products I-TREATMENT
a O
minimum O
of O
2 O
hours O
before O
or O
after O
a B-TREATMENT
levofloxacin I-TREATMENT
or O
ciprofloxacin B-TREATMENT
dose I-TREATMENT
dose O
If O
on O
tube B-TREATMENT
feeds I-TREATMENT
, O
please O
cycle O
( O
hold O
1 O
hr O
before O
to O
2 O
hr O
after O
) O

Take O
2 O
hours O
before O
or O
2 O
hours O
after O
dairy O
products O
. O

MAALOX-TABLETS B-TREATMENT
QUICK I-TREATMENT
DISSOLVE I-TREATMENT
/ I-TREATMENT
CHEWABLE I-TREATMENT
2 O
TAB O
PO O
Q6H O
PROTONIX B-TREATMENT
( I-TREATMENT
PANTOPRAZOLE I-TREATMENT
) I-TREATMENT
40 O
MG O
PO O
QD O

DIET O
: O

House B-TREATMENT
/ I-TREATMENT
Low I-TREATMENT
Residue I-TREATMENT
&lt; O
FDI O
&gt; O

ACTIVITY O
: O

Walking O
as O
tolerated O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Dr. O
Liley O
, O
call O
ASAP O
to O
schedule O
1-2 O
weeks O
, O
Your O
primary O
care O
physician O
1-2 O
weeks O
, O
Interventional O
Radiology O
, O
call O
329-125-0028 O
to O
schedule O
an O
appointment O
when O
drain O
outputs O
are O
less O
than O
10cc O
/ O
day O
. O
, O

ALLERGY O
: O

NKA B-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

abdominal B-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
abdominal B-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
liver B-SYMPTOM
hemangioma I-SYMPTOM
, O
bph B-SYMPTOM
, O
gout B-SYMPTOM
, O
meningioma B-SYMPTOM
, O
gerd B-SYMPTOM
, O
episodic B-SYMPTOM
vertigo I-SYMPTOM
, O
s O
/ O
p O
r B-TREATMENT
colectomy I-TREATMENT
, O
subtotal B-TREATMENT
colectomy I-TREATMENT

OPERATIONS O
AND O
PROCEDURES O
: O

NONE O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

IR B-TREATMENT
drainage I-TREATMENT
X2 O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

HPI O
This O
is O
a O
60 O
yo O
gentleman O
who O
previously O
had O
an B-TREATMENT
ileocolic I-TREATMENT
resection I-TREATMENT
for O
a B-SYMPTOM
right I-SYMPTOM
colon I-SYMPTOM
cancer I-SYMPTOM
, O
and O
was O
found O
to O
have O
recurrent B-SYMPTOM
disease I-SYMPTOM
on O
colonoscopy O
. O

He O
was O
also O
found O
to O
have O
a B-SYMPTOM
malignant I-SYMPTOM
lesion I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
descending I-SYMPTOM
colon I-SYMPTOM
. O

He O
had O
a B-TREATMENT
subtotal I-TREATMENT
colectomy I-TREATMENT
on O
03/22/05 O
which O
was O
uncomplicated O
. O

Postop O
he O
has O
had O
numerous O
visits O
to O
the O
ED O
for O
co O
fevers B-SYMPTOM
, O
sweats B-SYMPTOM
, O
and O
SOB B-SYMPTOM
. O

CTS O
chest O
was O
negative O
for O
PE B-SYMPTOM
, O
however O
it O
did O
reveal O
pulmonary B-SYMPTOM
nodules I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
RML I-SYMPTOM
which O
need O
fu O
imaging O
in O
3 O
months O
. O

He O
also O
had O
bl B-SYMPTOM
atelectasis I-SYMPTOM
on O
cxr O
. O

CT O
of O
the O
abdomen O
showed O
a B-SYMPTOM
collection I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
RLQ I-SYMPTOM
which O
appears O
to O
be O
amenable O
to O
IR B-TREATMENT
drainage I-TREATMENT
. O

He O
also O
has O
had O
urine O
and O
blood O
cultures O
sent O
from O
the O
ED O
on O
04/05 O
and O
was O
empirically O
started O
on O
avalox B-TREATMENT
last O
pm O
. O

PMH O
GERD B-SYMPTOM
, O
HTN B-SYMPTOM
, O
Gout B-SYMPTOM
, O
Meningioma B-SYMPTOM
, O
liver B-SYMPTOM
hemangioma I-SYMPTOM
, O
episodic B-SYMPTOM
vertigo I-SYMPTOM
, O
colon B-SYMPTOM
cancer I-SYMPTOM
. O

MEDS B-TREATMENT

Protonix B-TREATMENT
40 O
qd O
, O
Colchicine B-TREATMENT
6 O
mg O
bid O
, O
Meclizine B-TREATMENT
25 O
mg O
qid O
prn O
, O
glucosamine B-TREATMENT
and O
oxycodone B-TREATMENT
prn O
, O
tessalon B-TREATMENT
prn O
. O

ALL O
NKDA B-SYMPTOM
SH O
No O
smoking O
PE O

GEN O
- O
NAD B-SYMPTOM

HEENT O
-- O
perrla O
, O
eomi O
, O
mmm O
, O
tongue O
midline O
, O
op O
clear O
, O
no O
masses B-SYMPTOM

NECK O
-- O
no O
jvd B-SYMPTOM
/ O
lad/ B-SYMPTOM
; O
trachea O
midline O
CARD O
- O
RRR O
, O
S1/S2 O
, O
no O
m B-SYMPTOM
/ O
r/g B-SYMPTOM

PULM O
- O
CTAB O
no O
w B-SYMPTOM
/ I-SYMPTOM
r I-SYMPTOM
/ I-SYMPTOM
r I-SYMPTOM
ABD O
-nt B-SYMPTOM
/ O
nd B-SYMPTOM
; O
incision B-SYMPTOM
c O
/ O
d O
/ O
I O
; O
discrete B-SYMPTOM
3x3 I-SYMPTOM
cm I-SYMPTOM
slightly I-SYMPTOM
firm I-SYMPTOM
protuberant I-SYMPTOM
mass I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
R I-SYMPTOM
of I-SYMPTOM
umbilicus I-SYMPTOM
; O
no O
rebound B-SYMPTOM
, O
no O
guarding B-SYMPTOM
. O

BACK O
- O
no O
flank B-SYMPTOM
tenderness I-SYMPTOM

RECTAL O
-- O
deferred O

EXT O
- O
WWP O
; O
no O
edema B-SYMPTOM

On O
04/06/05 O
Mr. O
Liley O
was O
admitted O
to O
Dr. O
Liley O
&apos;s O
service O
. O

At O
that O
time O
he O
was O
made O
NPO B-TREATMENT
with O
IVF B-TREATMENT
, O
placed O
on O
Ampicillin B-TREATMENT
/ O
Levofloxacin B-TREATMENT
/ O
Flagyl B-TREATMENT
and O
underwent O
IR B-TREATMENT
placement I-TREATMENT
of I-TREATMENT
a I-TREATMENT
drainage I-TREATMENT
catheter I-TREATMENT
for O
his B-SYMPTOM
abdominopelvic I-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM
. O

Overnight O
he O
spiked O
a B-SYMPTOM
fever I-SYMPTOM
to O
103 O
and O
his O
WBC O
climbed O
from O
11 O
to O
13 O
. O

As O
a O
result O
, O
IR O
reviewed O
the O
patient O
&apos;s O
post-procedure O
imaging O
and O
felt O
that O
the B-TREATMENT
catheter I-TREATMENT
was O
not O
adequately O
draining O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM
. O

On O
04/07 O
they O
took O
the O
patient O
back O
to O
the O
IR O
suite O
and O
placed O
a B-TREATMENT
second I-TREATMENT
catheter I-TREATMENT
. O

The O
location O
of O
the B-TREATMENT
second I-TREATMENT
catheter I-TREATMENT
was O
confirmed O
that O
evening O
by O
a O
follow-up O
scan O
which O
revealed O
good O
placement O
. O

The O
following O
day O
the O
patient O
defervesced O
. O

Neurologic O
: O

The B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
pain I-SYMPTOM
from O
his B-TREATMENT
catheters I-TREATMENT
was O
controlled O
with O
Oxycodone B-TREATMENT
and O
Motrin B-TREATMENT
. O

CV O
: O

No O
active O
issues O
. O

R O
: O

The O
patient O
received O
chest B-TREATMENT
PT I-TREATMENT
and O
was O
encouraged O
to O
ambulate O
frequently O
. O

GI O
: O

After O
catheter B-TREATMENT
placement I-TREATMENT
, O
the O
patient O
was O
started O
on O
sips B-TREATMENT
. O

He O
tolerated O
this O
well O
. O

He O
was O
advanced O
to O
clears B-TREATMENT
which O
he O
tolerated O
and O
was O
restarted O
on O
a B-TREATMENT
low I-TREATMENT
residue I-TREATMENT
diet I-TREATMENT
. O

His O
bowel O
function O
resumed O
and O
in O
fact O
he O
had O
loose O
stool O
. O

He O
had O
3 O
specimens O
sent O
for O
C. B-SYMPTOM
difficile I-SYMPTOM
which O
were O
negative O
. O

GU O
: O

The O
patient O
&apos;s O
electrolytes O
and O
fluids O
were O
monitored O
closely O
during O
his O
admission O
. O

Heme O
: O

The O
patient O
&apos;s O
WBC O
trended O
down O
to O
10.7 O
at O
discharge O
from O
a O
peak O
of O
13 O
on O
04/07 O
. O

His O
hematocrit O
remained O
stable O
. O

He O
received O
DVT B-TREATMENT
prophylaxis I-TREATMENT
with O
SC B-TREATMENT
Heparin I-TREATMENT
. O

ID O
: O

Blood O
cultures O
04/05 O
revealed O
Bacteroides B-SYMPTOM
fragilis I-SYMPTOM
; O
04/06 O
Fluid O
collection O
drainage O
from O
IR O
revealed O

1) O
4+ B-SYMPTOM
alpha I-SYMPTOM
hemolytic I-SYMPTOM
Strep I-SYMPTOM
, O

2) O
2+ B-SYMPTOM
E. I-SYMPTOM
coli I-SYMPTOM
sensitive O
to O
Ampicillin B-TREATMENT
and O
Levofloxacin B-TREATMENT
, O

3) O
3+ B-SYMPTOM
Enterococci I-SYMPTOM
sensitive O
to O
Ampicillin B-TREATMENT
and O
Levofloxacin B-TREATMENT
, O

4) O
Bacteroides B-SYMPTOM
fragilis I-SYMPTOM
and O
Clostridium B-SYMPTOM
perfringens I-SYMPTOM
. O

Blood O
cultures O
from O
04/07 O
showed O
NGTD B-SYMPTOM
. O

Cdiff O
from O
04/08 O
, O
04/09 O
, O
04/10 O
were O
negative O
. O

Mr. O
Liley O
was O
discharged O
in O
stable O
condition O
, O
ambulating O
and O
voiding O
independently O
, O
and O
with O
adequate B-TREATMENT
pain I-TREATMENT
control I-TREATMENT
. O

LDAMC O
services O
were O
set-up O
for O
care B-TREATMENT
of O
his B-TREATMENT
IR I-TREATMENT
drains I-TREATMENT
. O

He O
was O
given O
explicit O
instructions O
to O
follow-up O
in O
clinic O
with O
Dr. O
Liley O
in O
1-2 O
weeks O
. O

ADDENDUM O
: O

An O
abscessogram O
was O
performed O
on O
04/12/05 O
and O
revealed O
no O
fistula B-SYMPTOM
. O

ADDITIONAL O
COMMENTS O
: O

- O
Seek O
medical O
attention O
for O
fevers B-SYMPTOM
( O
temp O
&gt; O
101.5 O
) O
, O
worsening B-SYMPTOM
pain I-SYMPTOM
, O
drainage B-SYMPTOM
or O
excessive B-SYMPTOM
bleeding I-SYMPTOM
from O
incision B-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
or O
any B-SYMPTOM
other I-SYMPTOM
symptoms I-SYMPTOM
of O
concern O
. O

- O
Follow O
up O
with O
your O
surgeon O
in O
1-2 O
weeks O
for O
wound O
check O
. O

- O
Please O
do O
not O
drive O
or O
consume O
alcohol O
while O
taking O
pain B-TREATMENT
medications I-TREATMENT
. O

- O
Resume O
home B-TREATMENT
medications I-TREATMENT
. O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

ALIKES O
, O
NATO O
T. O
, O
M.D. O
( O
FG980 O
) O

04/12/05 O
11:30 O
AM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2012-11-21 O

Discharge O
Date O
: O

2012-11-28 O

Date O
of O
Birth O
: O

1975-05-29 O

Sex O
: O

F O

Service O
: O

Transplant O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
37-year-old O
female O
who O
presents O
on O
an O
elective O
basis O
for O
a B-TREATMENT
living-related I-TREATMENT
kidney I-TREATMENT
transplant I-TREATMENT
. O

The O
patient O
has O
a O
history O
of O
end-stage B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
secondary O
to O
type B-SYMPTOM
1 I-SYMPTOM
diabetes I-SYMPTOM
with O
a O
baseline O
creatinine O
of O
around O
5 O
. O

She O
is O
receiving O
a B-TREATMENT
kidney I-TREATMENT
from O
her O
sister O
. O

The O
patient O
has O
a O
history O
of O
hypertension B-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
and O
insulin-dependent B-SYMPTOM
diabetes I-SYMPTOM
for O
32 O
years O
. O

She O
is O
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
April O
of O
this O
year O
and O
subsequently O
underwent O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
surgery I-TREATMENT
. O

She O
present O
electively O
on O
the O
morning O
of O
her B-TREATMENT
surgery I-TREATMENT
with O
no O
recent O
changes O
in O
her B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Sarcoidosis B-SYMPTOM
since O
2001 O
. O

2. O
She O
is O
status O
post O
cholecystectomy B-TREATMENT
. O

3. O
Status O
post O
tubal B-TREATMENT
ligation I-TREATMENT
. O

4. O
Status O
post O
left B-TREATMENT
arteriovenous I-TREATMENT
graft I-TREATMENT
placement I-TREATMENT
for O
hemodialysis B-TREATMENT
. O

5. O
Insulin-dependent B-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
times O
32 O
years O
. O

6. O
Hypertension B-SYMPTOM
. O

7. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
2012-05-06 O
. O

8. O
End-stage B-SYMPTOM
renal I-SYMPTOM
disease I-SYMPTOM
, O
on O
hemodialysis B-TREATMENT
for O
1.5 O
years O
. O

ALLERGIES O
: O

Allergies B-SYMPTOM
include O
AMOXICILLIN B-TREATMENT
and O
CODEINE B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION: O

1. O
Insulin B-TREATMENT
by O
sliding-scale O
, O
NPH B-TREATMENT
insulin I-TREATMENT
16 O
units O
in O
the O
morning O
and O
6 O
units O
in O
the O
evening O
. O

2. O
Lipitor B-TREATMENT
20 O
mg O
p.o. O
q.d. O

3. O
Zoloft B-TREATMENT
50 O
mg O
p.o. O
t.i.d. O

4. O
Reglan B-TREATMENT
10 O
mg O
p.o. O
t.i.d. O

5. O
Lopressor B-TREATMENT
50 O
mg O
p.o. O
b.i.d. O

6. O
Aspirin B-TREATMENT
81 O
mg O
p.o. O
q.d. O

7. O
Multivitamin B-TREATMENT
1 O
p.o. O
q.d. O

8. O
Remeron B-TREATMENT
p.o. O
q.d. O

SOCIAL O
HISTORY O
: O

She O
is O
a O
half O
to O
one O
pack O
per O
day O
smoker O
for O
10 O
years O
who O
quit O
approximately O
one O
week O
prior O
to O
her O
admission O
. O

She O
denies O
alcohol O
use O
. O

PHYSICAL O
EXAMINATION O
ON O
ADMISSION O
: O

Physical O
examination O
at O
the O
time O
of O
admission O
revealed O
she O
was O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Blood O
pressure O
was O
150/79 O
, O
a O
pulse O
of O
81 O
. O

She O
is O
legally B-SYMPTOM
blind I-SYMPTOM
. O

She O
was O
without O
any B-SYMPTOM
adenopathy I-SYMPTOM
. O

Her O
chest O
was O
clear O
to O
auscultation O
. O

Heart O
had O
a O
normal O
S1 O
and O
S2 O
, O
with O
no O
murmurs B-SYMPTOM
, O
gallops B-SYMPTOM
or O
rubs B-SYMPTOM
. O

Her O
abdomen O
was O
soft O
with O
well-healed B-SYMPTOM
incisions I-SYMPTOM
. O

There O
was O
no O
organomegaly B-SYMPTOM
. O

Extremities O
were O
without O
edema B-SYMPTOM
. O

She O
had O
a B-SYMPTOM
functioning I-SYMPTOM
arteriovenous I-SYMPTOM
fistula I-SYMPTOM
with O
a B-SYMPTOM
thrill I-SYMPTOM
and O
a B-SYMPTOM
bruit I-SYMPTOM
in O
her O
left O
arm O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
preoperative O
holding O
area O
and O
taken O
electively O
to O
the O
operating O
room O
. O

She O
underwent O
a B-TREATMENT
living-related I-TREATMENT
renal I-TREATMENT
transplant I-TREATMENT
in I-TREATMENT
the I-TREATMENT
right I-TREATMENT
iliac I-TREATMENT
fossa I-TREATMENT
. O

The B-TREATMENT
operation I-TREATMENT
was O
somewhat O
technically O
difficult O
secondary O
to O
a B-SYMPTOM
short I-SYMPTOM
segment I-SYMPTOM
of I-SYMPTOM
ureter I-SYMPTOM
which O
was O
anastomosed O
over O
a B-TREATMENT
stent I-TREATMENT
to O
the O
bladder O
. O

Otherwise O
, O
there O
were O
difficulties B-SYMPTOM
, O
and O
estimated B-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
was O
minimal O
. O

She O
was O
taken O
postoperatively O
to O
the O
recovery O
room O
already O
making O
a O
large O
amount O
of O
urine O
. O

Intraoperatively O
, O
for O
immunosuppression B-TREATMENT
she O
received O
thymoglobulin B-TREATMENT
and O
Solu-Medrol B-TREATMENT
. O

She O
was O
started O
on O
Prograf B-TREATMENT
and O
CellCept B-TREATMENT
in O
the O
postoperative O
period O
. O

She O
was O
also O
maintained O
on O
Bactrim B-TREATMENT
postoperatively O
and O
did O
not O
require O
ganciclovir B-TREATMENT
, O
as O
she O
and O
her O
sister O
were O
cytomegalovirus B-SYMPTOM
negative O
. O

The O
patient O
's O
initial O
postoperative O
course O
was O
relatively O
uneventful O
. O

Her O
creatinine O
, O
which O
was O
5 O
initially O
postoperatively O
, O
slowly O
dropped O
over O
the O
next O
few O
days O
until O
eventually O
reaching O
a O
low O
of O
1 O
. O

She O
did O
receive O
pamidronate B-TREATMENT
on O
postoperative O
day O
one O
and O
received O
a O
total O
of O
four O
doses O
thymoglobulin B-TREATMENT
. O

Her B-TREATMENT
steroid I-TREATMENT
doses I-TREATMENT
were O
slowly O
tapered O
over O
her O
hospital O
course O
, O
and O
her O
Prograf O
level O
was O
adjusted O
to O
maintain O
therapeutic O
values O
between O
10 O
and O
15 O
. O

She O
continued O
to O
make O
good O
urine O
over O
the O
first O
few O
days O
and O
had O
her O
urine O
losses O
replaced O
with O
intravenous B-TREATMENT
fluids I-TREATMENT
. O

On O
postoperative O
day O
three O
, O
the O
patient O
had O
an B-SYMPTOM
episode I-SYMPTOM
of I-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
that O
was O
evaluated O
by O
both O
the O
Renal O
and O
surgical O
residents O
. O

It O
was O
found O
that O
she O
was O
in O
acute B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
and O
required O
transfer O
to O
the O
Surgical O
Intensive O
Care O
Unit O
. O

Her O
blood O
pressure O
at O
the O
time O
of O
this O
incident O
was O
in O
the O
range O
of O
200/120 O
. O

Her O
electrocardiogram O
showed O
no O
specific B-SYMPTOM
ST I-SYMPTOM
changes I-SYMPTOM
, O
but O
there O
was O
some B-SYMPTOM
loss I-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
R I-SYMPTOM
wave I-SYMPTOM
progression I-SYMPTOM
laterally I-SYMPTOM
. O

Serial O
enzymes O
were O
drawn O
, O
and O
Cardiology O
was O
consulted O
. O

With O
blood B-TREATMENT
pressure I-TREATMENT
control I-TREATMENT
via O
a B-TREATMENT
nitroglycerin I-TREATMENT
drip I-TREATMENT
and O
fluid B-TREATMENT
restriction I-TREATMENT
, O
the O
patient O
quickly O
improved O
and O
a O
had O
a O
relatively O
short O
stay O
in O
the O
Intensive O
Care O
Unit O
. O

Throughout O
this O
time O
, O
her O
creatinine O
continued O
to O
drop O
, O
and O
there O
was O
no O
apparent B-SYMPTOM
deleterious I-SYMPTOM
effect I-SYMPTOM
on O
her B-TREATMENT
transplant I-TREATMENT
from O
this O
episode O
. O

Her B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
was O
progressively O
increased O
, O
and O
her B-TREATMENT
nitroglycerin I-TREATMENT
drip I-TREATMENT
was O
weaned O
down O
. O

Two O
days O
after O
this O
event O
, O
she O
underwent O
an O
echocardiogram O
which O
was O
significant O
for O
slightly B-SYMPTOM
depressed I-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
systolic I-SYMPTOM
function I-SYMPTOM
with O
severe B-SYMPTOM
posterior I-SYMPTOM
wall I-SYMPTOM
hypokinesis I-SYMPTOM
. O

This O
was O
a O
change O
from O
her O
prior O
echocardiogram O
and O
demonstrated O
evidence O
of O
a B-SYMPTOM
small I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

Clinically O
, O
she O
did O
much O
better O
and O
her O
blood O
pressure O
was O
optimized O
prior O
to O
discharge O
. O

She O
was O
transferred O
out O
of O
the O
Intensive O
Care O
Unit O
on O
postoperative O
day O
five O
and O
was O
stable O
on O
the O
floor O
for O
the O
next O
two O
days O
. O

DISCHARGE O
DISPOSITION O
: O

She O
was O
set O
to O
be O
discharged O
to O
home O
on O
11-28 O
, O
on O
postoperative O
day O
seven O
. O

MEDICATIONS O
ON O
DISCHARGE: O

1. O
Prograf B-TREATMENT
4 O
mg O
p.o. O
b.i.d. O
( O
this O
may O
change O
depending O
on O
her O
most O
recent O
Prograf O
level O
which O
will O
be O
drawn O
on O
the O
morning O
of O
11-28 O
) O
. O

2. O
Prednisone B-TREATMENT
20 O
mg O
p.o. O
q.d. O

3. O
CellCept B-TREATMENT
1 O
mg O
p.o. O
b.i.d. O

4. O
Bactrim B-TREATMENT
1 O
single-strength O
tablet O
p.o. O
q.d. O

5. O
Zantac B-TREATMENT
150 O
mg O
p.o. O
b.i.d. O

6. O
NPH B-TREATMENT
insulin I-TREATMENT
16 O
units O
q.a.m. O
and O
6 O
units O
q.p.m. O

7. O
Zoloft B-TREATMENT
175 O
mg O
p.o. O
q.d. O

8. O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

9. O
Reglan B-TREATMENT
10 O
mg O
p.o. O
t.i.d. O

10. O
Percocet B-TREATMENT
one O
to O
two O
tablets O
p.o. O
q.4-6h. O
p.r.n. O

11. O
Lopressor B-TREATMENT
125 O
mg O
p.o. O
b.i.d. O

12. O
Aspirin B-TREATMENT
81 O
mg O
p.o. O
q.d. O

13. O
Cardizem-CD B-TREATMENT
180 O
mg O
p.o. O
q.d. O

DISCHARGE O
FOLLOWUP O
: O

Follow-up O
appointments O
should O
be O
with O
Dr. O
Jones O
and O
Dr. O
Yost O
in O
the O
Transplant O
Clinic O
. O

Furthermore O
, O
she O
needs O
a O
follow-up O
appointment O
with O
Dr. O
Miller O
of O
Cardiology O
within O
the O
next O
two O
weeks O
. O

DISCHARGE O
STATUS O
: O

The O
patient O
was O
discharged O
to O
home O
. O

CONDITION O
AT O
DISCHARGE O
: O

Condition O
was O
good O
. O

DISCHARGE O
DIAGNOSES O
: O

Status O
post O
living-related B-TREATMENT
renal I-TREATMENT
transplant I-TREATMENT
with O
perioperative B-SYMPTOM
small I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

Christina O
Kinde O
, O
MD O

46-131 O

Dictated O
By:Lillian O
U O
Walley O
, O
M.D. O

MEDQUIST36 O

D O
: O

2012-11-27 O

18:32 O

T O
: O

2012-11-28 O

12:49 O

JOB# O
: O

09180 O

( O
cclist O
) O

Signed O
electronically O
by O
: O

DR. O
Thomas O
Rosier O
on O
: O

FRI O
2012-12-07 O
3:33 O
PM O

( O
End O
of O
Report O
) O

745232329 O

PUOMC O

9543139 O

96458/7hv1 O

139846 O

9/14/1993 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

9/14/93 O

DISCHARGE O
DATE O
: O

9/15/93 O

CHIEF O
COMPLAINT O
: O

left B-TREATMENT
axillary I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
, O
status O
post O
breast B-SYMPTOM
carcinoma I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Patient O
is O
a O
49 O
year O
old O
previously O
healthy O
female O
, O
who O
was O
diagnosed O
in O
June O
, O
1992 O
, O
with O
a B-SYMPTOM
breast I-SYMPTOM
carcinoma I-SYMPTOM
, O
after O
she O
presented O
with O
some B-SYMPTOM
breast I-SYMPTOM
discomfort I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
side I-SYMPTOM
. O

She O
underwent O
a B-TREATMENT
wide I-TREATMENT
resection I-TREATMENT
of O
a B-SYMPTOM
left I-SYMPTOM
breast I-SYMPTOM
mass I-SYMPTOM
by O
Dr. O
Ausguall O
on O
8/17/93 O
. O

Pathology O
of O
this B-TREATMENT
resection I-TREATMENT
revealed O
a B-SYMPTOM
Grade I-SYMPTOM
III I-SYMPTOM
/ I-SYMPTOM
III I-SYMPTOM
infiltrating I-SYMPTOM
ductal I-SYMPTOM
carcinoma I-SYMPTOM
. O

She O
now O
presents O
for O
left B-TREATMENT
axillary I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
, O
to O
complete O
her O
staging O
. O

She O
has O
no O
complaints O
at O
the O
time O
of O
presentation O
. O

REVIEW O
OF O
SYSTEMS O
: O

noncontributory O
, O
her O
last O
menstrual O
period O
was O
regular O
, O
and O
last O
week O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

:w O

:q O

none O
. O

PAST O
MEDICAL O
HISTORY O
: O

Noncontributory O
. O

ALLERGIES O
: O

no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

Denies O
cigarette O
, O
or O
alcohol O
use O
, O
she O
is O
married O
and O
has O
one O
child O
. O

FAMILY O
HISTORY O
: O

Is O
negative O
, O
there O
is O
no O
breast B-SYMPTOM
carcinoma I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

Patient O
is O
a O
pleasant O
female O
, O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
. O

Her O
vital O
signs O
are O
stable O
, O
she O
is O
afebrile B-SYMPTOM
. O

head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
: O

reveals O
no O
adenopathy B-SYMPTOM
, O
extra O
ocular O
movements O
intact O
, O
pupils O
equal O
, O
round O
, O
reactive O
to O
light O
and O
accommodation O
. O

Throat O
: O

benign O
. O

Cardiac O
: O

regular O
rate O
and O
rhythm O
, O
normal O
first O
and O
second O
heart O
sounds O
, O
no O
murmur B-SYMPTOM
, O
rub B-SYMPTOM
or O
gallop B-SYMPTOM
. O

The O
lungs O
were O
clear O
to O
auscultation O
and O
percussion O
. O

Abdomen O
: O

soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
positive O
bowel O
sounds O
, O
there O
is O
no O
hepatosplenomegaly B-SYMPTOM
. O

Chest O
: O

reveals O
a B-SYMPTOM
well I-SYMPTOM
healed I-SYMPTOM
incision I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
side I-SYMPTOM
, O
there O
are O
no O
axillary O
lymph O
nodes O
palpable O
on O
both O
sides O
. O

Extremities O
: O

reveal O
no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

Motor O
: O

5/5 O
throughout O
. O

Sensory O
: O

intact O
. O

LABORATORY O
DATA O
: O

sodium O
140 O
, O
potassium O
4.4 O
, O
BUN O
and O
creatinine O
14/.9 O
, O
glucose O
95 O
, O
prothrombin O
time O
10.0 O
, O
with O
a O
control O
of O
10.2 O
, O
partial O
thromboplastin O
time O
26.9 O
, O
urinalysis O
negative O
, O
white O
blood O
count O
5.8 O
, O
hematocrit O
37.5 O
, O
hemoglobin O
13.4 O
, O
platelet O
count O
274,000 O
. O

The O
electrocardiogram O
reveals O
normal O
sinus O
rhythm O
at O
66 O
beats O
per O
minute O
, O
with O
no O
ST B-SYMPTOM
changes I-SYMPTOM
, O
there O
is O
R B-SYMPTOM
wave I-SYMPTOM
progression I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
on O
9/14/93 O
, O
and O
underwent O
on O
that O
same O
day O
, O
a B-TREATMENT
left I-TREATMENT
axillary I-TREATMENT
lymph I-TREATMENT
nodes I-TREATMENT
dissection I-TREATMENT
, O
by O
Dr. O
Ausguall O
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
, O
there O
were O
no O
complications B-SYMPTOM
. O

Postoperative O
course O
was O
unremarkable O
. O

The O
patient O
was O
discharged O
home O
on O
9/15/93 O
. O

At O
that O
time O
her B-TREATMENT
JP I-TREATMENT
was O
still O
in O
place O
. O

DISPOSITION O
: O

Patient O
will O
follow O
up O
with O
Dr. O
Ausguall O
, O
in O
about O
4-5 O
days O
, O
at O
which O
time O
the B-TREATMENT
JP I-TREATMENT
drain I-TREATMENT
will O
be O
removed O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Percocet B-TREATMENT
1-2 O
tablets O
PO O
q3-4 O
prn O
. O

BESTI O
KOTEBREUN O
, O
M.D. O

DICTATING O
FOR O
: O

WILFTAM O
AUSGUALL O
, O
M.D. O

TR O
: O

th O
/ O
bmot O

DD O
: O

9/14/93 O

TD O
: O

09/15/93 O

CC O
: O

Dr. O
Ausguall O

Admission O
Date O
: O

2017-04-26 O

Discharge O
Date O
: O

2017-05-01 O

Date O
of O
Birth O
: O

1955-02-25 O

Sex O
: O

M O

Service O
: O

CARD O
CMED O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
62 O
year O
old O
gentleman O
who O
underwent O
an O
exercise O
treadmill O
test O
for O
screening O
through O
the O
Beth O
Israel O
Deaconess O
Hospital-Needham O
Clinic O
. O

The O
test O
was O
positive O
for O
EKG B-SYMPTOM
changes I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

The O
patient O
has O
no O
history O
of O
chest B-SYMPTOM
pain; I-SYMPTOM
no O
history O
of O
myocardial B-SYMPTOM
infarction I-SYMPTOM
. O

The O
patient O
was O
referred O
to O
Cambridge O
Health O
Alliance O
for O
cardiac O
catheterization O
. O

Cardiac O
catheterization O
showed O
an O
ejection O
fraction O
of O
50% O
, O
left O
ventricular O
end O
diastolic O
pressure O
of O
20 O
, O
90% B-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
descending I-SYMPTOM
lesion I-SYMPTOM
, O
80% B-SYMPTOM
left I-SYMPTOM
circumflex I-SYMPTOM
lesion I-SYMPTOM
, O
80% B-SYMPTOM
mid I-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
lesion I-SYMPTOM
and O
80% B-SYMPTOM
distal I-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
lesion I-SYMPTOM
. O

The O
patient O
was O
referred O
to O
Dr. O
Rota O
for O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Hypertension B-SYMPTOM
. O

2. O
Type B-SYMPTOM
2 I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

3. O
Hypercholesterolemia B-SYMPTOM
. O

4. O
Thirty O
pack O
year O
tobacco O
history O
, O
quit O
one O
month O
ago O
. O

5. O
Gout B-SYMPTOM
. O

6. O
Gastroesophageal B-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
. O

7. O
History O
of O
salivary B-TREATMENT
gland I-TREATMENT
removal I-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PREOPERATIVE O
MEDICATIONS O
: O

1. O
Glucophage B-TREATMENT
XR O
1000 O
mg O
p.o. O
q. O
day O
. O

2. O
Avandia B-TREATMENT
4 O
mg O
p.o. O
q. O
day O
. O

3. O
Diovan B-TREATMENT
160 O
mg O
p.o. O
q. O
day O
. O

4. O
Atenolol B-TREATMENT
25 O
mg O
p.o. O
q. O
day O
. O

5. O
Lipitor B-TREATMENT
10 O
mg O
p.o. O
q. O
day O
. O

6. O
Niaspan B-TREATMENT
500 O
mg O
p.o. O
q. O
day O
. O

7. O
Enteric-coated B-TREATMENT
aspirin I-TREATMENT
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
Saint O
Vincent O
Hospital O
on O
2017-04-26 O
and O
underwent O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
four O
with O
left B-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
to I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
right I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
PDA I-TREATMENT
and O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
obtuse I-TREATMENT
marginal I-TREATMENT
with O
Dr. O
Rota O
. O

Please O
see O
the O
Operative O
Note O
for O
further O
details O
. O

The O
patient O
was O
transferred O
to O
the O
Intensive O
Care O
Unit O
in O
stable O
condition O
on O
Neo-Synephrine B-TREATMENT
infusion I-TREATMENT
. O

The O
patient O
was O
weaned O
the O
next O
day O
from O
mechanical B-TREATMENT
ventilation I-TREATMENT
on O
his O
first O
postoperative O
night O
. O

Postoperative O
days O
one O
and O
two O
, O
the O
patient O
continued O
to O
require O
Neo-Synephrine B-TREATMENT
to O
maintain O
systolic O
blood O
pressures O
greater O
than O
100 O
. O

On O
postoperative O
day O
two O
, O
the O
patient O
's O
hematocrit O
was O
noted O
to O
be O
23.1 O
; O
he O
was O
transfused O
one O
unit O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
as O
well O
as O
given O
a O
dose O
of O
Lasix B-TREATMENT
. O

The B-TREATMENT
Neo-Synephrine I-TREATMENT
was O
weaned O
off O
by O
postoperative O
day O
number O
three O
. O

The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
chest I-TREATMENT
tubes I-TREATMENT
were O
removed O
on O
postoperative O
day O
three O
without O
incident B-SYMPTOM
. O

The O
patient O
was O
started O
on O
low B-TREATMENT
dose I-TREATMENT
Lasix I-TREATMENT
and O
Lopressor B-TREATMENT
which O
he O
tolerated O
well O
. O

On O
postoperative O
day O
number O
four O
, O
the O
patient O
was O
transferred O
from O
the O
Intensive O
Care O
Unit O
to O
the O
regular O
part O
of O
the O
hospital O
where O
he O
began O
working O
with O
Physical O
Therapy O
and O
on O
his O
first O
session O
he O
was O
able O
to O
ambulate O
500 O
feet O
and O
climb O
one O
flight O
of O
stairs O
while O
remaining O
hemodynamically O
stable O
without O
requiring O
any B-TREATMENT
oxygen I-TREATMENT
. O

On O
postoperative O
day O
number O
five O
, O
the O
patient O
continued O
to O
remain O
hemodynamically O
stable O
. O

The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
epicardial I-TREATMENT
pacing I-TREATMENT
wires I-TREATMENT
were O
removed O
without O
incident B-SYMPTOM
and O
the O
patient O
was O
cleared O
for O
discharge O
to O
home O
. O

CONDITION O
ON O
DISCHARGE O
: O

Temperature O
maximum O
99.8 O
F. O
; O
pulse O
76 O
and O
sinus O
rhythm O
; O
blood O
pressure O
107/61 O
; O
respiratory O
rate O
18 O
; O
room O
air O
oxygen O
saturation O
95% O
. O

The O
patient O
's O
weight O
on O
05-01 O
was O
101.4 O
. O

The O
patient O
weighed O
100 O
kilograms O
preoperatively O
. O

LABORATORY O
DATA O
: O

White O
blood O
cell O
count O
5.8 O
, O
hematocrit O
23.5 O
, O
platelet O
count O
118 O
. O

Sodium O
140 O
, O
potassium O
3.9 O
, O
chloride O
103 O
, O
bicarbonate O
18 O
, O
BUN O
11 O
, O
creatinine O
0.8 O
, O
glucose O
144 O
. O

PT O
29 O
, O
INR O
1.1 O
and O
PTT O
22.9 O
. O

Neurologically O
, O
the O
patient O
is O
alert O
and O
oriented O
times O
three O
, O
anxious O
. O

Neurological O
examination O
is O
non-focal O
. O

Heart O
is O
regular O
rate O
and O
rhythm O
without O
rub B-SYMPTOM
or O
murmur B-SYMPTOM
. O

Respiratory O
breath O
sounds O
are O
clear O
bilaterally O
, O
decreased B-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
bases I-SYMPTOM
. O

Abdomen O
with O
positive O
bowel O
sounds O
, O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
tolerating O
a O
regular O
diet O
. O

Sternal B-TREATMENT
incision I-TREATMENT
staples I-TREATMENT
are O
intact O
and O
open O
to O
air O
. O

Incision B-SYMPTOM
is O
clean O
and O
dry O
. O

There O
is O
no O
erythema B-SYMPTOM
and O
sternum O
is O
stable O
. O

Right B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
vein I-SYMPTOM
harvest I-SYMPTOM
site I-SYMPTOM
has O
a O
moderate O
amount O
of O
ecchymosis B-SYMPTOM
at O
the O
very O
distal O
portion O
of O
the B-SYMPTOM
incision I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
ankle I-SYMPTOM
. O

There O
is O
a O
minimum O
amount O
of O
serosanguinous B-SYMPTOM
drainage I-SYMPTOM
. O

There O
is O
no O
erythema B-SYMPTOM
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

2. O
Status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
four O
. O

3. O
Type B-SYMPTOM
2 I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

4. O
Postoperative B-SYMPTOM
anemia I-SYMPTOM
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Atenolol B-TREATMENT
25 O
mg O
p.o. O
q. O
day O
. O

2. O
Lasix B-TREATMENT
20 O
mg O
p.o. O
q. O
day O
times O
seven O
days O
. O

3. O
Potassium B-TREATMENT
chloride I-TREATMENT
20 O
mEq O
p.o. O
q. O
day O
times O
seven O
days O
. O

4. O
Niferex B-TREATMENT
150 O
mg O
p.o. O
q. O
day O
times O
one O
month O
. O

5. O
Vitamin B-TREATMENT
C I-TREATMENT
500 O
mg O
p.o. O
twice O
a O
day O
times O
one O
month O
. O

6. O
Multivitamin B-TREATMENT
one O
p.o. O
q. O
day O
times O
one O
month O
. O

7. O
Ambien B-TREATMENT
5 O
mg O
p.o. O
q. O
h.s. O
p.r.n. O

8. O
Colace B-TREATMENT
100 O
mg O
p.o. O
twice O
a O
day O
. O

9. O
Avandia B-TREATMENT
4 O
mg O
p.o. O
q. O
day O
. O

10. O
Glucophage B-TREATMENT
500 O
mg O
p.o. O
twice O
a O
day O
. O

11. O
Lipitor B-TREATMENT
20 O
mg O
p.o. O
q. O
day O
. O

12. O
Zantac B-TREATMENT
150 O
mg O
p.o. O
twice O
a O
day O
. O

13. O
Niaspan B-TREATMENT
500 O
mg O
p.o. O
q. O
day O
. O

14. O
Percocet B-TREATMENT
5/325 O
one O
to O
two O
p.o. O
q. O
four O
to O
six O
hours O
p.r.n. O

DISPOSITION O
: O

The O
patient O
is O
to O
be O
discharged O
to O
home O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
condition O
. O

DISCHARGE O
INSTRUCTIONS O
: O

1. O
The O
patient O
is O
to O
follow-up O
with O
Dr. O
Neri O
in O
one O
to O
two O
weeks O
. O

2. O
The O
patient O
is O
to O
follow-up O
with O
Dr. O
Rota O
in O
three O
to O
four O
weeks O
. O

3. O
The O
patient O
is O
to O
return O
to O
Smith O
on O
or O
about O
05-17 O
to O
have O
his B-TREATMENT
staples I-TREATMENT
removed O
. O

Gabriela O
E. O
D. O
Castillo O
, O
M.D. O
05-025 O

Dictated O
By O
: O
Julia O
Q O
Mcafee O
, O
M.D. O

MEDQUIST36 O

D O
: O
2017-05-01 O
15:06 O

T O
: O
2017-05-01 O
15:37 O

JOB O
# O
: O
59432 O

Signed O
electronically O
by O
: O
DR. O
Kathy O
Brendel O
on O
: O
TUE O
2017-05-02 O
8:08 O
AM O

( O
End O
of O
Report O
) O

708632336 O
YC O

32343989 O

0527629 O

10/14/2004 O
12:00:00 O
AM O

PELVIC B-SYMPTOM
MASS I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

10/14/2004 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

10/17/2004 O

ATTENDING O
: O

NAEELV O
CRUTCH O
MD O

PRINCIPAL O
DIAGNOSIS O
: O

Pelvic B-SYMPTOM
mass I-SYMPTOM
, O
benign B-SYMPTOM
mucinous I-SYMPTOM
cystadenoma I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Total B-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
, O
right B-TREATMENT
lymph I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
, O
appendectomy B-TREATMENT
, O
omental O
biopsy O
, O
and O
pelvic B-TREATMENT
washings I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
56-year-old O
menopausal O
female O
G3 O
, O
P3 O
who O
presented O
initially O
for O
evaluation O
of O
a B-SYMPTOM
pelvic I-SYMPTOM
mass I-SYMPTOM
while O
recently O
vacationing O
in O
An O
Saintcafield O
Terland O
. O

She O
had O
a O
physical O
over O
there O
, O
and O
the O
evaluation O
included O
an O
ultrasound O
which O
showed O
an B-SYMPTOM
ovarian I-SYMPTOM
mass I-SYMPTOM
. O

She O
was O
seen O
in O
the O
emergency O
room O
here O
on O
08/31/04 O
where O
they O
performed O
an O
abdominal O
CT O
that O
showed O
a B-SYMPTOM
14 I-SYMPTOM
x I-SYMPTOM
14 I-SYMPTOM
x I-SYMPTOM
10 I-SYMPTOM
cm I-SYMPTOM
pelvic I-SYMPTOM
mass I-SYMPTOM
with O
multiple B-SYMPTOM
enlarged I-SYMPTOM
lymph I-SYMPTOM
nodes I-SYMPTOM
. O

The O
patient O
was O
thus O
sent O
to O
GYN O
for O
further O
workup O
and O
is O
now O
here O
for O
surgical B-TREATMENT
management I-TREATMENT
of O
pelvic B-SYMPTOM
mass I-SYMPTOM
. O

Her O
CA-125 O
is O
9 O
. O

PAST O
MEDICAL O
HISTORY O
: O

None O
. O

PAST O
SURGICAL O
HISTORY O
: O

Tubal B-TREATMENT
ligation I-TREATMENT
. O

PAST O
OBSTETRICAL O
HISTORY O
: O

G3 O
, O
P3 O
, O
spontaneous B-TREATMENT
vaginal I-TREATMENT
delivery I-TREATMENT
x3 O
. O

MEDICATIONS O
: O

None O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

Denies O
tobacco O
, O
alcohol O
or O
drug O
use O
. O

Married O
, O
lives O
with O
husband O
, O
denies O
domestic O
violence O
. O

FAMILY O
HISTORY O
: O

No O
history O
of O
GYN B-SYMPTOM
, O
cancers B-SYMPTOM
, O
or O
breast B-SYMPTOM
cancer I-SYMPTOM
. O

REVIEW O
OF O
SYSTEMS O
: O

Negative O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
taken O
to O
the O
operating O
room O
on O
hospital O
day O
# O
1 O
where O
she O
underwent O
an B-TREATMENT
uncomplicated I-TREATMENT
total I-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
, O
bilateral B-TREATMENT
salpingo-oophorectomy I-TREATMENT
, O
right B-TREATMENT
lymph I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
, O
appendectomy B-TREATMENT
, O
omental O
biopsy O
, O
pelvic B-TREATMENT
washings I-TREATMENT
, O
and O
Pap B-TREATMENT
of I-TREATMENT
the I-TREATMENT
diaphragm I-TREATMENT
. O

An B-SYMPTOM
estimated I-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
was O
100 O
cc O
. O

At O
the O
time O
of O
surgery B-TREATMENT
, O
frozen O
section O
revealed O
benign B-SYMPTOM
mucinous I-SYMPTOM
cystadenoma I-SYMPTOM
. O

By O
postoperative O
day O
#3 O
, O
the O
patient O
was O
tolerating O
p.o.&apos; O
s O
, O
tolerating O
oral B-TREATMENT
pain I-TREATMENT
medications I-TREATMENT
, O
ambulating O
, O
passing O
flatus O
, O
and O
having O
a O
bowel O
movement O
. O

She O
was O
voiding O
without O
difficulty O
. O

Her O
hematocrit O
preoperatively O
was O
36 O
and O
postoperatively O
was O
33 O
and O
then O
32 O
. O

The O
patient O
did O
have O
some B-SYMPTOM
tachycardia I-SYMPTOM
postoperatively I-SYMPTOM
; O
however O
, O
her O
hematocrit O
remained O
stable O
. O

She O
was O
asymptomatic B-SYMPTOM
, O
and O
her O
EKG O
was O
within O
normal O
limits O
. O

Her B-SYMPTOM
tachycardia I-SYMPTOM
improved O
. O

Throughout O
this O
time O
, O
she O
had O
normal O
vital O
signs O
with O
a O
normal O
O2 O
saturation O
. O

DISPOSITION O
AND O
DISCHARGE O
MEDICATIONS O
: O

She O
was O
discharged O
home O
in O
stable O
condition O
with O
prescriptions O
for O
Colace B-TREATMENT
, O
Motrin B-TREATMENT
and O
Percocet B-TREATMENT
as O
needed O
. O

FOLLOW O
UP O
: O

She O
will O
follow O
up O
with O
Dr. O
Crutch O
in O
two O
weeks O
. O

She O
was O
again O
discharged O
home O
in O
stable O
condition O
. O

eScription O
document O
: O

2-8707232 O
WEBCtug O
Tel O

Dictated O
By O
: O

JAQUENATHE O
, O
MYA O

Attending O
: O

CRUTCH O
, O
NAEELV O
Dictation O
ID O
8975259 O

D O
: O

10/17/04 O

T O
: O

10/17/04 O

963005114 O

FIH O

1704696 O

04773/k096 O

064394 O

5/3/1993 O
12:00:00 O
AM O

ADULT B-SYMPTOM
RESPIRATORY I-SYMPTOM
DISTRESS I-SYMPTOM
SYNDROME I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

5-3-93 O

DISCHARGE O
DATE O
: O

5-12-93 O

PRINCIPAL O
DIAGNOSIS O
: O

Adult B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
, O
tracheostomy B-TREATMENT
status O
, O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Stain O
was O
transferred O
from O
the O
Oreiewlefell O
Merkane O
I O
Penaltbridgesgreat O
University O
Medical O
Center O
for O
progressive B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
and O
adult B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
superimposed O
on O
a O
history O
of O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
, O
perhaps O
asthma B-SYMPTOM
, O
and O
ulcerative B-SYMPTOM
colitis I-SYMPTOM
. O

His O
only O
positive O
result O
was O
a O
sputum O
culture O
for O
Pseudomonas B-SYMPTOM
and O
this O
came O
after O
he O
had O
already O
been O
on O
antibiotics B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

The O
physical O
examination O
on O
transfer O
showed O
an O
alert O
male O
with O
temperature O
100 O
degrees O
, O
blood O
pressure O
120/64 O
, O
heart O
rate O
80 O
. O

He O
was O
intubated B-TREATMENT
with O
pressor B-TREATMENT
support I-TREATMENT
of O
25 O
, O
and O
PEEP B-TREATMENT
of O
12.5 O
with O
70% O
FIO2 B-TREATMENT
. O

Tracheostomy B-TREATMENT
tube I-TREATMENT
was O
in O
good O
position O
. O

There O
was O
an B-SYMPTOM
audible I-SYMPTOM
air I-SYMPTOM
leak I-SYMPTOM
. O

His O
chest O
showed O
bilateral B-SYMPTOM
rhonchi I-SYMPTOM
. O

The O
abdomen O
was O
distended B-SYMPTOM
with O
active O
bowel O
sounds O
. O

The O
rectal O
examination O
was O
unremarkable O
. O

Extremities O
showed O
trace B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
. O

LABORATORY O
DATA O
: O

A O
chest O
X-ray O
showed O
diffuse B-SYMPTOM
bilateral I-SYMPTOM
alveolar I-SYMPTOM
infiltrates I-SYMPTOM
, O
greater O
in O
the O
lower O
lung O
fields O
than O
in O
the O
upper O
. O

The O
EKG O
showed O
normal O
sinus O
rhythm O
at O
83 O
, O
with O
an O
11 O
degree O
axis O
, O
non-specific B-SYMPTOM
ST-T I-SYMPTOM
wave I-SYMPTOM
changes I-SYMPTOM
. O

The O
sputum O
Gram O
stain O
showed O
a B-SYMPTOM
few I-SYMPTOM
polys I-SYMPTOM
and O
no O
organisms B-SYMPTOM
. O

The O
blood O
gas O
showed O
a O
pO2 O
of O
56 O
, O
pCO2 O
of O
48 O
and O
pH O
of O
7.47 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
seen O
in O
consultation O
by O
Dr. O
Wire O
who O
felt O
that O
manipulation B-TREATMENT
of I-TREATMENT
the I-TREATMENT
tracheal I-TREATMENT
tube I-TREATMENT
was O
the O
best O
approach O
to O
the B-SYMPTOM
air I-SYMPTOM
leak I-SYMPTOM
since O
it O
was O
a B-TREATMENT
new I-TREATMENT
trach I-TREATMENT
and O
he O
was O
requiring O
such O
high B-TREATMENT
ventilator I-TREATMENT
support I-TREATMENT
that O
it O
was O
risky O
to O
change O
it O
. O

He O
also O
felt O
that O
lung O
biopsy O
at O
this O
time O
was O
rather O
risky O
. O

The O
patient O
was O
therefore O
completely O
cultured O
again O
and O
begun O
on O
antibiotic B-TREATMENT
coverage I-TREATMENT
which O
would O
take O
care O
of O
the B-SYMPTOM
Pseudomonas I-SYMPTOM
he O
was O
known O
to O
have O
. O

The B-TREATMENT
steroids I-TREATMENT
were O
tapered O
. O

He O
was O
also O
begun O
on O
anti-Candida B-TREATMENT
regimen I-TREATMENT
for O
his B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
with O
yeast B-SYMPTOM
being O
seen O
. O

Because O
of O
the O
story O
of O
hemoptysis B-SYMPTOM
, O
he O
also O
underwent O
an O
exotic O
bleeding O
work O
up O
for O
such O
things O
as O
Wegner B-SYMPTOM
&apos;s I-SYMPTOM
and O
Goodpasture B-SYMPTOM
&apos;s I-SYMPTOM
. O

These O
results O
were O
all O
negative O
. O

He O
continued O
to O
require O
very B-TREATMENT
high I-TREATMENT
FIO2 I-TREATMENT
. O

He O
was O
found O
to O
have O
a B-SYMPTOM
DVT I-SYMPTOM
by O
ultrasound O
. O

He O
underwent O
a B-TREATMENT
trial I-TREATMENT
of I-TREATMENT
TPA I-TREATMENT
followed O
by O
heparin B-TREATMENT
. O

This O
produced O
substantially B-SYMPTOM
further I-SYMPTOM
hemoptysis I-SYMPTOM
and O
the O
need O
for O
transfusion B-TREATMENT
. O

He O
stabilized O
from O
this O
, O
but O
on O
the O
fifth O
while O
continuing O
to O
have O
extremely B-SYMPTOM
ventilator I-SYMPTOM
requirement I-SYMPTOM
. O

In O
consultation O
with O
his O
family O
, O
it O
was O
decided O
that O
enough O
support O
had O
been O
done O
. O

At O
that O
time O
, O
therefore O
, O
ventilator B-TREATMENT
support I-TREATMENT
was O
withdrawn O
under O
the B-TREATMENT
comfort I-TREATMENT
measures I-TREATMENT
of O
morphine B-TREATMENT
. O

STAIN O
J. O
A O
, O
M.D. O

TR O
: O

sj O
/ O
bmot O

DD O
: O

6-4-93 O

TD O
: O

06/05/93 O

CC O
: O

333145593 O

FIH O

9229891 O

50096/c65m O

571634 O

12/5/1993 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

12/05/93 O

DISCHARGE O
DATE O
: O

12/17/93 O

CAUSE O
OF O
DEATH O
: O

Cardiogenic B-SYMPTOM
shock I-SYMPTOM
. O

CAUSATIVE O
FACTORS O
: O

Including O
cardiomyopathy B-SYMPTOM
, O
aortic B-SYMPTOM
stenosis I-SYMPTOM
, O
status O
post O
aortic B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
with O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
and O
pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
65 O
year O
old O
male O
who O
sustained O
a B-SYMPTOM
small I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
first O
in O
1978 O
, O
with O
course O
thereafter O
including O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
by O
Dr. O
Wierst O
______________at O
Noughwell O
Entanbon O
Health O
in O
1986 O
. O

In O
1991 O
he O
presented O
with O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
and O
he O
underwent O
porcine B-TREATMENT
aortic I-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
. O

In O
the O
seven O
to O
eight O
months O
preceding O
admission O
, O
he O
developed O
recurrent B-SYMPTOM
angina I-SYMPTOM
with O
dyspnea B-SYMPTOM
on O
exertion O
. O

The O
patient O
was O
admitted O
for O
cardiac O
catheterization O
in O
early O
December O
, O
1993 O
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
for O
vertebrobasilar B-SYMPTOM
insufficiency I-SYMPTOM
, O
bipolar B-SYMPTOM
mood I-SYMPTOM
disorder I-SYMPTOM
, O
and O
hypercholesterolemia B-SYMPTOM
, O
as O
well O
as O
some B-SYMPTOM
baseline I-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Procardia B-TREATMENT
sustained I-TREATMENT
release I-TREATMENT
60 O
mg. O
po O
q.day O
, O
Digoxin B-TREATMENT
.25 O
mg. O
po O
q.day O
, O
Lasix B-TREATMENT
30 O
mg. O
( O
interval O
unspecified O
) O
, O
Prozac B-TREATMENT
40 O
mg. O
po O
q.day O
, O
Lovestatin B-TREATMENT
20 O
mg. O
po O
bid O
, O
aspirin B-TREATMENT
q. O
day O
and O
supplemental B-TREATMENT
potassium I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

Remarkable O
for O
an O
oriented O
, O
alert O
male O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
with O
decreased B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
base I-SYMPTOM
consistent O
with O
effusion B-SYMPTOM
and O
a B-SYMPTOM
3/6 I-SYMPTOM
systolic I-SYMPTOM
murmur I-SYMPTOM
consistent O
with O
aortic B-SYMPTOM
stenosis I-SYMPTOM
. O

His O
pulse O
exam O
was O
intact O
. O

Cardiac O
catheterization O
demonstrated O
elevated B-SYMPTOM
right I-SYMPTOM
and I-SYMPTOM
left-sided I-SYMPTOM
filling I-SYMPTOM
pressures I-SYMPTOM
at O
rest O
, O
with O
pulmonary B-SYMPTOM
hypertension I-SYMPTOM
and O
normal O
cardiac O
index O
. O

There O
was O
severe B-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM
of O
70 O
millimeter O
peak O
gradient O
, O
native B-SYMPTOM
three I-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
with O
patent B-TREATMENT
left I-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
left I-TREATMENT
circumflex I-TREATMENT
, O
dissection B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
main I-SYMPTOM
was O
induced O
by O
the B-TREATMENT
catheter I-TREATMENT
tip I-TREATMENT
. O

A B-TREATMENT
patent I-TREATMENT
right I-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
to I-TREATMENT
the I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
artery I-TREATMENT
and I-TREATMENT
diagonal I-TREATMENT
was O
noted O
, O
and O
a B-TREATMENT
patent I-TREATMENT
saphenous I-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
posterior I-TREATMENT
descending I-TREATMENT
artery I-TREATMENT
was O
present O
. O

Also O
of O
note O
, O
pulmonary B-SYMPTOM
edema I-SYMPTOM
was O
induced O
by O
dye B-TREATMENT
and O
anxiety B-SYMPTOM
and O
treated O
with O
Lasix B-TREATMENT
, O
Morphine B-TREATMENT
, O
oxygen B-TREATMENT
and O
nitroglycerin B-TREATMENT
. O

Post-procedure O
he O
was O
admitted O
to O
the O
CCU O
because O
of O
the O
history O
of O
left B-SYMPTOM
main I-SYMPTOM
dissection I-SYMPTOM
. O

He O
remained O
hemodynamically O
stable O
but O
of O
note O
, O
would O
not O
tolerate O
a O
transesophageal O
echo O
because O
of O
anxiety-he B-SYMPTOM
would O
not O
swallow O
the B-TREATMENT
probe I-TREATMENT
. O

Transthoracic O
echo O
demonstrated O
gradients O
of O
100 O
peak O
and O
65 O
mean O
across O
the O
aortic O
valve O
and O
there O
was O
mild B-SYMPTOM
aortic I-SYMPTOM
insufficiency I-SYMPTOM
and O
ejection O
fraction O
was O
noted O
to O
be O
18% O
with O
global B-SYMPTOM
hypokinesis I-SYMPTOM
. O

The O
next O
several O
days O
were O
remarkable O
for O
events O
in O
which O
the O
patient O
was O
quite B-SYMPTOM
agitated I-SYMPTOM
and O
was O
evaluated O
by O
Psychiatry O
and O
treated O
with O
Ativan B-TREATMENT
. O

The O
patient O
was O
then O
evaluated O
by O
Cardiac O
Surgery O
for O
probable O
re-do B-TREATMENT
aortic I-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
and O
possible O
re-do B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

In O
the O
course O
of O
preoperative O
workup O
, O
Mr. O
Has O
was O
evaluated O
completely O
by O
Psychiatry O
with O
diagnoses O
including O
underlying B-SYMPTOM
chronic I-SYMPTOM
depression I-SYMPTOM
well-controlled O
on O
Prozac B-TREATMENT
, O
underlying B-SYMPTOM
organ I-SYMPTOM
brain I-SYMPTOM
vulnerability I-SYMPTOM
of O
unclear O
etiology O
, O
possibly O
microvascular B-SYMPTOM
infarct I-SYMPTOM
, O
acute B-SYMPTOM
paranoid I-SYMPTOM
and I-SYMPTOM
belligerent I-SYMPTOM
behavior I-SYMPTOM
, O
possibly O
due O
to O
medications B-TREATMENT
. O

On O
December O
12 O
the O
patient O
underwent O
surgery B-TREATMENT
, O
including O
a B-TREATMENT
re-do I-TREATMENT
aortic I-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
with O
# B-TREATMENT
25 I-TREATMENT
St. I-TREATMENT
Jude I-TREATMENT
and O
re-do B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
times I-TREATMENT
one I-TREATMENT
; O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
posterior I-TREATMENT
descending I-TREATMENT
artery I-TREATMENT
as O
a B-TREATMENT
veno-venous I-TREATMENT
jump I-TREATMENT
graft I-TREATMENT
. O

The O
total O
bypass O
time O
: O

2 O
hours O
25 O
minutes O
. O

Total O
crossclamp O
time O
: O

1 O
hour O
and O
48 O
minutes O
. O

The O
patient O
was O
admitted O
to O
the O
Surgical O
Intensive O
Care O
Unit O
postoperatively O
with O
stable O
hemodynamics O
on O
Lidocaine B-TREATMENT
at O
one O
, O
Dobutamine B-TREATMENT
at O
200 O
and O
Nipride B-TREATMENT
. O

The O
patient O
was O
extubated O
by O
postoperative O
day O
# O
1 O
but O
was O
noted O
to O
be O
relatively B-SYMPTOM
hypoxemic I-SYMPTOM
with O
high B-SYMPTOM
oxygen I-SYMPTOM
requirement I-SYMPTOM
. O

Chest O
x-ray O
demonstrating O
pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

Aggressive B-TREATMENT
diuresis I-TREATMENT
was O
undertaken O
and O
the O
patient O
responded O
, O
albeit O
sluggishly O
. O

In O
addition O
, O
he O
remained O
agitated B-SYMPTOM
. O

This O
was O
attributed O
to O
mild B-SYMPTOM
hypoxia I-SYMPTOM
and O
/ O
or O
his B-SYMPTOM
underlying I-SYMPTOM
psychiatric I-SYMPTOM
diagnoses I-SYMPTOM
and O
he O
was O
treated O
with O
Haldol B-TREATMENT
appropriately O
. O

On O
day O
# O
2 O
the O
patient O
continued O
to O
diurese O
and O
this O
was O
maintained O
with O
the B-TREATMENT
Lasix/ I-TREATMENT
Mannitol I-TREATMENT
infusion I-TREATMENT
. O

His O
urine O
output O
remained O
at O
150 O
to O
200 O
cc. O
an O
hour O
. O

Despite O
this O
, O
his O
chest O
x-ray O
continued O
to O
show O
severe B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
and O
the O
clinical O
picture O
correlated O
. O

He O
required O
anti-hypertensive B-TREATMENT
therapy I-TREATMENT
initially O
with O
Nipride B-TREATMENT
which O
was O
changed O
to O
Hydralazine B-TREATMENT
to O
avoid O
shunting B-SYMPTOM
. O

He O
received O
several O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
to O
increase O
his O
hematocrit O
and O
oncotic O
pressure O
. O

Very O
early O
in O
the O
morning O
on O
postoperative O
day O
# O
3 O
, O
the O
patient O
became O
acutely B-SYMPTOM
hypoxic I-SYMPTOM
after O
several O
hours O
of O
marginal B-SYMPTOM
oxygenation I-SYMPTOM
with O
respiratory O
rates O
in O
the O
thirties O
and O
the O
patient O
was O
urgently O
intubated O
, O
without O
complication B-SYMPTOM
. O

With O
positive B-TREATMENT
pressure I-TREATMENT
ventilation I-TREATMENT
and O
continued B-TREATMENT
diuresis I-TREATMENT
, O
his O
arterial O
blood O
gases O
improved O
. O

Throughout O
this O
he O
remained O
hemodynamically O
stable O
. O

Exception O
was O
a O
ten O
beat O
run O
of O
ventricular B-SYMPTOM
tachycardia I-SYMPTOM
which O
was O
thought O
to O
be O
ischemic B-SYMPTOM
in O
origin O
and O
treated O
with O
nitrates B-TREATMENT
and O
Lidocaine B-TREATMENT
. O

His O
chest O
x-ray O
blossomed O
to O
demonstrate O
pulmonary B-SYMPTOM
infiltrate I-SYMPTOM
and O
the O
patient O
began O
to O
produce O
sputum B-SYMPTOM
. O

Infectious O
Disease O
consultation O
was O
obtained O
for O
evaluation O
of O
his B-SYMPTOM
purulent I-SYMPTOM
sputum I-SYMPTOM
and O
the O
patient O
was O
covered O
with O
Vancomycin B-TREATMENT
, O
Ceftazidime B-TREATMENT
and O
Gentamicin B-TREATMENT
. O

Cardiology O
evaluation O
commented O
on O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
increasing I-SYMPTOM
ventricular I-SYMPTOM
ectopy I-SYMPTOM
and O
suggested O
that O
these O
were O
due O
to O
an B-SYMPTOM
R I-SYMPTOM
and I-SYMPTOM
T I-SYMPTOM
phenomenon I-SYMPTOM
from O
his B-TREATMENT
pacer I-TREATMENT
in O
the O
setting O
of O
prolonged B-SYMPTOM
QT I-SYMPTOM
interval I-SYMPTOM
. O

Consequently O
his B-TREATMENT
Pronestyl I-TREATMENT
was O
discontinued O
. O

In O
addition O
, O
the O
patient O
was O
given O
magnesium B-TREATMENT
to O
bring O
his O
level O
above O
2 O
. O

On O
the O
evening O
of O
the O
18th O
, O
the O
patient O
continued O
to O
remain O
hemodynamically O
stable O
, O
although O
his O
oxygenation O
was O
clearly O
deteriorating O
and O
more O
marginal O
. O

On O
60% O
FIO2 B-TREATMENT
his O
pO2 O
was O
63 O
. O

It O
was O
increased O
to O
65% O
with O
pO2 O
of O
81 O
. O

At O
approximately O
7:50 O
a.m. O
, O
house O
officer O
was O
called O
to O
the O
room O
for O
blood O
pressure O
of O
70/40 O
with O
falling B-SYMPTOM
oxygen I-SYMPTOM
saturations I-SYMPTOM
. O

The O
patient O
was O
immediately O
given O
400 O
mg. O
of O
Calcium B-TREATMENT
Chloride I-TREATMENT
i.v. I-TREATMENT
push I-TREATMENT
and O
ventilator B-TREATMENT
disconnected O
and O
the O
patient O
manually B-TREATMENT
ventilated I-TREATMENT
. O

Within O
one O
minute O
, O
the O
patient O
lost O
his O
blood O
pressure O
and O
CPR B-TREATMENT
was O
initiated O
and O
code O
was O
called O
. O

The O
patient O
initially O
continued O
to O
have O
rhythm O
consistent O
with O
EMV B-SYMPTOM
and O
he O
was O
bolused O
with O
Levophed B-TREATMENT
and O
given O
some O
volume O
while O
compressions B-TREATMENT
continued O
. O

The O
patient O
&apos;s O
prothrombin O
time O
had O
been O
23 O
early O
the O
same O
morning O
and O
tamponade B-SYMPTOM
was O
considered O
and O
thoracotomy B-TREATMENT
instruments I-TREATMENT
obtained O
. O

The O
chest O
was O
opened O
partially O
and O
through O
sub-xyphoid O
area O
it O
was O
determined O
that O
there O
was O
no O
evidence O
of O
tamponade B-SYMPTOM
. O

Compressions B-TREATMENT
were O
continued O
and O
adequate O
pulse O
was O
felt O
and O
arterial O
blood O
gases O
demonstrated O
adequate O
oxygenation O
and O
perfusion O
. O

The O
patient O
&apos;s O
rhythm O
degenerated O
to O
ventricular B-SYMPTOM
tachycardia I-SYMPTOM
and O
he O
was O
shocked O
, O
initially O
without O
response O
but O
after O
several O
doses O
of O
Epinephine B-TREATMENT
, O
one-half O
mg. O
of O
Atropine B-TREATMENT
and O
a O
bolus O
of O
Lidocaine B-TREATMENT
we O
were O
able O
to O
obtain O
a O
blood O
pressure O
and O
rhythm O
only O
briefly O
, O
and O
quickly O
deteriorated O
back O
to O
ventricular B-SYMPTOM
fibrillation I-SYMPTOM
. O

Further O
attempts O
at O
resuscitation B-TREATMENT
were O
unsuccessful O
and O
the O
patient O
was O
pronounced O
dead O
at O
8:30 O
a.m. O

The O
family O
has O
been O
notified O
and O
autopsy O
consent O
has O
been O
obtained O
. O

LENNI O
BREUTZOLN O
, O
M.D. O

TR O
: O

bp O
/ O
bmot O

DD O
: O

12/17/93 O

TD O
: O

12/18/93 O

CC O
: O

G O
Hemp O
, O
M.D. O
Taarnna O
Has O
, O
M.D. O

Admission O
Date O
: O

2009-11-10 O

Discharge O
Date O
: O

2009-11-12 O

Date O
of O
Birth O
: O

1948-10-16 O

Sex O
: O

M O

Service O
: O

CCU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
61 O
- O
year-old O
white O
male O
with O
a O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
5-vessel B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
on O
2009-09-11 O
, O
who O
presents O
for O
elective O
right O
heart O
catheterization O
and O
pericardiocentesis B-TREATMENT
. O

The O
patient O
did O
well O
after O
his B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

On O
10-14 O
, O
the O
patient O
had O
a O
transthoracic O
echocardiogram O
which O
revealed O
a B-SYMPTOM
new I-SYMPTOM
, I-SYMPTOM
moderate-to-large I-SYMPTOM
sized I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
. O

The O
patient O
was O
asymptomatic B-SYMPTOM
at O
this O
time O
, O
and O
the O
decision O
was O
made O
to O
monitor O
him O
and O
to O
start O
him O
on O
Lasix B-TREATMENT
. O

The O
patient O
had O
follow-up O
transthoracic O
echocardiogram O
on O
11-04 O
which O
revealed O
a B-SYMPTOM
slightly I-SYMPTOM
large I-SYMPTOM
effusion I-SYMPTOM
. O

A O
few O
days O
later O
, O
on O
11-07 O
, O
the O
patient O
began O
to O
develop O
dyspnea B-SYMPTOM
on O
exertion O
with O
normal O
activity O
. O

He O
also O
noted O
a B-SYMPTOM
new I-SYMPTOM
two I-SYMPTOM
to I-SYMPTOM
three-pillow I-SYMPTOM
orthopnea I-SYMPTOM
and O
paroxysmal B-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
. O

On O
11-08 O
, O
he O
had O
an O
episode O
of O
acute B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
with O
chest B-SYMPTOM
pressure I-SYMPTOM
which O
he O
describes O
as O
different O
from O
his B-SYMPTOM
typical I-SYMPTOM
angina I-SYMPTOM
with O
minimal O
exertion O
. O

The O
patient O
spoke O
with O
his O
cardiologist O
who O
referred O
him O
for O
pericardiocentesis B-TREATMENT
for O
persistent B-SYMPTOM
and I-SYMPTOM
symptomatic I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
. O

On O
right O
heart O
catheterization O
, O
the O
patient O
was O
noted O
to O
have O
elevated B-SYMPTOM
right-sided I-SYMPTOM
and I-SYMPTOM
left-sided I-SYMPTOM
filling I-SYMPTOM
pressures I-SYMPTOM
with O
a O
pulmonary O
capillary O
wedge O
pressure O
of O
19 O
and O
a O
right O
atrial O
pressure O
of O
16 O
. O

After O
600 O
cc O
of O
serosanguineous B-SYMPTOM
pericardial I-SYMPTOM
fluid I-SYMPTOM
was O
removed O
, O
the O
patient O
was O
noted O
to O
have O
a O
pulmonary O
capillary O
wedge O
pressure O
of O
9 O
and O
a O
right O
atrial O
pressure O
of O
2 O
; O
indicating O
resolution O
of O
tamponade B-SYMPTOM
physiology I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
5-vessel B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
on O
2009-09-11 O
. O

Left O
internal O
mammary O
artery O
to O
left O
anterior O
descending O
artery O
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to O
left O
anterior O
descending O
artery O
to O
diagonal O
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to O
right O
posterior O
descending O
artery O
, O
and O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to O
first O
obtuse O
marginal O
. O

2. O
Type B-SYMPTOM
1 I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
for O
50 O
years O
. O

3. O
Hypercholesterolemia B-SYMPTOM
. O

4. O
Hypertension B-SYMPTOM
. O

5. O
Chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
with O
a O
baseline O
creatinine O
of O
1.1 O
to O
1.4 O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
has O
a O
positive O
tobacco O
history O
, O
but O
he O
quit O
smoking O
over O
20 O
years O
ago O
. O

He O
is O
married O
and O
lives O
in O
Burbank O
Hospital O
. O

He O
has O
retired O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Atenolol B-TREATMENT
50 O
mg O
p.o. O
q.d. O
, O
Lipitor B-TREATMENT
10 O
mg O
p.o. O
q.d. O
, O
baby B-TREATMENT
aspirin I-TREATMENT
81 O
mg O
p.o. O
q.d. O
, O
iron B-TREATMENT
sulfate I-TREATMENT
81 O
mg O
p.o. O
q.d. O
, O
Lasix B-TREATMENT
40 O
mg O
p.o. O
q.d. O
, O
Accupril B-TREATMENT
40 O
mg O
p.o. O
q.d. O
, O
hydrochlorothiazide B-TREATMENT
12.5 O
mg O
p.o. O
q.d. O
, O
NPH B-TREATMENT
insulin I-TREATMENT
18 O
units O
q.a.m. O
and O
10 O
units O
q.p.m. O
, O
Humalog B-TREATMENT
sliding-scale I-TREATMENT
q.a.m. O
and O
q.p.m. O

PHYSICAL O
EXAMINATION O
ON O
PRESENTATION O
: O

The O
patient O
had O
a O
temperature O
of O
100.9 O
. O

He O
had O
a O
blood O
pressure O
of O
148 O
to O
162/45 O
to O
54 O
. O

He O
had O
a O
heart O
rate O
of O
85 O
to O
87 O
, O
breathing O
at O
17 O
to O
23 O
, O
satting O
100% O
on O
room O
air O
. O

In O
general O
, O
he O
was O
alert O
and O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

His O
neck O
was O
supple O
without O
any B-SYMPTOM
jugular I-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
. O

HEENT O
examination O
revealed O
his O
pupils O
were O
equal O
, O
round O
, O
and O
reactive O
to O
light O
. O

His O
extraocular O
movements O
were O
intact O
. O

His O
sclerae O
were O
anicteric B-SYMPTOM
. O

His O
mucous O
membranes O
were O
moist O
. O

His O
oropharynx O
was O
benign O
. O

Cardiovascular O
revealed O
a O
regular O
rate O
and O
rhythm O
, O
heart B-SYMPTOM
sounds I-SYMPTOM
muffled I-SYMPTOM
, O
no O
murmurs B-SYMPTOM
. O

Respiratory O
revealed O
bibasilar B-SYMPTOM
rales I-SYMPTOM
. O

Abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
and O
nondistended B-SYMPTOM
, O
positive O
bowel O
sounds O
. O

Extremities O
revealed O
trace B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
, O
right O
greater O
than O
left O
, O
2+ O
dorsalis O
pedis O
and O
posterior O
tibialis O
pulses O
. O

He O
had O
2+ O
femoral O
pulses O
bilaterally O
. O

No O
hematomas B-SYMPTOM
were O
noted O
, O
but O
a B-SYMPTOM
soft I-SYMPTOM
right I-SYMPTOM
femoral I-SYMPTOM
bruit I-SYMPTOM
was O
heard O
. O

LABORATORY O
DATA O
ON O
PRESENTATION O
: O

The O
patient O
had O
a O
white O
blood O
cell O
count O
of O
9.5 O
, O
a O
hematocrit O
of O
34.5 O
, O
a O
platelet O
count O
of O
194 O
. O

His O
Chem-7 O
revealed O
sodium O
of O
132 O
, O
potassium O
of O
43 O
, O
chloride O
of O
97 O
, O
bicarbonate O
of O
28 O
, O
BUN O
of O
25 O
, O
creatinine O
of O
1.3 O
, O
glucose O
of O
220 O
. O

He O
had O
an O
INR O
of O
1.1 O
. O

A O
calcium O
of O
8.4 O
, O
phosphate O
of O
2.5 O
, O
magnesium O
of O
1.9 O
. O

Pericardial O
fluid O
analysis O
was O
consistent O
with O
an B-SYMPTOM
exudative I-SYMPTOM
etiology I-SYMPTOM
. O

RADIOLOGY O
/ O
IMAGING O
: O

The O
patient O
had O
an O
electrocardiogram O
with O
normal O
sinus O
rhythm O
at O
70 O
, O
normal O
axis O
, O
normal O
intervals O
, O
low B-SYMPTOM
voltage I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
limb I-SYMPTOM
leads I-SYMPTOM
. O

Chest O
x-ray O
on O
admission O
revealed O
a B-SYMPTOM
large I-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

The O
patient O
had O
an O
echocardiogram O
on O
11-10 O
which O
revealed O
the O
following O
: O

Global O
left O
ventricular O
systolic O
function O
appeared O
grossly O
preserved O
. O

Due O
to O
technical O
quality O
a B-SYMPTOM
focal I-SYMPTOM
wall I-SYMPTOM
motion I-SYMPTOM
abnormality I-SYMPTOM
could O
not O
be O
fully O
excluded O
. O

The O
aortic O
valve O
leaflets O
were O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

The O
mitral O
valve O
leaflets O
were O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

There O
was O
a B-SYMPTOM
large I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
( O
up O
to O
greater O
than O
6 O
cm O
wide O
anterior O
to O
the O
right O
ventricle O
). O

The O
right O
ventricle O
was O
compressed B-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
transferred O
to O
the O
Coronary O
Care O
Unit O
after O
his B-TREATMENT
therapeutic I-TREATMENT
pericardiocentesis I-TREATMENT
. O

He O
was O
hemodynamically O
stable O
and O
without O
any O
complaints O
. O

He O
was O
continued O
on O
his B-TREATMENT
home I-TREATMENT
cardiac I-TREATMENT
regimen I-TREATMENT
, O
but O
was O
started O
on O
indomethacin B-TREATMENT
for O
post B-SYMPTOM
pericardiotomy I-SYMPTOM
syndrome I-SYMPTOM
. O

Over O
the O
course O
of O
the O
night O
the O
patient O
drained O
an O
additional O
400 O
cc O
of O
serosanguineous B-SYMPTOM
fluid I-SYMPTOM
from O
his B-TREATMENT
pericardial I-TREATMENT
drain I-TREATMENT
pouch I-TREATMENT
. O

By O
the O
next O
morning O
, O
the O
degree O
of O
drainage B-SYMPTOM
had O
decreased O
considerably O
with O
only O
60 O
cc O
drained O
over O
six O
hours O
. O

The O
patient O
had O
a O
repeat O
transthoracic O
echocardiogram O
prior O
to O
drain B-TREATMENT
removal I-TREATMENT
which O
revealed O
the O
following O
: O

A B-SYMPTOM
trivial I-SYMPTOM
/ I-SYMPTOM
physiologic I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
one O
day O
post O
pericardiocentesis B-TREATMENT
with O
no O
change O
from O
the O
study O
immediately O
post O
pericardiocentesis B-TREATMENT
. O

The B-TREATMENT
pericardial I-TREATMENT
drain I-TREATMENT
was O
removed O
without O
any B-SYMPTOM
difficulty I-SYMPTOM
. O

The B-TREATMENT
pericardial I-TREATMENT
fluid I-TREATMENT
bag I-TREATMENT
was O
removed O
without O
any B-SYMPTOM
difficulty I-SYMPTOM
with O
the O
decision O
to O
monitor O
the O
patient O
overnight O
and O
repeat O
the O
echocardiogram O
prior O
to O
discharge O
. O

The O
patient O
had O
an B-SYMPTOM
enlarged I-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
which O
was O
noted O
to O
layer O
on O
a O
lateral O
decubitus O
film O
. O

We O
decided O
to O
perform O
a B-TREATMENT
therapeutic I-TREATMENT
thoracentesis I-TREATMENT
. O

The O
patient O
was O
prepped O
and O
draped O
in O
a O
sterile O
fashion O
, O
and O
1150 O
cc O
of O
fluid B-SYMPTOM
were O
drained B-TREATMENT
. O

A O
chest O
x-ray O
was O
obtained O
post O
thoracentesis B-TREATMENT
which O
revealed O
a O
significant O
decrease O
in O
the O
size O
of O
the B-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

No O
evidence O
of O
pneumothorax B-SYMPTOM
. O

On O
the O
morning O
of O
admission O
the O
patient O
had O
a O
markedly O
improved O
lung O
examination O
with O
increased O
air O
movement O
in O
the O
left O
base O
. O

He O
denied O
any B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
had O
oxygen O
saturations O
in O
the O
90 O
s O
on O
room O
air O
. O

He O
had O
a O
repeat O
echocardiogram O
which O
revealed O
a B-SYMPTOM
trivial I-SYMPTOM
/ I-SYMPTOM
physiologic I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
. O

The O
patient O
was O
without O
any O
complaints O
and O
remained O
stable O
. O

CONDITION O
AT O
DISCHARGE O
: O

Condition O
on O
discharge O
was O
stable O
. O

DISCHARGE O
STATUS O
: O

The O
patient O
was O
to O
be O
discharged O
to O
home O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Post B-SYMPTOM
pericardiotomy I-SYMPTOM
syndrome I-SYMPTOM
. O

2. O
Status O
post O
pericardiocentesis B-TREATMENT
. O

3. O
Status O
post O
thoracentesis B-TREATMENT
. O

4. O
Type B-SYMPTOM
1 I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
for O
50 O
years O
. O

5. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

6. O
Hypercholesterolemia B-SYMPTOM
. O

7. O
Hypertension B-SYMPTOM
. O

8. O
Chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O
( O
Discharge O
medications O
include O
) O

1. O
Indomethacin B-TREATMENT
25 O
mg O
p.o. O
t.i.d. O
for O
seven O
days. O

2. O
Atenolol B-TREATMENT
50 O
mg O
p.o. O
q.d. O

3. O
Lipitor B-TREATMENT
10 O
mg O
p.o. O
q.d. O

4. O
Baby B-TREATMENT
aspirin I-TREATMENT
81 O
mg O
p.o. O
q.d. O

5. O
Iron B-TREATMENT
sulfate I-TREATMENT
81 O
mg O
p.o. O
q.d. O

6. O
Accupril B-TREATMENT
40 O
mg O
p.o. O
q.d. O

7. O
Hydrochlorothiazide B-TREATMENT
12.5 O
mg O
p.o. O
q.d. O

8. O
NPH B-TREATMENT
insulin I-TREATMENT
18 O
units O
q.a.m. O
and O
10 O
units O
q.p.m. O

9. O
Humalog B-TREATMENT
sliding-scale I-TREATMENT
q.a.m. O
and O
q.p.m. O

DISCHARGE O
FOLLOWUP O
: O

The O
patient O
was O
to O
follow O
up O
with O
his O
primary O
cardiologist O
, O
Dr. O
Thomas O
, O
within O
one O
week O
. O

David O
Archibald O
, O
M.D. O
11-989 O

Dictated O
By O
: O
Dorothy O
Y. O
Madore O
, O
M.D. O

MEDQUIST36 O

D O
: O
2009-11-12 O
12:02 O

T O
: O
2009-11-12 O
17:44 O

JOB O
#: O
33199 O

( O
cclist O
) O

Signed O
electronically O
by O
: O
DR. O
Susan O
O. O
G. O
Aviles O
on O
: O
Robert O
2010-01-14 O
7:23 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2016-12-24 O

Discharge O
Date O
: O

2016-12-27 O

Date O
of O
Birth O
: O

1936-01-11 O

Sex: O

F O

Service O
: O

CMED O
CSRU O

CHIEF O
COMPLAINT O
: O

Cough B-SYMPTOM
, O
rhinorrhea B-SYMPTOM
, O
dehydration B-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
an O
80 O
year O
old O
female O
with O
breast B-SYMPTOM
cancer I-SYMPTOM
, O
status O
post O
lumpectomy B-TREATMENT
/ O
radiation B-TREATMENT
therapy I-TREATMENT
/ O
Tamoxifen B-TREATMENT
( O
2000 O
) O
, O
hypertension B-SYMPTOM
, O
hyperlipidemia B-SYMPTOM
, O
multiple B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infections I-SYMPTOM
who O
presents O
with O
a O
four O
day O
prodrome O
of O
dry B-SYMPTOM
cough I-SYMPTOM
, O
rhinorrhea B-SYMPTOM
, O
coryza B-SYMPTOM
, O
malaise B-SYMPTOM
, O
chills B-SYMPTOM
, O
headache B-SYMPTOM
, O
decreased B-SYMPTOM
p.o. I-SYMPTOM
intake I-SYMPTOM
, O
loose B-SYMPTOM
bowel I-SYMPTOM
movements I-SYMPTOM
with O
diarrhea B-SYMPTOM
and O
no O
blood B-SYMPTOM
, O
decreased B-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
, O
no O
sick O
contacts O
, O
had O
flu B-TREATMENT
shot I-TREATMENT
this O
year O
. O

In O
the O
Emergency O
Department O
, O
she O
had O
labile B-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
with O
systolic O
blood O
pressure O
in O
the O
80 O
s O
. O

Her O
usual O
is O
systolic O
blood O
pressure O
in O
the O
120 O
s O
, O
this O
was O
despite O
two B-TREATMENT
liters I-TREATMENT
of I-TREATMENT
intravenous I-TREATMENT
fluids I-TREATMENT
and O
she O
was O
transferred O
to O
the O
Medical O
Intensive O
Care O
Unit O
for O
closer O
monitoring O
for O
possible O
early B-SYMPTOM
sepsis I-SYMPTOM
. O

The O
Intensive O
Care O
Unit O
course O
was O
notable O
for O
initially O
receiving O
broad B-TREATMENT
spectrum I-TREATMENT
antibiotics I-TREATMENT
as O
well O
as O
a O
white O
blood O
cell O
count O
of O
11.0 O
with O
15 O
bands O
. O

She O
was O
ultimately O
changed O
to O
Levaquin B-TREATMENT
for O
a O
possible O
early B-SYMPTOM
pneumonia I-SYMPTOM
pending O
cultures O
. O

The O
Intensive O
Care O
Unit O
course O
was O
also O
notable O
for O
negative O
chest O
x-ray O
, O
two B-TREATMENT
units I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
for O
a O
hematocrit O
of O
24.0 O
with O
appropriate O
bump O
in O
her O
hematocrit O
and O
no O
evidence B-SYMPTOM
of I-SYMPTOM
bleeding I-SYMPTOM
, O
stable O
blood O
pressure O
despite O
a O
net O
fluid O
balance O
of O
negative O
2.5 O
liters O
. O

No O
central B-TREATMENT
access I-TREATMENT
was O
needed O
. O

The B-TREATMENT
sepsis I-TREATMENT
protocol I-TREATMENT
was O
aborted O
. O

Also O
of O
note O
, O
her O
liver O
function O
tests O
had O
been O
normal O
. O

Random O
cortisol O
was O
17 O
and O
her O
DFA O
was O
positive O
for O
influenzae B-SYMPTOM
A I-SYMPTOM
with O
a O
viral O
culture O
pending O
at O
the O
time O
of O
discharge O
. O

Blood O
and O
urine O
cultures O
were O
no O
growth O
at O
the O
time O
of O
discharge O
as O
well O
. O

She O
also O
had O
a O
right O
lower O
extremity O
noninvasive O
ultrasound O
that O
was O
negative O
for O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O
Breast B-SYMPTOM
cancer I-SYMPTOM
diagnosed O
in O
2010 O
, O
Stage O
I O
, O
status B-TREATMENT
post I-TREATMENT
left I-TREATMENT
lumpectomy I-TREATMENT
, O
on O
2012-05-08 O
, O
and O
repeat B-TREATMENT
surgery I-TREATMENT
with O
sentinel B-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
on O
2012-06-05 O
. O

Invasive B-SYMPTOM
mucinous I-SYMPTOM
carcinoma I-SYMPTOM
with O
estrogen B-SYMPTOM
receptor I-SYMPTOM
positivity I-SYMPTOM
and O
HER2/NEU B-SYMPTOM
negative O
. O

Left B-TREATMENT
chest I-TREATMENT
radiation I-TREATMENT
, O
on O
Tamoxifen B-TREATMENT
therapy I-TREATMENT
. O

She O
is O
followed O
by O
Dr. O
Alonso O
Naugle O
. O

Question O
of O
vertebral B-SYMPTOM
basilar I-SYMPTOM
cerebrovascular I-SYMPTOM
accident I-SYMPTOM
in O
2016-08-17 O
, O
with O
associated O
limb B-SYMPTOM
ataxia I-SYMPTOM
. O

Magnetic O
resonance O
imaging O
was O
negative O
except O
for O
some B-SYMPTOM
microvascular I-SYMPTOM
cerebral I-SYMPTOM
white I-SYMPTOM
matter I-SYMPTOM
changes I-SYMPTOM
. O

Question O
peripheral B-SYMPTOM
vertigo I-SYMPTOM
, O
takes O
Meclizine B-TREATMENT
p.r.n. O

Hypothyroidism B-SYMPTOM
. O

Hypertension B-SYMPTOM
. O

Hypercholesterolemia B-SYMPTOM
. O

Glaucoma B-SYMPTOM
. O

Cataract B-SYMPTOM
. O

Osteopenia B-SYMPTOM
. O

Left B-SYMPTOM
hip I-SYMPTOM
arthritis I-SYMPTOM
. O

History O
of O
urinary B-SYMPTOM
tract I-SYMPTOM
infections I-SYMPTOM
. O

Anemia B-SYMPTOM
, O
with O
a O
baseline O
hematocrit O
of O
31.0 O
, O
with O
a O
TIBC O
that O
was O
low B-SYMPTOM
and O
a B-SYMPTOM
high I-SYMPTOM
ferritin I-SYMPTOM
. O

Echocardiogram O
in O
2016-09-16 O
, O
with O
preserved O
ejection O
fraction O
of O
60 O
percent O
with O
trivial B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
and O
mild B-SYMPTOM
left I-SYMPTOM
atrial I-SYMPTOM
enlargement I-SYMPTOM
. O

Cardiac O
stress O
test O
in O
2016-03-17 O
, O
that O
was O
negative O
for O
inducible B-SYMPTOM
ischemia I-SYMPTOM
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Evista B-TREATMENT
60 O
mg O
p.o. O
daily O
. O

2. O
Tamoxifen B-TREATMENT
20 O
mg O
p.o. O
daily O
. O

3. O
Lisinopril B-TREATMENT
5 O
mg O
p.o. O
daily O
. O

4. O
Triamterene/Hydrochlorothiazide B-TREATMENT
37.5/25 O
mg O
p.o. O
daily O
. O

5. O
Enteric B-TREATMENT
Coated I-TREATMENT
Aspirin I-TREATMENT
325 O
mg O
p.o. O
daily O
. O

6. O
Meclizine B-TREATMENT
25 O
mg O
q8hours O
p.r.n. O

7. O
Aggrenox B-TREATMENT
twice O
a O
day O
, O
the O
dose O
was O
not O
known O
. O

8. O
Synthroid B-TREATMENT
125 O
mcg O
daily O
. O

SOCIAL O
HISTORY O
: O

She O
denies O
tobacco O
and O
alcohol O
abuse O
. O

She O
is O
a O
professional O
bowler O
. O

She O
lives O
alone O
though O
her O
family O
is O
in O
the O
area O
. O

FAMILY O
HISTORY O
: O

Breast B-SYMPTOM
cancer I-SYMPTOM
in O
multiple O
female O
relatives O
. O

PHYSICAL O
EXAMINATION O
: O

At O
the O
time O
of O
presentation O
, O
temperature O
100.8 O
, O
heart O
rate O
89 O
, O
blood O
pressure O
106 O
systolic O
, O
respiratory O
rate O
18 O
, O
oxygen O
saturation O
97 O
percent O
in O
room O
air O
. O

Physical O
examination O
is O
read O
off O
the O
admitting O
note O
from O
the O
Intensive O
Care O
Unit O
team O
and O
is O
not O
reflective O
of O
the O
examination O
by O
this O
dictator O
. O

General O
- O
The O
patient O
appears O
stated O
age O
, O
found O
lying O
flat O
in O
bed O
, O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
- O
Sclera B-SYMPTOM
anicteric I-SYMPTOM
, O
conjunctiva B-SYMPTOM
injected I-SYMPTOM
, O
the O
pupils O
are O
equal O
, O
round O
and O
reactive O
to O
light O
and O
accommodation O
, O
the O
mucous O
membranes O
are O
dry B-SYMPTOM
, O
oropharynx O
clear O
. O

Neck O
- O
No O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
, O
no O
lymphadenopathy B-SYMPTOM
. O

Cardiac O
regular O
rate O
and O
rhythm O
, O
normal O
S1 O
and O
S2 O
, O
I/VI B-SYMPTOM
holosystolic I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
apex I-SYMPTOM
. O

Chest O
clear O
to O
percussion O
and O
auscultation O
. O

Abdomen O
is O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
no O
hepatosplenomegaly B-SYMPTOM
. O

Extremities O
- O
No O
calf B-SYMPTOM
tenderness I-SYMPTOM
, O
no O
edema B-SYMPTOM
. O

Neurologically O
, O
mental O
status O
examination O
is O
normal O
. O

Cranial O
nerves O
II O
through O
XII O
are O
intact O
. O

LABORATORY O
DATA O
: O

On O
admission O
, O
chest O
x-ray O
with O
no O
acute B-SYMPTOM
cardiopulmonary I-SYMPTOM
process I-SYMPTOM
. O

Electrocardiogram O
notable O
for O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
with O
a O
rate O
of O
104 O
beats O
per O
minute O
, O
normal O
axis O
, O
normal O
intervals O
, O
new B-SYMPTOM
T I-SYMPTOM
wave I-SYMPTOM
inversion I-SYMPTOM
in I-SYMPTOM
III I-SYMPTOM
and O
old B-SYMPTOM
T I-SYMPTOM
wave I-SYMPTOM
inversions I-SYMPTOM
in I-SYMPTOM
aVL I-SYMPTOM
and I-SYMPTOM
V1 I-SYMPTOM
. O

This O
was O
not O
significantly O
changed O
from O
comparison O
with O
2016-03-17 O
. O

On O
admission O
, O
white O
blood O
cell O
count O
7.3 O
, O
73 O
percent O
neutrophils O
, O
15 O
percent O
bands O
, O
6 O
percent O
lymphocytes O
, O
hematocrit O
30.4 O
, O
platelet O
count O
228,000 O
. O

Sodium O
136 O
, O
potassium O
3.5 O
, O
chloride O
98 O
, O
bicarbonate O
23 O
, O
blood O
urea O
nitrogen O
16 O
, O
creatinine O
0.8 O
, O
glucose O
142 O
. O

HOSPITAL O
COURSE O
: O

This O
is O
an O
80 O
year O
old O
female O
with O
a O
history O
of O
Stage B-SYMPTOM
I I-SYMPTOM
breast I-SYMPTOM
cancer I-SYMPTOM
, O
hypertension B-SYMPTOM
, O
hyperlipidemia B-SYMPTOM
, O
who O
presents O
with O
a B-SYMPTOM
leukocytosis/bandemia I-SYMPTOM
, O
hypotension B-SYMPTOM
in O
the O
setting O
of O
dehydration B-SYMPTOM
and O
influenza B-SYMPTOM
. O

After O
a O
short O
Medical O
Intensive O
Care O
Unit O
course O
where O
she O
remained O
hemodynamically O
stable O
, O
she O
was O
transferred O
to O
the O
floor O
. O

Gerardi O
problem O
list O
is O
as O
follows O
: O

Hypotension B-SYMPTOM
- O
This O
was O
likely O
secondary O
to O
volume B-SYMPTOM
depletion I-SYMPTOM
in O
the O
setting O
of O
a B-SYMPTOM
diarrheal I-SYMPTOM
and I-SYMPTOM
viral I-SYMPTOM
respiratory I-SYMPTOM
syndrome I-SYMPTOM
. O

Her O
blood O
pressure O
was O
stable O
after O
three B-TREATMENT
liters I-TREATMENT
of I-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
. O

She O
was O
clinically O
euvolemic O
after O
that O
. O

She O
did O
receive O
two B-TREATMENT
units I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

There O
is O
no O
evidence O
of O
gastrointestinal B-SYMPTOM
bleed I-SYMPTOM
or O
adrenal B-SYMPTOM
insufficiency I-SYMPTOM
during O
the O
course O
of O
her O
evaluation O
. O

Her B-TREATMENT
antihypertensives I-TREATMENT
were O
initially O
held O
and O
reinstated O
upon O
discharge O
. O

Influenza B-SYMPTOM
A I-SYMPTOM
- O
DFA O
confirmed O
, O
the O
viral O
cultures O
were O
pending O
at O
the O
time O
of O
discharge O
. O

The B-SYMPTOM
initial I-SYMPTOM
bandemia I-SYMPTOM
would O
not O
have O
been O
consistent O
with O
a B-SYMPTOM
typical I-SYMPTOM
influenza I-SYMPTOM
presentation I-SYMPTOM
, O
so O
she O
was O
continued O
on O
a O
fourteen O
day O
course O
of O
Levaquin B-TREATMENT
to O
eliminate O
any O
possibility O
of O
a B-SYMPTOM
bacterial I-SYMPTOM
superinfection I-SYMPTOM
or O
early B-SYMPTOM
pneumonia I-SYMPTOM
. O

Loose B-SYMPTOM
bowel I-SYMPTOM
movements I-SYMPTOM
- O
This O
problem O
was O
resolved O
and O
had O
been O
a B-SYMPTOM
viral I-SYMPTOM
syndrome I-SYMPTOM
on O
presentation O
. O

There O
was O
no O
evidence O
of O
diarrhea B-SYMPTOM
during O
medical O
Lawrence O
Memorial O
Hospital O
stay O
. O

Anemia B-SYMPTOM
- O
This O
is O
a B-SYMPTOM
chronic I-SYMPTOM
problem I-SYMPTOM
. O

She O
has O
known B-SYMPTOM
iron I-SYMPTOM
deficiency I-SYMPTOM
. O

There O
was O
no O
evidence B-SYMPTOM
of I-SYMPTOM
bleeding I-SYMPTOM
. O

She O
was O
guaiac O
negative O
and O
the O
Hemophilus O
panel O
was O
negative O
. O

She O
was O
reinstated O
on O
iron B-TREATMENT
at O
discharge O
and O
her O
hematocrit O
was O
stable O
. O

Hypothyroid B-SYMPTOM
- O
She O
was O
continued O
on O
her B-TREATMENT
Synthroid I-TREATMENT
. O

Osteopenia B-SYMPTOM
- O
She O
was O
continued O
on O
Evista B-TREATMENT
. O

Fluids B-TREATMENT
, O
electrolytes B-TREATMENT
and O
nutrition B-TREATMENT
- O
She O
was O
tolerating O
a O
house O
diet O
upon O
discharge O
. O

FOLLOW O
UP O
: O

She O
is O
a O
patient O
of O
Dr. O
James O
Deighan O
and O
will O
follow-up O
with O
her O
in O
one O
to O
two O
weeks O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Evista B-TREATMENT
60 O
mg O
p.o. O
daily O
. O

2. O
Tamoxifen B-TREATMENT
20 O
mg O
p.o. O
daily O
. O

3. O
Lisinopril B-TREATMENT
5 O
mg O
p.o. O
daily O
. O

4. O
Triamterene/Hydrochlorothiazide B-TREATMENT
37.5/25 O
mg O
p.o. O
daily O
. O

5. O
Enteric B-TREATMENT
Coated I-TREATMENT
Aspirin I-TREATMENT
325 O
mg O
p.o. O
daily O
. O

6. O
Meclizine B-TREATMENT
25 O
mg O
q8hours O
p.r.n. O

7. O
Aggrenox B-TREATMENT
twice O
a O
day O
, O
the O
dose O
was O
not O
known O
. O

8. O
Synthroid B-TREATMENT
125 O
mcg O
daily O
. O

9. O
Levofloxacin B-TREATMENT
250 O
mg O
p.o. O
daily O
to O
complete O
a O
fourteen O
day O
course O
. O

She O
was O
given O
a O
prescription O
for O
ten O
more O
days O
. O

DISCHARGE O
DIAGNOSES O
: O

Influenza B-SYMPTOM
A I-SYMPTOM
. O

Hypotension B-SYMPTOM
secondary O
to O
volume B-SYMPTOM
depletion I-SYMPTOM
. O

Anemia B-SYMPTOM
. O

Hypothyroidism B-SYMPTOM
. O

CONDITION O
ON O
DISCHARGE O
: O

The O
patient O
was O
breathing O
comfortably O
in O
room O
air O
. O

She O
was O
normotensive O
and O
her O
hematocrit O
was O
stable O
at O
her O
baseline O
upon O
discharge O
. O

Linette O
Randall O
, O
Mississippi O
82499 O

Dictated O
By O
: O
Jason O
L O
Parra O
, O
M.D. O

MEDQUIST36 O

D O
: O

2016-12-28 O
16:25:42 O

T O
: O

2016-12-28 O
20:11:26 O

Job O
# O
: O

74466 O

Signed O
electronically O
by O
: O
DR. O
Wanda O
PARKS O
on O
: O
Yesenia O
2017-01-10 O
6:50 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2015-06-29 O

Discharge O
Date O
: O

2015-07-09 O

Date O
of O
Birth O
: O

1941-01-16 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Pedro O
D. O
Anderson O
, O
M.D. O

Chief O
Complaint O
: O

Chest B-SYMPTOM
Pain I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O
persantine O
MIBI O
cardiac O
stress O
test O
thoracentesis O

Chest B-TREATMENT
Tube I-TREATMENT

History O
of O
Present O
Illness O
: O

74 O
yo O
M O
with O
lung B-SYMPTOM
cancer I-SYMPTOM
DVT B-SYMPTOM
who O
presents O
with O
1 O
day O
of O
substernal B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
. O

Patient O
developed O
chest B-SYMPTOM
pain I-SYMPTOM
the O
night O
prior O
to O
admission O
. O

The B-SYMPTOM
pain I-SYMPTOM
was O
substernal O
07-08 O
, O
did O
not O
radiate O
. O

He O
reports O
that O
the B-SYMPTOM
pain I-SYMPTOM
was O
similar O
to O
his B-SYMPTOM
prior I-SYMPTOM
MI I-SYMPTOM
. O

The O
patient O
had O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

In O
the O
Amanda O
the B-SYMPTOM
patients I-SYMPTOM
pain I-SYMPTOM
resolved O
with O
NTG B-TREATMENT
and O
morphine B-TREATMENT
. O

he O
was O
given O
ASA B-TREATMENT
and O
bblocker B-TREATMENT
. O

At O
time O
of O
my O
evaluation O
, O
the O
patient O
denied O
nausea B-SYMPTOM
, O
vomitting B-SYMPTOM
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
dysuria B-SYMPTOM
, O
dizziness B-SYMPTOM
, O
changes B-SYMPTOM
in I-SYMPTOM
vision I-SYMPTOM
/hearing I-SYMPTOM

Past O
Medical O
History O
: O

- O
Lung B-SYMPTOM
cancer I-SYMPTOM
- O
Non-small B-SYMPTOM
cell I-SYMPTOM
lung I-SYMPTOM
cancer I-SYMPTOM
stage I-SYMPTOM
IIIA I-SYMPTOM
, O
status O
post O
weekly B-TREATMENT
carboplatin I-TREATMENT
and O
Taxol B-TREATMENT
chemotherapy I-TREATMENT
with O
XRT B-TREATMENT
for O
seven O
weeks O
followed O
by O
surgery B-TREATMENT
on O
2015-04-14 O
. O

- O
CAD B-SYMPTOM
- O
s/p O
inferior B-SYMPTOM
STEMI I-SYMPTOM
12-03 O
, O
stent B-TREATMENT
to I-TREATMENT
L I-TREATMENT
Cx I-TREATMENT

- O
CHF B-SYMPTOM
( O
EF O
55% O
on O
05-04 O
) O

- O
HTN B-SYMPTOM

- O
paroxismal B-SYMPTOM
afib I-SYMPTOM

- O
CVA B-SYMPTOM

- O
Left B-SYMPTOM
LE I-SYMPTOM
DVT I-SYMPTOM
on O
coumadin B-TREATMENT

- O
s/p O
IVC B-TREATMENT
filter I-TREATMENT

Social O
History O
: O
non-smoker O
, O
occasional O
etoh O
, O
no O
drugs O

Family O
History O
: O
father O
and O
mother O
with O
CAD B-SYMPTOM

Physical O
Exam O
: O

VS O
- O
98.0 O
67 O
140/63 O
22 O
99% O
on O
RA O

Gen O
- O
A+Ox3 O
, O
NAD B-SYMPTOM

HEENT O
- O
EOMI O
, O
OP O
clear O

Neck O
- O
supple O
, O
no O
LAD B-SYMPTOM
, O
no O
JVD B-SYMPTOM

Cor O
- O
RRR O
no O
murmurs B-SYMPTOM

Chest O
- O
R O
base O
with O
poor B-SYMPTOM
excursion I-SYMPTOM
and O
poor B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
. O

Clear O
otherwise O
. O

Abd O
- O
s/nt/nd B-SYMPTOM
+BS O

Ext O
- O
w/wp O
, O
no O
edema B-SYMPTOM
, O
R B-SYMPTOM
leg I-SYMPTOM
swollen I-SYMPTOM
compared O
to O
left O

Pertinent O
Results O
: O

2015-06-29 O
05:15PM O

CK O
( O
CPK O
)- O
67 O

2015-06-29 O
05:15PM O

CK O
- O
MB O
- O
NotDone O
cTropnT O
-< O
0.01 O

2015-06-29 O
09:55 O
AM O

GLUCOSE O
- O
159 O
* O
UREA O
N O
- O
17 O
CREAT O
- O
1.0 O
SODIUM O
- O
137 O
POTASSIUM O
- O
3.6 O
CHLORIDE O
- O
100 O
TOTAL O
CO2 O
- O
27 O
ANION O
GAP O
- O
14 O

2015-06-29 O
09:55 O
AM O

CK O
( O
CPK O
)- O
76 O

2015-06-29 O
09:55 O
AM O
cTropnT O
-< O
0.01 O

2015-06-29 O
09:55 O
AM O

CK O
- O
MB O
- O
NotDone O

2015-06-29 O
09:55 O
AM O

WBC O
- O
10.4 O
RBC O
- O
4.41 O
*# O
HGB O
- O
12.8 O
*# O
HCT O
- O
38.2 O
*# O
MCV O
- O
87 O
MCH O
- O
29.0 O
MCHC O
- O
33.5 O
RDW O
- O
15.9 O
* O

2015-06-29 O
09:55 O
AM O

NEUTS O
- O
86.1 O
* O
LYMPHS O
- O
5.4 O
* O
MONOS O
- O
5.7 O
EOS O
- O
2.2 O
BASOS O
- O
0.6 O

2015-06-29 O
09:55 O
AM O

MICROCYT O
- O
1+ O

2015-06-29 O
09:55 O
AM O

PLT O
COUNT O
- O
372 O

2015-06-29 O
09:50 O
AM O
URINE O

HOURS O
- O
RANDOM O

2015-06-29 O
09:50 O
AM O
URINE O

GR O
HOLD O
- O
HOLD O

2015-06-29 O
09:50 O
AM O

PT O
- O
20.4 O
* O
PTT O
- O
28.6 O
INR O
( O
PT O
)- O
2.0 O
* O

2015-06-29 O
09:50 O
AM O
URINE O

COLOR O
- O
Yellow O
APPEAR O
- O
Clear O
SP O
Dickson O
- O
1.013 O

2015-06-29 O
09:50 O
AM O
URINE O

BLOOD O
- O
MOD O
NITRITE O
- O
NEG O
PROTEIN O
- O
NEG O
GLUCOSE O
- O
NEG O
KETONE O
- O
NEG O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
NEG O
PH O
- O
6.0 O
LEUK O
- O
NEG O

2015-06-29 O
09:50 O
AM O
URINE O

RBC O
- O
05-03 O
* O
WBC O
- O
0 O
BACTERIA O
- O
NONE O
YEAST O
- O
NONE O
EPI O
-< O
1 O

CXR O
- O
Increased B-SYMPTOM
right I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
and O
partial B-SYMPTOM
collapse I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
lung I-SYMPTOM
. O

EKG O
- O
NSR O
70 O
, O
nl O
axis O
, O
nl O
int O
, O
old B-SYMPTOM
TWI I-SYMPTOM
III I-SYMPTOM
, O
F O
; O
old B-SYMPTOM
J I-SYMPTOM
pointing I-SYMPTOM
V I-SYMPTOM
04-04 O

07-03 O
CT O

CT O
CHEST O
: O

The O
heart O
, O
pericardium O
, O
and O
great O
vessels O
are O
stable O
. O

There O
is O
a O
small O
amount O
of O
pericardial B-SYMPTOM
fluid I-SYMPTOM
. O

No O
definite B-SYMPTOM
axillary I-SYMPTOM
, I-SYMPTOM
mediastinal I-SYMPTOM
, I-SYMPTOM
or I-SYMPTOM
hilar I-SYMPTOM
lymphadenopathy I-SYMPTOM
is O
seen O
. O

Again O
seen O
is O
a B-SYMPTOM
moderate I-SYMPTOM
- I-SYMPTOM
to I-SYMPTOM
large I-SYMPTOM
- I-SYMPTOM
sized I-SYMPTOM
right I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

There O
has O
been O
interval O
development O
of O
moderate O
amount O
of O
high-attenuation B-SYMPTOM
fluid I-SYMPTOM
within O
the B-SYMPTOM
effusion I-SYMPTOM
consistent O
with O
hemorrhage B-SYMPTOM
. O

Patchy B-SYMPTOM
consolidation I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lung I-SYMPTOM
is O
stable O
. O

Hazy B-SYMPTOM
patchy I-SYMPTOM
opacities I-SYMPTOM
are O
noted O
in O
the O
left O
lung O
field O
but O
no O
frank B-SYMPTOM
consolidation I-SYMPTOM
is O
seen O
. O

CT O
ABDOMEN O
: O

Within O
the O
limits O
of O
this O
non-contrast O
study O
, O
the O
liver O
, O
gallbladder O
, O
pancreas O
, O
spleen O
, O
adrenal O
glands O
, O
kidneys O
, O
stomach O
, O
and O
small O
bowel O
loops O
are O
within O
normal O
limits O
. O

There O
is O
colonic B-SYMPTOM
diverticulosis I-SYMPTOM
most O
prominent O
at O
the O
hepatic O
flexure O
. O

There O
is O
no O
free B-SYMPTOM
air I-SYMPTOM
or O
free B-SYMPTOM
fluid I-SYMPTOM
. O

No O
mesenteric B-SYMPTOM
or I-SYMPTOM
retroperitoneal I-SYMPTOM
lymphadenopathy I-SYMPTOM
is O
identified O
. O

An B-TREATMENT
IVC I-TREATMENT
filter I-TREATMENT
is O
seen O
. O

CT O
PELVIS O
: O

The O
bladder O
is O
unremarkable O
. O

The O
patient O
appears O
to O
be O
status O
post O
prostatectomy B-TREATMENT
. O

The O
rectum O
is O
unremarkable O
. O

There O
is O
no O
free B-SYMPTOM
fluid I-SYMPTOM
and O
no O
pelvic B-SYMPTOM
or I-SYMPTOM
inguinal I-SYMPTOM
lymphadenopathy I-SYMPTOM
. O

BONE O
WINDOWS O
: O

A B-SYMPTOM
lytic I-SYMPTOM
area I-SYMPTOM
is O
again O
seen O
in O
the O
L5 O
vertebral O
body O
but O
unchanged O
from O
prior O
examination O
. O

Several B-SYMPTOM
subacute I-SYMPTOM
or I-SYMPTOM
chronic I-SYMPTOM
rib I-SYMPTOM
fractures I-SYMPTOM
are O
identified O
on O
the O
right O
. O

IMPRESSION O
: O

1. O
Interval O
development O
of O
a O
moderate O
amount O
of O
hemorrhage B-SYMPTOM
within O
the B-SYMPTOM
right I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

2. O
No O
acute B-SYMPTOM
intra-abdominal I-SYMPTOM
abnormalities I-SYMPTOM
identified O
. O

07-01 O
Stress O
MIBI O

New B-SYMPTOM
moderate I-SYMPTOM
and I-SYMPTOM
fixed I-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
wall I-SYMPTOM
perfusion I-SYMPTOM
defect I-SYMPTOM
. O

Mild B-SYMPTOM
inferior I-SYMPTOM
wall I-SYMPTOM
hypokinesis I-SYMPTOM
. O

Calculated O
LVEF O
42% O
. O

Brief O
Hospital O
Course O
: O

A/P O
74 O
yo O
M O
with O
lung B-SYMPTOM
cancer I-SYMPTOM
, O
DVT B-SYMPTOM
, O
CAD B-SYMPTOM
s/p O
MI B-SYMPTOM
presents O
with O
chest B-SYMPTOM
pain I-SYMPTOM
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

# O
Chest B-SYMPTOM
Pain I-SYMPTOM
/ O
Ischemia B-SYMPTOM
- O
Patient O
with O
history O
of O
CAD B-SYMPTOM
a/p O
MI B-SYMPTOM
. O

Now O
with O
an O
episode O
of O
pain B-SYMPTOM
consistent O
with O
his B-SYMPTOM
anginal I-SYMPTOM
equivalent I-SYMPTOM
. O

No O
changes B-SYMPTOM
on O
EKG O
but O
not O
in O
pain B-SYMPTOM
at O
time O
of O
EKG O
. O

Patient O
was O
ruled O
out O
by O
enzymes O
. O

He O
also O
had O
a O
stress O
test O
which O
revealed O
an B-SYMPTOM
irreversible I-SYMPTOM
deficit I-SYMPTOM
from O
his B-SYMPTOM
prior I-SYMPTOM
known I-SYMPTOM
IMI I-SYMPTOM
. O

Continued O
on O
asa B-TREATMENT
, O
bblocker B-TREATMENT
, O
Hicks B-TREATMENT
, O
statin B-TREATMENT
, O
plavix B-TREATMENT
. O

BP B-TREATMENT
meds I-TREATMENT
held O
while O
was O
unstable B-SYMPTOM
. O

ASA B-TREATMENT
, O
plavix B-TREATMENT
held O
during O
hemothorax B-SYMPTOM
. O

# O
CHF B-SYMPTOM
- O
patient O
does O
not O
seem O
volume B-SYMPTOM
overloaded I-SYMPTOM
at O
this O
time O
. O

He O
has O
no O
JVD B-SYMPTOM
, O
no O
edema B-SYMPTOM
in I-SYMPTOM
legs I-SYMPTOM
( O
other O
than O
swelling B-SYMPTOM
from O
DVT B-SYMPTOM
) O
. O

Last O
Echo O
with O
EF O
55% O
. O

Does O
have O
increased B-SYMPTOM
effusion I-SYMPTOM
although O
loculated O
. O

Continued O
on O
lasix B-TREATMENT
, O
bblocker B-TREATMENT
Robertson O
. O

BP B-TREATMENT
meds I-TREATMENT
held O
while O
unstable B-SYMPTOM
. O

# O
Afib B-SYMPTOM
- O
In O
sinus O
during O
admission O
. O

Patients B-TREATMENT
anticoag I-TREATMENT
held O
during O
hemothorax B-SYMPTOM
. O

# O
Shortness B-SYMPTOM
of I-SYMPTOM
Breath I-SYMPTOM
/ O
loculated B-SYMPTOM
Effusion I-SYMPTOM
- O
patient O
with O
increaing B-SYMPTOM
loculated I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

Has O
chronic B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
which O
has O
worsened O
over O
the O
past O
few O
days O
. O

No O
sign O
of O
infeciton B-SYMPTOM
at O
this O
time O
. O

Had O
thoracentesis O
by O
interventional O
pumonology O
on O
2015-07-01 O
revealing O
almost O
2 O
L O
of O
serous B-SYMPTOM
exudative I-SYMPTOM
fluid I-SYMPTOM
. O

Patient O
had O
improved O
breathing O
. O

Cytology O
was O
negative O
. O

However O
on O
07-02 O
Hct O
dropped O
. O

CT O
revealed O
hemothorax B-SYMPTOM
. O

All B-TREATMENT
anticoagulation I-TREATMENT
stopped O
despite O
the O
risk O
of O
DVT B-SYMPTOM
, O
afib B-SYMPTOM
. O

Risk O
discussed O
with O
family O
. O

Thoracics O
consulted O
and O
chest B-TREATMENT
tube I-TREATMENT
placed O
. O

Frank B-SYMPTOM
blood I-SYMPTOM
was O
taken O
out O
. O

Patient O
continued O
to O
bleed O
in O
and O
around O
the B-TREATMENT
tube I-TREATMENT
. O

Patient O
sent O
to O
CMED O
for O
observation O
after O
Hct O
continued O
to O
drop O
. O

Patient O
spontaneously O
stablized O
and O
output O
of O
CT O
became O
more O
serous O
. O

Output O
resent O
for O
cytology O
which O
was O
pending O
at O
time O
of O
discharge O
. O

When O
output O
became O
< O
100 O
cc O
the B-TREATMENT
tube I-TREATMENT
was O
removed O
. O

Patient O
follwed O
with O
serial O
CXR O
that O
did O
not O
demonstrate O
reaccumulation B-SYMPTOM
. O

Hct O
also O
remained O
stable O
. O

# O
DVT B-SYMPTOM
- O
patient O
therapeutic O
on O
heparin B-TREATMENT
. O

Improving O
clots B-SYMPTOM
on O
LENI B-TREATMENT
. O

CTA O
neg O
for O
PE B-SYMPTOM
. O

Anticoagulaiton B-TREATMENT
held O
during O
hemothorax B-SYMPTOM
. O

Patient O
restarted O
on O
coumadin B-TREATMENT
and O
will O
be O
discharged O
on O
3mg O
coumadin B-TREATMENT
qday O
. O

# O
Lung B-SYMPTOM
Cancer I-SYMPTOM
- O
patient O
currently O
with O
no O
evidence O
of O
disease B-SYMPTOM
. O

s/p O
neoadjuvant B-TREATMENT
chemo/XRT I-TREATMENT
now O
s/p O
surgery B-TREATMENT
. O

1st O
cytology O
negative O
. O

2ng O
cytology O
pending O
. O

WIll O
follow O
up O
tih O
outpatient O
oncologist O
. O

Contacts O
- O
son O
506-1596 O

Medications O
on O
Admission O
: O

Lipitor B-TREATMENT
80 O
mg O
qday O

Asa B-TREATMENT
81 O
mg O
qday O

bowel B-TREATMENT
reg I-TREATMENT

percocet B-TREATMENT
prn O

plavix B-TREATMENT
75 O
mg O
qday O

losartan B-TREATMENT
25 O
mg O
qday O

coumadin B-TREATMENT
3 O
mg O
qday O

lasix B-TREATMENT
20 O
mg O
qday O

atenolol B-TREATMENT
25 O
mg O
qday O

Discharge O
Medications O
: O

1. O
Atorvastatin B-TREATMENT
80 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

2. O
Aspirin B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

3. O
Senna B-TREATMENT
8.6 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
as O
needed O
for O
constipation B-SYMPTOM
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

4. O
Bisacodyl B-TREATMENT
5 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
) O
as O
needed O
for O
constipation B-SYMPTOM
. O

Disp O
:* O
30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)( O
s O
)* O
Refills O
:* O
0 O
* O

5. O
Oxycodone B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
. O

Disp O
:* O
100 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

6. O
Clopidogrel B-TREATMENT
75 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

7. O
Furosemide B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

8. O
Nitroglycerin B-TREATMENT
0.3 O
mg O
Tablet O
, O
Sublingual O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Sublingual O
Sublingual O
PRN O
( O
as O
needed O
) O
. O

9. O
Atenolol B-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

10. O
Losartan B-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

11. O
Benzonatate B-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
TID O
( O
3 O
times O
a O
day O
) O
as O
needed O
for O
cough B-SYMPTOM
. O

Disp O
:* O
60 O
Capsule O
( O
s O
)* O
Refills O
:* O
3 O
* O

12. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
for O
pain B-SYMPTOM
. O

13. O
Oxycodone B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
. O

Disp O
:* O
50 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

14. O
Codeine B-TREATMENT
- O
Guaifenesin B-TREATMENT
10-100 O
mg O
/ O
5 O
mL O
Syrup O
Sig O
: O
5-10 O
MLs O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

Disp O
:*QS O
1 O
month O
ML O
( O
s O
)* O
Refills O
:* O
0 O
* O

15. O
Coumadin B-TREATMENT
3 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
2 O
* O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

Angina B-SYMPTOM

Pleural B-SYMPTOM
Effusion I-SYMPTOM

Secondary O

HTN B-SYMPTOM

Non B-SYMPTOM
small I-SYMPTOM
cell I-SYMPTOM
lung I-SYMPTOM
cancer I-SYMPTOM

CAD B-SYMPTOM

DVT B-SYMPTOM
h/o O
afib B-SYMPTOM

Discharge O
Condition O
: O
stable O
, O
eating O
, O
on O
room O
air O

Discharge O
Instructions O
: O

Please O
take O
all B-TREATMENT
medications I-TREATMENT
as O
listed O
in O
the O
discharge O
paperwork O
. O

Please O
make O
all O
appointments O
listed O
in O
the O
discharge O
paperwork O
. O

If O
you O
have O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
nausea B-SYMPTOM
or O
other B-SYMPTOM
concerning I-SYMPTOM
symptoms I-SYMPTOM
please O
call O
your O
MD O
or O
come O
to O
the O
emergency O
room O
. O

I O
have O
changed O
some O
of O
your B-TREATMENT
blood I-TREATMENT
pressure I-TREATMENT
meds I-TREATMENT
. O

Your B-TREATMENT
atenolol I-TREATMENT
has O
increased O
to O
50 O
mg O
a O
day O
. O

Your B-TREATMENT
losartan I-TREATMENT
has O
increased O
to O
50 O
mg O
a O
day O
. O

Followup O
Instructions O
: O

Provider O
: O

Kathleen O
Shirley O
, O
MD O
Phone O
:( O
870 O
) O
559-0424 O

Date O
/ O
Time O
: O
2015-08-06 O
9:00 O

You O
should O
call O
Dr. O
Worden O
to O
also O
see O
him O
again O
sooner O
09-07 O
days O
. O

( O
870 O
) O
559-0424 O
. O

Please O
see O
Dr. O
Holbrook O
( O
984 O
) O
452 O
0816 O
on O
monday O
and O
have O
your O
coumadin O
level O
checked O
. O

Merle O
Shirley O
MD O
87-502 O

Completed O
by O
: O
Nannie O
Brenda O
MD O
13-326 O
2015-07-10 O
@ O
1534 O

Signed O
electronically O
by O
: O
DR. O
Shanta O
PARKS O
on O
: O
TUE O
2015-07-14 O
9:08 O
AM O

( O
End O
of O
Report O
) O

125721767 O

CTMC O

34028893 O

597337 O

3/31/2001 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

03/31/2001 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

PRINCIPAL O
DIAGNOSIS O
: O

MYASTHENIA B-SYMPTOM
GRAVIS I-SYMPTOM
. O

SECONDARY O
DIAGNOSES O
: O

1. O
HYPOTHYROIDISM B-SYMPTOM
. O

2. O
HISTORY O
OF O
THYMOMA B-SYMPTOM
, O
STATUS O
POST O
RESECTION B-TREATMENT
. O

3. O
HYPERTENSION B-SYMPTOM
. O

4. O
HISTORY O
OF O
COLON B-SYMPTOM
CANCER I-SYMPTOM
, O
STATUS O
POST O
RESECTION B-TREATMENT
. O

5. O
BENIGN B-SYMPTOM
PROSTATIC I-SYMPTOM
HYPERTROPHY I-SYMPTOM
. O

6. O
HYDROCELE B-SYMPTOM
. O

OPERATIONS O
AND O
PROCEDURES O
: O

ECHOCARDIOGRAM O
, O
CARDIAC O
CATHETERIZATION O
, O
EMG O
, O
CT O
SCAN O
OF O
THE O
CHEST O
. O

MEDICATIONS O
: O

Aspirin B-TREATMENT
325 O
q.d. O
; O
albuterol B-TREATMENT
nebs I-TREATMENT
2.5 O
mg O
q. O
4h O
; O
Colace B-TREATMENT
100 O
mg O
b.i.d. O
; O
heparin B-TREATMENT
5,000 O
units O
subcu O
b.i.d. O
; O
Synthroid B-TREATMENT
200 O
mcg O
q.d. O
; O
Ocean B-TREATMENT
Spray I-TREATMENT
2 O
sprays O
q. O
i.d. O
; O
simvastatin B-TREATMENT
10 O
mg O
q. O
h.s. O
; O
Flovent B-TREATMENT
220 O
mcg O
2 O
puffs O
b.i.d. O
; O
Zantac B-TREATMENT
150 O
b.i.d. O
; O
nystatin B-TREATMENT
ointment I-TREATMENT
to O
the O
gluteal O
fold O
b.i.d. O
; O
Lisinopril B-TREATMENT
20 O
mg O
q.d. O
; O
Mestinon B-TREATMENT
controlled I-TREATMENT
release I-TREATMENT
180 O
q. O
h.s. O
; O
Mestinon B-TREATMENT
30 O
mg O
q. O
4h O
while O
awake O
; O
prednisone B-TREATMENT
60 O
mg O
p.o. O
q. O
IM O
; O
Atrovent B-TREATMENT
nebs I-TREATMENT
0.5 O
mg O
q. O
i.d. O

DIET O
: O

No O
restrictions O
. O

ACTIVITY O
: O

As O
tolerated O
. O

HOSPITAL O
COURSE O
: O

This O
is O
a O
72-year-old O
male O
with O
a O
history O
of O
thymoma B-SYMPTOM
resected O
in O
1996 O
, O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
, O
hypothyroidism B-SYMPTOM
who O
was O
transferred O
from O
Gobay O
Hos O
Memorial O
Hospital O
for O
an B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
and O
cardiac O
catheterization O
. O

The O
patient O
developed O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
at O
home O
and O
the O
EMTs O
were O
called O
and O
the O
patient O
was O
found O
to O
be O
in O
respiratory B-SYMPTOM
distress I-SYMPTOM
. O

He O
was O
transferred O
to O
Gobay O
Hos O
Memorial O
Hospital O
where O
chest O
x-ray O
showed O
left B-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
infiltrate I-SYMPTOM
and O
cardiac O
enzymes O
were O
elevated B-SYMPTOM
with O
a O
CK O
of O
297 O
, O
MB O
fraction O
of O
38 O
and O
troponin O
of O
12 O
. O

The O
patient O
was O
transferred O
to O
the O
medicine O
service O
at O
the O
Retelk O
County O
Medical O
Center O
and O
underwent O
cardiac O
catheterization O
which O
was O
negative O
for O
disease B-SYMPTOM
. O

He O
continued O
to O
complain O
of O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
with O
an O
episode O
of O
respiratory B-SYMPTOM
failure I-SYMPTOM
in O
the O
hospital O
requiring O
100% B-TREATMENT
nonrebreather I-TREATMENT
. O

Neurology O
was O
consulted O
for O
difficulty B-SYMPTOM
lifting I-SYMPTOM
his I-SYMPTOM
arms I-SYMPTOM
. O

On O
consultation O
the O
patient O
admitted O
to O
dysphasia B-SYMPTOM
and O
periods O
of O
diplopia B-SYMPTOM
in O
the O
past O
. O

The O
patient O
was O
found O
to O
have O
weakness B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
muscles I-SYMPTOM
as O
well O
as O
the O
capability O
of O
the O
muscles O
. O

He O
was O
started O
on O
IV B-TREATMENT
ig I-TREATMENT
and O
IV B-TREATMENT
Solu-Medrol I-TREATMENT
for O
a O
diagnosis O
of O
myasthenia B-SYMPTOM
gravis I-SYMPTOM
given O
his O
past O
history O
of O
thymoma B-SYMPTOM
. O

He O
markedly O
improved O
after O
a O
dose O
of O
Mestinon B-TREATMENT
. O

He O
completed O
a O
five-day O
course O
of O
IV B-TREATMENT
ig I-TREATMENT
. O

His O
work O
up O
included O
acetylcholine O
esterase O
, O
receptor O
antibodies O
, O
thyroglobulin O
antibody O
is O
pending O
. O

An O
ANA O
and O
rheumatoid O
factor O
were O
negative O
. O

Sed O
rate O
was O
58 O
and O
repeat O
75 O
. O

EMG O
studies O
were O
performed O
, O
the O
result O
is O
pending O
at O
the O
time O
of O
this O
dictation O
. O

He O
also O
had O
a O
repeat O
chest O
CT O
which O
showed O
a O
question O
of O
recurrence O
of O
the B-SYMPTOM
thymoma I-SYMPTOM
. O

Thoracic O
Surgery O
was O
consulted O
and O
recommended O
repeating O
the O
CT O
scan O
in O
six O
weeks O
as O
an O
outpatient O
. O

This O
could O
represent O
either O
recurrence O
of O
scar B-SYMPTOM
tissue I-SYMPTOM
. O

The O
patient O
was O
tapered O
to O
p.o. B-TREATMENT
prednisone I-TREATMENT
and O
tolerated O
Mestinon B-TREATMENT
30 O
mg O
q. O
4h O
with O
180 O
mg O
longacting O
at O
bedtime O
. O

Dictated O
By O
: O

THYRNCINDE O
BOTH O
, O
M.D. O
VZ84 O

Attending O
: O

LENNI O
E. O
STENT O
, O
M.D. O
UQ5 O
MX420/8849 O

Batch O
: O

85467 O

Index O
No. O
EJDFG7458J O

D O
: O

04/07/01 O

T O
: O

04/10/01 O

Admission O
Date O
: O

2019-02-01 O

Discharge O
Date O
: O

2019-02-09 O

Date O
of O
Birth O
: O

1940-04-28 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Nicholas O
E. O
E. O
Collard O
, O
M.D. O

Chief O
Complaint O
: O

Abdominal B-SYMPTOM
pain I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Intubation B-TREATMENT

ERCP O
with O
stent B-TREATMENT

Blood B-TREATMENT
transfusion I-TREATMENT

History O
of O
Present O
Illness O
: O

Pt O
is O
a O
78 O
yo O
male O
with O
h/o O
A B-SYMPTOM
fib I-SYMPTOM
, O
s/p O
multiple B-SYMPTOM
CVA I-SYMPTOM
s, I-SYMPTOM
CHF B-SYMPTOM
, O
HTN B-SYMPTOM
, O
DM2 B-SYMPTOM
admitted O
to O
Mediplex O
Rehab O
Hospital O
Robert O
on O
02-01 O
with O
abdominal B-SYMPTOM
pain I-SYMPTOM
and O
n/v B-SYMPTOM
since O
that O
morning O
. O

Pt O
's O
vitals O
on O
admission O
wer O
significant O
for O
T O
104 O
, O
SBP O
100 O
s, O
HR O
in O
the O
120 O
s. O

RUQ O
U/s O
demonstrated O
multiple B-SYMPTOM
small I-SYMPTOM
gallstones I-SYMPTOM
with O
sludges B-SYMPTOM
without O
evidence O
of O
pericholecystic B-SYMPTOM
fluid I-SYMPTOM
or O
significant B-SYMPTOM
dilatation I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
gallbladder I-SYMPTOM
. O

Surgery O
was O
consulted O
for O
concern O
of O
cholangitis B-SYMPTOM
with O
probable O
sepsis B-SYMPTOM
. O

Pt O
was O
admitted O
to O
the O
CMED O
CCU O
, O
intubated B-TREATMENT
overnight O
for O
ERCP O
procedure O
and O
fluid B-TREATMENT
resuscitation I-TREATMENT
. O

The O
patient O
was O
placed O
on O
zosyn B-TREATMENT
. O

Pt O
's O
INR O
was O
eleveted B-SYMPTOM
as O
he O
was O
on O
home B-TREATMENT
coumadin I-TREATMENT
. O

He O
was O
given O
4 B-TREATMENT
units I-TREATMENT
FFP I-TREATMENT
in O
anticipation O
of O
ERCP O
the O
following O
day O
. O

On O
02-02 O
ERCP O
demonstrated O
a B-SYMPTOM
large I-SYMPTOM
filling I-SYMPTOM
defect I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
duct I-SYMPTOM
representing O
a B-SYMPTOM
stone I-SYMPTOM
with O
CBD B-SYMPTOM
dilatation I-SYMPTOM
. O

A B-TREATMENT
biliary I-TREATMENT
stent I-TREATMENT
was O
placed O
after O
the B-TREATMENT
removal I-TREATMENT
of O
the B-SYMPTOM
stone I-SYMPTOM
. O

Pt O
was O
extubated O
the O
next O
day O
. O

He O
was O
then O
transferred O
to O
the O
medicine O
service O
. O

Past O
Medical O
History O
: O

1) O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM

2) O
s/p O
MVR B-TREATMENT
( I-TREATMENT
mechanical I-TREATMENT
) I-TREATMENT

3) O
CHF B-SYMPTOM
EF O
15% O

4) O
HTN B-SYMPTOM

5) O
multiple B-SYMPTOM
CVA I-SYMPTOM
s I-SYMPTOM
( O
last O
1998 O
) O

6) O
Hypercholesterolemia B-SYMPTOM

7) O
Type B-SYMPTOM
II I-SYMPTOM
DM I-SYMPTOM

8) O
Multiple B-SYMPTOM
prior I-SYMPTOM
UTI I-SYMPTOM

Social O
History O
: O

Lives O
in O
Danvers O
with O
wife O
, O
denies O
Timothy O
or O
alcohol O
. O

Family O
History O
: O

NC O

Physical O
Exam O
: O

upon O
tx O
to O
medicine O
service O

T O
: O
99.0 O
; O
BP O
142/61 O
; O
Pulse O
65 O
; O
Resp O
20 O
; O
O2 O
sat O
96% O
RA O

Gen O
- O
Alert O
, O
no O
acute B-SYMPTOM
distress I-SYMPTOM

HEENT O
- O
mucous B-SYMPTOM
membranes I-SYMPTOM
slightly I-SYMPTOM
dry I-SYMPTOM

Neck O
- O
no O
JVD B-SYMPTOM
, O
no O
cervical B-SYMPTOM
lymphadenopathy I-SYMPTOM

Chest O
- O
CTA O
b/l O
with O
good O
air O
entry O

CV O
- O
Normal O
S1/S2 O
, O
irreg B-SYMPTOM
irreg I-SYMPTOM

Abd O
- O
Soft O
, O
nontender B-SYMPTOM
, O
mild B-SYMPTOM
distension I-SYMPTOM
, O
normoactive O
bowel O
sounds O

Extr O
- O
No O
edema B-SYMPTOM
. O

2+ O
DP O
pulses O
bilaterally O

Neur O
: O
A O
& O
O O
X3 O
, O
dysarthric B-SYMPTOM
speech I-SYMPTOM
, O

CN O
: O
mild B-SYMPTOM
left I-SYMPTOM
facial I-SYMPTOM
droop I-SYMPTOM
, O
o/w O
appears O
intact O
; O
4/5 O
strength O
on O
flex O
at O
elbows O
b/l O
, O
legs O
06-22 O
strength O
, O
DTR O
s O
intact O
, O
sensation O
intact O

Skin O
- O
No O
rash B-SYMPTOM

Pertinent O
Results O
: O

ERCP O
report O
: O
Four O
fluoroscopic O
images O
and O
ERCP O
are O
provided O
. O

A B-SYMPTOM
large I-SYMPTOM
filling I-SYMPTOM
defect I-SYMPTOM
is O
seen O
in O
the O
distal O
duct O
representing O
a B-SYMPTOM
stone I-SYMPTOM
. O

The O
common O
duct O
is O
dilated B-SYMPTOM
. O

Subsequent B-TREATMENT
biliary I-TREATMENT
stent I-TREATMENT
was O
placed O
after O
the B-TREATMENT
removal I-TREATMENT
of O
the B-SYMPTOM
stone I-SYMPTOM
. O

Blood O
cultures O
: O

2019-02-01 O
( O
4 O
of O
4 O
bottles O
) O
E.coli B-SYMPTOM

CXR O
: O
Pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

ECHO O
: O

The O
left O
atrium O
is O
markedly B-SYMPTOM
dilated I-SYMPTOM
. O

There O
is O
mild B-SYMPTOM
symmetric I-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
. O

The O
left O
ventricular O
cavity O
is O
moderately B-SYMPTOM
dilated I-SYMPTOM
. O

There O
is O
moderate B-SYMPTOM
global I-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
hypokinesis I-SYMPTOM
. O

Overall O
left O
ventricular O
systolic O
function O
is O
moderately B-SYMPTOM
depressed I-SYMPTOM
. O

Right O
ventricular O
chamber O
size O
and O
free O
wall O
motion O
are O
normal O
. O

Right O
ventricular O
systolic O
function O
is O
normal O
. O

[ O
Intrinsic O
right O
ventricular O
systolic O
function O
is O
likely O
more B-SYMPTOM
depressed I-SYMPTOM
given O
the O
severity O
of O
tricuspid B-SYMPTOM
regurgitation I-SYMPTOM
.] O

The O
aortic O
valve O
leaflets O
( O
3 O
) O
are O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

There O
is O
no O
aortic B-SYMPTOM
valve I-SYMPTOM
stenosis I-SYMPTOM
. O

Mild B-SYMPTOM
( I-SYMPTOM
1+ I-SYMPTOM
) I-SYMPTOM
aortic I-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

A B-TREATMENT
bileaflet I-TREATMENT
mitral I-TREATMENT
valve I-TREATMENT
prosthesis I-TREATMENT
is O
present O
. O

The O
transmitral O
gradient O
is O
normal O
for O
this B-TREATMENT
prosthesis I-TREATMENT
. O

No O
mitral B-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

Mild B-SYMPTOM
( I-SYMPTOM
1+ I-SYMPTOM
) I-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

[ O
Due O
to O
acoustic O
shadowing O
, O
the O
severity O
of O
mitral B-SYMPTOM
regurgitation I-SYMPTOM
may O
be O
significantly O
UNDERestimated O
.] O

The O
tricuspid O
valve O
leaflets O
are O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

Moderate B-SYMPTOM
[ I-SYMPTOM
2+ I-SYMPTOM
] I-SYMPTOM
tricuspid I-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

There O
is O
mild B-SYMPTOM
pulmonary I-SYMPTOM
artery I-SYMPTOM
systolic I-SYMPTOM
hypertension I-SYMPTOM
. O

There O
is O
no O
pericardial B-SYMPTOM
effusion I-SYMPTOM
. O

Labs O
on O
admission O
: O

2019-02-01 O
03:20 O
PM O
BLOOD O
WBC O
- O
11.7 O
*# O
RBC O
- O
4.72 O
Hgb O
- O
14.1 O
Hct O
- O
42.7 O
MCV O
- O
91 O
MCH O
- O
29.9 O
MCHC O
- O
33.1 O
RDW O
- O
14.9 O
Plt O
Ct O
- O
91 O
* O

2019-02-01 O
03:20 O
PM O
BLOOD O
Neuts O
- O
94.6 O
* O
Bands O
- O
0 O
Lymphs O
- O
2.7 O
* O
Monos O
- O
1.9 O
* O
Eos O
- O
0.4 O
Baso O
- O
0.4 O

2019-02-01 O
03:20 O
PM O
BLOOD O
PT O
- O
28.0 O
* O
PTT O
- O
26.7 O
INR(PT) O
- O
2.9 O
* O

2019-02-01 O
03:20 O
PM O
BLOOD O
Glucose O
- O
202 O
* O
UreaN O
- O
31 O
* O
Creat O
- O
1.3 O
* O
Na O
- O
141 O
K O
- O
4.0 O
Cl O
- O
102 O
HCO3 O
- O
27 O
AnGap O
- O
16 O

2019-02-01 O
03:20 O
PM O
BLOOD O
ALT O
- O
167 O
* O
AST O
- O
218 O
* O
AlkPhos O
- O
108 O
Amylase O
- O
117 O
* O
TotBili O
- O
3.6 O
* O

2019-02-02 O
03:54 O
PM O
BLOOD O
Lipase O
- O
992 O
* O

2019-02-01 O
03:20 O
PM O
BLOOD O
Albumin O
- O
4.8 O
Calcium O
- O
9.4 O
Phos O
- O
1.9 O
* O
Mg O
- O
2.0 O

2019-02-01 O
04:15 O
PM O
BLOOD O
Digoxin O
- O
0.3 O
* O

2019-02-01 O
11:43 O
PM O
BLOOD O
Type O
- O
ART O
Temp O
- O
38.3 O
PEEP B-TREATMENT
- O
5 O
pO2 O
- O
115 O
* O
pCO2 O
- O
36 O
pH O
- O
7.33 O
* O
calTCO2 O
- O
20 O
* O
Base O
XS O
- O
-6 O
Intubat O
- O
INTUBATED B-TREATMENT

2019-02-01 O
04:06 O
PM O
BLOOD O
Lactate O
- O
3.4 O
* O

2019-02-01 O
08:00 O
PM O
BLOOD O
Lactate O
- O
6.4 O
* O

Labs O
on O
discharge O
: O

2019-02-06 O
06:30 O
AM O
BLOOD O
WBC O
- O
7.4 O
RBC O
- O
3.82 O
* O
Hgb O
- O
11.3 O
* O
Hct O
- O
34.7 O
* O
MCV O
- O
91 O
MCH O
- O
29.5 O
MCHC O
- O
32.5 O
RDW O
- O
15.1 O
Plt O
Ct O
- O
92 O
* O

2019-02-09 O
04:45 O
AM O
BLOOD O
PT O
- O
19.6 O
* O
PTT O
- O
74.9 O
* O
INR(PT) O
- O
1.9 O
* O

2019-02-07 O
09:00 O
AM O
BLOOD O
Glucose O
- O
124 O
* O
UreaN O
- O
26 O
* O
Creat O
- O
1.2 O
Na O
- O
140 O
K O
- O
3.7 O
Cl O
- O
102 O
HCO3 O
- O
29 O
AnGap O
- O
13 O

2019-02-07 O
09:00 O
AM O
BLOOD O
ALT O
- O
62 O
* O
AST O
- O
45 O
* O
AlkPhos O
- O
105 O
TotBili O
- O
2.2 O
* O

2019-02-04 O
02:40 O
AM O
BLOOD O
Lipase O
- O
74 O
* O

2019-02-07 O
09:00 O
AM O
BLOOD O
Mg O
- O
2.0 O

2019-02-04 O
02:50 O
AM O
BLOOD O
Lactate O
- O
1.0 O

Brief O
Hospital O
Course O
: O

Pt O
is O
a O
78 O
yo O
male O
with O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
s/p O
multiple B-SYMPTOM
CVA I-SYMPTOM
s, I-SYMPTOM
CHF B-SYMPTOM
, O
HTN B-SYMPTOM
, O
DM2 B-SYMPTOM
transferred O
from O
the O
CMED O
CCU O
s/p O
intervention B-TREATMENT
for O
cholangitis B-SYMPTOM
. O

1) O
Acute B-SYMPTOM
cholangitis I-SYMPTOM
: O
Pt O
was O
admitted O
to O
the O
ICU O
, O
intubated O
, O
and O
ERCP O
performed O
, O
likely O
stone B-SYMPTOM
obstructing O
CBD O
. O

Stent B-TREATMENT
was O
placed O
and O
patient O
was O
treated O
with O
antibiotics B-TREATMENT
( O
Zosyn B-TREATMENT
- O
> O
Ciprofloxacin B-TREATMENT
). O

Per O
ERCP O
fellow O
, O
plan O
is O
for O
patient O
to O
return O
in O
four O
weeks O
to O
see O
Dr. O
Suzanne O
Davis O
, O
at O
which O
time O
he O
will O
likely O
have O
repeat O
cholangiogram O
and O
removal B-TREATMENT
of O
stent B-TREATMENT
and O
stone B-SYMPTOM
. O

If O
this O
is O
still O
problematic O
, O
pt O
may O
also O
need O
a B-TREATMENT
sphincterotomy I-TREATMENT
. O

Dr.Demby O
secretary O
will O
contact O
patient O
at O
home O
the O
week O
after O
discharge O
to O
schedule O
this O
for O
the O
end O
of O
January O
. O

Pt O
is O
to O
continue O
ciprofloxacin B-TREATMENT
for O
a O
complete O
14 O
day O
course O
. O

2) O
Mechanical B-TREATMENT
mitral I-TREATMENT
valve I-TREATMENT
: O
Anticoagulation B-TREATMENT
was O
reversed O
for O
ERCP O
. O

After O
this O
he O
was O
anticoagulated O
with O
heparin B-TREATMENT
drip I-TREATMENT
. O

INR O
was O
1.9 O
on O
discharge O
. O

He O
was O
given O
sc B-TREATMENT
lovenox I-TREATMENT
x O
1 O
and O
will O
continue O
this O
the O
day O
after O
discharge O
bid O
for O
one O
day O
. O

VNA O
will O
check O
his O
INR O
at O
home O
and O
page O
his O
PCP O
with O
the O
results O
. O

3) O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM
: O
Rate O
controlled O
and O
on O
warfarin B-TREATMENT
. O

While O
in O
the O
hospital O
he O
had O
several O
episodes O
of O
pauses B-SYMPTOM
, O
none O
longer O
than O
2.5 O
seconds O
. O

His B-TREATMENT
digoxin I-TREATMENT
was O
held O
and O
his B-TREATMENT
metoprolol I-TREATMENT
was O
titrated O
down O
from O
his B-TREATMENT
home I-TREATMENT
dose I-TREATMENT
. O

Once O
the B-TREATMENT
digoxin I-TREATMENT
was O
no O
longer O
having O
effect O
, O
metoprolol B-TREATMENT
was O
titrated O
back O
to O
home O
dose O
. O

4) O
CHF B-SYMPTOM
: O
Pt O
was O
oxygen B-SYMPTOM
dependent I-SYMPTOM
for O
most O
of O
the O
hospital O
course O
, O
CXR O
was O
consistent O
with O
pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

He O
was O
diuresed O
with O
lasix B-TREATMENT
with O
good O
effect O
. O

Volume B-SYMPTOM
overload I-SYMPTOM
likely O
ocurred O
in O
the O
setting O
of O
IV B-TREATMENT
fluids I-TREATMENT
given O
in O
the O
ICU O
. O

Did O
not O
require O
lasix B-TREATMENT
on O
discharge O
. O

5) O
E. B-SYMPTOM
coli I-SYMPTOM
bacteremia I-SYMPTOM
/ O
sepsis B-SYMPTOM
: O
Source O
of O
acute B-SYMPTOM
cholangitis I-SYMPTOM
as O
above O
. O

Pt O
required O
3 O
day O
stay O
in O
the O
surgical O
ICU O
and O
intubation B-TREATMENT
as O
above O
. O

6) O
Intubation B-TREATMENT
: O
Pt O
was O
97% O
on O
room O
air O
on O
arrival O
to O
Cindy O
, O
developed O
rapid B-SYMPTOM
ventricular I-SYMPTOM
reponse I-SYMPTOM
to O
a B-SYMPTOM
fib I-SYMPTOM
which O
was O
treated O
, O
but O
after O
that O
period O
of O
time O
required O
oxygen B-TREATMENT
, O
presumably O
for O
pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

In O
the O
Lori O
pt O
was O
given O
3L B-TREATMENT
NS I-TREATMENT
as O
well O
as O
1 O
unit O
of O
FFP B-TREATMENT
, O
and O
oxygen B-SYMPTOM
requirements I-SYMPTOM
contimued O
to O
climb O
. O

In O
the O
CMED O
CCU O
pt O
was O
intubated O
for O
ERCP O
procedure O
. O

He O
was O
extubated O
the O
next O
morning O
. O

Medications O
on O
Admission O
: O

Lisinopril B-TREATMENT
2.5 O
qday O
, O
Buspiron B-TREATMENT
20 O
mg O
po O
qday O
, O
Digoxin B-TREATMENT
, O
Doxasozin B-TREATMENT
8 O
mg O
qhs O
, O
Glyburide B-TREATMENT
2.5 O
mg O
qday O
, O
metoprolol B-TREATMENT
bid O
, O
atorvastatin B-TREATMENT
20 O
mg O
qday O
, O
warfarin B-TREATMENT
5 O
mg O
qday O

Discharge O
Medications O
: O

1. O
Ciprofloxacin B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q12H O
( O
every O
12 O
hours O
) O
for O
6 O
days O
. O

Disp O
:* O
12 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

2. O
Medications B-TREATMENT

Continue O
all B-TREATMENT
other I-TREATMENT
home I-TREATMENT
medications I-TREATMENT
EXCEPT O
do O
not O
take O
digoxin B-TREATMENT
. O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

Primary O
diagnosis O
: O

acute B-SYMPTOM
cholangitis I-SYMPTOM

Secondary O
diagnosis O
: O

anticoagulation B-TREATMENT
with O
a B-TREATMENT
mechanical I-TREATMENT
valve I-TREATMENT

Atrial B-SYMPTOM
fibrillation I-SYMPTOM

Diabetes B-SYMPTOM
Mellitus I-SYMPTOM

Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM

Discharge O
Condition O
: O

stable O
, O
will O
work O
with O
home O
PT O

Discharge O
Instructions O
: O

Please O
continue O
Ciprofloxacin B-TREATMENT
antibiotic I-TREATMENT
until O
2019-02-14 O
. O

Dr. O
Mcfarlane O
is O
the O
doctor O
who O
performed O
the B-TREATMENT
procedure I-TREATMENT
to O
place O
a B-TREATMENT
stent I-TREATMENT
in I-TREATMENT
your I-TREATMENT
bile I-TREATMENT
duct I-TREATMENT
( O
a O
tube O
that O
drains O
the O
liver O
). O

His O
nurse O
is O
going O
to O
contact O
you O
at O
home O
to O
schedule O
a O
time O
for O
a B-TREATMENT
repeat I-TREATMENT
procedure I-TREATMENT
to O
remove O
that B-TREATMENT
stent I-TREATMENT
. O

You O
will O
have O
your O
blood O
drawn O
tomorrow O
( O
2019-02-10 O
) O
by O
VNA O
. O

It O
will O
be O
called O
in O
to O
Dr. O
Hamasaki O
office O
and O
he O
will O
call O
you O
to O
see O
how O
to O
change O
your B-TREATMENT
coumadin I-TREATMENT
. O

You O
will O
also O
take O
lovenox B-TREATMENT
subcutaneous I-TREATMENT
injections I-TREATMENT
tomorrow O
, O
2019-02-10 O
. O

You O
will O
take O
one O
if O
the O
morning O
and O
one O
at O
night O
. O

Continue O
all O
of O
your B-TREATMENT
medications I-TREATMENT
except O
for O
digoxin B-TREATMENT
. O

Followup O
Instructions O
: O

Dr. O
Mcfarlane O
is O
the O
doctor O
who O
performed O
the B-TREATMENT
procedure I-TREATMENT
to O
place O
a B-TREATMENT
stent I-TREATMENT
in I-TREATMENT
your I-TREATMENT
bile I-TREATMENT
duct I-TREATMENT
( O
a O
tube O
that O
drains O
the O
liver O
). O

His O
nurse O
is O
going O
to O
contact O
you O
at O
home O
to O
schedule O
a O
time O
for O
a B-TREATMENT
repeat I-TREATMENT
procedure I-TREATMENT
to O
remove O
that B-TREATMENT
stent I-TREATMENT
. O

Before O
you O
have O
the B-TREATMENT
procedure I-TREATMENT
with O
Dr. O
Morris O
you O
will O
need O
to O
talk O
to O
Dr. O
Moya O
to O
see O
if O
you O
need O
to O
stop O
your B-TREATMENT
coumadin I-TREATMENT
/ O
warfarin B-TREATMENT
for O
a O
few O
days O
. O

Shirley O
Anthony O
MD O
56-333 O

Completed O
by O
: O
Donald O
Beverly O
MD O
74-194 O
2019-02-09 O
@ O
1644 O

Signed O
electronically O
by O
: O
DR. O
Shirley O
V O
Usher O
on O
: O
SAT O
2019-02-09 O
5:32 O
PM O

( O
End O
of O
Report O
) O

225281111 O

GH O

59035229 O

7/4/1999 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

07/04/1999 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

07/09/1999 O

ADMISSION O
DIAGNOSIS O
: O

ABDOMINAL B-SYMPTOM
PAIN I-SYMPTOM
. O

DISCHARGE O
DIAGNOSIS O
: O

PARTIAL B-SYMPTOM
SMALL I-SYMPTOM
BOWEL I-SYMPTOM
OBSTRUCTION I-SYMPTOM
. O

HISTORY O
OF O
THE O
PRESENT O
ILLNESS O
: O

This O
is O
a O
49 O
year-old O
male O
with O
a O
history O
of O
a B-TREATMENT
low I-TREATMENT
anterior I-TREATMENT
resection I-TREATMENT
in O
May O
of O
1998 O
and O
a B-SYMPTOM
recurrence I-SYMPTOM
of O
metastasis B-SYMPTOM
with O
asleeve O
of O
section O
of O
left B-TREATMENT
colon I-TREATMENT
diverting I-TREATMENT
ileostomy I-TREATMENT
for O
recurrent B-SYMPTOM
metastasis I-SYMPTOM
later O
in O
May O
of O
1999 O
who O
presents O
with O
anterior B-SYMPTOM
midepigastric I-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
. O

The O
patient O
states O
that O
the B-SYMPTOM
pain I-SYMPTOM
began O
at O
10:30 O
on O
the O
day O
of O
admission O
with O
increase O
during O
the O
day O
of O
admission O
with O
positive O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
, O
no O
diarrhea B-SYMPTOM
, O
decreased B-SYMPTOM
output I-SYMPTOM
from I-SYMPTOM
the I-SYMPTOM
ostomy I-SYMPTOM
, O
and O
the B-SYMPTOM
pain I-SYMPTOM
was O
radiating O
to O
the O
back O
. O

PAST O
MEDICAL O
HISTORY O
: O

As O
above O
. O

PAST O
SURGICAL O
HISTORY O
: O

As O
above O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Percocet B-TREATMENT
and O
Naprosyn B-TREATMENT
. O

ALLERGIES O
: O

Demerol B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

No O
tobacco O
and O
no O
alcohol O
use O
. O

PHYSICAL O
EXAMINATION O
ON O
ADMISSION O
: O

Temperature O
98.8 O
, O
heart O
rate O
68 O
, O
blood O
pressure O
107/82 O
, O
and O
oxygen O
saturation O
99% O
on O
room O
air O
. O

CHEST O
: O

Clear O
to O
auscultation O
. O

HEART O
: O

Regular O
rate O
and O
rhythm O
with O
no O
murmurs B-SYMPTOM
. O

ABDOMEN O
: O

Soft O
, O
mildly B-SYMPTOM
distended I-SYMPTOM
, O
and O
tympanic B-SYMPTOM
with O
midepigastric B-SYMPTOM
tenderness I-SYMPTOM
to O
palpation O
and O
no O
rebound B-SYMPTOM
. O

The B-TREATMENT
ostomy I-TREATMENT
was O
pink O
with O
minimal O
fluid O
in O
the B-TREATMENT
ostomy I-TREATMENT
bag I-TREATMENT
. O

It O
was O
guaiac O
negative O
. O

EXTREMITIES O
: O

No O
signs O
of O
edema B-SYMPTOM
and O
the O
patient O
had O
warm O
and O
palpable O
pulses O
distally O
. O

HOSPITAL O
COURSE O
: O

Assessment O
was O
continued O
with O
laboratory O
studies O
which O
showed O
the O
patient O
to O
have O
a O
white O
blood O
cell O
count O
of O
9 O
, O
hematocrit O
39 O
, O
and O
platelets O
470 O
. O

The O
patient O
had O
a O
normal O
amylase O
and O
lipase O
, O
and O
a O
normal O
basic O
metabolic O
panel O
. O

The O
patient O
had O
KUB O
that O
showed O
multiple B-SYMPTOM
dilated I-SYMPTOM
loops I-SYMPTOM
of I-SYMPTOM
small I-SYMPTOM
bowel I-SYMPTOM
and O
was O
admitted O
for O
a O
partial B-SYMPTOM
small I-SYMPTOM
bowel I-SYMPTOM
obstruction I-SYMPTOM
. O

An B-TREATMENT
nasogastric I-TREATMENT
tube I-TREATMENT
was O
placed O
and O
had O
an B-TREATMENT
H2 I-TREATMENT
blocker I-TREATMENT
started O
, O
and O
was O
admitted O
for O
bowel B-TREATMENT
rest I-TREATMENT
and O
decompression B-TREATMENT
. O

The O
patient O
tolerated O
the B-TREATMENT
nasogastric I-TREATMENT
tube I-TREATMENT
well O
. O

The B-TREATMENT
nasogastric I-TREATMENT
tube I-TREATMENT
was O
removed O
on O
hsp O
day O
# O
3 O
. O

The B-SYMPTOM
pain I-SYMPTOM
improved O
quickly O
and O
the O
patient O
was O
started O
on O
a O
clear B-TREATMENT
liquid I-TREATMENT
diet I-TREATMENT
which O
was O
advanced O
as O
tolerated O
. O

On O
7/9/99 O
, O
the O
patient O
was O
tolerating O
a O
house O
diet O
. O

The O
patient O
had O
some B-SYMPTOM
minimal I-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
that O
occurred O
after O
food O
but O
with O
negative O
urinalysis O
and O
negative O
fever B-SYMPTOM
spikes I-SYMPTOM
over O
the O
entire O
course O
of O
this O
stay O
. O

The O
patient O
will O
be O
discharged O
home O
on O
Zantac B-TREATMENT
, O
Simethicone B-TREATMENT
, O
and O
preoperative B-TREATMENT
medications I-TREATMENT
with O
follow-up O
with O
Dr. O
Ur O
in O
two O
weeks O
. O

Dictated O
By O
: O

NISTE O
BLOCKER O
, O
M.D. O
AQ36 O

Attending O
: O

STIE O
FYFE O
, O
M.D. O
BW3 O
BL436/5666 O

Batch O
: O

85114 O

Index O
No. O

FNQXCX58 O
EM O

D O
: O

07/09/99 O

T O
: O

07/09/99 O
HP8 O

Admission O
Date O
: O

2013-11-01 O

Discharge O
Date O
: O

2013-12-10 O

Date O
of O
Birth O
: O

2013-11-01 O

Sex O
: O

F O

Service O
: O

Neonatology O

HISTORY O
: O

Mychelia O
Boyd O
was O
born O
at O
28-2/7 O
weeks O
gestation O
and O
delivered O
due O
to O
unstoppable B-SYMPTOM
premature I-SYMPTOM
labor I-SYMPTOM
. O

Mother O
is O
an O
18-year-old O
prima O
gravida O
, O
estimated O
date O
of O
delivery O
2014-01-22 O
. O

Prenatal O
screens O
include O
blood O
type O
O O
negative O
. O

Other O
prenatal O
screens O
were O
unknown O
at O
time O
of O
delivery B-TREATMENT
. O

Pregnancy O
was O
uncomplicated O
until O
the O
day O
of O
delivery B-TREATMENT
when O
mother O
presented O
to O
HealthSouth O
New O
England O
Rehab O
Hospital O
Hospital O
with O
bleeding B-SYMPTOM
and O
was O
sent O
home O
. O

She O
then O
presented O
to O
Jordan O
Hospital O
Hospital O
where O
she O
was O
noted O
to O
be O
5 B-SYMPTOM
cm I-SYMPTOM
dilated I-SYMPTOM
with O
a B-SYMPTOM
transverse I-SYMPTOM
lie I-SYMPTOM
presentation I-SYMPTOM
. O

She O
was O
given O
betamethasone B-TREATMENT
times O
one O
and O
transferred O
to O
the O
Nantucket O
Cottage O
Hospital O
where O
she O
was O
delivered O
by O
cesarean B-TREATMENT
section I-TREATMENT
with O
rupture B-SYMPTOM
of I-SYMPTOM
membranes I-SYMPTOM
at O
time O
of O
delivery B-TREATMENT
notable O
for O
slight B-SYMPTOM
meconium I-SYMPTOM
stained I-SYMPTOM
amniotic I-SYMPTOM
fluid I-SYMPTOM
. O

The O
baby O
emerged O
with O
spontaneous O
cry O
, O
received O
routine B-TREATMENT
care I-TREATMENT
and O
then O
was O
intubated O
in O
the O
Delivery O
Room O
due O
to O
inconsistent B-SYMPTOM
respiratory I-SYMPTOM
effort I-SYMPTOM
and O
increased B-SYMPTOM
work I-SYMPTOM
of I-SYMPTOM
breathing I-SYMPTOM
. O

Apgars O
were O
6 O
at O
one O
minute O
and O
8 O
at O
five O
minutes O
. O

She O
was O
transferred O
to O
the O
newborn O
Intensive O
Care O
Unit O
for O
further B-TREATMENT
management I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

Her O
admission O
physical O
revealed O
a O
birth O
weight O
of O
901 O
gm O
, O
20th O
percentile O
; O
length O
34 O
cm O
, O
25th O
percentile O
; O
head O
circumference O
25 O
cm O
, O
25th O
percentile O
. O

Anterior O
fontanelle O
open O
, O
soft O
and O
flat O
. O

Red O
reflex O
was O
difficult O
to O
appreciate O
bilaterally O
. O

Pupils O
were O
large O
but O
equal O
and O
reactive O
. O

Palate O
deferred O
due O
to O
oral B-TREATMENT
intubation I-TREATMENT
. O

No O
defect B-SYMPTOM
noted O
during O
procedure B-TREATMENT
. O

Increased B-SYMPTOM
work I-SYMPTOM
of I-SYMPTOM
breathing I-SYMPTOM
prior O
to O
intubation B-TREATMENT
, O
but O
presently O
comfortable O
. O

Breath O
sounds O
slightly B-SYMPTOM
crackly I-SYMPTOM
, O
symmetric O
equal O
air O
entry O
. O

Cardiovascular O
regular O
rate O
and O
rhythm O
without O
murmur B-SYMPTOM
. O

Peripheral O
pulses O
plus O
2 O
and O
symmetric O
. O

Abdomen O
soft O
without O
hepatosplenomegaly B-SYMPTOM
. O

Three-vessel O
cord O
, O
clamped O
. O

Normal O
female O
external O
genitalia O
. O

Normal O
back O
and O
hips O
. O

Skin O
was O
pink O
and O
well-perfused O
. O

Appropriate O
tone O
and O
activity O
. O

HOSPITAL O
COURSE O
BY O
SYSTEM O
: O

Respiratory O
: O

The O
baby O
was O
intubated O
in O
the O
Delivery O
Room O
, O
received O
two O
doses O
of O
surfactant B-TREATMENT
. O

Radiograph O
revealed O
bilateral B-SYMPTOM
diffuse I-SYMPTOM
granular I-SYMPTOM
pattern I-SYMPTOM
consistent O
with O
surfactant B-SYMPTOM
deficiency I-SYMPTOM
. O

Maximum B-TREATMENT
mechanical I-TREATMENT
ventilation I-TREATMENT
PIP B-TREATMENT
26 O
, O
PEEP B-TREATMENT
6 O
, O
rate B-TREATMENT
of O
25 O
, O
maximum B-TREATMENT
FIO2 I-TREATMENT
35 O
percent O
. O

Mychelia O
was O
extubated O
to O
a B-TREATMENT
CPAP I-TREATMENT
of O
6 O
cm O
on O
day O
of O
life O
two O
where O
she O
remained O
until O
day O
of O
life O
20 O
. O

On O
day O
of O
life O
two O
, O
she O
was O
also O
loaded O
with O
caffeine B-TREATMENT
and O
continues O
on O
caffeine B-TREATMENT
at O
time O
of O
transfer O
. O

She O
was O
transitioned O
to O
a B-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
on O
day O
of O
life O
20 O
and O
remains O
on O
nasal B-TREATMENT
cannula I-TREATMENT
O2 I-TREATMENT
100 O
percent O
at O
13 O
cc O
flow O
. O

She O
averaged O
2-3 O
apnea B-SYMPTOM
episodes I-SYMPTOM
a O
day O
with O
bradycardia B-SYMPTOM
and O
desaturations B-SYMPTOM
. O

She O
has O
a O
comfortable O
respiratory O
rate O
and O
good O
air O
exchange O
. O

Cardiovascular O
: O

She O
received O
a B-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
bolus I-TREATMENT
times O
one O
initially O
for O
poor B-SYMPTOM
perfusion I-SYMPTOM
and O
was O
started O
on O
dopamine B-TREATMENT
with O
a O
maximum O
infusion O
rate O
of O
6 O
mcg O
per O
kg O
per O
hour O
. O

This O
was O
discontinued O
on O
day O
of O
life O
two O
to O
maintain O
a O
mean O
arterial O
pressure O
of O
greater O
than O
33 O
. O

She O
has O
remained O
hemodynamically O
stable O
during O
the O
remainder O
of O
her O
hospitalization O
here O
. O

Fluids O
, O
electrolytes O
, O
nutrition O
: O

Initially O
maintained O
NPO B-TREATMENT
. O

UAC B-TREATMENT
and I-TREATMENT
UVC I-TREATMENT
lines I-TREATMENT
were O
placed O
upon O
admission O
to O
the O
CMED O
. O

The B-TREATMENT
UAC I-TREATMENT
was O
left O
in O
place O
until O
day O
of O
life O
two O
and O
was O
removed O
after O
wean O
from O
dopamine B-TREATMENT
. O

UVC B-TREATMENT
remained O
in O
place O
through O
day O
of O
life O
six O
and O
was O
utilized O
to O
administer O
parenteral B-TREATMENT
nutrition I-TREATMENT
. O

Electrolytes O
and O
glucose O
remained O
in O
the O
normal O
range O
throughout O
the O
first O
week O
. O

She O
was O
started O
on O
enteral B-TREATMENT
feeds I-TREATMENT
on O
day O
of O
life O
six O
with O
a O
slow O
advance O
secondary O
to O
increased B-SYMPTOM
abdominal I-SYMPTOM
girth I-SYMPTOM
which O
was O
felt O
to O
be O
due O
to O
CPAP B-TREATMENT
. O

She O
passed O
meconium O
. O

She O
achieved O
full O
feeds O
on O
day O
of O
life O
13 O
. O

Calories O
were O
gradually O
increased O
to O
breast O
milk O
30 O
calories O
with O
ProMod B-TREATMENT
consisting O
of O
four O
of O
human O
milk O
fortifier O
, O
four O
of O
MCT B-TREATMENT
and O
two O
of O
Polycose B-TREATMENT
with O
a O
12-28 O
teaspoon O
of O
ProMod B-TREATMENT
per O
50 O
ml O
of O
breast O
milk O
or O
60 O
ml O
of O
formula O
. O

On O
day O
of O
life O
six O
due O
to O
concerns O
for O
hyperglycemia B-SYMPTOM
and O
abdominal B-SYMPTOM
distention I-SYMPTOM
, O
sepsis O
evaluation O
was O
obtained O
. O

She O
was O
noted O
at O
this O
time O
to O
have O
hyperglycemia B-SYMPTOM
requiring O
two O
subcutaneous O
doses O
of O
insulin B-TREATMENT
and O
a B-TREATMENT
decreased I-TREATMENT
glucose I-TREATMENT
infusion I-TREATMENT
rate I-TREATMENT
to O
achieve O
euglycemia O
. O

This O
resolved O
that O
same O
day O
. O

Urine O
output O
was O
always O
noted O
to O
be O
of O
sufficient O
quantity O
. O

Gastrointestinal O
: O

Mychelia O
demonstrated O
slow B-SYMPTOM
gastrointestinal I-SYMPTOM
motility I-SYMPTOM
and O
abdominal B-SYMPTOM
distention I-SYMPTOM
felt O
to O
be O
due O
to O
CPAP B-TREATMENT
. O

She O
was O
slow O
to O
advance O
on O
enteral O
feeds O
and O
gradually O
attained O
full O
enteral O
volume O
on O
day O
of O
life O
13 O
. O

On O
day O
of O
life O
15 O
, O
she O
was O
made O
NPO B-TREATMENT
for O
a B-SYMPTOM
distended I-SYMPTOM
abdomen I-SYMPTOM
and O
a B-SYMPTOM
bilious I-SYMPTOM
spit I-SYMPTOM
. O

Serial O
KUBs O
revealed O
nonspecific B-SYMPTOM
changes I-SYMPTOM
with O
dilated B-SYMPTOM
loops I-SYMPTOM
. O

No O
pneumatosis B-SYMPTOM
or O
free B-SYMPTOM
air I-SYMPTOM
was O
seen O
. O

She O
was O
noted O
to O
have O
bluish B-SYMPTOM
discoloration I-SYMPTOM
thought O
to O
perhaps O
be O
a B-SYMPTOM
bruise I-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
. O

There O
was O
no O
radiographic O
correlation O
with O
this O
. O

Feeds O
were O
restarted O
. O

Again O
, O
she O
was O
advanced O
to O
full O
volume O
but O
was O
made O
NPO B-TREATMENT
on O
day O
of O
life O
20 O
for O
abdominal B-SYMPTOM
distention I-SYMPTOM
. O

This B-TREATMENT
NPO I-TREATMENT
was O
temporary O
for O
that O
day O
and O
she O
then O
resumed O
feedings O
and O
has O
been O
tolerating O
full B-TREATMENT
enteral I-TREATMENT
feeds I-TREATMENT
well O
, O
improved O
since O
off O
of O
CPAP B-TREATMENT
, O
passing O
normal O
stools O
, O
guaiac O
negative O
. O

Mychelia O
was O
also O
treated O
for O
physiologic B-SYMPTOM
jaundice I-SYMPTOM
. O

She O
was O
started O
under O
phototherapy B-TREATMENT
on O
day O
of O
life O
one O
through O
day O
of O
life O
three O
with O
a O
peak O
serum O
bilirubin O
of O
4.7/0.3 O
. O

This O
issue O
resolved O
. O

Hematologic O
and O
Infectious O
Disease O
: O

Initial O
CBC O
was O
notable O
for O
a O
white O
count O
of O
5.5 O
with O
49 O
polys O
, O
1 O
band O
and O
47 O
lymphs O
. O

Initial O
hematocrit O
was O
46.3 O
percent O
and O
platelets O
320,000 O
. O

Her O
initial O
blood O
culture O
remained O
negative O
and O
she O
received O
48 O
hours O
of O
ampicillin B-TREATMENT
and O
gentamicin B-TREATMENT
. O

As O
previously O
noted O
on O
day O
of O
life O
six O
with O
hyperglycemia B-SYMPTOM
, O
abdominal B-SYMPTOM
distention I-SYMPTOM
, O
a O
CBC O
and O
blood O
culture O
were O
again O
obtained O
revealing O
a O
white O
count O
of O
9.1 O
with O
30 O
polys O
, O
0 O
bands O
and O
58 O
lymphs O
. O

Hematocrit O
at O
that O
time O
was O
noted O
to O
be O
31 O
and O
platelets O
370,000 O
. O

Blood O
culture O
grew O
staph B-SYMPTOM
coagulase I-SYMPTOM
negative I-SYMPTOM
and O
the O
baby O
received O
seven O
days O
of O
vancomycin B-TREATMENT
and O
gentamicin B-TREATMENT
. O

A O
lumbar O
puncture O
was O
also O
performed O
to O
rule O
out O
meningitis B-SYMPTOM
. O

This O
culture O
remained O
negative O
with O
normal O
cell O
counts O
and O
chemistries O
. O

Antibiotic O
levels O
were O
monitored O
and O
doses O
adjusted O
accordingly O
. O

Mychelia O
required O
two B-TREATMENT
transfusions I-TREATMENT
during O
her O
hospital O
stay O
. O

On O
day O
of O
life O
15 O
for O
a O
hematocrit O
of O
29 O
, O
she O
received O
20 O
cc O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

She O
started O
on O
iron B-TREATMENT
and O
vitamin B-TREATMENT
E I-TREATMENT
supplements I-TREATMENT
on O
day O
of O
life O
25 O
and O
continues O
on O
that O
at O
this O
time O
of O
transfer O
. O

However O
, O
on O
day O
of O
life O
34 O
, O
12-04 O
, O
she O
was O
noted O
to O
be O
pale B-SYMPTOM
and O
less B-SYMPTOM
stress I-SYMPTOM
tolerant I-SYMPTOM
, O
mottling O
easily O
with O
care O
. O

A O
hematocrit O
and O
reticulocyte O
count O
showed O
a O
hematocrit O
of O
23 O
percent O
and O
a O
reticulocyte O
count O
of O
1.9 O
percent O
. O

Therefore O
, O
with O
blood B-TREATMENT
available O
from O
the O
first O
aliquot O
, O
a O
second O
20 O
cc O
per O
kg O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
were O
infused O
without O
incident O
. O

Neurological O
: O

Initial O
head O
ultrasound O
on O
day O
of O
life O
seven O
was O
normal O
. O

At O
one O
month O
of O
age O
, O
on O
12-03 O
, O
she O
was O
noted O
to O
have O
an B-SYMPTOM
absent I-SYMPTOM
septum I-SYMPTOM
pellucidum I-SYMPTOM
. O

An O
MRI O
obtained O
and O
reviewed O
by O
the O
Hallmark O
Health O
System O
Radiology O
Department O
revealed O
focal B-SYMPTOM
gyral I-SYMPTOM
morphology I-SYMPTOM
consistent O
with O
prematurity B-SYMPTOM
, O
normal O
midline O
structures O
, O
normal O
myelination O
, O
no O
lesions B-SYMPTOM
, O
no O
signal B-SYMPTOM
abnormalities I-SYMPTOM
or O
extracerebral B-SYMPTOM
collections I-SYMPTOM
. O

The O
cortical O
ribbon O
is O
intact O
. O

The O
major O
vascular O
structures O
at O
the O
skull O
base O
are O
normal O
. O

The O
septal O
leaflets O
may O
be O
partially B-SYMPTOM
absent I-SYMPTOM
, O
but O
there O
are O
no O
coronal O
images O
provided O
for O
confirmation O
and O
the O
pituitary O
stalk O
is O
present O
. O

An O
Ophthalmology O
consult O
was O
obtained O
to O
determine O
the O
presence O
of O
optic O
nerves O
. O

These O
were O
both O
determined O
to O
be O
present O
and O
intact O
. O

Endocrine O
was O
also O
consulted O
. O

Several O
labs O
were O
ordered O
. O

Electrolytes O
and O
thyroid O
studies O
were O
noted O
to O
be O
in O
the O
normal O
range O
with O
serum O
sodium O
of O
136 O
, O
potassium O
4.7 O
, O
chloride O
98 O
and O
CO2 O
34 O
. O

She O
had O
a O
calcium O
of O
10.3 O
, O
a O
phosphorus O
of O
4.8 O
and O
alkaline O
phosphatase O
of O
440 O
. O

Thyroid O
function O
studies O
revealed O
a O
TSH O
of O
2.2 O
, O
T4 O
of O
5.7 O
, O
T3 O
of O
101 O
and O
a O
cortisol O
level O
of O
43 O
, O
all O
within O
the O
normal O
range O
. O

A O
growth O
hormone O
was O
sent O
and O
the O
results O
were O
pending O
at O
time O
of O
transfer O
. O

In O
addition O
, O
an O
FSH O
and O
LH O
were O
obtained O
on O
12-10 O
and O
results O
are O
pending O
at O
time O
of O
transfer O
. O

Please O
contact O
lab O
control O
at O
Mattapan O
Community O
Health O
Center O
for O
results O
: O
( O
409 O
) O
238-8236 O
. O

The O
baby O
's O
neurologic O
examination O
is O
appropriate O
for O
corrected O
gestational O
age O
which O
is O
33 O
and O
6/7 O
weeks O
on O
day O
of O
transfer O
. O

By O
mother O
's O
report O
, O
a O
maternal O
cousin O
also O
has O
an B-SYMPTOM
absent I-SYMPTOM
septum I-SYMPTOM
pellucidum I-SYMPTOM
. O

Given O
normal O
pituitary O
tests O
thus O
far O
and O
normal O
optic O
nerve O
, O
no O
evidence O
of O
septic B-SYMPTOM
optic I-SYMPTOM
dysplasia I-SYMPTOM
. O

Pediatrician O
should O
have O
low O
threshold O
for O
endocrinology O
reconsult O
if O
any B-SYMPTOM
signs I-SYMPTOM
of I-SYMPTOM
pituitary I-SYMPTOM
problems I-SYMPTOM
. O

Sensory O
: O

Audiology O
hearing O
has O
not O
yet O
been O
obtained O
. O

This O
is O
recommended O
prior O
to O
discharge O
from O
hospital O
to O
home O
. O

Ophthalmology O
: O

Initial O
ROP O
screen O
was O
done O
on O
12-02 O
and O
revealed O
immature B-SYMPTOM
retinas I-SYMPTOM
to I-SYMPTOM
zone I-SYMPTOM
2 I-SYMPTOM
bilaterally I-SYMPTOM
. O

They O
recommended O
follow-up O
examination O
due O
on O
the O
week O
of O
12/20 O
. O

Psychosocial O
: O

Gardner O
State O
Hospital O
social O
worker O
has O
assisted O
in O
working O
with O
this O
family O
. O

The O
contact O
may O
be O
reached O
at O
( O
754 O
) O
791 O
7976 O
. O

Parents O
have O
been O
very O
involved O
and O
appropriate O
with O
infant O
and O
have O
eagerly O
learned O
to O
care O
for O
their O
baby O
. O

Condition O
at O
time O
of O
transfer O
is O
good O
. O

Discharge O
disposition O
is O
to O
level O
2 O
nursery O
at O
Jordan O
Hospital O
Hospital O
. O

Name O
of O
primary O
pediatrician O
is O
Ashley O
Daley O
of O
Village O
Pediatrics O
in O
Stockbridge O
. O

Feedings O
at O
the O
time O
of O
transfer O
include O
breast O
milk O
30 O
with O
ProMod B-TREATMENT
at O
150 O
cc O
per O
kg O
per O
day O
, O
all O
gavage B-TREATMENT
given O
over O
one O
hour O
. O

Medications B-TREATMENT
include O
Fer-In-Norman B-TREATMENT
, O
vitamin B-TREATMENT
E I-TREATMENT
5 O
international O
units O
each O
day O
and O
caffeine B-TREATMENT
citrate I-TREATMENT
once O
a O
day O
. O

Car O
seat O
positioning O
screening O
has O
not O
been O
obtained O
. O

Newborn O
state O
screens O
have O
been O
sent O
per O
protocol O
. O

Results O
have O
been O
in O
the O
normal O
range O
. O

IMMUNIZATIONS O
RECEIVED O
: O

Mychelia O
received O
hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
on O
11-02 O
due O
to O
unknown O
maternal O
hepatitis O
B O
surface O
antigen O
status O
. O

She O
also O
received O
hepatitis B-TREATMENT
B I-TREATMENT
immune I-TREATMENT
globulin I-TREATMENT
on O
11-02 O
. O

On O
12-06 O
, O
she O
received O
her B-TREATMENT
second I-TREATMENT
hepatitis I-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
. O

Her B-TREATMENT
two I-TREATMENT
month I-TREATMENT
immunizations I-TREATMENT
have O
not O
yet O
been O
given O
. O

IMMUNIZATIONS O
RECOMMENDED O
: O

Synagis B-TREATMENT
RSV I-TREATMENT
prophylaxis I-TREATMENT
should O
be O
considered O
from O
November O
through O
March O
for O
infants O
who O
meet O
any O
of O
the O
following O
three O
criteria O
: O

1) O
born O
at O
less O
than O
32 O
weeks O
, O

2) O
born O
at O
between O
32 O
and O
35 O
weeks O
with O
two O
of O
the O
following O
: O

Daycare O
during O
RSV O
season O
, O
a O
smoker O
in O
the O
household O
, O
neuromuscular B-SYMPTOM
disease I-SYMPTOM
, O
airway B-SYMPTOM
abnormalities I-SYMPTOM
or O
school O
age O
siblings O
or O

3) O
infants O
with O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
. O

Influenza B-TREATMENT
immunization I-TREATMENT
is O
recommended O
annually O
in O
the O
fall O
for O
all O
infants O
once O
they O
reach O
6 O
months O
of O
age O
. O

Before O
this O
age O
and O
for O
the O
first O
24 O
months O
of O
the O
infant O
's O
life O
, O
immunization B-TREATMENT
against O
influenza B-SYMPTOM
is O
recommended O
for O
household O
contacts O
and O
out O
of O
home O
caregivers O
. O

Follow-up O
appointments O
recommended O
with O
the O
primary O
pediatrician O
, O
Dr. O
Marilyn O
Daley O
of O
Stockbridge O
, O
Village O
Pediatrics O
, O
Dr. O
Lynn O
Warren O
of O
Neurology O
from O
Emerson O
Hospital O
and O
Ophthalmology O
to O
follow O
her O
ophthalmology O
status O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Prematurity B-SYMPTOM
at O
28-2/7 O
weeks O
. O

2. O
Surfactant B-SYMPTOM
deficiency I-SYMPTOM
. O

3. O
Hypotension B-SYMPTOM
. O

4. O
Sepsis B-SYMPTOM
suspect O
. O

5. O
Physiologic B-SYMPTOM
jaundice I-SYMPTOM
. O

6. O
Coagulase B-SYMPTOM
negative I-SYMPTOM
bacteremia I-SYMPTOM
. O

7. O
Anemia B-SYMPTOM
of O
prematurity B-SYMPTOM
. O

8. O
Apnea B-SYMPTOM
of O
prematurity B-SYMPTOM
. O

9. O
Absent B-SYMPTOM
septum I-SYMPTOM
pellucidum I-SYMPTOM
. O

Rosalie O
Gloria O
, O
North O
Dakota O
67177 O

Dictated O
By O
: O
George O
D O
Gregory O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-12-10 O
12:41:22 O

T O
: O
2013-12-10 O
14:03:32 O

Job O
# O
: O
48183 O

Signed O
electronically O
by O
: O
DR. O
Yolanda O
Corona O
on O
: O
WED O
2013-12-11 O
11:46 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2018-05-26 O

Discharge O
Date O
: O

2018-06-13 O

Date O
of O
Birth O
: O

1966-02-20 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Collette O
C. O
Higa O
, O
M.D. O

Chief O
Complaint O
: O

Altered B-SYMPTOM
Mental I-SYMPTOM
Status I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Intubatation B-TREATMENT

Central B-TREATMENT
line I-TREATMENT
placement I-TREATMENT

History O
of O
Present O
Illness O
: O

52 O
y.o. O
male O
with O
ESLD B-SYMPTOM
due O
to O
HCV B-SYMPTOM
/ O
EtOH B-SYMPTOM
Cirrhosis I-SYMPTOM
now O
with O
delta B-SYMPTOM
MS I-SYMPTOM
. O

Recently O
d/c O
'd O
on O
05-15 O
after O
admission O
for O
hepatic B-SYMPTOM
encephalopathy I-SYMPTOM
versus O
opiate B-SYMPTOM
abuse I-SYMPTOM
. O

Brought O
in O
by O
family O
for O
ams B-SYMPTOM
. O

No O
hx O
available O
at O
Youville O
Hospital O
Katherine O
, O
except O
for O
abdominal B-SYMPTOM
pain I-SYMPTOM
. O

Increasing B-SYMPTOM
tachypnea I-SYMPTOM
and O
tachycardia B-SYMPTOM
in O
Leola O
, O
cxr O
with O
likely O
aspiration B-SYMPTOM
pna I-SYMPTOM
versus O
chf B-SYMPTOM
, O
intubated B-TREATMENT
. O

Started O
on O
levo B-TREATMENT
/ O
flagyl B-TREATMENT
/ O
ceftriaxone B-TREATMENT
and O
lasix B-TREATMENT
for O
sbp B-SYMPTOM
and O
questionable O
meningitis B-SYMPTOM
. O

Past O
Medical O
History O
: O

1. O
HCV/ETOH B-SYMPTOM
Cirrhosis I-SYMPTOM

2. O
H/O O
SBP B-SYMPTOM

3. O
Esoph B-SYMPTOM
Varices I-SYMPTOM
( I-SYMPTOM
Grade I-SYMPTOM
I I-SYMPTOM
) I-SYMPTOM

4. O
Depression B-SYMPTOM

5. O
H/O O
IVDU O
( O
Heroin O
) O

6. O
Recurrent B-SYMPTOM
ARF I-SYMPTOM

7. O
H/O O
Seizure B-SYMPTOM

8. O
Chronic B-SYMPTOM
LBP I-SYMPTOM

9. O
Anemia B-SYMPTOM

Social O
History O
: O

The O
patient O
lives O
with O
his O
two O
sons O
. O

Charles O
quit O
using O
Cocaine O
, O
ETOH O
, O
and O
IV O
Heroin O
two O
years O
ago O
, O
and O
his O
son O
is O
unaware O
of O
any O
relapses O
. O

He O
currently O
smokes O
, O
about O
1 O
ppd O
. O

Family O
History O
: O

His O
father O
had O
Hemochromatosis B-SYMPTOM
and O
DMII B-SYMPTOM
. O

Physical O
Exam O
: O

101.8 O
, O
100 O
, O
144/92 O
, O
18 O
, O
98% O
3lnc O
lying O
in O
bed O
, O
oriented O
hospital O
only O
scleral B-SYMPTOM
icterus I-SYMPTOM
tachy B-SYMPTOM
but O
reg B-SYMPTOM
diffusely I-SYMPTOM
ttp I-SYMPTOM
and O
guaiac O
negative O
non-pitting B-SYMPTOM
brawny I-SYMPTOM
edema I-SYMPTOM
with O
lichenification B-SYMPTOM

Pertinent O
Results O
: O
wbc O
6.7 O
46% O
pmn O
40% O
bands O
, O
na O
128 O
tbili O
9.1 O
, O
alb O
2.3 O
, O
inr O
2.1 O
, O
lactate O
4.4 O
ecg O
unremarkable O

1st O
cxr O
normal O
; O
2nd O
prior O
to O
intubation B-TREATMENT
? O
rll B-SYMPTOM
opacity I-SYMPTOM
( O
mild B-SYMPTOM
chf I-SYMPTOM
? O
) O
ascites B-SYMPTOM
: O

2900 O
wbc O
98% O
pmn O
, O
suspcious O
for O
intra B-SYMPTOM
/ I-SYMPTOM
extracellular I-SYMPTOM
bact I-SYMPTOM

Brief O
Hospital O
Course O
: O

SBP B-SYMPTOM
: O

Pt O
admitted O
with O
E B-SYMPTOM
coli I-SYMPTOM
SPB I-SYMPTOM
and O
bacteremia B-SYMPTOM
. O

Was O
treated O
with O
ceftriaxone B-TREATMENT
2 O
gm O
IV O
daily O
with O
multiple B-TREATMENT
repeat I-TREATMENT
paracenteses I-TREATMENT
. O

Repeat O
taps O
did O
not O
revealed O
evidence O
of O
infection B-SYMPTOM
. O

Patient O
was O
treated O
with O
14 O
days O
of O
levoflox B-TREATMENT
. O

Resp B-SYMPTOM
failure I-SYMPTOM
: O

Unclear O
etiology O
, O
but O
likely O
aspiration B-SYMPTOM
event I-SYMPTOM
in O
Monica O
. O

Treated O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
. O

Weaning O
and O
potential B-TREATMENT
extubation I-TREATMENT
complicated O
by O
mechanical B-SYMPTOM
disadvantage I-SYMPTOM
from O
large B-SYMPTOM
ascites I-SYMPTOM
as O
well O
as O
continued B-SYMPTOM
somnolence I-SYMPTOM
( O
off O
sedation B-TREATMENT
). O

we O
Performed O
frequent B-TREATMENT
large I-TREATMENT
vol I-TREATMENT
taps I-TREATMENT
and O
attempted O
to O
give O
diuretics B-TREATMENT
, O
but O
were O
limited O
by O
renal B-SYMPTOM
failure I-SYMPTOM
. O

The B-SYMPTOM
ascites I-SYMPTOM
quickly O
accumulated O
after O
each B-TREATMENT
tap I-TREATMENT
. O

Patient O
was O
not O
a O
TIPS O
candidate O
. O

Cirrhosis B-SYMPTOM
: O

End-stage B-SYMPTOM
cirrhosis I-SYMPTOM
with O
refractory B-SYMPTOM
ascites I-SYMPTOM
. O

Each O
time O
we O
have O
initiated O
diuretics B-TREATMENT
, O
creatinine O
rose O
. O

Patient O
was O
continued O
on O
nadolol B-TREATMENT
( O
as O
bp O
tolerated O
) O
and O
lactulose B-TREATMENT
) O

Renal B-SYMPTOM
failure I-SYMPTOM
: O

Creatinine B-SYMPTOM
elevation I-SYMPTOM
appears O
to O
be O
related O
to O
both O
elevated B-SYMPTOM
abdominal I-SYMPTOM
pressures I-SYMPTOM
from O
ascites B-SYMPTOM
as O
well O
as O
to O
attempts O
at O
diuresis B-TREATMENT
. O

AMS B-SYMPTOM
: O

Likely O
hepatic B-SYMPTOM
encepholopathy I-SYMPTOM
initially O
, O
and O
later O
likely O
related O
to O
sedation B-TREATMENT
and O
delayed B-SYMPTOM
clearance I-SYMPTOM
from O
liver B-SYMPTOM
disease I-SYMPTOM
. O

Patient O
became O
increasingly O
hypotensive B-SYMPTOM
with O
a B-SYMPTOM
rising I-SYMPTOM
cr I-SYMPTOM
, O
eventually O
becoming O
pressor B-SYMPTOM
dependent I-SYMPTOM
. O

Family O
meeting O
was O
held O
to O
discuss O
grave O
prognosis O
, O
and O
patient O
was O
made O
cmo B-TREATMENT
. O

He O
passed O
away O
shortly O
thereafter O
. O

Medications O
on O
Admission O
: O
patient O
passed O
away O

Discharge O
Medications O
: O
patient O
passed O
away O

Discharge O
Disposition O
: O

Expired O

Discharge O
Diagnosis O
: O
patient O
passed O
away O

Discharge O
Condition O
: O
patient O
passed O
away O

Discharge O
Instructions O
: O
patient O
passed O
away O

Followup O
Instructions O
: O
patient O
passed O
away O

Efrain O
Zavala O
MD O
02-024 O

Completed O
by O
: O
Marcel O
L O
Beatty O
, O
M.D. O

Admission O
Date O
: O

2011-03-06 O

Discharge O
Date O
: O

2011-03-21 O

Date O
of O
Birth O
: O

1945-09-15 O

Sex O
: O

M O

Service: O

ADDENDUM O
: O

Addendum O
to O
hospital O
course O
. O

The O
patient O
's O
actual O
date O
of O
discharge O
was O
2011-03-21 O
. O

The O
patient O
will O
be O
discharged O
to O
rehabilitation B-TREATMENT
in O
Brain O
Tree O
Maryland O
. O

Service O
is O
actually O
Medicine O
, O
Newburyport O
Firm O
not O
C-CMED O
. O

The O
Jewish O
Memorial O
Hospital O
hospital O
course O
over O
the O
1-day O
addendum O
is O
improving O
. O

The O
patient O
is O
diuresing O
well O
, O
negative O
2 O
liters O
again O
per O
day O
. O

The O
patient O
will O
be O
continued O
on O
medications B-TREATMENT
per O
Discharge O
Summary O
with O
the O
addition O
of O
captopril B-TREATMENT
ACE I-TREATMENT
inhibitor I-TREATMENT
since O
the O
patient O
's O
blood O
pressure O
is O
stable O
. O

The O
patient O
with O
no O
new B-SYMPTOM
events I-SYMPTOM
. O

The O
patient O
's O
condition O
on O
discharge O
was O
stable O
and O
improved O
. O

The O
patient O
continues O
to O
improve O
with O
regard O
to O
his B-SYMPTOM
scrotal I-SYMPTOM
and I-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
. O

The O
patient O
has O
no O
lower B-SYMPTOM
extremity I-SYMPTOM
ulcers I-SYMPTOM
, O
and O
all B-SYMPTOM
former I-SYMPTOM
leg I-SYMPTOM
excoriations I-SYMPTOM
are O
healing O
well O
. O

The O
patient O
ambulating O
three O
to O
four O
times O
per O
day O
and O
able O
to O
get O
out O
of O
bed O
using O
a B-TREATMENT
walker I-TREATMENT
. O

The O
patient O
will O
get O
rehabilitation B-TREATMENT
and O
continue O
to O
get O
care O
for O
his B-SYMPTOM
fluid I-SYMPTOM
status I-SYMPTOM
. O

Shirley O
H.Q. O
Neller O
, O
M.D. O

56-333 O

Dictated O
By:Caroline O
D O
Dempsey O
, O
M.D. O

MEDQUIST36 O

D O
: O

2011-03-21 O

14:42 O

T O
: O

2011-03-23 O

13:01 O

JOB# O
: O

42266 O

Signed O
electronically O
by O
: O

DR. O
Shirley O
X O
Schaack O
on O
: O

Russell O
2011-03-24 O
7:54 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-08-26 O

Discharge O
Date O
: O

2013-09-17 O

Date O
of O
Birth O
: O

1945-02-07 O

Sex O
: O

M O

Service: O

NOTE O
: O

The O
Discharge O
Date O
of O
2013-09-17 O
is O
pending O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Briefly O
, O
this O
68 O
year O
old O
male O
with O
a O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
, O
was O
admitted O
originally O
to O
the O
Podiatry O
Service O
for O
a B-SYMPTOM
left I-SYMPTOM
patellar I-SYMPTOM
mid-foot I-SYMPTOM
ulcer I-SYMPTOM
. O

He O
underwent O
angiogram O
on O
2013-08-28 O
, O
to O
evaluate O
his O
circulation O
and O
found O
at O
that O
time O
that O
the O
patient O
had O
a B-SYMPTOM
poor I-SYMPTOM
circulation I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
leg I-SYMPTOM
. O

The O
patient O
was O
transferred O
to O
the O
Vascular O
Surgery O
Service O
for O
bilateral B-TREATMENT
iliac I-TREATMENT
stenting I-TREATMENT
at O
that O
time O
. O

The O
patient O
also O
at O
that O
time O
was O
followed O
by O
Cardiology O
and O
for O
preoperative O
evaluation O
had O
a O
stress O
test O
which O
was O
positive B-SYMPTOM
and O
he O
became O
diaphoretic B-SYMPTOM
but O
denied O
any B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
. O

Atropine B-TREATMENT
was O
given O
and O
heart O
rate O
returned O
to O
the O
70s O
and O
his O
blood O
pressure O
returned O
to O
the O
120s O
over O
80s O
. O

The O
patient O
denied O
any O
orthopnea B-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
paroxysmal B-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
or O
cough B-SYMPTOM
. O

He O
had O
occasional B-SYMPTOM
leg I-SYMPTOM
swelling I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY: O

1 O
. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
2006 O
and O
1997 O
and O
status O
post O
percutaneous B-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
times O
two O
. O

2. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
type I-SYMPTOM
2 I-SYMPTOM
since O
age O
25 O
; O
now O
currently O
on O
insulin B-TREATMENT
, O
which O
is O
complicated O
by O
peripheral B-SYMPTOM
neuropathy I-SYMPTOM
, O
nephropathy B-SYMPTOM
and O
Charcot B-SYMPTOM
's I-SYMPTOM
foot I-SYMPTOM
. O

3. O
Chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

4. O
Peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
status O
post O
left B-TREATMENT
iliac I-TREATMENT
stent I-TREATMENT
and O
right B-TREATMENT
femoral I-TREATMENT
stent I-TREATMENT
. O

5. O
Hypertension B-SYMPTOM
. O

6. O
High B-SYMPTOM
cholesterol I-SYMPTOM
. O

7. O
Question O
of O
tendonitis B-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Insulin B-TREATMENT
70/30 O
, O
40 O
units O
q. O
a.m. O
and O
40 O
units O
q. O
p.m. O

2. O
Diovan B-TREATMENT
160 O
mg O
p.o. O
q. O
day O
. O

3. O
Nortriptyline B-TREATMENT
25 O
mg O
p.o. O
q. O
h.s. O

4. O
Norvasc B-TREATMENT
10 O
mg O
p.o. O
q. O
day O
. O

5. O
Metoprolol B-TREATMENT
50 O
mg O
p.o. O
twice O
a O
day O
. O

6. O
Hydrochlorothiazide B-TREATMENT
, O
15 O
mg O
p.o. O
q. O
day O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
was O
afebrile B-SYMPTOM
; O
his O
vital O
signs O
were O
stable O
. O

His O
neck O
was O
supple O
; O
he O
had O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
. O

His O
carotids O
were O
two O
plus O
bilaterally O
without O
bruits B-SYMPTOM
. O

His O
lungs O
were O
clear O
. O

His O
heart O
was O
regular O
rate O
and O
rhythm O
with O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
. O

His O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Bowel O
sounds O
are O
present O
. O

He O
had O
bilateral B-SYMPTOM
femoral I-SYMPTOM
bruits I-SYMPTOM
and O
he O
had O
one O
plus O
popliteal O
pulses O
. O

His O
pedal O
pulses O
are O
absent B-SYMPTOM
. O

LABORATORY O
: O

On O
admission O
, O
his O
BUN O
was O
13 O
, O
creatinine O
1.7 O
, O
hematocrit O
43 O
and O
the O
cholesterol O
was O
208 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
is O
admitted O
to O
this O
hospital O
through O
the O
Podiatry O
Service O
; O
however O
, O
the O
stress O
test O
showed O
multi-vessel B-SYMPTOM
disease I-SYMPTOM
. O

Podiatry O
continued O
to O
follow O
for O
evaluation O
of O
his B-SYMPTOM
left I-SYMPTOM
foot I-SYMPTOM
ulcer I-SYMPTOM
. O

At O
the O
time O
of O
discharge O
, O
he O
was O
having O
acetic B-TREATMENT
acid I-TREATMENT
wet-to-dry I-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
, O
0.25% O
q. O
day O
. O

Vascular O
Surgery O
was O
following O
at O
the O
same O
time O
and O
decided O
that O
bilateral B-TREATMENT
iliac I-TREATMENT
stenting I-TREATMENT
would O
be O
the B-TREATMENT
most I-TREATMENT
optimum I-TREATMENT
treatment I-TREATMENT
currently O
and O
suggested O
that O
the O
patient O
should O
be O
worked O
up O
for O
cardiac B-SYMPTOM
disease I-SYMPTOM
prior O
to O
re-vascularization B-TREATMENT
. O

Medicine O
was O
also O
consulted O
at O
that O
time O
for O
high B-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
and O
for O
the B-SYMPTOM
biceps I-SYMPTOM
pain I-SYMPTOM
. O

While O
having O
angiography O
, O
he O
had O
a B-SYMPTOM
transient I-SYMPTOM
increase I-SYMPTOM
in O
his O
blood O
pressure O
and O
became O
diaphoretic B-SYMPTOM
and O
thus O
precipitated O
the O
evaluation O
for O
cardiac B-SYMPTOM
disease I-SYMPTOM
. O

Cardiology O
was O
consulted O
at O
that O
time O
to O
evaluate O
his O
heart O
. O

The O
patient O
was O
managed O
on O
the O
Medical O
Service O
for O
his B-SYMPTOM
drop I-SYMPTOM
in O
blood O
pressure O
and O
cardiac O
evaluation O
. O

He O
was O
also O
followed O
by O
Podiatry O
and O
Vascular O
Surgery O
. O

He O
was O
taken O
to O
the O
Cardiac O
Catheterization O
Laboratory O
which O
showed O
multi-vessel B-SYMPTOM
disease I-SYMPTOM
and O
Cardiothoracic O
Surgery O
was O
consulted O
. O

The O
patient O
was O
taken O
to O
the O
Operating O
Room O
on O
2013-09-04 O
, O
where O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
four O
was O
performed O
, O
left B-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
to I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
diagonal I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
obtuse I-TREATMENT
marginal I-TREATMENT
and O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
PC I-TREATMENT
by O
Dr. O
Wright O
. O

The O
patient O
was O
transferred O
to O
the O
CSRU O
postoperatively O
where O
he O
did O
well O
. O

He O
was O
slowly O
weaned O
from O
his B-TREATMENT
ventilator I-TREATMENT
and O
was O
able O
to O
be O
extubated O
. O

The O
patient O
was O
able O
to O
be O
weaned O
to O
six B-TREATMENT
liters I-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
after O
extubation B-TREATMENT
, O
however O
, O
it O
was O
noted O
on O
chest O
x-ray O
that O
he O
had O
a B-SYMPTOM
small I-SYMPTOM
apical I-SYMPTOM
pneumothorax I-SYMPTOM
. O

A O
repeat O
chest O
x-ray O
showed O
resolution O
of O
that B-SYMPTOM
pneumothorax I-SYMPTOM
. O

The O
patient O
was O
continued O
on O
an B-TREATMENT
insulin I-TREATMENT
drip I-TREATMENT
for O
his B-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
but O
continued O
to O
improve O
. O

His B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
in O
place O
for O
a B-SYMPTOM
high I-SYMPTOM
chest I-SYMPTOM
tube I-SYMPTOM
output I-SYMPTOM
. O

His B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
was O
removed O
and O
the O
patient O
was O
transferred O
to O
the O
Floor O
. O

Physical O
Therapy O
was O
consulted O
in O
order O
to O
assess O
the O
patient O
's O
ambulation O
and O
mobility O
, O
however O
, O
with O
his B-SYMPTOM
foot I-SYMPTOM
infection I-SYMPTOM
and O
associated B-SYMPTOM
pain I-SYMPTOM
, O
it O
was O
difficult O
to O
assess O
at O
that O
time O
. O

After O
arriving O
on O
the O
Floor O
, O
the O
patient O
had O
an O
episode O
of O
rapid B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
which O
was O
treated O
with O
amiodarone B-TREATMENT
and O
Lopressor B-TREATMENT
. O

The O
patient O
resolved O
, O
however O
, O
Lasix B-TREATMENT
was O
also O
given O
due O
to O
some B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
and O
increasing B-SYMPTOM
oxygen I-SYMPTOM
need I-SYMPTOM
. O

The O
patient O
continued O
to O
have O
episodes O
of O
rapid B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
while O
on O
the O
Floor O
, O
which O
required O
continued O
diuresis B-TREATMENT
as O
well O
as O
intravenous B-TREATMENT
Lopressor I-TREATMENT
. O

His B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
and O
Foley B-TREATMENT
catheter I-TREATMENT
were O
removed O
on O
postoperative O
day O
number O
three O
, O
and O
the O
patient O
had O
aggressive B-TREATMENT
chest I-TREATMENT
Physical I-TREATMENT
Therapy I-TREATMENT
and O
nebulizer B-TREATMENT
treatments I-TREATMENT
. O

His B-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
for I-TREATMENT
his I-TREATMENT
foot I-TREATMENT
continued O
per O
the O
Podiatry O
Service O
and O
his B-SYMPTOM
leg I-SYMPTOM
ulcer I-SYMPTOM
was O
noted O
to O
be O
slowly O
healing O
. O

The O
patient O
had O
multiple O
episodes O
of O
rapid B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
which O
again O
required O
intravenous B-TREATMENT
Lopressor I-TREATMENT
. O

Amiodarone B-TREATMENT
boluses I-TREATMENT
were O
given O
and O
the O
patient O
was O
started O
on O
400 O
three O
times O
a O
day O
of O
p.o. B-TREATMENT
amiodarone I-TREATMENT
, O
aggressive B-TREATMENT
pulmonary I-TREATMENT
toilet I-TREATMENT
and O
continued B-TREATMENT
diuresis I-TREATMENT
was O
done O
, O
however O
, O
the O
patient O
continued O
to O
have O
respiratory B-SYMPTOM
difficulties I-SYMPTOM
when O
in O
rapid B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
. O

The O
patient O
was O
evaluated O
on O
postoperative O
day O
number O
five O
and O
it O
was O
decided O
at O
that O
time O
that O
the O
patient O
should O
be O
transferred O
back O
to O
the O
Intensive O
Care O
Unit O
for O
respiratory B-SYMPTOM
difficulties I-SYMPTOM
. O

He O
was O
transferred O
back O
to O
the O
Surgical O
Intensive O
Care O
Unit O
where O
he O
was O
aggressively O
diuresed O
as O
well O
as O
his O
rate O
was O
controlled O
and O
chest B-TREATMENT
Physical I-TREATMENT
Therapy I-TREATMENT
and O
nebulizer B-TREATMENT
treatments I-TREATMENT
were O
done O
. O

The O
patient O
improved O
slowly O
. O

Also O
, O
his O
white O
blood O
cell O
count O
was O
found O
to O
rise O
to O
32.0 O
; O
this O
was O
most O
likely O
due O
to O
a B-SYMPTOM
secondary I-SYMPTOM
infection I-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
foot I-SYMPTOM
and O
Zosyn B-TREATMENT
was O
started O
. O

The O
patient O
continued O
to O
do O
well O
and O
his B-SYMPTOM
recurrent I-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
slowly O
improved O
; O
p.o. O
doses O
of O
Lopressor B-TREATMENT
slowly O
increased O
to O
get O
better O
control O
of O
his O
rate O
and O
the O
patient O
was O
able O
to O
be O
controlled O
with O
a O
heart O
rate O
in O
the O
50s O
to O
60s O
with O
Lopressor B-TREATMENT
. O

Following O
initiation O
of O
his B-TREATMENT
Zosyn I-TREATMENT
, O
the O
white O
count O
continued O
to O
improve O
and O
the O
patient O
was O
planned O
for O
a B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
for O
long-term B-TREATMENT
intravenous I-TREATMENT
antibiotics I-TREATMENT
. O

The O
patient O
was O
started O
on O
Lopressor B-TREATMENT
75 O
mg O
p.o. O
twice O
a O
day O
with O
good O
control O
with O
a O
heart O
rate O
of O
50s O
to O
60s O
. O

He O
is O
in O
sinus O
rhythm O
. O

He O
was O
also O
started O
on O
his B-TREATMENT
preoperative I-TREATMENT
medications I-TREATMENT
of O
Amlodipine B-TREATMENT
and O
Losartan B-TREATMENT
with O
improvement O
of O
his O
blood O
pressure O
. O

The O
patient O
was O
also O
reduced O
to O
400 O
mg O
q. O
day O
of O
amiodarone B-TREATMENT
. O

Pulmonary O
was O
consulted O
at O
this O
time O
for O
this B-SYMPTOM
difficulty I-SYMPTOM
of I-SYMPTOM
diuresis I-SYMPTOM
and O
pulmonary B-SYMPTOM
edema I-SYMPTOM
. O

They O
continued O
to O
agree O
with O
the O
management O
of O
the O
patient O
and O
with O
aggressive B-TREATMENT
pulmonary I-TREATMENT
toilet I-TREATMENT
as O
well O
as O
diuresis B-TREATMENT
and O
nebulizer B-TREATMENT
treatment I-TREATMENT
. O

The O
patient O
was O
transferred O
back O
from O
the O
Intensive O
Care O
Unit O
on O
2013-09-13 O
, O
and O
upon O
arriving O
on O
the O
floor O
, O
he O
continued O
to O
do O
well O
. O

Pulmonary B-TREATMENT
toilet I-TREATMENT
and O
aggressive B-TREATMENT
chest I-TREATMENT
Physical I-TREATMENT
Therapy I-TREATMENT
was O
continued O
and O
the O
patient O
was O
able O
to O
be O
weaned O
from O
his B-TREATMENT
oxygen I-TREATMENT
. O

Furthermore O
, O
his B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
was O
removed O
and O
he O
was O
started O
on O
anti-coagulation B-TREATMENT
for O
his O
episodes O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

He O
had O
been O
started O
on O
heparin B-TREATMENT
in O
the O
Intensive O
Care O
Unit O
and O
that O
was O
continued O
. O

Coumadin B-TREATMENT
was O
then O
begun O
with O
a O
goal O
INR O
of O
2.0 O
to O
3.0 O
. O

At O
that O
time O
he O
was O
stabilized O
from O
a O
cardiac O
perspective O
. O

Podiatry O
and O
Vascular O
Surgery O
were O
reconsulted O
to O
assess O
the O
patient O
's O
needs O
for O
revascularization B-TREATMENT
and O
for O
his B-SYMPTOM
foot I-SYMPTOM
ulcer I-SYMPTOM
. O

It O
was O
decided O
at O
that O
time O
that O
the O
patient O
could O
be O
discharged O
in O
follow-up O
with O
Vascular O
Surgery O
for O
revascularization B-TREATMENT
and O
Podiatry O
thereafter O
. O

On O
2013-08-28 O
, O
the O
patient O
had O
a B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
placed O
for O
a O
six O
week O
course O
of O
intravenous B-TREATMENT
Zosyn I-TREATMENT
for O
his B-SYMPTOM
foot I-SYMPTOM
ulcer I-SYMPTOM
and O
his B-TREATMENT
Coumadin I-TREATMENT
was O
also O
continued O
. O

The O
patient O
did O
well O
and O
was O
discharged O
to O
a O
rehabilitation O
facility O
at O
that O
time O
. O

His O
discharge O
date O
is O
pending O
. O

CURRENT O
DISCHARGE O
MEDICATIONS O
: O

1. O
Regular B-TREATMENT
insulin I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

2. O
Coumadin B-TREATMENT
7.5 O
mg O
p.o. O
q.d. O
for O
an O
INR O
goal O
of O
2.0 O
to O
3.0 O
and O
adjust O
the O
dose O
accordingly O
. O

3. O
Acetic B-TREATMENT
acid I-TREATMENT
0.25% O
wet-to-dry B-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
q. O
day O
for O
his B-SYMPTOM
left I-SYMPTOM
foot I-SYMPTOM
ulcer I-SYMPTOM
. O

4. O
Amiodarone B-TREATMENT
400 O
mg O
q. O
day O
. O

5. O
Albuterol B-TREATMENT
nebulizers I-TREATMENT
q. O
four O
hours O
and O
q. O
two O
hours O
p.r.n. O

6. O
Losartan B-TREATMENT
50 O
mg O
p.o. O
q. O
day O
. O

7. O
Iron B-TREATMENT
325 O
mg O
p.o. O
q. O
day O
. O

8. O
Albuterol B-TREATMENT
ipratropium B-TREATMENT
two O
puffs O
four O
times O
a O
day O
. O

9. O
Zosyn B-TREATMENT
4.5 O
grams O
intravenously O
q. O
six O
hours O
times O
six O
weeks O
; O
started O
on O
09-10 O
. O

10. O
Lipitor B-TREATMENT
10 O
mg O
p.o. O
q. O
day O
. O

11. O
Amlodipine B-TREATMENT
10 O
mg O
p.o. O
q. O
day O
. O

12. O
Nortriptyline B-TREATMENT
25 O
mg O
p.o. O
q. O
h.s. O

13. O
Mecsazopam B-TREATMENT
15 O
to O
30 O
mg O
p.o. O
q. O
h.s. O
p.r.n. O

14. O
Dulcolax B-TREATMENT
10 O
mg O
p.o. O
or O
p.r. O
q. O
day O
p.r.n. O

15. O
Milk B-TREATMENT
of I-TREATMENT
Magnesia I-TREATMENT
30 O
cc O
, O
p.o. O
q. O
h.s. O
p.r.n. O

16. O
Percocet B-TREATMENT
one O
to O
two O
tablets O
p.o. O
q. O
four O
hours O
p.r.n. O

17. O
Zantac B-TREATMENT
150 O
p.o. O
twice O
a O
day O
. O

18. O
Colace B-TREATMENT
100 O
mg O
p.o. O
twice O
a O
day O
. O

19. O
Alexandria O
Daly O
20 O
mEq O
p.o. O
twice O
a O
day O
. O

20. O
Lasix B-TREATMENT
20 O
mg O
intravenous O
twice O
a O
day O
. O

21. O
Lopressor B-TREATMENT
75 O
mg O
p.o. O
twice O
a O
day O
. O

DISCHARGE O
STATUS O
: O

The O
patient O
is O
discharged O
to O
rehabilitation O
. O

CONDITION O
AT O
DISCHARGE O
: O

Stable O
condition O
. O

DISCHARGE O
INSTRUCTIONS: O

1. O
He O
is O
instructed O
to O
follow-up O
with O
Dr. O
Holloway O
in O
four O
weeks O
. O

2. O
He O
is O
to O
follow-up O
with O
his O
primary O
care O
physician O
in O
one O
to O
two O
weeks O
. O

3. O
Follow-up O
with O
Cardiologist O
in O
four O
weeks O
. O

4. O
He O
is O
also O
instructed O
to O
follow-up O
with O
Vascular O
Surgery O
and O
Podiatry O
for O
revascularization B-TREATMENT
at O
the O
appropriate O
time O
frame O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
status O
post O
percutaneous B-TREATMENT
transluminal I-TREATMENT
coronary I-TREATMENT
angioplasty I-TREATMENT
, O
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

2. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
type I-SYMPTOM
2 I-SYMPTOM
, O
now O
currently O
on O
insulin B-TREATMENT
. O

3. O
Chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

4. O
Peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
status O
post O
bilateral B-TREATMENT
iliac I-TREATMENT
stenting I-TREATMENT
. O

5. O
Hypertension B-SYMPTOM
. O

6. O
High B-SYMPTOM
cholesterol I-SYMPTOM
. O

7. O
Question O
tendonitis B-SYMPTOM
with O
left B-SYMPTOM
biceps I-SYMPTOM
pain I-SYMPTOM
. O

8. O
Left B-SYMPTOM
foot I-SYMPTOM
ulcer I-SYMPTOM
status O
post O
debridement B-TREATMENT
. O

PLEASE O
SEE O
ADDENDUM O
FOR O
ANY O
CHANGE O
IN O
MEDICATIONS O
AND O
DISCHARGE O
DATE O
. O

Donna O
B. O
Christensen O
, O
M.D. O
31-932 O

Dictated O
By O
: O
Ervin O
Y. O
Nobles O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-09-16 O
16:00 O

T O
: O
2013-09-16 O
16:11 O

JOB O
# O
: O
82277 O

Signed O
electronically O
by O
: O
DR. O
Kenneth O
Din O
on O
: O
TUE O
2013-09-17 O
11:14 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2012-05-13 O

Discharge O
Date O
: O

2012-05-22 O

Date O
of O
Birth O
: O

2012-05-13 O

Sex O
: O

M O

Service O
: O

Neonatology O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Fred O
Grauman O
is O
the O
former O
2.252 O
kg O
product O
of O
a O
35-1/7 O
week O
gestation O
pregnancy O
born O
to O
a O
37-year-old O
G4 O
P3-5 O
woman O
. O

Prenatal O
screens O
: O

Blood O
type O
O+ O
, O
antibody O
negative O
, O
rubella O
immune O
, O
RPR O
nonreactive O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
group B-SYMPTOM
beta I-SYMPTOM
Strep I-SYMPTOM
positive I-SYMPTOM
. O

The O
pregnancy O
was O
complicated O
by O
anemia B-SYMPTOM
. O

Mother O
has O
a O
prior O
history O
of O
mitral B-SYMPTOM
valve I-SYMPTOM
prolapse I-SYMPTOM
. O

She O
had O
a B-TREATMENT
prior I-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
done O
, O
two O
vaginal O
births O
after O
cesarean B-TREATMENT
section I-TREATMENT
. O

She O
presented O
in O
labor O
on O
the O
day O
of O
delivery O
. O

These O
infants O
were O
delivered O
by O
repeat B-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
, O
this O
twin O
emerged O
with O
good O
tone O
, O
color O
, O
and O
cry O
. O

Apgars O
were O
eight O
at O
one O
minute O
and O
nine O
at O
five O
minutes O
. O

He O
was O
admitted O
to O
the O
Neonatal O
Intensive O
Care O
Unit O
for O
treatment B-TREATMENT
of O
prematurity B-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
UPON O
ADMISSION O
TO O
THE O
NEONATAL O
INTENSIVE O
CARE O
UNIT O
: O

Weight O
2.252 O
kg O
, O
65th O
percentile; O
length O
46 O
cm O
, O
50th O
percentile O
; O
head O
circumference O
33 O
cm O
75th O
percentile O
. O

General O
: O

A O
nondysmorphic O
preterm O
35 O
week O
gestation O
male O
. O

Skin O
: O

Color O
pink O
in O
room O
air O
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
, O
and O
throat O
: O

Anterior O
fontanel O
open O
, O
level O
and O
soft O
. O

Sutures O
are O
proximated O
. O

Positive O
red O
reflex O
bilaterally O
. O

Palate O
intact O
. O

Chest O
: O

Mild B-SYMPTOM
retractions I-SYMPTOM
, O
occasional B-SYMPTOM
grunting I-SYMPTOM
. O

Breath O
sounds O
equal O
with O
good O
aeration O
. O

Cardiovascular O
: O

Regular O
, O
rate O
, O
and O
rhythm O
, O
no O
murmur B-SYMPTOM
. O

Pulses O
+2 O
. O

Abdomen O
is O
soft O
, O
nontender B-SYMPTOM
, O
no O
masses B-SYMPTOM
, O
and O
no O
hepatosplenomegaly B-SYMPTOM
. O

Genitourinary O
: O

Normal O
male O
, O
testes O
descended O
. O

Extremities O
: O

Hips O
stable O
, O
moving O
all O
. O

Spine O
intact O
. O

Neurologic O
: O

Appropriate O
tone O
and O
reflexes O
. O

HOSPITAL O
COURSE O
BY O
SYSTEMS O
INCLUDING O
PERTINENT O
LABORATORY O
DATA: O

1. O
Respiratory O
: O

Raymond O
required O
some B-TREATMENT
intermittent I-TREATMENT
blow-by I-TREATMENT
oxygen I-TREATMENT
for O
the O
first O
two O
hours O
of O
birth O
. O

He O
has O
remained O
in O
room O
air O
since O
that O
time O
. O

The B-SYMPTOM
grunting I-SYMPTOM
noted O
on O
admission O
resolved O
within O
the O
first O
few O
hours O
after O
birth O
. O

He O
did O
not O
have O
any O
episodes O
of O
spontaneous B-SYMPTOM
apnea I-SYMPTOM
or O
bradycardia B-SYMPTOM
. O

2. O
Cardiovascular O
: O

No O
murmurs B-SYMPTOM
were O
noted O
, O
although O
normal O
heart O
rates O
and O
blood O
pressures O
. O

3. O
Fluids O
, O
electrolytes O
, O
and O
nutrition O
: O

Enteral B-TREATMENT
feeds I-TREATMENT
were O
started O
on O
the O
date O
of O
birth O
and O
gradually O
advanced O
to O
full O
volume O
. O

He O
required O
some B-TREATMENT
gavage I-TREATMENT
feeds I-TREATMENT
through O
day O
of O
life O
#4 O
, O
and O
has O
been O
all O
po O
since O
day O
of O
life O
#5 O
. O

At O
the O
time O
of O
discharge O
, O
he O
is O
taking O
Enfamil B-TREATMENT
20 I-TREATMENT
calories I-TREATMENT
/ I-TREATMENT
ounce I-TREATMENT
with I-TREATMENT
iron I-TREATMENT
. O

Discharge O
weight O
is O
2.37 O
kg O
, O
head O
circumference O
32 O
cm O
, O
length O
47 O
cm O
. O

4. O
Infectious O
Disease O
: O

Due O
to O
the B-SYMPTOM
unknown I-SYMPTOM
group I-SYMPTOM
B I-SYMPTOM
Strep I-SYMPTOM
status I-SYMPTOM
and O
prematurity B-SYMPTOM
, O
Raymond O
was O
evaluated O
for O
sepsis B-SYMPTOM
. O

A O
complete O
blood O
count O
had O
a O
white O
blood O
cell O
count O
of O
13,800 O
with O
17% O
polys O
, O
0% O
bands O
. O

A O
repeat O
on O
day O
of O
life O
two O
, O
had O
a O
white O
count O
of O
13,000 O
with O
50% O
polys O
, O
0% O
bands O
. O

A O
blood O
culture O
obtained O
prior O
to O
starting O
antibiotics B-TREATMENT
was O
no O
growth B-SYMPTOM
at O
48 O
hours O
. O

5. O
Gastrointestinal O
: O

Peak O
serum O
bilirubin O
occurred O
on O
day O
of O
life O
#4 O
, O
a O
total O
of O
10.0/0.3 O
direct O
. O

A O
repeat O
bilirubin O
on O
2012-05-19 O
was O
8.0/0.3 O
direct O
. O

6. O
Hematological O
: O

Hematocrit O
at O
birth O
was O
43.8%. O

Raymond O
did O
not O
receive O
any B-TREATMENT
transfusions I-TREATMENT
of I-TREATMENT
blood I-TREATMENT
products I-TREATMENT
during O
admission O
. O

7. O
Neurology O
: O

Raymond O
has O
maintained O
normal O
neurological O
examination O
throughout O
admission O
and O
there O
were O
no O
concerns O
at O
the O
time O
of O
discharge O
. O

8. O
Sensory O
: O

Audiology O
hearing O
screening O
was O
performed O
with O
automated O
auditory O
brain O
stem O
responses O
. O

Raymond O
passed O
in O
both O
ears O
. O

CONDITION O
ON O
DISCHARGE O
: O

Good O
. O

DISCHARGE O
/ O
DISPOSITION O
: O

Home O
with O
parents O
. O

PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Timothy O
Alexander O
, O
Gloucester O

Pediatric O
Associate O
, O
8219 O
W. O
Eighth O
Rd. O
, O
Terry O
, O
Illinois O
72097 O
, O
phone O
482-5289 O
. O

CARE O
AND O
RECOMMENDATIONS O
AT O
THE O
TIME O
OF O
DISCHARGE O
: O

1. O
Feeding O
: O

Adlib O
po B-TREATMENT
Enfamil I-TREATMENT
with I-TREATMENT
iron I-TREATMENT
. O

2. O
No O
medications B-TREATMENT
. O

3. O
Car O
seat O
position O
screening O
was O
performed O
successfully O
. O

4. O
State O
Newborn O
Screen O
was O
sent O
on O
day O
of O
life O
#3 O
. O

A O
report O
of O
an B-SYMPTOM
elevated I-SYMPTOM
17-OH I-SYMPTOM
was O
called O
to O
the O
CMED O
CCU O
. O

A O
subsequent O
sample O
was O
done O
( O
05-21 O
) O
and O
results O
are O
pending O
. O

Newborn O
State O
Screen O
phone O
number O
#( O
822 O
) O
923-2683 O
. O

5. O
Immunizations B-TREATMENT
received O
: O

Hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
was O
administered O
at O
the O
time O
of O
birth O
on O
2012-05-13 O
. O

IMMUNIZATIONS O
RECOMMENDED O
: O

1. O
Synagis B-TREATMENT
RSV I-TREATMENT
prophylaxis I-TREATMENT
should O
be O
considered O
from O
October O
through O
April O
for O
infants O
who O
meet O
any O
of O
the O
following O
three O
criteria O
: O

1) O
Born O
at O
less O
than O
32 O
weeks O
, O

2) O
born O
between O
32 O
and O
35 O
weeks O
with O
plans O
for O
daycare O
during O
RSV O
season O
, O
with O
a O
smoker O
in O
the O
household O
, O
or O
with O
preschool O
siblings O
, O
or O

3) O
with O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
. O

2. O
Influenza B-TREATMENT
immunization I-TREATMENT
should O
be O
considered O
annually O
in O
the O
fall O
for O
preterm B-SYMPTOM
infants I-SYMPTOM
with O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
once O
they O
reach O
six O
months O
of O
age O
. O

Before O
this O
age O
, O
the O
family O
and O
other O
caregivers O
should O
be O
considered O
for O
immunization B-TREATMENT
against O
influenza B-SYMPTOM
to O
protect O
the O
infant O
. O

FOLLOW-UP O
APPOINTMENT O
: O

Primary O
pediatrician O
recommended O
within O
three O
days O
of O
discharge O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
A O
35-1/7 O
week O
gestation O
. O

2. O
Twin O
#2 O
of O
twin O
gestation O
. O

3. O
Transitional B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
. O

4. O
Suspicion O
for O
sepsis B-SYMPTOM
ruled O
out O
. O

DR. O
Gloria O
, O
Lonnie O
55-454 O

Dictated O
By O
: O
John O
Z. O
Toledo O
, O
M.D. O

MEDQUIST36 O

D O
: O
2012-05-22 O
07:06 O

T O
: O
2012-05-22 O
07:17 O

JOB O
# O
: O
35651 O

Signed O
electronically O
by O
: O
DR. O
Freddy O
King O
on O
: O
WED O
2012-05-23 O
9:05 O
AM O

( O
End O
of O
Report O
) O

196768414 O
YC O

36611261 O

5472577 O

5/7/2003 O
12:00:00 O
AM O

SAVD B-TREATMENT

DIS O

Admission O
Date O
: O

05/07/2003 O

Report O
Status O
: O

Discharge O
Date O
: O

05/09/2003 O

****** O
DISCHARGE O
ORDERS O
****** O

BOORMKAYSSCAJE O
, O
PA O
A. O
967-94-23-8 O
R21 O

Room O
: O

FISHIP O
HOSPITAL O

Service O
: O

OBS O

DISCHARGE O
PATIENT O
ON O
: O

05/09/03 O
AT O
10:00 O
AM O

CONTINGENT O
UPON O

Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

DOUETLEPSGISS O
, O
VALETO O
, O
M.D. O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

DIET O
: O

No O
Restrictions O

ACTIVITY O
: O

Resume O
regular O
exercise O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

dr. O
kote O
6 O
weeks O
, O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

Spontaneous B-SYMPTOM
vaginal I-SYMPTOM
delivery I-SYMPTOM
Laceration I-SYMPTOM
2 O
degrees O

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
SAVD B-TREATMENT

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O

SAVD B-TREATMENT

OPERATIONS O
AND O
PROCEDURES O
: O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

none O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

G3 O
T2 O
P0 O
A0 O
L2 O
Estimated O

EDC O
: O

Maternal O
transfer O
: O

No O

ADDITIONAL O
COMMENTS O
: O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

DOUETLEPSGISS O
, O
VALETO O
, O
M.D. O
( O
MC71 O
) O
05/07/03 O
03:46 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

060514276 O
SC O

52175844 O

023928 O

2/17/2000 O
12:00:00 O
AM O

ACUTE B-SYMPTOM
PANCREATITIS I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

02/17/2000 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

02/29/2000 O

PRINCIPAL O
DIAGNOSIS O
: O

ACUTE B-SYMPTOM
PANCREATITIS I-SYMPTOM
. O

SECONDARY O
DIAGNOSIS O
: O

GASTROESOPHAGEAL B-SYMPTOM
REFLUX I-SYMPTOM
DISEASE I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Ri O
Strength O
is O
a O
40 O
year O
old O
man O
with O
a O
history O
of O
GERD B-SYMPTOM
, O
who O
presents O
with O
abdominal B-SYMPTOM
pain I-SYMPTOM
of O
seven O
days O
duration O
. O

The O
patient O
was O
in O
general O
good O
health O
until O
seven O
days O
ago O
( O
2/11/00 O
) O
, O
when O
he O
had O
a O
sudden O
onset O
of O
sharp B-SYMPTOM
left I-SYMPTOM
flank I-SYMPTOM
pain I-SYMPTOM
with O
radiation B-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
lower I-SYMPTOM
abdomen I-SYMPTOM
and O
then O
to O
the O
epigastrium O
. O

The O
patient O
described O
the B-SYMPTOM
pain I-SYMPTOM
as O
&quot; O
knife-like B-SYMPTOM
&quot; O
with O
a O
severity O
of O
1/25 O
at O
its O
worse O
. O

The O
patient O
was O
exacerbated O
when O
eating O
and O
when O
lying O
flat O
. O

The O
patient O
also O
reports O
blood-streaked B-SYMPTOM
diarrhea I-SYMPTOM
for O
two O
days O
. O

He O
denies O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
. O

He O
has O
had O
no O
fevers B-SYMPTOM
or O
chills B-SYMPTOM
. O

He O
has O
had O
no O
recent B-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
, O
no O
light-headedness B-SYMPTOM
or O
dizziness B-SYMPTOM
. O

He O
denies O
increased B-SYMPTOM
urinary I-SYMPTOM
frequent I-SYMPTOM
or O
urgency B-SYMPTOM
. O

The O
patient O
presented O
to O
the O
Sloan- O
Center O
Emergency O
Department O
, O
where O
he O
was O
resuscitated O
with O
normal B-TREATMENT
saline I-TREATMENT
and O
received O
morphine B-TREATMENT
for O
pain B-SYMPTOM
. O

He O
was O
then O
transferred O
to O
the O
general O
medicine O
service O
for O
further B-TREATMENT
management I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

(1) O
GERD B-SYMPTOM
; O
(2) O
Pneumonia B-SYMPTOM
with O
partially B-SYMPTOM
collapsed I-SYMPTOM
lung I-SYMPTOM
in O
1999 O
. O

PAST O
SURGICAL O
HISTORY O
: O

None O
. O

MEDICATIONS O
: O

Prilosec B-TREATMENT
20 O
mg O
p.o. O
q.d. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

FAMILY O
HISTORY O
: O

GERD B-SYMPTOM
and O
PUD B-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
currently O
lives O
in O
Son O
Wooda O
with O
his O
wife O
. O

He O
has O
been O
a O
construction O
worker O
for O
the O
past O
20 O
years O
. O

The O
patient O
admits O
to O
smoking O
one O
pack O
of O
cigarettes O
per O
day O
. O

The O
patient O
has O
a O
history O
of O
excessive O
alcohol O
use O
. O

He O
currently O
drinks O
10 O
beers O
every O
other O
day O
. O

PHYSICAL O
EXAMINATION O
: O

VITAL O
SIGNS O
: O

Temp O
98.5 O
, O
heart O
rate O
74 O
, O
BP O
140/90 O
, O
respiratory O
rate O
18 O
, O
O2 O
sat O
98% O
. O

GENERAL O
: O

The O
patient O
was O
alert O
but O
in O
mild B-SYMPTOM
discomfort I-SYMPTOM
. O

HEENT O
: O

PERRL O
, O
EOMI O
, O
oropharynx O
clear O
, O
moist O
buccal O
mucosa O
. O

NECK O
: O

No O
lymphadenopathy B-SYMPTOM
, O
no O
JVD B-SYMPTOM
. O

LUNGS O
: O

Bibasilar B-SYMPTOM
crackles I-SYMPTOM
. O

Breath O
sounds O
were O
of O
good O
intensity O
. O

HEART O
: O

Regular O
rate O
and O
rhythm O
, O
normal O
S1 O
, O
S2 O
, O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
, O
or O
gallops B-SYMPTOM
. O

ABDOMEN O
: O

Soft O
, O
non-distended B-SYMPTOM
. O

Tender B-SYMPTOM
to O
palpation O
at O
the O
left O
lower O
quadrant O
and O
especially O
at O
the O
epigastrium O
. O

There O
was O
no O
splenomegaly B-SYMPTOM
or O
hepatosplenomegaly B-SYMPTOM
. O

Bowel O
sounds O
were O
present O
. O

BACK O
: O

Point B-SYMPTOM
tenderness I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
costovertebral I-SYMPTOM
angle I-SYMPTOM
. O

EXTREMITIES O
: O

Warm O
to O
touch O
, O
no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
, O
or O
edema B-SYMPTOM
. O

NEURO O
: O

The O
patient O
was O
alert O
and O
oriented O
x3 O
. O

Deep O
tendon O
reflexes O
were O
equal O
and O
adequate O
in O
upper O
and O
lower O
extremities O
. O

Cerebellar O
function O
was O
intact O
. O

Sensation O
was O
intact O
to O
pain B-SYMPTOM
and O
light O
touch O
. O

LABORATORY O
DATA O
: O

Chem-7 O
- O
Na O
139 O
, O
K O
3.7 O
, O
Cl O
99 O
, O
bicarb O
28 O
, O
BUN O
15 O
, O
creatinine O
0.9 O
, O
glucose O
89 O
. O

Liver O
function O
tests O
were O
significant O
for O
an O
ALT O
41 O
, O
AST O
31 O
, O
alk O
phos O
76 O
, O
T. O
bili O
0.7 O
, O
D. O
bili O
0.2 O
, O
amylase O
345 O
, O
lipase O
2510 O
, O
T. O
protein O
8.1 O
, O
albumin O
4.9 O
, O
globulin O
3.2 O
, O
Ca O
9.9 O
. O

CBC O
- O
White O
blood O
cell O
count O
8.82 O
, O
hemoglobin O
15.2 O
, O
hematocrit O
43 O
, O
and O
platelets O
322 O
. O

Imaging O
studies O
: O

Abdominal O
CT O
scan O
on O
2/21/00 O
- O
Study O
revealed O
a B-SYMPTOM
prominent I-SYMPTOM
pancreas I-SYMPTOM
with O
associated B-SYMPTOM
mesenteric I-SYMPTOM
stranding I-SYMPTOM
. O

No O
abscess B-SYMPTOM
or O
pseudocyst B-SYMPTOM
. O

A B-SYMPTOM
small I-SYMPTOM
gallstone I-SYMPTOM
was O
noted O
in O
the O
gallbladder O
neck O
. O

Bilateral B-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
were O
seen O
with O
associated B-SYMPTOM
compression I-SYMPTOM
atelectasis I-SYMPTOM
. O

Abdominal O
ultrasound O
on O
2/23/00 O
- O
This O
study O
revealed O
gallbladder B-SYMPTOM
sludge I-SYMPTOM
but O
no O
cholelithiasis B-SYMPTOM
. O

There O
was O
swelling B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
body I-SYMPTOM
and O
tail O
of O
the O
pancreas O
. O

Portable O
chest O
on O
2/23/00 O
- O
Lungs O
were O
clear O
. O

Heart O
was O
normal O
. O

There O
was O
no O
pleural B-SYMPTOM
effusion I-SYMPTOM
. O

Chest O
( O
PA O
and O
lateral O
) O
on O
2/25/00 O
- O
Lungs O
were O
clear O
. O

There O
was O
no O
infiltrates B-SYMPTOM
or O
consolidation B-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

On O
admission O
, O
the O
patient O
was O
diagnosed O
with O
acute B-SYMPTOM
pancreatitis I-SYMPTOM
. O

He O
was O
made O
NPO B-TREATMENT
and O
was O
resuscitated O
with O
IV B-TREATMENT
fluids I-TREATMENT
. O

Pain B-TREATMENT
control I-TREATMENT
was O
initiated O
with O
morphine B-TREATMENT
but O
was O
then O
changed O
to O
Demerol B-TREATMENT
, O
which O
gave O
the O
patient O
better O
relief O
of O
his B-SYMPTOM
epigastric I-SYMPTOM
pain I-SYMPTOM
. O

From O
2/17/00 O
to O
2/21/00 O
, O
the O
patient O
complained O
of O
persistent B-SYMPTOM
and I-SYMPTOM
occasionally I-SYMPTOM
severe I-SYMPTOM
epigastric I-SYMPTOM
pain I-SYMPTOM
. O

His B-TREATMENT
pain I-TREATMENT
medication I-TREATMENT
was O
then O
changed O
to O
Dilaudid B-TREATMENT
IV I-TREATMENT
in O
an O
attempt O
to O
better O
alleviate O
his B-SYMPTOM
symptoms I-SYMPTOM
. O

Dilaudid B-TREATMENT
IV I-TREATMENT
was O
continued O
for O
the O
remainder O
of O
the O
patient O
&apos;s O
hospitalization O
. O

The O
does O
was O
titrated O
to O
the O
patient O
&apos;s O
need O
for O
comfort O
and O
was O
eventually O
tapered O
. O

The O
severity O
and O
persistent O
of O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
epigastric I-SYMPTOM
pain I-SYMPTOM
was O
concerning O
for O
a B-SYMPTOM
pancreatic I-SYMPTOM
complication I-SYMPTOM
such O
as O
necrosis B-SYMPTOM
or O
abscess B-SYMPTOM
. O

The O
patient O
had O
a O
CT O
scan O
, O
which O
revealed O
a B-SYMPTOM
mass I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
gallbladder I-SYMPTOM
neck I-SYMPTOM
, O
but O
no O
biliary B-SYMPTOM
dilatation I-SYMPTOM
. O

There O
was O
stranding B-SYMPTOM
along I-SYMPTOM
the I-SYMPTOM
pancreas I-SYMPTOM
, O
but O
no O
necrosis B-SYMPTOM
, O
abscess B-SYMPTOM
, O
or O
pseudocyst B-SYMPTOM
. O

On O
2/22/00 O
, O
the O
patient O
had O
fevers B-SYMPTOM
to O
103.5 O
. O

Blood O
and O
urine O
cultures O
were O
sent O
. O

A O
chest O
x-ray O
was O
done O
, O
which O
revealed O
no O
infiltrate B-SYMPTOM
or O
effusion B-SYMPTOM
. O

The O
patient O
was O
started O
on O
cefotaxime B-TREATMENT
1 O
gm O
IV O
for O
empiric B-TREATMENT
antibiotic I-TREATMENT
treatment I-TREATMENT
. O

All O
cultures O
were O
negative O
. O

On O
2/23/00 O
, O
the B-SYMPTOM
high I-SYMPTOM
grade I-SYMPTOM
fever I-SYMPTOM
persisted O
. O

An O
ultrasound O
was O
done O
to O
R O
/ O
O O
cholestasis B-SYMPTOM
or O
cholangitis B-SYMPTOM
. O

The O
ultrasound O
showed O
biliary B-SYMPTOM
sludge I-SYMPTOM
and O
swelling B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
body I-SYMPTOM
and O
tail O
of O
the O
pancreas O
. O

No O
other B-SYMPTOM
abnormalities I-SYMPTOM
were O
noted O
. O

On O
2/24/00 O
, O
the O
patient O
had O
an O
episode O
of O
exacerbation O
of O
epigastric B-SYMPTOM
pain I-SYMPTOM
with O
radiation B-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
. O

The B-SYMPTOM
pain I-SYMPTOM
was O
subsequently O
relieved O
with O
high B-TREATMENT
dose I-TREATMENT
Dilaudid I-TREATMENT
. O

The O
patient O
had O
a O
follow-up O
chest O
x-ray O
, O
which O
was O
essentially O
unchanged O
from O
previously O
, O
showing O
a O
normal O
heart O
and O
lungs O
without O
infiltrate B-SYMPTOM
. O

From O
2/25 O
- O
2/27/00 O
, O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
fever I-SYMPTOM
defervesced O
and O
his B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
gradually O
subsided O
. O

The B-TREATMENT
cefotaxime I-TREATMENT
was O
discontinued O
since O
no O
infection B-SYMPTOM
was O
identified O
. O

On O
2/28/00 O
, O
the O
patient O
&apos;s O
diet O
was O
advanced O
to O
a B-TREATMENT
low I-TREATMENT
fat I-TREATMENT
solids I-TREATMENT
( O
per O
pancreatitis O
study O
) O
, O
which O
the O
patient O
tolerated O
well O
. O

The O
patient O
was O
discharged O
home O
on O
2/29/00 O
, O
with O
much O
improvement O
of O
his B-SYMPTOM
symptoms I-SYMPTOM
. O

DISCHARGE O
MEDICATIONS O
: O

Prilosec B-TREATMENT
20 O
mg O
p.o. O
q.d. O
; O
Percocet B-TREATMENT
1-2 O
tabs O
p.o. O
q.6-8h. O
x5 O
days O
; O
MVI B-TREATMENT
1 O
tab O
p.o. O
q.d. O

DISCHARGE O
FOLLOW-UP O
: O

The O
patient O
was O
advised O
to O
follow-up O
with O
Dr. O
Edwards O
in O
clinic O
in O
one O
week O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
condition O
. O

DISCHARGE O
DISPOSITION O
: O

The O
patient O
was O
discharged O
to O
home O
. O

Dictated O
By O
: O

SON O
RHALT O
, O
SUBINTERN O
. O

Attending O
: O

MOPAIGEIT O
S. O
SOLID O
, O
M.D. O
KP91 O
KX681/6848 O

Batch O
: O

52108 O

Index O
No. O
GAEHS07465 O

D O
: O

03/01/00 O

T O
: O

03/01/00 O

CC O
: O

1. O
MOPAIGEIT O
S. O
SOLID O
, O
M.D. O

216451163 O
PUMC O

5642194 O

612016 O

023084 O

10/18/2001 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O
/ O
SUMMARY O

ZEISRHALTPROT O
, O
QUETSHA O

MRN O
: O

5642194 O

Age O
: O

40y O

REGISTRATION O
DATE O
: O

10/18/2001 O
09:18 O
AM O

Provider O
: O

BIRI O
WEERTLUC O
PRELIMINARY O
REPORT O

Discharge O
Date O
/ O
Time O
: O

10/18/2001 O
10:09 O

Discharge O
Status O
: O

Discharged O

Condition O
on O
Discharge O
: O

Stable O

Patient O
States O
Complaint O
: O

BACK B-SYMPTOM
PIAN I-SYMPTOM
Standardized O

Discharge O
Instructions O
: O

The O
patient O
was O
given O
printed O
instructions O
for O
back B-SYMPTOM
pain I-SYMPTOM
( O
English O
) O
. O

Diagnosis O
: O

back B-SYMPTOM
pain I-SYMPTOM

Treatment O
Rendered O
: O

evaluation O

Discharge O
Medications O
: O

ibuoprofen B-TREATMENT
800 O
every O
6-8 O
hrs O
as O
needed O
skelaxin B-TREATMENT
800mg O
for O
muscle B-TREATMENT
relaxation I-TREATMENT
vicodin B-TREATMENT
1 O
tab O
po O
every O
4-6 O
hrs O
for O
severe B-SYMPTOM
pain I-SYMPTOM

Follow O
up O
Service O
: O

please O
call O
your O
primary O
care O
doctor O
on O
monday O
for O
follow O
up O
next O
week O
. O

Disposition O
, O
Follow O
up O
and O
Instructions O
to O
Patient O
: O

take O
medication B-TREATMENT
as O
directed O
, O
return O
for O
severe B-SYMPTOM
or I-SYMPTOM
significantly I-SYMPTOM
worsening I-SYMPTOM
symptoms I-SYMPTOM
, O
weakness B-SYMPTOM
or O
loss B-SYMPTOM
of I-SYMPTOM
sensation I-SYMPTOM
work O
restrictions O
as O
written O
on O
accompanying O
form O
. O

PCP O
Name O
: O

ASQUARCELMES O
, O
NOROBEBER O

Provider O
Number O
: O

20599 O

This O
report O
was O
created O
by O
WEERTLUC O
, O
BIRI O
10/18/2001 O
10:23 O
AM O

Admission O
Date O
: O

2016-12-15 O

Discharge O
Date O
: O

2016-12-21 O

Date O
of O
Birth O
: O

1980-08-17 O

Sex O
: O

F O

Service O
: O

OBSTETRICS O
/ O
GYNECOLOGY O

Allergies O
: O

Sulfonamides B-TREATMENT

Attending O
: O
Melissa O
P O
Lowery O
, O
M.D. O

Chief O
Complaint O
: O

Term O
pregnancy O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

SVD B-TREATMENT

D&C B-TREATMENT

Supracervical B-TREATMENT
hysterectomy I-TREATMENT

Reexploration O
with O
vaginal B-TREATMENT
artery I-TREATMENT
ligation I-TREATMENT

Multiple B-TREATMENT
transfusions I-TREATMENT

History O
of O
Present O
Illness O
: O

36 O
yo O
G3P2 O
at O
38+5 O
weeks O
GA O
presented O
to O
L&D O
for O
elective B-TREATMENT
induction I-TREATMENT
of I-TREATMENT
labor I-TREATMENT
. O

Antenatal O
course O
benign O
. O

Past O
Medical O
History O
: O

PMHx O
: O

Narcolepsy B-SYMPTOM
. O

R B-SYMPTOM
inguinal I-SYMPTOM
hernia I-SYMPTOM
. O

ObHx O
: O

SVDX2 B-TREATMENT

Social O
History O
: O

Married O
. O

No O
T/E/D O

Family O
History O
: O

NC O

Physical O
Exam O
: O

Vital O
signs O
stable O
on O
admission O
. O

Heart O
RRR O

Lungs O
CTAB O

Abd B-SYMPTOM
Gravid I-SYMPTOM
, O
NT B-SYMPTOM

Ext O
without O
edema B-SYMPTOM

Cervix O
1 O
cm O
dilated O
. O

Pertinent O
Results O
: O

2016-12-15 O
03:31 O
PM O
BLOOD O
WBC O
- O
6.2 O
RBC O
- O
3.82 O
* O
Hgb O
- O
12.2 O
Hct O
- O
34.5 O
* O
MCV O
- O
91 O
MCH O
- O
32.0 O
MCHC O
- O
35.4 O
* O
RDW O
- O
12.7 O
Plt O
Ct O
- O
246 O

2016-12-21 O
07:45 O
AM O
BLOOD O
WBC O
- O
6.6 O
RBC O
- O
2.79 O
* O
Hgb O
- O
8.5 O
* O
Hct O
- O
23.9 O
* O
MCV O
- O
86 O
MCH O
- O
30.5 O
MCHC O
- O
35.7 O
* O
RDW O
- O
16.9 O
* O
Plt O
Ct O
- O
222 O
# O

Brief O
Hospital O
Course O
: O

After O
admission O
to O
L&D O
, O
the O
patient O
was O
administered O
Pitocin B-TREATMENT
for O
elective B-TREATMENT
induction I-TREATMENT
of I-TREATMENT
labor I-TREATMENT
and O
progressed O
uneventfully O
and O
went O
on O
to O
deliver O
a O
viable O
female O
infant O
, O
weight O
3595 O
g O
, O
Apgars O
11-11 O
. O

EBL B-SYMPTOM
during O
delivery O
was O
300 O
cc O
. O

Patient O
was O
transferred O
to O
the O
PP O
floor O
in O
stable O
condition O
. O

Soon O
after O
transfer O
, O
patient O
had O
a B-SYMPTOM
large I-SYMPTOM
post I-SYMPTOM
partum I-SYMPTOM
hemorrhage I-SYMPTOM
. O

This O
was O
treated O
with O
transfer O
back O
to O
L&D O
, O
bimanual B-TREATMENT
massage I-TREATMENT
, O
administration O
of O
various B-TREATMENT
uterotonics I-TREATMENT
, O
namely O
pitocin B-TREATMENT
100 O
U O
, O
Methergine B-TREATMENT
x O
1 O
, O
Hemabate B-TREATMENT
x O
1 O
, O
and O
cytotec B-TREATMENT
1000 O
mcgs O
with O
minimal O
response O
. O

Patient O
underwent O
suction B-TREATMENT
curettage I-TREATMENT
and O
finally O
a B-TREATMENT
supercervical I-TREATMENT
hysterectomy I-TREATMENT
. O

EBL B-SYMPTOM
4000 O
cc O
; O
IVF B-TREATMENT
6000 O
cc O
crystalloid B-TREATMENT
; O
U/O O
3500 O
cc O
. O

Products O
: O

8 B-TREATMENT
units I-TREATMENT
RBC I-TREATMENT
, O
6FFP B-TREATMENT
, O
1 B-TREATMENT
cryo I-TREATMENT
, O
1 B-TREATMENT
pack I-TREATMENT
plt I-TREATMENT
. O

After O
this B-TREATMENT
procedure I-TREATMENT
, O
the O
patient O
again O
hemorrhaged O
in O
the O
ICU O
and O
was O
taken O
back O
to O
the O
OR O
for O
reexploration O
and O
ligation B-TREATMENT
of O
a B-SYMPTOM
bleeding I-SYMPTOM
vaginal I-SYMPTOM
artery I-SYMPTOM
. O

EBL B-SYMPTOM
3500 O
; O
IVF B-TREATMENT
4000 O
; O
UO O
45 O
; O
RBC B-TREATMENT
9U O
; O
Plt B-TREATMENT
12 O
pack O
; O
1u B-TREATMENT
Cryo I-TREATMENT
; O
6U B-TREATMENT
FFP I-TREATMENT
. O

For O
details O
of O
these B-TREATMENT
procedures I-TREATMENT
, O
please O
see O
op O
notes O
dictated O
by O
Dr. O
Day O
on O
2016-12-16 O
. O

Overall O
, O
the O
pt O
maintained O
good O
BP O
throughout O
and O
was O
on O
pressors B-TREATMENT
only O
briefly O
. O

Hct O
was O
maintained O
in O
stable O
range O
with O
product B-TREATMENT
transfusions I-TREATMENT
. O

Patient O
did O
well O
and O
was O
extubated O
uneventfully O
on O
12-17 O
. O

She O
was O
transferred O
from O
the O
ICU O
back O
to O
the O
PP O
floor O
on O
12-19 O
. O

There O
, O
she O
made O
great O
progress O
. O

Her O
vital O
signs O
were O
stable O
, O
she O
remained O
afebrile B-SYMPTOM
off O
antibiotics B-TREATMENT
. O

Her B-SYMPTOM
pain I-SYMPTOM
was O
controlled O
with O
percocet B-TREATMENT
and O
motrin B-TREATMENT
. O

Her B-TREATMENT
foley I-TREATMENT
was O
removed O
and O
she O
voided O
without O
problems B-SYMPTOM
. O

She O
John O
, O
tolerated O
a O
regular O
diet O
, O
and O
was O
discharged O
home O
in O
good O
condition O
on O
12-21 O
. O

Medications O
on O
Admission O
: O

Cylert B-TREATMENT
. O

Discharge O
Medications O
: O

1. O
Ibuprofen B-TREATMENT
600 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

Disp O
:* O
25 O
Tablet O
( O
s O
)* O
Refills O
: O
* O
0 O
* O

2. O
Oxycodone B-TREATMENT
- I-TREATMENT
Acetaminophen I-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

Disp O
:* O
30 O
Tablet O
( O
s O
)* O
Refills O
:* O
0 O
* O

Discharge O
Disposition O
: O

Home O

Discharge O
Diagnosis O
: O

Full O
term O
pregnancy O
, O
s/p O
SVD B-TREATMENT

Uterine B-SYMPTOM
atony I-SYMPTOM
, O
postpartum B-SYMPTOM
hemorrhage I-SYMPTOM

Severe B-SYMPTOM
anemia I-SYMPTOM

Discharge O
Condition O
: O

Stable O

Discharge O
Instructions O
: O

Follow O
printed O
instructions O

Followup O
Instructions O
: O

6 O
wks O
for O
postpartum O
exam O

MOnday O
for O
staple B-TREATMENT
removal I-TREATMENT
. O

James O
Tricia O
MD O
61-345 O

Completed O
by O
: O
Greg O
Allen O
MD O
53-372 O
2016-12-22 O
@ O
1825 O

Signed O
electronically O
by O
: O
DR. O
Katherine O
Beaulieu O
Brush O
on O
: O
WED O
2017-01-25 O
12:05 O
AM O

( O
End O
of O
Report O
) O

525602122 O
EH O

25951463 O

363878 O

12/05/1997 O
12:00:00 O
AM O

BILATERAL B-SYMPTOM
LUNG I-SYMPTOM
NODULES I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

12/05/1997 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

12/07/1997 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
50 O
year-old O
female O
with O
a O
history O
of O
bilateral B-SYMPTOM
lung I-SYMPTOM
nodules I-SYMPTOM
dating O
back O
to O
the O
July O
of O
1995 O
discovered O
on O
a O
work-up O
for O
an B-SYMPTOM
adrenal I-SYMPTOM
abnormality I-SYMPTOM
. O

Diffuse B-SYMPTOM
adenopathy I-SYMPTOM
was O
noted O
at O
that O
time O
and O
an O
attempt O
was O
made O
at O
axillary O
node O
biopsy O
which O
was O
aborted O
secondary O
to O
positioning O
difficulty O
and O
difficult B-SYMPTOM
intubation I-SYMPTOM
. O

She O
was O
since O
then O
lost O
to O
follow-up O
with O
a O
recently O
re-establish O
primary O
care O
practitioner O
contact O
. O

Follow-up O
chest O
CT O
on O
October O
26 O
, O
1997 O
at O
the O
Ver O
Medical O
Center O
showed O
multiple B-SYMPTOM
pulmonary I-SYMPTOM
nodules I-SYMPTOM
in O
abundant O
number O
, O
very B-SYMPTOM
small I-SYMPTOM
nodes I-SYMPTOM
seen O
in O
the O
mediastinum O
but O
no O
hilar B-SYMPTOM
adenopathy I-SYMPTOM
, O
no O
hepatosplenomegaly B-SYMPTOM
or O
adrenal B-SYMPTOM
mass I-SYMPTOM
was O
noted O
. O

Chest O
x-ray O
on O
August O
6 O
, O
1997 O
revealed O
multiple B-SYMPTOM
pulmonary I-SYMPTOM
nodules I-SYMPTOM
increasing O
in O
size O
since O
July O
22 O
, O
1995 O
. O

PAST O
MEDICAL O
HISTORY O
: O

She O
denies O
any B-SYMPTOM
hypertension I-SYMPTOM
, O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
myocardial B-SYMPTOM
infarction I-SYMPTOM
or O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

She O
is O
status O
post O
an B-TREATMENT
open I-TREATMENT
cholecystectomy I-TREATMENT
in O
1968 O
, O
status O
post O
hysterectomy B-TREATMENT
and O
axillary O
node O
biopsy O
which O
failed O
. O

She O
has O
a O
history O
of O
hiatal B-SYMPTOM
hernia I-SYMPTOM
and O
umbilical B-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT
. O

She O
also O
has O
a O
history O
of O
an B-SYMPTOM
adrenal I-SYMPTOM
disorder I-SYMPTOM
treated O
with O
Prednisone B-TREATMENT
in O
the O
past O
, O
but O
not O
currently O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1) O
Spironolactone B-TREATMENT
50 O
mg O
p.o. O
b.i.d. O

2) O
Advil B-TREATMENT
p.r.n. O

3) O
Topical B-TREATMENT
steroids I-TREATMENT
for O
eczema B-SYMPTOM
p.r.n. O

ALLERGIES O
: O

The O
patient O
had O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
quit O
smoking O
approximately O
fourteen O
years O
ago O
after O
a O
four O
pack O
per O
year O
history O
. O

She O
is O
a O
single O
female O
who O
lives O
in O
Mifayston O
. O

PHYSICAL O
EXAMINATION O
: O

Vital O
signs O
: O

Blood O
pressure O
140/80 O
, O
heart O
rate O
86 O
. O

She O
is O
a O
pleasant O
, O
obese O
, O
black O
female O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
. O

There O
is O
no O
lymphadenopathy B-SYMPTOM
. O

Her O
skin O
is O
intact O
without O
lesions B-SYMPTOM
. O

Her O
HEENT O
examination O
is O
benign O
. O

Her O
neck O
is O
slightly B-SYMPTOM
tender I-SYMPTOM
with O
a B-SYMPTOM
firm I-SYMPTOM
thyroid I-SYMPTOM
, O
but O
no O
masses B-SYMPTOM
or O
bruits B-SYMPTOM
. O

Her O
lungs O
have O
decreased B-SYMPTOM
sounds I-SYMPTOM
bilaterally I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
upper I-SYMPTOM
lung I-SYMPTOM
fields I-SYMPTOM
. O

Her O
heart O
is O
regular O
rate O
and O
rhythm O
. O

She O
has O
a B-SYMPTOM
well I-SYMPTOM
healed I-SYMPTOM
umbilical I-SYMPTOM
hernia I-SYMPTOM
scar I-SYMPTOM
for I-SYMPTOM
approximately I-SYMPTOM
2 I-SYMPTOM
1/2 I-SYMPTOM
cm I-SYMPTOM
. O

She O
has O
no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
extremities I-SYMPTOM
. O

LABORATORY O
: O

Pulmonary O
function O
tests O
on O
September O
27 O
, O
1997 O
revealed O
an O
FVC O
of O
2.7 O
which O
is O
112% O
and O
FEV1 O
of O
2.23 O
which O
is O
123% O
. O

Her O
admission O
laboratory O
data O
includes O
serum O
chemistries O
with O
a O
sodium O
of O
144 O
, O
potassium O
4.1 O
, O
chloride O
101 O
, O
bicarbonate O
28 O
, O
BUN O
10 O
, O
creatinine O
0.9 O
and O
glucose O
of O
93 O
. O

White O
blood O
cell O
count O
is O
7.65 O
, O
hematocrit O
of O
42 O
and O
platelets O
of O
345 O
. O

Her O
urinalysis O
shows O
2+ B-SYMPTOM
bacteria I-SYMPTOM
and O
2+ B-SYMPTOM
squamous I-SYMPTOM
epithelium I-SYMPTOM
with O
greater B-SYMPTOM
than I-SYMPTOM
10,000 I-SYMPTOM
mixed I-SYMPTOM
bacteria I-SYMPTOM
. O

Chest O
x-ray O
on O
August O
6 O
, O
1997 O
revealed O
multiple B-SYMPTOM
pulmonary I-SYMPTOM
nodules I-SYMPTOM
increased O
in O
size O
as O
previously O
mentioned O
. O

PT O
was O
11.7 O
, O
PTT O
26.7 O
and O
INR O
of O
0.9 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
on O
December O
5 O
, O
1997 O
and O
underwent O
left B-TREATMENT
lung I-TREATMENT
wedge I-TREATMENT
thoracoscopic I-TREATMENT
resection I-TREATMENT
and O
bronchoscopy B-TREATMENT
. O

She O
was O
transferred O
to O
the O
Post O
Anesthesia O
Care O
Unit O
postoperatively O
in O
stable O
condition O
. O

Her B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
pulled O
on O
postoperative O
day O
number O
one O
and O
the O
patient O
did O
quite O
well O
and O
remained O
inhouse O
for O
observation O
until O
December O
7 O
, O
1997 O
and O
the O
patient O
was O
discharged O
to O
home O
in O
stable O
condition O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1) O
Lac-Hydrin B-TREATMENT
12% O
topically O
b.i.d. O

2) O
Colace B-TREATMENT
100 O
mg O
p.o. O
t.i.d. O

3) O
Tylenol B-TREATMENT
# I-TREATMENT
3 I-TREATMENT
tablets O
rather O
than O
Percocet B-TREATMENT
, O
1-2 O
tablets O
p.o. O
q.4-6h. O
p.r.n. O
pain B-SYMPTOM
. O

4) O
Spironolactone B-TREATMENT
50 O
mg O
p.o. O
b.i.d. O

DIET O
: O

No O
restrictions O
. O

ACTIVITY O
: O

No O
restrictions O
. O

FOLLOW-UP O
: O

The O
patient O
is O
to O
follow-up O
with O
Dr. O
Prus O
and O
she O
should O
call O
for O
an O
appointment O
. O

DISPOSITION O
: O

The O
patient O
was O
discharged O
to O
stay O
with O
her O
family O
until O
returning O
home O
and O
will O
be O
screened O
for O
house O
safety O
upon O
moving O
from O
the O
family O
&apos;s O
house O
. O

Dictated O
By O
: O

BURLTIS O
SHOULDER O
, O
M.D. O
UU24 O

Attending O
: O

LASHAUND O
PRUS O
, O
M.D. O
HY9 O
ZG840/5307 O

Batch O
: O

47331 O

Index O
No. O
HRMNNB82LK O

D O
: O

12/07/97 O

T O
: O

12/09/97 O

Admission O
Date O
: O

2018-04-23 O

Discharge O
Date O
: O

2018-05-01 O

Date O
of O
Birth O
: O

1818-04-23 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Penicillins B-TREATMENT

Attending O
: O

Crystal O
GQ O
Divers O
, O
M.D. O

Chief O
Complaint O
: O

respiratory B-SYMPTOM
distress I-SYMPTOM
, O
hemoptysis B-SYMPTOM
transferred O
from O
OSH O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

debridement B-TREATMENT
of O
mass B-SYMPTOM
from O
tracheal O
lumen O
by O
interventional O
pulmonary O

History O
of O
Present O
Illness O
: O

95 O
yo O
male O
with O
PMH O
large B-SYMPTOM
right I-SYMPTOM
thyroid I-SYMPTOM
cystic I-SYMPTOM
mass I-SYMPTOM
eroding I-SYMPTOM
into O
trachea O
, O
who O
presented O
to O
St. O
Anne O
's O
Hospital O
2018-04-22 O
with O
hemoptysis B-SYMPTOM
and O
respiratory B-SYMPTOM
distress I-SYMPTOM
, O
now O
diagnosed O
with O
anaplastic B-SYMPTOM
thyroid I-SYMPTOM
carcinoma I-SYMPTOM
. O

. O

Pt O
reports O
that O
he O
noticed O
a B-SYMPTOM
right I-SYMPTOM
neck I-SYMPTOM
mass I-SYMPTOM
last O
October O
. O

The B-SYMPTOM
mass I-SYMPTOM
grew O
larger O
, O
to O
the O
size O
of O
a O
baseball O
. O

It O
appears O
that O
FNA O
was O
performed O
but O
was O
non-diagnostic O
( O
probably O
because O
anaplastic B-SYMPTOM
tumors I-SYMPTOM
tend O
to O
be O
necrotic O
) O
. O

The B-SYMPTOM
mass I-SYMPTOM
appears O
to O
be O
cystic B-SYMPTOM
in O
nature O
and O
has O
been O
aspirated O
at O
least O
3 O
times O
, O
which O
decrease O
in O
size O
each O
time O
. O

Now O
size O
is O
6.5cm*6.5cm O
. O

Plan O
for O
surgery B-TREATMENT
in O
Oct O
was O
deferred O
04-05 O
syncope B-SYMPTOM
and O
pacer B-TREATMENT
placement I-TREATMENT
for O
SSS; B-SYMPTOM
again O
deferred O
2 O
weeks O
ago O
04-05 O
URI; B-SYMPTOM
was O
planned O
for O
surgery B-TREATMENT
this O
Thurday O
. O

. O

Pt O
was O
o/w O
in O
his O
USOH O
until O
2-3 O
weeks O
ago O
when O
he O
developed O
a B-SYMPTOM
URI I-SYMPTOM
with O
symptoms B-SYMPTOM
of O
dry B-SYMPTOM
cough; I-SYMPTOM
no O
fever B-SYMPTOM
, O
chills B-SYMPTOM
, O
sore B-SYMPTOM
throat I-SYMPTOM
, O
myalgias B-SYMPTOM
. O

Pt O
was O
treated O
with O
3 O
days O
of O
an B-TREATMENT
antibiotics I-TREATMENT
, O
followed O
by O
a O
10 O
day O
course O
of O
levaquin B-TREATMENT
( O
completed O
2 O
days O
PTA O
) O
. O

Per O
pt O
and O
son O
, O
no O
James B-SYMPTOM
pna I-SYMPTOM
. O

2 O
days O
prior O
to O
admission O
, O
pt O
developed O
hemoptysis; B-SYMPTOM
states O
he O
coughed O
up O
4 O
tsp O
of O
blood B-SYMPTOM
. O

1 O
day O
PTA O
, O
pt O
developed O
stridorous B-SYMPTOM
breathing I-SYMPTOM
and O
respiratory B-SYMPTOM
distress I-SYMPTOM
. O

Pt O
was O
initially O
seen O
at O
Lahey O
North O
, O
where O
he O
was O
given O
steroids B-TREATMENT
, O
with O
improvement O
in O
respiratory O
status O
. O

Pt O
was O
transferred O
to O
New O
England O
Baptist O
Hospital O
, O
where O
his O
surgeon O
is O
located O
. O

There O
he O
was O
admitted O
to O
the O
CMED O
. O

Thyroid B-SYMPTOM
cyst I-SYMPTOM
was O
aspirated O
with O
removal O
of O
300cc O
of O
fluid O
. O

Pt O
was O
given O
racemic B-TREATMENT
epinephrine I-TREATMENT
and O
Decadron B-TREATMENT
10mg O
IV O
x1. O
CT O
neck O
showed O
tracheal B-SYMPTOM
mass I-SYMPTOM
per O
nursing O
s/o O
( O
pt O
brought O
CT O
) O
. O

. O

Pt O
now O
breathing O
more O
comfortably O
. O

He O
has O
not O
had O
fever B-SYMPTOM
and O
night B-SYMPTOM
sweats I-SYMPTOM
but O
reports O
weakness B-SYMPTOM
and O
weight B-SYMPTOM
loss I-SYMPTOM
for O
several O
months O
recently O
. O

Past O
Medical O
History O
: O

R B-SYMPTOM
thyroid I-SYMPTOM
cyst I-SYMPTOM
( O
as O
above O
) O

Goiter B-SYMPTOM

CRI B-SYMPTOM

HTN B-SYMPTOM

SSS B-SYMPTOM
( O
s/p O
pacer B-TREATMENT
Michelle O
Matthew O
Mccaulley O
) O
prostate B-SYMPTOM
cancer I-SYMPTOM
-dx O
10 O
years O
ago; O
received O
monthly B-TREATMENT
shots I-TREATMENT
which O
were O
discontinued O
recently O
. O

anemia B-SYMPTOM
Afib I-SYMPTOM
( O
19 O
episodes O
since O
2017-12-02 O
, O
as O
documented O
on O
pacer O
interogation O
2018-04-04 O
) O

Social O
History O
: O

Was O
living O
alone O
in O
ALF O
. O

Walks O
with O
walker O
. O

Able O
to O
take O
care O
of O
himself; O
home O
health O
aide O
visits O
once O
a O
week O
. O

Denies O
history O
of O
tobacco O
, O
etoh O
, O
drugs O
. O

Used O
to O
work O
as O
hat O
manufacturer O
. O

Family O
History: O

No O
history O
of O
thyroid B-SYMPTOM
disease I-SYMPTOM
. O

Sister O
with O
lung B-SYMPTOM
ca I-SYMPTOM
. O

Brother O
with O
gastric B-SYMPTOM
ca I-SYMPTOM
. O

sister O
with O
unknown B-SYMPTOM
ca I-SYMPTOM
. O

Father O
with O
stroke B-SYMPTOM
. O

Physical O
Exam: O

VS O
: O

T O
99.4 O
, O
BP O
119/59 O
, O
HR O
76 O
, O
RR O
18 O
, O
99% O
RA O

Gen O
: O

NAD B-SYMPTOM

HEENT O
: O

PERRL O
, O
EOMI O
, O
clear O
OP O
, O
MMM O

Neck O
: O

Large B-SYMPTOM
~6 I-SYMPTOM
x I-SYMPTOM
6 I-SYMPTOM
cm I-SYMPTOM
sized I-SYMPTOM
right I-SYMPTOM
thyroid I-SYMPTOM
mass I-SYMPTOM
, O
soft O
, O
possibly O
cystic B-SYMPTOM
, O
non-tender. B-SYMPTOM

L O
lobe O
of O
the O
thyroid O
gland O
also O
prominent B-SYMPTOM
. O

CVS O
: O

RRR O
, O
nl O
s1 O
s2 O
, O
no O
m/g/r B-SYMPTOM

Lungs O
: O
transmitted B-SYMPTOM
upper I-SYMPTOM
airway I-SYMPTOM
stridor; I-SYMPTOM
otherwise O
clear O

Abd O
: O
soft O
, O
NT B-SYMPTOM
, O
ND B-SYMPTOM
, O
+BS O

Ext O
: O
no O
edema B-SYMPTOM

Neuro O
: O

CN O
04-15 O
intact O
, O
07-06 O
bilateral O
upper O
and O
lower O
extremity O
strength O
. O

Pertinent O
Results O
: O

CT O
Neck O
- O
IMPRESSION O
: O

1. O
7-cm B-SYMPTOM
diameter I-SYMPTOM
right I-SYMPTOM
neck I-SYMPTOM
mass I-SYMPTOM
, O
with O
direct B-SYMPTOM
invasion I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
subglottic I-SYMPTOM
, I-SYMPTOM
cervical I-SYMPTOM
and I-SYMPTOM
proximal I-SYMPTOM
thoracic I-SYMPTOM
trachea I-SYMPTOM
. O

The B-SYMPTOM
mass I-SYMPTOM
is O
reportedly O
thyroid O
in O
origin O
. O

Differential O
diagnosis O
includes O
primary B-SYMPTOM
head/neck I-SYMPTOM
cancer I-SYMPTOM
and O
lymphoma B-SYMPTOM
. O

2. O
Left B-SYMPTOM
lobe I-SYMPTOM
thyroid I-SYMPTOM
enlargement I-SYMPTOM
with O
heterogeneous O
appearance O
. O

3. O
Right B-SYMPTOM
upper I-SYMPTOM
paratracheal I-SYMPTOM
and I-SYMPTOM
prevascular I-SYMPTOM
lymphadenopathy I-SYMPTOM
as O
well O
as O
additional B-SYMPTOM
nodes I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
side I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
neck I-SYMPTOM
. O

Dedicated O
MR O
of O
the O
neck O
may O
be O
helpful O
for O
more O
complete O
assessment O
of O
the B-SYMPTOM
neck I-SYMPTOM
mass I-SYMPTOM
and O
lymphadenopathy B-SYMPTOM
if O
warranted O
clinically O
. O

. O

Pathology O
: O

The B-SYMPTOM
tumor I-SYMPTOM
is O
composed O
of O
a B-SYMPTOM
relatively I-SYMPTOM
monotonous I-SYMPTOM
proliferation I-SYMPTOM
of I-SYMPTOM
spindle I-SYMPTOM
cells I-SYMPTOM
which O
grow O
in O
sheets O
with O
a O
prominent O
vascular O
pattern O
. O

Immunostains O
for O
cytokeratin O
AE1/3 O
and O
CAM O
5.2 O
, O
CD-68 O
, O
CD-79a O
, O
CD-138 O
, O
S-100 O
, O
LCA O
absorbed O
CEA O
, O
EMA O
, O
CD34 O
, O
CD31 O
, O
TTF-1 O
, O
actin O
, O
desmin O
, O
MNF-116 O
, O
calcitonin O
, O
and O
thyroglobulin O
are O
negative O
. O

These O
results O
exclude O
both O
melanoma B-SYMPTOM
and O
hematopoietic B-SYMPTOM
neoplasms I-SYMPTOM
. O

The O
differential O
diagnosis O
includes O
, O
but O
is O
not O
limited O
to O
, O
sarcoma B-SYMPTOM
, O
spindle B-SYMPTOM
cell I-SYMPTOM
carcinomas I-SYMPTOM
( O
sarcomatoid B-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
upper I-SYMPTOM
aerodigestive I-SYMPTOM
tract I-SYMPTOM
and O
anaplastic B-SYMPTOM
thyroid I-SYMPTOM
carcinoma I-SYMPTOM
) O
, O
and O
malignant B-SYMPTOM
salivary I-SYMPTOM
gland I-SYMPTOM
neoplasms I-SYMPTOM
. O

Brief O
Hospital O
Course O
: O

Pt O
was O
transferred O
here O
for O
further B-TREATMENT
mgmt I-TREATMENT
of I-TREATMENT
airway I-TREATMENT
and O
large B-SYMPTOM
thyroid I-SYMPTOM
mass I-SYMPTOM
by O
our O
IP O
team O
. O

IP O
found O
endotracheal B-SYMPTOM
obstructing I-SYMPTOM
tumor I-SYMPTOM
and O
extrinsic B-SYMPTOM
compression I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
high I-SYMPTOM
trachea I-SYMPTOM
by O
thyroid B-SYMPTOM
mass I-SYMPTOM
. O

After O
rigid O
bronchoscopy O
with O
removal B-TREATMENT
of O
the B-SYMPTOM
intratracheal I-SYMPTOM
tumor I-SYMPTOM
component I-SYMPTOM
on O
2018-04-24 O
, O
stat O
pathology O
showed O
anaplastic B-SYMPTOM
tumor I-SYMPTOM
. O

He O
was O
tranferred O
to O
the O
CMED O
. O

Subsequently O
extubated O
and O
his O
respiratory B-SYMPTOM
Sx I-SYMPTOM
are O
now O
improved O
. O

Pt O
was O
seen O
by O
Rad O
Onc O
, O
who O
recommended O
transfer O
to O
the O
East O
Campus O
for O
XRT B-TREATMENT
. O

On O
the O
morning O
of O
possible B-TREATMENT
radiation I-TREATMENT
, O
patient O
and O
family O
met O
with O
interventional O
pulmonary O
team O
who O
explained O
that O
the O
most O
recent O
CT O
showed O
further B-SYMPTOM
invasion I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
tumor I-SYMPTOM
into O
the O
trachea O
. O

After O
a O
long O
discussion O
, O
patient O
and O
family O
asked O
to O
be O
made O
CMO B-TREATMENT
. O

Patient O
was O
started O
on O
morphine B-TREATMENT
drip I-TREATMENT
and O
palliative O
care O
team O
was O
consulted O
with O
recommendations O
to O
ensure O
comfort O
. O

Mr O
. O
Davison O
died O
approximately O
24 O
hours O
after O
decision O
to O
be O
CMO O
, O
on O
2018-05-01 O
. O

Discharge O
Disposition O
: O

Expired O

Discharge O
Diagnosis O
: O

NC O

Discharge O
Condition O
: O

NC O

Discharge O
Instructions O
: O

NC O

Followup O
Instructions O
: O

NC O

John O
Iris O
MD O
70-363 O

Completed O
by O
: O

Patricia O
Rojas O
MD O
73-701 O
2018-05-06 O
@ O
1434 O

Signed O
electronically O
by O
: O

DR. O
John O
J. O
Booker O
on O
: O

WED O
2018-05-30 O
5:50 O
PM O

( O
End O
of O
Report O
) O

190510002 O

TGCHO O

3067319 O

364639 O

3/16/2003 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

KOTE O
, O
LYFRANKLAPALM O

MRN O
: O

3067319 O

Age O
: O

56y O

REGISTRATION O
DATE O
: O

03/16/2003 O
05:16 O
PM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
KOTE O
, O
LYFRANKLAPALM O
arrived O
in O
the O
Emergency O
Department O
at O
Tecal O
Galecounxopt O
Community O
Hospital O
on O
03/16/2003 O
05:16 O
PM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
INCREASED B-SYMPTOM
LETHARGY I-SYMPTOM
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
of O
the O
visit O
was O
ADMITTED O
AS O
AN O
INPATIENT O
TO O
TECAL O
GALENCOUNXOPT O
COMMUNITY O
HOSPITAL O
. O

The O
patient O
&apos;s O
preliminary O
admitting O
physician O
is O
SCIMEWHILDAJESC O
, O
LA O
R O
and O
the O
preliminary O
diagnosis O
is O
DEHYDRATION B-SYMPTOM
.. O

Please O
note O
this O
information O
may O
have O
been O
updated O
on O
the O
inpatient O
unit O
. O

If O
you O
need O
additional O
information O
please O
call O
418-196-2156 O
. O

PCP O
Name O
: O

NONE O
, O
PHYSICIAN O

Provider O
Number O
: O

75055 O

014894512 O

FIH O

0589930 O

86515/6878 O

801232 O

10/27/1993 O
12:00:00 O
AM O

OSTEOCHONDROMATOSIS B-SYMPTOM
, I-SYMPTOM
RIGHT I-SYMPTOM
KNEE I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

10-27-93 O

DISCHARGE O
DATE O
: O

11-1-93 O

PRINCIPAL O
DIAGNOSIS O
: O

Osteochondromatosis B-SYMPTOM
, I-SYMPTOM
right I-SYMPTOM
knee I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
68 O
year O
old O
white O
male O
who O
had O
a O
seven O
to O
eight O
year O
history O
of O
knee B-SYMPTOM
pain I-SYMPTOM
. O

In O
1984 O
, O
he O
had O
the O
right O
knee O
aspirated O
and O
was O
noted O
to O
have O
some O
uric B-SYMPTOM
acid I-SYMPTOM
crystals I-SYMPTOM
, O
although O
serum O
uric O
acid O
was O
normal O
and O
erythrocyte O
sedimentation O
rate O
. O

He O
continued O
to O
have O
intermittent B-SYMPTOM
symptoms I-SYMPTOM
and O
was O
noted O
to O
have O
some B-SYMPTOM
fullness I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
suprapatellar I-SYMPTOM
pouch I-SYMPTOM
. O

Plain O
films O
taken O
by O
his O
orthopedist O
in O
Mongcana O
Ster O
Staarv O
revealed O
some B-SYMPTOM
soft I-SYMPTOM
tissue I-SYMPTOM
calcification I-SYMPTOM
within O
the O
medial O
and O
lateral O
compartments O
of O
the O
joint O
. O

an O
magnetic O
resonance O
imaging O
study O
demonstrated O
calcification B-SYMPTOM
densities I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
suprapatellar I-SYMPTOM
bursa I-SYMPTOM
region I-SYMPTOM
, O
also O
with O
hypertrophia B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
synovium I-SYMPTOM
. O

It O
was O
felt O
that O
the O
patient O
had O
synovial B-SYMPTOM
chondromatosis I-SYMPTOM
and O
would O
benefit O
from O
an B-TREATMENT
open I-TREATMENT
synovectomy I-TREATMENT
and O
debridement B-TREATMENT
. O

He O
was O
admitted O
for O
that B-TREATMENT
procedure I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

He O
had O
tonsillectomy B-TREATMENT
at O
the O
age O
of O
five O
, O
and O
appendectomy B-TREATMENT
in O
1940 O
. O

He O
had O
right B-TREATMENT
knee I-TREATMENT
aspirations I-TREATMENT
done O
in O
1986 O
, O
otherwise O
, O
he O
does O
not O
suffer O
from O
any B-SYMPTOM
other I-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
. O

ALLERGIES O
: O

He O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

He O
is O
on O
______________ O
2 O
tabs O
PO O
qd O
. O

SOCIAL O
HISTORY O
: O

Married O
and O
lives O
with O
his O
wife O
in O
Forda O
Minsas O
Ve O
, O
Wyoming O
. O

He O
is O
a O
retired O
school O
teacher O
by O
profession O
. O

He O
has O
a O
son O
who O
is O
an O
orthopedic O
surgeon O
. O

SOCIAL O
HISTORY O
: O

He O
has O
been O
a O
smoker O
for O
the O
last O
50 O
years O
and O
he O
drinks O
alcohol O
occasionally O
, O
but O
stopped O
in O
1987 O
. O

PHYSICAL O
EXAMINATION O
: O

He O
is O
healthy O
looking O
. O

The O
general O
physical O
examination O
did O
not O
reveal O
any B-SYMPTOM
abnormality I-SYMPTOM
. O

Heart O
, O
chest O
, O
and O
abdominal O
examinations O
were O
normal O
. O

The O
right O
knee O
examination O
showed O
some B-SYMPTOM
effusion I-SYMPTOM
. O

The O
range O
of O
motion O
was O
15 O
to O
120 O
degree O
on O
the O
right O
side O
; O
and O
on O
the O
left O
side O
, O
it O
was O
zero O
to O
135 O
. O

There O
was O
normal O
muscle O
power O
. O

The O
peripheral O
pulses O
were O
palpable O
. O

LABORATORY O
DATA O
: O

His O
hematocrit O
was O
44.4 O
, O
with O
white O
blood O
count O
of O
11.9 O
, O
and O
platelet O
count O
of O
410 O
. O

His O
MCV O
was O
92 O
, O
MCH O
32.1 O
, O
and O
MCHE O
34.8 O
. O

His O
chest O
X-ray O
did O
not O
reveal O
any B-SYMPTOM
abnormality I-SYMPTOM
. O

A O
electrocardiogram O
showed O
nonspecific B-SYMPTOM
T-wave I-SYMPTOM
abnormalities I-SYMPTOM
, O
otherwise O
, O
it O
was O
normal O
. O

HOSPITAL O
COURSE O
: O

He O
underwent O
right B-TREATMENT
knee I-TREATMENT
open I-TREATMENT
synovectomy I-TREATMENT
and O
debridement B-TREATMENT
of O
synovial B-SYMPTOM
chondromatosis I-SYMPTOM
on O
10-28-93 O
. O

Postoperatively O
, O
he O
has O
done O
well O
. O

He O
is O
mobilized O
with O
the O
help O
of O
physical B-TREATMENT
therapy I-TREATMENT
, O
on O
a B-TREATMENT
continuous I-TREATMENT
passive I-TREATMENT
motion I-TREATMENT
machine I-TREATMENT
. O

His O
discharge O
range O
of O
motion O
is O
from O
zero O
to O
40 O
degrees O
. O

He O
was O
on O
pain B-TREATMENT
medication I-TREATMENT
and O
he O
was O
also O
on O
Percocet B-TREATMENT
, O
but O
now O
he O
can O
manage O
without O
the O
Percocet B-TREATMENT
. O

He O
is O
on O
Coumadin B-TREATMENT
which O
is O
to O
be O
continued O
for O
six O
weeks O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Percocet B-TREATMENT
1-2 O
PO O
q4h O
prn O
. O

FOLLOW O
UP O
: O

He O
will O
be O
followed O
up O
in O
Cesa O
, O
New O
York O
. O

DISPOSITION O
: O

On O
discharge O
, O
he O
is O
mobilized O
, O
partial O
weight O
bearing O
with O
the O
help O
of O
a B-TREATMENT
walker I-TREATMENT
. O

The O
condition O
on O
discharge O
is O
good O
. O

STA O
AGE O
, O
M.D. O

DICTATING O
FOR O
: O

SHAA O
STONGE O
, O
M.D. O

TR O
: O

fu O
/ O
bmot O

DD O
: O

11-1-93 O

TD O
: O

11/01/93 O

CC O
: O

Admission O
Date O
: O

2016-05-05 O

Discharge O
Date O
: O

2016-06-15 O

Date O
of O
Birth O
: O

2016-05-05 O

Sex O
: O

F O

Service O
: O

NEONATOLOGY O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
30 O
and O
08-01 O
week O
gestation O
female O
, O
triplet O
number O
two O
, O
delivered O
by O
cesarean B-TREATMENT
section I-TREATMENT
due O
to O
progressive B-SYMPTOM
preterm I-SYMPTOM
labor I-SYMPTOM
and O
triplet B-SYMPTOM
gestation I-SYMPTOM
. O

PERINATAL O
HISTORY O
: O

Mother O
is O
a O
29 O
year-old O
gravida O
4 O
, O
para O
1 O
mother O
, O
Marian O
Jane O
conception O
, O
EDC O
2016-07-08 O
. O

Prenatal O
screen O
, O
O O
positive O
, O
antibody O
negative O
, O
RPR O
nonreactive O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
reportedly O
GBS O
negative O
, O
Rubella O
immune O
. O

Pregnancy O
complicated O
by O
gestational B-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
, O
then O
possible O
preterm B-SYMPTOM
labor I-SYMPTOM
. O

Mother O
presented O
with O
abdominal B-SYMPTOM
discomfort I-SYMPTOM
and O
vaginal B-SYMPTOM
pressure I-SYMPTOM
at O
23 O
and O
1/7 O
weeks O
. O

At O
that O
time O
she O
was O
admitted O
and O
received O
a B-TREATMENT
full I-TREATMENT
course I-TREATMENT
of I-TREATMENT
betamethasone I-TREATMENT
at O
24 O
weeks O
and O
remained O
in O
house O
until O
delivery B-TREATMENT
. O

Mother O
presented O
on O
day O
of O
delivery B-TREATMENT
with O
preterm B-SYMPTOM
labor I-SYMPTOM
, O
cervical B-SYMPTOM
dilation I-SYMPTOM
, O
therefore O
delivered O
by O
repeat B-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
. O

This O
triplet O
required O
only O
blow B-TREATMENT
by I-TREATMENT
oxygen I-TREATMENT
and O
routine B-TREATMENT
care I-TREATMENT
in O
delivery O
room O
. O

Apgars O
were O
8 O
at O
one O
minute O
and O
9 O
at O
five O
minutes O
. O

Infant O
demonstrated O
mild B-SYMPTOM
increased I-SYMPTOM
work I-SYMPTOM
of I-SYMPTOM
breathing I-SYMPTOM
in O
the O
delivery O
room O
. O

Infant O
transported O
to O
Neonatal O
Intensive O
Care O
Unit O
on O
facial B-TREATMENT
CPAP I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
ON O
ADMISSION O
: O

Birth O
weight O
1455 O
grams O
( O
50th O
percentile O
), O
head O
circumference O
29.25 O
cm O
( O
50th O
percentile O
), O
length O
41.5 O
cm O
( O
50th O
percentile O
). O

Nondysmorphic B-SYMPTOM
with O
overall O
appearance O
consistent O
with O
gestational O
age O
. O

Anterior O
fontanel O
soft O
, O
open O
, O
flat O
, O
red O
reflex O
present O
bilaterally O
, O
palate O
intact O
. O

Intermittent B-SYMPTOM
grunting I-SYMPTOM
, O
moderate B-SYMPTOM
intercostal I-SYMPTOM
retractions I-SYMPTOM
, O
diminished B-SYMPTOM
air I-SYMPTOM
entry I-SYMPTOM
, O
regular O
rate O
and O
rhythm O
without O
murmur B-SYMPTOM
, O
2+ O
femoral O
pulses O
. O

Abdomen O
benign O
with O
no O
hepatosplenomegaly B-SYMPTOM
or O
masses B-SYMPTOM
. O

No O
external O
female O
genitalia O
. O

Normal O
back O
and O
extremities O
with O
stable O
hips O
, O
appropriate O
tone O
, O
skin O
pink O
with O
fair O
perfusion O
. O

HOSPITAL O
COURSE O
: O

1. O
Pulmonary O
: O

On O
admission O
the O
infant O
required O
CPAP B-TREATMENT
6 O
cm O
of O
water O
, O
30% B-TREATMENT
oxygen I-TREATMENT
. O

Initial O
capillary O
blood O
gas O
was O
pH O
7.29 O
, O
CO2 O
47 O
. O

Infant O
was O
intubated B-TREATMENT
on O
day O
of O
life O
two O
for O
increased B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
and O
received O
one O
dose O
of O
surfactant B-TREATMENT
. O

Infant O
was O
extubated B-TREATMENT
on O
day O
of O
life O
four O
to O
CPAP B-TREATMENT
and O
transitioned O
to O
room O
air O
on O
day O
of O
life O
six O
. O

The O
infant O
has O
remained O
in O
room O
air O
throughout O
the O
hospitalization O
. O

Caffeine B-TREATMENT
citrate I-TREATMENT
was O
started O
on O
day O
of O
life O
six O
and O
was O
discontinued O
on O
05-23 O
( O
day O
of O
life O
18 O
). O

The B-SYMPTOM
last I-SYMPTOM
apnea I-SYMPTOM
and O
bradycardia B-SYMPTOM
was O
on O
06-10 O
. O

2. O
Cardiovascular O
: O

The O
infant O
has O
remained O
hemodynamically O
stable O
throughout O
this O
hospitalization O
, O
no O
murmur B-SYMPTOM
. O

Heart O
rate O
150 O
to O
160 O
, O
mean O
blood O
pressure O
40 O
to O
54 O
. O

3. O
Fluid O
, O
electrolytes O
and O
nutrition O
: O

Infant O
was O
initially O
nothing B-TREATMENT
by I-TREATMENT
mouth I-TREATMENT
receiving O
80 O
cc O
per O
kilogram O
per O
day O
of O
D10W B-TREATMENT
intravenously I-TREATMENT
. O

Infant O
was O
started O
on O
enteral B-TREATMENT
feedings I-TREATMENT
on O
day O
of O
life O
four O
and O
advanced O
to O
full O
volume O
feedings O
of O
150 O
cc O
per O
kilogram O
per O
day O
by O
day O
of O
life O
seven O
. O

During O
feeding B-TREATMENT
advancement I-TREATMENT
infant O
was O
given O
parenteral B-TREATMENT
nutrition I-TREATMENT
and O
intralipids B-TREATMENT
. O

The O
infant O
tolerated O
feeding B-TREATMENT
advancement I-TREATMENT
without O
difficulty B-SYMPTOM
. O

Infant O
was O
advanced O
to O
maximum O
caloric O
density O
of O
breast O
milk O
or O
premature B-TREATMENT
Enfamil I-TREATMENT
26 O
calories O
per O
ounce O
with O
ProMod B-TREATMENT
by O
day O
of O
life O
11 O
. O

Infant O
is O
currently O
on O
breast O
milk O
or O
Enfamil B-TREATMENT
24 O
calories O
per O
ounce O
po O
minimum O
140 O
cc O
per O
kilogram O
per O
day O
. O

The O
most O
recent O
weight O
is O
2525 O
g. O

Head O
circumference O
24.5 O
cm O
, O
length O
45.5 O
cm O
. O

The O
most O
recent O
electrolytes O
on O
day O
of O
life O
five O
were O
sodium O
145 O
, O
chloride O
115 O
, O
potassium O
4 O
, O
TCO2 O
of O
21 O
. O

On O
day O
of O
life O
25 O
, O
calcium O
10.1 O
, O
phosphorus O
6.9 O
, O
alkaline O
phosphatase O
341 O
. O

4. O
Gastrointestinal O
: O

Infant O
was O
started O
on O
double B-TREATMENT
phototherapy I-TREATMENT
on O
day O
of O
life O
two O
for O
a O
maximum O
bilirubin O
level O
of O
8.1 O
with O
a O
direct O
of O
0.3 O
. O

Infant O
decreased O
to O
single B-TREATMENT
phototherapy I-TREATMENT
and O
phototherapy B-TREATMENT
was O
discontinued O
on O
day O
of O
life O
six O
. O

Rebound O
bilirubin O
level O
on O
day O
of O
life O
seven O
was O
5.3 O
with O
a O
direct O
of O
0.3 O
. O

5. O
Hematology O
: O

The O
infant O
did O
not O
receive O
any B-TREATMENT
blood I-TREATMENT
transfusions I-TREATMENT
this B-TREATMENT
hospitalization I-TREATMENT
. O

The O
most O
recent O
hematocrit O
on O
day O
of O
life O
two O
was O
47% O
. O

CBC O
on O
admission O
white O
blood O
cell O
count O
8.9 O
, O
hematocrit O
47% O
, O
platelets O
243,000 O
, O
6% O
neutrophils O
, O
0 O
bands O
. O

Repeat O
CBC O
on O
day O
of O
life O
two O
showed O
a O
white O
blood O
cell O
count O
of O
8.4 O
, O
platelets O
95 O
, O
41% O
neutrophils O
, O
0 O
bands O
. O

Repeat O
platelet O
count O
on O
day O
of O
life O
three O
was O
229 O
. O

6. O
Infectious O
disease O
: O

The O
infant O
received O
48 O
hours O
of O
ampicillin B-TREATMENT
and O
gentamicin B-TREATMENT
for O
rule O
out O
sepsis B-SYMPTOM
. O

Blood O
cultures O
remained O
negative O
to O
date O
. O

Infant O
has O
not O
had O
any B-SYMPTOM
issues I-SYMPTOM
with I-SYMPTOM
sepsis I-SYMPTOM
this B-TREATMENT
hospitalization I-TREATMENT
. O

7. O
Neurology O
: O

Head O
ultrasound O
on O
day O
of O
life O
seven O
showed O
no O
intraventricular B-SYMPTOM
hemorrhage I-SYMPTOM
. O

A O
repeat O
head O
ultrasound O
on O
day O
of O
life O
33 O
06-07 O
showed O
a B-SYMPTOM
slight I-SYMPTOM
increase I-SYMPTOM
of I-SYMPTOM
echogenicity I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
caudothalamic I-SYMPTOM
groove I-SYMPTOM
, O
which O
may O
represent O
tiny B-SYMPTOM
bilateral I-SYMPTOM
germinal I-SYMPTOM
matrix I-SYMPTOM
hemorrhages I-SYMPTOM
, O
no O
periventricular B-SYMPTOM
leukomalacia I-SYMPTOM
. O

A O
repeat O
head O
ultrasound O
is O
recommended O
in O
one O
month O
. O

Normal O
neurological O
examination O
. O

Sensory O
, O
hearing O
screening O
was O
performed O
with O
automated O
auditory O
brain O
stem O
responses O
. O

Infant O
passed O
both O
ears O
. O

Ophthalmology O
, O
eyes O
examined O
most O
recently O
on O
05-30 O
revealing O
immaturity B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
retinal I-SYMPTOM
vessels I-SYMPTOM
, O
but O
no O
ROP B-SYMPTOM
as O
of O
yet O
. O

A O
follow O
up O
examination O
should O
be O
scheduled O
for O
the O
week O
of O
06-20 O
. O

Ophthalmologist O
is O
Dr. O
Cruea O
Franklin O
. O

8. O
Psycho O
/ O
social O
: O

Parents O
involved O
. O

Triplet O
number O
one O
is O
still O
in O
the O
Neonatal O
Intensive O
Care O
Unit O
and O
triplet O
number O
three O
is O
home O
with O
family O
and O
there O
is O
also O
a O
2 O
year-old O
sibling O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
on O
room O
air O
. O

DISCHARGE O
DISPOSITION O
: O

Home O
with O
parents O
. O

NAME O
OF O
PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Janetta O
Burmaster O
, O
phone O
number O
( O
262 O
) O
892 O
0330 O
, O
fax O
491-6171 O
. O

CARE O
AND O
RECOMMENDATIONS O
: O

Feedings O
breast O
milk O
or O
Enfamil B-TREATMENT
24 O
calories O
per O
ounce O
, O
breast O
milk O
mixed O
with O
4 O
calories O
per O
ounce O
of O
Enfamil B-TREATMENT
powder I-TREATMENT
, O
minimum O
of O
140 O
cc O
per O
kilogram O
per O
day O
po O
. O

MEDICATIONS O
: O

Ferrous B-TREATMENT
sulfate I-TREATMENT
25 O
mg O
per O
ml O
, O
2 O
mg O
per O
kilogram O
per O
day O
. O

Car O
seat O
position O
screening O
passed O
on O
06-07 O
. O

Hearing O
screen O
passed O
on O
2016-06-07 O
. O

State O
newborn O
screens O
were O
sent O
on O
05-08 O
and O
05-19 O
. O

No O
abnormal B-SYMPTOM
results I-SYMPTOM
have O
been O
reported O
. O

Immunizations B-TREATMENT
, O
the O
infant O
received O
hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
on O
2016-06-02 O
. O

Immunizations B-TREATMENT
recommended O
, O
Synagis B-TREATMENT
RSV I-TREATMENT
prophylaxis I-TREATMENT
should O
be O
considered O
from O
October O
through O
April O
for O
infants O
who O
meet O
any O
of O
the O
following O
three O
criteria O
, O
born O
at O
less O
then O
32 O
weeks O
, O
born O
between O
32 O
and O
35 O
weeks O
with O
two O
of O
three O
of O
the O
following O
, O
day O
care O
during O
RSV O
season O
, O
smoker O
on O
the O
household O
, O
neuromuscular B-SYMPTOM
disease I-SYMPTOM
, O
airway B-SYMPTOM
abnormalities I-SYMPTOM
or O
school O
age O
siblings O
or O
with O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
. O

Influenza B-TREATMENT
immunization I-TREATMENT
is O
recommended O
annually O
in O
the O
fall O
for O
all O
infants O
once O
they O
reach O
six O
months O
of O
age O
. O

Before O
this O
age O
and O
for O
the O
first O
24 O
months O
of O
the O
child O
's O
life O
immunization B-TREATMENT
against O
influenza B-SYMPTOM
is O
recommended O
for O
household O
contacts O
and O
out O
of O
home O
caregivers O
. O

FOLLOW O
UP O
APPOINTMENTS O
: O

1. O
Primary O
pediatrician O
. O

2. O
Ophthalmology O
Dr. O
Wilson O
. O

3. O
Visiting O
Nurse O
Association O
early O
intervention O
program O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Prematurity B-SYMPTOM
triplet O
number O
two O
. O

2. O
Status O
post O
respiratory B-SYMPTOM
distress I-SYMPTOM
. O

3. O
Status O
post O
rule O
out O
sepsis B-SYMPTOM
, O
ruled O
out O
. O

4. O
Status O
post O
apnea B-SYMPTOM
of I-SYMPTOM
prematurity I-SYMPTOM
. O

5. O
Status O
post O
indirect B-SYMPTOM
hyperbilirubinemia I-SYMPTOM
. O

Richard O
Hartney O
, O
M.D. O
02-219 O

Dictated O
By O
: O
Leonard O
J. O
Pellegrino O
, O
M.D. O

MEDQUIST36 O

D O
: O
2016-06-14 O
11:22 O

T O
: O
2016-06-15 O
07:09 O

JOB O
#: O
47623 O

Signed O
electronically O
by O
: O
DR. O
Thomas O
M. O
Muth O
on O
: O
WED O
2016-06-15 O
9:49 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-02-11 O

Discharge O
Date O
: O

2013-02-26 O

Date O
of O
Birth O
: O

1932-07-08 O

Sex O
: O

M O

Service O
: O

KURLIND O

ADDENDUM O
: O

The O
patient O
was O
discharged O
to O
Milton/Haverhill O
per O
family O
request O
for O
pain B-SYMPTOM
and O
comfort B-TREATMENT
( I-TREATMENT
hospice I-TREATMENT
) I-TREATMENT
management I-TREATMENT
. O

Please O
refer O
to O
full O
discharge O
summary O
for O
details O
. O

Patricia O
E. O
Burnett O
, O
M.D. O

54-256 O

Dictated O
By O
: O
Sarah O
G O
Sheahan O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-05-01 O
10:33 O

T O
: O
2013-05-01 O
12:59 O

JOB O
#: O
23157 O

Signed O
electronically O
by O
: O
DR. O
Edward O
Larue O
on O
: O
TUE O
2013-05-14 O
5:11 O
AM O

( O
End O
of O
Report O
) O

811533262 O
SC O

77894566 O

9188280 O

6/30/2006 O
12:00:00 O
AM O

Primary B-TREATMENT
c I-TREATMENT
/ I-TREATMENT
s I-TREATMENT
for O
breech B-SYMPTOM

DIS O

Admission O
Date O
: O

06/30/2006 O

Report O
Status O
: O

Discharge O
Date O
: O

07/04/2006 O

****** O
FINAL O
DISCHARGE O
ORDERS O
****** O

OBEFYFE O
, O
TREE O

373-78-78-7 O
O38 O

Room O
: O

DEALPERSANDERSWAUKE O
MISSJEANES O
MACOMTOMA O
GLANDSTATE O
MEDICAL O
CENTER O

Service O
: O

OBS O

DISCHARGE O
PATIENT O
ON O
: O

Independence O
Day O
AT O
10:00 O
AM O

CONTINGENT O
UPON O

Attending O
evaluation O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

PO O
, O
IEDEARC O
J O
, O
M.D. O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

IBUPROFEN B-TREATMENT
400-600 O
MG O
PO O
Q6H O
PRN O
Pain B-SYMPTOM

Food O
/ O
Drug O
Interaction O
Instruction O

Take O
with O
food O

OXYCODONE B-TREATMENT
5-10 O
MG O
PO O
Q3H O
PRN O
Pain B-SYMPTOM

Instructions O
: O

If O
pt O
received O
post B-TREATMENT
partum I-TREATMENT
spinal I-TREATMENT
morphine I-TREATMENT
, O
DO O
NOT O
administer O
Oxycodone B-TREATMENT
for O
18 O
hours O
after O
morphine B-TREATMENT
administration I-TREATMENT
. O

PRENATAL B-TREATMENT
MULTIVITAMINS I-TREATMENT
( I-TREATMENT
STUARTNATAL I-TREATMENT
) I-TREATMENT
1 O

TAB O
PO O
DAILY O
DIET O
: O

No O
Restrictions O

ACTIVITY O
: O

Resume O
regular O
exercise O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

PH O
Po O
6 O
wks O
, O

ALLERGY O
: O

Penicillins B-TREATMENT

ADMIT O
DIAGNOSIS O
: O

Breech B-SYMPTOM
failed I-SYMPTOM
version I-SYMPTOM
Pregnancy I-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
Primary B-TREATMENT
c I-TREATMENT
/ I-TREATMENT
s I-TREATMENT
for O
breech B-SYMPTOM

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O

scheduled B-TREATMENT
c I-TREATMENT
/ I-TREATMENT
s I-TREATMENT
for O
breech B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

Vaginal B-TREATMENT
delivery I-TREATMENT
: O

Undelivered B-SYMPTOM

Cesarean O
Status O
: O

Primary O

Urgency O
: O

Scheduled O

Indications O
: O

Breech B-SYMPTOM
, O

Uterine B-TREATMENT
incision I-TREATMENT
type I-TREATMENT
: O

Transverse O

Placenta O
: O

Delivery O
: O

Manual O

Condition O
: O

Normal O

Staff O
Obstetrician O
( O
supervising O
) O
: O

PO O
, O
IEDEARC O
J O
, O
M.D. O
Delivery O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

none O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

G1 O
T0 O
P0 O
A0 O
L0 O

Estimated O
EDC O
: O

07/09/06 O

Maternal O
transfer O
: O

No O

Initial O
newborn O
exam O
: O

No O
observed B-SYMPTOM
abnormalities I-SYMPTOM

ADDITIONAL O
COMMENTS O
: O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

PO O
, O
IEDEARC O
J O
, O
M.D. O
( O
NH10 O
) O
06/30/06 O
09:55 O
AM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2012-09-26 O

Discharge O
Date O
: O

2012-10-01 O

Date O
of O
Birth O
: O

2012-09-26 O

Sex O
: O

M O

Service O
: O

NEONATOLOGY O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
5235 O
- O
gram O
full-term O
male O
infant O
of O
a O
diabetic O
mother O
born O
by O
repeat B-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
to O
a O
29-year-old O
gravida O
1 O
, O
para O
2 O
, O
woman O
. O

Prenatal O
screens O
benign O
. O

Group O
B O
strep O
status O
negative O
. O

Pregnancy O
complicated O
by O
insulin-dependent B-SYMPTOM
gestational I-SYMPTOM
diabetes I-SYMPTOM
. O

Apgar O
scores O
were O
8 O
at O
1 O
minute O
and O
9 O
at O
5 O
minutes O
. O

The O
infant O
admitted O
to O
the O
Neonatal O
Intensive O
Care O
Unit O
for O
a O
dextrose O
stick O
of O
20 O
in O
the O
delivery O
room O
. O

PHYSICAL O
EXAMINATION O
ON O
ADMISSION O
: O

Birth O
weight O
was O
5235 O
grams O
, O
length O
was O
56 O
cm O
, O
and O
head O
circumference O
was O
37.5 O
cm O
. O

Anterior O
fontanel O
open O
and O
flat O
. O

The O
palate O
was O
intact O
. O

Nares O
were O
patent O
. O

Bilateral O
breath O
sounds O
were O
clear O
and O
equal O
. O

No O
grunting B-SYMPTOM
, O
flaring B-SYMPTOM
, O
or O
retracting B-SYMPTOM
. O

No O
murmurs B-SYMPTOM
. O

A O
regular O
rate O
and O
rhythm O
. O

Pink O
and O
well O
perfused O
. O

The O
abdomen O
was O
soft O
and O
nondistended B-SYMPTOM
. O

There O
was O
no O
hepatosplenomegaly B-SYMPTOM
. O

There O
was O
a O
3-vessel O
cord O
. O

The O
spine O
was O
intact O
. O

The O
anus O
was O
patent O
. O

Normal O
male O
genitalia O
. O

Tone O
was O
appropriate O
for O
gestational O
age O
. O

SUMMARY O
OF O
HOSPITAL O
COURSE O
BY O
ISSUES-SYSTEM O
: O

RESPIRATORY O
: O

The O
infant O
has O
remained O
on O
room O
air O
throughout O
his O
hospitalization O
with O
oxygen O
saturations O
of O
greater O
than O
95 O
percent O
. O

Respiratory O
rates O
have O
been O
40 O
s O
to O
60 O
s. O

The O
infant O
has O
had O
two B-SYMPTOM
spontaneous I-SYMPTOM
desaturations I-SYMPTOM
which O
quickly O
self-resolved O
on O
day O
of O
life O
one O
. O

No O
other O
issues O
. O

No O
apnea B-SYMPTOM
or O
bradycardia B-SYMPTOM
. O

CARDIOVASCULAR O
: O

The O
infant O
has O
remained O
hemodynamically O
stable O
with O
heart O
rates O
in O
the O
120 O
s O
to O
140 O
s O
and O
mean O
blood O
pressures O
of O
57 O
to O
60 O
. O

FLUIDS O
, O
ELECTROLYTES O
AND O
NUTRITION O
: O

The O
infant O
was O
admitted O
to O
the O
Neonatal O
Intensive O
Care O
Unit O
for O
treatment B-TREATMENT
of O
hypoglycemia B-SYMPTOM
. O

The O
infant O
was O
started O
on O
enteral B-TREATMENT
feedings I-TREATMENT
of O
Enfamil B-TREATMENT
20 I-TREATMENT
calories I-TREATMENT
per I-TREATMENT
ounce I-TREATMENT
by O
mouth O
ad O
lib O
and O
maintained O
glucoses O
in O
the O
middle O
to O
high O
40 O
s O
taking O
by B-TREATMENT
mouth I-TREATMENT
feedings I-TREATMENT
every O
two O
to O
three O
hours O
by O
mouth O
ad O
lib O
. O

On O
day O
of O
life O
one O
, O
the O
infant O
had O
a O
dextrose O
stick O
of O
34 O
. O

At O
that O
time O
, O
an B-TREATMENT
intravenous I-TREATMENT
of O
D-10-W B-TREATMENT
was O
started O
at O
80 O
cc O
/ O
kilogram O
per O
day O
. O

On O
day O
of O
life O
two O
, O
the O
infant O
began O
to O
wean O
off O
intravenous B-TREATMENT
fluids I-TREATMENT
, O
and O
this O
was O
completed O
by O
day O
of O
life O
four O
. O

Calories O
were O
increased O
to O
Similac B-TREATMENT
24 I-TREATMENT
calories I-TREATMENT
per I-TREATMENT
ounce I-TREATMENT
. O

Before O
discharge O
to O
the O
Newborn O
Nursery O
, O
the O
infant O
was O
taking O
Similac B-TREATMENT
22 I-TREATMENT
calories I-TREATMENT
per I-TREATMENT
ounce I-TREATMENT
by O
mouth O
ad O
lib O
and O
maintaining O
dextrose O
sticks O
in O
the O
60 O
s. O

Weight O
on O
discharge O
was O
5200 O
grams O
. O

GASTROINTESTINAL O
: O

No O
issues O
. O

HEMATOLOGY O
: O

No O
issues O
. O

NEUROLOGY O
: O

Normal O
neurologic O
examination O
. O

SCREENS O
: O

A O
hearing O
screen O
was O
performed O
with O
automated O
auditory O
brain O
stem O
responses O
and O
the O
infant O
passed O
on O
both O
ears O
. O

PSYCHOSOCIAL O
: O

The O
parents O
are O
involved O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
on O
room O
air O
. O

DISCHARGE O
DISPOSITION O
: O

To O
Newborn O
Nursery O
. O

PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Tamatha O
- O
Cape O
Cod O
Hospital O
. O

CARE O
RECOMMENDATIONS O
: O

1. O
Feedings O
at O
discharge O
: O

Similac B-TREATMENT
22 I-TREATMENT
calories I-TREATMENT
per I-TREATMENT
ounce I-TREATMENT
by O
mouth O
ad O
lib O
with O
a O
goal O
of O
decreasing O
to O
20 B-TREATMENT
calories I-TREATMENT
per I-TREATMENT
ounce I-TREATMENT
for O
dextrose O
sticks O
of O
greater O
than O
60 O
. O

2. O
Medications B-TREATMENT
: O

None O
. O

3. O
A O
state O
newborn O
screen O
was O
sent O
on O
day O
of O
life O
three O
; O
the O
results O
are O
pending O
. O

4. O
Received O
hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
on O
2012-09-30 O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Large B-SYMPTOM
for I-SYMPTOM
gestational I-SYMPTOM
age I-SYMPTOM
. O

2. O
Infant O
of O
a O
diabetic O
mother O
. O

3. O
Hypoglycemia B-SYMPTOM
. O

Reviewed O
By O
: O

Mary O
Karina O
, O
Oregon O
30621 O

Dictated O
By O
: O
James O
H. O
Acosta O
, O
M.D. O

MEDQUIST36 O

D O
: O
2012-10-02 O
15:46:05 O

T O
: O
2012-10-02 O
17:14:44 O

Job O
#: O
07783 O

Signed O
electronically O
by O
: O
DR. O
Richard O
Stripling O
on O
: O
Maxine O
2012-10-25 O
8:30 O
PM O

( O
End O
of O
Report O
) O

280594741 O

FIH O

7060363 O

70349/v957 O

068215 O

7/2/1993 O
12:00:00 O
AM O

SEVERE B-SYMPTOM
BLUNT I-SYMPTOM
ABDOMINAL I-SYMPTOM
TRAUMA I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

7-2-93 O

DISCHARGE O
DATE O
: O

7-30-93 O

PRINCIPAL O
DIAGNOSIS O
: O

Severe B-SYMPTOM
blunt I-SYMPTOM
abdominal I-SYMPTOM
trauma I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

1. O
Grade B-SYMPTOM
II I-SYMPTOM
/ I-SYMPTOM
V I-SYMPTOM
laceration I-SYMPTOM
of I-SYMPTOM
liver I-SYMPTOM
, O

2. O
rupture B-SYMPTOM
of I-SYMPTOM
left I-SYMPTOM
renal I-SYMPTOM
vein I-SYMPTOM
, O

3. O
tear B-SYMPTOM
of I-SYMPTOM
transverse I-SYMPTOM
mesocolon I-SYMPTOM
, O

4. O
serosal B-SYMPTOM
tear I-SYMPTOM
of I-SYMPTOM
transverse I-SYMPTOM
colon I-SYMPTOM
, O

5. O
blunt B-SYMPTOM
fracture I-SYMPTOM
of O
the O
neck O
of O
the O
pancreas O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
AND O
HOSPITAL O
COURSE O
: O

Mr. O
Breath O
was O
a O
32 O
year O
old O
previously O
healthy O
unbelted O
driver O
whose O
car O
was O
hit O
at O
high O
speed O
by O
a O
vehicle O
driven O
by O
an O
intoxicated O
driver O
. O

The O
patient O
was O
ejected O
and O
his O
vehicle O
rolled O
over O
, O
possibly O
over O
him O
. O

He O
was O
found O
awake O
at O
the O
scene O
, O
complaining O
of O
abdominal B-SYMPTOM
pain I-SYMPTOM
. O

He O
had O
a O
blood O
pressure O
of O
60 O
systolic O
upon O
arrival O
of O
the O
Giles O
Min O
General O
Hospital O
crew O
. O

Intravenous B-TREATMENT
fluids I-TREATMENT
was O
given O
. O

He O
was O
paralyzed B-SYMPTOM
and O
endotracheally O
intubated O
, O
and O
a B-TREATMENT
14 I-TREATMENT
gauge I-TREATMENT
catheter I-TREATMENT
was O
inserted O
in O
his O
left O
chest O
because O
of O
poor B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
. O

He O
arrived O
at O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
at O
02:30 O
with O
a O
blood O
pressure O
of O
86 O
and O
a O
heart O
rate O
of O
170 O
. O

Large B-TREATMENT
bore I-TREATMENT
cannulas I-TREATMENT
were O
inserted O
into O
the O
femoral O
veins O
, O
bilateral B-TREATMENT
chest I-TREATMENT
tubes I-TREATMENT
were O
placed O
, O
and O
his O
blood O
pressure O
rose O
to O
110 O
systolic O
after O
two O
liters O
of O
crystalloid B-TREATMENT
. O

He O
had O
an B-SYMPTOM
ecchymosis I-SYMPTOM
over O
the O
medial O
right O
costal O
margin O
and O
his O
abdomen O
was O
distended B-SYMPTOM
. O

His O
hematocrit O
was O
36 O
, O
and O
creatinine O
1.6 O
. O

The O
abdominal O
tap O
was O
grossly B-SYMPTOM
positive I-SYMPTOM
for I-SYMPTOM
blood I-SYMPTOM
. O

His O
blood O
pressure O
fell O
to O
60 O
systolic O
as O
he O
was O
being O
transferred O
to O
the O
computerized O
tomography O
scan O
table O
; O
the O
scan O
was O
aborted O
and O
he O
was O
taken O
directly O
to O
the O
operating O
room O
at O
03:00 O
. O

At O
laparotomy B-TREATMENT
, O
there O
was O
a O
liter O
of O
blood B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
peritoneal I-SYMPTOM
cavity I-SYMPTOM
. O

There O
was O
a B-SYMPTOM
class I-SYMPTOM
II I-SYMPTOM
laceration I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
liver I-SYMPTOM
at O
the O
falciform O
ligament O
which O
was O
actively O
bleeding O
, O
a B-SYMPTOM
tear I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
transverse I-SYMPTOM
mesocolon I-SYMPTOM
from O
its O
base O
to O
the O
bowel O
wall O
with O
active B-SYMPTOM
bleeding I-SYMPTOM
, O
a B-SYMPTOM
7 I-SYMPTOM
cm I-SYMPTOM
serosal I-SYMPTOM
tear I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
adjacent I-SYMPTOM
transverse I-SYMPTOM
colon I-SYMPTOM
, O
and O
a B-SYMPTOM
large I-SYMPTOM
central I-SYMPTOM
retroperitoneal I-SYMPTOM
hematoma I-SYMPTOM
. O

Control O
of O
the O
super-celiac O
aorta O
was O
obtained O
, O
and O
both O
left B-TREATMENT
and I-TREATMENT
right I-TREATMENT
sided I-TREATMENT
&quot; I-TREATMENT
Mattox I-TREATMENT
&quot; I-TREATMENT
maneuvers I-TREATMENT
were O
performed O
. O

The O
retroperitoneum O
was O
opened O
, O
with O
vigorous B-SYMPTOM
bleeding I-SYMPTOM
resulting O
. O

This O
was O
controlled O
, O
necessitating O
ten O
minutes O
of O
aortic B-TREATMENT
clamping I-TREATMENT
and O
found O
to O
have O
originated O
from O
the B-SYMPTOM
rupture I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
renal I-SYMPTOM
vein I-SYMPTOM
one O
centimeter O
from O
its O
junction O
with O
the O
inferior O
vena O
cava O
. O

The O
vein O
was O
divided O
and O
suture B-TREATMENT
ligated O
. O

Bleeding B-SYMPTOM
from I-SYMPTOM
the I-SYMPTOM
liver I-SYMPTOM
was O
controlled O
with O
sutures B-TREATMENT
. O

The B-SYMPTOM
tears I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
transverse I-SYMPTOM
mesocolon I-SYMPTOM
and I-SYMPTOM
colon I-SYMPTOM
serosa I-SYMPTOM
were O
repaired O
. O

The O
examination O
of O
the O
remainder O
of O
the O
abdominal O
contents O
revealed O
no O
other B-SYMPTOM
injury I-SYMPTOM
; O
in O
particular O
, O
the O
entire O
anterior O
surface O
and O
the O
immediately O
juxtaduodenal O
posterior O
surface O
of O
the O
pancreas O
were O
normal O
. O

The O
patient O
was O
now O
very O
stable O
, O
and O
he O
was O
taken O
to O
the O
Respiratory O
Intensive O
Care O
Unit O
. O

The O
patient O
had O
received O
ten O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
, O
five O
units O
of O
fresh B-TREATMENT
frozen I-TREATMENT
plasma I-TREATMENT
, O
seven O
units O
of O
platelets B-TREATMENT
, O
and O
nine O
liters O
of O
Ringer B-TREATMENT
&apos;s I-TREATMENT
lactate I-TREATMENT
. O

An O
intracranial O
pressure O
monitoring O
bolt O
had O
been O
placed O
by O
the O
Neurosurgery O
Service O
staff O
during O
the B-TREATMENT
laparotomy I-TREATMENT
. O

Intracranial O
pressures O
were O
normal O
. O

That O
day O
, O
cranial O
computerized O
tomography O
scan O
and O
cervical O
spine O
films O
were O
normal O
. O

An O
arch O
aortogram O
was O
normal O
. O

Over O
the O
ensuing O
twenty-four O
hours O
, O
bilateral B-SYMPTOM
infiltrates I-SYMPTOM
on O
chest O
X-ray O
with O
poor B-SYMPTOM
oxygenation I-SYMPTOM
and O
labile B-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
requiring O
PA B-TREATMENT
line I-TREATMENT
guided I-TREATMENT
fluid I-TREATMENT
and O
pressors B-TREATMENT
developed O
. O

The O
patient O
had O
a B-SYMPTOM
large I-SYMPTOM
fluid I-SYMPTOM
requirement I-SYMPTOM
with O
total B-SYMPTOM
body I-SYMPTOM
capillary I-SYMPTOM
leak I-SYMPTOM
, O
decreasing B-SYMPTOM
SVR I-SYMPTOM
, O
oliguria B-SYMPTOM
unresponsive O
to O
Lasix B-TREATMENT
/ O
Mannitol B-TREATMENT
accompanied O
by O
a B-SYMPTOM
rise I-SYMPTOM
in O
creatinine O
to O
3.2 O
, O
worsening B-SYMPTOM
ARDS I-SYMPTOM
, O
a B-SYMPTOM
rise I-SYMPTOM
in O
temperature O
to O
103 O
, O
and O
a O
serum O
amylase O
of O
1265 O
. O

He O
was O
returned O
to O
the O
operating O
room O
on O
July O
4 O
. O

Three O
liters O
of O
clear B-SYMPTOM
green I-SYMPTOM
fluid I-SYMPTOM
were O
found O
in O
the O
abdominal O
cavity O
. O

Exploration O
of O
the O
pancreas O
revealed O
a B-SYMPTOM
posterior I-SYMPTOM
fracture I-SYMPTOM
a I-SYMPTOM
the I-SYMPTOM
superior I-SYMPTOM
mesenteric I-SYMPTOM
vessels I-SYMPTOM
. O

Because O
of O
the B-SYMPTOM
intense I-SYMPTOM
diffuse I-SYMPTOM
inflammatory I-SYMPTOM
reaction I-SYMPTOM
that O
had O
already O
set O
in O
, O
it O
was O
decided O
that O
neither O
distal B-TREATMENT
pancreatic I-TREATMENT
resection I-TREATMENT
nor O
Roux-en-Y B-TREATMENT
drainage I-TREATMENT
was O
feasible O
. O

Four B-TREATMENT
large I-TREATMENT
flat I-TREATMENT
Jackson-Pratt I-TREATMENT
drains I-TREATMENT
were O
placed O
, O
and O
gastrostomy B-TREATMENT
, O
jejunostomy B-TREATMENT
, O
and O
cholecystostomy B-TREATMENT
tubes I-TREATMENT
, O
as O
well O
as O
a B-TREATMENT
right I-TREATMENT
subclavian I-TREATMENT
Quinton I-TREATMENT
catheter I-TREATMENT
were O
placed O
. O

The O
patient O
&apos;s O
hemodynamics O
had O
improved O
markedly O
with O
the B-TREATMENT
evacuation I-TREATMENT
of O
the B-SYMPTOM
peritoneal I-SYMPTOM
pancreatic I-SYMPTOM
fluid I-SYMPTOM
, O
so O
that O
he O
was O
no O
longer O
on O
pressors B-TREATMENT
. O

However O
, O
upon O
transfer O
from O
the O
operating O
room O
table O
to O
the O
RICU O
bed O
, O
he O
suffered O
a B-SYMPTOM
cardiac I-SYMPTOM
arrest I-SYMPTOM
, O
which O
upon O
investigation O
was O
a B-SYMPTOM
primary I-SYMPTOM
respiratory I-SYMPTOM
arrest I-SYMPTOM
; O
the O
initial O
arterial O
blood O
gas O
was O
32/88/6.92 O
. O

He O
was O
successfully O
resuscitated O
after O
fifteen O
minutes O
of O
cardiopulmonary B-TREATMENT
resuscitation I-TREATMENT
and O
he O
was O
taken O
to O
the O
RICU O
. O

Continuous B-TREATMENT
venovenous I-TREATMENT
hemodialysis I-TREATMENT
was O
started O
on O
July O
5 O
, O
and O
continued O
for O
most O
of O
the O
remainder O
of O
the O
patient O
&apos;s O
course O
. O

Vancomycin B-TREATMENT
, O
Flagyl B-TREATMENT
, O
and O
Aztreonam B-TREATMENT
were O
given O
for O
gram B-SYMPTOM
negative I-SYMPTOM
Coccobacilli I-SYMPTOM
( O
later O
identified O
as O
Bacteroides B-SYMPTOM
) O
that O
had O
grown O
in O
his O
blood O
cultures O
and O
gram B-SYMPTOM
negative I-SYMPTOM
rods I-SYMPTOM
( I-SYMPTOM
Enterobacter I-SYMPTOM
) I-SYMPTOM
in O
his O
peritoneal O
fluid O
. O

He O
was O
kept O
sedated B-TREATMENT
and O
paralyzed B-TREATMENT
because O
of O
his B-SYMPTOM
severe I-SYMPTOM
adult I-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
. O

Total B-TREATMENT
parenteral I-TREATMENT
nutrition I-TREATMENT
was O
started O
on O
July O
5 O
. O

Initial O
improvement O
was O
followed O
by O
recurrence O
of O
low B-SYMPTOM
SVR I-SYMPTOM
, O
high B-SYMPTOM
cardiac I-SYMPTOM
output I-SYMPTOM
, O
ongoing B-SYMPTOM
acidosis I-SYMPTOM
, O
requiring O
norepinephrine B-TREATMENT
infusion I-TREATMENT
in O
the O
30 O
to O
40 O
mcg O
per O
minute O
range O
; O
drainage B-SYMPTOM
from O
the B-TREATMENT
Jackson-Pratt I-TREATMENT
drains I-TREATMENT
were O
minimal O
despite O
irrigation B-TREATMENT
and O
manipulation B-TREATMENT
. O

The O
patient O
was O
returned O
to O
the O
operating O
room O
on O
July O
10 O
, O
where O
several B-SYMPTOM
loculated I-SYMPTOM
thin I-SYMPTOM
fluid I-SYMPTOM
collections I-SYMPTOM
were O
drained O
and O
obviously B-SYMPTOM
necrotic I-SYMPTOM
tissue I-SYMPTOM
was O
debrided O
. O

It O
was O
decided O
to O
place O
more B-TREATMENT
drains I-TREATMENT
and O
pack O
the O
lesser O
sac O
with O
Adaptic B-TREATMENT
and O
laparotomy B-TREATMENT
pads I-TREATMENT
. O

The O
abdomen O
was O
left O
open O
, O
with O
the B-SYMPTOM
wound I-SYMPTOM
margins I-SYMPTOM
connected O
by O
a O
sheet O
of O
Marlex B-TREATMENT
mesh I-TREATMENT
to O
prevent O
evisceration B-SYMPTOM
. O

He O
was O
returned O
to O
the O
operating O
room O
on O
July O
12 O
, O
13 O
, O
16 O
, O
19 O
, O
21 O
, O
and O
23 O
for O
packing B-TREATMENT
change I-TREATMENT
, O
irrigation B-TREATMENT
and O
debridement B-TREATMENT
. O

Tracheostomy B-TREATMENT
was O
also O
performed O
on O
July O
17 O
. O

There O
was O
severe B-SYMPTOM
diffuse I-SYMPTOM
peritonitis I-SYMPTOM
with O
intense B-SYMPTOM
inflammation I-SYMPTOM
, O
infection B-SYMPTOM
, O
and O
patchy B-SYMPTOM
necrosis I-SYMPTOM
of I-SYMPTOM
peritoneal I-SYMPTOM
surfaces I-SYMPTOM
and O
of O
the O
distal O
pancreas O
. O

The O
subsequent O
overall O
course O
was O
a O
slow O
downhill O
one O
, O
with O
ongoing B-SYMPTOM
extreme I-SYMPTOM
hyperdynamic I-SYMPTOM
( O
cardiac O
output O
12 O
to O
15 O
liters O
per O
minute O
) O
and O
catabolic B-SYMPTOM
state I-SYMPTOM
. O

On O
July O
26 O
, O
abdominal B-TREATMENT
irrigation I-TREATMENT
and O
debridement B-TREATMENT
was O
performed O
in O
the O
RICU O
; O
this O
was O
repeated O
daily O
for O
the O
next O
three O
days O
. O

On O
July O
29 O
, O
the B-SYMPTOM
septic I-SYMPTOM
state I-SYMPTOM
with O
low B-SYMPTOM
SVR I-SYMPTOM
and O
acidosis B-SYMPTOM
accelerated O
beyond O
the O
control O
of O
maximal B-TREATMENT
support I-TREATMENT
. O

His O
blood O
pressure O
gradually O
fell O
, O
and O
he O
died O
early O
on O
July O
30 O
, O
1993 O
. O

DISCHARGE O
DIAGNOSIS O
: O

Severe B-SYMPTOM
blunt I-SYMPTOM
abdominal I-SYMPTOM
trauma I-SYMPTOM
with O
rupture B-SYMPTOM
of I-SYMPTOM
liver I-SYMPTOM
, I-SYMPTOM
left I-SYMPTOM
renal I-SYMPTOM
vein I-SYMPTOM
, I-SYMPTOM
pancreas I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
transverse I-SYMPTOM
mesocolon I-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

1. O
7-2-93 O
, O
emergency O
room O
exploratory O
laparotomy O
, O
repair B-TREATMENT
of O
liver B-SYMPTOM
laceration I-SYMPTOM
, O
repair B-TREATMENT
of O
torn B-SYMPTOM
transverse I-SYMPTOM
mesocolon I-SYMPTOM
, O
repair B-TREATMENT
of O
serosal B-SYMPTOM
tear I-SYMPTOM
of I-SYMPTOM
transverse I-SYMPTOM
colon I-SYMPTOM
, O
ligation B-TREATMENT
and O
division B-TREATMENT
of O
ruptured B-SYMPTOM
left I-SYMPTOM
renal I-SYMPTOM
vein I-SYMPTOM
, O
exploration O
of O
pancreas O
, O

2. O
7-4-93 O
, O
exploratory O
laparotomy O
, O
irrigation B-TREATMENT
and O
debridement B-TREATMENT
, O
pancreatic B-TREATMENT
drainage I-TREATMENT
placement I-TREATMENT
, O
gastrostomy B-TREATMENT
tube I-TREATMENT
, O
jejunostomy B-TREATMENT
, O
cholecystostomy B-TREATMENT
, O
placement B-TREATMENT
of I-TREATMENT
right I-TREATMENT
subclavian I-TREATMENT
Quinton I-TREATMENT
catheter I-TREATMENT
, O

3. O
7-10-93 O
, O
abdominal B-TREATMENT
irrigation I-TREATMENT
and O
debridement B-TREATMENT
and O
packing B-TREATMENT
of I-TREATMENT
pancreas I-TREATMENT
, O

4. O
7-12-93 O
, O
7-14 O
, O
7-20 O
, O
7-22 O
, O
and O
7-24 O
, O
were O
the O
same O
as O
7-10-93 O
, O
and O
7-17 O
was O
the O
same O
with O
the O
addition O
of O
tracheostomy B-TREATMENT
were O
same O
as O
7-10 O
, O

COMPLICATIONS O
: O

Severe B-SYMPTOM
necrotizing I-SYMPTOM
pancreatitis I-SYMPTOM
and O
diffuse B-SYMPTOM
peritonitis I-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

N O
/ O
A. O

DOCTORS O
DISCHARGE O
ORDERS O
: O

N O
/ O
A. O

ESTIMATED O
DISABILITY O
AND O
PROBABLE O
DURATION O
: O

N O
/ O
A. O

DISPOSITION O
: O

Mason O
Street O
. O

RISSPA O
BREATH O
, O
M.D. O

TR O
: O

un O
/ O
bmot O

DD O
: O

08-07-93 O

TD O
: O

08/08/93 O

CC O
: O

139964603 O

NVH O

40876531 O

11/17/2003 O
12:00:00 O
AM O

PELVIC B-SYMPTOM
MASS I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

11/17/2003 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

12/22/2003 O

ATTENDING O
: O

DAY O
SECOND O
MD O

This O
dictation O
goes O
through O
12/21/03 O
. O

The O
patient O
received O
care O
on O
the O
Baydell O
Medical O
Center O
. O

PRINCIPAL O
DIAGNOSIS O
: O

Pelvic B-SYMPTOM
mass I-SYMPTOM
. O

PROBLEMS O
: O

Include O
hypertension B-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
57-year-old O
female O
status O
post O
ERT B-TREATMENT
with O
recurrence O
of O
a B-SYMPTOM
pelvic I-SYMPTOM
mass I-SYMPTOM
and O
resection B-TREATMENT
at O
an O
outside O
hospital O
in O
06/22 O
. O

Per O
the O
patient O
, O
the B-SYMPTOM
mass I-SYMPTOM
was O
benign O
. O

The O
patient O
developed O
severe B-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
pain I-SYMPTOM
in O
07/24 O
. O

An O
MRI O
was O
done O
on O
08/27/03 O
that O
showed O
an B-SYMPTOM
8 I-SYMPTOM
cm I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
mass I-SYMPTOM
with O
both B-SYMPTOM
cystic I-SYMPTOM
and I-SYMPTOM
solid I-SYMPTOM
components I-SYMPTOM
. O

The O
patient O
was O
started O
on O
Lupron B-TREATMENT
on O
10/18/03 O
, O
but O
pain B-SYMPTOM
was O
not O
affected O
. O

She O
was O
put O
on O
Vicodin B-TREATMENT
ES I-TREATMENT
and O
Ultram B-TREATMENT
with O
minimal O
relief O
. O

On O
11/16/03 O
, O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
pain I-SYMPTOM
increased O
and O
she O
presented O
to O
an O
outside O
hospital O
with O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
and O
an B-SYMPTOM
inability I-SYMPTOM
to I-SYMPTOM
tolerate I-SYMPTOM
p.o. I-SYMPTOM
intake I-SYMPTOM
. O

The B-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
pain I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
groin I-SYMPTOM
radiated O
to O
the O
left O
knee O
. O

No O
fevers B-SYMPTOM
or O
chills B-SYMPTOM
, O
no O
vaginal B-SYMPTOM
discharge I-SYMPTOM
or O
bleeding B-SYMPTOM
. O

Potassium O
at O
the O
outside O
hospital O
was O
3.1 O
. O

White O
count O
was O
27.3 O
with O
16% O
bands O
. O

Hematocrit O
was O
28.7 O
. O

The O
patient O
was O
transferred O
to O
NVH O
after O
receiving O
intravenous B-TREATMENT
fluid I-TREATMENT
with O
potassium B-TREATMENT
, O
Demerol B-TREATMENT
for O
pain B-TREATMENT
control I-TREATMENT
and O
clindamycin B-TREATMENT
, O
Valium B-TREATMENT
and O
droperidol B-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

Hypothyroidism B-SYMPTOM
, O
arthritis B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
hypercholesterolemia B-SYMPTOM
, O
anemia B-SYMPTOM
and O
asthma B-SYMPTOM
. O

SURGICAL O
HISTORY O
: O

A B-TREATMENT
TAH-BSO I-TREATMENT
in O
1980 O
and O
an O
exploratory O
laparotomy O
with O
resection B-TREATMENT
of O
a B-SYMPTOM
pelvic I-SYMPTOM
mass I-SYMPTOM
in O
06/22 O
. O

MEDICATIONS O
AT O
HOME O
: O

1. O
Vicodin B-TREATMENT
75/750 O
p.r.n. O

2. O
Ultram B-TREATMENT
. O

3. O
Verapamil B-TREATMENT
240 O
mg O
b.i.d. O

4. O
Synthroid B-TREATMENT
100 O
mcg O
q.d. O

5. O
HCTZ B-TREATMENT
25 O
mg O
q.d. O

6. O
Arthrotec B-TREATMENT
0.2 O
mg O
b.i.d. O

7. O
Advair B-TREATMENT
250/50 O
mcg O
one O
puff O
q.a.m. O

8. O
Tofranil B-TREATMENT
. O

9. O
Ambien B-TREATMENT
10 O
mg O
q.h.s. O

10. O
Trazadone B-TREATMENT
150 O
mg O
q.h.s. O

11. O
Ferrous B-TREATMENT
sulfate I-TREATMENT
325 O
mg O
t.i.d. O

12. O
Colace B-TREATMENT
. O

ALLERGIES O
: O

Her B-SYMPTOM
allergies I-SYMPTOM
are O
penicillin B-TREATMENT
, O
which O
cause O
throat B-SYMPTOM
edema I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

No O
tobacco O
, O
alcohol O
or O
drug O
use O
. O

The O
patient O
was O
admitted O
to O
NVH O
and O
started O
on O
vancomycin B-TREATMENT
, O
levofloxacin B-TREATMENT
and O
Flagyl B-TREATMENT
. O

Cultures O
were O
taken O
. O

Blood O
cultures O
were O
done O
for O
a O
possible O
rectosigmoid B-SYMPTOM
mass I-SYMPTOM
or O
fistula B-SYMPTOM
and O
a O
CT O
showed O
questionable O
abscess B-SYMPTOM
versus O
tumor B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
. O

Blood O
cultures O
done O
on O
11/17/03 O
grew O
C. B-SYMPTOM
perfringens I-SYMPTOM
. O

Other O
blood O
culture O
was O
negative O
. O

On O
11/20/03 O
, O
a O
PE O
protocol O
CT O
was O
negative O
for O
both O
DVT B-SYMPTOM
and O
PE B-SYMPTOM
. O

The O
patient O
was O
taken O
to O
the O
operating O
room O
for O
bilateral B-TREATMENT
stent I-TREATMENT
placement I-TREATMENT
, O
resection B-TREATMENT
of O
the B-SYMPTOM
pelvic I-SYMPTOM
mass I-SYMPTOM
, O
lysis B-TREATMENT
of O
adhesions B-SYMPTOM
, O
left B-TREATMENT
ureterolysis I-TREATMENT
, O
rectosigmoid B-TREATMENT
resection I-TREATMENT
, O
SBR B-TREATMENT
, O
removal B-TREATMENT
of O
a B-SYMPTOM
vaginal I-SYMPTOM
tumor I-SYMPTOM
, O
omentectomy B-TREATMENT
complicated O
by O
an B-SYMPTOM
enterotomy I-SYMPTOM
and O
was O
admitted O
to O
the O
ICU O
postoperatively O
on O
11/21/03 O
. O

Postoperative O
course O
by O
systems O
is O
as O
follows O
: O

1. O
Neuro O
: O

She O
had O
a B-TREATMENT
PCEA I-TREATMENT
for O
pain B-SYMPTOM
, O
then O
a B-TREATMENT
Dilaudid I-TREATMENT
PCA I-TREATMENT
. O

The O
patient O
was O
anxious B-SYMPTOM
with O
depression B-SYMPTOM
poorly I-SYMPTOM
controlled I-SYMPTOM
until O
12/14/03 O
. O

The O
patient O
was O
seen O
by O
Onc O
Psychiatry O
consult O
, O
who O
recommended O
imipramine B-TREATMENT
75 O
mg O
; O
that O
was O
subsequently O
increased O
to O
150 O
mg O
p.o. O
q.h.s. O
, O
trazadone B-TREATMENT
100 O
mg O
q.h.s. O
and O
Ambien B-TREATMENT
10 O
mg O
q.h.s. O

2. O
Cardiovascular O
: O

The O
patient O
has O
baseline B-SYMPTOM
hypertension I-SYMPTOM
that O
was O
difficult O
to O
control O
. O

In O
the O
ICU O
, O
the O
patient O
was O
on O
enalapril B-TREATMENT
, O
hydralazine B-TREATMENT
and O
labetalol B-TREATMENT
. O

After O
a O
Cardiology O
consulton O
12/13/03 O
, O
the O
patient O
was O
started O
on O
metoprolol B-TREATMENT
100 O
mg O
p.o. O
q.i.d. O
, O
lisinopril B-TREATMENT
10 O
mg O
q.d. O
, O
hydrochlorothiazide B-TREATMENT
25 O
mg O
q.d. O
. O

Hydralazine B-TREATMENT
was O
stopped O
. O

Blood O
pressure O
stayed O
high B-SYMPTOM
with O
an O
SBP O
in O
the O
170s O
, O
so O
amlodipine B-TREATMENT
10 O
mg O
q.d. O
was O
added O
and O
that O
blood O
pressure O
was O
still B-SYMPTOM
elevated I-SYMPTOM
. O

At O
the O
time O
of O
transfer O
to O
the O
________ O
Onc O
Service O
, O
blood O
pressure O
was O
within O
the O
normal O
range O
. O

3. O
Pulmonary O
: O

The O
patient O
was O
extubated O
on O
11/22/03 O
. O

Once O
the O
patient O
was O
extubated O
, O
after O
the B-TREATMENT
third I-TREATMENT
surgery I-TREATMENT
, O
the O
patient O
could O
not O
be O
weaned O
off O
2 B-TREATMENT
liters I-TREATMENT
of I-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
and O
was O
to O
______ O
to O
20 O
breaths O
per O
minute O
despite O
nebulizer B-TREATMENT
treatment I-TREATMENT
. O

The O
patient O
was O
restarted O
on O
Advair B-TREATMENT
and O
by O
12/15/03 O
, O
was O
weaned O
to O
room O
air O
likely O
an O
effective O
Advair B-TREATMENT
and O
control O
of O
anxiety B-SYMPTOM
and O
psychiatric B-SYMPTOM
issues I-SYMPTOM
. O

4. O
GI O
: O

On O
postoperative O
day O
4 O
, O
after O
the B-TREATMENT
initial I-TREATMENT
surgery I-TREATMENT
, O
the O
patient O
had O
increased B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
tachycardia B-SYMPTOM
with O
abdominal B-SYMPTOM
pain I-SYMPTOM
. O

A O
chest O
x-ray O
revealed O
increased B-SYMPTOM
free I-SYMPTOM
air I-SYMPTOM
under I-SYMPTOM
the I-SYMPTOM
diaphragm I-SYMPTOM
. O

A O
CT O
revealed O
a O
large O
amount O
of O
free B-SYMPTOM
air I-SYMPTOM
. O

The O
patient O
was O
taken O
to O
the O
OR O
on O
postop O
day O
5 O
for O
emergent O
exploratory O
laparotomy O
that O
disclosed O
a B-SYMPTOM
small I-SYMPTOM
bowel I-SYMPTOM
enterotomy I-SYMPTOM
with O
2 O
liters O
of O
bilious B-SYMPTOM
fluid I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
peritoneum I-SYMPTOM
. O

On O
postop O
day O
9 O
, O
the O
patient O
had O
a B-SYMPTOM
similar I-SYMPTOM
increased I-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
episode I-SYMPTOM
and O
was O
taken O
back O
to O
the O
operating O
room O
for O
another O
emergent O
exploratory O
laparotomy O
revealing O
another B-SYMPTOM
peroration I-SYMPTOM
at O
the B-SYMPTOM
site I-SYMPTOM
of I-SYMPTOM
previous I-SYMPTOM
repair I-SYMPTOM
. O

Intraoperatively B-TREATMENT
, O
the O
patient O
suffered O
hypotension B-SYMPTOM
with O
induction O
and O
respiratory B-SYMPTOM
insufficiency I-SYMPTOM
. O

The O
patient O
was O
transferred O
to O
the O
ICU O
intubated B-TREATMENT
with O
stable O
. O

The O
patient O
was O
kept O
NPO B-TREATMENT
with O
an B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
until O
postop O
day O
14 O
and_____ O
started O
on O
clear B-TREATMENT
sips I-TREATMENT
with O
TPN B-TREATMENT
for O
nutritional B-TREATMENT
supplementation I-TREATMENT
. O

The O
patient O
intermittently O
tolerated O
diet B-TREATMENT
advancement I-TREATMENT
, O
but O
then O
would O
vomit O
and O
would O
have O
the B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
replaced O
. O

The O
patient O
, O
at O
the O
time O
of O
transfer O
, O
was O
tolerating O
clears B-TREATMENT
with O
low B-SYMPTOM
stoma I-SYMPTOM
output I-SYMPTOM
, O
likely O
to O
tolerate O
slow O
advancement O
. O

The O
patient O
still O
had O
a B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
at O
the O
time O
, O
although O
TPN B-TREATMENT
was O
being O
held O
and O
calorie B-TREATMENT
counts I-TREATMENT
were O
done O
to O
evaluate O
the O
benefit O
of O
p.o. O
nutrition O
. O

5. O
GU O
: O

No O
issues O
. O

The O
patient O
generally O
had O
good O
urine O
output O
. O

Presumably O
, O
should O
follow O
up O
with O
the O
Urology O
Clinic O
for O
removal B-TREATMENT
of I-TREATMENT
the I-TREATMENT
ureteral I-TREATMENT
stents I-TREATMENT
at O
some O
point O
. O

6. O
Infectious B-SYMPTOM
Disease I-SYMPTOM
: O

Blood O
cultures O
mentioned O
previously O
were O
positive O
for O
C. B-SYMPTOM
perfringens I-SYMPTOM
. O

The O
patient O
was O
started O
on O
empiricvancomycin B-TREATMENT
, O
levofloxacin B-TREATMENT
and O
Flagyl B-TREATMENT
after O
the O
second O
exploratory O
laparotomy O
. O

She O
was O
started O
on O
vancomycin B-TREATMENT
, O
levofloxacin B-TREATMENT
, O
Flagyl B-TREATMENT
, O
doxycycline B-TREATMENT
and O
fluconazole B-TREATMENT
. O

Blood O
cultures O
drawn O
on O
12/01/03 O
were O
negative O
. O

JP B-TREATMENT
drain I-TREATMENT
was O
cultured O
on O
12/11/03 O
along O
with O
aurine O
culture O
. O

TLC O
, O
TIB O
and O
blood O
culture O
were O
all O
negative O
. O

These O
were O
cultured O
because O
the O
patient O
&apos;s O
white O
blood O
count O
was O
increasing O
to O
the O
mid O
20s O
without O
fever B-SYMPTOM
or O
other B-SYMPTOM
symptoms I-SYMPTOM
for O
explanation O
. O

The O
patient O
, O
at O
the O
time O
of O
transfer O
, O
to O
the O
Gyn O
/ O
Onc O
Service O
was O
not O
antibiotics B-TREATMENT
and O
the O
white O
blood O
cell O
count O
was O
trending O
down O
. O

7. O
Heme O
: O

The O
patient O
was O
stable O
. O

She O
was O
receiving O
sub B-TREATMENT
.q. I-TREATMENT
heparin I-TREATMENT
for O
DVT B-TREATMENT
prophylaxis I-TREATMENT
postoperatively O
. O

On O
postop O
day O
6 O
, O
an O
ID O
consult O
noted O
erythema B-SYMPTOM
at O
the B-TREATMENT
right I-TREATMENT
IJ I-TREATMENT
line I-TREATMENT
site I-TREATMENT
. O

On O
postop O
day O
8 O
, O
the B-TREATMENT
right I-TREATMENT
IJ I-TREATMENT
line I-TREATMENT
was O
pulled O
. O

The O
tip O
was O
cultured O
with O
no O
growth B-SYMPTOM
. O

On O
postop O
day O
9 O
, O
bilateral O
upper O
extremity O
Dopplers O
revealed O
a B-SYMPTOM
right I-SYMPTOM
IJ I-SYMPTOM
clot I-SYMPTOM
. O

The O
patient O
was O
started O
on O
heparin B-TREATMENT
. O

The O
patient O
transitioned O
to O
Lovenox B-TREATMENT
on O
12/09/03 O
after O
a O
Cardiology O
consult O
indicated O
increased O
survival O
with O
Lovenox B-TREATMENT
therapy I-TREATMENT
. O

8. O
Endocrine O
: O

Has O
a O
history O
of O
hypothyroidism B-SYMPTOM
. O

The O
patient O
was O
on O
home B-TREATMENT
Synthroid I-TREATMENT
dose I-TREATMENT
during O
her O
hospitalization O
, O
insulin B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
with O
q.6h. O
fingersticks O
while O
she O
was O
on O
TPN B-TREATMENT
. O

The O
patient O
was O
transferred O
to O
the O
Gynecologic O
Oncology O
Service O
on O
12/21/03 O
. O

The O
rest O
of O
the O
dictation O
is O
to O
follow O
. O

eScription O
document O
: O

2-9396725 O
JFDDaua O
Tel O

Dictated O
By O
: O

FOORDRIG O
, O
LA O
BOMA O

Attending O
: O

SECOND O
, O
CA O
Dictation O
ID O
0750210 O

D O
: O

12/24/03 O

T O
: O

12/24/03 O

125667950 O

PRGH O

10805085 O

360731 O

10/22/2000 O
12:00:00 O
AM O

CHRONIC B-SYMPTOM
LYMPHOCYTIC I-SYMPTOM
LEUKEMIA I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

10/22/2000 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

11/17/2000 O

PRINCIPAL O
DIAGNOSIS O
: O

CHRONIC B-SYMPTOM
LYMPHOCYTIC I-SYMPTOM
LEUKEMIA I-SYMPTOM
. O

OTHER O
PROBLEMS O
: O

1. O
FREQUENT B-SYMPTOM
HEADACHES I-SYMPTOM
. O

2. O
CHOLECYSTITIS B-SYMPTOM
. O

3. O
SPASTIC B-SYMPTOM
COLON I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
47-year-old O
man O
with O
advanced B-SYMPTOM
stage I-SYMPTOM
chronic I-SYMPTOM
lymphocytic I-SYMPTOM
leukemia I-SYMPTOM
who O
was O
admitted O
for O
autologous B-TREATMENT
bone I-TREATMENT
marrow I-TREATMENT
transplant I-TREATMENT
as O
per O
protocol O
94-055 O
of O
the O
Santusli O
Hospital O
. O

The O
patient O
was O
originally O
diagnosed O
in O
06/98 O
during O
a O
routine O
physical O
when O
he O
was O
noted O
to O
have O
a O
white O
blood O
cell O
count O
of O
20,000 O
, O
weight B-SYMPTOM
loss I-SYMPTOM
, O
and O
swelling B-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
neck I-SYMPTOM
and I-SYMPTOM
groin I-SYMPTOM
. O

He O
was O
watched O
after O
his B-SYMPTOM
initial I-SYMPTOM
diagnosis I-SYMPTOM
, O
but O
six O
months O
later O
he O
developed O
rapidly B-SYMPTOM
increasing I-SYMPTOM
leukocytosis I-SYMPTOM
and O
he O
became O
more B-SYMPTOM
symptomatic I-SYMPTOM
. O

After O
treatment B-TREATMENT
with I-TREATMENT
three I-TREATMENT
cycles I-TREATMENT
of I-TREATMENT
fludarabine I-TREATMENT
he O
had O
90% B-SYMPTOM
involvement I-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
intratrabecular I-SYMPTOM
space I-SYMPTOM
. O

He O
was O
therefore O
treated O
with O
three B-TREATMENT
cycles I-TREATMENT
of I-TREATMENT
fludarabine I-TREATMENT
in O
combination O
with O
cytoxan B-TREATMENT
. O

After O
this B-TREATMENT
therapy I-TREATMENT
he O
achieved O
a B-SYMPTOM
protocol I-SYMPTOM
eligible I-SYMPTOM
minimal I-SYMPTOM
disease I-SYMPTOM
state I-SYMPTOM
. O

However O
, O
he O
did O
have O
relative B-SYMPTOM
pancytopenia I-SYMPTOM
following O
this B-TREATMENT
therapy I-TREATMENT
. O

He O
was O
taken O
to O
bone B-TREATMENT
marrow I-TREATMENT
harvest I-TREATMENT
in O
08/22 O
at O
which O
time O
insufficient B-SYMPTOM
cells I-SYMPTOM
were O
obtained O
to O
proceed O
. O

He O
was O
returned O
previous O
to O
this O
admission O
for O
repeat B-TREATMENT
bone I-TREATMENT
marrow I-TREATMENT
harvest I-TREATMENT
and O
at O
that O
time O
he O
was O
given O
Neupogen B-TREATMENT
prior O
to O
his B-TREATMENT
harvest I-TREATMENT
, O
and O
sufficient O
cells O
were O
not O
obtained O
to O
proceed O
with O
autologous B-TREATMENT
bone I-TREATMENT
marrow I-TREATMENT
transplantation I-TREATMENT
. O

His O
most O
recent O
bone O
marrow O
biopsy O
revealed O
less B-SYMPTOM
than I-SYMPTOM
5% I-SYMPTOM
of I-SYMPTOM
intratrabecular I-SYMPTOM
space I-SYMPTOM
involvement I-SYMPTOM
. O

Recent O
CT O
scan O
showed O
no O
significant B-SYMPTOM
lymphadenopathy I-SYMPTOM
. O

The O
spleen O
was O
within O
normal O
limits O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Episode O
of O
pneumonia B-SYMPTOM
in O
1996 O
. O

2. O
At O
the O
age O
of O
40 O
he O
had O
problems O
with O
frequent B-SYMPTOM
headaches I-SYMPTOM
. O

3. O
Episodes O
of O
cholecystitis B-SYMPTOM
and O
spastic B-SYMPTOM
colon I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

No O
medications B-TREATMENT
upon O
admission O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

He O
works O
as O
an O
airline O
pilot O
for O
Vent O

He O
is O
currently O
flying O
on O
Hwy O
routes O
. O

He O
was O
married O
for O
many O
years O
. O

He O
has O
three O
children O
. O

He O
is O
separated O
and O
has O
a O
very O
supportive O
new O
partner O
. O

FAMILY O
HISTORY O
: O

His O
father O
had O
prostate B-SYMPTOM
cancer I-SYMPTOM
. O

Mother O
had O
breast B-SYMPTOM
cancer I-SYMPTOM
. O

Has O
a O
cousin O
with O
a B-SYMPTOM
brain I-SYMPTOM
tumor I-SYMPTOM
. O

No O
family O
history O
of O
leukemia B-SYMPTOM
or O
lymphoma B-SYMPTOM
. O

He O
has O
one O
sister O
and O
one O
brother O
who O
are O
alive O
and O
well O
. O

They O
are O
not O
HLA O
matched O
. O

REVIEW O
OF O
SYSTEMS O
: O

On O
admission O
he O
had O
no O
upper B-SYMPTOM
respiratory I-SYMPTOM
tract I-SYMPTOM
symptoms I-SYMPTOM
, O
recent B-SYMPTOM
infections I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
nausea B-SYMPTOM
or O
vomiting B-SYMPTOM
, O
change B-SYMPTOM
in I-SYMPTOM
bowel I-SYMPTOM
habits I-SYMPTOM
or O
abdomen B-SYMPTOM
pain I-SYMPTOM
. O

He O
did O
complain O
of O
frequent B-SYMPTOM
headaches I-SYMPTOM
. O

Following O
his B-TREATMENT
recent I-TREATMENT
bone I-TREATMENT
marrow I-TREATMENT
harvest I-TREATMENT
he O
had O
protracted O
episodes O
of O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
. O

All O
other O
systems O
were O
negative O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
. O

GENERAL O
: O

He O
was O
well-appearing O
and O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
. O

Performance O
status O
was O
0 O
. O

VITAL O
SIGNS O
: O

Weight O
70.4 O
kilograms O
, O
temperature O
96.5 O
, O
respiratory O
rate O
20 O
, O
blood O
pressure O
105/60 O
, O
pulse O
76 O
. O

SKIN O
: O

Unremarkable O
without O
rashes B-SYMPTOM
or O
lesions B-SYMPTOM
. O

HEENT O
: O

Sclerae B-SYMPTOM
anicteric I-SYMPTOM
. O

Pupils O
equal O
, O
round O
and O
reactive O
to O
light O
. O

Oropharynx O
, O
lips O
, O
teeth O
and O
gums O
were O
without O
lesions B-SYMPTOM
and O
without O
evidence O
of O
mucositis B-SYMPTOM
. O

NECK O
: O

Supple O
with O
a O
normal O
thyroid O
gland O
. O

No O
cervical B-SYMPTOM
, I-SYMPTOM
supraclavicular I-SYMPTOM
or I-SYMPTOM
axillary I-SYMPTOM
adenopathy I-SYMPTOM
. O

CHEST O
: O

Clear O
. O

HEART O
: O

Heart O
sounds O
normal O
. O

ABDOMEN O
: O

Soft O
, O
nontender B-SYMPTOM
, O
without O
any B-SYMPTOM
masses I-SYMPTOM
and O
without O
any B-SYMPTOM
hepatosplenomegaly I-SYMPTOM
. O

GU O
: O

Normal O
testes O
and O
penis O
. O

EXTREMITIES O
: O

Without O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

NEURO O
: O

Normal O
with O
intact O
cranial O
nerves O
, O
deep O
tendon O
reflexes O
and O
normal O
motor O
/ O
sensory O
exam O
. O

LABORATORY O
DATA O
: O

Electrolytes O
were O
within O
normal O
limits O
. O

Liver O
function O
tests O
were O
within O
normal O
limits O
. O

White O
blood O
cell O
count O
10.4 O
, O
hemoglobin O
11.9 O
, O
platelets O
124 O
, O
PT O
and O
PTT O
were O
within O
normal O
limits O
. O

HOSPITAL O
COURSE O
: O

1 O
) O
Oncology O
: O

The O
patient O
was O
admitted O
on O
10/22/00 O
and O
received O
cytoxan B-TREATMENT
and O
total B-TREATMENT
body I-TREATMENT
irradiation I-TREATMENT
per O
protocol O
. O

Autologous B-TREATMENT
bone I-TREATMENT
marrow I-TREATMENT
infusion I-TREATMENT
occurred O
on O
10/29/00 O
and O
was O
uneventful O
. O

His O
post-transplant O
course O
was O
complicated O
by O
pain B-SYMPTOM
from O
mucositis B-SYMPTOM
and O
recalcitrant B-SYMPTOM
nausea I-SYMPTOM
and I-SYMPTOM
vomiting I-SYMPTOM
. O

The O
patient O
did O
not O
tolerate O
antiemetics B-TREATMENT
well O
and O
it O
was O
subsequently O
decided O
to O
avoid O
phenothiazides B-TREATMENT
secondary O
to O
jitteryness B-SYMPTOM
and O
restless B-SYMPTOM
legs I-SYMPTOM
. O

2 O
) O
Infectious O
Disease O
: O

The O
patient O
remained O
afebrile B-SYMPTOM
until O
day O
+11 O
when O
he O
spiked O
and O
was O
started O
on O
ceftazidime B-TREATMENT
. O

Blood O
cultures O
and O
urine O
cultures O
were O
all O
negative O
. O

3 O
) O
Heme O
: O

The O
patient O
acquired O
intermittent B-TREATMENT
transfusions I-TREATMENT
for O
pancytopenia B-SYMPTOM
. O

4 O
) O
FEN O
: O

The O
patient O
was O
unable O
to O
tolerate O
adequate O
p.o.&apos;s O
in O
the O
last O
several O
days O
. O

He O
was O
well O
nourished O
so O
TPN B-TREATMENT
was O
not O
started O
. O

I O
&apos;s O
and O
O O
&apos;s O
were O
balanced O
and O
maintained O
with O
IV B-TREATMENT
fluids I-TREATMENT
. O

DISCHARGE O
MEDICATIONS O
: O

Tylenol B-TREATMENT
650 O
mg O
p.o. O
q. O
4-6h O
p.r.n. O
headache B-SYMPTOM
or O
pain B-SYMPTOM
; O
acyclovir B-TREATMENT
400 O
mg O
p.o. O
t.i.d.; O
acyclovir B-TREATMENT
topical I-TREATMENT
t.i.d. O
to O
be O
applied O
to O
lesion B-SYMPTOM
on I-SYMPTOM
corner I-SYMPTOM
of I-SYMPTOM
mouth I-SYMPTOM
; O
Peridex B-TREATMENT
15 O
ml O
p.o. O
b.i.d.; O
Mycelex B-TREATMENT
1 O
troche O
p.o. O
t.i.d.; O
g-csf O
404 O
mcg O
subcu O
q.d.; O
folic B-TREATMENT
acid I-TREATMENT
1 O
mg O
p.o. O
q.d.; O
lorazepam B-TREATMENT
1-2 O
mg O
p.o. O
q. O
4-6h O
p.r.n. O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
; O
Miracle B-TREATMENT
Cream I-TREATMENT
topical O
q.d. O
p.r.n. O
perianal B-SYMPTOM
irritation I-SYMPTOM
; O
Eucerin B-TREATMENT
Cream I-TREATMENT
topical O
b.i.d.; O
Zantac B-TREATMENT
150 O
mg O
p.o. O
b.i.d.; O
Restoril B-TREATMENT
15-30 O
mg O
p.o. O
q. O
h.s. O
p.r.n. O
insomnia B-SYMPTOM
; O
multivitamin B-TREATMENT
1 O
tablet O
p.o. O
q.d.; O
viscous B-TREATMENT
lidocaine I-TREATMENT
15 O
ml O
p.o. O
q. O
3h O
can O
be O
applied O
to O
corner O
of O
mouth O
or O
lips O
p.r.n. O
pain B-TREATMENT
control I-TREATMENT
. O

CONDITION O
UPON O
DISCHARGE O
: O

Stable O
. O

FOLLOWUP O
: O

Follow O
up O
appointment O
with O
Die O
Anoort O
and O
Tomedankell O
Care O
on O
11/18/00 O
at O
9:30 O
a.m. O
( O
one O
day O
after O
discharge O
) O
. O

The O
patient O
knows O
to O
go O
to O
Sper O
Medical O
Center O
every O
day O
for O
line B-TREATMENT
care I-TREATMENT
, O
blood O
draws O
, O
and O
monitoring O
. O

Dictated O
By O
: O

CONRELLIE O
KOTERUDES O
, O
M.D. O
VJ31 O

Attending O
: O

SUOT O
CARE O
, O
M.D. O
OB89 O
RL958/5760 O

Batch O
: O

24769 O

Index O
No. O
GFNC2Z5N8Q O

D O
: O

11/22/00 O

T O
: O

11/22/00 O

CC O
: O

1. O
TOMEDANKELL O
CARE O
, O
M.D. O
RE04 O

194830718 O
YC O

29157608 O

520377 O

10/25/1997 O
12:00:00 O
AM O

DIVERTICULITIS B-SYMPTOM
, O
S O
/ O
P O
AORTIC B-TREATMENT
VALVE I-TREATMENT
REPLACEMENT I-TREATMENT

Signed O

DIS O

Admission O
Date O
: O

10/25/1997 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

11/03/1997 O

CHIEF O
COMPLAINT O
: O

Diverticulitis B-SYMPTOM
, O
presenting O
for O
sigmoid B-TREATMENT
colectomy I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
67-year-old O
woman O
with O
occasional B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
and O
left O
lower O
quadrant O
. O

She O
has O
not O
complained O
of O
any B-SYMPTOM
fever I-SYMPTOM
, O
shaking B-SYMPTOM
, O
or O
chills B-SYMPTOM
. O

No O
nausea B-SYMPTOM
or O
vomiting B-SYMPTOM
, O
no O
change B-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
bowel I-SYMPTOM
movements I-SYMPTOM
. O

She O
has O
had O
attacks B-SYMPTOM
treated O
with O
antibiotics B-TREATMENT
in O
the O
past O
notably O
in O
12/96 O
and O
08/97 O
. O

She O
has O
had O
a O
diagnosis O
of O
diverticulitis B-SYMPTOM
flairs I-SYMPTOM
and O
baseline B-SYMPTOM
diverticulosis I-SYMPTOM
flairing I-SYMPTOM
in O
09/96 O
. O

Also O
, O
three O
years O
prior O
in O
1993 O
, O
she O
had O
an B-SYMPTOM
attack I-SYMPTOM
of I-SYMPTOM
diverticulitis I-SYMPTOM
. O

She O
has O
been O
worked O
up O
with O
barium O
enema O
in O
09/97 O
which O
showed O
multiple B-SYMPTOM
diverticula I-SYMPTOM
throughout I-SYMPTOM
the I-SYMPTOM
colon I-SYMPTOM
, O
but O
mostly O
in O
the O
sigmoid O
. O

At O
this O
time O
, O
there O
was O
diverticulosis B-SYMPTOM
with O
no O
acute B-SYMPTOM
diverticulitis I-SYMPTOM
. O

There O
was O
also O
no O
obstruction B-SYMPTOM
. O

The O
patient O
is O
also O
status O
post O
aortic B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
in O
1996 O
, O
and O
presented O
for O
heparinization B-TREATMENT
prior O
to O
her B-TREATMENT
elective I-TREATMENT
valve I-TREATMENT
surgery I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
patient O
has O
hypothyroidism B-SYMPTOM
, O
hypertension B-SYMPTOM
, O
and O
rheumatic B-SYMPTOM
fever I-SYMPTOM
age O
6 O
with O
aortic B-SYMPTOM
stenosis I-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

Aortic B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
in O
11/96 O
with O
a B-TREATMENT
St. I-TREATMENT
Jude I-TREATMENT
valve I-TREATMENT
and O
chronic B-TREATMENT
Coumadin I-TREATMENT
therapy I-TREATMENT
; O
breast O
biopsy O
negative O
in O
1984 O
; O
appendectomy B-TREATMENT
age O
15 O
; O
tonsillectomy B-TREATMENT
and O
adenoidectomy B-TREATMENT
age O
6 O
; O
hysterotomy B-TREATMENT
age O
30 O
; O
C-section B-TREATMENT
age O
37 O
due O
to O
placenta B-SYMPTOM
previa I-SYMPTOM
. O

MEDICATIONS O
: O

Lopressor B-TREATMENT
50 O
mg O
q.a.m. O
, O
25 O
mg O
q.p.m. O
, O
and O
25 O
mg O
q.h.s.; O
Synthroid B-TREATMENT
88 O
mcg O
q.d.; O
Norvasc B-TREATMENT
5 O
mg O
q.d.; O
Lescol B-TREATMENT
20 O
mg O
q.p.m. O
with O
meal O
; O
Coumadin B-TREATMENT
is O
usually O
4 O
mg O
p.o. O
3x O
a O
week O
and O
3 O
mg O
4x O
a O
week O
. O

It O
was O
held O
the O
day O
prior O
to O
admission O
. O

ALLERGIES O
: O

Percodan B-TREATMENT
and O
codeine B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

Alcohol O
and O
tobacco O
histories O
are O
negative O
. O

REVIEW O
OF O
SYSTEMS O
: O

Negative O
for O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
positive O
for O
occasional B-SYMPTOM
dyspnea I-SYMPTOM
on O
exertion O
, O
negative O
for O
dyspnea B-SYMPTOM
and O
she O
has O
excellent O
exercise O
tolerance O
. O

There O
is O
occasional B-SYMPTOM
left I-SYMPTOM
chest I-SYMPTOM
tightening I-SYMPTOM
which O
is O
brief O
. O

No O
bleeding B-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
urine I-SYMPTOM
or I-SYMPTOM
stool I-SYMPTOM
. O

Occasional B-SYMPTOM
bleeding I-SYMPTOM
when O
she O
flosses O
and O
occasional B-SYMPTOM
dizziness I-SYMPTOM
secondary O
to O
a B-SYMPTOM
drop I-SYMPTOM
in O
blood O
pressure O
transiently O
at O
home O
. O

PHYSICAL O
EXAMINATION O
: O

VITAL O
SIGNS O
- O
Temp O
98.8 O
, O
pulse O
60 O
, O
BP O
150/94 O
, O
respiratory O
rate O
18 O
, O
and O
saturation O
96% O
on O
room O
air O
. O

GENERAL O
- O
The O
patient O
is O
a O
pleasant O
older O
woman O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

HEENT O
- O
Normocephalic O
, O
atraumatic B-SYMPTOM
. O

Oropharynx O
is O
not O
injected O
. O

NECK O
- O
No O
carotid B-SYMPTOM
bruits I-SYMPTOM
, O
with O
2+ O
carotid O
pulses O
. O

LUNGS O
- O
Clear O
. O

HEART O
- O
Regular O
, O
with O
a B-SYMPTOM
III I-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
upper I-SYMPTOM
left I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
. O

ABDOMEN O
- O
There O
is O
a O
soft O
abdomen O
with O
a O
question O
of O
eventful B-SYMPTOM
hernia I-SYMPTOM
. O

RECTAL O
- O
Guaiac O
negative O
with O
normal O
tone O
. O

EXTREMITIES O
- O
Bilateral O
radial O
, O
dorsalis O
pedis O
, O
posterior O
tibial O
, O
and O
femoral O
pulses O
are O
all O
2+ O
. O

No O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
, O
or O
edema B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
extremities I-SYMPTOM
. O

LABORATORY O
DATA O
: O

Coagulation O
profile O
notable O
for O
a O
PT O
18 O
, O
PTT O
36.7 O
and O
an O
INR O
of O
2.4 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
and O
begun O
on O
cefotetan B-TREATMENT
and O
Flagyl B-TREATMENT
, O
as O
well O
as O
heparin B-TREATMENT
. O

Her O
INR O
dropped O
to O
1.6 O
prior O
to O
surgery B-TREATMENT
, O
and O
her O
PTT O
was O
in O
the O
mid O
80s O
prior O
to O
surgery B-TREATMENT
. O

She O
was O
admitted O
and O
placed O
on O
a B-TREATMENT
bowel I-TREATMENT
prep I-TREATMENT
two O
days O
before O
surgery B-TREATMENT
and O
was O
taken O
to O
the O
Operating O
Room O
on O
hospital O
day O
# O
3 O
, O
10/28/97 O
. O

At O
that O
time O
, O
she O
underwent O
sigmoid B-TREATMENT
colectomy I-TREATMENT
and O
ventral B-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT
. O
( O
A O
full O
account O
of O
this B-TREATMENT
operation I-TREATMENT
can O
be O
found O
in O
the O
Operative O
Note O
) O
. O

She O
tolerated O
this B-TREATMENT
procedure I-TREATMENT
without O
complications B-SYMPTOM
initially O
and O
was O
taken O
to O
the O
Recovery O
Room O
in O
stable O
condition O
. O

Postoperatively O
, O
she O
had O
her B-TREATMENT
heparin I-TREATMENT
restarted O
, O
and O
had O
a O
PTT O
rising O
to O
142.8 O
and O
then O
down O
to O
92 O
. O

Her O
primary O
postoperative O
development O
was O
the B-SYMPTOM
passage I-SYMPTOM
of I-SYMPTOM
some I-SYMPTOM
blood I-SYMPTOM
clots I-SYMPTOM
and O
blood B-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
on O
postoperative O
day O
# O
2 O
. O

She O
continued O
to O
pass O
blood B-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
and O
was O
transfused O
with O
one B-TREATMENT
unit I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

Her O
preoperative O
hematocrit O
was O
41 O
and O
her O
hematocrit O
dropped O
to O
30.4 O
on O
postoperative O
day O
# O
2 O
. O

This O
was O
a O
drop O
from O
an O
immediate O
postoperative O
hematocrit O
of O
35.4 O
. O

Upon O
receiving O
the B-TREATMENT
one I-TREATMENT
unit I-TREATMENT
of I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
, O
her O
hematocrit O
returned O
to O
33 O
, O
and O
in O
the O
two O
days O
subsequent O
to O
the B-TREATMENT
transfusion I-TREATMENT
, O
returned O
to O
34 O
. O

Otherwise O
, O
her O
postoperative O
course O
was O
uneventful O
with O
gradual O
resolution O
of O
the O
passage O
of O
blood B-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
. O

Her B-TREATMENT
heparin I-TREATMENT
was O
discontinued O
when O
it O
was O
noted O
that O
she O
was O
bleeding B-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
and O
her O
PTT O
drifted O
to O
a O
normal O
range O
of O
35 O
by O
postoperative O
day O
# O
3 O
. O

On O
postoperative O
day O
# O
1 O
, O
the O
patient O
was O
restarted O
on O
2 O
mg O
of O
Coumadin B-TREATMENT
. O

However O
, O
due O
to O
the O
episode O
of O
bleeding B-SYMPTOM
on O
postoperative O
day O
# O
2 O
, O
the B-TREATMENT
Coumadin I-TREATMENT
was O
held O
for O
two O
consecutive O
days O
, O
and O
then O
restarted O
on O
postoperative O
day O
# O
4 O
. O

At O
this O
time O
, O
she O
is O
given O
3 O
mg O
and O
was O
gradually O
increased O
to O
her B-TREATMENT
regular I-TREATMENT
regimen I-TREATMENT
of O
4 O
mg O
alternating O
with O
3 O
mg. O

The O
patient O
&apos;s O
INR O
had O
dropped O
to O
1.7 O
at O
the O
time O
of O
operation B-TREATMENT
, O
and O
remained O
in O
this O
range O
initially O
, O
but O
began O
to O
rise O
to O
2.0 O
with O
her B-TREATMENT
Coumadin I-TREATMENT
dosing I-TREATMENT
. O

At O
the O
time O
of O
discharge O
, O
it O
was O
1.9 O
, O
for O
which O
she O
received O
4 O
mg. O

On O
the O
next O
day O
, O
it O
was O
1.6 O
and O
she O
returned O
to O
a B-TREATMENT
normal I-TREATMENT
dosing I-TREATMENT
of O
4 O
mg O
followed O
by O
outpatient O
draws O
to O
determine O
the B-TREATMENT
further I-TREATMENT
Coumadin I-TREATMENT
dosing I-TREATMENT
. O

This O
was O
postoperative O
day O
# O
6 O
, O
at O
which O
time O
she O
is O
ready O
for O
discharge O
. O

The O
rest O
of O
her O
hospital O
course O
was O
unremarkable O
, O
with O
perioperative B-TREATMENT
ampicillin I-TREATMENT
, O
gentamicin B-TREATMENT
and O
Flagyl B-TREATMENT
discontinued O
on O
postoperative O
day O
# O
1 O
. O

She O
had O
some B-SYMPTOM
initial I-SYMPTOM
nausea I-SYMPTOM
but O
had O
no O
emesis B-SYMPTOM
. O

Her B-TREATMENT
nasogastric I-TREATMENT
tube I-TREATMENT
was O
discontinued O
on O
postoperative O
day O
# O
1 O
, O
and O
she O
tolerated O
a O
regular O
diet O
by O
postoperative O
day O
# O
3 O
. O

She O
had O
flatus O
and O
regular O
bowel O
movements O
by O
postoperative O
day O
# O
5 O
. O

She O
also O
complained O
of O
some B-SYMPTOM
slight I-SYMPTOM
dizziness I-SYMPTOM
upon O
getting O
up O
. O

For O
this O
reason O
, O
her B-TREATMENT
normal I-TREATMENT
Lopressor I-TREATMENT
and O
Norvasc B-TREATMENT
were O
held O
. O

It O
was O
felt O
that O
this O
was O
re-equalibration O
after O
being O
sedentary O
and O
mostly O
in O
bed O
following O
the B-TREATMENT
operation I-TREATMENT
. O

She O
had O
some B-SYMPTOM
slight I-SYMPTOM
headaches I-SYMPTOM
which O
resolved O
with O
Tylenol B-TREATMENT
, O
and O
the B-SYMPTOM
dizziness I-SYMPTOM
resolved O
as O
well O
. O

She O
was O
ready O
for O
discharge O
on O
postoperative O
day O
# O
6 O
. O

Her B-SYMPTOM
wound I-SYMPTOM
remained O
benign O
and O
was O
healing O
nicely O
at O
the O
time O
of O
discharge O
. O

DISCHARGE O
MEDICATIONS O
: O

Lopressor B-TREATMENT
50 O
mg O
q.a.m. O
, O
25 O
mg O
q.p.m. O
, O
and O
25 O
mg O
q.h.s. O
, O
Synthroid B-TREATMENT
88 O
mcg O
q.d. O
, O
Norvasc B-TREATMENT
5 O
mg O
q.d. O
, O
Lescol B-TREATMENT
20 O
mg O
q.p.m. O
with O
meal O
, O
Coumadin B-TREATMENT
is O
usually O
4 O
mg O
p.o. O
3x O
a O
week O
and O
3 O
mg O
4x O
a O
week O
; O
Percocet B-TREATMENT
1-2 O
tabs O
q.4h. O
p.r.n. O
pain B-SYMPTOM
. O

DISCHARGE O
FOLLOW-UP O
: O

Follow-up O
with O
Dr. O
Jesc O
in O
the O
office O
. O

DISCHARGE O
DISPOSITION O
: O

Her O
disposition O
was O
to O
home O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

Estimated O
disability O
was O
none O
. O

Dictated O
By O
: O

BELL O
REXBEATHEFARST O
, O
M.D. O
NM82 O

Attending O
: O

LINEMASE O
D. O
JESC O
, O
M.D. O
ZP2 O
SF477/5317 O

Batch O
: O

31967 O

Index O
No. O
PAWU09891C O

D O
: O

11/07/97 O

T O
: O

11/07/97 O

Admission O
Date O
: O

2014-08-07 O

Discharge O
Date O
: O

2014-08-09 O

Date O
of O
Birth O
: O

1958-03-14 O

Sex O
: O

M O

Service O
: O

NEUROSURG O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
56 O
- O
year-old O
man O
without O
any O
significant O
past O
medical O
history O
who O
presented O
to O
the O
emergency O
room O
after O
the O
sudden O
onset O
of O
headache B-SYMPTOM
while O
he O
was O
riding O
a O
bicycle O
. O

He O
characterized O
this B-SYMPTOM
headache I-SYMPTOM
as O
the B-SYMPTOM
worst I-SYMPTOM
headache I-SYMPTOM
of O
his O
life O
and O
had O
associated O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
times O
one O
. O

He O
also O
complained O
of O
dizziness B-SYMPTOM
at O
the O
time O
of O
headache B-SYMPTOM
onset O
. O

He O
presented O
to O
the O
Edith O
Nourse O
Rogers O
Memorial O
VA O
Hospital O
emergency O
room O
, O
where O
an O
initial O
head O
CT O
scan O
was O
read O
as O
negative O
. O

However O
, O
a O
lumbar O
puncture O
was O
done O
, O
in O
which O
tube O
1 O
showed O
4800 O
red O
blood O
cells O
and O
tube O
4 O
showed O
4000 O
red O
blood O
cells O
. O

The O
patient O
was O
sent O
for O
an O
MRI O
of O
the O
head O
, O
which O
raised O
the O
question O
of O
a B-SYMPTOM
right I-SYMPTOM
posterior I-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
aneurysm I-SYMPTOM
. O

The O
CT O
scan O
was O
revealed O
and O
, O
on O
second O
analysis O
, O
it O
was O
thought O
that O
it O
was O
suspicious O
for O
a B-SYMPTOM
subarachnoid I-SYMPTOM
hemorrhage I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
suprasellar I-SYMPTOM
cistern I-SYMPTOM
. O

The O
patient O
was O
then O
admitted O
for O
further O
evaluation O
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
past O
medical O
history O
was O
significant O
for O
left B-TREATMENT
shoulder I-TREATMENT
surgery I-TREATMENT
in O
2014-03-06 O
for O
repair B-TREATMENT
of O
a B-SYMPTOM
" I-SYMPTOM
minor I-SYMPTOM
rotator I-SYMPTOM
cuff I-SYMPTOM
tear I-SYMPTOM
" O
and O
removal B-TREATMENT
of O
osteophytes B-SYMPTOM
. O

Otherwise O
, O
the O
past O
medical O
history O
was O
insignificant O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

The O
patient O
was O
on O
no O
medications B-TREATMENT
. O

ALLERGIES O
: O

There O
were O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

FAMILY O
HISTORY O
: O

The O
father O
had O
leukemia B-SYMPTOM
and O
the O
mother O
had O
gastrointestinal B-SYMPTOM
cancer I-SYMPTOM
. O

There O
was O
no O
family O
history O
of O
aneurysms B-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
was O
a O
nonsmoker O
and O
used O
no O
ethanol O
. O

He O
was O
married O
, O
with O
children O
, O
and O
was O
a O
church O
minister O
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
examination O
, O
the O
patient O
was O
resting O
comfortably O
when O
seen O
, O
slightly B-SYMPTOM
sleepy I-SYMPTOM
at O
first O
but O
readily O
arousable O
, O
awake O
, O
alert O
, O
oriented O
and O
conversant O
. O

Of O
note O
, O
the O
patient O
had O
been O
given O
2 O
mg O
of O
Ativan B-TREATMENT
before O
the O
examination O
. O

The O
face O
was O
symmetric O
. O

The O
tongue O
was O
midline O
. O

The O
neck O
was O
supple O
with O
full O
range O
of O
motion O
. O

There O
was O
no O
rigidity B-SYMPTOM
, O
but O
the O
neck O
was O
slightly B-SYMPTOM
painful I-SYMPTOM
at O
extreme O
flexion O
. O

The O
general O
examination O
was O
essentially O
unremarkable O
, O
as O
per O
previous O
notes O
. O

On O
examination O
of O
the O
extremities O
, O
the O
patient O
moved O
all O
extremities O
and O
had O
strength O
of O
5/5 O
in O
all O
of O
the O
muscle O

groups O
tested O
in O
the O
upper O
and O
lower O
extremities O
. O

The O
sensory O
examination O
was O
intact O
to O
light O
touch O
. O

There O
was O
a B-SYMPTOM
very I-SYMPTOM
slight I-SYMPTOM
inward I-SYMPTOM
pronator I-SYMPTOM
drift I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
hand I-SYMPTOM
. O

Finger O
- O
nose O
- O
finger O
testing O
and O
heel O
- O
to O
- O
shin O
testing O
were O
normal O
. O

Rapid O
alternating O
movement O
was O
normal O
. O

The O
toes O
were O
downgoing O
bilaterally O
. O

Gait O
was O
reported O
to O
be O
normal O
, O
as O
per O
the O
emergency O
room O
staff O
. O

There O
was O
no O
ataxia B-SYMPTOM
noted O
. O

LABORATORY O
: O

Laboratory O
values O
were O
as O
per O
the O
History O
of O
Present O
Illness O
. O

RADIOLOGY O
: O

Neurological O
imaging O
data O
was O
as O
per O
the O
History O
of O
Present O
Illness O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
surgical O
intensive O
care O
unit O
, O
where O
a O
continued O
cerebral O
angiogram O
was O
done O
that O
was O
essentially O
normal O
, O
without O
evidence O
of O
any B-SYMPTOM
obvious I-SYMPTOM
aneurysm I-SYMPTOM
. O

The O
patient O
was O
observed O
for O
two O
days O
with O
a O
repeat O
CT O
scan O
showing O
no O
changes B-SYMPTOM
from O
the O
previous O
examination O
. O

The B-SYMPTOM
headache I-SYMPTOM
stabilized O
after O
the O
patient O
was O
transferred O
to O
the O
floor O
. O

The O
patient O
continued O
to O
do O
well O
and O
the O
decision O
was O
made O
to O
discharge O
him O
. O

DISCHARGE O
INSTRUCTIONS O
: O

The O
patient O
was O
discharged O
with O
strict O
instructions O
to O
return O
to O
the O
emergency O
room O
, O
should O
there O
be O
an O
exacerbation O
of O
symptoms B-SYMPTOM
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
DIAGNOSES O
: O

Ruled O
out O
subarachnoid B-SYMPTOM
hemorrhage I-SYMPTOM
. O

Michael O
Lawrence O
, O
M.D. O

41-707 O

Dictated O
By O
: O
Lena O
D. O
Mannie O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-08-09 O
14:04 O

T O
: O
2014-08-09 O
15:27 O

JOB O
#: O

45402 O

Signed O
electronically O
by O
: O
DR. O
Michael O
Jackson O
on O
: O
FRI O
2014-09-05 O
11:39 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2020-01-20 O

Discharge O
Date O
: O

2020-01-21 O

Date O
of O
Birth O
: O

1977-11-23 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Lipitor B-TREATMENT
/ O
Codeine B-TREATMENT

Attending O
: O
Sam O
M O
Ennis O
, O
M.D. O

Chief O
Complaint O
: O

GIB B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Endoscopy O
2020-01-20 O

History O
of O
Present O
Illness O
: O

42 O
yom O
with O
PMH O
of O
HTN B-SYMPTOM
, O
hyperchol B-SYMPTOM
admitted O
to O
OSH O
1 O
day O
ago O
with O
black B-SYMPTOM
tarry I-SYMPTOM
stools I-SYMPTOM
X O
2 O
days O
. O

Patient O
states O
that O
he O
had O
chronically O
had O
loose B-SYMPTOM
stools I-SYMPTOM
but O
over O
2 O
preeceeding O
days O
noticed O
the O
stool O
to O
be O
dark B-SYMPTOM
and O
tarry B-SYMPTOM
. O

+ O
Epigastric B-SYMPTOM
discomfort I-SYMPTOM
, O
gurgling B-SYMPTOM
gas-like I-SYMPTOM
pain I-SYMPTOM
, O
no O
association O
with O
food O
. O

+ O
lightheadedness B-SYMPTOM
when O
he O
stood O
up O
prompting O
him O
to O
go O
to O
OSH O
Nellie O
. O

He O
states O
that O
he O
takes O
ASA B-TREATMENT
daily O
and O
takes O
motrin B-TREATMENT
800 O
mg O
tid O
sometimes O
for O
pain B-SYMPTOM
, O
last O
use O
2 O
wks O
PTA O
. O

Denies O
BRBPR B-SYMPTOM
, O
n/v/d B-SYMPTOM
. O

Denies O
recent B-SYMPTOM
fevers I-SYMPTOM
, O
chills B-SYMPTOM
. O

Denies O
any B-SYMPTOM
hemetemesis I-SYMPTOM
. O

At O
OSH O
initial O
Hct O
= O
26 O
, O
and O
22 O
upon O
repeat O
. O

He O
was O
also O
orthostatic B-SYMPTOM
given O
3 O
units O
PRBC B-TREATMENT
and O
IVF B-TREATMENT
. O

EGD O
attempted O
but O
pt O
unable O
to O
tolerate O
. O

He O
is O
now O
transferred O
to O
Mediplex O
Rehab O
Hospital O
for O
futher O
workup O
and O
Rx B-TREATMENT
. O

On O
transfer O
pt O
denies O
any O
complaints O
. O

States O
that O
lightheadedness B-SYMPTOM
is O
resolved O
. O

Past O
Medical O
History O
: O

HTN B-SYMPTOM

Hyperchol B-SYMPTOM
h/o O
A. B-SYMPTOM
fib I-SYMPTOM
6 O
yrs O
ago O
-> O
cardioverted O
. O

Social O
History O
: O

Social O
Hx O
: O

Works O
as O
a O
police O
oficer O
, O
married O
, O
denies O
smoking O
, O
etoh O
. O

Family O
History O
: O

Family O
Hx O
: O
father O
with O
lung B-SYMPTOM
ca I-SYMPTOM
. O

Physical O
Exam O
: O

Physical O
Exam O
: O

Vitals O
: O

T O
: O
98 O

P O
: O
66 O

R O
: O
15 O

BP O
: O
122/51 O

SaO2 O
: O
100% O
RA O

General O
: O
young O
male O
in O
nad B-SYMPTOM
, O
awake O
alert O
oriented O

HEENT O
: O

MMM O
, O
eomi O
, O
OP O
clear O

Neck O
: O
supple O
, O
no O
JVD B-SYMPTOM

Pulmonary O
: O

Lungs O
CTA O
bilaterally O
without O
R/R/W B-SYMPTOM

Cardiac O
: O

RRR O
, O
nl. O
S1S2 O
, O
no O
M/R/G B-SYMPTOM
noted O

Abdomen O
: O
obese B-SYMPTOM
, O
soft O
, O
mild B-SYMPTOM
epigastric I-SYMPTOM
tenderness I-SYMPTOM
, O
NABS O

Extremities O
: O

No O
C/C/E B-SYMPTOM
bilaterally I-SYMPTOM
, O
2+ O
radial O
, O
DP O
and O
PT O
pulses O
b/l O
. O

Rectal O
: O
no O
hemrroiids B-SYMPTOM
, O
guiac B-SYMPTOM
positive I-SYMPTOM
brown I-SYMPTOM
stool I-SYMPTOM
. O

Pertinent O
Results O
: O

OSH O
27.5 O
hct O
at O
2:50 O
AM O
01-20 O
. O

EKG O
: O

OSH O
- O
sinus B-SYMPTOM
tach I-SYMPTOM
at O
108 O
, O
nl O
axis O
, O
nl O
intevals O
. O

No O
st-t B-SYMPTOM
abnormalities I-SYMPTOM
. O

2020-01-20 O
06:17 O
AM O

PT O
- O
13.2 O
* O
PTT O
- O
27.2 O
INR O
( O
PT O
)- O
1.1 O

2020-01-20 O
06:17 O
AM O

PLT O
COUNT O
- O
259 O

2020-01-20 O
06:17 O
AM O

WBC O
- O
9.3 O
RBC O
- O
3.21 O
* O
HGB O
- O
9.6 O
* O
HCT O
- O
27.3 O
* O
MCV O
- O
85 O
MCH O
- O
29.9 O
MCHC O
- O
35.2 O
* O
RDW O
- O
15.6 O
* O

2020-01-20 O
09:50 O
PM O

WBC O
- O
8.0 O
RBC O
- O
3.20 O
* O
HGB O
- O
9.6 O
* O
HCT O
- O
27.8 O
* O
MCV O
- O
87 O
MCH O
- O
30.1 O
MCHC O
- O
34.7 O
RDW O
- O
15.7 O
* O

2020-01-20 O
09:50 O
PM O

PLT O
COUNT O
- O
264 O

2020-01-20 O
12:38 O
PM O

WBC O
- O
7.4 O
RBC O
- O
3.38 O
* O
HGB O
- O
10.1 O
* O
HCT O
- O
29.2 O
* O
MCV O
- O
86 O
MCH O
- O
29.8 O
MCHC O
- O
34.5 O
RDW O
- O
15.5 O

Brief O
Hospital O
Course O
: O

Assessment O
and O
Plan O
: O

42 O
yom O
with O
h/o O
NSAID B-TREATMENT
use O
transferred O
from O
OSH O
with O
black B-SYMPTOM
tarry I-SYMPTOM
stools I-SYMPTOM
at O
home O
. O

Patient O
was O
admitted O
to O
CMED O
CCU O
with O
tid O
Hct O
check O
. O

GI O
was O
consulted O
and O
performed O
Endoscopy O
under O
general B-TREATMENT
anesthesia I-TREATMENT
which O
revealed O
a B-SYMPTOM
non I-SYMPTOM
bleeding I-SYMPTOM
ulcer I-SYMPTOM
and O
gastritis B-SYMPTOM
. O

Patient O
was O
continued O
on O
BID O
PPI B-TREATMENT
, O
H B-TREATMENT
. O

Pylori O
serology O
checked O
( O
pending O
at O
time O
of O
discharge O
) O
. O

His B-TREATMENT
antihypertensives I-TREATMENT
were O
held O
given O
concern O
for O
GI B-SYMPTOM
bleed I-SYMPTOM
and O
should O
be O
restarted O
at O
follow O
up O
appointment O
with O
PCP O
. O

Marie O
was O
discharged O
with O
goal B-TREATMENT
PPI I-TREATMENT
twice O
day O
for O
1 O
month O
followed O
by O
once O
a O
day O
. O

He O
is O
scheduled O
to O
follow O
up O
with O
daughter O
in O
2 O
days O
. O

Medications O
on O
Admission O
: O

Medications B-TREATMENT
on O
transfer O
: O
esmopreazole B-TREATMENT
40 O
mg O
iv O
bid O
hydrochlorthiazide B-TREATMENT
25 O
mg O
daily O
lisinopril B-TREATMENT
5 O
mg O
daily O
loratadine B-TREATMENT
10 O
mg O
daily O
metprolol B-TREATMENT
150 O
mg O
daily B-TREATMENT
multivitamin I-TREATMENT
niacin I-TREATMENT
500 O
mg O
daily O

Medications O
at O
home O
: O

ASA B-TREATMENT
325 O
mg O
daily O

motrin B-TREATMENT
800 O
mg O
tid O

lisinopril B-TREATMENT
5 O
mg O
daily O

hydrochlorthiazide B-TREATMENT
25 O
mg O
daily O

toprol B-TREATMENT
xl I-TREATMENT
150 O
mg O
daily O

niaspan B-TREATMENT
500 O
mg O
daily O

loratidine B-TREATMENT
10 O
mg O
daily O
. O

Discharge O
Medications O
: O

1. O
Niacin B-TREATMENT
500 O
mg O
Capsule O
, O
Sustained O
Release O
Sig O
: O
One O
( O
1 O
) O
Capsule O
, O
Sustained O
Release O
PO O
DAILY O
( O
Daily O
) O
. O

2. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q12H O
( O
every O
12 O
hours O
) O
: O

Twice O
a O
day O
for O
one O
month O
, O
followed O
by O
one O
tablet O
per O
day O
. O

Disp O
:* O
60 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)( O
s O
)* O
Refills O
:* O
2 O
* O

Discharge O
Disposition O
: O

Home O

Discharge O
Diagnosis O
: O

GI B-SYMPTOM
Bleeding I-SYMPTOM

Peptic B-SYMPTOM
Ulcer I-SYMPTOM
disease I-SYMPTOM

Gastritis B-SYMPTOM

Hypertension B-SYMPTOM

Hypercholestrolemia B-SYMPTOM

Discharge O
Condition O
: O

Good O

Discharge O
Instructions O
: O

Please O
continue O
to O
take O
all B-TREATMENT
your I-TREATMENT
medicaitons I-TREATMENT
and O
follow O
up O
with O
your O
appointments O
as O
below O
. O

You O
should O
avoid O
aspirin B-TREATMENT
, O
motrin B-TREATMENT
or O
any B-TREATMENT
other I-TREATMENT
nonsteroidal I-TREATMENT
antiinflammatory I-TREATMENT
agents I-TREATMENT
. O

You O
should O
restart O
your B-TREATMENT
BP I-TREATMENT
medications I-TREATMENT
after O
you O
see O
your O
PCP O
. O

If O
you O
have O
any B-SYMPTOM
further I-SYMPTOM
black I-SYMPTOM
stools I-SYMPTOM
, O
bleeding B-SYMPTOM
, O
lightheadedness B-SYMPTOM
or O
any B-SYMPTOM
other I-SYMPTOM
concerning I-SYMPTOM
symptoms I-SYMPTOM
please O
contact O
your O
PCP O
or O
return O
to O
the O
emergency O
room O
. O

Followup O
Instructions O
: O

Please O
call O
your O
PCP O
X. O
Neuse O
at O
( O
536 O
) O
671-1515 O
to O
set O
up O
an O
appointment O
by O
Friday O
this O
week O
. O

Richard O
Campbell O
MD O
99-028 O

Completed O
by O
: O

James O
Monique O
MD O
11-259 O
2020-01-21 O
@ O
1445 O

Signed O
electronically O
by O
: O
DR. O
William O
Dunbar O
on O
: O
FRI O
2020-09-25 O
1:30 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-12-03 O

Discharge O
Date O
: O

2014-12-18 O

Date O
of O
Birth O
: O

1962-09-23 O

Sex O
: O

F O

Service O
: O

Medicine O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
52 O
- O
year-old O
female O
with O
no O
known B-SYMPTOM
cardiopulmonary I-SYMPTOM
history I-SYMPTOM
who O
presented O
with O
a O
chief O
complaint O
of O
dyspnea B-SYMPTOM
on O
exertion O
as O
well O
as O
exertional B-SYMPTOM
chest I-SYMPTOM
tightness I-SYMPTOM
which O
was O
acute-on-chronic O
. O

The O
patient O
stated O
her B-SYMPTOM
symptoms I-SYMPTOM
began O
in O
2011 O
and O
have O
increased O
in O
intensity O
and O
frequency O
every O
since O
then O
. O

She O
reports O
dyspnea B-SYMPTOM
on O
exertion O
and O
chest B-SYMPTOM
tightness I-SYMPTOM
daily O
which O
worsened O
significantly O
one O
day O
prior O
to O
admission O
. O

Says O
that O
she O
could O
not O
walk O
a O
few O
yards O
without O
developing O
symptoms B-SYMPTOM
. O

She O
describes O
the B-SYMPTOM
chest I-SYMPTOM
tightness I-SYMPTOM
as O
substernal O
and O
epigastric O
. O

She O
denied O
any B-SYMPTOM
associated I-SYMPTOM
nausea I-SYMPTOM
, O
vomiting B-SYMPTOM
, O
diaphoresis B-SYMPTOM
, O
lightheadedness B-SYMPTOM
, O
or O
dizziness B-SYMPTOM
. O

She O
does O
have O
radiation B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
pain I-SYMPTOM
to O
her O
neck O
and O
jaw O
bilaterally O
. O

She O
also O
describes O
a B-SYMPTOM
fast I-SYMPTOM
heart I-SYMPTOM
rate I-SYMPTOM
and O
palpitations B-SYMPTOM
. O

She O
stated O
her B-SYMPTOM
symptoms I-SYMPTOM
improved O
with O
rest O
, O
and O
she O
denied O
any B-SYMPTOM
symptoms I-SYMPTOM
beginning O
when O
she O
was O
at O
rest O
. O

The O
patient O
reports O
a O
previous O
workup O
which O
included O
a O
negative O
exercise O
treadmill O
test O
, O
a O
normal O
MIBI O
in O
2011-04-10 O
, O
and O
a O
normal O
echocardiogram O
in O
2012 O
( O
except O
some B-SYMPTOM
borderline I-SYMPTOM
mild I-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
) O
with O
an O
ejection O
fraction O
of O
55% O
. O

REVIEW O
OF O
SYSTEMS O
: O

Review O
of O
systems O
was O
significant O
for O
menopausal B-SYMPTOM
symptoms I-SYMPTOM
( O
for O
which O
she O
has O
attempted O
hormone B-TREATMENT
replacement I-TREATMENT
therapy I-TREATMENT
, O
discontinued O
in O
2014 O
). O

She O
also O
reports O
difficulty B-SYMPTOM
sleeping I-SYMPTOM
, O
daytime B-SYMPTOM
sleepiness I-SYMPTOM
. O

She O
sleeps O
on O
elevated B-TREATMENT
pillows I-TREATMENT
secondary O
to O
her B-SYMPTOM
gastroesophageal I-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
. O

Occasional B-SYMPTOM
paroxysmal I-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
in O
the O
past O
but O
none O
recently O
. O

Occasional B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
, O
left O
greater O
than O
right O
. O

No O
abdominal B-SYMPTOM
or I-SYMPTOM
urinary I-SYMPTOM
complaints I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Gastroesophageal B-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
. O

2. O
Grave's B-SYMPTOM
, O
status O
post O
radiation B-TREATMENT
resulting O
in O
hypothyroidism B-SYMPTOM
. O

3. O
Migraines B-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Synthroid B-TREATMENT
, O
Prilosec B-TREATMENT
20 O
mg O
p.o. O
, O
Fioricet B-TREATMENT
, O
Celebrex B-TREATMENT
. O

ALLERGIES O
: O

PENICILLIN B-TREATMENT
causes O
a B-SYMPTOM
rash I-SYMPTOM
. O

FAMILY O
HISTORY O
: O

Diabetes B-SYMPTOM
, O
Grave's B-SYMPTOM
disease I-SYMPTOM
, O
but O
no O
history O
of O
cardiopulmonary B-SYMPTOM
disease I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
with O
her O
husband O
, O
and O
they O
have O
no O
children O
. O

She O
denies O
any O
tobacco O
or O
alcohol O
history O
. O

She O
does O
use O
herbal B-TREATMENT
remedies I-TREATMENT
including O
Primrose B-TREATMENT
oil I-TREATMENT
, O
Siberian B-TREATMENT
ginseng I-TREATMENT
, O
and O
has O
a O
history O
of O
use O
of O
wallerian B-TREATMENT
root I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
ON O
PRESENTATION O
: O

Vital O
signs O
were O
temperature O
of O
98.4 O
, O
heart O
rate O
74 O
, O
blood O
pressure O
130/91 O
, O
respiratory O
rate O
21 O
, O
satting O
98% O
on O
room O
air O
. O

HEENT O
revealed O
pupils O
were O
equally O
round O
and O
reactive O
to O
light O
. O

The O
oropharynx O
was O
clear O
. O

Neck O
was O
supple O
, O
no O
lymphadenopathy B-SYMPTOM
, O
no O
thyromegaly B-SYMPTOM
, O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
, O
and O
no O
bruits B-SYMPTOM
. O

Lungs O
had O
scant B-SYMPTOM
crackles I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
base I-SYMPTOM
and I-SYMPTOM
middle I-SYMPTOM
field I-SYMPTOM
; O
otherwise O
clear O
. O

Cardiovascular O
had O
a O
regular O
rate O
and O
rhythm O
. O

No O
murmurs B-SYMPTOM
. O

No O
fourth O
heart O
sound O
or O
third O
heart O
sound O
. O

No O
parasternal B-SYMPTOM
heave I-SYMPTOM
. O

Gastrointestinal O
revealed O
soft O
, O
nontender B-SYMPTOM
, O
and O
nondistended B-SYMPTOM
. O

No O
hepatosplenomegaly B-SYMPTOM
. O

No O
masses B-SYMPTOM
. O

No O
bruits B-SYMPTOM
. O

Normal O
active O
bowel O
sounds O
. O

Extremities O
had O
no O
edema B-SYMPTOM
, O
2+ O
distal O
pedis O
. O

Neurologically O
, O
grossly O
nonfocal O
. O

LABORATORY O
DATA O
ON O
PRESENTATION O
: O

At O
the O
time O
of O
admission O
, O
white O
blood O
cell O
count O
11.1 O
, O
hematocrit O
37.7 O
, O
platelets O
326 O
. O

Sodium O
140 O
, O
potassium O
4 O
, O
chloride O
105 O
, O
bicarbonate O
28 O
, O
BUN O
17 O
, O
creatinine O
0.8 O
, O
glucose O
76 O
. O

Creatine O
kinase O
100 O
, O
MB O
4 O
, O
troponin O
of O
less O
than O
0.3 O
. O

RADIOLOGY O
/ O
IMAGING O
: O

Electrocardiogram O
revealed O
left B-SYMPTOM
atrial I-SYMPTOM
hypertrophy I-SYMPTOM
, O
right B-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
, O
and O
poor B-SYMPTOM
R I-SYMPTOM
wave I-SYMPTOM
progression I-SYMPTOM
which O
were O
new O
. O

Also O
, O
T B-SYMPTOM
wave I-SYMPTOM
inversions I-SYMPTOM
in I-SYMPTOM
II I-SYMPTOM
, I-SYMPTOM
III I-SYMPTOM
, I-SYMPTOM
aVF I-SYMPTOM
, I-SYMPTOM
V1 I-SYMPTOM
through I-SYMPTOM
V5 I-SYMPTOM
; O
new B-SYMPTOM
evolving I-SYMPTOM
right I-SYMPTOM
bundle-branch I-SYMPTOM
block I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
is O
a O
52 O
- O
year-old O
female O
with O
no O
known O
history O
of O
cardiac B-SYMPTOM
disease I-SYMPTOM
presenting O
with O
dyspnea B-SYMPTOM
on O
exertion O
and O
chest B-SYMPTOM
tightness I-SYMPTOM
, O
who O
was O
admitted O
for O
evaluation O
and O
management B-TREATMENT
of O
her B-SYMPTOM
symptoms I-SYMPTOM
. O

1. O
CARDIOVASCULAR O
: O

The O
patient O
was O
admitted O
for O
complaints O
of O
dyspnea B-SYMPTOM
on O
exertion O
and O
chest B-SYMPTOM
pressure I-SYMPTOM
which O
could O
be O
consistent O
with O
angina B-SYMPTOM
. O

However O
, O
given O
the O
long O
duration O
of O
the B-SYMPTOM
symptoms I-SYMPTOM
and O
negative O
workup O
in O
the O
past O
, O
it O
was O
thought O
to O
be O
unlikely O
. O

However O
, O
the O
patient O
was O
started O
on O
an B-TREATMENT
aspirin I-TREATMENT
as O
well O
as O
a B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
, O
and O
a O
rule O
out O
myocardial O
infarction O
protocol O
was O
initiated O
. O

A O
stress O
thallium O
was O
planned O
for O
the O
day O
following O
admission O
. O

However O
, O
on O
the O
night O
of O
admission O
the O
patient O
was O
found O
lying O
in O
her O
bed O
diaphoretic B-SYMPTOM
and O
obtunded B-SYMPTOM
, O
and O
a O
code O
was O
called O
. O

Further O
examination O
revealed O
a O
strong O
palpable O
pulse O
with O
a O
systolic O
blood O
pressure O
in O
the O
130 O
s O
and O
a O
heart O
rate O
in O
the O
80 O
s. O

Over O
the O
course O
of O
the O
next O
few O
minutes O
the O
patient O
became O
increasingly O
more O
responsive O
. O

She O
was O
treated O
with O
a B-TREATMENT
fluid I-TREATMENT
bolus I-TREATMENT
. O

The O
patient O
quickly O
responded O
to O
a B-TREATMENT
fluid I-TREATMENT
bolus I-TREATMENT
and O
became O
interactive O
. O

She O
reported O
that O
she O
was O
sitting O
on O
the O
commode O
urinating O
and O
began O
to O
feel O
nauseous B-SYMPTOM
and O
presyncopal B-SYMPTOM
. O

She O
was O
able O
to O
get O
to O
bed O
at O
which O
point O
she O
passed O
out O
. O

She O
denied O
any B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
or O
pressure B-SYMPTOM
, O
and O
no O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
during O
this O
event O
. O

A O
rhythm O
check O
obtained O
during O
the O
time O
of O
this O
event O
demonstrated O
a B-SYMPTOM
pause I-SYMPTOM
of I-SYMPTOM
six I-SYMPTOM
seconds I-SYMPTOM
followed O
by O
a B-SYMPTOM
junctional I-SYMPTOM
escape I-SYMPTOM
rhythm I-SYMPTOM
. O

An O
electrocardiogram O
obtained O
after O
the O
code O
demonstrated O
no O
acute B-SYMPTOM
changes I-SYMPTOM
. O

Her B-SYMPTOM
acute I-SYMPTOM
bradycardic I-SYMPTOM
event I-SYMPTOM
was O
felt O
likely O
secondary O
to O
her B-TREATMENT
new I-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
in O
conjunction O
with O
a B-SYMPTOM
vagal I-SYMPTOM
response I-SYMPTOM
. O

It O
was O
determined O
to O
stop O
the B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
, O
and O
atropine B-TREATMENT
was O
placed O
at O
the O
bedside O
. O

On O
the O
following O
day O
the O
patient O
underwent O
an O
echocardiogram O
which O
demonstrated O
dilated B-SYMPTOM
right I-SYMPTOM
ventricle I-SYMPTOM
secondary O
to O
chronic B-SYMPTOM
dysfunction I-SYMPTOM
and O
a O
pulmonary O
artery O
pressure O
of O
greater O
than O
100 O
. O

Her O
stress O
test O
was O
cancelled O
. O

A O
CT O
angiogram O
was O
ordered O
to O
evaluate O
for O
chronic B-SYMPTOM
thromboembolic I-SYMPTOM
disease I-SYMPTOM
as O
a O
potential O
cause O
of O
her B-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
. O

She O
was O
ruled O
out O
for O
myocardial B-SYMPTOM
infarction I-SYMPTOM
with O
three O
sets O
of O
normal O
enzymes O
and O
continued O
to O
be O
monitored O
on O
telemetry O
. O

A O
Pulmonary O
consultation O
was O
obtained O
to O
evaluate O
for O
possible O
etiology O
of O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
hypotension I-SYMPTOM
. O

There O
was O
little O
evidence O
to O
suggest O
any B-SYMPTOM
cardiac I-SYMPTOM
disease I-SYMPTOM
, O
and O
given O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
Grave's I-SYMPTOM
disease I-SYMPTOM
an B-SYMPTOM
autoimmune I-SYMPTOM
process I-SYMPTOM
was O
felt O
to O
be O
possible O
. O

In O
addition O
, O
consideration O
was O
given O
to O
sarcoidosis B-SYMPTOM
, O
human B-SYMPTOM
immunodeficiency I-SYMPTOM
virus I-SYMPTOM
, O
and O
drug-induced O
given O
her O
history O
of O
herbal B-TREATMENT
medication I-TREATMENT
use O
. O

It O
was O
recommended O
that O
the O
patient O
begin O
anticoagulation B-TREATMENT
given O
the O
severity O
of O
her B-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
. O

It O
was O
also O
planned O
to O
undergo O
a O
right O
heart O
catheterization O
with O
a O
vasodilation O
trial O
by O
the O
catheterization O
laboratory O
. O

A O
right O
heart O
catheterization O
was O
performed O
on O
2014-12-05 O
. O

A O
pharmacologic O
pulmonary O
vasodilator O
challenge O
was O
performed O
with O
a O
positive O
response O
. O

In O
addition O
, O
a O
CT O
angiogram O
of O
the O
chest O
with O
pulmonary O
embolism O
protocol O
showed O
no O
intravascular B-SYMPTOM
filling I-SYMPTOM
defect I-SYMPTOM
but O
did O
show O
a B-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
ground-glass I-SYMPTOM
and O
scattered B-SYMPTOM
adenopathy I-SYMPTOM
. O

Therefore O
, O
in O
the O
end O
left B-SYMPTOM
atrial I-SYMPTOM
hypertension I-SYMPTOM
was O
essentially O
ruled O
out O
as O
a O
primary O
cause O
. O

Chronic B-SYMPTOM
pulmonary I-SYMPTOM
embolus I-SYMPTOM
was O
less O
likely O
given O
her O
negative O
CT O
angiogram O
. O

Chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
was O
unlikely O
given O
the O
patient O
's O
normal O
pulmonary O
function O
tests O
and O
DLCO O
in O
2012 O
as O
well O
as O
a O
normal O
CT O
angiogram O
. O

Collagen B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
could O
not O
be O
definitively O
ruled O
out O
; O
however O
, O
given O
the O
patient O
's O
lack O
of O
connective B-SYMPTOM
tissue I-SYMPTOM
disorder I-SYMPTOM
stigmata I-SYMPTOM
it O
was O
thought O
to O
be O
less O
likely O
, O
and O
the O
patient O
's O
human O
immunodeficiency O
virus O
test O
was O
negative O
. O

Therefore O
, O
it O
was O
felt O
that O
the O
patient O
was O
most O
likely O
experiencing O
a B-SYMPTOM
primary I-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
. O

Consideration O
was O
given O
to O
treating O
the O
patient O
with O
a O
course O
of O
calcium B-TREATMENT
channel I-TREATMENT
blocker I-TREATMENT
; O
however O
, O
given O
the O
patient O
's O
poor O
response O
to O
Lopressor B-TREATMENT
, O
it O
was O
determined O
that O
this O
would O
not O
be O
optimal O
treatment O
for O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
. O

Therefore O
, O
her O
insurance O
company O
was O
contacted O
regarding O
the O
potential O
of O
Flolan B-TREATMENT
as O
a O
treatment O
. O

Plans O
were O
made O
for O
placement O
of O
a B-TREATMENT
Hickman I-TREATMENT
catheter I-TREATMENT
and O
initiation O
of O
Flolan B-TREATMENT
treatment I-TREATMENT
. O

However O
, O
on O
12-07 O
, O
the O
patient O
once O
again O
experienced O
an O
episode O
of O
unresponsiveness B-SYMPTOM
. O

Upon O
arrival O
by O
the O
physician O
the O
patient O
was O
awake O
, O
alert O
, O
and O
oriented O
with O
a O
pulse O
in O
the O
80 O
s, O
with O
pressure O
in O
the O
80 O
s, O
and O
satting O
100% O
on O
room O
air O
. O

She O
described O
this O
episode O
as O
an B-SYMPTOM
uncomfortable I-SYMPTOM
feeling I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
chest I-SYMPTOM
. O

The O
patient O
was O
treated O
with O
2 O
liters O
of O
intravenous B-TREATMENT
fluids I-TREATMENT
with O
a O
bump O
in O
her O
systolic O
blood O
pressure O
to O
the O
90 O
s. O

Review O
of O
telemetry O
revealed O
an O
8 O
to O
9 O
beat O
episode O
of O
nonsustained B-SYMPTOM
ventricular I-SYMPTOM
tachycardia I-SYMPTOM
followed O
by O
an O
episode O
of O
bradycardia B-SYMPTOM
to O
60 O
beats O
per O
minute O
. O

The O
etiology O
of O
these B-SYMPTOM
cardiovascular I-SYMPTOM
episodes I-SYMPTOM
was O
unclear O
, O
but O
was O
felt O
likely O
secondary O
to O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
tenuous I-SYMPTOM
cardiovascular I-SYMPTOM
status I-SYMPTOM
given O
the O
fact O
that O
she O
had O
clear B-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
, O
was O
very B-SYMPTOM
preload I-SYMPTOM
dependent I-SYMPTOM
, O
and O
had O
an O
intact O
left O
ventricular O
function O
but O
with O
cardiac B-SYMPTOM
output I-SYMPTOM
limited I-SYMPTOM
due O
to O
left B-SYMPTOM
ventricular I-SYMPTOM
compression I-SYMPTOM
by O
a B-SYMPTOM
dilated I-SYMPTOM
left I-SYMPTOM
ventricle I-SYMPTOM
. O

Given O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
persistent I-SYMPTOM
hypotensive I-SYMPTOM
episodes I-SYMPTOM
, O
and O
decreased B-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
, O
she O
was O
transferred O
back O
to O
the O
Medical O
Intensive O
Care O
Unit O
for O
management O
prior O
to O
initiation O
of O
Flolan B-TREATMENT
therapy I-TREATMENT
. O

On O
12-08 O
, O
the B-TREATMENT
Hickman I-TREATMENT
catheter I-TREATMENT
was O
placed O
in O
preparation O
of O
Flolan B-TREATMENT
administration O
. O

During O
the O
Mass. O
Mental O
Health O
Center O
Medical O
Intensive O
Care O
Unit O
stay O
, O
the O
patient O
was O
found O
to O
exquisitely B-SYMPTOM
preload I-SYMPTOM
dependent I-SYMPTOM
and O
responded O
well O
to O
aggressive B-TREATMENT
fluids I-TREATMENT
as O
needed O
to O
maintain O
her O
blood O
pressure O
with O
a O
systolic O
of O
greater O
than O
90 O
. O

She O
had O
no O
further O
episodes O
of O
bradycardia B-SYMPTOM
during O
her O
Medical O
Intensive O
Care O
Unit O
stay O
. O

In O
addition O
, O
the O
patient O
's O
urine O
output O
improved O
dramatically O
with O
hydration B-TREATMENT
therapy I-TREATMENT
, O
suggesting O
her B-SYMPTOM
low I-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
was O
secondary O
to O
decreased B-SYMPTOM
cardiac I-SYMPTOM
output I-SYMPTOM
secondary O
to O
low B-SYMPTOM
preload I-SYMPTOM
. O

The O
patient O
continued O
to O
be O
followed O
by O
the O
Electrophysiology O
Service O
, O
who O
determined O
that O
the O
patient O
was O
demonstrating O
severe B-SYMPTOM
vasal I-SYMPTOM
sensitivity I-SYMPTOM
with O
bradycardia B-SYMPTOM
necessitating O
pacemaker B-TREATMENT
placement I-TREATMENT
. O

This O
was O
to O
be O
deferred O
until O
after O
the O
patient O
had O
her B-TREATMENT
Hickman I-TREATMENT
in O
place O
. O

Because O
the O
patient O
's O
pulmonary O
pressures O
responded O
so O
well O
to O
adenosine B-TREATMENT
during O
right O
heart O
catheterization O
, O
it O
was O
thought O
that O
the O
patient O
would O
be O
a O
good O
candidate O
for O
Flolan B-TREATMENT
therapy I-TREATMENT
. O

Flolan B-TREATMENT
was O
initiated O
on O
12-08 O
at O
5 O
nanograms O
per O
kilogram O
per O
minute O
. O

The O
patient O
was O
monitored O
for O
symptoms B-SYMPTOM
of O
Flolan B-TREATMENT
therapy I-TREATMENT
including O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
first B-SYMPTOM
bite I-SYMPTOM
jaw I-SYMPTOM
claudication I-SYMPTOM
, O
or O
hypotension B-SYMPTOM
. O

Over O
the O
course O
of O
the O
hospital O
stay O
the B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
Flolan I-TREATMENT
dose I-TREATMENT
was O
titrated O
to O
receive O
maximum O
benefit O
without O
precipitating O
symptoms O
of O
Flolan B-SYMPTOM
overdose I-SYMPTOM
. O

The O
patient O
was O
felt O
to O
be O
stable O
on O
her B-TREATMENT
current I-TREATMENT
Flolan I-TREATMENT
dose I-TREATMENT
and O
was O
therefore O
transferred O
back O
to O
the O
floor O
. O

A O
high O
resolution O
CT O
was O
requested O
to O
further O
evaluate O
for O
possible O
secondary O
cause O
of O
her B-SYMPTOM
primary I-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
; O
however O
, O
the O
patient O
refused O
it O
at O
this O
time O
. O

Plans O
for O
placement O
of O
a B-TREATMENT
pacemaker I-TREATMENT
were O
initiated O
. O

However O
, O
on O
the O
night O
prior O
to O
the O
planned O
surgical O
date O
the O
patient O
suffered O
an O
episode O
of O
bleeding B-SYMPTOM
from O
her B-TREATMENT
Hickman I-TREATMENT
catheter I-TREATMENT
site O
. O

Surgery O
was O
notified O
and O
pressure B-TREATMENT
was O
applied O
; O
however O
, O
it O
did O
not O
stop O
oozing O
. O

A B-TREATMENT
surgicel I-TREATMENT
dressing I-TREATMENT
was O
placed O
and O
prolonged B-TREATMENT
pressure I-TREATMENT
resulted O
in O
resolution O
of O
the B-SYMPTOM
bleeding I-SYMPTOM
. O

In O
addition O
, O
an B-TREATMENT
extra I-TREATMENT
stitch I-TREATMENT
was O
placed O
in O
an O
effort O
to O
stop O
the B-SYMPTOM
bleeding I-SYMPTOM
. O

Following O
this O
episode O
the O
patient O
felt O
like O
she O
was O
" O
too B-SYMPTOM
stressed I-SYMPTOM
" O
for O
pacemaker B-TREATMENT
placement I-TREATMENT
. O

Therefore O
, O
she O
was O
monitored O
over O
the O
next O
few O
days O
for O
any B-SYMPTOM
further I-SYMPTOM
bleeding I-SYMPTOM
events I-SYMPTOM
. O

Over O
the O
course O
of O
the O
next O
few O
days O
the O
patient O
became O
more O
accustomed O
to O
her B-TREATMENT
Flolan I-TREATMENT
, O
and O
Flolan B-TREATMENT
teaching O
was O
continued O
. O

She O
continued O
to O
have O
occasional O
episodes O
of O
dizziness B-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
and O
hypotension B-SYMPTOM
whenever O
the O
alarm O
sounded O
suggesting O
that O
the B-TREATMENT
Flolan I-TREATMENT
bag I-TREATMENT
needed O
to O
be O
changed O
. O

However O
, O
over O
the O
course O
of O
the O
hospital O
stay O
these O
decreased O
both O
in O
frequency O
and O
severity O
. O

On O
12-15 O
, O
the O
patient O
went O
for O
placement O
of O
a B-TREATMENT
pacemaker I-TREATMENT
. O

She O
had O
dual-mode B-TREATMENT
, I-TREATMENT
dual-pacing I-TREATMENT
, I-TREATMENT
dual-sensing I-TREATMENT
pacemaker I-TREATMENT
placed O
with O
a O
lower O
rate O
at O
60 O
ppm O
, O
and O
upper O
rate O
of O
120 O
ppm O
with O
a O
paced O
AV O
of O
150 O
msec O
. O

The O
patient O
recovered O
well O
from O
her B-TREATMENT
surgery I-TREATMENT
for O
pacemaker B-TREATMENT
placement I-TREATMENT
. O

At O
the O
time O
of O
discharge O
, O
the O
patient O
was O
tolerating O
her B-TREATMENT
Flolan I-TREATMENT
therapy I-TREATMENT
well O
. O

She O
had O
received O
a O
full O
course O
of O
Flolan B-TREATMENT
teaching I-TREATMENT
and O
reported O
that O
she O
and O
her O
husband O
felt O
comfortable O
with O
the O
administration O
of O
the B-TREATMENT
medication I-TREATMENT
at O
home O
. O

She O
was O
set O
up O
with O
a B-TREATMENT
primary I-TREATMENT
pulmonary I-TREATMENT
hypertension I-TREATMENT
support I-TREATMENT
group I-TREATMENT
, O
and O
home B-TREATMENT
services I-TREATMENT
were O
arranged O
to O
help O
her O
in O
the O
initiation O
of O
Flolan B-TREATMENT
therapy I-TREATMENT
. O

Following O
pacemaker B-TREATMENT
placement I-TREATMENT
the O
patient O
had O
no O
further O
episodes O
of O
bradycardia B-SYMPTOM
on O
telemetry O
, O
and O
therefore O
she O
was O
discharged O
in O
satisfactory O
condition O
. O

2. O
INFECTIOUS O
DISEASE O
: O

The O
patient O
had O
no O
signs O
or O
symptoms O
of O
infection B-SYMPTOM
at O
the O
time O
of O
admission O
. O

However O
, O
she O
was O
noted O
to O
have O
a B-SYMPTOM
relatively I-SYMPTOM
elevated I-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cell I-SYMPTOM
count I-SYMPTOM
that O
remained O
stable O
over O
the O
course O
of O
her O
hospital O
stay O
. O

However O
, O
near O
the O
end O
of O
her O
hospitalization O
the O
patient O
began O
describing O
increased B-SYMPTOM
urinary I-SYMPTOM
frequency I-SYMPTOM
which O
persisted O
once O
her B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
was O
removed O
. O

A O
urinalysis O
was O
positive B-SYMPTOM
and O
urine O
culture O
grew O
enterococcus B-SYMPTOM
which O
was O
pan O
sensitive O
. O

Therefore O
, O
the O
patient O
was O
started O
on O
levofloxacin B-TREATMENT
therapy I-TREATMENT
to O
complete O
a O
10 O
- O
day O
course O
. O

Following O
initiation O
of O
the B-TREATMENT
antibiotic I-TREATMENT
the O
patient O
's O
white O
blood O
cell O
count O
quickly O
came O
down O
, O
and O
she O
remained O
afebrile B-SYMPTOM
. O

At O
the O
time O
of O
discharge O
, O
the O
patient O
still O
had O
a B-SYMPTOM
mildly I-SYMPTOM
elevated I-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cell I-SYMPTOM
count I-SYMPTOM
but O
was O
asymptomatic B-SYMPTOM
with O
a O
normal O
temperature O
. O

She O
will O
complete O
two O
more O
days O
of O
Levaquin B-TREATMENT
therapy I-TREATMENT
as O
an O
outpatient O
. O

3. O
RENAL O
: O

The O
patient O
's O
BUN O
and O
creatinine O
were O
followed O
over O
the O
course O
of O
her O
hospital O
stay O
. O

These O
remained O
stable O
and O
within O
normal O
limits O
. O

It O
was O
felt O
that O
the B-SYMPTOM
decreased I-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
was O
secondary O
to O
her B-SYMPTOM
preload I-SYMPTOM
dependence I-SYMPTOM
, O
and O
that O
her O
urine O
output O
increased O
significantly O
when O
she O
was O
adequately O
hydrated O
in O
the O
Medical O
Intensive O
Care O
Unit O
. O

4. O
GASTROINTESTINAL O
: O

The O
patient O
has O
a O
history O
of O
gastroesophageal B-SYMPTOM
reflux I-SYMPTOM
disease I-SYMPTOM
. O

She O
was O
continued O
on O
Protonix B-TREATMENT
over O
the O
course O
of O
her O
hospital O
stay O
and O
had O
no O
further B-SYMPTOM
gastrointestinal I-SYMPTOM
issues I-SYMPTOM
. O

5. O
HEMATOLOGY O
: O

The O
patient O
's O
hematocrit O
remained O
stable O
over O
the O
course O
of O
her O
hospital O
stay O
. O

Despite O
bleeding B-SYMPTOM
from O
the B-TREATMENT
Hickman I-TREATMENT
site I-TREATMENT
, O
she O
did O
not O
require O
any B-TREATMENT
transfusion I-TREATMENT
therapy I-TREATMENT
. O

6. O
FLUIDS O
/ O
ELECTROLYTES O
/ O
NUTRITION O
: O

The O
patient O
tolerated O
a O
regular O
diet O
throughout O
the O
course O
of O
her O
hospital O
stay O
. O

Her O
electrolytes O
were O
checked O
on O
a O
daily O
basis O
and O
remained O
within O
normal O
limits O
, O
being O
replaced O
as O
needed O
. O

She O
was O
discharged O
to O
home O
on O
a O
regular O
diet O
. O

7. O
ENDOCRINE O
: O

The O
patient O
with O
a O
history O
of O
hypothyroidism B-SYMPTOM
. O

She O
was O
continued O
on O
her B-TREATMENT
regular I-TREATMENT
Synthroid I-TREATMENT
dose I-TREATMENT
. O

She O
will O
need O
a O
TSH O
and O
T4 O
checked O
as O
an O
outpatient O
. O

8. O
CODE O
STATUS O
: O

The O
patient O
is O
a B-TREATMENT
full I-TREATMENT
code I-TREATMENT
. O

9. O
FLOLAN B-TREATMENT
ADMINISTRATION I-TREATMENT
: O

At O
the O
time O
of O
discharge O
, O
the O
patient O
was O
tolerating O
a B-TREATMENT
Flolan I-TREATMENT
dose I-TREATMENT
of O
5 O
nanograms O
per O
kilogram O
per O
minute O
. O

A O
Physical O
Therapy O
consultation O
was O
obtained O
to O
initiate O
a O
6 O
- O
minute O
walk O
test O
. O

On O
room O
air O
, O
the O
patient O
's O
oxygen O
saturation O
was O
95% O
and O
dropped O
to O
88% O
following O
a O
6 O
- O
minute O
walk O
. O

The O
patient O
was O
discharged O
to O
home O
with O
appropriate O
Flolan B-TREATMENT
teaching I-TREATMENT
and O
supplies O
. O

She O
was O
to O
follow O
up O
with O
Dr. O
Savage O
in O
the O
Clinic O
the O
following O
week O
. O

CONDITION O
AT O
DISCHARGE O
: O

The O
patient O
was O
stable O
. O

DISCHARGE O
STATUS O
: O

She O
was O
discharged O
to O
home O
. O

DISCHARGE O
FOLLOWUP O
: O

She O
has O
follow O
up O
with O
Dr. O
Schwartz O
in O
the O
Clinic O
on O
Monday O
, O
12-22 O
, O
at O
2:30 O
p.m. O
to O
check O
her O
INR O
and O
digoxin O
level O
. O

She O
also O
has O
follow O
up O
with O
Dr. O
Savage O
in O
the O
Pulmonary O
Clinic O
on O
12-25 O
at O
12:15 O
p.m. O
for O
management B-TREATMENT
of O
her B-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Coumadin B-TREATMENT
2 O
mg O
p.o. O
q.6h. O

2. O
Tylenol B-TREATMENT
No. I-TREATMENT
3 I-TREATMENT
one O
to O
two O
tablets O
p.o. O
q.4h. O
p.r.n. O
for O
pain B-SYMPTOM
. O

3. O
Digoxin B-TREATMENT
0.125 O
mg O
p.o. O
q.d. O

4. O
Levofloxacin B-TREATMENT
500 O
mg O
p.o. O
t.i.d. O
times O
two O
days O
. O

5. O
Protonix B-TREATMENT
40 O
mg O
p.o. O
q.d. O

6. O
Tylenol B-TREATMENT
650 O
mg O
p.o. O
q.4-6h. O
p.r.n. O
for O
fever B-SYMPTOM
or O
pain B-SYMPTOM
. O

7. O
Synthroid B-TREATMENT
125 O
mcg O
p.o. O
q.d. O

8. O
Colace B-TREATMENT
100 O
mg O
p.o. O
q.d. O

9. O
Lactulose B-TREATMENT
30 O
cc O
p.o. O
q.6h. O
p.r.n. O
for O
constipation B-SYMPTOM
. O

10. O
Flolan B-TREATMENT
5 O
nanograms O
per O
kilograms O
per O
minute O
, O
continuous O
infusion O
. O

11. O
Oxygen B-TREATMENT
per O
nasal B-TREATMENT
cannula I-TREATMENT
as O
needed O
. O

Alan O
Q. O
Steckelberg O
, O
M.D. O

54-745 O

Dictated O
By O
: O
Roy O
C O
Ali O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-12-18 O
18:32 O

T O
: O
2014-12-21 O
10:44 O

JOB O
#: O

60351 O

( O
cclist O
) O

Signed O
electronically O
by O
: O
DR. O
Melody O
PARKS O
on O
: O
TUE O
2014-12-23 O
6:28 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2011-12-17 O

Discharge O
Date O
: O

2012-01-14 O

Date O
of O
Birth O
: O

1932-12-18 O

Sex O
: O

M O

Service O
: O

NEUROLOGY O

Allergies O
: O

Bactrim B-TREATMENT

Attending O
: O
Patricia O
Q O
Pendergrass O
, O
M.D. O

Chief O
Complaint O
: O
altered B-SYMPTOM
metnal I-SYMPTOM
status I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O
bronchoscopy O

History O
of O
Present O
Illness O
: O

79 O
- O
year-old O
M O
recently O
diagnosed O
by O
biopsy O
with O
gliomatosis B-SYMPTOM
cerebri I-SYMPTOM
( I-SYMPTOM
grade I-SYMPTOM
II I-SYMPTOM
astrocytoma I-SYMPTOM
) I-SYMPTOM
in O
8/04 O
, O
being O
treated O
with O
XRT B-TREATMENT
, O
timidar B-TREATMENT
. O

She O
is O
currently O
on O
a B-TREATMENT
decadron I-TREATMENT
taper I-TREATMENT
after O
it O
was O
increased O
several O
months O
ago O
secondary O
to O
increasing B-SYMPTOM
ocular I-SYMPTOM
symptoms I-SYMPTOM
. O

Seen O
by O
PMD O
on O
12-14 O
w/ O
symptoms O
of O
cough B-SYMPTOM
productive O
of O
yellow B-SYMPTOM
sputum I-SYMPTOM
, O
which O
wife O
also O
had O
, O
prescribed O
zpak B-TREATMENT
w/o O
improvement O
. O

Pt O
was O
brought O
to O
the O
Victor O
for O
increasing B-SYMPTOM
somnolence I-SYMPTOM
over O
past O
several O
days-weeks O
. O

Over O
the O
past O
two O
weeks O
, O
pt O
has O
declined O
in O
status O
. O

He O
is O
confused B-SYMPTOM
, O
has O
had O
hallucinations B-SYMPTOM
. O

Family O
believed O
pt O
was O
becoming O
dehydrated B-SYMPTOM
. O

Also O
, O
pt O
's O
strength O
has O
been O
declining O
over O
the O
past O
2 O
weeks O
. O

He O
used O
to O
be O
able O
to O
walk O
with O
a B-TREATMENT
walker I-TREATMENT
, O
and O
the O
past O
few O
days O
has O
required O
a B-TREATMENT
wheelchair I-TREATMENT
. O

+ O
incontinence B-SYMPTOM
over O
the O
past O
2 O
weeks O
. O

+ O
non-bloody B-SYMPTOM
diarrhea I-SYMPTOM
x O
1 O
on O
DOA O
. O

In O
the O
Deborah O
VS O
on O
arrival O
were O
T O
: O
97.5 O
; O
BP O
: O
90/65 O
; O
HR O
: O
82 O
; O
RR O
: O
16 O
; O
94 O
on O
RA O
. O

CXR O
shows O
diffuse B-SYMPTOM
b/l I-SYMPTOM
infiltrates I-SYMPTOM
R I-SYMPTOM
> I-SYMPTOM
L I-SYMPTOM
and O
pt O
was O
found O
to O
have O
a B-SYMPTOM
bandemia I-SYMPTOM
. O

LDH O
was O
511 O
. O

Pt O
received O
bactrim B-TREATMENT
500 O
mg O
x O
1 O
for O
possible O
PCP B-SYMPTOM
. O

Lillian O
R. O
/ O
hypoxic B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
. O

During O
admission O
, O
became O
steadily B-SYMPTOM
more I-SYMPTOM
SOB I-SYMPTOM
, O
increasing B-SYMPTOM
lethargy I-SYMPTOM
. O

12-20 O
satting O
initially O
~ O
90% O
on O
40% O
face B-TREATMENT
mask I-TREATMENT
. O

ABG O
7.45/33/57 O
. O

He O
was O
switched O
to O
a B-TREATMENT
100% I-TREATMENT
NRB I-TREATMENT
mask I-TREATMENT
and O
ABG O
was O
7.47/31/80 O
. O

On O
floor O
on O
day O
of O
transfer O
7.25/50/70 O
on O
100% B-TREATMENT
NRB I-TREATMENT
. O

During O
evaluation O
pt O
responsive O
to O
sternal O
rub O
but O
could O
not O
follow O
commands O
. O

Intubated O
for O
failure B-SYMPTOM
to I-SYMPTOM
protect I-SYMPTOM
airway I-SYMPTOM
, O
transferred O
to O
ICU O
. O

Past O
Medical O
History O
: O

PMHx O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
s/p O
MI B-SYMPTOM
20 O
years O
ago O

2. O
Hypertension B-SYMPTOM

3. O
Hyperlipidemia B-SYMPTOM

4. O
DJD B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
C-spine I-SYMPTOM

5. O
depression B-SYMPTOM

6. O
h/o O
DVT B-SYMPTOM

7. O
Shingles B-SYMPTOM
recently O
finished O
treatment B-TREATMENT

Social O
History O
: O

Landfill O
worker O
- O
retired O

15-20 O
pky O
h/o O
smoking O
, O
quit O
15 O
yrs O
ago O

Denies O
etoh O
/ O
drugs O

Family O
History O
: O
non-contributory O
. O

Physical O
Exam O
: O
t O
98.9 O
, O
bp O
63/28 O
on O
neo B-TREATMENT
, O
p O
114 O
, O
AC B-TREATMENT
fi02 B-TREATMENT
1/ O
vt B-TREATMENT
550/ O
peep B-TREATMENT
5/ O
breathing O
at O
16/22 O
, O
w/ O
volumes O
of O
500 O
s O
. O

Intubated O
, O
minimally B-SYMPTOM
responsive I-SYMPTOM
, O
localized O
pain O
. O

PERRL O
. O

OP O
clear O
. O

MMM O
. O

JVD B-SYMPTOM
not O
appreciated O
03-07 O
to O
deep O
inspiratory O
breaths O
. O

+ O
bs O
. O

Distended B-SYMPTOM
. O

Soft O
. O

NT B-SYMPTOM
> O

No O
le B-SYMPTOM
edema I-SYMPTOM
. O

Pertinent O
Results O
: O

2011-12-23 O
07:54 O
PM O
BLOOD O
WBC O
- O
9.7 O
RBC O
- O
3.02 O
* O
Hgb O
- O
10.0 O
* O
Hct O
- O
29.0 O
* O
MCV O
- O
96 O
MCH O
- O
33.1 O
* O
MCHC O
- O
34.4 O
RDW O
- O
17.7 O
* O
Plt O
Ct O
- O
307 O

2011-12-23 O
07:54 O
PM O
BLOOD O
Neuts O
- O
88 O
* O
Bands O
- O
0 O
Lymphs O
- O
7 O
* O
Monos O
- O
3 O
Eos O
- O
0 O
Baso O
- O
0 O
Atyps O
- O
0 O
Metas O
- O
1 O
* O
Myelos O
- O
1 O
* O

2011-12-23 O
07:54 O
PM O
BLOOD O
PT O
- O
16.0 O
* O
PTT O
- O
35.7 O
* O
INR O
( O
PT O
)- O
1.6 O

Chem O
7 O
: O

2011-12-23 O
07:54 O
PM O
BLOOD O
Glucose O
- O
108 O
* O
UreaN O
- O
27 O
* O
Creat O
- O
1.9 O
* O
Na O
- O
132 O
* O
K O
- O
4.6 O
Cl O
- O
102 O
HCO3 O
- O
20 O
* O
AnGap O
- O
15 O

2011-12-18 O
06:15 O
AM O
BLOOD O
ALT O
- O
29 O
AST O
- O
25 O
LD O
( O
LDH O
)- O
400 O
* O
AlkPhos O
- O
52 O
TotBili O
- O
0.3 O

2011-12-23 O
11:16 O
PM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
202 O
* O
pCO2 O
- O
40 O
pH O
- O
7.29 O
* O
calHCO3 O
- O
20 O
* O
Base O
XS O
-- O
6 O

2011-12-20 O
07:53 O
AM O
BLOOD O
Lactate O
- O
1.1 O

Brief O
Hospital O
Course O
: O

Impression O
: O

71 O
yo O
m O
w/ O
astrocytoma B-SYMPTOM
on O
xrt B-TREATMENT
and O
chemotx B-TREATMENT
, O
who O
p/w O
1 O
wk O
h/o O
productive B-SYMPTOM
cough I-SYMPTOM
, O
sick O
contact O
, O
hypoxic B-SYMPTOM
, O
now O
intubated O
, O
w/ O
increasing B-SYMPTOM
infiltrates I-SYMPTOM
b/l I-SYMPTOM
. O

1) O
Resp B-SYMPTOM
failure I-SYMPTOM
- O
pt O
admitted O
w/ O
primarily B-SYMPTOM
hypoxic I-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
. O

Following O
admission O
to O
the O
floor O
the O
pt O
developed O
increasing B-SYMPTOM
hypoxia I-SYMPTOM
and O
somnolence B-SYMPTOM
, O
requiring O
intubation B-TREATMENT
on O
HD O
5 O
. O

Pulm O
had O
previously O
been O
consulted O
and O
felt O
that O
presentation O
was O
c/w O
PCP B-SYMPTOM
, O
Joann O
started O
on O
Bactrim B-TREATMENT
. O

Previously O
treated O
for O
CAP B-SYMPTOM
as O
outpt O
but O
hypoxia B-SYMPTOM
continued O
to O
progress O
. O

Similar O
lack O
of O
improvement O
w/ O
additional B-TREATMENT
broad I-TREATMENT
spectrum I-TREATMENT
coverage I-TREATMENT
following O
admission O
. O

Pt O
underwent O
bronchoscopy O
on O
11-22 O
following O
transfer O
to O
the O
ICU O
for O
hypoxic B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
and O
intubation B-TREATMENT
( O
7.25/52/70 O
on O
100% B-TREATMENT
NRB I-TREATMENT
) O
. O

On O
admission O
to O
the O
ICU O
the B-TREATMENT
pt I-TREATMENT
' I-TREATMENT
steroid I-TREATMENT
dose I-TREATMENT
was O
increased O
to O
8 O
mg O
bid O
03-07 O
to O
a O
dead O
space O
measurement O
of O
50% O
. O

Pt O
did O
well O
in O
the O
ICU O
, O
w/ O
his O
respiratory O
status O
steadily O
improving O
and O
was O
extubated O
on O

01-03 O
. O

He O
was O
subsequently O
tranferred O
to O
the O
floor O
, O
where O
he O
continued O
to O
have O
a B-SYMPTOM
stable I-SYMPTOM
oxygen I-SYMPTOM
requirement I-SYMPTOM
. O

Repeat O
CXR O
was O
unchanged O
from O
previously O
in O
the O
ICU O
( O
official O
read O
noted O
mild B-SYMPTOM
CHF I-SYMPTOM
, O
but O
pt O
was O
continuing O
to O
autodiurese O
and O
has O
remained O
net O
negative O
everyday O
while O
on O
the O
floor O
. O

On O
discharge O
the O
patient O
has O
stable B-SYMPTOM
O2 I-SYMPTOM
req I-SYMPTOM
, O
90% O
on O
RA O
. O

2) O
astrocytoma B-SYMPTOM
- I-SYMPTOM
grade I-SYMPTOM
II I-SYMPTOM
, O
as O
per O
d/w O
PMD O
, O
Dr. O
Holscher O
, O
pt O
has O
poor O
prognosis O
, O
but O
reasonable O
for O
ongoing B-TREATMENT
treatment I-TREATMENT
. O

Pt O
has O
had O
two O
recent O
neg O
head O
CT O
s O
, O
so O
unlikely O
the O
etiology O
of O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
MS I-SYMPTOM
change I-SYMPTOM
. O

Pt O
was O
continued O
on O
keppra B-TREATMENT
during O
admission O
for O
sz B-SYMPTOM
px I-SYMPTOM
. O

Initially O
he O
had O
been O
on O
lamotrigine B-TREATMENT
but O
the O
was O
stopped O
in O
10/12 O
when O
the O
pt O
was O
noted O
to O
be O
developing O
a B-SYMPTOM
new I-SYMPTOM
rash I-SYMPTOM
. O

Decadron B-TREATMENT
has O
been O
steadily O
tapered O
since O
arrival O
on O
the O
floor O
. O

Now O
continued O
on O
1 O
mg O
BID O
, O
to O
complete O
a O
7 O
day O
course O
, O
which O
will O
be O
tapered O
to O
1 O
mg O
qday O
on O
01-15 O
, O
and O
subsequently O
to O
0.5 O
mg O
qday O
x O
7 O
days O
then O
to O
be O
discontinued O
. O

The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
keppra I-TREATMENT
should O
be O
continued O
for O
sz B-TREATMENT
prophylaxis I-TREATMENT
. O

3) O
MS B-SYMPTOM
change I-SYMPTOM
- O
on O
admission O
pt O
was O
agitated B-SYMPTOM
, O
requiring O
restraints B-TREATMENT
and O
antipsychotics B-TREATMENT
, O
however O
as O
he O
became O
increasingly B-SYMPTOM
hypoxic I-SYMPTOM
he O
became O
somnolent B-SYMPTOM
. O

In O
the O
ICU O
the O
pt O
remained O
stuporous B-SYMPTOM
, O
responsive O
to O
painful O
stimuli O
. O

On O
the O
floor O
the O
patient O
intially O
was O
imporved O
, O
but O
has O
plateaued O
, O
responding O
to O
simple O
commands O
and O
verbalizing O
groans O
but O
no B-SYMPTOM
real I-SYMPTOM
speech I-SYMPTOM
. O

Improvement O
has O
correlated O
w/ O
tapering O
of O
steroids B-TREATMENT
, O
one O
of O
the O
causes O
in O
the O
differential O
. O

Pt O
had O
multiple O
head O
CT O
s O
which O
ruled O
out O
progression O
of O
astrocytoma B-SYMPTOM
. O

MRI O
has O
been O
deferred O
given O
that O
the O
pt O
currently O
would O
not O
tolerate O
the O
procedure O
. O

EEG O
was O
w/o O
evidence O
of O
epileptiform B-SYMPTOM
activity I-SYMPTOM
and O
c/w O
toxic B-SYMPTOM
encephalopathy I-SYMPTOM
. O

Plan O
to O
continue O
to O
follow O
MS B-SYMPTOM
, O
expect O
improvement O
as O
steroids B-TREATMENT
are O
continued O
to O
be O
tapered O
. O

4) O
h/o O
DVT B-SYMPTOM
- O
cont O
heparin B-TREATMENT
, O
previously O
on O
enoxaparin B-TREATMENT
x10 O
days O
at O
treatment O
dose O
, O
followed O
by O
prophylactic B-TREATMENT
dose I-TREATMENT
. O

On O
admission O
, O
the O
pt O
was O
started O
on O
treatment O
doses O
of O
enoxaparin B-TREATMENT
. O

Upon O
transfer O
to O
the O
Intensive O
Care O
Unit O
the O
pt O
was O
started O
on O
heparin B-TREATMENT
gtt I-TREATMENT
. O

Course O
was O
c/b O
one O
episode O
of O
gross B-SYMPTOM
hematochezia I-SYMPTOM
on O
12-28 O
, O
w/ O
concomitant B-SYMPTOM
hct I-SYMPTOM
drop I-SYMPTOM
of O
~ O
3 O
pts O
. O

B/L O
lower O
ext O
duplex O
us O
and O
a O
cta O
were O
performed O
, O
both O
of O
which O
were O
negative O
. O

Given O
that O
the O
pt O
was O
w/o O
evidence O
of O
DVT B-SYMPTOM
it O
was O
felt O
that O
the O
risks O
of O
anticoagulation B-TREATMENT
in O
the O
setting O
of O
gross B-SYMPTOM
GIB I-SYMPTOM
, O
outweigh O
the O
risks O
of O
undetected B-SYMPTOM
deep I-SYMPTOM
vv I-SYMPTOM
thrombosis/pe I-SYMPTOM
. O

Pt O
was O
continued O
on O
prophylactic B-TREATMENT
heparin I-TREATMENT
. O

4) O
hypersensitivity B-SYMPTOM
reaction I-SYMPTOM
- O
on O
11-24 O
pt O
was O
noted O
to O
have O
developing O
rash B-SYMPTOM
of I-SYMPTOM
abdomen I-SYMPTOM
and I-SYMPTOM
anterior I-SYMPTOM
thighs I-SYMPTOM
. O

Derm O
initially O
reviewed O
and O
thought O
that O
it O
was O
not O
c/w O
hypersensitivity B-SYMPTOM
rxn I-SYMPTOM
. O

Over O
the O
next O
the B-SYMPTOM
rash I-SYMPTOM
progressed O
, O
and O
the O
patient O
subsequently O
began O
spiking O
fevers B-SYMPTOM
to O
approx O
103 O
F O
, O
c/b O
hypotension B-SYMPTOM
requiring O
aggressive B-TREATMENT
fluid I-TREATMENT
repletion I-TREATMENT
and O
pressors B-TREATMENT
, O
and O
tachycardia B-SYMPTOM
to O
the O

130s O
. O

The O
patient O
also O
developed O
elevated B-SYMPTOM
transaminases I-SYMPTOM
and I-SYMPTOM
pancreatic I-SYMPTOM
enzymes I-SYMPTOM
during O
this O
time O
. O

On O
the O
second O
day O
that O
the B-SYMPTOM
rash I-SYMPTOM
had O
been O
noted O
, O
Derm O
was O
asked O
to O
see O
again O
, O
felt O
c/w O
hypersensitivity B-SYMPTOM
, O
bactrim B-TREATMENT
was O
switched O
to O
pentamidine B-TREATMENT
, O
and O
lamictal B-TREATMENT
was O
held O
. O

Pt O
continued O
to O
have O
elev B-SYMPTOM
pancreatic I-SYMPTOM
enzymes I-SYMPTOM
and O
pentamidine B-TREATMENT
was O
switched O
to O
clinda/primaquine B-TREATMENT
. O

Following O
discontinuation O
of O
the B-TREATMENT
bactrim I-TREATMENT
the O
patient O
defervesced O
, O
and O
remained O
normotensive O
. O

He O
received O
one O
dose O
of O
furosemide B-TREATMENT
in O
the O
ICU O
and O
was O
transferred O
to O
the O
floor O
the O
next O
day O
. O

On O
arrival O
to O
the O
floor O
the O
patient O
was O
noted O
to O
have O
a B-SYMPTOM
lacy I-SYMPTOM
reticular I-SYMPTOM
rash I-SYMPTOM
of I-SYMPTOM
upper I-SYMPTOM
arms I-SYMPTOM
, O
which O
resolved O
over O
the O
next O
48h O
. O

Felt O
likely O
03-07 O
the B-TREATMENT
sulfa I-TREATMENT
moiety O
of O
the B-TREATMENT
furosemide I-TREATMENT
. O

Plan O
for O
pt O
to O
complete O
total O
of O
28 O
day O
course O
of O
therapy B-TREATMENT
for O
PCP B-SYMPTOM
, O
James O
will O
be O
completed O
on O
01-16 O
. O

5) O
Anemia B-SYMPTOM
- O
previous O
w/u O
c/w O
ACD B-SYMPTOM
( O
elev B-SYMPTOM
ferritin I-SYMPTOM
, O
low B-SYMPTOM
transferrin I-SYMPTOM
saturation I-SYMPTOM
) O
. O

- O
transfuse O
threshold O
< O
24 O

6) O
ARF B-SYMPTOM
- O
Cr O
mildly B-SYMPTOM
elevated I-SYMPTOM
on O
tx O
to O
ICU O
, O
u O
lytes O
c/w O
prerenal B-SYMPTOM
azotemia I-SYMPTOM
, O
which O
resolved O
w/ O
IVF B-TREATMENT
. O

7) O
hyponatremia B-SYMPTOM
- O
also O
hyponatremic B-SYMPTOM
on O
transfer O
, O
resolved O
w/ O
ivf B-TREATMENT
. O

8) O
CAD B-SYMPTOM
- O
w/ O
abnl B-SYMPTOM
EF I-SYMPTOM
, O
however O
pt O
tolerated O
aggressive B-TREATMENT
fluid I-TREATMENT
resusciation I-TREATMENT
w/o O
significant B-SYMPTOM
hypoxia I-SYMPTOM
. O

Continued O
on O
valsartan B-TREATMENT
, O
BB B-TREATMENT
continued O
, O
statin B-TREATMENT

9) O
Nutrition O
- O
pt O
was O
maintained O
on O
TFs B-TREATMENT
via O
post-pyloric B-TREATMENT

10) O
Px O
: O
Heparin B-TREATMENT
( O
full O
dose O
) O
, O
IV B-TREATMENT
PPI I-TREATMENT

11) O
Comm O
: O
Family O
very O
involved O
at O
bedside O
, O
evaluating O
rehab B-TREATMENT
today O

17) O
DNR O
, O
but O
may O
intubate O
for O
reversible O
causes O

18) O
Restraint B-TREATMENT

Medications O
on O
Admission O
: O

Meds O
on O
Transfer O
: O

Acyclovir B-TREATMENT

Bactrim B-TREATMENT

Zoloft B-TREATMENT

Valsartan B-TREATMENT

Metoprolol B-TREATMENT

Keppra B-TREATMENT

Lovenox B-TREATMENT

Levofloxacin B-TREATMENT

Ambisone B-TREATMENT

Atrovent B-TREATMENT
nebs I-TREATMENT

Albuterol B-TREATMENT
nebs I-TREATMENT

Lasix B-TREATMENT
10 O
mg O
qd O

Lipitor B-TREATMENT

Haldol B-TREATMENT
prn O

Discharge O
Medications O
: O

1. O
Miconazole B-TREATMENT
Nitrate I-TREATMENT
2 O
% O
Powder O
Sig O
: O
One O
( O
1 O
) O
Appl O
Topical O
QID O
( O
4 O
times O
a O
day O
) O
. O

2. O
Sertraline B-TREATMENT
HCl I-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

3. O
Albuterol B-TREATMENT
Sulfate I-TREATMENT
0.083 O
% O
Solution O
Sig O
: O
One O
( O
1 O
) O
Inhalation O
Q4H O
( O
every O
4 O
hours O
) O
. O

4. O
Ipratropium B-TREATMENT
Bromide I-TREATMENT
0.02 O
% O
Solution O
Sig O
: O
One O
( O
1 O
) O
Inhalation O
Q4H O
( O
every O
4 O
hours O
) O
. O

5. O
Senna B-TREATMENT
8.6 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
as O
needed O
. O

6. O
Bisacodyl B-TREATMENT
10 O
mg O
Suppository O
Sig O
: O
One O
( O
1 O
) O
Suppository O
Rectal O
BID O
( O
2 O
times O
a O
day O
) O
as O
needed O
for O
constipation B-SYMPTOM
. O

7. O
Levetiracetam B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

8. O
Nystatin B-TREATMENT
100,000 O
unit O
/ O
mL O
Suspension O
Sig O
: O
Five O
( O
5 O
) O
ML O
PO O
QID O
( O
4 O
times O
a O
day O
) O
. O

9. O
Heparin B-TREATMENT
Sodium I-TREATMENT
( I-TREATMENT
Porcine I-TREATMENT
) I-TREATMENT
5,000 O
unit O
/ O
mL O
Solution O
Sig O
: O
One O
( O
1 O
) O
Injection O
TID O
( O
3 O
times O
a O
day O
) O
. O

10. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

11. O
Primaquine B-TREATMENT
Phosphate I-TREATMENT
26.3 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
for O
3 O
days O
. O

12. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

13. O
Dexamethasone B-TREATMENT
0.5 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
Q12H O
( O
every O
12 O
hours O
) O
: O
Take O
2 O
tablet O
po O
bid O
for O
four O
days O
, O
then O
2 O
tablet O
po O
qday O
for O
7 O
days O
, O
then O
take O
one O
tablet O
qday O
for O
7 O
days O
. O

Then O
stop O
taking O
the B-TREATMENT
medication I-TREATMENT
. O

14. O
Acyclovir B-TREATMENT
Sodium I-TREATMENT
500 O
mg O
Recon O
Soln O
Sig O
: O
200mg O
Recon O
Solns O
Intravenous O
Q12H O
( O
every O
12 O
hours O
) O
. O

15. O
Pantoprazole B-TREATMENT
Sodium I-TREATMENT
40 O
mg O
Recon O
Soln O
Sig O
: O
One O
( O
1 O
) O
Recon O
Soln O
Intravenous O
Q12H O
( O
every O
12 O
hours O
) O
. O

16. O
Clindamycin B-TREATMENT
Phosphate I-TREATMENT
in O
D5W B-TREATMENT
600 O
mg O
/ O
50 O
mL O
Piggyback O
Sig O
: O
600 O
mg O
Intravenous O
Q8H O
( O
every O
8 O
hours O
) O
for O
3 O
days O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Danvers O
State O
Hospital O
& O
Rehab O
Center O
- O
Sterling O
Medical O
Center O

Discharge O
Diagnosis O
: O

1) O
PCP B-SYMPTOM
pna I-SYMPTOM

2) O
Astrocytoma B-SYMPTOM

3) O
Hypersensitivity B-SYMPTOM
to O
Bactrim B-TREATMENT

4) O
Hematochezia B-SYMPTOM

5) O
h/o O
DVT B-SYMPTOM

Discharge O
Condition O
: O

Good O
, O
still O
w/ O
altered B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
but O
improving O
. O

Discharge O
Instructions O
: O

1) O
Take O
your O
medications B-TREATMENT

2) O
Attend O
follow O
up O
appointments O

Followup O
Instructions O
: O

Provider O
: O

Irene O
FIELD O
SCREENING O
Where O
: O
Pembroke O
Hospital O

Winchester O
Hospital O
Phone O
:( O
217 O
) O
275 O
6206 O
Date O
/ O
Time O
: O
2012-02-13 O
1:30 O

Provider O
: O
Annie O
A. O
Payne O
, O
M.D. O
Where O
: O
Pembroke O
Hospital O

Winchester O
Hospital O
Phone O
:( O
217 O
) O
275 O
6206 O
Date O
/ O
Time O
: O
2012-02-13 O
2:30 O

Alfonso O
Daniel O
MD O
13-431 O

Completed O
by O
: O
Bernadette O
Sanders O
MD O
04-142 O
2012-01-14 O
@ O
0914 O

Signed O
electronically O
by O
: O
DR. O
Earnestine O
Marsden O
on O
: O
WED O
2012-03-21 O
1:21 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2020-05-23 O

Discharge O
Date O
: O

2020-05-29 O

Date O
of O
Birth O
: O

1955-11-14 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Sabrina O
Q. O
G. O
King O
, O
M.D. O

Chief O
Complaint O
: O
change B-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Intubation B-TREATMENT

Central B-TREATMENT
line I-TREATMENT
placement I-TREATMENT

History O
of O
Present O
Illness O
: O

64 O
F O
with O
breast B-SYMPTOM
CA I-SYMPTOM
s/p O
mastectomy B-TREATMENT
17 O
y O
ago O
with O
local B-SYMPTOM
recurrence I-SYMPTOM
leading O
to O
paralysis B-SYMPTOM
of I-SYMPTOM
L I-SYMPTOM
arm I-SYMPTOM
~ O
5-6 O
y O
ago O
. O

Now O
declining O
gradually O
since O
January O
( O
30 B-SYMPTOM
lbs I-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
, O
becoming O
more B-SYMPTOM
confused I-SYMPTOM
, O
decreased B-SYMPTOM
appetite I-SYMPTOM
). O

Patient O
declined O
workup O
/ O
imaging O
for O
mets B-SYMPTOM
as O
outpatient O
. O

Moving O
toward O
home O
hospice O
. O

Over O
the O
last O
2 O
weeks O
, O
husband O
reports O
patient O
becoming O
increasingly B-SYMPTOM
weak I-SYMPTOM
, O
unable O
to O
leave O
bed O
, O
confused B-SYMPTOM
, O
unable O
to O
feed O
herself O
. O

Seen O
by O
VNA O
and O
noted O
to O
be O
tachycardic B-SYMPTOM
and O
sent O
to O
Middleboroughfor O
evaluation O
. O

Now O
sent O
in O
to O
Amesbury O
by O
VNA O
because O
of O
asymptomatic B-SYMPTOM
sinus I-SYMPTOM
tachycardia I-SYMPTOM
. O

Transferred O
here O
for O
workup O
for O
CNS B-SYMPTOM
mets I-SYMPTOM
and O
admission O
. O

In O
John O
, O
VS O
- O
99.6 O
, O
135 O
, O
122/65 O
, O
20 O
. O

Neurology O
evaluated O
pt O
and O
felt O
to O
have O
intact O
brainstem O
reflexes O
but O
poor O
prognosis O
. O

Neurosurg O
evaluated O
pt O
and O
felt O
to O
not O
be O
surgical O
candidate O
; O
recommended O
dilantin B-TREATMENT
load I-TREATMENT
and O
decadron B-TREATMENT
. O

Received O
lorazepam B-TREATMENT
prior O
to O
CT O
scan O
. O

Intubated O
for O
MS B-SYMPTOM
changes I-SYMPTOM
and O
lethargy B-SYMPTOM
and O
concern O
for O
airway B-TREATMENT
protection I-TREATMENT
. O

Post O
intubation B-TREATMENT
, O
hypotensive B-SYMPTOM
and O
started O
on O
dopamine B-TREATMENT
and O
transitioned O
to O
levophed B-TREATMENT
. O

Received O
vancomycin B-TREATMENT
/ O
levafloxacin B-TREATMENT
at O
OSH O
. O

Received O
metronidazole B-TREATMENT
at O
Ricky O
in O
Mediplex O
Rehab O
Hospital O
. O

In O
CMED O
CCU O
, O
pt. O
responsive O
to O
noxious O
stimuli O
only O
. O

History O
obtained O
from O
husband O
as O
above O
. O

Past O
Medical O
History O
: O

PMHx O
: O

1. O
Left O
breast O
status O
post O
radical B-TREATMENT
mastectomy I-TREATMENT
in O
2002 O
with O
adjuvant B-TREATMENT
Tamoxifen I-TREATMENT
for O
five O
years O
. O

This O
was O
followed O
by O
later O
development O
of O
lymphedema B-SYMPTOM
and O
left B-SYMPTOM
arm I-SYMPTOM
( I-SYMPTOM
distal I-SYMPTOM
> I-SYMPTOM
proximal I-SYMPTOM
) I-SYMPTOM
weakness I-SYMPTOM
due O
to O
metastatic B-SYMPTOM
disease I-SYMPTOM
in I-SYMPTOM
left I-SYMPTOM
axilla I-SYMPTOM
ensheathing I-SYMPTOM
nerve I-SYMPTOM
plexus I-SYMPTOM
. O

Treated O
with O
course O
of O
local B-TREATMENT
XRT I-TREATMENT
in O
Springfield O
Municipal O
Hospital O
and O
Tamoxifen B-TREATMENT
. O

Switched O
to O
Arimedex B-TREATMENT
in O
2019-02-10 O
due O
to O
vaginal B-SYMPTOM
bleeding I-SYMPTOM
on O
Tamoxifen B-TREATMENT
. O

Self O
discontinued O
Arimedex B-TREATMENT
last O
month O
. O

No O
prior O
history O
of O
intracranial B-SYMPTOM
disease I-SYMPTOM
. O

2. O
Metastatic B-SYMPTOM
disease I-SYMPTOM
in I-SYMPTOM
left I-SYMPTOM
arm I-SYMPTOM
, I-SYMPTOM
brachial I-SYMPTOM
plexus I-SYMPTOM
resulting O
in O
left B-SYMPTOM
arm I-SYMPTOM
paresis I-SYMPTOM
, O
as O
above O

Social O
History O
: O

Married O
, O
lives O
with O
husband O
. O

Victoria O
't O
worked O
since O
2008 O
, O
prior O
to O
that O
worked O
in O
a O
school O
cafeteria O
. O

+ O
children O
( O
husband O
Gracia O
't O
quantify O
). O

Social O
smoker O
in O
her O
youth O
. O

Distant O
smoking O
history O
. O

Occasional O
alcohol O
use O
. O

Family O
History O
: O

Maternal O
aunt O
with O
breast B-SYMPTOM
cancer I-SYMPTOM
. O

Mother O
aged O
85 O
, O
alive O
and O
well O
. O

Three O
healthy O
siblings O
. O

Father O
deceased O
from O
complications B-SYMPTOM
from O
MS B-SYMPTOM
. O

Physical O
Exam O
: O

T O
99.8 O

HR O
124 O

SBP O
135/58 O

RR O
16 O

Ox O
100 O

Gen O
: O

Cachectic B-SYMPTOM
, O
lays O
with O
eyes O
closed O
. O

HEENT O
: O

Temporal B-SYMPTOM
wasting I-SYMPTOM
. O

NC/AT B-SYMPTOM
. O

Anicteric B-SYMPTOM
. O

Mucosa B-SYMPTOM
dry I-SYMPTOM
. O

Neck O
: O

Supple O
. O

Lungs O
: O

Clear O
anterolaterally O
. O

No O
R/R/W B-SYMPTOM
. O

Cardiac O
: O

Tachycardic B-SYMPTOM
, O
regular O
. O

S1/S2 O
. O

No O
M/R/G B-SYMPTOM
. O

Abd O
: O

Soft O
, O
NT B-SYMPTOM
, O
ND B-SYMPTOM
, O
+ O
NABS O
. O

No O
rebound B-SYMPTOM
or O
guarding B-SYMPTOM
. O

No O
HSM B-SYMPTOM
. O

Extrem O
: O

Wasted B-SYMPTOM
. O

Legs O
are O
rigid B-SYMPTOM
. O

Pertinent O
Results O
: O

Head O
CT O
There O
is O
diffuse B-SYMPTOM
metastatic I-SYMPTOM
disease I-SYMPTOM
. O

Three B-SYMPTOM
discrete I-SYMPTOM
lesions I-SYMPTOM
are O
seen O
within O
the O
left O
frontal O
, O
right O
occipital O
, O
and O
left O
parietal O
lobes O
with O
significant B-SYMPTOM
surrounding I-SYMPTOM
vasogenic I-SYMPTOM
edema I-SYMPTOM
. O

The B-SYMPTOM
largest I-SYMPTOM
single I-SYMPTOM
lesion I-SYMPTOM
measures O
3.7 O
x O
3.4 O
cm O
. O

There O
is O
moderate B-SYMPTOM
surrounding I-SYMPTOM
edema I-SYMPTOM
with O
10 O
mm O
rightward B-SYMPTOM
shift I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
normally I-SYMPTOM
midline I-SYMPTOM
structures I-SYMPTOM
with O
associated B-SYMPTOM
mass I-SYMPTOM
effect I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
lateral I-SYMPTOM
ventricles I-SYMPTOM
. O

The O
basilar O
cistern O
is O
preserved O
and O
there O
is O
no O
uncal B-SYMPTOM
herniation I-SYMPTOM
. O

The O
osseous O
structures O
are O
unremarkable O
. O

The O
paranasal O
sinuses O
and O
mastoid O
air O
cells O
are O
well O
aerated O
. O

CT O
torso O

1. O
Right B-SYMPTOM
middle I-SYMPTOM
lobe I-SYMPTOM
lung I-SYMPTOM
nodule I-SYMPTOM
, O
suspicious O
for O
metastatic B-SYMPTOM
disease I-SYMPTOM
. O

2. O
Right B-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
lung I-SYMPTOM
opacities I-SYMPTOM
which O
appear O
confluent B-SYMPTOM
, O
most O
suggestive O
of O
infectious B-SYMPTOM
etiology I-SYMPTOM
, O
however O
, O
cannot O
entirely O
exclude O
metastatic B-SYMPTOM
lesions I-SYMPTOM
. O

Recommend O
follow O
up O
CT O
to O
ensure O
resolution O
. O

3. O
Multiple B-SYMPTOM
hypodense I-SYMPTOM
liver I-SYMPTOM
lesions I-SYMPTOM
which O
are O
mildly B-SYMPTOM
enhancing I-SYMPTOM
, O
most O
consistent O
with O
metastatic B-SYMPTOM
disease I-SYMPTOM
. O

4. O
Bilateral B-SYMPTOM
small I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
, O
which O
certainly O
could O
be O
malignant B-SYMPTOM
given O
today O
's O
findings O
and O
history O
of O
breast B-SYMPTOM
cancer I-SYMPTOM
. O

5. O
No O
evidence O
of O
bony B-SYMPTOM
metastases I-SYMPTOM
. O

6. O
Uterine O
cavity O
fluid O
of O
unclear O
etiology O
. O

Brief O
Hospital O
Course O
: O

Metastatic B-SYMPTOM
breast I-SYMPTOM
CA I-SYMPTOM
- O
Large B-SYMPTOM
brain I-SYMPTOM
mets I-SYMPTOM
with O
midline B-SYMPTOM
shift I-SYMPTOM
. O

Intubated O
for O
airway B-TREATMENT
protection I-TREATMENT
. O

Treated O
with O
IV B-TREATMENT
dilantin I-TREATMENT
and O
decadron B-TREATMENT
. O

Patient O
mental O
status O
improved O
slightly O
. O

After O
discussion O
with O
primary O
oncologist O
goals O
of O
care O
where O
change O
to O
comfort O
. O

Dilantin B-TREATMENT
was O
stopped O
. O

Will O
go O
home O
with O
prn O
morphine B-TREATMENT
, O
ativan B-TREATMENT
, O
and O
PR B-TREATMENT
decadron I-TREATMENT
. O

Pnuemonia B-SYMPTOM
- O
Possible O
aspiration B-SYMPTOM
. O

Completed O
a O
7 O
day O
course O
of O
vancomycin B-TREATMENT
and O
levofloxacin B-TREATMENT
. O

Medications O
on O
Admission O
: O
none O

Discharge O
Medications O
: O

1. O
Morphine B-TREATMENT
Concentrate I-TREATMENT
20 O
mg O
/ O
mL O
Solution O
Sig O
: O
2.5-20 O
mg O
PO O
Q1-2H O
( O
) O
as O
needed O
for O
pain B-SYMPTOM
. O

Disp O
:* O
30 O
ml O
* O
Refills O
:* O
0 O
* O

2. O
Lorazepam B-TREATMENT
0.5 O
mg O
Tablet O
Sig O
: O
0.5-2 O
mg O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
for O
aggitation B-SYMPTOM
/ O
seizure B-SYMPTOM
: O
Please O
dispense O
liquid O
. O

Disp O
:* O
50 O
ml O
* O
Refills O
:* O
0 O
* O

3. O
Dexamethasone B-TREATMENT
4 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
Q8H O
( O
every O
8 O
hours O
) O
: O
please O
give O
8 O
mg O
suppository O
. O

Disp O
:* O
90 O
suppository O
* O
Refills O
:* O
0 O
* O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

Breast B-SYMPTOM
cancer I-SYMPTOM

Discharge O
Condition O
: O

Stable O

Discharge O
Instructions O
: O

Please O
call O
hospice O
for O
questions O
. O

Followup O
Instructions O
: O
as O
needed O

Ramirez O
Mary O
Lenora O
MD O
74-114 O

Completed O
by O
: O
Tony O
Cervantes O
MD O
43-424 O
2020-05-29 O
@ O
0951 O

Signed O
electronically O
by O
: O
DR. O
Patricia O
Noland O
on O
: O
SAT O
2020-05-30 O
9:10 O
AM O

( O
End O
of O
Report O
) O

791411240 O

PRGH O

80504780 O

383201 O

9/16/2000 O
12:00:00 O
AM O

RUPTURED B-SYMPTOM
AORTIC I-SYMPTOM
ANEURISM I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

09/16/2000 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

11/03/2000 O

PRINCIPAL O
DIAGNOSIS O
: O

RUPTURED B-SYMPTOM
PARATHYROID I-SYMPTOM
ADENOMA I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Ms. O
Shuffa O
is O
a O
73-year-old O
Portuguese O
speaking O
woman O
who O
was O
transferred O
via O
Med O
Flight O
to O
Verg O
Medical O
Center O
. O

She O
arrived O
intubated B-TREATMENT
and O
was O
hemodynamically O
stable O
despite O
concerns O
of O
a B-SYMPTOM
dissecting I-SYMPTOM
aortic I-SYMPTOM
arch I-SYMPTOM
aneurysm I-SYMPTOM
. O

She O
initially O
presented O
to O
Brottlake O
Medical O
Center O
on O
9/15/00 O
complaining O
of O
acute B-SYMPTOM
onset I-SYMPTOM
dysphasia I-SYMPTOM
to O
liquids O
and O
solids O
. O

While O
she O
was O
in O
Brottlake O
Medical O
Center O
, O
she O
developed O
new B-SYMPTOM
onset I-SYMPTOM
stridor I-SYMPTOM
, O
and O
an O
ENT O
consult O
was O
obtained O
. O

They O
attempted O
a B-TREATMENT
fiberoptic I-TREATMENT
intubation I-TREATMENT
with O
a B-TREATMENT
# I-TREATMENT
6 I-TREATMENT
endotracheal I-TREATMENT
tube I-TREATMENT
and O
found O
a B-SYMPTOM
5 I-SYMPTOM
mm I-SYMPTOM
severely I-SYMPTOM
compressed I-SYMPTOM
airway I-SYMPTOM
. O

She O
was O
also O
found O
to O
have O
a B-SYMPTOM
differential I-SYMPTOM
systolic I-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
and O
ecchymosis B-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
anterior I-SYMPTOM
chest I-SYMPTOM
. O

Given O
these O
findings O
, O
she O
underwent O
a O
CT O
scan O
which O
showed O
a B-SYMPTOM
retrotracheal I-SYMPTOM
mass I-SYMPTOM
that O
appeared O
to O
obliterate O
the O
esophagus O
. O

This O
raised O
concerns O
for O
a B-SYMPTOM
hemorrhage I-SYMPTOM
, O
and O
she O
was O
transferred O
to O
Verg O
Medical O
Center O
emergently O
. O

At O
the O
Ingree O
and O
Ot O
of O
Weamanshy O
Medical O
Center O
, O
she O
underwent O
an O
emergent O
CT O
scan O
with O
IV O
contrast O
. O

This O
revealed O
no O
extravasation B-SYMPTOM
of I-SYMPTOM
contrast I-SYMPTOM
and O
no O
aortic B-SYMPTOM
aneurysm I-SYMPTOM
. O

However O
, O
it O
did O
show O
an B-SYMPTOM
anterior I-SYMPTOM
mediastinal I-SYMPTOM
mass I-SYMPTOM
compressing O
the O
trachea O
with O
a O
density O
consistent O
with O
a B-SYMPTOM
hematoma I-SYMPTOM
. O

She O
was O
admitted O
to O
the O
Thoracic O
Surgery O
Service O
under O
the O
care O
of O
Dr. O
Sccrookes O
. O

PAST O
MEDICAL O
HISTORY O
: O

Severe B-SYMPTOM
hypertension I-SYMPTOM
, O
angina B-SYMPTOM
, O
GERD B-SYMPTOM
, O
peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
Billroth B-TREATMENT
II I-TREATMENT
, O
ovarian B-SYMPTOM
cancer I-SYMPTOM
, O
status O
post O
TAH-BSO B-TREATMENT
in O
1987 O
with O
a O
negative O
second O
look O
laparotomy O
in O
1988 O
, O
chronic B-SYMPTOM
anemia I-SYMPTOM
, O
chronic B-SYMPTOM
left I-SYMPTOM
ear I-SYMPTOM
infection I-SYMPTOM
. O

MEDICATIONS O
PRIOR O
TO O
ADMISSION O
: O

Celexa B-TREATMENT
10 O
mg O
p.o. O
q.d.; O
Lasix B-TREATMENT
40 O
mg O
p.o. O
q.d.; O
Capoten B-TREATMENT
50 O
mg O
p.o. O
b.i.d.; O
Pepcid B-TREATMENT
20 O
mg O
p.o. O
q.d.; O
Cardizem B-TREATMENT
180 O
mg O
p.o. O
q.d.; O
Xanax B-TREATMENT
0.5 O
mg O
tabs O
. O

On O
transfer O
, O
she O
was O
on O
her B-TREATMENT
preadmission I-TREATMENT
medications I-TREATMENT
plus O
Unasyn B-TREATMENT
and O
Tigan B-TREATMENT
250 O
mg O
p.o. O
q.6h. O
p.r.n. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

She O
is O
divorced O
and O
retired O
. O

She O
lives O
with O
her O
daughter O
, O
and O
denies O
any O
tobacco O
or O
alcohol O
use O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
is O
intubated B-TREATMENT
. O

VITAL O
SIGNS O
: O

Temperature O
98.6 O
, O
66 O
. O

Right O
arm O
was O
180/80 O
, O
left O
188/72 O
, O
and O
A-line O
was O
151/61 O
. O

Tidal B-TREATMENT
volume I-TREATMENT
is O
700 O
with O
a B-TREATMENT
rate I-TREATMENT
of O
10 O
, O
10 O
of O
pressure B-TREATMENT
support I-TREATMENT
, O
and O
10 O
of O
PEEP B-TREATMENT
, O
and O
100% B-TREATMENT
FiO2 I-TREATMENT
, O
satting O
100% O
. O

GENERAL O
: O

She O
was O
sedated B-TREATMENT
and O
spontaneously O
moving O
all O
four O
extremities O
. O

NECK O
: O

Edematous B-SYMPTOM
. O

Trachea O
was O
midline O
. O

She O
had O
bilateral B-SYMPTOM
crepitus I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
anterior I-SYMPTOM
neck I-SYMPTOM
. O

The O
superior O
clavicular O
area O
showed O
no O
signs O
of O
central B-TREATMENT
line I-TREATMENT
access I-TREATMENT
attempts O
. O

She O
had O
a B-SYMPTOM
3 I-SYMPTOM
cm I-SYMPTOM
mobile I-SYMPTOM
gelatinous I-SYMPTOM
well-circumscribed I-SYMPTOM
mass I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
supraclavicular I-SYMPTOM
region I-SYMPTOM
. O

Her O
anterior O
neck O
and O
chest O
had O
a B-SYMPTOM
1 I-SYMPTOM
cm I-SYMPTOM
to I-SYMPTOM
2 I-SYMPTOM
cm I-SYMPTOM
area I-SYMPTOM
of I-SYMPTOM
ecchymosis I-SYMPTOM
. O

LUNGS O
: O

She O
had O
bilateral B-SYMPTOM
expiratory I-SYMPTOM
wheezes I-SYMPTOM
. O

ABDOMEN O
: O

Soft O
with O
good O
bowel O
sounds O
. O

It O
was O
nontender B-SYMPTOM
. O

It O
was O
obese B-SYMPTOM
with O
a B-SYMPTOM
large I-SYMPTOM
midline I-SYMPTOM
defect I-SYMPTOM
consistent O
with O
a B-SYMPTOM
ventral I-SYMPTOM
hernia I-SYMPTOM
, O
as O
well O
as O
a B-SYMPTOM
smaller I-SYMPTOM
anterior I-SYMPTOM
defect I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
. O

Both O
were O
easily O
reducible O
. O

PULSE O
: O

On O
the O
right O
side O
, O
2+ O
femoral O
, O
popliteal O
, O
DP O
, O
PT O
, O
and O
radial O
; O
on O
the O
left O
side O
, O
2+ O
femoral O
, O
popliteal O
, O
DP O
, O
PT O
, O
and O
radial O
. O

LABORATORY O
DATA O
: O

CBC O
was O
8.7 O
, O
25.3 O
, O
and O
184 O
. O

Coags O
12.2 O
, O
24.8 O
, O
and O
1.0 O
. O

Her O
gas O
was O
7.47/40/332 O
. O

Electrolytes O
were O
143 O
, O
3.4 O
, O
105 O
, O
28 O
, O
24 O
, O
3 O
, O
and O
131 O
. O

EKG O
showed O
normal O
sinus O
rhythm O
with O
left B-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
and O
incomplete B-SYMPTOM
left I-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
. O

CT O
scan O
showed O
an B-SYMPTOM
anterior I-SYMPTOM
mediastinal I-SYMPTOM
mass I-SYMPTOM
compressing O
the O
trachea O
with O
air O
. O

It O
was O
consistent O
with O
a B-SYMPTOM
hematoma I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

Ms. O
Shuffa O
underwent O
an O
EGD O
and O
flexible O
bronchoscopy O
on O
9/16/00 O
shortly O
after O
she O
arrived O
. O

This O
showed O
tracheal B-SYMPTOM
compressions I-SYMPTOM
but O
no O
other B-SYMPTOM
lesions I-SYMPTOM
that O
were O
obvious O
at O
the O
time O
. O

She O
was O
hemodynamically O
stable O
and O
remained O
on O
the B-TREATMENT
ventilator I-TREATMENT
. O

The O
differential O
diagnoses O
at O
this O
point O
consisted O
of O
hematoma B-SYMPTOM
vs. O
neoplasm B-SYMPTOM
vs. O
an B-SYMPTOM
abscess I-SYMPTOM
vs. O
a B-SYMPTOM
thyroid I-SYMPTOM
tumor I-SYMPTOM
. O

On O
9/22/00 O
, O
she O
underwent O
a O
cervical O
mediastinoscopy O
. O

A O
biopsy O
of O
this B-SYMPTOM
mass I-SYMPTOM
was O
consistent O
with O
hematoma B-SYMPTOM
. O

The O
operative O
report O
shows O
that O
there O
was O
an B-SYMPTOM
abnormal I-SYMPTOM
area I-SYMPTOM
below I-SYMPTOM
the I-SYMPTOM
trachea I-SYMPTOM
to O
the O
left O
which O
represented O
a O
cavity O
between O
the O
esophagus O
, O
trachea O
, O
aorta O
, O
and O
spine O
that O
was O
full O
of O
clot B-SYMPTOM
. O

There O
was O
no O
active B-SYMPTOM
bleeding I-SYMPTOM
at O
the O
time O
. O

Over O
the O
next O
several O
days O
, O
the O
patient O
remained O
hemodynamically O
stable O
on O
the B-TREATMENT
ventilator I-TREATMENT
. O

She O
had O
an B-SYMPTOM
elevated I-SYMPTOM
calcium I-SYMPTOM
level I-SYMPTOM
that O
raised O
the O
suspicion O
that O
this B-SYMPTOM
mass I-SYMPTOM
could O
be O
a B-SYMPTOM
hematoma I-SYMPTOM
coming O
from O
a B-SYMPTOM
ruptured I-SYMPTOM
parathyroid I-SYMPTOM
adenoma I-SYMPTOM
. O

The O
ionized O
calcium O
was O
elevated B-SYMPTOM
as O
was O
the O
parathormone O
level O
. O

Given O
these O
findings O
, O
she O
underwent O
a O
Sestamibi O
scan O
. O

The O
Sestamibi O
scan O
showed O
findings O
that O
were O
consistent O
with O
a B-SYMPTOM
parathyroid I-SYMPTOM
adenoma I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lobe I-SYMPTOM
of O
the O
thyroid O
. O

At O
this O
time O
, O
it O
was O
believed O
that O
her B-SYMPTOM
clot I-SYMPTOM
was O
due O
to O
a B-SYMPTOM
rupture I-SYMPTOM
of O
this B-SYMPTOM
parathyroid I-SYMPTOM
adenoma I-SYMPTOM
. O

Dr. O
Ear O
brought O
the O
patient O
to O
the O
operating O
room O
on O
10/5/00 O
. O

She O
underwent O
a O
parathyroid O
exploration O
with O
resection B-TREATMENT
of O
a B-SYMPTOM
ruptured I-SYMPTOM
ectopic I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
parathyroid I-SYMPTOM
adenoma I-SYMPTOM
, O
a O
biopsy O
of O
a O
normal O
left O
and O
right O
lower O
parathyroids O
, O
resection B-TREATMENT
of I-TREATMENT
a I-TREATMENT
left I-TREATMENT
upper I-TREATMENT
parathyroid I-TREATMENT
, O
and O
tracheostomy B-TREATMENT
. O

She O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
and O
was O
transferred O
back O
to O
the O
Surgical O
Intensive O
Care O
Unit O
with O
her B-TREATMENT
new I-TREATMENT
tracheostomy I-TREATMENT
working O
well O
. O

Her O
postoperative O
course O
was O
complicated O
by O
serosanguineous B-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
. O

This O
required O
a B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
. O

Her O
hematocrit O
continued O
to O
drop O
over O
the O
next O
couple O
of O
days O
despite O
normal O
platelet O
count O
, O
normal O
coags O
, O
and O
no O
obvious O
source O
of O
bleeding B-SYMPTOM
. O

It O
was O
believed O
that O
she O
was O
continuing O
to O
bleed B-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
chest I-SYMPTOM
. O

However O
, O
we O
are O
not O
quite O
sure O
why O
this O
was O
occurring O
. O

She O
underwent O
an O
extensive O
workup O
by O
Hematology O
that O
revealed O
a B-SYMPTOM
bleeding I-SYMPTOM
diatheses I-SYMPTOM
of O
unknown O
etiology O
. O

It O
turns O
out O
that O
several O
people O
in O
her O
family O
have O
a B-SYMPTOM
similar I-SYMPTOM
bleeding I-SYMPTOM
diathesis I-SYMPTOM
of O
unknown O
etiology O
. O

In O
conclusion O
, O
by O
systems O
: O

1. O
Neuro O
. O

The O
patient O
became O
intermittently B-SYMPTOM
agitated I-SYMPTOM
. O

We O
have O
been O
giving O
her B-TREATMENT
Haldol I-TREATMENT
at O
bedtime O
as O
well O
as O
Ativan B-TREATMENT
p.r.n. O
throughout O
the O
day O
. O

She O
responds O
well O
to O
this O
. O

She O
speaks O
some O
English O
and O
seems O
to O
understand O
more O
than O
she O
speaks O
. O

She O
has O
a O
family O
member O
who O
is O
present O
for O
approximately O
12 O
hours O
each O
day O
. O

She O
has O
been O
very O
helpful O
in O
translating O
and O
seems O
to O
say O
that O
Ms. O
Shuffa O
is O
in O
good O
spirits O
. O

2. O
Cardiac O
. O

The O
patient O
&apos;s O
blood O
pressure O
has O
been O
ranging O
from O
approximately O
140 O
to O
160 O
systolic O
. O

This O
is O
on O
a O
current O
regimen O
of O
Lopressor B-TREATMENT
25 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
t.i.d. O
as O
well O
as O
Diltiazem B-TREATMENT
60 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
t.i.d. O
, O
and O
lisinopril B-TREATMENT
10 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
q.d. O
She O
occasionally O
gets O
hypertensive B-SYMPTOM
when O
she O
is O
agitated B-SYMPTOM
. O

For O
this O
, O
we O
have O
given O
her O
10 O
mg O
of O
hydralazine B-TREATMENT
. O

Her O
blood O
pressure O
responds O
well O
to O
this O
. O

Otherwise O
, O
she O
is O
in O
normal O
sinus O
rhythm O
and O
has O
been O
hemodynamically O
stable O
throughout O
her O
hospitalization O
. O

The O
patient O
developed O
a B-SYMPTOM
left I-SYMPTOM
femoral I-SYMPTOM
artery I-SYMPTOM
pseudoaneurysm I-SYMPTOM
after O
placement B-TREATMENT
of I-TREATMENT
a I-TREATMENT
Greenfield I-TREATMENT
filter I-TREATMENT
. O

This O
has O
been O
followed O
by O
the O
Vascular O
Surgery O
Service O
here O
at O
the O
Ingree O
and O
Ot O
of O
Weamanshy O
Medical O
Center O
. O

Dr. O
Lenni O
Lung O
has O
been O
consulted O
. O

The B-SYMPTOM
aneurysm I-SYMPTOM
at O
the O
time O
of O
discharge O
is O
approximately O
2.5 O
cm O
. O

They O
elected O
not O
to O
inject O
it O
with O
thrombin B-TREATMENT
. O

They O
asked O
that O
the O
patient O
follow-up O
with O
Dr. O
Ear O
in O
approximately O
three O
to O
four O
weeks O
so O
that O
this B-SYMPTOM
aneurysm I-SYMPTOM
can O
be O
assessed O
. O

They O
have O
opted O
for O
conservative O
management O
given O
the O
size O
. O

3. O
Respiratory O
. O

At O
the O
time O
of O
discharge O
, O
the O
patient O
remained O
on O
CPAP B-TREATMENT
with O
a B-TREATMENT
PEEP I-TREATMENT
of O
7.5 O
and O
a B-TREATMENT
pressure I-TREATMENT
support I-TREATMENT
of O
9 O
. O

She O
seems O
to O
be O
tolerating O
this O
well O
as O
she O
has O
an O
O2 O
sat O
of O
100% O
on O
40% B-TREATMENT
FIO2 I-TREATMENT
. O

Her O
chest O
x-ray O
shows O
a B-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
hematoma I-SYMPTOM
that O
had O
greatly O
improved O
in O
the O
last O
few O
days O
. O

Her O
right O
lung O
field O
is O
clear O
. O

Her B-TREATMENT
tracheostomy I-TREATMENT
is O
functioning O
well O
, O
and O
we O
have O
had O
no O
problems B-SYMPTOM
with O
it O
. O

She O
will O
obviously O
need O
to O
be O
weaned O
as O
tolerated O
. O

We O
had O
her O
down O
to O
a B-TREATMENT
low I-TREATMENT
pressure I-TREATMENT
support I-TREATMENT
of O
7 O
in O
the O
last O
week O
. O

With O
the B-TREATMENT
pressure I-TREATMENT
support I-TREATMENT
at O
7 O
, O
she O
became O
tachypneic B-SYMPTOM
and O
had O
to O
be O
brought O
back O
up O
to O
10 O
. O

Her O
oxygen O
saturation O
has O
always O
been O
good O
. O

4. O
GI O
. O

The O
patient O
is O
getting O
tube B-TREATMENT
feeds I-TREATMENT
via O
her B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
of O
full B-TREATMENT
strength I-TREATMENT
Jevity I-TREATMENT
of O
75 O
cc O
per O
hour O
. O

This O
is O
her O
goal O
. O

She O
tolerates O
them O
very O
well O
and O
has O
approximately O
200 O
cc O
to O
300 O
cc O
of O
stool O
per O
day O
. O

Last O
week O
, O
she O
had O
copious B-SYMPTOM
amounts I-SYMPTOM
of I-SYMPTOM
stool I-SYMPTOM
in O
the O
range O
of O
500 O
cc O
to O
1000 O
cc O
of O
liquid O
stool O
per O
day O
. O

Stool O
cultures O
have O
been O
sent O
numerous O
times O
as O
well O
as O
analysis O
for O
C. B-SYMPTOM
difficile I-SYMPTOM
toxin I-SYMPTOM
. O

These O
have O
all O
been O
negative O
. O

We O
believe O
the O
this O
was O
an B-SYMPTOM
osmotic I-SYMPTOM
diarrhea I-SYMPTOM
. O

Since O
her B-TREATMENT
tube I-TREATMENT
feeds I-TREATMENT
have O
been O
changed O
from O
full B-TREATMENT
strength I-TREATMENT
Nephro I-TREATMENT
to O
Jevity B-TREATMENT
, O
her B-SYMPTOM
diarrhea I-SYMPTOM
has O
resolved O
. O

She O
has O
been O
taking O
Zantac B-TREATMENT
, O
and O
the O
pH O
of O
her O
NG O
tube O
residuals O
have O
been O
in O
the O
5 O
to O
8 O
range O
. O

5. O
GU O
. O

The O
patient O
has O
had O
hypernatremia B-SYMPTOM
. O

She O
is O
approximately O
10 O
kg O
up O
her O
overall O
body O
weight O
. O

We O
believe O
her O
to O
still O
be O
total B-SYMPTOM
body I-SYMPTOM
overloaded I-SYMPTOM
. O

Over O
the O
last O
several O
days O
, O
we O
have O
been O
giving O
her O
approximately O
500 O
cc O
to O
1000 O
cc O
of O
free B-TREATMENT
water I-TREATMENT
through O
her B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
. O

We O
also O
have O
been O
diuresing O
her O
with O
Bumex B-TREATMENT
. O

This O
seems O
to O
trend O
her O
sodium O
down O
. O

This O
will O
need O
to O
be O
monitored O
closely O
. O

Her O
BUN O
and O
creatinine O
have O
been O
normal O
, O
and O
she O
has O
always O
made O
good O
urine O
. O

6. O
Heme O
. O

As O
stated O
before O
, O
the O
patient O
continued O
to O
ooze O
into O
her O
pleural O
space O
well O
after O
her B-TREATMENT
definitive I-TREATMENT
operation I-TREATMENT
. O

She O
had O
an O
extensive O
workup O
by O
Hematology O
which O
revealed O
a B-SYMPTOM
bleeding I-SYMPTOM
diathesis I-SYMPTOM
of O
unknown O
origin O
. O

Before O
we O
removed O
her B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
, O
we O
had O
to O
give O
her B-TREATMENT
platelets I-TREATMENT
. O

She O
had O
no O
problems B-SYMPTOM
with O
this O
. O

At O
the O
time O
of O
discharge O
, O
her O
hematocrit O
is O
stable O
in O
the O
28 O
to O
33 O
range O
. O

I O
stress O
that O
she O
cannot O
be O
anticoagulated B-TREATMENT
. O

We O
have O
given O
her B-TREATMENT
Lovenox I-TREATMENT
in O
the O
past O
, O
and O
she O
continues O
to O
bleed O
. O

Therefore O
, O
she O
is O
on O
no O
DVT B-TREATMENT
prophylaxis I-TREATMENT
. O

She O
does O
have O
a B-SYMPTOM
left I-SYMPTOM
iliac I-SYMPTOM
deep I-SYMPTOM
vein I-SYMPTOM
thrombosis I-SYMPTOM
. O

She O
has O
a B-TREATMENT
Greenfield I-TREATMENT
filter I-TREATMENT
in O
place O
, O
and O
this O
is O
her O
only O
DVT B-TREATMENT
prophylaxis I-TREATMENT
. O

7. O
ID O
. O

At O
the O
time O
of O
discharge O
, O
the O
patient O
has O
a B-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

She O
is O
growing O
Enterobacter B-SYMPTOM
cloacae I-SYMPTOM
that O
is O
sensitive O
only O
to O
Macrodantin B-TREATMENT
from O
her O
urine O
cultures O
. O

Interestingly O
enough O
, O
she O
also O
has O
Enterobacter B-SYMPTOM
cloacae I-SYMPTOM
growing O
out O
of O
her O
sputum O
. O

This O
is O
also O
sensitive O
only O
to O
Macrodantin B-TREATMENT
. O

We O
do O
not O
believe O
that O
she O
has O
any B-SYMPTOM
respiratory I-SYMPTOM
process I-SYMPTOM
going O
on O
at O
the O
time O
. O

She O
is O
just O
begun O
on O
Macrodantin B-TREATMENT
at O
the O
day O
of O
discharge O
and O
should O
continue O
100 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
q.i.d. O
for O
a O
ten O
day O
course O
. O

Her B-TREATMENT
Foley I-TREATMENT
was O
changed O
the O
day O
before O
discharge O
. O

8. O
Tubes B-TREATMENT
, O
lines B-TREATMENT
, O
and O
drains B-TREATMENT
. O

The O
patient O
has O
a B-TREATMENT
tracheostomy I-TREATMENT
, O
NG B-TREATMENT
tube I-TREATMENT
, O
and O
a B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
. O

Her B-TREATMENT
central I-TREATMENT
line I-TREATMENT
, O
which O
was O
left B-TREATMENT
subclavian I-TREATMENT
quad I-TREATMENT
lumen I-TREATMENT
, O
was O
removed O
on O
the O
day O
of O
discharge O
. O

DISCHARGE O
MEDICATIONS O
: O

Albuterol B-TREATMENT
nebulizers I-TREATMENT
2.5 O
mg O
q.4h. O
and O
Atrovent B-TREATMENT
nebulizers I-TREATMENT
0.5 O
mg O
q.4h. O
, O
please O
alternate O
albuterol B-TREATMENT
and O
Atrovent B-TREATMENT
; O
Rocaltrol B-TREATMENT
0.25 O
mcg O
per O
NG B-TREATMENT
tube I-TREATMENT
q.d.; O
calcium B-TREATMENT
carbonate I-TREATMENT
1250 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
q.i.d.; O
vitamin B-TREATMENT
B12 I-TREATMENT
1000 O
mcg O
IM O
q. O
month O
, O
next O
dose O
is O
due O
Nov O
18 O
; O
diltiazem B-TREATMENT
60 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
t.i.d.; O
ferrous B-TREATMENT
sulfate I-TREATMENT
300 O
mg O
per O
NG B-TREATMENT
t.i.d.; O
Haldol B-TREATMENT
5 O
mg O
IV O
q.h.s.; O
hydralazine B-TREATMENT
10 O
mg O
IV O
q.6h. O
p.r.n. O
hypertension B-SYMPTOM
; O
lisinopril B-TREATMENT
10 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
q.d.; O
Ativan B-TREATMENT
1 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
q.h.s.; O
Lopressor B-TREATMENT
25 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
t.i.d.; O
Zantac B-TREATMENT
150 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
b.i.d.; O
multivitamin B-TREATMENT
10 O
ml O
per O
NG B-TREATMENT
tube I-TREATMENT
q.d.; O
Macrodantin B-TREATMENT
100 O
mg O
per O
NG B-TREATMENT
tube I-TREATMENT
q.i.d. O
x O
10 O
days O
beginning O
on O
11/3/00 O
. O

CONDITION O
: O

Stable O
, O
with O
active B-SYMPTOM
problems I-SYMPTOM
being O
respiratory B-SYMPTOM
failure I-SYMPTOM
, O
urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
, O
and O
bleeding B-SYMPTOM
diathesis I-SYMPTOM
. O

DISCHARGE O
LABS O
: O

On O
the O
day O
of O
discharge O
, O
sodium O
145 O
, O
potassium O
4.1 O
, O
chloride O
109 O
, O
bicarb O
31 O
, O
creatinine O
0.7 O
, O
BUN O
43 O
, O
glucose O
116 O
. O

CBC O
14.9 O
, O
29.2 O
( O
which O
is O
stable O
) O
, O
and O
398 O
. O

PT O
12 O
, O
PTT O
27 O
, O
and O
INR O
1.0 O
. O

Magnesium O
of O
1.9 O
. O

Calcium O
8.1 O
. O

COMPLICATIONS O
: O

None O
. O

DISPOSITION O
: O

The O
patient O
is O
being O
discharged O
to O
an O
acute O
rehab O
facility O
. O

She O
should O
follow-up O
with O
Dr. O
Ryna O
Jescdrig O
as O
well O
as O
Dr. O
Lenni O
Lung O
in O
the O
Vascular O
Surgery O
Department O
in O
approximately O
three O
to O
four O
weeks O
. O

Please O
call O
the O
Surgical O
Intensive O
Care O
Unit O
at O
Verg O
Medical O
Center O
for O
any O
further O
details O
that O
may O
be O
needed O
. O

You O
can O
also O
page O
Sta O
Lung O
, O
M.D. O
as O
I O
am O
the O
dictating O
physician O
who O
has O
been O
taking O
care O
of O
Ms. O
Shuffa O
for O
quite O
some O
time O
now O
. O

I O
would O
be O
happy O
to O
answer O
any O
questions O
. O

My O
pager O
number O
at O
Verg O
Medical O
Center O
is O
number O
54930 O
. O

Dictated O
By O
: O

STA O
LUNG O
, O
M.D. O
HU53 O

Attending O
: O

RYNA O
R. O
JESCDRIG O
, O
M.D. O
GN3 O
QE555/1531 O

Batch O
: O

77428 O

Index O
No. O
DXXJ8U8529 O

D O
: O

11/03/00 O

T O
: O

11/03/00 O

186890029 O

SH O

58809909 O

1/5/1994 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

01/05/1994 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

01/25/1994 O

PRINCIPLE O
DIAGNOSIS O
: O

METASTATIC B-SYMPTOM
ADENOCARCINOMA I-SYMPTOM
OF I-SYMPTOM
THE I-SYMPTOM
BREAST I-SYMPTOM
. O

OTHER O
PROBLEMS O
: O

1. O
HYPONATREMIA B-SYMPTOM
, O
1-13-94 O
. O

2. O
PULMONARY B-SYMPTOM
EMBOLUS I-SYMPTOM
, O
1-14-94 O
. O

3. O
DIARRHEA B-SYMPTOM
, O
NAUSEA B-SYMPTOM
AND O
VOMITING B-SYMPTOM
, O
FEVER B-SYMPTOM
. O

4. O
HISTORY O
OF O
OVARIAN B-TREATMENT
CYST I-TREATMENT
RESECTION I-TREATMENT
, O
1975 O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
49 O
year O
old O
woman O
with O
a B-SYMPTOM
metastatic I-SYMPTOM
adenocarcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
breast I-SYMPTOM
who O
is O
status O
post O
high B-TREATMENT
dose I-TREATMENT
chemotherapy I-TREATMENT
with O
PBSE B-TREATMENT
and O
CCSS B-TREATMENT
support I-TREATMENT
ending O
June O
1994 O
. O

She O
was O
admitted O
on O
1-5-94 O
for O
fever B-SYMPTOM
, O
chest B-SYMPTOM
wall I-SYMPTOM
ulceration I-SYMPTOM
, O
cellulitis B-SYMPTOM
and O
pain B-TREATMENT
control I-TREATMENT
. O

The O
patient O
first O
presented O
in O
October O
1991 O
with O
a B-SYMPTOM
tender I-SYMPTOM
right I-SYMPTOM
axillary I-SYMPTOM
mass I-SYMPTOM
. O

A O
mammogram O
done O
in O
November O
1990 O
was O
negative O
. O

However O
, O
mammography O
repeated O
in O
October O
1991 O
showed O
bilateral B-SYMPTOM
breast I-SYMPTOM
masses I-SYMPTOM
, O
suspicious O
for O
carcinoma B-SYMPTOM
. O

Fine O
needle O
aspiration O
on O
October O
23 O
, O
1991 O
demonstrated O
atypical B-SYMPTOM
cells I-SYMPTOM
which O
occurred O
singly O
and O
in O
clusters O
. O

Staging O
evaluation O
included O
normal O
liver O
function O
tests O
, O
normal O
blood O
counts O
and O
normal O
chest O
x-ray O
. O

Bone O
scan O
showed O
degenerative B-SYMPTOM
joint I-SYMPTOM
disease I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
shoulders I-SYMPTOM
and I-SYMPTOM
lumbar I-SYMPTOM
spine I-SYMPTOM
as O
well O
as O
increased B-SYMPTOM
radio I-SYMPTOM
chaser I-SYMPTOM
uptake I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
breast I-SYMPTOM
bilaterally I-SYMPTOM
. O

Dr. O
Berca O
Gachfrum O
performed O
a B-TREATMENT
right I-TREATMENT
modified I-TREATMENT
mastectomy I-TREATMENT
and O
left B-TREATMENT
simple I-TREATMENT
mastectomy I-TREATMENT
on O
November O
4 O
, O
1991 O
. O

The B-TREATMENT
right I-TREATMENT
modified I-TREATMENT
radical I-TREATMENT
mastectomy I-TREATMENT
contained O
a B-SYMPTOM
5.5 I-SYMPTOM
cm I-SYMPTOM
poorly I-SYMPTOM
differentiated I-SYMPTOM
, I-SYMPTOM
Grade I-SYMPTOM
III I-SYMPTOM
out I-SYMPTOM
of I-SYMPTOM
III I-SYMPTOM
infiltrating I-SYMPTOM
ductal I-SYMPTOM
carcinoma I-SYMPTOM
. O

The O
margins O
were O
free O
of O
tumor B-SYMPTOM
, O
but O
10 O
out O
of O
21 O
lymph O
nodes O
were O
positive O
for O
metastatic B-SYMPTOM
carcinoma I-SYMPTOM
. O

Furthermore O
there O
was O
a B-SYMPTOM
mass I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
pectoralis I-SYMPTOM
muscle I-SYMPTOM
which O
is O
supposed O
to O
be O
metastatic B-SYMPTOM
cancer I-SYMPTOM
. O

The B-TREATMENT
left I-TREATMENT
simple I-TREATMENT
mastectomy I-TREATMENT
also O
contained O
5.5 B-SYMPTOM
cm I-SYMPTOM
poorly I-SYMPTOM
differentiated I-SYMPTOM
infiltrating I-SYMPTOM
ductal I-SYMPTOM
and I-SYMPTOM
intraductal I-SYMPTOM
carcinoma I-SYMPTOM
with O
extensive B-SYMPTOM
lymphatic I-SYMPTOM
vessel I-SYMPTOM
invasion I-SYMPTOM
. O

Estrogen O
receptor O
was O
0% O
by O
ERICA O
. O

The O
patient O
developed O
a B-SYMPTOM
large I-SYMPTOM
hematoma I-SYMPTOM
requiring O
surgical B-TREATMENT
drainage I-TREATMENT
. O

Therefore O
she O
had O
a B-SYMPTOM
Stage I-SYMPTOM
III-A I-SYMPTOM
adenocarcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
breast I-SYMPTOM
. O

Since O
she O
was O
at O
high O
risk O
for O
both O
local B-SYMPTOM
and I-SYMPTOM
metastatic I-SYMPTOM
recurrence I-SYMPTOM
of O
her B-SYMPTOM
tumor I-SYMPTOM
, O
she O
received O
both O
systemic B-TREATMENT
chemotherapy I-TREATMENT
and O
radiation B-TREATMENT
therapy I-TREATMENT
. O

The O
patient O
was O
treated O
with O
CMSAP B-TREATMENT
, O
which O
is O
Cytoxan B-TREATMENT
, O
Methotrexate B-TREATMENT
, O
Leukovoranrescue B-TREATMENT
, O
5-FU B-TREATMENT
, O
Adriamycin B-TREATMENT
and O
Prednisone B-TREATMENT
for O
four O
cycles O
. O

There O
were O
no O
dose O
reductions O
for O
mucositis B-SYMPTOM
or O
myelosuppression B-SYMPTOM
. O

However O
, O
following O
cycle O
4 O
, O
she O
developed O
a B-SYMPTOM
flu-like I-SYMPTOM
illness I-SYMPTOM
, O
followed O
by O
fever B-SYMPTOM
, O
nonproductive B-SYMPTOM
cough I-SYMPTOM
and O
dyspnea B-SYMPTOM
on O
exertion O
. O

ABGs O
showed O
a O
pO2 O
of O
79 O
, O
pH O
7.44 O
, O
pO2 O
33 O
. O

Chest O
x-ray O
showed O
diffuse B-SYMPTOM
interstitial I-SYMPTOM
infiltrates I-SYMPTOM
. O

The O
differential O
diagnosis O
included O
viral B-SYMPTOM
pneumonitis I-SYMPTOM
, O
Mycoplasma B-SYMPTOM
, O
Chlamydia B-SYMPTOM
. O

Basically O
in O
December O
1993 O
, O
she O
returned O
to O
the O
Hem O
/ O
Onc O
Clinic O
with O
chest B-SYMPTOM
wall I-SYMPTOM
nodules I-SYMPTOM
which O
turned O
out O
to O
be O
tumor B-SYMPTOM
recurrences I-SYMPTOM
and O
biopsied O
. O

Although O
she O
had O
mediastinal B-SYMPTOM
recurrence I-SYMPTOM
, O
bone O
scan O
, O
head O
and O
liver O
CT O
were O
negative O
for O
metastatic B-SYMPTOM
disease I-SYMPTOM
. O

She O
was O
thus O
started O
on O
a O
Protocol O
of O
high B-TREATMENT
dose I-TREATMENT
chemotherapy I-TREATMENT
with O
GCSF B-TREATMENT
and O
peripheral B-TREATMENT
stem I-TREATMENT
cell I-TREATMENT
support I-TREATMENT
. O

Complications B-SYMPTOM
has O
mainly O
included O
myelosuppression B-SYMPTOM
and O
mucositis B-SYMPTOM
. O

She O
also O
developed O
Klebsiella B-SYMPTOM
UTI I-SYMPTOM
after O
the O
second O
cycle O
of O
high B-TREATMENT
dose I-TREATMENT
chemotherapy I-TREATMENT
. O

It O
was O
treated O
with O
gent B-TREATMENT
and O
Cipro B-TREATMENT
. O

Re-staging O
done O
in O
April O
1993 O
showed O
a B-SYMPTOM
decrease I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
pretracheal I-SYMPTOM
nodes I-SYMPTOM
with O
question O
of O
some B-SYMPTOM
lymphangitic I-SYMPTOM
spread I-SYMPTOM
versus O
some B-SYMPTOM
pneumonitis I-SYMPTOM
. O

In O
May O
1994 O
she O
received O
her O
first O
course O
of O
thiotepa B-TREATMENT
and O
Velban B-TREATMENT
and O
Methotrexate B-TREATMENT
, O
which O
required O
some B-TREATMENT
red I-TREATMENT
cell I-TREATMENT
transfusions I-TREATMENT
. O

In O
mid O
May O
she O
was O
admitted O
for O
fever B-SYMPTOM
and O
neutropenia B-SYMPTOM
and O
at O
that O
time O
had O
a B-SYMPTOM
UTI I-SYMPTOM
with O
blood B-SYMPTOM
clots I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
urine I-SYMPTOM
. O

The O
patient O
presents O
today O
with O
complaints O
of O
fever B-SYMPTOM
and O
a O
temperature O
of O
100 O
. O

She O
has O
also O
been O
having O
diarrhea B-SYMPTOM
since O
November O
and O
her O
other O
complaints O
of O
admission O
include O
confusion B-SYMPTOM
, O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
. O

We O
will O
include O
a O
very O
thorough O
HPI O
with O
this O
dictation O
that O
was O
done O
by O
Dr. O
Wedleung O
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
for O
metastatic B-SYMPTOM
breast I-SYMPTOM
cancer I-SYMPTOM
, O
complicated O
by O
fever B-SYMPTOM
and O
neutropenia B-SYMPTOM
. O

UTIs B-SYMPTOM
, O
obstruction B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
subclavian I-SYMPTOM
vein I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
brachial I-SYMPTOM
cephalic I-SYMPTOM
vein I-SYMPTOM
, O
herpes B-SYMPTOM
zoster I-SYMPTOM
. O

Status O
post O
ovarian B-TREATMENT
cyst I-TREATMENT
resection I-TREATMENT
in O
1975 O
. O

She O
had O
menarche O
at O
age O
15 O
. O

She O
used O
the B-TREATMENT
pill I-TREATMENT
for O
five O
years O
in O
the O
past O
. O

She O
is O
G O
2 O
, O
P O
2 O
with O
spontaneous B-TREATMENT
vaginal I-TREATMENT
deliveries I-TREATMENT
. O

She O
has O
a O
history O
of O
easy B-SYMPTOM
bruis I-SYMPTOM
ability I-SYMPTOM
. O

She O
is O
allergic B-SYMPTOM
to O
Augmentin B-TREATMENT
which O
gives O
her O
a B-SYMPTOM
rash I-SYMPTOM
. O

MEDICATIONS O
: O

MS B-TREATMENT
Contin I-TREATMENT
, O
MSIR B-TREATMENT
, O
and O
Percocet B-TREATMENT
. I-TREATMENT

FAMILY O
HISTORY O
: O

Noncontributory O
. O

SOCIAL O
HISTORY O
: O

Married O
with O
two O
children O
. O

She O
worked O
as O
an O
occupational O
therapist O
at O
a O
professional O
center O
for O
handicapped O
children O
. O

She O
denies O
tobacco O
and O
drug O
use O
and O
drinks O
ethanol O
socially O
. O

PHYSICAL O
EXAMINATION O
: O

A O
cachectic O
white O
female O
. O

T O
100.1 O
, O
P O
104 O
, O
blood O
pressure O
130/90 O
, O
heart O
rate O
of O
16 O
, O
she O
was O
sating O
95% O
on O
room O
air O
. O

HEENT O
- O
Pupils O
were O
miotic B-SYMPTOM
, O
measuring O
2 O
mm O
but O
responsive O
to O
light O
. O

Neck O
- O
Tender B-SYMPTOM
on O
the O
leftside O
with O
no O
lymphadenopathy B-SYMPTOM
or O
thyromegaly B-SYMPTOM
. O

Lungs O
were O
clear O
. O

Chest O
actually O
had O
a B-SYMPTOM
5 I-SYMPTOM
x I-SYMPTOM
7 I-SYMPTOM
cm I-SYMPTOM
necrotic I-SYMPTOM
area I-SYMPTOM
on O
the O
left O
chest O
wall O
with O
some B-SYMPTOM
pus I-SYMPTOM
. O

Cardiovascular O
- O
Normal O
. O

Abdomen O
- O
Normal O
. O

There O
was O
no O
HSM B-SYMPTOM
. O

Extremities O
- O
Her O
left O
arm O
was O
very B-SYMPTOM
swollen I-SYMPTOM
. O

It O
was O
tested O
with O
no B-SYMPTOM
voluntary I-SYMPTOM
movement I-SYMPTOM
except O
at O
the O
finger O
tips O
. O

There O
was O
no O
edema B-SYMPTOM
elsewhere O
in O
her O
extremities O
, O
only O
the O
left O
arm O
. O

Neuro O
- O
The O
patient O
was O
oriented O
to O
place O
, O
but O
had O
difficulty B-SYMPTOM
with I-SYMPTOM
recent I-SYMPTOM
memory I-SYMPTOM
. O

She O
also O
had O
mild B-SYMPTOM
weakness I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
extremities I-SYMPTOM
, O
both O
upper O
and O
lower O
. O

Cranial O
nerves O
II O
- O
XII O
were O
grossly O
intact O
. O

Toes O
were O
downgoing O
. O

LABORATORY O
DATA O
: O

Of O
note O
- O
Na O
133 O
, O
K O
4 O
, O
WBC O
8.82 O
, O
hematocrit O
35.1 O
, O
platelets O
229 O
. O

PT O
13.8 O
with O
an O
INR O
of O
1.3 O
, O
PTT O
25.5 O
, O
total O
protein O
was O
6.2 O
, O
albumin O
3.4 O
, O
globulin O
of O
2.8 O
, O
calcium O
of O
9.1 O
, O
phos O
2.7 O
, O
mag O
2.1 O
, O
urea O
3.7 O
. O

ALT O
was O
elevated B-SYMPTOM
at O
240 O
, O
AST O
85 O
, O
LDH O
305 O
, O
alk O
phos O
85 O
, O
total O
bilirubin O
was O
1.3 O
, O
direct O
bili O
was O
.8 O
. O

Cholesterol O
188 O
, O
triglyceride O
was O
127 O
. O

UA O
- O
trace B-SYMPTOM
protein I-SYMPTOM
, O
trace B-SYMPTOM
ketones I-SYMPTOM
, O
positive B-SYMPTOM
for I-SYMPTOM
bilirubin I-SYMPTOM
and I-SYMPTOM
nitrogen I-SYMPTOM
and O
also O
4 B-SYMPTOM
to I-SYMPTOM
6 I-SYMPTOM
wbcs I-SYMPTOM
with O
1+ B-SYMPTOM
bacteria I-SYMPTOM
. O

Chest O
x-ray O
- O
Showed O
a B-SYMPTOM
left I-SYMPTOM
paratracheal I-SYMPTOM
adenopathy I-SYMPTOM
and O
small B-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
with O
no O
evidence O
of O
pneumonia B-SYMPTOM
. O

In O
summary O
, O
the O
patient O
is O
a O
49 O
year O
old O
woman O
with O
metastatic B-SYMPTOM
breast I-SYMPTOM
cell I-SYMPTOM
CA I-SYMPTOM
, O
status O
post O
chemotherapy B-TREATMENT
with O
CMSAP B-TREATMENT
and O
PVSC B-TREATMENT
and O
XRT B-TREATMENT
who O
presented O
with O
fever B-SYMPTOM
, O
four O
days O
of O
diarrhea B-SYMPTOM
, O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
and O
had O
been O
on O
Keflex B-TREATMENT
for O
an B-SYMPTOM
erythema I-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
left I-SYMPTOM
chest I-SYMPTOM
wall I-SYMPTOM
. O

The B-TREATMENT
Keflex I-TREATMENT
was O
stopped O
when O
she O
developed O
the B-SYMPTOM
diarrhea I-SYMPTOM
. O

When O
she O
arrived O
the O
plan O
was O
to O
go O
ahead O
and O
treat O
here B-SYMPTOM
rythematous I-SYMPTOM
induration I-SYMPTOM
and O
possible O
cellulitis B-SYMPTOM
with O
IV B-TREATMENT
antibiotics I-TREATMENT
. O

So O
she O
was O
put O
on O
dicloxicillin B-TREATMENT
and O
we O
did O
local B-TREATMENT
wound I-TREATMENT
care I-TREATMENT
with O
an B-TREATMENT
agent I-TREATMENT
called O
Santyl B-TREATMENT
, O
which O
is O
a B-TREATMENT
collagenace I-TREATMENT
ondebrided I-TREATMENT
which O
worked O
very O
well O
for O
her O
. O

Also O
at O
the O
time O
of O
admission O
we O
were O
also O
considering O
palliative B-TREATMENT
Taxol I-TREATMENT
chemotherapy I-TREATMENT
, O
which O
the O
patient O
declined O
. O

She O
refused O
the B-TREATMENT
Taxol I-TREATMENT
therapy I-TREATMENT
so O
that O
was O
not O
done O
. O

Another O
major O
issue O
with O
this O
patient O
was O
pain B-TREATMENT
control I-TREATMENT
. O

She O
had O
been O
in O
a O
whole O
lot O
of O
pain B-SYMPTOM
from O
her B-SYMPTOM
left I-SYMPTOM
arm I-SYMPTOM
lesion I-SYMPTOM
. O

So O
pain B-TREATMENT
control I-TREATMENT
was O
a O
big O
issue O
so O
she O
was O
on O
MS B-TREATMENT
Contin I-TREATMENT
and O
MSIR B-TREATMENT
at O
home O
she O
thought O
that O
clouded O
her O
thinking O
, O
so O
we O
tried O
different O
things O
for O
pain B-TREATMENT
management I-TREATMENT
. O

One O
of O
them O
was O
to O
do O
a B-TREATMENT
subarachnoid I-TREATMENT
neurologic I-TREATMENT
block I-TREATMENT
at I-TREATMENT
C6-C7 I-TREATMENT
interface I-TREATMENT
on O
1-6-94 O
. O

After O
that O
the O
patient O
had O
minimal O
relief O
of O
pain B-SYMPTOM
. O

However O
, O
she O
declined O
further B-TREATMENT
blocks I-TREATMENT
, O
which O
were O
offered O
to O
her O
. O

So O
accepted O
to O
be O
on O
dilaudid B-TREATMENT
p.o. I-TREATMENT
which O
was O
started O
at O
a O
dosage O
of O
2-4 O
meg O
but O
since O
then O
we O
have O
tapered O
it O
up O
. O

She O
is O
now O
getting O
dilaudid B-TREATMENT
8 O
mg O
q2h O
and O
in O
addition O
she O
has O
been O
on O
fentanyl B-TREATMENT
patch I-TREATMENT
. O

She O
is O
now O
getting O
75 O
micrograms O
per O
hour O
of O
the B-TREATMENT
fentanyl I-TREATMENT
patch I-TREATMENT
which O
is O
changed O
every O
72 O
hours O
. O

We O
can O
go O
up O
by O
25 O
mg O
on O
the B-TREATMENT
fentanyl I-TREATMENT
patch I-TREATMENT
as O
needed O
to O
control O
her B-SYMPTOM
pain I-SYMPTOM
and O
we O
can O
always O
go O
up O
on O
the B-TREATMENT
dilaudid I-TREATMENT
because O
she O
is O
still O
in O
considerable O
amount O
of O
pain B-SYMPTOM
. O

Other O
things O
that O
happened O
during O
this O
admission O
- O
we O
obtained O
ahead O
CT O
for O
her O
on O
the O
8th O
of O
January O
because O
of O
her B-SYMPTOM
clouded I-SYMPTOM
thinking I-SYMPTOM
and O
altered B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
, O
which O
was O
probably O
due O
to O
the B-TREATMENT
morphine I-TREATMENT
that O
she O
was O
taking O
. O

We O
went O
ahead O
and O
got O
a O
head O
CT O
scanand O
it O
showed O
no O
enhancing B-SYMPTOM
lesions I-SYMPTOM
. O

In O
addition O
her O
liver O
transaminases O
were O
elevated B-SYMPTOM
, O
we O
thought O
about O
doing O
further O
work-up O
, O
but O
that O
was O
deferred O
because O
the O
patient O
wanted O
to O
wait O
on O
that O
. O

That O
has O
been O
stable O
. O

The O
patient O
on O
January O
13 O
became O
hyponatremic B-SYMPTOM
. O

Her O
sodium O
went O
down O
to O
121 O
and O
before O
that O
on O
admission O
she O
was O
133 O
. O

A O
renal O
consult O
was O
obtained O
and O
their O
assessment O
was O
that O
this O
was O
probably O
a O
mixture O
of O
hypovolemia B-SYMPTOM
as O
well O
as O
SIADH B-SYMPTOM
. O

We O
proceeded O
to O
do O
for O
her B-SYMPTOM
hyponatremia I-SYMPTOM
- O
we O
gave O
her O
some B-TREATMENT
fluid I-TREATMENT
and O
her O
urine O
sodium O
became O
higher O
than O
her O
serum O
sodium O
; O
we O
stopped O
it O
. O

We O
had O
given O
her O
some B-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
and O
then O
we O
proceeded O
to O
just O
do O
fluid B-TREATMENT
restriction I-TREATMENT
. O

In O
addition O
we O
gave O
her O
a B-TREATMENT
sodium I-TREATMENT
chloride I-TREATMENT
one O
gram O
per O
day O
and O
that O
also O
helped O
, O
so O
that O
now O
at O
the O
time O
of O
discharge O
, O
the O
patient O
&apos;s O
sodium O
is O
between O
126 O
and O
129 O
; O
prior O
to O
that O
it O
had O
gone O
down O
to O
as O
low O
116. O

So O
that O
has O
really O
improved O
. O

We O
suggest O
continuing O
increased B-TREATMENT
salt I-TREATMENT
intake I-TREATMENT
in O
her O
diet O
and O
also O
continuing O
with O
the B-TREATMENT
fluid I-TREATMENT
restriction I-TREATMENT
of I-TREATMENT
free I-TREATMENT
water I-TREATMENT
intake I-TREATMENT
to O
one O
liter O
per O
day O
. O

On O
the O
14th O
of O
January O
, O
the O
patient O
developed O
increased B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
chest O
x-ray O
was O
taken O
showed O
a B-SYMPTOM
wedge I-SYMPTOM
shaped I-SYMPTOM
infiltrate I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
which O
was O
consistent O
with O
Hampton B-SYMPTOM
&apos;s I-SYMPTOM
hump I-SYMPTOM
. O

Also O
a O
VQ O
scan O
obtained O
the O
next O
day O
showed O
high O
probability O
for O
PE B-SYMPTOM
. O

So O
we O
proceeded O
to O
put O
her O
on O
heparin B-TREATMENT
for O
anticoagulation B-TREATMENT
and O
then O
when O
she O
was O
therapeutic O
on O
heparin B-TREATMENT
, O
we O
went O
ahead O
and O
started O
her O
on O
coumadin B-TREATMENT
and O
she O
is O
currently O
on O
coumadin B-TREATMENT
at O
2.5 O
mg O
q.h.s. O

Her O
INR O
is O
2.3 O
. O

We O
want O
her O
INR O
to O
remain O
between O
2 O
and O
3 O
. O

So O
if O
it O
goes O
much O
lower O
than O
2 O
, O
then O
we O
would O
consider O
increasing O
it O
to O
perhaps O
coumadin B-TREATMENT
2.5 O
and O
5 O
alternating O
every O
other O
night O
. O

However O
, O
we O
would O
leave O
it O
at O
2.5 O
for O
now O
. O

Other O
major O
issues O
- O
As O
a O
result O
of O
all O
the O
things O
happened O
and O
with O
her B-SYMPTOM
hyponatremia I-SYMPTOM
and O
also O
the B-SYMPTOM
other I-SYMPTOM
problems I-SYMPTOM
, O
her O
blood O
pressure O
was O
elevated B-SYMPTOM
also O
. O

We O
put O
her O
on O
nifedipine B-TREATMENT
IR I-TREATMENT
, O
SL O
and O
that O
was O
not O
enough O
to O
control O
her O
blood O
pressure O
which O
was O
in O
the O
200s O
in O
the O
systolic O
, O
so O
we O
had O
started O
her O
on O
atenolol B-TREATMENT
. O

So O
on O
discharge O
she O
is O
on O
atenolol B-TREATMENT
100 O
. O

If O
needed O
to O
you O
can O
give O
her O
some B-TREATMENT
nifedipine I-TREATMENT
SL I-TREATMENT
to O
decrease O
her O
blood O
pressure O
. O

The O
patient O
also O
has O
significant B-SYMPTOM
edema I-SYMPTOM
in I-SYMPTOM
both I-SYMPTOM
arms I-SYMPTOM
now O
and O
also O
some B-SYMPTOM
mild I-SYMPTOM
edema I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
, O
so O
I O
think O
that O
fluid B-TREATMENT
restriction I-TREATMENT
should O
help O
with O
that O
. O

She O
is O
also O
a B-SYMPTOM
little I-SYMPTOM
dry I-SYMPTOM
. O

The O
patient O
is O
on O
oxygen B-TREATMENT
. O

Ever O
since O
the B-SYMPTOM
pulmonary I-SYMPTOM
embolus I-SYMPTOM
she O
has O
been O
on O
oxygen B-TREATMENT
. O

She O
was O
on O
4 B-TREATMENT
liters I-TREATMENT
; O
now O
she O
is O
on O
5 B-TREATMENT
liters I-TREATMENT
, O
sating O
94 O
to O
96% O
on O
5 B-TREATMENT
liters I-TREATMENT
. O

We O
would O
like O
for O
her O
to O
remain O
on O
the B-TREATMENT
oxygen I-TREATMENT
as O
well O
. O

The B-SYMPTOM
complications I-SYMPTOM
that O
I O
have O
listed O
include O
the B-SYMPTOM
hyponatremia I-SYMPTOM
, O
pulmonary B-SYMPTOM
embolus I-SYMPTOM
and O
also O
the B-SYMPTOM
elevatd I-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
. O

DISPOSITION O
: O

Discharge B-TREATMENT
medications I-TREATMENT
- O
Baclofen B-TREATMENT
10 O
p.o. O
t.i.d. O
, O
MVI B-TREATMENT
one O
tablet O
p.o. O
q.d. O
, O
Mycostatin B-TREATMENT
powder I-TREATMENT
TP I-TREATMENT
q.d. O
to O
be O
applied O
to O
the B-SYMPTOM
rash I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
left I-SYMPTOM
groin I-SYMPTOM
area I-SYMPTOM
, O
also O
dilaudid B-TREATMENT
8 O
mg O
p.o. O
q2h O
, O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O
, O
coumadin B-TREATMENT
2.5 O
mg O
p.o. O
q.h.s. O
fentanyl B-TREATMENT
patch I-TREATMENT
75 O
micrograms O
per O
hour O
topical O
q72 O
hours O
, O
atenolol B-TREATMENT
100 O
mg O
p.o. O
q.d. O

CONDITION O
ON O
DISCHARGE O
: O

Fair O
. O

She O
remains O
very B-SYMPTOM
weak I-SYMPTOM
and O
will O
most O
likely O
benefit O
from O
some B-TREATMENT
physical I-TREATMENT
therapy I-TREATMENT
andshe O
still O
has O
the B-SYMPTOM
bilateral I-SYMPTOM
edema I-SYMPTOM
. O

She O
is O
to O
go O
to O
the O
Necsoncardel O
Medical O
Center O
for O
more B-TREATMENT
chronic I-TREATMENT
care I-TREATMENT
. O

Follow-up O
is O
with O
Dr. O
Wedleung O
in O
the O
Hem O
/ O
Onc O
in O
two O
weeks O
. O

The O
appointment O
has O
already O
been O
made O
. O

The O
patient O
is O
very O
limited O
in O
how O
much O
she O
can O
do O
right O
now O
because O
of O
her B-SYMPTOM
pain I-SYMPTOM
primarily O
and O
her B-SYMPTOM
difficulty I-SYMPTOM
breathing I-SYMPTOM
. O

Dictated O
By O
: O

JEABRIHARL O
FIGEFREIERMFOTHGRENDCAJAQUE O
, O
M.D. O

Attending O
: O

LA O
INEMACISTIN O
PRONTMANDES O
, O
M.D. O
HD45 O
SY882/1177 O

Batch O
: O

020 O

Index O
No. O

YJQI3J9VU6 O

D O
: O

01/25/94 O

T O
: O

01/25/94 O

166394283 O
PUMC O

1991524 O

328713 O

0095918 O

12/02/2002 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O
NAME O
: O

KOTENORT O
, O
OAN O
R O

UNIT O
NUMBER O
: O

105-24-06 O

ADMISSION O
DATE O
: O

12/02/2002 O

DISCHARGE O
DATE O
: O

12/04/2002 O

PRINCIPAL O
DIAGNOSIS O
: O

Probably O
sigmoid B-SYMPTOM
volvulus I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
an O
81 O
year O
old O
female O
with O
a O
history O
of O
cerebrovascular B-SYMPTOM
accident I-SYMPTOM
, O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
hypothyroidism B-SYMPTOM
and O
dementia B-SYMPTOM
who O
is O
status O
post O
laparoscopic B-TREATMENT
cholecystectomy I-TREATMENT
one O
week O
ago O
who O
currently O
presents O
with O
a O
4 O
day O
history O
of O
no B-SYMPTOM
bowel I-SYMPTOM
movement I-SYMPTOM
. O

She O
has O
complaints O
of O
abdominal B-SYMPTOM
distention I-SYMPTOM
, O
emesis B-SYMPTOM
, O
and O
constipation B-SYMPTOM
. O

She O
has O
no O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
fever B-SYMPTOM
. O

She O
has O
no O
nausea B-SYMPTOM
or O
vomiting B-SYMPTOM
, O
chills B-SYMPTOM
, O
dysuria B-SYMPTOM
, O
hematochezia B-SYMPTOM
, O
or O
melena B-SYMPTOM
. O

She O
was O
discharged O
from O
the O
hospital O
on O
11/28/02 O
to O
a O
short O
term O
rehabilitation O
facility O
. O

She O
was O
found O
to O
have O
normal O
bowel O
sounds O
. O

She O
presented O
to O
the O
Ponta,itri- O
University O
Medical O
Center O
Emergency O
Department O
on O
12/01/02 O
for O
evaluation O
of O
this B-SYMPTOM
constipation I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Cerebrovascular B-SYMPTOM
accident I-SYMPTOM
. O

2. O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM
on O
Coumadin B-TREATMENT
. O

3. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
type I-SYMPTOM
2 I-SYMPTOM
. O

4. O
Hypothyroidism B-SYMPTOM
. O

5. O
Mild B-SYMPTOM
dementia I-SYMPTOM
. O

6. O
Proteinuria B-SYMPTOM
. O

7. O
Nephropathy B-SYMPTOM
. O

8. O
Anemia B-SYMPTOM
. O

9. O
Hearing B-SYMPTOM
impaired I-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

1. O
Laparoscopic B-TREATMENT
cholecystectomy I-TREATMENT
as O
above O
. O

2. O
Total B-TREATMENT
hip I-TREATMENT
replacement I-TREATMENT
in O
2002 O
. O

3. O
Appendectomy B-TREATMENT
. O

4. O
Diskectomy B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Digoxin B-TREATMENT
.125 O
mg O
qod O
, O
.25 O
mg O
qod O
. O

2. O
Colace B-TREATMENT
100 O
mg O
po O
tid O
. O

3. O
Levoxyl B-TREATMENT
100 O
ugm O
po O
qd O
. O

4. O
Prinivil B-TREATMENT
20 O
mg O
po O
qd O
. O

5. O
Zantac B-TREATMENT
150 O
mg O
po O
bid O
. O

6. O
Aspirin B-TREATMENT
325 O
mg O
qd O
. O

7. O
Aricept B-TREATMENT
5 O
mg O
po O
qd O
. O

8. O
Glyburide B-TREATMENT
1.25 O
mg O
po O
qam O
. O

9. O
Oxybutynin B-TREATMENT
5 O
mg O
po O
bid O
. O

10. O
Coumadin B-TREATMENT
7.5 O
mg O
on O
Sun O
, O
Tues O
, O
Wed O
, O
Fri O
and O
Sat O
. O

5 O
mg O
on O
Mon O
and O
Thurs O
. O

ALLERGIES O
: O

Fluoroquinolones B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

No O
tobacco O
, O
alcohol O
or O
drugs O
. O

PHYSICAL O
EXAMINATION O
: O

Temperature O
96.7F O
, O
pulse O
63 O
, O
respiratory O
rate O
20 O
, O
blood O
pressure O
167/68 O
, O
02 O
sat O
99% O
on O
room O
air O
. O

In O
general O
the O
patient O
is O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
exam O
is O
within O
normal O
limits O
. O

Chest O
clear O
to O
auscultation O
bilaterally O
. O

Heart O
regular O
rate O
and O
rhythm O
. O

Abdomen B-SYMPTOM
grossly I-SYMPTOM
distended I-SYMPTOM
, O
tympanitic B-SYMPTOM
, O
plus O
right B-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
tenderness I-SYMPTOM
and O
no O
rebound B-SYMPTOM
. O

Rectal O
had O
normal O
tone O
, O
empty B-SYMPTOM
rectal I-SYMPTOM
vault I-SYMPTOM
, O
and O
guaiac O
negative O
. O

Extremities O
were O
warm O
and O
well O
perfused O
. O

LABORATORY O
AND O
RADIOLOGIC O
DATA O
: O

On O
admission O
Digoxin B-TREATMENT
7.3 O
, O
sodium B-TREATMENT
142 O
, O
potassium B-TREATMENT
2.8 O
( O
was O
supplemented O
) O
, O
blood B-TREATMENT
urea I-TREATMENT
nitrogen I-TREATMENT
15 O
, O
creatinine B-TREATMENT
.9 O
, O
calcium B-TREATMENT
9.3 O
, O
phosphorus B-TREATMENT
1.9 O
, O
magnesium B-TREATMENT
1.8 O
. O

Liver O
function O
tests O
were O
within O
normal O
limits O
. O

Hematocrit O
36 O
, O
white O
blood O
cell O
count O
8.3 O
, O
platelets O
342 O
. O

Electrocardiogram O
shows O
sinus B-SYMPTOM
bradycardia I-SYMPTOM
with O
Digitalis B-SYMPTOM
effect I-SYMPTOM
. O

Urinalysis O
is O
pending O
. O

Abdominal O
series O
showed O
non-specific B-SYMPTOM
dilatation I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
large I-SYMPTOM
bowel I-SYMPTOM
with O
no O
evidence O
of O
ileus B-SYMPTOM
. O

CT O
of O
the O
abdomen O
and O
pelvis O
showed O
dilated B-SYMPTOM
colon I-SYMPTOM
with O
a B-SYMPTOM
large I-SYMPTOM
amount I-SYMPTOM
of I-SYMPTOM
fluid I-SYMPTOM
. O

There O
was O
no O
free B-SYMPTOM
air I-SYMPTOM
and O
no O
bowel B-SYMPTOM
wall I-SYMPTOM
thickening I-SYMPTOM
. O

There O
was O
no O
obstruction B-SYMPTOM
. O

Normal O
appearing O
small O
bowel O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
presented O
to O
the O
operating O
room O
late O
at O
night O
on O
12/01/02 O
and O
was O
admitted O
to O
the O
floor O
early O
on O
the O
morning O
on O
12/02/02 O
. O

She O
was O
placed O
on O
a B-TREATMENT
bowel I-TREATMENT
regimen I-TREATMENT
of O
Dulcolax B-TREATMENT
, O
Fleet B-TREATMENT
enema I-TREATMENT
, O
and O
Colace B-TREATMENT
. O

On O
12/03/02 O
the O
patient O
underwent O
a O
repeat O
KUB O
which O
was O
suggestive O
of O
volvulus B-SYMPTOM
. O

She O
then O
underwent O
a O
CT O
scan O
which O
showed O
no O
evidence O
of O
volvulus B-SYMPTOM
. O

Rigid O
sigmoidoscopy O
revealed O
no O
obvious B-SYMPTOM
mucosal I-SYMPTOM
abnormalities I-SYMPTOM
but O
during O
the O
time O
of O
the O
procedure O
22cc O
of O
mucous B-SYMPTOM
like I-SYMPTOM
stool I-SYMPTOM
was O
evacuated O
with O
a B-SYMPTOM
large I-SYMPTOM
amount I-SYMPTOM
of I-SYMPTOM
gas I-SYMPTOM
. O

Subsequent O
to O
that O
the O
patients O
abdomen O
was O
significantly B-SYMPTOM
less I-SYMPTOM
distended I-SYMPTOM
and O
her B-SYMPTOM
pain I-SYMPTOM
decreased O
as O
well O
. O

On O
the O
following O
day O
, O
hospital O
day O
number O
3 O
, O
the O
patient O
was O
doing O
well O
. O

The O
abdomen O
was O
again O
far B-SYMPTOM
less I-SYMPTOM
distended I-SYMPTOM
. O

She O
was O
tolerating O
clear B-TREATMENT
liquids I-TREATMENT
ad O
lib O
. O

She O
was O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O
. O

A O
repeat O
KUB O
was O
performed O
which O
showed O
no O
evidence O
of O
volvulus B-SYMPTOM
. O

She O
was O
discharged O
back O
to O
a O
rehabilitation O
facility O
in O
good O
condition O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Digoxin B-TREATMENT
.125 O
mg O
qod O
, O
.25 O
mg O
qod O
. O

2. O
Colace B-TREATMENT
100 O
mg O
po O
tid O
. O

3. O
Levoxyl B-TREATMENT
100 O
ugm O
po O
qd O
. O

4. O
Prinivil B-TREATMENT
20 O
mg O
po O
qd O
. O

5. O
Zantac B-TREATMENT
150 O
mg O
po O
bid O
. O

6. O
Aspirin B-TREATMENT
325 O
mg O
qd O
. O

7. O
Aricept B-TREATMENT
5 O
mg O
po O
qd O
. O

8. O
Glyburide B-TREATMENT
1.25 O
mg O
po O
qam O
. O

9. O
Oxybutynin B-TREATMENT
5 O
mg O
po O
bid O
. O

10. O
Coumadin B-TREATMENT
7.5 O
mg O
on O
Sun O
, O
Tues O
, O
Wed O
, O
Fri O
and O
Sat O
. O

5 O
mg O
on O
Mon O
and O
Thurs O
. O

ERIN O
KENGEKOTE O
, O
MD O

DICTATING O
FOR O
: O

Electronically O
Signed O
MAENZET O
HEAD O
, O
M.D. O

12/25/2002 O
12:48 O

_____________________________ O
MAENZET O
HEAD O
, O
M.D. O

TR O
: O

su O

DD O
: O

12/04/2002 O

TD O
: O

12/04/2002 O
2:34 O
P O
328713 O

cc O
: O

ERIN O
KENGEKOTE O
, O
MD O
Surg O
Obrh O
ALBI O
OSHASON O
HEAD O
, O
M.D. O
SURGERY O
NIME O
ETHILLBRID O
HEALTHCARE O
MAENZET O
HEAD O
, O
M.D. O
Ston O
Community O
Hospital O
5223 O
Cannola O
Creek O
Rd O
Granger O
CO O
78438 O
STAT O

782836641 O
DH O

9369592 O

01111 O

974771 O

3/15/2002 O
12:00:00 O
AM O

OB O
Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O
OB O
EMR O
L O
and O
D O

DISCHARGE O
SUMMARY O

NAME O
: O

XIEACASS O
BETHCONRI O
BALLOON O

UNIT O
NUMBER O
: O

242-36-71 O

ADMISSION O
DATE O
: O

20020315 O

DISCHARGE O
DATE O
: O

20020318 O

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
: O

Vaginal B-TREATMENT
Delivery I-TREATMENT
With O
First B-SYMPTOM
Degree I-SYMPTOM
Laceration I-SYMPTOM

ASSOCIATED O
DIAGNOSES O
: O

Advanced B-SYMPTOM
Maternal I-SYMPTOM
Age I-SYMPTOM
; O
Depression B-SYMPTOM
, O
history O
of O
; O
Hepatitis B-SYMPTOM
C I-SYMPTOM
Antibody I-SYMPTOM
Positive I-SYMPTOM
; O
Polyneuropathy B-SYMPTOM
, O
history O
of O
; O
Problems O
With O
Abuse O
, O
history O
of O
; O
Rh O
Nonsensitization O
; O
Stopped O
Smoking O
This O
Pregnancy O
, O
history O
of O

PRINCIPAL O
PROCEDURE O
OR O
OPERATION O
: O

Spontaneous B-TREATMENT
Vertex I-TREATMENT
Vaginal I-TREATMENT
Delivery I-TREATMENT

ASSOCIATED O
PROCEDURES O
OR O
OPERATIONS O
: O

POSTPARTUM O
DIAGNOSTIC O
PROCEDURES O
: O

None O

POSTPARTUM O
THERAPEUTIC O
PROCEDURES O
: O

None O

HISTORY O
AND O
REASON O
FOR O
HOSPITALIZATION O
: O

Active B-SYMPTOM
Labor I-SYMPTOM

PHYSICAL O
EXAMINATION O
: O

HEIGHT O
NORMAL O
66 O
HEENT O
NORMAL O
MOUTH O
NORMAL O
NECK O
NORMAL O
BREASTS O
NORMAL O
NIPPLES O
NORMAL O
CHEST O
NORMAL O
COR O
NORMAL O
ABDOMEN O
NORMAL O
EXTREM O
NORMAL O
SKIN B-SYMPTOM
mottled I-SYMPTOM
on I-SYMPTOM
both I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
. O

NODES O
NORMAL O
VULVA O
NORMAL O
VAGINA O
NORMAL O
CERVIX O
NORMAL O
OS O
NORMAL O
ADNEXAE O
NORMAL O
UTERUS O
NORMAL O
UTERINE O
SIZE O
IN O
WEEKS O
15 O
HOSPITAL O
COURSE O
( O
include O
complications O
if O
any O
) O
: O

This O
42 O
year O
old O
Gravida O
3 O
Para O
2002 O
was O
admitted O
to O
the O
Naliheall O
County O
Memorial O
Hospital O
Obstetrical O
service O
on O
03/15/2002 O
at O
10:04 O
pm O
for O
the O
indication O
( O
s O
) O
: O

active B-SYMPTOM
labor I-SYMPTOM
. O

She O
delivered O
a O
2809 O
gram O
male O
infant O
on O
03/16/2002 O
at O
02:50 O
am O
with O
apgar O
scores O
of O
7 O
and O
9 O
at O
one O
and O
five O
minutes O
respectively O
at O
38.0 O
weeks O
gestation O
via O
spontaneous B-TREATMENT
vertex I-TREATMENT
vaginal I-TREATMENT
delivery I-TREATMENT
. O

During O
her O
labor O
she O
encountered O
the O
following O
complication O
( O
s O
) O
: O

none O
. O

During O
her O
delivery O
she O
encountered O
the O
following O
complication O
( O
s O
) O
: O

. O
Postpartum O
she O
encountered O
the O
following O
complication O
( O
s O
) O
: O

depression B-SYMPTOM
. O

She O
was O
discharged O
on O
03/18/2002 O
at O
12:45 O
pm O
in O
good O
condition O
. O

DISCHARGE O
ORDERS O
( O
medications O
instructions O
to O
patient O
, O
follow-up O
care) O
: O

DISCHARGE O
ACTIVITY O
: O

No O
Restrictions O

DISCHARGE O
DIET O
: O

No O
Restrictions O

POSTPARTUM O
DISPOSITION O
: O

Home O
Under O
Care O
Of O
Shingle O
Geabell O
Hospital O

POSTPARTUM O
CARE O
SITE O
: O

Dh O
Ob O

POSTPARTUM O
RETURN O
APPOINTMENT O
( O
DAYS O
) O
: O

42 O

BREAST O
FEEDING O
AT O
DISCHARGE O
: O

No O

POSTPARTUM B-TREATMENT
RH I-TREATMENT
IMMUNE I-TREATMENT
GLOBULIN I-TREATMENT
: O

Given O

POSTPARTUM B-TREATMENT
MEASLES I-TREATMENT
/ I-TREATMENT
MUMPS/RUBELLA I-TREATMENT
VACCINE I-TREATMENT
: O

Not O
Indicated O

MEDICATION O
( O
S O
) O
ON O
DISCHARGE O
: O

Multivitamins B-TREATMENT
And O
Folate B-TREATMENT
( O
Stuart B-TREATMENT
Prenatal I-TREATMENT
With O
Folate B-TREATMENT
) O
; O
Fluoxetine B-TREATMENT
( I-TREATMENT
Prozac I-TREATMENT
) I-TREATMENT

Electronically O
Signed O
: O

Polle O
, O
Nella O
O O
03/18/2002 O
9:01:18 O
PM O

348983165 O

FIH O

4912803 O

97509/32z1 O

028205 O

4/14/1994 O
12:00:00 O
AM O

SELF B-SYMPTOM
INFLICTED I-SYMPTOM
GUNSHOT I-SYMPTOM
WOUND I-SYMPTOM
TO I-SYMPTOM
THE I-SYMPTOM
HEAD I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

4/14/94 O

DISCHARGE O
DATE O
: O

4/20/94 O

PRINCIPAL O
DIAGNOSIS O
: O

Self B-SYMPTOM
inflicted I-SYMPTOM
gunshot I-SYMPTOM
wound I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
head I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

hypertension B-SYMPTOM
, O
poor B-SYMPTOM
dentition I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Suture B-TREATMENT
of O
right B-SYMPTOM
temporal I-SYMPTOM
head I-SYMPTOM
wound I-SYMPTOM
, O
performed O
on O
April O
14 O
, O
1994 O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Le O
is O
a O
seventy O
three O
year O
old O
male O
who O
presents O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
, O
following O
a B-SYMPTOM
self I-SYMPTOM
inflicted I-SYMPTOM
gunshot I-SYMPTOM
wound I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
head I-SYMPTOM
. O

Mr. O
Le O
was O
found O
in O
bed O
with O
a O
32 O
caliber O
revolver O
at O
his O
side O
. O

The O
patient O
was O
apparently O
alone O
at O
home O
, O
his O
neighbors O
heard O
a O
single O
shot O
, O
and O
the O
paramedics O
were O
called O
. O

Upon O
arrival O
, O
they O
found O
the O
patient O
in O
bed O
, O
with O
notes O
nearby O
, O
listing O
his O
funeral O
home O
preferences O
and O
information O
on O
his O
next O
of O
kin O
. O

The O
patient O
indicates O
that O
his O
neighbors O
were O
making O
excessive O
noise O
upstairs O
from O
his O
dwelling O
, O
and O
he O
found O
it O
unbearable O
. O

He O
therefore O
decided O
to O
take O
his O
life O
with O
a O
gun O
which O
he O
had O
found O
in O
the O
house O
. O

Apparently O
, O
the O
gun O
belonged O
to O
his O
father O
. O

On O
further O
questioning O
, O
the O
patient O
described O
that O
his O
father O
passed O
away O
approximately O
forty O
to O
fifty O
years O
prior O
to O
his O
admission O
, O
and O
the O
gun O
was O
found O
in O
a O
box O
in O
their O
home O
. O

The O
patient O
expressed O
concern O
that O
he O
had O
several O
utility O
bills O
that O
he O
was O
unable O
to O
pay O
. O

The O
patient O
&apos;s O
sister O
died O
eight O
years O
prior O
to O
the O
patient O
&apos;s O
admission O
of O
leukemia B-SYMPTOM
, O
and O
he O
otherwise O
has O
no O
next O
of O
kin O
with O
the O
exception O
of O
one O
brother O
in O
Washington O
, O
with O
whom O
his O
relationship O
is O
tenuous O
. O

On O
initial O
questioning O
, O
however O
, O
the O
patient O
denies O
any O
recent O
losses O
. O

On O
admission O
, O
the O
patient O
denies O
any B-SYMPTOM
suicidal I-SYMPTOM
or I-SYMPTOM
homicidal I-SYMPTOM
ideation I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
hypertension B-SYMPTOM
, O

2. O
poor B-SYMPTOM
dentition I-SYMPTOM
. O

ADVERSE O
DRUG O
REACTIONS O
: O

no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

NOne O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
is O
retired O
employee O
of O
the O
City O
of O
Avi O
Den O
, O
Hawaii O
, O
lives O
on O
a O
pension O
and O
Social O
Security O
. O

The O
patient O
has O
never O
been O
married O
and O
has O
no O
children O
. O

He O
has O
a O
sixty O
to O
seventy O
five O
pack O
year O
smoking O
history O
and O
drinks O
alcohol O
approximately O
one O
time O
per O
week O
. O

He O
denies O
any O
ilicit O
drug O
use O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
is O
an O
obese O
male O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

The O
vital O
signs O
temperature O
98.0 O
, O
heart O
rate O
78 O
, O
blood O
pressure O
186/69 O
, O
respirations O
18 O
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
examination O
revealed O
an B-SYMPTOM
entry I-SYMPTOM
wound I-SYMPTOM
approximately O
1 O
1/2 O
inches O
above O
the O
right O
ear O
, O
which O
is O
approximately O
1 O
cm. O
in O
length O
and O
surrounded O
by O
powder B-SYMPTOM
burn I-SYMPTOM
. O

There O
is O
a B-SYMPTOM
lump I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
parietal I-SYMPTOM
region I-SYMPTOM
, O
which O
corresponds O
with O
the O
bullet O
seen O
on O
the O
computerized O
tomography O
scan O
. O

There O
is O
no O
bruising B-SYMPTOM
about I-SYMPTOM
the I-SYMPTOM
eyes I-SYMPTOM
or I-SYMPTOM
mastoid I-SYMPTOM
sinuses I-SYMPTOM
, O
and O
there O
is O
no O
fluid B-SYMPTOM
from I-SYMPTOM
the I-SYMPTOM
nose I-SYMPTOM
or I-SYMPTOM
ears I-SYMPTOM
. O

The O
neck O
was O
supple O
, O
and O
without O
adenopathy B-SYMPTOM
. O

The O
lungs O
are O
clear O
to O
auscultation O
bilaterally O
. O

The O
heart O
sounds O
are O
regular O
rate O
and O
rhythm O
and O
no O
murmur B-SYMPTOM
, O
rub B-SYMPTOM
or O
gallop B-SYMPTOM
are O
appreciated O
. O

The O
abdomen O
is O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
without O
hepatosplenomegaly B-SYMPTOM
. O

There O
are O
no O
masses B-SYMPTOM
and O
the O
bowel O
sounds O
are O
present O
. O

The O
extremities O
are O
well O
perfused O
and O
there O
is O
no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

Neurological O
: O

examination O
revealed O
a O
patient O
who O
was O
alert O
and O
oriented O
X O
3 O
, O
with O
short O
term O
recall O
of O
2/3 O
objects O
at O
five O
minutes O
and O
fluent O
speech O
. O

The O
patient O
remembers O
the O
presidents O
as O
Carter-Bush-Regan-Truman-Roosevelt O
. O

The O
patient O
was O
able O
to O
spell O
world O
backwards O
on O
the O
third O
attempt O
. O

He O
performed O
serial O
7 O
&apos;s O
accurately O
. O

He O
demonstrated O
poor B-SYMPTOM
ability I-SYMPTOM
for I-SYMPTOM
abstract I-SYMPTOM
thinking I-SYMPTOM
. O

Cranial O
nerves O
II-XII O
were O
grossly O
intact O
. O

The O
pupils O
equal O
, O
round O
, O
reactive O
to O
light O
and O
accommodation O
, O
and O
the O
extra O
ocular O
movements O
are O
intact O
. O

The O
fundi O
are O
benign O
and O
the O
discs O
are O
sharp O
. O

The O
patient O
&apos;s O
strength O
is O
5/5 O
throughout O
and O
the O
sensorium O
is O
intact O
. O

The O
deep O
tendon O
reflexes O
are O
2+ O
and O
symmetrical O
throughout O
. O

LABORATORY O
DATA O
: O

A O
panel O
of O
serum O
electrolytes O
is O
normal O
. O

The O
white O
blood O
count O
is O
9.4 O
, O
hematocrit O
47.1 O
, O
and O
the O
platelets O
253,000 O
. O

Blood O
coagulation O
times O
are O
normal O
. O

Serum O
toxic O
screen O
is O
negative O
. O

Leukocyte O
differential O
count O
reveals O
64 O
neutrophils O
, O
24% O
lymphocytes O
, O
8% O
monocytes O
, O
2% O
eosinophils O
, O
and O
2% O
basophils O
. O

A O
panel O
of O
serum O
enzymes O
suggest O
normal O
hepatic O
function O
. O

A O
computerized O
tomography O
scan O
of O
the O
head O
reveals O
a B-SYMPTOM
small I-SYMPTOM
external I-SYMPTOM
skull I-SYMPTOM
fracture I-SYMPTOM
, O
approximately O
1-2 O
millemeters O
in O
size O
, O
near O
the O
right O
frontoparietal O
apex O
. O

A B-SYMPTOM
right I-SYMPTOM
parietal I-SYMPTOM
contusion I-SYMPTOM
is O
also O
identified O
, O
with O
blood O
tracking O
into O
the O
middle O
focus O
. O

Standard O
12 O
lead O
electrocardiogram O
revealed O
normal O
sinus O
rhythm O
at O
a O
rate O
of O
85 O
, O
with O
poor B-SYMPTOM
R I-SYMPTOM
wave I-SYMPTOM
progression I-SYMPTOM
in O
leads O
V1 O
through O
V3 O
suggesting O
the O
possibility O
of O
an B-SYMPTOM
old I-SYMPTOM
anteroseptal I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

Nonspecific B-SYMPTOM
ST I-SYMPTOM
segment I-SYMPTOM
and I-SYMPTOM
T I-SYMPTOM
wave I-SYMPTOM
abnormalities I-SYMPTOM
are O
present O
as O
well O
. O

Otherwise O
, O
the O
axis O
is O
normal O
and O
the O
intervals O
are O
normal O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
, O
on O
the O
Neurological O
Surgery O
Service O
of O
Lupevickette O
L. O
Ca O
, O
M.D. O

Prior O
to O
his O
admission O
, O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
gunshot I-SYMPTOM
wound I-SYMPTOM
was O
sutured O
close O
in O
the O
emergency O
room O
. O

The O
patient O
was O
placed O
on O
suicide B-TREATMENT
precautions I-TREATMENT
, O
and O
was O
hydrated O
with O
an B-TREATMENT
infusion I-TREATMENT
of I-TREATMENT
intravenous I-TREATMENT
fluid I-TREATMENT
. O

The O
patient O
was O
seen O
in O
consultation O
by O
the O
Psychiatry O
Service O
, O
who O
began O
a O
battery O
of O
testing O
, O
which O
continues O
at O
the O
time O
of O
discharge O
. O

The O
Consulting O
Psychiatrist O
recommended O
a O
minimum O
of O
2 B-TREATMENT
point I-TREATMENT
restraints I-TREATMENT
at O
all O
times O
, O
and O
recommended O
the O
patient O
be O
monitored O
by O
a O
sitter O
. O

Allowing O
the O
patient O
to O
ambulate O
was O
not O
recommended O
. O

From O
a O
medical O
standpoint O
, O
the O
patient O
did O
well O
. O

He O
was O
initially O
admitted O
to O
the O
Neurological O
Intensive O
Care O
Unit O
where O
he O
was O
closely O
monitored O
during O
the O
first O
two O
days O
of O
his O
hospitalization O
. O

The O
chief O
obstacle O
was O
bringing O
his O
blood O
pressure O
under O
control O
and O
this O
was O
ultimately O
achieved O
with O
a O
combination O
of O
Captopril B-TREATMENT
and O
Nifedipine B-TREATMENT
. O

After O
his O
blood O
pressure O
had O
stabilized O
, O
the O
patient O
was O
transferred O
to O
the O
Neurology O
Ward O
. O

Close O
monitoring O
demonstrated O
his O
blood O
pressure O
to O
be O
stable O
and O
within O
an O
acceptable O
rang O
on O
his B-TREATMENT
dosage I-TREATMENT
regimen I-TREATMENT
. O

The O
Psychiatry O
Service O
followed O
up O
extensively O
with O
the O
patient O
, O
and O
his O
Psychiatric O
progress O
is O
detailed O
in O
the O
Psychiatry O
transfer O
note O
. O

By O
the O
7th O
hospital O
day O
, O
the O
patient O
was O
medically O
stable O
. O

He O
had O
undergone O
full O
Psychiatric O
evaluation O
, O
and O
was O
prepared O
for O
transfer O
to O
a O
Psychiatric O
Hospital O
. O

Therefore O
, O
because O
of O
his O
need O
for O
intense B-TREATMENT
psychiatric I-TREATMENT
care I-TREATMENT
, O
the O
patient O
is O
discharged O
to O
the O
Vo O
Black O
Doylestrictshore O
Ft. O
Clinics O
Medical O
Center O
on O
the O
7th O
hospital O
day O
. O

CONDITION O
ON O
DISCHARGE O
: O

Improved O
. O

DOCTORS O
DISCHARGE O
ORDERS O
: O

Discharged O
to O
Sonpathcermu O
Jords O
Hospital O
. O

2. O
diet O
as O
tolerated O
. O

3. O
Activity O
ad O
lib O
, O
with O
restrictions O
as O
indicated O
by O
the O
Psychiatry O
Transfer O
Note O
. O

4. O
Followup O
with O
Dr. O
Rourdrick O
in O
four O
weeks O
time O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Dilantin B-TREATMENT
100 O
mg. O
po O
tid O
, O
Mylanta B-TREATMENT
30 O
cc. O
po O
q O
4 O
hours O
prn O
, O
Dyspepsia B-SYMPTOM
, O
Milk B-TREATMENT
of I-TREATMENT
Magnesia I-TREATMENT
30 O
cc. O
po O
q O
4 O
hours O
prn O
constipation B-SYMPTOM
, O
Cimetidine B-TREATMENT
400 O
mg. O
po O
bid O
, O
Haloperidol B-TREATMENT
1 O
mg. O
po O
or O
IM O
q O
3 O
hours O
prn O
agitation B-SYMPTOM
. O

Colace B-TREATMENT
100 O
mg. O
po O
bid O
, O
Captopril B-TREATMENT
50 O
mg. O
po O
tid O
, O
Nifedipine B-TREATMENT
20 O
mg. O
po O
q O
6 O
hours O
and O
Nifedipine B-TREATMENT
20 O
mg. O
po O
or O
sublingual O
q O
3 O
hours O
prn O
systolic B-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
greater I-SYMPTOM
than I-SYMPTOM
160 I-SYMPTOM
millemeters I-SYMPTOM
of I-SYMPTOM
Mercury I-SYMPTOM
. O

LUPEVICKETTE O
CA O
, O
M.D. O

TR O
: O

yz O
/ O
bmot O

DD O
: O

4/19/94 O

TD O
: O

04/19/94 O

CC O
: O

stat O

Admission O
Date O
: O

2018-05-12 O

Discharge O
Date O
: O

2018-05-14 O

Date O
of O
Birth O
: O

2018-05-07 O

Sex O
: O

M O

Service O
: O

Neonatology O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Melba O
Barnett O
is O
the O
3.710 O
- O
kg O
( O
8 O
- O
pound O
3 O
- O
ounce O
) O
product O
of O
a O
term O
gestation O
. O

He O
was O
born O
to O
a O
35 O
- O
year-old O
gravida O
2 O
, O
para O
1 O
( O
now O
2 O
) O
mother O
. O

Readmitted O
for O
hyperbilirubinemia B-SYMPTOM
on O
day O
of O
life O
#5 O
. O

The O
pregnancy O
was O
benign O
with O
an O
EDC O
of O
2018-05-07 O
. O

Prenatal O
screens O
were O
O+ O
, O
antibody O
negative O
, O
hepatitis O
surface O
antigen O
negative O
, O
rapid O
plasma O
reagin O
nonreactive O
, O
rubella O
immune O
, O
group O
B O
strep O
positive O
. O

The O
infant O
delivered O
vaginally O
with O
Apgar O
scores O
of O
9 O
at O
one O
minute O
and O
9 O
at O
five O
minutes O
. O

Alleyne O
blood O
type O
is O
O+ O
/ O
Coombs O
negative O
. O

He O
was O
readmitted O
for O
phototherapy B-TREATMENT
on O
day O
of O
life O
#5 O
for O
a O
bilirubin O
of O
23.3 O
. O

PHYSICAL O
EXAMINATION O
ON O
ADMISSION O
: O

On O
admission O
, O
Thomas O
was O
well-appearing O
though O
slightly B-SYMPTOM
sleepy I-SYMPTOM
with O
jaundice B-SYMPTOM
. O

He O
had O
bilateral O
breath O
sounds O
that O
were O
clear O
and O
equal O
. O

The O
heart O
rate O
was O
regular O
without O
murmur B-SYMPTOM
, O
and O
pulses O
were O
2+ O
and O
symmetrical O
. O

The O
abdomen O
was O
soft O
and O
nontender B-SYMPTOM
with O
no O
hepatosplenomegaly B-SYMPTOM
. O

His O
weight O
was O
3.505 O
( O
7 O
pounds O
/ O
12 O
ounces O
) O
on O
readmission O
. O

He O
had O
normal O
male O
genitalia O
with O
bilaterally O
descended O
testes O
. O

His O
hips O
were O
stable O
. O

His O
tone O
was O
normal O
with O
normal O
neonatal O
reflexes O
. O

He O
is O
tolerating O
his O
feedings O
well O
. O

SUMMARY O
OF O
HOSPITAL O
COURSE O
: O

RESPIRATORY O
: O

Without O
issues O
on O
this O
admission O
. O

Breath O
sounds O
are O
clear O
and O
equal O
. O

CARDIOVASCULAR O
: O

Without O
issues O
on O
this O
admission O
. O

He O
had O
a O
regular O
heart O
rate O
and O
rhythm O
, O
no O
murmur B-SYMPTOM
, O
and O
pulses O
were O
2+ O
and O
symmetric O
. O

FLUIDS O
, O
ELECTROLYTES O
AND O
NUTRITION O
: O

Alleyne O
birth O
weight O
was O
3.710 O
kg O
( O
8 O
pounds O
/ O
3 O
ounces O
). O

His O
weight O
on O
this O
admission O
was O
3.505 O
kg O
( O
7 O
pounds O
/ O
12 O
ounces O
). O

Linda O
is O
breast O
feeding O
every O
3 O
hours O
and O
supplementing O
with O
expressed O
breast O
milk O
. O

He O
is O
feeding O
well O
. O

His O
discharge O
weight O
is O
3585 O
grams O
( O
7 O
pounds O
13 O
ounces O
) O
. O

GASTROINTESTINAL O
: O

Alleyne O
bilirubin O
on O
2018-05-09 O
was O
10.4 O
; O
at O
which O
time O
he O
was O
discharged O
to O
home O
. O

At O
the O
primary O
pediatrician O
's O
office O
on O
2018-05-12 O
his O
bilirubin O
had O
been O
23 O
, O
at O
which O
time O
he O
was O
readmitted O
to O
the O
HealthSouth O
Rehab O
Hospital O
of O
Western O
Mass. O
and O
double B-TREATMENT
phototherapy I-TREATMENT
was O
started O
. O

His O
bilirubin O
on O
05-13 O
was O
18.4 O
; O
and O
on O
05-14 O
it O
was O
14.7 O
. O

Phototherapy B-TREATMENT
was O
discontinued O
on O
2018-05-14 O
, O
and O
a O
rebound O
bilirubin O
will O
be O
checked O
in O
the O
pediatrician O
's O
office O
. O

HEMATOLOGY O
: O

The O
hematocrit O
on O
05-12 O
was O
48.7 O
with O
a O
reticulocyte O
count O
of O
1.9 O
, O
and O
his O
blood O
type O
is O
O+ O
/ O
Coombs O
negative O
. O

INFECTIOUS O
DISEASE O
: O

No O
issues O
on O
this O
admission O
. O

NEUROLOGICAL O
: O

The O
infant O
has O
been O
appropriate O
for O
gestational O
age O
. O

SENSORY O
: O

Auditory O
hearing O
screening O
was O
performed O
with O
automated O
auditory O
brain O
stem O
responses O
, O
and O
the O
infant O
passed O
both O
ears O
on O
his O
previous O
admission O
. O

Hearing O
screens O
were O
repeated O
on O
2018-05-13 O
and O
he O
passed O
both O
ears O
. O

PSYCHOSOCIAL O
: O

Family O
is O
invested O
and O
involved O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
DISPOSITION O
: O

To O
home O
. O

SOURCE O
OF O
PRIMARY O
PEDIATRIC O
CARE O
: O

South O
Cove O
Community O
Health O
Center O
at O
5368 O
W. O
Sixth O
Rd. O
, O
Burlington O
, O
Oregon O
55832 O
; O
telephone O
number O
( O
391-5273 O
. O

CARE O
RECOMMENDATIONS O
: O

1. O
Continue O
ad O
lib O
feeding O
. O

2. O
Follow O
up O
with O
pediatrician O
at O
SCCHC O
on O
Tuesday O
2018-05-15 O
. O

3. O
Medications O
: O

Not O
applicable O
. O

4. O
Car O
seat O
positioning O
screen O
: O

Not O
applicable O
. O

5. O
State O
newborn O
screens O
were O
sent O
on O
2018-05-09 O
; O
and O
results O
are O
pending O
. O

On O
his O
previous O
admission O
, O
Terrance O
received O
hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
on O
2018-05-09 O
. O

6. O
Immunization B-TREATMENT
recommended O
: O

Influenza B-TREATMENT
immunization I-TREATMENT
is O
recommended O
annually O
in O
the O
Fall O
for O
all O
infants O
once O
they O
reach O
6 O
months O
of O
age O
. O

Before O
this O
age O
( O
and O
for O
the O
first O
24 O
months O
of O
the O
child O
's O
life O
) O
immunization B-TREATMENT
against O
influenza B-SYMPTOM
is O
recommended O
for O
household O
contacts O
and O
out O
of O
home O
caregivers O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Term O
, O
appropriate O
for O
gestational O
age O
, O
male O
neonate O
. O

2. O
Exaggerated B-SYMPTOM
physiologic I-SYMPTOM
hyperbilirubinemia I-SYMPTOM
responsive O
to O
phototherapy B-TREATMENT
. O

Jennifer O
Martin O
, O
North O
Dakota O
07287 O

Dictated O
By O
: O
Jean O
TE O
Fletcher O
, O
M.D. O

MEDQUIST36 O

D O
: O
2018-05-13 O
13:07:31 O

T O
: O
2018-05-13 O
14:24:41 O

Job O
#: O
75582 O

Signed O
electronically O
by O
: O
DR. O
Deloris O
O. O
Williams O
on O
: O
MON O
2018-05-14 O
9:37 O
AM O

( O
End O
of O
Report O
) O

988183518 O

PUOMC O

7961198 O

290757 O

137082 O

1/25/1997 O
12:00:00 O
AM O

CRYPTOGENIC B-SYMPTOM
CIRRHOSIS I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

BOEHKOTE O
, O
SONA O
S O

UNIT O
NUMBER O
: O

457-95-71 O

ADMISSION O
DATE O
: O

01/25/97 O

DISCHARGE O
DATE O
: O

01/30/97 O

PRINCIPAL O
DIAGNOSIS O
: O

Cryptogenic B-SYMPTOM
cirrhosis I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Variceal B-SYMPTOM
bleeding I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Variceal B-TREATMENT
banding I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
70-year-old O
female O
with O
cryptogenic B-SYMPTOM
cirrhosis I-SYMPTOM
. O

She O
has O
a O
history O
of O
esophageal B-SYMPTOM
varices I-SYMPTOM
and O
a O
history O
of O
an B-SYMPTOM
Upper I-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
. O

She O
has O
had O
one O
pervious O
episode O
of O
variceal B-SYMPTOM
bleeding I-SYMPTOM
with O
an O
unclear O
date O
. O

However O
she O
is O
followed O
by O
a O
Dr. O
Joasscchird O
at O
Vaila O
Medical O
Center O
. O

She O
was O
in O
her O
usual O
state O
of O
health O
until O
one O
day O
prior O
to O
admission O
when O
she O
felt O
increasing B-SYMPTOM
fatigue I-SYMPTOM
, O
nausea B-SYMPTOM
and O
vomiting B-SYMPTOM
productive O
of O
bright B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
and O
coffee B-SYMPTOM
ground I-SYMPTOM
emesis I-SYMPTOM
. O

She O
also O
had O
some B-SYMPTOM
black I-SYMPTOM
, I-SYMPTOM
tarry I-SYMPTOM
stool I-SYMPTOM
in O
her B-TREATMENT
colostomy I-TREATMENT
bag I-TREATMENT
. O

At O
Vaila O
Medical O
Center O
, O
she O
had O
a O
hematocrit O
of O
25 O
and O
was O
transfused O
2 O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

She O
had O
an O
upper O
endoscopy O
at O
Va O
Sit O
Namar O
Healthcare O
showing O
an O
esophagus O
filled O
with O
clots B-SYMPTOM
and O
small O
amount O
of O
bleeding B-SYMPTOM
varices I-SYMPTOM
, O
clot B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
stomach I-SYMPTOM
with O
antral B-SYMPTOM
gastritis I-SYMPTOM
, O
and O
a O
normal O
duodenum O
. O

She O
was O
started O
on O
Pitressin B-TREATMENT
, O
a B-TREATMENT
Blakemore I-TREATMENT
tube I-TREATMENT
was O
inserted O
. O

She O
was O
transferred O
to O
the O
Ph O
University O
Of O
Medical O
Center O
Intensive O
Care O
Unit O
where O
on O
January O
25 O
in O
the O
morning O
her O
hematocrit O
was O
found O
to O
be O
27.4 O
. O

She O
was O
transfused O
another O
2 O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
over O
the O
course O
of O
the O
day O
and O
her O
hematocrit O
improved O
to O
29.4 O
and O
then O
31.2 O
. O

The O
GI O
service O
was O
consulted O
and O
an O
upper O
endoscopy O
study O
showed O
grade B-SYMPTOM
III I-SYMPTOM
varices I-SYMPTOM
with O
no O
active B-SYMPTOM
bleeding I-SYMPTOM
and O
a B-SYMPTOM
clean I-SYMPTOM
base I-SYMPTOM
gastric I-SYMPTOM
ulcer I-SYMPTOM
possibly O
secondary O
to O
the B-TREATMENT
Blakemore I-TREATMENT
tube I-TREATMENT
. O

Her B-SYMPTOM
varices I-SYMPTOM
had O
stigmata B-SYMPTOM
of O
recent B-SYMPTOM
bleeding I-SYMPTOM
, O
were O
banded B-TREATMENT
successfully O
. O

after O
the B-TREATMENT
procedure I-TREATMENT
and O
2 O
more O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
, O
the O
patient O
was O
hemodynamically O
stable O
and O
hematocrit O
was O
stable O
at O
31.2 O
. O

At O
that O
time O
she O
was O
transferred O
from O
the O
Intensive O
Care O
Unit O
to O
Coden O
2 O
for O
the O
Lemgarson O
Hospital O
service O
. O

PAST O
MEDICAL O
HISTORY O
: O

Cryptogenic B-SYMPTOM
cirrhosis I-SYMPTOM
with O
an O
unclear O
work O
up O
. O

Diverticular B-SYMPTOM
bleed I-SYMPTOM
requiring O
colostomy B-TREATMENT
on O
May O
96 O
. O

Spinal B-SYMPTOM
stenosis I-SYMPTOM
. O

Hysterectomy B-TREATMENT
at O
the O
age O
of O
32 O
. O

No O
coronary B-SYMPTOM
disease I-SYMPTOM
, O
no O
diabetes B-SYMPTOM
and O
no O
hypertension B-SYMPTOM
. O

She O
had O
medications B-TREATMENT
on O
transfer O
which O
included O
Synthroid B-TREATMENT
0.15 O
mg O
QD O
, O
Zoloft B-TREATMENT
50 O
mg O
QD O
, O
Inderal B-TREATMENT
10 O
mg O
BID O
, O
Prilosec B-TREATMENT
20 O
mg O
QD O
, O
Neomycin B-TREATMENT
500 O
TID O
, O
Feosol B-TREATMENT
3 O
mg O
and O
Darvocet B-TREATMENT
PRN O
. O

She O
has O
allergies B-SYMPTOM
to O
Morphine B-TREATMENT
, O
Percocet B-TREATMENT
, O
Codeine B-TREATMENT
, O
Penicillin B-TREATMENT
, O
Xanax B-TREATMENT
and O
Toradol B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

She O
does O
not O
smoke O
tobacco O
. O

She O
uses O
only O
occasional O
alcohol O
and O
she O
is O
not O
sexually O
active O
. O

Her O
husband O
died O
of O
lung B-SYMPTOM
cancer I-SYMPTOM
. O

She O
lives O
alone O
in O
Burg O
Chi O
Sternafre O
, O
Massachusetts O
. O

Her O
friends O
check O
up O
on O
her O
. O

She O
does O
not O
have O
a O
home O
health O
aide O
. O

She O
has O
3 O
kids O
who O
live O
far O
away O
. O

She O
is O
able O
at O
baseline O
to O
walk O
one O
flight O
of O
stairs O
, O
2 O
floor O
apartment O
. O

FAMILY O
HISTORY O
: O

Non O
contributory O
and O
unavailable O
as O
she O
is O
adopted O
. O

PHYSICAL O
EXAMINATION O
: O

She O
is O
an O
obese O
, O
elderly O
woman O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

vital O
signs O
: O

158/60 O
with O
a O
heart O
rate O
of O
85 O
, O
temperature O
99.7 O
, O
respirations O
14 O
. O

Her O
neck O
showed O
no O
JVD B-SYMPTOM
. O

Lungs O
clear O
to O
auscultation O
. O

Her O
abdomen O
was O
obese B-SYMPTOM
and O
distended B-SYMPTOM
with O
good O
bowel O
sounds O
, O
large B-SYMPTOM
ventral I-SYMPTOM
hernia I-SYMPTOM
. O

Colostomy B-TREATMENT
with O
black B-SYMPTOM
stool I-SYMPTOM
. O

She O
had O
some B-SYMPTOM
mid I-SYMPTOM
epigastric I-SYMPTOM
tenderness I-SYMPTOM
and O
no O
rebound B-SYMPTOM
. O

Her O
heart O
showed O
a O
regular O
rate O
and O
rhythm O
with O
an O
S1-S2 O
, O
no O
murmur B-SYMPTOM
. O

Her O
neurological O
exam O
was O
alert O
and O
oriented O
. O

She O
had O
5 O
out O
of O
5 O
strength O
bilaterally O
and O
her O
toes O
were O
downgoing O
. O

She O
had O
no O
evidence O
of O
asterixis B-SYMPTOM
. O

Her O
skin O
looked O
very O
bronze O
and O
tan O
, O
especially O
in O
the O
sun O
exposed O
areas O
. O

She O
had O
no O
spider B-SYMPTOM
angiomata I-SYMPTOM
, O
no O
palmar B-SYMPTOM
erythema I-SYMPTOM
, O
no O
xanthomas B-SYMPTOM
and O
no O
caput B-SYMPTOM
medusae I-SYMPTOM
. O

She O
did O
not O
look O
teric B-SYMPTOM
( O
??? O
) O
. O

LABORATORY O
DATA O
: O

Notable O
for O
sodium O
141 O
, O
potassium O
4.2 O
, O
chloride O
109 O
, O
bicarb O
19.8 O
, O
BUN O
38 O
, O
creatinine O
1.2 O
and O
glucose O
388 O
. O

She O
had O
a B-SYMPTOM
pneumonia I-SYMPTOM
of O
31 O
, O
calcium O
was O
7.5 O
, O
phosphorous O
3.0 O
, O
magnesium O
1.3 O
. O

Her O
bilirubin O
was O
1.4 O
total O
, O
0.2 O
direct O
. O

alkaline O
phosphatase O
101 O
. O

SGPT O
22 O
, O
SGOT O
41 O
, O
amylase O
31 O
, O
lipase O
less O
than O
1 O
. O

LDH O
was O
38.9 O
, O
CK O
was O
66 O
, O
her O
hematocrit O
was O
27.4 O
, O
white O
count O
was O
8.0 O
and O
her O
platelets O
were O
55 O
. O

PT O
was O
14.5 O
, O
PTT O
25.5 O
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

As O
described O
above O
the O
patient O
was O
transfused O
an B-TREATMENT
additional I-TREATMENT
2 I-TREATMENT
units I-TREATMENT
in O
the O
Intensive O
Care O
Unit O
and O
the O
patient O
also O
received O
an O
upper O
endoscopy O
study O
and O
her B-SYMPTOM
varices I-SYMPTOM
were O
banded B-TREATMENT
. O

On O
transfer O
to O
the O
Lemgarson O
Hospital O
service O
, O
her O
hematocrit O
was O
31.2 O
, O
white O
count O
11.1 O
and O
a O
platelet O
count O
80 O
. O

Her O
PT O
was O
13.1 O
, O
PTT O
26.7 O
. O

The O
rest O
of O
her O
labs O
were O
unremarkable O
. O

She O
was O
watched O
very O
closely O
while O
on O
the O
floor O
. O

She O
was O
on O
GI B-TREATMENT
bleed I-TREATMENT
precautions I-TREATMENT
at O
all O
times O
, O
was O
too O
large O
for O
IV B-TREATMENT
. O

She O
had O
a B-SYMPTOM
clot I-SYMPTOM
at O
the O
blood O
bank O
and O
she O
had O
BID O
hematocrits O
checked O
. O

She O
was O
kept O
NPO B-TREATMENT
until O
January O
26 O
when O
she O
began O
to O
feel O
hungry O
. O

At O
that O
time O
clear B-TREATMENT
liquids I-TREATMENT
were O
started O
. O

All O
of O
her O
stools O
were O
guaiaced O
. O

She O
also O
began O
Nadolol B-TREATMENT
40 O
mg O
QD O
to O
reduce O
her B-SYMPTOM
portal I-SYMPTOM
hypertension I-SYMPTOM
. O

The O
GI O
consult O
team O
continued O
to O
follow O
her O
. O

We O
also O
tried O
to O
contact O
her O
physician O
at O
Va O
Sit O
Namar O
Healthcare O
and O
was O
unsuccessful O
. O

Therefore O
we O
decided O
to O
work O
up O
her O
cirrhosis B-SYMPTOM
. O

She O
was O
described O
as O
having O
_______ O
cirrhosis B-SYMPTOM
and O
we O
decided O
that O
we O
wanted O
to O
try O
to O
figure O
out O
the O
etiology O
. O

Her O
ferritin O
and O
iron O
studies O
did O
not O
reveal O
any O
evidence O
of O
hemochromatosis B-SYMPTOM
and O
her O
hep O
serologies O
were O
all O
negative O
. O

She O
also O
had O
negative O
antimitochondrial O
antibody O
and O
she O
also O
had O
no O
evidence O
of O
ceruloplasmin B-SYMPTOM
. O

Over O
the O
course O
of O
her O
admission O
were O
also O
sent O
an O
alpha-1-antitrypsin O
, O
which O
was O
negative O
. O

She O
did O
very O
well O
over O
the O
course O
of O
her O
admission O
with O
no O
evidence O
of O
further B-SYMPTOM
bleeding I-SYMPTOM
. O

Her O
hematocrit O
stayed O
stable O
at O
approximately O
32 O
. O

We O
also O
did O
an O
ultrasound O
guided O
paracentesis O
. O

The O
peritoneal O
fluid O
showed O
a O
glucose O
of O
244 O
, O
total O
protein O
0.8 O
and O
a O
albumin O
of O
0.5 O
, O
globulin O
0.3 O
, O
amylase O
16 O
, O
LDH O
of O
51 O
. O

The O
serum O
albumin O
gradient O
was O
1.8 O
consistent O
with O
portal B-SYMPTOM
hypertension I-SYMPTOM
. O

The O
cell O
count O
showed O
a O
white O
blood O
cell O
count O
of O
160 O
with O
16% O
polys O
. O

She O
therefore O
_________ O
criteria O
for O
a B-SYMPTOM
spontaneous I-SYMPTOM
bacterial I-SYMPTOM
peritonitis I-SYMPTOM
. O

Her O
platelet O
count O
stayed O
persistently B-SYMPTOM
low I-SYMPTOM
and O
we O
decided O
that O
it O
might O
be O
due O
to O
Cimetidine B-TREATMENT
. O

Therefore O
we O
switched O
her O
Cimetidine B-TREATMENT
to O
Prilosec B-TREATMENT
. O

By O
the O
2th O
the O
patient O
was O
feeling O
very O
well O
and O
desired O
to O
transfer O
or O
discharge O
to O
home O
. O

She O
wanted O
to O
be O
closer O
to O
North O
Dakota O
. O

After O
discussion O
with O
her O
private O
physician O
, O
Dr. O
Joasscchird O
, O
tel. O
090-249-6079 O
, O
at O
Va O
Sit O
Namar O
Healthcare O
and O
Dr. O
Acrookesjo O
at O
Do O
Of O
Hospital O
, O
the O
patient O
was O
judged O
to O
be O
fit O
for O
discharge O
and O
she O
was O
sent O
home O
with O
AH B-TREATMENT
and O
physical B-TREATMENT
therapy I-TREATMENT
. O

She O
was O
quite O
able O
to O
climb O
stairs O
on O
her O
own O
in O
the O
hospital O
. O

She O
is O
to O
follow O
up O
with O
Dr. O
Acrookesjo O
in O
one O
week O
and O
Dr. O
Work O
the O
gastrointestinal O
fellow O
here O
at O
PUOMC O
in O
2 O
weeks O
. O

She O
may O
require O
a O
repeat O
upper O
endoscopy O
study O
to O
see O
if O
she O
needs O
any B-TREATMENT
rebanding I-TREATMENT
. O

The O
patient O
however O
complained O
of O
a B-SYMPTOM
persistent I-SYMPTOM
wheeze I-SYMPTOM
with O
beta B-TREATMENT
blocker I-TREATMENT
, O
therefore O
it O
was O
agreed O
that O
we O
would O
stop O
the B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
until O
the O
patient O
was O
followed O
up O
as O
an O
outpatient O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Zoloft B-TREATMENT
50 O
mg O
PO O
QD O
, O
Lactulose B-TREATMENT
15 O
g O
PO O
BID O
, O
Synthroid B-TREATMENT
0.15 O
mg O
PO O
QD O
, O
Prilosec B-TREATMENT
20 O
mg O
PO O
BID O
. O

CONDITION O
ON O
DISCHARGE O
: O

Good O
. O

LENTNY O
WORK O
, O
M.D. O

TR O
: O

zs O

DD O
: O

03/06/97 O

TD O
: O

03/10/97 O
2:14 O
P O

cc O
: O

LENTNY O
MAYLUTYNA O
WORK O
, O
M.D. O

513119146 O

PUOMC O

2186824 O

425597 O

704384 O

4/16/2001 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

FALMDREPSGREND O
, O
LINE O

MRN O
: O

2186824 O

Age O
: O

40y O

REGISTRATION O
DATE O
: O

04/16/2001 O
03:46 O
PM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
FALMDREPSGREND O
, O
LINE O
arrived O
in O
the O
Emergency O
Department O
at O
Ph O
University O
Of O
Medical O
Center O
on O
04/16/2001 O
03:46 O
PM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
PAIN B-SYMPTOM
/ O
ASSAULT O
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
of O
the O
visit O
was O
ADMITTED O
TO O
OBSERVATION O
AT O
PH O
UNIVERSITY O
OF O
MEDICAL O
CENTER O
. O

Your O
patient O
was O
admitted O
under O
the O
care O
of O
SHUFFCUCH O
, O
SEYSHARMSE O
N O
with O
a O
preliminary O
diagnosis O
of O
VERTEBRAL B-SYMPTOM
FRACTURES I-SYMPTOM
. O

If O
you O
need O
additional O
information O
please O
call O
639-873-2993 O
. O

PCP O
Name O
: O

RALLSVERSGACH O
, O
DWAINCO O

Provider O
Number O
: O

91361 O

305265793_b O

FIH O

2833679 O

44807/072t O

458891 O

5/14/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

5/14/92 O

DISCHARGE O
DATE O
: O

5/19/92 O

CHIEF O
COMPLAINT O
: O

Right B-SYMPTOM
foot I-SYMPTOM
pain I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
71 O
year O
old O
white O
female O
with O
metastatic B-SYMPTOM
ovarian I-SYMPTOM
carcinoma I-SYMPTOM
, O
who O
recently O
underwent O
an O
exploratory O
laparotomy O
on O
5/2 O
by O
Dr. O
Korcblinknud O
. O

She O
was O
found O
to O
have O
widely B-SYMPTOM
metastatic I-SYMPTOM
ovarian I-SYMPTOM
carcinoma I-SYMPTOM
. O

There O
was O
sigmoid B-SYMPTOM
narrowing I-SYMPTOM
near O
a B-SYMPTOM
large I-SYMPTOM
left I-SYMPTOM
ovarian I-SYMPTOM
mass I-SYMPTOM
, O
and O
distal B-SYMPTOM
ileal I-SYMPTOM
narrowing I-SYMPTOM
by O
a B-SYMPTOM
right I-SYMPTOM
ovarian I-SYMPTOM
mass I-SYMPTOM
. O

The O
patient O
had O
an B-TREATMENT
ileostomy I-TREATMENT
performed O
and O
had O
had O
her O
first O
course O
of O
chemotherapy B-TREATMENT
and O
later O
debulking B-TREATMENT
operation I-TREATMENT
by O
Dr. O
Median O
. O

She O
was O
well O
at O
home O
until O
8:30 O
p.m. O
on O
the O
day O
of O
admission O
, O
when O
she O
developed O
acute O
onset O
of O
right B-SYMPTOM
foot I-SYMPTOM
pain I-SYMPTOM
, O
which O
was O
worse O
with O
walking O
. O

She O
complained O
of O
increased B-SYMPTOM
numbness I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
foot I-SYMPTOM
over O
time O
, O
and O
was O
seen O
at O
Sephsandpot O
Center O
, O
where O
she O
was O
found O
to O
have O
palpable O
right O
femoral O
and O
popliteal O
pulses O
, O
and O
no B-SYMPTOM
pedal I-SYMPTOM
pulses I-SYMPTOM
. O

The O
patient O
was O
transferred O
to O
the O
Fairm O
of O
Ijordcompmac O
Hospital O
. O

She O
had O
previous O
history O
of O
claudication B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
for O
glaucoma B-SYMPTOM
, O
right B-TREATMENT
knee I-TREATMENT
arthroscopic I-TREATMENT
surgery I-TREATMENT
in O
1988 O
, O
appendectomy B-TREATMENT
, O
dilation B-TREATMENT
and I-TREATMENT
curettage I-TREATMENT
times O
two O
, O
and O
a B-SYMPTOM
hiatus I-SYMPTOM
hernia I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Lorazepam B-TREATMENT
1 O
mg. O
PO O
q6 O
hours O
PRN O
, O
and O
Timoptic B-TREATMENT
0.5% O
1 O
drop O
b.i.d. O

ALLERGIES O
: O

Iodine B-TREATMENT
and O
shellfish O
cause O
throat B-SYMPTOM
tightening I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

No O
history O
of O
smoking O
and O
ethanol O
use O
. O

She O
lives O
with O
her O
husband O
. O

REVIEW O
OF O
SYSTEMS O
: O

Negative O
. O

PHYSICAL O
EXAMINATION O
: O

Showed O
a O
71 O
year O
old O
white O
female O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

The O
vital O
signs O
were O
blood O
pressure O
155/82 O
, O
pulse O
88 O
, O
temperature O
96.0. O

Her O
right O
foot O
was O
without B-SYMPTOM
capillary I-SYMPTOM
refill I-SYMPTOM
, O
with O
a B-SYMPTOM
marked I-SYMPTOM
change I-SYMPTOM
of O
temperature O
at O
a O
level O
of O
the O
mid O
calf O
. O

There O
was O
decreased B-SYMPTOM
sensation I-SYMPTOM
to O
touch O
over O
the O
entire O
foot O
. O

She O
was O
able O
to O
move O
her O
foot O
and O
toes O
. O

Radial O
, O
carotid O
and O
femoral O
pulses O
were O
symmetric O
and O
strong O
. O

The O
popliteal O
pulse O
on O
the O
right O
side O
was O
diminished B-SYMPTOM
. O

There O
was O
no B-SYMPTOM
dorsal I-SYMPTOM
, I-SYMPTOM
pedal I-SYMPTOM
pulse I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

ON O
5/14/92 O
, O
the O
patient O
received O
an O
arteriogram O
which O
demonstrated O
an B-SYMPTOM
embolus I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
profunda I-SYMPTOM
/ I-SYMPTOM
femoral I-SYMPTOM
artery I-SYMPTOM
. O

There O
was O
an B-SYMPTOM
occlusion I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
calf I-SYMPTOM
, O
of O
the O
peroneal O
and O
anterior O
tibial O
arteries O
. O

There O
was O
an B-SYMPTOM
occlusion I-SYMPTOM
of I-SYMPTOM
posterior I-SYMPTOM
tibial I-SYMPTOM
artery I-SYMPTOM
at O
the O
ankle O
. O

She O
was O
taken O
urgently O
to O
the O
operating O
room O
, O
where O
she O
underwent O
embolectomy B-TREATMENT
of I-TREATMENT
the I-TREATMENT
profunda I-TREATMENT
superficial I-TREATMENT
femoral I-TREATMENT
vessels I-TREATMENT
. O

The O
estimated O
blood O
loss O
was O
200 O
cc. O
and O
she O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
. O

Postoperatively O
, O
she O
was O
again O
noted O
to O
have O
a B-SYMPTOM
cold I-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
with O
diminished B-SYMPTOM
pulses I-SYMPTOM
and O
was O
again O
taken O
to O
the O
operating O
room O
, O
where O
she O
underwent O
a O
right O
popliteal O
exploration O
and O
thrombectomy B-TREATMENT
. O

She O
again O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
and O
did O
well O
postoperatively O
. O

On O
5/19 O
, O
she O
had O
an O
echocardiogram O
done O
which O
was O
to O
be O
evaluated O
as O
an O
out O
patient O
. O

By O
discharge O
she O
was O
walking O
and O
taking O
PO&apos;s O
without O
problem O
. O

DISCHARGE O
DIAGNOSIS O
: O

Thromboembolus B-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
profunda I-SYMPTOM
femoris I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
right I-SYMPTOM
superficial I-SYMPTOM
femoral I-SYMPTOM
artery I-SYMPTOM
. O

MA O
JAMTLANDBRANTESSLIGH O
, O
M.D. O

DICTATING O
FOR O
: O

COR O
TLAND O
, O
M.D. O

TR O
: O

qa O
/ O
bmot O

DD O
: O

07/02/92 O

TD O
: O

07/07/92 O

CC O
: O

712282401 O

OMH O

5834580 O

96137 O

10/24/1996 O
12:00:00 O
AM O

RIGHT B-SYMPTOM
MIDDLE I-SYMPTOM
CEREBRAL I-SYMPTOM
ARTERY I-SYMPTOM
INFARCT I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

FINGER O
, O
ASHA O

UNIT O
NUMBER O
: O

424-76-57 O

ADMISSION O
DATE O
: O

10/24/96 O

DISCHARGE O
DATE O
: O

Halloween O

PRINCIPAL O
DIAGNOSIS O
: O

Right B-SYMPTOM
middle I-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
infarct I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
. O

CLINICAL O
INFECTIONS O
: O

Urinary B-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
, O
E. B-SYMPTOM
Coli I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

MRI O
/ O
MRA O
. O

OTHER O
PROCEDURES O
: O

Echocardiogram O
, O
neurovascular O
ultrasound O
. O

HISTORY O
: O

Patient O
is O
a O
73-year-old O
retired O
cook O
with O
a O
history O
of O
cervical B-SYMPTOM
myelopathy I-SYMPTOM
, O
who O
is O
admitted O
for O
new B-SYMPTOM
left I-SYMPTOM
hemiparesis I-SYMPTOM
. O

He O
had O
undergone O
C-spine B-TREATMENT
surgery I-TREATMENT
for O
spinal B-SYMPTOM
stenosis I-SYMPTOM
with O
a O
question O
of O
myelopathy B-SYMPTOM
and O
radiculopathy B-SYMPTOM
in O
1992 O
with O
residual B-SYMPTOM
spastic I-SYMPTOM
paresis I-SYMPTOM
and O
monoparesis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
extremity I-SYMPTOM
, O
but O
was O
ambulatory O
until O
a O
day O
prior O
to O
admission O
. O

At O
his O
baseline O
, O
he O
was O
able O
to O
perform O
limited O
tasks O
with O
his O
left O
upper O
extremity O
, O
and O
was O
clearly O
able O
to O
move O
his O
hand O
and O
able O
to O
ambulate O
. O

He O
also O
at O
baseline O
has O
had O
urinary B-SYMPTOM
and I-SYMPTOM
fecal I-SYMPTOM
urgencies I-SYMPTOM
/ O
incontinence B-SYMPTOM
. O

His O
history O
is O
now O
that O
he O
has O
had O
a O
week O
of O
progressive B-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
extremity I-SYMPTOM
weakness I-SYMPTOM
, O
to O
the O
point O
of O
being O
unable O
to O
move O
the O
left O
hand O
and O
one O
day O
of O
being O
unable O
to O
walk O
secondary O
to O
left B-SYMPTOM
leg I-SYMPTOM
weakness I-SYMPTOM
with O
a O
marked O
tendency O
to O
fall O
leftward O
. O

PAST O
MEDICAL O
HISTORY O
: O

Notable O
for O
anemia B-SYMPTOM
, O
hypercholesterolemia B-SYMPTOM
, O
narcolepsy B-SYMPTOM
for O
the O
past O
6 O
years O
on O
Dexedrine B-TREATMENT
, O
impotence B-SYMPTOM
with O
decreased B-SYMPTOM
testosterone I-SYMPTOM
, O
status O
post O
implant B-TREATMENT
, O
peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
duodenal B-TREATMENT
resection I-TREATMENT
, O
cervical B-SYMPTOM
stenosis I-SYMPTOM
, O
status O
post O
decompression B-TREATMENT
&apos;92 O
, O
hernia B-SYMPTOM
, O
status O
post O
herniorrhaphy B-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS B-TREATMENT
ON O
ADMISSION O
: O

Dexedrine B-TREATMENT
5 O
mg O
per O
day O
and O
Motrin B-TREATMENT
600 O
mg O
tid O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
, O
older O
, O
black O
gentleman O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
with O
left O
upper O
extremity O
flex O
across O
his O
chest O
. O

His O
temperatureis O
98.9 O
. O

His O
pressure O
is O
150/90 O
. O

Rate O
76 O
. O

Respirations O
16 O
. O

He O
was O
edentulous B-SYMPTOM
. O

He O
had O
mild B-SYMPTOM
copper I-SYMPTOM
wiring I-SYMPTOM
. O

He O
has O
a B-SYMPTOM
I I-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
systolic I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
sternal I-SYMPTOM
border I-SYMPTOM
. O

Heart O
sounds O
were O
normal O
and O
regular O
. O

Breath O
sounds O
were O
equal O
bilaterally O
with O
course B-SYMPTOM
rhonchi I-SYMPTOM
. O

He O
had O
a B-SYMPTOM
midline I-SYMPTOM
abdominal I-SYMPTOM
scar I-SYMPTOM
and O
a B-SYMPTOM
reducible I-SYMPTOM
umbilical I-SYMPTOM
hernia I-SYMPTOM
. O

Abdomen O
was O
otherwise O
soft O
and O
nontender B-SYMPTOM
. O

He O
had O
2+ O
carotids O
, O
no O
bruits B-SYMPTOM
. O

He O
had O
gynecomastia B-SYMPTOM
. O

Rectal O
was O
guaiac O
negative O
with O
brown O
stool O
, O
good O
tone O
but O
unable O
to O
squeeze O
. O

Extremities O
: O

1+ O
right O
posterior O
tibialis O
, O
2+ O
left O
posterior O
tibialis O
, O
no O
edema B-SYMPTOM
, O
ichthyotic B-SYMPTOM
changes I-SYMPTOM
were O
present O
. O

He O
had O
0 O
left O
wrist O
flexion O
or O
extension O
while O
his O
left O
proximal O
muscles O
were O
4 O
including O
his O
biceps O
and O
triceps O
. O

His O
right O
arm O
muscles O
were O
also O
in O
the O
range O
of O
4/5. O

His O
hip O
flexion O
was O
4+ O
on O
the O
right O
and O
4- O
on O
the O
left O
; O
extension O
5 O
on O
the O
right O
, O
4+ O
on O
the O
left O
; O
knee O
flexion O
evidently O
trace O
on O
the O
right O
and O
4- O
on O
the O
left O
with O
knee O
extension O
5- O
on O
the O
left O
, O
5 O
on O
the O
right O
; O
knee O
flexion O
4- O
on O
the O
left O
, O
trace O
on O
the O
right O
; O
ankle O
dorsi O
flexion O
4- O
on O
the O
left O
, O
trace O
on O
the O
right O
. O

Reflexes O
4+ O
overall O
in O
the O
upper O
extremities O
and O
3+ O
overall O
in O
the O
lower O
extremities O
, O
an O
upgoing O
left O
toe O
and O
a O
down O
going O
right O
toe O
. O

His O
tone O
was O
increased O
on O
the O
left O
side O
and O
he O
had O
diminished O
pin O
prick O
and O
light O
touch O
in O
his O
left O
upper O
extremity O
and O
slightly O
in O
his O
left O
lower O
extremity O
with O
a O
similar O
finding O
for O
vibratory O
sense O
, O
but O
in O
an O
unreliable O
pattern O
. O

He O
occasionally O
had O
extinction O
in O
his O
left O
upper O
, O
greater O
than O
lower O
extremity O
, O
but O
this O
was O
fluctuating O
. O

Mental O
state O
: O

He O
was O
awake O
, O
occasionally O
sleepy O
but O
easily O
aroused O
, O
oriented O
to O
self O
, O
Oaksgekesser/ O
Memorial O
Hospital O
and O
the O
date O
. O

He O
was O
mildly B-SYMPTOM
perseverative I-SYMPTOM
and O
inattentive B-SYMPTOM
. O

Coordination O
: O

his O
fine O
finger O
movements O
and O
rapid O
alternating O
movements O
were O
within O
normal O
limits O
. O

He O
was O
unable O
to O
stand O
without O
extensive O
assistance O
. O

LABORATORY O
DATA O
: O

Sodium O
141 O
, O
potassium O
3.6 O
, O
BUN O
14 O
, O
creatinine O
1.1 O
, O
hematocrit O
37% O
, O
platelets O
177 O
, O
white O
blood O
count O
4.1 O
. O

Chest O
x-ray O
showed O
degenerative B-SYMPTOM
joint I-SYMPTOM
disease I-SYMPTOM
, O
an B-SYMPTOM
ill I-SYMPTOM
defined I-SYMPTOM
left I-SYMPTOM
hemi-diaphragm I-SYMPTOM
without O
air B-SYMPTOM
space I-SYMPTOM
disease I-SYMPTOM
. O

On O
the O
lateral O
view O
, O
surgical B-TREATMENT
clips I-TREATMENT
in I-TREATMENT
the I-TREATMENT
abdomen I-TREATMENT
. O

EKG O
showed O
normal O
sinus O
rhythm O
, O
no O
ST B-SYMPTOM
or I-SYMPTOM
T I-SYMPTOM
wave I-SYMPTOM
changes I-SYMPTOM
. O

HOSPITAL O
COURSE O
AND O
TREATMENT B-TREATMENT
: O

Mr. O
Finger O
was O
admitted O
for O
what O
appeared O
to O
be O
a B-SYMPTOM
stroke I-SYMPTOM
syndrome I-SYMPTOM
involving O
his O
left O
middle O
cerebral O
artery O
territory O
. O

He O
underwent O
neurovascular O
doppler O
studies O
which O
showed O
no O
significant O
change O
in O
either O
common O
carotid O
or O
in O
the O
left O
common O
internal O
ophthalmic O
system O
. O

However O
, O
there O
were O
hemodynamic B-SYMPTOM
changes I-SYMPTOM
which O
raised O
the O
question O
of O
right B-SYMPTOM
siphon I-SYMPTOM
disease I-SYMPTOM
. O

He O
had O
normal O
cervical O
vertebral O
arteries O
. O

Transcranial O
dopplers O
showed O
no O
abnormalities B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
ophthalmic I-SYMPTOM
siphon I-SYMPTOM
systems I-SYMPTOM
, O
distal O
vertebrals O
, O
or O
proximal O
basilar O
artery O
. O

The O
proximal O
, O
middle O
, O
anterior O
and O
posterior O
cerebral O
arteries O
, O
however O
, O
could O
not O
be O
insinuated O
. O

Over O
the O
course O
of O
the O
first O
hospital O
day O
, O
the O
patient O
&apos;s O
exam O
deteriorated O
in O
a O
manner O
that O
appeared O
to O
be O
blood O
pressure O
dependent O
. O

He O
had O
been O
started O
on O
Heparin B-TREATMENT
from O
the O
time O
of O
his O
admission O
. O

A O
computerized O
tomography O
scan O
had O
showed O
multiple B-SYMPTOM
lacunes I-SYMPTOM
, O
right O
greater O
than O
left O
, O
and O
the O
deep O
gray O
and O
white O
matters O
suspicious O
for O
proximal B-SYMPTOM
middle I-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
stem I-SYMPTOM
occlusion I-SYMPTOM
or O
stenosis B-SYMPTOM
. O

MRI O
/ O
MRA O
was O
performed O
with O
diffusion O
weighted O
images O
, O
showing O
subcortical B-SYMPTOM
white I-SYMPTOM
matter I-SYMPTOM
and O
basal B-SYMPTOM
ganglia I-SYMPTOM
infarcts I-SYMPTOM
, O
but O
preserved O
middle O
cerebral O
artery O
territory O
cortex O
. O

Because O
of O
his O
blood O
pressure O
, O
dependence O
of O
his O
left O
sided O
extremities O
, O
the O
lower O
leg O
specifically O
, O
he O
was O
transferred O
to O
the O
Intensive O
Care O
Unit O
where O
he O
underwent O
hypertensive B-TREATMENT
therapy I-TREATMENT
for O
several O
days O
. O

His O
systolic O
blood O
pressure O
goal O
was O
initially O
170-190 O
, O
which O
he O
was O
able O
to O
achieve O
spontaneously O
for O
the O
most O
part O
. O

However O
, O
due O
to O
the O
absence O
of O
clear O
benefit O
at O
this O
level O
, O
and O
further B-SYMPTOM
deterioration I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
left I-SYMPTOM
sided I-SYMPTOM
strength I-SYMPTOM
, O
this O
goal O
was O
increased O
and O
Neo-Synephrine B-TREATMENT
was O
added O
to O
his O
regimen O
to O
achieve O
mean O
arterial O
pressures O
in O
the O
110-120 O
range O
. O

This O
strategy O
and O
its O
incumbent O
risks O
, O
particularly O
in O
a O
patient O
on O
Heparin B-TREATMENT
, O
were O
discussed O
at O
length O
with O
both O
the O
patient O
and O
his O
family O
, O
who O
were O
very O
clear O
in O
wanting O
to O
proceed O
with O
all O
possible O
efforts O
to O
save O
the O
use O
of O
his O
left O
leg O
. O

While O
in O
the O
Intensive O
Care O
Unit O
, O
his O
strength O
deteriorated O
from O
being O
able O
to O
hold O
his O
left O
leg O
off O
the O
bed O
up O
to O
several O
inches O
to O
loosing O
virtually O
all O
distal O
extremity O
strength O
, O
and O
having O
a O
2-3/5 O
power O
in O
his O
proximal O
left O
leg O
groups O
. O

He O
also O
, O
as O
Neo-Synephrinewas B-TREATMENT
tapered O
, O
developed O
mild B-SYMPTOM
sensory I-SYMPTOM
findings I-SYMPTOM
, O
in O
particular O
diminished B-SYMPTOM
large I-SYMPTOM
fiber I-SYMPTOM
sensibility I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
left I-SYMPTOM
hand I-SYMPTOM
, O
although O
he O
at O
times O
, O
including O
near O
the O
end O
of O
his O
Intensive O
Care O
Unit O
stay O
had O
a B-SYMPTOM
right I-SYMPTOM
gaze I-SYMPTOM
preference I-SYMPTOM
. O

In O
terms O
of O
exploring O
his O
visual O
space O
, O
he O
was O
able O
to O
look O
to O
the O
left O
, O
and O
it O
was O
not O
possible O
to O
elicit O
clear O
evidence O
for O
a B-SYMPTOM
field I-SYMPTOM
deficit I-SYMPTOM
. O

He O
was O
followed O
by O
speech O
and O
swallowing O
service O
, O
who O
assisted O
in O
the B-TREATMENT
management I-TREATMENT
of I-TREATMENT
po I-TREATMENT
intake I-TREATMENT
which O
gradually O
improved O
, O
although O
he O
clearly O
had O
problems O
with O
manipulation O
of O
food O
in O
the O
left O
side O
of O
his O
mouth O
and O
would O
tend O
to O
accumulate O
a O
pouch O
of O
food O
in O
his O
left O
cheek O
. O

I O
should O
mention O
that O
his B-TREATMENT
blood I-TREATMENT
pressure I-TREATMENT
therapy I-TREATMENT
was O
at O
times O
limited O
by O
a B-SYMPTOM
severe I-SYMPTOM
headache I-SYMPTOM
, O
although O
he O
also O
had O
this O
off O
the B-TREATMENT
pressor I-TREATMENT
. O

He O
had O
several O
repeat O
imaging O
studies O
during O
his O
Intensive O
Care O
Unit O
stay O
which O
showed O
further B-SYMPTOM
demarcation I-SYMPTOM
, O
but O
not O
extension B-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
prior I-SYMPTOM
infarct I-SYMPTOM
, O
both O
on O
computerized O
tomography O
scan O
and O
DWI O
images O
. O

Additionally O
, O
he O
had O
a O
perfusion O
, O
diffusion O
MR O
study O
earlier O
on O
, O
which O
suggested O
the O
presence O
of O
viable B-SYMPTOM
penumbra I-SYMPTOM
, O
including O
the O
overlying O
cortex O
. O

He O
was O
transferred O
to O
the O
regular O
neurology O
floor O
once O
it O
became O
clear O
that O
he O
was O
not O
receiving O
any O
significant O
benefit O
from O
hypertensive B-TREATMENT
therapy I-TREATMENT
. O

At O
this O
time O
, O
his O
neurologic O
exam O
is O
notable O
for O
hemiplegia B-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
left I-SYMPTOM
arm I-SYMPTOM
, O
severe B-SYMPTOM
hemiparesis I-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
left I-SYMPTOM
leg I-SYMPTOM
, O
mild B-SYMPTOM
large I-SYMPTOM
fiber I-SYMPTOM
sensory I-SYMPTOM
loss I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
left I-SYMPTOM
arm I-SYMPTOM
, O
and O
otherwise O
fairly O
intact O
mental O
status O
, O
cranial O
nerve O
function O
, O
and O
right O
sided O
motor O
and O
sensory O
function O
. O

We O
anticipate O
that O
he O
represents O
a O
good O
rehab O
potential O
. O

He O
will O
be O
discharged O
to O
rehab O
on O
a O
regimen O
of O
Coumadin B-TREATMENT
5 O
mg O
po O
today O
then O
daily O
for O
an O
INR O
goal O
of O
2-3 O
, O
Ofloxacin B-TREATMENT
400 O
mg O
po O
bid O
to O
be O
discontinued O
on O
11/05/96 O
, O
Dexedrine B-TREATMENT
5 O
mg O
po O
qd O
, O
Omeprazole B-TREATMENT
20mg O
po O
qd O
, O
Erythromycin B-TREATMENT
eye I-TREATMENT
ointment I-TREATMENT
OU O
bid O
, O
Heparin B-TREATMENT
at O
its O
present O
rate O
adjusting O
per O
partial O
thromboplastin O
time O
bid O
, O
and O
discontinuing O
when O
the B-TREATMENT
Coumadin I-TREATMENT
is O
therapeutic O
, O
Tylenol B-TREATMENT
650 O
mg O
po O
q4 O
prn O
, O
Colace B-TREATMENT
100 O
mg O
po O
bid O
. O

Follow O
up O
will O
be O
with O
Dr. O
Tvi O
Fine O
of O
Neurology O
, O
and O
Dr. O
Doll O
Grendbly O
of O
internal O
medicine O
and O
primary O
care O
, O
shortly O
after O
discharge O
from O
rehab O
. O

BETHTATCHA O
W O
R O
NEW O
, O
M.D. O

DICTATING O
FOR O
: O

TVI O
SHANEL O
WASHING O
, O
M.D O
, O
PhD O
. O

TR O
: O

tu O

DD O
: O

Halloween O

TD O
: O

10/31/96 O
2:55 O

Pcc O
: O

LASDAJENA O
WASHING O
, O
M.D. O
TELSHEY O
KO O
SWATLLEEBTIK O
, O
JR O
, O
M.D. O
TVI O
SHANEL O
WASHING O
, O
M.D. O
, O
Ph.D. O
DOLL O
MAO O
GRENDBLY O
, O
M.D. O
BETHTATCHA O
W O
R O
NIQUE O
DOUETMONES O
, O
III O
, O
M.D. O
STAT O

Admission O
Date O
: O

2019-06-25 O

Discharge O
Date O
: O

2019-07-01 O

Date O
of O
Birth O
: O

1950-04-19 O

Sex O
: O

M O

Service O
: O

CARDIOTHORACIC O

Allergies O
: O

Penicillins B-TREATMENT
/ O
Norvasc B-TREATMENT
/ O
Verapamil B-TREATMENT

Attending O
: O
Christopher O
Q O
Thompson O
, O
M.D. O

Chief O
Complaint O
: O

preop O
w/ O
for O
knee B-TREATMENT
surgery I-TREATMENT
revealed O
cardiac B-SYMPTOM
dz I-SYMPTOM
, O
asymptomatic B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

CABGx4 B-TREATMENT
( O
06-26 O
) O

History O
of O
Present O
Illness O
: O

69yoM O
with O
OA B-SYMPTOM
having O
workup O
for O
knee B-TREATMENT
replacements I-TREATMENT
found O
to O
be O
in O
Afib B-SYMPTOM
, O
had O
stress O
test O
that O
was O
positive O
followed O
by O
cardiac O
catheterization O
which O
revealed O
severe B-SYMPTOM
3VD I-SYMPTOM
. O

Then O
referred O
for O
CABG B-TREATMENT

Past O
Medical O
History O
: O

HTN B-SYMPTOM

chol B-SYMPTOM

AFib B-SYMPTOM

OA B-SYMPTOM
needs O
bilat B-TREATMENT
arthroplasty I-TREATMENT

CRI B-SYMPTOM

Social O
History O
: O

Lives O
with O
wife O
. O

Remote O
Timothy O
, O
quit O
1990 O
. O
+ O
ETOH O
( O
1-2 O
drinks O
/ O
Rivero O
) O

Family O
History O
: O

Brother O
died O
64 O
/ O
MI B-SYMPTOM

Physical O
Exam O
: O

Admission O

VS O
T O
98 O
HR O
74 O
BP O
136/88 O
RR O
18 O

Gen O
NAD B-SYMPTOM

Neuro O
A&Ox3 O
, O
nonfocal O

Chest O
CTA O
bilat O

CV O
irreg-irreg B-SYMPTOM
, O
no O
M/R B-SYMPTOM

Abdn O
soft O
, O
NT/ND/+BS B-SYMPTOM

Ext O
warm O
no O
edema B-SYMPTOM

Discharge O

T99.9 O
HR O
70AF O
BP O
120/69 O
RR O
20 O
O2sat O
94%RA O

Neuro O
A&Ox3 O
MAE O
, O
non O
focal O
exam O

Pulm O
CTAB O

CV O
irreg B-SYMPTOM
irreg I-SYMPTOM
, O
sternum B-SYMPTOM
stable I-SYMPTOM
incision I-SYMPTOM
CDI O

Abdm O
soft O
, O
NT/ND/+BS B-SYMPTOM

Ext O
warm O
2+ B-SYMPTOM
edema I-SYMPTOM

Pertinent O
Results O
: O

2019-06-25 O
04:10 O
PM O

GLUCOSE O
- O
97 O
UREA O
N O
- O
44 O
* O
CREAT O
- O
2.0 O
* O
SODIUM O
- O
143 O
POTASSIUM O
- O
4.1 O
CHLORIDE O
- O
107 O
TOTAL O
CO2 O
- O
27 O
ANION O
GAP O
- O
13 O

2019-06-25 O
04:10 O
PM O

ALT(SGPT) O
- O
19 O
AST(SGOT) O
- O
19 O
LD(LDH) O
- O
153 O
ALK O
PHOS O
- O
58 O
TOT O
BILI O
- O
0.4 O

2019-06-25 O
04:10 O
PM O

ALBUMIN O
- O
4.3 O

2019-06-25 O
04:10 O
PM O

%HbA1c O
- O
5.7 O

2019-06-25 O
04:10 O
PM O

TSH O
- O
1.2 O

2019-06-25 O
04:10 O
PM O

WBC O
- O
7.0 O
RBC O
- O
3.92 O
* O
HGB O
- O
12.6 O
* O
HCT O
- O
36.4 O
* O
MCV O
- O
93 O
MCH O
- O
32.1 O
* O
MCHC O
- O
34.6 O
RDW O
- O
13.6 O

2019-06-25 O
04:10 O
PM O

PLT O
COUNT O
- O
207 O

2019-06-25 O
04:10 O
PM O

PT O
- O
11.8 O
PTT O
- O
22.4 O
INR(PT) O
- O
1.0 O

2019-07-01 O
07:30 O
AM O
BLOOD O
WBC O
- O
8.7 O
RBC O
- O
3.18 O
* O
Hgb O
- O
10.4 O
* O
Hct O
- O
30.4 O
* O
MCV O
- O
96 O
MCH O
- O
32.7 O
* O
MCHC O
- O
34.3 O
RDW O
- O
13.5 O
Plt O
Ct O
- O
303 O

2019-07-01 O
07:30 O
AM O
BLOOD O
Plt O
Ct O
- O
303 O

2019-07-01 O
07:30 O
AM O
BLOOD O
PT O
- O
14.4 O
* O
PTT O
- O
24.2 O
INR(PT)- O
1.3 O
* O

2019-06-30 O
06:45 O
AM O
BLOOD O
Glucose O
- O
99 O
UreaN O
- O
40 O
* O
Creat O
- O
1.9 O
* O
Na O
- O
137 O
K O
- O
4.1 O
Cl O
- O
99 O
HCO3 O
- O
28 O
AnGap O
- O
14 O

CHEST O
( O
PORTABLE O
A O
P) O

2019-06-30 O
11:26 O
AM O

CHEST O
( O
PORTABLE O
AP O
) O

Reason O
: O
Effusion B-SYMPTOM
? O
Pntx B-SYMPTOM
? O

UNDERLYING O
MEDICAL O
CONDITION O
: O

69 O
year O
old O
man O
with O
s/p O
Off B-TREATMENT
Pump I-TREATMENT
CABG I-TREATMENT

REASON O
FOR O
THIS O
EXAMINATION O
: O

Effusion B-SYMPTOM
? O
Pntx B-SYMPTOM
? O

PORTABLE O
CHEST O
ON O
2019-06-30 O
AT O
11:39 O

INDICATION O
: O
CABG B-TREATMENT
with O
chest B-TREATMENT
tube I-TREATMENT
in O
place O
. O

COMPARISON O
: O
2019-06-29 O
. O

FINDINGS O
: O
Left B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
remains O
in O
place O
with O
some B-SYMPTOM
density I-SYMPTOM
adjacent I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
tip I-SYMPTOM
, O
but O
there O
is O
no O
significant B-SYMPTOM
interval I-SYMPTOM
change I-SYMPTOM
vs O
. O
prior O
. O

Specifically O
, O
there O
is O
no O
pneumothorax B-SYMPTOM
and O
no O
interval B-SYMPTOM
development I-SYMPTOM
of I-SYMPTOM
effusion I-SYMPTOM
. O

Cardiac O
silhouette O
and O
mediastinal O
contours O
are O
stable O
. O

IMPRESSION O
: O
No O
change O
vs O
. O
prior O
. O

DR. O
James O
A O
Roberts O

Brief O
Hospital O
Course O
: O

69 O
yo O
M O
with O
known B-SYMPTOM
Atrial I-SYMPTOM
fibrillation I-SYMPTOM
and O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
admitted O
preop O
for O
transition O
fro O
Coumadin B-TREATMENT
to O
Heparin B-TREATMENT
. O

Brought O
to O
the O
OR O
on O
06-26 O
for O
CABG B-TREATMENT
, O
please O
see O
OR O
report O
for O
details O
. O

In O
summary O
pt O
had O
off B-TREATMENT
pump I-TREATMENT
CABGx4 I-TREATMENT
with O
LIMA-LAD B-TREATMENT
, O
SVG B-TREATMENT
OM-Y I-TREATMENT
graft I-TREATMENT
- I-TREATMENT
Diag I-TREATMENT
, O
SVG-PDA B-TREATMENT
. O

Pt O
tolerated O
surgery B-TREATMENT
well O
and O
was O
transferred O
to O
CT O
CMED O
ICU O
. O

He O
did O
well O
in O
immediate O
post-op O
period O
was O
extubated B-TREATMENT
and O
on O
POD1 O
he O
was O
transferred O
to O
the O
step O
down O
floor O
. O

On O
POD2 O
his B-TREATMENT
chest I-TREATMENT
tubes I-TREATMENT
and O
epicardial B-TREATMENT
pacing I-TREATMENT
wires I-TREATMENT
were O
removed O
and O
his B-TREATMENT
Coumadin I-TREATMENT
was O
restarted O
. O

Over O
the O
next O
several O
days O
his O
activity O
was O
advanced O
on O
POD5 O
it O
was O
decided O
he O
was O
stable O
and O
ready O
to O
be O
discharged O
home O
with O
visiting O
nurses O
. O

Medications O
on O
Admission O
: O

Atenolol B-TREATMENT
200 O
' O

HCTZ B-TREATMENT
25 O
' O

Lisinopril B-TREATMENT
20 O
' O

Ultram B-TREATMENT
50 O
' O

Prilosec B-TREATMENT
20 O
' O

Zocor B-TREATMENT
40 O
' O

Levitra B-TREATMENT
/ O
prn O

Warfarin B-TREATMENT
4 O
' O

Discharge O
Medications O
: O

1. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
Ellis O
). O

Disp O
:* O
60 O
Tablet O
(s)* O
Refills O
:* O
2 O
* O

2. O
Furosemide B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
Leukhardt O
for O
2 O
weeks O
. O

Disp O
:* O
14 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

3. O
Potassium B-TREATMENT
Chloride I-TREATMENT
10 O
mEq O
Tablet O
Sustained O
Release O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
Sustained O
Release O
PO O
once O
a O
Sine O
for O
2 O
weeks O
. O

Disp O
:* O
28 O
Tablet O
Sustained O
Release O
(s)* O
Refills O
:* O
0 O
* O

4. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
Costa O
). O

Disp O
:* O
60 O
Capsule O
(s)* O
Refills O
:* O
2 O
* O

5. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
). O

Disp O
:* O
30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)(s)* O
Refills O
:* O
2 O
* O

6. O
Warfarin B-TREATMENT
2 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
once O
a O
Avrett O
: O
target O
INR O
1.5-2 O
. O

Disp O
:* O
60 O
Tablet O
(s)* O
Refills O
:* O
2 O
* O

7. O
Oxycodone B-TREATMENT
- I-TREATMENT
Acetaminophen I-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
every O
4-6 O
hours O
as O
needed O
for O
pain B-SYMPTOM
. O

Disp O
:* O
50 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

8. O
Simvastatin B-TREATMENT
40 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

Disp O
:* O
30 O
Tablet O
(s)* O
Refills O
:* O
2 O
* O

9. O
Prilosec B-TREATMENT
20 O
mg O
Capsule O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Capsule O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
once O
a O
Gray O
. O

10. O
Ultram B-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q6 O
hrs O
/ O
PRN O
. O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

s/p O
off B-TREATMENT
pump I-TREATMENT
CABGx4 I-TREATMENT
LIMA-LAD B-TREATMENT
,Y B-TREATMENT
SVG-OM-Diag, I-TREATMENT
SVG-PDA B-TREATMENT
( O
06-26 O
) O
PMH O
: O
HTN B-SYMPTOM
, O
chol B-SYMPTOM
, O
AF B-SYMPTOM
, O
OA B-SYMPTOM
, O
CRI B-SYMPTOM
, O
s/p O
bilat B-TREATMENT
knee I-TREATMENT
surgery I-TREATMENT

Discharge O
Condition O
: O

good O

Discharge O
Instructions O
: O

Keep O
wounds B-SYMPTOM
clean O
and O
dry O
. O

OK O
to O
shower O
, O
no O
bathing O
or O
swimming O
. O

Take O
all B-TREATMENT
medications I-TREATMENT
as O
prescribed O

Call O
for O
any O
fever B-SYMPTOM
, O
redness B-SYMPTOM
or O
drainage B-SYMPTOM
from O
wounds B-SYMPTOM
. O

Followup O
Instructions O
: O

Wound O
clinic O
in O
2 O
weeks O

Dr O
Anderson O
in O
2-3 O
weeks O

Dr O
Brown O
in O
4 O
weeks O

Ada O
Jordan O
MD O
62-102 O

Completed O
by O
: O
MARK O
Eugene O
NP O
80-AUO O
2019-07-01 O
@ O
1417 O

Signed O
electronically O
by O
: O
DR. O
Elizabeth O
P. O
Fernandez O
on O
: O
TUE O
2019-07-30 O
8:03 O
AM O

( O
End O
of O
Report O
) O

676650879 O
RWH O

8529404 O

689059 O

5100093 O

10/16/2005 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

DOUETNOUNBREUNKOLL O
, O
STENRESLYSE O

MRN O
: O

8529404 O

Age O
: O

55y O

REGISTRATION O
DATE O
: O

10/16/2005 O
10:38 O
AM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
DOUETNOUNBREUNKOLL O
, O
STENRESLYSE O
arrived O
in O
the O
Emergency O
Department O
at O
Ro O
Woodma O
Healthcare O
on O
10/16/2005 O
10:38 O
AM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
RLQ B-SYMPTOM
PAIN I-SYMPTOM
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
of O
the O
visit O
was O
admitted O
as O
an O
inpatient O
to O
Ro O
Woodma O
Healthcare O
. O

The O
patient O
&apos;s O
preliminary O
admitting O
physician O
is O
DALEJESC O
, O
OIE O
and O
the O
preliminary O
admitting O
diagnosis O
is O
CHOLECYSTITIS B-SYMPTOM
. O

Please O
note O
this O
information O
may O
have O
been O
updated O
on O
the O
inpatient O
unit O
. O

If O
you O
need O
additional O
information O
please O
call O
662-747-1199 O
. O

PCP O
Name O
: O

BREUTZFREIERM O
, O
VIENNEE O

Provider O
Number O
: O

98704 O

086326823 O

FIH O

6708320 O

235967 O

594818 O

8/24/1998 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O
NAME O
: O

RIEFF O
, O
ALB O
P O

UNIT O
NUMBER O
: O

185-64-30 O

ADMISSION O
DATE O
: O

08/24/1998 O

DISCHARGE O
DATE O
: O

09/14/1998 O

PRINCIPAL O
DIAGNOSIS O
: O

Sternal B-SYMPTOM
wound I-SYMPTOM
infection I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSES O
: O

Infected B-SYMPTOM
aortic I-SYMPTOM
graft I-SYMPTOM
. O

Hypertension B-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

08/31/98 O
ascending B-TREATMENT
aortic I-TREATMENT
root I-TREATMENT
replacement I-TREATMENT
with O
homograft B-TREATMENT
with O
omentopexy B-TREATMENT
. O

ASSOCIATED O
PROCEDURES O
: O

09/02/98 O
sternal B-TREATMENT
debridement I-TREATMENT
. O

Bilateral B-TREATMENT
pectoralis I-TREATMENT
major I-TREATMENT
myocutaneous I-TREATMENT
advancement I-TREATMENT
flap I-TREATMENT
. O

Right B-TREATMENT
superiorly I-TREATMENT
based I-TREATMENT
rectus I-TREATMENT
abdominis I-TREATMENT
flap I-TREATMENT
. O

Primary B-TREATMENT
closure I-TREATMENT
of O
wound B-SYMPTOM
. O

HISTORY O
AND O
REASON O
FOR O
HOSPITALIZATION O
: O

The O
patient O
is O
a O
79 O
year O
old O
gentleman O
with O
a O
history O
of O
an B-TREATMENT
ascending I-TREATMENT
aortic I-TREATMENT
graft I-TREATMENT
replacement I-TREATMENT
in O
1991 O
for O
aortic B-SYMPTOM
dissection I-SYMPTOM
. O

At O
that O
time O
the O
patient O
's O
hospital O
course O
was O
complicated O
by O
a B-SYMPTOM
sternal I-SYMPTOM
wound I-SYMPTOM
infection I-SYMPTOM
requiring O
a B-TREATMENT
sternal I-TREATMENT
debridement I-TREATMENT
and O
subsequent B-TREATMENT
abdominal I-TREATMENT
flap I-TREATMENT
. O

The O
patient O
was O
then O
continued O
by O
report O
on O
Dicloxacillin B-TREATMENT
for O
approximately O
one O
year O
following O
that B-TREATMENT
reconstructive I-TREATMENT
operation I-TREATMENT
. O

The O
patient O
apparently O
did O
well O
until O
June O
1998 O
when O
he O
noted O
a B-SYMPTOM
bulge I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
sternal I-SYMPTOM
area I-SYMPTOM
. O

A B-SYMPTOM
ruptured I-SYMPTOM
aneurysm I-SYMPTOM
or O
pseudoaneurysm B-SYMPTOM
at O
the O
junction O
of O
the B-TREATMENT
graft I-TREATMENT
and O
arch O
was O
diagnosed O
and O
this O
was O
subsequently O
repaired O
. O

The O
patient O
then O
had O
recurrent B-SYMPTOM
bleeding I-SYMPTOM
two O
weeks O
later O
which O
was O
once O
again O
repaired O
. O

However O
the B-SYMPTOM
same I-SYMPTOM
problem I-SYMPTOM
recurred O
for O
a O
third O
time O
and O
a O
computer O
tomogram O
scan O
at O
an O
outside O
hospital O
showed O
an B-SYMPTOM
anterior I-SYMPTOM
hematoma I-SYMPTOM
. O

By O
report O
the O
patient O
was O
at O
that O
time O
told O
that O
there O
was O
no O
more O
that O
could O
be O
done O
for O
him O
and O
was O
then O
apparently O
placed O
on O
comfort B-TREATMENT
measures I-TREATMENT
and O
pain B-TREATMENT
control I-TREATMENT
at O
the O
outside O
hospital O
. O

However O
the O
patient O
was O
then O
subsequently O
transferred O
to O
Fairm O
of O
Ijordcompmac O
Hospital O
upon O
request O
of O
the O
family O
on O
8/24/98 O
for O
further O
evaluation O
and O
possible O
intervention B-TREATMENT
. O

The O
patient O
was O
evaluated O
by O
Dr. O
Rhalt O
of O
Dentvailr. O
Medical O
Center O
. O

As O
the O
patient O
's O
early O
evaluation O
the O
patient O
underwent O
an O
aortogram O
which O
showed O
an B-TREATMENT
ascending I-TREATMENT
aortic I-TREATMENT
graft I-TREATMENT
with O
bulging B-SYMPTOM
flaps I-SYMPTOM
and O
a B-SYMPTOM
pseudoaneurysm I-SYMPTOM
at O
the O
anastomosis O
of O
the B-TREATMENT
graft I-TREATMENT
and O
arch O
just O
below O
the O
great O
vessels O
. O

There O
was O
no O
evidence O
for O
a B-SYMPTOM
definite I-SYMPTOM
leak I-SYMPTOM
but O
there O
was O
evidence O
for O
gas B-SYMPTOM
bubbles I-SYMPTOM
in O
the O
anterior O
posterior O
distal O
ends O
of O
the B-TREATMENT
grafts I-TREATMENT
consistent O
with O
an B-SYMPTOM
infectious I-SYMPTOM
process I-SYMPTOM
. O

At O
the O
same O
time O
the O
patient O
was O
seen O
in O
consultation O
by O
the O
Infectious O
Disease O
Service O
who O
upon O
culturing O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
sternal I-SYMPTOM
drainage I-SYMPTOM
switched O
the O
patient O
from O
intravenous B-TREATMENT
Unasyn I-TREATMENT
to O
Levofloxacin B-TREATMENT
for O
what O
appeared O
to O
be O
Citrobacter B-SYMPTOM
and O
Diphtheroids B-SYMPTOM
in O
the O
wound O
cultures O
. O

Subsequent O
to O
starting O
this B-TREATMENT
antibiotic I-TREATMENT
regimen I-TREATMENT
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
wound I-SYMPTOM
drainage I-SYMPTOM
appeared O
to O
subside O
. O

Given O
all O
the O
findings O
on O
the O
aortogram O
and O
the O
subsequent O
chest O
computer O
tomogram O
scan O
it O
was O
discovered O
that O
the O
patient O
's O
only O
real O
surgical O
option O
for O
cure O
was O
a B-TREATMENT
risky I-TREATMENT
operation I-TREATMENT
that O
involved O
removal B-TREATMENT
and I-TREATMENT
replacement I-TREATMENT
of I-TREATMENT
the I-TREATMENT
aortic I-TREATMENT
graft I-TREATMENT
probably O
with O
homograft B-TREATMENT
and O
long B-TREATMENT
term I-TREATMENT
antibiotic I-TREATMENT
coverage I-TREATMENT
as O
well O
as O
a B-TREATMENT
plastic I-TREATMENT
surgical I-TREATMENT
reconstructive I-TREATMENT
procedure I-TREATMENT
. O

The O
patient O
understood O
the O
risks O
and O
potential O
benefits O
of O
the B-TREATMENT
procedure I-TREATMENT
and O
was O
willing O
to O
proceed O
. O

The O
patient O
otherwise O
complained O
of O
no O
angina B-SYMPTOM
, O
no O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
no O
paroxysmal B-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
, O
no O
edema B-SYMPTOM
, O
no O
palpitations B-SYMPTOM
or O
symptoms O
of O
syncope B-SYMPTOM
. O

He O
did O
report O
a B-SYMPTOM
20 I-SYMPTOM
lbs I-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
over O
the O
last O
several O
months O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Thoracic B-TREATMENT
aneurysm I-TREATMENT
repair I-TREATMENT
. O

2. O
Hypertension B-SYMPTOM
. O

3. O
Status O
post O
hernia B-TREATMENT
repair I-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Lopressor B-TREATMENT
100 O
mg O
po O
three O
times O
a O
day O
. O

2. O
Captopril B-TREATMENT
75 O
mg O
po O
three O
times O
a O
day O
. O

3. O
Prilosec B-TREATMENT
20 O
mg O
po O
per O
day O
. O

4. O
Hydralazine B-TREATMENT
12.5 O
mg O
four O
times O
per O
day O
. O

5. O
Reglan B-TREATMENT
10 O
mg O
po O
three O
times O
a O
day O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

FAMILY O
HISTORY O
: O

Noncontributory O
. O

SOCIAL O
HISTORY O
: O

The O
patient O
was O
married O
and O
denied O
any O
tobacco O
or O
alcohol O
use O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
was O
afebrile B-SYMPTOM
, O
vital O
signs O
were O
stable O
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
exam O
: O

negative O
. O

Neck O
was O
supple O
. O

There O
was O
no O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
. O

2+ O
carotids O
without O
bruits B-SYMPTOM
. O

Cardiovascular O
exam O
: O

regular O
rate O
and O
rhythm O
with O
a B-SYMPTOM
2/6 I-SYMPTOM
diastolic I-SYMPTOM
___ O
and O
a B-SYMPTOM
1/6 I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
. O

His O
lungs O
were O
clear O
to O
auscultation O
bilaterally O
without O
any O
evidence O
for O
crackles B-SYMPTOM
. O

Extremities O
: O

the O
patient O
had O
2+ O
femoral O
pulses O
and O
1+ O
pedal O
pulses O
. O

LABORATORY O
AND O
RADIOLOGIC O
DATA O
: O

Sodium O
137 O
, O
potassium O
4.0 O
, O
blood O
urea O
nitrogen O
16 O
, O
creatinine O
.9 O
, O
white O
blood O
cell O
count O
4.9 O
, O
hematocrit O
29.7 O
, O
platelet O
count O
207 O
. O

The O
patient O
's O
preoperative O
chest O
x-ray O
showed O
bilateral B-SYMPTOM
effusions I-SYMPTOM
and O
bibasilar B-SYMPTOM
atelectasis I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

The B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
sternal I-SYMPTOM
incision I-SYMPTOM
had O
a O
superior O
edge O
that O
was O
dehisced B-SYMPTOM
with O
evidence O
for O
stay B-TREATMENT
sutures I-TREATMENT
and O
some O
superficial B-TREATMENT
closure I-TREATMENT
sutures I-TREATMENT
exposed O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
initially O
admitted O
to O
the O
Cardiac O
Surgical O
Service O
under O
Dr. O
Rhalt O
. O

The O
patient O
was O
admitted O
to O
the O
Cardiac O
Surgical O
Intensive O
Care O
Unit O
given O
the O
patient O
's O
precarious O
condition O
. O

Over O
the O
next O
several O
hospital O
days O
the O
patient O
underwent O
aortogram O
as O
well O
as O
chest O
computer O
tomogram O
as O
outlined O
earlier O
. O

The O
patient O
was O
also O
seen O
in O
consultation O
by O
the O
Infectious O
Disease O
Service O
as O
well O
as O
the O
Cardiology O
Service O
who O
assisted O
in O
managing O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
intermittent I-SYMPTOM
hypertension I-SYMPTOM
. O

The O
patient O
was O
also O
seen O
preoperatively O
in O
consultation O
by O
the O
Plastic O
Surgical O
Service O
for O
potential B-TREATMENT
sternal I-TREATMENT
reconstruction I-TREATMENT
. O

After O
lengthy O
discussions O
with O
the O
patient O
and O
the O
patient O
's O
family O
as O
well O
as O
the O
various O
consultant O
services O
it O
was O
decided O
that O
the O
patient O
was O
a O
viable O
candidate O
for O
aortic B-TREATMENT
root I-TREATMENT
replacement I-TREATMENT
procedure I-TREATMENT
using O
homograft B-TREATMENT
. O

This O
was O
obtained O
on O
08/30/98 O
by O
Dr. O
Niste O
Rhalt O
of O
the O
Cardiac O
Surgical O
Service O
. O

The O
patient O
was O
then O
subsequently O
taken O
to O
the O
Operating O
Room O
on O
08/31/98 O
with O
the O
preoperative O
diagnosis O
of O
ascending B-SYMPTOM
aortic I-SYMPTOM
graft I-SYMPTOM
infection I-SYMPTOM
. O

The B-TREATMENT
procedure I-TREATMENT
performed O
was O
homograft B-TREATMENT
replacement I-TREATMENT
of I-TREATMENT
the I-TREATMENT
ascending I-TREATMENT
aorta I-TREATMENT
with O
omentopexy B-TREATMENT
and O
an B-SYMPTOM
open I-SYMPTOM
chest I-SYMPTOM
. O

The O
aortic O
perfusions O
were O
via O
the O
femoral O
artery O
with O
venous O
return O
by O
the O
femoral O
vein O
. O

The O
cardiopulmonary O
bypass O
time O
was O
one O
hour O
and O
49 O
minutes O
. O

The B-TREATMENT
graft I-TREATMENT
used O
was O
a B-TREATMENT
homograft I-TREATMENT
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
fairly O
well O
and O
was O
transferred O
intubated B-TREATMENT
to O
the O
Cardiac O
Surgical O
Intensive O
Care O
Unit O
with O
his B-SYMPTOM
chest I-SYMPTOM
open I-SYMPTOM
. O

The O
immediate O
postoperative O
plans O
were O
for O
a O
short O
Intensive O
Care O
Unit O
stay O
and O
subsequent B-TREATMENT
plastic I-TREATMENT
surgical I-TREATMENT
reconstruction I-TREATMENT
of I-TREATMENT
the I-TREATMENT
patient I-TREATMENT
's I-TREATMENT
sternum I-TREATMENT
. O

The O
patient O
was O
transferred O
to O
the O
Cardiac O
Surgical O
Intensive O
Care O
Unit O
in O
stable O
condition O
. O

There O
he O
continued O
to O
be O
hemodynamically O
stable O
. O

Of O
note O
, O
intraoperatively O
multiple O
tissue O
cultures O
had O
been O
sent O
. O

In O
the O
Intensive O
Care O
Unit O
the O
patient O
was O
kept O
intubated B-TREATMENT
and O
sedated B-TREATMENT
until O
09/02/98 O
which O
was O
postoperative O
day O
no. O
1 O
following O
the B-TREATMENT
homograft I-TREATMENT
replacement I-TREATMENT
. O

On O
that O
day O
the O
Plastic O
Surgical O
Service O
performed O
further B-TREATMENT
sternal I-TREATMENT
debridement I-TREATMENT
and O
subsequent B-TREATMENT
reconstruction I-TREATMENT
using O
bilateral B-TREATMENT
pectoralis I-TREATMENT
major I-TREATMENT
myocutaneous I-TREATMENT
advancement I-TREATMENT
flaps I-TREATMENT
and O
right B-TREATMENT
superiorly I-TREATMENT
rectus I-TREATMENT
abdominis I-TREATMENT
flap I-TREATMENT
to O
cover O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
sternal I-SYMPTOM
wound I-SYMPTOM
with O
subsequent B-TREATMENT
primary I-TREATMENT
closure I-TREATMENT
of O
that B-SYMPTOM
wound I-SYMPTOM
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
and O
there O
were O
no O
complications B-SYMPTOM
. O

A O
number O
of O
indwelling B-TREATMENT
closed I-TREATMENT
suction I-TREATMENT
drains I-TREATMENT
were O
left O
in O
place O
so O
as O
to O
drain O
the O
bed O
underneath O
the O
muscle O
flaps O
. O

The O
patient O
was O
then O
transferred O
back O
to O
the O
Cardiac O
Surgical O
Intensive O
Care O
Unit O
in O
stable O
condition O
. O

At O
this O
point O
the O
patient O
continued O
to O
followed O
by O
Infectious O
Disease O
Service O
and O
continued O
to O
be O
on O
intravenous B-TREATMENT
antibiotics I-TREATMENT
which O
included O
Vancomycin B-TREATMENT
and O
Levofloxacin B-TREATMENT
. O

The O
Operating O
Room O
cultures O
at O
that O
point O
were O
positive O
for O
Crinobactermium B-SYMPTOM
with O
sputum O
cultures O
being O
sensitive O
for O
yeast B-SYMPTOM
and O
gram B-SYMPTOM
positive I-SYMPTOM
cocci I-SYMPTOM
in I-SYMPTOM
clusters I-SYMPTOM
. O

Over O
the O
next O
postoperative O
day O
the O
patient O
was O
awakened O
and O
weaned O
to O
extubate O
without O
significant B-SYMPTOM
difficulties I-SYMPTOM
. O

The O
patient O
's O
subsequent O
postoperative O
course O
was O
characterized O
by O
persistent B-SYMPTOM
hypertension I-SYMPTOM
which O
required O
a O
significant O
amount O
of O
antihypertensives B-TREATMENT
including O
Lopressor B-TREATMENT
100 O
mg O
po O
three O
times O
a O
day O
, O
Captopril B-TREATMENT
100 O
mg O
po O
three O
times O
a O
day O
, O
as O
well O
as O
Procardia B-TREATMENT
. O

The O
patient O
otherwise O
continued O
to O
do O
well O
and O
was O
becoming O
more O
oriented O
as O
time O
went O
on O
and O
as O
his O
blood O
pressure O
was O
brought O
under O
control O
. O

Subsequently O
on O
postoperative O
day O
no. O
8 O
in O
the O
Intensive O
Care O
Unit O
the O
patient O
was O
felt O
to O
be O
ready O
for O
transfer O
to O
the O
Cardiac O
Surgical O
Inpatient O
Service O
. O

The O
patient O
continued O
to O
be O
followed O
by O
the O
Infectious O
Disease O
Service O
who O
felt O
that O
the B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
Jackson I-TREATMENT
Pratt I-TREATMENT
drains I-TREATMENT
needed O
to O
stay O
in O
as O
there O
was O
still O
some B-SYMPTOM
significant I-SYMPTOM
drainage I-SYMPTOM
from O
them O
. O

As O
per O
the O
Infectious O
Disease O
Service O
the O
patient O
was O
continued O
on O
Levofloxacin B-TREATMENT
, O
Vancomycin B-TREATMENT
as O
antibiotic B-TREATMENT
coverage I-TREATMENT
. O

However O
on O
09/08/98 O
the O
Infectious O
Disease O
Service O
was O
made O
aware O
that O
the O
patient O
's O
intraoperative O
cultures O
had O
also O
grown O
out O
Mycoplasma B-SYMPTOM
humilius I-SYMPTOM
. O

Given O
this O
finding O
it O
was O
felt O
that O
the O
patient O
would O
certainly O
need O
long B-TREATMENT
term I-TREATMENT
intravenous I-TREATMENT
antibiotics I-TREATMENT
to O
include O
at O
least O
six O
weeks O
of O
Vancomycin B-TREATMENT
and O
then O
subsequent B-TREATMENT
Levofloxacin I-TREATMENT
for O
the B-SYMPTOM
Citrobacter I-SYMPTOM
and O
Mycoplasma B-SYMPTOM
as O
well O
. O

The O
patient O
was O
scheduled O
for O
peripherally B-TREATMENT
inserted I-TREATMENT
central I-TREATMENT
catheter I-TREATMENT
line I-TREATMENT
placement I-TREATMENT
knowing O
that O
he O
was O
going O
to O
need O
long B-TREATMENT
term I-TREATMENT
intravenous I-TREATMENT
antibiotics I-TREATMENT
. O

This O
was O
placed O
on O
postoperative O
day O
no. O
9 O
without O
any B-SYMPTOM
difficulty I-SYMPTOM
. O

At O
the O
same O
time O
the O
patient O
continued O
to O
be O
stable O
on O
his B-TREATMENT
antihypertensive I-TREATMENT
regimen I-TREATMENT
. O

He O
was O
becoming O
more O
mobile O
and O
was O
taking O
a B-TREATMENT
high I-TREATMENT
protein I-TREATMENT
high I-TREATMENT
calories I-TREATMENT
diet I-TREATMENT
which O
he O
tolerated O
well O
. O

He O
continued O
to O
be O
afebrile B-SYMPTOM
and O
otherwise O
very O
stable O
. O

On O
postoperative O
day O
no. O
12 O
the O
patient O
was O
noted O
to O
have O
fallen O
and O
subsequently O
dislocating O
the O
PIP O
joint O
of O
his O
left O
middle O
finger O
. O

Subsequent O
hand O
x-rays O
obtained O
showed O
no O
evidence O
of O
fracture B-SYMPTOM
but O
the O
patient O
was O
seen O
in O
consultation O
by O
the O
Plastic O
Surgery O
Hand O
Service O
. O

The O
patient O
will O
benefit O
from O
splinting B-TREATMENT
of I-TREATMENT
his I-TREATMENT
finger I-TREATMENT
while O
the B-SYMPTOM
swelling I-SYMPTOM
subsided O
and O
subsequent B-TREATMENT
early I-TREATMENT
mobilization I-TREATMENT
to O
prevent O
any B-SYMPTOM
rigidity I-SYMPTOM
in I-SYMPTOM
that I-SYMPTOM
joint I-SYMPTOM
. O

The O
patient O
was O
also O
seen O
subsequently O
in O
consultation O
by O
the O
Plastic O
Surgical O
Service O
who O
discontinued O
a O
number O
of O
the B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
indwelling I-TREATMENT
drains I-TREATMENT
but O
they O
felt O
that O
others O
needed O
to O
stay O
while O
the O
patient O
was O
sent O
to O
rehabilitation O
. O

These B-TREATMENT
drains I-TREATMENT
will O
then O
be O
subsequently O
taken O
out O
by O
Dr. O
General O
upon O
his O
followup O
with O
the O
patient O
. O

Prior O
to O
discharge O
the O
patient O
also O
underwent O
an O
audiogram O
as O
a O
baseline O
hearing O
test O
while O
the O
patient O
was O
to O
stay O
on O
long B-TREATMENT
term I-TREATMENT
intravenous I-TREATMENT
antibiotics I-TREATMENT
. O

The O
patient O
otherwise O
continued O
to O
be O
hemodynamically O
stable O
making O
good O
progress O
. O

As O
a O
matter O
of O
fact O
the O
patient O
made O
remarkable O
progress O
given O
the O
severity O
of O
his B-SYMPTOM
disease I-SYMPTOM
condition I-SYMPTOM
prior O
to O
the B-TREATMENT
operation I-TREATMENT
. O

The O
patient O
's O
condition O
continued O
to O
be O
improved O
. O

Given O
this O
finding O
the O
patient O
was O
therefore O
felt O
to O
be O
ready O
for O
discharge O
to O
a O
rehabilitation O
facility O
on O
09/13/1998 O
. O

In O
consultation O
with O
the O
Infectious O
Disease O
Service O
the O
patient O
was O
to O
stay O
on O
long B-TREATMENT
term I-TREATMENT
intravenous I-TREATMENT
antibiotics I-TREATMENT
. O

CONDITION O
ON O
DISCHARGE O
: O

Good O
. O

DISCHARGE O
INSTRUCTIONS O
: O

Diet O
: O

High B-TREATMENT
calorie I-TREATMENT
, I-TREATMENT
high I-TREATMENT
protein I-TREATMENT
. O

The B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
treatment I-TREATMENT
will O
include O
typical B-TREATMENT
peripherally I-TREATMENT
inserted I-TREATMENT
central I-TREATMENT
catheter I-TREATMENT
line I-TREATMENT
care I-TREATMENT
with O
frequent O
wound O
checks O
. O

The O
patient O
prior O
to O
discharge O
was O
fitted O
with O
an B-TREATMENT
orthoplast I-TREATMENT
finger I-TREATMENT
splint I-TREATMENT
as O
manufactured O
by O
Occupational O
Therapy O
Services O
Fairm O
of O
Ijordcompmac O
Hospital O
. O

The O
patient O
was O
also O
instructed O
in O
range B-TREATMENT
of I-TREATMENT
motion I-TREATMENT
exercises I-TREATMENT
for O
the O
left O
middle O
finger O
. O

The O
patient O
on O
discharge O
is O
to O
have O
twice O
weekly O
Vancomycin O
peak O
and O
trough O
levels O
while O
he O
continues O
on O
long B-TREATMENT
term I-TREATMENT
Vancomycin I-TREATMENT
therapy I-TREATMENT
. O

The O
patient O
was O
instructed O
to O
return O
to O
Fairm O
of O
Ijordcompmac O
Hospital O
if O
he O
developed O
any O
signs O
of O
wound B-SYMPTOM
infection I-SYMPTOM
such O
a B-SYMPTOM
erythema I-SYMPTOM
, O
drainage B-SYMPTOM
, O
or O
increasing B-SYMPTOM
incisional I-SYMPTOM
pain I-SYMPTOM
. O

The O
patient O
was O
instructed O
to O
be O
vigilant O
for O
any B-SYMPTOM
fevers I-SYMPTOM
or O
chills B-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Vancomycin B-TREATMENT
750 O
mg O
intravenous O
q O
18h. O

2. O
Levofloxacin B-TREATMENT
500 O
mg O
po O
per O
day O
. O

3. O
Prilosec B-TREATMENT
20 O
mg O
po O
per O
day O
. O

4. O
Captopril B-TREATMENT
100 O
mg O
po O
three O
times O
a O
day O
. O

5. O
Lopressor B-TREATMENT
100 O
mg O
po O
three O
times O
a O
day O
. O

6. O
Albuterol B-TREATMENT
nebulizers I-TREATMENT
q6h O
as O
needed O
. O

7. O
Atrovent B-TREATMENT
nebulizers I-TREATMENT
q6h O
as O
needed O
. O

8. O
Lasix B-TREATMENT
20 O
mg O
po O
per O
day O
. O

9. O
Kay-Ciel B-TREATMENT
20 O
mEq O
po O
per O
day O
. O

FOLLOWUP O
: O

The O
patient O
was O
instructed O
that O
he O
needed O
to O
followup O
with O
Dr. O
Rhalt O
by O
calling O
his O
office O
for O
appointment O
at O
763-6361 O
subsequent O
to O
his O
discharge O
to O
his O
rehabilitation O
facility O
in O
Oaksale O
Lavalle O
. O

The O
patient O
was O
also O
instructed O
to O
followup O
with O
Dr. O
Both O
of O
the O
Cardiology O
Service O
Fairm O
of O
Ijordcompmac O
Hospital O
following O
his O
discharge O
so O
that O
his B-TREATMENT
antihypertension I-TREATMENT
medications I-TREATMENT
could O
be O
appropriately O
adjusted O
. O

The O
patient O
will O
also O
be O
seen O
in O
followup O
by O
Dr. O
Chpo O
E. O
Enla O
General O
of O
the O
Plastic O
Surgery O
Service O
Fairm O
of O
Ijordcompmac O
Hospital O
so O
that O
his B-TREATMENT
indwelling I-TREATMENT
Jackson I-TREATMENT
Pratt I-TREATMENT
drains I-TREATMENT
be O
appropriately O
management O
and O
if O
needed O
be O
discontinued O
by O
him O
. O

The O
patient O
will O
also O
be O
followed O
by O
the O
Infectious O
Disease O
Service O
so O
as O
to O
ascertain O
the O
exact O
length O
and O
course O
of O
his B-TREATMENT
antibiotic I-TREATMENT
therapy I-TREATMENT
. O

The O
patient O
was O
instructed O
to O
followup O
with O
Dr. O
Naco O
Mesprhalt O
of O
the O
Infectious O
Disease O
Service O
by O
calling O
her O
office O
for O
an O
appointment O
at O
094-902-2879 O
to O
be O
seen O
in O
approximately O
four O
weeks O
following O
the O
patient O
's O
discharge O
. O

Dr. O
Dau O
's O
recommendation O
is O
that O
the O
patient O
is O
to O
stay O
on O
Vancomycin B-TREATMENT
and O
Levofloxacin B-TREATMENT
for O
approximately O
six O
weeks O
following O
discharge O
and O
then O
subsequently O
on O
antibiotic B-TREATMENT
regimen I-TREATMENT
for O
chronic B-TREATMENT
suppression I-TREATMENT
. O

RYNA O
DAU O
, O
M.D. O

DICTATING O
FOR O
: O

NISTE O
MA O
RHALT O
, O
M.D. O

TR O
: O

oq O

DD O
: O

09/13/1998 O

TD O
: O

09/13/1998 O
7:18 O
A O

cc O
: O

KEND O
N O
BOTH O
, O
M.D. O
CARDIAC O
FELLOWS O
ROOM O
LOLI O
MEMORIAL O
MEDICAL O
CENTER O
NACO O
MESPRHALT O
, O
M.D. O
INFECTIOUS O
DISEASE O
UNIT O
CIL O
HOSPITAL O
RYNA O
R O
DAU O
, O
M.D. O
SURGICAL O
RESIDENT O
SURG O
AG O
NISTE O
MA O
RHALT O
, O
M.D. O
SURGERY O
BROTROJEUNECOCK O
HEALTH O
CHPO O
E O
ENLA O
GENERAL O
, O
M.D. O
SURGERY O
ON O
HOSPITAL O
STAT O
EDITED O
09/15/1998 O
RJ O

Admission O
Date O
: O

2009-03-27 O

Discharge O
Date O
: O

2009-04-03 O

Date O
of O
Birth O
: O

1960-03-06 O

Sex O
: O

F O

Service O
: O

GYNECOLOGY O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
49-year-old O
gravida O
III O
, O
para O
II O
, O
who O
was O
sent O
from O
her O
primary O
care O
physician O
's O
office O
secondary O
to O
lower B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
. O

The O
patient O
is O
status O
post O
uterine B-TREATMENT
artery I-TREATMENT
embolization I-TREATMENT
on O
2009-01-07 O
secondary O
to O
fibroids B-SYMPTOM
. O

She O
has O
had O
continuing B-SYMPTOM
vaginal I-SYMPTOM
discharge I-SYMPTOM
, O
and O
was O
diagnosed O
with O
bacterial B-SYMPTOM
vaginosis I-SYMPTOM
one O
day O
prior O
to O
admission O
, O
and O
was O
given O
a O
prescription O
for O
Flagyl B-TREATMENT
. O

She O
noted O
increasing B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
two O
days O
prior O
to O
admission O
, O
which O
became O
more O
severe O
on O
the O
day O
prior O
to O
admission O
. O

She O
went O
to O
her O
primary O
care O
physician O
's O
office O
on O
the O
day O
of O
admission O
complaining O
of O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
which O
she O
stated O
was O
constant O
but O
intermittently O
sharper O
at O
times O
. O

The O
location O
was O
variable O
. O

She O
also O
complained O
of O
some B-SYMPTOM
loose I-SYMPTOM
stools I-SYMPTOM
on O
the O
day O
of O
admission O
, O
no O
nausea B-SYMPTOM
or O
vomiting B-SYMPTOM
. O

Her O
temperature O
was O
100.4 O
in O
the O
office O
, O
and O
she O
had O
no O
chills B-SYMPTOM
. O

She O
was O
sent O
for O
a O
CT O
scan O
of O
her O
abdomen O
, O
which O
revealed O
fluid B-SYMPTOM
and O
question O
of O
gas B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
endometrial I-SYMPTOM
cavity I-SYMPTOM
, O
and O
she O
was O
sent O
to O
Pinewood O
, O
Norfolk O
for O
treatment B-TREATMENT
and O
admission B-TREATMENT
. O

PAST O
OBSTETRICAL O
HISTORY O
: O

Cesarean B-TREATMENT
section I-TREATMENT
x O
2 O
, O
spontaneous B-SYMPTOM
abortion I-SYMPTOM
x O
1 O
. O

PAST O
GYNECOLOGIC O
HISTORY O
: O

Last O
menstrual O
period O
2009-02-21 O
. O

Some B-SYMPTOM
spotting I-SYMPTOM
on O
the O
day O
prior O
to O
admission O
, O
but O
not O
a O
normal O
period O
. O

Periods O
regular O
. O

Lupron B-TREATMENT
x O
three O
months O
prior O
to O
embolization B-TREATMENT
. O

Fibroid B-SYMPTOM
uterus I-SYMPTOM
status O
post O
embolization B-TREATMENT
on O
2009-01-07 O
. O

Dilatation B-TREATMENT
and I-TREATMENT
curettage I-TREATMENT
x O
1 O
for O
SAB B-SYMPTOM
. O

History O
of O
herpes B-SYMPTOM
simplex I-SYMPTOM
virus I-SYMPTOM
, O
last O
outbreak O
in O
2000 O
. O

No O
history O
of O
abnormal B-SYMPTOM
Pap I-SYMPTOM
smears I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

None O
. O

PAST O
SURGICAL O
HISTORY O
: O

Cesarean B-TREATMENT
section I-TREATMENT
x O
2 O
, O
dilatation B-TREATMENT
and I-TREATMENT
curettage I-TREATMENT
x O
1 O
, O
neck B-TREATMENT
fusion I-TREATMENT
after O
motor O
vehicle O
accident O
, O
shoulder B-TREATMENT
surgery I-TREATMENT
after O
motor O
vehicle O
accident O
. O

MEDICATIONS O
: O

Flagyl B-TREATMENT
. O

ALLERGIES O
: O

None O
. O

SOCIAL O
HISTORY O
: O

No O
smoking O
, O
alcohol O
or O
drugs O
. O

PHYSICAL O
EXAMINATION O
: O

Temperature O
100.4 O
, O
pulse O
108 O
, O
respirations O
20 O
, O
blood O
pressure O
110/70 O
, O
oxygen O
saturation O
100% O
on O
room O
air O
. O

In O
general O
, O
she O
was O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

Her O
abdomen O
was O
notable O
for O
voluntary B-SYMPTOM
guarding I-SYMPTOM
but O
no O
involuntary B-SYMPTOM
guarding I-SYMPTOM
or O
rebound B-SYMPTOM
, O
mild B-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
tenderness I-SYMPTOM
greater O
than O
left O
lower O
quadrant O
, O
nondistended B-SYMPTOM
. O

Her O
pelvic O
examination O
was O
notable O
for O
some B-SYMPTOM
brownish I-SYMPTOM
discharge I-SYMPTOM
. O

Her O
uterus O
and O
adnexa O
were O
difficult O
to O
assess O
secondary O
to O
voluntary B-SYMPTOM
tensing I-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
abdomen I-SYMPTOM
. O

ASSESSMENT O
: O

This O
is O
a O
49-year-old O
gravida O
III O
, O
para O
II O
, O
status B-TREATMENT
post I-TREATMENT
uterine I-TREATMENT
artery I-TREATMENT
embolization I-TREATMENT
on O
2009-01-07 O
due O
to O
uterine B-SYMPTOM
fibroids I-SYMPTOM
, O
with O
continued B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
and O
CT O
scan O
revealing O
fluid B-SYMPTOM
and I-SYMPTOM
gas I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
endometrial I-SYMPTOM
cavity I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
and O
was O
initially O
started O
on O
intravenous B-TREATMENT
ampicillin I-TREATMENT
, O
gentamicin B-TREATMENT
and O
clindamycin B-TREATMENT
. O

Her O
initial O
white O
blood O
cell O
count O
was O
11.3 O
, O
with O
a O
normal O
differential O
. O

Her O
sedimentation O
rate O
was O
elevated B-SYMPTOM
at O
110 O
. O

Her O
electrolytes O
were O
within O
normal O
limits O
. O

She O
was O
maintained O
on O
intravenous B-TREATMENT
antibiotics I-TREATMENT
. O

On O
hospital O
day O
number O
three O
, O
her O
blood O
cultures O
came O
back O
positive B-SYMPTOM
in O
the O
anaerobic O
culture O
for O
gram-positive B-SYMPTOM
cocci I-SYMPTOM
in I-SYMPTOM
pairs I-SYMPTOM
and I-SYMPTOM
clusters I-SYMPTOM
. O

Further O
identification O
revealed O
staphylococcus B-SYMPTOM
coag-negative I-SYMPTOM
, O
which O
was O
sensitive O
to O
gentamicin B-TREATMENT
and O
clindamycin B-TREATMENT
. O

She O
was O
continued O
on O
her B-TREATMENT
antibiotics I-TREATMENT
, O
and O
was O
afebrile B-SYMPTOM
until O
hospital O
day O
number O
five O
, O
when O
she O
had O
a B-SYMPTOM
temperature I-SYMPTOM
spike I-SYMPTOM
to O
102.3 O
. O

Repeat O
blood O
cultures O
were O
sent O
. O

Her O
white O
blood O
cell O
count O
was O
12.8 O
, O
with O
a O
normal O
differential O
. O

At O
this O
time O
, O
an O
Infectious O
Disease O
consult O
was O
obtained O
, O
and O
the O
recommendation O
was O
to O
discontinue O
the B-TREATMENT
ampicillin I-TREATMENT
, O
gentamicin B-TREATMENT
and O
clindamycin B-TREATMENT
, O
and O
start O
her O
on O
intravenous B-TREATMENT
Unasyn I-TREATMENT
. O

She O
underwent O
a O
pelvic O
ultrasound O
and O
an O
abdomen O
and O
pelvis O
CT O
, O
which O
revealed O
continued B-SYMPTOM
air I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
endometrial I-SYMPTOM
cavity I-SYMPTOM
vs. O
in O
the B-SYMPTOM
fundal I-SYMPTOM
fibroid I-SYMPTOM
. O

Discussion O
was O
had O
at O
this O
time O
with O
the O
patient O
regarding O
whether O
or O
not O
this O
represented O
an B-SYMPTOM
infected I-SYMPTOM
abscess I-SYMPTOM
vs. O
post-surgical B-SYMPTOM
change I-SYMPTOM
. O

Extensive O
discussion O
was O
held O
, O
and O
second O
opinion O
was O
obtained O
regarding O
the O
need O
for O

possible O
drainage B-TREATMENT
of O
the B-SYMPTOM
abscess I-SYMPTOM
vs. O
hysterectomy B-TREATMENT
. O

The O
patient O
requested O
an O
outside O
second O
opinion O
, O
as O
she O
was O
reluctant O
to O
undergo O
hysterectomy B-TREATMENT
at O
this O
time O
. O

She O
was O
discharged O
to O
home O
on O
hospital O
day O
number O
eight O
, O
on O
oral B-TREATMENT
antibiotics I-TREATMENT
. O

The O
patient O
was O
to O
have O
a O
repeat O
CT O
scan O
in O
one O
week O
. O

She O
was O
also O
to O
obtain O
a O
second O
opinion O
regarding O
the O
question O
of O
possible O
surgical B-TREATMENT
management I-TREATMENT
. O

Claude O
U O
Bolanos O
, O
M.D. O

95-182 O

Dictated O
By O
: O
William O
MP O
Lajoie O
, O
M.D. O

MEDQUIST36 O

D O
: O
2009-04-02 O
22:09 O

T O
: O
2009-04-03 O
01:26 O

JOB O
#: O

61261 O

Signed O
electronically O
by O
: O
DR. O
Suzanne O
Simpson O
on O
: O
FRI O
2009-04-24 O
12:48 O
PM O

( O
End O
of O
Report O
) O

537167143 O

FIH O

1543338 O

75053/sqyo O

326247 O

12/3/1993 O
12:00:00 O
AM O

PAPILLARY B-SYMPTOM
ADENOCARCINOMA I-SYMPTOM
OF I-SYMPTOM
THE I-SYMPTOM
LUNG I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

12-3-93 O

DISCHARGE O
DATE O
: O

12-10-93 O

PRINCIPAL O
DIAGNOSIS O
: O

Papillary B-SYMPTOM
adenocarcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lung I-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

A O
flexible O
bronchoscopy O
and O
extrapleural-pleural B-TREATMENT
lobectomy I-TREATMENT
on O
12-4-93 O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
47 O
year O
old O
white O
male O
with O
a O
history O
of O
emphysema B-SYMPTOM
who O
presents O
for O
admission O
with O
a O
diagnosis O
of O
broncho-alveolar B-SYMPTOM
carcinoma I-SYMPTOM
and O
is O
scheduled O
for O
flexible O
bronchoscopy O
, O
mediastinoscopy O
and O
thoracotomy B-TREATMENT
with O
questionable O
pneumonectomy B-TREATMENT
by O
Dr. O
An O
on O
12-4-93 O
. O

The O
patient O
is O
a O
native O
of O
Nahuter O
with O
a O
70+ O
pack O
year O
smoking O
history O
( O
2 O
1/2-3 O
pack O
per O
day O
x O
35 O
years O
) O
whose O
symptoms O
began O
last O
12/92 O
when O
he O
had O
a B-SYMPTOM
persistent I-SYMPTOM
cough I-SYMPTOM
and O
fever B-SYMPTOM
. O

In O
six O
months O
, O
he O
was O
hospitalized O
for O
pneumonia B-SYMPTOM
x O
four O
. O

He O
has O
had O
worsening B-SYMPTOM
dyspnea I-SYMPTOM
and O
paroxysmal B-SYMPTOM
nocturnal I-SYMPTOM
dyspnea I-SYMPTOM
, O
though O
denies O
orthopnea B-SYMPTOM
. O

No O
hemoptysis B-SYMPTOM
, O
no O
fevers B-SYMPTOM
, O
chills B-SYMPTOM
, O
sweats B-SYMPTOM
, O
when O
pneumonia B-SYMPTOM
resolved O
. O

The O
patient O
also O
noticed O
a B-SYMPTOM
loss I-SYMPTOM
of I-SYMPTOM
weight I-SYMPTOM
of O
approximately O
25 O
pounds O
over O
a O
few O
months O
with O
increased B-SYMPTOM
fatigue I-SYMPTOM
and O
lower B-SYMPTOM
extremity I-SYMPTOM
weakness I-SYMPTOM
. O

A B-SYMPTOM
&quot; I-SYMPTOM
spot I-SYMPTOM
&quot; I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
on O
chest O
X-ray O
was O
noted O
in O
October O
of O
1993 O
, O
after O
his B-SYMPTOM
pneumonia I-SYMPTOM
cleared O
. O

A O
follow O
up O
chest O
computerized O
tomography O
scan O
led O
to O
a O
tissue O
biopsy O
via O
flexible O
bronchoscopy O
in O
07/93 O
. O

Tissue O
returned O
well B-SYMPTOM
differentiated I-SYMPTOM
adenocarcinoma I-SYMPTOM
. O

The O
patient O
was O
told O
nothing O
could O
be O
done O
until O
he O
was O
referred O
to O
Dr. O
An O
. O

His O
appetite O
has O
been O
good O
and O
he O
has O
only O
complained O
of O
occasional B-SYMPTOM
sharp I-SYMPTOM
pain I-SYMPTOM
under I-SYMPTOM
his I-SYMPTOM
rib I-SYMPTOM
cage I-SYMPTOM
, O
right O
greater O
than O
left O
. O

ALLERGIES O
: O

The O
patient O
is O
allergic B-SYMPTOM
to O
Percodan B-TREATMENT
, O
which O
gives O
him O
itchiness B-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Triamcinolone B-TREATMENT
, O
one O
tablet O
PO O
b.i.d. O
, O
dosage O
unknown O
, O
Xanax B-TREATMENT
one O
tablet O
PO O
t.i.d. O
, O
prn O
anxiety B-SYMPTOM
, O
dosage O
unknown O
, O
MS B-TREATMENT
Contin I-TREATMENT
prn O
. O

PAST O
MEDICAL O
HISTORY O
: O

Distant B-SYMPTOM
peptic I-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
, O
thumb B-SYMPTOM
and I-SYMPTOM
middle I-SYMPTOM
finger I-SYMPTOM
lost I-SYMPTOM
secondary O
to O
lawnmower O
accident O
at O
age O
five O
years O
, O
no O
peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

The O
patient O
is O
status O
post O
partial B-TREATMENT
gastrectomy I-TREATMENT
for O
peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
in O
1965 O
. O

REVIEW O
OF O
SYSTEMS O
: O

The O
review O
of O
systems O
was O
notable O
for O
anxiety B-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
examination O
, O
he O
is O
a O
cachectic O
white O
male O
looking O
older O
than O
his O
stated O
age O
, O
who O
is O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
examination O
was O
within O
normal O
limits O
. O

The O
neck O
showed O
a B-SYMPTOM
1 I-SYMPTOM
x I-SYMPTOM
1 I-SYMPTOM
centimeter I-SYMPTOM
submaxillary I-SYMPTOM
right I-SYMPTOM
lymph I-SYMPTOM
node I-SYMPTOM
. O

It O
was O
otherwise O
supple O
, O
with O
no O
thyromegaly B-SYMPTOM
. O

His O
chest O
and O
axillae O
showed O
no O
supraclavicular B-SYMPTOM
or I-SYMPTOM
axillary I-SYMPTOM
adenopathy I-SYMPTOM
. O

The O
lung O
sounds O
were O
rhonchorous B-SYMPTOM
, O
otherwise O
clear O
to O
auscultation O
and O
percussion O
. O

Cardiovascular O
exam O
: O

regular O
rate O
and O
rhythm O
, O
normal O
Sl O
and O
S2 O
, O
no O
murmur B-SYMPTOM
, O
rub B-SYMPTOM
or O
gallop B-SYMPTOM
. O

Abdomen O
: O

scaphoid O
, O
positive O
bowel O
sounds O
, O
no O
palpable B-SYMPTOM
masses I-SYMPTOM
, O
with O
a B-SYMPTOM
parasagittal I-SYMPTOM
scar I-SYMPTOM
right O
of O
the O
midline O
. O

Extremities O
: O

Pulses O
were O
2+ O
and O
symmetrical O
, O
no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

The O
neurological O
examination O
was O
nonfocal O
. O

LABORATORY O
DATA O
: O

Admission O
sodium O
of O
136 O
, O
potassium O
3.8 O
, O
chloride O
99 O
, O
bicarbonate O
27.3 O
, O
BUN O
and O
creatinine O
of O
13 O
and O
0.6 O
, O
glucose O
86 O
, O
calcium O
9.3 O
, O
liver O
function O
tests O
notable O
for O
an O
albumin O
of O
2.5 O
, O
globulin O
4.5 O
. O

The O
complete O
blood O
count O
on O
admission O
showed O
a O
white O
blood O
count O
of O
14.5 O
, O
hematocrit O
31.0 O
, O
hemoglobin O
10.3 O
and O
platelet O
count O
478,000 O
. O

The O
arterial O
blood O
gases O
on O
room O
air O
were O
7.46/70/41 O
. O

The O
pulmonary O
function O
tests O
revealed O
an O
FEV1 O
of O
1.51 O
, O
FVC O
2.72 O
, O
and O
FEV1/FVC O
ratio O
of O
56% O
. O

DLCO O
was O
2 O
, O
or O
19% O
of O
predicted O
. O

HOSPITAL O
COURSE O
: O

A O
quantitative O
V O
/ O
Q O
scan O
was O
also O
done O
preoperatively O
and O
Pulmonary O
consult O
was O
obtained O
preoperatively O
. O

Pulmonary O
recommended O
that O
he O
just O
be O
started O
on O
Albuterol B-TREATMENT
and O
Atrovent B-TREATMENT
metered I-TREATMENT
dose I-TREATMENT
inhalers I-TREATMENT
, O
2 O
puffs O
q6h O
, O
prior O
to O
surgery B-TREATMENT
. O

The O
patient O
underwent O
his B-TREATMENT
procedure I-TREATMENT
on O
12-4-93 O
, O
without O
complications B-SYMPTOM
. O

Findings O
included O
thickened B-SYMPTOM
pleura I-SYMPTOM
with O
multiple B-SYMPTOM
adhesions I-SYMPTOM
and O
an B-SYMPTOM
abscess I-SYMPTOM
near I-SYMPTOM
the I-SYMPTOM
margin I-SYMPTOM
major I-SYMPTOM
fissure I-SYMPTOM
. O

He O
had O
a B-SYMPTOM
firm I-SYMPTOM
nodule I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
. O

The O
patient O
was O
transferred O
to O
the O
Respiratory O
Intensive O
Care O
Unit O
in O
stable O
condition O
and O
had O
an O
uneventful O
stay O
there O
. O

He O
had O
oxygen O
saturations O
of O
99% O
with O
an O
Fi02 O
of O
40% O
and O
had O
no O
complaints O
. O

He O
was O
transferred O
to O
the O
floor O
on O
postoperative O
day O
number O
one O
and O
tolerated O
his O
PO&apos;s O
well O
. O

His O
left O
lower O
lobe O
micro O
results O
revealed O
alpha B-SYMPTOM
hemolytic I-SYMPTOM
Streptococcus I-SYMPTOM
on O
culture O
and O
he O
was O
then O
switched O
to O
penicillin B-TREATMENT
and O
Gentamicin B-TREATMENT
after O
being O
started O
on O
triples O
of O
Flagyl B-TREATMENT
, O
Ampicillin B-TREATMENT
, O
and O
Gentamicin B-TREATMENT
. O

He O
had O
low B-SYMPTOM
grade I-SYMPTOM
temperatures I-SYMPTOM
, O
though O
did O
not O
spike O
a B-SYMPTOM
high I-SYMPTOM
temperature I-SYMPTOM
during O
his O
hospital O
course O
. O

His O
hospital O
course O
was O
otherwise O
uneventful O
and O
the O
patient O
was O
discharged O
in O
stable O
condition O
on O
postoperative O
day O
, O
afebrile B-SYMPTOM
. O

The O
chest O
X-ray O
on O
the O
morning O
of O
discharge O
was O
unchanged O
from O
the O
previous O
day O
, O
with O
slight B-SYMPTOM
increase I-SYMPTOM
in I-SYMPTOM
left I-SYMPTOM
pleural I-SYMPTOM
fluid I-SYMPTOM
. O

He O
had O
completed O
six O
days O
of O
penicillin B-TREATMENT
and O
Gentamicin B-TREATMENT
and O
was O
discharged O
on O
Ciprofloxacin B-TREATMENT
and O
Flagyl B-TREATMENT
for O
the O
next O
seven O
days O
. O

He O
stayed O
at O
the O
local O
Comfort O
Inn O
before O
his O
return O
back O
to O
Aujer O
Cin O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Tylenol B-TREATMENT
# I-TREATMENT
3 I-TREATMENT
, O
Xanax B-TREATMENT
, O
Ciprofloxacin B-TREATMENT
, O
Flagyl B-TREATMENT
. O

TVI O
POST O
, O
M.D. O

DICTATING O
FOR O
: O

REG O
V. O
POST O
, O
M.D. O

TR O
: O

xr O
/ O
bmot O

DD O
: O

1-4-94 O

TD O
: O

01/05/94 O

CC O
: O

Admission O
Date O
: O

2015-08-22 O

Discharge O
Date O
: O

2015-08-26 O

Date O
of O
Birth O
: O

1946-09-05 O

Sex O
: O

M O

Service O
: O

CMED O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Leroy O
F O
Stalnaker O
, O
M.D. O

Chief O
Complaint O
: O

Right-sided B-SYMPTOM
weakness I-SYMPTOM
and O
difficulty B-SYMPTOM
speaking I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

TPA B-TREATMENT
administration I-TREATMENT

History O
of O
Present O
Illness O
: O

68 O
year O
old O
right O
handed O
man O
with O
multiple B-SYMPTOM
vascular I-SYMPTOM
risk I-SYMPTOM
factors I-SYMPTOM
, O
including O
2 B-SYMPTOM
previous I-SYMPTOM
strokes I-SYMPTOM
and O
two B-SYMPTOM
myocardial I-SYMPTOM
infarctions I-SYMPTOM
, O
hypertension B-SYMPTOM
and O
hypercholesterolemia B-SYMPTOM
, O
who O
presents O
with O
acute B-SYMPTOM
onset I-SYMPTOM
right I-SYMPTOM
sided I-SYMPTOM
hemiplegia I-SYMPTOM
and O
dysarthria B-SYMPTOM
. O

He O
went O
to O
the O
bathroom O
on O
his O
own O
at O
6:12 O
AM O
and O
then O
called O
for O
help O
at O
6:15 O
AM O
. O

His O
wife O
found O
him O
with O
weak B-SYMPTOM
right I-SYMPTOM
leg I-SYMPTOM
, O
flaccid B-SYMPTOM
right I-SYMPTOM
arm I-SYMPTOM
, O
and O
severe B-SYMPTOM
dysarthria I-SYMPTOM
. O

She O
called O
911 O
and O
he O
was O
brought O
to O
Hahnemann O
General O
Hospital O
Lydia O
. O

ROS O
: O

Wife O
denies O
any B-SYMPTOM
recent I-SYMPTOM
bleeding I-SYMPTOM
, O
surgeries B-TREATMENT
, O
or O
upper B-SYMPTOM
respiratory I-SYMPTOM
infection I-SYMPTOM
. O

Past O
Medical O
History O
: O

1. O
1992 O
anterior B-SYMPTOM
cerebellar I-SYMPTOM
infarction I-SYMPTOM

2. O
Silent B-SYMPTOM
stroke I-SYMPTOM
affecting O
anterior O
part O
of O
brain O

3. O
2014-09-24 O
left B-SYMPTOM
MCA I-SYMPTOM
stroke I-SYMPTOM
leaving O
him O
with O
right B-SYMPTOM
facial I-SYMPTOM
droop I-SYMPTOM

4. O
CAD B-SYMPTOM
with O
MI B-SYMPTOM
1999 O
and O
CABG B-TREATMENT

5. O
hypercholesterolinemia B-SYMPTOM

6. O
hypertension B-SYMPTOM

7. O
remote O
smoking O
history O

8. O
depression B-SYMPTOM

9. O
bipolar B-SYMPTOM
disorder I-SYMPTOM

Social O
History O
: O

He O
is O
N. O
Quinn O
educated O
retired O
data O
processor O
who O
lives O
with O
his O
wife O
. O

Brian O
quit O
smoking O
and O
drinking O
in O
1980s O
. O

No O
history O
of O
ivdu O

Family O
History O
: O

Patient O
's O
mother O
died O
of O
stroke B-SYMPTOM
at O
the O
age O
of O
54 O
. O

Physical O
Exam O
: O

Vitals O
97.2 O
164/97 O
59 O
20 O
100% O
room O
air O

General O
exam O
including O
head O
, O
neck O
, O
heart O
, O
lung O
, O
abdominal O
and O
extremity O
exam O
, O
was O
normal O
. O

Neuro O
exam O
: O

Awake O
, O
oriented O
to O
person O
and O
place O

Nonfluent B-SYMPTOM
speech I-SYMPTOM
with O
inability O
to O
repeat O
. O

Intact O
to O
simple O
comprehension O
such O
as O
" O
show O
your O
left O
hand O
" O
but O
not O
" O
show O
your O
left O
thumb O
" O
. O

No O
neglect B-SYMPTOM

CN O
- O
Pupil O
3 O
to O
2 O
mm O
reactive O
bilaterally O
. O

EOMI O
. O

Visual O
field O
full O
to O
hand O
waving O
. O

Right B-SYMPTOM
facial I-SYMPTOM
droop I-SYMPTOM
. O

Motor O
- O
Decreased B-SYMPTOM
tone I-SYMPTOM
on I-SYMPTOM
right I-SYMPTOM
arm I-SYMPTOM
. O

Unable O
to O
move O
right O
arm O
but O
able O
to O
lift O
right O
leg O
antigravity O
for O
less O
than O
5 O
seconds O

Sensory O
- O
Dense B-SYMPTOM
loss I-SYMPTOM
to O
touch O
on O
the O
right O
arm O
and O
leg O

Reflex O
- O
1+ O
/ O
4 O
in O
upper O
extremity O
, O
2+ O
/ O
4 O
at O
patellar O
, O
trace O
ankle O
. O

Toe O
upgoing O
on O
right O
only O
. O

Coordination O
: O

Intact O
on O
left O
finger O
to O
nose O
but O
limited B-SYMPTOM
on O
right O
due O
to O
weakness B-SYMPTOM

Pertinent O
Results O
: O

Creatinine B-SYMPTOM
slightly I-SYMPTOM
elevated I-SYMPTOM
at O
1.3 O
, O
otherwise O
CBC O
, O
chemistries O
normal O
. O

Cardiac O
enzymes O
normal O
. O

Valproate O
level O
within O
range O
. O

CT O
head O
: O

Slight B-SYMPTOM
effacement I-SYMPTOM
of I-SYMPTOM
posterior I-SYMPTOM
insular I-SYMPTOM
cortex I-SYMPTOM
. O

MRI O
head O
: O

Restricted B-SYMPTOM
diffusion I-SYMPTOM
in I-SYMPTOM
left I-SYMPTOM
frontotemporal I-SYMPTOM
region I-SYMPTOM
in O
the O
distribution O
of O
the O
right O
middle O
cerebral O
artery O
indicating O
acute B-SYMPTOM
infarct I-SYMPTOM
. O

Brain B-SYMPTOM
atrophy I-SYMPTOM
. O

Changes O
of O
small B-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
and O
chronic B-SYMPTOM
lacunes I-SYMPTOM
bilaterally I-SYMPTOM
in I-SYMPTOM
basal I-SYMPTOM
ganglia I-SYMPTOM
. O

Probable O
chronic B-SYMPTOM
infarct I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
occipital I-SYMPTOM
cortex I-SYMPTOM
. O

Also O
a B-SYMPTOM
chronic I-SYMPTOM
infarction I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
cerebellum I-SYMPTOM
. O

No O
acute B-SYMPTOM
hemorrhage I-SYMPTOM
. O

MRA O
: O

Subtle B-SYMPTOM
decreased I-SYMPTOM
flow I-SYMPTOM
signal I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
Sylvian I-SYMPTOM
branches I-SYMPTOM
of O
the O
left O
middle O
cerebral O
artery O
. O

No O
evidence O
of O
major B-SYMPTOM
vascular I-SYMPTOM
occlusion I-SYMPTOM
seen O
. O

Carotid O
ultrasound O
: O

No O
stenosis B-SYMPTOM

Echo O
: O

Elongated B-SYMPTOM
left I-SYMPTOM
atrium I-SYMPTOM
. O

LV B-SYMPTOM
cavity I-SYMPTOM
moderately I-SYMPTOM
dilated I-SYMPTOM
. O

LVEF O
30-35% O
. O

No O
masses B-SYMPTOM
or O
thrombi B-SYMPTOM
are O
seen O
in O
the O
left O
ventricle O
. O

Resting B-SYMPTOM
regional I-SYMPTOM
wall I-SYMPTOM
motion I-SYMPTOM
abnormalities I-SYMPTOM
include O
apical B-SYMPTOM
dyskinesis I-SYMPTOM
and O
distal O
anterior O
, O
septal O
, O
mid O
and O
distal B-SYMPTOM
inferior I-SYMPTOM
and I-SYMPTOM
inferolateral I-SYMPTOM
wall I-SYMPTOM
akinesis I-SYMPTOM
. O

Normal O
RV O
size O
and O
function O
. O

Mildly B-SYMPTOM
dilated I-SYMPTOM
aortic I-SYMPTOM
root I-SYMPTOM
and I-SYMPTOM
ascending I-SYMPTOM
aorta I-SYMPTOM
. O

No O
aortic B-SYMPTOM
or I-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
. O

No O
pericardial B-SYMPTOM
effusion I-SYMPTOM
. O

Brief O
Hospital O
Course O
: O

Assessment O
: O

68M O
with O
multiple B-SYMPTOM
vascular I-SYMPTOM
risk I-SYMPTOM
factors I-SYMPTOM
presents O
with O
acute B-SYMPTOM
onset I-SYMPTOM
right-sided I-SYMPTOM
hemiparesis I-SYMPTOM
and O
dysarthria B-SYMPTOM
, O
aphasia B-SYMPTOM
concerning O
for O
acute B-SYMPTOM
left I-SYMPTOM
MCA I-SYMPTOM
infarct I-SYMPTOM
. O

Patient O
arrived O
in O
Daniel O
within O
3 O
hours O
of O
symptom B-SYMPTOM
onset I-SYMPTOM
and O
head O
CT O
showed O
no O
evidence O
of O
bleed B-SYMPTOM
. O

However O
, O
as O
wife O
had O
not O
seen O
patient O
before O
he O
became O
symptomatic B-SYMPTOM
, O
there O
was O
some O
concern O
that O
he O
had O
symptoms B-SYMPTOM
earlier O
than O
6 O
am O
, O
and O
therefore O
would O
be O
outside O
the O
3 O
hour O
window O
for O
TPA B-TREATMENT
. O

MRI O
was O
performed O
which O
showed O
diffusion B-SYMPTOM
abnormalities I-SYMPTOM
but O
no O
hyperintensity B-SYMPTOM
on O
T2 O
/ O
FLAIR O
imaging O
supporting O
the O
acute O
onset O
. O

Therefore O
, O
IV B-TREATMENT
tpa I-TREATMENT
thrombolytics I-TREATMENT
were O
administered O
within O
3 O
hours O
of O
symptom B-SYMPTOM
onset I-SYMPTOM
. O

Within O
minutes O
the O
patient O
showed O
decreased B-SYMPTOM
right I-SYMPTOM
sided I-SYMPTOM
weakness I-SYMPTOM
and O
improved O
from O
a B-SYMPTOM
global I-SYMPTOM
aphasia I-SYMPTOM
to O
an B-SYMPTOM
anterior I-SYMPTOM
aphasia I-SYMPTOM
picture I-SYMPTOM
. O

Given O
the O
likely O
embolic B-SYMPTOM
etiology I-SYMPTOM
of O
infarct B-SYMPTOM
, O
carotid O
doppler O
and O
TTE O
were O
performed O
. O

Doppler O
revealed O
no O
hemodynamically B-SYMPTOM
significant I-SYMPTOM
lesions I-SYMPTOM
bilaterally I-SYMPTOM
. O

Echo O
did O
not O
reveal O
potential O
source O
of O
emboli B-SYMPTOM
, O
but O
showed O
striking B-SYMPTOM
left I-SYMPTOM
ventricle I-SYMPTOM
akinesis I-SYMPTOM
and O
hypokinesis B-SYMPTOM
presumbly O
due O
to O
past B-SYMPTOM
MI I-SYMPTOM
x O
2 O
. O

Given O
that O
the B-SYMPTOM
stroke I-SYMPTOM
occurred O
while O
taking O
aspirin B-TREATMENT
and O
plavix B-TREATMENT
, O
and O
given O
the B-SYMPTOM
severe I-SYMPTOM
akinesis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
ventricle I-SYMPTOM
, O
we O
decided O
to O
initiate O
anticoagulation B-TREATMENT
with O
warfarin B-TREATMENT
to O
help O
prevent O
future B-SYMPTOM
strokes I-SYMPTOM
. O

Anticoagulation B-TREATMENT
therapy I-TREATMENT
was O
initiated O
with O
heparin B-TREATMENT
and O
coumadin B-TREATMENT
beginning O
on O
the O
evening O
of O
2016-08-23 O
. O

The O
patient O
and O
his O
wife O
, O
a O
nurse O
, O
were O
educated O
on O
low B-TREATMENT
molecular I-TREATMENT
wt I-TREATMENT
heparin I-TREATMENT
, O
which O
was O
started O
in O
the O
hospital O
on O
2015-08-26 O
with O
close O
follow-up O
scheduled O
with O
Dr. O
Demmert O
of O
the O
Wareham O
VA O
primary O
care O
clinic O
the O
next O
morning O
. O

His B-TREATMENT
depakote I-TREATMENT
was O
continued O
for O
his B-SYMPTOM
bipolar I-SYMPTOM
disorder I-SYMPTOM
. O

On O
discharge O
, O
strength O
was O
nearly O
intact O
in O
the O
limbs O
, O
though O
he O
still O
had O
a B-SYMPTOM
right-sided I-SYMPTOM
facial I-SYMPTOM
droop I-SYMPTOM
. O

Additionally O
, O
he O
still O
had O
mild B-SYMPTOM
dysarthria I-SYMPTOM
and O
mild B-SYMPTOM
anterior I-SYMPTOM
aphasia I-SYMPTOM
. O

Additionally O
, O
risk B-TREATMENT
factor I-TREATMENT
modification I-TREATMENT
was O
continued O
. O

Lipid O
panel O
was O
checked O
and O
showed O
good O
control O
of O
lipids O
on O
his B-TREATMENT
home I-TREATMENT
dose I-TREATMENT
of I-TREATMENT
zocor I-TREATMENT
. O

Patient O
has O
no O
history O
of O
diabetes B-SYMPTOM
, O
and O
fasting O
glucose O
was O
78 O
, O
but O
A1C O
was O
slightly B-SYMPTOM
elevated I-SYMPTOM
at O
5.9 O
. O

He O
may O
need O
further O
glucose O
monitoring O
in O
the O
future O
. O

His B-TREATMENT
home I-TREATMENT
hypertensive I-TREATMENT
medications I-TREATMENT
were O
held O
while O
in O
the O
hospital O
to O
help O
increase O
cerebral O
perfusion O
and O
prevent O
further B-SYMPTOM
ischemia I-SYMPTOM
. O

They O
will O
be O
restarted O
on O
discharge O
. O

Speech O
therapy O
was O
also O
consulted O
, O
and O
recommended O
oupatient B-TREATMENT
speech I-TREATMENT
therapy I-TREATMENT
. O

Similarly O
, O
outpatient B-TREATMENT
PT I-TREATMENT
was O
recommended O
for O
his B-SYMPTOM
gait I-SYMPTOM
difficulties I-SYMPTOM
from O
his B-SYMPTOM
previous I-SYMPTOM
strokes I-SYMPTOM
. O

Residual B-SYMPTOM
deficits I-SYMPTOM
include O
right B-SYMPTOM
side I-SYMPTOM
facial I-SYMPTOM
droop I-SYMPTOM
from O
previous B-SYMPTOM
stroke I-SYMPTOM
and O
moderately B-SYMPTOM
severe I-SYMPTOM
dysarthria I-SYMPTOM
and O
anterior B-SYMPTOM
aphasia I-SYMPTOM
with O
word B-SYMPTOM
finding I-SYMPTOM
difficulties I-SYMPTOM
. O

Medications O
on O
Admission O
: O

Captopril B-TREATMENT
50 O
bid O
, O
asa B-TREATMENT
81 O
, O
plavix B-TREATMENT
75 O
, O
zocor B-TREATMENT
40 O
, O
imdur B-TREATMENT
30 O
, O
lasix B-TREATMENT
10 O
, O
prozac B-TREATMENT
20 O
, O
iron B-TREATMENT
, O
mvi B-TREATMENT

Discharge O
Medications O
: O

1. O
Enoxaparin B-TREATMENT
Sodium I-TREATMENT
80 O
mg O
/ O
0.8 O
mL O
Syringe O
Sig O
: O
One O
( O
1 O
) O
syringe O
Subcutaneous O
Q12H O
( O
every O
12 O
hours O
) O
: O
May O
discontinue O
once O
INR O
therapeutic O
as O
directed O
by O
your O
physician O
. O

2. O
Divalproex B-TREATMENT
Sodium I-TREATMENT
500 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

3. O
Aspirin B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
QD O
( O
once O
a O
day O
) O
for O
7 O
days O
. O

4. O
Warfarin B-TREATMENT
Sodium I-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
. O

5. O
Simvastatin B-TREATMENT
40 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

6. O
Prozac B-TREATMENT
20 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
once O
a O
day O
. O

7. O
Multivitamin B-TREATMENT
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
once O
a O
day O
. O

8. O
Captopril B-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
twice O
a O
day O
. O

9. O
Imdur B-TREATMENT
30 O
mg O
Tablet O
Sustained O
Release O
24 O
HR O
Sig O
: O
One O
( O
1 O
) O
Tablet O
Sustained O
Release O
24HR O
PO O
once O
a O
day O
. O

Discharge O
Disposition O
: O

Home O

Discharge O
Diagnosis O
: O

Infarction B-SYMPTOM
of I-SYMPTOM
left I-SYMPTOM
middle I-SYMPTOM
cerebral I-SYMPTOM
artery I-SYMPTOM
inferior I-SYMPTOM
division I-SYMPTOM
, O
s/p O

TPA B-TREATMENT
, O
with O
residual B-SYMPTOM
dysarthria I-SYMPTOM
and O
aphasia B-SYMPTOM

Hypertension B-SYMPTOM

Hypercholesterolemia B-SYMPTOM

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM

Discharge O
Condition O
: O

Good O
, O
with O
no O
motor B-SYMPTOM
deficits I-SYMPTOM
, O
mild B-SYMPTOM
dysarthria I-SYMPTOM
and O
mild B-SYMPTOM
anterior I-SYMPTOM
aphasia I-SYMPTOM

Discharge O
Instructions O
: O

Take O
all B-TREATMENT
medications I-TREATMENT
as O
directed O
and O
go O
for O
all O
scheduled O
appointments O
for O
anticoagulation O
monitoring O
. O

If O
problems B-SYMPTOM
with I-SYMPTOM
speech I-SYMPTOM
or O
weakness B-SYMPTOM
worsen O
, O
go O
immediately O
to O
an O
emergency O
room O
for O
evaluation O
. O

Followup O
Instructions O
: O

Dr. O
Demmert O
at O
Wareham O
Taunton O
State O
Hospital O
Clinic O
Thursday O
2015-08-27 O
10:30am O
and O
follow-up O
as O
scheduled O
by O
the O
VA O
in O
their O
coumadin O
clinic O
. O

Follow-up O
with O
Dr. O
Robert O
in O
1-2 O
weeks O
. O

Call O
his O
office O
for O
an O
appointment O
. O

Follow-up O
with O
Dr. O
Tina O
Phillips O
in O
Stroke O
Clinic O
in O
about O
2 O
months O
. O

Call O
415 O
9374 O
to O
schedule O
an O
appointment O
. O

William O
William O
MD O
, O
PHD O
13-279 O

Completed O
by O
: O
Patricia O
Francis O
MD O
16-284 O
2015-08-26 O
@ O
1922 O

Signed O
electronically O
by O
: O
DR. O
Exie O
Culbreath O
on O
: O
SUN O
2015-09-06 O
10:03 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-01-20 O

Discharge O
Date O
: O

2014-01-21 O

Date O
of O
Birth O
: O

1928-01-02 O

Sex O
: O

M O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Michael O
V. O
Hamlett O
, O
M.D. O

Chief O
Complaint O
: O

Hypoxia B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O
none O

History O
of O
Present O
Illness O
: O

CC O
: O
dyspnea B-SYMPTOM

HPI O
: O

86 O
yo O
man O
with O
h/o O
CVA B-SYMPTOM
, O
CHF B-SYMPTOM
, O
recent O
episodes O
of O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
, O
who O
p/w O
dyspnea B-SYMPTOM
from O
his O
NH O
. O

Per O
the O
pt O
's O
daughter O
, O
the O
patient O
has O
had O
2-3 O
episodes O
of O
asp B-SYMPTOM
pna I-SYMPTOM
in O
the O
last O
2 O
months O
, O
for O
which O
he O
has O
received O
IV B-TREATMENT
abx I-TREATMENT
at O
the O
NH O
with O
apparent O
resolution O
of O
symptoms B-SYMPTOM
. O

The O
daughter O
says O
that O
on O
the O
day O
PTA O
, O
when O
she O
visited O
the O
patient O
at O
the O
NH O
, O
he O
was O
" O
having O
a O
good O
day O
," O
more O
interactive O
than O
usual O
and O
in O
good O
spirits O
. O

She O
was O
called O
at O
430 O
am O
today O
from O
the O
NH O
with O
the O
news O
that O
the O
pt O
was O
not O
doing O
well O
, O
and O
she O
came O
to O
the O
Deanna O
to O
meet O
up O
with O
her O
father O
. O

Of O
note O
, O
the O
patient O
's O
daughter O
and O
son-in-law O
confirm O
his O
desire O
to O
be O
DNR/DNI B-TREATMENT
, O
stating O
that O
they O
want O
him O
to O
be O
comfortable O
. O

However O
, O
when O
asked O
if O
she O
thinks O
he O
would O
want O
comfort B-TREATMENT
measures I-TREATMENT
even O
if O
it O
meant O
that O
his O
respiratory O
status O
would O
worsen O
, O
the O
pt O
's O
daughter O
says O
that O
he O
would O
not O
. O

In O
particular O
, O
she O
feels O
that O
the O
pt O
would O
not O
want O
a B-TREATMENT
morphine I-TREATMENT
drip I-TREATMENT
if O
it O
would O
negatively O
impact O
his O
respiratory O
function O
. O

ROS O
: O
patient O
unable O
to O
communicate O
at O
current O
time O

Past O
Medical O
History O
: O

PMH O
: O

- O
DM2 B-SYMPTOM
, O
with O
mild B-SYMPTOM
background I-SYMPTOM
diabetic I-SYMPTOM
retinopathy I-SYMPTOM

- O
CVA B-SYMPTOM
x O
2 O
, O
1970 O
and O
1996 O

- O
HTN B-SYMPTOM

- O
CAD B-SYMPTOM

- O
CHF B-SYMPTOM
, O
LVEF O
unknown O

- O
PVD B-SYMPTOM
, O
s/p O
femoral-popliteal B-TREATMENT
bypass I-TREATMENT

- O
renal B-SYMPTOM
cell I-SYMPTOM
ca I-SYMPTOM
, O
s/p O
left B-TREATMENT
nephrectomy I-TREATMENT
1992 O

- O
BPH B-SYMPTOM

- O
dementia B-SYMPTOM
, O
since O
2000 O
, O
baseline O
MMSE O
21/29 O

- O
s/p O
fall O
with O
right B-SYMPTOM
hip I-SYMPTOM
fx I-SYMPTOM
and O
ORIF B-TREATMENT

- O
moderate B-SYMPTOM
R I-SYMPTOM
sided I-SYMPTOM
macular I-SYMPTOM
degeneration I-SYMPTOM

- O
Depression B-SYMPTOM

- O
s/p O
right B-TREATMENT
inguinal I-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT

Social O
History O
: O

Social O
hx O
: O
came O
to O
the O
States O
10 O
yrs O
ago O
with O
his O
wife O
. O

Robert O
a O
daughter O
who O
lives O
in O
Wareham O
. O

Used O
to O
work O
as O
an O
engineer O
at O
an O
automobile O
plant O
. O

World O
War O
II O
veteran O
. O

Currently O
living O
at O
Beth O
Israel O
Deaconess O
Hospital-Needham O
Rehab O
. O

Asian-speaking O
only O
. O

Family O
History O
: O
noncontributory O

Physical O
Exam O
: O

Vitals O
: O

T O
102.8 O

HR O
113 O

BP O
157/85 O

RR O
35 O

Sat O
97% O
on O
BIPAP B-TREATMENT

10-23 O

Gen O
: O
frail B-SYMPTOM
, O
elderly O
caucasian O
man O
lying O
in O
stretcher O
, O
HOB O
at O
45 O
degrees O
, O
breathing O
in O
moderate B-SYMPTOM
distress I-SYMPTOM
with O
accessory B-SYMPTOM
muscle I-SYMPTOM
use I-SYMPTOM

HEENT O
: O

BIPAP B-TREATMENT
mask I-TREATMENT
in O
place O
with O
no O
apparent B-SYMPTOM
leak I-SYMPTOM
, O
eyes O
closed O
, O
mouth O
open O
, O
no O
rhinorhea B-SYMPTOM
or O
oral B-SYMPTOM
discharge I-SYMPTOM
visible O

Neck O
: O

JVP O
flat O

CV O
: O
difficult O
to O
assess O
heart O
sounds O
over O
respiratory O
sounds O
, O
but O
appears O
to O
have O
RRR O
, O
nl O
s1 O
s2 O
, O
no O
murmurs B-SYMPTOM

Lungs O
: O

R O
lower O
01-20 O
with O
coarse B-SYMPTOM
BS I-SYMPTOM
and O
rales B-SYMPTOM
; O
L O
side O
clear O
; O
no O
wheezing B-SYMPTOM

Abd O
: O
thin O
, O
nd B-SYMPTOM
, O
nt B-SYMPTOM
, O
soft O
, O
no O
masses B-SYMPTOM
palpable O

Ext O
: O
thin O
, O
no O
edema B-SYMPTOM
, O
multiple B-SYMPTOM
old I-SYMPTOM
well-healed I-SYMPTOM
scars I-SYMPTOM
on I-SYMPTOM
R I-SYMPTOM
leg I-SYMPTOM

Skin O
: O
warm O
and O
dry O
, O
no O
rash B-SYMPTOM
or O
breakdown B-SYMPTOM
noted O
though O
could O
not O
examine O
sacrum O

Neuro O
: O
reactive O
to O
pain O
, O
otherwise O

Pertinent O
Results O
: O

2014-01-20 O
05:30 O
AM O
BLOOD O
WBC O
- O
10.9 O
RBC O
- O
4.63 O
Hgb O
- O
13.6 O
* O
Hct O
- O
40.3 O
# O
MCV O
- O
87 O
MCH O
- O
29.3 O
MCHC O
- O
33.7 O
RDW O
- O
14.0 O
Plt O
Ct O
- O
393 O
# O

2014-01-20 O
05:30 O
AM O
BLOOD O
Neuts O
- O
82.6 O
* O
Lymphs O
- O
14.5 O
* O
Monos O
- O
2.2 O
Eos O
- O
0.2 O
Baso O
- O
0.4 O

2014-01-20 O
02:08 O
PM O
BLOOD O
PT O
- O
13.2 O
PTT O
- O
27.4 O
INR O
( O
PT O
)- O
1.2 O

2014-01-20 O
05:30 O
AM O
BLOOD O
Plt O
Ct O
- O
393 O
# O

2014-01-20 O
05:30 O
AM O
BLOOD O
Glucose O
- O
334 O
* O
UreaN O
- O
22 O
* O
Creat O
- O
0.9 O
Na O
- O
144 O
K O
- O
5.0 O
Cl O
- O
108 O
HCO3 O
- O
25 O
AnGap O
- O
16 O

2014-01-20 O
02:08 O
PM O
BLOOD O
CK O
( O
CPK O
)- O
275 O
* O

2014-01-20 O
05:30 O
AM O
BLOOD O
ALT O
- O
15 O
AST O
- O
22 O
LD O
( O
LDH O
)- O
254 O
* O
CK O
( O
CPK O
)- O
398 O
* O
AlkPhos O
- O
125 O
* O
TotBili O
- O
0.5 O

2014-01-20 O
02:08 O
PM O
BLOOD O
CK-MB O
- O
9 O
cTropnT O
- O
0.08 O
* O

2014-01-20 O
05:30 O
AM O
BLOOD O
cTropnT O
- O
0.05 O
* O

2014-01-20 O
05:30 O
AM O
BLOOD O
CK-MB O
- O
7 O

2014-01-20 O
05:30 O
AM O
BLOOD O
Albumin O
- O
3.2 O
* O
Calcium O
- O
9.3 O
Phos O
- O
4.2 O
Mg O
- O
1.8 O

ABG O
s: O

2014-01-20 O
10:46 O
PM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
148 O
* O
pCO2 O
- O
129 O
* O
pH O
- O
7.03 O
* O
calHCO3 O
- O
37 O
* O
Base O
XS O
- O
-1 O

2014-01-20 O
11:49 O
AM O
BLOOD O
Type O
- O
ART O
PEEP B-TREATMENT
- O
5 O
FiO2 B-TREATMENT
- O
60 O
pO2 O
- O
75 O
* O
pCO2 O
- O
56 O
* O
pH O
- O
7.29 O
* O
calHCO3 O
- O
28 O
Base O
XS O
- O
0 O
Intubat O
- O
NOT O
INTUBA O
Comment O
- O
BIPAP B-TREATMENT

2014-01-20 O
10:46 O
PM O
BLOOD O
Glucose O
- O
114 O
* O
Lactate O
- O
1.8 O
K O
- O
4.8 O

2014-01-20 O
11:49 O
AM O
BLOOD O
Lactate O
- O
3.0 O
* O
K O
- O
5.1 O

2014-01-20 O
11:49 O
AM O
BLOOD O
freeCa O
- O
1.19 O

CXR O
: O

IMPRESSION O
: O

Focal B-SYMPTOM
consolidation I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
medial I-SYMPTOM
aspect I-SYMPTOM
of O
the O
right O
lower O
lung O

Brief O
Hospital O
Course O
: O

This O
86 O
yo O
man O
with O
h/o O
CVA B-SYMPTOM
, O
CHF B-SYMPTOM
, O
recent O
episodes O
of O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
, O
presented O
with O
dyspnea B-SYMPTOM
from O
his O
NH O
, O
likely O
from O
new O
RLL B-SYMPTOM
pneumonia I-SYMPTOM
. O

He O
was O
started O
on O
Zosyn B-TREATMENT
and O
Vanco B-TREATMENT
for O
his B-SYMPTOM
presumed I-SYMPTOM
aspiration I-SYMPTOM
, O
" B-SYMPTOM
hospital I-SYMPTOM
" I-SYMPTOM
aquired I-SYMPTOM
PNA I-SYMPTOM
. O

PE B-SYMPTOM
was O
considered O
but O
less O
likely O
given O
his B-SYMPTOM
fevers I-SYMPTOM
and O
clear B-SYMPTOM
pneumonia I-SYMPTOM
on O
CXR O
. O

He O
was O
supported O
on O
BIPAP B-TREATMENT
for O
his O
respiratory O
status O
. O

An O
ABG O
was O
attempted O
in O
the O
Deanna O
however O
it O
was O
limited O
by O
pt B-SYMPTOM
discomfort I-SYMPTOM
. O

ABG O
on O
arrival O
to O
the O
ICU O
was O
7.29/56/75 O
. O

He O
was O
continued O
on O
BIPAP B-TREATMENT
. O

Blood O
cultures O
and O
sputum O
cultures O
were O
sent O
. O

Over O
the O
course O
of O
the O
day O
he O
continued O
to O
decline O
. O

He O
was O
given O
some B-TREATMENT
prn I-TREATMENT
Morphine I-TREATMENT
for O
comfort O
. O

In O
the O
evening O
of O
the O
day O
of O
admission O
he O
was O
noted O
to O
be O
increasingly B-SYMPTOM
somnolent I-SYMPTOM
. O

A O
repeat O
ABG O
was O
performed O
which O
was O
7.03/129/148 O
. O

His O
family O
was O
notified O
that O
he O
was O
doing O
worse O
and O
came O
in O
to O
visit O
him O
. O

It O
was O
his O
family O
's O
wish O
that O
he O
be O
made O
comfortable O
. O

Based O
upon O
this O
wish O
the B-TREATMENT
BIPAP I-TREATMENT
was O
removed O
and O
he O
was O
placed O
on O
nasal B-TREATMENT
cannula I-TREATMENT
. O

He O
was O
written O
for O
a B-TREATMENT
morphine I-TREATMENT
drip I-TREATMENT
however O
he O
expired O
before O
this O
could O
be O
initiated O
. O

Secondary O
issues O

Elevated B-SYMPTOM
lactate I-SYMPTOM
: O

This O
was O
concerning O
for O
early B-SYMPTOM
sepsis I-SYMPTOM
given O
RLL B-SYMPTOM
PNA I-SYMPTOM
. O

His O
blood O
pressures O
remained O
elevated B-SYMPTOM
and O
he O
was O
hydrated O
with O
NS B-TREATMENT
conservatively O
, O
given O
h/o O
CHF B-SYMPTOM
and O
dyspnea B-SYMPTOM
. O

DM2 B-SYMPTOM
: O

He O
was O
covered O
with O
a B-TREATMENT
Insulin I-TREATMENT
drip I-TREATMENT
while O
unstable O

CV O
: O

CAD B-SYMPTOM
: O

He O
was O
not O
taking O
any B-TREATMENT
PO I-TREATMENT
medications I-TREATMENT
per O
Hunt O
Center O
Rehab O
so O
all B-TREATMENT
medications I-TREATMENT
were O
held O
. O

Medications O
on O
Admission O
: O

Meds O
: O

- O
Paxil B-TREATMENT

- O
Terazosin B-TREATMENT

- O
Glucophage B-TREATMENT

- O
Glyburide B-TREATMENT

- O
Atenolol B-TREATMENT

- O
Imdur B-TREATMENT

Discharge O
Disposition O
: O

Expired O

Discharge O
Diagnosis O
: O

Pneumonia B-SYMPTOM

Discharge O
Condition O
: O
expired O

Discharge O
Instructions O
: O

N/A O

Followup O
Instructions O
: O

N/A O

Daniel O
Monica O
MD O
55-804 O

Completed O
by O
: O
Sheri O
John O
MD O
30-456 O
2014-01-21 O
@ O
0659 O

Signed O
electronically O
by O
: O
DR. O
Meredith O
Davis O
on O
: O
Sandra O
2014-03-13 O
1:53 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2012-06-20 O

Discharge O
Date O
: O

2012-06-29 O

Date O
of O
Birth O
: O

1958-02-28 O

Sex O
: O

F O

Service O
: O

FICU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
54 O
year-old O
female O
with O
a O
history O
of O
breast B-SYMPTOM
cancer I-SYMPTOM
with O
known B-SYMPTOM
brain I-SYMPTOM
mets I-SYMPTOM
, O
history O
of O
PE B-SYMPTOM
, O
recent B-TREATMENT
radiation I-TREATMENT
therapy I-TREATMENT
and O
steroids B-TREATMENT
who O
presented O
in O
2012-04-23 O
with O
myopathy B-SYMPTOM
presumed O
secondary O
to O
sterids B-TREATMENT
, O
which O
have O
been O
given O
for O
her B-SYMPTOM
brain I-SYMPTOM
mets I-SYMPTOM
. O

She O
was O
later O
sent O
to O
rehab O
, O
but O
returned O
early O
in O
April O
with O
increased B-SYMPTOM
cough I-SYMPTOM
with O
exertion O
with O
fever B-SYMPTOM
to O
101 O
. O

She O
was O
treated O
with O
Levaquin B-TREATMENT
given O
her O
temperatures O
and O
differential O
diagnosis O
of O
increased B-SYMPTOM
PE I-SYMPTOM
burden I-SYMPTOM
load I-SYMPTOM
, O
infections B-SYMPTOM
or O
pneumonia B-SYMPTOM
and O
questionable O
lymphangitic B-SYMPTOM
spread I-SYMPTOM
of O
her B-SYMPTOM
cancer I-SYMPTOM
. O

The O
patient O
did O
not O
experience O
improvement O
in O
her B-SYMPTOM
symptoms I-SYMPTOM
and O
was O
readmitted O
on O
06-11 O
with O
continued B-SYMPTOM
dyspnea I-SYMPTOM
and O
fevers B-SYMPTOM
. O

Review O
of O
CTA O
showed O
no O
PE B-SYMPTOM
, O
but O
there O
was O
ground B-SYMPTOM
glass I-SYMPTOM
opacities I-SYMPTOM
on O
CT O
, O
so O
PCP B-SYMPTOM
was O
considered O
highly O
unlikely O
given O
her O
recent O
history O
of O
steroid B-TREATMENT
use I-TREATMENT
. O

Her O
induced O
sputum O
was O
negative O
and O
BOL O
was O
done O
and O
also O
negative O
. O

Sputum O
cultures O
were O
negative O
. O

She O
was O
given O
Bactrim B-TREATMENT
and O
she O
had O
improvement O
in O
the B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
after O
her B-TREATMENT
Bactrim I-TREATMENT
was O
started O
and O
improved O
room O
air O
sats O
and O
was O
sent O
home O
on O
Bactrim B-TREATMENT
. O

She O
then O
continued O
to O
do O
poorly O
and O
then O
returned O
on O
06-19 O
. O

She O
presented O
on O
clinic O
on O
06-20 O
with O
hypotension B-SYMPTOM
for O
which O
she O
was O
given O
intravenous B-TREATMENT
fluids I-TREATMENT
. O

She O
spiked O
a B-SYMPTOM
fever I-SYMPTOM
to O
103 O
with O
blood O
pressures O
hypertensive B-SYMPTOM
into O
the O
systolic O
80 O
s O
and O
with O
rigors B-SYMPTOM
. O

Chest O
x-ray O
showed O
a O
question O
of O
left B-SYMPTOM
lung I-SYMPTOM
opacity I-SYMPTOM
. O

The O
patient O
was O
given O
Vancomycin B-TREATMENT
and O
a O
gram O
of O
intravenous B-TREATMENT
fluids I-TREATMENT
. O

Today O
, O
the O
patient O
was O
found O
in O
the O
bathroom O
and O
became O
hypoxic B-SYMPTOM
with O
saturations O
in O
the O
80 O
s O
and O
was O
responsive O
to O
oxygen B-TREATMENT
, O
but O
was O
still O
tachypneic B-SYMPTOM
without O
improvement O
and O
was O
placed O
on O
nonrebreather B-TREATMENT
. O

Currently O
the O
patient O
is O
admitted O
to O
the O
Intensive O
Care O
Unit O
for O
further B-TREATMENT
medical I-TREATMENT
care I-TREATMENT
. O

Currently O
the O
patient O
is O
short B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
without O
chest B-SYMPTOM
pain I-SYMPTOM
or O
dysphagia B-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Breast B-SYMPTOM
cancer I-SYMPTOM
left I-SYMPTOM
side I-SYMPTOM
diagnosed O
in O
1982 O
status O
post O
1995 O
mastectomy B-TREATMENT
with O
5 O
out O
of O
9 O
positive B-SYMPTOM
lymph I-SYMPTOM
nodes I-SYMPTOM
. O

She O
was O
treated O
with O
chemotherapy B-TREATMENT
and O
bone B-TREATMENT
marrow I-TREATMENT
transplant I-TREATMENT
and O
then O
later O
with O
Tamoxifen B-TREATMENT
from O
2004 O
to O
2001 O
. O

In O
2011 O
she O
had O
mediastinal B-SYMPTOM
lymphadenopathy I-SYMPTOM
treated O
with O
Taxol B-TREATMENT
and O
changed O
to O
Navelbine B-TREATMENT
on O
03-28 O
. O

She O
had O
diagnosed O
brain B-SYMPTOM
mets I-SYMPTOM
in O
2012-03-25 O
right O
side O
cerebella O
and O
parietal O
for O
which O
she O
was O
treated O
with O
chemotherapy B-TREATMENT
, O
radiation B-TREATMENT
therapy I-TREATMENT
and O
Decadron B-TREATMENT
. O

2. O
History O
of O
pulmonary B-SYMPTOM
embolism I-SYMPTOM
in O
2012-04-23 O
treated O
with O
only O
aspirin B-TREATMENT
secondary O
to O
brain B-SYMPTOM
mets I-SYMPTOM
. O

3. O
Asthma B-SYMPTOM
. O

4. O
Gastritis B-SYMPTOM
. O

5. O
Questionable O
history O
of O
_______________. O

MEDICATIONS O
ON O
TRANSFER O
: O

1. O
Protonix B-TREATMENT
40 O
mg O
q O
day O
. O

2. O
Megace B-TREATMENT
400 O
q O
day O
. O

3. O
Colace B-TREATMENT
200 O
b.i.d. O

4. O
Aspirin B-TREATMENT
. O

5. O
Heparin B-TREATMENT
subq. O

6. O
Prednisone B-TREATMENT
40 O
q O
day O
. O

7. O
___________ O
30 O
q O
day O
. O

8. O
Clindamycin B-TREATMENT
900 O
q O
8 O
. O

9. O
Levaquin B-TREATMENT
500 O
q O
day O
. O

ALLERGIES O
: O

Penicillin B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

She O
is O
an O
emergency O
room O
physician O
at O
the O
Pauline O
. O

She O
is O
married O
with O
three O
children O
. O

PHYSICAL O
EXAMINATION O
: O

On O
examination O
on O
transfer O
to O
the O
Intensive O
Care O
Unit O
she O
is O
febrile B-SYMPTOM
with O
a B-SYMPTOM
low I-SYMPTOM
grade I-SYMPTOM
temperature I-SYMPTOM
of O
100.1 O
, O
tachycardic B-SYMPTOM
to O
110 O
, O
hypotensive B-SYMPTOM
85/49 O
, O
tachypneic B-SYMPTOM
into O
the O
50 O
s O
and O
60 O
s, O
95% O
on O
nonrebreather B-TREATMENT
. O

In O
general O
, O
she O
is O
extremely B-SYMPTOM
tachypneic I-SYMPTOM
, O
difficulty B-SYMPTOM
in I-SYMPTOM
speaking I-SYMPTOM
words I-SYMPTOM
. O

Her O
heart O
is O
regular O
without O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
or O
gallops B-SYMPTOM
, O
slightly B-SYMPTOM
tachycardic I-SYMPTOM
. O

Her O
pulmonary O
examination O
shows O
she O
has O
bronchial O
breath O
sounds O
with O
dry B-SYMPTOM
crackles I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
bases I-SYMPTOM
. O

Abdominal O
examination O
was O
benign O
. O

Extremities O
no O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

She O
is O
alert O
and O
following O
commands O
. O

LABORATORY O
: O

White O
blood O
cell O
count O
3.2 O
, O
hematocrit O
26.6 O
, O
platelets O
130 O
, O
chemistry O
is O
131 O
, O
potassium O
3.0 O
, O
chloride O
105 O
, O
bicarb O
17 O
, O
BUN O
10 O
, O
creatinine O
0.5 O
, O
glucose O
105 O
. O

Calcium O
7.3 O
, O
phos O
1.8 O
, O
magnesium O
1.5 O
. O

She O
had O
a O
gas O
showing O
7.36 O
, O
31 O
, O
96 O
. O

She O
had O
a O
CT O
from O
the O
29th O
of O
her O
abdomen O
and O
pelvis O
showing O
marked B-SYMPTOM
increased I-SYMPTOM
consolidations I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lung I-SYMPTOM
base I-SYMPTOM
and O
question O
of O
new B-SYMPTOM
left I-SYMPTOM
sided I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

1. O
Pulmonary O
: O

The O
patient O
was O
transferred O
to O
the O
Intensive O
Care O
Unit O
for O
respiratory B-SYMPTOM
distress I-SYMPTOM
and O
febrile B-SYMPTOM
hypotension I-SYMPTOM
with O
a O
question O
of O
a B-SYMPTOM
new I-SYMPTOM
infiltrate I-SYMPTOM
on O
her O
chest O
x-ray O
. O

The O
exact O
etiology O
of O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
was O
presumed O
to O
be O
questionable O
multifactorial O
. O

There O
was O
concern O
about O
possible O
pneumonia B-SYMPTOM
. O

Also O
she O
had O
a O
history O
of O
PE B-SYMPTOM
and O
also O
there O
was O
concern O
about O
possible O
lymphangitic B-SYMPTOM
spread I-SYMPTOM
of O
her B-SYMPTOM
breast I-SYMPTOM
CA I-SYMPTOM
. O

Given O
her B-SYMPTOM
fevers I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
the O
patient O
was O
treated O
with O
broad B-TREATMENT
spectrum I-TREATMENT
antibiotics I-TREATMENT
initially O
started O
on O
Ceptaz B-TREATMENT
, O
Levaquin B-TREATMENT
and O
__________ O
and O
Clindamycin B-TREATMENT
. O

Lab O
two B-TREATMENT
antibiotics I-TREATMENT
were O
added O
considering O
the O
patient O
was O
thought O
to O
be O
a O
relatively O
high O
risk O
for O
PCP B-SYMPTOM
Douglas O
. O

The O
patient O
was O
initially O
trialed O
on O
BiPAP B-TREATMENT
, O
but O
the O
patient O
was O
increasingly B-SYMPTOM
dyspneic I-SYMPTOM
, O
increased B-SYMPTOM
respiratory I-SYMPTOM
stress I-SYMPTOM
and O
ultimately O
needed O
to O
be O
intubated O
on O
06-22 O
. O

Earlier O
during O
her O
Intensive O
Care O
Unit O
course O
she O
underwent O
bronchoscopy O
, O
which O
was O
sent O
for O
cytology O
and O
multiple B-SYMPTOM
bacterial I-SYMPTOM
pathogens I-SYMPTOM
all O
of O
which O
were O
negative O
. O

Ultimately O
her O
Intensive O
Care O
Unit O
course O
continued O
and O
she O
began O
to O
defervesce O
and O
her O
bacterial O
studies O
particulaly O
from O
BAL O
lavage O
were O
found O
to O
be O
negative O
. O

The O
patient O
had O
multiple B-TREATMENT
antibiotics I-TREATMENT
withdrawn O
. O

Clindamycin B-TREATMENT
and O
_______________ O
was O
discontinued O
early O
in O
hospital O
course O
. O

Her O
PCP O
was O
thought O
to O
be O
negative O
. O

In O
addition O
, O
Vancomycin B-TREATMENT
, O
Levaquin B-TREATMENT
were O
also O
discontinued O
. O

She O
was O
later O
continued O
on O
Ceftazidine B-TREATMENT
and O
Clindamycin B-TREATMENT
for O
possible O
gram B-SYMPTOM
negative I-SYMPTOM
infection I-SYMPTOM
and O
also O
for O
possible O
post B-SYMPTOM
obstructive I-SYMPTOM
picture I-SYMPTOM
that O
she O
would O
be O
at O
risk O
for O
given O
her O
pulmonary O
anatomy O
. O

As O
the O
Hubbard O
Regional O
Hospital O
hospital O
course O
went O
on O
the O
patient O
's O
respiratory O
did O
not O
show O
mild O
improvement O
on O
the B-TREATMENT
ventilator I-TREATMENT
. O

She O
was O
able O
to O
oxygenate O
originally O
. O

Unfortunately O
her O
mental O
status O
failed O
to O
improve O
despite O
having O
been O
off O
all B-TREATMENT
sedative I-TREATMENT
medications I-TREATMENT
for O
several O
days O
. O

Later O
in O
her O
Intensive O
Care O
Unit O
course O
family O
meetings O
took O
place O
and O
given O
the O
patient O
's O
overall O
poor O
prognosis O
with O
decreased B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
it O
was O
decided O
that O
the O
patient O
would O
become O
CMO B-TREATMENT
. O

Subsequently O
she O
was O
extubated O
on O
06-28 O
. O

The O
patient O
continues O
to O
actually O
ventilate O
well O
off O
of O
the O
respiratory O
. O

However O
, O
she O
is O
CMO B-TREATMENT
and O
will O
not O
be O
intubated O
for O
respiratory B-SYMPTOM
distress I-SYMPTOM
. O

2. O
Cardiovascular O
: O

The O
patient O
was O
initially O
transferred O
to O
the O
Intensive O
Care O
Unit O
thought O
to O
be O
exhibiting O
septic B-SYMPTOM
physiology I-SYMPTOM
, O
respiratory B-SYMPTOM
distress I-SYMPTOM
and O
hypotensive B-SYMPTOM
. O

She O
required O
aggressive B-TREATMENT
intravenous I-TREATMENT
fluids I-TREATMENT
and O
later O
required O
pressor B-TREATMENT
support I-TREATMENT
with O
neo-synephrine B-TREATMENT
. O

Later O
during O
her O
Intensive O
Care O
Unit O
course O
she O
was O
felt O
to O
be O
somewhat B-SYMPTOM
overloaded I-SYMPTOM
and O
intravenous B-TREATMENT
fluids I-TREATMENT
were O
cut O
back O
. O

It O
was O
quite O
difficult O
weaning O
her O
off O
of O
neo-synephrine B-TREATMENT
. O

She O
was O
also O
given O
stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
. O

Later O
in O
her O
hospital O
course O
she O
also O
had O
an O
echocardiogram O
for O
question O
of O
new O
ECG O
findings O
in O
her O
inferior O
leads O
. O

Her O
echocardiogram O
, O
however O
, O
was O
essentially O
normal O
with O
an O
ejection O
fraction O
of O
55% O
without O
any B-SYMPTOM
gross I-SYMPTOM
wall I-SYMPTOM
motion I-SYMPTOM
abnormalities I-SYMPTOM
or O
valvular B-SYMPTOM
pathology I-SYMPTOM
. O

As O
mentioned O
above O
the O
patient O
's O
hemodynamic O
status O
was O
tenuous B-SYMPTOM
throughout O
her O
hospital O
course O
as O
it O
was O
difficult O
to O
wean O
the O
patient O
off O
of O
neo-synephrine B-TREATMENT
. O

By O
06-28 O
, O
however O
, O
the O
patient O
had O
been O
off O
of O
neo-synephrine B-TREATMENT
, O
but O
at O
this O
time O
as O
mentioned O
above O
the O
patient O
was O
deemed O
to O
be O
CMO B-TREATMENT
per O
discussion O
with O
physicians O
and O
her O
husband O
/ O
health O
care O
proxy O
. O

3. O
Hematology O
: O

Patient O
with O
a O
history O
of O
known B-SYMPTOM
malignancy I-SYMPTOM
and O
also O
a O
history O
of O
pulmonary B-SYMPTOM
embolisms I-SYMPTOM
from O
2012-04-23 O
. O

Earlier O
in O
her O
Intensive O
Care O
Unit O
course O
the O
team O
was O
concerned O
about O
possible O
pulmonary B-SYMPTOM
embolisms I-SYMPTOM
as O
a O
possible O
source O
of O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
respiratory I-SYMPTOM
decompensation I-SYMPTOM
. O

However O
, O
the O
patient O
also O
had O
brain B-SYMPTOM
metastasis I-SYMPTOM
and O
at O
this O
point O
anticoagulation B-TREATMENT
was O
thought O
to O
be O
a O
contraindication O
given O
risk O
for O
hemorrhage B-SYMPTOM
into O
these B-SYMPTOM
tumors I-SYMPTOM
. O

She O
did O
have O
lower O
extremity O
doppler O
ultrasounds O
, O
which O
were O
negative O
. O

4. O
Infectious O
disease O
: O

As O
mentioned O
above O
patient O
initially O
hypotension B-SYMPTOM
, O
febrile B-SYMPTOM
and O
in O
respiratory B-SYMPTOM
distress I-SYMPTOM
presumed O
to O
be O
septic B-SYMPTOM
source I-SYMPTOM
likely O
pulmonary O
. O

Initially O
the O
patient O
was O
treated O
with O
broad B-TREATMENT
spectrum I-TREATMENT
antibiotics I-TREATMENT
including O
Vancomycin B-TREATMENT
, O
Ceptaz B-TREATMENT
, O
Levaquin B-TREATMENT
, O
Clindamycin B-TREATMENT
and O
_________. O

All O
of O
her O
cultures O
are O
negative O
to O
date O
. O

She O
was O
negative O
for O
PCP B-SYMPTOM
and O
subsequently O
_____________ O
was O
continued O
and O
Clindamycin B-TREATMENT
was O
changed O
for O
anaerobic B-TREATMENT
coverage I-TREATMENT
. O

In O
addition O
her B-TREATMENT
Vancomycin I-TREATMENT
and O
Levaquin B-TREATMENT
were O
also O
discontinued O
. O

The O
patient O
remained O
afebrile B-SYMPTOM
during O
the O
majority O
of O
her O
hospital O
course O
. O

By O
virtue O
of O
discussions O
on O
06-28 O
the O
patient O
was O
deemed O
to O
be O
CMO B-TREATMENT
and O
all B-TREATMENT
antibiotics I-TREATMENT
were O
withdrawn O
at O
this O
point O
. O

5. O
Gastroenterology O
: O

The O
patient O
had O
an O
abdominal O
CT O
earlier O
in O
her O
Intensive O
Care O
Unit O
course O
, O
which O
was O
essentially O
negative O
for O
an B-SYMPTOM
intraabdominal I-SYMPTOM
pathology I-SYMPTOM
. O

She O
was O
initially O
supported O
with O
tube B-TREATMENT
feeds I-TREATMENT
during O
her O
Intensive O
Care O
Unit O
course O
, O
but O
at O
this O
point O
the O
patient O
is O
CMO B-TREATMENT
and O
tube B-TREATMENT
feeds I-TREATMENT
have O
been O
subsequently O
discontinued O
. O

DISPOSITION O
: O

The O
patient O
's O
attending O
physician O
was O
in O
constant O
communication O
with O
the O
patient O
's O
health O
care O
proxy O
her O
husband O
. O

As O
her O
Intensive O
Care O
Unit O
course O
continued O
and O
the O
patient O
showed O
minimal O
signs O
of O
meaningful O
improvement O
, O
continued O
discussions O
were O
had O
with O
the O
family O
about O
possibly O
changing O
code O
status O
. O

Ultimately O
it O
was O
decided O
by O
06-28 O
that O
the O
patient O
had O
shown O
minimal O
improvement O
and O
minimal O
evidence O
of O
improvement O
status O
, O
it O
was O
decided O
at O
this O
point O
for O
the O
patient O
to O
be O
extubated O
and O
to O
move O
toward O
CMO B-TREATMENT
care I-TREATMENT
. O

Subsequently O
all B-TREATMENT
antibiotics I-TREATMENT
, O
blood O
draws O
and O
supportive B-TREATMENT
blood I-TREATMENT
pressure I-TREATMENT
medications I-TREATMENT
were O
withdrawn O
. O

Currently O
she O
is O
comfortable O
with O
morphine B-TREATMENT
and O
Ativan B-TREATMENT
prn. O

Currently O
plans O
are O
in O
the O
making O
for O
arranging O
for O
the O
patient O
to O
have O
home B-TREATMENT
hospice I-TREATMENT
care I-TREATMENT
. O

Please O
see O
discharge O
addendum O
for O
further O
developments O
in O
the O
patient O
's O
care O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Metastatic B-SYMPTOM
breast I-SYMPTOM
cancer I-SYMPTOM
end I-SYMPTOM
stage I-SYMPTOM
. O

2. O
Respiratory B-SYMPTOM
failure I-SYMPTOM
unclear O
etiology O
, O
presumed O
secondary O
to O
possible O
pneumonia B-SYMPTOM
, O
questionable O
lymphangitic B-SYMPTOM
spread I-SYMPTOM
. O

3. O
Sepsis B-SYMPTOM
presumed O
pulmonary O
source O
. O

DISCHARGE O
CONDITION O
: O

Grim O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Morphine B-TREATMENT
prn O
. O

2. O
Ativan B-TREATMENT
prn O
. O

3. O
Tylenol B-TREATMENT
prn O
. O

4. O
Albuterol B-TREATMENT
and O
Atrovent B-TREATMENT
nebs I-TREATMENT
prn O
. O

Rice O
S.F. O
Thrash O
, O
M.D. O
15-419 O

Dictated O
By O
: O
Brett O
E.X. O
Im O
, O
M.D. O

MEDQUIST36 O

D O
: O
2012-06-29 O
01:15 O

T O
: O
2012-06-29 O
05:47 O

JOB O
#: O
44693 O

Signed O
electronically O
by O
: O
DR. O
Vicki O
Baker O
on O
: O
TUE O
2012-07-03 O
8:23 O
AM O

( O
End O
of O
Report O
) O

770828516 O

OMH O

9357991 O

58511/2j86 O

12/28/1995 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

12/28/95 O

DISCHARGE O
DATE O
: O

New O
Years O
Eve O

ADDENDUM O
: O

MEDICATIONS O
ON O
DISCHARGE O
: O

Mevacor B-TREATMENT
20 O
mg O
p.o. O
q.d. O
; O
Colace B-TREATMENT
100 O
t.i.d. O
; O
Carafate B-TREATMENT
1 O
gram O
q.i.d. O
; O
Serax B-TREATMENT
15 O
mg O
p.o. O
q.6.h. O
to O
hold O
for O
somnolence B-SYMPTOM
; O
thiamine B-TREATMENT
100 O
mg O
IM O
q.d. O
, O
folate B-TREATMENT
1 O
mg O
q.d. O
, O
Multivitamin B-TREATMENT
1 O
q.d. O
, O
Percocet B-TREATMENT
1-2 O
tabs O
p.o. O
q.4.h. O
p.r.n. O
pain B-SYMPTOM
, O
Dulcolax B-TREATMENT
2 O
tabs O
p.o. O
q.d. O
, O
p.r.n. O
no B-SYMPTOM
stool I-SYMPTOM
x O
48 O
hours O
; O
Tylenol B-TREATMENT
650 O
p.o. O
q.4.h. O
p.r.n. O
and O
heparin B-TREATMENT
7500 O
units O
subcu. O
b.i.d. O

STA O
TITCHEGRIESESC O
, O
M.D. O

TR O
: O

kk O
/ O
bmot O

DD O
: O

12-30-95 O

TD O
: O

01/02/96 O

CC O
: O

061486522 O

TGCHO O

8946835 O

850116 O

12/19/2001 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

KOTEFOOKS O
, O
DASHA O

MRN O
: O

8946835 O

Age O
: O

89y O

REGISTRATION O
DATE O
: O

12/19/2001 O
01:44 O
AM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
KOTEFOOKS O
, O
DASHA O
arrived O
in O
the O
Emergency O
Department O
at O
Tecal O
Galecounxopt O
Community O
Hospital O
on O
12/19/2001 O
01:44 O
AM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
S O
/ O
P O
FALL O
/ O
WEAK B-SYMPTOM
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
of O
the O
visit O
was O
ADMITTED O
AS O
AN O
INPATIENT O
TO O
TECAL O
GALENCOUNXOPT O
COMMUNITY O
HOSPITAL O
. O

The O
patient O
&apos;s O
preliminary O
admitting O
physician O
is O
SHUFFCUCH O
, O
SEYSHARMSE O
N O
and O
the O
preliminary O
diagnosis O
is O
HYPERGLYCEMIA B-SYMPTOM
. O

Please O
note O
this O
information O
may O
have O
been O
updated O
on O
the O
inpatient O
unit O
. O

If O
you O
need O
additional O
information O
please O
call O
418-196-2156 O
. O

PCP O
Name O
: O

LETTE O
, O
VITA O
N O

Provider O
Number O
: O

32325 O

Admission O
Date O
: O

2010-09-06 O

Discharge O
Date O
: O

2010-09-17 O

Date O
of O
Birth O
: O

1968-04-26 O

Sex O
: O

M O

Service O
: O

ADDENDUM O
: O

The O
patient O
was O
extubated O
overnight O
without O
incident B-SYMPTOM
. O

He O
had O
a O
good O
cardiac O
index O
off O
all B-TREATMENT
inotropic I-TREATMENT
medications I-TREATMENT
and O
his B-TREATMENT
Swan-Ganz I-TREATMENT
catheter I-TREATMENT
was O
discontinued O
. O

The O
patient O
underwent O
an B-TREATMENT
exchange I-TREATMENT
peritoneal I-TREATMENT
dialysis I-TREATMENT
. O

The O
Parrack O
Diabetes O
Center O
was O
consulted O
to O
help O
manage O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
hyperglycemia I-SYMPTOM
. O

By O
postoperative O
day O
two O
, O
the O
patient O
had O
remained O
in O
sinus O
rhythm O
and O
his B-TREATMENT
Lopressor I-TREATMENT
was O
increased O
. O

He O
was O
having O
a O
bit O
of O
a B-SYMPTOM
respiratory I-SYMPTOM
acidosis I-SYMPTOM
, O
therefore O
, O
bicarbonate B-TREATMENT
was O
added O
to O
the B-TREATMENT
dialysate I-TREATMENT
. O

His B-TREATMENT
mediastinal I-TREATMENT
chest I-TREATMENT
tubes I-TREATMENT
were O
removed O
, O
however O
, O
his B-TREATMENT
pleural I-TREATMENT
chest I-TREATMENT
tubes I-TREATMENT
remained O
in O
place O
. O

On O
postoperative O
day O
three O
, O
it O
was O
apparent O
that O
, O
despite O
an O
oxygen O
saturation O
of O
99% O
on O
three O
liters O
, O
that O
the O
patient O
was O
still O
in O
a B-SYMPTOM
respiratory I-SYMPTOM
acidosis I-SYMPTOM
, O
and O
he O
received O
aggressive B-TREATMENT
pulmonary I-TREATMENT
toilette I-TREATMENT
. O

His B-TREATMENT
pleural I-TREATMENT
chest I-TREATMENT
tubes I-TREATMENT
were O
removed O
. O

On O
postoperative O
day O
four O
, O
the B-TREATMENT
patient I-TREATMENT
Cordis I-TREATMENT
was O
removed O
. O

His B-TREATMENT
Lopressor I-TREATMENT
was O
increased O
another O
increment O
. O

The O
patient O
was O
subsequently O
transferred O
to O
the O
floor O
on O
postoperative O
day O
five O
in O
stable O
and O
good O
condition O
. O

Once O
on O
the O
floor O
, O
the O
patient O
had O
an O
uneventful O
hospital O
course O
, O
remaining O
afebrile B-SYMPTOM
for O
the O
remainder O
of O
his O
hospital O
stay O
. O

The O
patient O
's O
only O
issue O
was O
his B-SYMPTOM
hypertension I-SYMPTOM
. O

On O
postoperative O
day O
seven O
, O
the O
patient O
had O
a O
peak O
blood O
pressure O
of O
210/100 O
. O

The O
decision O
was O
made O
to O
start O
the O
patient O
on O
lisinopril B-TREATMENT
, O
and O
the O
initial O
dose O
of O
7.5 O
mg O
was O
increased O
to O
10 O
mg O
daily O
by O
the O
day O
of O
discharge O
in O
order O
to O
control O
his O
pressure O
more O
tightly O
. O

On O
postoperative O
day O
seven O
, O
the O
patient O
was O
refusing O
to O
be O
discharged O
to O
a O
rehabilitation O
facility O
despite O
his O
doctor O
's O
insistence O
that O
he O
would O
do O
much O
better O
in O
an O
assisted O
environment O
. O

Nevertheless O
, O
the O
patient O
was O
adamant O
about O
going O
home O
. O

The O
patient O
was O
discharged O
on O
postoperative O
day O
seven O
and O
arrangements O
were O
made O
to O
have O
physical O
therapy O
perform O
a O
home O
safety O
evaluation O
for O
the O
patient O
, O
to O
which O
he O
agreed O
. O

DISCHARGE O
DIAGNOSIS O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
times O
three O
. O

DISCHARGE O
MEDICATIONS O
: O

Lopressor B-TREATMENT
100 O
mg O
p.o.b.i.d. O

Lisinopril B-TREATMENT
10 O
mg O
p.o.q.d. O

Lipitor B-TREATMENT
10 O
mg O
p.o.q.d. O

Aspirin B-TREATMENT
81 O
mg O
p.o.q.d. O

Percocet B-TREATMENT
one O
to O
two O
tablets O
p.o.q. O
3-4 O
h. O
p.r.n. O
pain B-SYMPTOM
. O

Colace B-TREATMENT
100 O
mg O
p.o.b.i.d. O

DISCHARGE O
PHYSICAL O
EXAMINATION O
: O

The O
patient O
had O
a O
temperature O
of O
98.4 O
, O
heart O
rate O
72 O
, O
blood O
pressure O
154/89 O
, O
respiratory O
rate O
18 O
and O
oxygen O
saturation O
90% O
in O
room O
air O
. O

He O
was O
alert O
and O
oriented O
. O

His O
neck O
was O
supple O
without O
lymphadenopathy B-SYMPTOM
. O

He O
had O
faint B-SYMPTOM
bibasilar I-SYMPTOM
crackles I-SYMPTOM
on O
lung O
examination O
. O

His O
heart O
had O
a O
regular O
rate O
and O
rhythm O
with O
no O
murmur B-SYMPTOM
, O
rub B-SYMPTOM
or O
gallop B-SYMPTOM
. O

His O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
and O
nondistended B-SYMPTOM
with O
a B-SYMPTOM
nonerythematous I-SYMPTOM
peritoneal I-SYMPTOM
dialysis I-SYMPTOM
insertion I-SYMPTOM
site I-SYMPTOM
. O

Extremities O
were O
warm O
and O
well O
perfused O
. O

DR O
. O
Kemp O
, O
Julie O
R. O
02-358 O

Dictated O
By O
: O
Judy O
Y O
Carnevale O
, O
M.D. O

MEDQUIST36 O

D O
: O
2010-09-18 O
19:42 O

T O
: O
2010-09-22 O
11:10 O

JOB O
# O
: O
34822 O

Signed O
electronically O
by O
: O
DR. O
Dalila O
Talbot O
on O
: O
Robert O
2010-09-23 O
4:07 O
PM O

( O
End O
of O
Report O
) O

180414134 O

PUOMC O

8987576 O

39627 O

936967 O

09/08/1996 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

PRUESSCHIRD O
, O
RIIE O

UNIT O
NUMBER O
: O

825-78-07 O

ADMISSION O
DATE O
: O

09/08/96 O

DISCHARGE O
DATE O
: O

09/17/96 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
82 O
year O
old O
retired O
engineer O
has O
had O
multiple O
admissions O
to O
the O
Ph O
University O
Of O
Medical O
Center O
for O
multiple B-SYMPTOM
strokes I-SYMPTOM
and O
a B-SYMPTOM
spontaneous I-SYMPTOM
subdural I-SYMPTOM
hematoma I-SYMPTOM
and O
prostatic B-SYMPTOM
hypertrophy I-SYMPTOM
. O

He O
has O
been O
managing O
at O
home O
on O
restricted B-TREATMENT
activity I-TREATMENT
but O
able O
to O
get O
around O
with O
a B-TREATMENT
walker I-TREATMENT
but O
on O
the O
day O
before O
admission O
he O
became O
increasing B-SYMPTOM
dyspneic I-SYMPTOM
and O
on O
the O
day O
of O
admission O
he O
collapsed O
and O
was O
unable O
to O
walk O
to O
his O
bed O
. O

For O
this O
he O
was O
admitted O
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
examination O
the O
patient O
was O
both O
chronically B-SYMPTOM
and I-SYMPTOM
acutely I-SYMPTOM
ill I-SYMPTOM
, O
dyspneic B-SYMPTOM
, O
mildly B-SYMPTOM
febrile I-SYMPTOM
and O
with O
coarse B-SYMPTOM
rales I-SYMPTOM
in I-SYMPTOM
both I-SYMPTOM
bases I-SYMPTOM
. O

He O
was O
in O
chronic B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
and O
his O
vital O
signs O
were O
otherwise O
stable O
. O

His O
abdomen O
was O
negative O
. O

His B-SYMPTOM
prostate I-SYMPTOM
enlarged I-SYMPTOM
and O
he O
had O
no O
peripheral B-SYMPTOM
edema I-SYMPTOM
. O

LABORATORY O
DATA O
: O

He O
had O
mild B-SYMPTOM
elevation I-SYMPTOM
of O
the O
WBC O
intermittently B-SYMPTOM
grossly I-SYMPTOM
bloody I-SYMPTOM
urine I-SYMPTOM
. O

No O
cultures O
were O
positive B-SYMPTOM
but O
the O
chest O
x-ray O
showed O
bilateral B-SYMPTOM
densities I-SYMPTOM
more O
on O
the O
left O
than O
the O
right O
compatible O
with O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
. O

There O
were O
no O
radiographic O
indications O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
was O
started O
on O
Clindamycin B-TREATMENT
intravenous I-TREATMENT
and O
Cefuroxime B-TREATMENT
intravenous I-TREATMENT
with O
clearing O
of O
his B-SYMPTOM
fever I-SYMPTOM
but O
persistence O
of O
cough B-SYMPTOM
, O
choking B-SYMPTOM
, O
and O
intermittently B-SYMPTOM
many I-SYMPTOM
coarse I-SYMPTOM
rales I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
base I-SYMPTOM
with O
no O
clearing O
by O
x-ray O
. O

His O
ambulation O
was O
minimal O
and O
always O
with O
assistance O
but O
he O
had O
a B-TREATMENT
transurethral I-TREATMENT
resection I-TREATMENT
of I-TREATMENT
the I-TREATMENT
prostate I-TREATMENT
on O
09/14/96 O
. O

He O
is O
transferred O
to O
Louline O
Mauikings O
Medical O
Center O
for O
future B-TREATMENT
rehabilitation I-TREATMENT
and O
hopeful O
return O
home O
with O
considerable O
support O
and O
assistance O
. O

DISCHARGE O
DIAGNOSIS O
: O

Aspiration B-SYMPTOM
pneumonia I-SYMPTOM
bilateral I-SYMPTOM
, O
multiple B-SYMPTOM
strokes I-SYMPTOM
, O
chronic B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
, O
prostatic B-SYMPTOM
hypertrophy I-SYMPTOM
with O
gross B-SYMPTOM
hematuria I-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Digoxin B-TREATMENT
0.25 O
mg O
. O

Hytrin B-TREATMENT
2mg O
at O
bedtime O
. O

Ticlid B-TREATMENT
0.25 O
g O
po O
bid O
. O

Bronchodilators B-TREATMENT
as O
needed O
. O

DOCTOR O
&apos;S O
DISCHARGE O
ORDERS O
: O

Strict B-TREATMENT
aspiration I-TREATMENT
precautions I-TREATMENT
with O
avoidance B-TREATMENT
of I-TREATMENT
clear I-TREATMENT
liquids I-TREATMENT
and O
all O
other O
liquids O
thickened O
. O

Increased O
ambulation O
with O
assistance O
and O
daily B-TREATMENT
pulmonary I-TREATMENT
physical I-TREATMENT
therapy I-TREATMENT
. O

TOOB O
OBESTIMEUPH O
, O
M.D. O

TR O
: O

ua O

DD O
: O

09/16/96 O

TD O
: O

09/16/96 O
4:10 O
P O

cc O
: O

DOJE O
EED O
BOLMSHI O
, O
M.D. O
TOOB O
I O
OBESTIMEUPH O
, O
M.D. O
l1xk O
STAT O

Admission O
Date O
: O

2013-02-18 O

Discharge O
Date O
: O

2013-02-27 O

Date O
of O
Birth O
: O

1934-03-07 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to O
Drugs B-TREATMENT

Attending O
: O
Karen O
U.O. O
Berliner O
, O
M.D. O

Chief O
Complaint O
: O
abdominal B-SYMPTOM
pain I-SYMPTOM
/ O
nausea B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Intubation B-TREATMENT

IR B-TREATMENT
guided I-TREATMENT
nephrostomy I-TREATMENT
placement I-TREATMENT

History O
of O
Present O
Illness O
: O

The O
patient O
is O
a O
78 O
y/o O
WF O
w/a O
PMH O
significant O
for O
HTN B-SYMPTOM
and O
afib B-SYMPTOM
who O
presented O
to O
an O
OSH O
w/ O
complaints O
of O
abd B-SYMPTOM
pain I-SYMPTOM
and O
nausea B-SYMPTOM
. O

She O
was O
found O
to O
have O
a B-SYMPTOM
R I-SYMPTOM
ureteral I-SYMPTOM
stone I-SYMPTOM
w/ O
resultant O
hydronephrosis B-SYMPTOM
and O
was O
transferred O
to O
Nantucket O
Cottage O
Hospital O
for O
ureteral B-TREATMENT
stent I-TREATMENT
placement I-TREATMENT
. O

Her O
INR O
was O
found O
to O
be O
elevated B-SYMPTOM
when O
admitted O
and O
, O
in O
the O
course O
of O
waiting O
for O
this O
to O
normalize O
, O
the O
patient O
spiked O
a O
temperature O
to O
105 O
and O
became O
hypotensive B-SYMPTOM
to O
the O
70s O
. O

She O
was O
bolused O
w/out O
effect O
and O
had O
little O
response O
to O
neo B-TREATMENT
so O
she O
was O
changed O
to O
levophed B-TREATMENT
, O
given O
doses O
of O
cipro B-TREATMENT
/ O
vanco B-TREATMENT
/ O
gent B-TREATMENT
and O
transferred O
to O
the O
CMED O
CSRU O
for O
management O
. O

In O
the O
CMED O
, O
urology O
was O
consulted O
and O
the O
patient O
received O
a B-TREATMENT
R I-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
. O

However O
, O
tube B-TREATMENT
placement I-TREATMENT
was O
complicated O
by O
renal B-SYMPTOM
artery I-SYMPTOM
puncture I-SYMPTOM
, O
afib B-SYMPTOM
, O
and O
increased B-SYMPTOM
dyspnea I-SYMPTOM
. O

She O
was O
intubated O
for O
this B-SYMPTOM
hypoxia I-SYMPTOM
and O
treated O
with O
lasix B-TREATMENT
, O
metoprolol B-TREATMENT
, O
and O
diltiazem B-TREATMENT
. O

She O
was O
weaned O
off O
her B-TREATMENT
pressors I-TREATMENT
on O
02-21 O
and O
maintained O
her O
pressure O
w/out O
additional B-TREATMENT
fluid I-TREATMENT
boluses I-TREATMENT
. O

Her B-TREATMENT
sedation I-TREATMENT
was O
weaned O
down O
and O
she O
was O
successfully O
extubated O
shortly O
thereafter O
. O

UCx O
grew O
proteus B-SYMPTOM
and O
her B-TREATMENT
abx I-TREATMENT
were O
changed O
to O
levaquin B-TREATMENT
alone O
and O
she O
remained O
afebrile B-SYMPTOM
for O
> O
24 O
hr O
on O
this B-TREATMENT
regimen I-TREATMENT
. O

She O
continued O
to O
have O
trouble O
with O
afib B-SYMPTOM
and O
required O
a B-TREATMENT
dilt I-TREATMENT
gtt I-TREATMENT
on O
the O
day O
prior O
to O
call-out O
to O
control O
this O
rhythm O
but O
she O
was O
transitioned O
to O
PO B-TREATMENT
diltiazem I-TREATMENT
and O
has O
been O
in O
NSR O
since O
this O
time O
. O

She O
was O
restarted O
on O
heparin B-TREATMENT
prior O
to O
d/c O
as O
a O
bridge O
to O
therapeutic B-TREATMENT
coumadin I-TREATMENT
anticoagulation I-TREATMENT
. O

Past O
Medical O
History O
: O

1. O
HTN B-SYMPTOM

2. O
A.fib B-SYMPTOM
on O
Coumadin B-TREATMENT

3. O
Cataract B-SYMPTOM
disease I-SYMPTOM

4. O
01-22 O
closed B-SYMPTOM
fracture I-SYMPTOM
of I-SYMPTOM
radius I-SYMPTOM
s/p O
closed B-TREATMENT
reduction I-TREATMENT

5. O
MV B-SYMPTOM
, I-SYMPTOM
AV I-SYMPTOM
, I-SYMPTOM
TV I-SYMPTOM
insufficiency I-SYMPTOM

Social O
History O
: O

Single O
, O
lives O
with O
her O
daughter O
, O
doesn O
't O
smoke O
, O
doesn O
't O
drink O
, O
worked O
for O
bag O
company O

Family O
History O
: O

Brother O
with O
" O
heart B-SYMPTOM
trouble I-SYMPTOM
" O
. O

Physical O
Exam O
: O

140/66 O
, O
92 O
, O
18 O
, O
96% O
2L O

Gen O
: O

Pleasant O
obese O
female O
in O
NAD B-SYMPTOM
, O
in O
wrist B-TREATMENT
restraints I-TREATMENT

HEENT O
: O

EOMI O
, O
PERRLA O
, O
MM B-SYMPTOM
dry I-SYMPTOM
, O
O/P O
clear O

Lungs O
: O
clear O
anteriorly O

CV O
: O

RRR O
, O
S1/S2 O
intact O
, O
3/6 B-SYMPTOM
SEM I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
USB I-SYMPTOM

Abd O
: O

S/NT/ND B-SYMPTOM
, O
obese B-SYMPTOM
, O
+BS O

Back O
: O

R B-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
in O
place O
and O
draining O

Ext O
: O
brace B-TREATMENT
on I-TREATMENT
L I-TREATMENT
wrist I-TREATMENT
, O
2+ B-SYMPTOM
LE I-SYMPTOM
edema I-SYMPTOM

Neuro O
: O
CN O
03-31 O
grossly O
intact O
, O
strength O
5/5 O
bilaterally O
, O
AAO O
to O
person O
, O
place O
( O
hospital O
in O
Burlington O
) O
, O
and O
time O
( O
1997-02-23 O
) O

Pertinent O
Results O
: O

CXR O
2013-02-21 O
: O

Right B-TREATMENT
subclavian I-TREATMENT
CV I-TREATMENT
line I-TREATMENT
overlies O
proximal O
SVC O
. O

There O
is O
cardiomegaly B-SYMPTOM
and O
tortuosity B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
thoracic I-SYMPTOM
aorta I-SYMPTOM
with O
small B-SYMPTOM
bilateral I-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
consistent O
with O
CHF B-SYMPTOM
. O

No O
pneumothorax B-SYMPTOM
. O

Overall O
appearances O
are O
essentially O
unchanged O
since O
the O
prior O
film O
of O
2013-02-20 O
, O
apart O
from O
removal B-TREATMENT
of O
the B-TREATMENT
ET I-TREATMENT
tube I-TREATMENT
. O

CT O
Abd O
2013-02-18 O
: O

1) O
Moderate B-SYMPTOM
to I-SYMPTOM
severe I-SYMPTOM
right I-SYMPTOM
hydroureteronephrosis I-SYMPTOM
with O
two B-SYMPTOM
obstructing I-SYMPTOM
distal I-SYMPTOM
right I-SYMPTOM
ureteral I-SYMPTOM
stones I-SYMPTOM
, O
8 O
mm O
and O
6 O
mm O
respectively O
. O

2) O
Probable O
obstructing B-SYMPTOM
5 I-SYMPTOM
mm I-SYMPTOM
right I-SYMPTOM
mid I-SYMPTOM
ureteral I-SYMPTOM
calculus I-SYMPTOM
causing O
mild B-SYMPTOM
hydroureter I-SYMPTOM
, O
though O
it O
is O
difficult O
to O
tell O
definitively O
if O
this B-SYMPTOM
stone I-SYMPTOM
is O
within O
or O
just O
medial O
to O
the O
right O
ureter O
on O
this O
CT O
without O
IV O
contrast O
. O

3) O
Small B-SYMPTOM
bilateral I-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
. O

4) O
Coronary B-SYMPTOM
artery I-SYMPTOM
calcification I-SYMPTOM
. O

ECHO O
2013-02-19 O
: O

1. O
The O
left O
atrium O
is O
mildly B-SYMPTOM
dilated I-SYMPTOM
. O

2. O
The O
left O
ventricular O
cavity O
size O
is O
normal O
. O

Due O
to O
suboptimal O
technical O
quality O
, O
a B-SYMPTOM
focal I-SYMPTOM
wall I-SYMPTOM
motion I-SYMPTOM
abnormality I-SYMPTOM
cannot O
be O
fully O
excluded O
. O

Overall O
left O
ventricular O
systolic O
function O
is O
normal O
LVEF O
> O
55% O
) O
. O

3. O
The O
right O
ventricular O
cavity O
is O
dilated B-SYMPTOM
. O

Right O
ventricular O
systolic O
function O
appears O
depressed B-SYMPTOM
. O

4. O
The O
aortic O
valve O
leaflets O
( O
3 O
) O
are O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

There O
is O
mild B-SYMPTOM
aortic I-SYMPTOM
valve I-SYMPTOM
stenosis I-SYMPTOM
. O

5. O
The O
mitral O
valve O
leaflets O
are O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

There O
is O
severe B-SYMPTOM
mitral I-SYMPTOM
annular I-SYMPTOM
calcification I-SYMPTOM
. O

Trivial B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
is O
present O
. O

6. O
Moderate B-SYMPTOM
to I-SYMPTOM
severe I-SYMPTOM
[ I-SYMPTOM
3+ I-SYMPTOM
] I-SYMPTOM
tricuspid I-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

There O
is O
moderate B-SYMPTOM
pulmonary I-SYMPTOM
artery I-SYMPTOM
systolic I-SYMPTOM
hypertension I-SYMPTOM
. O

2013-02-18 O
05:49 O
PM O
BLOOD O
WBC O
- O
36.6 O
* O
RBC O
- O
4.29 O
Hgb O
- O
13.4 O
Hct O
- O
38.8 O
MCV O
- O
91 O
MCH O
- O
31.3 O
MCHC O
- O
34.6 O
RDW O
- O
13.2 O
Plt O
Ct O
- O
132 O
* O

2013-02-27 O
05:17 O
AM O
BLOOD O
WBC O
- O
11.8 O
* O
RBC O
- O
3.61 O
* O
Hgb O
- O
10.8 O
* O
Hct O
- O
32.2 O
* O
MCV O
- O
89 O
MCH O
- O
29.8 O
MCHC O
- O
33.5 O
RDW O
- O
13.2 O
Plt O
Ct O
- O
346 O

2013-02-18 O
05:49 O
PM O
BLOOD O
PT O
- O
20.6 O
* O
PTT O
- O
31.6 O
INR O
( O
PT O
)- O
3.0 O

2013-02-27 O
05:17 O
AM O
BLOOD O
PT O
- O
15.5 O
* O
PTT O
- O
75.0 O
* O
INR O
( O
PT O
)- O
1.6 O

2013-02-18 O
05:49 O
PM O
BLOOD O
Glucose O
- O
127 O
* O
UreaN O
- O
26 O
* O
Creat O
- O
1.7 O
* O
Na O
- O
136 O
K O
- O
3.9 O
Cl O
- O
103 O
HCO3 O
- O
20 O
* O
AnGap O
- O
17 O

2013-02-27 O
05:17 O
AM O
BLOOD O
Glucose O
- O
97 O
UreaN O
- O
14 O
Creat O
- O
1.2 O
* O
Na O
- O
144 O
K O
- O
3.9 O
Cl O
- O
106 O
HCO3 O
- O
29 O
AnGap O
- O
13 O

2013-02-22 O
03:00 O
AM O
BLOOD O
ALT O
- O
52 O
* O
AST O
- O
50 O
* O
LD O
( O
LDH O
)- O
300 O
* O
CK O
( O
CPK O
)- O
41 O
AlkPhos O
- O
280 O
* O
TotBili O
- O
0.8 O

2013-02-18 O
05:49 O
PM O
BLOOD O
Calcium O
- O
7.7 O
* O
Phos O
- O
3.3 O
Mg O
- O
1.1 O
* O

2013-02-27 O
05:17 O
AM O
BLOOD O
Calcium O
- O
8.7 O
Phos O
- O
4.0 O
Mg O
- O
1.9 O

Brief O
Hospital O
Course O
: O

A/P O
: O

78 O
year O
old O
female O
with O
history O
of O
HTN B-SYMPTOM
, O
a.fib B-SYMPTOM
presenting O
with O
ureteral B-SYMPTOM
stone I-SYMPTOM
, O
hydronephrosis B-SYMPTOM
, O
and O
urosepsis B-SYMPTOM
. O

She O
originally O
had O
hypotension B-SYMPTOM
and O
a B-SYMPTOM
leukocytosis I-SYMPTOM
in O
the O
ER O
and O
was O
admitted O
to O
the O
CMED O
CCU O
. O

In O
the O
CMED O
, O
urology O
was O
consulted O
and O
the O
patient O
received O
a B-TREATMENT
R I-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
. O

However O
, O
tube B-TREATMENT
placement I-TREATMENT
was O
complicated O
by O
renal B-SYMPTOM
artery I-SYMPTOM
puncture I-SYMPTOM
, O
afib B-SYMPTOM
, O
and O
increased B-SYMPTOM
dyspnea I-SYMPTOM
. O

She O
was O
intubated O
for O
this B-SYMPTOM
hypoxia I-SYMPTOM
and O
treated O
with O
lasix B-TREATMENT
, O
metoprolol B-TREATMENT
, O
and O
diltiazem B-TREATMENT
. O

She O
was O
weaned O
off O
her B-TREATMENT
pressors I-TREATMENT
on O
02-21 O
and O
maintained O
her O
pressure O
w/out O
additional B-TREATMENT
fluid I-TREATMENT
boluses I-TREATMENT
. O

Her B-TREATMENT
sedation I-TREATMENT
was O
weaned O
down O
and O
she O
was O
successfully O
extubated O
shortly O
thereafter O
. O

UCx O
grew O
proteus B-SYMPTOM
and O
her B-TREATMENT
abx I-TREATMENT
were O
changed O
to O
levaquin B-TREATMENT
alone O
and O
she O
remained O
afebrile B-SYMPTOM
for O
> O
24hr O
on O
this B-TREATMENT
regimen I-TREATMENT
. O

She O
continued O
to O
have O
trouble O
with O
afib B-SYMPTOM
and O
required O
a B-TREATMENT
dilt I-TREATMENT
gtt I-TREATMENT
on O
the O
day O
prior O
to O
call-out O
to O
control O
this O
rhythm O
but O
she O
was O
transitioned O
to O
PO B-TREATMENT
diltiazem I-TREATMENT
on O
the O
day O
of O
call-out O
. O

1. O
Sepsis B-SYMPTOM
- O
The O
patient O
was O
septic B-SYMPTOM
in O
the O
ER O
and O
her O
blood O
cultures O
eventually O
grew O
proteus B-SYMPTOM
. O

Her O
Bcx O
remained O
negative O
throughout O
her O
stay O
. O

She O
was O
treated O
with O
levaquin B-TREATMENT
on O
the O
floor O
and O
will O
complete O
a O
14d O
course O
at O
rehab O
. O

She O
has O
been O
afebrile B-SYMPTOM
since O
she O
was O
called O
out O
to O
the O
floor O
. O

2. O
Ureteral B-SYMPTOM
stone I-SYMPTOM
- O
The O
patient O
had O
a B-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
placed O
by O
IR O
to O
relieve O
her B-SYMPTOM
hydronephrosis I-SYMPTOM
. O

She O
was O
followed O
by O
urology O
during O
her O
stay O
and O
will O
see O
them O
again O
2 O
wk O
after O
d/c O
for O
definitive B-TREATMENT
treatment I-TREATMENT
of O
her B-SYMPTOM
nephrolithiasis I-SYMPTOM
. O

At O
this O
time O
, O
urology O
will O
coordinate O
removal B-TREATMENT
of O
her B-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
with O
IR O
. O

Her B-TREATMENT
nephrostomy I-TREATMENT
tube I-TREATMENT
was O
draining O
clear O
yellow O
urine O
at O
the O
time O
of O
d/c O
. O

3. O
a.fib B-SYMPTOM
- O
The O
patient O
has O
a O
history O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
controlled O
with O
beta B-TREATMENT
blockers I-TREATMENT
at O
home O
. O

She O
was O
treated O
in O
the O
CMED O
as O
above O
. O

Once O
on O
the O
floor O
, O
the O
patient O
had O
one O
episode O
of O
afib B-SYMPTOM
w/ O
RVR B-SYMPTOM
that O
responded O
immediately O
to O
IV B-TREATMENT
metoprolol I-TREATMENT
. O

Because O
of O
this O
, O
the B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
diltiazem I-TREATMENT
was O
stopped O
and O
she O
was O
started O
on O
tid B-TREATMENT
metoprolol I-TREATMENT
. O

After O
this O
, O
the O
patient O
had O
no O
further B-SYMPTOM
problems I-SYMPTOM
with O
her B-TREATMENT
rate I-TREATMENT
control I-TREATMENT
. O

She O
was O
maintained O
on O
a B-TREATMENT
heparin I-TREATMENT
gtt I-TREATMENT
for O
bridge O
to O
coumadin B-TREATMENT
while O
on O
the O
floor O
after O
this O
was O
cleared O
by O
IR O
and O
urology O
. O

She O
will O
be O
d/c O
w/out O
her B-TREATMENT
heparin I-TREATMENT
as O
she O
is O
trending O
upwards O
with O
her O
INR O
and O
has O
no O
MR B-SYMPTOM
Paul I-SYMPTOM
Paquettec I-SYMPTOM
heart I-SYMPTOM
disease I-SYMPTOM
. O

She O
will O
continue O
her B-TREATMENT
coumadin I-TREATMENT
at O
rehab O
to O
achieve O
an O
INR O
between O
03-22 O
. O

4. O
delirium B-SYMPTOM
- O
The O
patient O
had O
troubles O
with O
agitation B-SYMPTOM
while O
in O
the O
CMED O
CCU O
. O

She O
received O
prn B-TREATMENT
haldol I-TREATMENT
w/ O
little O
effect O
and O
improved O
as O
her B-SYMPTOM
infection I-SYMPTOM
cleared O
. O

Medications O
on O
Admission O
: O
toprol B-TREATMENT
( O
unknown O
dose O
) O
coumadin B-TREATMENT
1 O
mg O
qhs O

Discharge O
Medications O
: O

1. O
Bisacodyl B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
as O
needed O
for O
constipation B-SYMPTOM
. O

2. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

3. O
Levofloxacin B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q24H O
( O
every O
24 O
hours O
) O
for O
7 O
days O
. O

4. O
Warfarin B-TREATMENT
1 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
. O

5. O
Miconazole B-TREATMENT
Nitrate I-TREATMENT
2 O
% O
Powder O
Sig O
: O
One O
( O
1 O
) O
Appl O
Topical O
TID O
( O
3 O
times O
a O
day O
) O
. O

6. O
Ipratropium B-TREATMENT
Bromide I-TREATMENT
0.02 O
% O
Solution O
Sig O
: O
One O
( O
1 O
) O
neb O
Inhalation O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

7. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

8. O
Polyvinyl B-TREATMENT
Alcohol I-TREATMENT
1.4 O
% O
Drops O
Sig O
: O
1-2 O
Drops O
Ophthalmic O
PRN O
( O
as O
needed O
) O
. O

9. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

10. O
Outpatient O
Lab O
Work O
please O
have O
your O
INR O
checked O
at O
the O
rehab O
center O
with O
a O
goal O
of O
03-22 O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Danvers O
State O
Hospital O
& O
Rehab O
Center O
- O
Beverly O

Discharge O
Diagnosis O
: O

Urosepsis B-SYMPTOM

Nephrolithiasis B-SYMPTOM

Atrial B-SYMPTOM
fibrillation I-SYMPTOM

Discharge O
Condition O
: O

Good O

Discharge O
Instructions O
: O

Please O
take O
your B-TREATMENT
medications I-TREATMENT
as O
directed O

Please O
keep O
your O
follow-up O
appointments O

Followup O
Instructions O
: O

Dr. O
Emma O
Attar O
2013-03-26 O
10:15 O
AM O

George O
Yvonne O
, O
MD O
Phone O
: O
440-401-5366 O
Date O
/ O
Time O
: O
2013-03-19 O
10:40 O

Deborah O
Walter O
MD O
17-478 O

Completed O
by O
: O
Richard O
LYNCH O
MD O
72-568 O
2013-02-27 O
@ O
1558 O

Signed O
electronically O
by O
: O
DR. O
Brenda O
BELL O
on O
: O
WED O
2013-04-17 O
3:18 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2017-07-12 O

Discharge O
Date O
: O

2017-07-17 O

Date O
of O
Birth O
: O

1959-10-16 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Clindamycin B-TREATMENT
/ O
Erythromycin B-TREATMENT
Base I-TREATMENT
/ O
Amoxicillin B-TREATMENT
/ O
Keflex B-TREATMENT
/ O
Wellbutrin B-TREATMENT

Attending O
: O
Jerry O
R O
Morris O
, O
M.D. O

Chief O
Complaint O
: O
syncope B-SYMPTOM
and O
hypotension B-SYMPTOM
on O
Heywood O
Memorial O
Hospital O
4 O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Central B-TREATMENT
line I-TREATMENT
attempted O
but O
never O
placed O

History O
of O
Present O
Illness O
: O

57 O
y/o O
F O
with O
multiple B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
including O
polyendocrine B-SYMPTOM
deficiency I-SYMPTOM
comprised O
of O
adrenal B-SYMPTOM
insufficiency I-SYMPTOM
, O
DM B-SYMPTOM
, O
premature B-SYMPTOM
ovarian I-SYMPTOM
failure I-SYMPTOM
, O
hypoparathyroidism B-SYMPTOM
, O
addison B-SYMPTOM
's I-SYMPTOM
disease I-SYMPTOM
and O
also O
breast B-SYMPTOM
CA I-SYMPTOM
and O
depression B-SYMPTOM
with O
multiple O
suicide O
attempts O
in O
the O
past O
who O
originally O
presented O
s/p O
tylenol B-SYMPTOM
with I-SYMPTOM
codeine I-SYMPTOM
overdose I-SYMPTOM
and O
hypotension B-SYMPTOM
, O
was O
intubated O
and O
admitted O
to O
the O
FICU O
. O

She O
was O
eventually O
stabilized O
and O
transfered O
out O
of O
the O
ICU O
to O
the O
medical O
Mary O
Lane O
Hospital O
. O

Subsequently O
, O
she O
was O
transfered O
to O
the O
psychiatric O
Mary O
Lane O
Hospital O
in O
Boston O
Medical O
Center O
4 O
for O
further O
psychiatric O
w/u O
. O

This O
morning O
, O
2017-07-12 O
, O
Ms. O
Gallegos O
King O
feeling O
weaker B-SYMPTOM
than I-SYMPTOM
usual I-SYMPTOM
. O

She O
noted O
that O
she O
had O
increased B-SYMPTOM
pain I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
lower I-SYMPTOM
back I-SYMPTOM
, O
which O
she O
attributed O
to O
her B-SYMPTOM
arthritis I-SYMPTOM
. O

She O
ate O
a O
normal O
breakfast O
of O
cereal O
and O
milk O
. O

Later O
that O
am O
, O
she O
stood O
from O
her B-TREATMENT
wheelchair I-TREATMENT
, O
had O
a B-SYMPTOM
prodrome I-SYMPTOM
of I-SYMPTOM
LH I-SYMPTOM
and O
then O
reports O
LOC B-SYMPTOM
and O
fall O
. O

She O
denies O
any B-SYMPTOM
tunnel I-SYMPTOM
vision I-SYMPTOM
, O
darkened B-SYMPTOM
vision I-SYMPTOM
, O
or O
focal B-SYMPTOM
weakness I-SYMPTOM
this O
morning O
. O

No O
bowel B-SYMPTOM
/ I-SYMPTOM
bladder I-SYMPTOM
incont I-SYMPTOM
, O
no O
aura B-SYMPTOM
, O
no O
postictal B-SYMPTOM
state I-SYMPTOM
. O

She O
does O
not O
recall O
falling O
, O
but O
does O
recall O
waking O
up O
with O
people O
surrounding O
her O
. O

During O
the O
fall O
she O
hit O
her O
nose O
and O
her O
R O
knee O
. O

She O
does O
not O
recall O
hitting O
her O
head O
. O

She O
does O
not O
describe O
decreased B-SYMPTOM
PO I-SYMPTOM
intake I-SYMPTOM
from O
her O
norm O
this O
morning O
, O
but O
did O
feel O
dehydrated B-SYMPTOM
at O
the O
time O
of O
her O
fall O
. O

LOC B-SYMPTOM
was O
unwitnessed O
. O

Early O
this O
morning O
before O
breakfast O
her O
BS O
was O
reportedly O
145 O
, O
and O
after O
LOC B-SYMPTOM
, O
her O
BS O
was O
reportedly O
207 O
. O

She O
reports O
that O
her O
BP O
was O
read O
at O
60/48 O
after O
her O
fall O
. O

Her O
systolic O
BP O
measurements O
have O
been O
running O
around O
100-110 O
over O
the O
past O
few O
weeks O
. O

Ms. O
Cassata O
has O
a O
history O
of O
" O
passing O
out O
" O
in O
August O
of O
2004 O
, O
( O
? O
7 O
hours O
) O
, O
and O
reports O
that O
this O
episode O
did O
not O
feel O
similar O
. O

ROS O
: O

She O
denies O
any B-SYMPTOM
recent I-SYMPTOM
nausea I-SYMPTOM
, O
but O
had O
an O
episode O
of O
vomiting B-SYMPTOM
last O
week O
. O

She O
denies O
any B-SYMPTOM
pain I-SYMPTOM
with I-SYMPTOM
urination I-SYMPTOM
or O
incontinence B-SYMPTOM
. O

She O
also O
denies O
any B-SYMPTOM
recent I-SYMPTOM
cough I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
chest B-SYMPTOM
palpitations I-SYMPTOM
, O
heart B-SYMPTOM
racing I-SYMPTOM
. O

She O
reports O
2 O
nights O
with O
soaking B-SYMPTOM
NS I-SYMPTOM
. O

Denies O
subj B-SYMPTOM
/ I-SYMPTOM
obj I-SYMPTOM
fevers I-SYMPTOM
or O
chills B-SYMPTOM
. O

She O
describes O
her O
mood O
as O
depressed B-SYMPTOM
, O
however O
she O
denies O
suicidal B-SYMPTOM
ideation I-SYMPTOM
at O
this O
time O
. O

She O
reports O
that O
she O
took O
all B-TREATMENT
her I-TREATMENT
medications I-TREATMENT
as O
usual O
this O
morning O
, O
with O
no O
changes O
. O

Past O
Medical O
History O
: O

1) O
Polyendocrine B-SYMPTOM
deficiency I-SYMPTOM
syndrome I-SYMPTOM
Type I-SYMPTOM
I I-SYMPTOM
which O
is O
comprised O
of O
the O
following O
: O

a) O
Hypoparathyroidism B-SYMPTOM
, O
dxed O
1954 O

b) O
Addison B-SYMPTOM
's I-SYMPTOM
disease I-SYMPTOM
, O
dxed O
1960 O

c) O
Premature B-SYMPTOM
ovarian I-SYMPTOM
failure I-SYMPTOM
, O
dxed O
1967 O

d) O
Alopecia B-SYMPTOM
areata I-SYMPTOM
and I-SYMPTOM
totalis I-SYMPTOM
, O
dxed O
1970s O

e) O
mucocutaneous B-SYMPTOM
candidiasis I-SYMPTOM

f) O
Diabetes B-SYMPTOM
type I-SYMPTOM
I I-SYMPTOM

2) O
colonic B-SYMPTOM
dysfunction I-SYMPTOM
alternating O
with O
diarrhea B-SYMPTOM
and O
constipation B-SYMPTOM

3) O
? O
unstable B-SYMPTOM
serum I-SYMPTOM
calcium I-SYMPTOM
since O
1999 O

4) O
Generalized B-SYMPTOM
osteoarthritis I-SYMPTOM

5) O
depression B-SYMPTOM
requiring O
ECT B-TREATMENT
therapy I-TREATMENT
in O
the O
past O

6) O
bilateral B-SYMPTOM
Neuropathy I-SYMPTOM
of I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM

7) O
Bilateral B-SYMPTOM
cataracts I-SYMPTOM

8) O
PVD B-SYMPTOM

9) O
Spontaneous B-SYMPTOM
dislocation I-SYMPTOM
of I-SYMPTOM
left I-SYMPTOM
hip I-SYMPTOM
in O
2014 O

10) O
GERD B-SYMPTOM

11) O
Low B-SYMPTOM
grade I-SYMPTOM
anemia I-SYMPTOM

12) O
Elevated B-SYMPTOM
liver I-SYMPTOM
enzymes I-SYMPTOM

13) O
h/o O
amputation B-TREATMENT
of I-TREATMENT
right I-TREATMENT
2nd I-TREATMENT
toe I-TREATMENT
secondary O
to O
osteomyelitis B-SYMPTOM
in O
2005 O

14) O
h/o O
hemorrhoidectomy B-TREATMENT
in O
2007 O

15) O
h/o O
left B-TREATMENT
hip I-TREATMENT
joint I-TREATMENT
replacement I-TREATMENT
in O
2008 O

16) O
h/o O
total B-TREATMENT
hysterectomy I-TREATMENT
in O
2009 O

17) O
h/o O
breast B-SYMPTOM
CA I-SYMPTOM
s/p O
mastectomies B-TREATMENT

18) O
recent O
suicide O
attempt O
with O
tylenol B-TREATMENT
#3 I-TREATMENT
requiring O
CMED O
admission O
but O
relatively O
Jennifer O
transaminitis B-SYMPTOM
with O
full O
recovery O

PCP O
at O
Cynthia O
( O
656 O
) O
302 O
4444 O
Dr. O
Mosier O
. O

Has O
been O
hospitalized O
at O
Pocasset O
Mental O
Health O
Center O
and O
Children O
's O
Hospital O
Boston O
numerous O
times O
. O

Social O
History O
: O
lives O
in O
VA O
Hospital O
Northampton O
. O

Denies O
etoh O
, O
illicits O
. O

Multiple O
past O
suicide O
attempts O
. O

Medically O
savvy O
- O
has O
spent O
much O
of O
her O
life O
in O
the O
hospital O
with O
her B-SYMPTOM
multiple I-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
. O

Family O
History O
: O
father O
with O
history O
of O
liver B-SYMPTOM
cancer I-SYMPTOM
at O
a O
late O
age O

Physical O
Exam O
: O

T O
98.4 O
RR O
20 O
Sat O
100% O
RA O
, O
P O
100 O
in O
bed O
& O
same O
standing O
, O
BP O
= O
120/65 O
in O
bed O
, O
same O
standing O
. O

Gen O
: O

NAD B-SYMPTOM
, O
cooperative O
and O
conversant O
, O
able O
to O
ambulate O
independently O
around O
room O
using O
crutches B-TREATMENT

HEENT O
: O

NCAT B-SYMPTOM
, O
no O
tenderness B-SYMPTOM
to O
palpation O
of O
scalp O
, O
PERRL O
, O
EOMI O
, O
alopecia B-SYMPTOM
, O
no O
scleral B-SYMPTOM
icterus I-SYMPTOM
, O
mucus B-SYMPTOM
membranes I-SYMPTOM
moderately I-SYMPTOM
dry I-SYMPTOM
, O
slight O
amount O
of O
crusted B-SYMPTOM
blood I-SYMPTOM
on I-SYMPTOM
tip I-SYMPTOM
of O
R O
nostril O
from O
fall B-SYMPTOM
injury I-SYMPTOM

Neck O
: O
supple O
, O
no O
supraclavicular B-SYMPTOM
LAD I-SYMPTOM
, O
no O
JVD B-SYMPTOM

CV O
: O
tachycardic B-SYMPTOM
, O
regular O
rhythm O
, O
III/VI B-SYMPTOM
systolic I-SYMPTOM
, O
crescendo-decrescendo B-SYMPTOM
at I-SYMPTOM
USB I-SYMPTOM
bilaterally I-SYMPTOM
. O

Harsher B-SYMPTOM
holosystolic I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
apex I-SYMPTOM
heard O
best O
with O
bell O
. O

Pulm O
: O

CTAB O
aside O
from O
slightly B-SYMPTOM
dull I-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
bases I-SYMPTOM

Abd O
: O
soft O
, O
slightly B-SYMPTOM
obese I-SYMPTOM
, O
nondistended B-SYMPTOM
, O
+BS O

Ext O
: O
no O
edema B-SYMPTOM
/ O
cyanosis B-SYMPTOM
, O
2+ O
peripheral O
pulses O
, O
small B-SYMPTOM
1 I-SYMPTOM
cm I-SYMPTOM
abrasion I-SYMPTOM
on I-SYMPTOM
R I-SYMPTOM
knee I-SYMPTOM
, O
no O
active B-SYMPTOM
bleeding I-SYMPTOM
, O
no O
brusing B-SYMPTOM
, O
no O
limited O

ROM B-SYMPTOM
, O
no O
signs O
of O
effusion B-SYMPTOM

Neuro O
: O

A&Ox3 O
, O
no O
asterixis B-SYMPTOM
, O
strength O
4+ O
/ O
5 O
equal O
throughout O
, O
sensation O
light O
touch O
intact O
, O
toes O
upgoing O
bilaterally O
, O
no O
pronator B-SYMPTOM
drift I-SYMPTOM
. O

Gait O
does O
not O
appear O
unsteady B-SYMPTOM
, O
uses O
crutches B-TREATMENT
for O
support O
. O

Pertinent O
Results O
: O

ADMISSION O
LABS O
: O

2017-07-12 O
10:40 O
AM O
BLOOD O
WBC O
- O
17.1 O
* O
RBC O
- O
3.37 O
* O
Hgb O
- O
10.1 O
* O
Hct O
- O
30.1 O
* O
MCV O
- O
89 O
MCH O
- O
30.0 O
MCHC O
- O
33.6 O
RDW O
- O
18.8 O
* O
Plt O
Ct O
- O
526 O
* O

2017-07-12 O
10:40 O
AM O
BLOOD O
Neuts O
- O
86 O
* O
Bands O
- O
5 O
Lymphs O
- O
4 O
* O
Monos O
- O
5 O
Eos O
- O
0 O
Baso O
- O
0 O
Atyps O
- O
0 O
Metas O
- O
0 O
Myelos O
- O
0 O

2017-07-12 O
10:40 O
AM O
BLOOD O
Plt O
Smr O
- O
HIGH B-SYMPTOM
Plt I-SYMPTOM
Ct I-SYMPTOM
- O
526 O
* O

2017-07-13 O
05:30 O
AM O
BLOOD O
PT O
- O
11.3 O
PTT O
- O
24.9 O
INR O
( O
PT O
)- O
1.0 O

2017-07-11 O
08:00 O
AM O
BLOOD O
Glucose O
- O
137 O
* O
UreaN O
- O
19 O
Creat O
- O
1.0 O
Na O
- O
142 O
K O
- O
4.0 O
Cl O
- O
105 O
HCO3 O
- O
29 O
AnGap O
- O
12 O

2017-07-13 O
05:30 O
AM O
BLOOD O
ALT O
- O
85 O
* O
AST O
- O
238 O
* O
LD O
( O
LDH O
)- O
316 O
* O
CK O
( O
CPK O
)- O
55 O
AlkPhos O
- O
122 O
* O
Amylase O
- O
65 O
TotBili O
- O
0.3 O

2017-07-13 O
05:30 O
AM O
BLOOD O
Lipase O
- O
35 O

2017-07-14 O
05:20 O
AM O
BLOOD O
CK O
- O
MB O
- O
NotDone O
cTropnT O
-< O
0.01 O

2017-07-13 O
01:12 O
PM O
BLOOD O
CK O
- O
MB O
- O
2 O
cTropnT O
-< O
0.01 O

2017-07-13 O
05:30 O
AM O
BLOOD O
CK O
- O
MB O
- O
NotDone O
cTropnT O
-< O
0.01 O

2017-07-11 O
08:00 O
AM O
BLOOD O
Albumin O
- O
3.4 O
Calcium O
- O
8.0 O
* O
Phos O
- O
5.0 O
* O
Mg O
- O
1.6 O

2017-07-13 O
01:12 O
PM O
BLOOD O
HBsAg O
- O
NEGATIVE O
HBsAb O
- O
NEGATIVE O
HBcAb O
- O
NEGATIVE O

2017-07-13 O
05:30 O
AM O
BLOOD O
Acetmnp O
- O
NEG O

2017-07-13 O
01:12 O
PM O
BLOOD O
HCV O
Ab O
- O
NEGATIVE O

2017-07-13 O
08:40 O
AM O
BLOOD O
Type O
- O
ART O
pO2 O
- O
72 O
* O
pCO2 O
- O
34 O
* O
pH O
- O
7.46 O
* O
calHCO3 O
- O
25 O
Base O
XS O
- O
0 O

2017-07-13 O
08:40 O
AM O
BLOOD O
Lactate O
- O
2.0 O

2017-07-13 O
08:40 O
AM O
BLOOD O
freeCa O
- O
0.90 O
* O

STUDIES O
: O

EKG O
: O

2017-07-12 O
NSR O
, O
normal O
axis O
, O
likely O
V1 B-SYMPTOM
and I-SYMPTOM
V2 I-SYMPTOM
reversal I-SYMPTOM
, O
TWI B-SYMPTOM
in I-SYMPTOM
V2 I-SYMPTOM
, O
? O
ST B-SYMPTOM
depr I-SYMPTOM
< O
0.5 O
mm O
in O
II O
and O
V5/6 O
- O
repeat O
EKG O
without O
these B-SYMPTOM
changes I-SYMPTOM
. O

No O
change O
from O
prior O
EKG O
. O

CXR O
2017-07-12 O
: O

Heart O
normal O
in O
size O
, O
mediastinal O
and O
hilar O
contours O
are O
normal O
. O

Pulmonary O
vascularity O
is O
normal O
, O
lungs O
are O
clear O
. O

No O
effusions B-SYMPTOM
or O
pneumothorax B-SYMPTOM
. O

Multiple B-SYMPTOM
healed I-SYMPTOM
bilateral I-SYMPTOM
rib I-SYMPTOM
fractures I-SYMPTOM
are O
demonstrated O
. O

Clips B-TREATMENT
in I-TREATMENT
the I-TREATMENT
left I-TREATMENT
axilla I-TREATMENT
demonstrate O
prior B-TREATMENT
lymph I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
. O

Overall O
, O
no O
acute B-SYMPTOM
cardiopulmonary I-SYMPTOM
abnormality I-SYMPTOM
. O

2017-07-13 O
CXR O
: O

UPRIGHT O
AP O
VIEW O
OF O
THE O
CHEST O
: O

Aside O
from O
low B-SYMPTOM
lung I-SYMPTOM
volumes I-SYMPTOM
, O
the O
lungs O
are O
clear O
. O

The O
heart O
size O
, O
and O
mediastinal O
and O
hilar O
contours O
are O
normal O
. O

The O
pleurae O
are O
normal O
. O

Clips B-TREATMENT
in I-TREATMENT
the I-TREATMENT
left I-TREATMENT
axilla I-TREATMENT
denote O
prior B-TREATMENT
lymph I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
. O

Multiple B-SYMPTOM
bilateral I-SYMPTOM
healed I-SYMPTOM
rib I-SYMPTOM
fractures I-SYMPTOM
are O
present O
. O

2017-07-13 O
RUQ O
U/S O
: O

IMPRESSION O
: O

1. O
Normal O
liver O
. O

No O
evidence O
of O
bile B-SYMPTOM
duct I-SYMPTOM
dilatation I-SYMPTOM
. O

2. O
Gallbladder B-SYMPTOM
polyp I-SYMPTOM
and O
possible O
tiny B-SYMPTOM
stones I-SYMPTOM
. O

No O
cholecystitis B-SYMPTOM
. O

2017-07-14 O
ECHO O
: O

Conclusions O
: O

The O
left O
atrium O
is O
normal O
in O
size O
. O

There O
is O
mild B-SYMPTOM
symmetric I-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
. O

The O
left O
ventricular O
cavity O
size O
is O
normal O
. O

Overall O
left O
ventricular O
systolic O
function O
is O
normal O
( O
LVEF O
> O
55% O
). O

Right O
ventricular O
chamber O
size O
and O
free O
wall O
motion O
are O
normal O
. O

The O
aortic O
valve O
leaflets O
are O
moderately B-SYMPTOM
thickened I-SYMPTOM
. O

There O
is O
mild B-SYMPTOM
aortic I-SYMPTOM
valve I-SYMPTOM
stenosis I-SYMPTOM
. O

Trace B-SYMPTOM
aortic I-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

The O
mitral O
valve O
leaflets O
are O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

No O
mitral B-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

There O
is O
a B-SYMPTOM
small I-SYMPTOM
pericardial I-SYMPTOM
effusion I-SYMPTOM
. O

There O
are O
no O
echocardiographic O
signs O
of O
tamponade B-SYMPTOM
. O

Compared O
with O
the O
report O
of O
the O
prior O
study O
( O
images O
unavailable O
for O
review O
) O
of O
2017-06-13 O
, O
there O
is O
no O
significant B-SYMPTOM
change I-SYMPTOM
. O

DISCHARGE O
LABS O
: O

2017-07-17 O
04:50 O
AM O
BLOOD O
WBC O
- O
7.2 O
RBC O
- O
2.69 O
* O
Hgb O
- O
8.0 O
* O
Hct O
- O
24.0 O
* O
MCV O
- O
89 O
MCH O
- O
29.7 O
MCHC O
- O
33.3 O
RDW O
- O
18.7 O
* O
Plt O
Ct O
- O
363 O

2017-07-17 O
04:50 O
AM O
BLOOD O
Plt O
Ct O
- O
363 O

2017-07-17 O
04:50 O
AM O
BLOOD O
Glucose O
- O
60 O
* O
UreaN O
- O
13 O
Creat O
- O
0.9 O
Na O
- O
147 O
* O
K O
- O
3.0 O
* O
Cl O
- O
109 O
* O
HCO3 O
- O
29 O
AnGap O
- O
12 O

2017-07-17 O
04:50 O
AM O
BLOOD O
ALT O
- O
73 O
* O
AST O
- O
50 O
* O
LD O
( O
LDH O
)- O
195 O
AlkPhos O
- O
112 O
TotBili O
- O
0.3 O

2017-07-15 O
06:47 O
AM O
BLOOD O
Lipase O
- O
17 O

2017-07-17 O
04:50 O
AM O
BLOOD O
Calcium O
- O
8.2 O
* O
Phos O
- O
3.2 O
Mg O
- O
1.5 O
* O

2017-07-13 O
01:12 O
PM O
BLOOD O
HBsAg O
- O
NEGATIVE O
HBsAb O
- O
NEGATIVE O
HBcAb O
- O
NEGATIVE O

2017-07-13 O
05:30 O
AM O
BLOOD O
Acetmnp O
- O
NEG O

2017-07-13 O
01:12 O
PM O
BLOOD O
HCV O
Ab O
- O
NEGATIVE O

Brief O
Hospital O
Course O
: O

BRIEF O
OVERVIEW O
: O

57 O
yo O
F O
with O
h/o O
polyglandular B-SYMPTOM
autoimmune I-SYMPTOM
syndrome I-SYMPTOM
initially O
admitted O
in O
May O
to O
FICU O
for O
suicide B-SYMPTOM
overdose I-SYMPTOM
then O
transferred O
to O
Whittier O
Rehab O
Hospital O
4 O
for O
depression B-SYMPTOM
, O
who O
was O
transferred O
to O
the O
medical O
floor O
for O
a B-SYMPTOM
syncopal I-SYMPTOM
episode I-SYMPTOM
and O
hypotension B-SYMPTOM
to O
60 O
systolic O
that O
returned O
to O
baseline O
with O
2.5L O
IVF B-TREATMENT
who O
was O
subsequently O
transferred O
to O
the O
CMED O
CSRU O
for O
a O
recurrent O
episode O
of O
hypotension B-SYMPTOM
, O
fevers B-SYMPTOM
and O
concern O
for O
sepsis B-SYMPTOM
. O

Initially O
when O
she O
arrived O
to O
the O
floor O
she O
was O
afebrile B-SYMPTOM
, O
normotensive O
without O
signs O
of O
orthostasis B-SYMPTOM
, O
had O
a O
negative O
UA O
, O
a O
clear O
chest O
xray O
and O
no O
signs O
/ O
symptoms O
of O
a B-SYMPTOM
fever I-SYMPTOM
. O

She O
was O
slightly B-SYMPTOM
tachycardic I-SYMPTOM
. O

She O
was O
initially O
not O
started O
on O
antibiotics B-TREATMENT
. O

She O
was O
given O
a B-TREATMENT
standing I-TREATMENT
IVF I-TREATMENT
order I-TREATMENT
. O

Overnight O
she O
became O
febrile B-SYMPTOM
to O
102.3 O
, O
increasingly B-SYMPTOM
tachycardic I-SYMPTOM
to O
125 O
, O
and O
hypotensive B-SYMPTOM
to O
80 O
systolic O
. O

She O
was O
started O
on O
stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
and O
levo B-TREATMENT
, O
flagyl B-TREATMENT
, O
and O
vanco B-TREATMENT
. O

She O
was O
given O
4L O
of O
fluid B-TREATMENT
boluses I-TREATMENT
and O
transfered O
to O
the O
CMED O
CSRU O
. O

In O
the O
CMED O
CSRU O
, O
repeated O
attempts O
to O
place O
lines B-TREATMENT
were O
unsuccessful O
. O

The B-TREATMENT
above I-TREATMENT
treatments I-TREATMENT
were O
continued O
. O

Urine O
cultures O
returned O
with O
10-100,000 O
organisms B-SYMPTOM
coag O
negative O
staph B-SYMPTOM
. O

Blood O
cultures O
remained O
negative O
. O

Vital O
signs O
stabilized O
and O
she O
was O
transfered O
back O
to O
the O
medical O
floor O
after O
2 O
days O
in O
the O
ICU O
. O

Stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
were O
planned O
for O
a O
7 O
day O
course O
, O
antibiotics B-TREATMENT
were O
peeled O
back O
to O
levofloxacin B-TREATMENT
alone O
, O
and O
a O
R O
hip O
film O
revealed O
no O
loosening B-SYMPTOM
nor O
inflammation B-SYMPTOM
. O

Echo O
showed O
normal O
function O
, O
trace B-SYMPTOM
AR I-SYMPTOM
, O
and O
no O
MR B-SYMPTOM
. O

She O
had O
a O
normal O
RUQ O
US O
, O
as O
well O
. O

On O
the O
floor O
the O
patient O
remained O
stable O
hemodynamically O
without O
recurrent B-SYMPTOM
fever I-SYMPTOM
and O
was O
stable O
for O
transfer O
back O
to O
Franciscan O
Children O
's O
Hospital O
& O
Rehab O
Center O
4 O
. O

At O
the O
time O
of O
discharge O
, O
her O
potassium O
had O
been O
low B-SYMPTOM
despite O
repletion B-TREATMENT
, O
Na O
was O
elevated B-SYMPTOM
, O
as O
was O
blood O
pressure O
. O

On O
recommendation O
from O
endocrine O
, O
her B-TREATMENT
fludrocortisone I-TREATMENT
was O
decreased O
from O
0.2 O
to O
0.1 O
( O
higher O
than O
required O
doses O
of O
fludrocort B-TREATMENT
can O
cause O
these B-SYMPTOM
symptoms I-SYMPTOM
. O
) O
. O

1. O
Hypotension B-SYMPTOM
: O

Patient O
presented O
after O
episode O
of O
hypotension B-SYMPTOM
and O
syncope B-SYMPTOM
on O
Mass. O
Mental O
Health O
Center O
5 O
. O

Initially O
it O
was O
felt O
that O
this O
was O
a O
result O
of O
poor B-SYMPTOM
PO I-SYMPTOM
intake I-SYMPTOM
. O

She O
was O
afebrile B-SYMPTOM
without O
orthostatic B-SYMPTOM
vital I-SYMPTOM
signs I-SYMPTOM
nor O
hypotension B-SYMPTOM
. O

She O
had O
no O
symptoms O
of O
infectious B-SYMPTOM
source I-SYMPTOM
, O
normal O
UA O
, O
normal O
chest O
xray O
, O
and O
no O
symptoms O
nor O
signs O
of O
injury B-SYMPTOM
after O
her O
fall O
with O
syncope B-SYMPTOM
. O

Neuro O
exam O
was O
normal O
. O

Subsequently O
overnight O
, O
she O
developed O
a B-SYMPTOM
fever I-SYMPTOM
to O
102.3 O
and O
recurrent B-SYMPTOM
hypotension I-SYMPTOM
in O
the O
setting O
of O
fevers B-SYMPTOM
and O
tachycardia B-SYMPTOM
that O
was O
concerning O
for O
an B-SYMPTOM
infectious I-SYMPTOM
source I-SYMPTOM
. O

She O
still O
had O
no O
localizing O
signs O
of O
infection B-SYMPTOM
and O
culture O
data O
was O
negative O
to O
be O
negative O
. O

RUQ O
US O
was O
ordered O
and O
returned O
without O
signs O
of O
infection B-SYMPTOM
later O
. O

She O
was O
started O
on O
stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
. O

She O
had O
cultures O
drawn O
, O
was O
given O
tylenol B-TREATMENT
( O
tylenol O
screen O
prior O
to O
this O
dose O
was O
negative O
, O
as O
was O
a O
urine O
tox O
) O
, O
was O
started O
on O
levofloxacin B-TREATMENT
, O
metronidazole B-TREATMENT
, O
and O
vancomycin B-TREATMENT
to O
cover O
emperically O
for O
hospital B-SYMPTOM
aquired I-SYMPTOM
pneumonia I-SYMPTOM
, O
GI B-SYMPTOM
sources I-SYMPTOM
, O
and O
a O
potential O
hip B-SYMPTOM
infection I-SYMPTOM
. O

Her O
transaminases O
were O
slightly B-SYMPTOM
elevated I-SYMPTOM
, O
which O
was O
later O
attributed O
to O
shock B-SYMPTOM
liver I-SYMPTOM
as O
a O
result O
of O
her O
period O
of O
hypotension B-SYMPTOM
. O

Lipase O
and O
amylase O
remained O
normal O
. O

In O
the O
ICU O
she O
also O
received O
an O
echo O
that O
revealed O
normal O
function O
and O
little B-SYMPTOM
valvular I-SYMPTOM
disease I-SYMPTOM
( O
she O
has O
two B-SYMPTOM
loud I-SYMPTOM
systolic I-SYMPTOM
murmurs I-SYMPTOM
on O
exam O
) O
, O
and O
a O
hip O
film O
revealing O
no O
inflammation B-SYMPTOM
nor O
loosening B-SYMPTOM
. O

Urine O
culture O
twice O
grew O
10-100,000 O
coag B-SYMPTOM
negative O
staph B-SYMPTOM
. O

A B-TREATMENT
line I-TREATMENT
could O
not O
be O
placed O
for O
technical O
reasons O
, O
however O
after O
4L O
NS B-TREATMENT
on O
the O
floor O
and O
01-30 O
more O
in O
the O
ICU O
via O
peripheral B-TREATMENT
IV I-TREATMENT
's I-TREATMENT
she O
was O
stable O
. O

She O
remained O
hemodynamically O
stable O
with O
good O
UOP O
in O
the O
setting O
of O
being O
started O
on O
abx B-TREATMENT
and O
stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
. O

The B-TREATMENT
steroids I-TREATMENT
were O
thought O
to O
have O
helped O
significantly O
in O
in O
the O
setting O
of O
Addison B-SYMPTOM
's I-SYMPTOM
with O
possibely O
superimposed B-SYMPTOM
infection I-SYMPTOM
. O

The O
patient O
was O
planned O
for O
a O
7 O
day O
course O
of O
stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
followed O
by O
a O
return O
to O
her B-TREATMENT
basal I-TREATMENT
predinisone I-TREATMENT
/ O
fludrocortisone B-TREATMENT
dose I-TREATMENT
. O

2. O
Elevated B-SYMPTOM
LFTs I-SYMPTOM
: O

LFTs O
wre O
elevated B-SYMPTOM
at O
presentation O
. O

Initially O
the O
differential O
was O
thought O
to O
include O
shock B-SYMPTOM
liver I-SYMPTOM
from O
hypotension B-SYMPTOM
, O
hepatitis B-SYMPTOM
, O
cholangitis B-SYMPTOM
or O
choledocholithiasis B-SYMPTOM
. O

Hepatitis O
serologies O
were O
negative O
and O
the O
pt O
was O
eventually O
felt O
to O
have O
had O
shock B-SYMPTOM
liver I-SYMPTOM
from O
her B-SYMPTOM
hypotensive I-SYMPTOM
episode I-SYMPTOM
as O
the B-SYMPTOM
transaminitis I-SYMPTOM
resolved O
over O
time O
. O

3. O
Hypoparathyroidism B-SYMPTOM
: O

This O
is O
a B-SYMPTOM
chronic I-SYMPTOM
problem I-SYMPTOM
. O

calcium O
levels O
were O
followed O
with O
a O
goal O
to O
keep O
them O
around O
8.0 O
by O
continuing O
Calcium B-TREATMENT
carbonate I-TREATMENT
, O
calcitriol B-TREATMENT
. O

The O
pt O
required O
calcium B-TREATMENT
gluconate I-TREATMENT
x1 O
the O
day O
prior O
to O
discharge O
. O

Per O
endocrine O
at O
the O
time O
of O
discharge O
, O
the O
pt O
may O
need O
an O
increase O
in O
calcium B-TREATMENT
PO I-TREATMENT
, O
but O
at O
this O
time O
they O
recommended O
no O
change O
. O

It O
will O
need O
to O
be O
monitored O
over O
time O
. O

4. O
Addison B-SYMPTOM
's- I-SYMPTOM
The O
patient O
is O
on O
basal B-TREATMENT
prednisone I-TREATMENT
/ O
fludrocortisone B-TREATMENT
. O

These O
were O
initially O
continued O
as O
above O
and O
later O
, O
when O
she O
became O
hypotensive B-SYMPTOM
and O
febrile B-SYMPTOM
, O
stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
were O
started O
and O
planned O
for O
a O
7 O
day O
course O
followed O
by O
a O
return O
to O
her O
prior O
dose O
of O
prednisone B-TREATMENT
. O

At O
the O
time O
of O
discharge O
, O
her O
potassium O
had O
been O
low B-SYMPTOM
despite O
repletion B-TREATMENT
, O

Na O
was O
elevated B-SYMPTOM
, O
as O
was O
blood O
pressure O
. O

On O
recommendation O
from O
endocrine O
, O
her B-TREATMENT
fludrocortisone I-TREATMENT
was O
decreased O
from O
0.2 O
to O
0.1 O
( O
higher O
than O
required O
doses O
of O
fludrocort B-TREATMENT
can O
cause O
these B-SYMPTOM
symptoms. I-SYMPTOM
) O
. O

5. O
DM B-SYMPTOM
: O

Light O
followed O
the O
patient O
. O

She O
was O
continued O
on O
her O
prior O
dose O
of O
steroids B-TREATMENT
with O
sliding B-TREATMENT
scale I-TREATMENT
per O
patient O
using O
a B-TREATMENT
1:15 I-TREATMENT
carb I-TREATMENT
counting I-TREATMENT
scheme I-TREATMENT
with O
a B-TREATMENT
1:30 I-TREATMENT
correction I-TREATMENT
factor I-TREATMENT
. O

On O
the O
day O
of O
discharge O
her B-TREATMENT
glargine I-TREATMENT
was O
decreased O
by O
one O
unit O
because O
her O
glucose O
remained O
somewhat B-SYMPTOM
low I-SYMPTOM
in O
the O
mornings O
. O

6. O
R B-SYMPTOM
Hip I-SYMPTOM
pain I-SYMPTOM
: O

Later O
in O
her O
hospital O
course O
, O
the O
pt O
complained O
of O
hip B-SYMPTOM
pain I-SYMPTOM
. O

A O
R O
hip O
film O
was O
negative O
for O
pathology B-SYMPTOM
or O
failure B-SYMPTOM
of O
her B-TREATMENT
hip I-TREATMENT
replacement I-TREATMENT
. O

Pain B-SYMPTOM
was O
controlled O
with O
tylenol B-TREATMENT
and O
the O
pt O
was O
reassured O
. O

PT O
was O
consulted O
. O

The O
pt O
uses O
a B-TREATMENT
wheelchair I-TREATMENT
often O
at O
baseline O
due O
to O
pain B-SYMPTOM
from O
arthritis B-SYMPTOM
. O

7. O
Depression B-SYMPTOM
: O

The O
pt O
was O
being O
treated O
at O
Mediplex O
Rehab O
Hospital O
4 O
for O
suicidal B-SYMPTOM
ideation I-SYMPTOM
and O
a O
suicide O
attempt O
on O
original O
admission O
with O
tylenol B-TREATMENT
and O
oxycodone B-TREATMENT
. O

She O
had O
planned O
this O
attempt O
carefully O
without O
the O
knowledge O
of O
those O
close O
to O
her O
and O
very O
much O
expected O
her O
attempt O
to O
work O
. O

She O
had O
been O
depressed B-SYMPTOM
for O
some O
time O
but O
her O
loved O
ones O
were O
very O
surprised O
at O
her O
attempt O
. O

She O
remained O
very B-SYMPTOM
depressed I-SYMPTOM
at O
her O
inpatient O
admission O
and O
refractory B-SYMPTOM
to O
treatment B-TREATMENT
. O

One O
day O
prior O
to O
her O
transfer O
to O
the O
medical O
floor O
she O
was O
sectioned O
to O
initiate O
ECT B-TREATMENT
, O
which O
she O
had O
previously O
refused O
. O

As O
a O
result O
, O
she O
was O
maintained O
on O
her B-TREATMENT
ativan I-TREATMENT
, O
mirtazapine B-TREATMENT
, O
risperidone B-TREATMENT
, O
duloxetine B-TREATMENT
. O

She O
did O
not O
exhibit O
psychotic B-SYMPTOM
symptoms I-SYMPTOM
. O

She O
had O
a O
1:1 O
sitter O
at O
all O
times O
. O

She O
denied O
any B-SYMPTOM
suicidality I-SYMPTOM
but O
did O
endorse O
depression B-SYMPTOM
. O

She O
denied O
HI B-SYMPTOM
, O
SI B-SYMPTOM
, O
and O
illusions B-SYMPTOM
/ O
hallucinations B-SYMPTOM
. O

Her O
mood O
appeared O
stable O
throughout O
her O
hospitalization O
. O

She O
was O
followed O
by O
psychiatry O
in O
consultation O
while O
she O
was O
on O
the O
medical O
floor O
. O

The O
patient O
did O
have O
heparin B-TREATMENT
subcutaneously I-TREATMENT
while O
on O
the O
medical O
floor O
and O
in O
the O
ICU O
. O

She O
remained O
full B-TREATMENT
code I-TREATMENT
throughout O
the O
hospitalization O
. O

As O
on O
prior O
hospitalization O
, O
her O
HCP O
was O
shared O
by O
Dianne O
White O
. O

Medications O
on O
Admission O
: O

Meds O
on O
transfer O
: O

Fludrocortisone B-TREATMENT
Acetate I-TREATMENT
0.2 O
mg O
PO O
DAILY O
07-12 O
@ O
1033 O

Acetaminophen B-TREATMENT
650 O
mg O
PO O
BID O
07-11 O
@ O
1503 O
View O

Ibuprofen B-TREATMENT
400 O
mg O
PO O
BID O
07-11 O
@ O
1503 O
View O

Ibuprofen B-TREATMENT
400 O
mg O
PO O
Q8H O
: O
PRN O
07-11 O
@ O
1503 O
View O

Insulin B-TREATMENT
SC I-TREATMENT
( O
per O
Insulin O
Flowsheet O
) O

Risperidone B-TREATMENT
1 O
mg O
PO O
HS O
07-10 O
@ O
1135 O
View O

Risperidone B-TREATMENT
0.5 O
mg O
PO O
DAILY O
07-10 O
@ O
1135 O
View O

Potassium B-TREATMENT
Chloride I-TREATMENT
20 O
mEq O
PO O
BID O

Calcium B-TREATMENT
Carbonate I-TREATMENT
1500 O
mg O
PO O
TID O
07-04 O
@ O
1126 O
View O

Mirtazapine B-TREATMENT
15 O
mg O
PO O
HS O
07-03 O
@ O
1220 O
View O

Duloxetine B-TREATMENT
30 O
mg O
PO O
BID O
Start O
: O
In O
am O
07-03 O
@ O
1214 O

Psyllium B-TREATMENT
1 O
PKT O
PO O
TID O
: O
PRN O
06-30 O
@ O
1248 O
View O

Memantine B-TREATMENT
* O
N O
F* O
10 O
mg O
Oral O
daily O
06-27 O
@ O
1124 O
View O

Calcitriol B-TREATMENT
0.25 O
mcg O
PO O
EVERY O
OTHER O
DAY O
t/th/s/s O

Calcitriol B-TREATMENT
0.5 O
mcg O
PO O
EVERY O
OTHER O
DAY O
06-27 O
@ O
1051 O

Lorazepam B-TREATMENT
2 O
mg O
PO O
HS O
06-23 O
@ O
1215 O
View O

Alendronate B-TREATMENT
Sodium I-TREATMENT
70 O
mg O
PO O
QSUN O
06-22 O
@ O
1106 O
View O

Lactulose B-TREATMENT
60 O
ml O
PO O
QTHUR O
06-21 O
@ O
1600 O
View O

Milk B-TREATMENT
of I-TREATMENT
Magnesia I-TREATMENT
60 O
ml O
PO O
QTHUR O
06-21 O
@ O
1600 O
View O

Arimidex B-TREATMENT
* O
N O
F* O
1 O
mg O
Oral O
daily O
06-21 O
@ O
1414 O
View O

Magnesium B-TREATMENT
Oxide I-TREATMENT
400 O
mg O
PO O
BID O
06-20 O
@ O
2017 O
View O

Atorvastatin B-TREATMENT
20 O
mg O
PO O
DAILY O
06-20 O
@ O
2017 O
View O

Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
PO O
TID O
06-20 O
@ O
2017 O
View O

Pantoprazole B-TREATMENT
40 O
mg O
PO O
Q24H O
06-20 O
@ O
2017 O
View O

Prednisone B-TREATMENT
2.5 O
mg O
PO O
Q3PM O
06-20 O
@ O
2017 O
View O

Prednisone B-TREATMENT
5 O
mg O
PO O
QAM O
06-20 O
@ O
2017 O
View O

Chlorothiazide B-TREATMENT
500 O
mg O
PO O
DAILY O
06-20 O
@ O
2017 O
View O

Aspirin B-TREATMENT
81 O
mg O
PO O
DAILY O

Multivitamins B-TREATMENT
1 O
CAP O
PO O
DAILY O

Allergies O
: O

Clindamycin B-TREATMENT
/ O
Erythromycin B-TREATMENT
Base I-TREATMENT
/ O
Amoxicillin B-TREATMENT
/ O
Keflex B-TREATMENT
/ O
Wellbutrin B-TREATMENT

Discharge O
Medications O
: O

1. O
Risperidone B-TREATMENT
0.5 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
. O

2. O
Risperidone B-TREATMENT
0.5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

3. O
Mirtazapine B-TREATMENT
15 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
. O

4. O
Duloxetine B-TREATMENT
30 O
mg O
Capsule O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Capsule O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

5. O
Calcitriol B-TREATMENT
0.25 O
mcg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
EVERY O
OTHER O
DAY O
( O
Every O
Other O
Day O
) O
. O

6. O
Calcitriol B-TREATMENT
0.5 O
mcg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
EVERY O
OTHER O
DAY O
( O
Every O
Other O
Day O
) O
. O

7. O
Alendronate B-TREATMENT
70 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
QSUN O
( O
every O
Sunday O
) O
. O

8. O
Lactulose B-TREATMENT
10 O
g O
/ O
15 O
mL O
Syrup O
Sig O
: O
Sixty O
( O
60 O
) O
ML O
PO O
EVERY O
THURSDAY O
( O
) O
. O

9. O
Magnesium B-TREATMENT
Hydroxide I-TREATMENT
400 O
mg O
/ O
5 O
mL O
Suspension O
Sig O
: O
Thirty O
( O
30 O
) O
ML O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

10. O
Anastrozole B-TREATMENT
1 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
daily O
( O
) O
. O

11. O
Atorvastatin B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

12. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

13. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
) O
. O

14. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Chewable O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Chewable O
PO O
DAILY O
( O
Daily O
) O
. O

15. O
Multivitamin B-TREATMENT
Capsule I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Cap O
PO O
DAILY O
( O
Daily O
) O
. O

16. O
Ibuprofen B-TREATMENT
400 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

17. O
Ferrous B-TREATMENT
Sulfate I-TREATMENT
325 O
( O
65 O
) O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

18. O
Maalox B-TREATMENT
200-200-20 O
mg O
/ O
5 O
mL O
Suspension O
Sig O
: O
Fifteen O
( O
15 O
) O
ML O
PO O
PRN O
( O
as O
needed O
) O
. O

19. O
Levofloxacin B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q24H O
( O
every O
24 O
hours O
) O
for O
2 O
days O
. O

20. O
Calcium B-TREATMENT
Carbonate I-TREATMENT
500 O
mg O
Tablet O
, O
Chewable O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
, O
Chewable O
PO O
TID O
( O
3 O
times O
a O
day O
) O
. O

21. O
Calcium B-TREATMENT
Carbonate I-TREATMENT
500 O
mg O
Tablet O
, O
Chewable O
Sig O
: O
Three O
( O
3 O
) O
Tablet O
, O
Chewable O
PO O
QID O
( O
4 O
times O
a O
day O
) O
. O

22. O
Heparin B-TREATMENT
( I-TREATMENT
Porcine I-TREATMENT
) I-TREATMENT
5,000 O
unit O
/ O
mL O
Solution O
Sig O
: O
5000 O
( O
5000 O
) O
units O
Injection O
TID O
( O
3 O
times O
a O
day O
) O
. O

23. O
Prednisone B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

24. O
Prednisone B-TREATMENT
2.5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q O
3PM O
( O
) O
. O

25. O
Chlorothiazide B-TREATMENT
250 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

26. O
Fludrocortisone B-TREATMENT
0.1 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
. O

27. O
Potassium B-TREATMENT
Chloride I-TREATMENT
10 O
mEq O
Capsule O
, O
Sustained O
Release O
Sig O
: O
Four O
( O
4 O
) O
Capsule O
, O
Sustained O
Release O
PO O
DAILY O
( O
Daily O
) O
. O

28. O
Lorazepam B-TREATMENT
1 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

29. O
Memantine B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
daily O
( O
) O
. O

30. O
Insulin B-TREATMENT
Glargine I-TREATMENT
100 O
unit O
/ O
mL O
Solution O
Sig O
: O
AS O
INSTRUCTED O
Subcutaneous O
twice O
a O
day O
: O
7 O
units O
in O
the O
morning O
, O
18 O
units O
in O
the O
evening O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Quincy O
Medical O
Center O
4 O

Discharge O
Diagnosis O
: O

Hypotension B-SYMPTOM

Early B-SYMPTOM
Sepsis I-SYMPTOM

Adrenal B-SYMPTOM
Insufficiency I-SYMPTOM

Diabetes B-SYMPTOM
I I-SYMPTOM

Hypocalcemia B-SYMPTOM
( O
Hypoparathyroidism B-SYMPTOM
) O

Depression B-SYMPTOM

Transaminitis B-SYMPTOM

Discharge O
Condition O
: O

Stable O
vitals O
, O
depressed B-SYMPTOM
. O

Discharge O
Instructions O
: O

You O
were O
admitted O
with O
a B-SYMPTOM
low I-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
and O
developed O
a B-SYMPTOM
fever I-SYMPTOM
. O

You O
are O
finishing O
a O
course O
of O
antibiotics B-TREATMENT
and O
have O
been O
stable O
for O
days O
. O

If O
you O
lose O
consciousness O
, O
develop O
a B-SYMPTOM
low I-SYMPTOM
BP I-SYMPTOM
, O
have O
lightheadedness B-SYMPTOM
with O
standing O
, O
develop O
a B-SYMPTOM
fever I-SYMPTOM
, O
or O
have O
other B-SYMPTOM
worrisome I-SYMPTOM
symptoms I-SYMPTOM
, O
please O
seek O
medical B-TREATMENT
care I-TREATMENT
. O

Followup O
Instructions O
: O

As O
planned O
- O
continued O
consultation O
by O
Light O
and O
Endocrine O

Vivian O
LIEN O
MD O
88-143 O

Completed O
by O
: O
Mildred O
BERRY O
MD O
38-748 O
2017-07-18 O
@ O
0548 O

Signed O
electronically O
by O
: O
DR. O
Edith O
LIEN O
on O
: O
MON O
2017-07-24 O
1:03 O
PM O

( O
End O
of O
Report O
) O

599923748 O

PUOMC O

0079427 O

25598/1879 O

538465 O

5/8/1995 O
12:00:00 O
AM O

RIGHT B-SYMPTOM
OCCIPITAL I-SYMPTOM
, I-SYMPTOM
CEREBRAL I-SYMPTOM
INFARCTION I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

05/08/95 O

DISCHARGE O
DATE O
: O

05/14/95 O

DATE O
OF O
BIRTH O
: O

April O
1 O
, O
1923 O

PRINCIPAL O
DIAGNOSIS O
: O

Right B-SYMPTOM
occipital I-SYMPTOM
, I-SYMPTOM
cerebral I-SYMPTOM
infarction I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Old B-SYMPTOM
inferior I-SYMPTOM
wall I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
1984 O
. O

PRINCIPAL O
PROCEDURE O
: O

Head O
magnetic O
resonance O
imaging O
study O
and O
magnetic O
resonance O
imaging O
angiogram O
with O
and O
without O
gadolinium O
. O

ASSOCIATED O
PROCEDURES O
: O

Head O
computerized O
tomography O
scan O
, O
echocardiogram O
, O
transcranial O
Dopplers O
, O
carotid O
noninvasives O
, O
Holter O
electrocardiogram O
, O
electroencephalogram O
, O
and O
visual O
field O
testing O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
72-year-old O
right-handed O
gentleman O
with O
a O
history O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
1984 O
. O

Also O
with O
a O
history O
of O
noninsulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
, O
now O
presenting O
with O
acute B-SYMPTOM
blurry I-SYMPTOM
vision I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
side I-SYMPTOM
, O
which O
is O
homonymous O
. O

The O
patient O
woke O
up O
as O
usual O
on O
May O
8 O
, O
1995 O
. O

At O
8 O
a.m. O
the O
patient O
was O
looking O
at O
his O
wife O
with O
the O
background O
outside O
a O
large O
window O
. O

The O
patient O
had O
sudden O
onset O
of O
blurred B-SYMPTOM
vision I-SYMPTOM
, O
where O
the O
right O
side O
of O
his O
wife O
&apos;s O
face O
looked O
blurred O
. O

The O
patient O
did O
not O
notice O
change B-SYMPTOM
of I-SYMPTOM
vision I-SYMPTOM
in O
the O
background O
. O

The B-SYMPTOM
blurred I-SYMPTOM
vision I-SYMPTOM
was O
homonymous O
, O
which O
he O
had O
blurred O
in O
each O
eye O
in O
the O
left O
visual O
field O
. O

The B-SYMPTOM
same I-SYMPTOM
blurred I-SYMPTOM
vision I-SYMPTOM
was O
also O
noticed O
later O
when O
the O
patient O
was O
watching O
television O
and O
also O
when O
he O
was O
reading O
. O

The O
patient O
was O
seen O
at O
the O
Ochtuheihugh O
Put O
University O
Medical O
Center O
and O
then O
he O
was O
referred O
to O
the O
Purckecation O
Balpoingdelt O
Pabarnes- O
Campa O
Memorial O
Hospital O
. O

At O
8 O
p.m. O
the O
patient O
seen O
at O
the O
Purckecation O
Balpoingdelt O
Pabarnes- O
Campa O
Memorial O
Hospital O
and O
was O
examined O
and O
assessed O
. O

The O
patient O
was O
referred O
to O
Ph O
University O
Of O
Medical O
Center O
for O
rule O
out O
transient B-SYMPTOM
ischemic I-SYMPTOM
attack I-SYMPTOM
and O
rule O
out O
stroke B-SYMPTOM
. O

The O
patient O
denies O
any B-SYMPTOM
nausea I-SYMPTOM
, O
vomiting B-SYMPTOM
, O
ataxia B-SYMPTOM
, O
motor B-SYMPTOM
deficits I-SYMPTOM
, O
speech B-SYMPTOM
deficits I-SYMPTOM
or O
sensory B-SYMPTOM
deficits I-SYMPTOM
. O

The O
patient O
lightly O
bumped O
his O
head O
on O
the O
top O
three O
times O
on O
the O
previous O
night O
and O
the O
patient O
had O
frontal B-SYMPTOM
headaches I-SYMPTOM
and O
a B-SYMPTOM
tight I-SYMPTOM
neck I-SYMPTOM
. O

One O
hour O
after O
he O
had O
physical O
activity O
on O
the O
previously O
night O
as O
well O
. O

ALLERGIES O
: O

The O
patient O
denies O
any B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

is O
significant O
for O
a B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
1984 O
. O

The O
patient O
has O
been O
on O
cardiac B-TREATMENT
medications I-TREATMENT
since O
and O
has O
had O
no O
new B-SYMPTOM
episodes I-SYMPTOM
. O

The O
patient O
has O
been O
diagnosed O
with O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
since O
1991 O
and O
has O
been O
maintained O
on O
Glipizide B-TREATMENT
. O

In O
1992 O
, O
the O
patient O
has O
been O
diagnosed O
with O
bladder B-SYMPTOM
papilloma I-SYMPTOM
and O
has O
been O
cystoscoped O
seven O
times O
. O

The O
most O
recent O
was O
done O
on O
May O
4 O
, O
1995 O
. O

FAMILY O
HISTORY O
: O

The O
patient O
has O
a O
family O
history O
of O
prostate B-SYMPTOM
cancer I-SYMPTOM
and O
stroke B-SYMPTOM
but O
no O
history O
of O
migraines B-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
stopped O
smoking O
10 O
years O
ago O
and O
works O
as O
a O
lawyer O
20 O
hours O
per O
week O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Lopressor B-TREATMENT
25 O
mg O
PO O
b.i.d. O
, O
Cardizem B-TREATMENT
30 O
mg O
po O
q.i.d. O
, O
Zantac B-TREATMENT
150 O
mg O
po O
qd O
, O
Isordil B-TREATMENT
60 O
mg O
po O
q O
a.m. O
, O
60 O
mg O
po O
q O
noon O
, O
30 O
mg O
po O
q O
p.m. O
and O
30 O
mg O
po O
q O
hs O
, O
Glipizide B-TREATMENT
po O
5 O
mg O
q O
a.m. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
was O
afebrile B-SYMPTOM
with O
stable O
vital O
signs O
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
examination O
was O
unremarkable O
. O

The O
neck O
was O
supple O
and O
no O
goiter B-SYMPTOM
was O
noticed O
, O
no O
bruit B-SYMPTOM
was O
noticed O
. O

The O
lungs O
were O
clear O
. O

The O
heart O
had O
normal O
rate O
and O
rhythm O
, O
with O
normal O
Sl O
and O
S2 O
and O
no O
significant B-SYMPTOM
heart I-SYMPTOM
murmur I-SYMPTOM
was O
heard O
. O

The O
abdomen O
was O
soft O
, O
flat O
, O
nontender B-SYMPTOM
, O
with O
normal O
bowel O
sounds O
and O
no O
hepatosplenomegaly B-SYMPTOM
was O
noticed O
. O

No O
mass B-SYMPTOM
was O
noticed O
. O

Capillary O
refill O
was O
normal O
and O
there O
was O
no O
edema B-SYMPTOM
. O

The O
calves O
were O
nontender B-SYMPTOM
. O

On O
neurological O
examination O
, O
the O
patient O
was O
alert O
, O
oriented O
to O
time O
, O
place O
and O
person O
. O

The O
memory O
was O
intact O
for O
retention O
and O
long-term O
memory O
. O

Fort O
short-term O
memory O
the O
patient O
was O
able O
to O
recall O
one O
object O
out O
of O
thee O
at O
five O
minute O
, O
two O
out O
of O
three O
with O
clues O
and O
three O
out O
of O
three O
with O
multiple O
choice O
. O

The O
reading O
, O
writing O
, O
drawing O
clock O
and O
copying O
cubes O
were O
all O
intact O
. O

The O
speech O
was O
fluent O
and O
repetition O
was O
normal O
. O

The O
pattern O
recognition O
was O
intact O
. O

Insight O
, O
abstract O
thinking O
and O
______________ O
test O
were O
all O
intact O
. O

The O
patient O
had O
mild O
errors O
in O
sequential O
substracting O
sevens O
from O
100 O
test O
. O

The O
patient O
was O
able O
to O
follow O
complex O
commands O
of O
three O
parts O
involving O
right O
and O
left O
side O
. O

For O
cranial O
nerves O
the O
patient O
had O
minimal B-SYMPTOM
blurred I-SYMPTOM
vision I-SYMPTOM
in I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
. O

The O
optic O
fundi O
was O
normal O
. O

The O
extra O
ocular O
movements O
were O
full O
with O
mild B-SYMPTOM
terminal I-SYMPTOM
nystagmus I-SYMPTOM
, O
2-3 O
beats O
, O
in O
the O
right O
lateral O
gaze O
. O

The O
light O
reflex O
was O
slightly B-SYMPTOM
slow I-SYMPTOM
but O
equal O
and O
intact O
direct O
and O
indirectly O
. O

The O
pupils O
were O
bilaterally O
4.5 O
mm O
and O
had O
been O
dilated O
at O
the O
Purckecation O
Balpoingdelt O
Pabarnes- O
Campa O
Memorial O
Hospital O
. O

The O
pupils O
were O
round O
and O
regular O
. O

The O
nasolabial O
fold O
, O
the O
wrinkling O
of O
forehead O
and O
the O
eye O
closure O
were O
all O
symmetric O
and O
normal O
. O

The O
patient O
had O
conduction B-SYMPTOM
hearing I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
side I-SYMPTOM
, O
which O
had O
been O
old O
. O

The O
tongue O
was O
midline O
and O
uvula O
was O
midline O
as O
well O
. O

The O
gag O
reflex O
was O
intact O
. O

The O
sternocleidomastoid O
and O
the O
trapezius O
muscles O
were O
both O
intact O
. O

The O
motor O
examination O
, O
the O
tone O
and O
bulk O
were O
normal O
. O

The O
patient O
had O
no O
pronator B-SYMPTOM
drift I-SYMPTOM
. O

The O
patient O
had O
mild B-SYMPTOM
weakness I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
side I-SYMPTOM
with O
the O
strength O
of O
5 O
minus O
on O
the O
upper O
and O
lower O
extremities O
, O
distally O
and O
proximally O
. O

The O
coordination O
was O
intact O
for O
finger-nose-finger O
test O
, O
rapid O
alternating O
hand O
movements O
. O

The O
heel-shin-test O
was O
slightly B-SYMPTOM
clumsy I-SYMPTOM
bilaterally I-SYMPTOM
but O
the O
knee O
tapping O
was O
normal O
bilaterally O
. O

Sensory O
examination O
: O

The O
patient O
had O
decreased B-SYMPTOM
vibratory I-SYMPTOM
sense I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
, O
worse O
on O
the O
left O
side O
. O

The O
touch O
, O
pain O
, O
and O
position O
sense O
were O
all O
intact O
. O

The O
patient O
had O
reflexes O
of O
two-plus O
bilaterally O
in O
the O
radials O
, O
the O
biceps O
, O
the O
triceps O
and O
the O
knee O
jerk O
. O

The O
ankle O
jerks O
were O
one-plus O
bilaterally O
. O

The O
Babinski O
&apos;s O
were O
negative O
bilaterally O
. O

The O
cross O
extension O
reflex O
was O
positive O
on O
the O
left O
. O

The O
gait O
was O
intact O
and O
the O
tandem O
gait O
was O
intact O
as O
well O
. O

LABORATORY O
DATA O
: O

Complete O
blood O
count O
: O

white O
blood O
cells O
7 O
, O
hematocrit O
42.7% O
, O
hemoglobin O
14.3 O
, O
platelets O
161 O
. O

Differential O
: O

69% O
polys O
, O
60% O
lymphs O
, O
10% O
monos O
, O
5% O
eos O
. O

Prothrombin O
time O
11.7 O
, O
partial O
thromboplastin O
time O
30.4 O
. O

Urinalysis O
: O

over O
100 O
red O
blood O
cells O
per O
high O
powered O
field O
, O
20-50 O
white O
blood O
cells O
per O
high O
powered O
field O
. O

Sodium O
139 O
, O
potassium O
4.7 O
, O
chloride O
106 O
, O
bicarbonate O
21.6 O
, O
BUN O
22 O
, O
creatinine O
1.6 O
, O
glucose O
107 O
, O
amylase O
120 O
, O
calcium O
8.7 O
, O
phosphorus O
3.3 O
, O
magnesium O
1.9 O
, O
total O
protein O
7.5 O
, O
albumin O
3.9 O
, O
globulin O
3.6 O
, O
uric O
acid O
5.6 O
, O
alkaline O
phosphatase O
43 O
, O
GOT O
42 O
, O
LDH O
549 O
with O
hemolyzed O
sample O
. O

Chest O
x-ray O
revealed O
no O
pneumonia B-SYMPTOM
, O
no O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

Electrocardiogram O
revealed O
Q-waves B-SYMPTOM
in I-SYMPTOM
leads I-SYMPTOM
II I-SYMPTOM
, I-SYMPTOM
III I-SYMPTOM
and I-SYMPTOM
AVF I-SYMPTOM
. O

A O
computerized O
tomography O
scan O
revealed O
right B-SYMPTOM
lower I-SYMPTOM
occipital I-SYMPTOM
low-density I-SYMPTOM
area I-SYMPTOM
. O

Head O
magnetic O
resonance O
imaging O
study O
and O
magnetic O
resonance O
imaging O
angiogram O
obtained O
on O
May O
11 O
, O
1995 O
, O
revealed O
subacute B-SYMPTOM
right I-SYMPTOM
lateral I-SYMPTOM
occipital I-SYMPTOM
lobe I-SYMPTOM
infarction I-SYMPTOM
and O
decreased B-SYMPTOM
flow I-SYMPTOM
related I-SYMPTOM
enhancement I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
posterior I-SYMPTOM
communicating I-SYMPTOM
artery I-SYMPTOM
with O
respect O
to O
that O
on O
the O
right O
. O

The O
right O
suggested O
decreased B-SYMPTOM
flow I-SYMPTOM
. O

Carotid O
noninvasives O
revealed O
minimal B-SYMPTOM
carotid I-SYMPTOM
disease I-SYMPTOM
. O

Transcranial O
Dopplers O
: O

normal O
posterior O
and O
anterior O
circulation O
. O

Holter O
electrocardiogram O
: O

no O
significant B-SYMPTOM
arrhythmias I-SYMPTOM
. O

Electroencephalogram O
: O

normal O
study O
. O

Visual O
field O
testing O
: O

small B-SYMPTOM
wedge-shaped I-SYMPTOM
visual I-SYMPTOM
field I-SYMPTOM
defect I-SYMPTOM
in I-SYMPTOM
right I-SYMPTOM
eye I-SYMPTOM
, O
suggesting O
retinal B-SYMPTOM
lesion I-SYMPTOM
. O

Echocardiogram O
revealing O
segmental B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
dysfunction I-SYMPTOM
involving O
inferoseptal O
, O
inferior O
and O
posterior O
segments O
at O
the O
base O
and O
mid O
ventricular O
level O
. O

Overall O
left O
ventricle O
systolic O
function O
moderately B-SYMPTOM
impaired I-SYMPTOM
with O
and O
estimated O
ejection O
fraction O
of O
35% O
. O

Otherwise O
, O
there O
was O
pulmonary B-SYMPTOM
insufficiency I-SYMPTOM
, O
tricuspid B-SYMPTOM
insufficiency I-SYMPTOM
, O
mitral B-SYMPTOM
insufficiency I-SYMPTOM
and O
aortic B-SYMPTOM
insufficiency I-SYMPTOM
. O

There O
were O
no O
clots B-SYMPTOM
seen O
on O
the O
echocardiogram O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
with O
a B-SYMPTOM
right I-SYMPTOM
occipital I-SYMPTOM
cerebral I-SYMPTOM
infarction I-SYMPTOM
. O

The O
patient O
was O
started O
on O
intravenous B-TREATMENT
heparin I-TREATMENT
and O
had O
the O
studies O
as O
described O
above O
for O
rule O
out O
source O
of O
embolic B-SYMPTOM
strokes I-SYMPTOM
including O
carotid O
noninvasives O
, O
transcranial O
Dopplers O
, O
Holter O
electrocardiogram O
and O
echocardiogram O
. O

The O
patient O
also O
had O
serial O
electrocardiogram O
, O
which O
showed O
no O
change O
. O

The O
patient O
also O
had O
serial O
creatinine O
kinase O
with O
MB O
fractions O
studied O
, O
which O
revealed O
MB O
fraction O
too B-SYMPTOM
low I-SYMPTOM
to O
be O
tested O
. O

The O
patient O
also O
experienced O
a O
feeling O
of O
moving O
back O
and O
forth O
when O
lying O
down O
with O
neck O
extended O
during O
the O
magnetic O
resonance O
imaging O
study O
and O
also O
in O
bed O
. O

This B-SYMPTOM
moving I-SYMPTOM
sense I-SYMPTOM
, O
with O
normal O
electroencephalogram O
, O
was O
thought O
to O
be O
a B-SYMPTOM
mild I-SYMPTOM
vestibular I-SYMPTOM
dysfunction I-SYMPTOM
or O
from O
the O
acute O
episode O
of O
the B-SYMPTOM
stroke I-SYMPTOM
. O

The O
patient O
will O
have O
these B-SYMPTOM
symptoms I-SYMPTOM
only O
when O
the O
eyes O
are O
closed O
. O

Our O
opinion O
was O
not O
to O
intervene O
or O
have O
any O
further O
studies O
for O
acute O
period O
and O
to O
continued O
to O
observe O
. O

The O
patient O
did O
have O
a B-SYMPTOM
hypotensive I-SYMPTOM
episode I-SYMPTOM
and O
the O
systolic O
blood O
pressure O
was O
80 O
, O
after O
the O
patient O
received O
his B-TREATMENT
regular I-TREATMENT
cardiac I-TREATMENT
medications I-TREATMENT
. O

The O
patient O
had O
been O
off O
his B-TREATMENT
regular I-TREATMENT
medications I-TREATMENT
since O
during O
the O
admission O
and O
will O
be O
discharged O
off O
his B-TREATMENT
medications I-TREATMENT
. O

Otherwise O
, O
there O
were O
no O
further O
episodes O
of O
blurred B-SYMPTOM
vision I-SYMPTOM
. O

The O
patient O
was O
stable O
with O
an O
unchanged O
neurological O
and O
physical O
examination O
and O
was O
discharged O
on O
aspirin B-TREATMENT
325 O
mg O
po O
qd O
, O
on O
May O
14 O
, O
1995 O
. O

The O
patient O
will O
be O
randomized O
on O
the O
Wars O
study O
early O
next O
week O
by O
the O
Stroke O
Service O
at O
Ph O
University O
Of O
Medical O
Center O
. O

CONDITION O
ON O
DISCHARGE O
: O

The O
patient O
was O
stable O
with O
the O
physical O
examination O
as O
described O
above O
. O

DISCHARGE O
ORDERS O
: O

Medications B-TREATMENT
- O
aspirin B-TREATMENT
325 O
mg O
po O
qd O
, O
Glipizide B-TREATMENT
25 O
mg O
po O
qd O
. O

The O
patient O
will O
be O
discharged O
home O
without O
his B-TREATMENT
regular I-TREATMENT
cardiac I-TREATMENT
medications I-TREATMENT
. O

The O
patient O
will O
be O
followed O
by O
Dr. O
Ketyvi O
Liftjesc O
of O
the O
Neurology O
Service O
at O
Ph O
University O
Of O
Medical O
Center O
on O
May O
17 O
, O
1995 O
, O
for O
randomization O
on O
the O
Wars O
study O
. O

The O
patient O
will O
be O
also O
followed O
by O
Dr. O
Joseet O
Gelineau O
of O
the O
Neurology O
Service O
at O
Ph O
University O
Of O
Medical O
Center O
. O

The O
patient O
will O
also O
be O
followed O
by O
Dr. O
Margmimaui O
Gelineau O
, O
his O
primary O
care O
physician O
at O
Ochtuheihugh O
Put O
University O
Medical O
Center O
within O
one O
week O
after O
discharge O
. O

The O
patient O
will O
also O
be O
followed O
by O
his O
regular O
Urologist O
at O
Ochtuheihugh O
Put O
University O
Medical O
Center O
within O
one O
week O
after O
discharge O
for O
his B-SYMPTOM
continuing I-SYMPTOM
hematuria I-SYMPTOM
. O

JOSEET O
GELINEAU O
, O
M.D. O

TR O
: O

lj O
/ O
bmot O

DD O
: O

05/13/95 O

TD O
: O

05/17/95 O

CC O
: O

Dr. O
Besti O
Kotebreun O
, O
Neurology O
Service O
Dr. O
Margmimaui O
Gelineau O
, O
Ochtuheihugh O
Put O
University O
Medical O
Center O

383938711 O
ELMVH O

08236772 O

6307693 O

10/30/2006 O
12:00:00 O
AM O

s O
/ O
p O
Multiple O
falls O

DIS O

Admission O
Date O
: O

10/30/2006 O

Report O
Status O
: O

Discharge O
Date O
: O

11/03/2006 O

****** O
FINAL O
DISCHARGE O
ORDERS O
****** O

TROUITSA O
, O
WIN O

509-64-03-7 O
E03 O

Room O
: O

40R-480 O

Service O
: O

RNM O

DISCHARGE O
PATIENT O
ON O
: O

11/03/06 O
AT O
10:45 O
AM O

CONTINGENT O
UPON O

Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

FYFE O
, O
NAAN O
ACANDEA O
, O
M.D. O

CODE O
STATUS O
: O

Full O
code O

DISPOSITION O
: O

Home O
w/ O
services O

DISCHARGE O
MEDICATIONS O
: O

TYLENOL B-TREATMENT
( I-TREATMENT
ACETAMINOPHEN I-TREATMENT
) I-TREATMENT
650 O
MG O
PO O
Q4H O
Starting O
Today O
( O
11/02 O
) O
PRN O
Headache B-SYMPTOM

Instructions O
: O

Do O
not O
take O
more O
than O
4gm O
/ O
day O
ACETYLSALICYLIC B-TREATMENT
ACID I-TREATMENT
325 O
MG O
PO O
DAILY O
PHOSLO B-TREATMENT
( I-TREATMENT
CALCIUM I-TREATMENT
ACETATE I-TREATMENT
( O
1 O
GELCAP O
= O
667 O
MG O
) O
) O
1,334 O
MG O
PO O
TID O

Instructions O
: O

Please O
give O
with O
meals O
FLOVENT B-TREATMENT
HFA I-TREATMENT
( I-TREATMENT
FLUTICASONE I-TREATMENT
PROPIONATE I-TREATMENT
) I-TREATMENT
44 O
MCG O
INH O
BID O
LABETALOL B-TREATMENT
HCL I-TREATMENT
300 O

MG O
PO O
BID O

HOLD O
IF O
: O

SBP O
&lt; O
100 O
or O
HR O
&lt; O
55 O

Food O
/ O
Drug O
Interaction O
Instruction O

Take O
consistently O
with O
meals O
or O
on O
empty O
stomach O
. O

COZAAR B-TREATMENT
( I-TREATMENT
LOSARTAN I-TREATMENT
) I-TREATMENT
50 O

MG O
PO O
DAILY O
HOLD O
IF O
: O

SBP O
&lt; O
100 O

Number O
of O
Doses O
Required O
( O
approximate O
) O
: O

3 O

NEPHROCAPS B-TREATMENT
( I-TREATMENT
NEPHRO-VIT I-TREATMENT
RX I-TREATMENT
) I-TREATMENT
1 O
TAB O
PO O
DAILY O

Alert O
overridden O
: O

Override O
added O
on O
10/30/06 O
by O
FELSAPPRYDEFUSC O
, O
ERI O
N. O
, O
M.D. O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

SIMVASTATIN B-TREATMENT
and O
NIACIN B-TREATMENT
, O
VIT. B-TREATMENT
B-3 I-TREATMENT

Reason O
for O
override O
: O

will O
monitor O

ZOCOR B-TREATMENT
( I-TREATMENT
SIMVASTATIN I-TREATMENT
) I-TREATMENT
40 O
MG O
PO O
BEDTIME O

Food O
/ O
Drug O
Interaction O
Instruction O

Avoid O
grapefruit O
unless O
MD O
instructs O
otherwise O
. O

Override O
Notice O
: O

Override O
added O
on O
10/30/06 O
by O
FELSAPPRYDEFUSC O
, O
ERI O
N. O
, O
M.D. O
on O
order O
for O
NEPHROCAPS B-TREATMENT
PO I-TREATMENT
( O
ref O
# O
581988585 O
) O

POTENTIALLY O
SERIOUS B-SYMPTOM
INTERACTION I-SYMPTOM
: O

SIMVASTATIN B-TREATMENT
and O
NIACIN B-TREATMENT
, O
VIT B-TREATMENT
. I-TREATMENT

B-3 B-TREATMENT

Reason O
for O
override O
: O

will O
monitor O

DIET O
: O

House O
/ O
2 O
gm O
Na O
/ O
Low O
saturated O
fat O
low O
cholesterol O
/ O
2 O
gram O
K+ O
, O
Renal B-TREATMENT
diet I-TREATMENT
&lt; O
I O
&gt; O
&lt; O
FDI O
&gt; O

ACTIVITY O
: O

Walking O
as O
tolerated O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Hemodialysis B-TREATMENT
MWF O
, O
Dr. O
Gaetz O
220-871-6906 O
1-2 O
weeks O
, O
Dr. O
Clow O
836-771-4924 O
1 O
week O
, O
Cardiology O
Clinic O
452-860-1428 O
, O
please O
call O
to O
make O
an O
appointment O
in O
1-2 O
weeks O
with O
a O
cardiology O
fellow O
, O

ALLERGY O
: O

NKA B-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

s O
/ O
p O
Multiple O
falls O

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
s O
/ O
p O
Multiple O
falls O

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O

IHSS B-SYMPTOM
AF B-SYMPTOM
ESRD B-SYMPTOM
on O
HD B-TREATMENT
, O
IgA B-SYMPTOM
nephropathy I-SYMPTOM
on O
transplant O
list O
, O
COPD B-SYMPTOM
, O
s O
/ O
p O
pacemaker B-TREATMENT
for O
afib B-SYMPTOM
, O
BPH B-SYMPTOM
s O
/ O
p O
TURP B-TREATMENT
, O
HTN B-SYMPTOM
, O
hypothyroidism B-SYMPTOM
, O
gout B-SYMPTOM
, O
h O
/ O
o O
positive B-SYMPTOM
PPD I-SYMPTOM
MR B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

None O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

Hemodialysis B-TREATMENT
s O
/ O
p O
abdominal O
fat O
pad O
biopsy O
11/2/06 O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

cc O
: O

falls O

HPI O
: O

62 O
yo O
m O
w O
/ O
IgA B-SYMPTOM
nephropathy I-SYMPTOM
, O
developmental B-SYMPTOM
delay I-SYMPTOM
, O
began O
HD B-TREATMENT
7/31 O
. O

Was O
seen O
in O
dialysis O
on O
day O
of O
admission O
and O
was O
seen O
to O
have O
&quot; B-SYMPTOM
raccoon I-SYMPTOM
eyes I-SYMPTOM
&quot; I-SYMPTOM
and O
HD O
staff O
was O
worried O
about O
sending O
home O
. O

Head O
CT O
w O
/ O
o O
bleed B-SYMPTOM
. O

Trauma O
series O
normal O
. O

Pt O
denies O
abuse O
or O
loc B-SYMPTOM
associated O
w O
/ O
fall O
, O
but O
has O
noticed O
several O
recent O
falls O
. O

Recent O
neuro O
w O
/ O
u O
including O
EEG O
, O
carotid O
u O
/ O
s O
, O
head O
ct O
( O
old B-SYMPTOM
stroke I-SYMPTOM
) O
, O
dobutamine-MIBI O
( O
fixed B-SYMPTOM
defect I-SYMPTOM
and O
small B-SYMPTOM
inferolateral I-SYMPTOM
reversible I-SYMPTOM
) O
were O
all O
negative O
. O

Notable O

PMH O
: O

ESRD B-SYMPTOM
from O
IgA B-SYMPTOM
, O
s O
/ O
p O
PPI B-TREATMENT
after O
nodal B-TREATMENT
ablation I-TREATMENT
, O
HTN B-SYMPTOM
, O
COPD B-SYMPTOM
, O
hypothyroid B-SYMPTOM
, O
hypertrophic B-SYMPTOM

CM O
PE O
: O

T O
96.5 O
, O
BP O
145/97 O
, O
p O
70 O
, O
Pox O
98% O
Gen O
AO O
x O
3 O
, O
raccoon B-SYMPTOM
eyes I-SYMPTOM
, O
large B-SYMPTOM
forehead I-SYMPTOM
hematoma I-SYMPTOM

Lungs O
: O

clear O

Abd O
: O

soft O
, O
NT B-SYMPTOM

Ext O
: O

1+ B-SYMPTOM
edema I-SYMPTOM
b I-SYMPTOM
/ I-SYMPTOM
l I-SYMPTOM

Skin O
: O

warm O
, O
smooth O
, O
no O
rashes B-SYMPTOM

Access O
site O
: O

clean O
w O
/ O
o O
inflammation B-SYMPTOM

Labs O
: O

K O
3.5 O
, O
Creat O
3.8 O
, O
Trop-I O
0.45 O
, O
INR O
1.6 O

HOSPITAL O
COURSE O
: O

1. O
Falls-A O
PT O
consult O
was O
obtained O
to O
assist O
with O
ambulation O
. O

A O
social O
work O
consult O
was O
also O
obtained O
and O
deemed O
that O
the O
patient O
has O
appropriate O
support O
at O
home O
and O
is O
safe O
at O
home O
. O

The O
patient O
was O
placed O
on O
telemetry O
and O
had O
no O
telemetry B-SYMPTOM
events I-SYMPTOM
while O
an O
inpatient O
. O

He O
was O
also O
seen O
by O
the O
Electrophysiology O
service O
, O
his B-TREATMENT
pacemaker I-TREATMENT
was O
interrogated O
and O
working O
fine O
, O
with O
no O
signs O
of O
recent B-SYMPTOM
ventricular I-SYMPTOM
arrhythmia I-SYMPTOM
. O

The O
patient O
his O
undergoing O
a O
TTE O
prior O
to O
discharge O
to O
rule O
out O
a B-SYMPTOM
thrombus I-SYMPTOM
. O

His O
TTE O
showed O
EF O
45-50% O
, O
moderate B-SYMPTOM
cLVH I-SYMPTOM
, O
abnormal B-SYMPTOM
diastolic I-SYMPTOM
function I-SYMPTOM
, O
moderate B-SYMPTOM
MR I-SYMPTOM
, O
moderate B-SYMPTOM
TR I-SYMPTOM
and O
severe B-SYMPTOM
LAE I-SYMPTOM
. O

THere O
was O
a O
question O
of O
ionfiltrative B-SYMPTOM
cardiomyopathy I-SYMPTOM
, O
and O
the O
patient O
underwent O
abdominal O
fat O
pad O
biopsy O
to O
assess O
for O
amyloidosis B-SYMPTOM
. O

He O
also O
currently O
has O
an O
SPEP O
/ O
UPEP/Beta O
2 O
microglobulin O
/ O
ACE O
test O
that O
are O
currently O
pending O
. O

These O
should O
be O
followed O
up O
as O
an O
outaptient O
. O

He O
had O
carotid O
ultrasound O
studies O
3 O
months O
ago O
that O
were O
normal O
without O
evidence O
for O
stenosis B-SYMPTOM
. O

2. O
Renal O
- O
cont O
MWF O
HD B-TREATMENT
; O
electrolytes O
have O
been O
stable O
. O

Perhaps O
his O
recent O
falls O
are O
related O
to O
orthostatic B-SYMPTOM
hypotension I-SYMPTOM
after O
dialysis B-TREATMENT
. O

3. O
CV O
-The O
pt O
has O
a O
small O
area O
of O
reversible B-SYMPTOM
ischemia I-SYMPTOM
on O
recent O
MIBI O
, O
and O
has O
troponins B-SYMPTOM
persistently I-SYMPTOM
elevated I-SYMPTOM
in O
the O
setting O
of O
his B-SYMPTOM
renal I-SYMPTOM
disease I-SYMPTOM
. O

His O
troponins O
remained O
lower O
than O
his O
baseline O
levels O
and O
there O
was O
no O
suspicion O
of O
ACS B-SYMPTOM
causing O
syncope B-SYMPTOM
. O

He O
continued O
on O
his B-TREATMENT
zocor I-TREATMENT
, O
cozaar B-TREATMENT
and O
labetalol B-TREATMENT
. O

We O
will O
now O
hold O
his B-TREATMENT
coumadin I-TREATMENT
given O
his O
recent O
falls O
and O
bleeding B-SYMPTOM
risk I-SYMPTOM
. O

His B-TREATMENT
aspirin I-TREATMENT
was O
restarted O
prior O
to O
discharge O
. O

4. O
Endo O
- O
TSH O
was O
4.7 O
and O
normal O
. O

5. O
Heme O
: O

The O
patient O
has O
a B-SYMPTOM
macrocytosis I-SYMPTOM
. O

His O
B12 O
level O
was O
418 O
and O
normal O
. O

He O
does O
have O
a O
history O
of O
B12 B-SYMPTOM
deficiency I-SYMPTOM
in O
the O
past O
, O
and O
evidence O
for O
peripheral B-SYMPTOM
neuropathy I-SYMPTOM
BLE I-SYMPTOM
which O
may O
also O
be O
contributing O
to O
his O
recent O
falls O
. O
? O
EtOH O

6. O
Psych O
: O

watch O
for O
EtOH B-SYMPTOM
WD I-SYMPTOM
. O

THe O
patient O
had O
no O
signs O
of O
alcohol B-SYMPTOM
withdrawal I-SYMPTOM
. O

His O
serum O
toxicology O
screen O
was O
negative O
. O

7. O
Pulm O
: O

COPD B-SYMPTOM
and O
R B-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
, O
off O
oxygen B-TREATMENT
and O
stable O
. O

8. O
GU O
: O

R B-SYMPTOM
complex I-SYMPTOM
renal I-SYMPTOM
cyst I-SYMPTOM
, O
bladder B-SYMPTOM
diverticula I-SYMPTOM
. O

THe O
patient O
will O
need O
a O
follow O
up O
ultrasound O
to O
further O
evaluate O
these B-SYMPTOM
incidental I-SYMPTOM
findings I-SYMPTOM
seen O
on O
imaging O
upon O
admission O
. O

9. O
ID O
: O

The O
patient O
&apos;s O
urinalysis O
was O
normal O
. O

He O
had O
no O
fecal B-SYMPTOM
leukocytes I-SYMPTOM
. O

A O
c.difficile O
test O
is O
negative O
on O
prelim O
read O
, O
however O
very O
low O
suspicion O
given O
no O
recent B-TREATMENT
antibiotic I-TREATMENT
use I-TREATMENT
. O

ADDITIONAL O
COMMENTS O
: O

Please O
return O
to O
the O
hospital O
if O
you O
have O
falls B-SYMPTOM
, O
headache B-SYMPTOM
, O
visual B-SYMPTOM
changes I-SYMPTOM
, O
muscle B-SYMPTOM
weakness I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

1) O
Hemodialysis B-TREATMENT

2) O
Please O
do O
not O
take O
coumadin B-TREATMENT
. O

3) O
Please O
follow O
up O
with O
PCP O
to O
have O
ultrasound O
of O
right O
kidney O
and O
bladder O
to O
assess O
right B-SYMPTOM
kidney I-SYMPTOM
cyst I-SYMPTOM
and O
bladder B-SYMPTOM
diverticula I-SYMPTOM
seen O
incidentally O

4) O
Please O
follow O
up O
with O
Dr. O
Clow O
to O
follow O
up O
results O
of O
abdominal O
fat O
pad O
biopsy O
and O
blood O
tests O
to O
assess O
for O
amyloid B-SYMPTOM
. O

No O
dictated O
summary O

ENTERED O
BY O
: O

FELSAPPRYDEFUSC O
, O
ERI O
N. O
, O
M.D. O
( O
NT717 O
) O
11/03/06 O
10:51 O
AM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2010-08-30 O

Discharge O
Date O
: O

2010-08-31 O

Date O
of O
Birth O
: O

1977-03-27 O

Sex O
: O

M O

Service O
: O

MEDICINE B-TREATMENT

CHIEF O
COMPLAINT O
: O

Delta O
MS O
Rachel O
Rohrer O
. O

HISTORY O
OF O
THE O
PRESENT O
ILLNESS O
: O

This O
is O
a O
33 O
- O
year-old O
Asian-Caucasian O
male O
with O
a O
history O
of O
Type B-SYMPTOM
1 I-SYMPTOM
diabetes I-SYMPTOM
, O
asthma B-SYMPTOM
, O
alcohol O
abuse O
, O
and O
personality B-SYMPTOM
disorder I-SYMPTOM
/ O
depression B-SYMPTOM
admitted O
on O
2010-08-28 O
for O
persistent B-SYMPTOM
hypoglycemia I-SYMPTOM
. O

The O
patient O
complained O
of O
diaphoresis B-SYMPTOM
, O
confusion B-SYMPTOM
, O
dizziness B-SYMPTOM
, O
lightheadedness B-SYMPTOM
after O
drinking O
a O
24 O
ounce O
beer O
and O
taking O
at O
least O
an O
extra O
15 O
units O
of O
NPH B-TREATMENT
insulin I-TREATMENT
the O
evening O
of O
2010-08-27 O
( O
later O
reported O
over O
70 O
U O
insulin B-TREATMENT
administered O
from O
2.30 O
PM O
until O
time O
of O
presentation O
) O
followed O
by O
not O
eating O
dinner O
. O

His B-SYMPTOM
symptoms I-SYMPTOM
mildly O
improved O
after O
eating O
a O
candy O
bar O
. O

The O
EMS O
was O
called O
and O
found O
his O
blood O
sugar O
at O
the O
time O
to O
be O
61 O
and O
noted O
to O
be O
41 O
in O
the O
Emergency O
Department O
. O

He O
denied O
any B-SYMPTOM
seizure I-SYMPTOM
activity I-SYMPTOM
, O
loss B-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
, O
incontinence B-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
fevers B-SYMPTOM
, O
or O
chills B-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
change B-SYMPTOM
in I-SYMPTOM
urinary I-SYMPTOM
or I-SYMPTOM
bowel I-SYMPTOM
habits I-SYMPTOM
, O
or O
suicidal B-SYMPTOM
ideation I-SYMPTOM
. O

He O
has O
been O
depressed B-SYMPTOM
recently O
regarding O
stress O
with O
his O
home O
life O
and O
on O
the O
night O
of O
his B-TREATMENT
extra I-TREATMENT
insulin I-TREATMENT
doses I-TREATMENT
, O
his O
wife O
had O
just O
kicked O
him O
out O
of O
the O
house O
. O

He O
has O
had O
four O
past O
hospitalizations O
for O
attempted B-SYMPTOM
suicide I-SYMPTOM
with O
insulin B-SYMPTOM
overdosing I-SYMPTOM
, O
usually O
denied O
. O

The O
wife O
also O
states O
that O
he O
drinks O
more O
than O
he O
states O
. O

In O
the O
Emergency O
Department O
, O
he O
received O
3.5 O
amps O
of O
D50 B-TREATMENT
and O
then O
D5 B-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
and O
D10 B-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
with O
blood O
sugars O
that O
were O
slow B-SYMPTOM
to I-SYMPTOM
increase I-SYMPTOM
leading O
the O
ICU O
team O
to O
suspect O
that O
the O
patient O
had O
taken O
more O
insulin B-TREATMENT
than O
he O
admitted O
. O

He O
also O
had O
a O
very O
positive O
tox O
screen O
for O
alcohol O
. O

His O
fingersticks O
are O
currently O
in O
the O
200 O
s O
and O
his O
normal O
blood O
glucose O
at O
home O
ranges O
between O
90-200 O
per O
the O
patient O
. O

The O
patient O
also O
now O
complains O
of O
increased B-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
/ I-SYMPTOM
right I-SYMPTOM
rib I-SYMPTOM
cage I-SYMPTOM
pain I-SYMPTOM
and O
new B-SYMPTOM
headache I-SYMPTOM
. O

He O
also O
complains O
of O
chronic B-SYMPTOM
photophobia I-SYMPTOM
which O
is O
unchanged O
. O

He O
denied O
visual B-SYMPTOM
changes I-SYMPTOM
, O
lightheadedness B-SYMPTOM
of O
dizziness B-SYMPTOM
currently O
, O
neck B-SYMPTOM
stiffness I-SYMPTOM
, O
or O
pain B-SYMPTOM
in I-SYMPTOM
any I-SYMPTOM
other I-SYMPTOM
area I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Insulin-dependent B-SYMPTOM
diabetes I-SYMPTOM
. O

- O
followed O
by O
Johannes O
/ O
Brink O

2. O
Depression B-SYMPTOM
. O

3. O
Asthma B-SYMPTOM
. O

4. O
Alcohol O
abuse O
. O

5. O
Hypercholesterolemia B-SYMPTOM
. O

MEDICATIONS O
ON O
TRANSFER O
FROM O
THE O
INTENSIVE O
CARE O
4999801 O
. O

Humalog B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
insulin I-TREATMENT
. O

2. O
NPH B-TREATMENT
12 O
units O
q.a.m. O
, O
7 O
units O
q.p.m. O
with O
normal B-TREATMENT
home I-TREATMENT
dose I-TREATMENT
being O
30 O
units O
q.a.m. O
and O
15 O
units O
q.p.m. O

3. O
Thiamine B-TREATMENT
. O

4. O
Folate B-TREATMENT
. O

5. O
Multivitamin B-TREATMENT
. O

6. O
Fluticasone B-TREATMENT
. O

7. O
Albuterol B-TREATMENT
inhaler I-TREATMENT
p.r.n. O

8. O
Neutra-Phos B-TREATMENT
. O

ALLERGIES O
: O

The O
patient O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

Half O
pack O
per O
day O
of O
tobacco O
times O
20 O
years O
, O
alcohol O
about O
two O
24 O
ounce O
beers O
per O
week O
. O

Drugs O
: O

Denied O
IV O
drug O
abuse O
. O

He O
lives O
with O
his O
wife O
who O
has O
a O
baby O
with O
another O
boyfriend O
of O
two O
years O
. O

He O
recently O
came O
out O
as O
bisexual O
to O
his O
wife O
. O

The O
wife O
and O
the O
patient O
have O
two O
children O
together O
. O

He O
was O
fired O
as O
a O
Federal O
Express O
worker O
recently O
and O
his O
wife O
kicked O
the O
patient O
out O
of O
his O
home O
on O
2010-08-27 O
. O

FAMILY O
HISTORY O
: O

Grandmother O
with O
diabetes B-SYMPTOM
. O

Mother O
with O
asthma B-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
ON O
TRANSFER O
: O
Vital O
signs O
: O

T O
maximum O
98.6 O
, O
blood O
pressure O
90s-130s O
/ O
80s-90s O
, O
heart O
rate O
70s O
to O
80s O
, O
respirations O
18 O
, O
oxygen O
saturation O
98% O
on O
room O
air O
. O

General O
: O

The O
patient O
was O
a O
soft-spoken O
male O
resting O
in O
his O
bed O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

HEENT O
: O

The O
pupils O
were O
equally O
round O
and O
reactive O
to O
light O
. O

Extraocular O
muscles O
were O
intact O
. O

Sclerae O
were O
anicteric B-SYMPTOM
. O

Moist O
mucous O
membranes O
, O
clear O
oropharynx O
. O

Neck O
: O

Supple O
, O
no O
masses B-SYMPTOM
, O
no O
lymphadenopathy B-SYMPTOM
. O

Cardiovascular O
: O

Regular O
rate O
, O
no O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
, O
or O
gallops B-SYMPTOM
. O

Normal O
S1 O
, O
S2 O
. O

Pulmonary O
: O

Clear O
to O
auscultation O
bilaterally O
. O

Abdomen O
: O

Normoactive O
bowel O
sounds O
, O
soft O
, O
mildly B-SYMPTOM
tender I-SYMPTOM
at I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
just O
inferior O
to O
the O
lower O
ribs O
, O
no O
epigastric B-SYMPTOM
tenderness I-SYMPTOM
. O

Extremities O
: O
Warm O
and O
well O
perfuse O
. O

Normal O
peripheral O
pulses O
. O

Neurologic O
: O

Cranial O
nerves O
II O
through O
XII O
were O
intact O
. O

Normal O
sensation O
. O

Normal O
motor O
strength O
bilaterally O
. O

Psychiatric O
: O

Depressed B-SYMPTOM
affect I-SYMPTOM
. O

Denied O
suicidal B-SYMPTOM
ideation I-SYMPTOM
. O

LABORATORY O
/ O
RADIOLOGIC O
DATA O
: O

CBC O
with O
a O
white O
count O
of O
6.2 O
, O
hemoglobin O
13.3 O
, O
hematocrit O
39.4 O
, O
platelet O
307,000 O
. O

Sodium O
142 O
, O
potassium O
4.1 O
, O
chloride O
104 O
, O
bicarbonate O
30 O
, O
BUN O
7 O
, O
creatinine O
0.7 O
, O
glucose O
41 O
. O

Calcium O
9.6 O
, O
magnesium O
2.2 O
, O
phosphorus O
7.4 O
, O
vitamin O
B12 O
level O
320 O
, O
folate O
9.5 O
, O
TSH O
1.4 O
, O
acetone O
negative O
. O

Serum O
tox O
screen O
, O
alcohol O
32 O
mg O
per O
deciliter O
, O
negative O
for O
aspirin B-TREATMENT
, O
benzos B-TREATMENT
, O
barbiturates B-TREATMENT
, O
and O
TCA B-TREATMENT
. O

Urine O
tox O
screen O
negative O
for O
benzos B-TREATMENT
, O
barbiturates B-TREATMENT
, O
opiates B-TREATMENT
, O
cocaine B-TREATMENT
, O
amphetamines B-TREATMENT
, O
and O
methadone B-TREATMENT
. O

Telemetry O
was O
notable O
for O
episodes O
of O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
to O
120s O
to O
140s O
only O
. O

HOSPITAL O
COURSE O
: O

1. O
HYPOGLYCEMIA B-SYMPTOM
: O

The O
patient O
had O
been O
initially O
very B-SYMPTOM
hypoglycemic I-SYMPTOM
on O
admission O
secondary O
to O
overdosing B-SYMPTOM
on I-SYMPTOM
insulin I-SYMPTOM
; O
however O
, O
with O
glucose B-TREATMENT
repletion I-TREATMENT
both O
in O
the O
Emergency O
Department O
and O
in O
the O
ICU O
, O
this O
resolved O
and O
the O
patient O
also O
began O
to O
eat O
. O

We O
checked O
fingerstick O
glucoses O
q.i.d. O
and O
at O
3:00 O
a.m. O

His O
glucose O
on O
the O
morning O
of O
discharge O
was O
about O
60 O
so O
we O
opted O
to O
decrease O
his B-TREATMENT
p.m. I-TREATMENT
NPH I-TREATMENT
dose I-TREATMENT
slightly O
for O
discharge O
and O
continue O
covering O
him O
with O
sliding B-TREATMENT
scale I-TREATMENT
insulin I-TREATMENT
. O

He O
should O
also O
continue O
having O
a O
snack O
at O
midnight O
if O
able O
. O

It O
is O
likely O
that O
he O
required O
a O
much O
greater O
amount O
of O
insulin B-TREATMENT
as O
an O
outpatient O
due O
to O
poor B-SYMPTOM
compliance I-SYMPTOM
with O
Richard B-TREATMENT
Natalie I-TREATMENT
diet I-TREATMENT
. O

2. O
ALCOHOL O
ABUSE O
: O

It O
is O
likely O
that O
the O
patient O
continues O
to O
drink O
more O
than O
he O
admits O
. O

He O
did O
have O
past O
alcoholism O
consisting O
of O
a O
half O
a O
pint O
of O
brandy O
per O
day O
for O
three O
years O
but O
supposedly O
had O
quit O
in O
2009-09-03 O
. O

He O
had O
been O
on O
a B-TREATMENT
diazepam I-TREATMENT
CIWA I-TREATMENT
scale I-TREATMENT
prophylaxis I-TREATMENT
against O
DT B-SYMPTOM
s; I-SYMPTOM
however O
, O
he O
had O
a O
very O
low O
CIWA O
scale O
during O
his O
entire O
admission O
and O
did O
not O
need O
any B-TREATMENT
benzodiazepines I-TREATMENT
. O

This O
alcohol O
abuse O
may O
be O
further O
addressed O
as O
an O
inpatient O
on O
the O
Psychiatry O
Quincy O
Medical O
Center O
. O

We O
had O
also O
requested O
a O
Social O
Work O
consult O
regarding O
this O
. O

3. O
DEPRESSION B-SYMPTOM
vs. O
Borderline B-SYMPTOM
personality I-SYMPTOM
disorder I-SYMPTOM
: O

The O
patient O
has O
had O
several O
admissions O
in O
the O
past O
for O
attempted B-SYMPTOM
suicide I-SYMPTOM
with O
overdose B-SYMPTOM
of O
his B-TREATMENT
insulin I-TREATMENT
and O
though O
he O
denied O
at O
this O
time O
attempting O
to O
end O
his O
life O
, O
it O
appears O
that O
the O
social O
situation O
of O
increased B-SYMPTOM
stressors I-SYMPTOM
corresponding O
to O
this O
time O
suggest O
that O
this O
is O
not O
the O
truth O
. O

He O
received O
a O
one-to-one B-TREATMENT
sitter I-TREATMENT
during O
his O
admission O
and O
will O
be O
transferred O
to O
the O
Psychiatry O
HealthSouth O
New O
England O
Rehab O
Hospital O
to O
ensure O
the O
patient O
's O
safety O
and O
initiate O
further B-TREATMENT
antidepressant I-TREATMENT
treatment I-TREATMENT
. O

He O
will O
need O
close O
follow-up O
regarding O
his B-SYMPTOM
depression I-SYMPTOM
as O
an O
outpatient O
, O
although O
apparently O
this O
has O
been O
set O
up O
for O
him O
in O
the O
past O
and O
he O
had O
not O
followed O
through O
. O

4. O
HISTORY O
OF O
HIGH B-SYMPTOM
BLOOD I-SYMPTOM
PRESSURE I-SYMPTOM
: O

His O
blood O
pressure O
was O
fairly O
low O
with O
a O
maximum O
of O
130s O
systolic O
during O
his O
admission O
, O
thus O
we O
did O
not O
continue O
his B-TREATMENT
lisinopril I-TREATMENT
which O
he O
had O
been O
on O
in O
the O
past O
. O

5. O
RIGHT B-SYMPTOM
UPPER I-SYMPTOM
QUADRANT I-SYMPTOM
PAIN I-SYMPTOM
: O

We O
obtained O
a O
right O
upper O
quadrant O
ultrasound O
as O
well O
as O
LFTs O
, O
amylase O
, O
and O
lipase O
which O
were O
all O
normal O
. O

He O
had O
no O
evidence O
of O
cholecystitis B-SYMPTOM
or O
gallstones B-SYMPTOM
or O
any B-SYMPTOM
abnormalities I-SYMPTOM
with I-SYMPTOM
the I-SYMPTOM
liver I-SYMPTOM
or I-SYMPTOM
kidneys I-SYMPTOM
. O

it O
is O
possible O
that O
he O
has O
had O
a B-SYMPTOM
muscle I-SYMPTOM
strain I-SYMPTOM
or O
other B-SYMPTOM
musculoskeletal I-SYMPTOM
cause I-SYMPTOM
. O

6. O
PROPHYLAXIS B-TREATMENT
: O

He O
was O
put O
on O
Pepcid B-TREATMENT
for O
GI B-TREATMENT
prophylaxis I-TREATMENT
. O

7. O
FLUIDS O
, O
ELECTROLYTES O
, O
AND O
NUTRITION O
: O

He O
complied O
with O
Linda B-TREATMENT
Chad I-TREATMENT
diet I-TREATMENT
while O
hospitalized O
. O

The O
patient O
was O
hyperphosphatemic B-SYMPTOM
secondary O
to O
overadministration O
of O
Neutra-Phos B-TREATMENT
during O
his O
ICU O
stay O
. O

He O
was O
given O
two O
doses O
of O
calcium B-TREATMENT
carbonate I-TREATMENT
1 O
gram O
, O
and O
will O
most O
likely O
normalize O
secondary O
to O
both O
calcium O
binding O
and O
urinary O
excretion O
. O

He O
has O
been O
asymptomatic B-SYMPTOM
. O

DISCHARGE O
CONDITION O
: O

Stable O
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Depression B-SYMPTOM
. O

2. O
Insulin-dependent B-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

3. O
Asthma B-SYMPTOM
. O

4. O
Alcohol O
abuse O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Insulin B-TREATMENT
NPH I-TREATMENT
10 O
units O
q.a.m. O
, O
5 O
units O
q.p.m. O

2. O
Humalog B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
insulin I-TREATMENT
for O
fingerstick O
blood O
glucose O
151-200 O
2 O
units O
; O
201-250 O
4 O
units O
; O
251-300 O
6 O
units O
; O
301-350 O
8 O
units O
; O
351-400 O
10 O
units O
; O
greater O
than O
400 O
12 O
units O
. O

3. O
Multivitamin B-TREATMENT
. O

4. O
Fluticasone B-TREATMENT
. O

5. O
Albuterol B-TREATMENT
p.r.n. O

6. O
Pepcid B-TREATMENT
20 O
mg O
p.o. O
q.d. O

FOLLOW-UP O
PLANS O
: O

The O
patient O
will O
be O
transferred O
to O
the O
Inpatient O
Psychiatry O
Unit O
on O
Springfield O
Municipal O
Hospital O
IV O
for O
further O
evaluation O
and O
treatment B-TREATMENT
of O
his B-SYMPTOM
depression I-SYMPTOM
and O
possible O
suicidal B-SYMPTOM
ideation I-SYMPTOM
. O

He O
will O
follow-up O
with O
his O
primary O
care O
doctor O
, O
Dr. O
Gillis O
, O
after O
discharge O
, O
Johannes O
for O
Diabetes B-TREATMENT
management I-TREATMENT
, O
and O
Psychiatry O
for O
further B-TREATMENT
management I-TREATMENT
of O
his B-SYMPTOM
impulsive I-SYMPTOM
behaviors I-SYMPTOM
. O

Patty O
K. O
Wagner O
, O
M.D. O
01-820 O

Dictated O
By O
: O
Cora O
C. O
Haskett O
, O
M.D. O

MEDQUIST36 O

D O
: O
2010-08-31 O
09:08 O

T O
: O
2010-09-10 O
08:23 O

JOB O
#: O
34336 O

Signed O
electronically O
by O
: O
DR. O
Elizabeth O
Gabriele O
on O
: O
FRI O
2010-09-10 O
3:04 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2016-02-14 O

Discharge O
Date O
: O

Date O
of O
Birth O
: O

1952-03-27 O

Sex O
: O

M O

Service O
: O

ADMISSION O
DIAGNOSIS O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

2. O
Status O
post O
off B-TREATMENT
pump I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
three O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
63 O
year O
old O
gentleman O
who O
had O
initially O
presented O
with O
exertional B-SYMPTOM
chest I-SYMPTOM
pressure I-SYMPTOM
several O
weeks O
prior O
to O
this O
admission O
that O
would O
resolve O
with O
rest O
. O

Stress O
echocardiogram O
demonstrated O
an O
ejection O
fraction O
of O
40% O
, O
hypokinesis B-SYMPTOM
of I-SYMPTOM
distal I-SYMPTOM
anterior I-SYMPTOM
wall I-SYMPTOM
, O
akinesis B-SYMPTOM
of I-SYMPTOM
distal I-SYMPTOM
inferior I-SYMPTOM
wall I-SYMPTOM
and I-SYMPTOM
apex I-SYMPTOM
. O

The O
patient O
had O
a O
cardiac O
catheterization O
which O
revealed O
three B-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
and O
the O
patient O
now O
presents O
for O
elective B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Hypertension B-SYMPTOM
. O

2. O
Hypercholesterolemia B-SYMPTOM
. O

3. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

4. O
End B-SYMPTOM
stage I-SYMPTOM
renal I-SYMPTOM
disease I-SYMPTOM
. O

5. O
Status O
post O
cadaveric B-TREATMENT
kidney I-TREATMENT
transplant I-TREATMENT
in O
2012-09-21 O
. O

6. O
Chronic B-SYMPTOM
allograft I-SYMPTOM
nephropathy I-SYMPTOM
. O

7. O
Chronic B-SYMPTOM
anemia I-SYMPTOM
. O

8. O
History O
of O
upper B-SYMPTOM
gastrointestinal I-SYMPTOM
bleed I-SYMPTOM
. O

9. O
Depression B-SYMPTOM
. O

10. O
Gout B-SYMPTOM
. O

11. O
Question O
of O
transient B-SYMPTOM
ischemic I-SYMPTOM
attack I-SYMPTOM
. O

12. O
Status O
post O
left B-TREATMENT
AV I-TREATMENT
fistula I-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Aspirin B-TREATMENT
325 O
mg O
p.o. O
once O
daily O
. O

2. O
Neoral B-TREATMENT
25 O
mg O
three O
times O
a O
day O
. O

3. O
Diltiazem B-TREATMENT
240 O
mg O
once O
daily O
. O

4. O
Allopurinol B-TREATMENT
100 O
mg O
p.o. O
once O
daily O
. O

5. O
Hydralazine B-TREATMENT
100 O
mg O
twice O
a O
day O
. O

6. O
Enalapril B-TREATMENT
10 O
mg O
p.o. O
twice O
a O
day O
. O

7. O
Avandia B-TREATMENT
4 O
mg O
once O
daily O
. O

8. O
Lipitor B-TREATMENT
10 O
mg O
once O
daily O
. O

9. O
Bactrim B-TREATMENT
double I-TREATMENT
strength I-TREATMENT
once O
daily O
. O

10. O
Hydrochlorothiazide B-TREATMENT
25 O
mg O
once O
daily O
. O

11. O
Toprol B-TREATMENT
XL I-TREATMENT
25 O
mg O
once O
daily O
. O

12. O
Prednisone B-TREATMENT
5 O
mg O
once O
daily O
. O

LABORATORY O
DATA O
: O

Preoperative O
laboratory O
values O
showed O
white O
blood O
cell O
count O
6.8 O
, O
hematocrit O
33.3 O
, O
platelet O
count O

283,000 O
. O

INR O
1.1 O
. O

Chem7 O
showed O
sodium O
138 O
, O
potassium O
4.1 O
, O
chloride O
107 O
, O
bicarbonate O
20 O
, O
blood O
urea O
nitrogen O
49 O
, O
creatinine O
2.5 O
, O
glucose O
156 O
. O

Calcium O
9.2 O
, O
magnesium O
1.8 O
, O
and O
phosphorus O
4.2 O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
, O
in O
general O
, O
the O
patient O
was O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
, O
comfortable O
. O

Vital O
signs O
showed O
temperature O
96.3 O
, O
pulse O
64 O
, O
blood O
pressure O
170/70 O
, O
respiratory O
rate O
20 O
, O
oxygen O
saturation O
98% O
in O
room O
air O
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
examination O
is O
normocephalic O
and O
atraumatic B-SYMPTOM
. O

Extraocular O
movements O
are O
intact O
. O

The O
pupils O
are O
equal O
, O
round O
, O
and O
reactive O
to O
light O
and O
accommodation O
. O

Anicteric B-SYMPTOM
. O

Throat O
is O
clear O
. O

The O
chest O
is O
clear O
to O
auscultation O
bilaterally O
. O

Neck O
was O
supple O
with O
no O
lymphadenopathy B-SYMPTOM
. O

Cardiovascular O
shows O
grade B-SYMPTOM
II/VI I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
, O
regular O
rate O
and O
rhythm O
. O

The O
abdomen O
is O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
with O
a B-SYMPTOM
small I-SYMPTOM
umbilical I-SYMPTOM
hernia I-SYMPTOM
. O

Extremities O
are O
warm O
, O
noncyanotic B-SYMPTOM
and O
nonedematous B-SYMPTOM
times O
four O
. O

There O
is O
no O
peripheral B-SYMPTOM
edema I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
initially O
admitted O
to O
the O
medical O
service O
for O
optimization O
prior O
to O
his B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

The O
patient O
was O
given O
stress B-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
on O
the O
day O
prior O
to O
his B-TREATMENT
surgery I-TREATMENT
. O

He O
was O
closely O
followed O
from O
his O
admission O
through O
to O
his O
discharge O
by O
the O
renal O
service O
for O
his B-SYMPTOM
transplant I-SYMPTOM
issues I-SYMPTOM
. O

On O
2016-02-15 O
, O
the O
patient O
was O
taken O
to O
the O
operating O
room O
and O
had O
an B-TREATMENT
off I-TREATMENT
pump I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
performed O
with O
the B-TREATMENT
left I-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
to I-TREATMENT
the I-TREATMENT
left I-TREATMENT
anterior I-TREATMENT
descending I-TREATMENT
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
obtuse I-TREATMENT
marginal I-TREATMENT
and O
posterior O
descending O
artery O
. O

For O
details O
of O
this B-TREATMENT
operation I-TREATMENT
, O
please O
see O
the O
previously O
dictated O
operative O
note O
. O

Postoperatively O
, O
the O
patient O
was O
transferred O
to O
the O
CSRU O
for O
close O
monitoring O
. O

On O
the O
evening O
of O
postoperative O
day O
number O
zero O
, O
the O
patient O
had O
decreased B-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
and O
was O
placed O
on O
a B-TREATMENT
Lasix I-TREATMENT
drip I-TREATMENT
for O
diuresis B-TREATMENT
. O

The O
patient O
tolerated O
this O
well O
. O

The O
renal O
service O
continued O
to O
follow O
close B-TREATMENT
management I-TREATMENT
of O
his B-TREATMENT
immunosuppression I-TREATMENT
. O

On O
postoperative O
day O
number O
one O
, O
the O
patient O
was O
extubated O
and O
awakened O
from O
sedation B-TREATMENT
. O

He O
did O
well O
on O
this O
and O
his B-TREATMENT
Levophed I-TREATMENT
drip I-TREATMENT
was O
weaned O
to O
off O
as O
tolerated O
. O

Over O
the O
course O
of O
his O
Intensive O
Care O
Unit O
stay O
, O
the O
patient O
received O
six O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
for O
a B-SYMPTOM
low I-SYMPTOM
hematocrit I-SYMPTOM
. O

He O
otherwise O
had O
a O
fairly O
uncomplicated O
postoperative O
course O
. O

On O
postoperative O
day O
number O
three O
, O
the O
patient O
was O
transferred O
to O
the O
floor O
. O

On O
postoperative O
day O
number O
four O
, O
the O
patient O
was O
noted O
to O
have O
a B-SYMPTOM
low I-SYMPTOM
platelet I-SYMPTOM
level I-SYMPTOM
of O
43,000 O
. O

Heparin O
induced O
thrombocytopenia O
antibody O
panel O
was O
sent O
. O

Other O
than O
this O
, O
the O
patient O
did O
very O
well O
. O

Chest B-TREATMENT
tubes I-TREATMENT
were O
removed O
when O
output O
was O
low O
. O

Pacing B-TREATMENT
wires I-TREATMENT
were O
removed O
. O

Physical O
therapy O
saw O
the O
patient O
and O
cleared O
the O
patient O
for O
discharge O
. O

Ultimately O
, O
the O
patient O
was O
discharged O
on O
postoperative O
day O
number O
six O
tolerating O
a O
regular O
diet O
, O
adequate O
pain B-TREATMENT
control I-TREATMENT
on O
p.o. B-TREATMENT
pain I-TREATMENT
medications I-TREATMENT
, O
and O
ambulating O
well O
with O
clearance O
of O
physical O
therapy O
. O

DISPOSITION O
: O

To O
home O
. O

DIET O
: O

Cardiac B-TREATMENT
and I-TREATMENT
diabetic I-TREATMENT
diet I-TREATMENT
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

PHYSICAL O
EXAMINATION O
ON O
DISCHARGE O
: O

The O
chest O
is O
clear O
to O
auscultation O
bilaterally O
without O
sternal B-SYMPTOM
click I-SYMPTOM
or O
discharge B-SYMPTOM
. O

Cardiovascular O
is O
regular O
rate O
and O
rhythm O
. O

The O
abdomen O
is O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Extremities O
are O
warm O
, O
noncyanotic B-SYMPTOM
, O
minimal B-SYMPTOM
peripheral I-SYMPTOM
edema I-SYMPTOM
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Percocet B-TREATMENT
5/325 O
one O
to O
two O
q4hours O
p.r.n. O

2. O
Plavix B-TREATMENT
75 O
mg O
once O
daily O
. O

3. O
Aspirin B-TREATMENT
325 O
mg O
once O
daily O
. O

4. O
Bactrim B-TREATMENT
double I-TREATMENT
strength I-TREATMENT
one O
tablet O
once O
daily O
. O

5. O
Prednisone B-TREATMENT
5 O
mg O
once O
daily O
. O

6. O
Lipitor B-TREATMENT
10 O
mg O
once O
daily O
. O

7. O
Lopressor B-TREATMENT
25 O
mg O
twice O
a O
day O
. O

8. O
Hydralazine B-TREATMENT
75 O
mg O
q6hours O
. O

9. O
Cyclosporin B-TREATMENT
75 O
mg O
twice O
a O
day O
. O

10. O
Rosiglitazone B-TREATMENT
4 O
mg O
once O
daily O
. O

DISCHARGE O
INSTRUCTIONS O
: O

The O
patient O
is O
to O
follow-up O
with O
Dr. O
Herrick O
in O
four O
weeks O
time O
. O

He O
should O
follow-up O
with O
his O
cardiologist O
in O
one O
to O
two O
weeks O
for O
optimization O
of O
his B-TREATMENT
medications I-TREATMENT
. O

The O
patient O
should O
return O
or O
contact O
the O
office O
if O
he O
has O
a B-SYMPTOM
fever I-SYMPTOM
, O
sternal B-SYMPTOM
discharge I-SYMPTOM
or O
other B-SYMPTOM
significant I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
. O

Ellen O
Z O
Neher O
, O
M.D. O

65-969 O

Dictated O
By O
: O
Ann O
C O
Vinson O
, O
M.D. O

MEDQUIST36 O

D O
: O
2016-02-21 O
11:42 O

T O
: O
2016-02-21 O
13:33 O

JOB O
#: O
94475 O

Signed O
electronically O
by O
: O
DR. O
Georgia O
K. O
Dover O
on O
: O
FRI O
2016-03-18 O
3:35 O
PM O

( O
End O
of O
Report O
) O

858462183 O

SH O

20464340 O

11/3/1993 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

11/03/1993 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

11/07/1993 O

PRINCIPAL O
DIAGNOSIS O
: O

1. O
MYELODYSPLASTIC B-SYMPTOM
SYNDROME I-SYMPTOM
WITH O
SYMPTOMATIC B-SYMPTOM
ANEMIA I-SYMPTOM

OTHER O
DIAGNOSES O
: O

2. O
RHEUMATOID B-SYMPTOM
ARTHRITIS I-SYMPTOM

3. O
DIABETES B-SYMPTOM
MELLITUS I-SYMPTOM

4. O
HISTORY O
OF O
MULTIPLE B-SYMPTOM
FOCAL I-SYMPTOM
ATRIAL I-SYMPTOM
TACHYCARDIA I-SYMPTOM

5. O
CONGESTIVE B-SYMPTOM
HEART I-SYMPTOM
FAILURE I-SYMPTOM
WITH O
DILATED B-SYMPTOM
CARDIOMYOPATHY I-SYMPTOM
, O
EJECTION O
FRACTION O
OF O
30% O

6. O
CORONARY B-SYMPTOM
ARTERY I-SYMPTOM
DISEASE I-SYMPTOM

7. O
CHRONIC B-SYMPTOM
BRONCHIECTASIS I-SYMPTOM
ON O
HOME B-TREATMENT
O2 I-TREATMENT

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
69-year-old O
male O
with O
multiple B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
and O
known B-SYMPTOM
transfusion I-SYMPTOM
dependent I-SYMPTOM
secondary O
to O
myelodysplastic B-SYMPTOM
syndrome I-SYMPTOM
admitted O
with O
decreased B-SYMPTOM
hematocrit I-SYMPTOM
. O

The O
patient O
has O
had O
multiple O
previous O
admissions O
for O
cardiac B-SYMPTOM
and I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
. O

He O
has O
had O
chronic B-SYMPTOM
anemia I-SYMPTOM
since O
1990 O
, O
but O
a O
bone O
marrow O
biopsy O
in O
07-92 O
, O
was O
consistent O
with O
myelodysplastic B-SYMPTOM
syndrome I-SYMPTOM
. O

Over O
the O
past O
several O
months O
, O
the O
patient O
has O
had O
increasing B-SYMPTOM
transfusing I-SYMPTOM
requirements I-SYMPTOM
. O

His B-TREATMENT
transfusions I-TREATMENT
have O
been O
complicated O
by O
fluid B-SYMPTOM
overload I-SYMPTOM
and O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
secondary O
to O
ischemia B-SYMPTOM
cardiomyopathy I-SYMPTOM
. O

His O
last O
admission O
was O
9-14-93 O
, O
for O
a B-TREATMENT
transfusion I-TREATMENT
without O
complications B-SYMPTOM
, O
and O
prior O
to O
admission O
the O
patient O
reports O
having O
several O
days O
of O
increasing B-SYMPTOM
weakness I-SYMPTOM
, O
dizziness B-SYMPTOM
and O
fatigue B-SYMPTOM
. O

His O
wife O
says O
his O
hands O
and O
lips O
have O
been O
blue O
. O

Apparently O
, O
he O
had O
had O
a B-SYMPTOM
low I-SYMPTOM
hematocrit I-SYMPTOM
as O
an O
outpatient O
and O
was O
checked O
two O
weeks O
prior O
to O
admission O
but O
was O
not O
given O
transfusion B-TREATMENT
because O
the O
patient O
did O
not O
want O
to O
come O
in O
at O
that O
time O
. O

Aside O
from O
the O
above O
, O
the O
patient O
had O
felt O
that O
baseline O
without O
fever B-SYMPTOM
and O
chills B-SYMPTOM
or O
change B-SYMPTOM
in I-SYMPTOM
chronic I-SYMPTOM
cough I-SYMPTOM
. O

He O
had O
no O
increase O
in O
his B-SYMPTOM
congestive I-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
symptoms I-SYMPTOM
, O
no O
chest B-SYMPTOM
pain I-SYMPTOM
, O
and O
no O
hemoptysis B-SYMPTOM
or O
changed O
in O
arthritis B-SYMPTOM
. O

The O
patient O
did O
report O
taking O
a B-TREATMENT
po I-TREATMENT
antibiotic I-TREATMENT
( I-TREATMENT
Ciprofloxacin I-TREATMENT
) I-TREATMENT
for O
right B-SYMPTOM
great I-SYMPTOM
toe I-SYMPTOM
infection I-SYMPTOM
( O
question O
of O
cellulitis B-SYMPTOM
vs. O
paronychia B-SYMPTOM
) O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Myelodysplastic B-SYMPTOM
syndrome I-SYMPTOM
. O

2. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
/ O
ischemiccardiomyopathy B-SYMPTOM
with O
ejection O
fraction O
of O
30% O
. O

3. O
History O
of O
MAT B-SYMPTOM
for O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
/ O
chronic B-SYMPTOM
bronchi I-SYMPTOM
ectasis I-SYMPTOM
, O
on O
home B-TREATMENT
oxygen I-TREATMENT
. O

4. O
Non B-SYMPTOM
insulin I-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

5. O
Rheumatoid B-SYMPTOM
arthritis I-SYMPTOM
. O

6. O
History O
of O
alcohol O
abuse O
. O

7. O
History O
of O
peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
. O

8. O
Cataracts B-SYMPTOM
, O
status O
post O
bilateral B-TREATMENT
repair I-TREATMENT
. O

9. O
C3 B-SYMPTOM
radiculopathy I-SYMPTOM
. O

10. O
Psoriasis B-SYMPTOM
. O

11. O
History O
of O
hemoptysis B-SYMPTOM
, O
on O
Coumadin B-TREATMENT
. O

12. O
Status O
post O
TURP B-TREATMENT
. O

ALLERGIES O
: O

Quinine B-TREATMENT
, O
Quinidine B-TREATMENT
, O
Bactrim B-TREATMENT
, O
Plaquenil B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
has O
a O
50 O
pack O
year O
history O
of O
tobacco O
and O
quit O
10 O
years O
ago O
; O
also O
, O
a O
history O
of O
ethanol O
abuse O
. O

Still O
drinks O
occasionally O
. O

The O
patient O
lives O
with O
his O
wife O
and O
is O
a O
retired O
sardine O
packer O
. O

PHYSICAL O
EXAMINATION O
: O

Vital O
signs O
: O

Temperature O
98.8 O
; O
heart O
rate O
88-120 O
and O
irregular B-SYMPTOM
; O
blood O
pressure O
118/78 O
; O
O2 O
saturation O
96% O
on O
2 B-TREATMENT
liters I-TREATMENT
. O

HEENT O
: O

Bilateral B-SYMPTOM
cataracts I-SYMPTOM
; O
neck O
appeared O
to O
be O
somewhat B-SYMPTOM
asymmetric I-SYMPTOM
thyroid I-SYMPTOM
with O
small B-SYMPTOM
nodule I-SYMPTOM
barely O
palpable O
on O
the O
left O
lobe O
with O
the O
thyroid O
, O
otherwise O
negative O
. O

No O
lymphadenopathy B-SYMPTOM
was O
palpated O
. O

Lungs O
: O

Rales B-SYMPTOM
1/3 O
of O
the O
way O
upbilaterally O
. O

Cardiovascular O
examination O
revealed O
jugular B-SYMPTOM
venous I-SYMPTOM
distention I-SYMPTOM
at O
12 O
cm O
, O
no O
carotid B-SYMPTOM
bruits I-SYMPTOM
, O
heart O
rate O
was O
tachycardic B-SYMPTOM
and O
regular O
, O
normal O
S1 O
and O
S2 O
, O
palpable B-SYMPTOM
S4 I-SYMPTOM
, O
no O
murmur B-SYMPTOM
was O
auscultated O
. O

Abdominal O
examination O
: O

Obese B-SYMPTOM
, O
soft O
, O
non-tender B-SYMPTOM
, O
bowel O
sounds O
were O
present O
. O

Rectal O
examination O
: O

Heme O
negative O
. O

Extremities O
: O

Joint B-SYMPTOM
deformities I-SYMPTOM
consistent O
with O
rheumatoid B-SYMPTOM
arthritis I-SYMPTOM
, O
right O
MTP O
/ O
toe O
with O
minimal B-SYMPTOM
erythema I-SYMPTOM
. O

Skin O
examination O
: O

Diffuse B-SYMPTOM
psoriasis I-SYMPTOM
over I-SYMPTOM
trunk I-SYMPTOM
and I-SYMPTOM
arms I-SYMPTOM
. O

Neurological O
examination O
was O
non-focal O
. O

LABORATORY O
DATA O
: O

SMA-7 O
was O
unremarkable O
aside O
form O
a O
creatinine O
of O
1.6 O
and O
a O
glucose O
of O
207 O
; O
otherwise O
, O
was O
within O
normal O
limits O
. O

Hematocrit O
was O
22.4 O
; O
white O
count O
.59 O
; O
platelets O
84. O

The O
patient O
had O
an B-SYMPTOM
absolute I-SYMPTOM
neutropenia I-SYMPTOM
with O
a O
ANC O
of O
318 O
; O
differential O
revealed O
48 O
segs O
, O
6 O
bands O
, O
40 O
lymphs O
, O
4 O
monos O
. O

Digoxin O
level O
was O
1.4 O
. O

Theo-Dur O
level O
was O
15 O
. O

PT O
was O
12.5 O
; O
PTT O
27.0 O
. O

Urinalysis O
was O
within O
normal O
limits O
. O

Chest O
x-ray O
showed O
enlarged B-SYMPTOM
heart I-SYMPTOM
with O
mild B-SYMPTOM
pulmonary I-SYMPTOM
vascular I-SYMPTOM
redistribution I-SYMPTOM
, O
no O
gross B-SYMPTOM
congestive I-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
was O
noted O
. O

EKG O
showed O
question O
of O
MAT B-SYMPTOM
vs. O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
with O
a O
ventricular O
response O
of O
118 O
, O
axis O
was O
0 O
degrees O
. O

There O
was O
ST B-SYMPTOM
scooping I-SYMPTOM
in O
the O
lateral O
leads O
consistent O
with O
Dig B-TREATMENT
vs. O
a O
question O
of O
chronic B-SYMPTOM
ischemia I-SYMPTOM
changes I-SYMPTOM
. O

There O
was O
no O
significant B-SYMPTOM
change I-SYMPTOM
from O
his O
baseline O
EKG O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
and O
placed O
in O
isolation B-TREATMENT
on O
neutropenic B-TREATMENT
precautions I-TREATMENT
. O

He O
was O
transfused O
with O
1/2 B-TREATMENT
units I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
and O
given O
Lasix B-TREATMENT
periodically O
to O
prevent O
him O
from O
going O
into O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
has O
he O
had O
on O
his B-TREATMENT
prior I-TREATMENT
transfusion I-TREATMENT
. O

Because O
his O
need O
for O
multiple B-TREATMENT
transfusionsm I-TREATMENT
he O
was O
transfused O
with O
radiated B-TREATMENT
Leuco I-TREATMENT
four O
units O
. O

The O
patient O
had O
a O
good O
bump O
in O
his O
hematocrit O
, O
more O
than O
expected O
from O
22 O
to O
high O
20 O
&apos;s O
range O
next O
day O
after O
3 O
1/2 O
units O
, O
but O
later O
that O
evening O
had O
a B-SYMPTOM
drop I-SYMPTOM
in O
his O
hematocrit O
so O
was O
given O
4 O
more O
1/2 O
units O
at O
this O
point O
for O
a O
total O
of O
4 B-TREATMENT
units I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

He O
again O
did O
not O
bump O
his O
hematocrit O
sufficiently O
and O
remained O
in O
the O
high O
20 O
&apos;s O
after O
a O
total O
of O
4 O
units O
, O
so O
he O
was O
given O
2 O
more O
total O
units O
in O
1/2 O
units O
segments O
the O
following O
day O
. O

His O
hematocrit O
subsequently O
bumped O
to O
greater O
than O
30 O
and O
was O
discharged O
with O
hematocrit O
of O
32 O
on O
11-7-93 O
. O

The O
patient O
remained O
asymptomatic B-SYMPTOM
from O
a B-SYMPTOM
CHF I-SYMPTOM
stand I-SYMPTOM
point I-SYMPTOM
and O
felt O
much O
better O
after O
the B-TREATMENT
transfusions I-TREATMENT
. O

It O
is O
unclear O
why O
the O
patient O
did O
not O
bump O
his O
hematocrit O
more O
but O
he O
did O
not O
appear O
to O
be O
hemolyzing O
from O
laboratory O
data O
, O
that O
is O
his O
LDH O
was O
within O
normal O
limits O
. O

In O
addition O
, O
multiple O
stools O
were O
guaiaced O
and O
were O
all O
guaiac O
negative O
. O

The O
patient O
was O
discharged O
with O
follow-up O
with O
his O
Hematologist O
, O
Dr. O
Eci O
Area O
and O
Rheumatologist O
, O
Dr. O
Taange O
Peter O
, O
and O
Cardiologist O
, O
Dr. O
Peter O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Prednisone B-TREATMENT
10 O
mg O
po O
q O
day O
, O
Verapamil B-TREATMENT
80 O
mg O
po O
t.i.d. O
, O
Digoxin B-TREATMENT
0.25 O
mg O
po O
q O
day O
, O
Isordil B-TREATMENT
20 O
mg O
po O
t.i.d. O
, O
Theo-Dur B-TREATMENT
200 O
mg O
po O
b.i.d. O
, O
Lasix B-TREATMENT
80mg O
q O
am O
, O
40 O
mg O
po O
q O
pm O
, O
Enalapril B-TREATMENT
2.5 O
mg O
po O
b.i.d. O
, O
Pepcid B-TREATMENT
20 O
mg O
po O
b.i.d. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

FOLLOW O
UP O
CARE O
: O

Follow-up O
with O
his O
various O
doctors O
as O
noted O
above O
. O

Dictated O
By O
: O

CAGHALA O
UINTEELE O
, O
M.D. O
HE27 O

Attending O
: O

TAANGE O
Q. O
PETER O
, O
M.D. O
LX12 O
JL816/3429 O

Batch O
: O

2749 O

Index O
No. O

BHNZEG2MVV O

D O
: O

12/03/93 O

T O
: O

12/05/93 O

CC O
: O

1. O
DR. O
ECI O
AREA O
, O
HEMOTOLOGY O
FELLOW O
AT O
RWSTMMCO O

2. O
DR. O
PETER O
, O
CARDIOLOGY O

040076444 O

PUOMC O

2267360 O

95601/1m70 O

602566 O

10/17/1995 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

10/17/95 O

DISCHARGE O
DATE O
: O

10/20/95 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
73-year-old O
man O
with O
squamous B-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lung I-SYMPTOM
, O
status O
post O
lobectomy B-TREATMENT
and O
resection B-TREATMENT
of O
left B-SYMPTOM
cervical I-SYMPTOM
recurrence I-SYMPTOM
, O
admitted O
here O
with O
fever B-SYMPTOM
and O
neutropenia B-SYMPTOM
. O

Recently O
he O
had O
been O
receiving O
a O
combination O
of O
outpatient B-TREATMENT
chemotherapy I-TREATMENT
with O
the O
CAMP O
Program O
. O

Other B-SYMPTOM
medical I-SYMPTOM
problems I-SYMPTOM
include O
hypothyroidism B-SYMPTOM
, O
hypercholesterolemia B-SYMPTOM
, O
hypertension B-SYMPTOM
and O
neuropathy B-SYMPTOM
from O
Taxol B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

He O
was O
a O
well-developed O
, O
well-nourished O
man O
who O
was O
breathing O
comfortably O
. O

Temperature O
was O
101.3 O
. O

HEENT O
were O
normal O
. O

Neck O
was O
supple O
. O

Lungs O
were O
clear O
to O
percussion O
and O
auscultation O
with O
a B-SYMPTOM
few I-SYMPTOM
scattered I-SYMPTOM
rales I-SYMPTOM
, O
left O
greater O
than O
right O
. O

Abdominal O
examination O
was O
normal O
. O

Extremities O
were O
normal O
. O

Neurological O
examination O
was O
nonfocal O
. O

LABORATORY O
DATA O
: O

The O
WBC O
was O
0.9 O
, O
the O
ANC O
was O
540 O
, O
platelets O
were O
156,000 O
. O

HOSPITAL O
COURSE O
: O

He O
was O
started O
on O
Neupogen B-TREATMENT
, O
400 O
mcg. O
subq. O
q.d. O

He O
was O
initially O
treated O
with O
antibiotic B-TREATMENT
therapy I-TREATMENT
. O

Chest O
x-ray O
showed O
questionable O
nodule B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
, O
reasonably O
stable O
. O

Calcium O
8.7 O
, O
bilirubin O
0.3/1.3 O
, O
creatinine O
1.1 O
, O
glucose O
128 O
. O

Hematocrit O
24.6 O
. O

WBC O
rose O
to O
1.7 O
on O
10/19 O
. O

The O
patient O
had O
some B-SYMPTOM
diarrhea I-SYMPTOM
. O

There O
was O
no O
diarrhea B-SYMPTOM
on O
10/20 O
. O

He O
was O
feeling O
well O
and O
afebrile B-SYMPTOM
. O

The B-SYMPTOM
neutropenia I-SYMPTOM
resolved O
and O
he O
was O
felt O
to O
be O
in O
satisfactory O
condition O
on O
discharge O
on O
10/20/95 O
. O

He O
was O
discharged O
home O
on O
Neupogen B-TREATMENT
. O

DISCHARGE O
DIAGNOSIS O
: O

Fever B-SYMPTOM
neutropenia I-SYMPTOM
, O
metastatic B-SYMPTOM
squamous I-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lung I-SYMPTOM
, O
hypertension B-SYMPTOM
. O

DISCHARGE O
MEDICATIONS O
: O

Include O
Neupogen B-TREATMENT
, O
480 O
mcg. O
subq. O
q.d. O
and O
usual B-TREATMENT
medications I-TREATMENT
. O

GUABENFRANDA O
D. O
PATCH O
, O
M.D. O

TR O
: O

wl O
/ O
bmot O

DD O
: O

11/01/95 O

TD O
: O

11/02/95 O

CC O
: O

316810105 O

BH O

5442905 O

550393 O

03/17/2003 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O

KAYSLANCE O
, O
ICEROYLN O

MRN O
: O

5442905 O

Age O
: O

58y O

REGISTRATION O
DATE O
: O

03/17/2003 O
02:52 O
AM O

PRELIMINARY O
REPORT O

This O
is O
to O
notify O
you O
that O
your O
patient O
, O
KAYSLANCE O
, O
ICEROYLN O
arrived O
in O
the O
Emergency O
Department O
at O
Bri O
Health O
on O
03/17/2003 O
02:52 O
AM O
. O

The O
patient O
presented O
with O
a O
chief O
complaint O
of O
LEFT B-SYMPTOM
LEG I-SYMPTOM
FX I-SYMPTOM
HIP I-SYMPTOM
. O

Following O
evaluation O
and O
treatment B-TREATMENT
, O
the O
patient O
&apos;s O
disposition O
at O
the O
end O
ofthe O
visit O
was O
ADMITTED O
AS O
AN O
INPATIENT O
TO O
BRI O
HEALTH O
. O

The O
patient O
&apos;s O
preliminary O
admitting O
physician O
is O
HEAGLEINCHIRD O
, O
JEANSIA O
S O
and O
the O
preliminary O
diagnosis O
is O
HIP B-SYMPTOM
FRACTURE I-SYMPTOM
. O

Please O
note O
this O
information O
may O
have O
been O
updated O
on O
the O
inpatient O
unit O
. O

If O
you O
need O
additional O
information O
please O
call O
442-025-0303 O
. O

PCP O
Name O
: O

NONE O
, O
PHYSICIAN O

Provider O
Number O
: O

27715 O

Admission O
Date O
: O

2015-09-14 O

Discharge O
Date O
: O

2015-09-19 O

Date O
of O
Birth O
: O

2015-09-14 O

Sex O
: O

M O

Service O
: O

NEONATOLOGY O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
3285 O
gm O
infant O
born O
at O
37 O
5/7 O
weeks O
to O
a O
21 O
year O
old O
G3 O
P1 O
now O
2 O
mother O
with O
prenatal O
screens O
as O
follows O
: O

O O
positive O
, O
antibody O
negative O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
RPR O
nonreactive O
, O
GBS O
negative O
. O

Unremarkable O
pregnancy O
except O
for O
minor B-SYMPTOM
fullness I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
renal I-SYMPTOM
pelvis I-SYMPTOM
reported O
during O
the O
week O
prior O
to O
delivery B-TREATMENT
. O

Past O
OB O
history O
remarkable O
for O
postpartum B-SYMPTOM
depression I-SYMPTOM
. O

Mother O
was O
admitted O
in O
labor B-SYMPTOM
. O

Baby O
was O
delivered O
by O
repeat B-TREATMENT
C-section I-TREATMENT
with O
rupture B-TREATMENT
of I-TREATMENT
membranes I-TREATMENT
at O
delivery B-TREATMENT
. O

Apgars O
were O
8 O
and O
9 O
. O

CMED O
CSRU O
staff O
was O
called O
about O
30 O
minutes O
of O
age O
for O
grunting B-SYMPTOM
, O
flaring B-SYMPTOM
and O
retractions B-SYMPTOM
and O
the O
baby O
was O
admitted O
to O
the O
CMED O
CSRU O
. O

PHYSICAL O
EXAMINATION O
: O

Exam O
was O
notable O
for O
a O
term O
infant O
with O
flat O
anterior O
fontanelle O
, O
pink O
color O
, O
normal O
facies O
, O
intact O
palate O
, O
mild B-SYMPTOM
retractions I-SYMPTOM
, O
good O
air O
entry O
, O
no O
murmurs B-SYMPTOM
. O

Femoral O
pulses O
present O
. O

Flat O
, O
soft O
and O
nontender B-SYMPTOM
abdomen I-SYMPTOM
without O
hepatosplenomegaly B-SYMPTOM
. O

Stable O
hips O
. O

Normal O
male O
genitalia O
. O

Testes O
scrotum O
. O

Normal O
perfusion O
. O

Normal O
tone O
and O
activity O
. O

LABORATORY O
DATA O
: O

Initial O
white O
count O
19.4 O
thousand O
, O
64 O
polys O
, O
3 O
bands O
, O
hematocrit O
35.8 O
, O
platelets O
281,000 O
. O

Chest O
x-ray O
revealed O
streaky B-SYMPTOM
lung I-SYMPTOM
fields I-SYMPTOM
of O
normal O
situs O
, O
no O
consolidation B-SYMPTOM
, O
consistent O
with O
retained B-SYMPTOM
fetal I-SYMPTOM
lung I-SYMPTOM
fluid I-SYMPTOM
. O

HOSPITAL O
COURSE: O

1. O
Respiratory O
. O

The O
Athol O
Memorial O
Hospital O
hospital O
course O
was O
initially O
consistent O
with O
transient B-SYMPTOM
tachypnea I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
newborn I-SYMPTOM
. O

Chest O
x-ray O
revealed O
mild B-SYMPTOM
streakiness I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lung I-SYMPTOM
fields I-SYMPTOM
. O

He O
was O
initially O
placed O
on O
nasal B-TREATMENT
cannula I-TREATMENT
with O
subsequent O
resolution O
of O
respiratory B-SYMPTOM
distress I-SYMPTOM
. O

Nasal B-TREATMENT
cannula I-TREATMENT
was O
weaned O
off O
on O
day O
of O
life O
3 O
and O
he O
initially O
was O
maintaining O
O2 O
sat O
above O
94% O
and O
breathing O
comfortably O
. O

He O
was O
subsequently O
placed O
back O
on O
nasal B-TREATMENT
cannula I-TREATMENT
for O
mild B-SYMPTOM
oxygen I-SYMPTOM
desaturation I-SYMPTOM
and O
was O
requiring O
25 O
c/min O
flow O
at O
the O
time O
of O
discharge O
. O

No O
apneic B-SYMPTOM
or I-SYMPTOM
brady I-SYMPTOM
episodes I-SYMPTOM
. O

2. O
Cardiovascular O
. O

The O
patient O
's O
cardiovascular O
status O
has O
been O
stable O
throughout O
his O
CMED O
CSRU O
stay O
. O

No O
murmur B-SYMPTOM
on O
exam O
. O

3. O
FEN O
. O

The O
patient O
had O
been O
tolerating O
oral O
feeding O
as O
of O
day O
of O
life O
2 O
and O
is O
currently O
taking O
Enfamil B-TREATMENT
20 O
p.o. O
ad O
lib O
. O

He O
has O
been O
weaned O
off O
IV B-TREATMENT
fluids I-TREATMENT
and O
has O
been O
maintaining O
good O
blood O
glucose O
. O

His O
birth O
weight O
was O
3285 O
gm O
. O

His O
weight O
is O
3015 O
gm O
on O
day O
of O
life O
5 O
. O

4. O
GI O
. O

The O
patient O
's O
bilirubin O
level O
at O
24 O
hours O
of O
life O
was O
4.6. O

No O
phototherapy B-TREATMENT
was O
started O
. O

5. O
ID O
. O

The O
patient O
was O
not O
started O
on O
antibiotics B-TREATMENT
, O
given O
lack O
of O
sepsis B-SYMPTOM
risk I-SYMPTOM
factors I-SYMPTOM
. O

His O
initial O
CBC O
showed O
no O
left B-SYMPTOM
shift I-SYMPTOM
. O

Blood O
culture O
had O
remained O
no O
growth B-SYMPTOM
to O
date O
. O

6. O
Heme O
. O

The O
patient O
's O
initial O
hematocrit O
was O
35.8 O
. O

No O
transfusion B-TREATMENT
during O
this B-TREATMENT
admission I-TREATMENT
. O

CONDITION O
ON O
TRANSFER O
: O

The O
patient O
has O
been O
doing O
well O
on O
low B-TREATMENT
flow I-TREATMENT
nasal I-TREATMENT
cannula. I-TREATMENT
He O
has O
been O
tolerating O
p.o. O
ad O
lib O
feeds O
. O

DISCHARGE O
DISPOSITION O
: O

The O
patient O
is O
to O
be O
transferred O
to O
the O
Cambridge O
Hospital O
Hospital O
Special O
Care O
Nursery O
. O

PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Amanda O
Hilton O
of O
Crown O
Colony O

Pediatrics O
, O
phone O
number O
353-5927 O
, O
fax O
number O

( O
853 O
) O
390 O
1387 O
. O

CARE O
AND O
RECOMMENDATIONS: O

1. O
Feeds O
at O
discharge O
: O
Enfamil B-TREATMENT
20 O
p.o. O
ad O
lib O
. O

2. O
Medications B-TREATMENT
: O
none O
. O

3. O
Car O
seat O
positioning O
: O
not O
yet O
done O
. O

4. O
State O
newborn O
screening O
sent O
. O

5. O
Immunizations B-TREATMENT
: O
received O
hepatitis B-TREATMENT
B I-TREATMENT
on O
09-16 O
. O

DISCHARGE O
DIAGNOSES: O

1. O
Prolonged B-SYMPTOM
Respiratory I-SYMPTOM
Transition I-SYMPTOM
. O

1. O
Hyaline B-SYMPTOM
Membrane I-SYMPTOM
Disease I-SYMPTOM
. O

2. O
Rule O
out O
sepsis B-SYMPTOM
without O
antibiotics B-TREATMENT
. O

Kevin O
F O
Juliusson O
, O
M.D. O

04-834 O

Dictated O
By:Anita O
X. O
Duffy O
, O
M.D. O

MEDQUIST36 O

D O
: O

2015-09-17 O

13:45 O

T O
: O

2015-09-17 O

14:15 O

JOB# O
: O

24313 O

Signed O
electronically O
by O
: O

DR. O
Vanessa O
Riker O
on O
: O

SAT O
2015-09-19 O
2:01 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2018-12-04 O

Discharge O
Date O
: O

2018-12-12 O

Date O
of O
Birth O
: O

1984-02-13 O

Sex O
: O

F O

Service O
: O

OBSTETRICS/GYNECOLOGY O

Allergies O
: O

Ciprofloxacin B-TREATMENT
/ O
Flagyl B-TREATMENT

Attending O
: O

Ana O
K O
Warren O
, O
M.D. O

Chief O
Complaint O
: O

Pelvic B-SYMPTOM
organ I-SYMPTOM
prolapse I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

total B-TREATMENT
vaginal I-TREATMENT
hysterectomy; I-TREATMENT
combined O
anterior-posterior B-TREATMENT
colporrhaphy I-TREATMENT
with O
posterior B-TREATMENT
mesh; I-TREATMENT
subpubic B-TREATMENT
urethral I-TREATMENT
sling; I-TREATMENT
sacrospinous O
colpopexy O
exploratory O
laparotomy O

Reexploration O
of O
vaginal O
surgical O
area O
pelvic O
angiography O

History O
of O
Present O
Illness O
: O

34 O
yo O
G3P3 O
with O
pelvic B-SYMPTOM
organ I-SYMPTOM
prolapse I-SYMPTOM
after O
her O
second O
delivery; O
after O
her O
third O
delivery O
it O
became O
much B-SYMPTOM
worse I-SYMPTOM
. O

She O
feels O
like O
"everything O
is O
falling O
out." O

She O
urinates O
frequently O
, O
but O
occasionally O
the O
urine O
is O
very B-SYMPTOM
slow I-SYMPTOM
to I-SYMPTOM
start I-SYMPTOM
. O

She O
is O
unable O
to O
run O
without O
losing O
urine O
. O

The B-SYMPTOM
prolapse I-SYMPTOM
is O
especailly O
large B-SYMPTOM
and I-SYMPTOM
uncomfotable I-SYMPTOM
when O
she O
tries O
to O
move O
her O
bowels O
and O
it O
is O
easier O
for O
her O
to O
do O
sowhile O
standing O
rather O
than O
sitting O
. O

She O
has O
deep B-SYMPTOM
pain I-SYMPTOM
in O
intercourse O
. O

Past O
Medical O
History O
: O

Medical O

Chronic B-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
: O
several B-SYMPTOM
discs I-SYMPTOM
and O
spondylolisthesis B-SYMPTOM

Surgical O

Left B-TREATMENT
salpingo I-TREATMENT
oophorectomy I-TREATMENT
2002 O
for O
torsion; B-SYMPTOM
coloposcopy O
and O
cryotherapy B-TREATMENT
2001; O
appendectomy; B-TREATMENT
T B-TREATMENT
+ I-TREATMENT
A I-TREATMENT

Ob O

3 O
FTNDs O

Social O
History O
: O

Occasional O
EtOH O

1ppd O
tobacco O

Family O
History O
: O

Mother O
had O
breast B-SYMPTOM
cancer I-SYMPTOM

Physical O
Exam O
: O

112 O
# O

138/94 O

Gen O
: O

NAD B-SYMPTOM

Heart O
: O

RRR O
, O
no O
murmurs B-SYMPTOM

Lungs O
: O

Clear O
to O
percussion O
and O
auscultation O

Breast O
: O

Negative O

Abdomen O
: O

Negative O

Pelvic O

Ext O
gen O
: O

negative O

Support O
: O

Anterior B-SYMPTOM
wall I-SYMPTOM
prolapses I-SYMPTOM
3 O
cm O
past O
the O
hymen O
with O
loss B-SYMPTOM
of I-SYMPTOM
urine I-SYMPTOM
on I-SYMPTOM
valsalva; I-SYMPTOM
cervix O
1cm O
above O
the O
hymen; O
posterior B-SYMPTOM
prolapse I-SYMPTOM
only O
to O
the O
hymen O
but O
3.4 O
cm O
of O
perineal B-SYMPTOM
descent I-SYMPTOM
. O

Vagina O
: O

Negative O

Cervix O
: O

Negative O

Uterus O
: O

Anterior O
, O
tender B-SYMPTOM
on O
motion O

Adnexa O
: O

Right O
not O
palpable O
, O
left O
absent O

Rectal O
: O

Neg O

Pertinent O
Results O
: O

RADIOLABLED O
RED O
CELL O
STUDY O
12-05 O

IMPRESSION O
: O

No O
evidence O
of O
acute B-SYMPTOM
bleed I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
abdomen I-SYMPTOM
or I-SYMPTOM
pelvis I-SYMPTOM
. O

PELVIC O
ARTEROGRAM O
12-05 O

FINDINGS O
: O

Images O
demonstrate O
diffusely B-SYMPTOM
small I-SYMPTOM
caliber I-SYMPTOM
vasculature I-SYMPTOM
consistent O
with O
shock B-SYMPTOM
. O

There O
is O
luminal B-SYMPTOM
irregularity I-SYMPTOM
seen O
in O
segments O
of O
both O
the O
left O
and O
right O
external O
iliac O
arteries O
consistent O
with O
spasm B-SYMPTOM
. O

Specifically O
, O
no O
extravasation B-SYMPTOM
of I-SYMPTOM
contrast I-SYMPTOM
, O
obstruction B-SYMPTOM
of I-SYMPTOM
blood I-SYMPTOM
flow I-SYMPTOM
, O
AV B-SYMPTOM
fistulization I-SYMPTOM
or O
intimal B-SYMPTOM
injury I-SYMPTOM
was O
observed O
. O

Thus O
, O
no O
embolotherapy B-TREATMENT
was O
embarked O
upon O
. O

IMPRESSION O
: O

No O
active B-SYMPTOM
bleeding I-SYMPTOM
was O
observed O
. O

PATHOLOGY O
uterus O
, O
tubes O
, O
ovaries O
12-04 O

1. O
Uterus O
and O
cervix O
, O
hysterectomy B-TREATMENT
( O
A-E O
): O

A. O
Secretory B-SYMPTOM
endometrium I-SYMPTOM
. O

B. O
Cervix O
with O
squamous B-SYMPTOM
metaplasia I-SYMPTOM
. O

C. O
Unremarkable O
myometrium O
. O

D. O
One B-TREATMENT
intrauterine I-TREATMENT
device I-TREATMENT
, O
gross O
description O
. O

2. O
Vaginal O
epithelium O
( O
F O
): O

Squamous B-SYMPTOM
mucosa I-SYMPTOM
and O
skin O
with O
no O
significant B-SYMPTOM
pathologic I-SYMPTOM
change I-SYMPTOM
. O

2018-12-04 O
06:37PM O
BLOOD O

WBC O
- O
20.0* O
RBC O
- O
3.31* O
Hgb O
- O
10.2*# O
Hct O
- O
31.2* O

MCV O
- O
95 O
MCH O
- O
30.9 O
MCHC O
- O
32.7 O
RDW O
- O
13.6 O
Plt O
Ct O
- O
297 O

2018-12-04 O
08:48PM O
BLOOD O

Hct O
- O
19.5*# O

2018-12-05 O
01:46AM O
BLOOD O

WBC O
- O
20.0* O
RBC O
- O
3.96* O
Hgb O
- O
12.5 O
Hct O
- O
34.4*# O

MCV O
- O
87# O
MCH O
- O
31.5 O
MCHC O
- O
36.4*# O
RDW O
- O
13.6 O
Plt O
Ct O
- O
89*# O

2018-12-05 O
09:45AM O
BLOOD O

WBC O
- O
12.7* O
RBC O
- O
3.17* O
Hgb O
- O
9.9* O
Hct O
- O
27.6* O

MCV O
- O
87 O
MCH O
- O
31.3 O
MCHC O
- O
35.9* O
RDW O
- O
14.2 O
Plt O
Ct O
- O
104* O

2018-12-06 O
04:09AM O
BLOOD O

WBC O
- O
12.1* O
RBC O
- O
3.73* O
Hgb O
- O
11.3* O
Hct O
- O
31.5* O

MCV O
- O
84 O
MCH O
- O
30.2 O
MCHC O
- O
35.8* O
RDW O
- O
15.4 O
Plt O
Ct O
- O
91* O

2018-12-07 O
12:15AM O
BLOOD O

Hct O
- O
28.7* O

2018-12-08 O
06:30AM O
BLOOD O

Hct O
- O
27.9* O

2018-12-10 O
04:45AM O
BLOOD O

WBC O
- O
12.6* O
RBC O
- O
3.53* O
Hgb O
- O
10.5* O
Hct O
- O
30.1* O

MCV O
- O
85 O
MCH O
- O
29.8 O
MCHC O
- O
35.0 O
RDW O
- O
14.6 O
Plt O
Ct O
- O
308# O

2018-12-04 O
06:37PM O
BLOOD O

PT O
- O
13.0 O
PTT O
- O
26.1 O
INR O
( O
PT O
) O
- O
1.1 O

2018-12-05 O
02:03PM O
BLOOD O

PT O
- O
13.2* O
PTT O
- O
24.2 O
INR O
( O
PT O
) O
- O
1.1 O

2018-12-06 O
04:09AM O
BLOOD O

PT O
- O
11.6 O
PTT O
- O
23.8 O
INR O
( O
PT O
) O
- O
1.0 O

2018-12-04 O
06:37PM O
BLOOD O

Glucose O
- O
146* O
UreaN O
- O
12 O
Creat O
- O
0.6 O
Na O
- O
140 O

K O
- O
4.1 O
Cl O
- O
108 O
HCO3 O
- O
21* O
AnGap O
- O
15 O

2018-12-06 O
04:09AM O
BLOOD O

Glucose O
- O
96 O
UreaN O
- O
5* O
Creat O
- O
0.4 O
Na O
- O
139 O

K O
- O
3.1* O
Cl O
- O
108 O
HCO3 O
- O
26 O
AnGap O
- O
8 O

2018-12-08 O
09:20PM O
BLOOD O

UreaN O
- O
4* O
Creat O
- O
0.3* O
Na O
- O
140 O
K O
- O
4.0 O
Cl O
- O
108 O

HCO3 O
- O
27 O
AnGap O
- O
9 O

2018-12-04 O
06:37PM O
BLOOD O

Calcium O
- O
7.9* O
Phos O
- O
4.5 O
Mg O
- O
1.5* O

2018-12-06 O
01:03PM O
BLOOD O

Calcium O
- O
7.3* O
Phos O
- O
2.3* O
Mg O
- O
1.7 O

2018-12-07 O
06:30AM O
BLOOD O

Calcium O
- O
7.5* O
Mg O
- O
1.6 O

2018-12-08 O
09:20PM O
BLOOD O

Calcium O
- O
7.5* O
Phos O
- O
2.7 O
Mg O
- O
1.9 O

2018-12-04 O
10:53PM O
BLOOD O

Type O
- O
ART O
pO2 O
- O
229* O
pCO2 O
- O
44 O
pH O
- O
7.26* O
calTCO2 O
- O
21 O
Base O
XS O
- O
-6 O
Intubat O
- O
INTUBATED O
Vent O
- O
CONTROLLED O

2018-12-05 O
09:09AM O
BLOOD O

Type O
- O
ART O
Temp O
- O
37.2 O
Rates O
- O
/12 O
Tidal O
V O
- O
560 O

PEEP O
- O
5 O
FiO2 O
- O
50 O
pO2 O
- O
176* O
pCO2 O
- O
42 O
pH O
- O
7.35 O
calTCO2 O
- O
24 O
Base O
XS O
- O
-2 O

Intubat O
- O
INTUBATED O
Vent O
- O
SPONTANEOU O

Brief O
Hospital O
Course O
: O

The O
patient O
was O
taken O
to O
the O
operating O
room O
on O
2018-12-04 O
for O
TVH B-TREATMENT
, O
sacrospinous B-TREATMENT
fixation I-TREATMENT
, O
SPARC B-TREATMENT
, O
anterior B-TREATMENT
and I-TREATMENT
posterior I-TREATMENT
repair I-TREATMENT
with I-TREATMENT
mesh I-TREATMENT
, O
cystoscopy; O
for O
pelvic B-SYMPTOM
organ I-SYMPTOM
prolapse I-SYMPTOM
. O

There O
were O
no O
intraoperative B-SYMPTOM
complications I-SYMPTOM
and O
the O
surgical O
field O
was O
hemostatic O
at O
the O
conclusion O
of O
the O
case O
( O
see O
operative O
report O
for O
full O
description O
) O
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
and O
was O
stable O
in O
the O
PACU O
and O
admitted O
to O
the O
CMED O
CCU O
floor O
for O
routine B-TREATMENT
care I-TREATMENT
. O

At O
1645 O
12-04 O
, O
the O
patient O
was O
noted O
to O
be O
hypotensive B-SYMPTOM
to O
70/40 O

HR O
84 O
with O
symptoms B-SYMPTOM
of I-SYMPTOM
lightheadedness I-SYMPTOM
while O
lying O
supine O
. O

There O
was O
no O
active B-SYMPTOM
bleeding I-SYMPTOM
noted O
at O
the O
surgical O
site O
on O
examination O
. O

A O
STAT O
HCT O
drawn O
at O
this O
time O
was O
31.2 O
. O

The O
patient O
was O
re-evalutated O
at O
2000 O
and O
was O
found O
to O
be O
tacchycardic B-SYMPTOM
to O
115 O
with O
BP O
104/50 O
using O
a O
manual O
cuff O
. O

Urine O
output O
during O
the O
prior O
two O
hours O
had O
been O
50cc O
and O
24cc O
. O

A O
STAT O
HCT O
drawn O
at O
this O
time O
was O
19.5 O
. O

The O
clinical O
picture O
was O
concerning O
for O
a B-SYMPTOM
post-operative I-SYMPTOM
hematoma I-SYMPTOM
. O

The O
ICU O
was O
alerted O
to O
the O
patient O
's O
disposition O
and O
the O
operating O
room O
was O
activated O
for O
urgent O
re-exploration O
. O

The O
patient O
was O
taken O
to O
the O
OR O
on O
POD#0 O
for O
re-exploration O
with O
incision O
at O
2243 O
. O

Exploratory O
laparotomy O
revealed O
hemoperitonium B-SYMPTOM
and O
approximately O
1 O
L O
of O
blood B-SYMPTOM
was O
evacuated O
. O

There O
was O
approximately O
500cc O
of O
retroperitoneal B-SYMPTOM
clot I-SYMPTOM
. O

Despite O
laparotomy O
and O
re-exploration O
through O
the O
vaginal O
cuff O
, O
no O
source O
for O
the B-SYMPTOM
bleeding I-SYMPTOM
could O
be O
found O
. O

At O
the O
conclusion O
of O
the O
case O
, O
the O
patient O
continued O
to O
bleed O
, O
allbeit O
at O
a O
less O
brisk O
pace O
. O

The B-TREATMENT
endotracheal I-TREATMENT
tube I-TREATMENT
was O
left O
in O
place O
. O

Intraoperatively O
, O
the O
patient O
recieved O
5u O
PRBC B-TREATMENT
. O

IR O
was O
consulted O
to O
identify O
the B-SYMPTOM
bleeding I-SYMPTOM
vessel I-SYMPTOM
with O
angiography O
, O
then O
perform O
embolization B-TREATMENT
. O

Tagged O
cell O
and O
angiographic O
studies O
performed O
immediately O
after O
re-exploration O
on O
12-05 O
did O
not O
indetify O
active B-SYMPTOM
bleeding I-SYMPTOM
and O
no O
emobolization B-TREATMENT
was O
indicated O
. O

THe O
patient O
was O
stable O
and O
remained O
intubated B-SYMPTOM
. O

The O
patient O
was O
admitted O
to O
the O
ICU O
for O
further B-TREATMENT
care I-TREATMENT
. O

The O
patient O
's O
ICU O
course O
was O
uneventful O
. O

There O
was O
no O
evidence O
of O
continued O
bleeding B-SYMPTOM
and O
her O
HCT O
remained O
stable O
around O
30 O
. O

The O
pt O
self-extubated O
on O
POD O
#1 O
. O

The O
patient O
developed O
a B-SYMPTOM
low I-SYMPTOM
grade I-SYMPTOM
fever I-SYMPTOM
to O
100.1 O
on O
POD#1 O
which O
persisted O
to O
POD#2 O
and O
imperic B-TREATMENT
treatment I-TREATMENT
with O
gent/clinda B-TREATMENT
was O
started O
. O

The O
patient O
was O
stable O
for O
transfer O
to O
the O
CMED O
floor O
on O
POD#3 O
. O

Antibiotics B-TREATMENT
were O
discontinued O
on O
POD#8 O
and O
pt O
remained O
afebrile B-SYMPTOM
thereafter O
. O

On O
POD#9 O
, O
the O
patient O
was O
afebrile B-SYMPTOM
, O
tolerating O
a O
regular O
diet O
, O
ambultating O
without O
difficulty B-SYMPTOM
and O
voiding O
spontaneously O
. O

She O
was O
discharged O
home O
with O
follow-up O
in O
two O
weeks O
. O

Medications O
on O
Admission O
: O

Zoloft B-TREATMENT
100mg O
QD O

Ritalin B-TREATMENT
0.5mg O
BID O

Loraze3pam B-TREATMENT
0.5mg O
BID O

Percocet B-TREATMENT
5/325 O
QHS O

Allergies O
: O

Cipro B-TREATMENT
, O
Flagyl B-TREATMENT

Discharge O
Medications O
: O

1. O
Ibuprofen B-TREATMENT
600 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

Disp O
: O
*60 O
Tablets* O

Refills O
: O
*1* O

2. O
Oxycodone-Acetaminophen B-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
. O

Disp O
: O
*60 O
Tablet( O
s O
)* O

Refills O
: O
*0* O

3. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
: O
*60 O
Capsule( O
s O
)* O

Refills O
: O
*2* O

Continue O
home B-TREATMENT
meds I-TREATMENT
. O

Discharge O
Disposition O
: O

Home O

Discharge O
Diagnosis O
: O

pelvic B-SYMPTOM
organ I-SYMPTOM
prolapse I-SYMPTOM
stress B-SYMPTOM
urinary I-SYMPTOM
incontinence I-SYMPTOM
retroperitoneal B-SYMPTOM
bleed I-SYMPTOM
hemoperitoneum I-SYMPTOM

Discharge O
Condition O
: O

stable O

Discharge O
Instructions O
: O

No O
heavy O
lifting O
for O
6 O
weeks O

No O
abdominal O
exercises O
for O
6 O
weeks O

Nothing O
in O
the O
vagina O
for O
6 O
weeks O

Keep O
stools O
soft O

Followup O
Instructions O
: O

Please O
call O
Dr. O
Lewis O
office O
for O
an O
appointment O
in O
2 O
weeks O
. O

Adam O
Saundra O
MD O
46-863 O

Completed O
by O
: O

Michael O
KNIGHT O
MD O
21-317 O
2018-12-16 O
@ O
1245 O

Signed O
electronically O
by O
: O

DR. O
Wanda O
Detz O
on O
: O

TUE O
2018-12-18 O
8:13 O
AM O

( O
End O
of O
Report O
) O

164312247 O

NVH O

47624330 O

1/19/2002 O
12:00:00 O
AM O

Sepsis B-SYMPTOM
, O
myocardial B-SYMPTOM
infarction I-SYMPTOM
, O
ARDS B-SYMPTOM
, O
pneumonia B-SYMPTOM

DIS O

Admission O
Date O
: O

01/19/2002 O

Report O
Status O
: O

Discharge O
Date O
: O

01/20/2002 O

****** O
DISCHARGE O
ORDERS O

TROSPROB O
, O
STYEES O

650-29-95-3E45 O

Room O
: O

9V-851 O

Service O
: O

PUL O

DISCHARGE O
PATIENT O
ON O
: O

01/20/02 O
AT O
03:00 O
AM O

CONTINGENT O
UPON O

Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

GLOMOBESAP O
, O
BAMJET O
ELLDAN O
, O
M.D. O

CODE O
STATUS O
: O

Other-Expired O
. O

DISPOSITION O
: O

Expired O

DISCHARGE O
MEDICATIONS O
: O

RETURN O
TO O
WORK O
: O

Not O
Applicable O

ALLERGY O
: O

Penicillins B-TREATMENT

ADMIT O
DIAGNOSIS O
: O

Sepsis B-SYMPTOM
, O
ARDS B-SYMPTOM
, O
Pneumonia B-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O
Responsible O
After O
Study O
for O
Causing O
Admission O
) O
Sepsis B-SYMPTOM
, O
myocardial B-SYMPTOM
infarction I-SYMPTOM
, O
ARDS B-SYMPTOM
, O
pneumonia B-SYMPTOM

OTHER O
DIAGNOSIS O
; O
Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
DM2 B-SYMPTOM
, O
s O
/ O
p O
splenectomy B-TREATMENT
, O
depression B-SYMPTOM

OPERATIONS O
AND O
PROCEDURES O
: O

None O
. O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O
None O
. O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

Patient O
received O
as O
transfer O
from O
outside O
hospital O
. O

Patient O
on O
vent B-TREATMENT
, O
febrile B-SYMPTOM
, O
hypotensive B-SYMPTOM
. O

Developed O
requirement B-SYMPTOM
for O
multiple B-TREATMENT
pressors I-TREATMENT
, O
then O
arrhythmias B-SYMPTOM
. O

Full B-TREATMENT
code I-TREATMENT
carried O
out O
. O

Despite O
extraordinary B-TREATMENT
measures I-TREATMENT
, O
stable O
sinus O
rhythm O
could O
not O
be O
restored O
. O

Please O
see O
written O
medical O
record O
for O
complete O
report O
. O

ADDITIONAL O
COMMENTS O
: O

DISCHARGE O
CONDITION O
: O

Expired O

TO O
DO O
/ O
PLAN O
: O

No O
dictated O
summary O

ENTERED O
BY O
: O

NELLFYFE O
, O
SHATAYE O
I O
, O
M.D. O
, O
PH.D. O
( O
IY150 O
) O

01/20/02 O
03:35 O
AM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

468211586 O

PUOMC O

9651828 O

14540 O

719527 O

1/4/1996 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

DISCHARGE O
SUMMARY O

NAME O
: O

RALNMOTTEFUH O
, O
AEEN O

UNIT O
NUMBER O
: O

363-79-23 O

ADMISSION O
DATE O
: O

01/04/96 O

DISCHARGE O
DATE O
: O

01/10/96 O

FINAL O
DIAGNOSIS O
: O

Cervical B-SYMPTOM
carcinoma I-SYMPTOM
; O
bilateral B-SYMPTOM
ureteral I-SYMPTOM
obstruction I-SYMPTOM
secondary O
to O
the B-SYMPTOM
cancer I-SYMPTOM
. O

Uremia B-SYMPTOM
. O

Ileus B-SYMPTOM
. O

OPERATION O
: O

Bilateral B-TREATMENT
ureteral I-TREATMENT
stent I-TREATMENT
placement I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
78-year-old O
woman O
had O
stage B-SYMPTOM
IIIB I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
cervix I-SYMPTOM
and O
she O
has O
known B-SYMPTOM
periaortic I-SYMPTOM
and I-SYMPTOM
splenic I-SYMPTOM
metastases I-SYMPTOM
. O

She O
was O
discharged O
from O
the O
hospital O
about O
18 O
days O
prior O
to O
her O
admission O
, O
following O
a O
month O
long O
stay O
. O

When O
her B-SYMPTOM
cancer I-SYMPTOM
was O
diagnosed O
, O
she O
underwent O
total B-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
and O
bilateral B-TREATMENT
salpingo-oophorectomy I-TREATMENT
and O
pelvic B-TREATMENT
lymphadenectomy I-TREATMENT
. O

She O
had O
extensive B-SYMPTOM
disease I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
uterus I-SYMPTOM
, I-SYMPTOM
ovarian I-SYMPTOM
tubes I-SYMPTOM
, I-SYMPTOM
omentum I-SYMPTOM
and I-SYMPTOM
the I-SYMPTOM
periaortic I-SYMPTOM
lymph I-SYMPTOM
nodes I-SYMPTOM
. O

Postoperatively O
, O
she O
developed O
ileus B-SYMPTOM
, O
then O
finally O
she O
recovered O
and O
she O
was O
discharged O
to O
the O
nursing O
home O
. O

She O
was O
readmitted O
because O
of O
a O
problem O
with O
uremia B-SYMPTOM
and O
high B-SYMPTOM
BUN I-SYMPTOM
and I-SYMPTOM
creatinine I-SYMPTOM
when O
she O
seen O
in O
the O
office O
and O
the O
BUN O
and O
creatinine O
was O
ordered O
. O

The O
BUN O
was O
70 O
and O
creatinine O
was O
4.6 O
and O
for O
this O
reason O
she O
had O
ultrasound O
of O
the O
kidney O
which O
showed O
bilateral B-SYMPTOM
hydronephrosis I-SYMPTOM
. O

The O
patient O
was O
admitted O
to O
the O
hospital O
for O
ureteral B-TREATMENT
stent I-TREATMENT
placement I-TREATMENT
. O

On O
the O
day O
of O
admission O
, O
she O
was O
generally O
stable O
and O
she O
had O
no O
evidence O
of O
disease B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
pelvis I-SYMPTOM
, O
no O
bleeding B-SYMPTOM
and O
no O
other B-SYMPTOM
abnormality I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

Dr. O
Jescdrig O
was O
called O
and O
a O
consultation O
was O
done O
and O
he O
placed O
bilateral B-TREATMENT
ureteral I-TREATMENT
stents I-TREATMENT
in I-TREATMENT
her I-TREATMENT
kidneys I-TREATMENT
. O

Postoperatively O
, O
she O
diuresed O
very O
well O
. O

She O
had O
dropped O
her O
BUN O
and O
creatinine O
to O
normal O
and O
she O
was O
found O
to O
have O
may O
be O
metastatic B-SYMPTOM
disease I-SYMPTOM
to I-SYMPTOM
her I-SYMPTOM
skin I-SYMPTOM
on O
the O
right O
paraumbilical O
area O
. O

Because O
of O
her O
age O
and O
mental O
condition O
and O
the O
fact O
that O
she O
had O
cerebral B-SYMPTOM
atrophy I-SYMPTOM
, O
the O
decision O
was O
made O
for O
comfort O
unless O
she O
has O
any B-SYMPTOM
further I-SYMPTOM
problem I-SYMPTOM
and O
no O
further O
chemotherapy B-TREATMENT
or O
treatment B-TREATMENT
will O
be O
given O
. O

The O
possibility O
that O
she O
may O
need O
to O
receive O
radiation B-TREATMENT
therapy I-TREATMENT
to O
this O
area O
to O
prevent O
her O
from O
getting O
further B-SYMPTOM
obstruction I-SYMPTOM
was O
also O
brought O
up O
. O

Her O
family O
felt O
that O
at O
the O
present O
time O
, O
because O
her O
condition O
was O
no O
good O
, O
they O
would O
like O
to O
just O
take O
her O
home O
so O
that O
she O
could O
enjoy O
the O
quality O
of O
life O
. O

Indeed O
, O
at O
the O
time O
of O
discharge O
she O
was O
conscious O
and O
she O
was O
cooperative O
and O
she O
was O
able O
to O
communicate O
very O
nicely O
with O
everyone O
including O
her O
family O
, O
except O
for O
the B-SYMPTOM
mental I-SYMPTOM
instability I-SYMPTOM
that O
she O
had O
because O
of O
her B-SYMPTOM
cerebral I-SYMPTOM
atrophy I-SYMPTOM
due O
to O
senility B-SYMPTOM
. O

FOLLOW-UP O
: O

She O
will O
be O
followed O
in O
the O
Centu O
Fairgmer O
Queen O
Medical O
Center O
. O

AZEL O
U. O
HIBBSKAYS O
, O
M.D. O

DICTATING O
FOR O
: O

EARNRA O
HAWNSPANTKOTE O
, O
M.D. O

TR O
: O

yq O

DD O
: O

01/26/96 O

TD O
: O

01/30/96 O
12:18 O
P O

cc O
: O

AZEL O
USANNE O
HIBBSKAYS O
, O
M.D. O
EARNRA O
HAWNSPANTKOTE O
, O
M.D. O

Admission O
Date O
: O

2014-05-12 O

Discharge O
Date: O

Date O
of O
Birth O
: O

Sex O
: O

Service O
: O

ADMISSION O
DIAGNOSES O
: O

1. O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

2. O
Dilated B-SYMPTOM
cardiomyopathy I-SYMPTOM
. O

3. O
A O
27 O
week O
intrauterine B-SYMPTOM
pregnancy I-SYMPTOM
. O

4. O
Chronic B-SYMPTOM
hypertension I-SYMPTOM
. O

5. O
Asthma B-SYMPTOM
. O

6. O
History O
of O
atrioseptal B-SYMPTOM
defect I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
28 O
- O
year-old O
, O
gravida O
3 O
, O
para O
1 O
, O
at O
approximately O
27 O
weeks O
gestation O
, O
who O
was O
admitted O
on O
2014-05-12 O
due O
to O
increasing O
symptoms O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

She O
has O
known B-SYMPTOM
dilated I-SYMPTOM
cardiomyopathy I-SYMPTOM
with O
a O
baseline O
ejection O
fraction O
of O
approximately O
25% O
. O

She O
had O
been O
managed O
as O
an O
outpatient O
during O
her O
pregnancy O
and O
was O
on O
multiple B-TREATMENT
medications I-TREATMENT
including O
Lasix B-TREATMENT
40 O
mg O
daily O
, O
Hydralazine B-TREATMENT
25 O
mg O
daily O
, O
Toprol B-TREATMENT
XL I-TREATMENT
100 O
mg O
daily O
, O
digoxin B-TREATMENT
0.5 O
mg O
daily O
and O
Lovenox B-TREATMENT
40 O
mg O
twice O
daily O
subcutaneously O
. O

She O
also O
took O
albuterol B-TREATMENT
on O
a O
p.r.n. O
basis O
for O
her B-SYMPTOM
asthma I-SYMPTOM
. O

She O
has O
known B-SYMPTOM
allergy I-SYMPTOM
to O
penicillin B-TREATMENT
, O
vancomycin B-TREATMENT
and O
erythromycin B-TREATMENT
. O

She O
was O
evaluated O
upon O
presentation O
by O
the O
Maternal O
Fetal O
Medicine O
attending O
on O
call O
as O
well O
as O
by O
Cardiology O
. O

She O
was O
found O
to O
have O
symptoms O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
as O
well O
as O
decreased B-SYMPTOM
fetal I-SYMPTOM
movement I-SYMPTOM
. O

Fetal O
monitoring O
initially O
on O
admission O
was O
appropriate O
for O
gestational O
age O
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
exam O
, O
she O
was O
noted O
to O
have O
bilateral B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
, O
mildly B-SYMPTOM
elevated I-SYMPTOM
pressures I-SYMPTOM
in O
the O
140 O
to O
150/90 O
range O
, O
and O
jugular B-SYMPTOM
venous I-SYMPTOM
distension I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

After O
consultation O
with O
Cardiology O
as O
well O
as O
Anesthesia O
on O
call O
that O
evening O
, O
it O
was O
decided O
to O
transfer O
the O
patient O
to O
the O
ICU O
for O
intensive O
monitoring O
. O

Central B-TREATMENT
IV I-TREATMENT
access I-TREATMENT
was O
obtained O
. O

The O
patient O
was O
carefully O
diuresed O
over O
the O
next O
48 O
hours O
. O

Symptoms O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
gradually O
abated O
over O
the O
next O
48 O
to O
72 O
hours O
. O

The O
patient O
was O
given O
antenatal B-TREATMENT
corticosteroids I-TREATMENT
for O
fetal O
lung O
maturity O
. O

A O
Neonatology O
consultation O
was O
obtained O
during O
the O
course O
of O
the O
hospitalization O
. O

After O
discussion O
, O
it O
was O
decided O
to O
attempt O
to O
obtain O
28 O
weeks O
gestation O
and O
then O
deliver O
electively O
by O
cesarean B-TREATMENT
section I-TREATMENT
given O
the B-SYMPTOM
decompensation I-SYMPTOM
in O
the O
third O
trimester O
. O

The O
patient O
underwent O
primary B-TREATMENT
low I-TREATMENT
transverse I-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
on O
2014-05-19 O
at O
approximately O
28 O
weeks O
gestation O
. O

The B-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
was O
performed O
on O
the O
West O
Campus O
in O
the O
Cardiothoracic O
Surgical O
Suite O
. O

This O
was O
performed O
in O
this O
location O
in O
case O
any B-SYMPTOM
acute I-SYMPTOM
cardiac I-SYMPTOM
decompensation I-SYMPTOM
occurred O
during O
the O
time O
of O
cesarean B-TREATMENT
section I-TREATMENT
. O

Cardiothoracic O
Surgery O
was O
on O
standby O
during O
the B-TREATMENT
surgery I-TREATMENT
. O

The O
patient O
went O
to O
the O
cardiac O
Intensive O
Care O
Unit O
on O
the O
West O
Campus O
postoperatively O
. O

She O
did O
well O
during O
the O
postoperative O
period O
. O

She O
required O
several O
episodes O
of O
diuresis B-TREATMENT
due O
to O
increasing B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
on O
postoperative O
day O
#1 O
and O
postoperative O
day O
#2 O
due O
to O
worsening O
symptoms O
of O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
from O
fluid B-SYMPTOM
shifts I-SYMPTOM
that O
normally O
occur O
during O
the O
postpartum O
period O
. O

The O
patient O
was O
transferred O
to O
the O
West O
Campus O
on O
postoperative O
day O
#2 O
in O
stable O
condition O
. O

She O
did O
well O
during O
the O
remainder O
of O
her O
postoperative O
course O
and O
was O
continued O
on O
her B-TREATMENT
medication I-TREATMENT
regimen I-TREATMENT
that O
she O
had O
been O
on O
during O
the O
antepartum O
period O
. O

She O
was O
discharged O
to O
home O
on O
postoperative O
day O
#4 O
. O

She O
was O
to O
followup O
with O
Maternal O
Fetal O
Medicine O
in O
5 O
to O
7 O
days O
. O

She O
had O
followup O
with O
her O
primary O
cardiologist O
in O
Shaugnessy-Kaplan O
Rehab O
Hospital O
scheduled O
for O
1 O
week O
postoperatively O
. O

Of O
note O
, O
the O
patient O
also O
underwent O
tubal B-TREATMENT
ligation I-TREATMENT
at O
the O
time O
of O
cesarean B-TREATMENT
section I-TREATMENT
. O

DISCHARGE O
MEDICATIONS O
: O

Toprol B-TREATMENT
XL I-TREATMENT
100 O
mg O
daily O
, O
Hydralazine B-TREATMENT
25 O
mg O
daily O
, O
Lasix B-TREATMENT
40 O
mg O
twice O
a O
day O
, O
digoxin B-TREATMENT
0.75 O
mg O
daily O
, O
Lovenox B-TREATMENT
40 O
mg O
twice O
daily O
subcutaneously O
and O
albuterol B-TREATMENT
p.r.n. O

Peter O
Richard O
, O
MD O

Dictated O
By O
: O
Michael O
O. O
Tucker O
, O
M.D. O

MEDQUIST36 O

D O
: O
2016-01-29 O
09:07:27 O

T O
: O
2016-01-29 O
09:49:48 O

Job O
#: O
72842 O

Signed O
electronically O
by O
: O
DR. O
Homer O
Peterson O
on O
: O
FRI O
2016-01-29 O
11:36 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2011-06-10 O

Discharge O
Date O
: O

2011-06-13 O

Date O
of O
Birth O
: O

1976-04-17 O

Sex O
: O

M O

Service O
: O

CMED O
CSRU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
35-year-old O
gentleman O
with O
HIV B-SYMPTOM
on O
HAART B-TREATMENT
with O
last O
CD4 O
count O
of O
268 O
and O
undetectable O
viral O
load O
who O
was O
referred O
to O
the O
emergency O
room O
via O
his O
PCP O
for O
progressive B-SYMPTOM
throat I-SYMPTOM
pain I-SYMPTOM
and O
edema B-SYMPTOM
. O

His B-SYMPTOM
throat I-SYMPTOM
pain I-SYMPTOM
began O
2 O
to O
3 O
days O
prior O
to O
admission O
, O
initially O
treated O
with O
ibuprofen B-TREATMENT
, O
seen O
in O
an O
outside O
hospital O
emergency O
room O
day O
prior O
to O
admission O
where O
he O
received O
IV B-TREATMENT
penicillin I-TREATMENT
and O
was O
sent O
home O
. O

In O
clinic O
today O
, O
the O
patient O
desaturated O
to O
low O
90 O
s O
with O
ambulation O
and O
also O
had O
complaints O
of O
progressive B-SYMPTOM
swelling I-SYMPTOM
" O
like O
my O
throat O
is O
going O
to O
close O
up O
" O
with O
increasing B-SYMPTOM
drooling I-SYMPTOM
, O
unable O
to O
swallow O
the B-TREATMENT
HIV I-TREATMENT
medications I-TREATMENT
. O

Also O
noted O
to O
have O
low-grade B-SYMPTOM
temperature I-SYMPTOM
of O
99 O
to O
100 O
degrees O
with O
productive B-SYMPTOM
cough I-SYMPTOM
and O
yellow B-SYMPTOM
sputum I-SYMPTOM
times O
1 O
day O
with O

right B-SYMPTOM
ear I-SYMPTOM
pain I-SYMPTOM
. O

No O
subjective B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

The O
patient O
describes O
whole B-SYMPTOM
body I-SYMPTOM
numbness I-SYMPTOM
. O

He O
currently O
notes O
improvement O
in O
his B-SYMPTOM
throat I-SYMPTOM
pain I-SYMPTOM
after O
some B-TREATMENT
Decadron I-TREATMENT
and O
clindamycin B-TREATMENT
. O

He O
was O
seen O
by O
CMED O
CSRU O
in O
the O
emergency O
room O
and O
the O
exam O
was O
consistent O
with O
supraglottitis B-SYMPTOM
. O

REVIEW O
OF O
SYSTEMS O
: O

Review O
of O
systems O
was O
negative O
for O
history O
of O
opportunistic B-SYMPTOM
infections I-SYMPTOM
or O
prior O
hospitalizations O
. O

Of O
note O
, O
his O
CD4 O
count O
was O
less O
than O
200 O
last O
winter O
. O

He O
believes O
he O
is O
up-to-date O
on O
all O
his B-TREATMENT
vaccines I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

HIV B-SYMPTOM
times O
13 O
years O
. O

Last O
CD4 O
count O
of O
268 O
, O
viral O
load O
undetectable O
, O
followed O
at O
the O
Boston O
Regional O
Medical O
Centerr O
Clinic O
by O
Dr. O
Taylor O
. O

History O
of O
anal B-SYMPTOM
warts I-SYMPTOM
and O
rectal B-SYMPTOM
abscesses I-SYMPTOM
and O
fistula B-SYMPTOM
. O

FAMILY O
HISTORY O
: O

Positive O
for O
diabetes B-SYMPTOM
. O

Negative O
for O
CAD B-SYMPTOM
. O

Mother O
with O
throat B-SYMPTOM
cancer I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

Works O
in O
a O
restaurant O
. O

Lives O
with O
his O
partner O
. O

Negative O
Barbara O
. O

Positive O
occasional O
alcohol O
use O
, O
occasional O
pot O
and O
crystal O
meth O
, O
but O
negative O
IV O
drug O
use O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Atazanavir B-TREATMENT
300 O
mg O
q.d. O

2. O
Ritonavir B-TREATMENT
100 O
mg O
q.d. O

3. O
Tenofovir B-TREATMENT
300 O
mg O
q.d. O

4. O
Didanosine B-TREATMENT
250 O
mg O
q.d. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

Vital O
Signs O
: O

Temperature O
100.1 O
degrees O
, O
blood O
pressure O
134/79 O
, O
pulse O
100 O
, O
respiratory O
rate O
17 O
, O
and O
saturations O
95 O
percent O
on O
room O
air O
. O

General O
: O

He O
is O
awake O
, O
alert O
, O
and O
oriented O
times O
3 O
and O
pleasant O
. O

HEENT O
: O
Positive O
hoarse B-SYMPTOM
whisper I-SYMPTOM
. O

Positive O
drooling B-SYMPTOM
. O

Negative O
trismus B-SYMPTOM
or O
stridor B-SYMPTOM
. O

Bilateral B-SYMPTOM
tonsillar I-SYMPTOM
hypertrophy I-SYMPTOM
. O

No O
white B-SYMPTOM
exudate I-SYMPTOM
. O

Right O
external O
auditory O
canal O
was O
occluded B-SYMPTOM
bycerumen I-SYMPTOM
and O
left O
external O
auditory O
canal O
clear O
with O
tympanic O
membrane O
intact O
. O

Positive O
anterior B-SYMPTOM
cervical I-SYMPTOM
lymphadenopathy I-SYMPTOM
. O

Cardiovascular O
: O

Regular O
and O
tachycardic B-SYMPTOM
. O

Normal O
S1 O
and O
S2 O
. O

Lungs O
: O

Bilateral B-SYMPTOM
coarse I-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
. O

Negative O
rhonchi B-SYMPTOM
, O
rales B-SYMPTOM
, O
or O
wheezes B-SYMPTOM
. O

Abdomen O
: O

Soft O
and O
nontender B-SYMPTOM
. O

Extremities O
: O

Warm O
, O
well O
perfused O
. O

No O
edema B-SYMPTOM
. O

Neuro O
Exam O
: O

Cranial O
nerves O
II O
through O
XII O
are O
intact O
. O

Muscles O
are O
05-04 O
in O
all O
extremities O
with O
good O
sensation O
to O
light O
touch O
. O

LABORATORY O
DATA O
ON O
ADMISSION O
: O

White O
count O
18.3 O
, O
neutrophils O
89 O
percent O
, O
hematocrit O
41 O
, O
platelets O
261 O
, O
INR O
1.2 O
, O
and O
chem-7 O
otherwise O
normal O
. O

Chest O
x-ray O
was O
negative O
for O
effusions B-SYMPTOM
, O
pneumonia B-SYMPTOM
, O
or O
pneumothorax B-SYMPTOM
. O

Neck O
with O
soft B-SYMPTOM
tissue I-SYMPTOM
prominence I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
epiglottitis I-SYMPTOM
and I-SYMPTOM
uvula I-SYMPTOM
consistent O
with O
epiglottitis B-SYMPTOM
. O

Fiberoptic O
scope O
showed O
swelling B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
epiglottitis I-SYMPTOM
extending O
down O
to O
the O
right O
aryepiglottic O
fold O
obscuring O
view O
of O
the O
right O
vocal O
cord O
. O

Left O
vocal O
cord O
with O
glottic O
airway O
visible O
but O
narrow B-SYMPTOM
. O

Positive O
edema B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
supraglottitis I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

This O
is O
a O
35-year-old O
gentleman O
with O
HIV B-SYMPTOM
on O
HAART B-TREATMENT
, O
last O
CD4 O
count O
268 O
with O
undetectable O
viral O
load O
who O
was O
initially O
admitted O
to O
the O
CMED O
CSRU O
for O
supraglottitis B-SYMPTOM
with O
significant B-SYMPTOM
edema I-SYMPTOM
. O

PROBLEM O
LIST O
: O

1. O
Epiglottitis B-SYMPTOM
/ O
supraglottitis B-SYMPTOM
. O

The O
patient O
was O
observed O
in O
the O
CMED O
CSRU O
for O
48 O
hours O
and O
noted O
to O
have O
decrease O
in O
swelling B-SYMPTOM
on O
serial O
exams O
. O

He O
was O
followed O
by O
the O
CMED O
CSRU O
Service O
and O
was O
started O
on O
IV B-TREATMENT
Decadron I-TREATMENT
initially O
in O
addition O
to O
IV B-TREATMENT
Unasyn I-TREATMENT
, O
which O
he O
tolerated O
well O
. O

His B-SYMPTOM
edema I-SYMPTOM
was O
improving O
and O
was O
starting O
to O
tolerate O
p.o. O

His O
airway O
and O
symptoms B-SYMPTOM
continued O
to O
improve O
and O
remained O
stable O
. O

The O
patient O
was O
stable O
for O
transfer O
to O
the O
floor O
, O
was O
treated O
with O
over O
72 O
hours O
of O
IV B-TREATMENT
Unasyn I-TREATMENT
, O
and O
then O
transitioned O
to O
oral O
regimen O
of O
Augmentin B-TREATMENT
to O
be O
continued O
as O
an O
outpatient O
. O

Eventually O
, O
his B-TREATMENT
IV I-TREATMENT
steroids I-TREATMENT
were O
transitioned O
to O
a B-TREATMENT
p.o. I-TREATMENT
steroid I-TREATMENT
taper I-TREATMENT
, O
which O
he O
tolerated O
well O
, O
and O
was O
discharged O
on O
a B-TREATMENT
steroid I-TREATMENT
taper I-TREATMENT
also O
with O
CMED O
CSRU O
follow-up O
as O
an O
outpatient O
. O

His O
oxygenation O
and O
symptoms B-SYMPTOM
remained O
stable O
and O
again O
tolerated O
p.o. O
without O
difficulty O
. O

Eventually O
, O
as O
the O
patient O
remained O
hemodynamically O
stable O
, O
his O
airway O
remained O
stable O
, O
and O
he O
was O
tolerating O
PO O
s, O
he O
was O
transitioned O
to O
the O
floor O
where O
he O
remained O
otherwise O
stable O
and O
asymptomatic B-SYMPTOM
. O

His O
voice O
improved O
during O
the O
course O
of O
his O
stay O
and O
was O
talking O
clearly O
by O
the O
time O
of O
discharge O
. O

He O
remained O
afebrile B-SYMPTOM
during O
the O
course O
of O
his O
stay O
after O
transfer O
to O
the O
floor O
and O
per O
CMED O
CSRU O
was O
to O
be O
discharged O
on O
a O
2-week O
course O
of O
Augmentin B-TREATMENT
with O
follow-up O
with O
Dr. O
Thibodeau O
in O
2 O
weeks O
' O
time O
in O
addition O
to O
a B-TREATMENT
Medrol I-TREATMENT
Dosepak I-TREATMENT
. O

1. O
HIV B-SYMPTOM
. O

Once O
, O
the O
patient O
was O
tolerating O
p.o. O
, O
the O
patient O
was O
restarted O
on O
his B-TREATMENT
HAART I-TREATMENT
regimen I-TREATMENT
and O
remained O
stable O
from O
that O
perspective O
. O

DISCHARGE O
CONDITION O
: O

Good O
. O

The O
patient O
ambulating O
without O
difficulty O
, O
tolerating O
p.o. O
, O
stable O
oxygen O
saturation O
, O
and O
stable O
voice O
by O
the O
time O
of O
discharge O
. O

DISCHARGE O
DIAGNOSES O
: O

Epiglottitis B-SYMPTOM
/ O
supraglottitis B-SYMPTOM
. O

HIV B-SYMPTOM
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Menthol B-TREATMENT
- I-TREATMENT
Cetylpyridinium I-TREATMENT
lozenges I-TREATMENT
1 O
as O
needed O
. O

2. O
Tenofovir B-TREATMENT
300 O
mg O
p.o. O
q.d. O

3. O
Didanosine B-TREATMENT
250 O
mg O
p.o. O
q.d. O

4. O
Atazanavir B-TREATMENT
300 O
mg O
p.o. O
q.d. O

5. O
Ritonavir B-TREATMENT
100 O
mg O
p.o. O
q.d. O

6. O
Calcium B-TREATMENT
carbonate I-TREATMENT
500 O
mg O
p.o. O
q.d. O

7. O
Methylprednisolone B-TREATMENT
4 O
mg O
tablets O
per O
taper O
regimen O
. O

The O
patient O
was O
to O
take O
one O
4 O
mg O
tablet O
dinner O
and O
at O
bedtime O
the O
day O
of O
discharge O
, O
then O
the O
next O
day O
take O
one O
4 O
mg O
tablet O
in O
the O
morning O
, O
lunch O
time O
, O
and O
with O
dinner O
and O
then O
at O
bedtime O
, O
then O
the O
third O
day O
to O
take O
4 O
mg O
tablet O
in O
the O
morning O
, O
lunch O
, O
and O
bedtime O
, O
the O
fourth O
day O
to O
take O
one O
tablet O
in O
the O
morning O
and O
dinner O
, O
and O
in O
the O
last O
day O
take O
one O
4 O
mg O
tablet O
in O
the O
morning O
. O

He O
was O
also O
discharged O
on O
Augmentin B-TREATMENT
XR I-TREATMENT
1000 O
mg O
/ O
62.5 O
mg O
sustained O
release O
1 O
tablet O
q. O
12h O
. O
for O
2 O
weeks O
. O

FOLLOW-UP O
: O

The O
patient O
was O
to O
follow O
up O
with O
his O
PCP O
A. O
L. O
. O
Taylor O
in O
7 O
to O
10 O
days O
, O
and O
the O
patient O
was O
to O
call O
Dr. O
Thibodeau O
, O
CMED O
CSRU O
doctor O
to O
follow O
up O
in O
2 O
weeks O
' O
time O
. O

Teddy O
Stephen O
, O
Louisiana O
32870 O

Dictated O
By O
: O
Judy O
J O
Johnston O
, O
M.D. O

MEDQUIST36 O

D O
: O
2011-07-12 O
15:55:31 O

T O
: O
2011-07-13 O
11:14:52 O

Job O
#: O

79962 O

Signed O
electronically O
by O
: O
DR. O
Ruth O
Gibson O
on O
: O
MON O
2011-07-18 O
7:48 O
AM O

( O
End O
of O
Report O
) O

747495092 O

CTMC O

91057356 O

183023 O

7/3/1998 O
12:00:00 O
AM O

AMPULLARY B-SYMPTOM
ADENOCARCINOMA I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

07/03/1998 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

07/10/1998 O

PRINCIPAL O
DIAGNOSIS O
: O

AMPULLARY B-SYMPTOM
ADENOCARCINOMA I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
50 O
year O
old O
man O
in O
his O
usual O
state O
of O
health O
until O
two O
weeks O
prior O
to O
admission O
when O
the O
patient O
developed O
epigastric B-SYMPTOM
pain I-SYMPTOM
after O
meals O
. O

The O
next O
morning O
, O
the O
patient O
felt O
dizzy B-SYMPTOM
and O
went O
to O
his O
private O
medical O
doctor O
at O
Eifro O
Medical O
Center O
, O
and O
was O
found O
to O
have O
elevated B-SYMPTOM
bilirubins I-SYMPTOM
, I-SYMPTOM
alkaline I-SYMPTOM
phosphatase I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
transaminases I-SYMPTOM
. O

The O
patient O
reported O
fatigue B-SYMPTOM
and O
nausea B-SYMPTOM
, O
as O
well O
as O
noted O
coca B-SYMPTOM
cola I-SYMPTOM
colored I-SYMPTOM
urine I-SYMPTOM
. O

The O
patient O
has O
been O
constipated B-SYMPTOM
with O
hard B-SYMPTOM
stool I-SYMPTOM
, O
but O
no O
bright B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
. O

The O
patient O
also O
reported O
an B-SYMPTOM
18 I-SYMPTOM
lb I-SYMPTOM
weight I-SYMPTOM
loss I-SYMPTOM
over O
the O
last O
4-5 O
months O
. O

PAST O
MEDICAL O
HISTORY O
: O

Significant O
only O
for O
history O
of O
hypertension B-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

None O
. O

MEDICATIONS O
: O

Serax B-TREATMENT
p.r.n. O
insomnia B-SYMPTOM
; O
iron B-TREATMENT
; O
MVI B-TREATMENT
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

VITAL O
SIGNS O
: O

BP O
120/80 O
, O
temp O
96 O
, O
pulse O
78 O
, O
respiratory O
rate O
18 O
. O

GENERAL O
: O

No O
acute B-SYMPTOM
distress I-SYMPTOM
. O

SKIN O
: O

The O
skin O
is O
jaundiced B-SYMPTOM
. O

NODES O
: O

No O
lymph O
nodes O
palpated O
. O

HEENT O
: O

Notable O
for O
scleral B-SYMPTOM
icterus I-SYMPTOM
. O

LUNGS O
: O

Clear O
to O
auscultation O
bilaterally O
, O
no O
wheezes B-SYMPTOM
, O
rales B-SYMPTOM
, O
or O
rhonchi B-SYMPTOM
. O

HEART O
: O

Regular O
rate O
and O
rhythm O
, O
no O
murmur B-SYMPTOM
. O

ABDOMEN O
: O

Soft O
, O
bowel O
sounds O
present O
, O
tenderness B-SYMPTOM
present O
in O
epigastrium O
to O
moderate O
palpation O
. O

There O
was O
no O
rebound B-SYMPTOM
and O
no O
hepatosplenomegaly B-SYMPTOM
. O

No O
incisional B-SYMPTOM
scars I-SYMPTOM
. O

EXTREMITIES O
: O

Warm O
, O
with O
no O
edema B-SYMPTOM
and O
palpable O
pulses O
bilaterally O
. O

LABORATORY O
DATA O
: O

Na O
134 O
, O
K O
4.2 O
, O
Cl O
98 O
, O
bicarb O
26 O
, O
BUN O
11 O
, O
creatinine O
0.5 O
, O
glucose O
119 O
. O

CBC O
- O
White O
count O
7.5 O
, O
hematocrit O
28.5 O
, O
platelets O
452 O
. O

PT O
16.2 O
, O
PTT O
34.7 O
, O
INR O
1.8 O
. O

LDH O
254 O
, O
amylase O
727 O
, O
lipase O
8600 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
preoperatively O
for O
surgery B-TREATMENT
on O
7/4/98 O
. O

The O
patient O
&apos;s O
workup O
up O
until O
that O
time O
included O
a O
diagnosis O
of O
periampullary B-SYMPTOM
adenocarcinoma I-SYMPTOM
, O
which O
was O
proven O
by O
EGD O
directed O
biopsy O
, O
and O
a B-SYMPTOM
left I-SYMPTOM
renal I-SYMPTOM
mass I-SYMPTOM
, O
which O
was O
biopsied O
and O
found O
to O
be O
an B-SYMPTOM
oncocytoma I-SYMPTOM
. O

On O
7/4/98 O
, O
the O
patient O
underwent O
a B-TREATMENT
Whipple I-TREATMENT
procedure I-TREATMENT
, O
which O
proceeded O
without O
complications B-SYMPTOM
. O

Postoperatively O
, O
the O
patient O
did O
extremely O
well O
and O
was O
extubated O
the O
following O
morning O
. O

The B-TREATMENT
NG I-TREATMENT
tube I-TREATMENT
was O
D/C&apos;d O
on O
postoperative O
day O
#2 O
. O

The O
patient O
was O
to O
be O
transferred O
to O
the O
floor O
on O
postoperative O
day O
#2 O
, O
however O
, O
due O
to O
the O
lack O
of O
beds O
, O
he O
remained O
in O
the O
ICU O
until O
postoperative O
day O
#3 O
. O

On O
postoperative O
day O
#4 O
, O
the O
patient O
began O
tolerating O
clear B-TREATMENT
liquids I-TREATMENT
and O
his O
diet O
was O
advanced O
as O
tolerated O
by O
postoperative O
day O
#6 O
and O
7 O
. O

The O
patient O
was O
out O
of O
bed O
, O
doing O
fine O
, O
and O
tolerating O
a O
regular O
diet O
on O
7/10/98 O
. O

The O
patient O
is O
to O
be O
discharged O
to O
home O
with O
services O
and O
in O
stable O
condition O
. O

DISCHARGE O
MEDICATIONS O
: O

Sandostatin B-TREATMENT
100 O
mcg O
subcu. O
b.i.d. O
; O
Percocet B-TREATMENT
1-2 O
tabs O
q.3-4h. O
p.r.n. O
pain B-SYMPTOM
; O
Axid B-TREATMENT
150 O
mg O
p.o. O
b.i.d. O
; O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

DISCHARGE O
FOLLOW-UP O
: O

The O
patient O
has O
been O
instructed O
to O
follow-up O
with O
Dr. O
Red O
in O
one O
week O
and O
in O
the O
Urology O
Clinic O
in O
three O
weeks O
. O

DISCHARGE O
DISPOSITION O
: O

The O
patient O
is O
discharged O
to O
home O
on O
7/10/98 O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
condition O
. O

Dictated O
By O
: O

MALICHARLEAR O
KROENER O
, O
M.D. O
EB85 O

Attending O
: O

LEAND O
L. O
KROENER O
, O
M.D. O
QW18 O
FO508/6558 O

Batch O
: O

54270 O

Index O
No. O
YCCYST5DG2 O

D O
: O

07/10/98 O

T O
: O

07/12/98 O

CC O
: O

1. O
LEAND O
L. O
KROENER O
, O
M.D. O

0488076 O

Admission O
Date O
: O

2015-07-12 O

Discharge O
Date O
: O

2015-07-19 O

Date O
of O
Birth O
: O

1970-05-06 O

Sex O
: O

F O

Service O
: O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
48 O
- O
year-old O
woman O
who O
was O
transferred O
from O
Shaugnessy-Kaplan O
Rehab O
Hospital O
. O

The O
patient O
originally O
presented O
to O
her O
PCP O
approximately O
one O
week O
prior O
to O
admission O
here O
with O
increasing B-SYMPTOM
cough I-SYMPTOM
, O
dyspnea B-SYMPTOM
and O
fatigue B-SYMPTOM
. O

She O
was O
given O
a B-TREATMENT
Z-Pak I-TREATMENT
for O
treatment B-TREATMENT
along O
with O
albuterol B-TREATMENT
. O

Despite O
this O
, O
she O
continued O
to O
worsen O
and O
became O
febrile B-SYMPTOM
. O

So O
, O
she O
was O
admitted O
to O
Shaugnessy-Kaplan O
Rehab O
Hospital O
on O
2015-07-10 O
. O

At O
the O
hospital O
, O
she O
was O
started O
on O
Rocephin B-TREATMENT
and O
Levaquin B-TREATMENT
for O
a B-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
pneumonia I-SYMPTOM
seen O
on O
chest O
x-ray O
. O

She O
continued O
to O
have O
increasing B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
with O
hypoxia B-SYMPTOM
. O

She O
was O
also O
significantly B-SYMPTOM
tachypneic I-SYMPTOM
. O

At O
this O
time O
, O
repeat O
chest O
x-ray O
showed O
bilateral B-SYMPTOM
diffuse I-SYMPTOM
infiltrates I-SYMPTOM
consistent O
with O
ARDS B-SYMPTOM
. O

The O
patient O
was O
intubated O
and O
then O
transferred O
to O
Hahnemann O
General O
Hospital O
CMED O
. O

PAST O
MEDICAL O
HISTORY O
: O

Hypothyroidism B-SYMPTOM
. O

Depression B-SYMPTOM
. O

Anxiety B-SYMPTOM
disorder I-SYMPTOM
. O

MEDICATIONS O
: O

1. O
Levoxyl B-TREATMENT
112 O
mcg O
q.d. O

2. O
Prozac B-TREATMENT
. O

3. O
Codeine B-TREATMENT
for O
cough B-SYMPTOM
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
is O
unemployed O
. O

She O
smokes O
approximately O
one O
pack O
per O
day O
. O

She O
drinks O
alcohol O
socially O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
, O
vital O
signs: O

Temperature O
101.4 O
, O
blood O
pressure O
101/62 O
, O
pulse O
80 O
, O
respiratory O
rate O
19 O
on O
a B-TREATMENT
ventilator I-TREATMENT
with O
settings O
of O
assist B-TREATMENT
control I-TREATMENT
at O
500/12 O
and O
a B-TREATMENT
PEEP I-TREATMENT
of O
5 O
. O

General O
: O

The O
patient O
is O
intubated B-TREATMENT
and O
sedated B-TREATMENT
, O
but O
easily O
arousable O
. O

HEENT O
: O

Pupils O
equally O
round O
and O
reactive O
to O
light O
. O

Sclerae O
are O
anicteric B-SYMPTOM
. O

ET B-TREATMENT
tube I-TREATMENT
is O
in O
place O
. O

Neck O
: O

Soft O
and O
supple O
. O

Cardiovascular O
: O

Normal O
. O

Chest O
: O

Faint B-SYMPTOM
scattered I-SYMPTOM
wheezes I-SYMPTOM
bilaterally I-SYMPTOM
. O

Abdomen O
: O

Benign O
. O

Extremities O
: O

Warm O
with O
good O
distal O
pulses O
. O

There O
is O
no O
edema B-SYMPTOM
. O

Neurologic O
: O

Able O
to O
follow O
simple O
commands O
. O

LABORATORY O
DATA O
: O

Labs O
on O
admission O
from O
outside O
hospital O
, O
CBC O
notable O
for O
a O
white O
count O
of O
21.9 O
with O
hematocrit O
of O
36.3 O
and O
normal O
platelets O
. O

Chem-7 O
notable O
for O
potassium O
of O
3.2 O
and O
bicarbonate O
of O
30 O
. O

LFTs O
show O
an B-SYMPTOM
elevated I-SYMPTOM
ALT I-SYMPTOM
of O
52 O
and O
AST O
of O
101 O
with O
normal O
alkaline O
phosphatase O
and O
total O
bilirubin O
. O

Latest O
arterial O
blood O
gas O
with O
pH O
of O
7.45 O
, O
pCO2 O
43 O
and O
pO2 O
155 O
on O
100 B-TREATMENT
percent I-TREATMENT
oxygen I-TREATMENT
via O
ventilator B-TREATMENT
. O

RADIOGRAPHIC O
STUDIES O
: O

Chest O
x-ray O
shows O
right B-SYMPTOM
middle I-SYMPTOM
lobe I-SYMPTOM
, I-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
infiltrates I-SYMPTOM
. O

EKG O
shows O
normal O
sinus O
rhythm O
at O
70 O
beats O
per O
minute O
with O
normal O
axis O
and O
intervals O
, O
borderline B-SYMPTOM
LVH I-SYMPTOM
. O

SUMMARY O
OF O
HOSPITAL O
COURSE O
: O

Respiratory O
: O

On O
admission O
, O
the O
patient O
had O
what O
appeared O
to O
be O
acute B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
secondary O
to O
community B-SYMPTOM
- I-SYMPTOM
acquired I-SYMPTOM
pneumonia I-SYMPTOM
. O

She O
was O
maintained O
on O
a B-TREATMENT
ventilator I-TREATMENT
and O
ventilated O
according O
to O
ARDSNet O
protocol O
. O

For O
antibiotic B-TREATMENT
coverage I-TREATMENT
of O
her B-SYMPTOM
pneumonia I-SYMPTOM
, O
she O
was O
started O
on O
Levaquin B-TREATMENT
, O
ceftriaxone B-TREATMENT
, O
and O
vancomycin B-TREATMENT
. O

Over O
the O
next O
two O
days O
after O
admission O
, O
the B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
vent I-TREATMENT
settings I-TREATMENT
were O
gradually O
weaned O
, O
and O
she O
was O
extubated O
two O
days O
after O
being O
transferred O
to O
this O
hospital O
. O

After O
extubation B-TREATMENT
, O
the O
patient O
was O
oxygenating O
well O
on O
face B-TREATMENT
mask I-TREATMENT
. O

She O
did O
continue O
to O
have O
a B-SYMPTOM
persistent I-SYMPTOM
fairly I-SYMPTOM
severe I-SYMPTOM
cough I-SYMPTOM
; O
however O
, O
her B-SYMPTOM
cough I-SYMPTOM
was O
weak B-SYMPTOM
due O
to O
abdominal B-SYMPTOM
muscle I-SYMPTOM
pain I-SYMPTOM
from O
repeated B-SYMPTOM
coughing I-SYMPTOM
. O

The B-SYMPTOM
cough I-SYMPTOM
was O
mostly B-SYMPTOM
nonproductive I-SYMPTOM
. O

The O
patient O
was O
breathing O
comfortably O
. O

As O
there O
was O
no O
identified B-SYMPTOM
bacterial I-SYMPTOM
pathogen I-SYMPTOM
on O
any O
cultures O
, O
the O
patient O
was O
continued O
on O
the B-TREATMENT
triple I-TREATMENT
antibiotics I-TREATMENT
for O
first O
several O
days O
of O
the O
hospitalization O
. O

She O
was O
also O
on O
round-the-clock B-TREATMENT
Atrovent I-TREATMENT
and O
albuterol B-TREATMENT
nebulizers I-TREATMENT
. O

Once O
the O
patient O
was O
transferred O
out O
of O
the O
ICU O
and O
after O
extubation B-TREATMENT
, O
the B-TREATMENT
antibiotics I-TREATMENT
were O
gradually O
narrowed O
. O

The B-TREATMENT
vancomycin I-TREATMENT
and O
Levaquin B-TREATMENT
were O
discontinued O
after O
approximately O
four O
days O
in O
the O
hospital O
. O

The B-TREATMENT
ceftriaxone I-TREATMENT
was O
discontinued O
after O
four O
days O
in O
the O
hospital O
, O
and O
the O
patient O
was O
to O
continue O
on O
Levaquin B-TREATMENT
. O

The O
patient O
had O
gradual O
improvement O
in O
her O
oxygenation O
. O

Pain B-TREATMENT
control I-TREATMENT
: O

The O
patient O
had O
fairly B-SYMPTOM
significant I-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
secondary O
to O
persistent B-SYMPTOM
cough I-SYMPTOM
. O

She O
was O
started O
on O
a O
regimen O
of O
MS B-TREATMENT
Contin I-TREATMENT
with O
oxycodone B-TREATMENT
for O
breakthrough B-SYMPTOM
pain I-SYMPTOM
. O

This O
helped O
her O
somewhat O
though O
she O
has O
continued O
to O
have O
difficulty B-SYMPTOM
coughing I-SYMPTOM
due O
to O
the B-SYMPTOM
pain I-SYMPTOM
. O

Tylenol B-TREATMENT
and O
ibuprofen B-TREATMENT
were O
also O
added O
for O
better O
control O
. O

Transaminitis B-SYMPTOM
: O

The O
patient O
was O
noted O
to O
have O
mild B-SYMPTOM
transaminitis I-SYMPTOM
on O
admission O
. O

However O
, O
this O
was O
felt O
to O
be O
due O
to O
her B-SYMPTOM
significant I-SYMPTOM
infection I-SYMPTOM
. O

This O
should O
continue O
to O
be O
followed O
as O
an O
outpatient O
to O
assure O
that O
it O
returns O
back O
to O
normal O
. O

Anemia B-SYMPTOM
: O

The O
patient O
's O
reticulocyte O
count O
showed O
inadequate B-SYMPTOM
production I-SYMPTOM
. O

Iron O
studies O
showed O
a O
mixed O
picture O
with O
decreased B-SYMPTOM
iron I-SYMPTOM
and O
decreased B-SYMPTOM
iron I-SYMPTOM
to I-SYMPTOM
TIBC I-SYMPTOM
ratio I-SYMPTOM
suggestive O
of O
iron-deficiency B-SYMPTOM
anemia I-SYMPTOM
, O
but O
also O
normal O
to O
high B-SYMPTOM
MCV I-SYMPTOM
. O

B12 O
was O
noted O
to O
be O
low B-SYMPTOM
and O
the O
patient O
was O
given O
an O
injection O
of O
IM B-TREATMENT
B12 I-TREATMENT
while O
in O
the O
hospital O
. O

She O
was O
also O
started O
on O
iron B-TREATMENT
supplementation I-TREATMENT
. O

Hypothyroidism B-SYMPTOM
: O

The O
patient O
was O
continued O
on O
Synthroid B-TREATMENT
for O
her B-SYMPTOM
chronic I-SYMPTOM
hypothyroidism I-SYMPTOM
. O

DISCHARGE O
STATUS O
: O

The O
patient O
was O
discharged O
home O
with O
services O
. O

DISCHARGE O
CONDITION O
: O

Good O
. O

DISCHARGE O
DIAGNOSES O
: O

Community-acquired B-SYMPTOM
pneumonia I-SYMPTOM
. O

Acute B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
. O

Iron-deficiency B-SYMPTOM
anemia I-SYMPTOM
. O

Hypothyroidism B-SYMPTOM
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Levothyroxine B-TREATMENT
75 O
mcg O
q.d. O

2. O
Prozac B-TREATMENT
40 O
mg O
q.d. O

3. O
Levaquin B-TREATMENT
500 O
mg O
q.d. O
for O
7 O
days O
after O
discharge O
. O

4. O
Guaifenesin B-TREATMENT
syrup I-TREATMENT
p.r.n. O
cough B-SYMPTOM
. O

5. O
Oxycodone B-TREATMENT
10 O
mg O
q.4 O
h. O
p.r.n. O
for O
pain B-SYMPTOM
. O

6. O
Colace B-TREATMENT
100 O
mg O
b.i.d. O

7. O
MS B-TREATMENT
Contin I-TREATMENT
30 O
mg O
b.i.d. O

8. O
Ibuprofen B-TREATMENT
800 O
mg O
q.8 O
h O
. O

9. O
Albuterol B-TREATMENT
1 O
to O
2 O
puffs O
q.6 O
h. O
p.r.n. O

10. O
Atrovent B-TREATMENT
1 O
puff O
q.6 O
h. O
p.r.n. O

DISCHARGE O
INSTRUCTIONS O
: O

Follow-up O
Plans O
: O

The O
patient O
was O
instructed O
to O
call O
her O
PCP O
, O
Dr. O
Ruby O
Godfrey O
, O
to O
follow O
up O
the O
week O
of O
discharge O
. O

She O
is O
also O
to O
call O
her O
PCP O
if O
she O
has O
increasing B-SYMPTOM
shortness I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
fevers B-SYMPTOM
. O

Richard O
Wanita O
, O
Washington O
30778 O

Dictated O
By O
: O
Christopher O
QX O
Morse O
, O
M.D. O

MEDQUIST36 O

D O
: O
2015-09-14 O
17:19:48 O

T O
: O
2015-09-15 O
00:27:21 O

Job O
# O
: O
18355 O

Signed O
electronically O
by O
: O
DR. O
Phillip O
Garcia O
on O
: O
WED O
2015-09-16 O
5:10 O
PM O

( O
End O
of O
Report O
) O

169333047 O

FIH O

4852999 O

72670/2ol1 O

131444 O

9/7/1993 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

09-07-93 O

DISCHARGE O
DATE O
: O

09-08-93 O
PATIENT O
DIED O
ON O
9/8/93 O
. O

ADMISSION O
DIAGNOSIS O
: O

Renal B-SYMPTOM
tubular I-SYMPTOM
acidosis I-SYMPTOM
distal I-SYMPTOM
type I-SYMPTOM
I I-SYMPTOM
; O
shock B-SYMPTOM
; O
seizure B-SYMPTOM
disorder I-SYMPTOM
; O
severe B-SYMPTOM
acidosis I-SYMPTOM
and O
severe B-SYMPTOM
electrolyte I-SYMPTOM
imbalance I-SYMPTOM
; O
rule O
out O
sepsis B-SYMPTOM
. O

DISCHARGE O
DIAGNOSIS O
: O

Renal B-SYMPTOM
tubular I-SYMPTOM
acidosis I-SYMPTOM
distal I-SYMPTOM
type I-SYMPTOM
I I-SYMPTOM
; O
shock B-SYMPTOM
; O
severe B-SYMPTOM
acidosis I-SYMPTOM
and O
severe B-SYMPTOM
electrolyte I-SYMPTOM
imbalance I-SYMPTOM
; O
seizure B-SYMPTOM
disorder I-SYMPTOM
; O
rule O
out O
sepsis B-SYMPTOM
, O
varicella B-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Date O
of O
birth O
: O

10/4/88 O
. O

This O
patient O
is O
a O
5 O
year O
old O
white O
female O
with O
a O
history O
of O
type B-SYMPTOM
I I-SYMPTOM
renal I-SYMPTOM
tubular I-SYMPTOM
acidosis I-SYMPTOM
on O
nephrocalcinosis B-SYMPTOM
who O
was O
admitted O
to O
Noughwell O
Entanbon O
Health O
of O
Washington O
on O
9/5/93 O
at O
21:16 O
hours O
with O
a O
2-3 O
day O
history O
of O
chills B-SYMPTOM
, O
fevers B-SYMPTOM
, O
cough B-SYMPTOM
, O
vomiting B-SYMPTOM
and O
weakness B-SYMPTOM
( O
unable O
to O
walk O
) O
. O

At O
Noughwell O
Entanbon O
Health O
, O
her O
temperature O
was O
101 O
, O
pulse O
135 O
, O
blood O
pressure O
94/74 O
, O
respiratory O
rate O
20 O
. O

Positive O
findings O
of O
physical O
examination O
include O
chicken B-SYMPTOM
pox I-SYMPTOM
lesions I-SYMPTOM
on I-SYMPTOM
thorax I-SYMPTOM
, O
sunken B-SYMPTOM
eyes I-SYMPTOM
, O
thick B-SYMPTOM
nasal I-SYMPTOM
discharge I-SYMPTOM
, O
dry B-SYMPTOM
lips I-SYMPTOM
, I-SYMPTOM
tongue I-SYMPTOM
and I-SYMPTOM
mucous I-SYMPTOM
membranes I-SYMPTOM
, O
red B-SYMPTOM
tonsils I-SYMPTOM
. O

The O
remainder O
of O
the O
physical O
examination O
was O
considered O
within O
normal O
limits O
. O

Admission O
diagnosis O
at O
Ni O
Hospital O
&apos;s O
: O

vomiting B-SYMPTOM
and O
dehydration B-SYMPTOM
, O
hypokalemia B-SYMPTOM
, O
hyponatremia B-SYMPTOM
, O
tonsillitis B-SYMPTOM
. O

A B-TREATMENT
peripheral I-TREATMENT
intravenous I-TREATMENT
line I-TREATMENT
was O
started O
on O
Labor O
Day O
in O
the O
a.m. O
No O
respiratory B-SYMPTOM
distress I-SYMPTOM
was O
noted O
. O

Oral B-SYMPTOM
cyanosis I-SYMPTOM
and O
shallow B-SYMPTOM
respirations I-SYMPTOM
were O
noted O
on O
9/7/93 O
at O
2:45 O
a.m. O

Therefore O
the O
patient O
was O
intubated O
at O
3:45 O
a.m. O
on O
9/7/93 O
. O

Chest O
x-ray O
was O
unremarkable O
. O

Cardiovascular O
stable O
, O
significant B-SYMPTOM
hypertension I-SYMPTOM
was O
noted O
on O
9/7/93 O
at O
5:10 O
a.m. O
and O
therefore O
10 B-TREATMENT
cc&apos;s I-TREATMENT
per I-TREATMENT
kilo I-TREATMENT
albumin I-TREATMENT
was O
given O
. O

The O
patient O
was O
admitted O
was O
started O
on O
clear B-TREATMENT
fluids I-TREATMENT
, O
tolerated O
, O
with O
D5 B-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
plus O
40 O
mEq O
per O
liter O
of O
KCL B-TREATMENT
at O
a O
rate O
of O
50 O
cc O
&apos;s O
per O
hour O
for O
9 O
hours O
. O
( O
100 O
cc&apos;s O
per O
kilo O
) O
. O

Sodium O
and O
potassium O
at O
this O
time O
were O
128/1.5 O
. O

At O
Labor O
Day O
, O
9:30 O
a.m. O
, O
the B-TREATMENT
fluids I-TREATMENT
were O
increased O
to O
100 O
cc&apos;s O
per O
hour O
( O
200 O
cc&apos;s O
per O
kilo O
for O
5 O
hours O
) O
. O

Electrolytes O
at O
this O
point O
were O
sodium O
132 O
, O
potassium O
1.8 O
. O

At O
9/6/93 O
, O
2:30 O
p.m. O
, O
fluids B-TREATMENT
were O
decreased O
to O
75 O
cc&apos;s O
per O
hour O
, O
150 O
cc&apos;s O
per O
kilo O
, O
40 O
mEq O
of O
K B-TREATMENT
phosphate I-TREATMENT
added O
to O
the B-TREATMENT
intravenous I-TREATMENT
fluids I-TREATMENT
. O

Electrolytes O
at O
this O
point O
were O
a O
sodium O
of O
143 O
and O
potassium O
1.7 O
. O

On O
9/6/93 O
, O
22:00 O
, O
fluids B-TREATMENT
were O
changed O
to O
D5 B-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
plus O
40 O
KCL B-TREATMENT
and O
40 O
K B-TREATMENT
phosphate I-TREATMENT
at O
75 O
cc O
&apos;s O
per O
hour O
. O

This O
rate O
was O
maintained O
for O
11 O
hours O
. O

Electrolytes O
at O
this O
time O
were O
a O
sodium O
of O
148 O
, O
potassium O
1.7 O
. O

At O
9/7/93 O
, O
1:00 O
a.m. O
, O
intravenous B-TREATMENT
fluids I-TREATMENT
rate O
was O
decreased O
to O
50 O
cc&apos;s O
per O
hour O
, O
total B-TREATMENT
fluids I-TREATMENT
given O
during O
the O
first O
24 O
hours O
were O
140 O
to O
150 O
cc&apos;s O
per O
kilo O
per O
day O
. O

At O
this O
time O
, O
sodium O
was O
147 O
, O
potassium O
2.6 O
, O
total B-TREATMENT
sodium I-TREATMENT
given O
during O
the O
first O
24 O
hours O
20 O
mEq O
per O
kilo O
per O
day O
. O

On O
9/7/93 O
at O
4:00 O
a.m. O
, O
albumin B-TREATMENT
bolus I-TREATMENT
5% O
10 O
cc&apos;s O
per O
kilo O
was O
given O
, O
a O
total O
of O
120 O
cc&apos;s O
, O
electrolytes O
were O
sodium O
155 O
, O
potassium O
3.1 O
. O

At O
9/7/93 O
at O
5:00 O
a.m. O
, O
sodium B-TREATMENT
bicarbonate I-TREATMENT
given O
60 O
mEq O
, O
calcium B-TREATMENT
bolus I-TREATMENT
10 O
cc&apos;s O
given O
. O

On O
9/7 O
, O
5:30 O
a.m. O
, O
D5 B-TREATMENT
quarter I-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
, O
and O
40 O
of O
K B-TREATMENT
phosphate I-TREATMENT
at O
100 O
cc&apos;s O
per O
hour O
was O
given O
. O

The O
patient O
was O
taking O
PO O
initially O
until O
9/6/93 O
at O
17:45 O
. O

There O
were O
no O
abnormal B-SYMPTOM
findings I-SYMPTOM
in O
abdominal O
exam O
. O

On O
9/5/93 O
, O
hematocrit O
48 O
, O
white O
blood O
count O
11.2 O
, O
neutrophiles O
67 O
, O
bands O
14 O
, O
lymphs O
11 O
, O
monos O
6% O
, O
meta O
2% O
, O
platelets O
220,000 O
. O

Copious B-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
, O
BUN O
1.0 O
, O
creatinine O
.8 O
. O

Normal O
neurologic O
exam O
on O
admission O
, O
then O
lethargic B-SYMPTOM
on O
9/6/93 O
at O
17:45 O
, O
then O
patient O
became O
unresponsive B-SYMPTOM
, O
areflexic B-SYMPTOM
and O
limp B-SYMPTOM
at O
9/6/93 O
, O
at O
17:45 O
to O
22:00 O
. O

Patient O
was O
having O
seizures B-SYMPTOM
, O
twitching B-SYMPTOM
of I-SYMPTOM
face I-SYMPTOM
and O
rapid B-SYMPTOM
movements I-SYMPTOM
of I-SYMPTOM
eyes I-SYMPTOM
. O

Pupils B-SYMPTOM
dilated I-SYMPTOM
and I-SYMPTOM
sluggish I-SYMPTOM
. O

Valium B-TREATMENT
was O
given O
at O
9/7/93 O
, O
00:02 O
. O

IV B-TREATMENT
ampicillin I-TREATMENT
, O
chloramphenicol B-TREATMENT
, O
ceftriaxone B-TREATMENT
, O
and O
culture O
were O
sent O
. O

Finally O
, O
Fairm O
of O
Ijordcompmac O
Hospital O
transport O
team O
was O
called O
and O
transport O
team O
arrived O
on O
9/7/93 O
, O
6:30 O
a.m. O
, O
and O
on O
arrival O
patient O
was O
seizing O
with O
rhythmic B-SYMPTOM
eye I-SYMPTOM
movement I-SYMPTOM
to I-SYMPTOM
left I-SYMPTOM
. O

The O
patient O
was O
unresponsive B-SYMPTOM
, O
poor B-SYMPTOM
perfusion I-SYMPTOM
. O

Temperature O
was O
101.8 O
. O

A B-TREATMENT
second I-TREATMENT
intravenous I-TREATMENT
was O
started O
and O
given O
normal B-TREATMENT
saline I-TREATMENT
bolus I-TREATMENT
, O
change O
in O
intravenous B-TREATMENT
fluids I-TREATMENT
to O
D5 B-TREATMENT
water I-TREATMENT
with O
80 O
mEq O
of O
bicarbonate B-TREATMENT
, O
plus O
40 O
mEq O
of O
KCL B-TREATMENT
at O
45 O
cc&apos;s O
per O
hour O
, O
bicarbonate B-TREATMENT
given O
2 O
mEq O
per O
kilo O
, O
attempted O
to O
start O
dopa B-TREATMENT
for O
poor B-SYMPTOM
perfusion I-SYMPTOM
but O
worsening B-SYMPTOM
perfusion I-SYMPTOM
. O

Therefore O
, O
dopa B-TREATMENT
was O
stopped O
. O

Total O
volume O
given O
as O
bolus B-TREATMENT
50 O
cc&apos;s O
per O
kilo O
, O
sodium B-TREATMENT
bicarbonate I-TREATMENT
at O
2 O
mEq O
per O
kilo O
was O
given O
. O

Last O
ABG O
there O
was O
6.98 O
, O
31 O
, O
171 O
, O
bicarbonate O
of O
7 O
. O

Phenobarbital B-TREATMENT
and O
Dilantin B-TREATMENT
given O
for O
seizure B-TREATMENT
control I-TREATMENT
. O

Electrolytes O
before O
departure O
for O
Fairm O
of O
Ijordcompmac O
Hospital O
was O
a O
sodium O
of O
176 O
, O
potassium O
2.5 O
, O
chloride O
140 O
, O
bicarbonate O
14 O
, O
calcium O
7.2 O
, O
magnesium O
2.7 O
. O

Admission O
to O
the O
Pediatric O
Intensive O
Care O
Unit O
at O
Fairm O
of O
Ijordcompmac O
Hospital O
was O
9/7/93 O
, O
11:15 O
a.m. O

Lines B-TREATMENT
placed O
were O
a B-TREATMENT
right I-TREATMENT
femoral I-TREATMENT
triple I-TREATMENT
lumen I-TREATMENT
, O
endotracheal B-TREATMENT
tube I-TREATMENT
4.0 O
, O
arterial B-TREATMENT
line I-TREATMENT
, O
right B-TREATMENT
radial I-TREATMENT
line I-TREATMENT
, O
Foley B-TREATMENT
placed O
, O
peripheral B-TREATMENT
intravenous I-TREATMENT
line I-TREATMENT
, O
nasogastric B-TREATMENT
tube I-TREATMENT
. O

On O
admission O
to O
Fairm O
of O
Ijordcompmac O
Hospital O
, O
temperature O
100.2 O
, O
pulse O
149 O
, O
respiratory O
rate O
50 O
, O
blood O
pressure O
98/66 O
, O
mean O
arterial O
pressure O
of O
73 O
, O
weight O
12 O
kilos O
. O

PAST O
MEDICAL O
HISTORY O
: O

RTA B-SYMPTOM
diagnosed O
at O
14 O
months O
of O
age O
, O
she O
had O
a O
history O
of O
scarlet B-SYMPTOM
fever I-SYMPTOM
at O
14 O
months O
of O
age O
. O

She O
also O
had O
a O
recent O
exposure O
to O
varicella B-SYMPTOM
. O

Her O
brother O
had O
developed O
the B-SYMPTOM
typical I-SYMPTOM
rash I-SYMPTOM
on O
9/3/93 O
. O

ALLERGIES O
: O

None O
known O
. O

SOCIAL O
HISTORY O
: O

Mom O
on O
Medicaid O
, O
recovered O
alcoholic O
. O

11 O
year O
old O
brother,6 O
year O
old O
sister O
, O
healthy O
. O

Mom O
separated O
. O

HOSPITAL O
COURSE O
: O

On O
admission O
, O
FI02 B-TREATMENT
was O
50-60% O
, O
PID B-TREATMENT
30-32/PEEP B-TREATMENT
of O
5.7 O
, O
total O
volume O
was O
between O
140 O
to O
210 O
during O
Intensive O
Care O
Unit O
stay O
. O

Chest O
x-ray O
showed O
right B-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
pneumonia I-SYMPTOM
. O

Cardiovascular O
: O

CVP O
on O
admission O
was O
1 O
cm O
of O
water O
. O

Then O
during O
the O
Intensive O
Care O
Unit O
stay O
, O
the O
CVP O
remained O
between O
7 O
to O
8 O
after O
volume B-TREATMENT
resuscitation I-TREATMENT
. O

Dopamine B-TREATMENT
and O
epinephrine B-TREATMENT
given O
for O
cardiovascular B-TREATMENT
support I-TREATMENT
. O

Her O
electrocardiogram O
findings O
were O
compatible O
with O
hypokalemia B-SYMPTOM
( O
flattening B-SYMPTOM
T I-SYMPTOM
waves I-SYMPTOM
and O
ST B-SYMPTOM
changes I-SYMPTOM
) O
. O

Fluids O
/ O
electrolytes/nutrition O
: O

On O
admission O
to O
Fairm O
of O
Ijordcompmac O
Hospital O
, O
hypernatremia B-SYMPTOM
and O
hypovolemic B-SYMPTOM
shock I-SYMPTOM
. O

Fluids B-TREATMENT
of I-TREATMENT
D5 I-TREATMENT
water I-TREATMENT
with O
30 O
mEq O
of O
sodium B-TREATMENT
acetate I-TREATMENT
per O
liter O
, O
30 O
ml O
per O
liter O
of O
phosphate B-TREATMENT
, O
and O
30 O
mEq O
of O
K B-TREATMENT
acetate I-TREATMENT
per O
liter O
at O
90 O
cc&apos;s O
per O
hour O
was O
given O
. O

Free B-TREATMENT
water I-TREATMENT
deficit I-TREATMENT
over O
48 O
hours O
was O
given O
, O
plus O
maintenance O
, O
plus O
adjusting O
the O
ongoing O
losses O
. O

Pediatric O
Nephrology O
recommended O
on O
9/7/93 O
, O
5:50 O
p.m. O
, O
10 O
cc O
&apos;s O
per O
kilo O
of O
150 O
mEq O
of O
sodium B-TREATMENT
bicarbonate I-TREATMENT
per O
liter O
, O
( O
1.5 O
mEq O
per O
kilo O
bicarbonate B-TREATMENT
, O
one O
dose O
of O
Lasix B-TREATMENT
and O
volume B-TREATMENT
as O
needed O
) O
. O

The O
patient O
required O
multiple B-TREATMENT
boluses I-TREATMENT
of I-TREATMENT
albumin I-TREATMENT
for O
hypotension B-SYMPTOM
, O
patient O
also O
required O
multiple B-TREATMENT
boluses I-TREATMENT
of I-TREATMENT
calcium I-TREATMENT
because O
of O
hypocalcemia B-SYMPTOM
and O
hypotension B-SYMPTOM
. O

Magnesium B-TREATMENT
2.0 O
mEq O
per O
liter O
, O
phosphate B-TREATMENT
8 O
mg O
/ O
dl O
. O

Gastrointestinal O
: O

Normal O
. O

NPO B-TREATMENT
. O

Albumin O
was O
4.9 O
. O

Globulin O
was O
1.6 O
, O
uric O
acid O
was O
6.5 O
, O
alkaline O
phosphatase O
150 O
, O
SGPT O
11 O
, O
SGOT O
85 O
, O
LDH O
524 O
, O
CK O
152 O
, O
NH3 O
81 O
. O

Hematologic O
: O

White O
cell O
count O
9.4 O
, O
hematocrit O
42 O
, O
platelets O
151,000 O
. O

Differential O
was O
polys O
59 O
, O
bands O
3 O
, O
lymphs O
25 O
. O

Repeat O
white O
cell O
count O
6.4 O
, O
hematocrit O
34 O
, O
platelets O
103 O
. O

PT O
11.6/10.1 O
, O
repeat O
PT O
12.8/10.5 O
. O

PTT O
36.4 O
, O
repeat O
PTT O
50.9 O
. O

Fibrinogen O
211 O
. O

Renal O
: O

Urine O
output O
was O
about O
5 O
to O
8 O
cc&apos;s O
per O
kilo O
per O
hour O
. O

Renal O
ultrasound O
was O
scheduled O
during O
the O
Intensive O
Care O
Unit O
stay O
. O

Urinalysis O
showed O
specific O
gravity O
1.005 O
, O
pH O
8.0 O
, O
positive B-SYMPTOM
proteins I-SYMPTOM
, O
positive B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
cells I-SYMPTOM
, O
negative O
white O
cell O
count O
, O
positive B-SYMPTOM
glucose I-SYMPTOM
. O

Neurologic O
: O

Patient O
did O
not O
receive O
sedation B-TREATMENT
or O
muscle B-TREATMENT
relaxant I-TREATMENT
since O
admission O
to O
the O
Pediatric O
Intensive O
Care O
Unit O
. O

Phenobarbital O
levels O
were O
31.4 O
, O
30.2 O
, O
and O
50 O
. O

Dilantin O
level O
was O
22.6 O
, O
20.2 O
, O
20 O
. O

Neurology O
consultation O
on O
the O
evening O
of O
9/7/93 O
revealed O
supple O
neck O
, O
no B-SYMPTOM
response I-SYMPTOM
to O
external O
rub O
. O

Pupils O
were O
3.5 O
OD O
, O
and O
3.0 O
OS O
, O
irregular B-SYMPTOM
and O
non B-SYMPTOM
reactive I-SYMPTOM
. O

Corneal O
reflexes O
and O
oculocephalic O
reflexes O
were O
absent B-SYMPTOM
. O

There O
was O
no B-SYMPTOM
gag I-SYMPTOM
. O

Muscle O
tone O
was O
increased B-SYMPTOM
throughout I-SYMPTOM
, O
and O
the O
legs O
were O
both B-SYMPTOM
extended I-SYMPTOM
and I-SYMPTOM
internally I-SYMPTOM
rotated I-SYMPTOM
. O

Deep O
tendon O
reflexes O
could O
not O
be O
elicited O
and O
plantar O
responses O
were O
silent B-SYMPTOM
. O

Repeat O
neurological O
examination O
revealed O
no B-SYMPTOM
spontaneous I-SYMPTOM
movement I-SYMPTOM
and O
no B-SYMPTOM
response I-SYMPTOM
to O
voice O
or O
noxious O
stimulation O
. O

Pupils O
were O
dilated B-SYMPTOM
and O
non B-SYMPTOM
reactive I-SYMPTOM
. O

Disc O
margins O
appeared O
blurred B-SYMPTOM
on O
funduscopic O
exam O
. O

A O
non O
contrast O
head O
CT O
scan O
was O
obtained O
and O
CT O
revealed O
severe B-SYMPTOM
cerebral I-SYMPTOM
edema I-SYMPTOM
with O
thalamic B-SYMPTOM
mid I-SYMPTOM
brain I-SYMPTOM
, I-SYMPTOM
pons I-SYMPTOM
, I-SYMPTOM
medullar I-SYMPTOM
low I-SYMPTOM
attenuation I-SYMPTOM
, O
diffuse B-SYMPTOM
cerebral I-SYMPTOM
edema I-SYMPTOM
, O
loss B-SYMPTOM
of I-SYMPTOM
gray I-SYMPTOM
white I-SYMPTOM
matter I-SYMPTOM
differentiation I-SYMPTOM
. O

Cerebral O
blood O
flow O
was O
done O
on O
9/7/93 O
at O
2:30 O
p.m. O
, O
revealed O
complete B-SYMPTOM
absence I-SYMPTOM
of I-SYMPTOM
blood I-SYMPTOM
flow I-SYMPTOM
to I-SYMPTOM
brain I-SYMPTOM
. O

There O
was O
a B-SYMPTOM
tiny I-SYMPTOM
region I-SYMPTOM
of I-SYMPTOM
activity I-SYMPTOM
in O
what O
appears O
to O
be O
anterior O
scalp O
. O

Infectious O
Disease O
: O

Ampicillin B-TREATMENT
and O
chloramphenicol B-TREATMENT
were O
given O
at O
Noughwell O
Entanbon O
Health O
, O
and O
ceftriaxone B-TREATMENT
was O
given O
at O
Fairm O
of O
Ijordcompmac O
Hospital O
. O

Acyclovir B-TREATMENT
was O
started O
, O
also O
considering O
the B-SYMPTOM
varicella I-SYMPTOM
at O
120 O
mg O
intravenously O
every O
8 O
hours O
. O

Urine O
cultures O
, O
blood O
cultures O
and O
sputum O
cultures O
were O
sent O
. O

The O
patient O
finally O
died O
. O

The O
situation O
of O
the O
patient O
was O
extensively O
discussed O
with O
the O
parents O
, O
and O
the O
attending O
physician O
from O
Neurology O
, O
Dr. O
Breunkote O
, O
and O
the O
attending O
physician O
from O
Pediatric O
Intensive O
Care O
Unit O
, O
Dr. O
Boormcose O
, O
and O
the O
decision O
was O
finally O
made O
with O
the O
family O
and O
attendings O
to O
disconnect O
the O
patient O
from O
the B-TREATMENT
mechanical I-TREATMENT
ventilation I-TREATMENT
due O
to O
severe B-SYMPTOM
neurological I-SYMPTOM
injury I-SYMPTOM
and O
poor B-SYMPTOM
prognosis I-SYMPTOM
. O

ZAKAY O
COUGH O
, O
M.D. O

TR O
: O

jx O
/ O
bmot O

DD O
: O

10-20-93 O

TD O
: O

10/21/93 O

CC O
: O

edited O
10/24/93 O
rc O

991193550 O

PUOMC O

1585733 O

16900/0678 O

362005 O

11/30/1995 O
12:00:00 O
AM O

GASTRIC B-SYMPTOM
ULCER I-SYMPTOM
AND O
GASTRIC B-SYMPTOM
PERICARDIAL I-SYMPTOM
FISTULA I-SYMPTOM
, O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

11-30-95 O

DISCHARGE O
DATE O
: O

12-29-95 O

PRINCIPAL O
DIAGNOSIS O
: O

Gastric B-SYMPTOM
ulcer I-SYMPTOM
and O
gastric B-SYMPTOM
pericardial I-SYMPTOM
fistula I-SYMPTOM
, O
constricting B-SYMPTOM
pericarditis I-SYMPTOM
, O
adult B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
, O
status O
post O
gunshot B-SYMPTOM
wounds I-SYMPTOM
and O
paraplegia B-SYMPTOM
since O
1991 O
of O
T4 O
on O
down O
. O

The O
patient O
has O
a B-TREATMENT
Greenfield I-TREATMENT
filter I-TREATMENT
in O
. O

He O
has O
multiple B-SYMPTOM
decubiti I-SYMPTOM
on I-SYMPTOM
his I-SYMPTOM
buttocks I-SYMPTOM
and I-SYMPTOM
penis I-SYMPTOM
. O

He O
had O
a B-TREATMENT
gastric I-TREATMENT
pull I-TREATMENT
up I-TREATMENT
in O
1992 O
of O
the O
stomach O
into O
the O
left O
thorax O
and O
he O
has O
a B-TREATMENT
transverse I-TREATMENT
colostomy I-TREATMENT
and O
a B-SYMPTOM
sinus I-SYMPTOM
tract I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
abdomen I-SYMPTOM
. O

ALLERGIES O
: O

Bactrim B-TREATMENT
and O
Vancomycin B-TREATMENT
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Albuterol B-TREATMENT
inhaler I-TREATMENT
. O

Amphotericin B-TREATMENT
B I-TREATMENT
40 O
mg. O
qday O
. O

Ceftazidime B-TREATMENT
1 O
gram O
intravenous O
q O
8 O
. O

Ciprofloxacin B-TREATMENT
500 O
mg. O
po. O
q12 O
. O

Cisapride B-TREATMENT
10 O
mg. O
po. O
qid O
. O

Dakin B-TREATMENT
&apos;s I-TREATMENT
solution I-TREATMENT
1/4 O
strength O
to O
ulcer O
of O
penis O
. O

Benadryl B-TREATMENT
50 O
mg. O
intravenous O
tid O
prn O
. O

______________ O
capsule B-TREATMENT
1 O
po. O
tid O
. O

Lasix B-TREATMENT
prn O
. O

Nystatin B-TREATMENT
swish I-TREATMENT
and I-TREATMENT
swallow I-TREATMENT
tid O
. O

Percocet B-TREATMENT
po. O
q4 O
to O
6 O
prn O
. O

Trazodone B-TREATMENT
50 O
mg. O
qhs. O
multivitamins B-TREATMENT
1 O
po. O
qd O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
25 O
year O
old O
who O
has O
a O
history O
of O
a B-SYMPTOM
gunshot I-SYMPTOM
wound I-SYMPTOM
many O
years O
ago O
and O
has O
had O
multiple B-TREATMENT
surgical I-TREATMENT
procedures I-TREATMENT
since O
then O
. O

Most O
recently O
he O
was O
admitted O
to O
an O
outside O
hospital O
with O
a B-SYMPTOM
drug I-SYMPTOM
overdose I-SYMPTOM
in O
adult B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
and O
ultimately O
found O
to O
have O
Candidal B-SYMPTOM
pericarditis I-SYMPTOM
which O
eventually O
led O
to O
constrictive B-SYMPTOM
pericarditis I-SYMPTOM
. O

He O
had O
a B-TREATMENT
pericardial I-TREATMENT
window I-TREATMENT
. O

He O
had O
a O
barium O
swallow O
and O
endoscopy O
and O
was O
said O
not O
to O
have O
gastric B-SYMPTOM
or I-SYMPTOM
pericardial I-SYMPTOM
ulcer I-SYMPTOM
. O

He O
had O
previous B-TREATMENT
substernal I-TREATMENT
gastric I-TREATMENT
bypass I-TREATMENT
because O
of O
an B-SYMPTOM
interruption I-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
esophagus I-SYMPTOM
at O
the O
time O
of O
his B-SYMPTOM
gunshot I-SYMPTOM
wound I-SYMPTOM
. O

He O
had O
been O
noted O
to O
have O
an B-SYMPTOM
ulcer I-SYMPTOM
and O
ultimately O
when O
he O
stabilized O
it O
was O
our O
feeling O
that O
he O
most O
likely O
had O
a B-SYMPTOM
gastric I-SYMPTOM
pericardial I-SYMPTOM
ulcer I-SYMPTOM
and O
he O
was O
transferred O
here O
for O
further B-TREATMENT
management I-TREATMENT
. O

We O
discussed O
the O
risks O
with O
his O
family O
. O

It O
was O
a O
very O
high O
risk O
in O
very B-SYMPTOM
poor I-SYMPTOM
condition I-SYMPTOM
and O
a O
cachectic O
malnourished O
edematous O
individuals O
who O
have O
very B-SYMPTOM
high I-SYMPTOM
venous I-SYMPTOM
pressures I-SYMPTOM
and O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

The O
family O
understood O
that O
this O
was O
a B-TREATMENT
life I-TREATMENT
saving I-TREATMENT
procedure I-TREATMENT
and O
only O
carried O
with O
it O
approximately O
50% O
chance O
of O
success O
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

esophagoscopy O
, O
bronchoscopy O
, O
pericardectomy B-TREATMENT
, O
excision B-TREATMENT
of O
gastric B-SYMPTOM
ulcer I-SYMPTOM
, O
repair B-TREATMENT
of O
gastric B-SYMPTOM
ulcer I-SYMPTOM
and O
pectoralis B-TREATMENT
major I-TREATMENT
myocutaneous I-TREATMENT
flap I-TREATMENT
performed O
on O
December O
4 O
, O
1995 O
by O
Dr. O
Reg O
Cranka O
and O
Dr. O
Win O
Shufffyfe O
. O

In O
lieu O
of O
a O
standard O
discharge O
summary O
given O
this O
patient O
&apos;s O
complicated O
hospital O
course O
and O
associated B-SYMPTOM
illnesses I-SYMPTOM
I O
feel O
it O
best O
to O
just O
provide O
a O
system O
summary O
concerning O
this O
patient O
&apos;s O
current O
status O
. O

1. O
Neurologic O
and O
Psychologic O
: O

The O
patient O
is O
on O
Nortriptyline B-TREATMENT
for O
depression B-SYMPTOM
. O

He O
is O
a B-SYMPTOM
paraplegic I-SYMPTOM
from I-SYMPTOM
T4 I-SYMPTOM
down I-SYMPTOM
. O

Otherwise O
he O
is O
awake O
, O
alert O
and O
appropriate O
and O
can O
respond O
to O
questions O
and O
can O
move O
his O
upper O
extremities O
. O

The O
patient O
however O
spends O
most O
of O
his O
time O
at O
bedrest O
due O
to O
decubiti B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
. O

2. O
Cardiac O
: O

The O
patient O
had O
constrictive B-SYMPTOM
pericarditis I-SYMPTOM
that O
was O
relieved O
by O
his B-TREATMENT
surgical I-TREATMENT
procedure I-TREATMENT
. O

He O
had O
a O
cardiac O
catheterization O
on O
December O
1 O
, O
1995 O
that O
showed O
no O
complications B-SYMPTOM
, O
elevated B-SYMPTOM
right I-SYMPTOM
atrial I-SYMPTOM
pressure I-SYMPTOM
and O
moderate B-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
. O

The O
cardiac O
output O
was O
five O
liters O
per O
minute O
with O
an O
index O
at O
2.9 O
liters O
per O
minute O
per O
meter O
2 O
which O
is O
normal O
. O

A O
full O
copy O
of O
the O
cardiac O
catheterization O
report O
is O
enclosed O
with O
his O
transfer O
materials O
. O

The O
patient O
also O
underwent O
cardiac O
ultrasound O
on O
December O
11 O
, O
1995 O
that O
showed O
abnormal B-SYMPTOM
right I-SYMPTOM
ventricle I-SYMPTOM
wall I-SYMPTOM
motion I-SYMPTOM
, O
trace B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
, O
normal O
left O
ventricular O
size O
and O
function O
with O
an O
estimated O
ejection O
fraction O
of O
64% O
. O

There O
is O
Doppler O
evidence O
of O
tricuspid B-SYMPTOM
insufficiency I-SYMPTOM
and O
right B-SYMPTOM
atrial I-SYMPTOM
dilatation I-SYMPTOM
. O

There O
is O
trace B-SYMPTOM
pulmonary I-SYMPTOM
insufficiency I-SYMPTOM
. O

The O
right O
ventricle O
is O
dilated B-SYMPTOM
and O
diffusely B-SYMPTOM
hypokinetic I-SYMPTOM
and O
there O
is O
no O
evidence O
of O
constrictive B-SYMPTOM
physiology I-SYMPTOM
which O
was O
seen O
on O
December O
6 O
, O
1995 O
. O

A O
copy O
of O
this O
ultrasound O
is O
also O
found O
in O
his O
records O
. O

The O
patient O
is O
on O
no O
specific B-TREATMENT
medications I-TREATMENT
for O
his B-SYMPTOM
cardiac I-SYMPTOM
condition I-SYMPTOM
. O

3. O
Respiratory O
: O

the O
patient O
is O
status O
post O
thoracotomy B-TREATMENT
and O
has O
staples B-TREATMENT
and O
sutures B-TREATMENT
on I-TREATMENT
his I-TREATMENT
chest I-TREATMENT
. O

These O
may O
be O
removed O
when O
the B-SYMPTOM
incisions I-SYMPTOM
are O
noted O
to O
be O
well O
healed O
. O

The O
patient O
is O
approximately O
three O
weeks O
following O
his B-TREATMENT
procedure I-TREATMENT
and O
several O
of O
these B-TREATMENT
stitches I-TREATMENT
will O
be O
removed O
prior O
to O
discharge O
. O

The O
patient O
is O
on O
oxygen B-TREATMENT
by O
face B-TREATMENT
mask I-TREATMENT
and O
his O
saturations O
have O
been O
remaining O
normal O
. O

His B-TREATMENT
medications I-TREATMENT
for O
his O
respiratory O
system O
are O
Albuterol B-TREATMENT
nebulizer I-TREATMENT
0.5 O
mg. O
2.5 O
cc. O
q4hours O
. O

3. O
GI O
: O

The O
patient O
has O
had O
gastric B-TREATMENT
ulcer I-TREATMENT
repair I-TREATMENT
and O
also O
has O
a B-TREATMENT
colostomy I-TREATMENT
. O

The O
patient O
has O
a B-SYMPTOM
sinus I-SYMPTOM
tract I-SYMPTOM
that O
was O
studied O
with O
a O
fistulogram O
on O
December O
25 O
, O
1995 O
. O

This O
showed O
no O
communication B-SYMPTOM
with I-SYMPTOM
the I-SYMPTOM
intestines I-SYMPTOM
and O
was O
simply O
a B-SYMPTOM
sinus I-SYMPTOM
tract I-SYMPTOM
. O

There O
is O
no O
fistula B-SYMPTOM
seen O
. O

Dr. O
Asha O
Vengloan O
of O
General O
Surgery O
consulted O
on O
the O
patient O
and O
concluded O
the O
patient O
does O
not O
require O
any B-TREATMENT
surgical I-TREATMENT
treatment I-TREATMENT
of O
this B-SYMPTOM
problem I-SYMPTOM
at O
the O
current O
time O
and O
the B-TREATMENT
best I-TREATMENT
treatment I-TREATMENT
for O
this O
situation O
would O
be O
to O
increase O
the O
patient O
&apos;s O
nutrition O
. O

The O
patient O
takes O
poorly O
his O
po. O
diet O
. O

However O
he O
is O
able O
to O
swallow O
and O
tolerate O
po&apos;s O
. O

He O
just O
claims O
to O
have O
no B-SYMPTOM
appetite I-SYMPTOM
and O
has O
very B-SYMPTOM
poor I-SYMPTOM
effort I-SYMPTOM
with O
feeding O
. O

The O
patient O
is O
able O
to O
tolerate O
po. B-TREATMENT
medicines I-TREATMENT
. O

4. O
GU O
: O

The O
patient O
has O
an B-SYMPTOM
ulcer I-SYMPTOM
on I-SYMPTOM
his I-SYMPTOM
penis I-SYMPTOM
that O
has O
been O
treated O
with O
dressing B-TREATMENT
changes I-TREATMENT
. O

It O
has O
been O
noted O
to O
be O
improving O
. O

The O
patient O
has O
a B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
in O
and O
when O
the O
penile O
skin O
is O
very O
well O
healed O
his B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
may O
be O
removed O
. O

Until O
this O
time O
he O
should O
be O
kept O
on O
three O
times O
daily O
wet B-TREATMENT
to I-TREATMENT
dry I-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
. O

5. O
Skin O
: O

The O
patient O
has O
multiple B-SYMPTOM
decubiti I-SYMPTOM
over O
his O
body O
, O
in O
particular O
his O
perineum O
and O
buttocks O
have O
large B-SYMPTOM
decubiti I-SYMPTOM
. O

Plastic O
Surgery O
was O
consulted O
Dr. O
Ca O
Shuff O
who O
saw O
the O
patient O
and O
decided O
that O
the O
patient O
is O
not O
a O
surgical O
candidate O
at O
this O
point O
. O

These B-SYMPTOM
wounds I-SYMPTOM
should O
be O
treated O
with O
three O
times O
daily O
wet B-TREATMENT
to I-TREATMENT
dry I-TREATMENT
dressings I-TREATMENT
. O

The O
patient O
&apos;s O
activity O
should O
be O
limited O
to O
being O
up O
in O
a O
chair O
only O
for O
several O
minutes O
per O
day O
and O
sit O
on O
a O
special O
pad O
that O
the O
family O
has O
purchased O
. O

6. O
Infectious O
Disease O
: O

The O
patient O
&apos;s O
white O
count O
at O
the O
time O
of O
discharge O
is O
within O
normal O
limits O
. O

The O
patient O
remains O
on O
Fluconazole B-TREATMENT
. O

His B-TREATMENT
other I-TREATMENT
antibiotics I-TREATMENT
were O
discontinued O
. O

His O
most O
recent O
cultures O
are O
negative O
. O

The O
chest O
X-ray O
shows O
no O
evidence O
of O
pneumonia B-SYMPTOM
. O

7. O
Pain B-SYMPTOM
. O

The O
patient O
has O
been O
very O
closely O
with O
the O
Pain O
Service O
here O
while O
admitted O
. O

He O
has O
been O
placed O
on O
Oxycodone B-TREATMENT
10 O
mg. O
po. O
q3hours O
as O
needed O
for O
pain B-SYMPTOM
. O

The O
patient O
had O
a B-TREATMENT
PCA I-TREATMENT
and O
several B-TREATMENT
other I-TREATMENT
medications I-TREATMENT
have O
been O
discontinued O
. O

The O
patient O
has O
strong O
narcotic O
seeking O
behavior O
. O

The O
patient O
for O
sleep O
was O
given O
Benadryl B-TREATMENT
25 O
to O
50 O
mg. O
qhs. O
and O
was O
not O
allowed O
any O
increases O
in O
his B-TREATMENT
narcotics I-TREATMENT
after O
weaning O
him O
down O
to O
just O
requiring O
the B-TREATMENT
Oxycodone I-TREATMENT
. O

A O
complete O
summary O
of O
the B-TREATMENT
patient I-TREATMENT
&apos;s I-TREATMENT
medications I-TREATMENT
are O
as O
follows O
: O

Cimetidine B-TREATMENT
300 O
mg. O
intravenous O
q6hours O
. O

Albuterol B-TREATMENT
nebulizer I-TREATMENT
0.5 O
mg. O
2.5 O
cc. O
q4hours O
. O

Senokot B-TREATMENT
two O
tablets O
po. O
bid O
or O
Metamucil B-TREATMENT
one O
tablespoon O
po. O
bid O
. O

Nortriptyline B-TREATMENT
25 O
mg. O
po. O
qhs O
. O

KCL B-TREATMENT
40 O
mEq. O
po. O
bid O
. O

Saline B-TREATMENT
wet I-TREATMENT
to I-TREATMENT
dry I-TREATMENT
dressing I-TREATMENT
changes I-TREATMENT
three O
times O
daily O
to O
penis B-SYMPTOM
and I-SYMPTOM
pelvis I-SYMPTOM
decubiti I-SYMPTOM
, O
40% B-TREATMENT
humidified I-TREATMENT
oxygen I-TREATMENT
, O
Fluconazole B-TREATMENT
200 O
mg. O
po. O
bid O
. O

Lasix B-TREATMENT
2.5 O
mg. O
intravenous O
qid O
. O

Prilosec B-TREATMENT
20 O
mg. O
po. O
qd O
. O

Benadryl B-TREATMENT
25 O
to O
50 O
mg. O
po. O
qhs O
prn O
. O

Oxycodone B-TREATMENT
10 O
mg. O
po. O
q3 O
hours O
prn O
. O

Physicians O
that O
took O
care O
of O
this O
patient O
while O
at O
the O
Ph O
University O
Of O
Medical O
Center O
are O
as O
follows O
: O

Admitting O
Physician O
and O
Thoracic O
Surgeon O
: O

Reg O
Cranka O
, O
M.D. O

Consulting O
General O
Surgeon O
was O
Asha O
Vengloan O
, O
M.D. O

Consulting O
Urology O
was O
Ryna O
Baker O
, O
M.D. O

Consulting O
Plastic O
Surgeon O
: O

Ca O
Shuff O
, O
M.D. O

Consulting O
Cardiologist O
: O

Cealme O
Maressythe O
, O
M.D. O

Consulting O
Cardiac O
Surgeon O
: O

Win O
Shufffyfe O
, O
M.D. O

Infectious O
Disease O
Consultant O
: O

Dr. O
Jesc O
. O

Psychiatry O
: O

Dr. O
Rencobe O
and O
Dr. O
Saddbeem O
. O

Pain O
Service O
: O

Dr. O
Shuff O
. O

In O
summary O
this O
is O
a O
25 O
year O
old O
male O
with O
a O
very O
complicated O
history O
and O
a O
patient O
of O
Dr. O
Breunkays O
&apos;s O
. O

The O
patient O
was O
seen O
at O
Ph O
University O
Of O
Medical O
Center O
for O
problem O
regarding O
his B-SYMPTOM
constrictive I-SYMPTOM
pericarditis I-SYMPTOM
and O
underwent O
a B-TREATMENT
surgical I-TREATMENT
procedure I-TREATMENT
to O
correct O
this O
. O

Followup O
cardiac O
studies O
showed O
there O
was O
a O
resolution O
of O
his B-SYMPTOM
constrictive I-SYMPTOM
pericarditis I-SYMPTOM
. O

The O
patient O
also O
had O
a B-SYMPTOM
gastric I-SYMPTOM
ulcer I-SYMPTOM
repaired O
at O
the O
same O
time O
. O

Other O
issues O
of O
the O
patient O
are O
chronic O
and O
most O
likely O
will O
be O
followed O
up O
in O
hospitals O
closer O
to O
the O
patient O
&apos;s O
home O
. O

If O
there O
are O
any O
questions O
regarding O
his O
care O
they O
should O
be O
directed O
to O
Dr. O
Cranka O
&apos;s O
office O
at O
Ph O
University O
Of O
Medical O
Center O
and O
we O
will O
be O
happy O
to O
contact O
any O
or O
all O
of O
the O
consultations O
concerned O
with O
Hauth O
&apos;s O
care O
. O

Hauth O
is O
a O
very O
complicated O
patient O
and O
it O
was O
our O
pleasure O
to O
provide O
care O
for O
him O
at O
Ph O
University O
Of O
Medical O
Center O
. O

CA O
SHUFF O
, O
M.D. O

DICTATING O
FOR O
: O

REG O
CRANKA O
, O
M.D. O

TR O
: O

fp O
/ O
bmot O

DD O
: O

12-27-95 O

TD O
: O

12/27/95 O

CC O
: O

STAT O
: O

Goman O
4 O

662179752 O

PUOMC O

9175227 O

22849/871n O

818603 O

7/30/1993 O
12:00:00 O
AM O

CORONARY B-SYMPTOM
ARTERY I-SYMPTOM
DISEASE I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

07-30-93 O

DISCHARGE O
DATE O
: O

08-10-93 O

PRINCIPAL O
DIAGNOSIS O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

1. O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

2. O
Ventricular B-SYMPTOM
ectopy I-SYMPTOM
. O

3. O
Pulmonary B-SYMPTOM
hypertension I-SYMPTOM
. O

4. O
Cardiomegaly B-SYMPTOM
. O

5. O
Sinus B-SYMPTOM
tachycardia I-SYMPTOM
. O

6. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

7. O
Paraphimosis B-SYMPTOM
. O

8. O
Right B-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
. O

9. O
Pericarditis B-SYMPTOM
. O

ADVERSE O
DRUG O
REACTIONS O
: O

Heparin B-TREATMENT
, O
consisting O
of O
thrombocytopenia B-SYMPTOM
; O
Pronestyl B-TREATMENT
, O
consisting O
of O
nausea B-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

08/02/93 O
: O

coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
x I-TREATMENT
3 I-TREATMENT
. O

08/02/93 O
: O

left O
internal O
mammary O
artery O
to O
anterior O
descending O
artery O
x O
1 O
. O

08/02/93 O
: O

Insertion B-TREATMENT
of I-TREATMENT
intra-aortic I-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
. O

07/30/93 O
: O

bilateral O
cardiac O
catheterization O
. O

07/30/93 O
: O

Left O
ventriculography O
. O

07/30/93 O
: O

bilateral O
coronary O
angiography O
. O

08/02/93 O
: O

Signal O
average O
EKG O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Digoxin B-TREATMENT
, O
.25 O
mg O
PO O
QD O
; O
Ecotrin B-TREATMENT
, O
325 O
mg O
QD O
; O
Coumadin B-TREATMENT
, O
2.5 O
mg O
PO O
QD O
; O
Lisinopril B-TREATMENT
, O
2.5 O
mg O
PO O
QD O
; O
Micronase B-TREATMENT
, O
5 O
mg O
PO O
BID O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
47 O
year O
old O
patient O
of O
Dr. O
Laymie O
Fournier O
and O
Dr. O
Leebjescobe O
in O
Co O
In O
Saorlirv O
Frea O
, O
West O
Virginia O
who O
was O
well O
until O
a O
bout O
of O
double B-SYMPTOM
pneumonia I-SYMPTOM
in O
May O
1992 O
, O
at O
which O
time O
he O
was O
hospitalized O
at O
Centdick O
Naco O
Hospital O
Medical O
Center O
. O

He O
also O
has O
a O
history O
of O
hypertension B-SYMPTOM
and O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

He O
had O
a O
transient O
episode O
of O
headache B-SYMPTOM
and O
disorientation B-SYMPTOM
at O
that O
time O
. O

A O
CT O
and O
MRI O
scan O
corroborated O
multiple B-SYMPTOM
cerebral I-SYMPTOM
infarcts I-SYMPTOM
. O

He O
was O
started O
on O
aspirin B-TREATMENT
. O

He O
has O
a O
family O
history O
of O
hypertension B-SYMPTOM
as O
well O
. O

He O
was O
also O
placed O
on O
Vasotec B-TREATMENT
. O

A O
Holter O
monitor O
showed O
ventricular B-SYMPTOM
ectopy I-SYMPTOM
. O

A O
thallium O
stress O
test O
showed O
tachycardia B-SYMPTOM
and O
severe B-SYMPTOM
dyspnea I-SYMPTOM
as O
well O
as O
a B-SYMPTOM
fall I-SYMPTOM
in I-SYMPTOM
blood I-SYMPTOM
pressure I-SYMPTOM
with O
low O
level O
exercise O
. O

An O
echocardiogram O
showed O
global B-SYMPTOM
hypokinesis I-SYMPTOM
. O

Accordingly O
he O
was O
referred O
for O
further O
evaluation O
. O

PHYSICAL O
EXAMINATION O
: O

Blood O
pressure O
140/100 O
, O
phosphorus O
94 O
, O
weight O
181 O
lb O
. O

Head O
, O
neck O
: O

unremarkable O
. O

Lungs O
clear O
. O

Carotids O
normal O
. O

Cardiac O
: O

Loud B-SYMPTOM
S4 I-SYMPTOM
and O
a B-SYMPTOM
II I-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
regurgitant I-SYMPTOM
murmur I-SYMPTOM
. O

Abdomen O
was O
benign O
. O

Peripheral O
pulses O
intact O
. O

Neurological O
: O

Nonfocal O
. O

LABORATORY O
DATA O
: O

Sodium O
140 O
, O
potassium O
4.0 O
, O
chloride O
104 O
, O
CO2 O
28 O
, O
BUN O
14 O
, O
creatinine O
1.1 O
, O
glucose O
243 O
. O

Cholesterol O
197 O
, O
triglycerides O
118 O
, O
HDL O
31 O
, O
LDL O
142 O
, O
total O
protein O
6.2 O
, O
bilirubin O
1.0 O
, O
alkaline O
phosphatase O
72 O
, O
SGOT O
23 O
. O

Hematocrit O
on O
admission O
was O
43% O
with O
a O
white O
blood O
count O
of O
6600 O
. O

MCV O
was O
85 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
taken O
to O
the O
cardiac O
catheterization O
laboratory O
, O
where O
he O
was O
noted O
initially O
to O
have O
a O
pulmonary O
wedge O
pressure O
of O
45 O
with O
a O
pulmonary O
artery O
pressure O
of O
82/40 O
. O

This O
lowered O
with O
IV B-TREATMENT
nitroglycerin I-TREATMENT
. O

Selective O
coronary O
angiography O
showed O
an B-SYMPTOM
occluded I-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
in I-SYMPTOM
its I-SYMPTOM
midportion I-SYMPTOM
. O

He O
had O
an O
80% O
distal O
left O
main O
, O
a O
90% O
proximal O
circumflex O
, O
and O
multiple B-SYMPTOM
significant I-SYMPTOM
lesions I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
LAD I-SYMPTOM
. O

His O
left O
ventricle O
ejection O
showed O
diffuse B-SYMPTOM
hypokinesis I-SYMPTOM
. O

The O
situation O
was O
reviewed O
with O
his O
wife O
, O
Sligh O
. O

She O
noted O
that O
he O
was O
actively O
working O
full O
time O
and O
was O
a O
sales O
representative O
at O
the O
Leigh O
and O
lives O
at O
home O
with O
her O
and O
his O
daughter O
, O
age O
18 O
. O

It O
was O
felt O
that O
, O
because O
of O
the O
evidence O
of O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
and O
the B-SYMPTOM
critical I-SYMPTOM
left I-SYMPTOM
main I-SYMPTOM
lesion I-SYMPTOM
, O
he O
should O
be O
admitted O
for O
further O
evaluation O
. O

Indeed O
, O
he O
was O
treated O
with O
diuretics B-TREATMENT
and O
nitrates B-TREATMENT
along O
with O
cessation O
of O
his B-TREATMENT
aspirin I-TREATMENT
, O
and O
he O
was O
put O
on O
IV B-TREATMENT
Heparin I-TREATMENT
. O

He O
stabilized O
over O
the O
weekend O
. O

He O
was O
noted O
to O
have O
some B-SYMPTOM
ventricular I-SYMPTOM
ectopy I-SYMPTOM
on O
Holter O
monitor O
. O

He O
developed O
epigastric B-SYMPTOM
pain I-SYMPTOM
on O
07/31 O
which O
previously O
had O
been O
ignored O
but O
in O
retrospect O
was O
probably O
his B-SYMPTOM
anginal I-SYMPTOM
equivalent I-SYMPTOM
. O

He O
also O
had O
multifocal B-SYMPTOM
ventricular I-SYMPTOM
ectopy I-SYMPTOM
at O
that O
time O
. O

He O
had O
some B-SYMPTOM
further I-SYMPTOM
anterolateral I-SYMPTOM
ST I-SYMPTOM
segment I-SYMPTOM
changes I-SYMPTOM
. O

Therefore O
, O
he O
did O
have O
unstable B-SYMPTOM
angina I-SYMPTOM
with O
his B-SYMPTOM
critical I-SYMPTOM
coronary I-SYMPTOM
anatomy I-SYMPTOM
. O

The O
patient O
was O
seen O
in O
consultation O
by O
the O
Electrophysiology O
service O
, O
Dr. O
Slusslashgodle O
, O
who O
said O
that O
he O
had O
no O
indication O
for O
patch B-TREATMENT
placement I-TREATMENT
at O
the O
time O
of O
surgery B-TREATMENT
. O

On O
08/02/93 O
, O
an B-TREATMENT
intra-aortic I-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
was O
placed O
; O
then O
, O
Dr. O
Thorebreutz O
took O
him O
to O
the O
operating O
room O
, O
where O
he O
had O
quadruple B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

He O
had O
a B-TREATMENT
left I-TREATMENT
internal I-TREATMENT
mammary I-TREATMENT
artery I-TREATMENT
graft I-TREATMENT
of I-TREATMENT
the I-TREATMENT
LAD I-TREATMENT
, O
a O
single O
saphenous O
vein O
to O
the O
right O
coronary O
artery O
with O
280 O
cc O
per O
minute O
flow O
, O
and O
a B-TREATMENT
saphenous I-TREATMENT
vein I-TREATMENT
snake I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
diagonal I-TREATMENT
and O
circumflex O
with O
150 O
cc O
per O
minute O
flow O
. O

A B-SYMPTOM
paraphimosis I-SYMPTOM
was O
noted O
and O
treated O
by O
Dr. O
Ryna O
Jescdrig O
. O

After O
surgery B-TREATMENT
he O
had O
a B-SYMPTOM
ongoing I-SYMPTOM
sinus I-SYMPTOM
tachycardia I-SYMPTOM
. O

He O
was O
able O
to O
be O
rapidly O
weaned O
and O
extubated O
. O

He O
had O
good O
hemodynamics O
. O

He O
had O
occasional B-SYMPTOM
atrial I-SYMPTOM
and I-SYMPTOM
ventricular I-SYMPTOM
premature I-SYMPTOM
beats I-SYMPTOM
. O

His B-TREATMENT
intra-aortic I-TREATMENT
balloon I-TREATMENT
pump I-TREATMENT
was O
weaned O
the O
following O
day O
and O
he O
was O
transferred O
out O
of O
the O
Surgical O
Intensive O
Care O
Unit O
. O

He O
was O
seen O
in O
consultation O
by O
the O
Nutrition O
Service O
, O
who O
followed O
him O
for O
dietary O
management O
of O
his B-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

On O
08/05 O
it O
was O
noted O
that O
his O
platelet O
count O
had O
fallen O
from O
171,000 O
to O
54,000 O
; O
this O
was O
thought O
to O
be O
associated O
with O
intravenous B-TREATMENT
Heparin I-TREATMENT
and O
indeed O
, O
when O
Heparin B-TREATMENT
was O
discontinued O
, O
since O
it O
had O
been O
restarted O
after O
surgery O
, O
his O
platelet O
count O
rebounded O
to O
normal O
. O

Therefore O
, O
he O
does O
have O
a B-SYMPTOM
thrombocytopenic I-SYMPTOM
reaction I-SYMPTOM
to O
Heparin B-TREATMENT
. O

He O
remained O
in O
normal O
sinus O
rhythm O
. O

He O
did O
have O
runs O
of O
nonsustained B-SYMPTOM
ventricular I-SYMPTOM
tachycardia I-SYMPTOM
, O
which O
were O
clinically O
stable O
. O

He O
had O
a B-SYMPTOM
right I-SYMPTOM
bundle I-SYMPTOM
branch I-SYMPTOM
block I-SYMPTOM
. O

He O
is O
at O
increased O
risk O
for O
future O
events O
because O
of O
his B-SYMPTOM
low I-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
ejection I-SYMPTOM
fraction I-SYMPTOM
, O
but O
he O
is O
clinically O
stable O
on O
ACE B-TREATMENT
inhibitors I-TREATMENT
, O
Digoxin B-TREATMENT
, O
Coumadin B-TREATMENT
, O
and O
aspirin B-TREATMENT
. O

Therefore O
he O
was O
able O
to O
be O
discharged O
home O
. O

He O
understands O
that O
he O
does O
have O
significant B-SYMPTOM
left I-SYMPTOM
ventricle I-SYMPTOM
dysfunction I-SYMPTOM
and O
requires O
monitoring O
of O
his O
prothrombin O
times O
and O
his O
arrhythmias O
; O
these O
will O
be O
done O
in O
Grovea O
Co O
Terburgperv O
Portnew O
. O

ACHASTHA O
N. O
DAIZSMAELLILLE O
, O
M.D. O

TR O
: O

ssx O
/ O
bmot O

DD O
: O

08-09-93 O

TD O
: O

08/10/93 O

CC O
: O

Dr. O
Thorebreutz O
, O
E O
2 O

210974938 O

FIH O

4139381 O

98764/u6tl O

722206 O

5/30/1993 O
12:00:00 O
AM O

INTRAVENOUS B-TREATMENT
CHEMOTHERAPY I-TREATMENT
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

5-30-93 O

DISCHARGE O
DATE O
: O

6-2-93 O

PRINCIPAL O
DIAGNOSIS O
: O

INTRAVENOUS B-TREATMENT
CHEMOTHERAPY I-TREATMENT
. O

ASSOCIATED O
DIAGNOSIS O
: O

LEFT B-SYMPTOM
UPPER I-SYMPTOM
LOBE I-SYMPTOM
LARGE I-SYMPTOM
CELL I-SYMPTOM
CARCINOMA I-SYMPTOM
OF I-SYMPTOM
THE I-SYMPTOM
LUNG I-SYMPTOM
. O

ADVERSE O
DRUG O
REACTIONS O
: O

None O
. O

CLINICAL O
INFECTIONS O
: O

None O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

Intravenous B-TREATMENT
chemotherapy I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
63 O
year O
old O
woman O
with O
a O
history O
of O
mixed B-SYMPTOM
adenocarcinoma I-SYMPTOM
and O
large B-SYMPTOM
cell I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
lobe I-SYMPTOM
of O
the O
lung O
who O
is O
being O
admitted O
for O
Neoadjuvant B-TREATMENT
chemotherapy I-TREATMENT
with O
Cisplatinum B-TREATMENT
, O
5-FU B-TREATMENT
and O
Velban B-TREATMENT
. O

Her O
history O
has O
been O
well O
documented O
in O
her O
previous O
notes O
. O

Briefly O
, O
she O
was O
originally O
diagnosed O
in O
April O
1993 O
with O
lung B-SYMPTOM
carcinoma I-SYMPTOM
. O

Bronchoscopy O
and O
mediastinoscopy O
revealed O
an B-SYMPTOM
unresectable I-SYMPTOM
mediastinal I-SYMPTOM
tumor I-SYMPTOM
with O
the O
left O
tracheobronchial O
angle O
node O
positive O
for O
cancer B-SYMPTOM
, O
and O
the O
right O
paratracheal O
node O
positive O
for O
anthracosis B-SYMPTOM
. O

Formal O
pathology O
revealed O
a B-SYMPTOM
poorly I-SYMPTOM
differentiated I-SYMPTOM
adenocarcinoma I-SYMPTOM
with O
focal B-SYMPTOM
giant I-SYMPTOM
cells I-SYMPTOM
. O

Bone O
scan O
, O
head O
CT O
and O
other O
staging O
studies O
were O
all O
negative O
for O
evidence O
of O
metastatic B-SYMPTOM
disease I-SYMPTOM
. O

The O
patient O
is O
being O
treated O
with O
preoperative B-TREATMENT
neoadjuvant I-TREATMENT
chemotherapy I-TREATMENT
using I-TREATMENT
5 I-TREATMENT
FU I-TREATMENT
, O
Vinblastine B-TREATMENT
, O
Cisplatinum B-TREATMENT
and O
concomitant B-TREATMENT
radiation I-TREATMENT
therapy I-TREATMENT
. O

She O
is O
now O
admitted O
for O
her B-TREATMENT
second I-TREATMENT
course I-TREATMENT
of I-TREATMENT
that I-TREATMENT
therapy I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

temperature O
98.9 O
, O
pulse O
82 O
, O
respirations O
20 O
. O

HEENT O
: O

pupils O
equal O
, O
round O
, O
reactive O
to O
light O
and O
accommodation O
, O
extra O
ocular O
movements O
were O
intact O
. O

Sclera O
were O
anicteric B-SYMPTOM
. O

The O
oropharynx O
was O
clear O
. O

The O
neck O
was O
supple O
without O
JVD B-SYMPTOM
. O

The O
lungs O
showed O
decreased B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
base I-SYMPTOM
, O
otherwise O
were O
clear O
. O

The O
cardiac O
exam O
showed O
a O
regular O
rate O
and O
rhythm O
with O
a B-SYMPTOM
I I-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
. O

Abdomen O
was O
soft O
and O
nontender B-SYMPTOM
, O
without O
masses B-SYMPTOM
or O
hepatosplenomegaly B-SYMPTOM
. O

Rectal O
exam O
was O
guaiac O
negative O
. O

Extremities O
were O
without O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
or O
edema B-SYMPTOM
. O

Neurologic O
exam O
revealed O
a B-SYMPTOM
resting I-SYMPTOM
tremor I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
arm I-SYMPTOM
and I-SYMPTOM
hand I-SYMPTOM
. O

LABORATORY O
DATA O
: O

white O
blood O
count O
6.2 O
, O
hemoglobin O
12.4 O
, O
hematocrit O
36.1 O
, O
platelet O
count O
265,000 O
. O

The O
liver O
function O
tests O
were O
within O
normal O
limits O
. O

BUN O
8 O
, O
creatinine O
0.9 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Oncology O
Service O
on O
Founder O
&apos;s O
7 O
and O
received O
intravenous B-TREATMENT
chemotherapy I-TREATMENT
with O
a B-TREATMENT
72 I-TREATMENT
hour I-TREATMENT
continuous I-TREATMENT
infusion I-TREATMENT
of I-TREATMENT
5-FU I-TREATMENT
, O
Vinblastine B-TREATMENT
on O
day O
1 O
and O
day O
3 O
, O
and O
Cisplatinum B-TREATMENT
on O
day O
1 O
. O

She O
tolerated O
the B-TREATMENT
chemotherapy I-TREATMENT
well O
with O
mild B-SYMPTOM
nausea I-SYMPTOM
and O
vomiting B-SYMPTOM
. O

She O
had O
mild B-SYMPTOM
increase I-SYMPTOM
in O
her B-SYMPTOM
hypertension I-SYMPTOM
during O
the O
hospitalization O
, O
likely O
secondary O
to O
fluid B-SYMPTOM
overload I-SYMPTOM
. O

She O
also O
had O
some B-SYMPTOM
modest I-SYMPTOM
anemia I-SYMPTOM
, O
at O
the O
time O
of O
discharge O
her O
hematocrit O
was O
30.9 O
. O

Overall O
there O
were O
no O
unanticipated B-SYMPTOM
side I-SYMPTOM
effects I-SYMPTOM
of O
this B-TREATMENT
chemotherapy I-TREATMENT
. O

Following O
her O
recovery O
from O
chemotherapy B-TREATMENT
, O
she O
will O
proceed O
to O
surgical B-TREATMENT
resection I-TREATMENT
. O

DISCHARGE O
DIAGNOSIS O
: O

Intravenous B-TREATMENT
chemotherapy I-TREATMENT
for O
lung B-SYMPTOM
cancer I-SYMPTOM
. O

DOCTORS O
DISCHARGE O
ORDERS O
: O

Slo-Mag B-TREATMENT
one O
tab O
p.o. O
b.i.d. O
Stelazine B-TREATMENT
2 O
mg. O
p.o. O
q.d. O
Ativan B-TREATMENT
1 O
mg O
p.o. O
or O
s.l. O
q. O
4-6 O
hr. O
p.r.n. O
nausea B-SYMPTOM
. O

WORK O
DISABILITY O
AND O
PROBABLE O
DURATION O
, O
COMPLETE O
. O

Followup O
will O
be O
with O
Dr. O
Guabenfranda O
Day O
in O
his O
office O
. O

CA O
SHUFF O
, O
M.D. O

TR O
: O

ds O
/ O
bmot O

DD O
: O

6-2 O
93 O

TD O
: O

06/04/93 O

CC O
: O

GUABENFRANDA O
DAY O
, O
M.D. O

305265793_g O

FIH O

2833679 O

74738/2av5 O

543247 O

09/21/1992 O
12:00:00 O
AM O

STAGE B-SYMPTOM
3C I-SYMPTOM
PAPILLARY I-SYMPTOM
SEROUS I-SYMPTOM
CARCINOMA I-SYMPTOM
OF I-SYMPTOM
THE I-SYMPTOM
OVARY I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

09/21/92 O

DISCHARGE O
DATE O
: O

09/24/92 O

PRINCIPAL O
DIAGNOSIS O
: O

Stage B-SYMPTOM
3C I-SYMPTOM
papillary I-SYMPTOM
serous I-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
ovary I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Patient O
was O
admitted O
to O
the O
GYN O
Oncology O
SErvice O
in O
1980 O
by O
Dr. O
Slaineaee O
Ganz O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
seventy-one O
year O
old O
white O
female O
with O
stenotic B-SYMPTOM
area I-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
mid I-SYMPTOM
sigmoid I-SYMPTOM
, O
noticed O
on O
barium O
enema O
. O

The O
ultrasound O
showed O
ascites B-SYMPTOM
and O
question O
of O
pelvic B-SYMPTOM
mass I-SYMPTOM
. O

The O
patient O
was O
explored O
by O
General O
surgery O
, O
who O
saw O
the B-SYMPTOM
3C I-SYMPTOM
ovarian I-SYMPTOM
carcinoma I-SYMPTOM
. O

The O
patient O
also O
had O
an B-TREATMENT
omentectomy I-TREATMENT
and O
ileostomy B-TREATMENT
. O

The O
patient O
was O
admitted O
for O
one O
cycle O
of O
Cytoxan B-TREATMENT
and O
Cisplatin B-TREATMENT
, O
and O
subsequently O
underwent O
debulking B-TREATMENT
in O
June O
1992 O
, O
as O
well O
as O
a B-TREATMENT
total I-TREATMENT
abdominal I-TREATMENT
hysterectomy/ I-TREATMENT
bilateral B-TREATMENT
salpingo-oophorectomy I-TREATMENT
, O
omentectomy B-TREATMENT
, O
splenectomy B-TREATMENT
, O
rectosigmoid B-TREATMENT
resection I-TREATMENT
with O
a B-TREATMENT
take I-TREATMENT
down I-TREATMENT
of I-TREATMENT
the I-TREATMENT
ileostomy I-TREATMENT
. O

Also O
ileal B-TREATMENT
cecal I-TREATMENT
resection I-TREATMENT
, O
MDR O
showed O
that O
Cisplatin B-TREATMENT
and O
VP B-TREATMENT
16 I-TREATMENT
were O
more O
effective O
. O

The O
patient O
now O
presents O
for O
line O
1 O
, O
cycle O
4 O
to O
15 O
of O
VP B-TREATMENT
16 I-TREATMENT
and I-TREATMENT
Cisplatin I-TREATMENT
chemotherapy I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
patient O
&apos;s O
past O
medical O
history O
is O
unremarkable O
. O

PAST O
SURGICAL O
HISTORY O
: O

As O
above O
, O
including O
an B-TREATMENT
embolectomy I-TREATMENT
in O
June O
1992 O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Coumadin B-TREATMENT
2.5 O
mg. O
five O
times O
a O
week O
, O
Ativan B-TREATMENT
and O
Lomotil B-TREATMENT
prn O
. O

ADVERSE O
DRUG O
REACTIONS O
: O

no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
, O
but O
has O
shellfish B-SYMPTOM
allergy I-SYMPTOM
, O
and O
question O
of O
an B-SYMPTOM
Iodine I-SYMPTOM
allergy I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
exam O
the O
patient O
is O
a O
well O
appearing O
, O
elderly O
white O
female O
, O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

The O
blood O
pressure O
is O
120/82 O
, O
heart O
rate O
88 O
, O
weight O
125 O
pounds O
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
exam O
was O
notable O
for O
alopecia B-SYMPTOM
, O
otherwise O
unremarkable O
. O

Chest O
was O
clear O
, O
bilateral O
cardiac O
exam O
showed O
regular O
rate O
and O
rhythm O
, O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
except O
for O
mild B-SYMPTOM
left I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
tenderness I-SYMPTOM
with O
a B-SYMPTOM
well I-SYMPTOM
healed I-SYMPTOM
, I-SYMPTOM
midline I-SYMPTOM
abdominal I-SYMPTOM
scar I-SYMPTOM
. O

No O
other B-SYMPTOM
lower I-SYMPTOM
quadrant I-SYMPTOM
tenderness I-SYMPTOM
. O

Extremities O
were O
unremarkable O
. O

Neurological O
: O

exam O
was O
nonfocal O
, O
and O
there O
was O
no O
significant B-SYMPTOM
lymphadenopathy I-SYMPTOM
. O

LABORATORY O
DATA O
: O

Notable O
for O
a O
white O
blood O
cell O
of O
9.5 O
, O
ANC O
7.7 O
, O
hematocrit O
26 O
, O
platelets O
of O
248 O
, O
BUN O
and O
creatinine O
12. O
and O
1.2 O
respectively O
, O
magnesium O
1.1 O
, O
calcium O
8.7 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
hospital O
and O
received O
two O
units O
of O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
for O
her O
hematocrit O
of O
26 O
, O
and O
had O
a B-TREATMENT
magnesium I-TREATMENT
repleted O
. O

The O
patient O
received O
three O
days O
of O
chemotherapy B-TREATMENT
, O
consisting O
of O
45 O
mg. O
of O
Cisplatin B-TREATMENT
160 O
mg. O
of O
VP B-TREATMENT
16 I-TREATMENT
, O
and O
tolerated O
chemotherapy B-TREATMENT
resonably O
well O
. O

Serial O
PTs O
were O
obtained O
, O
and O
the O
patient O
was O
noted O
to O
have O
an O
initial O
PT O
of O
10.9 O
on O
admission O
, O
despite O
Coumadin B-TREATMENT
at O
home O
. O

She O
was O
given O
10 O
mg. O
on O
hospital O
day O
# O
1 O
, O
and O
5 O
mg. O
on O
hospital O
day O
2 O
, O
and O
back O
to O
2.5 O
qhs O
. O

The O
patient O
&apos;s O
pro O
time O
bumped O
to O
19.5 O
on O
hospital O
day O
# O
3 O
, O
and O
the O
patient O
was O
instructed O
to O
continue O
with O
2 O
1/2 O
mg. O
qhs O
and O
is O
to O
followup O
with O
Anticoagulation O
Clinic O
in O
one O
week O
for O
further O
pro O
time O
checks O
and O
adjustments B-TREATMENT
. O

The O
patient O
did O
develop O
some B-SYMPTOM
hypertension I-SYMPTOM
during O
infusion B-TREATMENT
of I-TREATMENT
her I-TREATMENT
VP I-TREATMENT
16 I-TREATMENT
to O
the O
170/100 O
range O
, O
which O
apparently O
happened O
during O
her B-TREATMENT
prior I-TREATMENT
chemotherapy I-TREATMENT
. O

The O
patient O
was O
instructed O
to O
followup O
with O
her O
internist O
regarding O
further O
evaluation O
of O
her B-SYMPTOM
hypertension I-SYMPTOM
, O
and O
should O
be O
assessed O
regarding O
further B-TREATMENT
management I-TREATMENT
, O
as O
an O
inpatient O
, O
or O
while O
receiving O
chemotherapy B-TREATMENT
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

The O
patient O
was O
discharged O
home O
on O
Coumadin B-TREATMENT
2.5 O
mg. O
po O
q O
d O
, O
and O
Ativan B-TREATMENT
and O
Lomotil B-TREATMENT
prn O
. O

The O
patient O
is O
to O
followup O
with O
Dr. O
Slaineaee O
Ganz O
and O
was O
discharged O
home O
in O
good O
condition O
. O

TOMEDANKELL O
FLOWAYLES O
, O
M.D. O
DICTATING O
FOR O
; O
SLAINEAEE O
GANZ O
, O
M.D. O

TR O
: O

qo O
/ O
bmot O

DD O
: O

09/24/92 O

TD O
: O

09/27/92 O

CC O
: O

487110437 O

TGCHO O

1128447 O

662727 O

10/15/1999 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Report O
Status O
: O

Signed O

DISCHARGE O
SUMMARY O
NAME O
: O

FACTOR O
, O
REBEM O

UNIT O
NUMBER O
: O

333-33-75 O

ADMISSION O
DATE O
: O

10/15/1999 O

DISCHARGE O
DATE O
: O

10/18/1999 O

PRINCIPAL O
DIAGNOSIS O
: O

Acute B-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Hypertension B-SYMPTOM
. O

Gout B-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

Stent B-TREATMENT
placement I-TREATMENT
of I-TREATMENT
the I-TREATMENT
RCA I-TREATMENT
on O
October O
15 O
, O
1999 O
. O

OTHER O
PROCEDURES O
: O

Right O
heart O
catheterization O
and O
coronary O
angiography O
on O
October O
15 O
, O
1999 O
. O

DOCTOR O
&apos; O
S O
DISCHARGE O
ORDERS O
: O

Aspirin B-TREATMENT
325 O
mg. O
qday O
. O

Plavix B-TREATMENT
75 O
mg. O
qday O
for O
four O
weeks O
. O

Atenolol B-TREATMENT
50 O
mg. O
qday O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Mr. O
Factor O
is O
a O
76 O
year O
old O
white O
male O
with O
acute B-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
who O
was O
urgently O
transferred O
by O
Dr. O
Lenni O
Factor O
for O
cardiac O
catheterization O
and O
possible O
angioplasty B-TREATMENT
. O

His O
only O
cardiac O
risk O
factor O
includes O
hypertension B-SYMPTOM
. O

The O
night O
of O
Oct O
14 O
, O
1999 O
the O
patient O
developed O
chest B-SYMPTOM
discomfort I-SYMPTOM
associated O
with O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
. O

On O
October O
15 O
, O
1999 O
at O
6 O
AM O
the O
patient O
was O
admitted O
to O
No O
Verlmerver O
Medical O
Center O
. O

An O
electrocardiogram O
showed O
acute B-SYMPTOM
inferior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

Due O
to O
unknown O
duration O
of O
the B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
the O
patient O
wastransferred O
urgently O
to O
the O
TGCHO O
for O
cardiac O
catheterization O
. O

Shortly O
after O
Aggrastat B-TREATMENT
was O
started O
, O
the O
patient O
became O
pain B-SYMPTOM
free O
. O

PAST O
MEDICAL O
HISTORY O
: O

Hypertension B-SYMPTOM
and O
gout B-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

Blood O
pressure O
115/77 O
. O

The O
heart O
rate O
64 O
. O

JVP O
6 O
cm O
. O

H20 O
. O

Carotid O
upstroke O
was O
normal O
. O

There O
was O
an B-SYMPTOM
S4 I-SYMPTOM
. O

The O
lungs O
were O
clear O
. O

Abdomen O
was O
benign O
. O

Femoral O
and O
distal O
pulses O
were O
full O
. O

There O
was O
no O
pedaledema B-SYMPTOM
. O

The O
neurological O
examination O
was O
nonfocal O
. O

The O
electrocardiogram O
normal O
sinus O
rhythm O
at O
62 O
beats O
per O
minute O
, O
small B-SYMPTOM
Qwaves I-SYMPTOM
in I-SYMPTOM
3 I-SYMPTOM
and I-SYMPTOM
F I-SYMPTOM
, O
ST B-SYMPTOM
elevation I-SYMPTOM
in I-SYMPTOM
2 I-SYMPTOM
, I-SYMPTOM
3 I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
F. I-SYMPTOM
ST B-SYMPTOM
Depression I-SYMPTOM
in I-SYMPTOM
1 I-SYMPTOM
, I-SYMPTOM
L I-SYMPTOM
and I-SYMPTOM
V2 I-SYMPTOM
and I-SYMPTOM
3 I-SYMPTOM
. O

LABORATORY O
DATA O
: O

Peak O
CPK O
1117 O
. O

Total O
cholesterol O
142 O
. O

LDL O
56 O
. O

HDL O
30 O
. O

Triglycerides O
281 O
. O

HOSPITAL O
COURSE O
AND O
TREATMENT O
: O

The O
patient O
was O
directly O
admitted O
to O
the O
cardiac O
catheterization O
laboratory O
. O

Coronary O
angiography O
, O
right O
heart O
catheterization O
and O
percutaneous B-TREATMENT
intervention I-TREATMENT
of I-TREATMENT
the I-TREATMENT
RCA I-TREATMENT
were O
performed O
from O
the O
right O
groin O
without O
complications B-SYMPTOM
. O

The O
proximal O
RCA O
was O
totally B-SYMPTOM
occluded I-SYMPTOM
with O
good O
left O
to O
right O
collaterals O
. O

The O
LAD O
showed O
a B-SYMPTOM
40% I-SYMPTOM
stenosis I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
proximal I-SYMPTOM
segment I-SYMPTOM
. O

The O
circumflex O
showed O
mild B-SYMPTOM
atherosclerotic I-SYMPTOM
. O

The B-SYMPTOM
RCA I-SYMPTOM
occlusion I-SYMPTOM
was O
successfully O
dilated O
and O
sent O
using O
a B-TREATMENT
3.0 I-TREATMENT
X I-TREATMENT
23 I-TREATMENT
mm I-TREATMENT
Duet I-TREATMENT
with O
post B-TREATMENT
stent I-TREATMENT
dilatation I-TREATMENT
up O
to O
16 O
atmospheres O
. O

Following O
intervention B-TREATMENT
right O
heart O
catheterization O
was O
performed O
to O
rule O
out O
RV B-SYMPTOM
infarct I-SYMPTOM
. O

The O
RA O
was O
5 O
. O

PA O
was O
19/7 O
with O
a O
mean O
of O
13 O
. O

PCW O
was O
11 O
. O

Of O
note O
there O
was O
a B-SYMPTOM
clear I-SYMPTOM
A I-SYMPTOM
wave I-SYMPTOM
in O
the O
RV O
tracing O
, O
suggestive O
of O
RV B-SYMPTOM
infarct I-SYMPTOM
. O

The O
next O
day O
the O
patient O
was O
quite B-SYMPTOM
confused I-SYMPTOM
and O
disoriented B-SYMPTOM
, O
which O
gradually O
disappeared O
. O

An O
echocardiogram O
was O
performed O
to O
evaluate O
the O
LV O
function O
, O
which O
showed O
an O
ejection O
fraction O
of O
53% O
with O
inferoposteriorakinesis B-SYMPTOM
/ O
hypokinesis B-SYMPTOM
. O

The O
next O
day O
the O
patient O
&apos;s O
mental O
status O
came O
back O
to O
baseline O
and O
he O
remained O
free O
of O
angina B-SYMPTOM
. O

ASHEE O
SHOULTSNER O
, O
M.D. O

Electronically O
Signed O
ASHEE O
SHOULTSNER O
, O
M.D. O

11/07/1999 O
11:06 O

TR O
: O

ghu O

DD O
: O

10/18/1999 O

TD O
: O

10/18/1999 O
10:59 O

Acc O
: O

ASHEE O
SHOULTSNER O
, O
M.D. O
Dr. O
Lenni O
Factor O
No O
Verlmerver O
Medical O
Center O
Dr. O
Tomedankell O
Flowayles O
No O
Verlmerver O
Medical O
Center O
STAT O

Admission O
Date O
: O

2014-04-21 O

Discharge O
Date O
: O

2014-04-24 O

Date O
of O
Birth O
: O

1960-10-27 O

Sex O
: O

M O

Service O
: O

CARDIOTHORACIC O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to I-SYMPTOM
Drugs I-SYMPTOM

Attending O
: O

Mary O
X O
Baxter O
, O
M.D. O

Chief O
Complaint O
: O

TIA/Palpitations B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

2014-04-21 O
- O
PFO B-TREATMENT
closure I-TREATMENT
via O
Right B-TREATMENT
mini I-TREATMENT
thoracotomy I-TREATMENT

History O
of O
Present O
Illness O
: O

This O
53-year-old O
with O
a O
history O
of O
multiple B-SYMPTOM
transient I-SYMPTOM
ischemic I-SYMPTOM
attacks I-SYMPTOM
in O
the O
past O
was O
investigated O
and O
was O
found O
to O
have O
a B-SYMPTOM
small I-SYMPTOM
patent I-SYMPTOM
foramen I-SYMPTOM
ovale I-SYMPTOM
, O
and O
he O
was O
electively O
admitted O
for O
closure B-TREATMENT
of O
the O
same O
. O

His O
preoperative O
investigations O
with O
coronary O
angiogram O
showed O
normal O
coronary O
arteries O
. O

His O
left O
ventricular O
function O
was O
well O
preserved O
. O

He O
had O
no O
valvular B-SYMPTOM
disease I-SYMPTOM
. O

Past O
Medical O
History O
: O

Right B-SYMPTOM
Upper I-SYMPTOM
lobe I-SYMPTOM
nodule I-SYMPTOM

TIA B-SYMPTOM
's I-SYMPTOM

Childhood B-SYMPTOM
skull I-SYMPTOM
fracture I-SYMPTOM

PFO B-SYMPTOM

Social O
History O
: O

Lives O
with O
wife O
. O

1 O
ETO O
drink O
daily O
. O

Quit O
smoking O
30 O
years O
ago O
after O
smoking O
1ppd O
. O

Retired O
. O

Family O
History O
: O

Brother O
with O
MI B-SYMPTOM
at O
age O
35 O

Father O
with O
MI/CABG B-SYMPTOM
died O
at O
age O
60 O
. O

Physical O
Exam O
: O

Vitals O
: O

BP O
144/90 O
, O
HR O
64 O
, O
RR O
14 O

General O
: O

well O
developed O
male O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM

HEENT O
: O

oropharynx O
benign O
, O
poor B-SYMPTOM
dental I-SYMPTOM
health I-SYMPTOM

Neck O
: O

supple O
, O
no O
JVD B-SYMPTOM

Heart O
: O

regular O
rate O
, O
normal O
s1s2 O
, O
no O
murmur B-SYMPTOM

Lungs O
: O

clear O
bilaterally O

Abdomen O
: O

soft O
, O
nontender B-SYMPTOM
, O
normoactive O
bowel O
sounds O

Ext O
: O

warm O
, O
no O
edema B-SYMPTOM
, O
no O
varicosities B-SYMPTOM

Pulses O
: O

2+ O
distally O

Neuro O
: O

nonfocal O

Pertinent O
Results: O

2014-04-24 O
07:30AM O
BLOOD O

Hct O
- O
25.9* O

2014-04-23 O
07:05AM O
BLOOD O

WBC O
- O
5.9 O
RBC O
- O
2.72* O
Hgb O
- O
8.6* O
Hct O
- O
25.2* O

MCV O
- O
93 O
MCH O
- O
31.5 O
MCHC O
- O
34.0 O
RDW O
- O
13.0 O
Plt O
Ct O
- O
150 O

2014-04-23 O
07:05AM O
BLOOD O

Plt O
Ct O
- O
150 O

2014-04-24 O
07:30AM O
BLOOD O

UreaN O
- O
11 O
Creat O
- O
0.8 O
K O
- O
4.4 O

2014-04-21 O
ECHO O

No O
spontaneous B-SYMPTOM
echo I-SYMPTOM
contrast I-SYMPTOM
is O
seen O
in O
the O
body O
of O
the O
left O
atrium O
. O

No O
mass/thrombus B-SYMPTOM
is O
seen O
in O
the O
left O
atrium O
or O
left O
atrial O
appendage O
. O

No O
spontaneous B-SYMPTOM
echo I-SYMPTOM
contrast I-SYMPTOM
is O
seen O
in O
the O
body O
of O
the O
right O
atrium O
. O

A B-SYMPTOM
patent I-SYMPTOM
foramen I-SYMPTOM
ovale/secundum I-SYMPTOM
ASD I-SYMPTOM
is O
present O
. O

A B-SYMPTOM
left-to-right I-SYMPTOM
shunt I-SYMPTOM
across I-SYMPTOM
the I-SYMPTOM
interatrial I-SYMPTOM
septum I-SYMPTOM
is O
seen O
at O
rest O
. O

A B-SYMPTOM
right-to-left I-SYMPTOM
shunt I-SYMPTOM
across I-SYMPTOM
the I-SYMPTOM
interatrial I-SYMPTOM
septum I-SYMPTOM
is O
seen O
at O
rest O
with O
injection O
of O
agitated O
saline O
contrast O
. O

The O
inferior O
vena O
cava O
is O
dilated B-SYMPTOM
( O
>2.5 O
cm O
) O
. O

Left O
ventricular O
wall O
thickness O
, O
cavity O
size O
, O
and O
systolic O
function O
are O
normal O
( O
LVEF O
>55% O
) O
. O

Left O
ventricular O
wall O
thicknesses O
are O
normal O
. O

Regional O
left O
ventricular O
wall O
motion O
is O
normal O
. O

Overall O
left O
ventricular O
systolic O
function O
is O
normal O
( O
LVEF>55% O
) O
. O

Right O
ventricular O
chamber O
size O
and O
free O
wall O
motion O
are O
normal O
. O

The O
ascending O
, O
transverse O
and O
descending O
thoracic O
aorta O
are O
normal O
in O
diameter O
and O
free O
of O
atherosclerotic B-SYMPTOM
plaque I-SYMPTOM
. O

The O
aortic O
valve O
leaflets O
( O
3 O
) O
appear O
structurally O
normal O
with O
good O
leaflet O
excursion O
and O
no O
aortic B-SYMPTOM
regurgitation I-SYMPTOM
. O

No O
aortic B-SYMPTOM
regurgitation I-SYMPTOM
is O
seen O
. O

The O
mitral O
valve O
appears O
structurally O
normal O
with O
trivial B-SYMPTOM
mitral I-SYMPTOM
regurgitation I-SYMPTOM
. O

The O
mitral O
valve O
leaflets O
are O
structurally O
normal O
. O

There O
is O
no O
pericardial B-SYMPTOM
effusion I-SYMPTOM
. O

POST O
BYPASS B-TREATMENT

Flow O
across O
the O
interatrial O
septum O
is O
no O
longer O
visualized O
with O
color O
flow O
doppler O
or O
with O
injection O
of O
agitatated O
saline O
at O
rest O
or O
with O
valsalva O
. O

The O
study O
is O
otherwise O
unchanged O
from O
pre-bypass O
. O

2014-04-22 O
CXR O

Previous B-SYMPTOM
right I-SYMPTOM
pneumothorax I-SYMPTOM
has O
resolved O
except O
for O
what O
is O
either O
a B-SYMPTOM
small I-SYMPTOM
fissural I-SYMPTOM
component I-SYMPTOM
or O
a B-SYMPTOM
bulla I-SYMPTOM
adjacent O
to O
the O
minor O
fissure O
. O

May O
be O
a B-SYMPTOM
small I-SYMPTOM
right I-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

Right B-TREATMENT
apical I-TREATMENT
pleural I-TREATMENT
tube I-TREATMENT
in O
place O
. O

Left O
lung O
clear O
from O
basal B-SYMPTOM
atelectasis I-SYMPTOM
. O

Paratracheal B-SYMPTOM
mediastinal I-SYMPTOM
hematoma I-SYMPTOM
is O
resolving O
. O

Heart O
size O
is O
normal O
. O

Tip O
of O
the O
left O
internal O
jugular O
line O
projects O
over O
the O
SVC O
. O

Brief O
Hospital O
Course O
: O

Mr. O
Freeman O
was O
admitted O
to O
the O
Nantucket O
Cottage O
Hospital O
on O
2014-04-21 O
for O
surgical B-TREATMENT
management I-TREATMENT
of O
his B-SYMPTOM
PFO I-SYMPTOM
. O

He O
was O
taken O
to O
the O
operating O
room O
where O
he O
underwent O
a B-TREATMENT
mini-thoracotomy I-TREATMENT
with O
closure B-TREATMENT
of O
his B-SYMPTOM
patent I-SYMPTOM
foramen I-SYMPTOM
ovale I-SYMPTOM
( I-SYMPTOM
PFO I-SYMPTOM
) I-SYMPTOM
. O

Postoperatively O
he O
was O
taken O
to O
the O
cardiac O
surgical O
intensive O
care O
unit O
for O
monitoring O
. O

Within O
a O
few O
hours O
, O
he O
woke O
neurologically O
intact O
and O
was O
extubated B-TREATMENT
. O

Aspirin B-TREATMENT
was O
resumed. O
On O
postoperative O
day O
one O
, O
he O
was O
transferred O
to O
the O
cardiac O
surgical O
step O
down O
unit O
. O

He O
was O
gently O
diuresed O
towards O
his O
preoperative O
weight O
. O

The O
physical O
therapy O
service O
was O
consulted O
for O
assistance O
with O
his O
postoperative O
strength O
and O
mobility O
. O

Iron B-TREATMENT
and O
vitamin B-TREATMENT
C I-TREATMENT
were O
started O
for O
postoperative B-SYMPTOM
anemia I-SYMPTOM
. O

Mr. O
Freeman O
maintained O
stable O
hemodynamics O
with O
a O
normal O
sinus O
rhythm O
throughout O
his O
postoperative O
course O
. O

He O
continued O
to O
make O
steady O
progress O
and O
was O
discharged O
home O
on O
postoperative O
day O
three O
. O

He O
will O
follow-up O
with O
Dr. O
de O
la O
Cisneros O
, O
Dr. O
Belt O
, O
his O
cardiologist O
and O
his O
primary O
care O
physician O
as O
an O
outpatient O
. O

Medications O
on O
Admission O
: O

Plavix B-TREATMENT
75mg O
daily O
aspirin B-TREATMENT
81mg O
daily O

Discharge O
Medications O
: O

1. O
Potassium B-TREATMENT
Chloride I-TREATMENT
10 O
mEq O
Capsule O
, O
Sustained O
Release O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
, O
Sustained O
Release O
PO O
Q12H O
( O
every O
12 O
hours O
) O
for O
5 O
days O
. O

Disp O
: O
*10 O
Capsule O
, O
Sustained O
Release( O
s O
)* O

Refills O
: O
*0* O

2. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Disp O
: O
*60 O
Capsule( O
s O
)* O

Refills O
: O
*0* O

3. O
Aspirin B-TREATMENT
81 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
DAILY O
( O
Daily O
) O
. O

Disp O
: O
*30 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)( O
s O
)* O

Refills O
: O
*2* O

4. O
Oxycodone-Acetaminophen B-TREATMENT
5-325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
every O
4-6 O
hours O
as O
needed O
for O
pain B-SYMPTOM
. O

Disp O
: O
*50 O
Tablet( O
s O
)* O

Refills O
: O
*0* O

5. O
Ferrous B-TREATMENT
Sulfate I-TREATMENT
325 O
( O
65 O
) O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
: O
Take O
for O
one O
month O
then O
stop O
. O

Disp O
: O
*30 O
Tablet( O
s O
)* O

Refills O
: O
*0* O

6. O
Camphor-Menthol B-TREATMENT
0.5-0.5 O
% O
Lotion O
Sig O
: O
One O
( O
1 O
) O
Appl O
Topical O
TID O
( O
3 O
times O
a O
day O
) O
as O
needed O
. O

Disp O
: O
*qs O
qs* O

Refills O
: O
*0* O

7. O
Ascorbic B-TREATMENT
Acid I-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
: O
Take O
for O
one O
month O
then O
stop O
. O

Disp O
: O
*60 O
Tablet( O
s O
)* O

Refills O
: O
*0* O

8. O
Furosemide B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
for O
5 O
days O
. O

Disp O
: O
*10 O
Tablet( O
s O
)* O

Refills O
: O
*0* O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

PFO B-SYMPTOM

TIA B-SYMPTOM
lung I-SYMPTOM
nodule I-SYMPTOM
( O
followed O
by O
Dr. O
Belt O
) O
s/p O
fissurectomy/skull B-SYMPTOM
Fx I-SYMPTOM

Discharge O
Condition O
: O

Good O

Discharge O
Instructions O
: O

1) O
Shower O
, O
wash O
incisions B-SYMPTOM
with O
mild O
soap O
and O
water O
and O
pat O
dry O
. O

No O
lotions B-TREATMENT
, O
creams B-TREATMENT
or O
powders B-TREATMENT
to O
incisions B-SYMPTOM
. O

2) O
Call O
with O
fever B-SYMPTOM
>101 I-SYMPTOM
, O
redness B-SYMPTOM
or O
drainage B-SYMPTOM
from I-SYMPTOM
incision I-SYMPTOM
, O
or O
weight B-SYMPTOM
gain I-SYMPTOM
more I-SYMPTOM
than I-SYMPTOM
2 I-SYMPTOM
pounds I-SYMPTOM
in O
one O
day O
or O
five O
pounds O
in O
one O
week O
. O

3) O
No O
driving O
while O
on O
narcotics B-TREATMENT
. O

4) O
Take O
lasix B-TREATMENT
twice O
daily O
with O
potassium B-TREATMENT
for O
five O
days O
then O
stop O
. O

5) O
Take O
Vitamin B-TREATMENT
C I-TREATMENT
with O
iron B-TREATMENT
for O
one O
month O
then O
stop O
. O

6) O
Call O
with O
any O
questions O
or O
concerns O
. O

Followup O
Instructions: O

Follow O
up O
with O
Dr. O
Heird O
in O
four O
weeks O
, O
671 O
745 O
2553 O

Follow O
up O
with O
Dr. O
Knowlton O
in O
1-2 O
weeks O
, O
(246) O
828-4417 O

Follow O
up O
with O
Dr. O
Eckman O
in O
2-3 O
weeks O
, O
(506) O
946-4576 O

Call O
all O
providers O
for O
appointments O
. O

CAT O
SCAN O
Phone O
: O

(476) O
713 O
6117 O

Date/Time O
: O
2014-10-16 O
9:15 O

Edna O
Arnold O
, O
MD O

Phone O
: O
(300) O
922-6590 O

Date/Time O
: O
2014-10-16 O
2:30 O

Melonson O
de O
la O
Donnelly O
MD O
08-301 O

Completed O
by O
: O

Jeremy O
N. O
P. O
Moschella O
PA O
80-BYE O
2014-04-24 O
@ O
1103 O

Signed O
electronically O
by O
: O

DR. O
Dorothy O
au O
Pratt O
on O
: O

FRI O
2014-06-06 O
10:27 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2010-03-11 O

Discharge O
Date O
: O

2010-03-28 O

Date O
of O
Birth O
: O

1946-10-26 O

Sex O
: O

M O

Service: O

ADMISSION O
DIAGNOSIS: O

1. O
Unstable B-SYMPTOM
angina I-SYMPTOM
. O

2. O
Non-ST B-SYMPTOM
elevation I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

3. O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Persistent B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
. O

2. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

3. O
Coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
times O
two O
. O

HISTORY O
OF O
THE O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
63 O
- O
year-old O
man O
with O
a O
history O
of O
hypertension B-SYMPTOM
and O
prior O
history O
of O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
secondary O
to O
hyperthyroidism B-SYMPTOM
who O
presented O
to O
an O
outside O
hospital O
with O
a O
history O
of O
left-sided B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
at O
rest O
. O

The O
patient O
awoke O
with O
chest B-SYMPTOM
pressure I-SYMPTOM
radiating O
to O
the O
right O
chest O
associated O
with O
diaphoresis B-SYMPTOM
. O

The O
patient O
was O
found O
to O
have O
a O
blood O
pressure O
of O
170/108 O
with O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
and O
rapid B-SYMPTOM
ventricular I-SYMPTOM
response I-SYMPTOM
to O
a O
heart O
rate O
of O
140s O
. O

The O
patient O
was O
rate O
controlled O
and O
transferred O
to O
the O
Stillman O
Infirmary O
for O
emergent O
cardiac O
catheterization O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Atrial B-SYMPTOM
fibrillation I-SYMPTOM
secondary O
to O
hyperthyroidism B-SYMPTOM
, O
initially O
diagnosed O
in O
2005 O
. O

2. O
Status O
post O
current O
cardioversion B-TREATMENT
times O
four O
. O

3. O
Hyperthyroidism B-SYMPTOM
, O
status O
post O
radioactive B-TREATMENT
iodine I-TREATMENT
ablation I-TREATMENT
. O

4. O
Status O
post O
carpal B-TREATMENT
tunnel I-TREATMENT
release I-TREATMENT
. O

5. O
Status O
post O
umbilical B-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT
. O

6. O
Hypertension B-SYMPTOM
. O

MEDICATIONS O
AT O
HOME O
: O

1. O
Accupril B-TREATMENT
40 O
mg O
q.d. O

2. O
Aspirin B-TREATMENT
325 O
mg O
q.d. O

3. O
Clonidine B-TREATMENT
0.1 O
mg O
b.i.d. O

PHYSICAL O
EXAMINATION O
ON O
ADMISSION O
: O

General O
: O

The O
patient O
was O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
, O
well O
developed O
. O

Vital O
signs O
: O

Stable O
, O
afebrile B-SYMPTOM
. O

HEENT O
: O

Normocephalic O
, O
atraumatic B-SYMPTOM
. O

PERRL O
, O
anicteric B-SYMPTOM
, O
EOMI O
. O

The O
throat O
was O
clear O
. O

Neck O
: O

Supple O
, O
midline O
, O
without O
masses B-SYMPTOM
or O
lymphadenopathy B-SYMPTOM
. O

No O
bruit B-SYMPTOM
or O
JVD B-SYMPTOM
. O

Cardiovascular O
: O

Irregularly B-SYMPTOM
/ I-SYMPTOM
irregular I-SYMPTOM
without O
murmurs B-SYMPTOM
, O
rubs B-SYMPTOM
, O
or O
gallops B-SYMPTOM
. O

Chest O
: O

Clear O
to O
auscultation O
bilaterally O
. O

Abdomen O
: O

Soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
without O
masses B-SYMPTOM
or O
organomegaly B-SYMPTOM
. O

Extremities O
: O

Warm O
, O
noncyanotic B-SYMPTOM
, O
nonedematous B-SYMPTOM
times O
four O
. O

Neurological O
: O

Grossly O
intact O
. O

ADMISSION O
LABORATORY O
DATA O
: O

CBC O
11.3 O
/ O
15.7 O
/ O
44.6 O
/ O
183 O
. O

PT O
14 O
, O
INR O
1.3 O
, O
PTT O
115 O
. O

Chemistries O
: O

137 O
/ O
4.3 O
/ O
104 O
/ O
22 O
/ O
14 O
/ O
0.7 O
/ O
155 O
. O

ALT O
27 O
, O
AST O
21 O
, O
alkaline O
phosphatase O
72 O
, O
total O
bilirubin O
1.2 O
, O
amylase O
47 O
. O

The O
U/A O
was O
negative O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
transferred O
for O
cardiac O
catheterization O
. O

Emergent O
cardiac O
catheterization O
revealed O
an O
ejection O
fraction O
of O
45% O
, O
right B-SYMPTOM
dominant I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
system I-SYMPTOM
with O
occlusive B-SYMPTOM
single I-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
LAD I-SYMPTOM
. O

Multiple B-TREATMENT
wires I-TREATMENT
were O
used O
to O
attempt O
to O
cross O
the B-SYMPTOM
total I-SYMPTOM
occlusion I-SYMPTOM
, O
but O
were O
ultimately O
unsuccessful O
. O

The O
patient O
was O
continued O
on O
a B-TREATMENT
heparin I-TREATMENT
drip I-TREATMENT
for O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

Cardiothoracic O
Surgery O
consultation O
was O
obtained O
and O
the O
patient O
was O
taken O
to O
the O
Operating O
Room O
on O
2010-03-12 O
for O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
times O
two O
; O
LIMA O
to O
the O
LAD O
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
the I-TREATMENT
diagonal I-TREATMENT
artery I-TREATMENT
. O

Subsequent O
to O
this O
, O
the O
patient O
was O
transferred O
to O
the O
CRSU O
for O
closer O
monitoring O
. O

He O
was O
deemed O
to O
be O
too B-SYMPTOM
lethargic I-SYMPTOM
and O
sleepy B-SYMPTOM
to O
be O
extubated O
on O
postoperative O
day O
number O
zero O
. O

The O
patient O
was O
extubated O
early O
on O
postoperative O
day O
number O
one O
without O
significant B-SYMPTOM
complication I-SYMPTOM
. O

He O
remained O
in O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

The O
EP O
Service O
was O
consulted O
regarding O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
. O

This O
was O
his B-SYMPTOM
main I-SYMPTOM
issue I-SYMPTOM
in O
the O
postoperative O
course O
. O

He O
was O
attempted O
on O
multiple B-TREATMENT
different I-TREATMENT
drugs I-TREATMENT
including O
Procainamide B-TREATMENT
, O
Diltiazem B-TREATMENT
, O
Esmolol B-TREATMENT
, O
Sotalol B-TREATMENT
, O
Amiodarone B-TREATMENT
. O

The O
patient O
was O
kept O
therapeutically B-TREATMENT
anticoagulated I-TREATMENT
throughout O
this O
period O
. O

The O
patient O
was O
also O
started O
on O
digoxin B-TREATMENT
. O

Ultimately O
, O
the O
patient O
was O
transferred O
to O
the O
floor O
and O
anticoagulation B-TREATMENT
with O
Coumadin B-TREATMENT
was O
begun O
. O

The O
patient O
arrived O
on O
the O
floor O
with O
medications B-TREATMENT
as O
follows O
: O

Sotalol B-TREATMENT
180 O
mg O
b.i.d. O
, O
Diltiazem B-TREATMENT
90 O
mg O
q.i.d. O
, O
digoxin B-TREATMENT
0.125 O
mg O
q.d. O

While O
the O
patient O
was O
awaiting O
therapeutic B-TREATMENT
anticoagulation I-TREATMENT
with O
Coumadin B-TREATMENT
, O
he O
spontaneously O
converted O
into O
normal O
sinus O
rhythm O
. O

The O
patient O
was O
found O
to O
have O
a O
resting O
heart O
rate O
of O
approximately O
50 O
subsequent O
to O
this O
. O

In O
consultation O
with O
the O
EP O
Service O
, O
Diltiazem B-TREATMENT
was O
stopped O
. O

After O
approximately O
24 O
hours O
, O
the O
patient O
converted O
back O
into O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
and O
Diltiazem B-TREATMENT
was O
restarted O
at O
60 O
mg O
q.i.d. O

The O
patient O
then O
had O
one B-SYMPTOM
more I-SYMPTOM
episode I-SYMPTOM
where O
he O
was O
converted O
to O
normal O
sinus O
rhythm O
but O
this O
lasted O
only O
a O
few O
hours O
before O
reverting O
back O
to O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
. O

The O
patient O
was O
ultimately O
discharged O
on O
postoperative O
day O
number O
16 O
, O
tolerating O
a O
regular O
diet O
, O
and O
adequate O
pain O
control O
on O
p.o. B-TREATMENT
pain I-TREATMENT
medications I-TREATMENT
, O
having O
no O
anginal B-SYMPTOM
symptoms I-SYMPTOM
and O
with O
an O
INR O
of O
2.0 O
. O

The O
patient O
failed O
multiple O
attempts O
at O
cardioversion B-TREATMENT
. O

DISCHARGE O
CONDITION O
: O

Stable O
. O

INR O
2.0. O

DISPOSITION O
: O

To O
home O
. O

DIET O
: O

Cardiac O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Percocet B-TREATMENT
5/325 O
mg O
one O
to O
two O
q. O
four O
hours O
p.r.n. O

2. O
Aspirin B-TREATMENT
325 O
mg O
q.d. O

3. O
Colace B-TREATMENT
100 O
mg O
b.i.d. O

4. O
Coumadin B-TREATMENT
5 O
mg O
q.d. O

5. O
Sotalol B-TREATMENT
180 O
mg O
b.i.d. O

6. O
Digoxin B-TREATMENT
0.125 O
mg O
q.d. O

7. O
Diltiazem B-TREATMENT
60 O
mg O
q.i.d. O

8. O
Ambien B-TREATMENT
5-10 O
mg O
q.h.s. O
p.r.n. O

DISCHARGE O
INSTRUCTIONS O
: O

The O
patient O
should O
follow-up O
with O
his O
cardiologist O
in O
one O
to O
two O
weeks O
. O

He O
will O
also O
go O
home O
with O
VNA O
for O
INRs O
twice O
weekly O
with O
the O
results O
reported O
to O
his O
PCP O
or O
cardiologist O
for O
Coumadin B-TREATMENT
adjustment I-TREATMENT
. O

The O
patient O
should O
follow-up O
with O
Dr. O
Halcomb O
in O
six O
weeks O
time O
. O

Octavia O
W. O
Levitre O
, O
M.D. O
05-383 O

Dictated O
By O
: O
James O
Q. O
Mitchell O
, O
M.D. O

MEDQUIST36 O

D O
: O
2010-03-28 O
10:15 O

T O
: O
2010-03-28 O
10:46 O

JOB O
# O
: O
41466 O

Signed O
electronically O
by O
: O
DR. O
Janice O
Carpenter O
on O
: O
Andrea O
2010-04-01 O
8:20 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-07-30 O

Discharge O
Date O
: O

2014-08-04 O

Date O
of O
Birth O
: O

1930-08-11 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Penicillins B-TREATMENT

Attending O
: O
William O
Q. O
Williams O
, O
M.D. O

Chief O
Complaint O
: O

dyspnea B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

None O

History O
of O
Present O
Illness O
: O

This O
is O
an O
83 O
y/o O
female O
with O
moderate B-SYMPTOM
AS I-SYMPTOM
, O
s/p O
MVR B-TREATMENT
27 O
years O
ago O
, O
s/p O
PPM B-TREATMENT
, O
DM B-SYMPTOM
, O
CHF B-SYMPTOM
, O
p/w O
dsypnea B-SYMPTOM
and O
increased B-SYMPTOM
work I-SYMPTOM
of I-SYMPTOM
breathing I-SYMPTOM
x O
4-5 O
days O
. O

Per O
family O
, O
the O
patient O
has O
had O
worsening B-SYMPTOM
CHF/volume I-SYMPTOM
overload I-SYMPTOM
over O
the O
last O
several O
weeks O
, O
requiring O
supplemental B-TREATMENT
O2 I-TREATMENT
at O
rehab O
. O

Over O
the O
last O
few O
days O
, O
she O
has O
been O
noted O
to O
be O
more B-SYMPTOM
short I-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
and O
having O
sats O
to O
60% O
on O
RA O
. O

Her B-TREATMENT
lasix I-TREATMENT
was O
increased O
to O
60 O
mg O
bid O
. O

Beginning O
today O
, O
she O
was O
noted O
to O
be O
in O
hypoxic B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
, O
87-91% O
on O
2L/NC B-TREATMENT
. O

She O
was O
increased O
to O
5L O
, O
with O
her O
sats O
going O
up O
to O
97% O
. O

She O
was O
also O
noted O
to O
be O
more B-SYMPTOM
confused I-SYMPTOM
over O
the O
last O
few O
days O
and O
especially O
today O
. O

She O
was O
given O
lasix B-TREATMENT
and O
2 B-TREATMENT
mg I-TREATMENT
IV I-TREATMENT
morphine I-TREATMENT
at O
New O
England O
Sinai O
Hospital O
& O
Rehab O
Center O
Rehab O
, O
and O
sent O
to O
Nantucket O
Cottage O
Hospital O
for O
further O
evaluation O
. O

En O
route O
, O
she O
was O
given O
additional B-TREATMENT
lasix I-TREATMENT
of O
60 O
mg O
IV O
and O
nitro B-TREATMENT
spray I-TREATMENT
x O
2 O
. O

In O
the O
Deanna O
, O
her O
VS O
were O
Tc O
97.2 O
, O
BP O
146/25 O
, O
HR O
70 O
, O
RR O
27 O
, O
SaO2 O
95%/NRB B-TREATMENT
. O

Foley B-TREATMENT
was O
placed O
in O
Deanna O
. O

She O
was O
given O
40 O
mg O
IV B-TREATMENT
lasix I-TREATMENT
and O
325 O
mg O
ASA B-TREATMENT
. O

She O
was O
placed O
on O
BiPAP B-TREATMENT
for O
comfort O
at O
30% O
FiO2 B-TREATMENT
, O
5 O
PEEP B-TREATMENT
, O
12 O
PS B-TREATMENT
. O

Admitted O
to O
the O
CMED O
CSRU O
for O
further B-TREATMENT
management I-TREATMENT
. O

Per O
family O
, O
besides O
the B-SYMPTOM
dyspnea I-SYMPTOM
and O
SOB B-SYMPTOM
, O
the O
patient O
has O
had O
no O
other B-SYMPTOM
symptoms I-SYMPTOM
, O
including O
f/c/s B-SYMPTOM
, O
CP B-SYMPTOM
, O
palpitations B-SYMPTOM
, O
abd B-SYMPTOM
pain I-SYMPTOM
, O
n/v/diarrhea B-SYMPTOM
. O

She O
has O
had O
decreased B-SYMPTOM
appetite I-SYMPTOM
over O
the O
last O
few O
days O
in O
the O
context O
of O
increasing B-SYMPTOM
confusion I-SYMPTOM
. O

Past O
Medical O
History O
: O

1. O
Moderate B-SYMPTOM
AS I-SYMPTOM

2. O
s/p O
MVR B-TREATMENT

3. O
s/p O
PPM B-TREATMENT

4. O
A B-SYMPTOM
fib I-SYMPTOM

5. O
DM B-SYMPTOM
2 I-SYMPTOM
on O
insulin B-TREATMENT

6. O
Hypercholesterolemia B-SYMPTOM

7. O
Gout B-SYMPTOM

8. O
Depression B-SYMPTOM

9. O
? O
Pulmonary B-SYMPTOM
fibrosis I-SYMPTOM

10. O
CHF/CAD B-SYMPTOM
, O
last O
EF O
55% O
4/06 O

Social O
History O
: O

Lives O
at O
Salem O
Hospital O
- O
North O
Shore O
Medical O
Center O
Rehab O
. O

Prior O
h/o O
heavy O
tobacco O
use O
. O

Ambulates O
at O
baseline O
. O

Family O
History O
: O

Mother O
with O
h/o O
emphysema B-SYMPTOM
, O
CAD B-SYMPTOM

Physical O
Exam O
: O

General O
: O
Asleep O
, O
easily O
arousable O
. O

On O
BiPAP B-TREATMENT
, O
NAD B-SYMPTOM

HEENT O
: O
NC/AT O
, O
PERRL O
, O
EOMI O
. O

MMM O
, O
OP O
clear O

Neck O
: O
+ O
elevated B-SYMPTOM
JVD I-SYMPTOM
to O
earlobe O
, O
supple O

Chest O
: O
decreased B-SYMPTOM
BS I-SYMPTOM
at O
bases O
with O
few B-SYMPTOM
crackles I-SYMPTOM
b/l I-SYMPTOM

CV O
: O
RRR O
3/6 O
HSM B-SYMPTOM
, O
loudest O
at O
LUSB O

Abd O
: O
soft O
, O
NT/ND B-SYMPTOM
, O
NABS O

Ext O
: O
2 O
+ O
pitting B-SYMPTOM
edema I-SYMPTOM
b/l I-SYMPTOM
, O
warm O
with O
faint O
DP O

Pertinent O
Results O
: O

2014-07-30 O
01:30PM O

WBC O
- O
9.6 O
RBC O
- O
4.02 O
* O
HGB O
- O
11.4 O
* O
HCT O
- O
36.3 O
MCV O
- O
90 O
MCH O
- O
28.4 O
MCHC O
- O
31.4 O
RDW O
- O
17.8 O
* O

2014-07-30 O
01:30PM O

NEUTS O
- O
87.0 O
* O
LYMPHS O
- O
6.7 O
* O
MONOS O
- O
5.0 O
EOS O
- O
0.9 O
BASOS O
- O
0.4 O

2014-07-30 O
01:30PM O

PLT O
COUNT O
- O
161 O

2014-07-30 O
01:30PM O

PT O
- O
23.2 O
* O
INR O
( O
PT O
) O
- O
2.3 O
* O

2014-07-30 O
01:30PM O

cTropnT O
- O
0.08 O
* O

2014-07-30 O
01:30PM O

CK O
( O
CPK O
) O
- O
37 O

2014-07-30 O
01:30PM O

cTropnT O
- O
0.08 O
* O

2014-07-30 O
01:30PM O

CK-MB O
- O
NotDone O
proBNP O
- O
5313 O
* O

2014-07-30 O
01:30PM O

GLUCOSE O
- O
173 O
* O
UREA O
N O
- O
52 O
* O
CREAT O
- O
1.5 O
* O
SODIUM O
- O
145 O
POTASSIUM O
- O
4.8 O
CHLORIDE O
- O
100 O
TOTAL O
CO2 O
- O
40 O
* O
ANION O
GAP O
- O
10 O

2014-07-30 O
01:45PM O

TYPE O
- O
ART O
PO2 O
- O
249 O
* O
PCO2 O
- O
99 O
* O
PH O
- O
7.28 O
* O
TOTAL O
CO2 O
- O
49 O
* O
BASE O
XS O
- O
15 O
INTUBATED O
- O
NOT O
INTUBA O

2014-07-30 O
06:20PM O

TYPE O
- O
ART O
TEMP O
- O
37.0 O
O2-90 O
O2 B-TREATMENT
FLOW I-TREATMENT
- O
5 O
PO2 O
- O
63 O
* O
PCO2 O
- O
81 O
* O
PH O
- O
7.39 O
TOTAL O
CO2 O
- O
51 O
* O
BASE O
XS O
- O
19 O
AADO2 O
- O
513 O
REQ O
O2 O
- O
84 O

INTUBATED O
- O
NOT O
INTUBA O
COMMENTS O
- O
NASAL O
Harper O

Echo O
: O
The O
left O
atrium O
is O
mildly B-SYMPTOM
dilated I-SYMPTOM
. O

There O
is O
mild B-SYMPTOM
symmetric I-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
hypertrophy I-SYMPTOM
. O

The O
left O
ventricular O
cavity O
size O
is O
normal O
. O

Overall O
left O
ventricular O
systolic O
function O
is O
normal O
( O
LVEF O
70% O
). O

There O
is O
no O
ventricular B-SYMPTOM
septal I-SYMPTOM
defect I-SYMPTOM
. O

The O
right O
ventricular O
free O
wall O
is O
hypertrophied B-SYMPTOM
. O

The O
right O
ventricular O
cavity O
is O
dilated B-SYMPTOM
. O

Right O
ventricular O
systolic O
function O
appears O
depressed B-SYMPTOM
. O

The O
aortic O
arch O
is O
mildly B-SYMPTOM
dilated I-SYMPTOM
. O

There O
are O
focal B-SYMPTOM
calcifications I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
aortic I-SYMPTOM
arch I-SYMPTOM
. O

There O
are O
three B-SYMPTOM
aortic I-SYMPTOM
valve I-SYMPTOM
leaflets I-SYMPTOM
. O

The O
aortic O
valve O
leaflets O
are O
moderately B-SYMPTOM
thickened I-SYMPTOM
. O

There O
is O
at O
least O
moderate B-SYMPTOM
aortic I-SYMPTOM
valve I-SYMPTOM
stenosis I-SYMPTOM
. O

A B-TREATMENT
bileaflet I-TREATMENT
mitral I-TREATMENT
valve I-TREATMENT
prosthesis I-TREATMENT
is O
present O
. O

The O
gradients O
are O
higher O
than O
expected O
for O
this O
type O
of O
prosthesis B-TREATMENT
. O

The O
tricuspid O
valve O
leaflets O
are O
mildly B-SYMPTOM
thickened I-SYMPTOM
. O

There O
is O
moderate B-SYMPTOM
pulmonary I-SYMPTOM
artery I-SYMPTOM
systolic I-SYMPTOM
hypertension I-SYMPTOM
. O

The O
end-diastolic O
pulmonic O
regurgitation O
velocity O
is O
increased B-SYMPTOM
suggesting O
pulmonary B-SYMPTOM
artery I-SYMPTOM
diastolic I-SYMPTOM
hypertension I-SYMPTOM
. O

There O
is O
no O
pericardial B-SYMPTOM
effusion I-SYMPTOM
. O

Compared O
with O
the O
findings O
of O
the O
prior O
study O
( O
images O
reviewed O
) O
of O
2013-06-18 O
, O
the O
pressure O
gradient O
across O
the B-TREATMENT
mitral I-TREATMENT
valve I-TREATMENT
prosthesis I-TREATMENT
is O
increased B-SYMPTOM
. O

IMPRESSION O
: O
AP O
chest O
compared O
to O
07-30 O
through O
26 O
: O
Mild B-SYMPTOM
pulmonary I-SYMPTOM
edema I-SYMPTOM
is O
unchanged O
. O

Bilateral B-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
small O
on O
the O
right O
and O
moderate O
on O
the O
left O
is O
stable O
. O

Severe B-SYMPTOM
cardiomegaly I-SYMPTOM
and O
left B-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
atelectasis I-SYMPTOM
unchanged O
. O

No O
pneumothorax B-SYMPTOM
. O

Transvenous B-TREATMENT
right I-TREATMENT
ventricular I-TREATMENT
pacer I-TREATMENT
lead I-TREATMENT
in O
standard O
placement O
. O

ECG O
: O
Ventricular O
paced O
rhythm O
. O

Compared O
to O
the O
previous O
tracing O
of O
2014-07-30 O
no O
significant O
change O
. O

Intervals O
Axes O

Rate O
PR O
QRS O
QT/QTc O
P O
QRS O
T O
70 O
0 O
160 O
466/486.42 O
0 O
-71 O
112 O

Brief O
Hospital O
Course O
: O

A/P O
- O
83yo O
F O
with O
valvular B-SYMPTOM
disorder I-SYMPTOM
, O
AF B-SYMPTOM
, O
and O
h/o O
CAD B-SYMPTOM
a/w O
hypercarbic B-SYMPTOM
respiratory I-SYMPTOM
failure I-SYMPTOM
. O

# O
Respiratory B-SYMPTOM
failure I-SYMPTOM
- O
She O
was O
admitted O
to O
the O
CMED O
CSRU O
for O
her B-SYMPTOM
repiratory I-SYMPTOM
failure I-SYMPTOM
which O
was O
thought O
to O
be O
secondary O
to O
CHF B-SYMPTOM
. O

Pt O
was O
diuresed O
with O
iv B-TREATMENT
lasix I-TREATMENT
/ O
acetazolamide B-TREATMENT
and O
given O
iv B-TREATMENT
morphine I-TREATMENT
/ O
prn O
for O
respiratory B-SYMPTOM
distress I-SYMPTOM
and O
BIPAP B-TREATMENT
was O
tried O
. O

However O
, O
hypercarbia B-SYMPTOM
( O
04-11 O
metabolic B-SYMPTOM
alkalosis I-SYMPTOM
) O
remained O
in O
the O
90s O
. O

Pt O
was O
mentating O
okay O
, O
having O
conversations O
with O
intermittent B-SYMPTOM
somnolence I-SYMPTOM
despite O
hypercarbia B-SYMPTOM
. O

TTE O
showed O
preserved O
EF O
with O
moderate B-SYMPTOM
AS I-SYMPTOM
and O
moderate B-SYMPTOM
MS I-SYMPTOM
and O
mod B-SYMPTOM
pulm I-SYMPTOM
HTN I-SYMPTOM
. O

Cardiology O
was O
consulted O
and O
thought O
MS B-SYMPTOM
Harold O
Holcomb O
to O
her B-SYMPTOM
pulm I-SYMPTOM
edema I-SYMPTOM
and O
pulm B-SYMPTOM
HTN I-SYMPTOM
. O

Cardiology O
recommended O
d/cing O
digoxin B-TREATMENT
and O
starting O
amiodarone B-TREATMENT
. O

Family O
declined O
valvuloplasty B-TREATMENT
. O

For O
possible O
COPD B-SYMPTOM
, O
pt O
was O
started O
on O
steroids B-TREATMENT
and O
nebs B-TREATMENT
on O
08-03 O
. O

Pt O
is O
currently O
satting O
90s O
on O
1 O
L O
NC B-TREATMENT
while O
sitting O
in O
a O
chair O
but O
needs O
more B-TREATMENT
O2 I-TREATMENT
when O
supine O
. O

Pt O
is O
a O
mouth O
breather O
and O
occasionally O
needs O
a B-TREATMENT
face I-TREATMENT
mask I-TREATMENT
. O

Pt O
will O
need O
I/Os O
monitored O
to O
goal O
even O
to O
slightly O
negative O
as O
she O
was O
diursed O
4.8 O
L O
during O
her O
CMED O
stay O
. O

Depending O
on O
her O
I/O O
, O
lasix B-TREATMENT
and O
acetazolamide B-TREATMENT
can O
be O
decreased O
or O
discontinued O
. O

If O
she O
were O
to O
decompensate O
at O
the O
rehab O
, O
goals O
of O
care O
will O
need O
to O
be O
readdressed O
. O

# O
h/o O
CAD B-SYMPTOM
- O
There O
were O
new O
changes O
on O
EKG O
but O
pt O
was O
ruled O
out O
with O
3 O
sets O
of O
negative O
cardiac O
enzymes O
. O

Pt O
was O
continued O
on O
BB B-TREATMENT
, O
ASA B-TREATMENT
, O
and O
nitrates B-TREATMENT
. O

# O
Acid O
/ O
base O
status O
- O
Respiratory B-SYMPTOM
acidosis I-SYMPTOM
with O
metabolic O
compensation O
. O

Appears O
to O
be O
chronic O
in O
nature O
given O
degree O
of O
metabolic O
compensation O
with O
acute O
component O
earlier O
today O
. O

Pt O
failed O
BIPAP B-TREATMENT
and O
pCO2 O
remained O
in O
the O
90s O
but O
maintaining O
mentation O
. O

# O
Renal B-SYMPTOM
insufficiency I-SYMPTOM
- O
baseline O
Cr O
unknown O
, O
may O
have O
CRI B-SYMPTOM
from O
DM B-SYMPTOM
. O

Creatinine O
stayed O
stable O
from O
1.3-1.5 O
. O

Will O
need O
to O
renally O
dose O
all B-TREATMENT
medications I-TREATMENT
. O

# O
A B-SYMPTOM
fib I-SYMPTOM
- O
continued O
BB B-TREATMENT
. O

Per O
cardiology O
consult O
recs O
, O
discontinued O
digoxin B-TREATMENT
and O
started O
amiodarone B-TREATMENT
. O

Due O
to O
elevated B-SYMPTOM
INR I-SYMPTOM
, O
coumadin B-TREATMENT
was O
held O
. O

Pt O
is O
also O
paced O
. O

Pt O
needs O
to O
be O
on O
amiodarone B-TREATMENT
400mg O
BID O
x O
7 O
days O
( O
loading O
dose O
) O
and O
then O
400mg O
daily O
for O
maintenance O
. O

# O
DM B-SYMPTOM
- O
insulin B-TREATMENT
standing O
+ O
HISS O
, O
FS O
qid O

# O
Depression B-SYMPTOM
- O
continued B-TREATMENT
home I-TREATMENT
regimen I-TREATMENT

# O
F/E/N O
- O
NPO O
initially O
while O
on O
BIPAP B-TREATMENT
and O
now O
low B-TREATMENT
sodium I-TREATMENT
cardiac I-TREATMENT
diet I-TREATMENT
. O

# O
PPx O
- O
supratherpeutic B-SYMPTOM
INR I-SYMPTOM

# O
Access O
- O
PIV B-TREATMENT

# O
Code O
- O
DNR/DNI O
. O

No O
pressors B-TREATMENT
or O
central B-TREATMENT
line I-TREATMENT
per O
HCP O
. O

If O
she O
were O
to O
decompensate O
at O
the O
rehab O
, O
goals O
of O
care O
will O
need O
to O
be O
readressed O
. O

# O
Communication O
- O
Evelyn O
Matos O
( O
niece O
) O
492 O
- O
9977 O
, O
cell O
( O
921 O
) O
815 O
- O
7040 O

Medications O
on O
Admission O
: O

Coumadin B-TREATMENT
2.5 O
mg O
/ O
3 O
mg O

Insulin B-TREATMENT
- O
Humulin B-TREATMENT
N I-TREATMENT
36 O
U O
daily O
/ O
14 O
U O
qhs O

Lasix B-TREATMENT
40 O
mg O
bid O

Venlafaxine B-TREATMENT
XR O
75 O
mg O
qd O

Sorbitol B-TREATMENT

Metoprolol B-TREATMENT
25 O
mg O
bid O

Imdur B-TREATMENT
30 O
mg O
qd O

Hydralazine B-TREATMENT
50 O
mg O
bid O

Digoxin B-TREATMENT
0.125 O
qd O

Oscal B-TREATMENT
250 O
mg O
+ O
D O

Tylenol B-TREATMENT
prn O

Morphine B-TREATMENT
sulfate I-TREATMENT
4 O
mg O
q2 O
hrs O
prn O

Discharge O
Medications O
: O

1. O
NPH B-TREATMENT

18 O
units O
qam O
and O
7 O
units O
qhs O

2. O
Humalog B-TREATMENT

Per O
sliding O
scale O
q O
breakfast O
, O
lunch O
, O
and O
dinner O

3. O
Venlafaxine B-TREATMENT
37.5 O
mg O
Capsule O
, O
Sust O
. O
Release O
24 O
hr O
Sig O
: O
One O
( O
1 O
) O
Capsule O
, O
Sust O
. O
Release O
24 O
hr O
PO O
DAILY O
( O
Daily O
). O

4. O
Aspirin B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

5. O
Isosorbide B-TREATMENT
Mononitrate I-TREATMENT
30 O
mg O
Tablet O
Sustained O
Release O
24 O
hr O
Sig O
: O
One O
( O
1 O
) O
Tablet O
Sustained O
Release O
24 O
hr O
PO O
DAILY O
( O
Daily O
). O

6. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

7. O
Albuterol B-TREATMENT
Sulfate I-TREATMENT
0.083 O
% O
( O
0.83 O
mg O
/ O
mL O
) O
Solution O
Sig O
: O
One O
( O
1 O
) O
Inhalation O
Q6H O
( O
every O
6 O
hours O
). O

8. O
Ipratropium B-TREATMENT
Bromide I-TREATMENT
0.02 O
% O
Solution O
Sig O
: O
One O
( O
1 O
) O
Inhalation O
Q6H O
( O
every O
6 O
hours O
). O

9. O
Albuterol B-TREATMENT
Sulfate I-TREATMENT
0.083 O
% O
( O
0.83 O
mg O
/ O
mL O
) O
Solution O
Sig O
: O
One O
( O
1 O
) O
Inhalation O
Q2H O
( O
every O
2 O
hours O
) O
as O
needed O
. O

10. O
Prednisone B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
) O
for O
4 O
days O
. O

11. O
Furosemide B-TREATMENT
10 O
mg O
/ O
mL O
Solution O
Sig O
: O
Forty O
( O
40 O
) O
mg O
Injection O
BID O
( O
2 O
times O
a O
day O
). O

12. O
Acetazolamide B-TREATMENT
Sodium I-TREATMENT
500 O
mg O
Recon O
Soln O
Sig O
: O
Two O
Hundred O
Fifty O
( O
250 O
) O
Recon O
Soln O
Injection O
Q12H O
( O
every O
12 O
hours O
). O

13. O
Morphine B-TREATMENT
2 O
mg O
/ O
mL O
Syringe O
Sig O
: O
1-2 O
mg O
Injection O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
. O

14. O
Amiodarone B-TREATMENT
200 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
for O
7 O
days O
. O

15. O
Amiodarone B-TREATMENT
400 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
: O
after O
finishing O
400mg O
BID O
x O
6 O
days O
. O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

Whidden O
Memorial O
Hospital O
for O
the O
Aged O
- O
LTC O

Discharge O
Diagnosis O
: O

Primary O
diagnoses O
: O

Diastolic B-SYMPTOM
congestive I-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM

Aortic B-SYMPTOM
stenosis I-SYMPTOM

Mitral B-SYMPTOM
stenosis I-SYMPTOM

Possible O
chronic B-SYMPTOM
obstructive I-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM

Secondary O
diagnoses O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM

Chronic B-SYMPTOM
kidney I-SYMPTOM
disease I-SYMPTOM

Depression B-SYMPTOM

Diabetes B-SYMPTOM
mellitus I-SYMPTOM

Discharge O
Condition O
: O

Stable O
, O
satting O
98% O
on O
1L B-TREATMENT
via I-TREATMENT
NC I-TREATMENT
, O
sitting O
up O
in O
a O
chair O

Discharge O
Instructions O
: O

Please O
call O
your O
doctor O
at O
the O
rehabilitation O
if O
you O
develop O
any O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
or O
any B-SYMPTOM
other I-SYMPTOM
concerning I-SYMPTOM
symptoms I-SYMPTOM
. O

Please O
take O
medications B-TREATMENT
as O
instructed O
. O

Keep O
all O
your O
follow-up O
appointments O
. O

Followup O
Instructions O
: O

Provider O
: O
David O
Phone O
: O
912-6800-0569 O
Date O
/ O
Time O
: O
2014-08-11 O
1:00 O

Jim O
Stanley O
MD O
78-708 O

Completed O
by O
: O
Junko O
Alpha O
MD O
22-842 O
2014-08-04 O
@ O
1725 O

Signed O
electronically O
by O
: O
DR. O
Jane O
B. O
Hardy O
on O
: O
Sandra O
2014-08-07 O
11:10 O
AM O

( O
End O
of O
Report O
) O

356529973_a O

FIH O

2102647 O

14892/3n8v O

481088 O

7/9/1993 O
12:00:00 O
AM O

OVARIAN B-SYMPTOM
MASS I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

7-9-93 O

DISCHARGE O
DATE O
: O

7-15-93 O

PRINCIPAL O
DIAGNOSIS O
: O

Ovarian B-SYMPTOM
mass I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Papanicolaou O
smear O
positive O
for O
somomabodies B-SYMPTOM
, O
incontinence B-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Total B-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
, O
bilateral B-TREATMENT
salpingo-oophorectomy I-TREATMENT
, O
lysis B-TREATMENT
of O
adhesions B-SYMPTOM
, O
open B-TREATMENT
laparoscopy I-TREATMENT
, O
Birch B-TREATMENT
procedure I-TREATMENT
, O
suprapubic B-TREATMENT
bladder I-TREATMENT
catheter I-TREATMENT
placement I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
52 O
year O
old O
female O
with O
gravida O
3 O
para O
3 O
who O
presents O
with O
complains O
of O
abdominal B-SYMPTOM
pain I-SYMPTOM
and O
enlarged B-SYMPTOM
ovary I-SYMPTOM
by O
ultrasound O
. O

The O
patient O
is O
also O
complaining O
of O
several B-SYMPTOM
years I-SYMPTOM
urinary I-SYMPTOM
incontinence I-SYMPTOM
. O

The O
patient O
&apos;s O
recent O
history O
is O
also O
notable O
for O
a O
Papanicolaou O
smear O
which O
revealed O
somomabodies B-SYMPTOM
. O

The O
patient O
also O
had O
vaginal B-SYMPTOM
bleeding I-SYMPTOM
in O
April O
1992 O
following O
radiation B-TREATMENT
therapy I-TREATMENT
. O

The O
patient O
initially O
presented O
with O
hypercalcemia B-SYMPTOM
and O
underwent O
a B-TREATMENT
parathyroidectomy I-TREATMENT
on O
June O
22 O
, O
1993 O
. O

It O
was O
at O
that O
time O
that O
her O
abnormal O
Papanicolaou O
smear O
was O
obtained O
. O

The O
patient O
is O
now O
admitted O
for O
exploratory O
laparotomy O
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
past O
medical O
history O
is O
notable O
for O
lymphosarcoma B-SYMPTOM
in O
1970 O
. O

She O
was O
treated O
with O
radiation B-TREATMENT
therapy I-TREATMENT
. O

In O
1980 O
, O
the O
patient O
had O
a B-SYMPTOM
left I-SYMPTOM
axillary I-SYMPTOM
recurrence I-SYMPTOM
that O
was O
treated O
with O
radiation B-TREATMENT
therapy I-TREATMENT
. O

The O
patient O
also O
has O
a O
history O
of O
hyperparathyroidism B-SYMPTOM
secondary O
to O
papillary B-SYMPTOM
thyroid I-SYMPTOM
cancer I-SYMPTOM
. O

The O
history O
is O
also O
notable O
for O
gallstones B-SYMPTOM
, O
kidney B-SYMPTOM
stones I-SYMPTOM
, O
episodic B-SYMPTOM
tachycardia I-SYMPTOM
, O
chronic B-SYMPTOM
pancreatitis I-SYMPTOM
. O

Of O
note O
, O
the O
patient O
also O
has O
a O
history O
of O
incontinence B-SYMPTOM
. O

The O
patient O
also O
has O
hypothyroidism B-SYMPTOM
. O

PAST O
SURGICAL O
HISTORY O
: O

The O
patient O
&apos;s O
past O
surgical O
history O
is O
notable O
for O
the B-TREATMENT
removal I-TREATMENT
of O
a B-SYMPTOM
thyroid I-SYMPTOM
nodule I-SYMPTOM
in O
February O
1989 O
. O

This O
revealed O
papillary B-SYMPTOM
thyroid I-SYMPTOM
cancer I-SYMPTOM
and O
the O
patient O
received O
radioactive B-TREATMENT
iodine I-TREATMENT
ablation I-TREATMENT
. O

In O
June O
1993 O
, O
the O
patient O
had O
a B-TREATMENT
parathyroidectomy I-TREATMENT
and O
also O
of O
note O
, O
in O
September O
1992 O
, O
the O
patient O
had O
an O
exploratory O
laparotomy O
for O
pain B-SYMPTOM
and O
chronic B-SYMPTOM
pancreatitis I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Include O
Librax B-TREATMENT
1 O
PO O
before O
meals O
, O
Pancrease B-TREATMENT
2 O
tabs O
before O
meals O
, O
Synthroid B-TREATMENT
0.125 O
mg O
PO O
qd O
. O

Tenormin B-TREATMENT
50 O
mg O
bid O
, O
Valium B-TREATMENT
5 O
mg O
bid O
to O
tid O
, O
Premarin B-TREATMENT
0.625 O
mg O
qd O
, O
Provera B-TREATMENT
2.5 O
mg O
qod O
, O
Desyrel B-TREATMENT
50 O
mg O
qhs O
. O

ALLERGIES O
: O

The B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
allergies I-SYMPTOM
include O
Septra B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
&apos;s O
social O
history O
is O
notable O
for O
a O
heavy O
smoking O
history O
. O

She O
is O
interested O
in O
quitting O
smoking O
. O

The O
patient O
has O
no O
history O
of O
alcohol O
abuse O
. O

PHYSICAL O
EXAMINATION O
: O

The O
patient O
&apos;s O
preoperative O
examination O
is O
notable O
for O
normal O
breasts O
, O
normal O
heart O
and O
lungs O
. O

The O
pelvic O
examination O
is O
normal O
except O
for O
the O
presence O
of O
a B-SYMPTOM
full I-SYMPTOM
right I-SYMPTOM
ovary I-SYMPTOM
. O

The O
rectovaginal O
examination O
is O
normal O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
judged O
to O
be O
at O
risk O
secondary O
to O
her O
history O
of O
somomabodies B-SYMPTOM
and O
vaginal B-SYMPTOM
bleeding I-SYMPTOM
. O

Her O
differential O
diagnosis O
included O
ovarian B-SYMPTOM
cancer I-SYMPTOM
. O

The O
patient O
was O
admitted O
on O
July O
9 O
to O
the O
operating O
room O
. O

She O
underwent O
an B-TREATMENT
open I-TREATMENT
laparoscopy I-TREATMENT
, O
total B-TREATMENT
abdominal I-TREATMENT
hysterectomy I-TREATMENT
, O
bilateral B-TREATMENT
salpingo-oophorectomy I-TREATMENT
, O
lysis B-TREATMENT
of O
adhesions B-SYMPTOM
, O
Birch B-TREATMENT
procedure I-TREATMENT
, O
and O
suprapubic B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
placement I-TREATMENT
and O
Jackson-Pratt B-TREATMENT
drain I-TREATMENT
placement I-TREATMENT
. O

The O
estimated O
blood O
loss O
was O
300 O
cc O
. O

There O
were O
no O
complications B-SYMPTOM
during O
the B-TREATMENT
procedure I-TREATMENT
and O
the O
patient O
returned O
to O
the O
recovery O
room O
in O
stable O
condition O
. O

Postoperatively O
, O
the O
patient O
did O
well O
. O

Her O
calcium O
was O
followed O
daily O
and O
repleted O
as O
needed O
. O

Her B-TREATMENT
Jackson-Pratt I-TREATMENT
drain I-TREATMENT
was O
removed O
on O
postoperative O
day O
number O
two O
. O

The O
patient O
had O
a O
temperature O
of O
101.6 O
on O
postoperative O
day O
two O
. O

Her O
lungs O
revealed O
coarse B-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
. O

She O
was O
encouraged O
to O
ambulate O
and O
deep O
breath O
. O

The O
patient O
was O
started O
on O
nebulizer B-TREATMENT
treatment I-TREATMENT
. O

The O
patient O
did O
well O
and O
her B-TREATMENT
suprapubic I-TREATMENT
tube I-TREATMENT
was O
clamped B-TREATMENT
starting O
on O
postoperative O
day O
four O
. O

The O
patient O
voided O
spontaneously O
. O

Clamping O
continued O
until O
postoperative O
day O
six O
. O

At O
this O
time O
, O
her O
post-void O
residuals O
range O
from O
2 O
cc O
to O
25 O
cc O
. O

The B-TREATMENT
suprapubic I-TREATMENT
tube I-TREATMENT
was O
therefore O
discontinued O
. O

By O
postoperative O
day O
six O
, O
the O
patient O
was O
also O
tolerating O
a O
regular O
diet O
and O
passing O
flatus O
. O

A O
chest O
X-ray O
was O
performed O
secondary O
to O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
coarse I-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
, O
however O
, O
the O
chest O
X-ray O
was O
clear O
except O
for O
a O
small O
amount O
of O
atelectasis B-SYMPTOM
. O

The O
patient O
was O
discharged O
home O
. O

final O
pathology O
revealed O
right O
Fallopian O
tube O
and O
ovary O
with O
benign B-SYMPTOM
paratubal I-SYMPTOM
cysts I-SYMPTOM
and O
adhesions B-SYMPTOM
. O

The O
cervix O
revealed O
squamous B-SYMPTOM
metaplasia I-SYMPTOM
. O

The O
patient O
was O
discharged O
home O
on O
admission B-TREATMENT
medications I-TREATMENT
. O

In O
addition O
, O
she O
will O
take O
Ciprofloxacin B-TREATMENT
for O
nine O
more O
days O
. O

She O
will O
also O
take O
Percocet B-TREATMENT
. O

DISPOSITION O
: O

The O
patient O
is O
discharged O
to O
home O
and O
is O
to O
follow O
up O
with O
Dr. O
Cancer O
, O
as O
well O
as O
Dr. O
Kotefold O
and O
Dr. O
Cancer O
. O

KITRI O
CURB O
, O
M.D. O

DICTATING O
FOR O
: O

EARNRA O
CANCER O
, O
M.D. O

TR O
: O

nx O
/ O
bmot O

DD O
: O

07-15-93 O

TD O
: O

07/16/93 O

CC O
: O

Dr. O
Ertca O
Cancer O
, O
Dr. O
Kotefold O

866196074 O
RWH O

6639378 O

578141 O

0325706 O

3/10/2003 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O
/ O
SUMMARY O

KNOLESA O
, O
VIA O

MRN O
: O

6639378 O

Age O
: O

39y O

REGISTRATION O
DATE O
: O

03/10/2003 O
06:42 O
PM O

Provider O
: O

Inachelle O
Breutzbreunbreuncotfalke O

PRELMINARY O
REPORT O

Benefits O
Assigned O
: O

Y O

Discharge O
Date O
/ O
Time O
: O

03/10/2003 O
23:26 O

Discharge O
Status O
: O

Discharged O

Condition O
on O
Discharge O
: O

Stable O

Patient O
States O
Complaint O
: O

INCREASED O
ACID B-SYMPTOM
REFLUX I-SYMPTOM

Standardized O
Discharge O
Instructions O
: O

The O
patient O
was O
given O
printed O
instructions O
for O
abdominal B-SYMPTOM
pain I-SYMPTOM
( O
Spanish O
) O
. O

Diagnosis O
: O

GERD B-SYMPTOM

Treatment O
Rendered O
: O

h O
, O
p, O
labs O
, O
mylanta B-TREATMENT
/ O
viscous B-TREATMENT
lidocaine I-TREATMENT

Discharge O
Medications O
: O

mylanta B-TREATMENT
15 O
cc O
mixed O
with O
Viscous B-TREATMENT
lidocaine I-TREATMENT
every O
8 O
hours O
if O
needed O
for O
severe O
pain B-SYMPTOM
only O
can O
use O
mylanta B-TREATMENT
without O
lidocaine B-TREATMENT
more O
frequently O
bland B-TREATMENT
diet I-TREATMENT
, O
no O
caffeine O
, O
chilli O
, O
or O
alcohol O
... O

Follow O
up O
Service O
: O

call O
your O
PCP O
to O
schedule O
your O
GI O
follow O
up O
date O

Disposition O
, O
Follow O
up O
and O
Instructions O
to O
Patient O
: O

return O
to O
ED O
if O
worsening B-SYMPTOM
pain I-SYMPTOM
, O
black B-SYMPTOM
stools I-SYMPTOM
, O
blood B-SYMPTOM
in I-SYMPTOM
stool I-SYMPTOM

PCP O
Name O
: O

LEEBKAYSHAUPKERTH O
, O
MAENZET O
N O

Provider O
Number O
: O

31710 O

This O
report O
was O
created O
by O
Breutzbreunbreuncotfalke O
, O
Inachelle O
03/10/2003 O
11:28 O
PM O

Admission O
Date O
: O

2010-07-15 O

Discharge O
Date O
: O

2010-07-18 O

Date O
of O
Birth O
: O

1978-01-25 O

Sex O
: O

F O

Service O
: O

KULAND O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
32-year-old O
white O
female O
with O
history O
of O
diabetes B-SYMPTOM
type I-SYMPTOM
1 I-SYMPTOM
and O
migraines B-SYMPTOM
who O
presented O
with O
complaints O
of O
nausea B-SYMPTOM
, O
diarrhea B-SYMPTOM
and O
vomiting B-SYMPTOM
for O
24 O
hours O
. O

Patient O
states O
she O
was O
unable O
to O
take O
her B-TREATMENT
usual I-TREATMENT
insulin I-TREATMENT
regimen I-TREATMENT
because O
she O
was O
vomiting B-SYMPTOM
. O

The O
patient O
denied O
any O
fevers B-SYMPTOM
, O
chills B-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
dysuria B-SYMPTOM
but O
does O
state O
she O
had O
her B-SYMPTOM
usual I-SYMPTOM
migraine I-SYMPTOM
headache I-SYMPTOM
the O
night O
prior O
to O
admission O
. O

The O
patient O
's O
arterial O
blood O
gases O
in O
the O
Emergency O
Department O
were O
7.19 O
, O
22 O
and O
109 O
with O
a O
bicarbonate O
of O
9 O
and O
a O
fingerstick O
of O
greater O
than O
500 O
. O

Patient O
was O
given O
two B-TREATMENT
boluses I-TREATMENT
of I-TREATMENT
15 I-TREATMENT
units I-TREATMENT
of I-TREATMENT
regular I-TREATMENT
insulin I-TREATMENT
and O
was O
started O
on O
an B-TREATMENT
insulin I-TREATMENT
drip I-TREATMENT
of O
one O
unit O
per O
hour O
and O
given O
a B-TREATMENT
total I-TREATMENT
of I-TREATMENT
five I-TREATMENT
liters I-TREATMENT
of I-TREATMENT
normal I-TREATMENT
saline I-TREATMENT
. O

Her O
fingersticks O
decreased O
with O
the B-TREATMENT
insulin I-TREATMENT
drip I-TREATMENT
and O
the B-TREATMENT
intravenous I-TREATMENT
fluids I-TREATMENT
. O

The O
patient O
was O
admitted O
to O
the O
Intensive O
Care O
Unit O
for O
an B-TREATMENT
insulin I-TREATMENT
drip I-TREATMENT
and O
frequent O
blood O
sugar O
monitoring O
and O
Chem-7 O
monitoring O
. O

The O
patient O
did O
well O
overnight O
in O
the O
Medical O
Intensive O
Care O
Unit O
. O

Her O
anion O
gap O
closed O
and O
her O
fingersticks O
were O
less O
than O
200 O
. O

Her B-TREATMENT
NPH I-TREATMENT
and O
a B-TREATMENT
regular I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
were O
started O
and O
her B-TREATMENT
drip I-TREATMENT
was O
discontinued O
. O

The O
patient O
denied O
any B-SYMPTOM
more I-SYMPTOM
gastrointestinal I-SYMPTOM
symptoms I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Includes O
diabetes B-SYMPTOM
, O
diagnosed O
at O
age O
14 O
. O

Multiple O
episodes O
of O
diabetic B-SYMPTOM
ketoacidosis I-SYMPTOM
in O
the O
past O
, O
migraine B-SYMPTOM
headaches I-SYMPTOM
and O
attention B-SYMPTOM
deficit I-SYMPTOM
disorder I-SYMPTOM
. O

MEDICATIONS O
AT O
HOME O
: O

Included O
Wellbutrin B-TREATMENT
, O
Imitrex B-TREATMENT
, O
Tylenol B-TREATMENT
, O
Humalog B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
and O
NPH B-TREATMENT
insulin I-TREATMENT
two O
units O
in O
the O
morning O
, O
7 O
units O
at O
noon O
and O
13 O
units O
at O
bedtime O
. O

ALLERGIES O
: O

Patient O
has O
allergies B-SYMPTOM
to O
penicillin B-TREATMENT
. O

She O
gets O
hives B-SYMPTOM
. O

Bactrim B-TREATMENT
, O
she O
gets O
hives B-SYMPTOM
. O

Percocet B-TREATMENT
and O
erythromycin B-TREATMENT
, O
she O
gets O
gastrointestinal B-SYMPTOM
upset I-SYMPTOM
and O
Keflex B-TREATMENT
she O
gets O
hives B-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
lives O
with O
mother O
and O
father O
. O

She O
had O
a O
recent O
pregnancy O
with O
a O
five O
month O
stay O
at O
Erich O
Lindemann O
Mental O
Health O
Center O
. O

Patient O
had O
a B-TREATMENT
cesarean I-TREATMENT
section I-TREATMENT
at O
eight O
months O
. O

The O
baby O
is O
now O
healthy O
, O
about O
four O
months O
old O
. O

Tobacco O
history O
, O
three O
cigarettes O
a O
week O
. O

Denies O
alcohol O
or O
drugs O
. O

FAMILY O
HISTORY O
: O

Hypertension B-SYMPTOM
. O

PHYSICAL O
EXAM O
ON O
ADMISSION O
: O

Includes O
a O
temperature O
of O
99.9 O
. O

Pulse O
of O
94 O
. O

Blood O
pressure O
of O
138/49 O
. O

Patient O
was O
generally B-SYMPTOM
ill-appearing I-SYMPTOM
and O
nauseated B-SYMPTOM
, O
but O
alert O
and O
oriented O
times O
three O
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
and O
throat O
exam O
: O

Pupils O
equal O
, O
round O
and O
reactive O
to O
light O
. O

Oropharynx O
clear O
. O

Dry O
mucous O
membranes O
. O

Neck O
supple O
, O
no O
lymphadenopathy B-SYMPTOM
. O

Chest O
clear O
to O
auscultation O
. O

Heart O
regular O
. O

Abdomen O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

Extremities O
: O

No O
edema B-SYMPTOM
. O

Neurological O
exam O
: O

Alert O
and O
oriented O
times O
three O
. O

Cranial O
nerves O
II O
through O
XII O
are O
intact O
, O
nonfocal O
, O
moving O
all O
extremities O
. O

LABORATORY O
ON O
ADMISSION O
: O

White O
blood O
cell O
count O
of O
22.8 O
, O
hematocrit O
of O
42.1 O
. O

Sodium O
of O
136 O
, O
chloride O
96 O
, O
bicarbonate O
8 O
, O
BUN O
25 O
, O
creatinine O
1.2 O
, O
glucose O
720 O
. O

Arterial O
blood O
gases O
showed O
a O
pH O
of O
7.19 O
, O
pCO2 O
of O
22 O
and O
PO2 O
of O
102 O
and O
a O
potassium O
of O
3.9 O
. O

Chest O
x-ray O
was O
negative O
for O
infiltrate B-SYMPTOM
. O

Electrocardiogram O
was O
normal O
sinus O
rhythm O
with O
a B-SYMPTOM
T I-SYMPTOM
wave I-SYMPTOM
inversion I-SYMPTOM
in I-SYMPTOM
V2 I-SYMPTOM
, O
but O
no O
ST B-SYMPTOM
segment I-SYMPTOM
elevations I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

As O
above O
, O
and O
once O
transferred O
to O
the O
floor O
, O
patient O
had O
fingersticks O
monitored O
every O
four O
hours O
with O
a B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

Patient O
reached O
goal O
of O
fingersticks O
between O
50 O
and O
300 O
, O
which O
is O
what O
she O
maintains O
at O
home O
. O

Sliding B-TREATMENT
scale I-TREATMENT
was O
adjusted O
as O
necessary O
. O

Patient O
was O
continued O
on O
intravenous B-TREATMENT
fluids I-TREATMENT
until O
taking O
good O
po O
. O

Infectious O
Disease O
: O

The O
patient O
had O
an B-SYMPTOM
elevated I-SYMPTOM
white I-SYMPTOM
count I-SYMPTOM
upon O
admission O
, O
however O
, O
white O
count O
came O
down O
to O
7.1 O
and O
prior O
to O
discharge O
, O
patient O
was O
afebrile B-SYMPTOM
and O
no O
clear O
etiology O
for O
elevated B-SYMPTOM
white I-SYMPTOM
blood I-SYMPTOM
cell I-SYMPTOM
on O
admission O
, O
questionably O
secondary O
to O
short B-SYMPTOM
gastrointestinal I-SYMPTOM
infection I-SYMPTOM
, O
however O
, O
patient O
is O
completely O
symptom O
free O
upon O
discharge O
. O

Fluid O
, O
electrolytes O
and O
nutrition O
: O

The O
patient O
's O
electrolytes O
were O
repleted O
as O
necessary O
. O

Potassium B-TREATMENT
was O
given O
with O
her B-TREATMENT
intravenous I-TREATMENT
fluids I-TREATMENT
and O
phosphate B-TREATMENT
will O
be O
repleted O
as O
patient O
increases O
her O
po O
intake O
. O

CONDITION O
OF O
DISCHARGE O
: O

Good O
. O

DISCHARGE O
STATUS O
: O

To O
home O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Diabetic B-SYMPTOM
ketoacidosis I-SYMPTOM
. O

2. O
Viral B-SYMPTOM
gastroenteritis I-SYMPTOM
. O

DISCHARGE O
MEDICATIONS O
: O

Includes O
her B-TREATMENT
regular I-TREATMENT
insulin I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
and O
her B-TREATMENT
NPH I-TREATMENT
fixed O
scale O
of O
7 O
units O
in O
the O
morning O
, O
2 O
units O
at O
noon O
and O
13 O
units O
at O
bedtime O
. O

Patient O
was O
instructed O
to O
decrease O
her B-TREATMENT
evening I-TREATMENT
dose I-TREATMENT
if O
she O
does O
not O
continue O
to O
take O
good O
po O
. O

Patient O
will O
also O
continue O
on O
her B-TREATMENT
Wellbutrin I-TREATMENT
and O
Imitrex B-TREATMENT
as O
needed O
for O
migraines B-SYMPTOM
. O

FOLLOW-UP O
PLANS O
: O

The O
patient O
is O
to O
follow-up O
with O
her O
endocrinologist O
at O
the O
Mahoney O
, O
as O
well O
as O
her O
primary O
care O
physician O
. O

Diane O
Sands O
, O
M.D. O

11-089 O

Dictated O
By O
: O
Pamela O
F. O
Williams O
, O
M.D. O

MEDQUIST36 O

D O
: O
2010-07-20 O
21:01 O

T O
: O
2010-07-20 O
21:01 O

JOB O
#: O

65230 O

Signed O
electronically O
by O
: O
DR. O
Timothy O
Clemons O
on O
: O
MON O
2010-07-26 O
11:01 O
AM O

( O
End O
of O
Report O
) O

1191042 O

Admission O
Date O
: O

2015-04-21 O

Discharge O
Date O
: O

2015-04-29 O

Date O
of O
Birth O
: O

2015-04-21 O

Sex O
: O

M O

Service O
: O

CMED O

HISTORY O
: O

Baby O
Daniel O
Holman O
was O
born O
at O
39 O
and O
3/7 O
weeks O
gestation O
( O
EDC O
2015-04-25 O
). O

His O
mother O
is O
a O
31-year-old O
female O
gravida O
2 O
, O
para O
1 O
, O
now O
2 O
. O

Prenatal O
screens O
: O
blood O
type O
A O
positive O
, O
antibody O
negative O
, O
rubella O
immune O
, O
RPR O
nonreactive O
, O
hepatitis O
B O
surface O
antigen O
negative O
, O
GBS O
unknown O
. O

He O
was O
born O
by O
repeat B-TREATMENT
C-section I-TREATMENT
. O

There O
was O
artificial B-TREATMENT
rupture I-TREATMENT
of I-TREATMENT
membranes I-TREATMENT
was O
performed O
at O
the B-TREATMENT
delivery I-TREATMENT
. O

Amniotic O
fluid O
was O
clear O
. O

Mother O
received O
epidural B-TREATMENT
and O
spinal B-TREATMENT
anesthesia I-TREATMENT
. O

Baby O
was O
vigorous O
at O
birth O
and O
received O
routine O
DR O
Johnson O
. O

Apgars O
were O
9 O
and O
9 O
at O
1 O
and O
5 O
minutes O
. O

He O
was O
transferred O
to O
the O
newborn O
nursery O
for O
further B-TREATMENT
care I-TREATMENT
. O

In O
the O
newborn O
nursery O
he O
was O
started O
on O
PO B-TREATMENT
feedings I-TREATMENT
on O
demand O
. O

He O
was O
noted O
to O
be O
large B-SYMPTOM
for I-SYMPTOM
gestational I-SYMPTOM
age I-SYMPTOM
with O
a O
weight O
of O
4525 O
grams O
. O

His O
d-sticks O
were O
greater O
than O
80 O
. O

At O
5 O
hours O
of O
life O
he O
was O
noted O
to O
have O
grunting B-SYMPTOM
and O
flaring B-SYMPTOM
and O
E.C. O
Bovell O
consult O
was O
done O
. O

He O
was O
in O
mild B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
and O
a O
diagnosis O
of O
transient B-SYMPTOM
tachypnea I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
newborn I-SYMPTOM
was O
made O
. O

He O
was O
observed O
in O
the O
nursery O
for O
progression B-SYMPTOM
of I-SYMPTOM
symptoms I-SYMPTOM
. O

At O
16 O
hours O
of O
life O
he O
was O
noted O
to O
have O
increased B-SYMPTOM
work I-SYMPTOM
of I-SYMPTOM
breathing I-SYMPTOM
with O
tachypnea B-SYMPTOM
, O
flaring B-SYMPTOM
and O
grunting B-SYMPTOM
. O

He O
was O
also O
noted O
to O
have O
axillary O
temperature O
of O
100.4 O
and O
a O
rectal O
temperature O
of O
100.9 O
. O

At O
this O
point O
CMED O
was O
consulted O
again O
and O
he O
was O
transferred O
to O
the O
CMED O
triage O
for O
further B-TREATMENT
care I-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

Birth O
weight O
of O
4525 O
grams O
which O
is O
greater O
than O
90th O
percentile O
; O
length O
54 O
cm O
which O
is O
greater O
than O
90th O
percentile O
; O
head O
circumference O
37 O
cm O
which O
is O
greater O
than O
90th O
percentile O
. O

D-sticks O
of O
117 O
. O

Large B-SYMPTOM
for I-SYMPTOM
gestational I-SYMPTOM
age I-SYMPTOM
appearance I-SYMPTOM
of O
an O
infant O
with O
tachypnea B-SYMPTOM
, O
grunting B-SYMPTOM
and O
flaring B-SYMPTOM
. O

HEENT O
: O
Anterior O
fontanel O
open O
and O
flat O
. O

Bilateral O
red O
reflexes O
. O

Patent O
nares O
. O

Mild B-SYMPTOM
flaring I-SYMPTOM
. O

Neck O
supple O
. O

Clavicles O
stable O
. O

RESPIRATORY O
: O
Tachypneic B-SYMPTOM
with O
mild B-SYMPTOM
retractions I-SYMPTOM
, O
increased B-SYMPTOM
work I-SYMPTOM
of I-SYMPTOM
breathing I-SYMPTOM
, O
clear O
and O
equal O
breath O
sounds O
. O

CARDIOVASCULAR O
: O
Normal O
rate O
and O
rhythm O
. O

Normal O
S1 O
and O
S2 O
without O
murmur B-SYMPTOM
. O

Brachial O
pulses O
equal O
femoral O
pulses O
and O
are O
2+ O
. O

ABDOMEN O
: O
Soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

No O
hepatosplenomegaly B-SYMPTOM
. O

Patent O
anus O
. O

Umbilical O
stump O
dry O
. O

GENITALIA O
: O
Normal O
male O
. O

Testes O
distended O
bilaterally O
. O

NEUROLOGIC O
: O
Alert O
and O
crying O
. O

Normal O
tone O
and O
neonatal O
reflexes O
. O

EXTREMITIES O
: O
Warm O
and O
pink O
. O

Moves O
all O
extremities O
well O
. O

Hips O
stable O
. O

Skin O
pink O
and O
capillary O
refill O
less O
than O
2 O
seconds O
. O

Spine O
straight O
and O
no O
abnormalities B-SYMPTOM
. O

SUMMARY O
OF O
HOSPITAL O
COURSE O
BY O
SYSTEMS O
: O

RESPIRATORY O
: O
The O
infant O
was O
placed O
on O
CPAP B-TREATMENT
on O
admission O
to O
the O
CMED O
and O
remained O
on O
CPAP B-TREATMENT
until O
day O
of O
life O
2 O
at O
which O
time O
he O
weaned O
to O
nasal B-TREATMENT
cannula I-TREATMENT
and O
then O
subsequently O
to O
room O
air O
on O
day O
of O
life O
3 O
. O

He O
has O
remained O
on O
room O
air O
since O
that O
time O
and O
has O
had O
no O
issues O
with O
apnea B-SYMPTOM
or O
desaturation B-SYMPTOM
since O
being O
on O
room O
air O
. O

Initial O
chest O
x-ray O
in O
the O
CMED O
showed O
haziness B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
and O
patchy B-SYMPTOM
areas I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
side I-SYMPTOM
consistent O
with O
concerns O
for O
pneumonia B-SYMPTOM
. O

The O
infant O
was O
treated O
for O
pneumonia B-SYMPTOM
from O
admission O
to O
the O
CMED O
. O

CARDIOVASCULAR O
: O
The O
infant O
has O
maintained O
stable O
cardiovascular O
status O
with O
normal O
heart O
rates O
and O
blood O
pressures O
and O
no O
murmurs B-SYMPTOM
. O

FLUIDS O
, O
ELECTROLYTES O
AND O
NUTRITION O
: O
The O
infant O
was O
started O
on O
IV B-TREATMENT
fluids I-TREATMENT
on O
admission O
to O
the O
CMED O
. O

Electrolytes O
were O
measured O
on O
day O
of O
life O
2 O
and O
were O
stable O
at O
that O
time O
. O

No O
further O
electrolytes O
have O
been O
measured O
. O

Enteral B-TREATMENT
feedings I-TREATMENT
were O
initiated O
on O
day O
of O
life O
3 O
and O
the O
infant O
has O
been O
ad B-TREATMENT
lib I-TREATMENT
PO I-TREATMENT
feeding I-TREATMENT
on O
demand O
since O
that O
time O
. O

His O
discharge O
weight O
is O
4180 O
grams O
. O

GASTROINTESTINAL O
: O

Bilirubin O
level O
was O
peaked O
on O
day O
of O
life O
4 O
to O
10.9/0.3 O
. O

He O
has O
required O
no O
phototherapy B-TREATMENT
. O

HEMATOLOGY O
: O
Hematocrit O
was O
done O
on O
admission O
to O
the O
CMED O
. O

Hematocrit O
was O
41 O
, O
platelet O
count O
of O
404,000 O
. O

No O
further O
hematocrit O
or O
platelets O
have O
been O
measured O
. O

Blood O
typing O
has O
been O
done O
on O
this O
infant O
. O

The O
baby O
's O
blood O
type O
is O
B O
negative O
, O
antibody O
negative O
. O

INFECTIOUS O
DISEASE O
: O
CBC O
and O
blood O
culture O
were O
screened O
on O
admission O
. O

CBC O
was O
benign O
with O
22,000 O
whites O
, O
80 O
poly O
's, O
0 O
bands O
, O
15 O
lymphs O
. O

Ampicillin B-TREATMENT
and O
gentamycin B-TREATMENT
were O
initiated O
on O
admission O
and O
an O
LP O
was O
done O
due O
to O
the O
clinical O
issues O
of O
respiratory B-SYMPTOM
distress I-SYMPTOM
and O
fever B-SYMPTOM
on O
admission O
to O
the O
CMED O
. O

CSF O
showed O
white O
count O
of O
7 O
, O
reds O
4 O
, O
protein O
119 O
, O
glucose O
69 O
. O

The O
infant O
was O
treated O
for O
7 O
days O
of O
presumed O
pneumonia B-SYMPTOM
with O
ampicillin B-TREATMENT
and O
gentamycin B-TREATMENT
. O

Antibiotics B-TREATMENT
were O
discontinued O
on O
the O
evening O
of O
2015-04-28 O
. O

NEUROLOGY O
: O
The O
infant O
has O
maintained O
a O
normal O
neurologic O
examination O
. O

SENSORY O
: O
Hearing O
screen O
was O
performed O
with O
automated O
auditory O
brain O
stem O
responses O
and O
the O
results O
was O
the O
infant O
passing O
in O
both O
ears O
. O

PSYCHOSOCIAL O
: O
A O
Arbour O
Hospital O
social O
worker O
has O
been O
involved O
with O
the O
family O
. O

The O
contact O
social O
worker O
can O
be O
reached O
at O
( O
374 O
) O
419-2007 O
. O

There O
are O
no O
active B-SYMPTOM
ongoing I-SYMPTOM
issues I-SYMPTOM
at O
this O
time O
. O

CONDITION O
ON O
DISCHARGE O
: O
Good O
. O

DISCHARGE O
DISPOSITION O
: O

Home O
with O
the O
parents O
. O

NAME O
OF O
PRIMARY O
PEDIATRICIAN O
: O

Dr. O
Gene O
Hardy O
from O
Webster O
Pediatrics O
. O

Telephone O
No. O
: O
( O
309 O
) O
642-6861 O
fax O
( O
515 O
) O
568-6798 O
. O

CARE O
RECOMMENDATIONS O
: O

1. O
Ad B-TREATMENT
lib I-TREATMENT
PO I-TREATMENT
feedings I-TREATMENT
of O
Similac B-TREATMENT
20 I-TREATMENT
cal I-TREATMENT
/ I-TREATMENT
oz I-TREATMENT
with I-TREATMENT
iron I-TREATMENT
. O

2. O
Medications B-TREATMENT
: O
None O
. O

3. O
State O
newborn O
screen O
was O
sent O
on O
2015-04-24 O
and O
results O
are O
pending O
. O

4. O
Immunizations B-TREATMENT
received O
: O
Hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
was O
given O
on O
2015-04-25 O
. O

5. O
Immunizations B-TREATMENT
Recommended O
: O

6. O
Synagis B-TREATMENT
RSV I-TREATMENT
prophylaxis I-TREATMENT
should O
be O
considered O
from O
November O
through O
March O
for O
infants O
who O
meet O
any O
of O
the O
following O
three O
criteria O
. O

A. O
Born O
at O
less O
than O
32 O
weeks O
gestation O
. O

B. O
Born O
between O
32 O
and O
35 O
weeks O
gestation O
with O
two O
of O
the O
following O
: O

daycare O
during O
the O
RSV O
season O
a O
smoker O
in O
the O
household O
, O
neuromuscular B-SYMPTOM
disease I-SYMPTOM
, O
airway B-SYMPTOM
abnormalities I-SYMPTOM
, O
or O
school O
age O
siblings O

C. O
with O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
. O

7. O
Influenza B-TREATMENT
immunization I-TREATMENT
is O
recommended O
annually O
in O
the O
fall O
for O
all O
infants O
once O
they O
reach O
6 O
months O
of O
age O
. O

Before O
this O
age O
and O
for O
the O
first O
24 O
months O
of O
the O
child O
's O
life O
, O
immunization B-TREATMENT
against O
influenza B-SYMPTOM
is O
recommended O
for O
household O
contacts O
and O
out O
of O
home O
caregivers O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Presumed O
pneumonia B-SYMPTOM
, O
treated O
. O

2. O
Large B-SYMPTOM
for I-SYMPTOM
gestational I-SYMPTOM
age I-SYMPTOM
term O
male O
. O

3. O
Respiratory B-SYMPTOM
distress I-SYMPTOM
, O
resolved O
. O

4. O
Mild B-SYMPTOM
hyperbilirubinemia I-SYMPTOM
, O
resolving O
. O

Claudia O
Ernest O
, O
MD O
50AAD O

Dictated O
By O
: O
Stan O
C. O
Haaz O
, O
M.D. O

MEDQUIST36 O

D O
: O
2015-04-28 O
23:50:08 O

T O
: O
2015-04-29 O
02:50:40 O

Job O
#: O
76623 O

Signed O
electronically O
by O
: O
DR. O
Maria O
L O
Ulabarro O
on O
: O
WED O
2015-04-29 O
2:21 O
PM O

( O
End O
of O
Report O
) O

385215362 O

CTMC O

47531332 O

8504886 O

11/17/2003 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

11/17/2003 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

PRINCIPAL O
DIAGNOSIS O
: O

PROGRESSIVE B-SYMPTOM
ACANTHAMOEBA I-SYMPTOM
INFECTION I-SYMPTOM
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
65-year-old O
man O
with O
refractory B-SYMPTOM
CLL I-SYMPTOM
, O
status O
post O
non-myeloblative B-TREATMENT
stem I-TREATMENT
cell I-TREATMENT
transplant I-TREATMENT
approximately O
nine O
months O
prior O
to O
admission O
, O
and O
status O
post O
prolonged O
recent O
Retelk O
County O
Medical O
Center O
stay O
for O
Acanthamoeba B-SYMPTOM
infection I-SYMPTOM
of I-SYMPTOM
skin I-SYMPTOM
and O
sinuses O
, O
complicated O
by O
ARS B-SYMPTOM
due O
to O
medication B-SYMPTOM
toxicity I-SYMPTOM
, O
as O
well O
as O
GVHD B-SYMPTOM
and O
recent B-SYMPTOM
CMV I-SYMPTOM
infection I-SYMPTOM
, O
readmitted O
for O
new B-SYMPTOM
fever I-SYMPTOM
, O
increasing B-SYMPTOM
creatinine I-SYMPTOM
, O
hepatomegaly B-SYMPTOM
and O
fluid B-SYMPTOM
surge I-SYMPTOM
spacing I-SYMPTOM
, O
in O
the O
setting O
of O
hyponatremia B-SYMPTOM
. O

Patient O
initially O
presented O
in O
1991 O
with O
cervical B-SYMPTOM
lymphadenopathy I-SYMPTOM
, O
was O
treated O
with O
MACE B-TREATMENT
/ O
CytaBOM B-TREATMENT
, O
and O
did O
well O
until O
1997 O
, O
when O
he O
received O
six O
cycles O
of O
fludarabine B-TREATMENT
for O
progressive B-SYMPTOM
disease I-SYMPTOM
. O

In O
November O
, O
2001 O
, O
he O
progressed O
to O
leukemic B-SYMPTOM
phase I-SYMPTOM
, O
received O
Rituxan B-TREATMENT
and O
CVP B-TREATMENT
. O

Started O
Campath B-TREATMENT
in O
July O
, O
2001 O
, O
complicated O
by O
lymphopenia B-SYMPTOM
/ O
neutropenia B-SYMPTOM
and O
CMV B-SYMPTOM
infection I-SYMPTOM
, O
and O
underwent O
MUD B-TREATMENT
stem I-TREATMENT
cell I-TREATMENT
transplant I-TREATMENT
in O
December O
, O
2002 O
. O

The O
patient O
had O
bone O
marrow O
biopsy O
, O
August O
, O
2003 O
, O
for O
persistent B-SYMPTOM
pancytopenia I-SYMPTOM
, O
revealing O
mild B-SYMPTOM
hypercelluarity I-SYMPTOM
with O
80% B-SYMPTOM
leukemic I-SYMPTOM
cells I-SYMPTOM
. O

He O
was O
again O
treated O
with O
Campath B-TREATMENT
, O
had O
recurrent B-SYMPTOM
fever I-SYMPTOM
in O
association O
with O
sinus B-SYMPTOM
symptoms I-SYMPTOM
, O
with O
CT O
scan O
showing O
left B-SYMPTOM
maxillary I-SYMPTOM
sinusitis I-SYMPTOM
in O
association O
with O
new B-SYMPTOM
skin I-SYMPTOM
nodules I-SYMPTOM
on I-SYMPTOM
right I-SYMPTOM
elbow I-SYMPTOM
and I-SYMPTOM
buttocks I-SYMPTOM
. O

Patient O
was O
hospitalized O
September O
26 O
to O
November O
11 O
for O
what O
was O
diagnosed O
by O
skin O
biopsy O
and O
sinus O
washings O
as O
Acanthamoeba B-SYMPTOM
infection I-SYMPTOM
of I-SYMPTOM
skin I-SYMPTOM
and O
sinuses O
, O
without O
any O
progression O
to O
neurologic B-SYMPTOM
infection I-SYMPTOM
( O
as O
assessed O
by O
head O
CT O
and O
MRI O
) O
. O

ID O
consult O
was O
obtained O
and O
he O
was O
initially O
treated O
with O
azithromycin B-TREATMENT
, O
itraconazole B-TREATMENT
, O
and O
pentamidine B-TREATMENT
, O
with O
progression O
of O
skin B-SYMPTOM
infection I-SYMPTOM
. O

Subsequent O
discontinuance O
of O
azithromycin B-TREATMENT
, O
trial B-TREATMENT
of I-TREATMENT
5-FC I-TREATMENT
, O
with O
increasing B-SYMPTOM
neutropenia I-SYMPTOM
requiring O
discontinuance O
, O
change O
if O
itraconazole B-TREATMENT
to O
voriconazole B-TREATMENT
, O
given O
continued B-SYMPTOM
neutropenia I-SYMPTOM
, O
and O
trial O
of O
sulfadiazine B-TREATMENT
, O
discontinued O
for O
increasing B-SYMPTOM
ARS I-SYMPTOM
. O

Patient O
was O
maintained O
on O
p.o. B-TREATMENT
voriconazole I-TREATMENT
and O
IV B-TREATMENT
pentamidine I-TREATMENT
, O
with O
pentamidine B-TREATMENT
nasal I-TREATMENT
washings I-TREATMENT
, O
with O
re-CT O
of O
sinuses O
near O
end O
of O
stay O
showing O
no O
change O
in O
disease B-SYMPTOM
burden I-SYMPTOM
. O

He O
has O
had O
recurrent B-SYMPTOM
CMB I-SYMPTOM
infection I-SYMPTOM
in O
the O
setting O
of O
Campath B-TREATMENT
therapy I-TREATMENT
, O
requiring O
IV B-TREATMENT
Foscarnet I-TREATMENT
therapy I-TREATMENT
during O
stay O
, O
with O
inability O
to O
tolerate O
valganciclovir B-TREATMENT
maintenance I-TREATMENT
suppression I-TREATMENT
subsequently O
due O
to O
increasing B-SYMPTOM
ARS I-SYMPTOM
. O

Hypercapture O
near O
end O
of O
stay O
was O
negative O
. O

Patient O
experienced O
acute B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
on O
chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
, O
with O
previous O
baseline O
creatinine O
1.6 O
, O
felt O
to O
be O
due O
to O
medication B-SYMPTOM
toxicity I-SYMPTOM
, O
requiring O
Kayexalate B-TREATMENT
and O
Phoslo B-TREATMENT
to O
manage O
electrolytes O
, O
but O
never O
any O
need O
for O
hemodialysis B-TREATMENT
, O
with O
mild O
improvement O
of O
creatinine O
by O
discharge O
, O
with O
peak O
creatinine O
3.4 O
, O
discharge O
creatinine O
2.6 O
. O

Patient O
struggled O
with O
GVHD B-SYMPTOM
, O
with O
extensive B-SYMPTOM
skin I-SYMPTOM
involvement I-SYMPTOM
, O
taking O
Cellcept B-TREATMENT
, O
prednisone B-TREATMENT
and O
cyclosporine B-TREATMENT
at O
time O
of O
last O
admission O
. O

Cellcept B-TREATMENT
was O
discontinued O
in O
the O
setting O
of O
infection B-SYMPTOM
, O
but O
attempts O
to O
decrease O
prednisone B-TREATMENT
or O
cyclosporine B-TREATMENT
were O
unsuccessful O
. O

Patient O
returns O
from O
rehabilitation B-TREATMENT
after O
discharge O
on O
November O
11 O
, O
with O
new B-SYMPTOM
fever I-SYMPTOM
up O
to O
102.0 O
in O
DSCI O
clinic O
, O
increasing B-SYMPTOM
hepatomegaly I-SYMPTOM
as O
assessed O
by O
examination O
in O
clinic O
, O
and O
increasing B-SYMPTOM
creatinine I-SYMPTOM
. O

Patient O
reports O
no O
significant O
changes O
in O
how O
he O
feels O
over O
the O
past O
week O
. O

Denies O
cough B-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
diarrhea B-SYMPTOM
, O
dysuria B-SYMPTOM
, O
neck B-SYMPTOM
stiffness I-SYMPTOM
, O
new B-SYMPTOM
skin I-SYMPTOM
lesions I-SYMPTOM
, O
worsening B-SYMPTOM
red I-SYMPTOM
petechiae I-SYMPTOM
, O
or O
increasing B-SYMPTOM
sinus I-SYMPTOM
symptoms I-SYMPTOM
. O

Patient O
reports O
persistent B-SYMPTOM
mild I-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
discomfort I-SYMPTOM
, O
recent B-SYMPTOM
poor I-SYMPTOM
appetite I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Refractory B-SYMPTOM
CLL I-SYMPTOM
with O
bone B-SYMPTOM
marrow I-SYMPTOM
involvement I-SYMPTOM
, O
status O
post O
MUD B-TREATMENT
, I-TREATMENT
mini-allo I-TREATMENT
stem I-TREATMENT
cell I-TREATMENT
transplant I-TREATMENT
, O
December O
, O
2002 O
, O
Acanthamoeba B-SYMPTOM
infection I-SYMPTOM
of I-SYMPTOM
skin I-SYMPTOM
and I-SYMPTOM
sinuses I-SYMPTOM
, O
recently O
treated O
with O
IV B-TREATMENT
pentamidine I-TREATMENT
and O
p.o. B-TREATMENT
voriconazole I-TREATMENT
, O
history O
of O
recurrent B-SYMPTOM
CMB I-SYMPTOM
infection I-SYMPTOM
, O
recent B-SYMPTOM
ARS I-SYMPTOM
on O
CRI B-SYMPTOM
, O
thought O
due O
to O
medication B-SYMPTOM
toxicity I-SYMPTOM
( O
creatinine O
on O
discharge O
from O
Retelk O
County O
Medical O
Center O
on O
October O
16 O
was O
2.6) O
. O

No O
history O
of O
hemodialysis B-TREATMENT
. O

Graft B-SYMPTOM
versus I-SYMPTOM
host I-SYMPTOM
disease I-SYMPTOM
, O
recently O
on O
cyclosporine B-TREATMENT
50 O
b.i.d. O
and O
prednisone B-TREATMENT
60 O
q.d. O

History O
of O
SVT B-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Pentamidine B-TREATMENT
300 O
mg O
IV O
q. O
36 O
hours O
, O
Pentamidine B-TREATMENT
nasal I-TREATMENT
wash I-TREATMENT
60 O
mg O
per O
6 O
ml O
of O
sterile B-TREATMENT
water I-TREATMENT
q.d. O
, O
voriconazole B-TREATMENT
200 O
mg O
p.o. O
b.i.d. O
, O
acyclovir B-TREATMENT
400 O
mg O
p.o. O
b.i.d. O
, O
cyclosporine B-TREATMENT
50 O
mg O
p.o. O
b.i.d. O
, O
prednisone B-TREATMENT
60 O
mg O
p.o. O
q.d. O
, O
GCSF B-TREATMENT
480 O
mcg O
IV O
q.d. O
, O
Epogen B-TREATMENT
40,000 O
units O
subcu O
q. O
week O
, O
Protonix B-TREATMENT
40 O
mg O
q.d. O
, O
Simethicone B-TREATMENT
80 O
mg O
p.o. O
q. O
8 O
, O
nitroglycerin B-TREATMENT
paste I-TREATMENT
1 O
&quot; O
q. O
4 O
h. O
p.r.n. O
, O
flunisolide B-TREATMENT
nasal I-TREATMENT
inhaler I-TREATMENT
, O
2 O
puffs O
q. O
8 O
, O
OxyCodone B-TREATMENT
10-15 O
mg O
p.o. O
q. O
6 O
p.r.n. O
, O
Sudafed B-TREATMENT
30 O
mg O
q. O
6 O
p.o. O
p.r.n. O
, O
Fluconazole B-TREATMENT
2% I-TREATMENT
cream I-TREATMENT
b.i.d. O
to O
erythematous B-SYMPTOM
skin I-SYMPTOM
lesions I-SYMPTOM
, O
Ditropan B-TREATMENT
5 O
mg O
p.o. O
b.i.d. O
, O
Tylenol B-TREATMENT
650 O
mg O
p.o. O
q. O
4 O
h. O
p.r.n. O
, O
Ambien B-TREATMENT
5-10 O
mg O
p.o. O
q. O
h.s. O
p.r.n. O
, O
Neurontin B-TREATMENT
100 O
mg O
q. O
a.m. O
, O
200 O
mg O
q. O
p.m. O
, O
Aquaphor B-TREATMENT
cream I-TREATMENT
b.i.d. O
p.r.n. O
, O
Lotrimin B-TREATMENT
1% I-TREATMENT
cream I-TREATMENT
b.i.d. O
to O
feet O
, O
Dulcolax B-TREATMENT
5-10 O
mg O
p.o. O
q.d. O
p.r.n. O
, O
Phoslo B-TREATMENT
667 O
mg O
p.o. O
t.i.d. O
, O
Peridex B-TREATMENT
0.12% O
, O
15 O
ml O
p.o. O
b.i.d. O
mouthwash O
, O
Benadryl B-TREATMENT
25-50 O
mg O
q. O
4-6 O
h. O
p.r.n. O
pruritus B-SYMPTOM
, O
Sarna B-TREATMENT
cream I-TREATMENT
q.d. O
p.r.n. O
pruritus B-SYMPTOM
, O
Nystatin B-TREATMENT
5 O
ml O
p.o. O
q.i.d. O
swish O
and O
! O

spit O
, O
folate B-TREATMENT
1 O
mg O
p.o. O
q.d. O
, O
vitamin B-TREATMENT
E I-TREATMENT
400 O
units O
p.o. O
q.d. O
, O
Haldol B-TREATMENT
2 O
mg O
IV O
q. O
6 O
p.r.n. O
agitation B-SYMPTOM
, O
Colace B-TREATMENT
100 O
mg O
b.i.d. O
, O
Senna B-TREATMENT
2 O
tablets O
p.o. O
b.i.d. O

ALLERGIES O
: O

BACTRIM B-TREATMENT
( O
SEVERE B-SYMPTOM
RASH I-SYMPTOM
) O
, O
GANCICLOVIR B-TREATMENT
( O
RASH B-SYMPTOM
, O
HAS O
BEEN O
DESENSITIZED O
) O
. O

SOCIAL O
HISTORY O
: O

Patient O
works O
formerly O
as O
a O
structural O
engineer O
, O
has O
not O
been O
employed O
over O
the O
last O
two O
years O
. O

Patient O
is O
married O
, O
an O
immigrant O
from O
Mondca O
, O
South O
Carolina O
who O
lived O
close O
to O
Scond O
at O
time O
of O
nuclear O
disaster O
. O

PHYSICAL O
EXAMINATION O
: O

VITAL O
SIGNS O
: O

98.6 O
, O
85 O
, O
130/80 O
, O
20 O
, O
97% O
on O
room O
air O
, O
82.2 O
kg O
. O

GENERAL O
: O

Comfortable O
, O
conversational O
, O
appears O
same O
as O
week O
prior O
, O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
. O

HEENT O
: O

Pupils O
were O
equal O
, O
round O
, O
reactive O
to O
light O
, O
anicteric B-SYMPTOM
. O

Oropharynx O
clear O
. O

CARDIOVASCULAR O
: O

Regular O
, O
normal O
S1 O
and O
S2 O
, O
no O
murmurs B-SYMPTOM
, O
gallops B-SYMPTOM
or O
rubs B-SYMPTOM
. O

JVP O
flat O
. O

RESPIRATORY O
: O

Lungs O
clear O
to O
auscultation O
bilaterally O
. O

ABDOMEN O
: O

Normoactive O
bowel O
sounds O
, O
soft O
, O
mild B-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
tenderness I-SYMPTOM
, O
not O
dissimilar O
from O
week O
prior O
, O
pronounced B-SYMPTOM
hepatomegaly I-SYMPTOM
with O
liver O
edge O
7 O
cm O
below O
costal O
margin O
, O
midclavicular O
line O
, O
no O
splenomegaly B-SYMPTOM
, O
no O
CVA B-SYMPTOM
tenderness I-SYMPTOM
. O

EXTREMITIES O
: O

Slightly B-SYMPTOM
cool I-SYMPTOM
, O
3-4+ B-SYMPTOM
edema I-SYMPTOM
bilaterally I-SYMPTOM
. O

DERMATOLOGY O
: O

Erythematous B-SYMPTOM
eruption I-SYMPTOM
on O
80% O
of O
body O
, O
not O
much O
change O
from O
week O
prior O
. O

Erythematous B-SYMPTOM
nodules I-SYMPTOM
on I-SYMPTOM
arms I-SYMPTOM
at O
elbows O
and O
on O
right O
thigh O
, O
as O
previous O
. O

NEUROLOGIC O
: O

Alert O
and O
appropriate O
. O

ADMISSION O
LABORATORY O
DATA O
: O

Sodium O
129 O
, O
creatinine O
3.0 O
, O
BUN O
70 O
, O
potassium O
5.0 O
, O
bicarbonate O
23 O
, O
chloride O
99 O
, O
ALT O
36 O
, O
AST O
30 O
, O
alkaline O
phosphatase O
215 O
, O
total O
bilirubin O
1.1 O
, O
albumin O
2.6 O
, O
white O
blood O
cell O
count O
2.0 O
, O
hematocrit O
30.5 O
, O
platelets O
60 O
. O

HOSPITAL O
COURSE O
: O

Patient O
was O
admitted O
for O
diagnosis O
and O
treatment B-TREATMENT
of O
new B-SYMPTOM
fever I-SYMPTOM
. O

Workup O
on O
admission O
included O
a O
chest O
x-ray O
negative O
for O
pneumonia B-SYMPTOM
, O
an O
MRI O
of O
the O
liver O
to O
investigate O
for O
focal B-SYMPTOM
lesion I-SYMPTOM
, O
with O
no O
evidence O
for O
abscess B-SYMPTOM
or O
focal B-SYMPTOM
lesion I-SYMPTOM
on O
report O
. O

Blood O
and O
urine O
cultures O
with O
only O
positive O
culture O
a O
blood O
culture O
on O
November O
20 O
, O
with O
one O
of O
two O
bottles O
positive O
for O
coagulase B-SYMPTOM
negative I-SYMPTOM
Staphylococcus I-SYMPTOM
. O

A O
repeat O
CMV O
hypercapture O
, O
negative O
for O
presence O
of O
CMV B-SYMPTOM
. O

A O
repeat O
CAT O
scan O
of O
the O
sinuses O
with O
finding O
of O
progressive B-SYMPTOM
thickening I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
maxillary I-SYMPTOM
sinus I-SYMPTOM
and O
both O
sets O
of O
ethmoid O
air O
cells O
since O
prior O
study O
of O
November O
9 O
, O
indicating O
progressive B-SYMPTOM
infection I-SYMPTOM
of I-SYMPTOM
Acanthamoeba I-SYMPTOM
and O
any O
possible O
superinfection B-SYMPTOM
with O
bacterial B-SYMPTOM
sinusitis I-SYMPTOM
. O

In O
the O
days O
following O
admission O
, O
there O
was O
clear O
evidence O
for O
progression O
of O
erythematous B-SYMPTOM
nodules I-SYMPTOM
over I-SYMPTOM
both I-SYMPTOM
arms I-SYMPTOM
and O
right O
thigh O
at O
foci O
of O
Acanthamoeba B-SYMPTOM
infection I-SYMPTOM
, O
suggesting O
progressive B-SYMPTOM
skin I-SYMPTOM
involvement I-SYMPTOM
with O
Acanthamoeba B-SYMPTOM
. O

Infectious O
disease O
consult O
was O
obtained O
and O
recommendation O
was O
to O
switch O
from O
voriconazole B-TREATMENT
to O
itraconazole B-TREATMENT
, O
on O
which O
there O
was O
more O
existing O
data O
on O
treatment B-TREATMENT
of O
Acanthamoeba B-SYMPTOM
infection I-SYMPTOM
. O

Pentamidine B-TREATMENT
intravenous I-TREATMENT
and I-TREATMENT
nasal I-TREATMENT
washings I-TREATMENT
were O
continued O
. O

Clinical O
progression O
of O
skin B-SYMPTOM
and I-SYMPTOM
sinus I-SYMPTOM
infection I-SYMPTOM
on O
maximal B-TREATMENT
antimicrobial I-TREATMENT
therapy I-TREATMENT
continued O
, O
with O
emergence O
on O
November O
20 O
of O
a B-SYMPTOM
new I-SYMPTOM
right-sided I-SYMPTOM
ptosis I-SYMPTOM
in O
association O
with O
a B-SYMPTOM
left I-SYMPTOM
homonymous I-SYMPTOM
hemianopsia I-SYMPTOM
, O
and O
fleeting B-SYMPTOM
confusion I-SYMPTOM
while O
febrile B-SYMPTOM
, O
prompting O
head O
MRI O
which O
revealed O
a O
large O
5 O
x O
2 O
x O
4.3 O
cm O
region O
in O
the O
right O
occipital O
lobe O
of O
hemorrhage B-SYMPTOM
and O
edema B-SYMPTOM
, O
with O
dural B-SYMPTOM
and I-SYMPTOM
, I-SYMPTOM
likely I-SYMPTOM
, I-SYMPTOM
leptomeningeal I-SYMPTOM
enhancement I-SYMPTOM
in O
association O
with O
small B-SYMPTOM
foci I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
cerebellum I-SYMPTOM
and O
pons O
, O
concerning O
for O
early B-SYMPTOM
lesions I-SYMPTOM
of O
similar O
type O
. O

Idiosyncratic B-SYMPTOM
reaction I-SYMPTOM
to O
cyclosporine B-TREATMENT
was O
considered O
as O
cause O
for O
cerebritis B-SYMPTOM
, O
and O
cyclosporine B-TREATMENT
was O
discontinued O
. O

However O
, O
much O
more O
likely O
explanation O
is O
progressive B-SYMPTOM
infection I-SYMPTOM
of O
Acanthamoeba B-SYMPTOM
with O
new B-SYMPTOM
neurologic I-SYMPTOM
involvement I-SYMPTOM
. O

Most O
likely O
source O
of O
fevers B-SYMPTOM
was O
judged O
to O
be O
progressive B-SYMPTOM
Acanthamoeba I-SYMPTOM
infection I-SYMPTOM
, O
even O
on O
maximal B-TREATMENT
antimicrobial I-TREATMENT
therapy I-TREATMENT
. O

A O
single O
blood O
culture O
positive O
for O
coagulase B-SYMPTOM
negative I-SYMPTOM
Staphylococcus I-SYMPTOM
was O
treated O
with O
a O
course O
of O
vancomycin B-TREATMENT
in O
the O
setting O
of O
a B-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
and O
a O
chest O
x-ray O
on O
November O
20 O
indicating O
possible O
developing B-SYMPTOM
pneumonia I-SYMPTOM
, O
resulted O
in O
a O
course O
of O
levofloxacin B-TREATMENT
, O
for O
both O
possible O
pneumonia B-SYMPTOM
, O
as O
well O
as O
treatment B-TREATMENT
of O
any B-SYMPTOM
bacterial I-SYMPTOM
superinfection I-SYMPTOM
of O
Acanthamoeba B-SYMPTOM
sinusitis I-SYMPTOM
. O

Patient O
experienced O
steady O
decline O
, O
with O
persistent B-SYMPTOM
fevers I-SYMPTOM
despite O
all B-TREATMENT
above I-TREATMENT
measures I-TREATMENT
, O
progressive O
areas O
of O
skin B-SYMPTOM
infection I-SYMPTOM
, O
more O
frequent O
episodes O
of O
confusion B-SYMPTOM
, O
and O
decreasing B-SYMPTOM
oxygen I-SYMPTOM
saturation I-SYMPTOM
in O
the O
setting O
of O
bilateral B-SYMPTOM
effusion I-SYMPTOM
, O
in O
the O
setting O
of O
fluid B-SYMPTOM
surge I-SYMPTOM
spacing I-SYMPTOM
. O

On O
November O
30 O
, O
a O
family O
meeting O
with O
patient O
&apos;s O
daughter O
and O
spouse O
, O
along O
with O
primary O
oncologist O
, O
Dr. O
Tomedankell O
Bile O
, O
attending O
physician O
, O
Dr. O
Mellerny O
Close O
, O
and O
house O
staff O
, O
was O
held O
to O
discuss O
patient B-SYMPTOM
&apos;s I-SYMPTOM
critical I-SYMPTOM
condition I-SYMPTOM
and O
inability O
to O
prevent O
progression O
of O
skin B-SYMPTOM
, I-SYMPTOM
sinus I-SYMPTOM
and I-SYMPTOM
neurological I-SYMPTOM
Acanthamoeba I-SYMPTOM
infection I-SYMPTOM
on O
maximal B-TREATMENT
antimicrobial I-TREATMENT
therapy I-TREATMENT
. O

Decision O
was O
made O
to O
withdraw O
aggressive B-TREATMENT
measures I-TREATMENT
of I-TREATMENT
care I-TREATMENT
, O
with O
priority O
on O
patient O
&apos;s O
comfort O
. O

Pentamidine B-TREATMENT
, O
itraconazole B-TREATMENT
, O
Levaquin B-TREATMENT
, O
acyclovir B-TREATMENT
and O
GCSF B-TREATMENT
were O
discontinued O
, O
along O
with O
other B-TREATMENT
medications I-TREATMENT
nonessential O
to O
patient O
&apos;s O
comfort O
. O

DNR O
/ O
DNI O
status O
initially O
established O
early O
during O
hospital O
stay O
remained O
in O
effect O
. O

The O
patient O
was O
made O
comfortable O
with O
morphine B-TREATMENT
for O
pain B-SYMPTOM
and O
for O
air B-SYMPTOM
hunger I-SYMPTOM
, O
and O
sinus B-TREATMENT
suctioning I-TREATMENT
was O
continued O
to O
relieve O
congestion B-SYMPTOM
, O
in O
conjunction O
with O
continuation O
of O
nasal B-TREATMENT
sprays I-TREATMENT
. O

Tylenol B-TREATMENT
was O
continued O
to O
control O
fevers B-SYMPTOM
and O
prednisone B-TREATMENT
was O
continued O
to O
control O
inflammation B-SYMPTOM
and O
prevent O
precipitation O
of O
adrenal B-SYMPTOM
insufficiency I-SYMPTOM
. O

Such O
measures O
have O
been O
continued O
through O
December O
3 O
, O
and O
patient O
remains O
comfortable O
through O
this O
time O
. O

This O
interim O
dictation O
to O
be O
followed O
by O
an O
addendum O
detailing O
end O
of O
hospital O
course O
. O

Dictated O
By O
: O

SHAA O
KACHOLERA O
STONGE O
, O
M.D. O
LN00 O

Attending O
: O

LA O
K. O
SKI O
, O
M.D. O
OF1 O
WS584/564649 O

Batch O
: O

2235 O

Index O
No. O
UWHS3TCPJ2 O

D O
: O

12/03/03 O

T O
: O

12/04/03 O

Admission O
Date O
: O

2011-10-17 O

Discharge O
Date O
: O

2011-10-31 O

Date O
of O
Birth O
: O

1955-09-01 O

Sex O
: O

M O

Service O
: O

Cardiothor O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
56 O
year-old O
gentleman O
with O
severe B-SYMPTOM
aortic I-SYMPTOM
stenosis I-SYMPTOM
, O
reports O
having O
been O
told O
he O
had O
a B-SYMPTOM
heart I-SYMPTOM
murmur I-SYMPTOM
many O
years O
ago O
but O
just O
recently O
diagnosed O
with O
aortic B-SYMPTOM
stenosis I-SYMPTOM
. O

He O
has O
had O
mild B-SYMPTOM
dyspnea I-SYMPTOM
on O
exertion O
increasing O
over O
the O
past O
couple O
of O
months O
prior O
to O
admission O
. O

An O
echocardiogram O
in O
2011-09-05 O
revealed O
a O
left O
ventricular O
ejection O
fraction O
of O
20 O
to O
25% O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Cigarette O
smoking O
. O

2. O
Insulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

3. O
Proteinuria B-SYMPTOM
. O

4. O
Aortic B-SYMPTOM
stenosis I-SYMPTOM
. O

5. O
Cellulitis B-SYMPTOM
. O

6. O
Gangrene B-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
left I-SYMPTOM
second I-SYMPTOM
toe I-SYMPTOM
in O
2010-06-06 O
followed O
by O
an B-TREATMENT
amputation I-TREATMENT
. O

7. O
Left B-TREATMENT
common I-TREATMENT
femoral I-TREATMENT
dorsalis I-TREATMENT
pedis I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

8. O
Right B-TREATMENT
leg I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
in O
1999 O
. O

9. O
Right B-TREATMENT
below I-TREATMENT
the I-TREATMENT
knee I-TREATMENT
amputation I-TREATMENT
in O
2008 O
. O

ALLERGIES O
: O

The O
patient O
states O
he O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
: O

1. O
Aspirin B-TREATMENT
325 O
mg O
po O
q O
day O
. O

2. O
Vasotec B-TREATMENT
7.5 O
mg O
po O
q O
day O
. O

3. O
Humalog B-TREATMENT
insulin I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
with O
meals O
and O
at O
bedtime O
. O

4. O
Humulin B-TREATMENT
Walters I-TREATMENT
insulin I-TREATMENT
24 O
units O
subcutaneous O
q O
A.M. O
and O
8 O
to O
16 O
in O
the O
evening O
depending O
upon O
where O
his O
blood O
sugar O
has O
been O
. O

Preoperative O
laboratory O
values O
were O
unremarkable O
. O

The O
patient O
underwent O
cardiac O
catheterization O
on O
2011-10-17 O
which O
revealed O
a B-SYMPTOM
20% I-SYMPTOM
left I-SYMPTOM
vein I-SYMPTOM
osteal I-SYMPTOM
lesion I-SYMPTOM
as O
well O
as O
70% B-SYMPTOM
LAD I-SYMPTOM
lesion I-SYMPTOM
and O
an B-SYMPTOM
80% I-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
. O

The O
patient O
was O
taken O
to O
the O
operating O
room O
on O
2011-10-18 O
where O
he O
underwent O
an B-TREATMENT
aortic I-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
with O
#23 B-TREATMENT
mm I-TREATMENT
pericardial I-TREATMENT
valve I-TREATMENT
as O
well O
as O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times O
two O
with O
a O
LIMA O
to O
the O
LAD O
and O
saphenous O
vein O
to O
the O
acute O
marginal O
. O

Postoperatively O
the O
patient O
was O
transported O
to O
the O
cardiac O
surgery O
recovery O
unit O
on O
Milrinone B-TREATMENT
, O
Neo-Synephrine B-TREATMENT
and O
Levophed B-TREATMENT
drip I-TREATMENT
. O

The O
patient O
was O
weaned O
from O
mechanical B-TREATMENT
ventilation I-TREATMENT
and O
subsequently O
extubated O
on O
the O
night O
of O
surgery B-TREATMENT
. O

He O
remained O
on O
Levophed B-TREATMENT
, O
Milrinone B-TREATMENT
and O
Neo-Synephrine B-TREATMENT
drips I-TREATMENT
and O
was O
hemodynamically O
stable O
. O

N. O
Saez O
clinic O
consult O
was O
obtained O
due O
to O
hyperglycemia B-SYMPTOM
and O
the O
need O
for O
insulin B-TREATMENT
drip I-TREATMENT
in O
the O
Intensive O
Care O
Unit O
. O

On O
postoperative O
day O
the B-TREATMENT
Milrinone I-TREATMENT
was O
weaned O
down O
. O

The B-TREATMENT
Levophed I-TREATMENT
had O
been O
discontinued O
as O
the B-TREATMENT
Neo-Synephrine I-TREATMENT
and O
the O
patient O
was O
beginning O
to O
progress O
hemodynamically O
. O

Upon O
discontinuation O
of O
the B-TREATMENT
Milrinone I-TREATMENT
the O
patient O
's O
SV02 O
had O
dropped O
significantly O
in O
the O
low O
50 O
s. O

The O
patient O
had O
decreased B-SYMPTOM
exercise I-SYMPTOM
tolerance I-SYMPTOM
and O
therefore O
was O
placed O
back O
on O
his B-TREATMENT
milrinone I-TREATMENT
to O
keep O
his O
cardiac O
index O
greater O
than O
2.0 O
. O

Over O
the O
next O
couple O
of O
days O
it O
was O
very O
slowly O
decreased O
as O
his B-TREATMENT
Ace I-TREATMENT
inhibitors I-TREATMENT
were O
increased O
orally O
. O

The O
patient O
ultimately O
was O
weaned O
off O
the B-TREATMENT
Milrinone I-TREATMENT
, O
transitioned O
to O
Captopril B-TREATMENT
on O
postoperative O
day O
five O
and O
remained O
hemodynamically O
stable O
. O

Once O
the O
patient O
had O
remained O
off O
of O
inotropics B-TREATMENT
for O
approximately O
24 O
hours O
, O
he O
had O
been O
given O
diuretics B-TREATMENT
and O
Ace B-TREATMENT
inhibitors I-TREATMENT
and O
remained O
hemodynamically O
stable O
he O
was O
transferred O
from O
the O
Intensive O
Care O
Unit O
to O
the O
Telemetry O
floor O
on O
postoperative O
day O
six O
. O

A O
physical O
therapy O
evaluation O
was O
obtained O
for O
assistance O
and O
mobility O
. O

Cardiac B-TREATMENT
rehabilitation I-TREATMENT
was O
initiated O
at O
that O
time O
. O

On O
2011-10-24 O
postoperative O
day O
six O
consultation O
heart O
failure O
cardiology O
service O
was O
obtained O
. O

It O
was O
their O
recommendation O
to O
continue O
Ace B-TREATMENT
inhibitors I-TREATMENT
, O
to O
continue O
daily O
weights O
, O
to O
switch O
the O
patient O
to O
a B-TREATMENT
long I-TREATMENT
acting I-TREATMENT
beta-blocker I-TREATMENT
and O
to O
enroll O
the O
patient O
in O
postoperative B-TREATMENT
cardiac I-TREATMENT
rehabilitation I-TREATMENT
as O
well O
as O
to O
make O
sure O
the O
patient O
was O
on O
statin B-TREATMENT
drugs I-TREATMENT
. O

These O
measures O
were O
all O
instituted O
. O

The O
patient O
continued O
to O
progress O
from O
cardiac O
rehabilitation O
and O
physical O
therapy O
standpoint O
while O
on O
the O
floor O
. O

The O
patient O
remained O
hemodynamically O
stable O
over O
the O
next O
few O
days O
, O
continued O
to O
increase O
with O
physical B-TREATMENT
therapy I-TREATMENT
and O
ambulation O
. O

His O
blood O
sugars O
were O
followed O
by O
the O
Cape O
Cod O
Hospital O
Clinic O
service O
and O
insulin B-TREATMENT
has O
been O
adjusted O
accordingly O
. O

Today O
, O
2011-10-31 O
, O
postoperative O
day O
13 O
the O
patient O
remains O
stable O
and O
ready O
for O
discharge O
to O
home O
. O

The O
patient O
's O
condition O
today O
is O
as O
follows O
: O

Temperature O
96.9 O
F O
, O
pulse O
84 O
, O
respiratory O
rate O
18 O
, O
blood O
pressure O
106/59 O
. O

Most O
recent O
laboratory O
values O
are O
from O
2011-10-25 O
which O
revealed O
a O
white O
blood O
cell O
count O
8.4000 O
, O
hematocrit O
35 O
, O
platelet O
count O
202,000. O
Sodium O
133 O
, O
potassium O
4.4 O
, O
chloride O
93 O
, O
CO2 O
30 O
, O
BUN O
24 O
, O
creatinine O
0.7 O
, O
glucose O
198 O
. O

The O
patient O
's O
finger O
stick O
blood O
glucose O
levels O
range O
from O
151 O
to O
390 O
over O
the O
past O
24 O
hours O
and O
his B-TREATMENT
insulin I-TREATMENT
scale I-TREATMENT
has O
been O
adjusted O
upward O
to O
compensate O
for O
that O
. O

Neurologically O
the O
patient O
is O
grossly O
intact O
. O

Pulmonary O
exam O
he O
is O
clear O
upper O
lobes O
, O
diminished B-SYMPTOM
bilateral I-SYMPTOM
bases I-SYMPTOM
left O
greater O
than O
right O
. O

Coronary O
exam O
is O
regular O
rate O
and O
rhythm O
. O

His O
abdomen O
is O
benign O
. O

His O
sternum O
is O
stable. O
His B-SYMPTOM
incision I-SYMPTOM
is O
clean O
and O
dry O
Steri B-TREATMENT
Strips I-TREATMENT
intact O
. O

His O
extremities O
are O
warm O
and O
well O
perfused O
with O
minimal B-SYMPTOM
edema I-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
left I-SYMPTOM
foot I-SYMPTOM
as O
well O
as O
his O
right O
stump O
. O

He O
is O
able O
to O
apply O
his B-TREATMENT
prosthesis I-TREATMENT
and O
ambulate O
as O
well O
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Lasix B-TREATMENT
40 O
mg O
po O
bid O
. O

2. O
Potassium B-TREATMENT
Chloride I-TREATMENT
20 O
milliequivalents O
po O
bid O
. O

3. O
Colace B-TREATMENT
100 O
mg O
po O
bid O
. O

4. O
Zantac B-TREATMENT
150 O
mg O
po O
bid O
. O

5. O
Aspirin B-TREATMENT
325 O
mg O
po O
qd O
. O

6. O
Captopril B-TREATMENT
25 O
mg O
po O
tid O
. O

7. O
Digoxin B-TREATMENT
0.25 O
mg O
po O
q O
day O
. O

8. O
Atorvastatin B-TREATMENT
10 O
mg O
po O
q O
day O
. O

9. O
Toprol B-TREATMENT
XL I-TREATMENT
100 O
mg O
po O
q O
day O
. O

10. O
Bollin B-TREATMENT
insulin I-TREATMENT
18 O
units O
subcutaneous O
q O
A.M. O
, O
Richard B-TREATMENT
insulin I-TREATMENT
14 O
units O
subcutaneous O
q O
P.M. O

11. O
Sliding B-TREATMENT
scale I-TREATMENT
Humalog I-TREATMENT
regular I-TREATMENT
insulin I-TREATMENT
for O
breakfast O
is O
blood O
glucose O
of O
151 O
to O
200 O
equal O
4 O
units O
, O
201 O
to O
250 O
equal O
6 O
units O
, O
251 O
to O
350 O
equal O
12 O
units O
, O
greater O
than O
350 O
equals O
15 O
units O
. O

For O
lunch O
blood O
glucose O
of O
101 O
to O
150 O
equals O
4 O
units O
, O
151 O
to O
200 O
equals O
7 O
units O
, O
201 O
to O
250 O
equals O
8 O
units O
, O
251 O
to O
350 O
equals O
12 O
units O
, O
greater O
than O
350 O
equals O
15 O
units O
. O

Dinner O
blood O
glucose O
101 O
to O
150 O
equals O
2 O
units O
, O
151 O
to O
200 O
equals O
3 O
units O
, O
201 O
to O
250 O
equals O
6 O
units O
, O
251 O
to O
350 O
equals O
12 O
units O
, O
greater O
than O
350 O
equals O
15 O
units O
. O

DISCHARGE O
CONDITION O
: O

Stable O
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Aortic B-SYMPTOM
stenosis I-SYMPTOM
. O

2. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

3. O
Type B-SYMPTOM
I I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

4. O
Peripheral B-SYMPTOM
vascular I-SYMPTOM
disease I-SYMPTOM
. O

FOLLOW O
UP O
: O

Dr. O
Lloyd O
van O
de O
Clark O
in O
approximately O
one O
month O
postoperative O
. O

Please O
call O
the O
office O
at O
( O
854 O
) O
787-3243 O
for O
an O
appointment O
. O

The O
patient O
is O
also O
to O
follow O
up O
with O
his O
primary O
care O
physician O
for O
diabetes B-TREATMENT
management I-TREATMENT
. O

He O
is O
to O
follow O
up O
with O
Dr. O
East O
here O
at O
the O
Heart O
Failure O
Clinic O
to O
continue O
follow O
up O
with O
cardiac B-TREATMENT
rehabilitation I-TREATMENT
and O
heart B-TREATMENT
failure I-TREATMENT
management I-TREATMENT
. O

Brown O
des O
Stone O
, O
M.D. O

07-760 O

Dictated O
By O
: O
Anthony O
O O
Carreno O
, O
M.D. O

MEDQUIST36 O

D O
: O
2011-10-31 O
10:25 O

T O
: O
2011-10-31 O
10:45 O

JOB O
#: O
02527 O

Signed O
electronically O
by O
: O
DR. O
John O
della O
Hopper O
on O
: O
WED O
2011-11-16 O
7:16 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2013-10-27 O

Discharge O
Date O
: O

2013-11-03 O

Date O
of O
Birth O
: O

1971-05-13 O

Sex O
: O

F O

Service O
: O

MEDICINE B-TREATMENT

Allergies O
: O

Morphine B-TREATMENT
/ O
Latex B-TREATMENT

Attending O
: O
Everett O
J. O
Decardo O
, O
M.D. O

Chief O
Complaint O
: O

GIB B-SYMPTOM
, O
hematemesis B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

EGD O
with O
esophageal B-TREATMENT
varices I-TREATMENT
sclerosis I-TREATMENT

History O
of O
Present O
Illness O
: O

42 O
year O
old O
female O
with O
h/o O
cholangiocarcinoma B-SYMPTOM
dx O
in O
2009 O
s/p O
resection B-TREATMENT
, O
with O
recent O
CT O
showing O
met B-SYMPTOM
cholangiocarcinoma I-SYMPTOM
in O
9/2004 O
. O

Pt O
was O
recently O
admitted O
for O
fever B-SYMPTOM
due O
to O
cholangitis B-SYMPTOM
on O
10-18 O
and O
had O
chemo B-TREATMENT
( O
CDDP B-TREATMENT
and O
Gemcitabine B-TREATMENT
) O
on O
Monday O
, O
10-21 O
. O

Since O
chemo B-TREATMENT
pt O
has O
intermittent B-SYMPTOM
nausea I-SYMPTOM
adequately O
controlled O
by O
zofran B-TREATMENT
and O
compazine B-TREATMENT
. O

Pt O
was O
doing O
well O
till O
night O
of O
admission O
when O
she O
developed O
nausea B-SYMPTOM
/ O
vomitting B-SYMPTOM
and O
sizable O
amount O
of O
hemoptysis B-SYMPTOM
and O
clots B-SYMPTOM
. O

Has O
low B-SYMPTOM
grade I-SYMPTOM
fever I-SYMPTOM
since O
chemo B-TREATMENT
but O
otherwise O
ROS O
was O
neg O
for O
shaking B-SYMPTOM
chills I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
SOB B-SYMPTOM
, O
coughing B-SYMPTOM
, O
constipation B-SYMPTOM
, O
diarrhea B-SYMPTOM
, O
tarry B-SYMPTOM
stools I-SYMPTOM
, O
abd B-SYMPTOM
pain I-SYMPTOM
. O

Pt O
has O
reported O
gaining O
30 O
lbs O
since O
08-31 O
due O
to O
ascites B-SYMPTOM
. O

In O
Monica O
: O
vitals O
: O
T O
98.8 O
P O
98 O
BP O
136/68 O
R O
29 O
Sat O
98% O
RAPt O
had O
NG B-TREATMENT
lavage I-TREATMENT
which O
evantually O
cleared O
up O
, O
also O
was O
transfused O
1U B-TREATMENT
PRBC I-TREATMENT
, O
GI O
consult O
called O
, O
also O
got O
zofran B-TREATMENT
and O
iv B-TREATMENT
protonix I-TREATMENT
. O

Past O
Medical O
History O
: O

1. O
Ca O
Hx-Klatskin B-SYMPTOM
tumor I-SYMPTOM
originally O
diagnosed O
2010-08-28 O
after O
presenting O
with O
painless B-SYMPTOM
jaundice I-SYMPTOM
. O

2010-10-01 O
pt O
underwent O
ex. O
lap O
with O
en B-TREATMENT
bloc I-TREATMENT
resection I-TREATMENT
of I-TREATMENT
L I-TREATMENT
liver I-TREATMENT
lobe I-TREATMENT
, I-TREATMENT
biliary I-TREATMENT
tree I-TREATMENT
, I-TREATMENT
and I-TREATMENT
portal I-TREATMENT
vein I-TREATMENT
. O

Reconstructed B-TREATMENT
portal I-TREATMENT
vein I-TREATMENT
followed O
by O
Roux-en-Y B-TREATMENT
hepaticojejunostomy I-TREATMENT
. O

Per O
notes O
, O
pathology O
demonstrated O
biliary B-SYMPTOM
ductal I-SYMPTOM
adenocarcinoma I-SYMPTOM
( O
T3N0M0 B-SYMPTOM
) O
stage O
Margit O
. O

Since O
presentation O
, O
patient O
had O
multiple O
episodes O
of O
cholangitis B-SYMPTOM
( O
08-06 O
in O
past O
3 O
years O
with O
last O
on O
10-18 O
), O
always O
short O
lived O
and O
treated O
with O
antimicrobial B-TREATMENT
therapy I-TREATMENT
. O

She O
has O
been O
on O
ciprofloxacin B-TREATMENT
proph I-TREATMENT
for O
about O
1 O
year O
. O

Followed O
with O
yearly O
abdominal O
CT O
without O
radiographic B-SYMPTOM
progression I-SYMPTOM
. O

CAT O
scan O
was O
performed O
on O
2013-09-20 O
at O
Kindred O
Park O
View O
Specialty O
Hospital O
of O
Springfield O
, O
which O
revealed O
that O
she O
had O
a B-SYMPTOM
recurrence I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
tumor I-SYMPTOM
with O
occlusion B-SYMPTOM
of I-SYMPTOM
her I-SYMPTOM
portal I-SYMPTOM
vein I-SYMPTOM
occluding B-SYMPTOM
bile I-SYMPTOM
ducts I-SYMPTOM
, O
hepatic B-SYMPTOM
artery I-SYMPTOM
nearly I-SYMPTOM
completely I-SYMPTOM
occluded I-SYMPTOM
, O
and O
much B-SYMPTOM
ascites I-SYMPTOM
and O
was O
started O
on O
diuretics B-TREATMENT
. O

She O
was O
was O
seen O
at O
Hallmark O
Health O
System O
heme O
/ O
on O
clinic O
10-09 O
and O
had O
repeat O
CT O
scan O
which O
revealed O
metastatic B-SYMPTOM
cholangiocarcinoma I-SYMPTOM
with O
mets B-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
ovaries I-SYMPTOM
, O
with O
tremendous B-SYMPTOM
increase I-SYMPTOM
in I-SYMPTOM
metastatic I-SYMPTOM
disease I-SYMPTOM
. O

There O
was O
there O
was O
obstructive B-SYMPTOM
uropathy I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
side I-SYMPTOM
, O
as O
well O
as O
questionable O
gastric B-SYMPTOM
outlet I-SYMPTOM
obstruction I-SYMPTOM
and O
peritoneal B-SYMPTOM
carcinomatosis I-SYMPTOM
. O

2. O
cholecystectomy B-TREATMENT
at O
age O
25 O

3. O
MVA-multiple B-TREATMENT
orthopedic I-TREATMENT
procedures I-TREATMENT

4. O
Strabismus B-SYMPTOM

Social O
History O
: O

She O
is O
a O
nurse O
Damian O
Mary O
Lane O
Hospital O
. O

She O
denies O
any O
alcohol O
, O
drugs O
or O
tobacco O
. O

She O
lives O
in O
Tobey O
Hospital O
with O
her O
mom O
. O

She O
is O
single O
, O
no O
children O
. O

Family O
History O
: O

Her O
maternal O
grandmother O
had O
breast B-SYMPTOM
cancer I-SYMPTOM
in O
her O
80 O
s O
and O
her O
dad O
's O
grandmother O
had O
stomach B-SYMPTOM
cancer I-SYMPTOM
and O
died O
in O
her O
50 O
s. O

On O
her O
mom O
's O
side O
is O
an B-SYMPTOM
extensive I-SYMPTOM
family I-SYMPTOM
cardiac I-SYMPTOM
history I-SYMPTOM
. O

Physical O
Exam O
: O

VITAL O
: O
afebrile B-SYMPTOM
, O
96 O
, O
108/51 O
, O
O2sat99%RA O

GENERAL O
: O
pleasant O
female O
in O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
, O
jaundiced B-SYMPTOM
skin I-SYMPTOM
. O

HEENT O
: O
sclera B-SYMPTOM
icteric I-SYMPTOM
, O
OP O
clear O
, O
EOMI O
, O
PERRL O
. O

NECK O
: O
Supple O
. O

NODES O
: O
No O
supraclavicular B-SYMPTOM
, I-SYMPTOM
submandibular I-SYMPTOM
, I-SYMPTOM
axillary I-SYMPTOM
or I-SYMPTOM
inguinal I-SYMPTOM
lymphadenopathy I-SYMPTOM
. O

LUNGS O
: O
Clear O
to O
auscultation O
bilaterally O
. O

HEART O
: O
Regular O
rate O
, O
s1 O
s2 O
. O

ABDOMEN O
: O
soft O
and O
distended B-SYMPTOM
, O
but O
no O
actual B-SYMPTOM
tenderness I-SYMPTOM
. O

Guaiac O
neg O
by O
Monica O

BACK O
: O
No O
CVA B-SYMPTOM
tenderness I-SYMPTOM
. O

EXTREMITIES O
: O
No O
clubbing B-SYMPTOM
, O
cyanosis B-SYMPTOM
, O
but O
+ O
edema B-SYMPTOM
. O

Pertinent O
Results O
: O

2013-10-27 O
01:30 O
AM O

GLUCOSE O
- O
112 O
* O
UREA O
N O
- O
14 O
CREAT O
- O
0.8 O
SODIUM O
- O
133 O
POTASSIUM O
- O
4.0 O
CHLORIDE O
- O
97 O
TOTAL O
CO2 O
- O
23 O
ANION O
GAP O
- O
17 O

2013-10-27 O
01:30 O
AM O

ALT(SGPT) O
- O
149 O
* O
AST(SGOT) O
- O
83 O
* O
ALK O
PHOS O
- O
663 O
* O
AMYLASE O
- O
37 O
TOT O
BILI O
- O
8.2 O
* O

2013-10-27 O
01:30 O
AM O

LIPASE O
- O
42 O

2013-10-27 O
01:30 O
AM O

IRON O
- O
52 O

2013-10-27 O
01:30 O
AM O

calTIBC O
- O
230 O
* O
FERRITIN O
- O
197 O
* O
TRF O
- O
177 O
* O

2013-10-27 O
01:30 O
AM O

WBC O
- O
3.0 O
* O
RBC O
- O
2.25 O
* O
HGB O
- O
7.2 O
* O
HCT O
- O
20.9 O
* O
MCV O
- O
93 O
MCH O
- O
31.8 O
MCHC O
- O
34.3 O
RDW O
- O
14.7 O

2013-10-27 O
01:30 O
AM O

NEUTS O
- O
79.7 O
* O
BANDS O
- O
0 O
LYMPHS O
- O
13.3 O
* O
MONOS O
- O
4.6 O
EOS O
- O
2.2 O
BASOS O
- O
0.2 O

2013-10-27 O
01:30 O
AM O

HYPOCHROM O
- O
1+ O
ANISOCYT O
- O
NORMAL O
POIKILOCY O
- O
1+ O
MACROCYT O
- O
NORMAL O
MICROCYT O
- O
NORMAL O
POLYCHROM O
- O
NORMAL O
OVALOCYT O
- O
1+ O

2013-10-27 O
01:30 O
AM O

PLT O
COUNT O
- O
88 O
* O

2013-10-27 O
01:30 O
AM O

PT O
- O
13.4 O
PTT O
- O
25.9 O
INR(PT) O
- O
1.1 O

2013-10-27 O
01:30 O
AM O

RET O
AUT O
- O
0.3 O
* O

2013-10-27 O
01:30 O
AM O
URINE O

COLOR O
- O
Amber O
APPEAR O
- O
SlHazy O
SP O
Barajas O
- O
1.025 O

2013-10-27 O
01:30 O
AM O
URINE O

BLOOD O
- O
NEG O
NITRITE O
- O
POS O
PROTEIN O
- O
30 O
GLUCOSE O
- O
NEG O
KETONE O
- O
TR O
BILIRUBIN O
- O
LG O
UROBILNGN O
- O
0.2 O
PH O
- O
5.5 O
LEUK O
- O
NEG O

2013-10-27 O
01:30 O
AM O
URINE O

RBC O
- O
0-2 O
WBC O
- O
0-2 O
BACTERIA O
- O
MOD O
YEAST O
- O
NONE O
EPI O
- O
03-01 O
RENAL O
EPI O
- O
0-2 O

2013-10-27 O
01:30 O
AM O
URINE O

HYALINE O
- O
0-2 O

CT O
abd O
on O
2013-10-17 O
showed O
: O

1. O
Recurrent B-SYMPTOM
cholangiocarcinoma I-SYMPTOM
, O
with O
intrahepatic B-SYMPTOM
bile I-SYMPTOM
duct I-SYMPTOM
dilatation I-SYMPTOM
and O
gastric B-SYMPTOM
outlet I-SYMPTOM
obstruction I-SYMPTOM
; O
exact O
extent O
of O
disease B-SYMPTOM
is O
unclear O
, O
but O
likely O
extensive O
. O

No O
evidence O
of O
portal B-SYMPTOM
hypertension I-SYMPTOM
is O
seen O
. O

2. O
Large B-SYMPTOM
, I-SYMPTOM
cystic I-SYMPTOM
, I-SYMPTOM
multiseptated I-SYMPTOM
mass I-SYMPTOM
arising O
from O
the O
adnexa O
, O
worrisome O
for O
second B-SYMPTOM
primary I-SYMPTOM
malignancy I-SYMPTOM
. O

3. O
Ascites B-SYMPTOM
, O
and O
intraperitoneal B-SYMPTOM
carcinomatosis I-SYMPTOM
, O
which O
can O
arise O
from O
either O
of O
the O
two O
processes O
described O
above O
. O

4. O
Hiatal B-SYMPTOM
hernia I-SYMPTOM
. O

2013-11-03 O
07:30 O
AM O

BLOOD O
WBC O
- O
2.2 O
* O
RBC O
- O
3.09 O
* O
Hgb O
- O
9.6 O
* O
Hct O
- O
28.7 O
* O
MCV O
- O
93 O
MCH O
- O
31.2 O
MCHC O
- O
33.6 O
RDW O
- O
17.0 O
* O
Plt O
Ct O
- O
89 O
* O

2013-10-31 O
06:00 O
AM O

BLOOD O
Neuts O
- O
89.7 O
* O
Bands O
- O
0 O
Lymphs O
- O
6.9 O
* O
Monos O
- O
2.6 O
Eos O
- O
0.2 O
Baso O
- O
0.7 O

2013-11-03 O
07:30 O
AM O

BLOOD O
PT O
- O
15.2 O
* O
PTT O
- O
29.7 O
INR(PT) O
- O
1.5 O

2013-11-03 O
07:30 O
AM O

BLOOD O
Glucose O
- O
117 O
* O
UreaN O
- O
11 O
Creat O
- O
0.9 O
Na O
- O
135 O
K O
- O
3.5 O
Cl O
- O
97 O
HCO3 O
- O
28 O
AnGap O
- O
14 O

2013-11-03 O
07:30 O
AM O

BLOOD O
AlkPhos O
- O
431 O
* O
TotBili O
- O
7.8 O
* O

2013-11-03 O
07:30 O
AM O

BLOOD O
Calcium O
- O
8.3 O
* O
Phos O
- O
3.5 O
Mg O
- O
1.9 O

2013-10-27 O
01:30 O
AM O

BLOOD O
calTIBC O
- O
230 O
* O
Ferritn O
- O
197 O
* O
TRF O
- O
177 O
* O

Brief O
Hospital O
Course O
: O

1) O
GI O
- O
In O
the O
Monica O
pt O
had O
Hct O
of O
20 O
and O
bloody B-SYMPTOM
NG I-SYMPTOM
lavage I-SYMPTOM
which O
did O
not O
clear O
. O

She O
was O
transfused O
1U B-TREATMENT
PRBC I-TREATMENT
, O
GI O
consult O
called O
, O
also O
got O
zofran B-TREATMENT
and O
iv B-TREATMENT
protonix I-TREATMENT
and O
admitted O
to O
the O
FICU O
. O

On O
arrival O
to O
unit O
pt O
had O
EGD O
which O
revealed O
grade B-SYMPTOM
III I-SYMPTOM
esophageal I-SYMPTOM
varices I-SYMPTOM
with O
signs O
of O
old B-SYMPTOM
bleeding I-SYMPTOM
. O

She O
was O
started O
on O
octreotide B-TREATMENT
and O
nadolol B-TREATMENT
to O
control O
portal B-SYMPTOM
htn I-SYMPTOM
. O

Pt O
was O
stable O
and O
had O
appropriate O
Hct B-SYMPTOM
bump I-SYMPTOM
to O
25 O
after O
2U B-TREATMENT
PRBC I-TREATMENT
's. I-TREATMENT

She O
also O
had O
climbing B-SYMPTOM
bilirubin I-SYMPTOM
and O
low B-SYMPTOM
grade I-SYMPTOM
temp I-SYMPTOM
and O
was O
started O
on O
Zosyn B-TREATMENT
for O
suspected O
biliary B-SYMPTOM
obstruction I-SYMPTOM
and O
ascending B-SYMPTOM
cholangitis I-SYMPTOM
coverage O
. O

She O
was O
rescoped O
on O
10-28 O
and O
varices B-SYMPTOM
were O
sclerosed O
( O
no O
banding B-TREATMENT
due O
to O
latex B-SYMPTOM
allergy I-SYMPTOM
) O
and O
diuretics B-TREATMENT
of O
lasix B-TREATMENT
and O
aldactone B-TREATMENT
were O
readded O
for O
ascites B-SYMPTOM
since O
BP O
stable O
. O

10-29 O
she O
was O
transfused O
another O
3U B-TREATMENT
PRBC I-TREATMENT
's I-TREATMENT
with O
hct B-SYMPTOM
bump I-SYMPTOM
to O
31.9 O
and O
antibiotic B-TREATMENT
coverage I-TREATMENT
broadend O
to O
Unasyn B-TREATMENT
, O
Ceftriaxone B-TREATMENT
, O
Flagyl B-TREATMENT
because O
she O
continued O
to O
spike O
, O
and O
for O
SBP B-TREATMENT
prophylaxis I-TREATMENT
. O

Preprocedure O
of O
PTC O
on O
10-30 O
she O
was O
transfused O
1 B-TREATMENT
unit I-TREATMENT
PRBC I-TREATMENT
's, I-TREATMENT
2 B-TREATMENT
platelets I-TREATMENT
and O
2U B-TREATMENT
FFP I-TREATMENT
and O
procedure O
went O
without O
complication B-SYMPTOM
. O

ON O
transfer O
to O
the O
floor O
she O
remained O
hemodynamically O
stable O
with O
stable O
Hct O
and O
declining B-SYMPTOM
bilirubin I-SYMPTOM
. O

She O
remained O
afebrile B-SYMPTOM
so O
on O
11-02 O
antibiotic B-TREATMENT
regimen I-TREATMENT
was O
weaned O
to O
only O
levofloxacin B-TREATMENT
. O

Liver O
teams O
recommended O
to O
repeat O
EGD O
with O
non B-TREATMENT
latex I-TREATMENT
banding I-TREATMENT
in O
7-10 O
days O
. O

She O
also O
went O
home O
on O
naldolol B-TREATMENT
20 O
mg O
qd O
for O
portal B-SYMPTOM
htn I-SYMPTOM
, O
and O
her B-TREATMENT
home I-TREATMENT
doses I-TREATMENT
of O
diuretics B-TREATMENT
to O
control O
her B-SYMPTOM
ascites I-SYMPTOM
. O

2. O
US O
finding O
- O
Pt O
was O
incidentally O
found O
to O
have O
R B-SYMPTOM
hydronephrosis I-SYMPTOM
and O
a B-SYMPTOM
R I-SYMPTOM
adenexal I-SYMPTOM
mass I-SYMPTOM
on O
her O
US O
. O

The B-SYMPTOM
hydronephrosis I-SYMPTOM
was O
likely O
caused O
by O
blockage B-SYMPTOM
by O
her B-SYMPTOM
tumor I-SYMPTOM
. O

Given O
her O
disease O
prognosis O
and O
the O
fact O
that O
her O
other O
kidney O
is O
functioning O
well O
, O
no O
intervention B-TREATMENT
was O
done O
. O

Also O
the B-SYMPTOM
adenexal I-SYMPTOM
mass I-SYMPTOM
may O
represent O
a B-SYMPTOM
second I-SYMPTOM
primary I-SYMPTOM
maligancy I-SYMPTOM
. O

This O
was O
seen O
on O
a O
prior O
CT O
scan O
and O
her O
oncologist O
is O
aware O
. O

Again O
given O
the B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
poor I-SYMPTOM
disease I-SYMPTOM
prognosis I-SYMPTOM
, O
there O
was O
no O
intervention B-TREATMENT
made O
at O
this O
time O
. O

Medications O
on O
Admission O
: O

MEDICATIONS O
: O
She O
is O
on O
Lasix B-TREATMENT
40 O
mg O
p.o. O
b.i.d. O
, O
Aldactone B-TREATMENT
25 O
mg O
p.o. O
b.i.d. O
, O
Prilosec B-TREATMENT
20 O
mg O
p.o. O
daily O
, O
ciprofloxacin B-TREATMENT
250 O
mg O
p.o. O
daily O
, O
this O
is O
for O
prophylaxis B-TREATMENT
for O
cholangitis B-SYMPTOM
and O
iron B-TREATMENT
. O

Discharge O
Medications O
: O

1. O
Pantoprazole B-TREATMENT
Sodium I-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q12H O
( O
every O
12 O
hours O
). O

Disp O
:* O
60 O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
)(s)* O
Refills O
:* O
2 O
* O

2. O
Furosemide B-TREATMENT
40 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

Disp O
:* O
60 O
Tablet O
(s)* O
Refills O
:* O
2 O
* O

3. O
Spironolactone B-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

Disp O
:* O
60 O
Tablet O
(s)* O
Refills O
:* O
2 O
* O

4. O
Levofloxacin B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q24H O
( O
every O
24 O
hours O
). O

Disp O
:* O
30 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

5. O
Ursodiol B-TREATMENT
300 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
TID O
( O
3 O
times O
a O
day O
). O

Disp O
:* O
90 O
Capsule O
(s)* O
Refills O
:* O
2 O
* O

6. O
Prochlorperazine B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q6H O
( O
every O
6 O
hours O
) O
as O
needed O
. O

Disp O
:* O
30 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

7. O
Nystatin B-TREATMENT
100,000 O
unit O
/ O
mL O
Suspension O
Sig O
: O
Five O
( O
5 O
) O
mL O
PO O
four O
times O
a O
day O
: O
Swish O
and O
swallow O
. O

Disp O
:* O
qs O
mL O
* O
Refills O
:* O
2 O
* O

8. O
Nadolol B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

Disp O
:* O
30 O
Tablet O
(s)* O
Refills O
:* O
2 O
* O

9. O
Outpatient O
Lab O
Work O

Please O
have O
CBC O
and O
alkaline O
phosphatase O
and O
total O
bilirubin O
checked O
on O
Monday O
11-04 O

Discharge O
Disposition O
: O

Home O
with O
Service O

Discharge O
Diagnosis O
: O

Cholangiocarcinoma B-SYMPTOM

Biliary B-SYMPTOM
obstruction I-SYMPTOM

Grade B-SYMPTOM
III I-SYMPTOM
esophageal I-SYMPTOM
varices I-SYMPTOM

Discharge O
Condition O
: O

Stable O
. O

Discharge O
Instructions O
: O

Call O
your O
primary O
care O
doctor O
, O
oncologist O
, O
or O
return O
to O
the O
Emergency O
Room O
if O
you O
have O
increasing B-SYMPTOM
nausea I-SYMPTOM
, O
vomiting B-SYMPTOM
, O
leg B-SYMPTOM
swelling I-SYMPTOM
, O
confusion B-SYMPTOM
, O
or O
pain B-SYMPTOM
. O

Followup O
Instructions O
: O

Please O
follow O
up O
at O
all O
scheduled O
appointments O
including O
Wednesday O
in O
IR O
clinic O
. O

Call O
the O
IR O
clinic O
on O
Monday O
to O
confirm O
your O
appointment O
: O
( O
236 O
) O
672 O
0628 O
. O

Ask O
to O
speak O
with O
May O
Chen O
, O
PA. O

Call O
your O
primary O
care O
doctor O
Joanne O
Dennen O
for O
follow O
up O
appointments O
. O

You O
will O
have O
a B-TREATMENT
banding I-TREATMENT
procedure I-TREATMENT
in O
9 O
days O
. O

Please O
call O
the O
GI O
clinic O
and O
arrange O
to O
see O
Dr. O
Langton O
for O
an O
appointment O
: O
232-2590 O
. O

Ronald O
Donna O
MD O
19-658 O

Completed O
by O
: O
Neal O
Robert O
MD O
12-904 O
2013-11-04 O
@ O
1405 O

Signed O
electronically O
by O
: O
DR. O
Wilson O
J. O
Sanchez O
on O
: O
WED O
2013-11-13 O
9:05 O
AM O

( O
End O
of O
Report O
) O

0880410 O

Admission O
Date O
: O

2013-07-23 O

Discharge O
Date O
: O

2013-08-01 O

Date O
of O
Birth O
: O

2013-07-23 O

Sex O
: O

F O

Service O
: O

CMED O
CSRU O

HISTORY O
: O

Baby O
Girl O
Kathryn O
Frazier O
, O
triplet O
III O
, O
delivered O
at O
32 O
- O
5/7 O
weeks O
gestation O
was O
admitted O
to O
the O
newborn O
intensive O
care O
unit O
for O
management B-TREATMENT
of O
prematurity B-SYMPTOM
. O

Birth O
weight O
was O
1630 O
grams O
. O

The O
mother O
is O
a O
31 O
- O
year-old O
Gravida O
5 O
, O
para O
1 O
, O
now O
4 O
woman O
with O
estimated O
date O
of O
delivery O
2013-09-12 O
. O

Prenatal O
screens O
included O
blood O
type O
A+ O
, O
antibody O
screen O
negative O
, O
rubella O
immune O
, O
RPR O
nonreactive O
. O

Hepatitis O
B O
surface O
antigen O
negative O
, O
cystic O
fibrosis O
negative O
, O
and O
Group O
B O
strep O
unknown O
. O

Mother O
's O
medical O
history O
was O
notable O
for O
depression B-SYMPTOM
treated O
with O
Zoloft B-TREATMENT
. O

OB O
history O
notable O
for O
infertility B-SYMPTOM
treated O
with O
Clomid B-TREATMENT
. O

This O
pregnancy O
was O
complicate O
by O
triplet B-SYMPTOM
gestation I-SYMPTOM
, O
cervical B-SYMPTOM
shortening I-SYMPTOM
, O
and O
pregnancy B-SYMPTOM
induced I-SYMPTOM
hypertension I-SYMPTOM
. O

Delivery O
was O
by O
cesarean B-TREATMENT
section I-TREATMENT
under O
spinal B-TREATMENT
anesthesia I-TREATMENT
for O
pre-eclampsia B-SYMPTOM
. O

There O
was O
no O
labor B-SYMPTOM
or I-SYMPTOM
maternal I-SYMPTOM
fever I-SYMPTOM
. O

Membranes O
were O
ruptured O
at O
delivery O
for O
clear O
fluid O
. O

Mother O
did O
not O
receive O
any B-TREATMENT
antibiotics I-TREATMENT
prior O
to O
delivery O
. O

The O
infant O
emerged O
vigorous O
, O
was O
dried O
, O
bulb O
suctioned O
and O
given O
free B-TREATMENT
flow I-TREATMENT
oxygen I-TREATMENT
. O

Apgar O
scores O
were O
7 O
at O
one O
minute O
and O
8 O
at O
5 O
minutes O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
birth O
weight O
1630 O
grams O
( O
50th O
percentile O
) O
, O
length O
43.5 O
cm O
( O
50th O
percentile O
) O
, O
head O
circumference O
31.5 O
cm O
( O
75th O
percentile O
). O

Infant O
with O
non- B-SYMPTOM
dysmorphic I-SYMPTOM
facies I-SYMPTOM
, O
palate O
intact O
. O

Anterior O
fontanel O
soft O
and O
flat O
, O
moderate B-SYMPTOM
nasal I-SYMPTOM
flaring I-SYMPTOM
. O

Chest O
with O
moderate B-SYMPTOM
intercostal I-SYMPTOM
retractions I-SYMPTOM
, O
fair O
breath O
sounds O
bilaterally O
, O
no O
crackles B-SYMPTOM
. O

Cardiovascular O
is O
well O
perfused O
with O
regular O
rate O
and O
rhythm O
and O
normal O
S1 O
and O
S2 O
, O
no O
murmur B-SYMPTOM
, O
normal O
pulses O
and O
perfusion O
. O

Abdomen O
soft O
, O
not O
distended B-SYMPTOM
. O

No O
organomegaly B-SYMPTOM
or O
masses B-SYMPTOM
. O

Bowel O
sounds O
are O
active O
, O
patent O
anus O
, O
three O
vessel O
umbilical O
cord O
. O

Genitourinary O
normal O
female O
genitalia O
. O

Skin O
without O
rashes B-SYMPTOM
or O
lesions B-SYMPTOM
. O

Spine O
intact O
. O

Hips O
stable O
. O

Active O
, O
alert O
, O
responding O
to O
stimulation O
. O

Tone B-SYMPTOM
decreased I-SYMPTOM
slightly I-SYMPTOM
in O
symmetric O
distribution O
, O
moves O
all O
extremities O
equally O
. O

Suck O
and O
gag O
present O
. O

Grasp O
symmetric O
. O

SUMMARY O
OF O
HOSPITAL O
COURSE O
BY O
SYSTEMS O
: O

Initially O
was O
placed O
on O
continuous B-TREATMENT
positive I-TREATMENT
airway I-TREATMENT
pressure I-TREATMENT
40% B-TREATMENT
oxygen I-TREATMENT
. O

Due O
to O
increasing B-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
was O
intubated O
, O
placed O
on O
conventional B-TREATMENT
ventilation I-TREATMENT
and O
pressures B-TREATMENT
of O
24/6 O
, O
rate B-TREATMENT
of O
25 O
. O

She O
received O
one O
dose O
of O
Survanta B-TREATMENT
and O
then O
weaned O
well O
on O
ventilator B-TREATMENT
settings I-TREATMENT
. O

She O
was O
extubated O
to O
room O
air O
at O
13 O
hours O
of O
age O
. O

Has O
remained O
in O
room O
air O
since O
with O
comfortable O
work O
of O
breathing O
, O
respiratory O
rates O
in O
the O
40 O
's O
to O
70 O
's. O

No O
apnea B-SYMPTOM
. O

Cardiovascular O
has O
been O
hemodynamically O
stable O
throughout O
hospital O
stay O
. O

Heart O
rates O
range O
in O
the O
140 O
to O
160 O
's O
, O
no O
heart B-SYMPTOM
murmur I-SYMPTOM
. O

Recent O
blood O
pressure O
71/31 O
with O
a O
mean O
of O
48 O
. O

Fluids O
, O
electrolytes O
, O
nutrition O
: O

Was O
initially O
NPO B-TREATMENT
on O
receiving O
D10-W B-TREATMENT
by O
peripheral O
intravenous O
. O

Enteral B-TREATMENT
feeds I-TREATMENT
were O
started O
on O
day O
of O
life O
one O
and O
she O
advanced O
to O
full B-TREATMENT
volume I-TREATMENT
feeds I-TREATMENT
of O
breast O
milk O
or O
special B-TREATMENT
care I-TREATMENT
formula I-TREATMENT
on O
day O
of O
life O
six O
( O
2013-07-29 O
) O
without O
problems B-SYMPTOM
. O

She O
is O
presently O
receiving O
breast O
milk O
or O
special B-TREATMENT
care I-TREATMENT
formula I-TREATMENT
24 O
cal O
at O
150 O
mls O
per O
kilo O
per O
day O
with O
tolerance O
. O

Voiding O
and O
stooling O
appropriately O
. O

Most O
recent O
electrolytes O
done O
on O
day O
of O
life O
one O
showed O
a O
sodium O
of O
132 O
, O
potassium O
6.1 O
, O
chloride O
100 O
, O
Co2 O
20 O
. O

Discharge O
weight O
is O
1700 O
grams O
up O
15 O
grams O
.. O

Gastrointestinal O
: O

Received O
phototherapy B-TREATMENT
from O
07-27 O
to O
2013-07-28 O
for O
a O
peak O
bilirubin O
of O
8.1 O
. O

Phototherapy B-TREATMENT
was O
discontinued O
when O
bilirubin O
was O
a O
total O
of O
4.7 O
. O

Most O
recent O
bilirubin O
on O
2013-07-29 O
total O
of O
4.2 O
, O
direct O
.4 O
. O

Hematology O
: O

Hematocrit O
on O
admission O
47% O
. O

No O
transfusions B-TREATMENT
given O
. O

Infectious O
Disease O
: O

Received O
48 O
hours O
of O
Ampicillin B-TREATMENT
and O
gentamicin B-TREATMENT
for O
rule O
out O
sepsis B-SYMPTOM
. O

CBC O
on O
admission O
showed O
a O
white O
count O
of O
9.3 O
with O
37 O
polys O
, O
0 O
bands O
, O
platelets O
399,000 O
. O

The O
blood O
culture O
was O
negative O
. O

Neurology O
: O

Head O
ultrasound O
not O
indicated O
. O

Sensory O
: O

A O
hearing O
screening O
has O
not O
been O
performed O
, O
will O
need O
prior O
to O
discharge O
home O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
7 O
day O
old O
former O
32-5/7 O
week O
and O
now O
33-5/7 O
weeks O
age O
. O

DISPOSITION O
: O

Saint O
Vincent O
Hospital O
Hospital O
. O

PEDIATRICIAN O
: O

Dr. O
Manuel O
Burke O
, O
1 O
Parkway O
, O
Fall O
River O
, O
New O
Mexico O
57362 O
. O

CARE O
AND O
RECOMMENDATIONS O
: O

1. O
Feeds O
. O

Breast O
milk O
or O
special B-TREATMENT
care I-TREATMENT
formula I-TREATMENT
24 O
calories O
per O
ounce O
at O
150 O
mls O
per O
kilo O
per O
day O
with O
plans O
to O
advance O
calories O
. O

2. O
Medications O
: O

Currently O
on O
no O
medications B-TREATMENT
. O

3. O
State O
newborn O
screen O
was O
sent O
on O
2013-07-26 O
and O
is O
pending O
. O

4. O
Has O
not O
received O
any B-TREATMENT
immunization I-TREATMENT
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
AGA O
32-5/7 O
week O
pre-term O
female O
. O

2. O
Triplet O
#3 O

3. O
Respiratory B-SYMPTOM
distress I-SYMPTOM
syndrome I-SYMPTOM
resolved O
. O

4. O
Physiologic B-SYMPTOM
jaundice I-SYMPTOM
. O

5. O
Perinatal B-SYMPTOM
sepsis I-SYMPTOM
ruled O
out O
. O

Joseph O
Clarence O
, O
Oklahoma O
91525 O

Dictated O
By O
: O
Doris O
Q. O
Marszalek O
, O
M.D. O

MEDQUIST36 O

D O
: O
2013-07-29 O
17:28:46 O

T O
: O
2013-07-29 O
18:39:50 O

Job O
# O
: O
97834 O

Signed O
electronically O
by O
: O
DR. O
Lance O
GRAY O
on O
: O
Maxine O
2013-08-01 O
12:50 O
PM O

( O
End O
of O
Report O
) O

176318078 O

FIH O

4189699 O

98761/1k47 O

867797 O

6/22/1994 O
12:00:00 O
AM O

MITRAL B-SYMPTOM
STENOSIS I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

06/22/94 O

DISCHARGE O
DATE O
: O

07/04/94 O

PRINCIPAL O
DIAGNOSIS O
: O

Mitral B-SYMPTOM
stenosis I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

Tricuspid B-SYMPTOM
insufficiency I-SYMPTOM
, O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
, O
chronic B-SYMPTOM
obstructive I-SYMPTOM
pulmonary I-SYMPTOM
disease I-SYMPTOM
, O
pulmonary B-SYMPTOM
hypertension I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

04/22/94 O
, O
mitral B-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
and O
tricuspid B-TREATMENT
valve I-TREATMENT
reconstruction I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
68 O
year O
old O
female O
had O
rheumatic B-SYMPTOM
fever I-SYMPTOM
in O
the O
past O
, O
and O
has O
had O
chronic B-SYMPTOM
atrial I-SYMPTOM
fibrillation I-SYMPTOM
. O

She O
has O
had O
progressive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
and O
an O
evaluation O
demonstrated O
worsening B-SYMPTOM
mitral I-SYMPTOM
stenosis I-SYMPTOM
with O
severe B-SYMPTOM
pulmonary I-SYMPTOM
hypertension I-SYMPTOM
. O

Because O
of O
her O
deteriorating O
status O
, O
she O
underwent O
prior O
cardiac O
catheterization O
, O
which O
confirmed O
severe B-SYMPTOM
mitral I-SYMPTOM
stenosis I-SYMPTOM
with O
secondary B-SYMPTOM
tricuspid I-SYMPTOM
valve I-SYMPTOM
regurgitation I-SYMPTOM
due O
to O
pulmonary B-SYMPTOM
hypertension I-SYMPTOM
. O

She O
was O
referred O
for O
valve B-TREATMENT
surgery I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
is O
remarkable O
for O
chronic B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
due O
to O
smoking O
. O

She O
had O
undergone O
a B-TREATMENT
previous I-TREATMENT
nasal I-TREATMENT
arterial I-TREATMENT
embolization I-TREATMENT
for O
treatment B-TREATMENT
of O
recurrent B-SYMPTOM
epistaxis I-SYMPTOM
. O

She O
had O
a B-TREATMENT
partial I-TREATMENT
gastrectomy I-TREATMENT
in O
1972 O
. O

Her B-TREATMENT
MEDICATIONS I-TREATMENT
ON I-TREATMENT
ADMISSION I-TREATMENT
included O
Coumadin B-TREATMENT
, O
digoxin B-TREATMENT
, O
0.125 O
, O
qD O
, O
Lasix B-TREATMENT
, O
40 O
, O
q.i.d. O
, O
and O
Vanceril B-TREATMENT
inhaler I-TREATMENT
. O

PERTINENT O
EXAMINATION O
demonstrated O
mild B-SYMPTOM
elevation I-SYMPTOM
of O
her O
jugular O
venous O
pulse O
, O
with O
prominent B-SYMPTOM
V-waves I-SYMPTOM
, O
and O
systolic B-SYMPTOM
and I-SYMPTOM
diastolic I-SYMPTOM
murmurs I-SYMPTOM
. O

Peripheral O
pulses O
were O
all O
intact O
, O
and O
there O
was O
venous B-SYMPTOM
stasis I-SYMPTOM
changes I-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
legs I-SYMPTOM
, O
with O
some B-SYMPTOM
edema I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
brought O
to O
the O
Operating O
Room O
, O
on O
April O
22 O
. O

She O
underwent O
a B-TREATMENT
mitral I-TREATMENT
valve I-TREATMENT
replacement I-TREATMENT
, O
utilizing O
a O
27 O
mm O
. O

St. B-TREATMENT
Jude I-TREATMENT
prosthesis I-TREATMENT
, O
and O
tricuspid B-TREATMENT
valve I-TREATMENT
reconstruction I-TREATMENT
by O
ring B-TREATMENT
anuloplasty I-TREATMENT
. O

She O
weaned O
from O
cardiopulmonary B-TREATMENT
bypass I-TREATMENT
with O
good O
hemodynamics O
. O

She O
initially O
awoke O
after O
surgery B-TREATMENT
, O
with O
good O
hemodynamics O
. O

She O
was O
transiently O
in O
sinus O
rhythm O
, O
but O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
recurred O
. O

She O
was O
extubated O
on O
the O
third O
postoperative O
day O
, O
and O
was O
initially B-SYMPTOM
slightly I-SYMPTOM
agitated I-SYMPTOM
and O
confused B-SYMPTOM
, O
largely O
due O
to O
an B-SYMPTOM
Intensive I-SYMPTOM
Care I-SYMPTOM
Unit I-SYMPTOM
psychosis I-SYMPTOM
. O

She O
continued O
to O
improve O
, O
with O
mobilization O
of O
fluid O
. O

She O
was O
initially O
noted O
to O
have O
a B-SYMPTOM
slow I-SYMPTOM
ventricular I-SYMPTOM
response I-SYMPTOM
in O
atrial B-SYMPTOM
fibrillation I-SYMPTOM
, O
but O
this O
gradually O
improved O
over O
time O
. O

She O
was O
initially O
noted O
to O
be O
somewhat B-SYMPTOM
anemic I-SYMPTOM
, O
and O
received O
transfusions B-TREATMENT
. O

Coumadin B-TREATMENT
was O
restarted O
, O
and O
her B-TREATMENT
anticoagulation I-TREATMENT
came O
into O
range O
. O

She O
was O
ultimately O
discharged O
with O
a O
heart O
rate O
in O
the O
90 O
's O
, O
and O
with O
resolving B-SYMPTOM
edema I-SYMPTOM
and O
a O
clear O
chest O
. O

Her B-TREATMENT
MEDICATIONS I-TREATMENT
ON I-TREATMENT
DISCHARGE I-TREATMENT
included O
Lasix B-TREATMENT
, O
40 O
, O
b.i.d. O
, O
potassium B-TREATMENT
, O
20 O
mEq. O
, O
b.i.d. O
, O
iron B-TREATMENT
, O
and O
folic B-TREATMENT
acid I-TREATMENT
replacement I-TREATMENT
, O
and O
Coumadin B-TREATMENT
. O

RIEMUND O
C. O
ALL O
, O
M.D. O

TR O
: O

dun O
/ O
bmot O

DD O
: O

7/12/94 O

TD O
: O

07/13/94 O

CC O
: O

Dr. O
Ca O
Shuff O
. O

142995994 O
SC O

54818584 O

976113 O

1/23/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

01/23/1992 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

01/26/1992 O

DIAGNOSIS O
ON O
DISCHARGE O
: O

1. O
STATUS O
POST O
MOTORVEHICLE O
ACCIDENT O
WITH O
TRANSIENT B-SYMPTOM
PARAPLEGIA I-SYMPTOM
. O

2. O
RIGHT B-SYMPTOM
HYDRONEPHROSIS I-SYMPTOM
ON O
CT O
SCAN O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
20 O
year O
old O
black O
female O
who O
was O
a O
pedestrian O
when O
struck O
by O
a O
car O
at O
apparent O
high O
speed O
. O

There O
was O
apparent B-SYMPTOM
loss I-SYMPTOM
of I-SYMPTOM
consciousness I-SYMPTOM
at O
the O
scene O
and O
significant O
deformity O
of O
the O
anterior O
portion O
of O
the O
motorvehicle O
with O
positive O
starring O
of O
the O
windshield O
. O

The O
patient O
was O
conscious O
on O
the O
scene O
when O
evaluated O
by O
EMT O
&apos;s O
but O
at O
the O
scene O
, O
the O
patient O
was O
apparently B-SYMPTOM
paraplegic I-SYMPTOM
below I-SYMPTOM
the I-SYMPTOM
umbilicus I-SYMPTOM
with O
absence B-SYMPTOM
of I-SYMPTOM
movement I-SYMPTOM
and I-SYMPTOM
sensation I-SYMPTOM
below I-SYMPTOM
the I-SYMPTOM
umbilicus I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

None O
. O

PAST O
SURGICAL O
HISTORY O
: O

Status O
post O
laparotomy B-TREATMENT
for O
an B-SYMPTOM
ovarian I-SYMPTOM
cyst I-SYMPTOM
in O
1988 O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

None O
. O

ALLERGIES O
: O

None O
. O

She O
denies O
cigarette O
use O
and O
ethanol O
use O
as O
well O
as O
a O
recreational O
drug O
use O
. O

PHYSICAL O
EXAMINATION O
: O

On O
initial O
exam O
, O
her O
left O
shoulder O
was O
tender B-SYMPTOM
to O
palpation O
over O
the O
proximal O
humerus O
with O
decreased B-SYMPTOM
range I-SYMPTOM
of I-SYMPTOM
motion I-SYMPTOM
. O

She O
was O
without O
the O
ability O
to O
move O
her O
left O
lower O
extremity O
with O
decreased B-SYMPTOM
sensation I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
leg I-SYMPTOM
. O

The O
right O
leg O
was O
with O
decreased B-SYMPTOM
range I-SYMPTOM
of I-SYMPTOM
motion I-SYMPTOM
of O
thigh O
flexion O
and O
extension O
. O

The O
back O
was O
notable O
for O
tenderness B-SYMPTOM
at O
the O
level O
of O
L3-L5 O
. O

LABORATORY O
EXAMINATION O
: O

Initial O
radiologic O
evaluation O
showed O
negative O
C-spine O
, O
thoracic O
spine O
, O
and O
lumbosacral O
spine O
films O
. O

Abdominal O
CT O
was O
negative O
except O
for O
right B-SYMPTOM
hydronephrosis I-SYMPTOM
with O
mild B-SYMPTOM
right I-SYMPTOM
hydroureter I-SYMPTOM
. O

Back O
MRI O
was O
negative O
. O

Film O
of O
the O
left O
humerus O
was O
also O
negative O
. O

HOSPITAL O
COURSE O
: O

A O
Neurosurgery O
consultation O
was O
obtained O
, O
and O
it O
was O
their O
impression O
that O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
paraplegia I-SYMPTOM
might O
possibly O
represent O
a B-SYMPTOM
cord I-SYMPTOM
concussion I-SYMPTOM
, O
and O
recommended O
treatment B-TREATMENT
with I-TREATMENT
intravenous I-TREATMENT
steroids I-TREATMENT
for O
24 O
hours O
. O

The B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
paraplegia I-SYMPTOM
resolved O
by O
the O
morning O
of O
her O
second O
hospital O
day O
, O
and O
she O
maintained O
5/5 O
motor O
strength O
in O
all O
groups O
. O

A O
Urology O
consultation O
was O
obtained O
, O
and O
it O
was O
recommended O
that O
an O
IVP O
be O
obtained O
. O

This O
was O
obtained O
on O
the O
day O
of O
discharge O
, O
however O
, O
due O
to O
residual B-SYMPTOM
contrast I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
colon I-SYMPTOM
from O
the O
patient O
&apos;s O
prior O
abdominal O
CT O
scan O
, O
the O
exam O
was O
postponed O
after O
a O
scout O
film O
was O
obtained O
. O

The O
patient O
fell O
well O
on O
the O
day O
of O
discharge O
. O

She O
remained O
afebrile B-SYMPTOM
throughout O
her O
hospital O
course O
. O

Additionally O
on O
the O
night O
before O
discharge O
, O
flexion O
and O
extension O
views O
of O
the O
lumbosacral O
spine O
were O
obtained O
, O
and O
showed O
no O
fracture B-SYMPTOM
or O
instability B-SYMPTOM
. O

DISPOSITION O
: O

CONDITION O
ON O
DISCHARGE O
: O

Good O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Tylenol B-TREATMENT
650 O
mg O
p.o. O
q4 O
hours O
p.r.n. O
pain B-SYMPTOM
. O

She O
will O
followup O
in O
the O
Wardca O
Presiew O
Hospital O
in O
one O
week O
. O

She O
will O
have O
an O
IVP O
repeated O
in O
one O
week O
at O
which O
time O
she O
should O
have O
cleared O
the B-SYMPTOM
residual I-SYMPTOM
contrast I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
colon I-SYMPTOM
. O

She O
will O
have O
urology O
followup O
after O
her O
IVP O
. O

OP303/0134 O
NARI O
BLACK O
, O
M.D. O
SU1 O

D O
: O

01/26/92 O

Batch O
: O

7505 O

Report O
: O

K7798E74 O

T O
: O

01/27/92 O

Dictated O
By O
: O

SHAZA O
C. O
SCHAUMANN O
, O
M.D. O

768768524 O

PRGH O

91287406 O

057469 O

6/19/1998 O
12:00:00 O
AM O

RESPIRATORY B-SYMPTOM
DISTRESS I-SYMPTOM

Signed O

DIS O

Admission O
Date O
: O

06/19/1998 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

08/01/1998 O

PRINCIPAL O
DIAGNOSES O
: O

1 O
) O
THROMBOTIC B-SYMPTOM
THROMBOCYTOPENIC I-SYMPTOM
PURPURA I-SYMPTOM
. O

2 O
) O
BRONCHIOLITIS B-SYMPTOM
OBLITERANS I-SYMPTOM
ORGANIZING I-SYMPTOM
PNEUMONIA I-SYMPTOM
. O

3 O
) O
RENAL B-SYMPTOM
FAILURE I-SYMPTOM
REQUIRING O
CHRONIC B-TREATMENT
DIALYSIS I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
63 O
year-old O
woman O
transferred O
from O
Pre O
Health O
on O
June O
19 O
, O
1998 O
to O
the O
Verg O
Medical O
Center O
Intensive O
Care O
Unit O
for O
evaluation O
of O
thrombotic B-SYMPTOM
thrombocytopenic I-SYMPTOM
purpura I-SYMPTOM
and O
bronchiolitis B-SYMPTOM
obliterans I-SYMPTOM
organizing I-SYMPTOM
pneumonia I-SYMPTOM
. O

On O
May O
12 O
, O
1998 O
, O
the O
patient O
presented O
to O
Pre O
Health O
with O
fever B-SYMPTOM
, O
cough B-SYMPTOM
, O
dyspnea B-SYMPTOM
and O
a O
chest O
x-ray O
revealing O
a B-SYMPTOM
patchy I-SYMPTOM
infiltrate I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lung I-SYMPTOM
. O

She O
was O
treated O
with O
Clindamycin B-TREATMENT
and O
Erythromycin B-TREATMENT
which O
were O
changed O
to O
Trovan B-TREATMENT
and O
then O
transferred O
to O
A O
Hospital O
. O

On O
May O
27 O
, O
1998 O
, O
the O
patient O
desaturated O
to O
40% O
with O
a O
temperature O
of O
100.5 O
degrees O
. O

Her O
oxygen O
saturations O
improved O
to O
only O
92% O
on O
100% B-TREATMENT
face I-TREATMENT
mask I-TREATMENT
and O
she O
was O
admitted O
to O
Pre O
Health O
Intensive O
Care O
Unit O
. O

Chest O
x-ray O
there O
revealed O
bilateral B-SYMPTOM
pulmonary I-SYMPTOM
infiltrates I-SYMPTOM
with O
increasing B-SYMPTOM
pleural I-SYMPTOM
effusion I-SYMPTOM
. O

A O
VQ O
scan O
was O
high O
probability O
, O
but O
no O
pulmonary O
angiogram O
was O
done O
and O
an O
echocardiogram O
revealed O
a O
normal O
left O
ventricle O
with O
no O
wall B-SYMPTOM
motion I-SYMPTOM
abnormality I-SYMPTOM
and O
an O
ejection O
fraction O
of O
75% O
. O

On O
May O
24 O
, O
1998 O
, O
the O
patient O
had O
a O
CT O
scan O
of O
the O
chest O
which O
revealed O
diffuse B-SYMPTOM
alveolar I-SYMPTOM
infiltrates I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
base I-SYMPTOM
, O
mediastinal B-SYMPTOM
lymphadenopathy I-SYMPTOM
and O
bilateral B-SYMPTOM
pleural I-SYMPTOM
effusions I-SYMPTOM
. O

At O
this O
point O
, O
a O
diagnosis O
of O
lupus B-SYMPTOM
was O
considered O
and O
her O
ANA O
was O
1:640 O
and O
her O
rheumatoid O
factor O
and O
ANCA O
were O
negative O
. O

She O
was O
started O
on O
a B-TREATMENT
steroid I-TREATMENT
trial I-TREATMENT
at O
that O
point O
. O

Her O
pleural O
fluid O
was O
tapped O
and O
it O
was O
negative O
for O
malignancy B-SYMPTOM
. O

On O
June O
11 O
, O
1998 O
, O
the O
patient O
had O
a O
video O
assisted O
thoracoscopic O
study O
of O
the O
right O
lung O
which O
revealed O
chronic B-SYMPTOM
interstitial I-SYMPTOM
pneumonitis I-SYMPTOM
with O
a B-SYMPTOM
bronchiolitis I-SYMPTOM
obliterans I-SYMPTOM
organizing I-SYMPTOM
pneumonia-like I-SYMPTOM
reaction I-SYMPTOM
and O
a B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
placed O
. O

The O
patient O
was O
then O
started O
on O
40 O
mg O
of O
Prednisone B-TREATMENT
q. O
day O
. O

From O
May O
27 O
, O
1998 O
through O
June O
19 O
, O
1998 O
, O
the O
patient O
had O
a O
decline O
in O
her O
platelets O
from O
394 O
to O
28 O
with O
a O
stable O
hematocrit O
of O
32 O
to O
33 O
and O
a B-SYMPTOM
rise I-SYMPTOM
in O
creatinine O
from O
1.0 O
to O
3.8 O
. O

On O
June O
19 O
, O
1998 O
, O
she O
was O
transferred O
to O
the O
Verg O
Medical O
Center O
Medical O
Intensive O
Care O
Unit O
for O
evaluation O
of O
possible O
thrombotic B-SYMPTOM
thrombocytopenic I-SYMPTOM
purpura I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

1 O
) O
Cerebrovascular B-SYMPTOM
accident I-SYMPTOM
in O
1995 O
in O
the O
pontine O
region O
secondary O
to O
hypertension B-SYMPTOM
. O

2 O
) O
Hypertension B-SYMPTOM
. O

3 O
) O
Status O
post O
hysterectomy B-TREATMENT
. O

4 O
) O
Status O
post O
appendectomy B-TREATMENT
. O

MEDICATIONS O
ON O
TRANSFER O
: O

1 O
) O
Albuterol B-TREATMENT
inhaler I-TREATMENT
4 O
puffs O
q.i.d. O

2 O
) O
Lasix B-TREATMENT
p.r.n. O

3 O
) O
Prednisone B-TREATMENT
40 O
mg O
p.o. O
q. O
day O
. O

4 O
) O
Inderal B-TREATMENT
40 O
mg O
p.o. O
q.i.d. O

5 O
) O
Thiamine B-TREATMENT
. O

6 O
) O
Lasix B-TREATMENT
p.r.n. O

7 O
) O
Atrovent B-TREATMENT
inhaler I-TREATMENT
4 O
puffs O
q.i.d. O

8 O
) O
Folic B-TREATMENT
acid I-TREATMENT
. O

9 O
) O
Premarin B-TREATMENT
0.625 O
mg O
p.o. O
q. O
day O
. O

10 O
) O
Omeprazole B-TREATMENT
20 O
mg O
p.o. O
q. O
day O
. O

11 O
) O
Insulin B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

ALLERGIES O
: O

The O
patient O
had O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

The O
patient O
is O
divorced O
. O

She O
has O
two O
children O
. O

She O
recently O
retired O
as O
a O
clerical O
worker O
. O

She O
denies O
any O
tobacco O
. O

She O
has O
only O
social O
alcohol O
use O
. O

FAMILY O
HISTORY O
: O

Father O
died O
at O
age O
56 O
of O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

Mother O
died O
at O
age O
68 O
of O
pancreatic B-SYMPTOM
carcinoma I-SYMPTOM
. O

Brother O
has O
coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

There O
is O
no O
family O
history O
of O
hematologic B-SYMPTOM
problems I-SYMPTOM
. O

LABORATORY O
: O

Laboratory O
studies O
on O
admission O
were O
notable O
for O
a O
sodium O
of O
131 O
, O
potassium O
6.2 O
, O
BUN O
111 O
, O
creatinine O
3.9 O
, O
white O
blood O
cell O
count O
23 O
, O
hematocrit O
27 O
with O
2+ B-SYMPTOM
schistocytes I-SYMPTOM
and O
2+ B-SYMPTOM
spherocytes I-SYMPTOM
on O
the O
smear O
, O
platelet O
count O
92 O
and O
LDH O
496 O
. O

HOSPITAL O
COURSE O
: O

1 O
) O
Bronchiolitis B-SYMPTOM
obliterans I-SYMPTOM
organizing I-SYMPTOM
pneumonia I-SYMPTOM
: O

The O
video O
assisted O
thoracoscopic O
study O
at O
the O
outside O
hospital O
was O
consistent O
with O
bronchiolitis B-SYMPTOM
obliterans I-SYMPTOM
organizing I-SYMPTOM
pneumonia I-SYMPTOM
. O

The O
patient O
was O
continued O
on O
steroids B-TREATMENT
throughout O
the O
course O
of O
her O
stay O
. O

This O
was O
changed O
to O
Solu-Medrol B-TREATMENT
part O
way O
through O
the O
course O
due O
to O
her B-SYMPTOM
hematologic I-SYMPTOM
problems I-SYMPTOM
, O
see O
below O
. O

By O
discharge O
, O
she O
was O
returned O
to O
40 O
mg O
of O
Prednisone B-TREATMENT
q. O
day O
times O
one O
month O
to O
be O
followed O
by O
a B-TREATMENT
slow I-TREATMENT
taper I-TREATMENT
. O

The B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
bronchiolitis I-SYMPTOM
obliterans I-SYMPTOM
organizing I-SYMPTOM
pneumonia I-SYMPTOM
appeared O
to O
improve O
slowly O
throughout O
her O
hospital O
course O
, O
however O
on O
July O
12 O
, O
1998 O
, O
after O
starting O
dialysis B-TREATMENT
( O
see O
below O
) O
, O
the O
patient O
desaturated O
and O
required O
supplemental B-TREATMENT
oxygen I-TREATMENT
. O

Repeat O
chest O
x-rays O
and O
chest O
CT O
scans O
appeared O
consistent O
with O
pulmonary B-SYMPTOM
edema I-SYMPTOM
from O
volume B-SYMPTOM
overload I-SYMPTOM
given O
her B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
and O
eventually O
, O
the O
patient O
&apos;s O
pulmonary O
status O
did O
improve O
after O
significant B-TREATMENT
volume I-TREATMENT
removal I-TREATMENT
with O
dialysis B-TREATMENT
for O
several O
weeks O
. O

At O
the O
time O
of O
her O
discharge O
, O
the O
patient O
was O
still O
requiring O
two O
liters O
of O
supplemental B-TREATMENT
oxygen I-TREATMENT
to O
maintain O
her O
oxygen O
saturations O
in O
the O
mid O
90% O
. O

2 O
) O
Thrombotic B-SYMPTOM
thrombocytopenic I-SYMPTOM
purpura I-SYMPTOM
: O

The O
patient O
was O
initially O
admitted O
with O
platelet O
count O
of O
28 O
, O
hematocrit O
of O
32 O
, O
LDH O
of O
496 O
with O
2+ B-SYMPTOM
schistocytes I-SYMPTOM
and O
2+ B-SYMPTOM
spherocytes I-SYMPTOM
on O
her O
smear O
. O

This O
was O
felt O
to O
be O
consistent O
with O
thrombotic B-SYMPTOM
thrombocytopenic I-SYMPTOM
purpura I-SYMPTOM
and O
on O
June O
20 O
, O
1998 O
, O
she O
was O
started O
on O
daily B-TREATMENT
plasma I-TREATMENT
exchange I-TREATMENT
which O
continued O
through O
July O
27 O
, O
1999 O
. O

She O
was O
also O
changed O
to O
intravenous B-TREATMENT
Solu-Medrol I-TREATMENT
50 O
mg O
q. O
day O
which O
was O
changed O
back O
to O
40 O
mg O
of O
Prednisone B-TREATMENT
prior O
to O
discharge O
. O

Her O
platelet O
count O
initially O
rose O
to O
a O
maximum O
of O
159 O
on O
July O
3 O
, O
1998 O
, O
then O
they O
steadily O
fell O
to O
a O
low O
of O
60 O
on O
July O
20 O
, O
1999 O
. O

Her O
LDH O
which O
peaked O
at O
1255 O
decreased O
to O
the O
mid O
200s O
, O
but O
remained O
elevated B-SYMPTOM
. O

She O
continued O
to O
have O
a B-SYMPTOM
few I-SYMPTOM
schistocytes I-SYMPTOM
on O
her O
smear O
, O
but O
it O
was O
much O
decreased O
. O

The O
patient O
also O
required O
red B-TREATMENT
blood I-TREATMENT
cell I-TREATMENT
transfusions I-TREATMENT
, O
approximately O
two O
units O
every O
seven O
to O
ten O
days O
to O
maintain O
her O
hematocrit O
. O

Eventually O
, O
her B-TREATMENT
plasma I-TREATMENT
exchange I-TREATMENT
was O
tapered O
to O
a O
smaller O
and O
smaller O
dose O
each O
day O
and O
then O
discontinued O
altogether O
after O
July O
27 O
, O
1999 O
. O

After O
this O
, O
the O
patient O
&apos;s O
platelet O
count O
rose O
to O
a O
maximum O
of O
177 O
on O
discharge O
. O

It O
is O
felt O
that O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
thrombotic I-SYMPTOM
thrombocytopenic I-SYMPTOM
purpura I-SYMPTOM
has O
resolved O
. O

She O
will O
continue O
on O
her B-TREATMENT
Prednisone I-TREATMENT
for O
one O
month O
as O
above O
for O
the B-SYMPTOM
bronchiolitis I-SYMPTOM
obliterans I-SYMPTOM
organizing I-SYMPTOM
pneumonia I-SYMPTOM
with O
a B-TREATMENT
very I-TREATMENT
slow I-TREATMENT
taper I-TREATMENT
. O

3 O
) O
Renal O
: O

The O
patient O
presented O
in O
acute B-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
with O
a O
BUN O
of O
101 O
and O
a O
creatinine O
of O
3.7 O
. O

Throughout O
the O
month O
of O
June O
, O
she O
had O
a B-SYMPTOM
rising I-SYMPTOM
Potassium I-SYMPTOM
phosphate I-SYMPTOM
and O
increasing B-SYMPTOM
volume I-SYMPTOM
overload I-SYMPTOM
with O
decreasing O
response O
to O
diuretics B-TREATMENT
and O
she O
was O
finally O
initiated O
on O
dialysis B-TREATMENT
with O
ultrafiltration B-TREATMENT
on O
July O
12 O
, O
1998 O
. O

The O
opinion O
of O
the O
Renal O
consult O
was O
that O
this O
was O
permanent B-SYMPTOM
and I-SYMPTOM
non-reversible I-SYMPTOM
renal I-SYMPTOM
failure I-SYMPTOM
since O
it O
did O
not O
improve O
with O
dialysis B-TREATMENT
and O
the O
patient O
will O
continue O
on O
dialysis B-TREATMENT
three O
times O
per O
week O
. O

She O
required O
approximately O
five O
liters O
of O
ultrafiltration B-TREATMENT
fluid I-TREATMENT
removal I-TREATMENT
at O
each O
dialysis O
session O
due O
to O
her B-SYMPTOM
significant I-SYMPTOM
volume I-SYMPTOM
overload I-SYMPTOM
. O

During O
the O
course O
of O
her B-TREATMENT
dialysis I-TREATMENT
, O
she O
had O
a O
great O
improvement O
in O
her B-SYMPTOM
lower I-SYMPTOM
extremity I-SYMPTOM
edema I-SYMPTOM
and O
her O
oxygen O
saturation O
. O

4 O
) O
Infectious O
disease O
: O

The O
patient O
had O
multiple B-SYMPTOM
line I-SYMPTOM
infections I-SYMPTOM
during O
her O
admission O
including O
a B-SYMPTOM
confirmed I-SYMPTOM
coag. I-SYMPTOM
negative I-SYMPTOM
Staphylococcus I-SYMPTOM
line I-SYMPTOM
infection I-SYMPTOM
with O
positive B-SYMPTOM
blood I-SYMPTOM
cultures I-SYMPTOM
on O
June O
23 O
, O
1998 O
, O
July O
4 O
, O
1998 O
, O
July O
8 O
, O
1998 O
and O
July O
9 O
, O
1998 O
. O

The O
patient O
eventually O
had O
a B-TREATMENT
left I-TREATMENT
subclavian I-TREATMENT
Tesio I-TREATMENT
catheter I-TREATMENT
placed O
and O
a B-TREATMENT
right I-TREATMENT
brachial I-TREATMENT
PICC I-TREATMENT
line I-TREATMENT
placed O
on O
July O
10 O
, O
1998 O
which O
remained O
patent O
and O
uninfected B-SYMPTOM
. O

She O
received O
a B-TREATMENT
full I-TREATMENT
three I-TREATMENT
week I-TREATMENT
course I-TREATMENT
of I-TREATMENT
Vancomycin I-TREATMENT
and O
also O
received O
a B-TREATMENT
three I-TREATMENT
week I-TREATMENT
course I-TREATMENT
of I-TREATMENT
Ceftazidime I-TREATMENT
. O

In O
addition O
, O
she O
had O
a B-SYMPTOM
fungal I-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
treated O
with O
Amphojel B-TREATMENT
bladder I-TREATMENT
irrigation I-TREATMENT
, O
which O
was O
followed O
by O
a B-SYMPTOM
Klebsiella I-SYMPTOM
urinary I-SYMPTOM
tract I-SYMPTOM
infection I-SYMPTOM
for O
which O
she O
received O
Levofloxacin B-TREATMENT
times O
fourteen O
days O
. O

She O
also O
received O
a B-TREATMENT
fourteen I-TREATMENT
day I-TREATMENT
course I-TREATMENT
of I-TREATMENT
Acyclovir I-TREATMENT
which O
was O
begun O
on O
June O
21 O
, O
1998 O
for O
perianal B-SYMPTOM
lesions I-SYMPTOM
consistent O
with O
herpes B-SYMPTOM
simplex I-SYMPTOM
virus I-SYMPTOM
. O

She O
was O
also O
on O
Fluconazole B-TREATMENT
for O
some B-SYMPTOM
oral I-SYMPTOM
thrush I-SYMPTOM
which O
was O
inadvertently O
continued O
for O
a O
total O
of O
thirty O
days O
. O

The O
patient O
was O
also O
started O
on O
Bactrim B-TREATMENT
one I-TREATMENT
double I-TREATMENT
strength I-TREATMENT
tablet O
q.o.d. O
as O
prophylaxis O
for O
Pneumocystis B-SYMPTOM
carinii I-SYMPTOM
pneumonia I-SYMPTOM
while O
on O
her B-TREATMENT
high I-TREATMENT
dose I-TREATMENT
steroids I-TREATMENT
. O

5 O
) O
Rheumatology O
: O

The O
patient O
was O
admitted O
with O
a O
question O
of O
lupus B-SYMPTOM
given O
her O
ANA O
of O
1:640 O
although O
her O
rheumatoid O
factor O
and O
ANCA O
were O
negative O
. O

Unfortunately O
throughout O
her O
admission O
, O
we O
were O
unable O
to O
test O
any O
more O
titers O
since O
she O
was O
receiving O
daily B-TREATMENT
plasma I-TREATMENT
exchange I-TREATMENT
. O

A O
repeat O
ANA O
, O
rheumatoid O
factor O
and O
ANCA O
may O
be O
repeated O
as O
an O
outpatient O
. O

FOLLOW-UP O
: O

1 O
) O
The O
patient O
will O
follow-up O
with O
her O
primary O
care O
physician O
, O
Dr. O
Tamarg O
Study O
, O
in O
Arvus O
after O
she O
is O
discharged O
from O
rehabilitation B-TREATMENT
. O

2 O
) O
The O
patient O
is O
being O
discharged O
to O
A O
Hospital O
where O
she O
will O
receive O
onsite B-TREATMENT
hemodialysis I-TREATMENT
three O
times O
per O
week O
on O
Monday O
, O
Wednesday O
and O
Friday O
. O

The O
nephrologist O
who O
will O
follow O
her O
there O
is O
Dr. O
Study O
. O

3 O
) O
The O
patient O
will O
continue O
to O
have O
her O
CBC O
, O
LDH O
, O
bilirubin O
, O
chem-7 O
and O
magnesium O
and O
calcium O
checked O
with O
each B-TREATMENT
dialysis I-TREATMENT
and O
the O
results O
will O
be O
faxed O
to O
Dr. O
Ian O
Zineisfreierm O
, O
the O
hematology O
attending O
at O
fax O
number O
751-329-8840 O
. O

4 O
) O
The O
patient O
will O
eventually O
need O
a B-TREATMENT
permanent I-TREATMENT
dialysis I-TREATMENT
fistula I-TREATMENT
. O

The B-TREATMENT
left I-TREATMENT
subclavian I-TREATMENT
Tesio I-TREATMENT
which O
she O
has O
in O
place O
will O
last O
for O
several O
months O
in O
the O
mean O
time O
. O

She O
would O
like O
to O
arrange O
to O
have O
her B-TREATMENT
fistula I-TREATMENT
placed O
at O
Pre O
Health O
and O
the O
vascular O
surgeons O
there O
should O
be O
contacted O
regarding O
this O
. O

5 O
) O
The O
patient O
will O
need O
packed B-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cell I-TREATMENT
transfusions I-TREATMENT
with O
dialysis B-TREATMENT
when O
her O
hematocrit O
falls O
below O
26 O
. O

6 O
) O
The O
patient O
will O
continue O
her B-TREATMENT
Prednisone I-TREATMENT
at O
40 O
mg O
p.o. O
q. O
day O
times O
one O
month O
( O
this O
was O
started O
on O
July O
27 O
, O
1999 O
) O
and O
then O
she O
will O
begin O
a B-TREATMENT
slow I-TREATMENT
taper I-TREATMENT
as O
guided O
by O
Pulmonary O
. O

7 O
) O
The O
patient O
has O
a O
follow-up O
appointment O
in O
the O
Pulmonary O
Clinic O
with O
Dr. O
Cedwi O
Stone O
at O
336-2931 O
on O
August O
30 O
, O
1999 O
at O
1:40 O
PM O
. O

8 O
) O
The O
patient O
has O
a O
follow-up O
appointment O
with O
Dr. O
Ian O
Zineisfreierm O
at O
the O
We O
Erthunt O
Hospital O
at O
180-0455 O
on O
August O
15 O
, O
1999 O
at O
12:30 O
PM O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1 O
) O
Calcitriol B-TREATMENT
0.25 O
mcg O
p.o. O
q. O
day O
. O

2 O
) O
TUMS B-TREATMENT
1250 O
mg O
p.o. O
t.i.d. O

3 O
) O
Premarin B-TREATMENT
0.625 O
mg O
p.o. O
q. O
day O
. O

4 O
) O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

5 O
) O
Humulin B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
q.a.c. O
and O
q.h.s. O

6 O
) O
Labetalol B-TREATMENT
400 O
mg O
p.o. O
t.i.d. O

7 O
) O
Omeprazole B-TREATMENT
20 O
mg O
p.o. O
q. O
day O
. O

8 O
) O
Serax B-TREATMENT
15 O
mg O
p.o. O
q.h.s. O
p.r.n. O
insomnia B-SYMPTOM
. O

9 O
) O
Prednisone B-TREATMENT
40 O
mg O
p.o. O
q. O
day O
times O
thirty O
days O
beginning O
on O
July O
27 O
, O
1999 O
to O
be O
followed O
by O
a B-TREATMENT
slow I-TREATMENT
taper I-TREATMENT
as O
directed O
by O
the O
pulmonologist O
. O

10 O
) O
Metamucil B-TREATMENT
one O
packet O
p.o. O
q. O
day O
. O

11 O
) O
Amlodipine B-TREATMENT
10 O
mg O
p.o. O
q. O
day O
. O

12 O
) O
Bactrim B-TREATMENT
Double I-TREATMENT
Strength I-TREATMENT
one O
tablet O
p.o. O
q.o.d. O

13 O
) O
Nephrocaps B-TREATMENT
one O
tablet O
p.o. O
q. O
day O
. O

14 O
) O
Epogen B-TREATMENT
1,000 O
units O
subcutaneously O
three O
times O
per O
week O
. O

15 O
) O
Iron B-TREATMENT
sulfate I-TREATMENT
300 O
mg O
p.o. O
t.i.d. O

Dictated O
By O
: O

CHELA O
FYFENEIGH O
, O
M.D. O
NY5 O

Attending O
: O

LENNI O
E. O
NECESSARY O
, O
M.D. O
BE1 O
IZ845/6789 O

Batch O
: O

7665 O

Index O
No. O
YQGKGG4LST O

D O
: O

08/01/98 O

T O
: O

08/01/98 O

CC O
: O

CEDWI O
STONE O
, O
MD O
, O
BMH O
PULMONARY O
CLINIC O
TAMARG O
STUDY O
, O
MD O
, O
Port O
O O
, O
PHONE O
912-434-8561 O
A O
HOSPITAL O
, O
Sburgbuff O

801499036 O

FIH O

3380885 O

04891/6516 O

412982 O

06/06/1993 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

06-06-93 O

DISCHARGE O
DATE O
: O

06-07-93 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
68 O
year O
old O
male O
status O
post O
three O
and O
a O
half O
cycles O
of O
adjuvant B-TREATMENT
EAP I-TREATMENT
chemotherapy I-TREATMENT
. O

He O
had O
a O
good O
response O
to O
preoperative B-TREATMENT
therapy I-TREATMENT
and O
negative O
nodes O
, O
and O
is O
admitted O
for O
the O
final O
portion O
of O
his B-TREATMENT
postoperative I-TREATMENT
cycles I-TREATMENT
. O

His B-TREATMENT
chemotherapy I-TREATMENT
the O
week O
before O
was O
decreased O
because O
the O
white O
blood O
count O
dropped O
to O
2.8 O
. O

In O
the O
interim O
, O
the O
white O
blood O
count O
rose O
again O
to O
4.2 O
with O
a O
hematocrit O
of O
30.5 O
, O
platelet O
count O
of O
196 O
thousand O
. O

PHYSICAL O
EXAMINATION O
: O

On O
physical O
examination O
on O
admission O
, O
the O
blood O
pressure O
was O
146/80 O
, O
weight O
146 O
, O
temperature O
98.6 O
, O
and O
pulse O
of O
92 O
. O

The O
skin O
was O
normal O
. O

The O
neck O
was O
supple O
. O

The O
cardiac O
examination O
demonstrated O
single O
S1 O
, O
S2 O
, O
no O
murmurs B-SYMPTOM
. O

The O
lungs O
were O
clear O
. O

The O
abdominal O
examination O
was O
within O
normal O
limits O
. O

The O
extremities O
were O
normal O
. O

The O
neurological O
examination O
was O
nonfocal O
. O

LABORATORY O
DATA O
: O

The O
creatinine O
was O
1.3 O
and O
dropping O
to O
1.1 O
. O

The O
bilirubin O
was O
0.2 O
, O
SGOT O
20 O
, O
magnesium O
of O
1.4 O
. O

The O
white O
blood O
count O
was O
4.0 O
, O
platelet O
count O
190 O
, O
with O
62% O
polys O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
treated O
with O
Adriamycin B-TREATMENT
25 O
mg O
, O
Cis-platinum B-TREATMENT
40 O
mg O
, O
preceded O
by O
Mannitol B-TREATMENT
12.5 O
grams O
intravenous O
bolus O
, O
and O
Zofran B-TREATMENT
11 O
mg O
on O
two O
occasions O
given O
as O
an B-TREATMENT
antiemetic I-TREATMENT
. O

The B-TREATMENT
chemotherapy I-TREATMENT
was O
well O
tolerated O
. O

DOCTORS O
DISCHARGE O
ORDERS O
: O

1. O
Intravenous B-TREATMENT
chemotherapy I-TREATMENT
, O

2. O
adenocarcinoma B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
esophagus I-SYMPTOM
, O

3. O
mild B-SYMPTOM
hypomagnesemia I-SYMPTOM
. O

SPECIAL O
PROCEDURES O
AND O
OPERATIONS O
: O

Intravenous B-TREATMENT
antibiotics I-TREATMENT
chemotherapy I-TREATMENT
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Slow-Mag B-TREATMENT
2 O
tablets O
PO O
bid O
, O
Ativan B-TREATMENT
1 O
mg O
sublingually O
q4h O
prn O
nausea B-SYMPTOM
. O

GUABENFRANDA O
D. O
PO O
, O
M.D. O

TR O
: O

ff O
/ O
bmot O

DD O
: O

06-07-93 O

TD O
: O

06/09/93 O

CC O
: O

Admission O
Date O
: O

2018-12-29 O

Discharge O
Date O
: O

2019-01-04 O

Date O
of O
Birth O
: O

2018-12-29 O

Sex O
: O

M O

Service O
: O

Neonatology O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Baby O
Davis O
is O
the O
3.160 O
kilogram O
product O
of O
a O
term O
pregnancy O
. O

He O
was O
born O
to O
a O
38 O
- O
year-old O
gravida O
I O
, O
para O
0 O
( O
now O
1 O
) O
mother O
at O
37 O
and O
1/7 O
weeks O
. O

The O
pregnancy O
was O
benign O
with O
an O
EDC O
of O
2019-01-18 O
. O

Prenatal O
screens O
were O
O O
positive O
, O
antibody O
negative O
, O
hepatitis O
surface O
antigen O
negative O
, O
rapid O
plasma O
reagent O
nonreactive O
, O
rubella O
immune O
, O
group O
B O
strep O
negative O
. O

The O
infant O
delivered O
by O
spontaneous O
vaginal O
delivery O
with O
Apgar O
scores O
of O
8 O
at O
one O
minute O
and O
8 O
at O
five O
minutes O
. O

PHYSICAL O
EXAMINATION O
: O

On O
admission O
, O
the O
Baby O
Lucas O
is O
well O
appearing O
, O
no O
jaundice B-SYMPTOM
. O

He O
has O
bilateral O
breath O
sounds O
that O
are O
clear O
and O
equal O
. O

The O
heart O
rate O
is O
regular O
without O
murmur B-SYMPTOM
. O

Pulses O
are O
2+ O
and O
symmetrical O
. O

The O
abdomen O
is O
soft O
and O
nontender B-SYMPTOM
with O
no O
hepatosplenomegaly B-SYMPTOM
. O

His O
weight O
is O
3.160 O
kilograms O
( O
7 O
pounds O
3 O
ounces O
) O
at O
birth O
. O

He O
is O
circumcised O
with O
testes O
descended O
bilaterally O
. O

His O
hips O
are O
stable O
. O

His O
tone O
is O
normal O
. O

Normal O
neonatal O
reflexes O
. O

He O
is O
tolerating O
his O
feedings O
well O
. O

HOSPITAL O
COURSE O
: O

1. O
Respiratory O
. O

Without O
issues O
on O
this O
admission O
. O

Breath O
sounds O
are O
clear O
and O
equal O
. O

2. O
Cardiovascular O
. O

Without O
issues O
on O
this O
admission O
. O

He O
had O
a O
regular O
heart O
rate O
and O
rhythm O
, O
no O
murmur B-SYMPTOM
, O
pulses O
were O
2+ O
and O
symmetric O
. O

3. O
Fluids O
, O
electrolytes O
and O
nutrition O
. O

The O
baby O
's O
weight O
was O
3.160 O
kilograms O
( O
7 O
pounds O
3 O
ounces O
). O

He O
is O
breast O
and O
bottle O
feeding O
every O
3 O
hours O
with O
expressed O
breast O
milk O
and O
/ O
or O
Enfamil B-TREATMENT
. O

He O
is O
feeding O
well O
. O

His O
discharge O
weight O
is O
3025 O
gm O
, O
and O
has O
been O
stable O
for O
past O
2 O
days O
. O

4. O
Gastrointestinal O
. O

The O
baby O
's O
bilirubin O
on O
2018-12-31 O
, O
was O
15.5 O
/ O
0.5 O
at O
which O
time O
double B-TREATMENT
phototherapy I-TREATMENT
was O
started O
. O

On O
01-01 O
, O
his O
bilirubin O
was O
17.3 O
/ O
0.4 O
at O
which O
time O
triple B-TREATMENT
phototherapy I-TREATMENT
was O
started O
and O
then O
his O
subsequent O
bilirubins O
are O
16.5 O
/ O
0.4 O
on O
2019-01-01 O
, O
and O
16.2 O
/ O
0.5 O
on O
2019-01-02 O
. O

Phototherapy B-TREATMENT
was O
discontinued O
on O
2019-01-04 O
for O
a O
bilirubin O
of O
12.1 O
, O
and O
a O
rebound O
bilirubin O
will O
be O
checked O
on O
01-05 O
. O

5. O
Hematology O
. O

The O
hematocrit O
on O
01-02 O
, O
was O
61 O
with O
a O
reticulocyte O
of O
2.6% O
. O

His O
blood O
type O
is O
A+ O
, O
Coombs O
negative O
. O

6. O
Infectious O
disease O
. O

No O
issues O
on O
this O
admission O
. O

7. O
Neurological O
. O

The O
baby O
has O
been O
appropriate O
for O
gestational O
age O
with O
normal O
newborn O
reflexes O
. O

8. O
Sensory O
. O

Auditory O
hearing O
screening O
was O
performed O
with O
automated O
brainstem O
responses O
. O

The O
infant O
passed O
both O
ears O
on O
2018-12-30 O
. O

9. O
Psychosocial O
. O

The O
family O
is O
invested O
and O
involved O
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

DISCHARGE O
DISPOSITION O
: O

Home O
. O

PRIMARY O
PEDIATRIC O
CARE O
: O

Source O
of O
primary O
pediatric O
care O
is O
David O
Bull O
at O
1899 O
S. O
Fifth O
Rd. O
, O
Salem O
, O
Florida O
92564 O
. O

Phone O
is O
( O
( O
256 O
) O
348-3764 O
. O

CARE O
RECOMMENDATIONS O
: O

1. O
Continue O
breast O
feeding O
with O
post-feed B-TREATMENT
supplemental I-TREATMENT
EBM I-TREATMENT
. O

2. O
Follow-up O
bilirubin O
in O
1 O
day O
; O
f/u O
with O
PMD O
in O
1-3 O
days O
. O

3. O
Medications O
: O

Not O
applicable O
. O

4. O
Car O
seat O
position O
and O
screening O
: O
Not O
applicable O
. O

5. O
State O
newborn O
screens O
were O
sent O
on O
2018-12-31 O
, O
and O
the O
results O
are O
pending O
. O

6. O
Immunizations B-TREATMENT
received O
: O
Hepatitis B-TREATMENT
B I-TREATMENT
vaccine I-TREATMENT
on O
12-31 O
, O
2006 O
. O

7. O
Immunization B-TREATMENT
recommended O
: O

Influenza B-TREATMENT
immunization I-TREATMENT
is O
recommended O
annually O
in O
the O
fall O
for O
all O
infants O
once O
they O
reach O
6 O
months O
of O
age O
. O

Before O
this O
age O
( O
and O
for O
the O
first O
24 O
months O
of O
the O
child O
's O
life O
) O
, O
immunization B-TREATMENT
against O
influenza B-SYMPTOM
is O
recommended O
for O
all O
household O
contacts O
and O
out O
of O
home O
caregivers O
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Term O
( O
37 O
and O
1/7 O
weeks O
) O
appropriate O
for O
gestational O
age O
male O
neonate O
. O

2. O
Exaggerated B-SYMPTOM
physiologic I-SYMPTOM
hyperbilirubinemia I-SYMPTOM
responsive O
to O
phototherapy B-TREATMENT
. O

Nicole O
Monica O
, O
MD O
48-041 O

Dictated O
By O
: O
Michelle O
A O
Sweeney O
, O
M.D. O

MEDQUIST36 O

D O
: O
2019-01-02 O
12:16:10 O

T O
: O
2019-01-02 O
13:00:35 O

Job O
# O
: O
38170 O

Signed O
electronically O
by O
: O
DR. O
Victoria O
Cox O
on O
: O
FRI O
2019-01-04 O
11:25 O
AM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2017-09-13 O

Discharge O
Date O
: O

2017-09-15 O

Date O
of O
Birth O
: O

1972-05-09 O

Sex O
: O

F O

Service O
: O

NSU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
45 O
- O
year-old O
female O
here O
for O
a O
diagnostic O
cerebral O
angiogram O
with O
coiling B-TREATMENT
. O

HOSPITAL O
COURSE O
: O

On O
admission O
, O
the O
patient O
's O
vital O
signs O
were O
stable O
. O

Her O
blood O
pressure O
was O
102/82 O
. O

Her O
heart O
rate O
was O
71 O
. O

Her O
SPO2 O
was O
98 O
percent O
on O
room O
air O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1. O
Plavix B-TREATMENT
75 O
mg O
times O
6 O
doses O
. O

2. O
Xanax B-TREATMENT
q.d. O

3. O
Prozac B-TREATMENT
20 O
mg O
q.d. O

4. O
Cyclobenzaprine B-TREATMENT
10 O
mg O
q.d. O

5. O
Aspirin B-TREATMENT
325 O
mg O
times O
3 O
doses O
. O

6. O
Vitamin B-TREATMENT
E I-TREATMENT
. O

PAST O
SURGICAL O
HISTORY O
: O

Tubal B-TREATMENT
ligation I-TREATMENT
, O
1986 O
. O

Cystectomy B-TREATMENT
, O
1992 O
and O
1998 O
. O

Breast B-TREATMENT
lesion I-TREATMENT
excision I-TREATMENT
, O
1989 O
. O

ALLERGIES O
: O

TETRACYCLINE B-TREATMENT
. O

SOCIAL O
HISTORY O
: O

The O
patient O
uses O
alcohol O
socially O
; O
was O
a O
smoker O
, O
used O
tobacco O
, O
she O
quit O
4 O
years O
ago O
; O
denies O
using O
recreational O
drug O
. O

PAST O
MEDICAL O
HISTORY O
: O

The O
patient O
had O
complaint O
of O
headaches B-SYMPTOM
in O
the O
past O
. O

She O
has O
fibromyalgia B-SYMPTOM
and O
a O
history O
of O
slurred B-SYMPTOM
speech I-SYMPTOM
. O

Her O
last O
menstrual O
period O
was O
on O
2017-08-29 O
. O

HOSPITAL O
COURSE O
: O

On O
2017-09-13 O
, O
the O
patient O
was O
brought O
to O
the O
operating O
room O
and O
underwent O
a B-TREATMENT
coiling I-TREATMENT
with O
stent B-TREATMENT
placement I-TREATMENT
of O
the B-SYMPTOM
left I-SYMPTOM
carotid I-SYMPTOM
ophthalmic I-SYMPTOM
aneurysm I-SYMPTOM
. O

The O
patient O
underwent O
coiling B-TREATMENT
and O
stent B-TREATMENT
placement I-TREATMENT
without O
complications B-SYMPTOM
. O

She O
was O
discharged O
to O
the O
PACU O
in O
stable O
condition O
. O

Postoperative O
check O
, O
the O
patient O
's O
vital O
signs O
were O
stable O
. O

Her O
temperature O
was O
96.3 O
degrees O
, O
blood O
pressure O
was O
128/63 O
. O

Her O
pulse O
was O
61 O
, O
respirations O
12 O
, O
and O
her O
O2 O
saturation O
was O
98 O
percent O
on O
room O
air O
. O

Her O
labs O
showed O
a O
white O
blood O
count O
of O
7.7 O
, O
hematocrit O
of O
33.3 O
, O
and O
platelets O
were O
305 O
. O

Her O
coags O
, O
her O
PT O
was O
14.5 O
, O
PTT O
was O
143.4 O
, O
and O
her O
INR O
was O
1.3 O
. O

Her O
electrolytes O
were O
all O
within O
normal O
limits O
. O

On O
physical O
exam O
, O
the O
patient O
was O
awake O
, O
alert O
, O
and O
oriented O
times O
3 O
. O

She O
had O
a O
symmetric O
smile O
. O

Her O
extraocular O
movements O
were O
full O
. O

Her O
pupils O
were O
3 O
to O
2 O
bilaterally O
, O
briskly O
reactive O
. O

The O
visual O
fields O
were O
intact O
. O

Her O
strength O
was O
05-31 O
throughout O
except O
for O
right O
was O
not O
tested O
due O
to O
the B-SYMPTOM
angiocele I-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
groin I-SYMPTOM
. O

Angiocele B-SYMPTOM
was O
intact O
without O
hematoma B-SYMPTOM
, O
and O
she O
exhibited O
strong O
pedal O
pulses O
on O
the O
right O
side O
. O

The O
assessment O
at O
that O
time O
was O
she O
was O
neurologically O
stable O
. O

The O
plan O
was O
q. O
1-hour O
neuro O
checks O
. O

She O
was O
started O
on O
a B-TREATMENT
heparin I-TREATMENT
drip I-TREATMENT
at O
800 O
per O
hour O
. O

Her O
PTT O
goes O
50 O
to O
60 O
at O
that O
time O
. O

She O
was O
cleared O
to O
take O
sips O
of O
clear O
fluids O
and O
was O
to O
remain O
flat O
for O
4 O
hours O
. O

On O
postoperative O
day O
1 O
, O
the O
patient O
was O
alert O
and O
oriented O
times O
3 O
. O

She O
exhibited O
no O
drift B-SYMPTOM
. O

Her O
IPs O
were O
full O
at O
5/5 O
. O

She O
had O
no O
hematoma B-SYMPTOM
in I-SYMPTOM
her I-SYMPTOM
groin I-SYMPTOM
site I-SYMPTOM
. O

Visual O
fields O
were O
full O
, O
her O
pupils O
were O
round O
and O
reactive O
bilaterally O
. O

Her O
vital O
signs O
were O
stable O
with O
a O
temperature O
of O
97.8 O
degrees O
, O
blood O
pressure O
was O
104 O
to O
121 O
over O
50s O
. O

Pulse O
was O
60 O
to O
70 O
. O

Respirations O
were O
15 O
, O
and O
she O
was O
saturating O
at O
96 O
percent O
on O
room O
air O
. O

Her O
PTT O
at O
that O
time O
was O
67.8 O
. O

She O
was O
started O
on O
aspirin B-TREATMENT
325 O
mg O
q.d. O
and O
Plavix B-TREATMENT
75 O
mg O
q.d. O

On O
2017-09-14 O
, O
she O
was O
transferred O
to O
the O
regular O
floor O
at O
Far O
5 O
. O

Postoperative O
day O
2 O
, O
the O
patient O
was O
stable O
without O
events O
, O
all O
vital O
signs O
were O
stable O
. O

She O
was O
moving O
all O
extremities O
and O
exhibiting O
good O
strength O
. O

Her O
visual O
fields O
were O
intact O
. O

Her O
extraocular O
movements O
were O
full O
. O

Angio B-SYMPTOM
site I-SYMPTOM
was O
clean O
, O
dry O
, O
and O
intact O
without O
bleeding B-SYMPTOM
or O
drainage B-SYMPTOM
. O

She O
was O
to O
be O
discharged O
today O
and O
encouraged O
to O
ambulate O
on O
her O
own O
. O

Discharge O
condition O
for O
this O
patient O
was O
good O
. O

She O
was O
ambulating O
on O
her O
own O
and O
tolerating O
a O
p.o. O
diet O
. O

She O
was O
discharged O
to O
home O
in O
stable O
condition O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Plavix B-TREATMENT
75 O
mg O
q.d. O

2. O
Aspirin B-TREATMENT
325 O
mg O
q.d. O

DISCHARGE O
INSTRUCTIONS O
: O

She O
is O
to O
continue O
taking O
medications B-TREATMENT
as O
prescribed O
. O

She O
is O
to O
undergo O
no O
strenuous O
activity O
until O
follow-up O
in O
2 O
weeks O
. O

FINAL O
DIAGNOSIS O
: O

She O
is O
status O
post O
coiling B-TREATMENT
with O
stent B-TREATMENT
placement I-TREATMENT
for O
left B-SYMPTOM
carotid I-SYMPTOM
ophthalmic I-SYMPTOM
aneurysm I-SYMPTOM
. O

RECOMMENDED O
FOLLOW-UP O
: O

She O
is O
following O
up O
with O
Dr. O
Mcmaster O
on O
2017-09-29 O
at O
11:30 O
a.m. O

She O
is O
also O
to O
follow O
up O
with O
her O
primary O
care O
physician O
to O
review O
her B-TREATMENT
hypertensive I-TREATMENT
medications I-TREATMENT
. O

SURGICAL O
INTERVENTION O
: O

Coiling B-TREATMENT
with O
a B-TREATMENT
stent I-TREATMENT
placement I-TREATMENT
for O
left B-SYMPTOM
carotid I-SYMPTOM
artery I-SYMPTOM
aneurysm I-SYMPTOM
. O

CONDITION O
ON O
DISCHARGE O
: O

She O
is O
neurologically O
stable O
. O

Helen O
Cynthia O
, O
New O
York O
10969 O

Dictated O
By O
: O
Scott O
T O
Little O
, O
M.D. O

MEDQUIST36 O

D O
: O
2017-09-15 O
09:28:45 O

T O
: O
2017-09-15 O
15:37:05 O

Job O
# O
: O
23470 O

Signed O
electronically O
by O
: O
DR. O
Mae O
Behlmer O
on O
: O
MON O
2017-10-09 O
5:18 O
AM O

( O
End O
of O
Report O
) O

126304158 O

PRGH O

30872450 O

619542 O

2/10/1998 O
12:00:00 O
AM O

CORONARY B-SYMPTOM
ARTERY I-SYMPTOM
DISEASE I-SYMPTOM

Unsigned O

DIS O

Admission O
Date O
: O

02/10/1998 O

Report O
Status O
: O

Unsigned O

Discharge O
Date O
: O

02/26/1998 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
69 O
year-old O
white O
gentleman O
who O
is O
status O
post O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
in O
1985 O
with O
a B-SYMPTOM
large I-SYMPTOM
anterior I-SYMPTOM
septal I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
intraoperatively O
. O

Two O
years O
after O
this B-TREATMENT
operation I-TREATMENT
, O
he O
required O
a B-TREATMENT
pacer I-TREATMENT
implantation I-TREATMENT
for O
sick B-SYMPTOM
sinus I-SYMPTOM
syndrome I-SYMPTOM
. O

The O
patient O
presents O
now O
with O
progressive B-SYMPTOM
dyspnea I-SYMPTOM
, O
but O
no O
anginal B-SYMPTOM
pain I-SYMPTOM
. O

Ejection O
fraction O
was O
noted O
to O
be O
20% O
. O

He O
is O
status O
post O
multiple B-TREATMENT
angioplasty I-TREATMENT
stents I-TREATMENT
. O

He O
presents O
now O
for O
possible O
reoperative B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

1 O
) O
Non-insulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
. O

2 O
) O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
, O
status O
post O
anterior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
sick B-SYMPTOM
sinus I-SYMPTOM
syndrome I-SYMPTOM
, O
status O
post O
a B-TREATMENT
VVI I-TREATMENT
pacer I-TREATMENT
placement I-TREATMENT
. O

Cardiac O
catheterization O
demonstrates O
severe B-SYMPTOM
triple I-SYMPTOM
vessel I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
RCA B-SYMPTOM
100% I-SYMPTOM
occluded I-SYMPTOM
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to O
OM1 B-TREATMENT
graft I-TREATMENT
was O
100% B-SYMPTOM
occluded I-SYMPTOM
and O
a O
patent O
LIMA O
, O
but O
severely B-SYMPTOM
diseased I-SYMPTOM
LAD I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

1 O
) O
Enteric B-TREATMENT
coated I-TREATMENT
aspirin I-TREATMENT
325 O
mg O
p.o. O
q. O
day O
. O

2 O
) O
Capoten B-TREATMENT
25 O
mg O
p.o. O
t.i.d. O

3 O
) O
Lanoxin B-TREATMENT
0.25 O
mg O
p.o. O
q. O
day O
. O

4 O
) O
Cardizem B-TREATMENT
125 O
mg O
p.o. O
q. O
day O
. O

5 O
) O
Glucotrol B-TREATMENT
XL I-TREATMENT
10 O
mg O
p.o. O
b.i.d. O

6 O
) O
Glucophage B-TREATMENT
500 O
mg O
p.o. O
q. O
day O
. O

7 O
) O
Amaryl B-TREATMENT
2 O
mg O
p.o. O
q.h.s. O

PHYSICAL O
EXAMINATION O
: O

Physical O
examination O
revealed O
that O
the O
vital O
signs O
were O
stable O
. O

Lungs O
were O
clear O
to O
auscultation O
bilaterally O
. O

Heart O
was O
irregular B-SYMPTOM
with O
no O
murmurs B-SYMPTOM
palpated O
. O

Abdomen O
was O
benign O
. O

Pulses O
were O
2+ O
throughout O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
Verg O
Medical O
Center O
. O

Subsequent O
exercise O
treadmill O
test O
demonstrated O
no O
evidence O
of O
ischemia B-SYMPTOM
by O
EKG O
. O

The O
patient O
was O
subsequently O
taken O
to O
the O
operating O
room O
where O
he O
underwent O
a B-TREATMENT
reoperative I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
times I-TREATMENT
three I-TREATMENT
with O
a B-TREATMENT
subaortic I-TREATMENT
proximal I-TREATMENT
graft I-TREATMENT
from O
the O
aorta O
to O
the O
OM1 O
and O
then O
OM2 O
and O
aorta O
to O
the O
LAD O
with O
a B-TREATMENT
wide I-TREATMENT
graft I-TREATMENT
per O
Dr. O
Lumar O
Jongguild O
. O

Postoperatively O
, O
the O
patient O
was O
ventilated O
. O

The O
patient O
was O
weaned O
off O
an B-TREATMENT
Epinephrine I-TREATMENT
drip I-TREATMENT
. O

Rhythm O
became O
more O
stable O
. O

Balloon B-TREATMENT
was O
weaned O
and O
finally O
discontinued O
. O

The O
patient O
was O
extubated O
. O

His B-TREATMENT
Melranon I-TREATMENT
was O
weaned O
off O
and O
his B-TREATMENT
ACE I-TREATMENT
inhibitor I-TREATMENT
began O
. O

The O
patient O
was O
started O
on O
Amiodarone B-TREATMENT
and O
diuresed O
. O

The O
patient O
&apos;s O
lower O
extremities O
began O
to O
swell O
and O
the O
patient O
was O
begun O
on O
Hirudin B-TREATMENT
for O
deep B-SYMPTOM
venous I-SYMPTOM
thrombosis I-SYMPTOM
. O

The B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
heparin I-SYMPTOM
induced I-SYMPTOM
thrombocytopenia I-SYMPTOM
became O
positive O
and O
so O
he O
is O
allergic B-SYMPTOM
to O
heparin B-TREATMENT
. O

The O
patient O
was O
begun O
on O
Coumadin B-TREATMENT
and O
he O
stayed O
several O
days O
for O
Coumadinization B-TREATMENT
and O
was O
finally O
discharged O
on O
therapeutic B-TREATMENT
Coumadin I-TREATMENT
. O

The O
patient O
tolerated O
a O
regular O
diet O
on O
postoperative O
day O
number O
thirteen O
from O
his B-TREATMENT
reoperative I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1 O
) O
Amiodarone B-TREATMENT
400 O
mg O
p.o. O
q. O
day O
. O

2 O
) O
Captopril B-TREATMENT
50 O
mg O
p.o. O
t.i.d. O

3 O
) O
Digoxin B-TREATMENT
0.125 O
mg O
p.o. O
q. O
day O
. O

4 O
) O
Colace B-TREATMENT
100 O
mg O
p.o. O
t.i.d. O

5 O
) O
Lasix B-TREATMENT
80 O
mg O
p.o. O
b.i.d. O

6 O
) O
Potassium B-TREATMENT
chloride I-TREATMENT
40 O
mEq O
p.o. O
b.i.d. O

7 O
) O
Glucophage B-TREATMENT
500 O
mg O
p.o. O
q. O
day O
. O

8 O
) O
Glucotrol B-TREATMENT
XL I-TREATMENT
10 O
mg O
p.o. O
b.i.d. O

9 O
) O
Coumadin B-TREATMENT
5 O
mg O
p.o. O
q. O
day O
. O

FOLLOW-UP O
: O

The O
patient O
was O
instructed O
to O
follow-up O
with O
Dr. O
Lumar O
Jongguild O
. O

Dictated O
By O
: O

RAMAG O
TROISQUARCKAYS O
, O
M.D. O
JB48 O

Attending O
: O

LUMAR O
R. O
JONGGUILD O
, O
M.D. O
NJ48 O
RO267/6080 O

Batch O
: O

5076 O

Index O
No. O
KHQTW3FS3 O

D O
: O

04/26/98 O

T O
: O

04/27/98 O

Admission O
Date O
: O

2014-03-05 O

Discharge O
Date O
: O

2014-04-04 O

Date O
of O
Birth O
: O

1942-08-15 O

Sex O
: O

M O

Service O
: O

CARDIOTHORACIC O
SURGERY O

HISTORY O
OF O
THE O
PRESENT O
ILLNESS O
: O

This O
is O
a O
71 O
- O
year-old O
gentleman O
who O
was O
admitted O
to O
the O
St. O
Anne O
's O
Hospital O
as O
a O
transfer O
from O
the O
Kindred O
Park O
View O
Specialty O
Hospital O
of O
Springfield O
. O

Prior O
to O
admission O
, O
he O
had O
a O
long O
and O
complicated O
hospital O
course O
at O
the O
outside O
hospital O
. O

His O
hospital O
course O
began O
on O
2014-02-13 O
when O
he O
underwent O
a B-TREATMENT
right I-TREATMENT
carotid I-TREATMENT
endarterectomy I-TREATMENT
for O
95% B-SYMPTOM
stenosis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
carotid I-SYMPTOM
artery I-SYMPTOM
. O

His O
postoperative O
course O
was O
complicated O
by O
nonspecific B-SYMPTOM
T I-SYMPTOM
wave I-SYMPTOM
changes I-SYMPTOM
consistent O
with O
myocardial B-SYMPTOM
infarction I-SYMPTOM
postoperatively O
as O
well O
as O
hematoma B-SYMPTOM
formation I-SYMPTOM
. O

The B-SYMPTOM
hematoma I-SYMPTOM
formation I-SYMPTOM
was O
rapidly O
expanding O
and O
he O
received O
an B-TREATMENT
emergent I-TREATMENT
surgical I-TREATMENT
airway I-TREATMENT
in O
the O
Intensive O
Care O
Unit O
. O

This B-TREATMENT
emergent I-TREATMENT
cricothyroidotomy I-TREATMENT
was O
converted O
then O
to O
a B-TREATMENT
formal I-TREATMENT
tracheostomy I-TREATMENT
. O

During O
his O
subsequent O
hospital O
course O
, O
he O
had O
an B-SYMPTOM
additional I-SYMPTOM
CHF I-SYMPTOM
exacerbation I-SYMPTOM
. O

He O
was O
medically O
managed O
and O
eventually O
his B-TREATMENT
tracheostomy I-TREATMENT
was O
decannulated O
. O

However O
, O
just O
prior O
to O
admission O
to O
Mass. O
Eye O
& O
Ear O
Infirmary O
he O
had O
another B-SYMPTOM
acute I-SYMPTOM
decompensation I-SYMPTOM
with O
CHF B-SYMPTOM
exacerbation I-SYMPTOM
. O

This O
necessitated O
emergent B-TREATMENT
intubation I-TREATMENT
. O

With O
EKG B-SYMPTOM
changes I-SYMPTOM
consistent O
with O
myocardial B-SYMPTOM
infarction I-SYMPTOM
, O
he O
was O
transferred O
to O
the O
Mass. O
Eye O
& O
Ear O
Infirmary O
for O
further O
management O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Diabetes B-SYMPTOM
type I-SYMPTOM
2 I-SYMPTOM
treated O
with O
oral B-TREATMENT
medication I-TREATMENT
. O

2. O
Cerebrovascular B-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
left B-TREATMENT
carotid I-TREATMENT
endarterectomy I-TREATMENT
in O
2008 O
. O

3. O
Status O
post O
right B-SYMPTOM
cerebrovascular I-SYMPTOM
accident I-SYMPTOM
in O
2009 O
with O
residual B-SYMPTOM
left-sided I-SYMPTOM
weakness I-SYMPTOM
. O

4. O
Status O
post O
right B-TREATMENT
carotid I-TREATMENT
endarterectomy I-TREATMENT
on O
2014-02-13 O
. O

5. O
Fall O
from O
standing O
on O
2014-01-29 O
with O
resultant O
displaced B-SYMPTOM
radial I-SYMPTOM
fracture I-SYMPTOM
which O
was O
reduced O
, O
closed O
, O
and O
casted O
. O

6. O
Hypertension B-SYMPTOM
. O

7. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
. O

No O
history O
of O
catheterization O
prior O
to O
admission O
to O
the O
Saint O
Vincent O
Hospital O
. O

8. O
Chronic B-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
with O
a O
baseline O
creatinine O
of O
2.0 O
to O
2.7. O

MEDICATIONS O
ON O
TRANSFER O
THE O
Stillman O
Infirmary O
: O

1. O
Lovenox B-TREATMENT
1 O
mg O
per O
kilogram O
subcutaneously O
b.i.d. O

2. O
Aspirin B-TREATMENT
81 O
mg O
p.o. O
q.d. O

3. O
Lopressor B-TREATMENT
50 O
mg O
p.o. O
b.i.d. O

4. O
Lansoprazole B-TREATMENT
30 O
mg O
p.o. O
q.d. O

5. O
Regular B-TREATMENT
insulin I-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
. O

6. O
Captopril B-TREATMENT
6.25 O
mg O
q.i.d. O

7. O
Lasix B-TREATMENT
drip I-TREATMENT
at O
2 O
per O
hour O
. O

8. O
Versed B-TREATMENT
drip I-TREATMENT
. O

9. O
TPN B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
ON O
ADMISSION O
: O

This O
is O
a O
gentleman O
who O
is O
intubated B-TREATMENT
, O
comfortable O
, O
with O
minimal B-TREATMENT
sedation I-TREATMENT
. O

He O
was O
afebrile B-SYMPTOM
with O
a O
temperature O
of O
99.1 O
. O

His O
pulse O
was O
in O
the O
70s O
, O
blood O
pressure O
119/58 O
. O

He O
was O
breathing O
12 O
per O
minute O
and O
saturating O
98% O
. O

His O
CVP O
is O
ranging O
from O
07-27 O
. O

He O
was O
intubated O
and O
has O
a B-TREATMENT
nasogastric I-TREATMENT
tube I-TREATMENT
. O

His O
neck O
has O
a B-SYMPTOM
well-healed I-SYMPTOM
right I-SYMPTOM
carotid I-SYMPTOM
endarterectomy I-SYMPTOM
scar I-SYMPTOM
. O

There O
is O
also O
a B-SYMPTOM
well-healing I-SYMPTOM
tracheostomy I-SYMPTOM
scar I-SYMPTOM
. O

The O
lungs O
were O
clear O
to O
auscultation O
bilaterally O
. O

The O
heart O
was O
regular O
with O
an O
S1 O
and O
S2 O
. O

The O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
with O
normoactive O
bowel O
sounds O
. O

The O
extremities O
were O
without O
edema B-SYMPTOM
. O

The O
left O
arm O
was O
in O
a B-TREATMENT
cast I-TREATMENT
. O

HOSPITAL O
COURSE O
: O

Mr. O
Knueppel O
was O
admitted O
to O
the O
CCU O
at O
the O
Mass. O
Eye O
& O
Ear O
Infirmary O
. O

Upon O
admission O
, O
he O
was O
treated O
for O
his B-SYMPTOM
pneumonia I-SYMPTOM
. O

He O
was O
medically O
managed O
for O
CHF B-SYMPTOM
and O
underwent O
a O
cardiac O
catheterization O
on O
2014-03-06 O
. O

His O
catheterization O
revealed O
70% B-SYMPTOM
stenosis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
distal I-SYMPTOM
left I-SYMPTOM
main I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
, O
90% B-SYMPTOM
stenosis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
LAD I-SYMPTOM
, O
80% B-SYMPTOM
stenosis I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
circumflex I-SYMPTOM
, O
90% B-SYMPTOM
stenosis I-SYMPTOM
of I-SYMPTOM
OM2 I-SYMPTOM
and O
a B-SYMPTOM
proximally I-SYMPTOM
occluded I-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
. O

After O
reviewing O
cardiac O
catheterization O
data O
, O
a O
consultation O
was O
made O
with O
Cardiothoracic O
Surgery O
who O
deemed O
that O
he O
was O
a O
good O
candidate O
for O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

Over O
the O
ensuing O
days O
, O
Mr. O
Nina O
CHF B-SYMPTOM
was O
managed O
by O
the O
CCU O
Team O
and O
he O
received O
treatment B-TREATMENT
for O
what O
was O
now O
determined O
to O
be O
a B-SYMPTOM
Klebsiella I-SYMPTOM
pneumonia I-SYMPTOM
. O

He O
was O
treated O
with O
a O
full O
course O
of O
Zosyn B-TREATMENT
. O

On O
2014-03-11 O
, O
Mr. O
Knueppel O
went O
to O
the O
Operating O
Room O
with O
Dr. O
Streeter O
. O

He O
underwent O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
of I-TREATMENT
four I-TREATMENT
vessels I-TREATMENT
. O

He O
had O
a B-TREATMENT
saphenous I-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
his I-TREATMENT
LAD I-TREATMENT
and I-TREATMENT
diagonal I-TREATMENT
in O
a O
sequential O
fashion O
, O
saphenous B-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
his I-TREATMENT
PDA I-TREATMENT
and O
a B-TREATMENT
saphenous I-TREATMENT
vein I-TREATMENT
graft I-TREATMENT
to I-TREATMENT
his I-TREATMENT
OM I-TREATMENT
. O

The B-TREATMENT
procedure I-TREATMENT
was O
performed O
by O
Dr. O
Streeter O
and O
assisted O
by O
Dr O
. O
..................... O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
without O
complication B-SYMPTOM
and O
was O
transferred O
to O
the O
Cardiac O

Surgery O
Recovery O
Unit O
without O
complication B-SYMPTOM
. O

Please O
see O
the O
previously O
dictated O
operative O
note O
for O
more O
details O
. O

Mr. O
Knueppel O
had O
a O
long O
postoperative O
course O
. O

His O
postoperative O
course O
was O
complicated O
by O
hypertension B-SYMPTOM
which O
was O
managed O
medically O
. O

During O
his O
postoperative O
course O
, O
he O
did O
not O
suffer O
from O
any B-SYMPTOM
arrhythmias I-SYMPTOM
nor O
did O
he O
have O
any O
episode O
of O
hypotension B-SYMPTOM
. O

At O
the O
time O
of O
discharge O
, O
he O
was O
on O
a B-TREATMENT
stable I-TREATMENT
antihypertensive I-TREATMENT
regimen I-TREATMENT
appropriate O
for O
someone O
with O
a B-SYMPTOM
decreased I-SYMPTOM
ejection I-SYMPTOM
fraction I-SYMPTOM
. O

Mr. O
Knueppel O
had O
had O
a O
long O
protracted O
period O
of O
intubation B-TREATMENT
prior O
to O
the O
operation B-TREATMENT
. O

The O
status O
of O
Mr. O
Nina O
pulmonary O
system O
necessitated O
a B-TREATMENT
prolonged I-TREATMENT
postoperative I-TREATMENT
intubation I-TREATMENT
. O

After O
a O
very O
slow O
wean O
from O
ventilatory B-TREATMENT
support I-TREATMENT
, O
Mr. O
Knueppel O
was O
successfully O
extubated O
on O
postoperative O
day O
number O
nine O
. O

He O
continued O
to O
be O
very O
tenuous O
from O
a O
pulmonary O
point O
of O
view O
and O
required O
frequent B-TREATMENT
chest I-TREATMENT
PT I-TREATMENT
. O

For O
this O
reason O
, O
Mr. O
Knueppel O
was O
kept O
in O
the O
Intensive O
Care O
Unit O
where O
very O
close O
monitoring O
could O
be O
performed O
. O

In O
addition O
, O
he O
had O
chest B-TREATMENT
PT I-TREATMENT
performed O
at O
very O
regular O
intervals O
by O
the O
ICU O
staff O
. O

His O
pulmonary O
status O
was O
so O
tenuous O
that O
we O
were O
unable O
to O
transfer O
him O
to O
the O
regular O
patient O
care O
floor O
during O
his O
hospitalization O
. O

Mr. O
Knueppel O
had O
an B-TREATMENT
emergent I-TREATMENT
cricothyroidotomy I-TREATMENT
followed O
by O
a B-TREATMENT
formal I-TREATMENT
tracheostomy I-TREATMENT
at O
the O
outside O
hospital O
. O

There O
is O
much B-SYMPTOM
scarring I-SYMPTOM
surrounding I-SYMPTOM
his I-SYMPTOM
larynx I-SYMPTOM
. O

Such O
a O
situation O
frequently O
makes O
it O
very O
difficult O
to O
swallow O
without O
aspirating O
. O

As O
is O
expected O
, O
Mr. O
Knueppel O
failed O
a O
swallowing O
study O
early O
on O
in O
his O
Boston O
Regional O
Medical O
Centerr O
hospital O
course O
. O

The O
study O
was O
repeated O
and O
yet O
again O
Mr. O
Knueppel O
was O
unable O
to O
swallow O
without O
evidence O
of O
aspiration B-SYMPTOM
. O

After O
a O
prolonged O
period O
of O
being O
fed O
via O
nasogastric B-TREATMENT
tube I-TREATMENT
, O
Mr. O
Knueppel O
finally O
had O
a B-TREATMENT
formal I-TREATMENT
percutaneous I-TREATMENT
endoscopic I-TREATMENT
gastrostomy I-TREATMENT
tube I-TREATMENT
placed O
in O
the O
Intensive O
Care O
Unit O
. O

This O
was O
performed O
on O
2014-04-01 O
, O
postoperative O
day O
number O
21 O
. O

This B-TREATMENT
procedure I-TREATMENT
was O
performed O
by O
Dr. O
Kevin O
Taussig O
and O
assisted O
by O
Dr. O
Carla O
Solan O
. O

The B-TREATMENT
procedure I-TREATMENT
was O
performed O
under O
endoscopic B-TREATMENT
guidance I-TREATMENT
in O
the O
Intensive O
Care O
Unit O
without O
complication B-SYMPTOM
. O

Please O
see O
the O
previously O
dictated O
operative O
note O
for O
more O
details O
. O

Mr. O
Knueppel O
Robertson O
a B-SYMPTOM
distal I-SYMPTOM
radius I-SYMPTOM
fracture I-SYMPTOM
prior O
to O
arriving O
to O
the O
hospital O
. O

This B-SYMPTOM
injury I-SYMPTOM
had O
been O
reduced O
and O
casted O
at O
the O
outside O
institution O
. O

Postoperatively O
, O
there O
was O
much B-SYMPTOM
edema I-SYMPTOM
associated O
in O
the O
postoperative O
course O
from O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
grafting I-TREATMENT
. O

His B-TREATMENT
cast I-TREATMENT
was O
removed O
by O
the O
Orthopedic O
Service O
in O
anticipation O
of O
this B-SYMPTOM
edema I-SYMPTOM
and O
to O
avoid O
compartment B-SYMPTOM
syndrome I-SYMPTOM
. O

The B-TREATMENT
cast I-TREATMENT
was O
replaced O
by O
a B-TREATMENT
plaster I-TREATMENT
splint I-TREATMENT
. O

Mr. O
Knueppel O
should O
follow-up O
with O
his O
orthopedic O
surgeon O
in O
the O
Worcester O
State O
Hospital O
for O
reassessment O
of O
his B-SYMPTOM
injury I-SYMPTOM
and O
possible O
removal B-TREATMENT
of O
the B-TREATMENT
splint I-TREATMENT
. O

By O
postoperative O
day O
number O
23 O
, O
Mr. O
Nina O
pulmonary O
status O
was O
deemed O
sufficiently O
stable O
. O

His B-SYMPTOM
hypertension I-SYMPTOM
was O
well O
controlled O
and O
he O
was O
tolerating O
tube B-TREATMENT
feeds I-TREATMENT
. O

At O
this O
point O
, O
he O
was O
ready O
to O
be O
discharged O
to O
rehabilitation O
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
coronary B-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
, I-TREATMENT
four I-TREATMENT
vessels I-TREATMENT
. O

2. O
Congestive B-SYMPTOM
heart I-SYMPTOM
failure I-SYMPTOM
. O

3. O
Klebsiella B-SYMPTOM
pneumonia I-SYMPTOM
. O

4. O
Failed B-SYMPTOM
swallow I-SYMPTOM
study I-SYMPTOM
status O
post O
percutaneous B-TREATMENT
endoscopic I-TREATMENT
gastrostomy I-TREATMENT
tube I-TREATMENT
placement I-TREATMENT
. O

5. O
Central O
line O
culture O
positive O
for O
coagulase B-SYMPTOM
- I-SYMPTOM
negative I-SYMPTOM
Staphylococcus I-SYMPTOM
aureus I-SYMPTOM
, O
status O
post O
a B-TREATMENT
14 I-TREATMENT
day I-TREATMENT
treatment I-TREATMENT
with O
vancomycin B-TREATMENT
and O
removal B-TREATMENT
of O
the B-TREATMENT
line I-TREATMENT
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Methylphenidate B-TREATMENT
5 O
mg O
p.o. O
q.d. O

2. O
Lasix B-TREATMENT
40 O
mg O
p.o. O
b.i.d. O

3. O
Captopril B-TREATMENT
50 O
mg O
p.o. O
t.i.d. O

4. O
Glyburide B-TREATMENT
10 O
mg O
p.o. O
b.i.d. O

5. O
Miconazole B-TREATMENT
powder I-TREATMENT
2% O
, O
apply O
q.i.d. O
p.r.n. O

6. O
Paxil B-TREATMENT
20 O
mg O
p.o. O
q.d. O

7. O
Albuterol B-TREATMENT
nebulizer I-TREATMENT
solution I-TREATMENT
one O
nebulizer O
q. O
four O
hours O
. O

8. O
Metoprolol B-TREATMENT
100 O
mg O
p.o. O
t.i.d. O

9. O
Heparin B-TREATMENT
5,000 O
units O
subcutaneously O
q. O
12 O
hours O
. O

10. O
Amlodipine B-TREATMENT
5 O
mg O
p.o. O
b.i.d. O

11. O
Percocet B-TREATMENT
one O
to O
two O
tablets O
p.o. O
q. O
four O
hours O
p.r.n. O
pain B-SYMPTOM
. O

12. O
Colace B-TREATMENT
100 O
mg O
p.o. O
b.i.d. O

13. O
Aspirin B-TREATMENT
325 O
mg O
p.o. O
q.d. O

14. O
Tube B-TREATMENT
feedings I-TREATMENT
; O
Mr. O
Knueppel O
is O
to O
be O
discharged O
on O
tube B-TREATMENT
feeds I-TREATMENT
, O
Promote B-TREATMENT
, I-TREATMENT
with I-TREATMENT
fiber I-TREATMENT
full-strength I-TREATMENT
at O
80 O
cc O
per O
hour O
around O
the O
clock O
. O

His B-TREATMENT
PEG I-TREATMENT
tube I-TREATMENT
should O
be O
flushed O
with O
30 O
cc O
of O
water O
after O
every O
use O
. O

ACTIVITY O
: O

Mr. O
Nina O
activity O
is O
ad O
lib O
. O

He O
is O
also O
to O
be O
strict B-TREATMENT
n.p.o. I-TREATMENT

He O
should O
be O
n.p.o. B-TREATMENT
until O
he O
has O
a O
repeat O
swallow O
evaluation O
which O
demonstrates O
his O
ability O
to O
swallow O
without O
aspiration B-SYMPTOM
. O

FOLLOW-UP O
: O

The O
patient O
will O
follow-up O
with O
Dr. O
Streeter O
in O
his O
office O
in O
four O
to O
six O
weeks O
. O

The O
patient O
should O
follow-up O
with O
his O
primary O
care O
physician O
within O
one O
week O
. O

The O
patient O
should O
follow-up O
with O
his O
orthopedic O
surgeon O
at O
the O
next O
convenient O
time O
to O
determine O
the O
length O
of O
duration O
of O
his B-TREATMENT
casting I-TREATMENT
. O

CONDITION O
ON O
DISCHARGE O
: O

Stable O
. O

PHYSICAL O
EXAMINATION O
ON O
DISCHARGE O
: O

Mr. O
Knueppel O
is O
afebrile B-SYMPTOM
with O
a O
temperature O
of O
97.1 O
, O
pulse O
77 O
, O
sinus O
rhythm O
. O

His O
blood O
pressure O
was O
142/68 O
, O
breathing O
21 O
breaths O
per O
minute O
, O
94% O
on O
2 B-TREATMENT
liters I-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
. O

His O
pupils O
were O
equal O
, O
round O
, O
and O
reactive O
. O

Extraocular O
muscles O
intact O
. O

His O
head O
was O
normocephalic O
, O
atraumatic B-SYMPTOM
. O

The O
lungs O
were O
clear O
to O
auscultation O
bilaterally O
. O

The O
heart O
revealed O
a O
regular O
rate O
and O
rhythm O
. O

The O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
. O

He O
had O
a B-TREATMENT
PEG I-TREATMENT
tube I-TREATMENT
in I-TREATMENT
his I-TREATMENT
left I-TREATMENT
upper I-TREATMENT
quadrant I-TREATMENT
. O

The B-SYMPTOM
site I-SYMPTOM
was O
clean O
and O
dry O
. O

There O
was O
no O
evidence O
of O
necrosis B-SYMPTOM
, O
erythema B-SYMPTOM
or O
exudate B-SYMPTOM
at O
the B-SYMPTOM
site I-SYMPTOM
. O

The O
extremities O
were O
warm O
and O
well O
perfuse O
. O

There O
was O
trace B-SYMPTOM
edema I-SYMPTOM
in I-SYMPTOM
both I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
. O

His O
right O
lower O
extremity O
has O
ecchymosis B-SYMPTOM
related O
to O
a B-SYMPTOM
saphenectomy I-SYMPTOM
site I-SYMPTOM
. O

This B-SYMPTOM
ecchymosis I-SYMPTOM
is O
much O
improved O
from O
previous O
examinations O
. O

There O
was O
no O
increased B-SYMPTOM
warmth I-SYMPTOM
over O
this O
area O
nor O
is O
there O
any B-SYMPTOM
exudate I-SYMPTOM
from O
his B-SYMPTOM
wounds I-SYMPTOM
. O

All O
of O
his B-SYMPTOM
wounds I-SYMPTOM
including O
sternotomy B-SYMPTOM
wound I-SYMPTOM
were O
clean O
, O
dry O
, O
and O
intact O
. O

Timothy O
M O
Geibel O
, O
M.D. O
92-534 O

Dictated O
By O
: O
Melinda O
U O
Yantis O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-04-04 O
02:23 O

T O
: O
2014-04-04 O
15:35 O

JOB O
# O
: O
79430 O

Signed O
electronically O
by O
: O
DR. O
Timothy O
B. O
Chew O
on O
: O
TUE O
2014-06-03 O
4:10 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2016-03-30 O

Discharge O
Date O
: O

2016-04-03 O

Date O
of O
Birth O
: O

1951-08-19 O

Sex O
: O

F O

Service O
: O

CCU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

This O
is O
a O
64-year-old O
female O
with O
a O
history O
of O
hypertension B-SYMPTOM
, O
hypercholesterolemia B-SYMPTOM
, O
diabetes B-SYMPTOM
mellitus I-SYMPTOM
, O
and O
dilated B-SYMPTOM
cardiomyopathy I-SYMPTOM
( O
with O
a O
transthoracic O
echocardiogram O
in O
2016-01-13 O
showing O
an O
ejection O
fraction O
of O
40% O
, O
posterior B-SYMPTOM
and I-SYMPTOM
inferior I-SYMPTOM
apical I-SYMPTOM
akinesis I-SYMPTOM
, O
and O
large B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
thrombus I-SYMPTOM
). O

The O
patient O
was O
admitted O
from O
2016-01-21 O
to O
2016-02-03 O
; O
at O
which O
time O
she O
was O
ruled O
out O
for O
a B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
. O

She O
had O
a O
cardiac O
catheterization O
which O
revealed O
3-vessel B-SYMPTOM
disease I-SYMPTOM
with O
normal O
left O
main O
, O
mid O
left O
anterior O
descending O
artery O
60% O
, O
diffuse B-SYMPTOM
90% I-SYMPTOM
mid I-SYMPTOM
distal I-SYMPTOM
stenosis I-SYMPTOM
at O
the O
origin O
of O
the O
diagonal O
, O
serial O
70% O
and O
90% B-SYMPTOM
left I-SYMPTOM
circumflex I-SYMPTOM
lesions I-SYMPTOM
, O
and O
90% O
first O
obtuse O
marginal O
, O
and O
mid O
right O
coronary O
artery O
60% O
. O

During O
initial O
evaluation O
for O
a B-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
, O
80% O
to O
90% O
of O
the B-SYMPTOM
right I-SYMPTOM
coronary I-SYMPTOM
artery I-SYMPTOM
stenosis I-SYMPTOM
was O
found O
; O
for O
which O
she O
underwent O
a B-TREATMENT
right I-TREATMENT
internal I-TREATMENT
carotid I-TREATMENT
artery I-TREATMENT
stent I-TREATMENT
. O

She O
was O
discharged O
on O
Coumadin B-TREATMENT
for O
a O
goal O
INR O
of O
2.5 O
to O
3 O
. O

She O
was O
then O
admitted O
again O
on O
2016-03-30 O
for O
an B-TREATMENT
elective I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
. O

At O
surgery B-TREATMENT
, O
the O
descending O
aorta O
was O
noted O
to O
be O
calcified B-SYMPTOM
, O
and O
an O
intraoperative O
transesophageal O
echocardiogram O
revealed O
an B-SYMPTOM
irregular I-SYMPTOM
intra-aortic I-SYMPTOM
pedunculated I-SYMPTOM
lesion I-SYMPTOM
. O

Given O
the B-SYMPTOM
elevated I-SYMPTOM
stroke I-SYMPTOM
risk I-SYMPTOM
of O
aortic B-TREATMENT
cross-clamping I-TREATMENT
in O
the O
setting O
of O
this O
finding O
, O
the O
plan O
for O
a B-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
was O
aborted O
. O

The O
patient O
was O
then O
transferred O
to O
the O
Coronary O
Care O
Unit O
Service O
for O
medical O
management O
in O
anticipation O
of O
possible O
percutaneous B-TREATMENT
coronary I-TREATMENT
intervention I-TREATMENT
later O
in O
the O
admission O
. O

PAST O
MEDICAL O
HISTORY O
: O

1. O
Diabetes B-SYMPTOM
mellitus I-SYMPTOM
. O

2. O
Hypertension B-SYMPTOM
. O

3. O
Hypercholesterolemia B-SYMPTOM
. O

4. O
Asthma B-SYMPTOM
. O

5. O
Chronic B-SYMPTOM
low I-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
. O

6. O
Cholelithiasis B-SYMPTOM
. O

7. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
( O
as O
noted O
previously O
). O

8. O
Dilated B-SYMPTOM
cardiomyopathy I-SYMPTOM
( O
also O
as O
noted O
above O
). O

MEDICATIONS O
ON O
TRANSFER O
: O

1. O
Dopamine B-TREATMENT
drip I-TREATMENT
at O
3 O
. O

2. O
Insulin B-TREATMENT
drip I-TREATMENT
at O
2 O
. O

3. O
Regular B-TREATMENT
10 O
units O
intravenously O
q.6h. O
as O
needed O
. O

4. O
Percocet B-TREATMENT
as O
needed O
. O

5. O
Sucralfate B-TREATMENT
1 O
g O
via O
nasogastric O
tube O
q.6h. O

6. O
Aspirin B-TREATMENT
325 O
mg O
p.o. O
once O
per O
day O
. O

7. O
Colace B-TREATMENT
100 O
mg O
p.o. O
twice O
per O
day O
. O

8. O
Flonase B-TREATMENT
2 O
puffs O
twice O
per O
day O
. O

9. O
Lipitor B-TREATMENT
10 O
mg O
p.o. O
once O
per O
day O
. O

10. O
Protonix B-TREATMENT
40 O
mg O
p.o. O
once O
per O
day O
. O

11. O
Plavix B-TREATMENT
75 O
mg O
p.o. O
once O
per O
day O
. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

SOCIAL O
HISTORY O
: O

Social O
history O
is O
positive O
for O
smoking O
. O

PHYSICAL O
EXAMINATION O
ON O
PRESENTATION O
: O

Physical O
examination O
revealed O
temperature O
was O
99.3 O
, O
heart O
rate O
was O
66 O
in O
a O
normal O
sinus O
rhythm O
, O
blood O
pressure O
was O
132/51 O
, O
respiratory O
rate O
was O
22 O
, O
and O
oxygen O
saturation O
was O
100% O
on O
3 B-TREATMENT
liters I-TREATMENT
nasal I-TREATMENT
cannula I-TREATMENT
. O

Swan O
showed O
a O
PA O
of O
29/11 O
, O
SVR O
of O
14/9 O
, O
cardiac O
output O
of O
3.86 O
, O
cardiac O
index O
of O
2.14 O
. O

Urine O
output O
of O
30 O
cc O
to O
100 O
cc O
per O
hour O
over O
the O
last O
four O
hours O
. O

Chest B-TREATMENT
tube I-TREATMENT
showed O
30 O
cc O
per O
hour O
over O
the O
last O
four O
hours O
. O

In O
general O
, O
the O
patient O
was O
alert O
and O
oriented O
times O
three O
. O

In O
no O
apparent B-SYMPTOM
distress I-SYMPTOM
and O
denied O
pain B-SYMPTOM
. O

Head O
, O
eyes O
, O
ears O
, O
nose O
, O
and O
throat O
examination O
was O
without O
bruits B-SYMPTOM
. O

Lungs O
were O
clear O
to O
auscultation O
anteriorly O
. O

Heart O
was O
regular O
in O
rate O
and O
rhythm O
. O

Normal O
first O
heart O
sounds O
and O
second O
heart O
sounds O
. O

No O
audible B-SYMPTOM
murmurs I-SYMPTOM
. O

The O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
and O
nondistended B-SYMPTOM
with O
active O
bowel O
sounds O
. O

Extremities O
were O
without O
edema B-SYMPTOM
. O

Neurologic O
examination O
was O
nonfocal O
. O

Lines B-TREATMENT
included O
a B-TREATMENT
right I-TREATMENT
antecubital I-TREATMENT
peripheral I-TREATMENT
intravenous I-TREATMENT
. O

Chest B-TREATMENT
tube I-TREATMENT
was O
in O
place O
in O
left O
internal O
jugular O
an B-TREATMENT
pulmonary I-TREATMENT
artery I-TREATMENT
catheter I-TREATMENT
. O

PERTINENT O
LABORATORY O
VALUES O
ON O
PRESENTATION O
: O

Laboratories O
revealed O
white O
blood O
cell O
count O
was O
12.7 O
, O
hematocrit O
was O
32.4 O
, O
platelets O
were O
140 O
, O
and O
mean O
cell O
volume O
was O
80 O
. O

Patient O
was O
4.4 O
, O
blood O
urea O
nitrogen O
was O
14 O
, O
creatinine O
was O
0.6 O
, O
and O
glucose O
was O
147 O
. O

INR O
was O
1.2 O
, O
partial O
thromboplastin O
time O
was O
23.7 O
, O
and O
prothrombin O
time O
was O
13.4 O
. O

Free O
calcium O
was O
0.95 O
on O
03-30 O
. O

Phosphate O
was O
3.6 O
and O
magnesium O
was O
2.2 O
. O

Arterial O
blood O
gas O
at O
3 O
a.m. O
demonstrated O
7.4/45/125 O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
is O
a O
64-year-old O
female O
with O
3-vessel B-SYMPTOM
disease I-SYMPTOM
who O
was O
admitted O
to O
the O
Coronary O
Care O
Unit O
Service O
for O
Western O
Mass O
. O

Hospital O
medical O
optimization O
and O
management O
following O
an B-TREATMENT
aborted I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
when O
a B-SYMPTOM
mobile I-SYMPTOM
aortic I-SYMPTOM
atheroma I-SYMPTOM
was O
noted O
. O

The O
patient O
was O
continued O
on O
aspirin B-TREATMENT
, O
Plavix B-TREATMENT
, O
and O
statin B-TREATMENT
. O

Once O
the O
patient O
was O
titrated O
off O
dopamine B-TREATMENT
, O
the B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
and O
ACE B-TREATMENT
inhibitor I-TREATMENT
were O
restarted O
. O

With O
regard O
to O
the B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
thrombus I-SYMPTOM
, O
her O
goal O
INR O
remained O
2.5 O
to O
3 O
; O
and O
the O
goal O
was O
to O
start O
heparin B-TREATMENT
once O
the O
patient O
was O
stable O
from O
a B-TREATMENT
thoracotomy I-TREATMENT
and O
chest B-TREATMENT
tube I-TREATMENT

standpoint O
. O

The O
patient O
remained O
comfortable O
. O

By O
04-01 O
, O
on O
postoperative O
day O
two O
, O
the O
patient O
was O
doing O
well O
and O
the B-TREATMENT
chest I-TREATMENT
tube I-TREATMENT
was O
discontinued O
. O

The O
patient O
still O
had O
transcutaneous B-TREATMENT
pacing I-TREATMENT
wires I-TREATMENT
in O
place O
. O

Likewise O
, O
on O
04-01 O
, O
the O
patient O
was O
weaned O
off O
surgery B-TREATMENT
without O
difficulty O
. O

Thus O
, O
the B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
and O
ACE B-TREATMENT
inhibitor I-TREATMENT
were O
started O
to O
be O
titrated O
up O
. O

In O
addition O
, O
the O
patient O
was O
started O
on O
Wellbutrin B-TREATMENT
for O
smoking O
cessation O
. O

At O
this O
point O
, O
it O
was O
determined O
that O
the O
patient O
would O
not O
receive O
percutaneous B-TREATMENT
coronary I-TREATMENT
intervention I-TREATMENT
on O
this O
admission O
and O
would O
likely O
be O
discharged O
to O
the O
floor O
for O
stabilization O
with O
followup O
. O

The O
patient O
did O
well O
and O
was O
transferred O
to O
the O
floor O
on O
04-02 O
. O

After O
evaluation O
and O
a O
discussion O
with O
Dr. O
Gunter O
, O
it O
was O
determined O
that O
the O
patient O
no O
longer O
needed O
anticoagulation B-TREATMENT
since O
there O
was O
no O
aortic B-SYMPTOM
thrombus I-SYMPTOM
but O
only O
an B-SYMPTOM
aortic I-SYMPTOM
plaque I-SYMPTOM
, O
and O
there O
was O
no O
anterior/apical B-SYMPTOM
akinesis I-SYMPTOM
noted O
. O

At O
this O
point O
, O
the B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
thrombus I-SYMPTOM
( O
for O
which O
she O
was O
initially O
started O
therapy B-TREATMENT
for O
) O
was O
no O
longer O
present O
. O

The O
patient O
was O
noted O
to O
have O
a B-SYMPTOM
slight I-SYMPTOM
hematocrit I-SYMPTOM
drop I-SYMPTOM
and O
was O
transfused O
one B-TREATMENT
unit I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
for O
a O
goal O
hematocrit O
of O
greater O
than O
30 O
. O

By O
04-03 O
, O
captopril B-TREATMENT
and O
atenolol B-TREATMENT
were O
started O
, O
and O
the B-TREATMENT
patient I-TREATMENT
's I-TREATMENT
leg I-TREATMENT
bandage I-TREATMENT
from O
the B-TREATMENT
vein I-TREATMENT
harvest I-TREATMENT
was O
removed O
. O

The O
patient O
continued O
to O
do O
well O
on O
the B-TREATMENT
medical I-TREATMENT
regimen I-TREATMENT
and O
was O
without O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
or O
any B-SYMPTOM
other I-SYMPTOM
symptoms I-SYMPTOM
. O

DISCHARGE O
DISPOSITION O
: O

Thus O
, O
the O
patient O
was O
discharged O
to O
home O
. O

DISCHARGE O
INSTRUCTIONS/FOLLOWUP O
: O

The O
patient O
was O
to O
follow O
up O
with O
her O
primary O
care O
physician O
( O
Dr. O
Desmet O
) O
, O
as O
well O
as O

with O
Dr. O
Gunter O
for O
an B-TREATMENT
eventual I-TREATMENT
percutaneous I-TREATMENT
coronary I-TREATMENT
intervention I-TREATMENT
, O
and O
her O
surgeon O
( O
Dr. O
Halcomb O
) O
following O
her B-TREATMENT
thoracotomy I-TREATMENT
. O

DISCHARGE O
DIAGNOSES: O

1. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
; O
3-vessel B-SYMPTOM
disease I-SYMPTOM
. O

2. O
Status B-TREATMENT
post I-TREATMENT
aborted I-TREATMENT
coronary I-TREATMENT
artery I-TREATMENT
bypass I-TREATMENT
graft I-TREATMENT
due O
to O
mobile B-SYMPTOM
aortic I-SYMPTOM
atheroma I-SYMPTOM
. O

3. O
Diabetes B-SYMPTOM
. O

4. O
Hypertension B-SYMPTOM
. O

CONDITION O
AT O
DISCHARGE O
: O

Condition O
on O
discharge O
was O
stable O
and O
asymptomatic O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

1. O
Aspirin B-TREATMENT
325 O
mg O
p.o. O
once O
per O
day O
. O

2. O
Docusate B-TREATMENT
100 O
mg O
p.o. O
twice O
per O
day O
. O

3. O
Fluticasone B-TREATMENT
2 O
puffs O
inhaled O
twice O
per O
day O
. O

4. O
Protonix B-TREATMENT
40 O
mg O
p.o. O
once O
per O
day O
. O

5. O
Plavix B-TREATMENT
75 O
mg O
p.o. O
once O
per O
day O
. O

6. O
Pravastatin B-TREATMENT
20 O
mg O
p.o. O
once O
per O
day O
. O

7. O
Bupropion B-TREATMENT
100 O
mg O
p.o. O
twice O
per O
day O
( O
for O
smoking O
cessation O
). O

8. O
Atenolol B-TREATMENT
25 O
mg O
p.o. O
once O
per O
day O
. O

9. O
Lisinopril B-TREATMENT
5 O
mg O
p.o. O
once O
per O
day O
. O

Miriam O
C O
Hebert O
, O
M.D. O

05-383 O

Dictated O
By O
: O
Barbara O
B. O
Phillips O
, O
M.D. O

MEDQUIST36 O

D: O
2016-06-15 O

21:48 O

T: O
2016-06-19 O

10:46 O

JOB O
#: O

26532 O

Signed O
electronically O
by O
: O
DR. O
Kevin O
Sineath O
on O
: O
Andrea O
2016-06-30 O
1:09 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2014-07-24 O

Discharge O
Date O
: O

2014-08-09 O

Date O
of O
Birth O
: O

1946-08-07 O

Sex O
: O

F O

Service O
: O

BLUE O
GENERAL O
SURGERY O

HISTORY O
OF O
THE O
PRESENT O
ILLNESS O
: O

Mrs. O
Gonzalez O
is O
a O
patient O
with O
a O
prior O
medical O
history O
including O
hypothyroidism B-SYMPTOM
, O
iron-deficiency B-SYMPTOM
anemia I-SYMPTOM
, O
osteoporosis B-SYMPTOM
, O
increased B-SYMPTOM
cholesterol I-SYMPTOM
, O
peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
, O
chronic B-SYMPTOM
constipation I-SYMPTOM
, O
and O
status O
post O
appendectomy B-TREATMENT
as O
well O
as O
status O
post O
hysterectomy B-TREATMENT
and O
bilateral B-TREATMENT
salpingo-oophorectomy I-TREATMENT
. O

She O
was O
transferred O
from O
an O
outside O
hospital O
for O
evaluation O
and O
treatment B-TREATMENT
of O
adenocarcinoma B-SYMPTOM
involving O
the O
transverse O
colon O
and O
gallbladder O
. O

At O
the O
outside O
hospital O
the O
patient O
had O
already O
seemed O
some O
workup O
for O
a O
couple O
weeks O
duration O
of O
bilateral B-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
pain I-SYMPTOM
which O
occasionally O
radiated O
to O
her O
back O
. O

She O
was O
also O
complaining O
of O
fatigue B-SYMPTOM
for O
two O
weeks O
but O
a O
good O
appetite O
and O
the O
patient O
denied O
weight B-SYMPTOM
loss I-SYMPTOM
, O
melena B-SYMPTOM
, O
or O
bright B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
. O

A O
CAT O
scan O
of O
the O
abdomen O
showed O
air-fluid B-SYMPTOM
levels I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
gallbladder I-SYMPTOM
. O

It O
also O
showed O
a B-SYMPTOM
thickened I-SYMPTOM
gallbladder I-SYMPTOM
wall I-SYMPTOM
as O
well O
as O
a B-SYMPTOM
dilated I-SYMPTOM
common I-SYMPTOM
bile I-SYMPTOM
duct I-SYMPTOM
. O

Incidentally O
, O
it O
also O
showed O
diverticulosis B-SYMPTOM
. O

A O
HIDA O
scan O
at O
the O
other O
hospital O
did O
not O
show O
filling B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
gallbladder I-SYMPTOM
indicating O
some O
sort O
of O

cystic B-SYMPTOM
duct I-SYMPTOM
obstruction I-SYMPTOM
. O

The O
first O
imaging O
study O
that O
was O
done O
at O
Hahnemann O
General O
Hospital O
was O
a O
MRCP O
which O
revealed O
an B-SYMPTOM
enhanced I-SYMPTOM
thickened I-SYMPTOM
gallbladder I-SYMPTOM
wall I-SYMPTOM
consistent O
with O
chronic B-SYMPTOM
cholecystitis I-SYMPTOM
. O

A O
differential O
according O
to O
the O
imaging O
included O
a B-SYMPTOM
fistula I-SYMPTOM
with O
adjacent B-SYMPTOM
inflammatory I-SYMPTOM
change I-SYMPTOM
but O
also O
carcinoma B-SYMPTOM
or O
adenomatosis B-SYMPTOM
. O

In O
addition, O
also O
the O
MRCP O
showed O
a B-SYMPTOM
mass I-SYMPTOM
near O
the O
region O
of O
the O
neck O
of O
the O
gallbladder O
. O

Of O
note O
, O
at O
the O
outside O
hospital O
, O
an O
endoscopy O
and O
colonoscopy O
were O
performed O
. O

The O
colonoscopy O
showed O
two B-SYMPTOM
polyps I-SYMPTOM
and O
also O
a O
region O
in O
the O
transverse O
colon O
that O
was O
biopsied O
. O

This O
biopsy O
came O
back O
as O
positive O
for O
adenocarcinoma B-SYMPTOM
. O

The O
diagnosis O
of O
adenocarcinoma B-SYMPTOM
was O
already O
established O
prior O
to O
her O
admission O
at O
this O
hospital O
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
scheduled O
for O
an O
operative O
date O
on O
2014-07-29 O
and O
over O
the O
next O
few O
days O
she O
was O

given O
a B-TREATMENT
low-residual I-TREATMENT
diet I-TREATMENT
. O

She O
had O
her O
belly O
cleaned O
with O
Hibiclens B-TREATMENT
one O
a O
day O
and O
once O
an O
adequate O
preoperative O
evaluation O
was O
performed O
, O
she O
was O
given O
a B-TREATMENT
bowel I-TREATMENT
prep I-TREATMENT
on O
Monday O
afternoon O
and O
evening O
in O
preparation O
for O
an O

exploratory O
laparotomy O
on O
Tuesday O
, O
2014-07-29 O
. O

On O
the O
morning O
of O
2014-07-29 O
, O
the O
patient O
was O
taken O
to O
the O
Operating O
Room O
and O
underwent O
a B-TREATMENT
cholecystectomy I-TREATMENT
, O
partial B-TREATMENT
hepatectomy I-TREATMENT
, O
partial B-TREATMENT
lymph I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
, O
a B-TREATMENT
colocolostomy I-TREATMENT
, O
partial B-TREATMENT
colectomy I-TREATMENT
, O
and O
in O
addition O
a B-TREATMENT
gastrostomy I-TREATMENT
and O
a B-TREATMENT
feeding I-TREATMENT
jejunostomy I-TREATMENT
were O
also O
put O
in O
place O
. O

Please O
refer O
to O
the O
previously O
dictated O
operative O
notes O
for O
the O
details O
of O
this B-TREATMENT
surgery I-TREATMENT
. O

Briefly O
, O
the B-TREATMENT
surgery I-TREATMENT
on O
2014-07-29 O
revealed O
a B-SYMPTOM
carcinoma I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
gallbladder I-SYMPTOM
with O
a B-SYMPTOM
cholecystocolonic I-SYMPTOM
fistula I-SYMPTOM
which O
crossed O
into O
the O
liver O
as O
well O
as O
metastatic B-SYMPTOM
adenopathy I-SYMPTOM
around I-SYMPTOM
the I-SYMPTOM
portal I-SYMPTOM
nodes I-SYMPTOM
as O
well O
as O
retroperitoneal B-SYMPTOM
nodes I-SYMPTOM
around I-SYMPTOM
the I-SYMPTOM
inferior I-SYMPTOM
vena I-SYMPTOM
cava I-SYMPTOM
and I-SYMPTOM
the I-SYMPTOM
hepatic I-SYMPTOM
artery I-SYMPTOM
. O

In O
addition O
to O
the B-TREATMENT
gastrostomy I-TREATMENT
and O
feeding B-TREATMENT
jejunostomy I-TREATMENT
tube I-TREATMENT
, O
two B-TREATMENT
Belmont-Gardner I-TREATMENT
drains I-TREATMENT
were O
placed O
. O

The B-SYMPTOM
patient I-SYMPTOM
's I-SYMPTOM
pain I-SYMPTOM
postoperatively O
was O
controlled O
with O
an B-TREATMENT
epidural I-TREATMENT
catheter I-TREATMENT
. O

However O
, O
the B-TREATMENT
epidural I-TREATMENT
had O
the O
consequence O
of O
causing O
a O
bit O
of O
a B-SYMPTOM
hypotension I-SYMPTOM
in O
the O
patient O
and O
the O
patient O
was O
admitted O
to O
the O
Surgical O
ICU O
for O
the O
first O
postoperative O
day O
. O

In O
addition O
, O
the O
patient O
had O
low B-SYMPTOM
hematocrits I-SYMPTOM
which O
required O
a B-TREATMENT
transfusion I-TREATMENT
of I-TREATMENT
packed I-TREATMENT
red I-TREATMENT
blood I-TREATMENT
cells I-TREATMENT
. O

In O
addition O
, O
on O
postoperative O
day O
number O
two O
, O
the O
patient O
was O
transferred O
out O
to O
the O
floor O
and O
she O
was O
doing O
better O
in O
terms O
of O
pain B-TREATMENT
control I-TREATMENT
on O
a B-TREATMENT
Dilaudid I-TREATMENT
PCA I-TREATMENT
machine I-TREATMENT
. O

On O
postoperative O
day O
number O
two O
, O
interestingly O
, O
the O
patient O
was O
complaining O
of O
sensitivity B-SYMPTOM
to I-SYMPTOM
light I-SYMPTOM
from O
an O
unknown O
etiology O
. O

The O
patient O
's O
postoperative O
course O
was O
unremarkable O
aside O
from O
the B-SYMPTOM
photophobia I-SYMPTOM
. O

On O
postoperative O
day O
number O
two O
, O
an O
Oncology O
consult O
with O
Dr. O
Natalie O
Mcalister O
was O
obtained O
and O

follow-up O
appointments O
were O
scheduled O
with O
him O
as O
an O
outpatient O
. O

Following O
that O
, O
the O
patient O
was O
slowly O
advanced O
to O
clear B-TREATMENT
liquids I-TREATMENT
and O
to O
a O
regular O
diet O
once O
her O
bowels O
began O
working O
when O
she O
began O
having O
flatus O
. O

Her O
bowel O
function O
was O
slow O
to O
develop O
and O
she O
needed O
to O
remain O
n.p.o. B-TREATMENT
until O
postoperative O
day O
number O
six O
. O

The O
patient O
was O
also O
given O
supplemental B-TREATMENT
tube I-TREATMENT
feedings I-TREATMENT
to O
supplement O
her O
calories O
and O
caloric O
intake O
. O

On O
postoperative O
day O
number O
seven O
, O
the O
patient O
was O
tolerating O
her B-TREATMENT
clear I-TREATMENT
liquid I-TREATMENT
diet I-TREATMENT
and O
her B-TREATMENT
tube I-TREATMENT
feeds I-TREATMENT
. O

She O
was O
started O
on O
p.o. B-TREATMENT
medicines I-TREATMENT
and O
her B-TREATMENT
first I-TREATMENT
Belmont-Gardner I-TREATMENT
drain I-TREATMENT
was O
pulled O
due O
to O
scant O
output O
. O

By O
2014-08-09 O
, O
the O
patient O
was O
tolerating O
a O
full O
solid O
diet O
as O
well O
as O
her B-TREATMENT
tube I-TREATMENT
feeds I-TREATMENT
. O

Between O
the O
two O
of O
those O
, O
her O
caloric O
intake O
was O
sufficient O
for O
her O
to O
sustain O
herself O
. O

She O
was O
discharged O
to O
home O
with O
services O
including O
tube B-TREATMENT
feedings I-TREATMENT
for O
her O
home O
care O
. O

Therefore O
, O
she O
was O
discharged O
on O
2014-08-09 O
in O
good O
condition O
. O

DISCHARGE O
DIAGNOSIS O
: O

1. O
Metastatic B-SYMPTOM
gallbladder I-SYMPTOM
cancer I-SYMPTOM
. O

2. O
Status O
post O
cholecystectomy B-TREATMENT
. O

3. O
Status O
post O
transverse B-TREATMENT
colectomy I-TREATMENT
with O
anastomosis B-SYMPTOM
. O

4. O
G B-TREATMENT
tube I-TREATMENT
placement I-TREATMENT
. O

5. O
Feeding B-TREATMENT
jejunostomy I-TREATMENT
. O

6. O
Hypothyroidism B-SYMPTOM
. O

7. O
Blood B-SYMPTOM
loss I-SYMPTOM
requiring O
transfusion B-TREATMENT
. O

DISCHARGE O
MEDICATIONS O
: O

1. O
Levothyroxine B-TREATMENT
100 O
micrograms O
orally O
once O
a O
day O
. O

2. O
Pantoprazole B-TREATMENT
one O
tablet O
once O
a O
day O
. O

3. O
Ambien B-TREATMENT
10 O
mg O
orally O
before O
bed O
. O

4. O
Tylenol B-TREATMENT
# O
3 O
one O
tablet O
every O
four O
hours O
as O
needed O
for O
pain B-SYMPTOM
. O

5. O
Reglan B-TREATMENT
10 O
mg O
four O
times O
a O
day O
before O
meals O
and O
at O
bedtime O
. O

6. O
Colace B-TREATMENT
100 O
mg O
twice O
a O
day O
. O

DISCHARGE O
INSTRUCTIONS O
: O

Follow-up O
with O
the O
Visiting O
Nurses O
Association O
to O
arrange O
assistance O
with O
her B-TREATMENT
tube I-TREATMENT
feeding I-TREATMENT
and O

her O
activities O
of O
daily O
living O
. O

The O
patient O
is O
also O
scheduled O
for O
an O
appointment O
with O
Dr. O
Patterson O
approximately O
two O
weeks O
after O
her O
discharge O
from O
the O
hospital O
. O

Heather O
FISCHER O
, O
M.D. O

91-657 O

Dictated O
By O
: O
Raymond O
Q. O
Martinez O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-08-16 O
01:23 O

T O
: O
2014-08-16 O
13:25 O

JOB O
#: O

23786 O

Signed O
electronically O
by O
: O
DR. O
Brian O
S O
Heath O
on O
: O
Danielle O
2014-08-28 O
2:52 O
PM O

( O
End O
of O
Report O
) O

158656269 O

CTMC O

02692537 O

322365 O

7/8/2000 O
12:00:00 O
AM O

chest B-SYMPTOM
pain I-SYMPTOM

DIS O

Admission O
Date O
: O

07/08/2000 O

Report O
Status O
: O

Discharge O
Date O
: O

07/09/2000 O

****** O
DISCHARGE O
ORDERS O
****** O

CLOZLUIN O
, O
NOSHIN O
699-77-12-2 O
K97 O

Room O
: O

18J-512 O

Service O
: O

MED O

DISCHARGE O
PATIENT O
ON O
: O

07/09/00 O
AT O
04:00 O
PM O
CONTINGENT O
UPON O
Attending O
evaluation O

WILL O
D/C O
ORDER O
BE O
USED O
AS O
THE O
D/C O
SUMMARY O
: O

YES O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

TYLENOL B-TREATMENT
#3 I-TREATMENT
( I-TREATMENT
ACETAMINOPHEN I-TREATMENT
W I-TREATMENT
/ I-TREATMENT
CODEINE I-TREATMENT
30MG O
) O
1-2 O
TAB O
PO O
Q4H O
PRN O
pain B-SYMPTOM
ALLOPURINOL B-TREATMENT
300 O
MG O
PO O
QD O
COLACE B-TREATMENT
( I-TREATMENT
DOCUSATE I-TREATMENT
SODIUM I-TREATMENT
) I-TREATMENT
100 O
MG O
PO O
BID O
HYDROCHLOROTHIAZIDE B-TREATMENT
25 O
MG O
PO O
QD O
LEVOFLOXACIN B-TREATMENT
500 O
MG O
PO O
QD O
Starting O
Today O
( O
07/09 O
) O

Instructions O
: O

continue O
through O
7/16/00 O

FLAGYL B-TREATMENT
( I-TREATMENT
METRONIDAZOLE I-TREATMENT
) I-TREATMENT
500 O
MG O
PO O
TID O

Instructions O
: O

through O
7/16/00 O

Food O
/ O
Drug O
Interaction O
Instruction O

Give O
with O
meals O

DIET O
: O

No O
Restrictions O
Activity O
- O
As O
tolerated O

RETURN O
TO O
WORK O
: O

Not O
Applicable O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

dr. O
mandessquarc O
, O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

chest B-SYMPTOM
pain I-SYMPTOM
unclear I-SYMPTOM
etiology I-SYMPTOM

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O
Responsible O
After O
Study O
for O
Causing O
Admission O
) O
chest B-SYMPTOM
pain I-SYMPTOM

OTHER O
DIAGNOSIS O
; O
Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O

OPERATIONS O
AND O
PROCEDURES O
: O

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

*** O
07/09/00 O
*** O

80 O
yo O
woman O
recently O
diagnosed O
with O
metastatic B-SYMPTOM
squamous I-SYMPTOM
cell I-SYMPTOM
lung I-SYMPTOM
CA I-SYMPTOM
. O

Mets B-SYMPTOM
to I-SYMPTOM
spine I-SYMPTOM
, I-SYMPTOM
femur I-SYMPTOM
. O

On O
XRT B-TREATMENT
. O

Tumor B-SYMPTOM
invasive I-SYMPTOM
of I-SYMPTOM
pleura I-SYMPTOM
and I-SYMPTOM
rib I-SYMPTOM
. O

Admitted O
after O
acute B-SYMPTOM
onset I-SYMPTOM
left I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
. O

Transferred O
today O
from O
Ez O
Ephtro O
Health O
Center O
on O
LMWH O
for O
R O
/ O
O O
PE B-SYMPTOM
vs O
pneumonia B-SYMPTOM
vs O
tumor B-SYMPTOM
invasion I-SYMPTOM
. O

Following O
enzymes O
to O
rule O
out O
unstable B-SYMPTOM
angina I-SYMPTOM
( O
no O
EKG B-SYMPTOM
changes I-SYMPTOM
) O
. O

v O
/ O
q O
at O
outside O
hospital O
read O
as O
low O
prob. O
leni O
&apos;s O
here O
neg. O
d/c&apos;ed O
on O
levo B-TREATMENT
/ O
flagyl B-TREATMENT
for O
presumed O
post-obstructive B-SYMPTOM
pneumonia I-SYMPTOM
. O

ADDITIONAL O
COMMENTS O
: O

1. O
Continue O
with O
medications B-TREATMENT
as O
prescribed O
, O
including O
antibiotics B-TREATMENT
( O
levofloxacin B-TREATMENT
/ O
flagyl B-TREATMENT
) O
through O
7/16/00 O
. O

2. O
If O
you O
have O
further B-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
fevers B-SYMPTOM
, O
or O
other B-SYMPTOM
symptoms I-SYMPTOM
which O
concern O
you O
, O
call O
your O
doctor O
. O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

ENTERED O
BY O
: O

ISNIFF O
, O
DALA O
TAN O
, O
M.D. O
( O
EP01 O
) O

07/09/00 O
02:54 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

649953363_e O

FIH O

8723483 O

249112 O

912397 O

12/19/2000 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O
/ O
SUMMARY O

UPH O
, O
JIM O

MRN O
: O

8723483 O

Age O
: O

57y O

REGISTRATION O
DATE O
: O

12/19/2000 O
02:48 O
PM O

Provider O
: O

Asha O
Vengloan O

PRELIMINARY O
REPORT O

Benefits O
Assigned O
: O

Y O

Discharge O
Date O
/ O
Time O
: O

12/19/00 O
6:13:06 O
PM O

Discharge O
Status O
: O

Discharged O

Patient O
States O
Complaint O
: O

SOB B-SYMPTOM

Diagnosis O
: O

COPD B-SYMPTOM
exacerbation I-SYMPTOM
( I-SYMPTOM
emphysema I-SYMPTOM
) I-SYMPTOM

Treatment O
Rendered O
: O

Prednisone B-TREATMENT
, O
nebulizers B-TREATMENT
. O

Chest O
x-ray O
shows O
question O
of O
a B-SYMPTOM
pulmonary I-SYMPTOM
nodule I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
lower I-SYMPTOM
lobe I-SYMPTOM
which O
may O
be O
cancer B-SYMPTOM
. O

Discharge O
Medications O
: O

Prednisone B-TREATMENT
60 O
mg O
daily O
for O
4 O
days O
. O

Continue O
inhalers B-TREATMENT
as O
prescribed O
. O

Disposition O
, O
Follow O
up O
and O
Instructions O
to O
Patient O
: O

Call O
Dr. O
Linketerf O
tomorrow O
and O
make O
an O
appointment O
for O
follow-up O
on O
the B-SYMPTOM
lung I-SYMPTOM
nodule I-SYMPTOM
. O

THIS O
IS O
VERY O
IMPORTANT O
. O

This O
report O
was O
created O
by O
Vengloan O
, O
Asha O
12/19/2000 O
06:15 O
PM O

Admission O
Date O
: O

2015-04-16 O

Discharge O
Date O
: O

2015-04-24 O

Date O
of O
Birth O
: O

1937-04-06 O

Sex O
: O

F O

Service O
: O

SURGERY O

Allergies O
: O

Patient O
recorded O
as O
having O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM
to I-SYMPTOM
Drugs I-SYMPTOM

Attending O
: O
Mattie O
R. O
A. O
Hamilton O
, O
M.D. O

Chief O
Complaint O
: O

Altered B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM

Diaphoresis B-SYMPTOM

Abdominal B-SYMPTOM
pain I-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

Lap B-TREATMENT
converted O
to O
open B-TREATMENT
cholecystectomy I-TREATMENT

History O
of O
Present O
Illness O
: O

This O
78 O
year O
old O
Mexican O
speaking O
female O
presented O
to O
the O
emergency O
department O
on O
2015-04-16 O
. O

Her O
family O
memebers O
stated O
that O
she O
was O
found O
at O
home O
with O
altered B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
and O
diaphoresis B-SYMPTOM
. O

She O
is O
diabetic B-SYMPTOM
. O

Mental O
status O
improved O
after O
binasal B-TREATMENT
cannula I-TREATMENT
oxygen I-TREATMENT
applied O
, O
at O
which O
time O
she O
localized O
right B-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
pain I-SYMPTOM
. O

She O
developed O
leukocytosis B-SYMPTOM
and O
transaminasemia B-SYMPTOM
. O

Past O
Medical O
History O
: O

DM B-SYMPTOM
on O
insulin B-TREATMENT

HTN B-SYMPTOM

gerd B-SYMPTOM

pvd B-SYMPTOM

osteo-arthritis B-SYMPTOM

osteoporosis B-SYMPTOM

anemia B-SYMPTOM

cholelithiasis B-SYMPTOM

left B-SYMPTOM
humeral I-SYMPTOM
fracture I-SYMPTOM

b/l B-SYMPTOM
cataracts I-SYMPTOM
s/p O
surgery B-TREATMENT

s/p O
uterine B-TREATMENT
myomectomy I-TREATMENT

Social O
History O
: O

distant O
tobacco O

drinks O
often O
- O
including O
vodka O

walks O
without O
cane B-TREATMENT

trained O
engineer O
in O
Papua O
New O
Guinea O

Has O
brother O
, O
nephew O
and O
daughter O
in O
law O
near O
by O
. O

Family O
History O
: O

denies O
cad B-SYMPTOM

Physical O
Exam O
: O

T O
: O
99.2 O
HR O
97 O
BP O
131/68 O
RR O
: O
20 O
Spo2 O
100% O
on O
RA O

Constitutional O
: O
alert O
& O
oriented O
x O
3 O
. O

Head O
/ O
eyes O
: O
EOMI O
, O
PERRL O

Chest O
/ O
respiratory O
: O
clear O
to O
auscultation O
bilaterally O

Cardiovascular O
: O
Regular O
rate O
& O
rhythm O
+ O
S1/S2 O
. O

No O
Mumur B-SYMPTOM
/ O
regurgiation B-SYMPTOM
/ O
gallop B-SYMPTOM

GI O
/ O
Abdomen O
: O
soft O
. O

+ O
Haskell O
sign O
, O
right B-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
tenderness I-SYMPTOM
. O

Nondistended B-SYMPTOM
. O

No O
rebounding B-SYMPTOM

Musculoskeletal O
: O
5/5 O
strength O
all O
extremities O

Skin O
: O
no O
C/C/E B-SYMPTOM

Neuro O
: O
CN O
II-XII O
intact O
, O
no O
dysdiadokinesis B-SYMPTOM
. O

decreased B-SYMPTOM
Babinski I-SYMPTOM
's I-SYMPTOM

Pertinent O
Results O
: O

2015-04-16 O
07:10 O
PM O
BLOOD O
Albumin O
- O
3.8 O
Calcium O
- O
9.0 O
Phos O
- O
2.6 O
*# O
Mg O
- O
1.9 O

2015-04-16 O
07:10 O
PM O
BLOOD O
ALT O
- O
295 O
* O
AST O
- O
56 O
* O
CK(CPK) O
- O
60 O
AlkPhos O
- O
208 O
* O
Amylase O
- O
23 O
TotBili O
- O
1.6 O
* O

2015-04-16 O
07:10 O
PM O
BLOOD O
Glucose O
- O
280 O
* O
UreaN O
- O
18 O
Creat O
- O
1.0 O
Na O
- O
135 O
K O
- O
4.2 O
Cl O
- O
98 O
HCO3 O
- O
22 O
AnGap O
- O
19 O

2015-04-16 O
07:10 O
PM O
BLOOD O
WBC O
- O
18.4 O
*# O
RBC O
- O
4.27 O
Hgb O
- O
11.9 O
* O
Hct O
- O
34.8 O
* O
MCV O
- O
82 O
MCH O
- O
27.9 O
MCHC O
- O
34.1 O
RDW O
- O
15.0 O
Plt O
Ct O
- O
317 O

2015-04-24 O
06:35 O
AM O
BLOOD O
ALT O
- O
82 O
* O
AST O
- O
62 O
* O
AlkPhos O
- O
145 O
* O
Amylase O
- O
51 O
TotBili O
- O
0.4 O

2015-04-24 O
06:35 O
AM O
BLOOD O
Glucose O
- O
134 O
* O
UreaN O
- O
8 O
Creat O
- O
0.6 O
Na O
- O
144 O
K O
- O
3.7 O
Cl O
- O
106 O
HCO3 O
- O
31 O
AnGap O
- O
11 O

2015-04-24 O
06:35 O
AM O
BLOOD O
WBC O
- O
10.5 O
RBC O
- O
3.49 O
* O
Hgb O
- O
9.6 O
* O
Hct O
- O
28.0 O
* O
MCV O
- O
80 O
* O
MCH O
- O
27.5 O
MCHC O
- O
34.3 O
RDW O
- O
15.8 O
* O
Plt O
Ct O
- O
504 O
* O

GB O
US O
2015-04-16 O

IMPRESSION O
: O

1. O
Distended B-SYMPTOM
gallbladder I-SYMPTOM
with O
impacted B-SYMPTOM
1.6 I-SYMPTOM
cm I-SYMPTOM
gallstone I-SYMPTOM
, O
focal B-SYMPTOM
wall I-SYMPTOM
thickening I-SYMPTOM
, O
and O
positive B-SYMPTOM
sonAllan I-SYMPTOM
Stephens I-SYMPTOM
sign I-SYMPTOM
- O
findings O
consistent O
with O
acute B-SYMPTOM
cholecystitis I-SYMPTOM
. O

2. O
Right B-SYMPTOM
renal I-SYMPTOM
cysts I-SYMPTOM
- O
lower B-SYMPTOM
pole I-SYMPTOM
cyst I-SYMPTOM
is O
unchanged O
from O
prior O
exam O
of O
2010-10-25 O
and O
upper B-SYMPTOM
pole I-SYMPTOM
exophytic I-SYMPTOM
cyst I-SYMPTOM
was O
not O
previously O
seen O
sonStacy O
. O

ERCP O
report O
2015-04-21 O

IMPRESSION O
: O

1. O
Successful O
removal B-TREATMENT
of O
CBD B-SYMPTOM
stone I-SYMPTOM
and O
placement O
of O
plastic B-TREATMENT
biliary I-TREATMENT
stent I-TREATMENT
for O
confirmed B-SYMPTOM
cystic I-SYMPTOM
duct I-SYMPTOM
leak I-SYMPTOM
. O

Brief O
Hospital O
Course O
: O

Ms O
Malek O
was O
admitted O
on O
2015-04-16 O
due O
to O
altered B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
and O
acute B-SYMPTOM
right I-SYMPTOM
upper I-SYMPTOM
quadrant I-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
. O

Gallbladder O
ultra O
sound O
revealed O
a B-SYMPTOM
distended I-SYMPTOM
1.6 I-SYMPTOM
cm I-SYMPTOM
non I-SYMPTOM
mobile I-SYMPTOM
stone I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
neck I-SYMPTOM
. O

HD O
# O
01-20 O
She O
was O
monitored O
closely O
in O
the O
CMED O
. O

On O
2015-04-17 O
she O
was O
taken O
to O
the O
OR O
for O
lap B-TREATMENT
converted O
to O
open B-TREATMENT
cholecystectomy I-TREATMENT
. O

She O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
, O
see O
op O
report O
for O
details O
. O

She O
was O
extubated B-TREATMENT
and O
recovered O
well O
in O
PACU O
. O

She O
remained O
NPO B-TREATMENT
with O
IV B-TREATMENT
fluids I-TREATMENT
, O
foley B-TREATMENT
catheter I-TREATMENT
and O
Dilaudid B-TREATMENT
IV I-TREATMENT
for O
pain B-TREATMENT
control I-TREATMENT
, O
Unasyn B-TREATMENT
for O
antibiotic B-TREATMENT
coverage I-TREATMENT
. O

She O
returned O
to O
CMED O
for O
further O
monitoring O
. O

She O
was O
noted O
to O
have O
low B-SYMPTOM
urine I-SYMPTOM
output I-SYMPTOM
at O
times O
. O

She O
responded O
well O
to O
fluid B-TREATMENT
bolusing I-TREATMENT
. O

POD#1 O
she O
was O
transferred O
to O
CC6 O
for O
further O
recovery O
. O

She O
remained O
afebrile B-SYMPTOM
, O
she O
was O
given O
ice O
chips O
. O

Physical O
therapy O
was O
consulted O
for O
strength O
and O
mobility O
. O

POD#2 O
her B-SYMPTOM
pain I-SYMPTOM
was O
somewhat O
uncontrolled O
, O
she O
was O
placed O
on O
Dilaudid B-TREATMENT
PCA I-TREATMENT
with O
fair O
effect O
. O

Urine O
output O
remained O
adequate O
. O

She O
was O
monitored O
on O
telemetry O
for O
mild B-SYMPTOM
tachycardia I-SYMPTOM
and O
recieved O
IV B-TREATMENT
beta I-TREATMENT
blockers I-TREATMENT
. O

She O
ambulated O
with O
assistance O
. O

POD#3 O
she O
was O
advanced O
to O
sips B-TREATMENT
and I-TREATMENT
clears I-TREATMENT
, O
foley B-TREATMENT
catheter I-TREATMENT
was O
discontinued O
. O

POD#4 O
, O
bilious B-SYMPTOM
drainage I-SYMPTOM
was O
noted O
in O
her B-TREATMENT
JP I-TREATMENT
. O

She O
had O
worsening B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
on O
exam O
. O

She O
was O
held O
NPO B-TREATMENT
. O

She O
was O
taken O
to O
ERCP O
where O
sphincterotomy B-TREATMENT
was O
performed O
and O
biliary B-TREATMENT
stent I-TREATMENT
was O
placed O
. O

She O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
and O
returned O
to O
CC6 O
post-procedure O
. O

JP B-TREATMENT
remained O
intact O
with O
serosainguinous B-SYMPTOM
drainage I-SYMPTOM
. O

POD#5 O
she O
c/o O
difficulty B-SYMPTOM
voiding I-SYMPTOM
, O
pt O
was O
straight B-TREATMENT
cathed I-TREATMENT
after O
bladder O
scan O
was O
obtained O
and O
revealed O
> O
600 O
ccs O
urine O
. O

POD# O
05-25 O
she O
continued O
with O
intermittent O
complaints O
of O
urinary B-SYMPTOM
retention I-SYMPTOM
. O

However O
she O
was O
able O
to O
void O
. O

Renal O
function O
remained O
normal O
. O

She O
did O
not O
require O
further B-TREATMENT
straight I-TREATMENT
catheterization I-TREATMENT
. O

She O
was O
advanced O
to O
clear B-TREATMENT
liquids I-TREATMENT
again O
without O
nausea B-SYMPTOM
or O
vomiting B-SYMPTOM
. O

Her B-SYMPTOM
pain I-SYMPTOM
was O
well O
controlled O
by O
Tylenol B-TREATMENT
. O

Her O
home O
regimen O
of O
lantus B-TREATMENT
was O
resumed O
for O
elevated B-SYMPTOM
blood I-SYMPTOM
glucose I-SYMPTOM
. O

POD#6 O
, O
her O
diet O
was O
advanced O
to O
regular O
. O

She O
required O
disimpaction B-TREATMENT
and O
had O
hard B-SYMPTOM
stool I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
rectum I-SYMPTOM
. O

She O
was O
initiated O
on O
a B-TREATMENT
bowel I-TREATMENT
regimen I-TREATMENT
and O
had O
no O
further O
incidents O
of O
diarrhea B-SYMPTOM
or O
constipation B-SYMPTOM
. O

POD#7 O
she O
was O
discharged O
to O
rehab O
in O
stable O
condition O
. O

Appropriate O
follow O
up O
appointments O
are O
recommended O
as O
well O
as O
prescriptions B-TREATMENT
. O

She O
should O
return O
in O
6 O
weeks O
for O
removal B-TREATMENT
of O
biliary B-TREATMENT
stent I-TREATMENT
. O

Medications O
on O
Admission O
: O

Tramadol B-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day) O
. O

2. O
Senna B-TREATMENT
8.6 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

3. O
Nortriptyline B-TREATMENT
25 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
). O

4. O
Atenolol B-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

5. O
Buspirone B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

6. O
Clonazepam B-TREATMENT
0.5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

7. O
Cholecalciferol B-TREATMENT
( I-TREATMENT
Vitamin I-TREATMENT
D3 I-TREATMENT
) I-TREATMENT
400 O
unit O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

8. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
). O

9. O
Docusate B-TREATMENT
Sodium I-TREATMENT
50 O
mg O
/ O
5 O
mL O
Liquid O
Sig O
: O
Ten O
( O
10 O
) O
mL O
PO O
BID O
( O
2 O
times O
a O
day O
). O

10. O
Hexavitamin B-TREATMENT
Tablet I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Cap O
PO O
DAILY O
( O
Daily O
). O

11. O
Dicyclomine B-TREATMENT
10 O
mg O
Capsule O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
). O

12. O
Atorvastatin B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

15. O
Bisacodyl B-TREATMENT
5 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
BID O
( O
2 O
times O
a O
day O
) O
as O
needed O
. O

16. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
for O
pain B-SYMPTOM
. O

17. O
Ibuprofen B-TREATMENT
600 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q8H O
( O
every O
8 O
hours O
) O
as O
needed O
for O
pain B-SYMPTOM
. O

18. O
Insulin B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT
Insulin B-TREATMENT
SC I-TREATMENT
Sliding I-TREATMENT
Scale I-TREATMENT
Q6H B-TREATMENT
Regular I-TREATMENT
Glucose I-TREATMENT
Insulin I-TREATMENT
Dose I-TREATMENT
0-60 O
mg O
/ O
dL O
01-20 O
amp O
D50 O
61-120 O
mg O
/ O
dL O
0 O
Units O
121-140 O
mg O
/ O
dL O
3 O
Units O
141-160 O
mg/dL O
5 O
Units O
161-180 O
mg/dL O
7 O

Units O
181-200 O
mg O
/ O
dL O
9 O
Units O
201-220 O
mg O
/ O
dL O
11 O
Units O
221-240 O
mg O
/ O
dL O
13 O
Units O
241-260 O
mg O
/ O
dL O
15 O
Units O
261-280 O
mg O
/ O
dL O
17 O
Units O
281-300 O
mg O
/ O
dL O
19 O
Units O
301-320 O
mg O
/ O
dL O
21 O
Units O
> O
320 O
mg O
/ O
dL O
Notify O
M.D. O

19. O
Lantus B-TREATMENT
30 O
units O
Lantus B-TREATMENT
insulin I-TREATMENT
with O
breakfast O

Discharge O
Medications O
: O

1. O
Tramadol B-TREATMENT
50 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
TID O
( O
3 O
times O
a O
day O
). O

2. O
Senna B-TREATMENT
8.6 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

3. O
Nortriptyline B-TREATMENT
25 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
). O

4. O
Atenolol B-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

5. O
Buspirone B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

6. O
Clonazepam B-TREATMENT
0.5 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

7. O
Cholecalciferol B-TREATMENT
( I-TREATMENT
Vitamin I-TREATMENT
D3 I-TREATMENT
) I-TREATMENT
400 O
unit O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

8. O
Pantoprazole B-TREATMENT
40 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
Q24H O
( O
every O
24 O
hours O
). O

9. O
Docusate B-TREATMENT
Sodium I-TREATMENT
50 O
mg O
/ O
5 O
mL O
Liquid O
Sig O
: O
Ten O
( O
10 O
) O
mL O
PO O
BID O
( O
2 O
times O
a O
day O
). O

10. O
Hexavitamin B-TREATMENT
Tablet I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Cap O
PO O
DAILY O
( O
Daily O
). O

11. O
Dicyclomine B-TREATMENT
10 O
mg O
Capsule O
Sig O
: O
Two O
( O
2 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
). O

12. O
Atorvastatin B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

13. O
Amoxicillin-Pot B-TREATMENT
Clavulanate I-TREATMENT
875-125 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
for O
4 O
days O
. O

14. O
Heparin B-TREATMENT
( I-TREATMENT
Porcine I-TREATMENT
) I-TREATMENT
5,000 O
unit O
/ O
mL O
Solution O
Sig O
: O
One O
( O
1 O
) O
injection O
Injection O
BID O
( O
2 O
times O
a O
day O
). O

15. O
Bisacodyl B-TREATMENT
5 O
mg O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
BID O
( O
2 O
times O
a O
day O
) O
as O
needed O
. O

16. O
Acetaminophen B-TREATMENT
325 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
for O
pain B-SYMPTOM
. O

17. O
Ibuprofen B-TREATMENT
600 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
Q8H O
( O
every O
8 O
hours O
) O
as O
needed O
for O
pain B-SYMPTOM
. O

18. O
Insulin B-TREATMENT
sliding I-TREATMENT
scale I-TREATMENT

Insulin B-TREATMENT
SC I-TREATMENT
Sliding I-TREATMENT
Scale I-TREATMENT

Q6H O

Regular O

Glucose B-TREATMENT
Insulin I-TREATMENT
Dose I-TREATMENT

0-60 O
mg O
/ O
dL O
01-20 O
amp O
D50 O

61-120 O
mg O
/ O
dL O
0 O
Units O

121-140 O
mg O
/ O
dL O
3 O
Units O

141-160 O
mg O
/ O
dL O
5 O
Units O

161-180 O
mg O
/ O
dL O
7 O
Units O

181-200 O
mg O
/ O
dL O
9 O
Units O

201-220 O
mg O
/ O
dL O
11 O
Units O

221-240 O
mg O
/ O
dL O
13 O
Units O

241-260 O
mg O
/ O
dL O
15 O
Units O

261-280 O
mg O
/ O
dL O
17 O
Units O

281-300 O
mg O
/ O
dL O
19 O
Units O

301-320 O
mg O
/ O
dL O
21 O
Units O

> O
320 O
mg O
/ O
dL O
Notify O
M.D. O

30 O
units O
Lantus B-TREATMENT
insulin I-TREATMENT
with O
breakfast O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

New O
England O
Sinai O
Hospital O
& O
Rehab O
Center O
- O
Everett O

Discharge O
Diagnosis O
: O

Acute B-SYMPTOM
Cholecystitis I-SYMPTOM

Gangrenous B-SYMPTOM
cholecystitis I-SYMPTOM
with O
perforation B-SYMPTOM

Discharge O
Condition O
: O

good O

Discharge O
Instructions O
: O

Please O
call O
your O
surgeon O
if O
you O
develop O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
fever B-SYMPTOM
greater O
than O
101.5 O
, O
foul B-SYMPTOM
smelling I-SYMPTOM
or I-SYMPTOM
colorful I-SYMPTOM
drainage I-SYMPTOM
from O
your B-SYMPTOM
incisions I-SYMPTOM
, O
redness B-SYMPTOM
or O
swelling B-SYMPTOM
, O
severe B-SYMPTOM
abdominal I-SYMPTOM
pain I-SYMPTOM
or O
distention B-SYMPTOM
, O
persistent B-SYMPTOM
nausea I-SYMPTOM
or O
vomiting B-SYMPTOM
, O
inability B-SYMPTOM
to I-SYMPTOM
eat I-SYMPTOM
or I-SYMPTOM
drink I-SYMPTOM
, O
or O
any B-SYMPTOM
other I-SYMPTOM
symptoms I-SYMPTOM
which O
are O
concerning O
to O
you O
. O

No O
tub O
baths O
or O
swimming O
. O

You O
may O
shower O
. O

If O
there O
is O
clear B-SYMPTOM
drainage I-SYMPTOM
from O
your B-SYMPTOM
incisions I-SYMPTOM
, O
cover O
with O
a B-TREATMENT
dry I-TREATMENT
dressing I-TREATMENT
. O

Leave O
white B-TREATMENT
strips I-TREATMENT
above O
your B-SYMPTOM
incisions I-SYMPTOM
in O
place O
, O
allow O
them O
to O
fall O
off O
on O
their O
own O
. O

Activity O
: O
No O
heavy O
lifting O
of O
items O
11-02 O
pounds O
until O
the O
follow O
up O
appointment O
with O
your O
doctor O
. O

Medications O
: O
Resume O
your B-TREATMENT
home I-TREATMENT
medications I-TREATMENT
. O

You O
should O
take O
a B-TREATMENT
stool I-TREATMENT
softener I-TREATMENT
, O
Colace B-TREATMENT
100 O
mg O
twice O
daily O
as O
needed O
for O
constipation B-SYMPTOM
. O

You O
will O
be O
given O
pain B-TREATMENT
medication I-TREATMENT
which O
may O
make O
you O
drowsy B-SYMPTOM
. O

No O
driving O
while O
taking O
pain B-TREATMENT
medicine I-TREATMENT
. O

Followup O
Instructions O
: O

Provider O
: O
Gregory O
X O
Wingard O
, O
M.D. O
Phone O
:( O
855 O
) O
651-4418 O

Date O
/ O
Time O
: O
2015-06-03 O
9:30 O

Please O
call O
( O
808 O
) O
246-1373 O
and O
schedule O
an O
appointment O
to O
see O
Dr. O
Lewis O
in O
2 O
weeks O
. O

You O
will O
be O
contacted O
by O
the O
gastrointestinal O
doctors O
Pat O
Barrow O
the B-TREATMENT
removal I-TREATMENT
of O
your B-TREATMENT
biliary I-TREATMENT
stent I-TREATMENT
in O
6 O
weeks O
. O

Joe O
Kari O
MD O
09-697 O

Completed O
by O
: O
Carol O
Robert O
NP O
80-CIY O
2015-04-24 O
@ O
1506 O

Signed O
electronically O
by O
: O
DR. O
Marion O
SCHNEIDER O
on O
: O
FRI O
2015-04-24 O
5:11 O
PM O

( O
End O
of O
Report O
) O

341909688 O
EH O

48646747 O

6988856 O

2/14/2003 O
12:00:00 O
AM O

s O
/ O
p O
ventral B-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT

DIS O

Admission O
Date O
: O

02/14/2003 O

Report O
Status O
: O

Discharge O
Date O
: O

02/15/2003 O

****** O
DISCHARGE O
ORDERS O
****** O

KAYSKUDZ O
, O
NARO O
307-36-32-7 O
E32 O

Room O
: O

80A-171 O

Service O
: O

GGI O

DISCHARGE O
PATIENT O
ON O
: O

02/15/03 O
AT O
02:00 O
PM O

CONTINGENT O
UPON O

Not O
Applicable O

WILL O
D O
/ O
C O
ORDER O
BE O
USED O
AS O
THE O
D O
/ O
C O
SUMMARY O
: O

YES O

Attending O
: O

GRENDWIERST O
, O
SONLYN O
R. O
, O
M.D. O

DISPOSITION O
: O

Home O

DISCHARGE O
MEDICATIONS O
: O

COLACE B-TREATMENT
( I-TREATMENT
DOCUSATE I-TREATMENT
SODIUM I-TREATMENT
) I-TREATMENT
100 O
MG O
PO O
BID O
PERCOCET B-TREATMENT
1-2 O
TAB O
PO O
Q4H O
PRN O
pain B-SYMPTOM

DIET O
: O

No O
Restrictions O

ACTIVITY O
: O

Avoid O
any O
heavy O
lifting O

FOLLOW O
UP O
APPOINTMENT O
( O
S O
) O
: O

Dr. O
Grendwierst O
1-2 O
weeks O
, O
No O
Known B-SYMPTOM
Allergies I-SYMPTOM

ADMIT O
DIAGNOSIS O
: O

s O
/ O
p O
ventral B-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT

PRINCIPAL O
DISCHARGE O
DIAGNOSIS O
; O

Responsible O
After O
Study O
for O
Causing O
Admission O
) O
s O
/ O
p O
ventral B-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT

OTHER O
DIAGNOSIS O
; O

Conditions O
, O
Infections O
, O
Complications O
, O
affecting O
Treatment O
/ O
Stay O
s O
/ O
p O
Roux B-TREATMENT
en I-TREATMENT
Y I-TREATMENT
gastric I-TREATMENT
bypass I-TREATMENT
. O

s O
/ O
p O
c-section B-TREATMENT
B12 B-SYMPTOM
deficiency I-SYMPTOM
Anemia I-SYMPTOM

GERD B-TREATMENT
OPERATIONS I-TREATMENT
AND O
PROCEDURES B-TREATMENT
: O

02/14/03 O
GRENDWIERST O
, O
SONLYN O
R. O
, O
M.D. O
VENTRAL B-TREATMENT
HERNIA I-TREATMENT
REPAIR I-TREATMENT
W I-TREATMENT
/ I-TREATMENT
MESH I-TREATMENT

OTHER O
TREATMENTS O
/ O
PROCEDURES O
( O
NOT O
IN O
O.R. O
) O

None O

BRIEF O
RESUME O
OF O
HOSPITAL O
COURSE O
: O

This O
is O
a O
39 O
year O
old O
female O
, O
s O
/ O
p O
Roux-en-Y B-TREATMENT
gastric I-TREATMENT
bypass I-TREATMENT
in O
09/06 O
who O
is O
admitted O
for O
elective B-TREATMENT
repair I-TREATMENT
of O
a B-SYMPTOM
ventral I-SYMPTOM
hernia I-SYMPTOM
. O

The O
patient O
went O
to O
the O
operating O
room O
on O
2/14/03 O
for O
repair B-TREATMENT
of O
the B-SYMPTOM
hernia I-SYMPTOM
. O

The O
patient O
was O
admitted O
to O
the O
hospital O
overnight O
for O
pai B-TREATMENT
n I-TREATMENT
management I-TREATMENT
in O
the O
setting O
of O
a B-SYMPTOM
large I-SYMPTOM
incision I-SYMPTOM
with O
large O
amounts O
of O
dissection B-SYMPTOM
during O
the B-TREATMENT
procedure I-TREATMENT
. O

She O
did O
well O
overnight O
with O
minimal B-SYMPTOM
pain I-SYMPTOM
medication I-SYMPTOM
requirements I-SYMPTOM
. O

She O
voided O
on O
the O
morning O
of O
POD O
# O
1 O
. O

She O
had O
no O
complaints O
of O
nausea B-SYMPTOM
or O
vomiting B-SYMPTOM
and O
was O
tolerating O
PO&apos;s O
well O
. O

ADDITIONAL O
COMMENTS O
: O

No O
heavy O
lifting O
x O
3 O
weeks O
. O

Keep O
the B-TREATMENT
dressing I-TREATMENT
on O
and O
dry O
for O
48 O
hours O
after O
the B-TREATMENT
surgery I-TREATMENT
. O

You O
can O
shower O
when O
you O
get O
home O
. O

Avoid O
getting O
the B-SYMPTOM
incision I-SYMPTOM
soaking O
wet O
. O

DISCHARGE O
CONDITION O
: O

Stable O

TO O
DO O
/ O
PLAN O
: O

You O
should O
follow-up O
with O
Dr. O
Grendwierst O
. O

Call O
his O
office O
to O
make O
an O
appointment O
. O

Take O
the B-TREATMENT
pain I-TREATMENT
medication I-TREATMENT
as O
prescribed O
. O

You O
can O
take O
regular O
tylenol B-TREATMENT
or O
motrin B-TREATMENT
for O
pain B-SYMPTOM
and O
use O
the B-TREATMENT
percocet I-TREATMENT
for O
breakthrough B-SYMPTOM
pain I-SYMPTOM
. O

REturn O
to O
the O
ER O
or O
call O
your O
doctor O
if O
you O
develop O
fevers B-SYMPTOM
, O
notice O
pus B-SYMPTOM
from O
the B-SYMPTOM
incision I-SYMPTOM
, O
develop O
surrounding B-SYMPTOM
redness I-SYMPTOM
, O
have O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
have O
vomiting B-SYMPTOM
where O
you O
can O
&apos;t O
keep O
anything O
down O
or O
develop O
any B-SYMPTOM
symptoms I-SYMPTOM
that O
concern O
you O
. O

No O
dictated O
summary O

ENTERED O
BY O
: O

MSSHUFFBREUN O
, O
RERE O
N. O
, O
M.D. O
( O
KX79 O
) O

02/15/03 O
01:29 O
PM O

****** O
END O
OF O
DISCHARGE O
ORDERS O
****** O

Admission O
Date O
: O

2014-04-19 O

Discharge O
Date O
: O

2014-04-20 O

Date O
of O
Birth O
: O

2014-04-19 O

Sex O
: O

M O

Service O
: O

CMED O
CSRU O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Baby O
Thomas O
Moss O
was O
born O
at O
39 O
and O
1/2 O
weeks O
gestation O
to O
a O
20-year-old O
gravida O
IV O
, O
para O
III O
, O
now O
IV O
woman O
. O

The O
mother O
's O
prenatal O
screens O
were O
blood O
type O
B O
positive O
, O
antibody O
negative O
, O
rubella O
immune O
, O
RPR O
nonreactive O
, O
hepatitis O
surface O
antigen O
negative O
and O
group O
B O
strep O
negative O
. O

This O
pregnancy O
was O
complicated O
by O
a O
prenatal O
diagnosis O
of O
a B-SYMPTOM
congenital I-SYMPTOM
cystic I-SYMPTOM
adenomatoid I-SYMPTOM
malformation I-SYMPTOM

( O
CCAM B-SYMPTOM
). O

The O
mother O
was O
followed O
in O
the O
Massachusetts O
General O
Hospital O
Advanced O
Fetal O
Care O
Center O
and O
was O
followed O
by O
Dr. O
Ralph O
Wilson O
. O

The O
mother O
had O
spontaneous O
onset O
of O
labor O
and O
progressed O
to O
a O
spontaneous O
vaginal O
delivery O
. O

The O
infant O
emerged O
vigorous O
with O
Apgars O
of O
9 O
at O
one O
and O
five O
minutes O
. O

His O
birth O
weight O
was O
2905 O
grams O
. O

PHYSICAL O
EXAMINATION O
: O

Wt O
2905 O
gm O

Length O
19 O
inches O

HC O
34.5 O
cm O

His O
admission O
physical O
exam O
reveals O
a B-SYMPTOM
vigorous I-SYMPTOM
nondysmorphic I-SYMPTOM
term O
infant O
. O

Anterior O
fontanelle O
open O
and O
flat O
. O

Palate O
intact O
. O

Red O
reflex O
not O
checked O
. O

Neck O
supple O
and O
without O
masses B-SYMPTOM
. O

Clavicles O
intact O
. O

Lungs O
clear O
bilaterally O
with O
slightly B-SYMPTOM
decreased I-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
but O
symmetric O
chest O
rise O
and O
fall O
. O

Heart O
was O
regular O
rate O
and O
rhythm O
, O
no O
murmur B-SYMPTOM
. O

Femoral O
pulses O
present O
bilaterally O
. O

Abdomen O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
active O
bowel O
sounds O
. O

Normal O
male O
genitalia O
, O
testes O
descended O
bilaterally O
. O

No O
sacral B-SYMPTOM
anomalies I-SYMPTOM
. O

Stable O
hips O
. O

Patent O
anus O
. O

Age O
appropriate O
tone O
and O
reflexes O
. O

CMED O
CCU O
: O

By O
systems O
: O

Respiratory O
status O
: O

He O
has O
remained O
in O
room O
air O
well O
saturated O
with O
comfortable O
respirations O
until O
approximately O
22 O
hours O
of O
age O
when O
he O
started O
with O
increased B-SYMPTOM
work I-SYMPTOM
of I-SYMPTOM
breathing I-SYMPTOM
although O
he O
has O
remained O
well-saturated O
in O
room O
air O
. O

His O
chest O
x-ray O
was O
initially O
remarkable O
for O
some B-SYMPTOM
mediastinal I-SYMPTOM
shift I-SYMPTOM
due O
to O
the B-SYMPTOM
right-sided I-SYMPTOM
lesion I-SYMPTOM
with O
increasing B-SYMPTOM
shift I-SYMPTOM
present O
on O
the O
last O
x-ray O
. O

Cardiovascular O
status O
: O

He O
has O
remained O
normotensive O
throughout O
his O
CMED O
stay O
. O

There O
are O
no O
cardiovascular B-SYMPTOM
issues I-SYMPTOM
. O

Fluid O
, O
electrolytes O
and O
nutrition O
status O
: O

His O
weight O
at O
the O
time O
of O
transfer O
is O
2800 O
grams O
. O

He O
has O
been O
breast O
feeding O
or O
taking O
20 O
calorie O
per O
ounce O
formula O
until O
the B-SYMPTOM
increased I-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
so O
that O
at O
the O
time O
of O
transfer O
he O
is O
NPO B-TREATMENT
with O
a B-TREATMENT
peripheral I-TREATMENT
IV I-TREATMENT
with O
total B-TREATMENT
fluids I-TREATMENT
of O
150 O
ml O
/ O
kg O
/ O
day O
of O
10% B-TREATMENT
dextrose I-TREATMENT
with O
electrolytes B-TREATMENT
. O

He O
has O
had O
no O
blood O
work O
except O
for O
blood O
glucose O
checks O
and O
he O
has O
been O
euglycemic O
throughout O
his O
CMED O
stay O
with O
his O
blood O
glucose O
being O
in O
the O
70s O
. O

Gastrointestinal O
status O
: O

He O
has O
passed O
meconium O
stool O
and O
is O
voiding O
with O
each O
diaper O
change O
. O

He O
has O
not O
had O
a O
bilirubin O
checked O
. O

Hematology O
: O

He O
has O
not O
had O
any O
blood O
work O
done O
. O

Infectious O
disease O
: O

He O
has O
had O
no O
antibiotic B-TREATMENT
therapy I-TREATMENT
or O
blood O
cultures O
sent O
. O

Sensory O
: O

Audiology O
: O

Hearing O
screening O
is O
recommended O
prior O
to O
discharge O
. O

It O
has O
not O
been O
done O
yet O
. O

Psychosocial O
: O

The O
mother O
has O
3 O
older O
children O
who O
are O
alive O
and O
well O
. O

Her O
own O
mother O
has O
been O
with O
her O
during O
this O
stay O
. O

The O
infant O
is O
discharged O
in O
guarded B-SYMPTOM
condition I-SYMPTOM
. O

He O
is O
being O
transferred O
to O
Massachusetts O
General O
Hospital O
Newborn O
Intensive O
Care O
Unit O
for O
continuing B-TREATMENT
care I-TREATMENT
. O

His O
primary O
pediatric O
care O
provider O
will O
be O
Dr. O
Schrader O
at O
Deaconess-Nashoba O
Hospital O
. O

RECOMMENDATIONS O
AFTER O
DISCHARGE O
: O

1. O
Feedings O
: O

The O
infant O
is O
NPO B-TREATMENT
. O

2. O
He O
is O
on O
peripheral B-TREATMENT
IV I-TREATMENT
of O
total B-TREATMENT
fluids I-TREATMENT
150 O
ml O
/ O
kg O
/ O
day O
of O
10% O
dextrose B-TREATMENT
with O
2 O
mEq O
of O
sodium B-TREATMENT
chloride I-TREATMENT
per O
100 O
ml O
and O
1 O
mEq O
of O
potassium B-TREATMENT
chloride I-TREATMENT
per O
100 O
ml O
. O

3. O
He O
has O
not O
had O
a O
car O
seat O
position O
screening O
test O
. O

4. O
A O
State O
newborn O
screen O
will O
be O
done O
prior O
to O
transfer O
. O

5. O
He O
has O
received O
no O
immunizations B-TREATMENT
. O

DISCHARGE O
DIAGNOSES O
: O

1. O
Term O
male O
newborn O
. O

2. O
Right-sided B-SYMPTOM
congenital I-SYMPTOM
cystic I-SYMPTOM
adenomatoid I-SYMPTOM
malformation I-SYMPTOM
. O

Kathy O
Hougland O
, O
M.D. O
50AHB O

Dictated O
By O
: O
Gina O
C.K. O
Brantner O
, O
M.D. O

MEDQUIST36 O

D O
: O
2014-04-20 O
07:20:44 O

T O
: O
2014-04-20 O
10:08:45 O

Job O
#: O
07882 O

Signed O
electronically O
by O
: O
DR. O
Jaqueline O
RHEIN O
on O
: O
SUN O
2014-04-20 O
8:13 O
PM O

( O
End O
of O
Report O
) O

Admission O
Date O
: O

2019-03-29 O

Discharge O
Date O
: O

2019-04-01 O

Date O
of O
Birth O
: O

1935-12-05 O

Sex O
: O

M O

Service O
: O

NEUROLOGY O

Allergies O
: O

Lorazepam B-TREATMENT
/ O
Penicillins B-TREATMENT
/ O
Prednisone B-TREATMENT
/ O
Hydrochlorothiazide B-TREATMENT
/ O
Ceftriaxone B-TREATMENT
/ O
Phenytoin B-TREATMENT

Attending O
: O
Derrick O
Z O
Wooster O
, O
M.D. O

Chief O
Complaint O
: O
progressing B-SYMPTOM
slowing I-SYMPTOM
of I-SYMPTOM
mentation I-SYMPTOM
and O
gait B-SYMPTOM
difficulties I-SYMPTOM
since O
a O
week O
; O
evaluation O
for O
ICH B-SYMPTOM

Major O
Surgical O
or O
Invasive O
Procedure O
: O

None O

History O
of O
Present O
Illness O
: O

The O
patient O
is O
a O
83 O
yo O
R-handed O
man O
with O
a O
history O
of O
multiple B-SYMPTOM
intracranial I-SYMPTOM
hemorrhages I-SYMPTOM
during O
the O
last O
few O
years O
, O
pacemaker B-TREATMENT
, O
hyperlipidemia B-SYMPTOM
, O
arrhythmia B-SYMPTOM
who O
now O
presents O
with O
gradual B-SYMPTOM
decline I-SYMPTOM
in I-SYMPTOM
gait I-SYMPTOM
and O
slowing B-SYMPTOM
of I-SYMPTOM
mentation I-SYMPTOM
over O
the O
last O
week O
. O

The O
patient O
had O
a O
fall O
about O
ten O
days O
ago O
, O
when O
he O
was O
walking O
the O
dog O
. O

The O
leash O
got O
wrapped O
around O
his O
legs O
. O

According O
to O
his O
wife O
he O
had O
a B-SYMPTOM
small I-SYMPTOM
abrasion I-SYMPTOM
on O
the O
top O
of O
his O
head O
, O
but O
nothing O
major O
. O

He O
did O
not O
complain O
about O
a B-SYMPTOM
headache I-SYMPTOM
. O

He O
was O
at O
baseline O
with O
respect O
to O
his O
gait O
( O
at O
baseline O
unsteady B-SYMPTOM
, O
though O
he O
refuses O
to O
walk O
with O
a B-TREATMENT
walker I-TREATMENT
) O
and O
his O
mentation O
( O
at O
baseline O
difficulties B-SYMPTOM
with I-SYMPTOM
memory I-SYMPTOM
since O
months O
; O
keeps O
forgetting O
appointments O
). O

Then O
about O
a O
week O
ago O
, O
the O
patient O
and O
his O
wife O
noted O
that O
his O
gait O
became O
even B-SYMPTOM
more I-SYMPTOM
unsteady I-SYMPTOM
, O
though O
he O
did O
not O
fall O
. O

He O
also O
had O
difficulties B-SYMPTOM
navigating O
through O
his O
apartment O
, O
having O
difficulties B-SYMPTOM
finding O
the O
fridge O
for O
example O
. O

They O
were O
concerned O
that O
the O
fall O
might O
have O
caused O
another B-SYMPTOM
bleed I-SYMPTOM
, O
as O
had O
happened O
in O
the O
past O
, O
and O
this O
prompted O
them O
to O
come O
to O
the O
Deanna O
. O

No O
headache B-SYMPTOM
, O
neckpain B-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
or O
focal B-SYMPTOM
weakness I-SYMPTOM
/ O
numbness B-SYMPTOM
. O

Review O
of O
systems O
: O
denies O
any B-SYMPTOM
fever I-SYMPTOM
, O
chills B-SYMPTOM
, O
weight B-SYMPTOM
loss I-SYMPTOM
, O
visual B-SYMPTOM
changes I-SYMPTOM
, O
hearing B-SYMPTOM
changes I-SYMPTOM
, O
dysphagia B-SYMPTOM
, O
tingling B-SYMPTOM
, O
numbness B-SYMPTOM
, O
bowel-bladder B-SYMPTOM
dysfunction I-SYMPTOM
, O
chest B-SYMPTOM
pain I-SYMPTOM
, O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
, O
abdominal B-SYMPTOM
pain I-SYMPTOM
, O
dysuria B-SYMPTOM
, O
hematuria B-SYMPTOM
, O
or O
bright B-SYMPTOM
red I-SYMPTOM
blood I-SYMPTOM
per I-SYMPTOM
rectum I-SYMPTOM
. O

His O
legs O
have O
been O
feeling O
weaker B-SYMPTOM
, I-SYMPTOM
bilaterally I-SYMPTOM
since O
the O
last O
week O
. O

Past O
Medical O
History O
: O

1. O
Previous B-SYMPTOM
interventricular I-SYMPTOM
hemorrhages I-SYMPTOM
: O

06-30 O
resolved O
as O
of O
repeat O
head O
CT O
one O
month O
later O
, O
no O
residual B-SYMPTOM
deficits; I-SYMPTOM
03-03 O
: O
ICH B-SYMPTOM
in I-SYMPTOM
3rd I-SYMPTOM
, I-SYMPTOM
4th I-SYMPTOM
, I-SYMPTOM
and I-SYMPTOM
L-lat I-SYMPTOM
ventricle I-SYMPTOM
; O
no O
aneurysm B-SYMPTOM
; O
07-01 O
: O
ICH B-SYMPTOM
in I-SYMPTOM
R-temporal I-SYMPTOM
lobe I-SYMPTOM
; O
question O
of O
underlying B-SYMPTOM
mass I-SYMPTOM
at O
that O
time O
per O
contrast O
CT O
; O
decided O
to O
follow O
up O
with O
serial O
scans O
rather O
than O
to O
biopsy O

2. O
pacemaker B-TREATMENT
placement I-TREATMENT
for O
arrhythmia B-SYMPTOM
, O
Afibb B-SYMPTOM
; O
during O
last O
hospitalization O
episodes O
of O
NSVT B-SYMPTOM

3. O
history O
of O
slowness B-SYMPTOM
of I-SYMPTOM
gait I-SYMPTOM
, O
? O
parkinsons B-SYMPTOM
? O
and O
possibly O
dementia B-SYMPTOM
followed O
by O
Dr. O
Ahern O
( O
Laurence O
Eichorn O
). O

Sinemet B-TREATMENT
was O
stopped O
during O
last O
admission O
06-30 O
as O
he O
was O
thought O
to O
NOT O
have O
PD B-SYMPTOM
. O

4. O
Depression B-SYMPTOM

5. O
COPD B-SYMPTOM

6. O
hyperlipidemia B-SYMPTOM

7. O
bilateral B-TREATMENT
cataract I-TREATMENT
surgery I-TREATMENT

8. O
orthostatic B-SYMPTOM
hypotension I-SYMPTOM
, O
on O
midodrine B-TREATMENT

Social O
History O
: O

The O
pt. O
is O
married O
, O
independent O
in O
ADLS O
, O
lives O
with O
wife O
in O
a O
retirement O
community O
. O

Significant O
tobacco O
history O
x O
40 O
yrs O
x O
1ppd O
, O
quit O
20 O
yrs O
ago O
, O

Reported O
occassional O
glass O
of O
wine O
, O
no O
illicit O
drugs O

He O
is O
a O
retired O
architect O
. O

Wife O
states O
that O
he O
would O
NOT O
want O
to O
be O
recussitated O
, O
and O
that O
OSH O
placed O
ETT B-TREATMENT
before O
asking O
her O
. O

Family O
History O
: O
no O
kids O
, O
no O
bleeds B-SYMPTOM
or O
strokes B-SYMPTOM
in O
other O
family O
members O

Physical O
Exam O
: O

Vitals O
: O

96.7 O
HR60 O
BP153/52 O
, O
later O
178/85 O
RR O
18T O
sO298% O
RA O

Gen O
: O

NAD B-SYMPTOM
, O
in O
bed O

HEENT O
: O
mmm O

Neck O
: O
no O
LAD B-SYMPTOM
; O
no O
carotid B-SYMPTOM
bruits I-SYMPTOM
; O
limited B-SYMPTOM
range I-SYMPTOM
neck I-SYMPTOM
movements I-SYMPTOM
bilaterally I-SYMPTOM

Lungs O
: O

Clear O
to O
auscultation O
bilaterally O

Cardiovascular O
: O

Regular O
rate O
and O
rhythm O
, O
normal O
S1 O
and O
S2 O
, O
no O
murmurs B-SYMPTOM
, O
gallops B-SYMPTOM
and O
rubs B-SYMPTOM
. O

Abdomen O
: O
normal O
bowel O
sounds O
, O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM

Extremities O
: O
no O
edema; B-SYMPTOM
cold B-SYMPTOM
feet I-SYMPTOM
bilaterally I-SYMPTOM

Mental O
Status O
: O

Awake O
and O
alert O
, O
cooperative O
with O
exam O
, O
normal O
affect O
; O
facial B-SYMPTOM
expression I-SYMPTOM
somewhat I-SYMPTOM
sparse I-SYMPTOM
. O

Oriented O
to O
place O
and O
person O
, O
not O
date O
1996 O
. O

Attention O
: O

DOYbw O
. O

Memory O
: O

Registration O
: O

03-29 O
items O
; O
Recall O
03-29 O
at O
5 O
min O
. O

Language O
: O
fluent O
; O
repetition O
: O
intact O
; O
Naming O
intact O
; O
Comprehension O
intact O
; O
no O
dysarthria B-SYMPTOM
, O
no O
paraphasic B-SYMPTOM
errors I-SYMPTOM
. O

East O
Sandwich O
: O
intact O
; O

3D-construction O
: O
poor O
, O
difficulties B-SYMPTOM
putting I-SYMPTOM
handles I-SYMPTOM
in I-SYMPTOM
clock I-SYMPTOM
; O
No O
Apraxia B-SYMPTOM
. O

No O
Neglect B-SYMPTOM
. O

Unable O
to O
do O
luria O
. O

Named O
10 O
animals O
in O
1 O
minute O
, O
no O
perseveration O
, O
but O
no O
further O
animals O
after O
30 O
secs O
. O

Cranial O
Nerves O
: O

II O
: O

Visual O
fields O
are O
full O
to O
confrontation O
, O
pupils O
equally O
round O
and O
reactive O
to O
light O
both O
directly O
and O
consensually O
, O
2.5 O
--> O
2 O
mm O
bilaterally O
. O

III O
, O
IV O
, O
VI O
: O

Extraocular O
movements O
intact O
with O
few O
beats O
of O
horizontal B-SYMPTOM
endgaze I-SYMPTOM
nystagmus I-SYMPTOM
. O

Limited B-SYMPTOM
CMED I-SYMPTOM
CCU I-SYMPTOM
movements I-SYMPTOM
in I-SYMPTOM
upgaze I-SYMPTOM
. O

Fixation O
and O
saccades O
are O
normal O
. O

V O
: O

Facial O
sensation O
intact O
to O
light O
touch O
and O
pinprick O
. O

VII O
: O

Facial O
movement O
symmetrical O
; O
no O
facial B-SYMPTOM
droop I-SYMPTOM
. O

VIII O
: O

Hearing O
intact O
to O
finger O
rub O
bilaterally O
. O

IX O
: O

Palate O
elevates O
in O
midline O
. O

XII O
: O

Tongue O
protrudes O
in O
midline O
, O
no O
fasciculations B-SYMPTOM
. O

XI O
: O

Sternocleidomastoid O
and O
trapezius O
normal O
bilaterally O
. O

Motor O
System O
: O

Decreased B-SYMPTOM
bulk I-SYMPTOM
throughout I-SYMPTOM
; O
tone O
normal O
bilaterally O
. O

No O
adventitious B-SYMPTOM
movements I-SYMPTOM
, O
no O
tremor B-SYMPTOM
, O
no O
asterixis B-SYMPTOM
. O

Right O

D O
- O
5 O
; O
T O
- O
5 O
; O
B O
- O
5 O
; O
WF O
- O
5 O
; O
WE O
- O
5 O
; O
FiF O
- O
5 O
; O
Bruner O
- O
5 O
; O
Ip O
- O
5 O
; O
Gl O
- O
5 O
; O
Q O
- O
5- O
; O
H O
- O
5 O
; O
AF O
- O
5 O
; O
TF O
- O
5 O
; O
TE O
- O
5 O

Left O

D O
- O
5 O
; O
T O
- O
5 O
; O
B O
- O
5 O
; O
WF O
- O
5 O
; O
WE O
- O
5 O
; O
FiF O
- O
5 O
; O
Bruner O
- O
5 O
; O
Ip O
- O
5 O
; O
Gl O
- O
5 O
; O
Q O
- O
5- O
; O
H O
- O
5 O
; O
AF O
- O
5 O
; O
TF O
- O
5 O
; O
TE O
- O
5- O

No O
pronator B-SYMPTOM
drift I-SYMPTOM
. O

No O
rebound B-SYMPTOM
. O

Sensory O
system O
: O

Sensation O
intact O
to O
light O
touch O
, O
pin O
prick O
, O
temperature O
( O
cold O
) O
. O

Decreased B-SYMPTOM
vibration I-SYMPTOM
in I-SYMPTOM
feet I-SYMPTOM
and I-SYMPTOM
ankles I-SYMPTOM
bilaterally I-SYMPTOM
, O
some O
in O
knees O
; O
proprioception B-SYMPTOM
decreased I-SYMPTOM
in I-SYMPTOM
his I-SYMPTOM
feet I-SYMPTOM
bilaterally I-SYMPTOM
. O

Reflexes O
: O

Right O
B O
- O
2 O
; O
T O
- O
2 O
; O
Br O
- O
2 O
; O
Pa O
- O
1 O
; O
Pl O
- O
0 O

Left O

B O
- O
2 O
; O
T O
- O
2 O
; O
Br O
- O
2 O
; O
Pa O
- O
1 O
; O
Pl O
- O
0 O
( O
Less O
brisk O
than O
on O
R O
, O
but O
exam O
limited O
due O
to O
cuff O
) O

Toes O
: O
mute O
bilaterally O
; O
TFL B-SYMPTOM
contracted I-SYMPTOM
on I-SYMPTOM
the I-SYMPTOM
L I-SYMPTOM
. O

Coordination O
: O

Normal O
Correa O
, O
Kimberly O
, O
HTS O
. O

No O
dysmetria B-SYMPTOM
or O
pastpointing B-SYMPTOM
. O

Gait O
: O
not O
tested O

( O
later O
tested O
and O
patient O
markedly B-SYMPTOM
unstable I-SYMPTOM
on I-SYMPTOM
feet I-SYMPTOM
) O

Pertinent O
Results O
: O

2019-03-29 O
10:59 O
PM O

GLUCOSE O
- O
89 O

2019-03-29 O
10:59 O
PM O

CK O
( O
CPK O
)- O
128 O

2019-03-29 O
10:59 O
PM O

CK O
- O
MB O
- O
6 O
cTropnT O
-< O
0.01 O

2019-03-29 O
04:00 O
PM O
URINE O

HOURS O
- O
RANDOM O

2019-03-29 O
04:00 O
PM O
URINE O

GR O
HOLD O
- O
HOLD O

2019-03-29 O
04:00 O
PM O
URINE O

COLOR O
- O
Straw O
APPEAR O
- O
Clear O
SP O
Stickney O
- O
1.017 O

2019-03-29 O
04:00 O
PM O
URINE O

BLOOD O
- O
NEG O
NITRITE O
- O
NEG O
PROTEIN O
- O
NEG O
GLUCOSE O
- O
NEG O
KETONE O
- O
NEG O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
NEG O
PH O
- O
7.0 O
LEUK O
- O
NEG O

2019-03-29 O
02:00 O
PM O

GLUCOSE O
- O
72 O
UREA O
N O
- O
17 O
CREAT O
- O
0.8 O
SODIUM O
- O
140 O
POTASSIUM O
- O
4.4 O
CHLORIDE O
- O
103 O
TOTAL O
CO2 O
- O
29 O
ANION O
GAP O
- O
12 O

2019-03-29 O
02:00 O
PM O

WBC O
- O
6.7 O
RBC O
- O
4.53 O
* O
HGB O
- O
14.8 O
HCT O
- O
44.6 O
MCV O
- O
99 O
* O
MCH O
- O
32.8 O
* O
MCHC O
- O
33.3 O
RDW O
- O
12.6 O

2019-03-29 O
02:00 O
PM O

NEUTS O
- O
65.5 O
LYMPHS O
- O
25.8 O
MONOS O
- O
7.0 O
EOS O
- O
1.4 O
BASOS O
- O
0.2 O

2019-03-29 O
02:00 O
PM O

MACROCYT O
- O
1+ O

2019-03-29 O
02:00 O
PM O

PLT O
COUNT O
- O
213 O

2019-03-29 O
02:00 O
PM O

PT O
- O
12.3 O
PTT O
- O
24.5 O
INR O
( O
PT O
)- O
1.1 O

CT O
BRAIN O
( O
INITIAL O
) O

FINDINGS O
: O

There O
is O
a O
41 O
x O
23 O
mm O
area O
of O
hyperdensity B-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
lobe I-SYMPTOM
, O
with O
moderate B-SYMPTOM
surrounding I-SYMPTOM
vasogenic I-SYMPTOM
edema I-SYMPTOM

( O
series O
2 O
, O
image O
23 O
) O
, O
compatible O
with O
acute B-SYMPTOM
intraparenchymal I-SYMPTOM
hemorrhage I-SYMPTOM
. O

The B-SYMPTOM
chronic I-SYMPTOM
encephalomalacic I-SYMPTOM
changes I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
adjacent I-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
lobe I-SYMPTOM
and O
the O
right O
parietal O
/ O
occipital O
region O
remain O
stable O
in O
appearance O
. O

There O
is O
mild B-SYMPTOM
mass I-SYMPTOM
effect I-SYMPTOM
upon I-SYMPTOM
the I-SYMPTOM
anterior I-SYMPTOM
Mims I-SYMPTOM
of O
the O
right O
lateral O
ventricle O
. O

No O
further O
intraaxial B-SYMPTOM
or I-SYMPTOM
extraaxial I-SYMPTOM
fluid I-SYMPTOM
collections I-SYMPTOM
or O
hematoma B-SYMPTOM
are O
identified O
. O

There O
is O
no O
displacement B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
normally I-SYMPTOM
midline I-SYMPTOM
structures I-SYMPTOM
, O
hydrocephalus B-SYMPTOM
, O
or O
effacement B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
basal I-SYMPTOM
cisterns I-SYMPTOM
at O
present O
. O

Review O
of O
bone O
windows O
demonstrates O
no O
skull B-SYMPTOM
bulge I-SYMPTOM
or O
skull B-SYMPTOM
base I-SYMPTOM
fracture I-SYMPTOM
. O

There O
is O
an B-SYMPTOM
air I-SYMPTOM
/ I-SYMPTOM
fluid I-SYMPTOM
level I-SYMPTOM
within I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
maxillary I-SYMPTOM
sinus I-SYMPTOM
- O
? O
acute B-SYMPTOM
sinusitis I-SYMPTOM
, O
but O
acute B-SYMPTOM
blood I-SYMPTOM
cannot O
be O
excluded O
, O
in O
the O
setting O
of O
acute B-SYMPTOM
trauma I-SYMPTOM
. O

CONCLUSION O
: O

41 B-SYMPTOM
x I-SYMPTOM
23 I-SYMPTOM
mm I-SYMPTOM
acute I-SYMPTOM
intraparenchymal I-SYMPTOM
hematoma I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
lobe I-SYMPTOM
, O
causing O
mild B-SYMPTOM
mass I-SYMPTOM
effect I-SYMPTOM
upon I-SYMPTOM
the I-SYMPTOM
ipsilateral I-SYMPTOM
lateral I-SYMPTOM
ventricle I-SYMPTOM
, O
suspicious O
of O
hemorrhage B-SYMPTOM
secondary O
to O
congophilic B-SYMPTOM
angiopathy I-SYMPTOM
in O
this O
age O
group O
. O

Chronic B-SYMPTOM
encephalomalacic I-SYMPTOM
changes I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
frontal I-SYMPTOM
lobe I-SYMPTOM
and O
right O
parietal O
/ O
occipital O
region O
are O
unchanged O
in O
appearance O
since O
2018-11-27 O
. O

REPEAT O
HEAD O
CT O
03-30 O
: O
no O
significant B-SYMPTOM
change I-SYMPTOM
from O
above O
. O

EKG O
: O

Atrial B-TREATMENT
pacing I-TREATMENT
. O

Since O
the O
previous O
tracing O
of O
2018-03-15 O
atrial B-TREATMENT
pacing I-TREATMENT
is O
a O
new O
finding O
. O

The O
electrocardiogram O
is O
otherwise O
, O
unchanged O
and O
continues O
to O
Weymouth B-TREATMENT
voltage I-TREATMENT
in I-TREATMENT
the I-TREATMENT
limb I-TREATMENT
leads I-TREATMENT
and O
non-specific B-SYMPTOM
ST-T I-SYMPTOM
wave I-SYMPTOM
abnormalities I-SYMPTOM
. O

Read O
by O
: O

Stella O
, O
Kendra O
B O
. O

Intervals O
Axes O

Rate O
60 O
PR O
188 O
QRS O
104 O
QT/QTc O
460/460 O
P O
85 O
QRS O
55 O
T O
75 O

Brief O
Hospital O
Course O
: O

The O
patient O
is O
a O
83 O
yo O
man O
with O
a O
history O
of O
past B-SYMPTOM
intracranial I-SYMPTOM
hemorrhages I-SYMPTOM
( O
most O
recent O
07-01 O
with O
R-frontal B-SYMPTOM
hemorrhage I-SYMPTOM
) O
who O
presented O
with O
gradually B-SYMPTOM
slowing I-SYMPTOM
of I-SYMPTOM
mentation I-SYMPTOM
and O
increased B-SYMPTOM
gait I-SYMPTOM
instability I-SYMPTOM
since O
one O
week O
. O

On O
initial O
exam O
the O
patient O
was O
not B-SYMPTOM
oriented I-SYMPTOM
to I-SYMPTOM
time I-SYMPTOM
, O
seemed O
somewhat B-SYMPTOM
slow I-SYMPTOM
, O
and O
had O
difficulties B-SYMPTOM
generating I-SYMPTOM
a I-SYMPTOM
list I-SYMPTOM
of I-SYMPTOM
animals I-SYMPTOM
. O

His O
cranial O
nerves O
and O
strength O
were O
full O
, O
and O
the O
sensory O
exam O
showed O
mildly B-SYMPTOM
decreased I-SYMPTOM
vibration I-SYMPTOM
and I-SYMPTOM
proprioception I-SYMPTOM
in I-SYMPTOM
both I-SYMPTOM
LE I-SYMPTOM
, O
suggesting O
peripheral B-SYMPTOM
neuropathy I-SYMPTOM
. O

A O
CT O
was O
performed O
in O
the O
Deanna O
that O
showed O
a B-SYMPTOM
new I-SYMPTOM
significant I-SYMPTOM
R-frontal I-SYMPTOM
intraparenchymal I-SYMPTOM
hemorrhage I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
same I-SYMPTOM
location I-SYMPTOM
as O
the B-SYMPTOM
prior I-SYMPTOM
bleed I-SYMPTOM
. O

The O
patient O
was O
seen O
by O
both O
neurology O
and O
neurosurgery O
, O
and O
the O
two O
teams O
agreed O
that O
the O
etiology O
seemed O
to O
be O
related O
to O
underlying B-SYMPTOM
amyloidosis I-SYMPTOM
. O

During O
the O
last O
admission O
the O
question O
of O
a B-SYMPTOM
mass I-SYMPTOM
underlying O
a B-SYMPTOM
hemorrhage I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
R-frontal I-SYMPTOM
region I-SYMPTOM
was O
raised O
. O

The O
location O
of O
the B-SYMPTOM
hemorrhage I-SYMPTOM
was O
not O
felt O
to O
be O
typical O
for O
hypertensive B-SYMPTOM
bleed I-SYMPTOM
( I-SYMPTOM
cortical I-SYMPTOM
) I-SYMPTOM
and O
it O
was O
felt O
to O
be O
unlikely O
that O
the O
recent O
fall O
was O
related O
to O
the B-SYMPTOM
bleed I-SYMPTOM
. O

The O
patient O
could O
not O
undergo O
an O
MRI O
due O
to O
his B-TREATMENT
pacer I-TREATMENT
. O

He O
was O
admitted O
to O
the O
neurology O
ICU O
for O
closer O
monitoring O
and O
was O
stable O
overnight O
- O
BP O
was O
initially B-SYMPTOM
elevated I-SYMPTOM
and O
required O
a B-TREATMENT
labetalol I-TREATMENT
drip I-TREATMENT
for O
< O
24 O
hours O
, O
then O
stabilized O
. O

The O
goal O
SBP O
of O
< O
150 O
was O
achieved O
. O

Coags O
and O
UA O
were O
checked O
and O
were O
normal O
. O

For O
the O
question O
of O
seizure B-SYMPTOM
activity I-SYMPTOM
associated O
with O
a B-SYMPTOM
cortical I-SYMPTOM
bleed I-SYMPTOM
, O
he O
was O
started O
prophylactically O
on O
Keppra B-TREATMENT
( O
given O
questionable O
allergy B-SYMPTOM
to O
dilantin B-TREATMENT
) O
, O
at O
500 O
mg O
bid O
; O
no O
seizure B-SYMPTOM
activity I-SYMPTOM
was O
seen O
. O

This B-TREATMENT
medication I-TREATMENT
should O
be O
continued O
as O
an O
outpatient O
at O
least O
while O
the B-SYMPTOM
bleed I-SYMPTOM
has O
time O
to O
clear O
up O
, O
with O
planned O
titration O
up O
to O
1000 O
mg O
bid O
on O
04-05 O
. O

Head O
CT O
repeated O
on O
03-30 O
was O
unchanged O
, O
and O
the O
patient O
remained O
stable O
with O
only O
very O
suble O
focal O
exam O
findings O
( O
very B-SYMPTOM
mild I-SYMPTOM
right I-SYMPTOM
pronator I-SYMPTOM
drift I-SYMPTOM
) O
as O
well O
as O
his B-SYMPTOM
persistently I-SYMPTOM
poor I-SYMPTOM
memory I-SYMPTOM
related O
to O
dementia B-SYMPTOM
. O

The O
plan O
after O
24 O
hours O
was O
to O
transfer O
him O
to O
the O
floor O
, O
but O
the O
hospital O
was O
full O
and O
he O
never O
got O
a O
bed O
. O

Cardiovascularly O
, O
lipitor B-TREATMENT
and O
amiodarone B-TREATMENT
were O
continued O
. O

He O
could O
not O
get O
an O
MRI O
due O
to O
his B-TREATMENT
pacemaker I-TREATMENT
. O

There O
were O
no O
telemetry B-SYMPTOM
events I-SYMPTOM
, O
and O
he O
ruled O
out O
by O
enzyme O
. O

Pulmonlologically O
, O
his O
chest O
xray O
was O
negative O
and O
he O
complained O
of O
no O
breathing B-SYMPTOM
problems I-SYMPTOM
. O

Endocrinologically O
, O
BG O
was O
monitored O
to O
improve O
outcome O
in O
ICU O
setting O
though O
he O
had O
no O
history O
of O
DM B-SYMPTOM
. O

Of O
note O
, O
Hba1c O
done O
03-04 O
was O
slightly B-SYMPTOM
elevated I-SYMPTOM
( O
" O
borderline B-SYMPTOM
DM I-SYMPTOM
" O
) O
at O
6.3 O
; O
this O
was O
repeated O
and O
was O
still O
pending O
on O
the O
day O
of O
discharge O
. O

Ins O
/ O
outs O
and O
electrolytes O
were O
monitored O
and O
were O
not O
abnormal B-SYMPTOM
; O
he O
was O
on O
a B-TREATMENT
bowel I-TREATMENT
regimen I-TREATMENT
, O
VD B-TREATMENT
boots I-TREATMENT
and O
PUD B-TREATMENT
prophylaxis I-TREATMENT
with O
protonix B-TREATMENT
during O
the O
admission O
. O

Walking O
was O
assessed O
later O
and O
the O
patient O
was O
unstable B-SYMPTOM
on I-SYMPTOM
his I-SYMPTOM
feet I-SYMPTOM
. O

PT O
was O
asked O
to O
see O
him O
for O
this B-SYMPTOM
gait I-SYMPTOM
problem I-SYMPTOM
. O

Brandon O
felt O
well O
and O
was O
seen O
by O
PT O
who O
suggested O
a O
rehab/Hahnemann O
Hospital O
( O
Worcester O
) O
to O
work O
on O
walking O
with O
the O
eventual O
goal O
of O
returning O
to O
assisted O
living O
with O
his O
wife O
when O
walking O
improved O
. O

Follow-up O
was O
arranged O
with O
neurosurgery O
in O
5-6 O
weeks O
with O
repeat O
head O
ct O
to O
be O
arranged O
by O
neurosurgery O
office O
to O
make O
sure O
blood B-SYMPTOM
has O
cleared O
, O
and O
if O
indicated O
, O
to O
look O
for O
a O
possible O
underlying B-SYMPTOM
lesion I-SYMPTOM
( O
although O
unlikely O
) O
. O

Medications O
on O
Admission O
: O

Amiodarone B-TREATMENT
200 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
qod O
- O
in O
March O
, O
should O
be O
on O
odd O
days O
. O

Donepezil B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
. O

Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

Multivitamin B-TREATMENT
Capsule I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Cap O
PO O
DAILY O
( O
Daily O
) O
. O

Mirtazapine B-TREATMENT
30 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
. O

Atorvastatin B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
at O
bedtime O
. O

Ocuvite B-TREATMENT
Tablet I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

Artificial B-TREATMENT
Tears I-TREATMENT
Drops I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
drop O
Ophthalmic O
twice O
a O
day O
: O
ou O
. O

Ensure B-TREATMENT
Liquid I-TREATMENT
Sig O
: O
0.5 O
to O
1 O
can O
PO O
three O
times O
a O
day O
. O

Midodrine B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
1.5 O
Tablets O
PO O
twice O
a O
day O
: O
at O
8am O
and O
noon O
. O

Ritalin B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
see O
below O
Tablet O
PO O
see O
below O
: O
1.5 O
tablets O
at O
10am O
( O
7.5mg O
) O
, O
1 O
tablet O
2pm O
( O
5mg O
) O
. O

Prilosec B-TREATMENT
20 O
mg O
Capsule O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Capsule O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
once O
a O
day O
. O

Guaifenesin B-TREATMENT
100 O
mg O
/ O
5 O
mL O
Liquid O
Sig O
: O
01-28 O
teaspoons O
PO O
every O
six O
( O
6 O
) O
hours O
as O
needed O
for O
cold B-SYMPTOM
symptoms I-SYMPTOM
. O

Discharge O
Medications O
: O

1. O
Amiodarone B-TREATMENT
200 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
qod O
- O
in O
March O
, O
should O
be O
on O
odd O
days O
. O

2. O
Donepezil B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
Two O
( O
2 O
) O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
. O

3. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
) O
. O

4. O
Multivitamin B-TREATMENT
Capsule I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Cap O
PO O
DAILY O
( O
Daily O
) O
. O

5. O
Mirtazapine B-TREATMENT
30 O
mg O
Tablet O
Sig O
: O
0.5 O
Tablet O
PO O
HS O
( O
at O
bedtime O
) O
. O

6. O
Atorvastatin B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
at O
bedtime O
. O

7. O
Levetiracetam B-TREATMENT
500 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
) O
: O
on O
04-05 O
, O
please O
increase O
to O
TWO O
tablets O
bid O
( O
1000 O
mg O
bid O
) O
. O

8. O
Ocuvite B-TREATMENT
Tablet I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
once O
a O
day O
. O

9. O
Artificial B-TREATMENT
Tears I-TREATMENT
Drops I-TREATMENT
Sig O
: O
One O
( O
1 O
) O
drop O
Ophthalmic O
twice O
a O
day O
: O
ou O
. O

10. O
Ensure B-TREATMENT
Liquid I-TREATMENT
Sig O
: O
0.5 O
to O
1 O
can O
PO O
three O
times O
a O
day O
. O

11. O
Midodrine B-TREATMENT
10 O
mg O
Tablet O
Sig O
: O
1.5 O
Tablets O
PO O
twice O
a O
day O
: O
at O
8 O
am O
and O
noon O
. O

12. O
Ritalin B-TREATMENT
5 O
mg O
Tablet O
Sig O
: O
see O
below O
Tablet O
PO O
see O
below O
: O
1.5 O
tablets O
at O
10 O
am O
( O
7.5 O
mg O
) O
, O
1 O
tablet O
2 O
pm O
( O
5 O
mg O
) O
. O

13. O
Prilosec B-TREATMENT
20 O
mg O
Capsule O
, O
Delayed O
Release O
( O
E.C. O
) O
Sig O
: O
One O
( O
1 O
) O
Capsule O
, O
Delayed O
Release O
( O
E.C. O
) O
PO O
once O
a O
day O
. O

14. O
Guaifenesin B-TREATMENT
100 O
mg O
/ O
5 O
mL O
Liquid O
Sig O
: O
01-28 O
teaspoons O
PO O
every O
six O
( O
6 O
) O
hours O
as O
needed O
for O
cold B-SYMPTOM
symptoms I-SYMPTOM
. O

Discharge O
Disposition O
: O

Extended O
Care O

Discharge O
Diagnosis O
: O

Right B-SYMPTOM
sided I-SYMPTOM
intraparenchymal I-SYMPTOM
cerebral I-SYMPTOM
hemorrhage I-SYMPTOM

Discharge O
Condition O
: O

Stable O
- O
still O
with O
difficulty B-SYMPTOM
walking I-SYMPTOM
, O
and O
mental O
status O
exam O
with O
memory B-SYMPTOM
loss I-SYMPTOM
c/w O
dementia B-SYMPTOM
, O
but O
otherwise O
no O
focal B-SYMPTOM
weakness I-SYMPTOM
. O

Discharge O
Instructions O
: O

Please O
call O
MD O
or O
return O
to O
Deanna O
if O
new O
symptoms O
suggestive O
of O
stroke B-SYMPTOM
or O
brain B-SYMPTOM
hemorrhage I-SYMPTOM
including O
weakness B-SYMPTOM
, O
numbness B-SYMPTOM
/ O
tingling B-SYMPTOM
, O
facial B-SYMPTOM
droop I-SYMPTOM
, O
visual B-SYMPTOM
changes I-SYMPTOM
, O
vertigo B-SYMPTOM
, O
loss B-SYMPTOM
of I-SYMPTOM
coordination I-SYMPTOM
, O
or O
worsened B-SYMPTOM
problems I-SYMPTOM
with I-SYMPTOM
walking I-SYMPTOM
. O

Followup O
Instructions O
: O

Please O
f/u O
with O
Dr. O
Hernandez O
/ O
neurosurgery O
in O
6 O
weeks O
- O
patient O
will O
receive O
a O
call O
from O
the O
neurosurgery O
office O
to O
set O
up O
a O
repeat O
head O
CT O
prior O
and O
to O
schedule O
this O
visit O
. O

Daniel O
Laura O
MD O
, O
PHD O
13-279 O

Completed O
by O
: O
Charles O
Rodriguez O
MD O
38-818 O
2019-04-01 O
@ O
1518 O

Signed O
electronically O
by O
: O
DR. O
Stacie O
Henry O
on O
: O
MON O
2019-05-06 O
12:14 O
PM O

( O
End O
of O
Report O
) O

736743101 O

PUOMC O

2427050 O

19324/7383 O

418074 O

4/17/1995 O
12:00:00 O
AM O

NECROTIZING B-SYMPTOM
PANCREATITIS I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

4/17/95 O

DISCHARGE O
DATE O
: O

07/16/95 O

DATE O
OF O
BIRTH O
: O

7/2/1928 O
. O

PRINCIPAL O
DIAGNOSIS O
: O

Necrotizing B-SYMPTOM
pancreatitis I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

1. O
Wegener B-SYMPTOM
&apos;s I-SYMPTOM
granulomatosis I-SYMPTOM
. O

2. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
anterior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
in O
1993 O
. O

3. O
Left B-SYMPTOM
ventricular I-SYMPTOM
aneurysm I-SYMPTOM
. O

4. O
Dementia B-SYMPTOM
. O

5. O
Gallstone B-SYMPTOM
pancreatitis I-SYMPTOM
. O

6. O
Fungal B-SYMPTOM
cystitis I-SYMPTOM
. O

7. O
Intra-abdominal B-SYMPTOM
infection I-SYMPTOM
. O

8. O
Total B-SYMPTOM
parenteral I-SYMPTOM
nutrition I-SYMPTOM
dependent I-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

Exploratory O
laparotomy O
, O
left B-TREATMENT
colectomy I-TREATMENT
, O
end-transverse B-TREATMENT
colostomy I-TREATMENT
, O
drainage B-TREATMENT
of O
pancreatic B-SYMPTOM
necrosis I-SYMPTOM
. O

Date O
of O
operation O
: O

4/28/95 O
. O

HISTORY O
AND O
REASON O
FOR O
ADMISSION O
: O

Mr. O
Mass O
was O
a O
56 O
year O
old O
white O
male O
who O
was O
transferred O
from O
Vassdiysey O
Medical O
Center O
for O
rule O
out O
pancreatic B-SYMPTOM
pseudocyst I-SYMPTOM
. O

Mr. O
Mass O
had O
a O
past O
medical O
history O
which O
included O
Wegener B-SYMPTOM
&apos;s I-SYMPTOM
granulomatosis I-SYMPTOM
, O
history O
of O
an B-SYMPTOM
anterior I-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
and O
gallstone B-SYMPTOM
pancreatitis I-SYMPTOM
. O

He O
was O
admitted O
to O
Vassdiysey O
Medical O
Center O
with O
severe B-SYMPTOM
recurrent I-SYMPTOM
pancreatitis I-SYMPTOM
, O
nausea B-SYMPTOM
, O
vomiting B-SYMPTOM
, O
and O
abdominal B-SYMPTOM
pain I-SYMPTOM
. O

His O
amylase O
on O
admission O
there O
was O
1,961 O
. O

The O
patient O
had O
two O
recent O
admissions O
for O
pancreatitis B-SYMPTOM
in O
January O
1994 O
, O
and O
August O
1994 O
. O

On O
his O
current O
admission O
, O
the O
patient O
was O
admitted O
to O
Free O
Medical O
Center O
. O

His O
amylase O
decreased O
to O
51 O
, O
and O
the O
increased O
back O
to O
151 O
on O
hospital O
day O
#10 O
. O

At O
that O
time O
, O
he O
spiked O
a O
temperature O
to O
103 O
. O

He O
also O
became O
increasingly B-SYMPTOM
confused I-SYMPTOM
. O

A O
computerized O
tomography O
scan O
done O
on O
4/16/95 O
showed O
a B-SYMPTOM
large I-SYMPTOM
&quot; I-SYMPTOM
pseudocyst I-SYMPTOM
&quot; I-SYMPTOM
. O

He O
was O
transferred O
to O
Ph O
University O
Of O
Medical O
Center O
for O
further O
surgical O
evaluation O
.&apos; O

PAST O
MEDICAL O
HISTORY O
: O

1. O
As O
above O
. O

2. O
Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
, O
status O
post O
anterior B-SYMPTOM
myocardial I-SYMPTOM
infarction I-SYMPTOM
, O
in O
1993 O
. O

Ejection O
fraction O
was O
felt O
to O
be O
35% O
in O
1993 O
. O

Recent O
echocardiogram O
suggests O
ejection O
fraction O
of O
15% O
. O

3. O
Wegener B-SYMPTOM
&apos;s I-SYMPTOM
granulomatosis I-SYMPTOM
, O
with O
associated B-SYMPTOM
chronic I-SYMPTOM
renal I-SYMPTOM
insufficiency I-SYMPTOM
. O

4. O
Mild B-SYMPTOM
dementia I-SYMPTOM
. O

MEDICATIONS O
: O

Vitamin B-TREATMENT
K I-TREATMENT
, O
10 O
mg. O
, O
IM O
, O
q-week O
. O

2. O
Pepcid B-TREATMENT
, O
20 O
mg. O
, O
intravenously O
, O
q12h. O

3. O
Digoxin B-TREATMENT
, O
0.125 O
mg. O
, O
intravenously O
, O
qD O
. O

4. O
Imipenem B-TREATMENT
, O
500 O
mg. O
, O
intravenously O
, O
q6h. O

5. O
Nitropaste B-TREATMENT
, O
one-half O
inch O
to O
chest O
wall O
, O
q6h. O

6. O
Vasotec B-TREATMENT
. O

7. O
Alterajel B-TREATMENT
. O

8. O
Lasix B-TREATMENT
, O
20 O
mg. O
, O
po O
, O
qD O
. O

9. O
Haldol B-TREATMENT
. O

10. O
Demerol B-TREATMENT
, O
prn O
. O

ALLERGIES O
: O

Ativan B-TREATMENT
. O

PHYSICAL O
EXAMINATION O
: O

In O
general O
, O
confused O
white O
man O
, O
in O
mild B-SYMPTOM
distress I-SYMPTOM
. O

Vital O
signs O
: O

Temperature O
was O
102 O
, O
heart O
rate O
was O
110 O
, O
respiratory O
rate O
was O
22 O
, O
blood O
pressure O
was O
113/63 O
. O

His O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
was O
benign O
. O

His O
neck O
was O
supple O
. O

Lungs O
: O

Rales B-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
base I-SYMPTOM
, O
bilateral B-SYMPTOM
decreased I-SYMPTOM
breath I-SYMPTOM
sounds I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
bases I-SYMPTOM
. O

Cor O
: O

Regular O
rate O
and O
rhythm O
, O
S1 O
and O
S2 O
, O
no O
extra B-SYMPTOM
heart I-SYMPTOM
sounds I-SYMPTOM
, O
abdomen B-SYMPTOM
distended I-SYMPTOM
with O
an B-SYMPTOM
epigastric I-SYMPTOM
mass I-SYMPTOM
noted O
, O
mildly B-SYMPTOM
tender I-SYMPTOM
to O
palpation O
, O
no O
guarding B-SYMPTOM
. O

Bowel O
sounds O
were O
present O
. O

The O
neurological O
examination O
was O
nonfocal O
. O

LABORATORY O
DATA O
: O

White O
count O
was O
14.4 O
, O
hematocrit O
was O
36.2 O
, O
platelet O
count O
was O
217 O
, O
sodium O
was O
135 O
, O
potassium O
was O
3.3 O
, O
chloride O
was O
99 O
, O
bicarbonate O
was O
25 O
, O
BUN O
was O
40 O
, O
creatinine O
was O
1.9 O
, O
glucose O
was O
124 O
, O
urinalysis O
was O
negative O
, O
PT O
was O
12.2 O
, O
PTT O
was O
24.5 O
, O
calcium O
was O
7.8 O
, O
phosphorus O
was O
3.7 O
, O
albumin O
was O
2.3 O
, O
total O
bilirubin O
was O
1.3 O
, O
alkaline O
phosphatase O
was O
202 O
, O
SGPT O
was O
32 O
, O
SGOT O
was O
64 O
, O
LDH O
was O
998 O
, O
amylase O
was O
150 O
. O

EKG O
revealed O
sinus B-SYMPTOM
tachycardia I-SYMPTOM
at O
107 O
beats O
per O
minute O
. O

Evidence O
of O
old B-SYMPTOM
left I-SYMPTOM
anterior I-SYMPTOM
septal I-SYMPTOM
infarct I-SYMPTOM
. O

Chest O
X-ray O
: O

Large B-SYMPTOM
left I-SYMPTOM
ventricle I-SYMPTOM
, O
bilateral B-SYMPTOM
atelectasis I-SYMPTOM
or O
effusion B-SYMPTOM
. O

Abdominal O
computerized O
tomography O
scan O
: O

Pancreatitis B-SYMPTOM
, O
fluid B-SYMPTOM
collection I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
lesser I-SYMPTOM
sac I-SYMPTOM
. O

A B-SYMPTOM
perisplenic I-SYMPTOM
effusion I-SYMPTOM
was O
noted O
which O
appeared O
to O
communicate O
with O
the B-SYMPTOM
lesser I-SYMPTOM
sac I-SYMPTOM
collection I-SYMPTOM
. O

Gallbladder O
was O
visualized O
with O
stones B-SYMPTOM
. O

IN O
SUMMARY O
, O
the O
patient O
was O
considered O
to O
have O
severe B-SYMPTOM
necrotizing I-SYMPTOM
pancreatitis I-SYMPTOM
, O
with O
severe B-SYMPTOM
cardiac I-SYMPTOM
disease I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
, O
placed O
on O
intravenous B-TREATMENT
fluids I-TREATMENT
. O

He O
was O
continued O
on O
his B-TREATMENT
imipenem I-TREATMENT
, I-TREATMENT
intravenously I-TREATMENT
. O

The O
patient O
was O
started O
on O
total B-TREATMENT
parenteral I-TREATMENT
nutrition I-TREATMENT
. O

On O
4/17/95 O
, O
GI O
Interventional O
Radiology O
performed O
drainage B-TREATMENT
of O
the B-SYMPTOM
peripancreatic I-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM
. O

Approximately O
one O
liter O
of O
brownish B-SYMPTOM
fluid I-SYMPTOM
was O
obtained O
and O
sent O
for O
culture O
. O

The B-TREATMENT
drainage I-TREATMENT
catheter I-TREATMENT
was O
left O
in O
a B-SYMPTOM
pseudocyst I-SYMPTOM
. O

The O
patient O
was O
evaluated O
by O
Cardiology O
. O

A O
Persantine O
Thallium O
study O
demonstrated O
a B-SYMPTOM
large I-SYMPTOM
infarct I-SYMPTOM
, O
involving O
the O
posteroseptal O
, O
anteroseptal O
areas O
. O

Left B-SYMPTOM
ventricular I-SYMPTOM
aneurysm I-SYMPTOM
was O
also O
noted O
; O
however O
, O
no O
ischemia B-SYMPTOM
was O
seen O
. O

An O
echocardiogram O
was O
done O
. O

The O
echocardiogram O
showed O
terrible B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
function I-SYMPTOM
, O
with O
left B-SYMPTOM
ventricular I-SYMPTOM
aneurysm I-SYMPTOM
. O

The O
right O
ventricle O
appeared O
to O
be O
acceptable O
. O

The B-TREATMENT
percutaneous I-TREATMENT
drainage I-TREATMENT
catheter I-TREATMENT
continued O
to O
have O
high O
output O
. O

The O
fluid O
was O
sent O
for O
amylase O
, O
which O
came O
back O
53,230 O
. O

On O
4/28/95 O
, O
the O
patient O
had O
new O
onset O
of O
abdominal B-SYMPTOM
pain I-SYMPTOM
. O

His O
white O
count O
had O
bumped O
from O
8.3 O
on O
admission O
to O
18.5 O
, O
on O
4/27 O
. O

A O
computerized O
tomography O
scan O
of O
the O
abdomen O
was O
performed O
. O

Approximately O
100 O
cc.&apos;s O
of O
thick B-SYMPTOM
brownish I-SYMPTOM
material I-SYMPTOM
was O
aspirated O
through O
the B-TREATMENT
indwelling I-TREATMENT
catheter I-TREATMENT
. O

The O
computerized O
tomography O
scan O
showed O
the B-TREATMENT
catheter I-TREATMENT
tip I-TREATMENT
in O
good O
position O
. O

Because O
of O
the B-SYMPTOM
patient I-SYMPTOM
&apos;s I-SYMPTOM
deteriorating I-SYMPTOM
state I-SYMPTOM
, O
the O
patient O
was O
brought O
to O
the O
operating O
room O
on O
4/28/95 O
. O

An O
exploratory O
laparotomy O
was O
performed O
. O

The O
splenic O
flexure O
had O
a B-SYMPTOM
purulent I-SYMPTOM
exudative I-SYMPTOM
process I-SYMPTOM
along I-SYMPTOM
the I-SYMPTOM
antimesenteric I-SYMPTOM
surface I-SYMPTOM
. O

Thus O
, O
the O
splenic O
flexure O
and O
a O
portion O
of O
the O
descending O
colon O
were O
resected B-TREATMENT
. O

The O
patient O
underwent O
a B-TREATMENT
left I-TREATMENT
colectomy I-TREATMENT
with O
end B-TREATMENT
transverse I-TREATMENT
colostomy I-TREATMENT
, O
and O
oversewing B-TREATMENT
of I-TREATMENT
the I-TREATMENT
descending I-TREATMENT
colon I-TREATMENT
. O

Drainage B-TREATMENT
of O
the B-SYMPTOM
pancreatic I-SYMPTOM
necrosis I-SYMPTOM
was O
also O
done O
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
fairly O
well O
, O
and O
was O
transferred O
to O
the O
Intensive O
Care O
Unit O
. O

In O
the O
Intensive O
Care O
Unit O
, O
the O
patient O
had O
a O
prolonged O
course O
. O

The O
patient O
was O
then O
extubated O
on O
postoperative O
day O
#2 O
, O
but O
remained O
pressor-dependent B-SYMPTOM
. O

He O
remained O
on O
imipenem B-TREATMENT
, O
and O
Vancomycin B-TREATMENT
was O
also O
started O
. O

Thereafter O
, O
the O
patient O
had O
a B-SYMPTOM
long I-SYMPTOM
and I-SYMPTOM
complicated I-SYMPTOM
postoperative I-SYMPTOM
course I-SYMPTOM
. O

He O
was O
eventually O
transferred O
to O
the O
floor O
, O
where O
he O
remained O
meta-stable O
. O

He O
had O
repeated O
episodes O
of O
hypotension B-SYMPTOM
to O
80-90 O
systolic/40-50 O
diastolic O
. O

These O
resolved O
without O
incident O
. O

He O
also O
had O
repeated B-SYMPTOM
temperature I-SYMPTOM
spikes I-SYMPTOM
. O

After O
repeated O
work O
ups O
, O
it O
was O
felt O
that O
these O
were O
probably O
due O
to O
remaining B-SYMPTOM
infection I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
peripancreatic I-SYMPTOM
area I-SYMPTOM
. O

His B-TREATMENT
drainage I-TREATMENT
tube I-TREATMENT
from I-TREATMENT
the I-TREATMENT
peripancreatic I-TREATMENT
area I-TREATMENT
was O
gradually O
advanced O
, O
and O
eventually O
discontinued O
. O

Mr. O
Mass O
was O
placed O
on O
multiple O
courses O
of O
antibiotics B-TREATMENT
. O

Most O
recently O
, O
he O
was O
on O
a O
28 O
day O
course O
of O
Vancomycin B-TREATMENT
, O
ofloxacin B-TREATMENT
, O
and O
Flagyl B-TREATMENT
, O
for O
blood O
cultures O
that O
were O
positive O
for O
gram B-SYMPTOM
positive I-SYMPTOM
cocci I-SYMPTOM
and O
enteric B-SYMPTOM
and I-SYMPTOM
non-enteric I-SYMPTOM
gram I-SYMPTOM
negative I-SYMPTOM
rods I-SYMPTOM
. O

This B-TREATMENT
28 I-TREATMENT
day I-TREATMENT
course I-TREATMENT
was O
completed O
on O
07/15/95 O
. O

The O
patient O
was O
also O
treated O
initially O
with O
amphotericin-B B-TREATMENT
and O
then O
with O
fluconazole B-TREATMENT
for O
a O
computerized O
tomography O
guided O
aspirate O
of O
a B-SYMPTOM
small I-SYMPTOM
fluid I-SYMPTOM
collection I-SYMPTOM
around I-SYMPTOM
his I-SYMPTOM
pancreas I-SYMPTOM
, O
which O
grew O
Candida B-SYMPTOM
albicans I-SYMPTOM
. O

The O
patient O
also O
had O
several O
episodes O
of O
fungal B-SYMPTOM
cystitis I-SYMPTOM
with O
Torulopsis B-SYMPTOM
glabrata I-SYMPTOM
, O
going O
from O
his O
urine O
. O

He O
was O
treated O
with O
amphotericin-B B-TREATMENT
bladder I-TREATMENT
washes I-TREATMENT
for O
this O
. O

Mr. O
Mass O
was O
initially O
anticoagulated B-TREATMENT
for O
his B-SYMPTOM
left I-SYMPTOM
ventricular I-SYMPTOM
aneurysm I-SYMPTOM
. O

He O
remained O
stable O
from O
a O
cardiac O
fashion O
. O

He O
did O
have O
problems B-SYMPTOM
with O
po O
intake O
. O

He O
had O
repeated O
bouts O
of O
small-volume B-SYMPTOM
emesis I-SYMPTOM
that O
may O
have O
been O
secondary O
to O
reflux B-SYMPTOM
. O

He O
was O
treated O
with O
a O
variety O
of O
anti-emetics B-TREATMENT
, O
most O
recently O
Granisetron B-TREATMENT
, O
with O
only O
mild O
success O
. O

He O
remained O
total B-SYMPTOM
parenteral I-SYMPTOM
nutrition-dependent I-SYMPTOM
throughout O
his O
hospital O
course O
. O

By O
the O
end O
of O
June O
, O
it O
became O
clear O
that O
Mr. O
Mass O
would O
require O
aggressive B-TREATMENT
surgical I-TREATMENT
intervention I-TREATMENT
in O
order O
to O
eradicate O
his B-SYMPTOM
intra-abdominal I-SYMPTOM
bursts I-SYMPTOM
of I-SYMPTOM
intermittent I-SYMPTOM
sepsis I-SYMPTOM
; O
however O
, O
long O
discussions O
with O
the O
patient O
and O
his O
wife O
, O
who O
was O
his O
health-care O
proxy O
, O
revealed O
that O
they O
felt O
that O
no O
further B-TREATMENT
aggressive I-TREATMENT
intervention I-TREATMENT
be O
attempted O
. O

The O
patient O
had O
been O
made O
a O
do O
not O
resuscitate O
do O
not O
intubate O
patient O
earlier O
in O
his O
hospital O
stay O
. O

Multiple O
discussions O
were O
held O
between O
Dr. O
Mass O
, O
the O
rest O
of O
the O
surgical O
team O
, O
and O
the O
patient O
&apos;s O
wife O
, O
with O
this O
same O
result O
. O

After O
discussion O
with O
the O
patient O
&apos;s O
primary O
doctor O
, O
Dr. O
Douet O
at O
Vassdiysey O
Medical O
Center O
, O
it O
was O
felt O
that O
the O
patient O
and O
his O
family O
would O
be O
best O
served O
if O
the O
patient O
were O
transferred O
to O
Vassdiysey O
Medical O
Center O
. O

Of O
note O
, O
given O
the O
patient O
&apos;s O
do O
not O
resuscitate O
status O
and O
the B-SYMPTOM
risk I-SYMPTOM
for I-SYMPTOM
bleeding I-SYMPTOM
, O
the B-TREATMENT
patient I-TREATMENT
&apos;s I-TREATMENT
Coumadin I-TREATMENT
was O
stopped O
without O
incident O
several O
weeks O
before O
transfer O
. O

DOCTORS O
DISCHARGE O
INSTRUCTIONS O
: O

MEDICATIONS O
: O

1. O
Heparin B-TREATMENT
, O
5,000 O
units O
, O
sc. O
, O
b.i.d. O

2. O
Lisinopril B-TREATMENT
, O
20 O
mg. O
, O
po O
, O
qD O
. O

3. O
Isordil B-TREATMENT
, O
10 O
mg. O
, O
po O
, O
t.i.d. O

4. O
Nitropaste B-TREATMENT
, O
1 O
inch O
to O
chest O
wall O
, O
q8h. O

5. O
Carafate B-TREATMENT
, O
one O
gram O
, O
po O
or O
per O
nasogastric B-TREATMENT
tube I-TREATMENT
, O
q.i.d. O
, O
Cardizem B-TREATMENT
, O
30 O
mg. O
, O
po O
, O
q6h O
, O
digoxin B-TREATMENT
, O
0.25 O
mg. O
, O
po O
or O
intravenously O
, O
qD O
, O
fluconazole B-TREATMENT
, O
200 O
mg. O
, O
qD O
, O
for O
five O
more O
days O
, O
after O
transfer O
, O
for O
a O
total O
of O
a O
14 O
day O
course O
, O
total B-TREATMENT
parenteral I-TREATMENT
nutrition I-TREATMENT
to O
meet O
the O
patient O
&apos;s O
nutritional O
needs O
. O

The O
patient O
has O
an B-TREATMENT
ostomy I-TREATMENT
appliance I-TREATMENT
around O
the O
former O
site O
of O
his B-TREATMENT
pancreatic I-TREATMENT
fistula I-TREATMENT
drain I-TREATMENT
. O

This O
area O
has O
continued O
to O
drain O
and O
it O
is O
felt O
that O
it O
could O
be O
best O
managed O
by O
an B-TREATMENT
ostomy I-TREATMENT
appliance I-TREATMENT
and O
stoma B-TREATMENT
care I-TREATMENT
. O

The O
patient O
is O
also O
treated O
with O
shots B-TREATMENT
of I-TREATMENT
morphine I-TREATMENT
for O
intermittent B-SYMPTOM
pain I-SYMPTOM
. O

I O
DRAIN O
, O
M.D. O

DICTATING O
FOR O
: O

LIASUN O
L. O
MASS O
, O
M.D. O

TR O
: O

aet O
/ O
bmot O

DD O
: O

07/16/95 O

TD O
: O

07/15/95 O

CC O
: O

STAT O
discharge O
summary O
. O

Copies O
to O
Dr. O
Liasun O
Mass O
, O
Dr. O
Tomedankell O
New O
of O
Cardiology O
, O
and O
Dr. O
Scosthuang O
of O
Vassdiysey O
Medical O
Center O
. O

Please O
have O
a O
copy O
in O
the O
chart O
; O
the O
patient O
will O
be O
leaving O
on O
the O
morning O
of O
07/16/95 O
. O

Admission O
Date O
: O

2013-03-27 O

Discharge O
Date O
: O

2013-04-01 O

Date O
of O
Birth O
: O

1954-08-12 O

Sex O
: O

F O

Service O
: O
NEUROSURGERY O

Allergies O
: O

Shellfish O

Attending O
: O
Sam O
K. O
Laudato O
, O
M.D. O

Chief O
Complaint O
: O

s/p O
MVC O

Major O
Surgical O
or O
Invasive O
Procedure O
: O

none O

History O
of O
Present O
Illness O
: O

58 O
yo O
female O
s/p O
high O
speed O
MVC O
. O

She O
lost O
contaol O
of O
her O
car O
, O
she O
hit O
the O
Barnes O
rails O
then O
the O
car O
stopped O
. O

Another O
car O
was O
coming O
behind O
her O
did O
not O
see O
her O
car O
, O
hit O
again O
, O
the O
person O
checked O
the O
car O
, O
she O
was O
not O
inside O
. O

+LOC B-SYMPTOM
, O
GCS:14 O
. O

She O
ejected O
. O

She O
brought O
by O
EMS O
to O
Nantucket O
Cottage O
Hospital O
for O
furher O
evaluation O
. O

Past O
Medical O
History O
: O

1. O
EtOH O
addiction O
in O
past O

2. O
h/o O
depression B-SYMPTOM

3. O
? O
h/o O
hypomania B-SYMPTOM

4. O
L5-S1 B-SYMPTOM
spondylolisthesis I-SYMPTOM

all O
: O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM

Social O
History O
: O

divorced O
twice O
. O

smokes O
1ppd O
for O
many O
years O
, O
no O
EtOH O
or O
illicit O
drug O
use O
. O

Family O
History O
: O

brother O
who O
was O
alcoholic O

Physical O
Exam O
: O

O O
: O
T O
: O
100.1 O
BP O
: O
162/84 O
HR O
: O
80 O
RR O
: O
20 O
O2Sats O
: O
100 O

Gen O
: O
lying O
in O
strecther O
, O
NAD B-SYMPTOM
, O
shaking B-SYMPTOM
om I-SYMPTOM
bilateral I-SYMPTOM
lower I-SYMPTOM
extremities I-SYMPTOM
. O

HEENT O
: O
Neck O
Supple O
, O
right O
CMED O
CCU O
ecchymotic B-SYMPTOM
and O
edematous B-SYMPTOM
, O
c-collor B-TREATMENT
in O
place O
. O

Lungs O
: O
CTA O
bilaterally O
. O

Cardiac O
: O
RRR O
. O

S1/S2 O
. O

Abd O
: O
Soft O
, O
NT B-SYMPTOM
, O
BS+ O

Extrem O
: O
Cool O
, O
No O
C/C/E B-SYMPTOM
. O

Neuro O
: O

Mental O
status O
: O
Awake O
and O
alert O
, O
cooperative O
with O
exam O
, O
normal O
affect O
. O

Orientation O
: O
Oriented O
to O
person O
, O
place O
, O
and O
date O
. O

Language O
: O
Speech O
fluent O
with O
good O
comprehension O
and O
repetition O
. O

Naming O
intact O
. O

No O
dysarthria B-SYMPTOM
or O
paraphasic B-SYMPTOM
errors I-SYMPTOM
. O

Cranial O
Nerves O
: O

I: O
Not O
tested O

II: O
Pupils O
equally O
round O
and O
reactive O
to O
light O
, O
3to O
2 O
mm O
bilaterally O
. O

Visual O
fields O
are O
full O
to O
confrontation O
. O

III O
, O
IV O
, O
VI: O
Extraocular O
movements O
intact O
bilaterally O
without O
nystagmus B-SYMPTOM
. O

V O
, O
VII: O
Facial O
strength O
and O
sensation O
intact O
and O
symmetric O
. O

VIII: O
Hearing O
intact O
to O
finger O
rub O
bilaterally O
. O

IX O
, O
X: O
Palatal O
elevation O
symmetrical O
. O

XI: O
Sternocleidomastoid O
and O
trapezius O
normal O
bilaterally O
. O

XII: O
Tongue O
midline O
without O
fasciculations B-SYMPTOM
. O

Motor O
: O
Normal O
bulk O
and O
tone O
bilaterally O
. O

No O
abnormal B-SYMPTOM
movements I-SYMPTOM
, O
tremors B-SYMPTOM
. O

Strength O
full O
power O
05-31 O
execept O
Right O
Dubord O
03-31 O
. O

No O
pronator B-SYMPTOM
drift I-SYMPTOM

Sensation O
: O
Intact O
to O
light O
touch O
, O
propioception O
, O
pinprick O
execept O
decreased B-SYMPTOM
sensation I-SYMPTOM
L5-S1 I-SYMPTOM
distrubution I-SYMPTOM
. O

Reflexes O
: O

Right O
: O
B O
- O
2 O
; O
T O
- O
2 O
; O
Br O
- O
2 O
; O
Pa O
- O
2 O
; O
Ac O
- O
2 O

Left O
: O
B O
- O
2 O
; O
T O
- O
2 O
; O
Br O
- O
2 O
; O
Pa O
- O
2 O
; O
Ac O
- O
2 O

Toes O
downgoing O
bilaterally O

Coordination O
: O
normal O
finger-nose-finger O

Pertinent O
Results O
: O

2013-03-27 O
12:59 O
AM O
URINE O
COLOR O
- O
Yellow O
APPEAR O
- O
Clear O
SP O
Stickney O
- O
1.032 O

2013-03-27 O
12:59 O
AM O
URINE O
BLOOD O
- O
NEG O
NITRITE O
- O
NEG O
PROTEIN O
- O
TR O
GLUCOSE O
- O
NEG O
KETONE O
- O
50 O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
1 O
PH O
- O
7.0 O
LEUK O
- O
NEG O

2013-03-27 O
12:59 O
AM O
URINE O
RBC- O
0-2 O
WBC O
- O
0 O
BACTERIA O
- O
NONE O
YEAST O
- O
NONE O
EPI O
- O
0-2 O

2013-03-27 O
12:59 O
AM O
WBC O
- O
5.0 O
RBC O
- O
4.23 O
HGB O
- O
13.4 O
HCT O
- O
38.5 O
MCV O
- O
91 O
MCH O
- O
31.8 O
MCHC O
- O
34.9 O
RDW O
- O
12.7 O

2013-03-27 O
12:59 O
AM O
PLT O
COUNT O
- O
213 O

2013-03-27 O
12:59 O
AM O
URINE O
bnzodzpn O
- O
NEG O
barbitrt O
- O
NEG O
opiates O
- O
NEG O
cocaine O
- O
NEG O
amphetmn O
- O
POS O
mthdone O
- O
NEG O

2013-03-27 O
01:09 O
AM O
HGB O
- O
13.4 O
calcHCT O
- O
40 O
O2 O
SAT O
- O
95 O
CARBOXYHB O
- O
1.2 O
MET O
HGB O
- O
0.2 O

2013-03-27 O
12:59 O
AM O
UREA O
N O
- O
21 O
* O
CREAT O
- O
0.8 O

2013-03-27 O
02:25 O
AM O
PT O
- O
13.2 O
* O
PTT O
- O
22.9 O
INR(PT) O
- O
1.2 O
* O

Brief O
Hospital O
Course O
: O

The O
patient O
was O
admitted O
to O
Nantucket O
Cottage O
Hospital O
on O
2013-03-27 O
following O
a O
motor O
vehicle O
crash O
as O
described O
previously O
. O

Chest O
and O
pelvis O
X-rays O
were O
negative O
for O
fractures B-SYMPTOM
. O

A O
CT O
of O
her O
head O
demonstrated O
intraparenchymal B-SYMPTOM
and I-SYMPTOM
extraaxial I-SYMPTOM
blood I-SYMPTOM
( I-SYMPTOM
mostly I-SYMPTOM
subarachnoid I-SYMPTOM
) I-SYMPTOM
in I-SYMPTOM
bilateral I-SYMPTOM
cerebral I-SYMPTOM
hemispheres I-SYMPTOM
, O
right O
greater O
than O
left O
, O
in O
a O
pattern O
indicating O
contrecoup B-SYMPTOM
injury I-SYMPTOM
. O

A O
CT O
of O
her O
C-spine O
revealed O
a O
possible O
fracture B-SYMPTOM
of I-SYMPTOM
right I-SYMPTOM
C7 I-SYMPTOM
pedicle I-SYMPTOM
. O

A O
CT O
of O
her O
chest O
revealed O
bliateral B-SYMPTOM
lung I-SYMPTOM
nodules I-SYMPTOM
and O
a B-SYMPTOM
right I-SYMPTOM
thyroid I-SYMPTOM
nodule I-SYMPTOM
. O

A O
CT O
of O
her O
sinues O
revealed O
no O
fractures B-SYMPTOM
. O

X-rays O
of O
her O
right O
lower O
extremity O
were O
negative O
for O
any B-SYMPTOM
acute I-SYMPTOM
injury I-SYMPTOM
. O

A O
neurosurgery O
consult O
was O
obtained O
. O

Our O
recommendations O
were O
to O
load O
her O
with O
Dilantin B-TREATMENT
and O
then O
continue O
at O
100 O
mg O
PO O
TID O
. O

The O
orthopedics O
spine O
service O
saw O
her O
and O
put O
her O
in O
a B-TREATMENT
C-collar I-TREATMENT
. O

She O
was O
admitted O
to O
the O
trauma O
ICU O
. O

A O
repeat O
head O
CT O
12 O
hours O
after O
the O
first O
was O
largely O
unchanged O
. O

She O
was O
transferred O
to O
step O
down O
. O

She O
was O
having O
some B-SYMPTOM
pain I-SYMPTOM
issues I-SYMPTOM
and O
morphine B-TREATMENT
was O
making O
her O
" O
jittery B-SYMPTOM
." O

On O
HD O
2 O
she O
was O
switched O
to O
Fioricet B-TREATMENT
, O
which O
helped O
with O
her B-SYMPTOM
headaches I-SYMPTOM
. O

A O
repeact O
head O
CT O
was O
unchanged O
. O

An O
MRI O
of O
her O
C-spine O
was O
done O
to O
evaluate O
for O
ligamentous B-SYMPTOM
injury I-SYMPTOM
, O
but O
this O
was O
extremely O
limited O
examination O
due O
to O
patient O
motion O
and O
the O
signal O
in O
the O
spinal O
cord O
could O
not O
be O
adequately O
assessed O
for O
edema B-SYMPTOM
. O

As O
per O
CMED O
CSRU O
spine O
, O
the O
patient O
was O
instructed O
to O
follow-up O
in O
2 O
weeks O
for O
repeat O
X-rays O
. O

On O
discharge O
she O
was O
awake O
, O
alert O
and O
orientated O
X3 O
with O
c/o O
mild B-SYMPTOM
headache I-SYMPTOM
. O

She O
had O
full O
strength O
motor O
exam O
, O
no O
pronator B-SYMPTOM
drift I-SYMPTOM
and O
PERRLA O
with O
full O
EOM O
s. O

She O
was O
ambulating O
without O
difficulties B-SYMPTOM
. O

On O
04-01 O
she O
was O
seen O
by O
physical B-TREATMENT
therapy I-TREATMENT
was O
thought O
to O
benefit O
from O
acute B-TREATMENT
rehabilitation I-TREATMENT
. O

She O
had O
a O
head O
CT O
prior O
to O
discharge O
that O
showed O
resolution O
of O
the B-SYMPTOM
subarachnoid I-SYMPTOM
hemorrhage I-SYMPTOM
. O

Follow-up O
in O
1 O
month O
with O
neurosurgery O
for O
a O
repeat O
head O
CT O
was O
arranged O
. O

She O
was O
discharged O
on O
fioricet B-TREATMENT
and O
dilantin B-TREATMENT
. O

She O
was O
counseled O
to O
follow-up O
with O
her O
PCP O
F O
6-12 O
months O
regading O
the B-SYMPTOM
right I-SYMPTOM
thyroid I-SYMPTOM
nodule I-SYMPTOM
and O
the B-SYMPTOM
bilateral I-SYMPTOM
small I-SYMPTOM
lung I-SYMPTOM
nodules I-SYMPTOM
seen O
on O
her O
chest O
CT O
. O

Medications O
on O
Admission O
: O

1. O
celexa B-TREATMENT

2. O
premarin B-TREATMENT

3. O
trazodone B-TREATMENT

4. O
6-MP B-TREATMENT

5. O
Prednisone B-TREATMENT

Discharge O
Medications O
: O

1. O
Phenytoin B-TREATMENT
Sodium I-TREATMENT
Extended I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
TID O
( O
3 O
times O
a O
day O
) O
for O
1 O
months O
. O

Disp O
:* O
90 O
Capsule O
(s)* O
Refills O
:* O
0 O
* O

2. O
Acetaminophen B-TREATMENT
- O
Caff B-TREATMENT
- O
Butalbital B-TREATMENT
504-61-78 O
mg O
Capsule O
Sig O
: O
01-28 O
Tablets O
PO O
Q4-6H O
( O
every O
4 O
to O
6 O
hours O
) O
as O
needed O
for O
1 O
months O
. O

Disp O
:* O
60 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

3. O
Citalopram B-TREATMENT
20 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
DAILY O
( O
Daily O
). O

4. O
Metoprolol B-TREATMENT
Tartrate I-TREATMENT
25 O
mg O
Tablet O
Sig O
: O
One O
( O
1 O
) O
Tablet O
PO O
BID O
( O
2 O
times O
a O
day O
). O

5. O
Hydromorphone B-TREATMENT
2 O
mg O
Tablet O
Sig O
: O
1-2 O
Tablets O
PO O
Q4H O
( O
every O
4 O
hours O
) O
as O
needed O
for O
pain B-SYMPTOM
. O

Disp O
:* O
40 O
Tablet O
(s)* O
Refills O
:* O
0 O
* O

6. O
Docusate B-TREATMENT
Sodium I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
BID O
( O
2 O
times O
a O
day O
): O
Use O
while O
taking O
narcotics B-TREATMENT
. O

7. O
Phenytoin B-TREATMENT
Sodium I-TREATMENT
Extended I-TREATMENT
100 O
mg O
Capsule O
Sig O
: O
One O
( O
1 O
) O
Capsule O
PO O
TID O
( O
3 O
times O
a O
day O
). O

Disp O
:* O
90 O
Capsule O
(s)* O
Refills O
:* O
0 O
* O

Discharge O
Disposition O
: O

Extended O
Care O

Facility O
: O

St. O
Anne's O
Hospital O
- O
Burlington O

Discharge O
Diagnosis O
: O

Head B-SYMPTOM
trauma I-SYMPTOM
with O
subarachnoid B-SYMPTOM
hemorrhage I-SYMPTOM

C7 B-SYMPTOM
fracture I-SYMPTOM

Discharge O
Condition O
: O

neurologically O
stable O

Discharge O
Instructions O
: O

Call O
for O
severe B-SYMPTOM
headache I-SYMPTOM
or O
any B-SYMPTOM
other I-SYMPTOM
problems I-SYMPTOM
. O

Please O
take O
Fioricet B-TREATMENT
as O
directed O
for O
headaches B-SYMPTOM
. O

Please O
do O
not O
drive O
while O
on O
this B-TREATMENT
medication I-TREATMENT
. O

Please O
continue O
to O
wear O
your B-TREATMENT
C-collar I-TREATMENT
at O
all O
times O
. O

Please O
continue O
Dilantin B-TREATMENT
as O
directed O
for O
seizure B-TREATMENT
prophylaxis I-TREATMENT
. O

Followup O
Instructions O
: O

Follow O
up O
with O
Dr. O
Kelley O
in O
4 O
weeks O
with O
head O
CT O
- O
call O
716 O
3268 O

Please O
also O
follow-up O
with O
Dr. O
Obrecht O
of O
CMED O
CCU O
spine O
in O
2 O
weeks O
for O
flexion O
/ O
extension O
X-rays O
(( O
228 O
) O
411-7660 O
) O

Please O
follow-up O
with O
your O
PCP O
N O
6-12 O
months O
reguading O
the B-SYMPTOM
right I-SYMPTOM
thyroid I-SYMPTOM
nodule I-SYMPTOM
and O
the B-SYMPTOM
bilateral I-SYMPTOM
small I-SYMPTOM
lung I-SYMPTOM
nodules I-SYMPTOM
seen O
on O
your O
chest O
CT O
. O

Vernia O
Diana O
MD O
76-016 O

Completed O
by O
: O
Sonya O
Ramona O
NP O
80-AKY O
2013-04-01 O
@ O
1453 O

Signed O
electronically O
by O
: O
DR. O
Shirley O
Bennett O
on O
: O
Sandra O
2013-05-02 O
4:53 O
PM O

( O
End O
of O
Report O
) O

399210956 O

FIH O

6954426 O

59986/3015 O

071004 O

08/27/1992 O
12:00:00 O
AM O

Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

08-27-92 O

DISCHARGE O
DATE O
: O

09-05-92 O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
a O
75 O
year O
old O
Hispanic O
male O
with O
insulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
, O
status O
post O
a B-TREATMENT
right I-TREATMENT
above-knee I-TREATMENT
amputation I-TREATMENT
about O
five O
years O
ago O
, O
who O
reportedly O
approximately O
four O
months O
ago O
, O
he O
developed O
a B-SYMPTOM
small I-SYMPTOM
ulceration I-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
great I-SYMPTOM
toe I-SYMPTOM
, O
which O
progressively O
worsened O
. O

He O
was O
seen O
by O
a O
doctor O
in O
Arizona O
and O
treated O
with O
dressing B-TREATMENT
changes I-TREATMENT
and O
debridement B-TREATMENT
until O
approximately O
six O
weeks O
ago O
, O
when O
antibiotics B-TREATMENT
were O
started O
with O
Ciprofloxacin B-TREATMENT
. O

The O
patient O
was O
seen O
and O
it O
was O
suggested O
that O
he O
should O
have O
an B-TREATMENT
amputation I-TREATMENT
and O
he O
decided O
to O
come O
to O
Fairm O
of O
Ijordcompmac O
Hospital O
for O
further O
evaluation O
. O

PAST O
MEDICAL O
HISTORY O
: O

insulin B-SYMPTOM
dependent I-SYMPTOM
diabetes I-SYMPTOM
mellitus I-SYMPTOM
for O
fifteen O
years O
. O

PAST O
SURGICAL O
HISTORY O
: O

right B-TREATMENT
above-knee I-TREATMENT
amputation I-TREATMENT
five O
years O
ago O
, O
status O
post O
motor O
vehicle O
accident O
. O

He O
sustained O
left B-SYMPTOM
humerus I-SYMPTOM
fracture I-SYMPTOM
and O
left B-SYMPTOM
tib-fib I-SYMPTOM
fracture I-SYMPTOM
. O

ALLERGIES O
: O

The O
patient O
has O
no O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Tylenol B-TREATMENT
, O
Ciprofloxacin B-TREATMENT
and O
Insulin B-TREATMENT
, O
about O
16 O
units O
of O
NPH B-TREATMENT
qa.m. O

REVIEW O
OF O
SYSTEMS O
: O

On O
review O
of O
systems O
, O
denies O
fevers B-SYMPTOM
, O
has O
pain B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
foot I-SYMPTOM
, O
no O
shortness B-SYMPTOM
of I-SYMPTOM
breath I-SYMPTOM
or O
chest B-SYMPTOM
pain I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

The O
physical O
examination O
reveals O
him O
to O
be O
an O
elderly O
gentleman O
who O
is O
alert O
and O
oriented O
and O
in O
no O
acute B-SYMPTOM
distress I-SYMPTOM
. O

The O
head O
, O
eyes O
, O
ears O
, O
nose O
, O
throat O
examination O
was O
unremarkable O
. O

Chest O
was O
clear O
to O
auscultation O
and O
percussion O
. O

Cardiovascular O
exam O
: O

regular O
rate O
and O
rhythm O
. O

The O
abdomen O
was O
soft O
, O
nontender B-SYMPTOM
, O
nondistended B-SYMPTOM
, O
no O
visceromegaly B-SYMPTOM
. O

The O
rectal O
examination O
showed O
normal O
prostate O
, O
guaiac O
negative O
. O

His O
neurological O
examination O
was O
nonfocal O
. O

Pulses O
remained O
, O
aside O
from O
the B-TREATMENT
above-knee I-TREATMENT
amputation I-TREATMENT
on I-TREATMENT
the I-TREATMENT
right I-TREATMENT
side I-TREATMENT
, O
they O
remained O
symmetrical O
bilaterally O
with O
3+ O
carotid O
, O
2+ O
brachial O
, O
1+ O
radial O
, O
3+ O
femoral O
. O

LABORATORY O
DATA O
: O

significant O
for O
a O
white O
blood O
count O
of O
6.0 O
, O
hematocrit O
35.9 O
, O
electrolytes O
within O
normal O
limits O
, O
BUN O
and O
creatinine O
of O
13 O
and O
0.8 O
, O
amylase O
of O
56 O
. O

The O
patient O
had O
an O
electrocardiogram O
which O
showed O
no O
acute B-SYMPTOM
ischemic I-SYMPTOM
change I-SYMPTOM
. O

His O
chest O
X-ray O
ruled O
out O
acute B-SYMPTOM
cardiopulmonary I-SYMPTOM
process I-SYMPTOM
. O

Left B-SYMPTOM
foot I-SYMPTOM
changes I-SYMPTOM
consistent O
with O
osteomyelitis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
great I-SYMPTOM
toe I-SYMPTOM
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
for O
intravenous B-TREATMENT
antibiotics I-TREATMENT
and O
a O
question O
of O
evaluation O
of O
circulation O
to O
the O
left O
great O
toe O
and O
also O
possible O
debridement B-TREATMENT
and O
possibly O
a B-TREATMENT
toe I-TREATMENT
amputation I-TREATMENT
. O

The O
patient O
had O
the O
following O
radiological O
studies O
: O

08-27-92 O
, O
left O
foot O
film O
, O
correlation O
, O
patient O
consistent O
with O
osteomyelitis B-SYMPTOM
involving I-SYMPTOM
the I-SYMPTOM
first I-SYMPTOM
digit I-SYMPTOM
and O
possibly O
the O
second O
digit O
of O
the O
left O
foot O
. O

The O
chest O
X-ray O
reveals O
no O
evidence O
of O
acute B-SYMPTOM
disease I-SYMPTOM
. O

The O
patient O
had O
lower O
extremity O
arterial O
non-invasive O
study O
which O
showed O
good O
arterial O
hemodynamics O
of O
the O
left O
lower O
extremity O
, O
perfusion O
to O
the O
TM O
level O
, O
but O
there O
was O
evidence O
of O
diabetic B-SYMPTOM
small I-SYMPTOM
vessel I-SYMPTOM
disease I-SYMPTOM
and O
spasm B-SYMPTOM
of I-SYMPTOM
his I-SYMPTOM
digits I-SYMPTOM
. O

The O
arterial O
circulation O
is O
adequate O
for O
healing O
of O
his B-SYMPTOM
left I-SYMPTOM
great I-SYMPTOM
toe I-SYMPTOM
ulcer I-SYMPTOM
, O
noncompressible B-SYMPTOM
left I-SYMPTOM
thigh I-SYMPTOM
and I-SYMPTOM
calf I-SYMPTOM
pressures I-SYMPTOM
highly B-SYMPTOM
calcified I-SYMPTOM
arterial I-SYMPTOM
system I-SYMPTOM
. O

On O
09-03-92 O
, O
patient O
underwent O
a B-TREATMENT
left I-TREATMENT
great I-TREATMENT
toe I-TREATMENT
buttontoe I-TREATMENT
amputation I-TREATMENT
under O
regional B-TREATMENT
ankle I-TREATMENT
block I-TREATMENT
for O
chronic B-SYMPTOM
ulcer I-SYMPTOM
and O
osteomyelitis B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
left I-SYMPTOM
great I-SYMPTOM
toe I-SYMPTOM
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
. O

There O
were O
no O
complications B-SYMPTOM
during O
the B-TREATMENT
procedure I-TREATMENT
. O

There O
was O
a B-TREATMENT
small I-TREATMENT
Penrose I-TREATMENT
drain I-TREATMENT
postoperatively O
that O
was O
placed O
intraoperatively O
and O
discontinued O
on O
approximately O
postoperative O
day O
number O
three O
. O

The O
patient O
was O
preoperatively O
treated O
with O
about O
a O
seven O
day O
course O
of O
intravenous B-TREATMENT
Unasyn I-TREATMENT
and O
postoperatively O
treated O
for O
approximately O
four O
days O
of O
intravenous B-TREATMENT
Unasyn I-TREATMENT
. O

The O
patient O
was O
discharged O
home O
in O
stable O
condition O
on O
postoperative O
day O
number O
five O
, O
without O
any B-SYMPTOM
complications I-SYMPTOM
. O

The B-SYMPTOM
incision I-SYMPTOM
from O
buttontoe B-TREATMENT
amputation I-TREATMENT
of I-TREATMENT
the I-TREATMENT
left I-TREATMENT
foot I-TREATMENT
healing O
well O
, O
without O
any O
further B-SYMPTOM
complications I-SYMPTOM
. O

FOLLOWUP O
: O

The O
patient O
is O
to O
follow O
up O
in O
clinic O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Included O
his B-TREATMENT
pre-admission I-TREATMENT
medications I-TREATMENT
. O

A O
HAS O
, O
M.D. O

TR O
: O

yy O
/ O
bmot O

DD O
: O

10-21-92 O

TD O
: O

10/22/92 O

CC O
: O

Admission O
Date O
: O

2016-03-22 O

Discharge O
Date O
: O

2016-04-04 O

Date O
of O
Birth O
: O

1940-06-17 O

Sex O
: O

F O

Service O
: O

MEDICINE O

Allergies O
: O

Morphine B-TREATMENT

Attending O
: O
Michael O
I. O
Miller O
, O
M.D. O

Chief O
Complaint O
: O
s/p O
Fall O

Major O
Surgical O
or O
Invasive O
Procedure O
: O
s/p O
right B-TREATMENT
hip I-TREATMENT
ORIF I-TREATMENT

s/p O
intubation B-TREATMENT

History O
of O
Present O
Illness O
: O

75 O
yo O
F O
with O
CAD B-SYMPTOM
s/p O
MI B-SYMPTOM
x4 O
( O
s/p O
LAD B-TREATMENT
stent I-TREATMENT
'09 O
and O
RCA B-TREATMENT
stent I-TREATMENT
x O
2 O
in O
'00 O
and O
'04 O
) O
, O
CHF B-SYMPTOM
with O
EF O
55% O
, O
PAF B-SYMPTOM
, O
Inducible B-SYMPTOM
Vtach I-SYMPTOM
s/p O
AICD B-TREATMENT
placement I-TREATMENT
, O
sick B-SYMPTOM
sinus I-SYMPTOM
syndrome I-SYMPTOM
s/p O
pacer B-TREATMENT
and O
COPD B-SYMPTOM
with O
restrictive B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
. O

Per O
daughter O
, O
pt O
was O
in O
her O
USOH O
until O
two O
days O
prior O
to O
admission O
when O
she O
was O
noted O
to O
have O
a B-SYMPTOM
superficial I-SYMPTOM
ulcerations I-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
foot I-SYMPTOM
with O
erythema B-SYMPTOM
. O

Pt O
was O
taken O
to O
Bridgewater O
Chelsea O
Soldier O
's O
Home O
Hospital O
and O
started O
on O
unasyn B-TREATMENT
IV I-TREATMENT
. O

Pt O
awoke O
later O
that O
night O
and O
felt O
unsteady B-SYMPTOM
on I-SYMPTOM
her I-SYMPTOM
feet I-SYMPTOM
and O
sustained O
a O
mechanical O
fall O
. O

Per O
daughter O
, O
pt O
did O
not O
note O
chest B-SYMPTOM
pain I-SYMPTOM
, O
tachycardia B-SYMPTOM
, O
had O
a O
good O
PO O
intake O
and O
no O
noted B-SYMPTOM
seizure I-SYMPTOM
activity I-SYMPTOM
. O

Pt O
was O
in O
severe B-SYMPTOM
" I-SYMPTOM
back I-SYMPTOM
pain I-SYMPTOM
" I-SYMPTOM
as O
per O
daughter O
which O
was O
treated O
with O
dilaudid B-TREATMENT
. O

CT O
of O
the O
neck O
revealed O
a O
possible O
C1 B-SYMPTOM
fracture I-SYMPTOM
and O
the O
X-ray O
at O
the O
OSH O
revealed O
intratrochanteric B-SYMPTOM
fracture I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
femur I-SYMPTOM
. O

Pt O
was O
subsequently O
transferred O
to O
Hallmark O
Health O
System O
for O
orthopaedic O
evaluation O
. O

In O
Monica O
at O
Hallmark O
Health O
System O
, O
pt O
was O
seen O
by O
the O
Trauma O
service O
where O
a O
CT O
of O
the O
neck O
revealed O
no O
fracture B-SYMPTOM
( O
however O
, O
the B-TREATMENT
c-collar I-TREATMENT
was O
maintained O
secondary O
to O
pain B-SYMPTOM
) O
. O

The O
orthopaedic O
service O
recommended O
emergent B-TREATMENT
repair I-TREATMENT
of O
the B-SYMPTOM
intratrochanteric I-SYMPTOM
fracture I-SYMPTOM
secondary O
to O
instability B-SYMPTOM
. O

The O
Monica O
stay O
was O
complicated O
by O
runs O
of O
afib B-SYMPTOM
to O
133 O
requiring O
IV B-TREATMENT
lopressor I-TREATMENT
. O

ROS O
: O

Pt O
is O
very B-SYMPTOM
SOB I-SYMPTOM
at O
baseline O
, O
not O
on O
home B-TREATMENT
ox I-TREATMENT
, O
no O
CP B-SYMPTOM
at O
rest O
, O
no O
LE B-SYMPTOM
edema I-SYMPTOM
, O
no O
PND B-SYMPTOM
, O
stable B-SYMPTOM
orthopnea I-SYMPTOM
( O
2 O
pillows O
) O
. O

Pt O
ambulates O
10 O
feet O
with O
significant B-SYMPTOM
fatigue I-SYMPTOM
as O
per O
daughter O
. O

( O
? O
dec B-SYMPTOM
in I-SYMPTOM
exercise I-SYMPTOM
tolerance I-SYMPTOM
) O
. O

CMED O
CCU O
change O
include O
discontinuation O
of O
coumadin B-TREATMENT
secondary O
to O
inc O
risk O
of O
upper B-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM
. O

Digoxin B-TREATMENT
, O
Norvasc B-TREATMENT
and O
Imdur B-TREATMENT
was O
also O
discontinued O
. O

HPI O
: O

75 O
yo O
F O
with O
CAD B-SYMPTOM
s/p O
stenting B-TREATMENT
, O
VT B-SYMPTOM
, O
SSS B-SYMPTOM
s/p O
pacer B-TREATMENT
, O
COPD B-SYMPTOM
, O
presented O
to O
OSH O
2016-03-21 O
with O
foot B-SYMPTOM
ulceration I-SYMPTOM
. O

Started O
on O
unasyn B-TREATMENT
, O
in O
hospital O
suffered O
mech. O
fall O
with O
hip B-SYMPTOM
fx I-SYMPTOM
. O

Transferred O
to O
Hallmark O
Health O
System O
03-22 O
. O

Medically O
eval O
not O
high B-TREATMENT
risk I-TREATMENT
surgery I-TREATMENT
, O
preop B-TREATMENT
beta I-TREATMENT
blocker I-TREATMENT
given O
. O

ORIF B-TREATMENT
with O
repair B-TREATMENT
of O
neck B-SYMPTOM
fracture I-SYMPTOM
2016-03-23 O
. O

Expected B-TREATMENT
prolonged I-TREATMENT
extubation I-TREATMENT
course I-TREATMENT
given O
COPD B-SYMPTOM
history I-SYMPTOM
, O
as O
with O
colon B-TREATMENT
CA I-TREATMENT
resection I-TREATMENT
surgery I-TREATMENT
. O

In O
PM O
extubated O
, O
transferred O
to O
floor O
2016-03-23 O
. O

Late O
03-23 O
found O
with O
afib B-SYMPTOM
and O
RVR B-SYMPTOM
, O
given O
beta B-TREATMENT
blocker I-TREATMENT
with O
min. O
response O
, O
started O
dilt. B-TREATMENT
drip I-TREATMENT
. O

Received O
2 B-TREATMENT
mg I-TREATMENT
dilaudid I-TREATMENT
for O
pain B-SYMPTOM
o/n O
. O

This O
AM O
with O
respiratory B-SYMPTOM
failure I-SYMPTOM
, O
continued B-SYMPTOM
tachycardia I-SYMPTOM
on O
dilt. B-TREATMENT
gtt I-TREATMENT
. O

Transferred O
to O
unit O
and O
urgently O
intubated O
( O
labs O
below. O
) O

Of O
note O
, O
a B-TREATMENT
NGT I-TREATMENT
by O
Xray O
was O
not O
in O
correct O
position O
? O
lungs O
-> O
possibly O
used O
for O
medication B-TREATMENT
administration I-TREATMENT
this O
AM O
. O

Past O
Medical O
History O
: O

1. O
CAD B-SYMPTOM
s/p O
LAD B-TREATMENT
stent I-TREATMENT
in O
' O
98 O
+ O
RCA B-TREATMENT
stet I-TREATMENT
in O
' O
00 O
with O
repeat B-TREATMENT
RCA I-TREATMENT
stent I-TREATMENT
in O
' O
04 O
. O

Last O
cath O
in O
9-04 O

2. O
PAF B-SYMPTOM

3. O
DM B-SYMPTOM

4. O
Sick B-SYMPTOM
sinus I-SYMPTOM
syndrome I-SYMPTOM
s/p O
pacer B-TREATMENT
placement I-TREATMENT
in O
' O
98 O

5. O
Depression B-SYMPTOM

6. O
COPD B-SYMPTOM
( O
no O
PFT O
available O
) O

7. O
Chronic B-SYMPTOM
restrictive I-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
( O
no O
PFT O
available O
) O

8. O
HTN B-SYMPTOM

9. O
Hyperlipidemia B-SYMPTOM

10. O
Obesity B-SYMPTOM

11. O
s/p O
TAH B-TREATMENT

12. O
s/p O
colonic B-TREATMENT
resection I-TREATMENT
secondary O
to O
perforation B-SYMPTOM
s/p O
polypectomy B-TREATMENT

13. O
Inducible B-SYMPTOM
Vtach I-SYMPTOM
on O
EP O
study O
with O
AICD B-TREATMENT
placement I-TREATMENT
11-01 O

14. O
CHF B-SYMPTOM

15. O
Upper B-SYMPTOM
GI I-SYMPTOM
bleed I-SYMPTOM

Physical O
Exam O
: O

VS O
: O

HR O
: O
133 O

BP O
: O
110/80 O

Gen O
: O
sedated B-TREATMENT
but O
A+O O
x3 O

HEENT O
: O
cervical B-TREATMENT
collar I-TREATMENT
in O
place O

CV O
: O
tachycardia B-SYMPTOM

Chest O
: O
CTA O
bilaterally O

Abd O
: O
+ O
BS O
, O
soft O
, O
NT B-SYMPTOM
, O
ND B-SYMPTOM
, O
BS O
+ O

Ext O
: O
no O
peripheral B-SYMPTOM
edema I-SYMPTOM
, O
R B-SYMPTOM
leg I-SYMPTOM
shortened I-SYMPTOM
and I-SYMPTOM
rotated I-SYMPTOM
, O
+ O
cellulitis B-SYMPTOM

Pertinent O
Results O
: O

2016-03-22 O
02:45 O
AM O

WBC O
- O
12.7 O
* O
RBC O
- O
4.32 O
HGB O
- O
10.5 O
* O
HCT O
- O
33.2 O
* O
MCV O
- O
77 O
* O
MCH O
- O
24.2 O
* O
MCHC O
- O
31.5 O
RDW O
- O
15.4 O

2016-03-22 O
02:45 O
AM O

NEUTS O
- O
90.5 O
* O
LYMPHS O
- O
5.1 O
* O
MONOS O
- O
3.7 O
EOS O
- O
0.6 O
BASOS O
- O
0.2 O

2016-03-22 O
02:45 O
AM O

HYPOCHROM O
- O
3+ O
POIKILOCY O
- O
1+ O
MICROCYT O
- O
2+ O

2016-03-22 O
02:45 O
AM O

PLT O
COUNT O
- O
324 O

2016-03-22 O
02:45 O
AM O

PT O
- O
13.6 O
PTT O
- O
25.2 O
INR O
( O
PT O
)- O
1.2 O

2016-03-22 O
02:45 O
AM O

GLUCOSE O
- O
191 O
* O
UREA O
N O
- O
14 O
CREAT O
- O
0.6 O
SODIUM O
- O
141 O
POTASSIUM O
- O
3.5 O
CHLORIDE O
- O
101 O
TOTAL O
CO2 O
- O
28 O
ANION O
GAP O
- O
16 O

2016-03-22 O
02:45 O
AM O

CALCIUM O
- O
8.8 O
PHOSPHATE O
- O
4.4 O
MAGNESIUM O
- O
1.9 O

2016-03-22 O
11:25 O
AM O
URINE O

COLOR O
- O
Yellow O
APPEAR O
- O
Clear O
SP O
Barajas O
- O
1.020 O

2016-03-22 O
11:25 O
AM O
URINE O

BLOOD O
- O
LG O
NITRITE O
- O
NEG O
PROTEIN O
- O
NEG O
GLUCOSE O
- O
250 O
KETONE O
- O
NEG O
BILIRUBIN O
- O
NEG O
UROBILNGN O
- O
NEG O
PH O
- O
6.5 O

LEUK O
- O
NEG O

2016-03-22 O
11:25 O
AM O
URINE O

RBC O
- O
0-2 O
WBC O
- O
04-02 O
BACTERIA O
- O
OCC O
YEAST O
- O
NONE O
EPI O
- O
0 O

2016-03-22 O
11:25 O
AM O
URINE O

HYALINE O
- O
3 O
* O

2016-03-22 O
11:25 O
AM O

CK O
( O
CPK O
)- O
178 O
* O

2016-03-22 O
11:25 O
AM O

CK-MB O
- O
7 O

2016-03-22 O
04:45 O
PM O

D-DIMER O
- O
1748 O
* O

2016-03-22 O
04:45 O
PM O

CK O
( O
CPK O
)- O
153 O
* O

2016-03-22 O
04:45 O
PM O

CK-MB O
- O
5 O
cTropnT O
-< O
0.01 O

' O
00 O
TTE O
: O

EF O
50-55% O
; O
mild B-SYMPTOM
to I-SYMPTOM
moderate I-SYMPTOM
MR I-SYMPTOM
, O
left O
atrium O
is O
moderately B-SYMPTOM
dilated I-SYMPTOM
, O
trace B-SYMPTOM
AR I-SYMPTOM

10-02 O
: O

Cardiac O
catheterization O
: O
inferior B-SYMPTOM
, I-SYMPTOM
posterobasilar I-SYMPTOM
hypokinesis I-SYMPTOM
, O
1 B-SYMPTOM
+ I-SYMPTOM
MR I-SYMPTOM
, O
EF O
48% O
, O
mid O
RCA O
50% O
, O
distal O
RCA O
40% O
, O
mid O
LAD O
50% O
, O
OM3 B-SYMPTOM
diffusely I-SYMPTOM
diseased I-SYMPTOM
s/p O
stenting B-TREATMENT
of I-TREATMENT
RCA I-TREATMENT
with O
drug B-TREATMENT
eluting I-TREATMENT
stent I-TREATMENT
with O
10% O
residual O
flow O
. O

2016-03-22 O
CXR O
: O
moderate B-SYMPTOM
cardiomegaly I-SYMPTOM
without O
CHF B-SYMPTOM
, O
no O
effusions B-SYMPTOM
, O
left B-SYMPTOM
retrocardiac I-SYMPTOM
opacity I-SYMPTOM
consistent O
with O
atelectasis B-SYMPTOM
vs. O
consolidation B-SYMPTOM

2016-03-22 O
CT O
c-spine O
: O

1) O
No O
evidence O
of O
fracture B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
cervical I-SYMPTOM
spine I-SYMPTOM
. O

No O
definite B-SYMPTOM
fracture I-SYMPTOM
of I-SYMPTOM
C1 I-SYMPTOM
is O
identified O
to O
correlate O
with O
the O
history O
of O
questioned O
C1 B-SYMPTOM
fracture I-SYMPTOM
from O
outside O
hospital O
. O

2) O
Extensive B-SYMPTOM
degenerative I-SYMPTOM
change I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
cervical I-SYMPTOM
spine I-SYMPTOM
." O

2016-03-22 O
Femur O
& O
R O
knee O
X-ray O
: O

1) O
Comminuted B-SYMPTOM
intertrochanteric I-SYMPTOM
fracture I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
right I-SYMPTOM
femur I-SYMPTOM
, O
with O
avulsion B-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lesser I-SYMPTOM
trochanter I-SYMPTOM
, O
displacement B-SYMPTOM
and O
angulation B-SYMPTOM
. O

2) O
No O
other B-SYMPTOM
definite I-SYMPTOM
fractures I-SYMPTOM
identified. O
degenerative B-SYMPTOM
changes I-SYMPTOM
of I-SYMPTOM
the I-SYMPTOM
lumbosacral I-SYMPTOM
spine I-SYMPTOM
." O

2016-04-01 O
Flexion O
extension O
xrays O
of O
cervical O
spine O
: O

Mild O
degree O
of O
instability B-SYMPTOM
at I-SYMPTOM
level I-SYMPTOM
C3-C4 I-SYMPTOM
as O
described O
. O

Possibility O
of O
arch B-SYMPTOM
element I-SYMPTOM
in I-SYMPTOM
this I-SYMPTOM
region I-SYMPTOM
cannot O
be O
excluded O
. O

Brief O
Hospital O
Course O
: O

A/P O
: O

75 O
yo O
F O
s/p O
MIx4 B-SYMPTOM
, O
numerous O
cath O
, O
PAF B-SYMPTOM
, O
Inducible B-SYMPTOM
VTach I-SYMPTOM
s/p O
AICD B-TREATMENT
and O
pacer B-TREATMENT
with O
severe B-SYMPTOM
COPD I-SYMPTOM
/ O
restrictive B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
s/p O
fall O
with O
intertrochanteric B-SYMPTOM
fracture I-SYMPTOM
. O

As O
per O
CMED O
CCU O
, O
pt O
requires O
emergent B-TREATMENT
repair I-TREATMENT
of O
intertrochanteric B-SYMPTOM
fracture I-SYMPTOM
to O
preserve O
neurovascular O
function O
. O

Pt O
is O
a O
moderate O
risk O
for O
a B-TREATMENT
needed I-TREATMENT
emergent I-TREATMENT
non-cardiac I-TREATMENT
procedure I-TREATMENT
. O

Pt O
is O
medically O
cleared O
for O
procedure B-TREATMENT
, O
likely O
has O
some B-SYMPTOM
mile I-SYMPTOM
rate I-SYMPTOM
related I-SYMPTOM
ischemia I-SYMPTOM
. O

1. O
Cards O
: O

--- O
Pre-op B-TREATMENT
B-blocker I-TREATMENT
with O
goal O
HR O
< O
70 O

--- O
No O
real O
utility O
in O
MIBI B-TREATMENT
/ O
cath O
prior O
to O
procedure B-TREATMENT
gien O
previous O
caths O
with O
no O
significant B-SYMPTOM
lesions I-SYMPTOM
to O
be O
intervened O
on O
. O

--- O
V-Tach B-SYMPTOM
: O
pt O
has O
AICD B-TREATMENT
in O
place O
, O
however O
b-blocker B-TREATMENT
should O
contorl O
Vtach B-SYMPTOM
for O
now O
. O

--- O
B-blocker B-TREATMENT
IV I-TREATMENT
, O
Dilt B-TREATMENT
PRN O
for O
PAF B-SYMPTOM

--- O
Hold O
coumadin B-TREATMENT
for O
afib B-SYMPTOM
given O
hx O
of O
upper B-SYMPTOM
GIB I-SYMPTOM
and O
surgery B-TREATMENT
in O
AM O

--- O
Continue O
ASA B-TREATMENT
, O
plavix B-TREATMENT

--- O
ROMI B-SYMPTOM
, O
check O
AM O
ECG O

2. O
COPD B-SYMPTOM
/ O
Restrictive B-SYMPTOM
lung I-SYMPTOM
disease I-SYMPTOM
: O

--- O
Nebs B-TREATMENT
/ O
MDI B-TREATMENT
PRN O

--- O
no O
need O
for O
steroids B-TREATMENT
now O

--- O
expect O
prolonged B-SYMPTOM
wean I-SYMPTOM
given O
previous O
history O
of O
prolonged B-SYMPTOM
wean I-SYMPTOM
s/p O
colonic B-TREATMENT
resection I-TREATMENT

--- O
incentive B-TREATMENT
spirometry I-TREATMENT
for O
atelectasis B-SYMPTOM

3. O
Hip B-SYMPTOM
fracture I-SYMPTOM
: O

--- O
pain B-TREATMENT
control I-TREATMENT
with O
diluadid B-TREATMENT
, O
tylenol B-TREATMENT

--- O
lovenox B-TREATMENT
tonight O
x1 O
, O
hold O
AM O
dose O
per O
CMED O
CCU O

--- O
Pt O
to O
OR O
in O
early O
AM O

4. O
Anemia B-SYMPTOM
: O

--- O
iron O
studies O

--- O
TSH O

--- O
no O
need O
fortransfusion B-TREATMENT
currently O
, O
keep O
Hct O
> O
30 O

5. O
Hypokalemia B-SYMPTOM
: O

--- O
60IV B-TREATMENT
K I-TREATMENT
now O

--- O
continue O
PO B-TREATMENT
K I-TREATMENT

--- O
check O
lytes O
in O
PM O

6. O
Cellulitis B-SYMPTOM
: O

--- O
continue O
unasyn B-TREATMENT

--- O
hold O
off O
on O
X-rays O
for O
now O

7. O
DM B-SYMPTOM
: O

--- O
RISS B-TREATMENT
- O
tight O
glucose B-TREATMENT
control I-TREATMENT
pre-op O

8. O
PPx B-TREATMENT
: O

--- O
Protonix B-TREATMENT
, O
Lovenox B-TREATMENT
, O
R B-TREATMENT
boot I-TREATMENT
as O
per O
CMED O
CCU O

9. O
Diet O
: O

NPO B-TREATMENT

10. O
Code O
: O

Full O
--> O
DNR O
/ O
DNI O

CMED O
course O
: O

ORIF B-TREATMENT
with O
repair B-TREATMENT
of O
neck B-SYMPTOM
fracture I-SYMPTOM
2016-03-23 O
. O

Had O
expected O
prolonged B-SYMPTOM
post-op I-SYMPTOM
extubation I-SYMPTOM
in O
PACU O
given O
COPD B-SYMPTOM
history I-SYMPTOM
, O
as O
with O
colon B-TREATMENT
CA I-TREATMENT
resection I-TREATMENT
surgery I-TREATMENT
. O

In O
PM O
extubated O
, O
transferred O
to O
floor O
2016-03-23 O
. O

Late O
03-23 O
found O
with O
afib B-SYMPTOM
and O
RVR B-SYMPTOM
, O
given O
beta B-TREATMENT
blocker I-TREATMENT
with O
min. O
response O
, O
started O
dilt. B-TREATMENT
drip I-TREATMENT
. O

Received O
2 B-TREATMENT
mg I-TREATMENT
dilaudid I-TREATMENT
for O
pain B-SYMPTOM
o/n O
. O

On O
03-24 O
AM O
p/w O
with O
respiratory B-SYMPTOM
failure I-SYMPTOM
, O
continued B-SYMPTOM
tachycardia I-SYMPTOM
on O
dilt. B-TREATMENT
gtt. I-TREATMENT

Transferred O
to O
unit O
and O
urgently O
intubated O
. O

Of O
note O
, O
there O
was O
a O
question O
of O
misplaced B-SYMPTOM
NGT I-SYMPTOM
. O

When O
NGT B-TREATMENT
tube I-TREATMENT
was O
pulled O
out O
, O
it O
was O
noted O
to O
have O
respiratory-like O
secretions O
. O

Concern O
for O
aspiration B-SYMPTOM
of O
mediations B-TREATMENT
to O
lungs O
. O

However O
, O
evaluation O
of O
CXR O
revealed O
NGT B-SYMPTOM
coiled I-SYMPTOM
in I-SYMPTOM
esophagus I-SYMPTOM
. O

Pt B-SYMPTOM
's I-SYMPTOM
respiratory I-SYMPTOM
distress I-SYMPTOM
is O
most O
likely O
on O
setting O
of O
aspiration B-SYMPTOM
pneumonia I-SYMPTOM
vs. O
pneumonitis B-SYMPTOM
in O
the O
setting O
of O
depressed B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
secondary O
to O
post-operative B-TREATMENT
narcotics I-TREATMENT
. O

Pt O
was O
pan-cultured O
and O
switched O
from O
unasyn B-TREATMENT
( O
started O
at O
OSH O
for O
foot B-SYMPTOM
ulcer I-SYMPTOM
) O
to O
zosyn B-TREATMENT
. O

Vanco B-TREATMENT
was O
added O
for O
possible O
nosocomial B-SYMPTOM
infection I-SYMPTOM
. O

CTA O
was O
performed O
which O
was O
negative O
for O
PE B-SYMPTOM
, O
but O
revealed O
bilateral B-SYMPTOM
patchy I-SYMPTOM
ground I-SYMPTOM
glass I-SYMPTOM
opacities I-SYMPTOM
c/w O
aspiration B-SYMPTOM
vs. O
pneumonia B-SYMPTOM
vs. O
edema B-SYMPTOM
. O

Pt O
was O
weaned O
down O
on O
ventilator B-TREATMENT
, O
minimal B-SYMPTOM
secretions I-SYMPTOM
noted O
. O

On O
03-27 O
, O
pt O
was O
noted O
to O
have O
depressed B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
off O
all B-TREATMENT
sedating I-TREATMENT
medications I-TREATMENT
; O
mental O
status O
improved O
over O
the O
course O
of O
the O
day O
. O

Pt O
was O
diuresed O
. O

Atrial B-SYMPTOM
fibrillation I-SYMPTOM
was O
rate-controlled O
on O
dilt B-TREATMENT
drip I-TREATMENT
. O

Dilt B-TREATMENT
drip I-TREATMENT
was O
discontinued O
and O
metoprolol B-TREATMENT
titrated O
up O
. O

Cardiac O
enzymes O
were O
cycled O
in O
setting O
of O
rapid B-SYMPTOM
AF I-SYMPTOM
and O
were O
flat O
. O

Initially O
, O
pt O
was O
noted O
to O
be O
dry B-SYMPTOM
with O
low B-SYMPTOM
FeNa I-SYMPTOM
and O
given O
IVF B-TREATMENT
. O

Then O
, O
noted O
to O
be O
volume B-SYMPTOM
overloaded I-SYMPTOM
and O
diuresed O
with O
lasix B-TREATMENT
. O

Pt O
had O
depressed B-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
on O
transfer O
to O
CMED O
in O
setting O
of O
narcotics B-TREATMENT
. O

She O
was O
then O
started O
on O
propofol B-TREATMENT
while O
intubated B-TREATMENT
. O

Head O
CT O
was O
negative O
for O
acute B-SYMPTOM
bleed I-SYMPTOM
, O
mass B-SYMPTOM
effect I-SYMPTOM
, O
or O
stroke B-SYMPTOM
. O

Mental O
status O
improved O
during O
times O
when O
propofol B-TREATMENT
was O
held O
. O

On O
03-27 O
, O
pt O
was O
noted O
to O
have O
significantly B-SYMPTOM
depressed I-SYMPTOM
M.S. I-SYMPTOM
off O
propol B-TREATMENT
improved O
off O
sedation B-TREATMENT
. O

All B-TREATMENT
sedating I-TREATMENT
medications I-TREATMENT
including O
prn B-TREATMENT
narcotics I-TREATMENT
were O
held O
and O
mental O
status O
cleared O
somewhat O
. O

s/p O
hip B-TREATMENT
fx I-TREATMENT
repair I-TREATMENT
: O
started O
on O
lovenox B-TREATMENT
for O
anti-coagulation B-TREATMENT
. O

Given O
standing B-TREATMENT
NSAID I-TREATMENT
, O
tylenol B-TREATMENT
for O
pain B-TREATMENT
control I-TREATMENT
. O

opiates B-TREATMENT
used O
very O
sparingly O
in O
setting O
of O
MS B-SYMPTOM
change I-SYMPTOM

On O
transfer O
to O
floor O
team O
from O
CMED O
active O
issues O
and O
plan O
included O
: O

Resp B-SYMPTOM
failure I-SYMPTOM
/ O
COPD B-SYMPTOM
: O

Initially O
got O
steroids B-TREATMENT
upon O
intubation B-TREATMENT
. O

Off O
for O
days O
now O
. O

Extubated O
on O
03-31 O
. O

Still O
tachypneic B-SYMPTOM
and O
hypoxic B-SYMPTOM
on O
room O
air O
. O

Lung O
sounds O
fairly O
clear O
. O

? O
COPD B-SYMPTOM
vs O
atelectasis B-SYMPTOM
as O
cause O
of O
hypoxia B-SYMPTOM
. O

On O
Blake O
, O
Nancy O
pe O
less O
likely O

- O
atrovent B-TREATMENT
standing O
. O

prn O
albuterol B-TREATMENT
only O
given O
A B-SYMPTOM
fib I-SYMPTOM
with O
RVR B-SYMPTOM

- O
inhaled B-TREATMENT
steroids I-TREATMENT

- O
obtaining O
pcp O
set O
of O
Reginald O

Fever B-SYMPTOM
: O

In O
the O
ICU O
. O

Had O
received O
unasyn B-TREATMENT
, O
vanc B-TREATMENT
, O
zosyn B-TREATMENT
during O
hospital O
course O
for O
cellulitis B-SYMPTOM
and O
other O
unclear O
reasons O
, O
including O
possible O
vent B-SYMPTOM
associated I-SYMPTOM
pna I-SYMPTOM
. O

No O
true O
source O
found O
. O

Afebrile B-SYMPTOM
> O
24 O
hours O
off O
abx B-TREATMENT
. O

- O
culture O
if O
spikes O
. O

No O
abx B-TREATMENT
unless O
source O
found O

a.fib B-SYMPTOM
with O
RVR B-SYMPTOM
- O
Has O
ppm B-TREATMENT
, O
so O
can O
have O
lot O
of O
nodal B-TREATMENT
agents I-TREATMENT
. O

Now O
rate O
controlled O
on O
metop B-TREATMENT
125 O
tid O
and O
dilt B-TREATMENT
. O

30 O
QID O
. O

Titrate O
prn O
. O

- O
continue O
nodal B-TREATMENT
agents I-TREATMENT

- O
consider O
anti B-TREATMENT
coag I-TREATMENT
for O
cva B-TREATMENT
prevention I-TREATMENT
, O
but O
wait O
until O
ambulating O
better O

CAD B-SYMPTOM
: O
on O
asa B-TREATMENT
, O
b B-TREATMENT
blocker I-TREATMENT
, O
ace B-TREATMENT
. O

No O
statin B-TREATMENT
. O

need O
to O
clear O
with O
family O

Heme O
- O
anemic B-SYMPTOM
. O

Unclear O
baseline O
. O

Possible O
anemia B-SYMPTOM
03-02 O
operative B-SYMPTOM
blood I-SYMPTOM
loss I-SYMPTOM
. O

Follow O
hct O
daily O
Goal O
> O
28 O

Neck O
: O
never O
had O
c O
spine O
cleared O
by O
neurosurg O
. O

Had O
fall O
pta O
with O
? O
fx B-SYMPTOM
on O
initial O
CT O
, O
neg O
fx B-SYMPTOM
on O
f/u O
ct O
. O

- O
flex O
/ O
ext O
films O
done O

- O
will O
clear O
with O
neursurg O
prior O
to O
removing O
hard B-TREATMENT
collar I-TREATMENT

Overnight O
on O
pt O
's O
first O
evening O
on O
the O
floor O
, O
she O
had O
episode O
of O
desaturation B-SYMPTOM
with O
inc B-SYMPTOM
O2 I-SYMPTOM
requirement I-SYMPTOM
( O
4L O
-> O
6L O
-> O
sating O
91% O
on O
NRB B-TREATMENT
) O
- O
CXR O
with O
worsening B-SYMPTOM
- O
non O
responsive O
to O
lasix B-TREATMENT
. O

Family O
meeting O
held O
and O
pt O
made O
clear O
wishes O
after O
extubation B-TREATMENT
that O
she O
does O
not O
want O
to O
be O
intubated O
again O
and O
made O
DNR B-TREATMENT
/ O
DNI B-TREATMENT
. O

No O
BIPAP B-TREATMENT
. O

Now O
pt O
lethargic B-SYMPTOM
and O
min B-SYMPTOM
responsive I-SYMPTOM
. O

All O
four O
children O
in O
pts O
room O
and O
agree O
on O
CMO B-TREATMENT
- O
want O
to O
d/c O
c-collar B-TREATMENT
and O
start O
morphine B-TREATMENT
ggt I-TREATMENT
. O

Discussed O
with O
night O
float O
cover O
Dr. O
Dennis O
COmmander O
and O
Dr. O
Mike O
French O
. O

Although O
Dr. O
Ray O
will O
be O
covering O
pt O
today O
, O
Dr. O
Stephanie O
Wilson O
spoke O
with O
family O
this O
morning O
and O
has O
noted O
that O
pt O
is O
CMO B-TREATMENT
. O

EP O
was O
called O
to O
deactivate O
pt O
dual B-TREATMENT
chamber I-TREATMENT
ICD I-TREATMENT
as O
per O
family O
wishes O
. O

On O
exam O
, O
pt O
lethargic B-SYMPTOM
, O
responsive O
to O
pain B-SYMPTOM
but O
not O
voice O
, O
with O
NRB B-TREATMENT
in O
place O
; O
obvious B-SYMPTOM
inc I-SYMPTOM
wob I-SYMPTOM
. O

IV B-TREATMENT
in I-TREATMENT
R I-TREATMENT
foot I-TREATMENT
for O
access O
. O

Family O
at O
bedside O
. O

afebrile B-SYMPTOM
; O

BP O
: O
159-161-139-98 O
( O
after O
morphine B-TREATMENT
)/ O
69 O
HR O
: O
148 O
--> O
88 O
; O
rr O
: O
28-40 O
O2 O
: O
94% O
NRB B-TREATMENT

As O
above O
, O
made O
CMO B-TREATMENT
after O
meeting O
with O
NF O
team O
and O
family O
and O
reconfirmed O
with O
primary O
medical O
team O
on O
04-02 O
. O

Start O
morphine B-TREATMENT
ggt I-TREATMENT
and O
titrate O
to O
comfort O
. O

D/c O
'ed O
all O
lab O
draws O
/ O
vitals O
. O

Prn B-TREATMENT
nebs I-TREATMENT
for O
comfort O
. O

Family O
at O
bedside O
and O
aware O
and O
in O
agreement O
of O
plan O
. O

Morhpine B-TREATMENT
ggt I-TREATMENT
titrated O
up O
to O
18 O
mg O
/ O
hr O
by O
monday O
morning O
and O
pt O
expired O
04-04 O
at O
7:40 O
am O
. O

Medications O
on O
Admission O
: O

MEDICATION O
: O

1. O
Coumadin B-TREATMENT
2 O
mg O
once O
daily O
( O
stopped O
recently O
due O
to O
risk O
of O
GI B-SYMPTOM
bleed I-SYMPTOM
) O

2. O
Zoloft B-TREATMENT
100 O
mg O
once O
daily O

3. O
Toprol B-TREATMENT
100 O
mg O
BID O

4. O
Lasix B-TREATMENT
40 O
mg O
BID O

5. O
AS B-TREATMENT
81 O
mg O
once O
daily O

6. O
Plavix B-TREATMENT
75 O
mg O
once O
daily O

7. O
KCl B-TREATMENT
40 O
mEq O
once O
daily O

8. O
Prandin B-TREATMENT
0.5 O
mg O
once O
daily O

9. O
Unasyn B-TREATMENT
3 O
gIV O
Q8hours O

ALLERGIES O
: O

Morphine B-TREATMENT
-> O
confusion B-SYMPTOM
/ O
delerium B-SYMPTOM
. O

Discharge O
Disposition O
: O

Expired O

Discharge O
Diagnosis O
: O
n/a O

Discharge O
Condition O
: O
n/a O

Discharge O
Instructions O
: O
n/a O

Followup O
Instructions O
: O
n/a O

Ruby O
Eric O
MD O
73-490 O

Completed O
by O
: O
Verna O
Richard O
MD O
01-822 O
2016-04-04 O
@ O
2005 O

Signed O
electronically O
by O
: O
DR. O
Brandon O
Mangum O
on O
: O
WED O
2016-04-13 O
3:17 O
PM O

( O
End O
of O
Report O
) O

570922581 O

CTMC O

93618376 O

016906 O

1/11/1996 O
12:00:00 O
AM O

Discharge O
Summary O

Signed O

DIS O

Admission O
Date O
: O

01/11/1996 O

Report O
Status O
: O

Signed O

Discharge O
Date O
: O

01/19/1996 O

IDENTIFICATION O
: O

Ms. O
Less O
was O
initially O
admitted O
to O
the O
Vascular O
Surgery O
Service O
for O
Dr. O
Scosthuang O
and O
was O
recently O
transferred O
to O
the O
Neurosurgery O
Service O
under O
the O
care O
of O
Dr. O
Pae O
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

Ms. O
Less O
is O
a O
79 O
year O
old O
white O
female O
with O
history O
of O
non B-SYMPTOM
small I-SYMPTOM
cell I-SYMPTOM
lung I-SYMPTOM
cancer I-SYMPTOM
diagnosed O
in O
02/95 O
. O

She O
underwent O
a B-TREATMENT
resection I-TREATMENT
for O
stage B-SYMPTOM
I I-SYMPTOM
in O
10/95 O
and O
treated O
with O
XRT B-TREATMENT
. O

She O
presented O
to O
the O
hospital O
with O
a B-SYMPTOM
numb I-SYMPTOM
right I-SYMPTOM
leg I-SYMPTOM
this O
morning O
and O
underwent O
an B-TREATMENT
emergent I-TREATMENT
embolectomy I-TREATMENT
. O

PAST O
MEDICAL O
HISTORY O
: O

Coronary B-SYMPTOM
artery I-SYMPTOM
disease I-SYMPTOM
status O
post O
myocardial B-SYMPTOM
infarction I-SYMPTOM
in O
1990 O
, O
peptic B-SYMPTOM
ulcer I-SYMPTOM
disease I-SYMPTOM
and O
hypertension B-SYMPTOM
. O

MEDICATIONS O
: O

Medications B-TREATMENT
on I-TREATMENT
admission I-TREATMENT
were O
Coumadin B-TREATMENT
, O
Digoxin B-TREATMENT
Synthroid B-TREATMENT
, O
Lopressor B-TREATMENT
and O
Zantac B-TREATMENT
. O

On O
1/14/96 O
, O
she O
had O
a B-TREATMENT
dialysis I-TREATMENT
catheter I-TREATMENT
. O

On O
1/18/96 O
, O
she O
had O
an B-SYMPTOM
acute I-SYMPTOM
change I-SYMPTOM
in I-SYMPTOM
mental I-SYMPTOM
status I-SYMPTOM
and O
underwent O
an O
emergent O
head O
CT O
scan O
which O
showed O
a B-SYMPTOM
massive I-SYMPTOM
subarachnoid I-SYMPTOM
hemorrhage I-SYMPTOM
with O
bleeding B-SYMPTOM
in I-SYMPTOM
the I-SYMPTOM
subarachnoid I-SYMPTOM
space I-SYMPTOM
, O
and O
throughout O
the O
ventricles O
. O

She O
also O
had O
significant B-SYMPTOM
hydrocephalus I-SYMPTOM
. O

Follow O
up O
CT O
scan O
showed O
worsening O
of O
her B-SYMPTOM
hydrocephalus I-SYMPTOM
and O
she O
had O
a B-TREATMENT
ventriculostomy I-TREATMENT
placed O
in O
the O
Intensive O
Care O
Unit O
. O

She O
failed O
to O
improve O
following O
placement O
of O
the B-TREATMENT
ventriculostomy I-TREATMENT
and O
her O
poor O
prognosis O
was O
discussed O
with O
the O
family O
. O

The O
family O
at O
that O
point O
considering O
the O
multiple O
system O
involvement O
of O
her B-SYMPTOM
diseases I-SYMPTOM
, O
decided O
to O
make O
the O
patient O
DNR B-TREATMENT
and O
withdraw O
care B-TREATMENT
. O

The O
patient O
expired O
on O
1/19/96 O
at O
11:35 O
p.m. O

The O
medical O
examiner O
was O
called O
and O
the O
case O
was O
discussed O
, O
and O
he O
declined O
autopsy O
of O
the O
case O
. O

The O
family O
was O
informed O
and O
all O
questions O
were O
answered O
. O

Dictated O
By O
: O

RORIEZAILA O
FERNE O
KOTEKAYSKOTEKAYSCOA O
, O
M.D. O
AV9 O

Attending O
: O

NAREA O
L. O
RUDESTHIR O
, O
M.D. O
XS62 O
RS286/0162 O

Batch O
: O

2998 O

Index O
No. O
WLDOVN4PV4 O

D O
: O

01/19/96 O

T O
: O

01/19/96 O

704319103 O
PUMC O

6340505 O

274938 O

7752547 O

10/14/2004 O
12:00:00 O
AM O

ED O
Discharge O
Summary O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ED O
DISCHARGE O
NOTIFICATION O
/ O
SUMMARY O

A O
, O
MIFER O

MRN O
: O

6340505 O

Age O
: O

41y O

REGISTRATION O
DATE O
: O

10/14/2004 O
03:51 O
PM O

Provider O
: O

KOTEJESCZUK O
, O
M.D. O
STOCKADALELEEFNATHE O

PRELIMINARY O
REPORT O

PCP O
notified O
by O
MD O
: O

E-mail O
PCP O

Benefits O
Assigned O
: O

Y O

Discharge O
Date O
/ O
Time O
: O

10/14/2004 O
21:17 O

Discharge O
Status O
: O

Discharged O

Condition O
on O
Discharge O
: O

Stable O

Patient O
States O
Complaint O
: O

CP B-SYMPTOM
Standardized I-SYMPTOM

Discharge O
Instructions O
: O

The O
patient O
was O
given O
printed O
instructions O
for O
chest B-SYMPTOM
pain I-SYMPTOM
( O
English O
) O
. O

Diagnosis O
: O

lt B-SYMPTOM
arm/ I-SYMPTOM
chest I-SYMPTOM
pain I-SYMPTOM

Treatment O
Rendered O
: O

ekg O
= O
normal O
, O
cxr O
normal O
, O
ddimer O
/ O
cardiac O
enzymes O
negative O

Discharge O
Medications O
: O

ibuprofen B-TREATMENT
as O
needed O

Follow O
up O
Service O
: O

call O
dr O
koorskote O
&apos;s O
office O
tomorrow O

PCP O
Name O
: O

KOORSKOTE O
, O
SHARA O
G O

Provider O
Number O
: O

00708 O

This O
report O
was O
created O
by O
STOCKADALELEEFNATHE O
, O
LISHE O
, O
M.D. O
10/14/2004 O
09:35 O
PM O

573620996 O

FIH O

7728564 O

87294/8g15 O

879796 O

6/26/1994 O
12:00:00 O
AM O

MIXED B-SYMPTOM
MESODERMAL I-SYMPTOM
CANCER I-SYMPTOM
. O

Unsigned O

DIS O

Report O
Status O
: O

Unsigned O

ADMISSION O
DATE O
: O

06/26/94 O

DISCHARGE O
DATE O
: O

06/30/94 O

PRINCIPAL O
DIAGNOSIS O
: O

mixed B-SYMPTOM
mesodermal I-SYMPTOM
cancer I-SYMPTOM
. O

ASSOCIATED O
DIAGNOSIS O
: O

( O
1 O
) O
status O
post O
hysterectomy B-TREATMENT
and O
bilateral B-TREATMENT
oophorectomy I-TREATMENT
. O

( O
2 O
) O
abdominal B-SYMPTOM
wall I-SYMPTOM
hernia I-SYMPTOM
. O

( O
3 O
) O
hypertension B-SYMPTOM
. O

PRINCIPAL O
PROCEDURE O
: O

On O
June O
26 O
, O
1994 O
tumor B-TREATMENT
debulking I-TREATMENT
, O
pelvic B-TREATMENT
lymph I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
, O
lysis B-TREATMENT
of O
adhesions B-SYMPTOM
, O
abdominal B-TREATMENT
wall I-TREATMENT
hernia I-TREATMENT
repair I-TREATMENT
. O

HISTORY O
OF O
PRESENT O
ILLNESS O
: O

The O
patient O
is O
an O
81 O
year O
old O
female O
, O
G2 O
, O
P2 O
, O
who O
status O
post O
total B-TREATMENT
abdominal I-TREATMENT
hysterectomy-bilateral I-TREATMENT
salpingo-oophorectomy I-TREATMENT
one O
years O
ago O
for O
a B-SYMPTOM
mixed I-SYMPTOM
mesodermal I-SYMPTOM
cancer I-SYMPTOM
who O
presents O
with O
vaginal B-SYMPTOM
apex I-SYMPTOM
recurrence I-SYMPTOM
. O

She O
had O
a O
normal O
pelvic O
examination O
and O
CT O
scan O
in O
February O
of O
1993 O
but O
one O
month O
prior O
to O
this O
admission O
starting O
bleeding B-SYMPTOM
per I-SYMPTOM
vagina I-SYMPTOM
. O

An O
examination O
revealed O
an B-SYMPTOM
apicovaginal I-SYMPTOM
lesion I-SYMPTOM
consistent O
with O
recurrent B-SYMPTOM
tumor I-SYMPTOM
. O

A O
computerized O
tomography O
scan O
was O
performed O
which O
showed O
a B-SYMPTOM
central I-SYMPTOM
recurrence I-SYMPTOM
and O
biopsy O
of O
this B-SYMPTOM
lesion I-SYMPTOM
was O
positive O
. O

She O
presents O
now O
for O
excision B-TREATMENT
of O
her B-SYMPTOM
local I-SYMPTOM
cancer I-SYMPTOM
recurrence I-SYMPTOM
. O

PAST O
MEDICAL O
HISTORY O
: O

Is O
as O
above O
. O

MEDICATIONS O
ON O
ADMISSION O
: O

Halcion B-TREATMENT
0.25 O
mg. O
P.O. O
q.h.s. O
, O

Valium B-TREATMENT
5 O
mg. O
P.O. O
p.r.n O
and O
methyclothiazide B-TREATMENT
5 O
mg. O
q.d. O

ALLERGIES O
: O

No O
known B-SYMPTOM
drug I-SYMPTOM
allergies I-SYMPTOM
. O

PHYSICAL O
EXAMINATION O
: O

Her O
temperature O
is O
97.9 O
, O
blood O
pressure O
160/80 O
, O
heart O
rate O
92 O
, O
her O
HEENT O
examination O
reveals O
anicteric B-SYMPTOM
sclerae I-SYMPTOM
and O
her O
left O
eye O
has O
slightly B-SYMPTOM
relaxed I-SYMPTOM
inferoorbital I-SYMPTOM
wall I-SYMPTOM
. O

Her O
chest O
is O
clear O
to O
auscultation O
. O

Her O
heart O
has O
regular O
rate O
and O
rhythm O
with O
I B-SYMPTOM
/ I-SYMPTOM
VI I-SYMPTOM
systolic I-SYMPTOM
ejection I-SYMPTOM
murmur I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
base I-SYMPTOM
. O

Abdomen O
is O
obese B-SYMPTOM
, O
soft O
, O
non-tender B-SYMPTOM
, O
and O
without O
palpable B-SYMPTOM
masses I-SYMPTOM
. O

Extremities O
two O
plus O
pulses O
bilaterally O
and O
nonpitting B-SYMPTOM
edema I-SYMPTOM
up I-SYMPTOM
to I-SYMPTOM
the I-SYMPTOM
knees I-SYMPTOM
in O
both O
legs O
. O

Neurologic O
examination O
: O

is O
unremarkable O
. O

LABORATORY O
DATA O
: O

sodium O
142 O
, O
potassium O
3.3 O
, O
chloride O
98 O
, O
bicarbonate O
34 O
, O
BUN O
and O
creatinine O
14/0.9 O
. O

Her O
alkaline O
phosphatase O
is O
77 O
, O
white O
blood O
count O
12.5 O
, O
hematocrit O
42.6 O
, O
platelet O
count O
268 O
. O

IN O
SUMMARY O
: O

This O
is O
a O
patient O
with O
recurrence O
of O
a B-SYMPTOM
mixed I-SYMPTOM
mesodermal I-SYMPTOM
cancer I-SYMPTOM
at I-SYMPTOM
the I-SYMPTOM
vaginal I-SYMPTOM
apex I-SYMPTOM
who O
presents O
for O
local B-TREATMENT
excision I-TREATMENT
. O

HOSPITAL O
COURSE O
: O

The O
patient O
was O
admitted O
to O
the O
GYN O
/ O
Oncology O
Service O
under O
the O
care O
of O
Dr. O
Top O
on O
June O
26 O
, O
1994 O
. O

On O
that O
day O
she O
was O
taken O
to O
the O
operating O
room O
where O
she O
underwent O
an O
exam O
under O
anesthesia B-TREATMENT
, O
an O
exploratory O
laparotomy O
with O
lysis B-TREATMENT
of O
adhesions B-SYMPTOM
, O
tumor B-TREATMENT
debulking I-TREATMENT
and O
bilateral B-TREATMENT
pelvic I-TREATMENT
lymph I-TREATMENT
node I-TREATMENT
dissection I-TREATMENT
. O

An B-SYMPTOM
abdominal I-SYMPTOM
wall I-SYMPTOM
hernia I-SYMPTOM
was O
also O
repaired O
. O

The O
patient O
tolerated O
the B-TREATMENT
procedure I-TREATMENT
well O
without O
any B-SYMPTOM
complications I-SYMPTOM
. O

Her O
postoperative O
course O
was O
unremarkable O
. O

Her B-TREATMENT
vaginal I-TREATMENT
pack I-TREATMENT
was O
removed O
on O
the O
second O
postoperative O
day O
as O
well O
as O
the B-TREATMENT
Foley I-TREATMENT
catheter I-TREATMENT
. O

By O
postoperative O
day O
three O
she O
had O
return O
of O
normal O
bowel O
function O
and O
was O
able O
to O
tolerate O
a O
regular O
diet O
without O
any B-SYMPTOM
difficulty I-SYMPTOM
. O

Her B-TREATMENT
Jackson-Pratt I-TREATMENT
drain I-TREATMENT
was O
removed O
on O
June O
30 O
, O
1994 O
, O
postoperative O
day O
four O
. O

On O
that O
day O
she O
was O
feeling O
well O
enough O
, O
eating O
well O
, O
and O
voiding O
without O
difficulty B-SYMPTOM
. O

As O
a O
result O
she O
was O
able O
to O
be O
discharged O
home O
on O
June O
30 O
, O
1994 O
. O

FOLLOW-UP O
: O

She O
will O
follow O
up O
with O
Dr. O
Top O
in O
his O
office O
. O

MEDICATIONS O
ON O
DISCHARGE O
: O

Her B-TREATMENT
only I-TREATMENT
additional I-TREATMENT
medication I-TREATMENT
on O
discharge O
is O
Percocet B-TREATMENT
as O
needed O
for O
pain B-SYMPTOM
. O

In O
addition O
Dr. O
Blincarour O
from O
Radiation O
Oncology O
saw O
the O
patient O
and O
recommended O
pelvic B-TREATMENT
radiation I-TREATMENT
therapy I-TREATMENT
. O

She O
wishes O
to O
get O
her B-TREATMENT
radiation I-TREATMENT
in O
O O
and O
has O
spoken O
to O
her O
primary O
care O
physician O
regarding O
this O
. O

Of O
note O
the O
pelvic O
lymph O
nodes O
which O
were O
dissected O
were O
positive O
for O
tumor B-SYMPTOM
by O
frozen O
section O
analysis O
. O

The O
permanent O
pathology O
sections O
are O
still O
pending O
. O

DOLL O
GRENDBLY O
, O
M.D. O

DICTATING O
FOR O
: O

SLAINEAEE O
S. O
NIET O
TOP O
, O
M.D. O

TR O
: O

egi O
/ O
bmot O

DD O
: O

06/30/94 O

TD O
: O

07/01/94 O

CC O
: O

Dr. O
Top O
Dr. O
Grendbly O

